{"meta":{"query_hash":"d5e6cd8faae5","filters":{"topic":"Cancer Treatment and Pharmacology"},"cohort_total":1351,"direct_labels_cover":6,"predictions_cover":1351,"exported":1351,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/d5e6cd8faae5","api":"https://metacan.xera.ac/api/v1/cohort?topic=Cancer+Treatment+and+Pharmacology"},"results":[{"id":"W10896107","doi":"10.1016/s0968-0896(00)00056-0","title":"转变教育理念 端正教育导向 改变教育模式——从十八大报告中感悟教育制度改革心得体会","year":2012,"lang":"en","type":"article","venue":"课外阅读：中下","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.03841844524240467,"score_gpt":0.3888931238744794,"score_spread":0.3504746786320747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W10896107","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8110121,0.013812478,0.053855,0.0008491526,0.00054397125,0.0003091611,0.0008281383,0.00037181523,0.11841812],"genre_scores_gemma":[0.9751106,0.00268298,0.009878645,0.000088921915,0.000029754448,0.00002647804,0.00033143745,0.000036971152,0.011814149],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999461,0.000007874121,0.0000027191174,0.000013597375,0.00001498324,0.000014616012],"domain_scores_gemma":[0.9999646,0.0000054693883,0.000011091478,0.0000057700095,0.0000057910124,0.0000072917915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000073768046,0.00021629254,0.00009116697,0.00018591422,0.0002650028,0.00024831295,0.0001546312,0.00015651857,0.0029994822],"category_scores_gemma":[0.00008780198,0.00009313483,0.00018524271,0.00016914814,0.0002781365,0.00027700726,0.0002431721,0.0004512403,0.0011309787],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015248907,0.000047253914,0.00055005826,0.00015521854,0.000017739509,0.00035617288,0.00008252263,0.00050701376,0.9614075,0.009266071,0.0004897125,0.026968215],"study_design_scores_gemma":[0.000011807431,0.0002177205,0.00079170184,0.00000987799,0.000011339123,0.00054273906,0.00004465152,0.00043452118,0.9678675,0.0011052985,0.028953543,0.00000939385],"about_ca_topic_score_codex":0.0011092754,"about_ca_topic_score_gemma":0.0017755996,"teacher_disagreement_score":0.0029994822,"about_ca_system_score_codex":0.00046826465,"about_ca_system_score_gemma":0.00039374878,"threshold_uncertainty_score":0.010034263},"labels":[],"label_agreement":null},{"id":"W1120767843","doi":"","title":"Visudyne Anti-VEGF Combination Therapy (VACT): A Multicentred, Retrospective Clinical Practice Review of Combination Therapy in AMD","year":2007,"lang":"en","type":"article","venue":"Investigative Ophthalmology & Visual Science","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Combination therapy; VEGF receptors; Ophthalmology; Internal medicine","score_opus":0.07950657732233785,"score_gpt":0.47712645754696337,"score_spread":0.3976198802246255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1120767843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71949226,0.27535927,0.0008356532,0.0003794177,0.00006971748,0.00022909962,0.00079470675,0.000023976767,0.002815898],"genre_scores_gemma":[0.9385672,0.05825952,0.0015526307,0.00046436727,0.00010653681,0.00010585936,0.00061254523,0.00001854497,0.00031270145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99247,0.003126357,0.0021821223,0.00091551925,0.0011514822,0.00015441435],"domain_scores_gemma":[0.9758232,0.011244569,0.009657355,0.0007476135,0.0021336407,0.00039347896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046770363,0.0002950263,0.0020450845,0.0025310065,0.00049112394,0.0012952375,0.00053464907,0.00079072296,0.0012397352],"category_scores_gemma":[0.016321063,0.00044052125,0.0010002767,0.0051267464,0.0005804454,0.00077773386,0.00043314914,0.00041047117,0.00029264652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074501857,0.00039440166,0.776902,0.0057920543,0.002854973,0.0018138818,0.0007865086,0.0002341128,0.004767412,0.00016877249,0.0011681987,0.19766752],"study_design_scores_gemma":[0.0014688984,0.009089233,0.94149154,0.0019032229,0.008688899,0.021835245,0.00085907703,0.0005189717,0.0026316075,0.00011306152,0.011293588,0.00010671303],"about_ca_topic_score_codex":0.0014877114,"about_ca_topic_score_gemma":0.0029549778,"teacher_disagreement_score":0.0046770363,"about_ca_system_score_codex":0.00097333,"about_ca_system_score_gemma":0.0017170813,"threshold_uncertainty_score":0.024734855},"labels":[],"label_agreement":null},{"id":"W1159765411","doi":"10.1007/s00520-015-2873-8","title":"Randomized study of sequential cisplatin-topotecan/carboplatin-paclitaxel versus carboplatin-paclitaxel: effects on quality of life","year":2015,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Carboplatin; Topotecan; Nausea; Quality of life (healthcare); Internal medicine; Debulking; Gynecologic oncology; Randomization; Ovarian cancer; Randomized controlled trial; Paclitaxel; Oncology; Vomiting; Chemotherapy; Cisplatin; Surgery; Cancer","score_opus":0.11104213079230227,"score_gpt":0.44755087150081274,"score_spread":0.33650874070851045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1159765411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899458,0.0026309316,0.00085619156,0.0006309221,0.0007511545,0.0022912535,0.0010749376,0.00011319407,0.001705577],"genre_scores_gemma":[0.9919103,0.0010910132,0.0014414305,0.00069284963,0.0005959895,0.0015975827,0.0008146723,0.000035425535,0.0018207883],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99795365,0.0010726023,0.00014528946,0.00041721118,0.0001244235,0.00028684555],"domain_scores_gemma":[0.9956434,0.0017006195,0.00073224946,0.00043934988,0.00023031278,0.0012542141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002723397,0.0019952755,0.006601804,0.0007653044,0.0006766649,0.0015461869,0.0018526386,0.0021044011,0.012026224],"category_scores_gemma":[0.0037130273,0.0012450543,0.0029577145,0.00092490664,0.002064285,0.0017805684,0.00075405417,0.005101495,0.0011994359],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99455017,0.002327293,0.00012634408,0.00006124558,0.00033960384,0.000007021086,0.000006052196,0.00011338745,0.0003205472,0.000027318165,0.00008918328,0.0020318774],"study_design_scores_gemma":[0.95879406,0.03934387,0.00065810804,0.000008999355,0.00053193327,0.000010341995,0.00000911894,0.0002823685,0.00015557595,0.00008297574,0.00011453525,0.000008082231],"about_ca_topic_score_codex":0.003105624,"about_ca_topic_score_gemma":0.0041474863,"teacher_disagreement_score":0.012026224,"about_ca_system_score_codex":0.0018197931,"about_ca_system_score_gemma":0.0024081327,"threshold_uncertainty_score":0.040231705},"labels":[],"label_agreement":null},{"id":"W1177680491","doi":"10.71781/12120","title":"Synthèse totale de la lépadine B : plate-forme pour la découverte de nouvelles tranformations chimiques","year":2009,"lang":"fr","type":"dissertation","venue":"Open MIND","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Université de Montréal; Fonds Québécois de la Recherche sur la Nature et les Technologies; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs","keywords":"Humanities; Physics; Art","score_opus":0.02108450600674212,"score_gpt":0.35985464413133206,"score_spread":0.33877013812458995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1177680491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8053882,0.03917398,0.0891342,0.0008627362,0.0008134767,0.0006612885,0.004303776,0.0010840534,0.058578312],"genre_scores_gemma":[0.8483755,0.019587714,0.062133845,0.0004071085,0.000055763496,0.0004906233,0.0021313757,0.0005101038,0.06630792],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996685,0.000042834843,0.000018942446,0.000088128414,0.00013992142,0.000041745006],"domain_scores_gemma":[0.9997713,0.00005930372,0.000033565255,0.000038466682,0.00006482639,0.000032540072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042968537,0.00058291754,0.00039290884,0.00048057383,0.0005965525,0.00065415684,0.00027525288,0.0005154904,0.0122489855],"category_scores_gemma":[0.0005514509,0.00033652052,0.00045673782,0.0005368428,0.00037857058,0.0008516334,0.0004693692,0.0014182397,0.0038290662],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001749145,0.000039030787,0.00019976721,0.0010419189,0.00002735262,0.00017332142,0.0002716031,0.00072106114,0.97452605,0.0014007734,0.0007185028,0.020705719],"study_design_scores_gemma":[0.000017802397,0.00051585585,0.00080473744,0.00008354194,0.000031194697,0.00033082877,0.00016605428,0.0006402791,0.9328067,0.00022939082,0.06433703,0.00003661118],"about_ca_topic_score_codex":0.0019745342,"about_ca_topic_score_gemma":0.0053854366,"teacher_disagreement_score":0.0122489855,"about_ca_system_score_codex":0.0005341654,"about_ca_system_score_gemma":0.0009870582,"threshold_uncertainty_score":0.04097694},"labels":[],"label_agreement":null},{"id":"W1185454313","doi":"","title":"The Visudyne Registry Database: Collecting Data from Patients Treated with Verteporfin Therapy for CNV due to AMD","year":2004,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"QLT (Canada)","funders":"","keywords":"Verteporfin; Medicine; Ophthalmology; Macular degeneration; Optometry; Choroidal neovascularization","score_opus":0.06628907457578062,"score_gpt":0.3649306742439641,"score_spread":0.2986415996681835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1185454313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5501321,0.0022451913,0.0016259716,0.00038352606,0.00007346052,0.00095762714,0.4388132,0.00024412228,0.005524764],"genre_scores_gemma":[0.50622445,0.0022459736,0.0052436935,0.00052449416,0.00011268414,0.002372961,0.48122504,0.00016009307,0.0018906466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977906,0.00038055537,0.0006808523,0.00048666602,0.00046430802,0.00019696276],"domain_scores_gemma":[0.9922381,0.0017547912,0.0036510176,0.0007959159,0.0010371718,0.0005230322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014427039,0.0004992718,0.0015349465,0.003973902,0.00048768832,0.0014467948,0.00095898233,0.0007259024,0.0037618594],"category_scores_gemma":[0.008406369,0.00058118283,0.00078704994,0.008171597,0.00025562986,0.00093312975,0.00091027934,0.0006249844,0.0012431176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017960634,0.00028442047,0.9361009,0.00067725603,0.00067124324,0.00054375135,0.00023484825,0.00055731426,0.001679292,0.00063240906,0.032681104,0.024141278],"study_design_scores_gemma":[0.0009785995,0.00025106137,0.96099293,0.00026596512,0.00069925183,0.0015251063,0.00030018037,0.0013423951,0.0017247669,0.00021487345,0.031644773,0.000060122362],"about_ca_topic_score_codex":0.026777774,"about_ca_topic_score_gemma":0.022886967,"teacher_disagreement_score":0.026777774,"about_ca_system_score_codex":0.0016099388,"about_ca_system_score_gemma":0.0037975588,"threshold_uncertainty_score":0.053243816},"labels":[],"label_agreement":null},{"id":"W1447575175","doi":"10.1007/s10549-015-3547-4","title":"Octreotide LAR and tamoxifen versus tamoxifen in phase III randomize early breast cancer trials: NCIC CTG MA.14 and NSABP B-29","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Sunnybrook Health Science Centre; University of Toronto; Jewish General Hospital; McGill University; Queen's University","funders":"National Cancer Institute; Canadian Cancer Society Research Institute","keywords":"Medicine; Internal medicine; Breast cancer; Tamoxifen; Hazard ratio; Cancer; Oncology; Gastroenterology; Gynecology; Confidence interval","score_opus":0.18917399873553203,"score_gpt":0.4822184187308608,"score_spread":0.29304441999532876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1447575175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9454319,0.032288827,0.0016870842,0.0067077857,0.0009439142,0.002973173,0.001937114,0.00028560648,0.00774464],"genre_scores_gemma":[0.9775892,0.0070708105,0.0022730634,0.0026337083,0.000539713,0.0023991282,0.0014838584,0.000060973493,0.0059495308],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99758494,0.0020302264,0.000076702956,0.000091558184,0.0000884737,0.00012806126],"domain_scores_gemma":[0.9971425,0.0015772141,0.00053230167,0.00013833551,0.00013371467,0.00047595275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00470554,0.0009129834,0.0018185144,0.00042896817,0.00026840196,0.000884474,0.00065482175,0.0012207237,0.006130554],"category_scores_gemma":[0.0054772897,0.0003253912,0.0015891993,0.00038411407,0.00059105986,0.0012119112,0.00044841715,0.002966372,0.0005466627],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94826156,0.001731255,0.00079226686,0.00054662424,0.0016376255,0.000038940292,0.00005091764,0.0010139096,0.0012006706,0.00042159786,0.0027773455,0.04152737],"study_design_scores_gemma":[0.9423705,0.04530152,0.0041812127,0.00020997056,0.0019104931,0.00006449339,0.000055827626,0.0017289827,0.00045529977,0.0008992902,0.0027913963,0.00003114045],"about_ca_topic_score_codex":0.0013432192,"about_ca_topic_score_gemma":0.006760107,"teacher_disagreement_score":0.006130554,"about_ca_system_score_codex":0.0008104082,"about_ca_system_score_gemma":0.0011704916,"threshold_uncertainty_score":0.024885535},"labels":[],"label_agreement":null},{"id":"W1480235848","doi":"10.1371/journal.pone.0133133","title":"Bevacizumab in Combination with Modified FOLFOX6 in Heavily Pretreated Patients with HER2/Neu-Negative Metastatic Breast Cancer: A Phase II Clinical Trial","year":2015,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Fudan University; National Natural Science Foundation of China","keywords":"Bevacizumab; Medicine; Regimen; Leukopenia; Internal medicine; Metastatic breast cancer; Neutropenia; Oxaliplatin; Adverse effect; Anemia; Phases of clinical research; Progression-free survival; Gastroenterology; Febrile neutropenia; Chemotherapy regimen; Oncology; Breast cancer; Chemotherapy; Surgery; Colorectal cancer; Cancer","score_opus":0.14130538864159053,"score_gpt":0.3873994333068337,"score_spread":0.24609404466524315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1480235848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937309,0.003004498,0.00026773245,0.0003355684,0.00010506063,0.0012687835,0.00028320283,0.00005025341,0.000953981],"genre_scores_gemma":[0.99167585,0.002682909,0.0009976056,0.00070950954,0.00022009031,0.0014238864,0.0010442819,0.000013517569,0.0012322951],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99978954,0.000095554075,0.000012016038,0.000034527748,0.000024004235,0.000044395263],"domain_scores_gemma":[0.999632,0.000045101388,0.00008231031,0.000021125938,0.000022099586,0.0001973718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009923285,0.0010299329,0.0015223498,0.0003081876,0.00027268106,0.0007483702,0.0006363113,0.0009154036,0.002198783],"category_scores_gemma":[0.00057223724,0.00041578143,0.0009248415,0.0003489291,0.0005170001,0.00047955706,0.00027738677,0.0016826206,0.00038699753],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8013103,0.048000477,0.00568942,0.0009618744,0.0020156186,0.00024112398,0.00018478469,0.002262401,0.028104339,0.00016770052,0.002876416,0.10818563],"study_design_scores_gemma":[0.7087939,0.27549848,0.009946821,0.00005273651,0.0005343329,0.00021217333,0.000029807268,0.0015812054,0.0013157048,0.000106744956,0.0019033366,0.000024851686],"about_ca_topic_score_codex":0.00096965407,"about_ca_topic_score_gemma":0.002843144,"teacher_disagreement_score":0.002198783,"about_ca_system_score_codex":0.0006770355,"about_ca_system_score_gemma":0.0009539075,"threshold_uncertainty_score":0.00735569},"labels":[],"label_agreement":null},{"id":"W1492054099","doi":"10.4049/jimmunol.192.supp.116.7","title":"Protein tyrosine kinase 7 promotes PI3K/AKT signaling and survival in primary and neoplastic CD4+ T-lineage cells. (HEM4P.231)","year":2014,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Protein kinase B; Cancer research; PI3K/AKT/mTOR pathway; Biology; Receptor tyrosine kinase; Tyrosine kinase; Cell biology; Jurkat cells; Cell growth; T cell; Kinase; Signal transduction; Immunology; Biochemistry","score_opus":0.01105942657080223,"score_gpt":0.250114114078076,"score_spread":0.23905468750727377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1492054099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945373,0.0011817006,0.0014187298,0.000111761234,0.000042994863,0.000027666883,0.00080045295,0.00010462405,0.0017746829],"genre_scores_gemma":[0.99106324,0.0006671445,0.0019136162,0.00005941982,0.00001237717,0.00007539422,0.001463635,0.000021674994,0.004723523],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998543,0.0000151164995,0.000012837175,0.00003144141,0.000038280086,0.0000479341],"domain_scores_gemma":[0.99994254,0.000008486842,0.000012490086,0.000005424828,0.000008287057,0.00002270993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009228322,0.00028201874,0.00019829534,0.00021896907,0.00017585253,0.00023863223,0.00015130415,0.0001904491,0.0022631267],"category_scores_gemma":[0.000059009002,0.00012113796,0.00018957962,0.00016823068,0.00017126084,0.00012824069,0.00013707778,0.00065619993,0.00074512593],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013504145,0.000044421366,0.00014459812,0.00003121567,0.000004306955,0.0000445613,0.0000069605485,0.00004288178,0.9987968,0.00006450247,0.000091814654,0.0005929314],"study_design_scores_gemma":[0.000028558688,0.00027987023,0.0036079297,0.0000036612896,0.00001300399,0.00019124373,0.000016179174,0.0009586895,0.99328434,0.00003338884,0.0015815331,0.0000016922246],"about_ca_topic_score_codex":0.00076280796,"about_ca_topic_score_gemma":0.0010373001,"teacher_disagreement_score":0.0022631267,"about_ca_system_score_codex":0.00037695092,"about_ca_system_score_gemma":0.00022662077,"threshold_uncertainty_score":0.0075709224},"labels":[],"label_agreement":null},{"id":"W1506197408","doi":"10.4212/cjhp.v54i1.619","title":"Concepts in Oncology Therapeutics","year":2001,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Medical physics","score_opus":0.05167590841878891,"score_gpt":0.40191812047487696,"score_spread":0.3502422120560881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1506197408","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026060448,0.115442894,0.05038467,0.15605545,0.019011054,0.00014420187,0.00014896062,0.00015858741,0.6560482],"genre_scores_gemma":[0.32146263,0.1425938,0.045916878,0.101495236,0.040300444,0.0011531629,0.00024687636,0.00027021303,0.3465608],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971271,0.0011850987,0.00014683077,0.00029218,0.001005644,0.00024324938],"domain_scores_gemma":[0.99752086,0.0010620599,0.00021853863,0.0002221004,0.0005797342,0.0003966333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048051784,0.0010974355,0.0009882621,0.003140345,0.004341811,0.006989967,0.0016482428,0.0037722618,0.008751921],"category_scores_gemma":[0.005129785,0.00032114342,0.00076223584,0.0023294184,0.029729143,0.0066093826,0.0035893281,0.008932976,0.0031746423],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000024402295,0.000007811729,0.000019522908,0.000041927276,0.0000018005793,0.000016270873,0.00036722465,0.000051188108,0.000020387395,0.979329,0.014232812,0.0059096552],"study_design_scores_gemma":[0.000010151197,0.000018378707,0.00009147454,0.00014242594,0.000005604879,0.00011061677,0.00024534136,0.00013975058,0.0000399005,0.6717347,0.3274546,0.0000070447577],"about_ca_topic_score_codex":0.010031753,"about_ca_topic_score_gemma":0.00921619,"teacher_disagreement_score":0.0119936345,"about_ca_system_score_codex":0.0119936345,"about_ca_system_score_gemma":0.010977874,"threshold_uncertainty_score":0.08702028},"labels":[],"label_agreement":null},{"id":"W1517956406","doi":"10.1016/j.ijpharm.2004.05.027","title":"Paclitaxel loaded poly(l-lactic acid) (PLLA) microspheres","year":2004,"lang":"en","type":"article","venue":"International Journal of Pharmaceutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); University of British Columbia","funders":"","keywords":"Paclitaxel; Kinetics; Diffusion; Dosage form; Materials science; Dispersion (optics); Chemical engineering; Microsphere; Dichloromethane; Drug carrier; Microparticle; Deposition (geology); Chemistry; Chromatography; Drug delivery; Solvent; Nanotechnology; Organic chemistry; Surgery; Chemotherapy","score_opus":0.046155434121474825,"score_gpt":0.41231550041655074,"score_spread":0.3661600662950759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1517956406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762279,0.0033158364,0.014193779,0.000388746,0.00016348675,0.00008119644,0.00024604934,0.000342705,0.005040229],"genre_scores_gemma":[0.9814777,0.001161928,0.0071023284,0.00010358621,0.00006026448,0.00005134638,0.00015285474,0.000054272474,0.009835867],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988294,0.00001456647,0.000011154172,0.000030489524,0.000028232345,0.000032551183],"domain_scores_gemma":[0.99989593,0.000026737105,0.00002630991,0.000008915892,0.000021525067,0.000020454394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013636869,0.0002180817,0.00021461029,0.00020273917,0.00022399674,0.0003907275,0.00018771866,0.00029459404,0.0013842337],"category_scores_gemma":[0.00020800742,0.00016068642,0.00013802713,0.00019630184,0.00015539656,0.0004715635,0.0001432574,0.0003657779,0.0005793938],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029479747,0.00005963481,0.00013468704,0.000059428494,0.0000073767396,0.000075068,0.000021124066,0.00036452725,0.990162,0.00029833274,0.00015347134,0.008369607],"study_design_scores_gemma":[0.000040212028,0.0003970632,0.00056462,0.000004150078,0.000018967683,0.00007624857,0.000009115003,0.001245302,0.9944463,0.000042507214,0.0031489905,0.000006577662],"about_ca_topic_score_codex":0.00091047667,"about_ca_topic_score_gemma":0.0013085665,"teacher_disagreement_score":0.0013842337,"about_ca_system_score_codex":0.000401904,"about_ca_system_score_gemma":0.00037845207,"threshold_uncertainty_score":0.004630685},"labels":[],"label_agreement":null},{"id":"W1518347581","doi":"10.1002/cncr.27463","title":"A prospective surveillance model for physical rehabilitation of women with breast cancer","year":2012,"lang":"en","type":"review","venue":"Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Breast cancer; Rehabilitation; Cancer; Physical therapy; Physical medicine and rehabilitation; Peripheral neuropathy; Intensive care medicine; Internal medicine","score_opus":0.04279504833703277,"score_gpt":0.40727564011774536,"score_spread":0.36448059178071257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1518347581","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22172306,0.008165306,0.42395785,0.1349731,0.0031628544,0.017557897,0.0019046867,0.0041678506,0.18438737],"genre_scores_gemma":[0.5889009,0.00773427,0.3508175,0.011719043,0.0008340045,0.012598375,0.0023068837,0.00019798841,0.024891011],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9961422,0.0024345948,0.00022363233,0.00036939848,0.00063924375,0.00019095844],"domain_scores_gemma":[0.99600947,0.0009887485,0.000615362,0.00040949197,0.00067165296,0.0013052172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065702004,0.000464497,0.00031019383,0.0012017546,0.0016158065,0.0019403535,0.0015591126,0.0009300223,0.0067273113],"category_scores_gemma":[0.008958751,0.0003287046,0.001068912,0.00064374605,0.0006707432,0.0019796952,0.0023922191,0.0015183823,0.0017188338],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011324773,0.0056134933,0.106826164,0.00056588586,0.00018445322,0.00081919075,0.004138998,0.007794274,0.0013545605,0.070316866,0.054185446,0.74706817],"study_design_scores_gemma":[0.0041748374,0.03274699,0.1826274,0.004316794,0.0008055129,0.0097355405,0.008856228,0.11790616,0.0041568875,0.11274963,0.52129614,0.00062793866],"about_ca_topic_score_codex":0.0041957577,"about_ca_topic_score_gemma":0.011397404,"teacher_disagreement_score":0.0067273113,"about_ca_system_score_codex":0.002614537,"about_ca_system_score_gemma":0.011397581,"threshold_uncertainty_score":0.034747005},"labels":[],"label_agreement":null},{"id":"W152180321","doi":"10.1007/978-3-662-43604-2_18","title":"Adverse Side Effects Associated with the Use of Low-Dose Metronomic Chemotherapy","year":2014,"lang":"en","type":"book-chapter","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Chemotherapy; Medicine; Adverse effect; Therapeutic index; Neutropenia; Toxicity; Oncology; Internal medicine; Therapeutic effect; Regimen; Clinical trial; Side effect (computer science); Chemotherapy regimen; Pharmacology; Drug","score_opus":0.023394503526238918,"score_gpt":0.2630178437575722,"score_spread":0.23962334023133328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W152180321","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08512389,0.56561846,0.024453258,0.010992937,0.0022242034,0.00013186988,0.00075153145,0.0006387436,0.31006506],"genre_scores_gemma":[0.38871098,0.3666565,0.01735889,0.007910676,0.00309737,0.000108618995,0.0007227499,0.00023877919,0.21519543],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998497,0.00005269027,0.0000143776,0.000010472812,0.00006309267,0.000009665965],"domain_scores_gemma":[0.99965334,0.00023108428,0.00005600128,0.000013823889,0.000031435688,0.0000142954295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023142525,0.00019141323,0.00025545686,0.00030161167,0.00014859585,0.0003192106,0.00022686656,0.00030919677,0.0058573694],"category_scores_gemma":[0.00070315646,0.00006738116,0.00029104383,0.00027733733,0.00018915514,0.00021165679,0.00025572564,0.0007529628,0.0008256685],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026296158,0.00008423647,0.0023911516,0.0011012238,0.00004370501,0.0025173319,0.00016254635,0.00061727414,0.01292473,0.005094446,0.026292231,0.94850814],"study_design_scores_gemma":[0.00006308431,0.0014869084,0.04471808,0.0020341256,0.00022929885,0.08256594,0.00025811637,0.0014186968,0.019735403,0.010888305,0.8365441,0.00005793764],"about_ca_topic_score_codex":0.0003688691,"about_ca_topic_score_gemma":0.0015838321,"teacher_disagreement_score":0.0058573694,"about_ca_system_score_codex":0.00025810138,"about_ca_system_score_gemma":0.00016872272,"threshold_uncertainty_score":0.019594908},"labels":[],"label_agreement":null},{"id":"W1522433939","doi":"10.1002/cncr.21122","title":"Capecitabine plus docetaxel combination therapy","year":2005,"lang":"en","type":"article","venue":"Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Docetaxel; Medicine; Capecitabine; Quality-adjusted life year; Internal medicine; Oncology; Cost effectiveness; Chemotherapy; Surgery; Cancer; Colorectal cancer","score_opus":0.03792038833672323,"score_gpt":0.3667094676793864,"score_spread":0.32878907934266316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1522433939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78576547,0.16765708,0.0032965222,0.0021536038,0.00095689617,0.0017512109,0.001400302,0.00019574836,0.03682312],"genre_scores_gemma":[0.96359754,0.024567094,0.002467436,0.000830924,0.00026638454,0.00073604373,0.00087187736,0.00000830491,0.00665435],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998323,0.00004750074,0.000017050419,0.000042648473,0.000042373198,0.00001810751],"domain_scores_gemma":[0.9998876,0.00003118081,0.00003283509,0.000008071817,0.000010359874,0.000030014935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023899246,0.00028891754,0.00079847005,0.00032399758,0.00013167522,0.0003010351,0.00019923899,0.0001673477,0.0036479936],"category_scores_gemma":[0.00041501538,0.00009833842,0.00033000702,0.0003520172,0.00016446624,0.00015567093,0.00014560328,0.0005675493,0.0006724329],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.063537195,0.0035312823,0.012365073,0.0038154086,0.0018855493,0.0017277478,0.00006483439,0.007763173,0.029212223,0.0020328665,0.01973459,0.85433006],"study_design_scores_gemma":[0.21202295,0.20732094,0.09839906,0.0029393155,0.00784935,0.02445864,0.000101314785,0.014146219,0.033349853,0.006573208,0.39263022,0.00020890575],"about_ca_topic_score_codex":0.00051957375,"about_ca_topic_score_gemma":0.0014981527,"teacher_disagreement_score":0.0036479936,"about_ca_system_score_codex":0.00052261795,"about_ca_system_score_gemma":0.00047633811,"threshold_uncertainty_score":0.012203693},"labels":[],"label_agreement":null},{"id":"W1542409929","doi":"10.3138/cbmh.17.1.155","title":"Poisoning the Spindle: Serendipity and Discovery of the Anti-Tumor Properties of the Vinca Alkaloids","year":2000,"lang":"en","type":"article","venue":"Canadian Journal of Health History","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Vinca; Serendipity; Scientific discovery; Key (lock); Drug discovery; Lunatic; History; Traditional medicine; Medicine; Law; Political science; Psychology; Computer science; Pharmacology; Epistemology; Philosophy; Cognitive science; Biology; Bioinformatics","score_opus":0.027472882758810685,"score_gpt":0.24718986079605756,"score_spread":0.21971697803724688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1542409929","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07595249,0.57433385,0.0028863498,0.1777342,0.0072916923,0.00004345879,0.00022379462,0.000103246566,0.16143091],"genre_scores_gemma":[0.45871434,0.3838157,0.0013990849,0.033581313,0.0046215774,0.000023645554,0.00014623537,0.000052120457,0.117646],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99932396,0.00014164904,0.000018198309,0.00008742455,0.00029369936,0.00013504458],"domain_scores_gemma":[0.9993862,0.00017659998,0.0001363799,0.00004883436,0.00014232587,0.00010956373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012201937,0.0003071085,0.00030924685,0.0010985719,0.004056703,0.003335615,0.00054324546,0.0020432537,0.0027956779],"category_scores_gemma":[0.0016032715,0.00022968929,0.00018046575,0.00089401327,0.009768974,0.0022394622,0.0018228794,0.002775857,0.0008516679],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008739282,0.00008978884,0.0049193515,0.0017845909,0.00004841075,0.00771196,0.029598748,0.00026402704,0.020411236,0.3441051,0.23464495,0.35554793],"study_design_scores_gemma":[0.000020624966,0.0001947439,0.0020359985,0.00028540724,0.000017126215,0.0034754022,0.006553155,0.000045461493,0.005477682,0.021083966,0.96078587,0.000024585757],"about_ca_topic_score_codex":0.03488024,"about_ca_topic_score_gemma":0.0670286,"teacher_disagreement_score":0.9651198,"about_ca_system_score_codex":0.004356641,"about_ca_system_score_gemma":0.0033998261,"threshold_uncertainty_score":0.069354475},"labels":[],"label_agreement":null},{"id":"W1542863370","doi":"10.1158/1538-7445.sabcs14-p4-15-08","title":"Abstract P4-15-08: A phase 1b study of ONT-380, an oral HER2-specific inhibitor, combined with ado-trastuzumab emtansine (T-DM1), in HER2+ metastatic breast cancer (MBC)","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; La Cité Médicale","funders":"","keywords":"Lapatinib; Medicine; Taxane; Trastuzumab; Metastatic breast cancer; Internal medicine; Neratinib; Oncology; Trastuzumab emtansine; Progressive disease; Anthracycline; Cancer; Breast cancer; Pharmacology; Chemotherapy","score_opus":0.19817550286950686,"score_gpt":0.4931715194821537,"score_spread":0.29499601661264685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1542863370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98990494,0.0012424958,0.000812847,0.00043171295,0.00010607313,0.0022973553,0.0019217376,0.0001921777,0.0030907115],"genre_scores_gemma":[0.9740349,0.0020232196,0.003232936,0.0010479382,0.00012046918,0.002419063,0.0069598085,0.000088041525,0.010073538],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997291,0.00008623488,0.000014647442,0.000058295875,0.000037766433,0.00007392504],"domain_scores_gemma":[0.9996126,0.00004324297,0.000053033553,0.000029240244,0.000033718472,0.00022811069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010610321,0.0019474595,0.0013529616,0.00045080154,0.00037982044,0.0009731404,0.0012529489,0.001307708,0.0049478756],"category_scores_gemma":[0.00048777432,0.0005966753,0.000913502,0.00032960458,0.00086720765,0.0008065442,0.00031417637,0.0035081212,0.0013470831],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32082793,0.237352,0.006422496,0.0014820648,0.0019416336,0.0009659784,0.0006475233,0.0065400437,0.24341458,0.0008574715,0.016885825,0.16266258],"study_design_scores_gemma":[0.23778598,0.72538763,0.008923836,0.000047300953,0.00042847707,0.0006640067,0.000093613475,0.0021877438,0.01813442,0.0002977003,0.005999931,0.000049296552],"about_ca_topic_score_codex":0.0026325802,"about_ca_topic_score_gemma":0.0044805952,"teacher_disagreement_score":0.0049478756,"about_ca_system_score_codex":0.0010162721,"about_ca_system_score_gemma":0.0018144923,"threshold_uncertainty_score":0.01655227},"labels":[],"label_agreement":null},{"id":"W1543311118","doi":"","title":"Comparative pharmacokinetics, tissue distribution and excretion of free versus liposomal vincristine in rats.","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada); Cantox Health Sciences International","funders":"","keywords":"Vincristine; Pharmacokinetics; Pharmacology; Liposome; Distribution (mathematics); Chemistry; Medicine; Internal medicine; Chemotherapy; Biochemistry","score_opus":0.13425563897400392,"score_gpt":0.49710398120301547,"score_spread":0.3628483422290115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1543311118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913236,0.002243104,0.0025381437,0.00017369885,0.00007737727,0.000092911185,0.0015423981,0.00033039102,0.0016783258],"genre_scores_gemma":[0.9817695,0.0027708877,0.002665995,0.00016798632,0.00005198621,0.00022508249,0.0021913631,0.00011695771,0.010040338],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997831,0.000026842128,0.000010200168,0.000058699086,0.0000361586,0.00008498499],"domain_scores_gemma":[0.999592,0.00006341744,0.00010633579,0.000047792822,0.000059238766,0.00013134087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026403536,0.00083508756,0.0006628522,0.00086621,0.00023840483,0.00048463742,0.0003394448,0.00062088604,0.0014614536],"category_scores_gemma":[0.00032388422,0.00040121283,0.00042284472,0.00038554022,0.00047620598,0.00079098035,0.00016639015,0.0011198075,0.00070850743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020316098,0.0015428537,0.0024085063,0.00019195511,0.00010511604,0.0002933189,0.00014828857,0.0010625207,0.9493783,0.00039178715,0.00064432726,0.023516912],"study_design_scores_gemma":[0.00050498615,0.03435665,0.018729128,0.000024025052,0.0002508709,0.00045977387,0.00018227418,0.005025869,0.9344399,0.00028465025,0.005663295,0.000078632496],"about_ca_topic_score_codex":0.0025216748,"about_ca_topic_score_gemma":0.0026862808,"teacher_disagreement_score":0.0025216748,"about_ca_system_score_codex":0.00077377155,"about_ca_system_score_gemma":0.0008117309,"threshold_uncertainty_score":0.0056141615},"labels":[],"label_agreement":null},{"id":"W1553189449","doi":"10.1096/fasebj.28.1_supplement.647.10","title":"Flavonoids from rooibos tea promote cell death in an osteosarcoma cell line (647.10)","year":2014,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"","keywords":"Chemistry; Vitexin; Formazan; Luteolin; Viability assay; Cell culture; Cell growth; Pharmacology; Biochemistry; Antioxidant; Cell; Flavonoid; Biology","score_opus":0.024620339619040102,"score_gpt":0.2980593696849902,"score_spread":0.2734390300659501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1553189449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901731,0.0020840638,0.002016534,0.00018948845,0.000055847482,0.00006755736,0.0012312958,0.000057735346,0.004124377],"genre_scores_gemma":[0.97213775,0.003688397,0.004307898,0.00012698003,0.000049815986,0.00019451774,0.0042354674,0.000037144975,0.015221945],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982363,0.000030005487,0.000024040657,0.00002999928,0.000048362414,0.00004390411],"domain_scores_gemma":[0.99988675,0.0000314418,0.000020064266,0.000019848012,0.000025950952,0.000015972815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002691551,0.00034164632,0.0003148225,0.00036155473,0.0002210148,0.0002362279,0.00018319463,0.0003139383,0.0030460837],"category_scores_gemma":[0.00011933576,0.00014448108,0.0003869833,0.00038021823,0.0001811013,0.00020217628,0.00020072208,0.00041430228,0.0009658737],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043010144,0.00008638006,0.0003639814,0.00006496376,0.0000075729763,0.00011663862,0.000063472486,0.00004368462,0.99669504,0.00008399073,0.00014365415,0.0019004132],"study_design_scores_gemma":[0.00011085643,0.0016560031,0.014985923,0.000017812157,0.000049360202,0.0004318646,0.00014922602,0.0006598637,0.97381634,0.0000774099,0.0080383485,0.0000070075785],"about_ca_topic_score_codex":0.0025347495,"about_ca_topic_score_gemma":0.0029888193,"teacher_disagreement_score":0.0030460837,"about_ca_system_score_codex":0.00016817887,"about_ca_system_score_gemma":0.0002855416,"threshold_uncertainty_score":0.010190189},"labels":[],"label_agreement":null},{"id":"W1559459501","doi":"10.1002/cncr.24359","title":"Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non‐Hodgkin lymphoma","year":2009,"lang":"en","type":"article","venue":"Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Vincristine; Tolerability; Internal medicine; Gastroenterology; Refractory (planetary science); Aggressive lymphoma; Lymphoma; Chemotherapy; Surgery; Adverse effect; Rituximab; Cyclophosphamide","score_opus":0.00701641614179865,"score_gpt":0.2875676238083607,"score_spread":0.28055120766656205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1559459501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99823064,0.0011289066,0.000097550925,0.00007251747,0.000007977421,0.00007186927,0.00002676558,0.000013602972,0.00035016146],"genre_scores_gemma":[0.9990814,0.00041204554,0.00014544546,0.000071091956,0.000023702236,0.00003121834,0.000062931926,0.0000015128176,0.00017070882],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9999306,0.0000255901,0.0000054896345,0.0000105750105,0.000008895358,0.000018815497],"domain_scores_gemma":[0.9998826,0.000025625992,0.00003242139,0.000005238199,0.0000061143064,0.00004808839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026472678,0.00025937578,0.00039363545,0.00014084441,0.00018482226,0.00020672778,0.0001430633,0.00018153855,0.00075503095],"category_scores_gemma":[0.00031385155,0.000119229866,0.00015655349,0.000122077,0.00016015807,0.000183942,0.00014636526,0.00033370004,0.00014878172],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11702456,0.010828317,0.1644646,0.0011542665,0.0008271867,0.004158267,0.0013063771,0.0037383633,0.16981815,0.0004405242,0.0041143554,0.522125],"study_design_scores_gemma":[0.055835012,0.3207992,0.5718318,0.000190196,0.0010042465,0.0068064444,0.00042062456,0.00689495,0.019141106,0.00040924165,0.016604463,0.00006266469],"about_ca_topic_score_codex":0.0005959444,"about_ca_topic_score_gemma":0.0013222724,"teacher_disagreement_score":0.00075503095,"about_ca_system_score_codex":0.00031921393,"about_ca_system_score_gemma":0.00025645472,"threshold_uncertainty_score":0.002525866},"labels":[],"label_agreement":null},{"id":"W1563983159","doi":"10.1158/1538-7445.sabcs14-p6-09-03","title":"Abstract P6-09-03: Development of a cardiac toxicity prediction tool for HER2 (+) breast cancer patients receiving trastuzumab","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Trastuzumab; Ejection fraction; Internal medicine; Breast cancer; Discontinuation; Oncology; Cancer; Cardiotoxicity; Cardiology; Metastatic breast cancer; Concomitant; Heart failure; Toxicity","score_opus":0.1123989428833025,"score_gpt":0.4361029065365645,"score_spread":0.32370396365326204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1563983159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9014896,0.00033799504,0.08030466,0.0013482283,0.0001131556,0.001424529,0.0061447225,0.002526194,0.0063109095],"genre_scores_gemma":[0.93466246,0.00011394985,0.060264632,0.00016000628,0.000038275146,0.00050566724,0.003156568,0.00005620017,0.001042131],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989365,0.00048056475,0.00015313203,0.00009676576,0.00026554268,0.00006755088],"domain_scores_gemma":[0.9946168,0.0033026554,0.000575677,0.00015839846,0.0011073647,0.00023907033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027233167,0.0005460919,0.00055390835,0.00162137,0.00022472577,0.0012121963,0.00058153045,0.00062696426,0.0031305726],"category_scores_gemma":[0.015459444,0.00018392396,0.00067285215,0.00063260307,0.00012980758,0.0005885922,0.00055974186,0.0005476309,0.0011920563],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017987661,0.0017197502,0.750579,0.00024380362,0.00023765744,0.0007103468,0.00026896212,0.024770824,0.0039261207,0.00079734245,0.013308194,0.20163928],"study_design_scores_gemma":[0.00029111284,0.0018098532,0.30644172,0.00019720836,0.00021239083,0.0016109592,0.0003460303,0.6750003,0.006388537,0.0011857501,0.0064426633,0.000073551244],"about_ca_topic_score_codex":0.0028426882,"about_ca_topic_score_gemma":0.002255144,"teacher_disagreement_score":0.0031305726,"about_ca_system_score_codex":0.00045704268,"about_ca_system_score_gemma":0.0010125943,"threshold_uncertainty_score":0.014402449},"labels":[],"label_agreement":null},{"id":"W1564497062","doi":"10.1684/bdc.2008.0628","title":"[Outpatient chemotherapy and oncology network : Onco Pays-de-la-Loire experiment].","year":2008,"lang":"en","type":"article","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Humanities; Gynecology; Art","score_opus":0.030273942759395833,"score_gpt":0.31136516344697435,"score_spread":0.2810912206875785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1564497062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4613624,0.0041579213,0.014417719,0.046992816,0.009189025,0.026283065,0.13423684,0.0022660773,0.30109417],"genre_scores_gemma":[0.72348213,0.0014413449,0.024369853,0.024487339,0.0019231729,0.055141784,0.045366995,0.0004828416,0.123304516],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.98878574,0.007948473,0.00020126683,0.0007946388,0.0014698023,0.0008001617],"domain_scores_gemma":[0.98954344,0.0053357882,0.001407741,0.0011846778,0.0011093171,0.0014189695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010448857,0.0006615802,0.00064363563,0.00090057537,0.0020136943,0.0017247661,0.0016933525,0.002413192,0.04697783],"category_scores_gemma":[0.009741972,0.0004947534,0.00064920675,0.0016248695,0.0011942914,0.00143688,0.0015469932,0.0027359803,0.0034575416],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11609553,0.03479901,0.032137267,0.0017087613,0.0011060942,0.0006604107,0.0011429149,0.005637155,0.0028549747,0.047812432,0.65755826,0.098487265],"study_design_scores_gemma":[0.13998361,0.0361423,0.13273983,0.00050932966,0.0012477047,0.00056131027,0.0022713824,0.013466023,0.0047373367,0.015351632,0.6524595,0.0005299899],"about_ca_topic_score_codex":0.05839046,"about_ca_topic_score_gemma":0.05244094,"teacher_disagreement_score":0.05839046,"about_ca_system_score_codex":0.0027258706,"about_ca_system_score_gemma":0.005336238,"threshold_uncertainty_score":0.15715647},"labels":[],"label_agreement":null},{"id":"W1564958769","doi":"10.1023/a:1013018218360","title":"Responsiveness of the EuroQol in breast cancer patients undergoing high dose chemotherapy","year":2001,"lang":"en","type":"article","venue":"Quality of Life Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Breast cancer; Quality of life (healthcare); Quality of Life Research; EQ-5D; Health related quality of life; Internal medicine; Cancer; Chemotherapy; Analysis of variance; Oncology; Physical therapy; Public health; Pathology","score_opus":0.1878835862729618,"score_gpt":0.4955512457154663,"score_spread":0.3076676594425045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1564958769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99806255,0.00043215463,0.00005525855,0.00021990157,0.00001552743,0.000009222486,0.00014195828,0.0000029011205,0.0010604959],"genre_scores_gemma":[0.9996507,0.000073001356,0.00001664982,0.000064422245,0.000007074897,0.000006072419,0.00010484633,8.499026e-7,0.00007635826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991647,0.00046196097,0.00008582702,0.00005194098,0.00010048675,0.00013501148],"domain_scores_gemma":[0.9955799,0.002104227,0.0014415886,0.00014667452,0.0002778413,0.0004497339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011893349,0.00016505773,0.0004423009,0.0005027166,0.00027398198,0.00087127433,0.00019904795,0.00046364122,0.0014651171],"category_scores_gemma":[0.01098516,0.00008979169,0.00061409315,0.0006607626,0.00028699634,0.00041055746,0.00046022757,0.0008481854,0.0002166062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001077957,0.00015158163,0.9886303,0.000038054248,0.00014714173,0.00019441651,0.00044562685,0.0002921587,0.00039092073,0.00007758959,0.00031001255,0.008244318],"study_design_scores_gemma":[0.000031810352,0.000757741,0.9972209,0.0000148111285,0.00006211473,0.00027294038,0.0006004603,0.00038419873,0.00012865622,0.00012427538,0.0003914005,0.000010827572],"about_ca_topic_score_codex":0.0012745472,"about_ca_topic_score_gemma":0.0008383863,"teacher_disagreement_score":0.0014651171,"about_ca_system_score_codex":0.00047270863,"about_ca_system_score_gemma":0.00027996852,"threshold_uncertainty_score":0.0062898993},"labels":[],"label_agreement":null},{"id":"W1579173109","doi":"10.4212/cjhp.v60i4.184","title":"Stability of Docetaxel Solution after Dilution in Ethanol and Storage in Vials and after Dilution in Normal Saline and Storage in Bags","year":2007,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Docetaxel; Vial; Chromatography; Dilution; Chemistry; Polyethylene; Ethanol; Drug packaging; Surgery; Medicine; Biochemistry; Organic chemistry","score_opus":0.01561378250195662,"score_gpt":0.2941140342746935,"score_spread":0.2785002517727369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1579173109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818979,0.006016829,0.00873709,0.00008561226,0.000131417,0.0002089141,0.0003225785,0.000091414935,0.0025081432],"genre_scores_gemma":[0.97944367,0.0032804043,0.011393394,0.00010839238,0.00004667201,0.00019751291,0.0006355449,0.00005060018,0.004843693],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994822,0.00011817583,0.000063408675,0.00011178146,0.00018449819,0.000040025916],"domain_scores_gemma":[0.99953973,0.00007553761,0.000101287194,0.000040270053,0.00021745196,0.000025754454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007530668,0.00040512692,0.00020791957,0.0002614751,0.00022280052,0.00040582224,0.0001919837,0.0002697416,0.0017560057],"category_scores_gemma":[0.0011200497,0.00012728506,0.00028159772,0.00024306479,0.00021464018,0.00039204102,0.00013363072,0.00038540794,0.00070418743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011293235,0.00014272965,0.0037172514,0.00008210075,0.000034948065,0.00012150331,0.00014894495,0.0001971212,0.97602284,0.000097417025,0.00014757318,0.01815826],"study_design_scores_gemma":[0.000030312754,0.0025665585,0.01082782,0.000027742764,0.000079534206,0.0004890626,0.00008786775,0.0010933733,0.98088664,0.000039568025,0.003844518,0.000027137165],"about_ca_topic_score_codex":0.0008708954,"about_ca_topic_score_gemma":0.0008766142,"teacher_disagreement_score":0.0017560057,"about_ca_system_score_codex":0.00032973813,"about_ca_system_score_gemma":0.0005044285,"threshold_uncertainty_score":0.005874455},"labels":[],"label_agreement":null},{"id":"W1588538733","doi":"","title":"Preferential potentiation of paclitaxel and doxorubicin cytotoxicity in drug-resistant breast tumor cells by tesmilifene.","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sudbury Regional Hospital","funders":"","keywords":"Paclitaxel; Doxorubicin; Clonogenic assay; Cytotoxicity; Anthracycline; Medicine; Chemotherapy; Breast cancer; Pharmacology; Cancer research; Internal medicine; Cancer; Oncology; In vitro; Chemistry; Biochemistry","score_opus":0.027685970481697564,"score_gpt":0.36610498746509595,"score_spread":0.3384190169833984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1588538733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99229056,0.0028015166,0.0006582077,0.00011760321,0.00005285769,0.00007695443,0.00047556136,0.00006572376,0.003460959],"genre_scores_gemma":[0.9944073,0.001594323,0.00094005204,0.00006827001,0.000022964448,0.00006184296,0.0008705497,0.000017654093,0.0020169718],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998405,0.00005236768,0.000016743943,0.000022909577,0.000026186173,0.00004128442],"domain_scores_gemma":[0.99981767,0.000055653316,0.000043561726,0.000024220286,0.000027839013,0.000031095013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017599242,0.00045841798,0.00054795825,0.00034601305,0.00012526356,0.0003433378,0.00027285478,0.00029125562,0.001910207],"category_scores_gemma":[0.00024353847,0.00020234559,0.00038372795,0.00023508671,0.0001681152,0.00021871534,0.00020838101,0.00055902713,0.0006214372],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008685399,0.00037472934,0.00045517544,0.00009918597,0.0000201404,0.0000958002,0.000028391307,0.00023188435,0.9891338,0.00008052696,0.00013767759,0.008474107],"study_design_scores_gemma":[0.0002437293,0.008701217,0.0073182345,0.000016616035,0.000051587525,0.000538121,0.00003619035,0.000738162,0.97988886,0.00004486189,0.0024118149,0.000010477414],"about_ca_topic_score_codex":0.00037282266,"about_ca_topic_score_gemma":0.0012507198,"teacher_disagreement_score":0.001910207,"about_ca_system_score_codex":0.00019882337,"about_ca_system_score_gemma":0.00017811719,"threshold_uncertainty_score":0.0063902736},"labels":[],"label_agreement":null},{"id":"W1593763867","doi":"10.1186/1471-2407-4-60","title":"Survival of patients with metastatic breast cancer: twenty-year data from two SEER registries","year":2004,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Saskatoon Medical Imaging; University of Saskatchewan","funders":"Magyar Tudományos Akadémia; Saskatchewan Cancer Agency","keywords":"Surgical oncology; Medicine; Oncology; Breast cancer; Internal medicine; Cancer","score_opus":0.05922309304366742,"score_gpt":0.3584372324348214,"score_spread":0.299214139391154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1593763867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792172,0.0012583976,0.0004227132,0.00020551406,0.0000117988375,0.000034114575,0.017916122,0.000019742232,0.00091451587],"genre_scores_gemma":[0.9701119,0.0008187469,0.0006398336,0.0000838859,0.000019158093,0.00006404664,0.028070318,0.000005779577,0.00018630363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972709,0.0011102925,0.000405093,0.00042761932,0.0005681662,0.00021803738],"domain_scores_gemma":[0.9909292,0.0021492562,0.004384644,0.00078786945,0.0011234304,0.00062557124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004129777,0.00027392767,0.0005114234,0.0021758582,0.00026049573,0.00062138156,0.00046401905,0.00038502197,0.00062651024],"category_scores_gemma":[0.006831366,0.000204027,0.0005881405,0.0035662148,0.0001779203,0.00047990892,0.000825772,0.00035569607,0.0001965039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018867542,0.000016456366,0.99589634,0.000038105794,0.0001649701,0.00007399785,0.000103901264,0.00026683247,0.00007233348,0.0000427869,0.0008116559,0.00232396],"study_design_scores_gemma":[0.000027073942,0.000042460993,0.99820435,0.00003168345,0.000107143256,0.00017855005,0.00011428522,0.0002668,0.000056438297,0.00002126528,0.0009413468,0.000008696545],"about_ca_topic_score_codex":0.018094048,"about_ca_topic_score_gemma":0.02634736,"teacher_disagreement_score":0.018094048,"about_ca_system_score_codex":0.0008256198,"about_ca_system_score_gemma":0.0011148523,"threshold_uncertainty_score":0.035977483},"labels":[],"label_agreement":null},{"id":"W1594175490","doi":"10.1158/1538-7445.sabcs14-pd2-1","title":"Abstract PD2-1: The effect on overall and disease-free survival (OS &amp; DFS) by adding bevacizumab and/or antimetabolites to standard neoadjuvant chemotherapy: NSABP Protocol B-40","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Docetaxel; Bevacizumab; Internal medicine; Capecitabine; Chemotherapy; Breast cancer; Gemcitabine; Neoadjuvant therapy; Oncology; Taxane; Gastroenterology; Cancer; Colorectal cancer","score_opus":0.09054911960160768,"score_gpt":0.46391539685108785,"score_spread":0.3733662772494802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1594175490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96683604,0.0019027707,0.0011845712,0.0007765678,0.00021387359,0.015638802,0.0053900043,0.00012432497,0.007933087],"genre_scores_gemma":[0.9555087,0.0012014807,0.003954198,0.0008597297,0.00012651552,0.026565252,0.005545007,0.000034482357,0.0062046642],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99913776,0.000508439,0.00008436995,0.000077759345,0.00009981166,0.00009184318],"domain_scores_gemma":[0.999275,0.00015791784,0.000140757,0.000049770257,0.00007653176,0.00029999224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017709302,0.00077563303,0.0009272683,0.00046352763,0.00055108574,0.0005642521,0.00096713705,0.0007234287,0.0071006967],"category_scores_gemma":[0.0014754253,0.00033360557,0.0006777408,0.00041414236,0.0007573838,0.00037083478,0.0004973929,0.0018014335,0.000528623],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84731215,0.026016247,0.006232536,0.0011216665,0.00051550695,0.00014778045,0.000077029385,0.0034249849,0.044001665,0.00057225913,0.009637254,0.06094086],"study_design_scores_gemma":[0.4099495,0.5003472,0.022951256,0.00017576285,0.00088062685,0.0003312321,0.000091718626,0.003434778,0.042447533,0.0010759475,0.018253218,0.00006122954],"about_ca_topic_score_codex":0.0010850746,"about_ca_topic_score_gemma":0.0021463241,"teacher_disagreement_score":0.0071006967,"about_ca_system_score_codex":0.0014488589,"about_ca_system_score_gemma":0.0031619319,"threshold_uncertainty_score":0.02375424},"labels":[],"label_agreement":null},{"id":"W1607081374","doi":"10.4137/cmt.s3410","title":"A Review of the Impact of Lapatinib on Health-Related Quality of Life in the Management of Advanced solid Tumors","year":2009,"lang":"en","type":"review","venue":"Clinical Medicine Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Lapatinib; Medicine; Quality of life (healthcare); Clinical trial; Metastatic breast cancer; Epidermal growth factor receptor; Breast cancer; Oncology; Internal medicine; Cancer; Trastuzumab","score_opus":0.3530756171237509,"score_gpt":0.6077769786051451,"score_spread":0.2547013614813942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1607081374","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000079776255,0.99932444,0.000038039867,0.00010610334,0.000064779924,0.0000050420813,0.000018131966,0.0000022134489,0.00036160747],"genre_scores_gemma":[0.0003423459,0.9993144,0.00010505373,0.00008095101,0.000037099737,0.000004421784,0.000014585453,4.6796012e-7,0.00010073882],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99965286,0.00008928328,0.00008679494,0.00003788945,0.00011741462,0.000015801228],"domain_scores_gemma":[0.9993388,0.00037312726,0.000112512855,0.000010440763,0.00013507337,0.000030019753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000803732,0.0007480896,0.0019448022,0.0032451537,0.00025387717,0.0008153174,0.0007383596,0.00070566277,0.0034017896],"category_scores_gemma":[0.0012886905,0.00027500864,0.00076462235,0.0044714883,0.000283638,0.00096485135,0.0004385808,0.0008712544,0.0009012462],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001005832,0.000052667237,0.00015490055,0.09432818,0.0002508835,0.00019287928,0.00007396847,0.00024067913,0.0008001122,0.0011060497,0.022827545,0.8798714],"study_design_scores_gemma":[0.00007143494,0.0002829354,0.0034083994,0.06268686,0.0012243919,0.0024218617,0.00017400896,0.000163277,0.0005204777,0.0015444935,0.92746055,0.00004132181],"about_ca_topic_score_codex":0.0016813668,"about_ca_topic_score_gemma":0.0040575294,"teacher_disagreement_score":0.0034017896,"about_ca_system_score_codex":0.0006489646,"about_ca_system_score_gemma":0.0016501758,"threshold_uncertainty_score":0.011380136},"labels":[],"label_agreement":null},{"id":"W1633250892","doi":"10.1096/fasebj.26.1_supplement.lb784","title":"Skeletal muscle as a possible compartment for the sequestering of Doxorubicin following administration","year":2012,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Laurentian University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Skeletal muscle; Doxorubicin; Intramuscular injection; Chemistry; Bolus (digestion); Pharmacokinetics; Gastrocnemius muscle; Internal medicine; Medicine; Pharmacology; Intravenous bolus; Endocrinology; Chemotherapy","score_opus":0.0540137135544045,"score_gpt":0.37058505357302096,"score_spread":0.3165713400186165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1633250892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96697336,0.014944451,0.012750299,0.00042200706,0.00014545502,0.00015238672,0.0005436966,0.0001798111,0.0038885192],"genre_scores_gemma":[0.9623431,0.007222154,0.011131889,0.0003485553,0.000063197396,0.00017382258,0.0008755633,0.000056316876,0.01778541],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998287,0.00003263972,0.000011033343,0.00005075212,0.000042171476,0.000034635],"domain_scores_gemma":[0.99981755,0.000029191564,0.000058569418,0.000020515183,0.000048775786,0.000025537889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029117428,0.00042752447,0.0004586328,0.00038400624,0.0002907213,0.00047095952,0.00031000315,0.0005836711,0.002188484],"category_scores_gemma":[0.00018388835,0.00031776135,0.00032514648,0.00019869034,0.00027851647,0.00055318663,0.0003103524,0.0005420266,0.0006381965],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044631353,0.000025050955,0.0016831558,0.00017732449,0.000020020514,0.00035960268,0.00008624568,0.00004146646,0.9926952,0.00018421939,0.00010085219,0.0041806917],"study_design_scores_gemma":[0.000042427368,0.002487161,0.08198226,0.00011118837,0.00012517469,0.0018132622,0.0004810081,0.0020358881,0.8999263,0.00038849917,0.010575363,0.000031496522],"about_ca_topic_score_codex":0.0014093764,"about_ca_topic_score_gemma":0.002488896,"teacher_disagreement_score":0.002188484,"about_ca_system_score_codex":0.00027064554,"about_ca_system_score_gemma":0.00044430097,"threshold_uncertainty_score":0.007321179},"labels":[],"label_agreement":null},{"id":"W1750189415","doi":"10.1200/jco.2005.23.16_suppl.756","title":"Subgroup analysis of a phase III trial of doxorubicin vs doxorubicin plus tesmilifene in advanced breast cancer (ABC): Tesmilifene survival benefit focused on patients with more aggressive disease","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Doxorubicin; Internal medicine; Chemotherapy; Subgroup analysis; Oncology; Breast cancer; Proportional hazards model; Survival analysis; Cancer; Gastroenterology; Confidence interval","score_opus":0.05199588958467272,"score_gpt":0.45966956780422985,"score_spread":0.40767367821955713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1750189415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98952067,0.0052846316,0.00069386844,0.0005542643,0.00025556493,0.0007665021,0.0019191194,0.000035458044,0.00096999144],"genre_scores_gemma":[0.9953858,0.00055524317,0.00051890465,0.0006391191,0.00014910905,0.0005618898,0.0014585636,0.000015281803,0.0007160453],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99788815,0.0012167295,0.00027764033,0.000286058,0.00014526815,0.0001861912],"domain_scores_gemma":[0.99809784,0.0009653242,0.00027774737,0.0003303227,0.000094454015,0.00023437935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004244766,0.0011309934,0.0027422952,0.00052147545,0.00031405868,0.0010322197,0.00060864096,0.0011166891,0.0038088069],"category_scores_gemma":[0.004957642,0.00032508947,0.007124791,0.00046175942,0.00035968743,0.00049572776,0.00055472436,0.0016109714,0.0004048113],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90122765,0.0013771013,0.021388508,0.0010213545,0.03740507,0.00028438453,0.00017149362,0.0014972276,0.009792822,0.00025002196,0.0023461522,0.02323826],"study_design_scores_gemma":[0.58627194,0.11224249,0.14613704,0.0003025354,0.12873979,0.0006834574,0.0004553303,0.0073832627,0.0070578316,0.002656896,0.0079020895,0.00016730693],"about_ca_topic_score_codex":0.00097125076,"about_ca_topic_score_gemma":0.0035938758,"teacher_disagreement_score":0.004244766,"about_ca_system_score_codex":0.000825643,"about_ca_system_score_gemma":0.000932545,"threshold_uncertainty_score":0.022448719},"labels":[],"label_agreement":null},{"id":"W1783154753","doi":"10.1200/jco.2000.18.12.2385","title":"Phase III Comparative Study of Vinorelbine Combined With Doxorubicin Versus Doxorubicin Alone in Disseminated Metastatic/Recurrent Breast Cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8","year":2000,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Occupational Cancer Research Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Vinorelbine; Metastatic breast cancer; Anthracycline; Chemotherapy; Neutropenia; Internal medicine; Doxorubicin; Surgery; Breast cancer; Toxicity; Vinca alkaloid; Cancer; Febrile neutropenia; Gastroenterology; Phases of clinical research; Cyclophosphamide; Vincristine; Cisplatin","score_opus":0.310743133948084,"score_gpt":0.5937902368847396,"score_spread":0.28304710293665564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1783154753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97874737,0.008018233,0.00054312707,0.00084907684,0.00023441292,0.0069720373,0.0020064297,0.000100948084,0.0025283974],"genre_scores_gemma":[0.97182894,0.0074194283,0.0025090075,0.0016976941,0.00048001888,0.008099971,0.00340104,0.000045219193,0.0045188204],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987514,0.0007175232,0.000055199533,0.00013877108,0.00015026126,0.0001867604],"domain_scores_gemma":[0.9983063,0.0003215676,0.000408804,0.00011076132,0.00014957435,0.00070295326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034665768,0.0018228082,0.004043161,0.0005600986,0.00060319866,0.0011585249,0.0020563095,0.0018046235,0.0052509196],"category_scores_gemma":[0.0020333186,0.00069637597,0.001724643,0.0009142952,0.0015625905,0.0005289944,0.0004021811,0.0031335664,0.00093993894],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9417113,0.020181771,0.0020782603,0.0006745463,0.0018544038,0.000079580794,0.0000897614,0.00077851856,0.0059969313,0.000092246686,0.0018640875,0.024598561],"study_design_scores_gemma":[0.82886463,0.16334975,0.004589776,0.0000394168,0.0006902871,0.00006601991,0.000021160013,0.00037862273,0.0005888461,0.000059864262,0.0013353295,0.000016393911],"about_ca_topic_score_codex":0.023301873,"about_ca_topic_score_gemma":0.06841375,"teacher_disagreement_score":0.023301873,"about_ca_system_score_codex":0.004219505,"about_ca_system_score_gemma":0.006977708,"threshold_uncertainty_score":0.04633248},"labels":[],"label_agreement":null},{"id":"W1803601410","doi":"10.1093/pch/16.9.537","title":"Using pharmacogenetics to understand adverse drug reactions in children","year":2011,"lang":"en","type":"article","venue":"Paediatrics & Child Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; BC Children's Hospital; University of British Columbia","funders":"","keywords":"Ototoxicity; Medicine; Chemotherapy; Cisplatin; Methotrexate; Pharmacogenetics; Adverse effect; Drug; Adverse drug reaction; Drug reaction; Osteosarcoma; Doxorubicin; Hearing loss; Pharmacotherapy; Chemotherapeutic drugs; Oncology; Internal medicine; Surgery; Intensive care medicine; Pharmacology; Audiology; Pathology; Genotype","score_opus":0.07098040104866947,"score_gpt":0.3632881871008259,"score_spread":0.2923077860521564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1803601410","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98520744,0.0041959854,0.0050658053,0.0013493922,0.000021641366,0.00006515562,0.00029180123,0.000031906333,0.0037708497],"genre_scores_gemma":[0.9930789,0.001969771,0.004180128,0.00035754056,0.000024081533,0.000022483307,0.00012820752,0.000010817268,0.00022813804],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9993242,0.0003373526,0.00008811621,0.00009835308,0.00009394577,0.000058022833],"domain_scores_gemma":[0.9977428,0.0011555097,0.00084555504,0.00007852401,0.000103112296,0.000074496216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088481494,0.00022163733,0.0002883045,0.00069638493,0.0002446894,0.000633407,0.00020775806,0.00048655426,0.0006768439],"category_scores_gemma":[0.0049580396,0.00012374454,0.00024906054,0.00073332613,0.00037076938,0.00048825535,0.00036749392,0.00061781623,0.00013403258],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120804965,0.000047957397,0.9579648,0.000058638212,0.000070146896,0.0026224111,0.00059759925,0.0006528475,0.0021830772,0.0007795178,0.0004017833,0.03450047],"study_design_scores_gemma":[0.000025878307,0.00041682032,0.9469975,0.0001337137,0.00019417655,0.030149544,0.0014663816,0.0029313092,0.0044369893,0.0029589648,0.010255643,0.000032987813],"about_ca_topic_score_codex":0.0020352178,"about_ca_topic_score_gemma":0.0014443672,"teacher_disagreement_score":0.0020352178,"about_ca_system_score_codex":0.00043638496,"about_ca_system_score_gemma":0.0003226004,"threshold_uncertainty_score":0.004679382},"labels":[],"label_agreement":null},{"id":"W1814462863","doi":"10.1200/jco.2009.27.15_suppl.5148","title":"Use of pain at baseline and pain progression to predict overall survival (OS) in patients (pts) with docetaxel pretreated metastatic castration-refractory prostate cancer (CRPC): Results from the SPARC trial","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Randomization; Placebo; Docetaxel; Clinical endpoint; Prostate cancer; Analgesic; Internal medicine; Prednisone; Randomized controlled trial; Chemotherapy; Cancer; Anesthesia","score_opus":0.1391352726429714,"score_gpt":0.45676784729240283,"score_spread":0.3176325746494314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1814462863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964432,0.0024483036,0.00008769928,0.00009763875,0.000021293208,0.00012826077,0.0004566641,0.000005701525,0.0003111826],"genre_scores_gemma":[0.9975272,0.0008545705,0.00017212889,0.00010635219,0.000069084424,0.00012525903,0.0009117213,0.0000021495355,0.00023150237],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99928445,0.0004437345,0.000052693642,0.000096882955,0.00007780549,0.000044550496],"domain_scores_gemma":[0.9980422,0.0007657163,0.00060140865,0.00015947783,0.00010055456,0.00033054283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025571552,0.00045714597,0.00095496955,0.0001961832,0.00020295598,0.00056184543,0.0003624781,0.00045385666,0.0014489555],"category_scores_gemma":[0.0022744038,0.00024417855,0.0012982108,0.00035179927,0.00035170978,0.00035937535,0.0002513962,0.0012408422,0.00013816197],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6856324,0.0031645847,0.26050338,0.0007877559,0.005928709,0.000088613924,0.0001181168,0.00132674,0.003021765,0.00007988685,0.001358013,0.03799003],"study_design_scores_gemma":[0.16395068,0.13301645,0.68906164,0.000128869,0.0076136515,0.00039005183,0.00007369758,0.0022635006,0.0012695913,0.00022181025,0.001957259,0.000052815554],"about_ca_topic_score_codex":0.00080208015,"about_ca_topic_score_gemma":0.0017919042,"teacher_disagreement_score":0.0025571552,"about_ca_system_score_codex":0.00036569717,"about_ca_system_score_gemma":0.0004417018,"threshold_uncertainty_score":0.013523698},"labels":[],"label_agreement":null},{"id":"W181489850","doi":"10.1200/jco.2012.30.27_suppl.65","title":"Acute care utilization (ACU) among women receiving adjuvant chemotherapy for early breast cancer (EBC).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Ottawa Hospital; Institute for Clinical Evaluative Sciences; University Health Network; University of Toronto; Ontario Institute for Cancer Research; Health Sciences Centre; Credit Valley Hospital","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Breast cancer; Population; Taxane; Cancer; Anthracycline; Logistic regression; Cancer registry; Toxicity; Oncology; Environmental health","score_opus":0.12673114578102893,"score_gpt":0.5171077527380621,"score_spread":0.39037660695703313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W181489850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99833566,0.00029441935,0.000015006991,0.00006976201,0.000003814862,0.000012042482,0.0008744769,0.0000015868546,0.00039316746],"genre_scores_gemma":[0.9993407,0.00010846311,0.000014720465,0.000021590047,0.0000038429903,0.0000073710257,0.0003910825,5.065536e-7,0.00011169158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996995,0.00004242381,0.000029641373,0.00005315341,0.000086504384,0.00008884092],"domain_scores_gemma":[0.99919194,0.000062278225,0.00047824136,0.00001848481,0.00007837557,0.0001706618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021124873,0.00012948159,0.00015693656,0.00049373746,0.00044609932,0.00048633188,0.000246609,0.00022709294,0.0011727699],"category_scores_gemma":[0.0013104004,0.00017773564,0.0002950955,0.0012767726,0.00020593671,0.00020793841,0.00034026048,0.00037187806,0.00008452893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003351423,0.000012049933,0.9993049,0.000007439163,0.00001268333,0.000024118639,0.000043742195,0.000010228088,0.000041096693,0.000006317191,0.000089459114,0.00041447353],"study_design_scores_gemma":[0.0000028533148,0.00002221438,0.9997118,0.000004184086,0.0000055299765,0.000036795573,0.00008485227,0.000046194575,0.000007234618,0.000003733254,0.00007374547,7.678993e-7],"about_ca_topic_score_codex":0.28045717,"about_ca_topic_score_gemma":0.3188049,"teacher_disagreement_score":0.28045717,"about_ca_system_score_codex":0.0022276477,"about_ca_system_score_gemma":0.0012793794,"threshold_uncertainty_score":0.5576495},"labels":[],"label_agreement":null},{"id":"W1830813972","doi":"10.1200/jco.2000.18.12.2395","title":"Palliative Effect of Chemotherapy: Objective Tumor Response Is Associated With Symptom Improvement in Patients With Metastatic Breast Cancer","year":2000,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Quality of life (healthcare); Nausea; Cancer; Performance status; Lethargy; Mood; Anorexia; Metastatic breast cancer; Chemotherapy; Palliative care; Constipation; Disease; Oncology; Physical therapy","score_opus":0.02691237818351398,"score_gpt":0.4283669197826241,"score_spread":0.4014545415991101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1830813972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966659,0.00222714,0.00017860158,0.00017950319,0.000009664471,0.000018912533,0.00011575138,0.000009598703,0.00059495325],"genre_scores_gemma":[0.9993351,0.000221962,0.0001141087,0.000072324256,0.000022972978,0.000010681633,0.00012490041,0.0000018898163,0.0000960047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991437,0.00041682625,0.00008834043,0.00008168066,0.00022272432,0.000046594196],"domain_scores_gemma":[0.99264,0.0038812086,0.0027994341,0.00014062852,0.00025475395,0.00028404655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012859423,0.0001422839,0.00043569287,0.00023699903,0.00012324053,0.00031044352,0.00016808636,0.0003368563,0.0016285387],"category_scores_gemma":[0.010104867,0.00009928235,0.0002776712,0.00032391326,0.0002915443,0.00029805137,0.0002067528,0.00042757092,0.00015418201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005095615,0.0003601044,0.96423465,0.00024375212,0.00029768597,0.00014472085,0.000088783454,0.0004647714,0.0023911106,0.00002539391,0.00029325444,0.026360285],"study_design_scores_gemma":[0.00014893853,0.0018584384,0.9962131,0.000014083496,0.00009867264,0.0005102135,0.000027347747,0.0004986323,0.00030841684,0.0000356368,0.0002813134,0.0000052665946],"about_ca_topic_score_codex":0.0001589983,"about_ca_topic_score_gemma":0.00031903444,"teacher_disagreement_score":0.0016285387,"about_ca_system_score_codex":0.00015345876,"about_ca_system_score_gemma":0.00015526413,"threshold_uncertainty_score":0.0068007708},"labels":[],"label_agreement":null},{"id":"W1835740169","doi":"10.1016/j.jsc.2010.10.001","title":"Bruno Buchberger and the world of Gröbner bases","year":2010,"lang":"fr","type":"article","venue":"Journal of Symbolic Computation","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University","funders":"","keywords":"Mathematics; Algebra over a field; Pure mathematics","score_opus":0.010168701182477277,"score_gpt":0.3259391925822616,"score_spread":0.31577049139978436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1835740169","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034082096,0.10729228,0.30857623,0.15377317,0.00951317,0.00008828004,0.0009012343,0.0005748276,0.3851987],"genre_scores_gemma":[0.72679305,0.042805027,0.14730757,0.012764486,0.012105553,0.0002507212,0.00051250483,0.00051107234,0.05694996],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9974371,0.0011624084,0.00013838787,0.0002926948,0.0007827206,0.00018662853],"domain_scores_gemma":[0.9954573,0.0032719271,0.00016077243,0.0005567726,0.00041295742,0.00014026953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034756716,0.0009873877,0.0016049913,0.0025784418,0.0032552397,0.0058131763,0.0011281843,0.0030642587,0.008183481],"category_scores_gemma":[0.013326395,0.00091414544,0.0010341775,0.002875868,0.013002855,0.012454726,0.0035842361,0.009171802,0.0020982637],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013752241,0.0000055139985,0.000015148629,0.000023426279,0.0000037009913,0.0000074999452,0.00004232697,0.0008954393,0.000046367804,0.9947425,0.0021657452,0.0020387266],"study_design_scores_gemma":[0.0000065552695,0.0000026932112,0.000007859843,0.000012859391,0.0000013597459,0.000005736959,0.000007463604,0.0011569464,0.00003994871,0.9936046,0.005148473,0.000005562318],"about_ca_topic_score_codex":0.003928098,"about_ca_topic_score_gemma":0.0024055156,"teacher_disagreement_score":0.008183481,"about_ca_system_score_codex":0.0039258134,"about_ca_system_score_gemma":0.0019320283,"threshold_uncertainty_score":0.028483927},"labels":[],"label_agreement":null},{"id":"W1847026520","doi":"10.1200/jco.2009.27.15_suppl.e20514","title":"A randomized phase II trial of a new anticoagulant, apixaban, in metastatic cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada); Montreal General Hospital","funders":"","keywords":"Medicine; Apixaban; Internal medicine; Cancer; Population; Adverse effect; Surgery; Randomized controlled trial; Vitamin K antagonist; Warfarin; Oncology; Rivaroxaban","score_opus":0.29037449288737294,"score_gpt":0.6024170944603658,"score_spread":0.3120426015729929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1847026520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97616553,0.0038473175,0.00082368474,0.0016251062,0.001195321,0.010871141,0.0016532202,0.00015906955,0.0036596814],"genre_scores_gemma":[0.97111547,0.0030157287,0.002228941,0.0025058843,0.0009516989,0.012930115,0.0021191335,0.000028459368,0.005104565],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99902546,0.00067363406,0.000036877565,0.00010975893,0.00005834647,0.00009591931],"domain_scores_gemma":[0.99868387,0.00033283076,0.0003015959,0.000086158114,0.00008833295,0.0005072489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024230797,0.0017849392,0.0023860342,0.0004483361,0.0004045162,0.0010211447,0.00084897457,0.0014086826,0.009005182],"category_scores_gemma":[0.0022855178,0.0006631242,0.0013736946,0.0005113737,0.0010306652,0.0007365447,0.00044539265,0.0024636937,0.0010761495],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.970469,0.009709174,0.0007432527,0.0006279903,0.000512938,0.000065466425,0.000037113685,0.0003941562,0.0021877175,0.000154569,0.001906604,0.013191996],"study_design_scores_gemma":[0.95335305,0.044944048,0.0006733842,0.000016735174,0.00012133341,0.000032526183,0.000007969463,0.00021446329,0.00012441288,0.0000677825,0.00043864772,0.0000055162964],"about_ca_topic_score_codex":0.00093792647,"about_ca_topic_score_gemma":0.0023480991,"teacher_disagreement_score":0.009005182,"about_ca_system_score_codex":0.0009496676,"about_ca_system_score_gemma":0.0019998339,"threshold_uncertainty_score":0.03012538},"labels":[],"label_agreement":null},{"id":"W1857859295","doi":"","title":"Taxane-antibody conjugates afford potent cytotoxicity, enhanced solubility, and tumor target selectivity.","year":2001,"lang":"en","type":"article","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Paclitaxel; Taxane; Cytotoxicity; Pharmacology; Toxicity; Conjugate; Chemistry; Monoclonal antibody; Antibody; Therapeutic index; In vivo; Cancer research; Chemotherapy; In vitro; Cancer; Medicine; Immunology; Biology; Biochemistry; Drug; Breast cancer; Internal medicine","score_opus":0.02077247025562807,"score_gpt":0.28750150077240233,"score_spread":0.26672903051677427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1857859295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94061506,0.011127433,0.03193095,0.00038422915,0.00008292747,0.00028048863,0.00050857407,0.00036526314,0.014705085],"genre_scores_gemma":[0.9648739,0.004164283,0.020057976,0.00012136023,0.00003801734,0.000076774,0.0006477265,0.00009033566,0.009929601],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998271,0.000049213366,0.000012277309,0.00003356476,0.000054180673,0.000023598242],"domain_scores_gemma":[0.9997937,0.000045168475,0.00006487577,0.00002392188,0.000036516365,0.000035885765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017058432,0.00036097577,0.00027419548,0.00029793603,0.00019018905,0.00029967603,0.00020646302,0.0002876442,0.0019597681],"category_scores_gemma":[0.0003376038,0.00017932747,0.00014306942,0.00027014798,0.00013337396,0.0003322908,0.00018968938,0.00038937197,0.00075599004],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049292354,0.00003624988,0.00013224586,0.00003718008,0.000008592793,0.000045117446,0.000016039387,0.00011836535,0.99270284,0.00027177169,0.00009149637,0.0064907046],"study_design_scores_gemma":[0.00002968804,0.00025369675,0.001064348,0.000004118509,0.00001934961,0.0003991008,0.0000038889757,0.00033830636,0.99043906,0.000056879966,0.0073882644,0.0000033383888],"about_ca_topic_score_codex":0.0003587137,"about_ca_topic_score_gemma":0.0011398797,"teacher_disagreement_score":0.0019597681,"about_ca_system_score_codex":0.0004247696,"about_ca_system_score_gemma":0.0002840661,"threshold_uncertainty_score":0.0065560937},"labels":[],"label_agreement":null},{"id":"W1883775064","doi":"","title":"THE EFFECT OF TEMPERATURE, PH, AND DIFFERENT SOLUBILIZING AGENTS ON STABILITY OF TAXOL","year":2005,"lang":"en","type":"article","venue":"Iranian journal of pharmaceutical sciences","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chemistry; Solubility; Polyethylene glycol; PEG ratio; Chromatography; Paclitaxel; Ethanol; Aqueous solution; Glycerol; Nuclear chemistry; Organic chemistry","score_opus":0.06613048537324216,"score_gpt":0.4060296896675298,"score_spread":0.3398992042942876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1883775064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936154,0.00392826,0.0013708391,0.000071728944,0.00003151137,0.00002537913,0.00015831416,0.00002080529,0.00077772763],"genre_scores_gemma":[0.99383426,0.002798067,0.002243942,0.000043248703,0.000013437478,0.000033429314,0.00017765939,0.000016564942,0.0008394061],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982005,0.000043995617,0.00002315706,0.00003489699,0.000046810677,0.000031118638],"domain_scores_gemma":[0.99969184,0.00013470423,0.000078733996,0.000018678898,0.00005101939,0.000025061721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022898629,0.0002456902,0.00023833982,0.00017408161,0.00016763645,0.00026978893,0.0001345049,0.00022142168,0.00073029316],"category_scores_gemma":[0.0005365282,0.00014647694,0.000179733,0.0001958087,0.00020310021,0.00027517258,0.0001276682,0.00041879626,0.00017215051],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036401727,0.00004501287,0.0011159523,0.00007637453,0.000013078858,0.000063110354,0.000061973966,0.00025407242,0.99435025,0.0000373899,0.000040179395,0.0035786193],"study_design_scores_gemma":[0.0000069314037,0.00045867905,0.0048418334,0.0000084697,0.000026133212,0.00011203406,0.00003583806,0.0007691375,0.99278754,0.000025683901,0.00091982016,0.000007828046],"about_ca_topic_score_codex":0.0010377616,"about_ca_topic_score_gemma":0.0013352782,"teacher_disagreement_score":0.0010377616,"about_ca_system_score_codex":0.00022833746,"about_ca_system_score_gemma":0.00025383214,"threshold_uncertainty_score":0.0024431348},"labels":[],"label_agreement":null},{"id":"W1893993642","doi":"10.2147/ceor.s82194","title":"Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective","year":2015,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"Celgene","keywords":"Paclitaxel; Docetaxel; Medicine; Metastatic breast cancer; Breast cancer; Oncology; Perspective (graphical); Cancer; Internal medicine","score_opus":0.18292777179286226,"score_gpt":0.5555170525744136,"score_spread":0.3725892807815514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1893993642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9118774,0.062611334,0.010259961,0.0032997043,0.00013416747,0.0011785689,0.004627621,0.000050872724,0.0059604],"genre_scores_gemma":[0.9892452,0.0068413992,0.0018705137,0.0002724247,0.0000424988,0.00025198623,0.0010598525,0.000008722761,0.0004074144],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99608636,0.0028897503,0.00016554205,0.00026709068,0.00034195348,0.0002492733],"domain_scores_gemma":[0.996151,0.0029476325,0.00036906527,0.00009036522,0.0002781529,0.00016389939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006633052,0.0012596018,0.0022799964,0.003995442,0.00031283824,0.0018118678,0.0011004348,0.00112297,0.0032536124],"category_scores_gemma":[0.012150529,0.00058229914,0.006841302,0.0037883106,0.00063066947,0.00091325125,0.00092521345,0.00095845433,0.000082629114],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018555816,0.00096396665,0.18090403,0.008368657,0.04024156,0.0026269862,0.00037045244,0.6171038,0.0015932687,0.010332104,0.004538348,0.11440104],"study_design_scores_gemma":[0.004858902,0.0064715305,0.16178837,0.0018739641,0.06000501,0.0012906083,0.0012105581,0.74137515,0.0011000714,0.01374991,0.005968176,0.00030772336],"about_ca_topic_score_codex":0.046317145,"about_ca_topic_score_gemma":0.024131307,"teacher_disagreement_score":0.046317145,"about_ca_system_score_codex":0.008885441,"about_ca_system_score_gemma":0.0058943955,"threshold_uncertainty_score":0.09209514},"labels":[],"label_agreement":null},{"id":"W1898942311","doi":"10.1111/j.1460-9568.2011.07652.x","title":"Terminal arbor degeneration - a novel lesion produced by the antineoplastic agent paclitaxel","year":2011,"lang":"en","type":"article","venue":"European Journal of Neuroscience","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"National Institute of Neurological Disorders and Stroke","keywords":"McGill Pain Questionnaire; History; Art; Medicine; Anesthesia","score_opus":0.11304793073527654,"score_gpt":0.31662390928996,"score_spread":0.20357597855468346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1898942311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99532795,0.00064310397,0.0025221317,0.000023550328,0.000012628566,0.000040138937,0.00017059232,0.00007094128,0.0011889661],"genre_scores_gemma":[0.994197,0.0007934578,0.0026119773,0.000033603857,0.000006185575,0.00003549827,0.00020667988,0.000016660011,0.002098892],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999269,0.0000091087395,0.0000057026155,0.00001551747,0.000024753368,0.000017961274],"domain_scores_gemma":[0.99989676,0.000018291097,0.0000355062,0.000015610598,0.000013553748,0.000020251999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058141984,0.00028353036,0.00022998425,0.00030754128,0.00012558467,0.00018282485,0.00011175375,0.00030666994,0.0006056135],"category_scores_gemma":[0.00012306943,0.00013977222,0.00018378456,0.00013770688,0.00016973008,0.00021422595,0.00012951085,0.00036494198,0.00014683578],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048936763,0.000015663309,0.00022686146,0.000017494029,0.0000023721066,0.00008125953,0.000004785635,0.00003262572,0.9988949,0.00001858532,0.0000085006905,0.0006480385],"study_design_scores_gemma":[0.00001557938,0.0007675084,0.020748908,0.0000074547365,0.000016621154,0.0013926792,0.000017827915,0.0007477818,0.9754431,0.000046046833,0.0007922354,0.00000423354],"about_ca_topic_score_codex":0.0004816587,"about_ca_topic_score_gemma":0.0008638021,"teacher_disagreement_score":0.0006056135,"about_ca_system_score_codex":0.00018275688,"about_ca_system_score_gemma":0.000109409215,"threshold_uncertainty_score":0.0020259619},"labels":[],"label_agreement":null},{"id":"W1915661725","doi":"10.1007/s00520-015-2941-0","title":"Treatment of taxane acute pain syndrome (TAPS) in cancer patients receiving taxane-based chemotherapy—a systematic review","year":2015,"lang":"en","type":"review","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Taxane; Amifostine; Gabapentin; Internal medicine; Randomized controlled trial; Placebo; Cancer; Chemotherapy; Oncology; Breast cancer; Pathology","score_opus":0.054903137657369656,"score_gpt":0.42459476693563314,"score_spread":0.3696916292782635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1915661725","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006116432,0.9989365,0.000049608458,0.000059832837,0.000047609043,0.00005721313,0.00010471098,0.0000031417924,0.00012980489],"genre_scores_gemma":[0.007588912,0.9916842,0.00026724063,0.000249811,0.00003576165,0.0000500722,0.00006780579,0.0000013879687,0.00005478041],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9988085,0.00031747873,0.00047959466,0.00012985413,0.00021180008,0.000052740066],"domain_scores_gemma":[0.9962657,0.0024776354,0.00092661433,0.000039107297,0.00022480499,0.000066192515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016101466,0.0008442606,0.0044174218,0.0027750018,0.00029665855,0.0012341412,0.0011010069,0.0010948235,0.0036518916],"category_scores_gemma":[0.00783942,0.000548554,0.0058562285,0.0036033392,0.00041860229,0.0010213018,0.0008397291,0.0011669297,0.0001740904],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005886059,0.000050231214,0.0007033254,0.8944118,0.01434426,0.00008945959,0.000098867225,0.0001693573,0.00026986905,0.00018938232,0.0020464854,0.08703838],"study_design_scores_gemma":[0.0021836634,0.0010268672,0.012675337,0.69493717,0.22904073,0.00096911774,0.00041092242,0.00026203747,0.00037865623,0.00062107405,0.057387467,0.00010693545],"about_ca_topic_score_codex":0.006064695,"about_ca_topic_score_gemma":0.022527374,"teacher_disagreement_score":0.006064695,"about_ca_system_score_codex":0.0011059942,"about_ca_system_score_gemma":0.0026975807,"threshold_uncertainty_score":0.012216806},"labels":[],"label_agreement":null},{"id":"W1918344113","doi":"10.1002/3527600906.mcb.200300127","title":"Antitumor Agents: Taxol and Taxanes-Production by Yew Cell Culture","year":2006,"lang":"en","type":"reference-entry","venue":"Encyclopedia of Molecular Cell Biology and Molecular Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Taxus; Semisynthesis; Biology; Paclitaxel; Botany; Cancer; Biochemistry; Genetics","score_opus":0.008366471509278816,"score_gpt":0.2750037074870158,"score_spread":0.266637235977737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1918344113","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7188975,0.039375708,0.10568027,0.001064633,0.0006648628,0.0025476967,0.051270448,0.0018248566,0.07867395],"genre_scores_gemma":[0.6997452,0.026390944,0.0978061,0.0002483761,0.00013651706,0.0020055796,0.09271517,0.00047091948,0.08048122],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997904,0.000029632876,0.00003922178,0.00004526686,0.00006721921,0.000028372078],"domain_scores_gemma":[0.99992573,0.000016238839,0.000010571592,0.000019669807,0.000018374993,0.000009430793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022681727,0.0005690839,0.00062119804,0.00035446355,0.0002971715,0.0005060428,0.00066080724,0.0004090569,0.0032931564],"category_scores_gemma":[0.00013640067,0.00020108813,0.00031500956,0.0010471038,0.00016829115,0.0003921313,0.000414499,0.00082280766,0.0060672103],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037776263,0.00013426584,0.0002337938,0.0003298842,0.000010121369,0.0002675706,0.000059138772,0.00039177557,0.98564506,0.0008152652,0.0012569309,0.0104784705],"study_design_scores_gemma":[0.000052474825,0.0002159468,0.0006558862,0.000037440812,0.000025778136,0.0004472218,0.000022540813,0.00084135693,0.9389813,0.00016536324,0.058540948,0.000013786558],"about_ca_topic_score_codex":0.00086388935,"about_ca_topic_score_gemma":0.0013756637,"teacher_disagreement_score":0.0032931564,"about_ca_system_score_codex":0.00029148508,"about_ca_system_score_gemma":0.00029363728,"threshold_uncertainty_score":0.0110167265},"labels":[],"label_agreement":null},{"id":"W1924569161","doi":"10.1039/c5md90032h","title":"Correction: Identification of a novel class of autotaxin inhibitors through cross-screening","year":2015,"lang":"en","type":"article","venue":"MedChemComm","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cystic Fibrosis Canada","funders":"","keywords":"Autotaxin; Identification (biology); Class (philosophy); Computational biology; Computer science; Bioinformatics; Chemistry; Artificial intelligence; Biology; Biochemistry; Lysophosphatidic acid","score_opus":0.0887488986745686,"score_gpt":0.3935148326447293,"score_spread":0.3047659339701607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1924569161","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024289731,0.0014314859,0.0017094548,0.05310584,0.9392504,0.000034758523,0.0014501896,0.00095666345,0.0018182575],"genre_scores_gemma":[0.032809786,0.015375357,0.016826168,0.19393793,0.4502925,0.0004928702,0.00853522,0.004009042,0.27772114],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944305,0.0006724043,0.000824729,0.0007889972,0.0025859505,0.0006973861],"domain_scores_gemma":[0.97132605,0.006594281,0.0020680916,0.0018449699,0.016280118,0.0018864711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034468246,0.002224757,0.0023662029,0.0025327755,0.0023743007,0.0037216397,0.004008629,0.007874721,0.0623626],"category_scores_gemma":[0.047854044,0.0012611876,0.002079755,0.0016277807,0.0026263192,0.002394675,0.0024056344,0.01090493,0.040734258],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005526581,0.000007550415,0.00004656223,0.0001848353,0.000020651205,0.00039605607,0.00002074287,0.0000546823,0.000386401,0.0007348752,0.9927065,0.0053859744],"study_design_scores_gemma":[0.000088169756,0.00003658613,0.00052100216,0.00019708007,0.000042413056,0.0010661142,0.00003916104,0.00029624862,0.0013114735,0.0011747921,0.9951841,0.000042833362],"about_ca_topic_score_codex":0.006474139,"about_ca_topic_score_gemma":0.007634381,"teacher_disagreement_score":0.0623626,"about_ca_system_score_codex":0.003247692,"about_ca_system_score_gemma":0.004740453,"threshold_uncertainty_score":0.20862365},"labels":[],"label_agreement":null},{"id":"W1929450387","doi":"10.1200/jco.2000.18.24.4098","title":"Phase I Dose-Finding Study of a New Taxane, RPR 109881A, Administered as a One-Hour Intravenous Infusion Days 1 and 8 to Patients With Advanced Solid Tumors","year":2000,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Pharmacokinetics; Toxicity; Volume of distribution; Taxane; Diarrhea; Renal cell carcinoma; Urology; Gastroenterology; Internal medicine; Pharmacology; Cancer","score_opus":0.11412075096877355,"score_gpt":0.5012709397139472,"score_spread":0.38715018874517365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1929450387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980301,0.0006775144,0.00026298172,0.00009312443,0.000020439913,0.00038868902,0.00011325155,0.000028456765,0.00038540998],"genre_scores_gemma":[0.99490803,0.0007395266,0.0019866019,0.00020023271,0.000058237485,0.00065392826,0.0006816292,0.000016418868,0.0007553209],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996439,0.00015366882,0.00002008219,0.00007362186,0.000057858528,0.000050774594],"domain_scores_gemma":[0.9994777,0.000085749816,0.00019680288,0.000049517752,0.000030160529,0.00016005484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055192,0.0010975249,0.00140237,0.00026993713,0.00025943908,0.0004968674,0.0006996692,0.00083397934,0.0013823234],"category_scores_gemma":[0.00080054,0.00034952606,0.0005859829,0.00021648087,0.0007379719,0.0005004618,0.00024924654,0.0026529322,0.00044211437],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2543909,0.106473476,0.022914216,0.0009238346,0.0010146218,0.00084804214,0.00068301207,0.008654308,0.37672153,0.000361439,0.0031242776,0.22389042],"study_design_scores_gemma":[0.14987223,0.7772692,0.034098547,0.000052648604,0.0003706651,0.001706295,0.000074305935,0.003052201,0.028812412,0.00015935785,0.0044901837,0.0000418981],"about_ca_topic_score_codex":0.00044690436,"about_ca_topic_score_gemma":0.0011376645,"teacher_disagreement_score":0.00140237,"about_ca_system_score_codex":0.0008831283,"about_ca_system_score_gemma":0.00080275227,"threshold_uncertainty_score":0.0064076185},"labels":[],"label_agreement":null},{"id":"W193386846","doi":"10.1200/jco.2009.27.15_suppl.598","title":"Phase II trial of neoadjuvant sequential FEC100 followed by docetaxel and capecitabine for HER2-negative locally advanced breast cancer (LABC): A multicenter study from British Columbia","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Docetaxel; Taxane; Breast cancer; Internal medicine; Capecitabine; Febrile neutropenia; Epirubicin; Population; Regimen; Oncology; Cyclophosphamide; Breast-conserving surgery; Hazard ratio; Neutropenia; Anthracycline; Surgery; Chemotherapy; Cancer; Mastectomy; Confidence interval","score_opus":0.05665022831420631,"score_gpt":0.4761407311572904,"score_spread":0.4194905028430841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W193386846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991271,0.0009403436,0.00019901899,0.00047848243,0.000047430334,0.00402566,0.0011214673,0.00005077964,0.001865782],"genre_scores_gemma":[0.98323935,0.0015871037,0.0012018112,0.0013541379,0.00007774242,0.002895825,0.0031070188,0.000028253113,0.006508726],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99937016,0.00029028917,0.000021191789,0.00008747572,0.00008869199,0.00014230757],"domain_scores_gemma":[0.99879056,0.00011225526,0.00009412154,0.00006370033,0.00014784861,0.00079145696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023486654,0.0015362046,0.0019098205,0.00051133684,0.0014525066,0.0008208471,0.0015196031,0.0011379014,0.0041893097],"category_scores_gemma":[0.0010850767,0.0008601438,0.0006152174,0.00072123244,0.0012801869,0.00037910312,0.00052824395,0.0021862753,0.00093118823],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6442964,0.13627417,0.046014857,0.001146632,0.0017775481,0.001265362,0.000938498,0.0024555663,0.044243444,0.00018701008,0.0150862625,0.10631425],"study_design_scores_gemma":[0.55620456,0.30897465,0.121470824,0.00010133733,0.0009783691,0.0005586706,0.00035936318,0.0015689987,0.0023914617,0.00014342793,0.007152931,0.000095300165],"about_ca_topic_score_codex":0.17454962,"about_ca_topic_score_gemma":0.3749736,"teacher_disagreement_score":0.17454962,"about_ca_system_score_codex":0.00431056,"about_ca_system_score_gemma":0.009100168,"threshold_uncertainty_score":0.3470673},"labels":[],"label_agreement":null},{"id":"W1935026499","doi":"10.1158/1538-7445.sabcs14-pd2-2","title":"Abstract PD2-2: Final efficacy results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Bevacizumab; Breast cancer; Internal medicine; Hazard ratio; Oncology; Taxane; Triple-negative breast cancer; Population; Anthracycline; Randomized controlled trial; Adjuvant therapy; Cancer; Chemotherapy; Confidence interval","score_opus":0.28649548767260063,"score_gpt":0.5366607232827357,"score_spread":0.2501652356101351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1935026499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9589637,0.01713252,0.0016992815,0.0027198957,0.0007037441,0.002748585,0.007245263,0.00012558924,0.008661423],"genre_scores_gemma":[0.9788896,0.0026495392,0.0017232331,0.0023127361,0.0004950812,0.0015882907,0.0087331375,0.000034737604,0.0035736454],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99822026,0.0011897902,0.00007955575,0.00021061618,0.00019618112,0.00010342111],"domain_scores_gemma":[0.9980342,0.0005530836,0.00051506574,0.0001934125,0.00022725038,0.00047704214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040651094,0.00077895995,0.0013673583,0.00019906863,0.00028111783,0.0012296718,0.0006387015,0.0009862394,0.0032917073],"category_scores_gemma":[0.0036353231,0.00030728453,0.0015278988,0.00029427008,0.0004574001,0.00054903625,0.00046660495,0.002507546,0.00056339335],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9196309,0.004679671,0.0057279114,0.0009914826,0.006450295,0.00010030507,0.00007256114,0.0012442372,0.005101416,0.000365349,0.010031379,0.04560437],"study_design_scores_gemma":[0.8872181,0.06844346,0.026833331,0.00014213794,0.005564411,0.00017424724,0.00004425549,0.0016222318,0.0021160818,0.0007597329,0.0070327837,0.0000493275],"about_ca_topic_score_codex":0.0006018388,"about_ca_topic_score_gemma":0.0013596656,"teacher_disagreement_score":0.0040651094,"about_ca_system_score_codex":0.00069657475,"about_ca_system_score_gemma":0.0006995728,"threshold_uncertainty_score":0.02149862},"labels":[],"label_agreement":null},{"id":"W1946451131","doi":"10.18433/j3rp6z","title":"A Rapid and Sensitive HPLC Method for Quantitation of Paclitaxel in Biological Samples using Liquid-Liquid Extraction and UV Detection: Application to Pharmacokinetics and Tissues Distribution Study of Paclitaxel Loaded Targeted Polymeric Micelles in.....","year":2015,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chromatography; High-performance liquid chromatography; Pharmacokinetics; Chemistry; Extraction (chemistry); Paclitaxel; Sodium acetate; Diethyl ether; Elution; Solid phase extraction; Pharmacology; Cancer; Medicine","score_opus":0.19060485613017678,"score_gpt":0.4941516919595262,"score_spread":0.3035468358293494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1946451131","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16520105,0.023150781,0.7969758,0.0010256197,0.0007687935,0.0015144009,0.0015003934,0.004842632,0.005020541],"genre_scores_gemma":[0.28296444,0.016124938,0.6765692,0.0011911358,0.00023165389,0.0021705357,0.002332194,0.00022357238,0.018192375],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99926907,0.00015871559,0.00006590255,0.00013645107,0.00032063175,0.000049225273],"domain_scores_gemma":[0.99964666,0.00006875642,0.000079751306,0.000017506627,0.00016535856,0.000021965141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010200144,0.0010113235,0.0007478901,0.0009593135,0.0003868918,0.00036506462,0.00061822153,0.0008962738,0.0013918052],"category_scores_gemma":[0.00058620726,0.000661023,0.0004590652,0.0005195151,0.00036147633,0.0004037865,0.0003592565,0.0009387714,0.0017606339],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064473825,0.000063647676,0.00019838249,0.00027680557,0.000010982935,0.0000624841,0.0000142639365,0.00013245986,0.9774229,0.000110411966,0.00044975983,0.021193443],"study_design_scores_gemma":[0.000059277125,0.0005423087,0.0020474219,0.00003273166,0.000043629,0.0014085387,0.000019390554,0.0033248775,0.9798915,0.00012240246,0.012461848,0.000046222118],"about_ca_topic_score_codex":0.00074602006,"about_ca_topic_score_gemma":0.00168363,"teacher_disagreement_score":0.0013918052,"about_ca_system_score_codex":0.0005606413,"about_ca_system_score_gemma":0.0011841417,"threshold_uncertainty_score":0.005394399},"labels":[],"label_agreement":null},{"id":"W1948155544","doi":"10.1093/annonc/mdu326.14","title":"Genome-Wide Association Study (Gwas) Identifies Candidate Neurotoxicity Markers in Platinum-Taxane Treated Ovarian Cancer Patients in Icon7","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Genome-wide association study; Oncology; Internal medicine; Hazard ratio; Taxane; Genetic model; Carboplatin; Odds ratio; Confidence interval; Cancer; Single-nucleotide polymorphism; Breast cancer; Genetics; Genotype; Biology; Chemotherapy","score_opus":0.038762503880015134,"score_gpt":0.3719917841676429,"score_spread":0.33322928028762777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1948155544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99735236,0.0005907857,0.00015423108,0.0001270965,0.0000215316,0.000010437552,0.00060137105,0.0000069355183,0.0011353719],"genre_scores_gemma":[0.99819607,0.00023997415,0.00014936157,0.000113789865,0.000022444643,0.000008292505,0.0006971777,0.000011376138,0.00056153873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993875,0.00012322792,0.000073712756,0.00017219844,0.000109289824,0.00013402567],"domain_scores_gemma":[0.99894184,0.00026106124,0.00036882272,0.000112441565,0.00016495102,0.00015095786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005580346,0.0004160651,0.0005582559,0.0008938889,0.0009407619,0.0011746426,0.00049434986,0.00063575024,0.0032726277],"category_scores_gemma":[0.0019201117,0.00024215408,0.0010159406,0.0025423528,0.0003060268,0.000277739,0.00060719386,0.0008835589,0.00028967988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010185181,0.000067157314,0.9902547,0.00004281744,0.0005665013,0.0006091848,0.000121750534,0.00006678642,0.0022593793,0.0001433836,0.0004290516,0.0044207005],"study_design_scores_gemma":[0.00005600804,0.0001779949,0.99627715,0.0000197447,0.0006372248,0.000756931,0.00017571896,0.00020653833,0.0003458098,0.00014616446,0.0011931421,0.0000074899913],"about_ca_topic_score_codex":0.0074994178,"about_ca_topic_score_gemma":0.015642341,"teacher_disagreement_score":0.0074994178,"about_ca_system_score_codex":0.0004178874,"about_ca_system_score_gemma":0.000724477,"threshold_uncertainty_score":0.014911532},"labels":[],"label_agreement":null},{"id":"W1949239131","doi":"10.1016/j.jsc.2015.11.008","title":"Quantifier elimination by cylindrical algebraic decomposition based on regular chains","year":2015,"lang":"en","type":"article","venue":"Journal of Symbolic Computation","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Natural Science Foundation of China","keywords":"Quantifier elimination; Mathematics; Maple; Algebraic number; Decomposition; Tree (set theory); Algebra over a field; Quantifier (linguistics); Algorithm; Discrete mathematics; Combinatorics; Pure mathematics; Computer science; Mathematical analysis; Artificial intelligence","score_opus":0.0341643223409559,"score_gpt":0.3701513871499987,"score_spread":0.3359870648090428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1949239131","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.056313872,0.00020286492,0.93066496,0.00021553093,0.00009423314,0.00007693637,0.00018863665,0.000716798,0.011526164],"genre_scores_gemma":[0.56244874,0.0003232732,0.42585814,0.00018842015,0.00011417169,0.00010093294,0.00055559987,0.00039961308,0.010011091],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9992893,0.00013157773,0.000049993076,0.00013297153,0.00024964067,0.00014641845],"domain_scores_gemma":[0.99919504,0.0003418348,0.00006391347,0.0001513844,0.00018735351,0.000060413917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073766476,0.0004797342,0.000996988,0.0013918749,0.0009279887,0.0017174876,0.00080551003,0.00039204943,0.0053683277],"category_scores_gemma":[0.0022406837,0.00038815063,0.0014549347,0.0010368668,0.0016351341,0.0022582093,0.0018803745,0.0013433569,0.00090586895],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017927328,0.00006611803,0.00046250338,0.00012603603,0.000043681226,0.00020214875,0.00023343945,0.020304361,0.009521156,0.91198444,0.0021150236,0.05476188],"study_design_scores_gemma":[0.000040162264,0.000059667444,0.00020658912,0.000039007686,0.000050263334,0.00012867425,0.000067188936,0.15164015,0.0054911515,0.8357248,0.0065130573,0.000039282822],"about_ca_topic_score_codex":0.0021398214,"about_ca_topic_score_gemma":0.0034811276,"teacher_disagreement_score":0.0053683277,"about_ca_system_score_codex":0.0006407941,"about_ca_system_score_gemma":0.0010821522,"threshold_uncertainty_score":0.01795882},"labels":[],"label_agreement":null},{"id":"W1949811104","doi":"10.1200/jco.2001.19.2.314","title":"Phase II Study of Docetaxel, Doxorubicin, and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer","year":2001,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"","keywords":"Medicine; Docetaxel; Metastatic breast cancer; Neutropenia; Cyclophosphamide; Febrile neutropenia; Internal medicine; Chemotherapy; Doxorubicin; Regimen; Breast cancer; Surgery; Phases of clinical research; Gastroenterology; Adverse effect; Cancer; Oncology","score_opus":0.1341035759241524,"score_gpt":0.5424805441816323,"score_spread":0.4083769682574799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1949811104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905172,0.0029479892,0.0006854861,0.00033273714,0.0001718065,0.0037894954,0.00052142696,0.00008073099,0.0009531471],"genre_scores_gemma":[0.98111695,0.0027048725,0.004151252,0.0009451654,0.00028928128,0.0051492513,0.0028600662,0.000029048233,0.002754087],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99938893,0.0003159312,0.00003119952,0.0000812967,0.000074972784,0.0001076846],"domain_scores_gemma":[0.9989697,0.00015800922,0.00018231414,0.000072569565,0.00007338657,0.0005440938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019173119,0.0014596699,0.0018943866,0.00048590952,0.00039052733,0.00071372936,0.0011610521,0.0010016818,0.002826396],"category_scores_gemma":[0.0011518943,0.0006443795,0.00095996,0.0005025314,0.0008610496,0.0005128403,0.000332281,0.0024913112,0.00073634996],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.53889155,0.23012505,0.014445541,0.0013026376,0.001495573,0.0007882439,0.0003790026,0.0037133154,0.07662302,0.00023943935,0.0046101497,0.12738645],"study_design_scores_gemma":[0.512972,0.46556762,0.011826038,0.000043279695,0.0003402527,0.00045394897,0.000036552923,0.0010214637,0.004892633,0.000072650495,0.0027532373,0.000020331712],"about_ca_topic_score_codex":0.0014079214,"about_ca_topic_score_gemma":0.0039539235,"teacher_disagreement_score":0.002826396,"about_ca_system_score_codex":0.0009359546,"about_ca_system_score_gemma":0.0022637255,"threshold_uncertainty_score":0.010139883},"labels":[],"label_agreement":null},{"id":"W1951680383","doi":"","title":"BOOK REVIEW: Chemotherapy and Biotherapy Guidelines, and Recommendations for Practice 4th Edition","year":2015,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oncology nursing; Medicine; Clinical Oncology; Clinical Practice; Medical education; Best practice; Alternative medicine; Oncology; Nursing; Internal medicine; Political science; Nurse education; Pathology; Cancer","score_opus":0.41398725240106415,"score_gpt":0.6490444620350906,"score_spread":0.23505720963402643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1951680383","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00065951166,0.4587429,0.0043182448,0.09700136,0.15057878,0.0006436151,0.003232264,0.0014672526,0.28335616],"genre_scores_gemma":[0.002866512,0.37827608,0.0064639477,0.054219067,0.03928384,0.0006724516,0.0042619463,0.00046948539,0.5134867],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99873775,0.00018532516,0.00012028568,0.00006793581,0.0008291073,0.000059641265],"domain_scores_gemma":[0.9956215,0.0012070519,0.00039725204,0.000084496794,0.0023571255,0.0003325191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010622462,0.000983165,0.001475402,0.0025705379,0.0006543264,0.0037988615,0.0013265668,0.0022144313,0.080895625],"category_scores_gemma":[0.0089517515,0.0005806479,0.0008409275,0.003238143,0.0005724058,0.0025245526,0.0009511173,0.0041268915,0.079145215],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004530914,0.000009467085,0.000018637344,0.00022694563,0.0000017187882,0.000016406872,0.000008690287,0.000033717148,0.0000332041,0.00033231502,0.96704,0.032274373],"study_design_scores_gemma":[0.0000057928282,0.000010537222,0.00017250235,0.0008039348,0.000003911662,0.00015701575,0.000014819135,0.000028907598,0.000022027993,0.00041344046,0.9983606,0.000006521953],"about_ca_topic_score_codex":0.005576143,"about_ca_topic_score_gemma":0.012490823,"teacher_disagreement_score":0.080895625,"about_ca_system_score_codex":0.0017109914,"about_ca_system_score_gemma":0.0050897854,"threshold_uncertainty_score":0.27062285},"labels":[],"label_agreement":null},{"id":"W1955302899","doi":"10.1002/jlcr.701","title":"A convenient synthesis of <sup>13</sup>C<sub>4</sub>‐Leflunomide and its primary metabolite <sup>13</sup>C<sub>4</sub>‐A77 1726","year":2003,"lang":"en","type":"article","venue":"Journal of Labelled Compounds and Radiopharmaceuticals","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Chemistry; Metabolite; Yield (engineering); Leflunomide; Bioavailability; Primary metabolite; Primary (astronomy); Stereochemistry; Radiochemistry; Biochemistry; Pharmacology","score_opus":0.022294699551875245,"score_gpt":0.29185898935229937,"score_spread":0.26956428980042413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1955302899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81234443,0.0075902743,0.126148,0.0006049928,0.000352786,0.0019674823,0.0065148724,0.0009441201,0.043533094],"genre_scores_gemma":[0.87297225,0.006076737,0.092378415,0.00018284106,0.00008474452,0.0007300991,0.004216452,0.00025850759,0.023099944],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998982,0.000015833755,0.000009078178,0.000018426286,0.000033819,0.000024639727],"domain_scores_gemma":[0.9999114,0.000015693164,0.000014444361,0.00001199664,0.000021712256,0.000024719957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021017528,0.00052458735,0.0004430873,0.00025835744,0.00028116928,0.0002559232,0.00033473558,0.0003024026,0.0057936264],"category_scores_gemma":[0.00018419174,0.0002360003,0.00023992373,0.00022991716,0.00018883617,0.0002825546,0.00027175713,0.00053802354,0.0025022668],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015110582,0.000027118947,0.00003804515,0.0001312651,0.0000084242365,0.00025401308,0.00003610107,0.00031837172,0.9894258,0.0008416243,0.00030194878,0.008466226],"study_design_scores_gemma":[0.000058472477,0.0005187837,0.000365031,0.000007850525,0.000018308094,0.00039313734,0.000014900139,0.00026329394,0.98053074,0.00020840864,0.01760527,0.000015865928],"about_ca_topic_score_codex":0.000592732,"about_ca_topic_score_gemma":0.0013489653,"teacher_disagreement_score":0.0057936264,"about_ca_system_score_codex":0.00027368253,"about_ca_system_score_gemma":0.0007265952,"threshold_uncertainty_score":0.019381642},"labels":[],"label_agreement":null},{"id":"W1963774763","doi":"10.4048/jbc.2006.9.3.172","title":"The evidence for adjuvant taxanes in early breast cancer","year":2006,"lang":"en","type":"article","venue":"Journal of Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Breast cancer; Oncology; Adjuvant; Internal medicine; Cancer","score_opus":0.03311051664040824,"score_gpt":0.373304807404305,"score_spread":0.34019429076389673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963774763","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.086213835,0.8763683,0.0007447687,0.022303777,0.0015005636,0.00009508913,0.0006933426,0.000023387283,0.012056914],"genre_scores_gemma":[0.39735317,0.5792563,0.0015242059,0.012534872,0.0049488065,0.000094244206,0.0009544461,0.000028880986,0.0033051404],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9986546,0.000663954,0.00021690104,0.00010879729,0.00026046627,0.000095245385],"domain_scores_gemma":[0.9780457,0.016853372,0.002690123,0.00067882944,0.0010657479,0.000666237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040872935,0.00040950498,0.0016857103,0.00070315035,0.00033511457,0.0011103954,0.00070322753,0.0013998075,0.010171664],"category_scores_gemma":[0.014961311,0.00026808202,0.0013035857,0.0008859818,0.0011653772,0.0014301075,0.00077389984,0.003163951,0.00071945105],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.065556295,0.00089496496,0.034831736,0.03317836,0.0041979,0.00081594725,0.0002482137,0.0011583447,0.011390798,0.0064864387,0.010985102,0.83025587],"study_design_scores_gemma":[0.0247046,0.058882818,0.24378733,0.05495282,0.026549269,0.006771283,0.001032007,0.0014053953,0.009164171,0.026539294,0.5460443,0.00016676047],"about_ca_topic_score_codex":0.0009693889,"about_ca_topic_score_gemma":0.0041368133,"teacher_disagreement_score":0.010171664,"about_ca_system_score_codex":0.00077226403,"about_ca_system_score_gemma":0.0013508834,"threshold_uncertainty_score":0.034027576},"labels":[],"label_agreement":null},{"id":"W1964079865","doi":"10.2146/ajhp110342","title":"Physical compatibility of calcium gluconate and magnesium sulfate injections","year":2012,"lang":"en","type":"letter","venue":"American Journal of Health-System Pharmacy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Charles-Le Moyne; Université de Montréal","funders":"","keywords":"Pharmacy; Pharmacist; Library science; Medicine; Art; Family medicine; Computer science","score_opus":0.05049993515399365,"score_gpt":0.39045579353365756,"score_spread":0.3399558583796639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964079865","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26979575,0.35135946,0.011326029,0.011663383,0.007962874,0.0018301811,0.0028370253,0.0013679013,0.34185737],"genre_scores_gemma":[0.6725685,0.17235914,0.012202635,0.004278772,0.0039535877,0.0007236361,0.0019506444,0.0004970105,0.1314661],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981541,0.00027700415,0.00010676141,0.00007519946,0.001273965,0.0001129375],"domain_scores_gemma":[0.9986313,0.000421265,0.00040261762,0.00006408425,0.0002992565,0.00018144267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013429085,0.00033462868,0.0005897881,0.0017629494,0.00048441137,0.001651276,0.00053968123,0.0008007411,0.025328256],"category_scores_gemma":[0.003538789,0.00018149163,0.0007077175,0.0012369909,0.0004991481,0.0007844144,0.0008069463,0.0006721395,0.0051259706],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037494584,0.00077464076,0.007164366,0.007078548,0.0002986448,0.003023205,0.00039775524,0.00037108897,0.09586329,0.006207916,0.11854425,0.7565268],"study_design_scores_gemma":[0.00074596686,0.00865614,0.0458538,0.0028003373,0.00068870094,0.017278759,0.0007128629,0.0014493197,0.090881936,0.0023962904,0.8283607,0.00017527262],"about_ca_topic_score_codex":0.0035812077,"about_ca_topic_score_gemma":0.0042009032,"teacher_disagreement_score":0.025328256,"about_ca_system_score_codex":0.0007027304,"about_ca_system_score_gemma":0.0015717011,"threshold_uncertainty_score":0.08473146},"labels":[],"label_agreement":null},{"id":"W1966160601","doi":"10.1002/chin.200133273","title":"ChemInform Abstract: The Transannular Diels—Alder Strategy: Applications to Total Synthesis","year":2001,"lang":"en","type":"article","venue":"ChemInform","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Chemistry; Service (business); Nanotechnology; Business; Marketing","score_opus":0.02693718241581238,"score_gpt":0.3123991488376083,"score_spread":0.2854619664217959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966160601","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.053544525,0.037611756,0.70750856,0.0032228692,0.0039573167,0.00065259874,0.004112116,0.0071527786,0.18223754],"genre_scores_gemma":[0.42280942,0.08206375,0.24781886,0.0015044968,0.00076088705,0.0008002939,0.004955993,0.0018710681,0.23741528],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99967813,0.000055646186,0.000018501072,0.0000578695,0.00015412144,0.000035861776],"domain_scores_gemma":[0.99991834,0.00001536671,0.000010162734,0.0000165098,0.000022789436,0.00001686715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005962296,0.0011225406,0.0006566046,0.001047912,0.00051332783,0.0010508167,0.00066782726,0.00049541483,0.01510983],"category_scores_gemma":[0.00036353045,0.00042727325,0.0007132071,0.0011175541,0.00041565404,0.0010880055,0.0008991195,0.001468187,0.009100685],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007584983,0.00024383947,0.00011709346,0.0027364555,0.00018080237,0.00045256212,0.00028998105,0.010923033,0.38138258,0.07686304,0.07535808,0.450694],"study_design_scores_gemma":[0.00021233913,0.00094336184,0.00028113252,0.00013334546,0.00011571584,0.00073738856,0.000061676285,0.018251756,0.6463238,0.033180278,0.29965279,0.000106356485],"about_ca_topic_score_codex":0.00051673874,"about_ca_topic_score_gemma":0.0008441922,"teacher_disagreement_score":0.01510983,"about_ca_system_score_codex":0.00063145376,"about_ca_system_score_gemma":0.00074404385,"threshold_uncertainty_score":0.05054742},"labels":[],"label_agreement":null},{"id":"W1966385883","doi":"10.1007/s10549-014-3221-2","title":"Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Ottawa Regional Cancer Foundation; Montreal General Hospital; Ottawa Hospital; Centre Hospitalier de l’Université de Montréal","funders":"NSABP Foundation; GlaxoSmithKline","keywords":"Pazopanib; Medicine; Cyclophosphamide; Oncology; Breast cancer; Paclitaxel; Doxorubicin; Internal medicine; Neoadjuvant therapy; Chemotherapy; Cancer","score_opus":0.048088481825683545,"score_gpt":0.43952695847675566,"score_spread":0.3914384766510721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966385883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951133,0.0014737982,0.00030743508,0.00023700982,0.0001281194,0.00082212716,0.0004455683,0.000072557275,0.0014000587],"genre_scores_gemma":[0.9889698,0.0031723282,0.0014820975,0.00044576416,0.0002567118,0.001138801,0.0015301219,0.000047803063,0.002956657],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994221,0.00022823083,0.00003394646,0.00010211193,0.00006298599,0.0001506093],"domain_scores_gemma":[0.9991242,0.00015275762,0.00014466069,0.00010516514,0.000030081766,0.00044300442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016271578,0.0014168277,0.0028504708,0.00070729374,0.0004574648,0.0012376321,0.0011590907,0.00135783,0.0027292455],"category_scores_gemma":[0.0011163603,0.0008713582,0.0016124302,0.00068907975,0.0013305106,0.0014457578,0.00044261533,0.00433417,0.0010784448],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7577937,0.09852014,0.0038750828,0.00050957646,0.0011538031,0.0002029261,0.00022234717,0.0033592272,0.020901347,0.00020407887,0.0016357566,0.11162208],"study_design_scores_gemma":[0.42867526,0.55225974,0.011512286,0.000044382246,0.00060159323,0.000350706,0.000069285656,0.0012907962,0.0032109718,0.0001641402,0.0017746086,0.000046245754],"about_ca_topic_score_codex":0.0016472372,"about_ca_topic_score_gemma":0.0058770804,"teacher_disagreement_score":0.0028504708,"about_ca_system_score_codex":0.0010639157,"about_ca_system_score_gemma":0.0017561577,"threshold_uncertainty_score":0.00913018},"labels":[],"label_agreement":null},{"id":"W1966438134","doi":"10.1158/0008-5472.sabcs11-p2-14-02","title":"P2-14-02: NCIC CTG MA.27: Clinical Tolerability and Overall Survival of Racial and Ethnic Minority Women on Aromatase Inhibitor Therapy.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Aromatase inhibitor; Breast cancer; Pacific islanders; Anastrozole; Proportional hazards model; Exemestane; Cancer; Tamoxifen; Oncology; Demography; Population","score_opus":0.34842295435104587,"score_gpt":0.5226997295747786,"score_spread":0.17427677522373275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966438134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994528,0.0016103816,0.00006922216,0.00037637356,0.0000321684,0.00023767733,0.0014278998,0.000020477843,0.0016978835],"genre_scores_gemma":[0.9921095,0.00069503987,0.00023619007,0.0005120174,0.00010922677,0.00040290304,0.003565325,0.000015298088,0.0023544692],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99982834,0.000086082146,0.000010346277,0.000020799918,0.000026832848,0.000027504033],"domain_scores_gemma":[0.9995871,0.00006308688,0.0000869061,0.000026107633,0.000043386277,0.00019346752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008218658,0.00032275266,0.00055928907,0.00020443302,0.00020280898,0.000318143,0.000350599,0.00041000205,0.0040406655],"category_scores_gemma":[0.00077170524,0.00010390592,0.00036619746,0.0002477031,0.00021932408,0.00023134779,0.00020172397,0.00081262673,0.00066818984],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6415875,0.019851115,0.10722007,0.00048588766,0.0011277243,0.00045003544,0.00021871389,0.0010191322,0.054081332,0.00017461754,0.01620191,0.15758196],"study_design_scores_gemma":[0.15420134,0.3851622,0.42571935,0.00013014468,0.0013918679,0.0010392348,0.00017392062,0.0020641503,0.015666429,0.00014160198,0.014255238,0.000054582535],"about_ca_topic_score_codex":0.0021313548,"about_ca_topic_score_gemma":0.003511592,"teacher_disagreement_score":0.0040406655,"about_ca_system_score_codex":0.00043085476,"about_ca_system_score_gemma":0.00078323757,"threshold_uncertainty_score":0.01351732},"labels":[],"label_agreement":null},{"id":"W1967669588","doi":"10.1007/s00280-005-0145-x","title":"Preferential extravasation and accumulation of liposomal vincristine in tumor comparing to normal tissue enhances antitumor activity","year":2005,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"","keywords":"Extravasation; Vincristine; Liposome; Pharmacology; Medicine; Cancer research; Chemotherapy; Chemistry; Pathology; Internal medicine; Cyclophosphamide; Biochemistry","score_opus":0.05915090412979619,"score_gpt":0.41597934344471604,"score_spread":0.35682843931491987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967669588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929516,0.0016631002,0.0028536874,0.00004740963,0.000015998867,0.000022599123,0.00009711603,0.000065394284,0.0022830586],"genre_scores_gemma":[0.99654406,0.00043425293,0.0008555454,0.000015678275,0.0000085579995,0.000012849271,0.00008599417,0.000021159589,0.0020218617],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999144,0.000015622445,0.0000047097633,0.000018812414,0.000015540583,0.000030899362],"domain_scores_gemma":[0.9998728,0.000041940784,0.000020154734,0.000016646276,0.000015232102,0.0000331574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001242737,0.00020492736,0.00025733205,0.00025433602,0.00012392082,0.00027378273,0.00011807481,0.00020094073,0.0019123427],"category_scores_gemma":[0.00015610273,0.00012630645,0.00012386424,0.0001250708,0.00017975648,0.0003613745,0.00021231429,0.00036018636,0.00036710643],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016368268,0.00001321547,0.000118835495,0.000024181514,0.0000021218766,0.00002084716,0.0000073118326,0.00004496854,0.99813914,0.00009210136,0.000015102764,0.0013583729],"study_design_scores_gemma":[0.0000069441903,0.00027754533,0.0021807598,0.0000024217031,0.000009362199,0.00019789905,0.000010920464,0.00044186672,0.9961569,0.000035246983,0.0006785247,0.0000016666581],"about_ca_topic_score_codex":0.00032584998,"about_ca_topic_score_gemma":0.00036293955,"teacher_disagreement_score":0.0019123427,"about_ca_system_score_codex":0.00023289747,"about_ca_system_score_gemma":0.00021452436,"threshold_uncertainty_score":0.0063974857},"labels":[],"label_agreement":null},{"id":"W1968260891","doi":"10.1038/nrclinonc.2013.87","title":"Maintenance therapy in breast cancer—many questions remain","year":2013,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canada Research Chairs","keywords":"Medicine; Breast cancer; Oncology; Chemotherapy; Internal medicine; Clinical trial; Disease; Maintenance therapy; Cancer","score_opus":0.19734653868178328,"score_gpt":0.5794666941963679,"score_spread":0.38212015551458456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968260891","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009687073,0.99787474,0.00010012261,0.0010848325,0.0002654725,0.000003846846,0.000024704215,0.000006081016,0.0005433612],"genre_scores_gemma":[0.0011355365,0.99633527,0.00021738643,0.0012739716,0.00046067318,0.000008850586,0.000031187803,0.0000024585067,0.00053456303],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978894,0.000061418345,0.00004194723,0.0000393847,0.000049824735,0.00001846026],"domain_scores_gemma":[0.99939907,0.00036393036,0.00009089759,0.000021065916,0.00009342378,0.000031573032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011690786,0.0005404581,0.0017853243,0.0008190282,0.00021373935,0.0011305969,0.00093637477,0.0009778333,0.0052568964],"category_scores_gemma":[0.001557938,0.00022975015,0.0005547162,0.0012046689,0.0006267196,0.0019115073,0.0006188308,0.0025539887,0.0018964335],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015835781,0.000059987367,0.00015999864,0.011165169,0.0001029833,0.00006368277,0.000032689266,0.00020289767,0.0006277207,0.0024378367,0.03646625,0.9485224],"study_design_scores_gemma":[0.000117948235,0.0002416808,0.0011059609,0.0073867273,0.00030852217,0.0005447446,0.00006343103,0.00013502265,0.00026861092,0.0027204289,0.9870861,0.0000208529],"about_ca_topic_score_codex":0.00094928994,"about_ca_topic_score_gemma":0.0032048938,"teacher_disagreement_score":0.0052568964,"about_ca_system_score_codex":0.00059202255,"about_ca_system_score_gemma":0.0011707001,"threshold_uncertainty_score":0.017586052},"labels":[],"label_agreement":null},{"id":"W1968449590","doi":"10.1016/j.ejca.2011.06.018","title":"Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: Results from AVADO","year":2011,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Sanofi; F. Hoffmann-La Roche; Amgen","keywords":"Docetaxel; Bevacizumab; Medicine; Metastatic breast cancer; Neutropenia; Internal medicine; Hazard ratio; Febrile neutropenia; Adverse effect; Oncology; Breast cancer; Placebo; Population; Chemotherapy; Cancer; Confidence interval; Surgery; Pathology","score_opus":0.03946862490249079,"score_gpt":0.3032199038091107,"score_spread":0.26375127890661987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968449590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99184,0.0062874863,0.000084927706,0.00015008361,0.000048987662,0.000085037114,0.00040730418,0.000016070302,0.0010800405],"genre_scores_gemma":[0.99338174,0.0041423775,0.00033017204,0.00018561288,0.000070147806,0.000050875246,0.0006245198,0.000014184029,0.0012004595],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999772,0.00008088234,0.0000146614175,0.000048843063,0.00004918044,0.000034421344],"domain_scores_gemma":[0.9996859,0.00007412056,0.00008401908,0.000024792662,0.000031574324,0.00009958206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054349663,0.00031768624,0.0013062496,0.00028635023,0.00019545651,0.0005399936,0.00038019504,0.00036498634,0.0010972469],"category_scores_gemma":[0.0008106731,0.00018321698,0.0009571941,0.00028080842,0.00022671607,0.00027076426,0.00016549774,0.0010216127,0.00022075616],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44347984,0.020184323,0.04531596,0.0011979877,0.0033524313,0.00030302367,0.0003625828,0.0021032095,0.051216878,0.00021969598,0.0026876815,0.42957637],"study_design_scores_gemma":[0.223925,0.45855203,0.27650478,0.0002690871,0.006960885,0.001619884,0.00041169435,0.002509719,0.012807435,0.00025610605,0.016068965,0.00011432187],"about_ca_topic_score_codex":0.0026714632,"about_ca_topic_score_gemma":0.007889883,"teacher_disagreement_score":0.0026714632,"about_ca_system_score_codex":0.0006815646,"about_ca_system_score_gemma":0.0005383275,"threshold_uncertainty_score":0.0053118467},"labels":[],"label_agreement":null},{"id":"W1968974195","doi":"10.1097/mph.0b013e3181d419ad","title":"Vincristine-induced Peripheral Neuropathy in a Neonate With Congenital Acute Lymphoblastic Leukemia","year":2010,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Vincristine; Peripheral neuropathy; Fulminant; Neurotoxicity; Pediatrics; Anesthesia; Surgery; Internal medicine; Chemotherapy; Toxicity; Cyclophosphamide; Endocrinology","score_opus":0.013607410682939625,"score_gpt":0.3117093861858941,"score_spread":0.2981019755029545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968974195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99084854,0.0025632456,0.0012257043,0.001161741,0.00012599704,0.00005770045,0.00008341401,0.000098082804,0.0038355188],"genre_scores_gemma":[0.99716055,0.0011377003,0.0006583453,0.00030857683,0.00008068285,0.000012762495,0.000040044335,0.000014916302,0.0005864296],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996076,0.00007052419,0.00005049153,0.000080061385,0.000063537336,0.00012780773],"domain_scores_gemma":[0.99886274,0.00037424997,0.00028199953,0.000064309614,0.00007222427,0.00034448484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032258165,0.0010130864,0.0007971879,0.0009759797,0.0015849688,0.0007265952,0.0005757682,0.0020955808,0.0011610067],"category_scores_gemma":[0.003073724,0.0006140203,0.0004983394,0.0005102027,0.0011489114,0.00081958715,0.001144487,0.0020968975,0.000382437],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032317137,0.000014932289,0.006050531,0.000022294476,0.0000032827295,0.9919905,0.00012605099,0.000051638603,0.0007471187,0.00007620722,0.000065392705,0.0008197704],"study_design_scores_gemma":[0.000006753202,0.00009691757,0.004289685,0.00001225158,0.000008554646,0.9944982,0.0001069822,0.00013435041,0.0006024111,0.0000488494,0.00019044375,0.0000045489355],"about_ca_topic_score_codex":0.0024071648,"about_ca_topic_score_gemma":0.0028129471,"teacher_disagreement_score":0.0024071648,"about_ca_system_score_codex":0.0011414471,"about_ca_system_score_gemma":0.0007073379,"threshold_uncertainty_score":0.008281767},"labels":[],"label_agreement":null},{"id":"W1969417922","doi":"10.1007/s13318-014-0205-x","title":"A metoprolol–terbinafine combination induced bradycardia","year":2014,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Metoprolol; Bradycardia; Medicine; Sinus bradycardia; Anesthesia; Terbinafine; Bisoprolol; Heart rate; Coronary artery disease; Adverse effect; Cardiology; Internal medicine; Pharmacology; Heart failure; Blood pressure; Dermatology","score_opus":0.0174463820794326,"score_gpt":0.2840406483624154,"score_spread":0.2665942662829828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969417922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99168783,0.0013709855,0.0021866392,0.00086581416,0.00035738925,0.00018507915,0.00023117801,0.00012097075,0.0029941648],"genre_scores_gemma":[0.9982439,0.00029702432,0.00027174337,0.000358407,0.0000676775,0.000026071008,0.000075198484,0.000008138781,0.0006518899],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.999806,0.00005519325,0.000022993469,0.000038857455,0.000040171257,0.000036796762],"domain_scores_gemma":[0.9996704,0.00012964013,0.00006802073,0.000035916913,0.000015970654,0.000080024045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001499865,0.00039688984,0.0005769919,0.0001785893,0.00020301096,0.00019886014,0.00026001086,0.0007382755,0.0014987749],"category_scores_gemma":[0.000712952,0.00015732207,0.00044758414,0.0001773598,0.0001825418,0.0001584418,0.00015288549,0.0019337228,0.0002777353],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061776806,0.0054237493,0.01867725,0.0006123587,0.0006991582,0.23936702,0.00042580935,0.0015281822,0.5030602,0.0010294662,0.0037588116,0.16364111],"study_design_scores_gemma":[0.011978524,0.14702676,0.22147374,0.00009274375,0.0012021739,0.3705078,0.00035824487,0.016338011,0.20373239,0.0009585283,0.026177535,0.00015356093],"about_ca_topic_score_codex":0.00063726417,"about_ca_topic_score_gemma":0.0008357518,"teacher_disagreement_score":0.0014987749,"about_ca_system_score_codex":0.00035048937,"about_ca_system_score_gemma":0.00023873943,"threshold_uncertainty_score":0.0050139427},"labels":[],"label_agreement":null},{"id":"W1970571080","doi":"10.1016/j.chroma.2011.03.010","title":"Efficient purification of paclitaxel from yews using high-performance displacement chromatography technique","year":2011,"lang":"en","type":"article","venue":"Journal of Chromatography A","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Biotechnology Research Institute","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Trifluoroacetic acid; Chemistry; Chromatography; Methanol; Solvent; Hexane; Elution; Paclitaxel; Chloroform; Aqueous solution; Acetic acid; Taxus; Acetonitrile; Organic chemistry","score_opus":0.030166633912510687,"score_gpt":0.2873817177376819,"score_spread":0.2572150838251712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970571080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8829923,0.0040062563,0.10683417,0.0009930333,0.00012692624,0.00017259484,0.0011581724,0.00064511294,0.0030713987],"genre_scores_gemma":[0.9164173,0.0028675203,0.054079447,0.00022396502,0.000034653214,0.00013768495,0.0038969053,0.00017660916,0.022165995],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991465,0.000012648803,0.000008971363,0.000013481978,0.000025706193,0.000024481158],"domain_scores_gemma":[0.99993944,0.000016417778,0.00001054441,0.000009902241,0.000016169366,0.000007484211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012589918,0.00039485068,0.00033524368,0.00019450781,0.00021707512,0.00030494426,0.00027283138,0.00024412153,0.0009802468],"category_scores_gemma":[0.0002070414,0.00013294454,0.00027388014,0.000277304,0.00016138445,0.00023748557,0.00024661887,0.0006820637,0.0009310374],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004883542,0.000016628002,0.00021726369,0.000036912836,0.000008263289,0.000076211545,0.000019117262,0.00011810923,0.99391973,0.00017078953,0.00021093976,0.005157235],"study_design_scores_gemma":[0.000005394239,0.000025074574,0.0005642907,0.0000023951518,0.0000046769296,0.00009256988,0.000009876794,0.0004590145,0.9962205,0.000034135614,0.0025790937,0.0000030620465],"about_ca_topic_score_codex":0.0014446953,"about_ca_topic_score_gemma":0.0023660464,"teacher_disagreement_score":0.0014446953,"about_ca_system_score_codex":0.00030454883,"about_ca_system_score_gemma":0.000350777,"threshold_uncertainty_score":0.0032792687},"labels":[],"label_agreement":null},{"id":"W1970591544","doi":"10.5737/1181912x153168174","title":"La fonction nerveuse périphérique et la souffrance liée aux symptômes pendant la biothérapie du mélanome malin","year":2005,"lang":"fr","type":"article","venue":"Canadian Oncology Nursing Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.019041825788651774,"score_gpt":0.36398372966816045,"score_spread":0.3449419038795087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970591544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858094,0.008717202,0.0018266123,0.00032604928,0.000051798896,0.00026927647,0.00025719794,0.000020367004,0.0027220156],"genre_scores_gemma":[0.9919586,0.0023739622,0.0014532747,0.0002494932,0.000024941102,0.00045057508,0.00014157018,0.000009572903,0.0033379467],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99864095,0.0006172909,0.00009202016,0.00023785952,0.0003068743,0.00010496671],"domain_scores_gemma":[0.996912,0.0014689796,0.0007844407,0.00016672569,0.0005566865,0.00011115077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002658378,0.00029294132,0.000485969,0.0003120542,0.00040168889,0.00064821227,0.00021203491,0.00040666224,0.004243106],"category_scores_gemma":[0.0044433842,0.00016033927,0.0005755079,0.0002904379,0.00048351503,0.00052109535,0.0003924348,0.0006270049,0.00029949355],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019664831,0.0014126824,0.33753315,0.006912348,0.0016667655,0.00107994,0.009327136,0.0009860729,0.2339082,0.00069300074,0.0017062479,0.38510972],"study_design_scores_gemma":[0.0002867401,0.014671814,0.9467083,0.00067895296,0.0008326294,0.0013979481,0.0028228143,0.00058199454,0.021387972,0.00051110267,0.0100696245,0.000050254457],"about_ca_topic_score_codex":0.0017297199,"about_ca_topic_score_gemma":0.0034938413,"teacher_disagreement_score":0.004243106,"about_ca_system_score_codex":0.00047837087,"about_ca_system_score_gemma":0.00049788074,"threshold_uncertainty_score":0.014194608},"labels":[],"label_agreement":null},{"id":"W1971422709","doi":"10.1139/v01-125","title":"Reanalysis of the biotransformation of 4(20),11(12)-taxadiene derivatives","year":2001,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Taxane; Biotransformation; Stereochemistry; Chemistry; Terpene; Terpenoid; Diterpene; Taxoid; Organic chemistry; Biology; Enzyme; Paclitaxel","score_opus":0.01406355443019332,"score_gpt":0.2578501507101483,"score_spread":0.24378659627995494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971422709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99344563,0.00061483367,0.0029463477,0.00004407324,0.000027663755,0.000061380924,0.000461576,0.000034792654,0.0023637502],"genre_scores_gemma":[0.99041104,0.0011022032,0.0037361179,0.000023252693,0.000005712562,0.000027481661,0.0008654527,0.000023535002,0.0038051966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999232,0.00001255645,0.0000057111174,0.000013802168,0.00002219519,0.000022509117],"domain_scores_gemma":[0.9999225,0.000011599761,0.00001762384,0.000014468385,0.000017256682,0.000016533457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012075403,0.00039961442,0.00024756262,0.0001886123,0.00017018271,0.0001632882,0.00014848991,0.00016006386,0.001727013],"category_scores_gemma":[0.00016950705,0.000097181364,0.00020611074,0.0002524078,0.0001584681,0.00019863463,0.00013288143,0.00045839485,0.0004994865],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006199292,0.000018145847,0.00021472752,0.000019865272,0.0000035633352,0.00008996456,0.00003186503,0.0000912363,0.9978258,0.000046508463,0.000012156015,0.001584179],"study_design_scores_gemma":[0.000008320298,0.0002478257,0.0021932388,0.0000037251539,0.000011131047,0.00010940887,0.000040603736,0.00013311091,0.9952905,0.000028682707,0.0019294898,0.000003927693],"about_ca_topic_score_codex":0.0016587363,"about_ca_topic_score_gemma":0.0038273206,"teacher_disagreement_score":0.001727013,"about_ca_system_score_codex":0.00021256445,"about_ca_system_score_gemma":0.00047832803,"threshold_uncertainty_score":0.0057774186},"labels":[],"label_agreement":null},{"id":"W1971932257","doi":"10.17294/2330-0698.1169","title":"Cost-Effectiveness of Taxanes in the Treatment of Metastatic Breast Cancer: A Review of the Literature","year":2015,"lang":"en","type":"review","venue":"Journal of patient-centered research and reviews","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Docetaxel; Paclitaxel; Medicine; Metastatic breast cancer; Oncology; Chemotherapy; Breast cancer; Cancer; Internal medicine; Quality of life (healthcare); Randomized controlled trial; Intensive care medicine","score_opus":0.3276796005693077,"score_gpt":0.5348964550708113,"score_spread":0.20721685450150357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971932257","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036206102,0.99898654,0.000037752456,0.0002582295,0.00006385548,0.000022665185,0.00005711737,0.0000014001586,0.00021043341],"genre_scores_gemma":[0.004656702,0.9947495,0.0001749251,0.0002140145,0.00009747967,0.000038666945,0.000035693512,0.000001316487,0.000031766907],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99665487,0.0010219008,0.001021811,0.00022413848,0.0009532151,0.00012403331],"domain_scores_gemma":[0.976602,0.01886029,0.002585194,0.00011924201,0.0016744448,0.00015876927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051591876,0.0013523715,0.004789004,0.010162787,0.00042677767,0.0024039575,0.0017543999,0.0022043525,0.0045878757],"category_scores_gemma":[0.021921104,0.00073550135,0.0047211354,0.011023735,0.0006281285,0.0019874347,0.00065750134,0.0012078396,0.00030786163],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056462106,0.00008377409,0.0012736904,0.6966066,0.0047370275,0.00024597227,0.00010786782,0.0007938893,0.00017694868,0.0016022315,0.005548746,0.2882587],"study_design_scores_gemma":[0.00040107238,0.0006401819,0.010816481,0.86330414,0.038031593,0.0020471201,0.0004723891,0.00074418756,0.0003230286,0.0024383245,0.08070228,0.00007921269],"about_ca_topic_score_codex":0.00554197,"about_ca_topic_score_gemma":0.008154251,"teacher_disagreement_score":0.010162787,"about_ca_system_score_codex":0.004750878,"about_ca_system_score_gemma":0.0061733583,"threshold_uncertainty_score":0.0344702},"labels":[],"label_agreement":null},{"id":"W1971954228","doi":"10.3816/cbc.2004.n.032","title":"Final Results of a Phase II Clinical Trial of Weekly Docetaxel in Combination with Capecitabine in Anthracycline-Pretreated Metastatic Breast Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Alberta","funders":"","keywords":"Medicine; Docetaxel; Capecitabine; Metastatic breast cancer; Internal medicine; Anthracycline; Discontinuation; Progressive disease; Breast cancer; Chemotherapy; Phases of clinical research; Gastroenterology; Cancer; Surgery; Oncology; Colorectal cancer","score_opus":0.09835630191254444,"score_gpt":0.4714088183810935,"score_spread":0.3730525164685491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971954228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846502,0.004080276,0.0009835993,0.0014804639,0.00038374207,0.0025549792,0.0020823982,0.00014454809,0.00363988],"genre_scores_gemma":[0.980828,0.0034379126,0.0024798808,0.0014262015,0.0003617672,0.0018675142,0.0043319636,0.00008191607,0.0051848665],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99920446,0.00035761116,0.00004330408,0.00010575341,0.000070747374,0.00021808856],"domain_scores_gemma":[0.99868315,0.00030658685,0.000147354,0.00013120705,0.00009941653,0.00063226273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002436473,0.0018538622,0.0034969721,0.000511072,0.0007533252,0.0012635328,0.0010745181,0.001663796,0.0033654594],"category_scores_gemma":[0.0019040257,0.0007591246,0.0018329482,0.00049633323,0.0012570746,0.0008630118,0.00035336515,0.0045553395,0.000926772],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73384947,0.10437173,0.0039255633,0.0008690778,0.002444356,0.0005508026,0.0004233499,0.004219171,0.038491555,0.000320446,0.009652217,0.10088238],"study_design_scores_gemma":[0.59091073,0.3903084,0.009126774,0.0000417736,0.0010193572,0.0002875904,0.000061994615,0.0007042479,0.0039306623,0.00019606052,0.0033761708,0.00003617059],"about_ca_topic_score_codex":0.002931191,"about_ca_topic_score_gemma":0.007303584,"teacher_disagreement_score":0.0034969721,"about_ca_system_score_codex":0.0011620035,"about_ca_system_score_gemma":0.0020111364,"threshold_uncertainty_score":0.012885451},"labels":[],"label_agreement":null},{"id":"W1973471572","doi":"10.1158/0008-5472.can-12-4183","title":"A Model of Postsurgical Advanced Metastatic Breast Cancer More Accurately Replicates the Clinical Efficacy of Antiangiogenic Drugs","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Pfizer; Eli Lilly and Company","keywords":"Medicine; Pazopanib; Sunitinib; Metastatic breast cancer; Bevacizumab; Oncology; Breast cancer; Internal medicine; Cancer; Clinical trial; Chemotherapy; Phases of clinical research","score_opus":0.26187886519085657,"score_gpt":0.5499455557350358,"score_spread":0.2880666905441792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973471572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8907807,0.006799932,0.07639252,0.0021855575,0.00071045494,0.0024879929,0.0055228625,0.0006506067,0.014469458],"genre_scores_gemma":[0.9573381,0.0034911279,0.028152,0.00048587876,0.0001038171,0.002079868,0.0033364035,0.00008888445,0.0049238973],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9992797,0.0002636424,0.00006460392,0.00012494938,0.00016772441,0.00009943087],"domain_scores_gemma":[0.9993048,0.00019217824,0.0001377409,0.00016641238,0.000072991555,0.00012595029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013349704,0.00091062207,0.0010700505,0.0007718943,0.0004210861,0.0009478899,0.0007470378,0.0008961034,0.0036706217],"category_scores_gemma":[0.0006356185,0.000310742,0.00061778,0.00045925513,0.0006827624,0.00073336595,0.00038862714,0.0023271546,0.00096998806],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029964892,0.0063013425,0.0062991795,0.00072068773,0.00019291065,0.00038896728,0.0001456634,0.012062039,0.9425893,0.0070601576,0.00429612,0.016947184],"study_design_scores_gemma":[0.003087084,0.051368672,0.03333617,0.00022289091,0.00063117297,0.0035346993,0.0004214289,0.06231768,0.7451515,0.006358204,0.093410484,0.00016007188],"about_ca_topic_score_codex":0.003547368,"about_ca_topic_score_gemma":0.005039443,"teacher_disagreement_score":0.0036706217,"about_ca_system_score_codex":0.0011073718,"about_ca_system_score_gemma":0.0016220377,"threshold_uncertainty_score":0.0122795105},"labels":[],"label_agreement":null},{"id":"W1973742157","doi":"10.1634/theoncologist.2013-0359","title":"Use of Conjoint Analysis to Assess Breast Cancer Patient Preferences for Chemotherapy Side Effects","year":2014,"lang":"en","type":"article","venue":"The Oncologist","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Ottawa Hospital; Royal Victoria Hospital; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"","keywords":"Medicine; Conjoint analysis; Breast cancer; Oncology; Chemotherapy; Internal medicine; Cancer; Preference; Statistics","score_opus":0.0910081580114505,"score_gpt":0.3948186789986069,"score_spread":0.3038105209871564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973742157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784466,0.0011627569,0.015151404,0.0002632106,0.000040783514,0.0013205203,0.00070974743,0.000039506576,0.0028655436],"genre_scores_gemma":[0.9859104,0.00028211172,0.012536918,0.000061544655,0.000014553372,0.0007060135,0.00021720423,0.000003698156,0.0002675365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9742649,0.02139592,0.0011027427,0.0004932399,0.00239859,0.000344606],"domain_scores_gemma":[0.9631729,0.028170524,0.0048602982,0.0012136953,0.0019578252,0.00062475406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018910613,0.0007994484,0.0010378027,0.0034647223,0.0006070935,0.0013362118,0.00054313877,0.0004373842,0.002599296],"category_scores_gemma":[0.03262193,0.00023624637,0.0020787062,0.0034295274,0.0004906756,0.00071113347,0.0011085058,0.0009948262,0.0003060916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0113947475,0.0028963606,0.66515523,0.0014081509,0.004468529,0.00035779143,0.004786252,0.019181645,0.0034814563,0.0018098395,0.0017466197,0.2833133],"study_design_scores_gemma":[0.00086009386,0.015128853,0.8217601,0.00046736997,0.0014002009,0.0014265055,0.008171234,0.13450997,0.004705655,0.0076725236,0.0034846014,0.00041286557],"about_ca_topic_score_codex":0.0008930044,"about_ca_topic_score_gemma":0.0012768541,"teacher_disagreement_score":0.018910613,"about_ca_system_score_codex":0.0009597761,"about_ca_system_score_gemma":0.0006750848,"threshold_uncertainty_score":0.1000101},"labels":[],"label_agreement":null},{"id":"W1973823302","doi":"10.1158/0008-5472.sabcs12-s6-6","title":"Abstract S6-6: A Phase III, open-label, randomized, multicenter study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with anthracyclines and taxanes","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Eribulin; Capecitabine; Medicine; Taxane; Internal medicine; Metastatic breast cancer; Oncology; Clinical endpoint; Anthracycline; Breast cancer; Phases of clinical research; Cancer; Randomized controlled trial; Clinical trial; Colorectal cancer","score_opus":0.09217394740378554,"score_gpt":0.4726768322864767,"score_spread":0.3805028848826912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973823302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820148,0.0016830758,0.000792344,0.0009982865,0.00045973872,0.010571092,0.0016454324,0.00014079003,0.001694565],"genre_scores_gemma":[0.970739,0.0020426153,0.002999431,0.0020764703,0.0006982797,0.012677338,0.0025690468,0.000051294057,0.0061464733],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992267,0.00044391962,0.00005013523,0.0001150051,0.000053433145,0.00011076674],"domain_scores_gemma":[0.9985536,0.00026583785,0.0002788993,0.000084177045,0.000098543576,0.00071888504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028255307,0.0026706872,0.0030766025,0.0005816485,0.00075359223,0.0012880511,0.0013077148,0.0023208063,0.010946126],"category_scores_gemma":[0.0017652737,0.0010117018,0.0020130782,0.0005521791,0.0017357465,0.0014970752,0.0005276077,0.005471062,0.0021772203],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.953639,0.029455714,0.00063434173,0.00036657762,0.00048185972,0.000054620734,0.00007368433,0.00037498726,0.0068757767,0.000081931576,0.0007758372,0.0071856794],"study_design_scores_gemma":[0.878036,0.12011909,0.0007539665,0.000011379442,0.00012144694,0.00002090253,0.000014698381,0.00021098045,0.00035219808,0.000051369265,0.0003006609,0.0000073299516],"about_ca_topic_score_codex":0.0009207508,"about_ca_topic_score_gemma":0.0021769158,"teacher_disagreement_score":0.010946126,"about_ca_system_score_codex":0.000850199,"about_ca_system_score_gemma":0.002198847,"threshold_uncertainty_score":0.03661841},"labels":[],"label_agreement":null},{"id":"W1974524561","doi":"10.1159/000220451","title":"The Psychodynamics of Medication","year":2009,"lang":"en","type":"article","venue":"Chemotherapia","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Icon; Citation; Computer science; Download; World Wide Web; Information retrieval; Subject (documents); Library science","score_opus":0.01006196200424361,"score_gpt":0.33857599374787806,"score_spread":0.32851403174363447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974524561","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10134108,0.18482545,0.013160161,0.2640424,0.0058903666,0.0001901,0.00046553015,0.00019108524,0.42989394],"genre_scores_gemma":[0.81343275,0.07819895,0.0049916324,0.039381277,0.0031597032,0.00017405636,0.00020314561,0.00011322424,0.060345218],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99748033,0.0012408283,0.000100265504,0.00018239769,0.00083503814,0.00016110546],"domain_scores_gemma":[0.9976618,0.0010033388,0.0004072111,0.00017661855,0.00035719853,0.0003938617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015824722,0.00029287062,0.00033364692,0.000581311,0.0010764294,0.0033548048,0.0004068241,0.0012203854,0.006714445],"category_scores_gemma":[0.008183067,0.00018978237,0.00037342575,0.0004516696,0.005738982,0.0017153968,0.0024139774,0.003559457,0.001676892],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044755067,0.00047484122,0.01681074,0.0011667688,0.00016768256,0.002888713,0.034253106,0.00053854636,0.009135759,0.21230869,0.15666054,0.565147],"study_design_scores_gemma":[0.00008858507,0.0005972608,0.03814663,0.0010618257,0.00007156952,0.009311665,0.013079184,0.0005363918,0.001535518,0.086330675,0.84914774,0.00009302797],"about_ca_topic_score_codex":0.0011845349,"about_ca_topic_score_gemma":0.0011040142,"teacher_disagreement_score":0.006714445,"about_ca_system_score_codex":0.0023875954,"about_ca_system_score_gemma":0.002787041,"threshold_uncertainty_score":0.02246201},"labels":[],"label_agreement":null},{"id":"W1974584024","doi":"10.1159/000226796","title":"Phase II Study of Pirarubicin (THP-Adriamycin) in Metastatic Breast Cancer Patients","year":2009,"lang":"en","type":"article","venue":"Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Pirarubicin; Medicine; Metastatic breast cancer; Leukopenia; Nausea; Vomiting; Breast cancer; Chemotherapy; Internal medicine; Regimen; Cancer; Gastroenterology; Surgery","score_opus":0.03595685724314979,"score_gpt":0.42504412754698984,"score_spread":0.38908727030384005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974584024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99660873,0.0014989665,0.0003221359,0.00014296712,0.000049539423,0.0003786184,0.00012341779,0.00003569409,0.000839974],"genre_scores_gemma":[0.995021,0.0014555623,0.0009940964,0.00028806904,0.00013274795,0.00053338107,0.00076618744,0.000011749546,0.0007971865],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997032,0.0001449082,0.000014738646,0.00004644792,0.00003129863,0.00005923575],"domain_scores_gemma":[0.9996728,0.000062660365,0.000048750175,0.00004162179,0.000018054363,0.00015616383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008086771,0.000555767,0.0012614676,0.00022001755,0.00037345887,0.00044686112,0.00036710242,0.0004499217,0.0015223157],"category_scores_gemma":[0.0006516892,0.0003757519,0.0004983988,0.00026875638,0.0005294144,0.00034014258,0.0002821497,0.001413867,0.0005584927],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31608102,0.09942483,0.03818457,0.0011884994,0.0015080038,0.0021326186,0.0011737962,0.0051839515,0.20148088,0.00044966265,0.0045314836,0.32866076],"study_design_scores_gemma":[0.16331048,0.77277166,0.036922887,0.00006131494,0.0005264045,0.0020307081,0.00012011937,0.0013337581,0.014787894,0.0001955167,0.007907073,0.000032137323],"about_ca_topic_score_codex":0.00036796628,"about_ca_topic_score_gemma":0.0007710702,"teacher_disagreement_score":0.0015223157,"about_ca_system_score_codex":0.00034705453,"about_ca_system_score_gemma":0.0007108028,"threshold_uncertainty_score":0.005092621},"labels":[],"label_agreement":null},{"id":"W1975369490","doi":"10.1158/1078-0432.tcmusa10-a44","title":"Abstract A44: Inhibition of EGFR phosphorylation in a panel of human breast cancer cells correlates with synergistic interactions between gefitinib and 5'-DFUR, the bioactive metabolite of Xeloda®","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Gefitinib; Capecitabine; Pharmacology; Breast cancer; Chemistry; Cancer research; Thymidine phosphorylase; Growth inhibition; Cancer; Epidermal growth factor receptor; Cell growth; Medicine; Internal medicine; Colorectal cancer; Biochemistry","score_opus":0.17920524362037962,"score_gpt":0.5115915909656693,"score_spread":0.3323863473452897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975369490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894907,0.0034511902,0.0016046687,0.00010756973,0.00007504337,0.000083686915,0.0016605991,0.00014590957,0.003380638],"genre_scores_gemma":[0.9867622,0.0012766806,0.0019449213,0.000060248487,0.000033052576,0.00014794557,0.003930627,0.000020406611,0.005823765],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996238,0.000092800045,0.000034663055,0.00005538475,0.000110639594,0.00008272783],"domain_scores_gemma":[0.9998486,0.00004792889,0.000019852801,0.00001688474,0.00003077558,0.00003594833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002254462,0.0005589934,0.0005010167,0.00039785678,0.0001740997,0.00028602144,0.00015576878,0.00027878108,0.004361098],"category_scores_gemma":[0.00020253149,0.0001704622,0.00041101192,0.0004397071,0.00012603456,0.00015322817,0.0001700476,0.00046813104,0.0010103432],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041411046,0.00018832152,0.00066939567,0.000050675273,0.000018614906,0.00004379786,0.000016181937,0.000092709015,0.99548256,0.000022203403,0.00020068661,0.0028006649],"study_design_scores_gemma":[0.00003700578,0.0024275603,0.029817566,0.0000064102255,0.00004525541,0.00039137722,0.000036944177,0.0013713388,0.9634668,0.000019460324,0.0023706588,0.00000960719],"about_ca_topic_score_codex":0.0014316542,"about_ca_topic_score_gemma":0.001425761,"teacher_disagreement_score":0.004361098,"about_ca_system_score_codex":0.00021326482,"about_ca_system_score_gemma":0.00020191581,"threshold_uncertainty_score":0.01458931},"labels":[],"label_agreement":null},{"id":"W1976585485","doi":"10.1016/s1470-2045(11)70037-7","title":"Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a phase 2, randomised, double-blind, placebo-controlled study","year":2011,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; Centre hospitalier universitaire de Québec","funders":"","keywords":"Bevacizumab; Metastatic breast cancer; Medicine; Paclitaxel; Placebo; HER2 negative; Oncology; Breast cancer; Internal medicine; Open label; Double blind; Cancer; Clinical trial; Chemotherapy; Pathology; Alternative medicine","score_opus":0.24401072602498708,"score_gpt":0.47205516413850956,"score_spread":0.22804443811352249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976585485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97667515,0.0113213435,0.0011760346,0.0009045581,0.0012991669,0.003980356,0.0013272351,0.00030691744,0.0030093708],"genre_scores_gemma":[0.9749536,0.008418277,0.0022906645,0.0014772521,0.0009983232,0.004017677,0.0015297756,0.00005594459,0.0062585226],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993544,0.00031655212,0.000035085817,0.00011196016,0.000065777946,0.00011620473],"domain_scores_gemma":[0.99935263,0.00019150006,0.0001157262,0.000045852143,0.000046214544,0.00024811135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015855038,0.0023750055,0.0044601043,0.0007854956,0.00041236627,0.0009562743,0.0012371641,0.0021743288,0.0064401827],"category_scores_gemma":[0.0016173397,0.0011988247,0.0016824276,0.00063681573,0.0015061143,0.0014294058,0.0004132828,0.0033001818,0.001160062],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97458726,0.007023655,0.00015897206,0.0006663162,0.00057864643,0.000024991637,0.000025715974,0.00020064604,0.0031975782,0.00007445806,0.0005787234,0.012882941],"study_design_scores_gemma":[0.945169,0.053065203,0.0005397508,0.000018857945,0.00025700068,0.000020631207,0.000009667522,0.00022438008,0.0002869657,0.000052689815,0.00034391793,0.000011956025],"about_ca_topic_score_codex":0.0014794666,"about_ca_topic_score_gemma":0.0037568999,"teacher_disagreement_score":0.0064401827,"about_ca_system_score_codex":0.0008891764,"about_ca_system_score_gemma":0.001083182,"threshold_uncertainty_score":0.021544576},"labels":[],"label_agreement":null},{"id":"W1977284775","doi":"10.3747/co.19.879","title":"Phase II Trial of a Metronomic Schedule of Docetaxel and Capecitabine with Concurrent Celecoxib in Patients with Prior Anthracycline Exposure for Metastatic Breast Cancer","year":2012,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; NOSM University; Sudbury Regional Hospital","funders":"","keywords":"Medicine; Capecitabine; Docetaxel; Metastatic breast cancer; Internal medicine; Mucositis; Breast cancer; Celecoxib; Neutropenia; Clinical endpoint; Chemotherapy; Nausea; Oncology; Cancer; Clinical trial; Gastroenterology; Surgery","score_opus":0.07069277064196859,"score_gpt":0.4318936970225765,"score_spread":0.3612009263806079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977284775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926643,0.001632863,0.0005106004,0.00052915607,0.00017436125,0.0025484778,0.00041621766,0.00008160449,0.0014424436],"genre_scores_gemma":[0.98993087,0.0011301724,0.0014857283,0.0007659523,0.00024756516,0.00293383,0.0013197974,0.000018661402,0.0021673336],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99970067,0.00012400074,0.000017438053,0.000054502416,0.000032884793,0.00007059389],"domain_scores_gemma":[0.99929905,0.00008417508,0.00014883277,0.000046103472,0.000034028755,0.00038780496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011184925,0.0013720478,0.0015115098,0.0003894622,0.0003674804,0.0008300371,0.0008221963,0.001045605,0.0033864581],"category_scores_gemma":[0.00085765834,0.00057520566,0.0008705175,0.00041528727,0.0007334114,0.0005914428,0.00033548844,0.0031409645,0.00076187705],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7930187,0.08695996,0.0051684775,0.0008579405,0.0009879328,0.00031577915,0.0002331356,0.0028831467,0.029507138,0.00031818208,0.0036766957,0.07607294],"study_design_scores_gemma":[0.7556821,0.23582205,0.0045068013,0.00002537424,0.00016180253,0.00017909393,0.000021129801,0.0009764639,0.0013462201,0.00007894105,0.0011851907,0.000014745619],"about_ca_topic_score_codex":0.0010219392,"about_ca_topic_score_gemma":0.002795122,"teacher_disagreement_score":0.0033864581,"about_ca_system_score_codex":0.00093789794,"about_ca_system_score_gemma":0.0018728212,"threshold_uncertainty_score":0.011328876},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"nonrandomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W1977704967","doi":"10.3747/co.19.1024","title":"Advances in the Management of Metastatic Breast Cancer: Options Beyond First-Line Chemotherapy","year":2012,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Ottawa Hospital; Centre Hospitalier de l’Université de Montréal","funders":"Eisai Canada; Eisai","keywords":"Medicine; Metastatic breast cancer; Chemotherapy; Breast cancer; Oncology; First line; Cancer; Internal medicine; Bioinformatics; Cancer research; Biology","score_opus":0.08873687054459974,"score_gpt":0.4667276146840497,"score_spread":0.37799074413945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977704967","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025567703,0.9558274,0.003667553,0.028102027,0.00095121586,0.000026012012,0.000030712727,0.00005562518,0.008782761],"genre_scores_gemma":[0.017575478,0.9680043,0.0050585736,0.00393387,0.0033106701,0.000027290558,0.000045926525,0.000014782041,0.002029106],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995426,0.00015931597,0.000047213958,0.00004857375,0.00014894786,0.00005341447],"domain_scores_gemma":[0.99927205,0.0002953449,0.00015213757,0.00003659026,0.00012700228,0.00011692725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014472613,0.00046825642,0.0008905945,0.0010233169,0.00046845822,0.0017417638,0.0007636561,0.0008900402,0.0037528868],"category_scores_gemma":[0.0012092101,0.00013380809,0.000583781,0.0007276245,0.00075979327,0.0024635107,0.0010588414,0.0031859085,0.0011342398],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017446632,0.00028646537,0.0008119518,0.0033445999,0.000053080897,0.00055438705,0.00016562117,0.0007838435,0.002530798,0.012792807,0.02010627,0.9583958],"study_design_scores_gemma":[0.0001178296,0.0010814972,0.0024838594,0.003250979,0.00012937139,0.004634163,0.00026240048,0.0007448523,0.001476305,0.018560208,0.96721786,0.00004070692],"about_ca_topic_score_codex":0.00061687897,"about_ca_topic_score_gemma":0.0025346158,"teacher_disagreement_score":0.0037528868,"about_ca_system_score_codex":0.0010177313,"about_ca_system_score_gemma":0.0011517621,"threshold_uncertainty_score":0.012554646},"labels":[],"label_agreement":null},{"id":"W1978585178","doi":"10.1097/00001813-200606000-00014","title":"Improved anti-tumor response rate with decreased cardiotoxicity of non-pegylated liposomal doxorubicin compared with conventional doxorubicin in first-line treatment of metastatic breast cancer in patients who had received prior adjuvant doxorubicin: results of a retrospective analysis","year":2006,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Doxorubicin; Cardiotoxicity; Anthracycline; Internal medicine; Metastatic breast cancer; Cyclophosphamide; Breast cancer; Adjuvant; Randomization; Oncology; Cancer; Chemotherapy; Surgery; Randomized controlled trial; Gastroenterology","score_opus":0.008634561448113807,"score_gpt":0.2784867038953679,"score_spread":0.2698521424472541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978585178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983311,0.0012735554,0.00015226155,0.000012123354,0.0000030711512,0.000014638794,0.000095768315,0.000002519124,0.000114996095],"genre_scores_gemma":[0.9995585,0.00018960777,0.00007357682,0.000016579486,0.000008152771,0.000009317009,0.000111013265,0.0000010776894,0.00003214217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990408,0.00043801742,0.00015127374,0.00017635837,0.00014681094,0.00004673593],"domain_scores_gemma":[0.99702305,0.0010841108,0.0013459232,0.00024511715,0.00015690457,0.00014497938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018185508,0.00015159542,0.00048561272,0.00030904557,0.00008904509,0.0003498576,0.00017399067,0.00028750242,0.00052240206],"category_scores_gemma":[0.003654877,0.00013714681,0.0006303116,0.00035244416,0.0002252782,0.00023187957,0.00012308867,0.00023721965,0.00010558653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026076611,0.00031688655,0.94144815,0.00025951656,0.0013332735,0.0004214041,0.0001296202,0.0005945108,0.0070761084,0.000045000725,0.00012470613,0.02217426],"study_design_scores_gemma":[0.00091158715,0.015823947,0.9746799,0.000022458074,0.0012799088,0.0022504355,0.00006615081,0.00088412594,0.0031347184,0.000034752746,0.0008955836,0.000016520804],"about_ca_topic_score_codex":0.00017958652,"about_ca_topic_score_gemma":0.0002632594,"teacher_disagreement_score":0.0018185508,"about_ca_system_score_codex":0.0002189052,"about_ca_system_score_gemma":0.00014929788,"threshold_uncertainty_score":0.009617567},"labels":[],"label_agreement":null},{"id":"W1978871709","doi":"10.1158/0008-5472.sabcs12-p3-06-34","title":"Abstract P3-06-34: Plasma (p) VEGF-A and VEGFR-2 biomarker (BM) results from the BEATRICE phase III trial of bevacizumab (BEV) in triple-negative early breast cancer (BC)","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Bevacizumab; Taxane; Population; Oncology; Breast cancer; Anthracycline; Cancer; Clinical endpoint; Triple-negative breast cancer; Chemotherapy; Metastatic breast cancer; Randomized controlled trial; Epirubicin","score_opus":0.12452955586661835,"score_gpt":0.45668403905827626,"score_spread":0.3321544831916579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978871709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98919415,0.0014686029,0.0005241771,0.0005593222,0.00008435854,0.0017002332,0.003349946,0.00006613332,0.0030530356],"genre_scores_gemma":[0.9872376,0.0004701508,0.0014188039,0.00081674836,0.0001416879,0.0014819772,0.005308326,0.000026865737,0.0030977456],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99943334,0.00030789376,0.000027236036,0.00009039827,0.00007249697,0.00006864151],"domain_scores_gemma":[0.9991793,0.00017023212,0.00017870756,0.00006755447,0.00006314636,0.000341144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016219043,0.0006748945,0.00108045,0.0002538665,0.00030940495,0.0007245036,0.00048284396,0.0007836564,0.004762142],"category_scores_gemma":[0.0012228331,0.00025853413,0.00063408073,0.00027595813,0.00040408125,0.00040822892,0.00036042472,0.0020106914,0.00077519263],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87573785,0.016989559,0.012452222,0.0002954865,0.0011647263,0.000076761025,0.00006072251,0.0011106639,0.025413478,0.0001921204,0.007965186,0.058541235],"study_design_scores_gemma":[0.5109802,0.38217515,0.08285687,0.000051589075,0.0018562885,0.00031632354,0.000050541435,0.0022709968,0.012397442,0.0004915902,0.006508935,0.000044139815],"about_ca_topic_score_codex":0.0010157485,"about_ca_topic_score_gemma":0.0015026374,"teacher_disagreement_score":0.004762142,"about_ca_system_score_codex":0.0006982227,"about_ca_system_score_gemma":0.0010837734,"threshold_uncertainty_score":0.01593095},"labels":[],"label_agreement":null},{"id":"W1979391857","doi":"10.1023/a:1006480504790","title":"Liarozole Fumarate (R85246): In the Treatment of ER Negative, Tamoxifen Refractory or Chemotherapy Resistant Postmenopausal Metastatic Breast Cancer","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Princess Margaret Cancer Centre; Kingston General Hospital; Mount Sinai Hospital; Credit Valley Hospital; Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Internal medicine; Tamoxifen; Tolerability; Breast cancer; Chemotherapy; Refractory (planetary science); Oncology; Endocrinology; Estrogen receptor; Gastroenterology; Cancer; Adverse effect; Biology","score_opus":0.07173302003090129,"score_gpt":0.420558018104273,"score_spread":0.34882499807337175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979391857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84579813,0.13630562,0.00077243656,0.0038694423,0.0003865315,0.00020111403,0.0004836807,0.00030077418,0.011882217],"genre_scores_gemma":[0.95744,0.03648504,0.0005240172,0.0005697298,0.0002548823,0.00004087769,0.0003150532,0.000011974168,0.0043583354],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99989414,0.000044131506,0.000011439196,0.0000095157875,0.000018313025,0.000022416798],"domain_scores_gemma":[0.9999144,0.000018815337,0.000023100305,0.0000047331328,0.000007253232,0.000031631098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028519583,0.00030233167,0.0004667235,0.00038722096,0.00021068269,0.00029264844,0.0002941531,0.00054339354,0.0014176948],"category_scores_gemma":[0.00042719938,0.00009401491,0.0003451311,0.00035680836,0.00017179942,0.00020396826,0.00017169396,0.00062125636,0.0003306394],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09228038,0.0022005392,0.008533523,0.0017213128,0.00087115925,0.0030936394,0.000307503,0.0022163729,0.10999625,0.0015881179,0.010097387,0.7670938],"study_design_scores_gemma":[0.10009426,0.21002561,0.17979628,0.0011075983,0.006367427,0.019995399,0.001235356,0.006607386,0.13920954,0.0031574948,0.33213714,0.00026657476],"about_ca_topic_score_codex":0.0016911478,"about_ca_topic_score_gemma":0.0059364582,"teacher_disagreement_score":0.0016911478,"about_ca_system_score_codex":0.00032342755,"about_ca_system_score_gemma":0.00037633427,"threshold_uncertainty_score":0.004742682},"labels":[],"label_agreement":null},{"id":"W1979687843","doi":"10.1038/sj.bjc.6604960","title":"Cancer neurology in clinical practice, neurological complications of cancer and its treatment (2nd Edn)","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Neurology; Medicine; Cancer; Clinical Practice; Clinical neurology; Internal medicine; Physical therapy; Psychology; Psychiatry; Neuroscience","score_opus":0.0573256548277383,"score_gpt":0.45236094634042867,"score_spread":0.39503529151269035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979687843","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00051126006,0.8395183,0.002171434,0.020936187,0.03716373,0.0001021958,0.00028316613,0.00029873312,0.09901498],"genre_scores_gemma":[0.0049639577,0.6812106,0.0039435253,0.024349023,0.02353067,0.00028324738,0.0005835741,0.00019601888,0.26093942],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99930763,0.00012881619,0.0000858922,0.00006967434,0.000352139,0.000055806646],"domain_scores_gemma":[0.9990753,0.00031472946,0.0001350344,0.000039739476,0.0002256235,0.00020963262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010669626,0.0012077154,0.0012464023,0.0027629328,0.00081100455,0.0034995486,0.0011083964,0.0026051535,0.041602544],"category_scores_gemma":[0.0028735483,0.0007115405,0.0007783274,0.0027607675,0.0009793708,0.0032317794,0.0018021102,0.0037580887,0.027515767],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027549602,0.000045724806,0.0002259788,0.00091030914,0.000010753183,0.00027943138,0.00035256092,0.00023302386,0.0002554032,0.0044644065,0.8013346,0.19186011],"study_design_scores_gemma":[0.000008233975,0.000033270662,0.0006912832,0.00090161397,0.0000051350885,0.0013553494,0.00012763086,0.00007581382,0.000024674297,0.0027795024,0.9939866,0.0000109251105],"about_ca_topic_score_codex":0.002954895,"about_ca_topic_score_gemma":0.009429807,"teacher_disagreement_score":0.041602544,"about_ca_system_score_codex":0.0018805519,"about_ca_system_score_gemma":0.0029720326,"threshold_uncertainty_score":0.1391744},"labels":[],"label_agreement":null},{"id":"W1979995079","doi":"10.1016/j.jchromb.2008.10.055","title":"Determination of intact oxaliplatin in human plasma using high performance liquid chromatography-tandem mass spectrometry","year":2008,"lang":"en","type":"article","venue":"Journal of Chromatography B","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Chemistry; Chromatography; Tandem mass spectrometry; Liquid chromatography–mass spectrometry; Mass spectrometry; Oxaliplatin; High-performance liquid chromatography; Human plasma","score_opus":0.023687180771527077,"score_gpt":0.30194375656082767,"score_spread":0.2782565757893006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979995079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92233145,0.020969523,0.050056648,0.00069851027,0.00030775205,0.0002565633,0.0013967322,0.0008977915,0.003085036],"genre_scores_gemma":[0.966014,0.0034567225,0.025817802,0.0007465613,0.00008929176,0.00016100392,0.00094451173,0.000038993876,0.0027310771],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995297,0.00011805787,0.00003969057,0.00013022976,0.00013652492,0.000045766596],"domain_scores_gemma":[0.9997925,0.0000671216,0.000036657497,0.000021033771,0.000052500025,0.000030193545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000464408,0.0004373688,0.00052742765,0.0005724121,0.00047070926,0.0005388716,0.00033597444,0.000708314,0.000507905],"category_scores_gemma":[0.0008826001,0.0002532225,0.00025191254,0.00035883856,0.00037579454,0.00048169863,0.00026913278,0.0006145021,0.00035220836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024882883,0.00024851202,0.008030015,0.00016923143,0.00018082149,0.0003240532,0.00013585386,0.00049422466,0.95332336,0.0002858218,0.0005710417,0.033748843],"study_design_scores_gemma":[0.00024278603,0.0016539509,0.024209434,0.000035027784,0.00017169623,0.0027940453,0.00007623619,0.0064875796,0.9579596,0.00048536513,0.0058445353,0.000039642462],"about_ca_topic_score_codex":0.0009641599,"about_ca_topic_score_gemma":0.0011153165,"teacher_disagreement_score":0.0009641599,"about_ca_system_score_codex":0.00034213046,"about_ca_system_score_gemma":0.000758683,"threshold_uncertainty_score":0.0024823546},"labels":[],"label_agreement":null},{"id":"W1980561290","doi":"10.1139/v04-061","title":"Taxol interaction with DNA and RNA Stability and structural features","year":2004,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Polynucleotide; Chemistry; DNA; RNA; Nucleic acid; Stereochemistry; Capillary electrophoresis; Base pair; Binding constant; Helix (gastropod); Binding site; In vitro; Nucleotide; Biochemistry; Chromatography","score_opus":0.010150331845352746,"score_gpt":0.2619643774082967,"score_spread":0.25181404556294396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980561290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99647564,0.000997264,0.0012636727,0.000049909875,0.0000062202785,0.000010381997,0.00010911085,0.000017073131,0.0010707125],"genre_scores_gemma":[0.9959686,0.000527619,0.0013735192,0.00005320135,0.0000037427667,0.000016116617,0.0002641248,0.000009886649,0.0017832437],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983644,0.000026305912,0.0000066201296,0.000047455702,0.000047263617,0.000035816967],"domain_scores_gemma":[0.99986815,0.000043039727,0.00003486251,0.000006093007,0.00002754114,0.000020329944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099456505,0.0001946607,0.00014366575,0.00022464094,0.00014510156,0.00028476273,0.00016522527,0.0003252922,0.0012567185],"category_scores_gemma":[0.00030258717,0.00014486513,0.0001597286,0.00014531186,0.00015845375,0.00019281013,0.00011812323,0.00029859575,0.00032534433],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049789174,0.000007531407,0.00025386317,0.000015440404,0.0000029212977,0.00001224657,0.000011728431,0.00004325363,0.998862,0.000022267755,0.000010284145,0.00070864573],"study_design_scores_gemma":[0.0000036995802,0.00008567352,0.004763337,0.0000025295512,0.0000071990557,0.00006400564,0.000026917576,0.0007103134,0.9936087,0.000015266076,0.00070741965,0.0000049843625],"about_ca_topic_score_codex":0.0013129727,"about_ca_topic_score_gemma":0.0013963332,"teacher_disagreement_score":0.0013129727,"about_ca_system_score_codex":0.00031718082,"about_ca_system_score_gemma":0.00015586549,"threshold_uncertainty_score":0.0042040944},"labels":[],"label_agreement":null},{"id":"W1980766188","doi":"10.1158/0008-5472.sabcs-09-6093","title":"First-Line Bevacizumab (Bev) Combination Therapy in Triple-Negative (TN) Locally Recurrent/Metastatic Breast Cancer (LR/MBC): Subpopulation Analysis of Study MO19391 in &amp;gt;2000 Patients (Pts).","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Bevacizumab; Taxane; Capecitabine; Population; Oncology; Regimen; Combination therapy; Clinical endpoint; Metastatic breast cancer; Anthracycline; Cancer; Gastroenterology; Breast cancer; Chemotherapy; Randomized controlled trial; Colorectal cancer","score_opus":0.11227216648163586,"score_gpt":0.47499098614583407,"score_spread":0.3627188196641982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980766188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987795,0.0005284565,0.00007590048,0.000025798805,0.0000039927554,0.00008910529,0.0003078931,0.0000038766193,0.00018553258],"genre_scores_gemma":[0.9984397,0.00025934775,0.00014853655,0.0000537817,0.000017471088,0.000093972885,0.0007684952,0.000002982544,0.0002156615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995449,0.00022696277,0.000039226554,0.000087893524,0.00005263188,0.000048330858],"domain_scores_gemma":[0.9993999,0.00011138407,0.00025110724,0.000079455844,0.000029410694,0.00012866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011618525,0.0004546831,0.00077628816,0.0003145891,0.00021618098,0.00044330722,0.00033931652,0.00037067925,0.0012325775],"category_scores_gemma":[0.0009855579,0.00024069038,0.0009628197,0.0004928436,0.00025109196,0.00028727666,0.00030473122,0.0005688092,0.00022631047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3032394,0.009781843,0.5882761,0.0007339574,0.009246804,0.00059263234,0.00047465262,0.001369283,0.022023894,0.00013465885,0.0018799829,0.062246814],"study_design_scores_gemma":[0.052403945,0.107911006,0.82040125,0.00009032299,0.0065712123,0.0014563565,0.00027781032,0.0023033351,0.004099147,0.00019994783,0.0042365864,0.000048986796],"about_ca_topic_score_codex":0.001569321,"about_ca_topic_score_gemma":0.003404395,"teacher_disagreement_score":0.001569321,"about_ca_system_score_codex":0.00064519927,"about_ca_system_score_gemma":0.00049300195,"threshold_uncertainty_score":0.006144583},"labels":[],"label_agreement":null},{"id":"W1981065236","doi":"10.1007/s10549-011-1695-8","title":"Final overall survival results and effect of prolonged (≥1 year) first-line bevacizumab-containing therapy for metastatic breast cancer in the ATHENA trial","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Institute of Cancer Research","funders":"","keywords":"Bevacizumab; Metastatic breast cancer; Breast cancer; Medicine; Oncology; Internal medicine; Cancer; Surgery; Chemotherapy","score_opus":0.1811653887197427,"score_gpt":0.43949079744762376,"score_spread":0.25832540872788107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981065236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896902,0.0058493568,0.0002066032,0.0005336027,0.00019149209,0.000085335734,0.0008925152,0.00002346858,0.0025274896],"genre_scores_gemma":[0.9947331,0.0012924211,0.00022944198,0.0004755364,0.00017021046,0.00012498087,0.0014931997,0.000013664495,0.0014676013],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99950373,0.00023876806,0.000028674322,0.000100680016,0.000036647536,0.000091375776],"domain_scores_gemma":[0.9993554,0.00016168407,0.00016523285,0.00009183954,0.00002886521,0.00019705297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014888942,0.0006491359,0.0015675895,0.00017160378,0.00027083504,0.000899051,0.00048224875,0.0008140831,0.0015777458],"category_scores_gemma":[0.0014550006,0.0002209282,0.0021544173,0.0002236939,0.0004088713,0.0006890407,0.00044864588,0.0020139953,0.0003171757],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90165937,0.0020171453,0.017167052,0.0008169038,0.010362417,0.0002107956,0.0001314366,0.0036570227,0.007593992,0.0005621771,0.0039443406,0.051877346],"study_design_scores_gemma":[0.5025998,0.17468502,0.267988,0.0004441236,0.02660935,0.0008933844,0.00024618933,0.0038067312,0.0040422017,0.003375975,0.015127531,0.00018171172],"about_ca_topic_score_codex":0.00097461295,"about_ca_topic_score_gemma":0.0040450776,"teacher_disagreement_score":0.0015777458,"about_ca_system_score_codex":0.0007991186,"about_ca_system_score_gemma":0.0005763274,"threshold_uncertainty_score":0.007874131},"labels":[],"label_agreement":null},{"id":"W1981530875","doi":"10.1016/j.jpain.2015.01.307","title":"(388) Tetrodotoxin treatment of mechanical allodynia in rats with oxaliplatin and vincristine-induced neuropathy","year":2015,"lang":"en","type":"article","venue":"Journal of Pain","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"","keywords":"Duloxetine; Medicine; Allodynia; Chemotherapy-induced peripheral neuropathy; Oxaliplatin; Peripheral neuropathy; Anesthesia; Vincristine; Neuropathic pain; Dosing; Pregabalin; Chemotherapy; Pharmacology; Hyperalgesia; Internal medicine; Cancer; Nociception; Endocrinology; Cyclophosphamide; Colorectal cancer; Diabetes mellitus","score_opus":0.048251827598589536,"score_gpt":0.326349305834645,"score_spread":0.27809747823605546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981530875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99704677,0.0004914942,0.00067006977,0.0001465319,0.00010014044,0.00006199322,0.00027138434,0.000066574125,0.0011449312],"genre_scores_gemma":[0.99500763,0.00071442267,0.00071609794,0.000058150737,0.00003662956,0.00010313891,0.00025528145,0.00001329345,0.0030953463],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996568,0.00003417254,0.00002401964,0.000052691263,0.00004812514,0.00018407885],"domain_scores_gemma":[0.9996964,0.000026256163,0.00009439711,0.000039838196,0.00003118294,0.000111914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002737183,0.00091020565,0.0010552488,0.0008963754,0.0004400921,0.0003043822,0.00058843545,0.0007662552,0.0030404776],"category_scores_gemma":[0.00024594401,0.00055031804,0.0005735376,0.00052220764,0.00078817015,0.00083401514,0.00025125602,0.001701448,0.00036004133],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019517273,0.0022950214,0.0011450816,0.00019287718,0.00008322375,0.00048789344,0.00012085784,0.0005044277,0.96639276,0.0007116465,0.00028491867,0.008264125],"study_design_scores_gemma":[0.001393068,0.027923666,0.0127152875,0.00004886271,0.00023503584,0.0004919171,0.0002720165,0.0024743096,0.95247066,0.0004080538,0.0015158168,0.00005138359],"about_ca_topic_score_codex":0.0026094264,"about_ca_topic_score_gemma":0.004764676,"teacher_disagreement_score":0.0030404776,"about_ca_system_score_codex":0.00057477964,"about_ca_system_score_gemma":0.0009335571,"threshold_uncertainty_score":0.010171354},"labels":[],"label_agreement":null},{"id":"W1982189934","doi":"10.1002/mpo.1177","title":"A phase II study of homoharringtonine for the treatment of children with refractory or recurrent acute myelogenous leukemia: A pediatric oncology group study","year":2001,"lang":"en","type":"article","venue":"Medical and Pediatric Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"National Cancer Institute","keywords":"Medicine; Homoharringtonine; Refractory (planetary science); Toxicity; Internal medicine; Chemotherapy; Leukemia; Oncology","score_opus":0.03549899831607542,"score_gpt":0.3845588882647767,"score_spread":0.3490598899487013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982189934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98722935,0.004134725,0.0008113925,0.00064178964,0.000111877955,0.0042610774,0.0013187764,0.00008471465,0.0014063809],"genre_scores_gemma":[0.96824026,0.010035741,0.0048724324,0.001459481,0.00033357088,0.008496349,0.003973481,0.00006021011,0.002528455],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99943465,0.00034300284,0.000024169298,0.000060796385,0.00005307106,0.00008432374],"domain_scores_gemma":[0.99902856,0.00015337943,0.0002070416,0.000081892904,0.000071341114,0.00045788454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017433364,0.0015600697,0.0024994868,0.00039256405,0.00039627476,0.00071105384,0.0010014666,0.0012414278,0.0033551971],"category_scores_gemma":[0.0008729222,0.00050488015,0.0011447007,0.0005576507,0.00090450275,0.00058063545,0.0003029581,0.0026647723,0.0007506386],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5779,0.11645276,0.029081658,0.0027407566,0.0035559065,0.0019519837,0.0010892431,0.0049720756,0.0611905,0.0008447476,0.010410406,0.18981001],"study_design_scores_gemma":[0.5151033,0.4488408,0.021045692,0.00007057385,0.00074484164,0.0012664119,0.00013026314,0.00084060663,0.0039969925,0.00021337162,0.0077170776,0.00003008263],"about_ca_topic_score_codex":0.0016183378,"about_ca_topic_score_gemma":0.0025873922,"teacher_disagreement_score":0.0033551971,"about_ca_system_score_codex":0.0010967352,"about_ca_system_score_gemma":0.0024413501,"threshold_uncertainty_score":0.01122427},"labels":[],"label_agreement":null},{"id":"W1982387456","doi":"10.1002/hlca.201200045","title":"New 6/8/6‐Taxanes Isolated from the Heartwood of <i>Taxus cuspidata</i>","year":2012,"lang":"en","type":"article","venue":"Helvetica Chimica Acta","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Chemistry; Stereochemistry; Organic chemistry; Botany","score_opus":0.023293382999773852,"score_gpt":0.2957230188127763,"score_spread":0.27242963581300245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982387456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816513,0.0059304126,0.0029275054,0.00017504596,0.000093319475,0.00012446874,0.0019496797,0.00006380626,0.007084411],"genre_scores_gemma":[0.97496116,0.005352576,0.005599435,0.00018814419,0.000051773757,0.00006248813,0.002947147,0.000026642563,0.01081068],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999777,0.000002373188,0.0000017923129,0.0000062665463,0.000006019965,0.000005806285],"domain_scores_gemma":[0.9999502,0.0000035417677,0.000010105736,0.0000038097296,0.000010522984,0.00002183855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003905121,0.00047782148,0.00021460008,0.00054212735,0.00024794388,0.00016889109,0.0001336403,0.00017962334,0.0027421764],"category_scores_gemma":[0.000053873177,0.0001275553,0.00019740663,0.0002955815,0.0002263707,0.0002201611,0.00017372443,0.0005862503,0.00050239393],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014247783,0.00002848369,0.00048282117,0.00012835625,0.000010379088,0.0002296402,0.000058309735,0.000081970036,0.99239784,0.000102368096,0.000077656165,0.0062596365],"study_design_scores_gemma":[0.00013955159,0.0015592251,0.049964823,0.00009468215,0.00013024472,0.001153468,0.0004770626,0.00044233142,0.9079655,0.00047365105,0.037551593,0.000047831716],"about_ca_topic_score_codex":0.0010302122,"about_ca_topic_score_gemma":0.002440231,"teacher_disagreement_score":0.0027421764,"about_ca_system_score_codex":0.00016954537,"about_ca_system_score_gemma":0.00033877266,"threshold_uncertainty_score":0.009173453},"labels":[],"label_agreement":null},{"id":"W1982416489","doi":"10.1016/s0515-3700(12)71358-7","title":"L’éducation thérapeutique d’un patient atteint d’un cancer du poumon","year":2012,"lang":"fr","type":"article","venue":"Actualités Pharmaceutiques","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine","score_opus":0.07119127118383797,"score_gpt":0.40959497890451335,"score_spread":0.3384037077206754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982416489","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29972824,0.020296652,0.009689712,0.5310922,0.0057304967,0.00022431523,0.00007814317,0.00012016277,0.13303995],"genre_scores_gemma":[0.8213246,0.017541109,0.011710052,0.049273323,0.0025874355,0.00022127005,0.00009517849,0.00006270836,0.09718426],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99928755,0.00037948444,0.000025705853,0.000050514413,0.00009752288,0.00015914929],"domain_scores_gemma":[0.99856734,0.0006556431,0.00008692066,0.000028250295,0.00015990938,0.0005020252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006576411,0.00026131835,0.00022872094,0.00026475126,0.0027807583,0.0016095885,0.00040661648,0.0043869847,0.010032535],"category_scores_gemma":[0.0050897053,0.00015744497,0.0004427833,0.00013833083,0.0014791447,0.001148301,0.001292165,0.005385975,0.0010748929],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014564513,0.007680272,0.037095822,0.0014263252,0.00015902014,0.06691495,0.06521624,0.0024126417,0.016391505,0.07238719,0.1482214,0.58063823],"study_design_scores_gemma":[0.00034273154,0.002397388,0.019952936,0.0014573545,0.000057855068,0.0651284,0.023291158,0.0021547207,0.0054131257,0.014694411,0.8649945,0.00011533186],"about_ca_topic_score_codex":0.008152631,"about_ca_topic_score_gemma":0.011954671,"teacher_disagreement_score":0.010032535,"about_ca_system_score_codex":0.0023859218,"about_ca_system_score_gemma":0.0044921683,"threshold_uncertainty_score":0.033562183},"labels":[],"label_agreement":null},{"id":"W1982504188","doi":"10.1002/ejoc.200800587","title":"Taxpropellane: A Novel Taxane with an Unprecedented Polycyclic Skeleton from the Needles of <i>Taxus canadensis</i>","year":2008,"lang":"en","type":"article","venue":"European Journal of Organic Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Taxane; Chemistry; Propellane; Stereochemistry; Ring (chemistry); Cycloaddition; Skeleton (computer programming); Diterpene; Organic chemistry; Bicyclic molecule; Catalysis","score_opus":0.018627405194229764,"score_gpt":0.2317929821072508,"score_spread":0.21316557691302104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982504188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9673582,0.0049385508,0.0048643393,0.00020503279,0.00010808385,0.00017405786,0.0029056561,0.00015892464,0.01928722],"genre_scores_gemma":[0.9779573,0.0038544384,0.005551093,0.000115495335,0.000029315303,0.000050140927,0.0023576308,0.000024972425,0.010059565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99998164,0.0000017152026,0.0000010784025,0.000006022768,0.0000043243685,0.000005292838],"domain_scores_gemma":[0.99997413,0.0000018135165,0.0000048393244,0.0000025608365,0.0000031648688,0.000013383011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000026783453,0.00028225922,0.000112688904,0.0002884777,0.00018839214,0.00023636376,0.00015794915,0.00020483378,0.0024882155],"category_scores_gemma":[0.000039296505,0.000083285544,0.00011392602,0.00023820829,0.0001628137,0.00027412412,0.00022774127,0.00034767643,0.0005674409],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081570535,0.000020375937,0.00021953398,0.00013914284,0.0000075373787,0.0003625634,0.000032551776,0.00015918807,0.9902906,0.00039861232,0.00015630112,0.008132082],"study_design_scores_gemma":[0.00010632704,0.0009512474,0.010326832,0.000063840555,0.000062960105,0.0027205318,0.00009854804,0.0004134985,0.90580815,0.0005901875,0.07881855,0.00003926256],"about_ca_topic_score_codex":0.0006300834,"about_ca_topic_score_gemma":0.0010789622,"teacher_disagreement_score":0.9993699,"about_ca_system_score_codex":0.00014815557,"about_ca_system_score_gemma":0.00023449775,"threshold_uncertainty_score":0.008323967},"labels":[],"label_agreement":null},{"id":"W1983346346","doi":"10.1002/jps.21061","title":"Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Ethambutol Dihydrochloride**This paper reflects the scientific opinion of the authors and not the policies of regulating agencies.**A project of the International Pharmaceutical Federation FIP, Groupe BCS, http://www.fip.org/bcs.","year":2007,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Bioequivalence; Biopharmaceutics Classification System; Ethambutol; Medicine; Pharmacology; Drug; Dosage form; Active ingredient; Pharmacokinetics; Rifampicin","score_opus":0.11776486107021811,"score_gpt":0.4449384872786766,"score_spread":0.32717362620845847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983346346","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018382898,0.18454176,0.026177082,0.06471527,0.026926177,0.0024457562,0.011955633,0.0043039992,0.6605514],"genre_scores_gemma":[0.04289293,0.06403989,0.012386735,0.016957482,0.00840907,0.0011443703,0.006659427,0.0006935306,0.8468165],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99922264,0.00017612742,0.00011435162,0.000052045838,0.00038931772,0.000045572382],"domain_scores_gemma":[0.9976405,0.00059306814,0.0005457437,0.00016707076,0.00090348185,0.00015017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012315876,0.0006587859,0.0004119074,0.0020120514,0.00059366715,0.0007912404,0.0010464755,0.002047548,0.03594634],"category_scores_gemma":[0.0021213826,0.00032173638,0.00027812322,0.0010694335,0.0004020824,0.0006349673,0.00044236184,0.0017324638,0.024051106],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024704315,0.00020944687,0.0003696557,0.0009295022,0.000012688562,0.0002798708,0.000075602264,0.00016582823,0.013288439,0.0032681632,0.625112,0.3560417],"study_design_scores_gemma":[0.000023830626,0.00011477634,0.0010866924,0.00010767237,0.00000659855,0.0003232382,0.000008770753,0.0000643606,0.0019134434,0.0003052703,0.99603856,0.0000067799815],"about_ca_topic_score_codex":0.0021960188,"about_ca_topic_score_gemma":0.0064263334,"teacher_disagreement_score":0.03594634,"about_ca_system_score_codex":0.0005620088,"about_ca_system_score_gemma":0.001413083,"threshold_uncertainty_score":0.12025249},"labels":[],"label_agreement":null},{"id":"W1983562303","doi":"10.3747/co.22.2360","title":"Systemic Treatment Approaches in her2-Negative Advanced Breast Cancer—Guidance on the Guidelines","year":2015,"lang":"en","type":"review","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Alberta","funders":"","keywords":"Medicine; Breast cancer; Context (archaeology); Metastatic breast cancer; Disease; Cancer; Oncology; Intensive care medicine; Endocrine system; Targeted therapy; Human Epidermal Growth Factor Receptor 2; Systemic therapy; Internal medicine; Hormone","score_opus":0.586920207741529,"score_gpt":0.5595977810184571,"score_spread":0.027322426723071835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983562303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015817623,0.98463714,0.0008872265,0.0057212836,0.00063267595,0.00009587004,0.00028318586,0.000039425104,0.007545055],"genre_scores_gemma":[0.00085660303,0.9908274,0.0028508133,0.0023345286,0.0002224413,0.00009409384,0.00036513538,0.000007946285,0.0024410917],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993869,0.00017108346,0.0001317894,0.000041243144,0.00023037037,0.00003860195],"domain_scores_gemma":[0.9989911,0.00041403898,0.00014080078,0.000019819323,0.00037925952,0.00005499438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014109758,0.00062452594,0.0010832368,0.0024655003,0.00033532808,0.0010068935,0.0013755877,0.0016863878,0.0048190188],"category_scores_gemma":[0.002265337,0.00027089234,0.00094273407,0.0020503523,0.00039761714,0.0009771554,0.00062125485,0.0021898295,0.0032571198],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004037701,0.000079298385,0.00015892086,0.016543634,0.00005778959,0.00019749126,0.000112518006,0.00035570707,0.00058207614,0.0056745177,0.2134207,0.762777],"study_design_scores_gemma":[0.000015789155,0.000023034887,0.00038648848,0.010189984,0.000053509673,0.00035238956,0.00003645175,0.000055142216,0.00008878864,0.0013463934,0.9874429,0.000009127089],"about_ca_topic_score_codex":0.008344368,"about_ca_topic_score_gemma":0.021592852,"teacher_disagreement_score":0.008344368,"about_ca_system_score_codex":0.0013078002,"about_ca_system_score_gemma":0.0037673586,"threshold_uncertainty_score":0.016591609},"labels":[],"label_agreement":null},{"id":"W1984083792","doi":"10.1007/s11864-012-0181-9","title":"Patients With Metastatic Breast Cancer Using Bevacizumab as a Treatment: Is There Still a Role for it?","year":2012,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Bevacizumab; Medicine; Metastatic breast cancer; Oncology; Breast cancer; Clinical trial; Angiogenesis; Internal medicine; Cancer; Vascular endothelial growth factor; Biomarker; Chemotherapy; Colorectal cancer; Paclitaxel; Metastasis; VEGF receptors","score_opus":0.19670101289944478,"score_gpt":0.50025470231862,"score_spread":0.30355368941917527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984083792","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018631388,0.998218,0.000085064625,0.0006150475,0.00012118357,0.000002838626,0.000011424226,0.000004523268,0.0007554654],"genre_scores_gemma":[0.0014834022,0.9969722,0.00022345313,0.0005803588,0.00020217594,0.0000064293913,0.000025993013,0.0000011581644,0.0005048023],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998529,0.000036523023,0.000024309864,0.000024980993,0.000045095952,0.000016210533],"domain_scores_gemma":[0.9996892,0.0001587787,0.00007246687,0.000005446571,0.000049396203,0.000024722764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005234508,0.0005014419,0.0014841231,0.00091568835,0.00017469318,0.0007659376,0.0005383942,0.0007796873,0.0029361967],"category_scores_gemma":[0.0007178245,0.00016313334,0.0004818033,0.0010596486,0.00035840334,0.00096267654,0.00036324104,0.0014161748,0.00085929723],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017719886,0.00007008816,0.00028544347,0.008373492,0.0001099895,0.00012838122,0.000023969964,0.00012289164,0.0006918486,0.0013403466,0.020311344,0.9683649],"study_design_scores_gemma":[0.00020129446,0.00034622473,0.0027142302,0.00799736,0.00066910486,0.0024249612,0.00009404147,0.000204663,0.00053658255,0.0019788994,0.98280185,0.0000307306],"about_ca_topic_score_codex":0.00085830095,"about_ca_topic_score_gemma":0.003053276,"teacher_disagreement_score":0.0029361967,"about_ca_system_score_codex":0.00043330155,"about_ca_system_score_gemma":0.00097495096,"threshold_uncertainty_score":0.009822488},"labels":[],"label_agreement":null},{"id":"W1984199328","doi":"10.1016/j.breast.2013.07.011","title":"Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis","year":2013,"lang":"en","type":"review","venue":"The Breast","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Medicine; Sunitinib; Bevacizumab; Breast cancer; Metastatic breast cancer; Oncology; Cancer; Internal medicine; Context (archaeology); Clinical trial; Paclitaxel; Chemotherapy","score_opus":0.3010749332658669,"score_gpt":0.5013807287201687,"score_spread":0.20030579545430183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984199328","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700655,0.0041482667,0.015031329,0.0004209998,0.00029187385,0.0008479393,0.0036365138,0.00047109422,0.0050864154],"genre_scores_gemma":[0.9771952,0.0033592908,0.0081316205,0.00019802785,0.00004830104,0.0008076211,0.003676928,0.00010402047,0.006478967],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996948,0.00006338974,0.00003693188,0.000050477345,0.000071650065,0.00008278051],"domain_scores_gemma":[0.99966395,0.00006571203,0.00007125991,0.00006439798,0.00004246031,0.00009220142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005908118,0.0006070047,0.0006247289,0.00045348753,0.00019341722,0.0005384522,0.00044790277,0.0004836102,0.0023890815],"category_scores_gemma":[0.00026608258,0.0002444821,0.00045742886,0.00021675993,0.0002433646,0.00045707423,0.00021849689,0.0023157387,0.00072297273],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006215964,0.0018232226,0.00039034444,0.00014632837,0.000033732318,0.00006337677,0.000046209003,0.00083230325,0.99001116,0.0003929125,0.0005705422,0.005068353],"study_design_scores_gemma":[0.0001645654,0.018018086,0.0026910105,0.000018663617,0.000072962524,0.00034668337,0.000039667335,0.002276555,0.9699126,0.00014918888,0.00629481,0.000015228153],"about_ca_topic_score_codex":0.00091750704,"about_ca_topic_score_gemma":0.0018988629,"teacher_disagreement_score":0.0023890815,"about_ca_system_score_codex":0.00057572866,"about_ca_system_score_gemma":0.00055869314,"threshold_uncertainty_score":0.007992268},"labels":[],"label_agreement":null},{"id":"W1985698558","doi":"10.1023/a:1026394718897","title":"Consensus on Medical Treatment of Metastatic Breast Cancer","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Medicine; Metastatic breast cancer; Oncology; Cancer; Internal medicine","score_opus":0.11568431217018388,"score_gpt":0.4625313005886781,"score_spread":0.3468469884184942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985698558","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00061925565,0.5082766,0.004050344,0.42304626,0.04537587,0.00008179828,0.00040736736,0.00007561837,0.018067015],"genre_scores_gemma":[0.022693336,0.53399307,0.014803754,0.370054,0.0451475,0.00044125062,0.0009316089,0.00010448815,0.011830978],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98765326,0.0042614983,0.0027601125,0.00094384316,0.003600351,0.0007810416],"domain_scores_gemma":[0.96967465,0.0142489765,0.002255962,0.0008547702,0.01102716,0.0019385066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018275678,0.00089593825,0.003185232,0.003087227,0.002459366,0.0032448263,0.005066806,0.011492272,0.006817249],"category_scores_gemma":[0.029910924,0.0005990384,0.0026959225,0.0030049887,0.0038552408,0.003143798,0.003251805,0.018286418,0.003234504],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038241755,0.00013230473,0.00037275173,0.014531568,0.00030013575,0.00037186424,0.00049342884,0.0007338398,0.0009910301,0.03322197,0.5175366,0.4309321],"study_design_scores_gemma":[0.00013741794,0.00010961881,0.00089143857,0.016319664,0.00026115842,0.00037451307,0.00026035847,0.00015843475,0.0003534859,0.013978366,0.9671144,0.000041204745],"about_ca_topic_score_codex":0.007916851,"about_ca_topic_score_gemma":0.013800697,"teacher_disagreement_score":0.018275678,"about_ca_system_score_codex":0.004974928,"about_ca_system_score_gemma":0.015518976,"threshold_uncertainty_score":0.09665215},"labels":[],"label_agreement":null},{"id":"W1985716194","doi":"10.5737/1181912x153161167","title":"Peripheral nerve function and symptom distress during biotherapy for malignant melanoma","year":2005,"lang":"en","type":"article","venue":"Canadian Oncology Nursing Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Oncology Nursing Society Foundation; Oncology Nursing Society","keywords":"Medicine; Sensation; Distress; Peripheral neuropathy; Peripheral; Orthostatic vital signs; Physical medicine and rehabilitation; Melanoma; Balance (ability); Cancer; Physical therapy; Internal medicine; Blood pressure; Diabetes mellitus; Endocrinology","score_opus":0.01633641665314523,"score_gpt":0.321700685123009,"score_spread":0.30536426846986375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985716194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997398,0.000054248634,0.000036700025,0.000010401979,0.0000011862536,0.0000138166115,0.000011573598,0.0000011037197,0.00013104896],"genre_scores_gemma":[0.9996259,0.000058522688,0.00007122377,0.000016252698,0.0000034884408,0.000017967584,0.000025329706,4.5419264e-7,0.00018083958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997702,0.000099595585,0.00001134191,0.000020429754,0.000062206855,0.000036251942],"domain_scores_gemma":[0.9993426,0.00017645743,0.0002671598,0.000020891614,0.00008509276,0.000107722444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043792013,0.00015427348,0.0002690712,0.00011888088,0.000259939,0.00014385051,0.00009233383,0.0001764027,0.0011366723],"category_scores_gemma":[0.0018500201,0.000076517696,0.00015027051,0.000117956086,0.00013809268,0.00015592198,0.00014556607,0.0003365658,0.000089399626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00978237,0.003326169,0.8563003,0.00031673818,0.00012152895,0.00063945993,0.0029890588,0.00035379746,0.040840257,0.000033592794,0.00037145574,0.08492522],"study_design_scores_gemma":[0.000046298876,0.00800377,0.9900248,0.0000061594405,0.00002373287,0.00019169298,0.0003402097,0.00012095449,0.0010840105,0.000009713606,0.00014375268,0.000004838558],"about_ca_topic_score_codex":0.001764595,"about_ca_topic_score_gemma":0.0044408008,"teacher_disagreement_score":0.001764595,"about_ca_system_score_codex":0.00027052636,"about_ca_system_score_gemma":0.00023153074,"threshold_uncertainty_score":0.003802538},"labels":[],"label_agreement":null},{"id":"W1985725341","doi":"10.1016/j.jpainsymman.2006.10.003","title":"Pain Management for Older Adults","year":2006,"lang":"en","type":"article","venue":"Journal of Pain and Symptom Management","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital; University of Regina; Canadian Institutes of Health Research","funders":"","keywords":"Medicine; Psychosocial; Tramadol; Pain management; Population; Coping (psychology); Intensive care medicine; Physical therapy; Psychiatry; Analgesic","score_opus":0.00677315910624999,"score_gpt":0.27291507036656826,"score_spread":0.2661419112603183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985725341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7400499,0.16197082,0.0008780647,0.026619043,0.0016637574,0.0002948789,0.0008473226,0.000077069846,0.06759911],"genre_scores_gemma":[0.9186449,0.056571875,0.0017509384,0.008754253,0.0013884483,0.00018264537,0.0006773833,0.000007408941,0.012022105],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998708,0.000025477168,0.00002410297,0.000010213562,0.00003426726,0.00003521967],"domain_scores_gemma":[0.9996644,0.00003691594,0.00008719808,0.000007720847,0.00007473471,0.00012902905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030097942,0.00013702447,0.00026029238,0.00025330606,0.00045872244,0.00031060696,0.00010747544,0.0004506215,0.0047017112],"category_scores_gemma":[0.0012375583,0.000057705336,0.000321868,0.00026930735,0.00006195235,0.00029441575,0.00030847185,0.00044878508,0.0005747588],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001238154,0.000988468,0.21058331,0.0014222981,0.0001608461,0.00180579,0.0011819913,0.00010179325,0.0026138045,0.00044429165,0.047160093,0.73229915],"study_design_scores_gemma":[0.0004711065,0.0031819923,0.8980155,0.0016149847,0.00027650796,0.006650941,0.0017119328,0.0002438432,0.00043405083,0.0006566942,0.08672167,0.000020749017],"about_ca_topic_score_codex":0.0023611428,"about_ca_topic_score_gemma":0.007374187,"teacher_disagreement_score":0.0047017112,"about_ca_system_score_codex":0.00031538188,"about_ca_system_score_gemma":0.00061166025,"threshold_uncertainty_score":0.015728772},"labels":[],"label_agreement":null},{"id":"W1985754465","doi":"10.1016/j.jpain.2005.01.088","title":"Role of calcium in chemotherapy-evoked neuropathic pain","year":2005,"lang":"en","type":"article","venue":"Journal of Pain","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Neuropathic pain; Anesthesia; Allodynia; Hyperalgesia; Gabapentin; Pharmacology; Chemotherapy; Calcium; Peripheral neuropathy; Nociception; Surgery; Internal medicine; Endocrinology; Pathology","score_opus":0.016782924438574286,"score_gpt":0.31247128030664323,"score_spread":0.29568835586806896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985754465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64467466,0.3011347,0.006764997,0.009446584,0.0014738161,0.0003280098,0.0005415598,0.00018424186,0.035451375],"genre_scores_gemma":[0.95743513,0.035894696,0.001574707,0.0004965774,0.00039671973,0.0000737101,0.00013515704,0.00002140911,0.003971947],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99955136,0.00015972841,0.000048914317,0.00004627675,0.00009199255,0.0001016655],"domain_scores_gemma":[0.99891067,0.00048028064,0.0002904946,0.00008752368,0.00012808589,0.0001029044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068899273,0.000595339,0.00079738925,0.0010499582,0.0008456837,0.0017205938,0.00120054,0.0023910177,0.0031024844],"category_scores_gemma":[0.0021203072,0.0003153813,0.00054257375,0.0005826195,0.0012717176,0.0017633456,0.0008270284,0.0012384546,0.00036429596],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057266735,0.002430661,0.015813038,0.009434786,0.0009078997,0.03252535,0.001611586,0.005089814,0.62591255,0.06553619,0.0096251285,0.1738463],"study_design_scores_gemma":[0.013268837,0.02771739,0.21055922,0.003636599,0.0033423959,0.04694638,0.004412522,0.023862982,0.4718171,0.07436888,0.11962689,0.0004408587],"about_ca_topic_score_codex":0.0016150359,"about_ca_topic_score_gemma":0.0016584006,"teacher_disagreement_score":0.0031024844,"about_ca_system_score_codex":0.0012331278,"about_ca_system_score_gemma":0.0010386305,"threshold_uncertainty_score":0.010378838},"labels":[],"label_agreement":null},{"id":"W1986337659","doi":"10.1200/jco.2013.52.0288","title":"Wither the Cooperative Groups?","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.17177293971052338,"score_gpt":0.5331492846017156,"score_spread":0.36137634489119225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986337659","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014796942,0.006754976,0.008417469,0.8345067,0.04845548,0.0005745961,0.0012862225,0.001451133,0.097073756],"genre_scores_gemma":[0.034791246,0.009703832,0.01885993,0.6685649,0.03151942,0.002908713,0.0034792952,0.0021097378,0.22806297],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9348936,0.03160671,0.003854985,0.00763147,0.014389155,0.0076240236],"domain_scores_gemma":[0.8505855,0.053624958,0.011739723,0.023035714,0.027118234,0.03389586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08625131,0.0011779374,0.0011852838,0.0027220207,0.0066153244,0.016703112,0.0058214995,0.01820253,0.21122384],"category_scores_gemma":[0.2525627,0.0012288258,0.0014959325,0.0040980703,0.006778638,0.029702114,0.012282301,0.012761146,0.08602619],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051320105,0.000057700854,0.0007515129,0.00012410936,0.000012553969,0.00008637276,0.00044098805,0.000061848215,0.000043916636,0.038293034,0.8990458,0.061030786],"study_design_scores_gemma":[0.0000770816,0.000026125368,0.00020042909,0.00030458058,0.000006215327,0.000061195366,0.00040170507,0.000049136564,0.000044019525,0.013239054,0.98557013,0.00002031059],"about_ca_topic_score_codex":0.008177995,"about_ca_topic_score_gemma":0.008919714,"teacher_disagreement_score":0.21122384,"about_ca_system_score_codex":0.005841121,"about_ca_system_score_gemma":0.036544636,"threshold_uncertainty_score":0.70661414},"labels":[],"label_agreement":null},{"id":"W1986388359","doi":"10.1517/14656560802653206","title":"Economic evaluation of docetaxel for breast cancer","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Docetaxel; Medicine; Taxane; Breast cancer; Oncology; Cancer; Internal medicine; Prostate cancer; Adjuvant; Chemotherapy; Intensive care medicine","score_opus":0.19665257186682186,"score_gpt":0.5538454632338995,"score_spread":0.35719289136707766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986388359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008945161,0.9935942,0.00041672718,0.0010720035,0.0001610199,0.000046653986,0.00006006508,0.0000034050447,0.0037513978],"genre_scores_gemma":[0.03006237,0.9670943,0.00078904605,0.0005606228,0.0003464377,0.00012494496,0.00010501983,0.0000044206854,0.0009128089],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9977028,0.001488262,0.00013905663,0.00006595499,0.00053668604,0.00006737756],"domain_scores_gemma":[0.9973525,0.0019099537,0.0004293928,0.000030984113,0.00021630962,0.000060837283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035703697,0.00076299155,0.0022433044,0.0015804832,0.00017713623,0.0012860456,0.000963978,0.0011140656,0.004557111],"category_scores_gemma":[0.009244252,0.00020925127,0.0017301027,0.0017117384,0.00033820182,0.00070276525,0.0003776723,0.0013264846,0.00043792409],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021844348,0.00020098666,0.00058702164,0.029324645,0.0019645265,0.00036095304,0.00003149581,0.0077631464,0.0004243104,0.01320363,0.022181733,0.9217731],"study_design_scores_gemma":[0.00444196,0.003983131,0.012772212,0.08364501,0.0075315065,0.005338593,0.00024321981,0.012943598,0.0026163063,0.045131065,0.8211846,0.00016888347],"about_ca_topic_score_codex":0.002874606,"about_ca_topic_score_gemma":0.0041068993,"teacher_disagreement_score":0.004557111,"about_ca_system_score_codex":0.0031690747,"about_ca_system_score_gemma":0.0026213587,"threshold_uncertainty_score":0.022993326},"labels":[],"label_agreement":null},{"id":"W1986429657","doi":"10.1158/0008-5472.sabcs10-p5-10-09","title":"Abstract P5-10-09: Comparison of the (Non-)Hematological Toxicity and Compliance of Different Anthracycline Containing Regimen with the Standard AC/EC in Elderly Patients with Primary Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epirubicin; Anthracycline; Medicine; Docetaxel; Regimen; Taxane; Cyclophosphamide; Doxorubicin; Internal medicine; Breast cancer; Chemotherapy; Paclitaxel; Gastroenterology; Pharmacology; Cancer","score_opus":0.07047424158493303,"score_gpt":0.43264467587703886,"score_spread":0.3621704342921058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986429657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810409,0.016466375,0.0003083699,0.000104008526,0.0000398965,0.00025246115,0.0008370374,0.000015592555,0.00093532406],"genre_scores_gemma":[0.9969599,0.001618554,0.00026542548,0.00012959712,0.000049175724,0.000082009,0.0007272409,0.0000031528475,0.00016491901],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9983082,0.0010793563,0.00021018604,0.00018099413,0.00016661356,0.000054646916],"domain_scores_gemma":[0.99801564,0.0007078397,0.0008181127,0.00013700314,0.0001383637,0.00018306873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027786673,0.00033519766,0.0010539994,0.00040468975,0.00009613852,0.00045934555,0.00028614854,0.00039504247,0.0014089831],"category_scores_gemma":[0.0024791546,0.0001559205,0.0017870783,0.0007221785,0.0002900801,0.00032141482,0.00026658308,0.0004413179,0.000101421974],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63391167,0.0031521423,0.14519644,0.0052555795,0.04999276,0.00017067333,0.00012465833,0.0027802598,0.0070860903,0.00017613826,0.0013218714,0.15083167],"study_design_scores_gemma":[0.088660665,0.2485592,0.5919285,0.00072642224,0.058280587,0.00047800763,0.00015346895,0.0020610187,0.003659429,0.00027485032,0.0051606954,0.000057187248],"about_ca_topic_score_codex":0.0006356533,"about_ca_topic_score_gemma":0.0015322508,"teacher_disagreement_score":0.0027786673,"about_ca_system_score_codex":0.0004517182,"about_ca_system_score_gemma":0.000492764,"threshold_uncertainty_score":0.014695168},"labels":[],"label_agreement":null},{"id":"W1986533778","doi":"10.1007/s10600-012-0102-y","title":"A new taxane from Taxus canadensis needles","year":2012,"lang":"en","type":"article","venue":"Chemistry of Natural Compounds","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Hebei Medical University; Hebei University","keywords":"Taxane; Chemistry; Stereochemistry; Taxus; Botany; Biology","score_opus":0.017324371127557137,"score_gpt":0.28728905463954707,"score_spread":0.26996468351198993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986533778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83360606,0.039913356,0.010452111,0.0014561198,0.001001208,0.001024353,0.0053978525,0.00039711563,0.10675178],"genre_scores_gemma":[0.9266348,0.021956144,0.0061457036,0.00045686518,0.00020767361,0.00009079772,0.002261071,0.00004961621,0.042197313],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99997663,0.0000015728822,0.0000015531585,0.000007826551,0.0000070952133,0.0000052388773],"domain_scores_gemma":[0.9999652,0.0000047222593,0.0000049188648,0.0000037202876,0.000005607442,0.000015888667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000034986268,0.00037576281,0.000212665,0.0007809674,0.0004019561,0.00024435043,0.0002888897,0.00026353967,0.0057724803],"category_scores_gemma":[0.000065147025,0.0001384249,0.00022614936,0.000446429,0.000242249,0.0005009233,0.00034184553,0.00073958386,0.00086681236],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039697258,0.00031406258,0.0007525597,0.0013907048,0.00005370667,0.002770043,0.00028543765,0.001348037,0.8974444,0.0041894005,0.0031292995,0.08792523],"study_design_scores_gemma":[0.00034058324,0.0043577403,0.017679218,0.00029297624,0.00036379963,0.0053182617,0.00043976496,0.0017388233,0.6118383,0.0051710447,0.35234144,0.00011795783],"about_ca_topic_score_codex":0.0021537766,"about_ca_topic_score_gemma":0.004966155,"teacher_disagreement_score":0.0057724803,"about_ca_system_score_codex":0.00025047676,"about_ca_system_score_gemma":0.00039973823,"threshold_uncertainty_score":0.019310832},"labels":[],"label_agreement":null},{"id":"W1987122320","doi":"10.1158/0008-5472.sabcs-4118","title":"Primary analysis of study MO19391, an open-label safety study of bevacizumab (B) plus taxane-based therapy as 1st-line treatment of patients (pts) with locally recurrent (LR) or metastatic breast cancer (mBC).","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Taxane; Bevacizumab; Internal medicine; Population; Regimen; Clinical endpoint; Metastatic breast cancer; Phases of clinical research; Gastroenterology; Surgery; Oncology; Chemotherapy; Cancer; Breast cancer; Clinical trial","score_opus":0.1958622123719409,"score_gpt":0.5105737341160985,"score_spread":0.3147115217441576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987122320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94767565,0.0061560185,0.002352041,0.000762268,0.00026753632,0.018698871,0.017255548,0.00024096452,0.006591054],"genre_scores_gemma":[0.96543294,0.0019832512,0.00267708,0.0016214458,0.0005176919,0.011453416,0.011920538,0.00010183115,0.0042919214],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99689937,0.0019725931,0.0001866927,0.00045024836,0.0002892394,0.0002018666],"domain_scores_gemma":[0.99520606,0.0011768464,0.0016592192,0.0004375704,0.0004393337,0.0010809443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00695669,0.001980678,0.002800614,0.00065330265,0.00058139744,0.0014422409,0.0010709694,0.0017259307,0.0091420235],"category_scores_gemma":[0.004765673,0.0006968121,0.003103517,0.0008615273,0.00085321156,0.0010475651,0.00069431536,0.002421264,0.0017041513],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92853653,0.012244471,0.012390879,0.0020820387,0.006866823,0.00025051602,0.00012217095,0.00069994916,0.011286522,0.00014692021,0.0043034437,0.021069754],"study_design_scores_gemma":[0.65100855,0.25064522,0.077095106,0.00019806383,0.0065362067,0.00040279632,0.00005978514,0.0011345405,0.0038865816,0.00031448258,0.008652116,0.000066538225],"about_ca_topic_score_codex":0.00085350545,"about_ca_topic_score_gemma":0.0023023118,"teacher_disagreement_score":0.0091420235,"about_ca_system_score_codex":0.001331807,"about_ca_system_score_gemma":0.0027563178,"threshold_uncertainty_score":0.036790967},"labels":[],"label_agreement":null},{"id":"W1987130488","doi":"10.1002/cbdv.201000017","title":"A New Taxane with an Opened Oxetane Ring from the Needles of <i>Taxus cuspidata</i>","year":2010,"lang":"en","type":"article","venue":"Chemistry & Biodiversity","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Chemistry; Oxetane; Taxane; Taxoid; Stereochemistry; Two-dimensional nuclear magnetic resonance spectroscopy; Organic chemistry; Paclitaxel","score_opus":0.015133089308162798,"score_gpt":0.2463394895889128,"score_spread":0.23120640028075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987130488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98279107,0.0058132443,0.0031301149,0.00018153634,0.000059481623,0.00010120288,0.0021322132,0.00008400325,0.005707149],"genre_scores_gemma":[0.97550946,0.0059152343,0.0066675944,0.00021169614,0.00006359721,0.000053347772,0.003422254,0.000032799853,0.008123854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999825,0.000001658088,0.0000013623797,0.000006313564,0.0000039565307,0.0000043139967],"domain_scores_gemma":[0.99996686,0.0000018216086,0.0000075638927,0.0000025160623,0.0000054128823,0.000015919863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000026158443,0.0003621522,0.00025522485,0.0002719598,0.00021314184,0.00020076225,0.00017087214,0.00020727172,0.0022730713],"category_scores_gemma":[0.00004050811,0.00016238546,0.00018939552,0.00022836511,0.00018388641,0.00023637955,0.00017744675,0.0004164252,0.0004494478],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016911859,0.000018021741,0.00044988684,0.00009662332,0.000007820397,0.0003627724,0.0000423638,0.000052297895,0.9931386,0.0000721894,0.00005709884,0.005533281],"study_design_scores_gemma":[0.00024984774,0.002745651,0.0634556,0.000082921484,0.0001740988,0.00485044,0.00026954664,0.00040437432,0.88306266,0.00040404397,0.044240873,0.00005992281],"about_ca_topic_score_codex":0.0009990386,"about_ca_topic_score_gemma":0.0020425646,"teacher_disagreement_score":0.0022730713,"about_ca_system_score_codex":0.00020111114,"about_ca_system_score_gemma":0.00029143115,"threshold_uncertainty_score":0.0076042414},"labels":[],"label_agreement":null},{"id":"W1987278392","doi":"10.1021/bm800571s","title":"Effect of Extracellular Matrix Elements on the Transport of Paclitaxel through an Arterial Wall Tissue Mimic","year":2008,"lang":"en","type":"article","venue":"Biomacromolecules","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Paclitaxel; Extracellular matrix; Arterial wall; Chemistry; Extracellular; Matrix (chemical analysis); Biophysics; Biochemistry; Biology; Medicine; Chromatography; Cardiology; Genetics; Chemotherapy","score_opus":0.024093944434701718,"score_gpt":0.34005538757409676,"score_spread":0.31596144313939506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987278392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99794835,0.00059529004,0.000724951,0.000030103956,0.000009947778,0.000012102836,0.00004073492,0.000014154616,0.00062432315],"genre_scores_gemma":[0.9965822,0.00046286135,0.0020977745,0.000021484913,0.000004598635,0.0000145583845,0.00007359507,0.000008665183,0.00073432905],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986994,0.000048290352,0.000009647007,0.000017527562,0.000026475649,0.00002810993],"domain_scores_gemma":[0.9998197,0.00009453885,0.000033071196,0.000013641477,0.000014616534,0.000024502146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014338997,0.00023367327,0.00017680616,0.000091160015,0.00013457442,0.00029470443,0.00011109564,0.00017798868,0.00051251723],"category_scores_gemma":[0.00026829963,0.00012308375,0.00010471739,0.000090266105,0.00014953582,0.00016219281,0.00015119367,0.00022788919,0.00015769798],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012308007,0.000022979444,0.000085164465,0.00002767059,0.000004173493,0.000058860933,0.000016823027,0.00015146457,0.9986731,0.000044331355,0.000014493921,0.0007779056],"study_design_scores_gemma":[0.000009633381,0.0003303501,0.00052180997,0.000002613419,0.000009267777,0.000068665664,0.000009739864,0.00084136304,0.99751925,0.0000072994635,0.0006778434,0.0000022416905],"about_ca_topic_score_codex":0.0010508437,"about_ca_topic_score_gemma":0.0012996318,"teacher_disagreement_score":0.0010508437,"about_ca_system_score_codex":0.00022713472,"about_ca_system_score_gemma":0.00016950561,"threshold_uncertainty_score":0.0020894408},"labels":[],"label_agreement":null},{"id":"W1987689517","doi":"10.1515/znc-2003-7-827","title":"Hydrogen Peroxide from the Oxidative Burst is Not Involved in the Induction of Taxol Biosynthesis in Taxus chinensis Cells","year":2003,"lang":"en","type":"article","venue":"Zeitschrift für Naturforschung C","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Cancer Institute","keywords":"Elicitor; Hydrogen peroxide; Catalase; Taxus; Superoxide dismutase; Chemistry; Biochemistry; Biosynthesis; Respiratory burst; Aspergillus niger; Oxidative stress; Biology; Enzyme; Botany","score_opus":0.023011013833779594,"score_gpt":0.29680672563203603,"score_spread":0.27379571179825646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987689517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953904,0.0005807968,0.0011099695,0.00009229897,0.000024561297,0.000036608162,0.0005411824,0.000046585774,0.0021774825],"genre_scores_gemma":[0.9955527,0.0002615061,0.00048907637,0.000028247754,0.000005558881,0.000022619311,0.0009945524,0.000013275312,0.0026324403],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999198,0.000010351428,0.0000071497125,0.0000143122825,0.00002604392,0.00002237141],"domain_scores_gemma":[0.99990654,0.000015372789,0.000015647835,0.000019491175,0.00001612261,0.00002689741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006991563,0.00028194886,0.00028911454,0.00017766093,0.00019845327,0.0004326552,0.00014128358,0.00021394608,0.0012673495],"category_scores_gemma":[0.000104029255,0.00013550851,0.00023799784,0.00020848495,0.00021116938,0.00022063727,0.00021903944,0.0004203251,0.00042466837],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063847336,0.0000067759943,0.00019032629,0.000010865257,0.000001796813,0.00002682292,0.000010113817,0.0000067741653,0.9993117,0.000027436787,0.000008689661,0.0003348186],"study_design_scores_gemma":[0.000015394795,0.00011476431,0.008318626,0.0000033224876,0.00001107459,0.000136501,0.000046754136,0.00027893754,0.9896673,0.00006218141,0.0013410067,0.000004200146],"about_ca_topic_score_codex":0.0020632276,"about_ca_topic_score_gemma":0.002898642,"teacher_disagreement_score":0.0020632276,"about_ca_system_score_codex":0.00031576667,"about_ca_system_score_gemma":0.00035362667,"threshold_uncertainty_score":0.0042396784},"labels":[],"label_agreement":null},{"id":"W1988917398","doi":"10.2174/1568006033481375","title":"Selective Protein Kinase C Inhibitors and Their Applications","year":2003,"lang":"en","type":"review","venue":"Current Drug Targets - Cardiovascular & Hematological Disorders","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Protein kinase C; Gene isoform; Medicine; Clinical trial; Kinase; Pharmacology; Cancer research; Internal medicine; Cell biology; Biology; Biochemistry","score_opus":0.03009395729194943,"score_gpt":0.32358456588424717,"score_spread":0.29349060859229775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988917398","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01115184,0.9479716,0.00886079,0.002759475,0.0016385453,0.00027762615,0.00033785944,0.0002122595,0.026790015],"genre_scores_gemma":[0.109955296,0.8373635,0.012121023,0.0048678215,0.0013279378,0.0008579081,0.0012952323,0.00005924271,0.032152038],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996369,0.00005589525,0.000027240414,0.00008447701,0.0001361526,0.000059222562],"domain_scores_gemma":[0.99984133,0.000028731947,0.00003120275,0.000011908373,0.000046742705,0.000040064893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006147792,0.0006977471,0.00055793003,0.001135311,0.00037068507,0.00084548345,0.0006541708,0.001111133,0.004872277],"category_scores_gemma":[0.00048860384,0.0002372597,0.0005148614,0.00096375064,0.00040150093,0.0006539259,0.0006011927,0.0022847361,0.003056137],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011307914,0.0006311629,0.0005074522,0.0030250982,0.00012600851,0.00059952185,0.000071674476,0.00061498384,0.053170215,0.013235,0.033150896,0.89373714],"study_design_scores_gemma":[0.00050230674,0.0015074802,0.0019940229,0.0005399951,0.00013656203,0.0032951809,0.00003702667,0.0007535331,0.04684284,0.0035970814,0.94073516,0.000058759077],"about_ca_topic_score_codex":0.00083201646,"about_ca_topic_score_gemma":0.0011824449,"teacher_disagreement_score":0.004872277,"about_ca_system_score_codex":0.00089769595,"about_ca_system_score_gemma":0.00066041347,"threshold_uncertainty_score":0.016299367},"labels":[],"label_agreement":null},{"id":"W1990195000","doi":"10.1007/s10549-011-1756-z","title":"Inhibition of EGFR phosphorylation in a panel of human breast cancer cells correlates with synergistic interactions between gefitinib and 5′-DFUR, the bioactive metabolite of Xeloda®","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital; Royal Victoria Regional Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Gefitinib; Metabolite; Breast cancer; Phosphorylation; Cancer research; Pharmacology; Chemistry; Medicine; Internal medicine; Cancer; Epidermal growth factor receptor; Biochemistry","score_opus":0.11291987091672188,"score_gpt":0.3855439548003682,"score_spread":0.2726240838836463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990195000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99215186,0.0023827814,0.0009489378,0.00011235606,0.000040664618,0.00004769784,0.001136633,0.000097308875,0.0030818784],"genre_scores_gemma":[0.9916598,0.0015869853,0.0012124095,0.0000452363,0.000012656616,0.00007152677,0.003039715,0.000013471857,0.002358319],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997675,0.000044310953,0.00001766922,0.000033943947,0.000058526395,0.00007806404],"domain_scores_gemma":[0.99994147,0.000015336233,0.000009826166,0.00000895111,0.0000089416735,0.000015525924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020547931,0.00055312144,0.00051897333,0.00039060737,0.0002494629,0.00025903448,0.0001924538,0.00023514143,0.0029957686],"category_scores_gemma":[0.00011188383,0.00018293488,0.0005126511,0.0003473637,0.00013063122,0.0001505407,0.00015395004,0.00044970732,0.00067218527],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008210356,0.00034201678,0.0013923729,0.00009981901,0.00004699274,0.000079993246,0.000037606635,0.00022074988,0.9898756,0.000069599555,0.00060734514,0.0064068553],"study_design_scores_gemma":[0.000070249145,0.0019311196,0.024599388,0.00000580832,0.000054652155,0.0006706217,0.000052257536,0.0005911604,0.96882105,0.000023523762,0.0031712777,0.000008922136],"about_ca_topic_score_codex":0.0021262667,"about_ca_topic_score_gemma":0.0046770857,"teacher_disagreement_score":0.0029957686,"about_ca_system_score_codex":0.00032443958,"about_ca_system_score_gemma":0.0002224346,"threshold_uncertainty_score":0.010021806},"labels":[],"label_agreement":null},{"id":"W1992769594","doi":"10.1002/rcm.2622","title":"Mass spectrometry study of hemoglobin‐oxaliplatin complexes in colorectal cancer patients and potential association with chemotherapeutic responses","year":2006,"lang":"en","type":"article","venue":"Rapid Communications in Mass Spectrometry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Oxaliplatin; Chemistry; Colorectal cancer; Mass spectrometry; High-performance liquid chromatography; Chromatography; Inductively coupled plasma mass spectrometry; Hemoglobin; Cancer; Internal medicine; Biochemistry; Medicine","score_opus":0.016617150837549673,"score_gpt":0.3119982607222098,"score_spread":0.29538110988466015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992769594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99905294,0.00040008916,0.00018788721,0.00002637698,0.0000029174512,0.000007560988,0.00007640305,0.000008307717,0.00023764743],"genre_scores_gemma":[0.9995214,0.000079676385,0.00017075062,0.000021217342,0.0000053628605,0.000005460915,0.00009655445,0.0000016533736,0.00009810752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997497,0.00006040867,0.000029903093,0.000057535202,0.00006598722,0.000036416655],"domain_scores_gemma":[0.9992712,0.00014973762,0.0003565225,0.000021890151,0.000117237345,0.00008335792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024136163,0.00021137264,0.00034103548,0.0006271304,0.00020031215,0.00033451006,0.00014716883,0.00031000553,0.00045943182],"category_scores_gemma":[0.0012946381,0.000113003865,0.00013720279,0.00070254185,0.00013990342,0.00012427855,0.00012339234,0.0003479654,0.00010898169],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014478468,0.00011533893,0.9635956,0.00004032008,0.00009399489,0.0006649265,0.00019095902,0.0001837775,0.024587056,0.00004388172,0.00011978903,0.008916502],"study_design_scores_gemma":[0.000017334602,0.00059964036,0.99111044,0.000003675334,0.00006586659,0.0011981849,0.0000963124,0.000740636,0.0057119397,0.000028430846,0.0004215576,0.0000060169705],"about_ca_topic_score_codex":0.0010349827,"about_ca_topic_score_gemma":0.0006569145,"teacher_disagreement_score":0.0010349827,"about_ca_system_score_codex":0.00029616288,"about_ca_system_score_gemma":0.00012219463,"threshold_uncertainty_score":0.002148807},"labels":[],"label_agreement":null},{"id":"W1992816765","doi":"10.1177/1078155214556008","title":"Abraxane® versus Taxol® for patients with advanced breast cancer: A prospective time and motion analysis from a Chinese health care perspective","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Breast cancer; Adverse effect; Premedication; Cancer; Paclitaxel; Emergency medicine; Internal medicine; Surgery","score_opus":0.011455966854408016,"score_gpt":0.41087533716621105,"score_spread":0.399419370311803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992816765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986205,0.0005973538,0.000041971074,0.000065795866,0.0000044822837,0.00002908796,0.0004101737,9.354483e-7,0.00022959233],"genre_scores_gemma":[0.99896216,0.00024738556,0.00004258252,0.000056607973,0.000014691178,0.000025656736,0.0005725537,8.5071235e-7,0.00007769328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918157,0.00021600357,0.00009101451,0.00013340464,0.00013743344,0.00024058498],"domain_scores_gemma":[0.9971239,0.0005436263,0.0015841484,0.00006534995,0.00023332497,0.00044965302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014243848,0.00038584854,0.0006724239,0.0017931234,0.00054061157,0.0007652649,0.00034649085,0.0004654639,0.0024085152],"category_scores_gemma":[0.002457909,0.0002316387,0.002568061,0.0027810321,0.00039529375,0.0005759411,0.0006949751,0.00064209773,0.00013070859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002463322,0.00011869611,0.9936841,0.000070249436,0.0005142503,0.00010315152,0.00011315028,0.00036556987,0.00009880613,0.000055604058,0.00013939374,0.0022735687],"study_design_scores_gemma":[0.00015495018,0.0014562763,0.99577725,0.00001907568,0.00058046007,0.00009079511,0.0004307923,0.0011592081,0.000045907924,0.000051414434,0.00021719301,0.000016596727],"about_ca_topic_score_codex":0.017700754,"about_ca_topic_score_gemma":0.016652854,"teacher_disagreement_score":0.017700754,"about_ca_system_score_codex":0.0019618173,"about_ca_system_score_gemma":0.0016929124,"threshold_uncertainty_score":0.03519547},"labels":[],"label_agreement":null},{"id":"W1993857407","doi":"10.1016/j.bmcl.2007.02.031","title":"Synthesis and biological evaluation of novel analogues of dictyostatin","year":2007,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; National Cancer Institute; Public Health Agency of Canada","keywords":"Chemistry; In vitro; Microtubule; Cell culture; Chemical synthesis; Cytotoxicity; Stereochemistry; Biological activity; Cancer cell lines; Combinatorial chemistry; Cell growth; Cancer cell; Biochemistry; Cancer; Cell biology","score_opus":0.06544543634468435,"score_gpt":0.34055084448830103,"score_spread":0.27510540814361667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993857407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99017346,0.0040535205,0.0017303779,0.00013111212,0.00008576643,0.000157279,0.0006083064,0.000028094264,0.003032027],"genre_scores_gemma":[0.9915065,0.0024539935,0.0021412051,0.00007562588,0.000016664451,0.000049666152,0.0007421957,0.000008409137,0.0030057956],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999948,0.000007901051,0.0000058165983,0.000009419688,0.000011468367,0.000017410957],"domain_scores_gemma":[0.9999292,0.000011746886,0.00001605324,0.000006339871,0.000010577961,0.00002600247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014881563,0.00021802721,0.00020142662,0.00010592153,0.00012049086,0.00017006218,0.00021865092,0.00021151981,0.001666449],"category_scores_gemma":[0.00013722255,0.0000993529,0.00015846311,0.00008300661,0.00016152623,0.00017497675,0.00014510113,0.00043269127,0.00026803758],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010068737,0.00012995482,0.00014010868,0.00012294912,0.000012585019,0.00018250104,0.000025412062,0.0005908001,0.99303824,0.00019762485,0.00011860459,0.0044344603],"study_design_scores_gemma":[0.00038335557,0.0043037077,0.0012157499,0.000011109181,0.000036869355,0.00047797407,0.000029846922,0.0005039941,0.984306,0.00004725413,0.008674737,0.000009432278],"about_ca_topic_score_codex":0.00044413938,"about_ca_topic_score_gemma":0.00079785817,"teacher_disagreement_score":0.001666449,"about_ca_system_score_codex":0.00031164958,"about_ca_system_score_gemma":0.00019531178,"threshold_uncertainty_score":0.005574882},"labels":[],"label_agreement":null},{"id":"W1994685129","doi":"10.1007/s10549-012-2288-x","title":"Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Capecitabine; Medicine; Metastatic breast cancer; Internal medicine; Regimen; Adverse effect; Breast cancer; Oncology; Odds ratio; Cancer; Progression-free survival; Gastroenterology; Surgery; Chemotherapy; Colorectal cancer","score_opus":0.3623807112931028,"score_gpt":0.5579478726196762,"score_spread":0.19556716132657337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994685129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80095,0.14910603,0.02009,0.00052640104,0.0007080154,0.0013444833,0.022051018,0.00041753892,0.0048064967],"genre_scores_gemma":[0.9830111,0.0049642217,0.002746343,0.00029027378,0.00020643689,0.00067134015,0.007298968,0.00009309029,0.0007181061],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9654961,0.023098812,0.005159015,0.00327037,0.0021555538,0.00082009606],"domain_scores_gemma":[0.94865113,0.03508511,0.008251145,0.005936956,0.0016088976,0.00046673225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027653374,0.0016676189,0.011586873,0.0024117655,0.00032353733,0.002317589,0.00089139806,0.0012479936,0.002817662],"category_scores_gemma":[0.054613885,0.0009618601,0.01834049,0.0028293056,0.0005000641,0.0016346019,0.0011332721,0.0013710982,0.00033645605],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16907534,0.00016785707,0.059960406,0.008968477,0.71121144,0.0003647886,0.00017496638,0.0068189544,0.0035328125,0.00028854303,0.002326003,0.03711048],"study_design_scores_gemma":[0.019007575,0.012928765,0.21837604,0.00074587774,0.73054814,0.00092597964,0.00021051594,0.006145838,0.002440661,0.0014889844,0.0069788136,0.00020278878],"about_ca_topic_score_codex":0.0010327375,"about_ca_topic_score_gemma":0.002007004,"teacher_disagreement_score":0.027653374,"about_ca_system_score_codex":0.00089178205,"about_ca_system_score_gemma":0.000763428,"threshold_uncertainty_score":0.14624679},"labels":[],"label_agreement":null},{"id":"W1995047633","doi":"10.1016/j.ejphar.2009.08.020","title":"Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer","year":2009,"lang":"en","type":"article","venue":"European Journal of Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Associazione Italiana per la Ricerca sul Cancro; Pfizer","keywords":"Irinotecan; Oxaliplatin; Medicine; Colorectal cancer; Pharmacology; In vivo; Cancer; Vascular endothelial growth factor; Combination therapy; Cancer research; Internal medicine; Biology; VEGF receptors","score_opus":0.019697290253670244,"score_gpt":0.33267862689666106,"score_spread":0.3129813366429908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995047633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9573266,0.03953065,0.0001107169,0.00081048347,0.0001345494,0.000036507805,0.00007428199,0.000022546314,0.0019536603],"genre_scores_gemma":[0.9939773,0.005103603,0.00013817745,0.0001418092,0.00007472841,0.00001020738,0.00006603897,0.000002233392,0.00048587925],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999835,0.000078985504,0.000018736348,0.000013219164,0.000020705553,0.000033258053],"domain_scores_gemma":[0.99982846,0.00006683115,0.000026745247,0.000009002883,0.000010107377,0.000058805857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004531328,0.0001348456,0.0005758552,0.00025466285,0.00018697376,0.0002211961,0.00019836532,0.00030466236,0.000871279],"category_scores_gemma":[0.0008280649,0.000116079726,0.0003651659,0.00036699537,0.00014947864,0.00027794403,0.000113997085,0.00055305375,0.00007007061],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2665418,0.004556982,0.06371574,0.0015407731,0.001261514,0.0023892378,0.00027683942,0.0033213745,0.035004355,0.0006364238,0.0045135687,0.6162414],"study_design_scores_gemma":[0.0269405,0.24840608,0.6740462,0.0002617981,0.002512533,0.0063499925,0.00055733946,0.0033929618,0.013546136,0.00074169715,0.023147585,0.00009712893],"about_ca_topic_score_codex":0.003124002,"about_ca_topic_score_gemma":0.012800054,"teacher_disagreement_score":0.003124002,"about_ca_system_score_codex":0.0006643261,"about_ca_system_score_gemma":0.0006796278,"threshold_uncertainty_score":0.0062116385},"labels":[],"label_agreement":null},{"id":"W1995153811","doi":"10.3747/co.20.1256","title":"Evaluation of the Clinical Benefits of Nanoparticle Albumin-Bound Paclitaxel in Women with Metastatic Breast Cancer in British Columbia","year":2013,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Taxane; Medicine; Paclitaxel; Internal medicine; Breast cancer; Oncology; Metastatic breast cancer; Adjuvant; Chemotherapy; Cancer","score_opus":0.14664838490070736,"score_gpt":0.4609856244973868,"score_spread":0.3143372395966794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995153811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943212,0.0017830901,0.00005174468,0.00042356708,0.000007504795,0.00008815348,0.0011536565,0.0000076717615,0.0021634516],"genre_scores_gemma":[0.9976025,0.00076417846,0.000120716904,0.00019402463,0.0000050673098,0.000038918886,0.00065797626,0.0000031215752,0.00061340776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956876,0.000098094584,0.000030997217,0.00005668396,0.0001547213,0.00009078273],"domain_scores_gemma":[0.99870205,0.0002744994,0.00026561762,0.000031625146,0.00047118298,0.00025500217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005971051,0.00015244776,0.00036078278,0.0006819525,0.0006287726,0.0005916759,0.0005635655,0.00027520722,0.001639176],"category_scores_gemma":[0.0028676563,0.00015208333,0.00021904676,0.0014473503,0.0003372771,0.00014138789,0.0004521908,0.00037390826,0.00016134013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002473742,0.00014180051,0.95982647,0.00026943366,0.00012539572,0.000246825,0.00032480678,0.00044270296,0.0010323436,0.000049677405,0.0018417789,0.033224903],"study_design_scores_gemma":[0.00016202148,0.0004357614,0.99506617,0.000103340906,0.00011200029,0.00024938732,0.0007039308,0.00059221097,0.00035660178,0.000037269878,0.0021711027,0.000010211294],"about_ca_topic_score_codex":0.7636534,"about_ca_topic_score_gemma":0.88617605,"teacher_disagreement_score":0.2363466,"about_ca_system_score_codex":0.011633186,"about_ca_system_score_gemma":0.008682908,"threshold_uncertainty_score":0.47547698},"labels":[],"label_agreement":null},{"id":"W1995300665","doi":"10.1016/j.expneurol.2012.08.023","title":"Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy","year":2012,"lang":"en","type":"article","venue":"Experimental Neurology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Neurological Disorders and Stroke; Canadian Institutes of Health Research; National Institutes of Health; Louise and Alan Edwards Foundation; Canada Research Chairs","keywords":"Bortezomib; Peripheral neuropathy; Medicine; Peripheral; Physical medicine and rehabilitation; Neuroscience; Internal medicine; Psychology; Multiple myeloma; Endocrinology","score_opus":0.02297038949789539,"score_gpt":0.3203093488017512,"score_spread":0.29733895930385584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995300665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803083,0.015235744,0.0004713617,0.0002441177,0.00006540157,0.00004579825,0.00012101864,0.000018604442,0.003489621],"genre_scores_gemma":[0.99513274,0.0033554817,0.00016731805,0.00007924074,0.000056009365,0.00001770678,0.00010435118,0.000002033013,0.0010850615],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986696,0.000057641308,0.0000138922305,0.000009648302,0.000021657192,0.000030112742],"domain_scores_gemma":[0.999856,0.000034767596,0.000059178055,0.000014966581,0.000009916156,0.000025222518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031018793,0.0003129134,0.00025074172,0.00046360414,0.0003547487,0.0002107536,0.0002149113,0.00048122133,0.0034516826],"category_scores_gemma":[0.00027681404,0.00016781205,0.00024395401,0.00028227456,0.00042314595,0.00034290322,0.00027053666,0.00052922114,0.00027843946],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09219443,0.0045625777,0.06075181,0.0032329494,0.0006477663,0.029341845,0.00067235355,0.0022764327,0.68439984,0.0067672627,0.00232234,0.11283043],"study_design_scores_gemma":[0.0061359513,0.0610721,0.5484767,0.0005533377,0.0008822807,0.06215921,0.00087496615,0.004276833,0.28553918,0.005395882,0.024558749,0.000074760384],"about_ca_topic_score_codex":0.0009701586,"about_ca_topic_score_gemma":0.0016272446,"teacher_disagreement_score":0.0034516826,"about_ca_system_score_codex":0.0003637756,"about_ca_system_score_gemma":0.00027373497,"threshold_uncertainty_score":0.011547029},"labels":[],"label_agreement":null},{"id":"W1995811281","doi":"10.1007/s00280-006-0362-y","title":"Phase I trial of oral MAC-321 in subjects with advanced malignant solid tumors","year":2006,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Pharmacokinetics; Tolerability; Neutropenia; Taxane; Internal medicine; Refractory (planetary science); Paclitaxel; Adverse effect; Toxicity; Pharmacology; Oncology; Chemotherapy; Gastroenterology; Cancer; Breast cancer","score_opus":0.01851690814974668,"score_gpt":0.37115694981906044,"score_spread":0.3526400416693138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995811281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934168,0.0009957353,0.00044218238,0.0006374677,0.00014561629,0.0013456271,0.0008031805,0.00012192356,0.0020915281],"genre_scores_gemma":[0.98672473,0.0017985071,0.0011769525,0.000698019,0.0002784686,0.0025715847,0.0017584974,0.000045614084,0.004947643],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997336,0.0001275164,0.000010064177,0.00004529625,0.000016666005,0.00006687843],"domain_scores_gemma":[0.99950004,0.00008654224,0.00006528291,0.00005080414,0.000029574137,0.00026778248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082939037,0.0018078897,0.0024347675,0.00041720676,0.0005807755,0.0007171736,0.00075632834,0.0011340394,0.0053252624],"category_scores_gemma":[0.00075049134,0.0005375384,0.0010479565,0.00032055212,0.0011710504,0.00072102493,0.00039374124,0.0028970963,0.0013296702],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87244606,0.044672895,0.0031230454,0.0004611527,0.00066527666,0.00013706821,0.00020475953,0.0017997785,0.023303458,0.0004802195,0.0040981057,0.04860823],"study_design_scores_gemma":[0.64270073,0.34526792,0.006006973,0.000022941475,0.0003208723,0.00012964153,0.00005806205,0.00089997036,0.0024508017,0.0003300821,0.001792049,0.000019965057],"about_ca_topic_score_codex":0.0011631995,"about_ca_topic_score_gemma":0.0018637807,"teacher_disagreement_score":0.0053252624,"about_ca_system_score_codex":0.0006900408,"about_ca_system_score_gemma":0.0015644908,"threshold_uncertainty_score":0.017814755},"labels":[],"label_agreement":null},{"id":"W1995930791","doi":"10.1007/s10637-014-0171-9","title":"A phase I pharmacokinetic and safety analysis of epothilone folate (BMS-753493), a folate receptor targeted chemotherapeutic agent in humans with advanced solid tumors","year":2014,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Norris Cotton Cancer Center; Bristol-Myers Squibb","keywords":"Medicine; Pharmacokinetics; Mucositis; Neutropenia; Pharmacology; Toxicity; Epothilone; Folate receptor; Cancer; Dosing; Internal medicine; Oncology; Cancer cell; Chemistry","score_opus":0.016924110530593332,"score_gpt":0.3168864988068077,"score_spread":0.29996238827621435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995930791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99306846,0.0012414934,0.0016602881,0.00027784143,0.000052753378,0.00104143,0.0011421761,0.000121272446,0.0013941803],"genre_scores_gemma":[0.9917663,0.0014297423,0.001872041,0.00046548108,0.0000802476,0.0006320296,0.0015659676,0.00006605162,0.002122061],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996511,0.00015085557,0.000012644021,0.000079566365,0.000054145617,0.00005176164],"domain_scores_gemma":[0.99959964,0.000056506786,0.000092919305,0.00005640874,0.000032434047,0.00016209263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085245335,0.00095959747,0.001267621,0.00038524703,0.0004696245,0.0007699017,0.00051631976,0.00093247916,0.0027791217],"category_scores_gemma":[0.00081403105,0.00052967056,0.000996107,0.0003814057,0.00077035744,0.00066339,0.00021569035,0.00216265,0.0006120011],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47791424,0.055773064,0.008202609,0.00059061113,0.0019939323,0.00059124484,0.00048646695,0.00558628,0.30485502,0.0008167805,0.006799426,0.1363903],"study_design_scores_gemma":[0.20110443,0.6941885,0.035732724,0.00005240523,0.0018880832,0.0013186045,0.00016504568,0.0055718566,0.046980865,0.0006527798,0.01224267,0.00010209671],"about_ca_topic_score_codex":0.0021071837,"about_ca_topic_score_gemma":0.0035050174,"teacher_disagreement_score":0.0027791217,"about_ca_system_score_codex":0.00096146384,"about_ca_system_score_gemma":0.0015141215,"threshold_uncertainty_score":0.0092971325},"labels":[],"label_agreement":null},{"id":"W1996330154","doi":"10.1038/bjc.2012.319","title":"A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Regeneron Pharmaceuticals","keywords":"Medicine; Aflibercept; Pemetrexed; Neutropenia; Internal medicine; Febrile neutropenia; Adverse effect; Cisplatin; Gastroenterology; Pharmacology; Bevacizumab; Chemotherapy","score_opus":0.015153943021905881,"score_gpt":0.3460659373982292,"score_spread":0.33091199437632335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996330154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995593,0.0010235431,0.00046685178,0.00019110415,0.00004990168,0.0016311745,0.00029073755,0.000048456302,0.0007053044],"genre_scores_gemma":[0.99374783,0.00088519993,0.0017262974,0.00045454083,0.00007882962,0.0015949653,0.0007791417,0.000022621105,0.00071066286],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99928904,0.00026846587,0.000047950696,0.00017669011,0.000102488164,0.00011535952],"domain_scores_gemma":[0.99897385,0.00013136346,0.0002821167,0.000111587986,0.00006744931,0.00043373165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015446749,0.0013825913,0.0024882557,0.00049873337,0.00039291842,0.0011110414,0.0009233131,0.0010750433,0.00243974],"category_scores_gemma":[0.0014009932,0.00069714425,0.001104,0.00069497176,0.0009420422,0.0009303143,0.00040204273,0.0044766115,0.00079252897],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5328284,0.16166207,0.019079668,0.0012352522,0.0021989797,0.00048276072,0.00093692413,0.005932955,0.10901236,0.00025545846,0.0034827755,0.16289237],"study_design_scores_gemma":[0.36568904,0.60177445,0.021542756,0.0000317614,0.00050076796,0.0005901915,0.00006732165,0.0016705238,0.00494843,0.00015623194,0.0029957527,0.00003275737],"about_ca_topic_score_codex":0.00065566134,"about_ca_topic_score_gemma":0.0011760097,"teacher_disagreement_score":0.0024882557,"about_ca_system_score_codex":0.0013838473,"about_ca_system_score_gemma":0.001605855,"threshold_uncertainty_score":0.010040522},"labels":[],"label_agreement":null},{"id":"W1996338020","doi":"10.1515/znb-2011-0721","title":"A Novel Taxatetraene Framework Formed From a New Natural Taxane from Taxus cuspidata","year":2011,"lang":"en","type":"article","venue":"Zeitschrift für Naturforschung B","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Hebei Medical University; National Natural Science Foundation of China","keywords":"Taxane; Double bond; Chemistry; Stereochemistry; Organic chemistry; Biology","score_opus":0.04225980535016611,"score_gpt":0.3213735757774767,"score_spread":0.2791137704273106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996338020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861137,0.0019812493,0.0027471182,0.000070737166,0.000034208184,0.00008219415,0.0011264019,0.000065486165,0.0077789365],"genre_scores_gemma":[0.9861872,0.0016131905,0.0041603385,0.00007432312,0.000009268377,0.00002846002,0.0008616089,0.000013856674,0.007051817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999846,0.0000017435314,8.750729e-7,0.0000051609145,0.0000034496286,0.000004190787],"domain_scores_gemma":[0.9999751,0.000002069776,0.000004208586,0.000002667467,0.000003292415,0.000012636087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000029519515,0.0002234185,0.00012149009,0.00019926614,0.00014076156,0.00012401138,0.000135153,0.00015101557,0.0027456684],"category_scores_gemma":[0.000032760858,0.00011170676,0.000116335264,0.00015249502,0.00013988248,0.00019183713,0.00018590836,0.00024449793,0.00039121782],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007952706,0.000019644776,0.00024095338,0.00010267499,0.0000060934203,0.000199858,0.00004434582,0.00013985333,0.99394244,0.00029045352,0.000058671852,0.0048755617],"study_design_scores_gemma":[0.000094364084,0.0018924949,0.016839055,0.000041623054,0.000046237543,0.0010115383,0.00015007907,0.0004916943,0.9444324,0.00053973024,0.034429546,0.00003126334],"about_ca_topic_score_codex":0.00047784133,"about_ca_topic_score_gemma":0.0019318003,"teacher_disagreement_score":0.0027456684,"about_ca_system_score_codex":0.00012061077,"about_ca_system_score_gemma":0.00023851533,"threshold_uncertainty_score":0.009185135},"labels":[],"label_agreement":null},{"id":"W1996435991","doi":"10.1016/j.cvsm.2007.07.002","title":"Chemotherapy: New Uses for Old Drugs","year":2007,"lang":"en","type":"review","venue":"Veterinary Clinics of North America Small Animal Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Chemotherapy; Intensive care medicine; Computer science; Internal medicine","score_opus":0.21365287087917145,"score_gpt":0.4873636878889482,"score_spread":0.27371081700977673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996435991","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006183664,0.99761,0.00014239193,0.0006995048,0.00037750357,0.0000031929903,0.000008611164,0.000010178083,0.0010867863],"genre_scores_gemma":[0.00041728353,0.9968863,0.0002669819,0.00080116536,0.0005978958,0.000004181254,0.000015904896,0.0000028585557,0.0010073495],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99962246,0.00007508805,0.000045959936,0.00006564304,0.00016447839,0.000026305876],"domain_scores_gemma":[0.9989649,0.0005117526,0.00013433672,0.000041933406,0.00025248041,0.00009465154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009630944,0.0012088531,0.0019547096,0.003165642,0.00045356777,0.0016729566,0.0013462655,0.0018476088,0.0060426653],"category_scores_gemma":[0.0011664262,0.00034709094,0.00059672305,0.003188634,0.0014100168,0.0035129688,0.0010227433,0.0033165687,0.0029864246],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065631204,0.00008115177,0.0001438136,0.0083186785,0.000049175425,0.00020292499,0.000072367686,0.00030518943,0.0009992233,0.004699175,0.06624823,0.9188145],"study_design_scores_gemma":[0.000017087625,0.00005580169,0.00039312255,0.0021132056,0.00003807218,0.00095350115,0.0000523474,0.00008839975,0.00012848711,0.0016341505,0.9945111,0.000014577079],"about_ca_topic_score_codex":0.0012366169,"about_ca_topic_score_gemma":0.0042433776,"teacher_disagreement_score":0.0060426653,"about_ca_system_score_codex":0.0009797832,"about_ca_system_score_gemma":0.0013360471,"threshold_uncertainty_score":0.020214736},"labels":[],"label_agreement":null},{"id":"W1996697383","doi":"10.1007/s00280-006-0245-2","title":"A pharmacokinetic and safety study of a novel polymeric paclitaxel formulation for oral application","year":2006,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada)","funders":"","keywords":"Paclitaxel; Pharmacokinetics; Pharmacology; Medicine; Chemotherapy; Internal medicine","score_opus":0.0242078547080019,"score_gpt":0.3711345531872951,"score_spread":0.3469266984792932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996697383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965011,0.0006290765,0.0015046751,0.00011092963,0.00002793635,0.00018282559,0.000098904406,0.00004195695,0.0009026242],"genre_scores_gemma":[0.9965149,0.0006024153,0.0011658968,0.00007189252,0.00004138717,0.0000710233,0.00015767339,0.000029616125,0.0013452186],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997925,0.000071558316,0.000008442634,0.00004918014,0.00003930102,0.000038933566],"domain_scores_gemma":[0.9996618,0.00010234879,0.000090045636,0.00004347982,0.00002634389,0.00007588911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004586868,0.00038285865,0.000495187,0.00032867197,0.00032425777,0.0005432169,0.00039695704,0.00048128827,0.0022213547],"category_scores_gemma":[0.0006377022,0.00026028344,0.00046382868,0.00027121097,0.00051400135,0.00048319573,0.00012668557,0.0010867402,0.00038204397],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0813751,0.017557116,0.0033578046,0.00040244343,0.0002887542,0.0011361934,0.0003424856,0.003863249,0.7709015,0.0008112431,0.0013751213,0.118588954],"study_design_scores_gemma":[0.019977681,0.49375632,0.01823188,0.000044875753,0.00090166746,0.00411574,0.00020362211,0.013950387,0.43615124,0.00040692062,0.012170684,0.00008901149],"about_ca_topic_score_codex":0.0009645412,"about_ca_topic_score_gemma":0.0009561295,"teacher_disagreement_score":0.0022213547,"about_ca_system_score_codex":0.00046990326,"about_ca_system_score_gemma":0.0007454736,"threshold_uncertainty_score":0.0074311495},"labels":[],"label_agreement":null},{"id":"W1998636049","doi":"10.14740/jmc.v6i5.2066","title":"Prolonged Bradycardia Induced by Bevacizumab-Associated Infusion Reaction in Advanced Metastatic Colon Cancer","year":2015,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bevacizumab; Bradycardia; FOLFOX; Sinus bradycardia; Oxaliplatin; Anesthesia; Colorectal cancer; Surgery; Heart rate; Internal medicine; Cancer; Chemotherapy; Blood pressure","score_opus":0.06864916599421104,"score_gpt":0.4057790226430278,"score_spread":0.33712985664881673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998636049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9460534,0.036848664,0.0031319747,0.002473922,0.00038180794,0.0001850806,0.00015678164,0.00011196816,0.010656592],"genre_scores_gemma":[0.9947233,0.0034600766,0.000355648,0.0005891463,0.00029754353,0.000014637478,0.00005631458,0.000005854944,0.00049760024],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99973327,0.00006971033,0.000039954422,0.000044822387,0.000045447676,0.000066822555],"domain_scores_gemma":[0.9992079,0.00025795365,0.0003131233,0.00003070276,0.000042739597,0.00014754564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022529472,0.00040618918,0.00060977926,0.0007041225,0.0005867025,0.0005327523,0.0002466553,0.0009616054,0.0012306325],"category_scores_gemma":[0.0018962829,0.00026965546,0.000409768,0.0006757475,0.00037877835,0.0006487812,0.00036133593,0.0010388468,0.00026970095],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002607282,0.000067048735,0.028114913,0.00017109349,0.000037059974,0.9617763,0.00014881286,0.00009748307,0.0022327316,0.00018241227,0.0005718063,0.006339513],"study_design_scores_gemma":[0.000076888966,0.00031492952,0.033641364,0.0000811541,0.000080087935,0.9619853,0.00015782731,0.0003672086,0.0008967756,0.00026338705,0.0021149833,0.00002010984],"about_ca_topic_score_codex":0.0009119127,"about_ca_topic_score_gemma":0.0017150121,"teacher_disagreement_score":0.0012306325,"about_ca_system_score_codex":0.0005544085,"about_ca_system_score_gemma":0.00036639287,"threshold_uncertainty_score":0.004116833},"labels":[],"label_agreement":null},{"id":"W1998835358","doi":"10.1021/np0304565","title":"Characterization of an <i>a</i><i>beo</i>-Taxane:  Brevifoliol and Derivatives","year":2004,"lang":"en","type":"article","venue":"Journal of Natural Products","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; University of British Columbia","funders":"","keywords":"Taxane; Diterpene; Characterization (materials science); Stereochemistry; Chemistry; Nanotechnology; Materials science; Medicine; Internal medicine","score_opus":0.013493539910616987,"score_gpt":0.29663005938363246,"score_spread":0.2831365194730155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998835358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914308,0.0019103502,0.0021175595,0.00007633992,0.00001581825,0.00009173239,0.0014392493,0.000028226521,0.0028897617],"genre_scores_gemma":[0.97987235,0.0025571026,0.0067209927,0.000092353126,0.000010379437,0.00005388621,0.0042833276,0.000026565403,0.0063829245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99996126,0.0000052815312,0.0000037472996,0.000007874684,0.000013853056,0.000008007111],"domain_scores_gemma":[0.99992275,0.000006902005,0.000012506216,0.000008245027,0.000022451391,0.000027188009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007101879,0.00019294512,0.000113600356,0.00019872272,0.00010589255,0.00018018324,0.00015275668,0.00017877517,0.0013393653],"category_scores_gemma":[0.00013507208,0.000052180912,0.00012361881,0.0002164332,0.00008558839,0.00014009565,0.00008146112,0.00022349798,0.00044695337],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009292838,0.000026725267,0.0002409873,0.000033850596,0.000003106944,0.00005728745,0.00001302519,0.0000751846,0.9976591,0.00003862727,0.000016595646,0.0017426922],"study_design_scores_gemma":[0.000022684642,0.0007254141,0.006550518,0.000013492243,0.000017597438,0.00029899427,0.00005007176,0.00028128954,0.97898054,0.00005586899,0.012997304,0.0000062724116],"about_ca_topic_score_codex":0.00094842335,"about_ca_topic_score_gemma":0.0016467269,"teacher_disagreement_score":0.0013393653,"about_ca_system_score_codex":0.00013653029,"about_ca_system_score_gemma":0.00015471822,"threshold_uncertainty_score":0.00448066},"labels":[],"label_agreement":null},{"id":"W1999197607","doi":"10.1093/neuonc/nos229","title":"CLIN-NEURO/MEDICAL ONCOLOGY","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Neurological Institute and Hospital; Western University; McGill University","funders":"","keywords":"Medicine; Internal medicine; Oncology; Medical physics","score_opus":0.05223163820791155,"score_gpt":0.4116295984714325,"score_spread":0.35939796026352094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999197607","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22382292,0.22124131,0.0076083527,0.02875518,0.0061255437,0.0006358362,0.004374926,0.001151107,0.50628483],"genre_scores_gemma":[0.7163192,0.07305847,0.012135838,0.02266869,0.006151707,0.0005797544,0.0059038107,0.00027915955,0.16290332],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995734,0.00012767751,0.000040767958,0.00007774742,0.00009158203,0.00008871814],"domain_scores_gemma":[0.9994066,0.000082407205,0.00013014085,0.00005134847,0.00017892798,0.00015062334],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005277578,0.00045326632,0.00036995256,0.0008542801,0.0004929617,0.0013747514,0.0003987949,0.00067155616,0.029822502],"category_scores_gemma":[0.0013462316,0.00013617365,0.00029082055,0.00058858015,0.00043949654,0.0005563126,0.0006802415,0.0008199715,0.015186481],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006520149,0.00047347776,0.0966002,0.0015412607,0.00014611371,0.007274331,0.00023936073,0.0003898064,0.005928219,0.005702459,0.12303475,0.758018],"study_design_scores_gemma":[0.00020910328,0.00072672573,0.08829449,0.0013912932,0.00016990528,0.067317024,0.00044013266,0.00089368765,0.004529777,0.0046428614,0.8313527,0.000032387987],"about_ca_topic_score_codex":0.00070144905,"about_ca_topic_score_gemma":0.0014023287,"teacher_disagreement_score":0.9701775,"about_ca_system_score_codex":0.0009347025,"about_ca_system_score_gemma":0.0013511594,"threshold_uncertainty_score":0.099766195},"labels":[],"label_agreement":null},{"id":"W1999935086","doi":"10.1002/cncr.27593","title":"Long‐term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project trials C‐07 and LTS‐01","year":2012,"lang":"en","type":"article","venue":"Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Oxaliplatin; Fluorouracil; Adjuvant; Colorectal cancer; Adjuvant therapy; Oncology; Breast cancer; Internal medicine; Surgery; Cancer","score_opus":0.0764465076246434,"score_gpt":0.41872244330565533,"score_spread":0.34227593568101194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999935086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997273,0.0021622423,0.000028966906,0.00009701112,0.000011985793,0.00007186814,0.00021783313,0.0000019774004,0.00013510097],"genre_scores_gemma":[0.99689925,0.0016578984,0.00010909656,0.00015851733,0.000043943382,0.000117066185,0.0008693073,0.0000022961422,0.00014254855],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99634016,0.002614529,0.00035674046,0.00021601815,0.0002701932,0.0002023206],"domain_scores_gemma":[0.9878444,0.0045548584,0.0044880905,0.0006997377,0.00090324564,0.0015097139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076675536,0.0004207944,0.0010616144,0.00041320955,0.0003290068,0.0008216118,0.00055501476,0.0006166591,0.0005789241],"category_scores_gemma":[0.008814162,0.00029139535,0.0023894578,0.0006374831,0.0005731431,0.00057148724,0.00070167705,0.0012926075,0.00008465929],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5652533,0.005953568,0.35479644,0.0020744333,0.01726882,0.00020937808,0.0005296895,0.0020046437,0.0030663898,0.00011482047,0.0013752956,0.04735318],"study_design_scores_gemma":[0.060652696,0.20963895,0.7093525,0.0005247924,0.013825811,0.00050586317,0.00045820553,0.00090949796,0.0018722564,0.00015590707,0.0020274909,0.00007594912],"about_ca_topic_score_codex":0.0025992068,"about_ca_topic_score_gemma":0.0061262175,"teacher_disagreement_score":0.0076675536,"about_ca_system_score_codex":0.0010389161,"about_ca_system_score_gemma":0.001621627,"threshold_uncertainty_score":0.04055041},"labels":[],"label_agreement":null},{"id":"W2000487628","doi":"10.1002/cbdv.201200032","title":"Chemical Studies on <i>Taxus canadensis</i>","year":2013,"lang":"en","type":"review","venue":"Chemistry & Biodiversity","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Taxane; Semisynthesis; Taxus; Chemistry; Propellane; Diterpene; Paclitaxel; Stereochemistry; Taxoid; Terpene; Ring (chemistry); Botany; Organic chemistry; Biology; Bicyclic molecule","score_opus":0.12960637931877345,"score_gpt":0.37748746800321475,"score_spread":0.2478810886844413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000487628","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9623334,0.011859205,0.001420059,0.00018782796,0.00006898459,0.00020959378,0.0031184102,0.000055239594,0.020747324],"genre_scores_gemma":[0.9685949,0.012359014,0.0032078205,0.00015287987,0.00004927881,0.000051561226,0.0035131534,0.000019764333,0.012051546],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99994683,0.000003173853,0.000002150434,0.000010835985,0.000022023216,0.00001492229],"domain_scores_gemma":[0.9999238,0.00000935148,0.000015330157,0.0000057568195,0.00002575273,0.000019976475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000619507,0.00030581155,0.00013824235,0.00045484563,0.00048232093,0.00014575745,0.00019739024,0.00017881642,0.002384871],"category_scores_gemma":[0.000111533904,0.00007144538,0.00020412567,0.00055525545,0.00021392731,0.00024775718,0.000115678624,0.00043830226,0.00046121617],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021801151,0.00005514324,0.0012534419,0.0003330219,0.000019496585,0.00022714472,0.0000739493,0.00033937985,0.9837531,0.0002101266,0.00019036767,0.013326854],"study_design_scores_gemma":[0.00004583916,0.0017367019,0.03545614,0.000058168484,0.00011993246,0.00058271503,0.00025071105,0.0004916595,0.91760164,0.00020506709,0.043416984,0.000034474895],"about_ca_topic_score_codex":0.012666739,"about_ca_topic_score_gemma":0.023920523,"teacher_disagreement_score":0.012666739,"about_ca_system_score_codex":0.00038701578,"about_ca_system_score_gemma":0.00058986986,"threshold_uncertainty_score":0.025186002},"labels":[],"label_agreement":null},{"id":"W2001030403","doi":"10.7326/0003-4819-136-4-200202190-00017","title":"Physicians' Cancer Chemotherapy Drug Manual 2001","year":2002,"lang":"en","type":"article","venue":"Annals of Internal Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Family medicine; Cancer chemotherapy; Library science; Oncology; Internal medicine","score_opus":0.06903256186356233,"score_gpt":0.4166417173557671,"score_spread":0.3476091554922048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001030403","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009994836,0.046383996,0.0026754357,0.013275107,0.0060742325,0.0012514939,0.0187483,0.0033699488,0.907222],"genre_scores_gemma":[0.0023503434,0.02832769,0.0028019992,0.0063639516,0.0012157784,0.00060844806,0.014114155,0.0003753004,0.9438423],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993112,0.000066302804,0.000057942787,0.000071269424,0.00043925803,0.00005412814],"domain_scores_gemma":[0.99844426,0.00042511724,0.00017082936,0.00009801059,0.000687234,0.00017463446],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00070895016,0.0009529482,0.00088804227,0.002689401,0.00087328826,0.002149439,0.0013397429,0.0019489652,0.4908651],"category_scores_gemma":[0.0032994824,0.0005250115,0.00055180764,0.0022485703,0.0003778421,0.0013853018,0.0010437538,0.0024490117,0.3647887],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023060777,0.0000330012,0.00003186888,0.00018273736,0.0000012028842,0.000018333618,0.000010855268,0.000032527543,0.00016935148,0.00047727046,0.9082793,0.09074057],"study_design_scores_gemma":[0.0000123398,0.000022231712,0.00022667219,0.0001351539,0.0000012928306,0.000069796544,0.0000065107156,0.000018061468,0.00004660013,0.00016753719,0.9992901,0.000003516011],"about_ca_topic_score_codex":0.003937754,"about_ca_topic_score_gemma":0.009232088,"teacher_disagreement_score":0.4908651,"about_ca_system_score_codex":0.0013171347,"about_ca_system_score_gemma":0.0023441068,"threshold_uncertainty_score":0.7262191},"labels":[],"label_agreement":null},{"id":"W2001078258","doi":"10.1016/j.eujim.2014.06.009","title":"Recent research shows maturity in addressing safety issues associated with CAM therapies","year":2014,"lang":"en","type":"article","venue":"European Journal of Integrative Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Maturity (psychological); Medicine; Psychology; Developmental psychology","score_opus":0.126743253904005,"score_gpt":0.42695603936865806,"score_spread":0.300212785464653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001078258","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.098209955,0.53538936,0.102973856,0.120362446,0.0028245042,0.0007379446,0.00056854327,0.0003169751,0.13861643],"genre_scores_gemma":[0.53535205,0.3153128,0.085891,0.042163085,0.009017852,0.00060108176,0.0006094046,0.00011649174,0.010936209],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929033,0.0028595922,0.0007712954,0.0005669468,0.0026690552,0.00022986147],"domain_scores_gemma":[0.87039113,0.09914502,0.009386374,0.0037333851,0.016112424,0.0012317122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020939533,0.00038359006,0.00085990253,0.0012364538,0.0007367501,0.0033925795,0.0012132094,0.002278551,0.008932001],"category_scores_gemma":[0.054590788,0.00020086949,0.0010045402,0.0011382418,0.0024528552,0.0044383435,0.0019099169,0.0039536604,0.001218744],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004956264,0.00049826264,0.01012945,0.0063418834,0.00019829246,0.00022101618,0.0011442743,0.00049604493,0.0068768742,0.034364637,0.0040417686,0.93519205],"study_design_scores_gemma":[0.00024182824,0.0073076775,0.09552561,0.016981859,0.0010529545,0.006489079,0.0052544447,0.0042169904,0.02152227,0.122236684,0.71897537,0.00019519444],"about_ca_topic_score_codex":0.0007070232,"about_ca_topic_score_gemma":0.0017196988,"teacher_disagreement_score":0.020939533,"about_ca_system_score_codex":0.0012415586,"about_ca_system_score_gemma":0.0039224434,"threshold_uncertainty_score":0.110740125},"labels":[],"label_agreement":null},{"id":"W2002137462","doi":"10.1016/s0031-9422(00)00079-0","title":"Taxoids from the needles of the Canadian yew","year":2000,"lang":"en","type":"article","venue":"Phytochemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Queen's University; Armand Frappier Museum; Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Taxus; Stereochemistry; Diterpene; Chemistry; Botany; Biology","score_opus":0.01287052676535041,"score_gpt":0.2589191486433964,"score_spread":0.24604862187804596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002137462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87682736,0.033860527,0.0015922225,0.0089024,0.00093210785,0.00021134286,0.0032323557,0.00011989825,0.07432183],"genre_scores_gemma":[0.8752777,0.018323498,0.0018871587,0.0017002338,0.0001492679,0.000018948529,0.0013989797,0.000058379384,0.10118581],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994874,0.0000022427696,0.0000011643793,0.0000072304892,0.000021008289,0.000019586847],"domain_scores_gemma":[0.9999441,0.0000059833037,0.000005492977,0.0000025554948,0.000024047542,0.000017747227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006499983,0.00029927492,0.0003551519,0.0008517705,0.002962026,0.0006219661,0.00020820246,0.00050895417,0.006106712],"category_scores_gemma":[0.00017576417,0.00012014335,0.00018568941,0.0008336493,0.00069637067,0.0002742164,0.00030351462,0.0011025297,0.0007150938],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031266923,0.00026507603,0.016734047,0.0013008852,0.0001566156,0.015663447,0.0073778857,0.00071834575,0.61071193,0.012688015,0.03640927,0.29484794],"study_design_scores_gemma":[0.00017460171,0.0007095479,0.14635164,0.00048387842,0.00029573395,0.00915036,0.01762808,0.000708955,0.13578887,0.0042564673,0.68424994,0.00020186545],"about_ca_topic_score_codex":0.47156456,"about_ca_topic_score_gemma":0.6838296,"teacher_disagreement_score":0.52843547,"about_ca_system_score_codex":0.0021015222,"about_ca_system_score_gemma":0.0030651605,"threshold_uncertainty_score":0.9376395},"labels":[],"label_agreement":null},{"id":"W2002396150","doi":"10.1016/j.jval.2014.03.411","title":"A Comparison of Toxicity and Supportive Care Use Between Four Cytotoxic Agents Used in the Management of Metastatic Breast Cancer (MBC))","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Neutropenia; Internal medicine; Metastatic breast cancer; Capecitabine; Anemia; Toxicity; Gemcitabine; Adverse effect; Vinorelbine; Breast cancer; Eribulin; Cancer; Oncology; Chemotherapy; Colorectal cancer","score_opus":0.17380227733604714,"score_gpt":0.4436858291776548,"score_spread":0.26988355184160767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002396150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99757594,0.0013786693,0.00009445903,0.000036831785,0.000012333644,0.000035192894,0.00014252674,0.000003748228,0.00072035124],"genre_scores_gemma":[0.9989699,0.00038977418,0.0001556517,0.000035595116,0.000017054568,0.000023100283,0.00018369117,0.000001520975,0.00022365696],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99889165,0.00059206184,0.00015497507,0.000095283256,0.00018988486,0.00007611814],"domain_scores_gemma":[0.9965928,0.0018769136,0.00081912027,0.00011527253,0.00026406784,0.00033172898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001310081,0.00015383968,0.00047133813,0.0006414399,0.00022692888,0.0004572366,0.000280787,0.00044363886,0.0013104753],"category_scores_gemma":[0.004481208,0.00007072919,0.0008284675,0.0007379361,0.00027709047,0.00042386094,0.000311488,0.0004417746,0.00011812605],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.429332,0.007745757,0.3287539,0.0010028332,0.0033290042,0.0003887873,0.0006154155,0.0018564418,0.01726529,0.00044484696,0.00065948267,0.20860618],"study_design_scores_gemma":[0.0049631707,0.17987461,0.8022472,0.00009240238,0.001827235,0.0005327135,0.0005734479,0.0015201232,0.0050182375,0.00025031675,0.0030543983,0.000046096553],"about_ca_topic_score_codex":0.001253517,"about_ca_topic_score_gemma":0.0015876369,"teacher_disagreement_score":0.0013104753,"about_ca_system_score_codex":0.00080103375,"about_ca_system_score_gemma":0.00043858044,"threshold_uncertainty_score":0.006928444},"labels":[],"label_agreement":null},{"id":"W2002520499","doi":"10.1139/cjc-78-6-925","title":"Synthesis of dimeric and tetrameric macrolactams with cytotoxic activity&lt;sup&gt;1&lt;/sup&gt;","year":2000,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chemistry; Taxoid; Stereochemistry; Taxane; Docetaxel; Cytotoxicity; Cytotoxic T cell; Paclitaxel; Side chain; In vitro; Organic chemistry; Biochemistry","score_opus":0.0064814991304868,"score_gpt":0.22852887291663082,"score_spread":0.22204737378614403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002520499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97170854,0.004347674,0.014979442,0.000190649,0.000101493846,0.000388913,0.001574118,0.00021506747,0.0064941877],"genre_scores_gemma":[0.95940274,0.0020770254,0.030677775,0.00012371599,0.00001929632,0.00021320423,0.0023580233,0.000048188358,0.0050800024],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988854,0.000018698687,0.000017546236,0.000026907268,0.000022396114,0.000025897598],"domain_scores_gemma":[0.99987566,0.000009223525,0.000029031344,0.000018405148,0.000017707014,0.00004979447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019000073,0.00029643322,0.0002703804,0.00021327824,0.00010867316,0.00024574526,0.00020411728,0.00024268246,0.0014291791],"category_scores_gemma":[0.00020384385,0.00014785115,0.00018530135,0.00023495092,0.000111128255,0.00015917365,0.00021813536,0.00042198904,0.0006285818],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015545756,0.00007699656,0.00019879779,0.00006853521,0.000012103439,0.00008910879,0.000033381744,0.0002801293,0.98612356,0.0002574053,0.00020490849,0.012499648],"study_design_scores_gemma":[0.00015528494,0.0015901284,0.0024268262,0.000016799348,0.000036564703,0.00056408957,0.000025366839,0.000813631,0.9752998,0.000083404135,0.018972265,0.000015917714],"about_ca_topic_score_codex":0.0002795383,"about_ca_topic_score_gemma":0.0007643747,"teacher_disagreement_score":0.0014291791,"about_ca_system_score_codex":0.00024745055,"about_ca_system_score_gemma":0.00033680635,"threshold_uncertainty_score":0.0047810674},"labels":[],"label_agreement":null},{"id":"W2003792648","doi":"10.1158/1538-7445.am10-3550","title":"Abstract 3550: Role of TNFα in the cytotoxicity of docetaxel and in docetaxel resistance in MCF-7 cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sudbury Regional Hospital","funders":"","keywords":"Docetaxel; Paclitaxel; Cytotoxicity; Taxane; Pharmacology; MCF-7; Cancer research; Tumor necrosis factor alpha; Cancer cell; Cell culture; Medicine; Cancer; Internal medicine; Biology; In vitro; Breast cancer; Biochemistry","score_opus":0.05495347651965236,"score_gpt":0.43160454713153956,"score_spread":0.3766510706118872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003792648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978872,0.011470373,0.0020460086,0.0005720667,0.00021898616,0.00007455455,0.0023931183,0.00014505262,0.004207707],"genre_scores_gemma":[0.9856974,0.0025627313,0.0014142364,0.00016228198,0.000030031633,0.000039856313,0.0024575263,0.000014229772,0.0076216734],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998679,0.000023205966,0.000017155808,0.000016953674,0.000043554195,0.000031228676],"domain_scores_gemma":[0.99993765,0.000008183756,0.000014439245,0.000006146196,0.00001739131,0.000016134662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012631067,0.00028056276,0.00026706795,0.00021249839,0.00018815446,0.00028925957,0.00014746634,0.00032402846,0.002512619],"category_scores_gemma":[0.0000877198,0.000112965194,0.0002914706,0.00027415837,0.00012943913,0.00013068254,0.00010269776,0.0005289228,0.0010622952],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027783282,0.00006669488,0.00036157144,0.000065406006,0.000007142877,0.00014666405,0.000020578205,0.00005136,0.99714017,0.00010385359,0.00021766167,0.0015411909],"study_design_scores_gemma":[0.00007388533,0.0008078382,0.012864809,0.000023627286,0.00003730845,0.000966288,0.00008864202,0.0009243345,0.97632504,0.00009666985,0.007782126,0.000009360877],"about_ca_topic_score_codex":0.0012732563,"about_ca_topic_score_gemma":0.0009907377,"teacher_disagreement_score":0.002512619,"about_ca_system_score_codex":0.0003742272,"about_ca_system_score_gemma":0.0002042086,"threshold_uncertainty_score":0.008405507},"labels":[],"label_agreement":null},{"id":"W2003894443","doi":"10.1016/s0093-7754(01)90198-8","title":"Epirubicin in combination with the taxanes","year":2001,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Epirubicin; Medicine; Anthracycline; Cardiotoxicity; Taxane; Docetaxel; Doxorubicin; Breast cancer; Oncology; Metastatic breast cancer; Pharmacology; Internal medicine; Trastuzumab; Paclitaxel; Chemotherapy; Cancer","score_opus":0.020006710689128585,"score_gpt":0.3529680784910304,"score_spread":0.33296136780190183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003894443","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.960163,0.014369221,0.0025146217,0.0009080688,0.00038428933,0.00024891738,0.00040600658,0.00027365383,0.020732218],"genre_scores_gemma":[0.9841877,0.0043164706,0.0015038766,0.00010938437,0.00011518647,0.0000614768,0.00029483798,0.00002547908,0.009385583],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998528,0.000071390234,0.0000061233495,0.000015340709,0.000024517985,0.000029857527],"domain_scores_gemma":[0.99990153,0.00003148007,0.00001166726,0.000013803579,0.0000061367086,0.00003545497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020652958,0.00033246225,0.00074314815,0.00044296507,0.00020228639,0.0002961561,0.00022090378,0.00019803403,0.0035902064],"category_scores_gemma":[0.0005426896,0.00013130634,0.00013133878,0.00035319052,0.00017921942,0.00029519794,0.00019571239,0.00075372116,0.0004490934],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04553323,0.0037911118,0.0023326164,0.00043650536,0.00028509213,0.0015069656,0.00029652868,0.003629912,0.39669347,0.003660399,0.00737779,0.5344564],"study_design_scores_gemma":[0.011106751,0.116167,0.049579885,0.0002196146,0.0005757989,0.012304914,0.00034013923,0.009212844,0.6194722,0.0037781016,0.1771274,0.00011526833],"about_ca_topic_score_codex":0.0005541476,"about_ca_topic_score_gemma":0.0023214524,"teacher_disagreement_score":0.0035902064,"about_ca_system_score_codex":0.00019814662,"about_ca_system_score_gemma":0.0003220798,"threshold_uncertainty_score":0.0120103955},"labels":[],"label_agreement":null},{"id":"W2004173427","doi":"10.1021/jo0007635","title":"New Approach to Aphidicolin and Total Asymmetric Synthesis of Unnatural (11<i>R</i>)-(−)-8-Epi-11-hydroxyaphidicolin by Tandem Transannular Diels−Alder/Aldol Reactions","year":2000,"lang":"en","type":"article","venue":"The Journal of Organic Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Chemistry; Aldol reaction; Tandem; Aphidicolin; Stereochemistry; Total synthesis; Derivative (finance); Diels–Alder reaction; Stereoselectivity; Organic chemistry; Catalysis; Enzyme","score_opus":0.009316717491846045,"score_gpt":0.25021229278338447,"score_spread":0.24089557529153843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004173427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84888256,0.0057266788,0.1170006,0.0005469492,0.00033762972,0.00047409008,0.00091468217,0.00076816033,0.025348742],"genre_scores_gemma":[0.91955155,0.0034703754,0.06600752,0.0001634931,0.000070599446,0.00015427046,0.0005276859,0.000089084504,0.00996549],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998591,0.000019019959,0.000015337193,0.000039153914,0.000038359754,0.00002892171],"domain_scores_gemma":[0.99993145,0.000008393226,0.000015765241,0.000012596037,0.000010204649,0.000021624246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018480887,0.0004076481,0.00030755566,0.00027393363,0.00020115582,0.00034728457,0.00036081165,0.00027742353,0.0012649737],"category_scores_gemma":[0.000136003,0.00023133414,0.00028030237,0.00017761452,0.0002691397,0.0003911533,0.00047425806,0.000878483,0.00064984127],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050709026,0.0000264093,0.00004952547,0.00008288737,0.0000079673655,0.00022417912,0.000045313656,0.00028427356,0.99020785,0.0019950105,0.00010080251,0.0069251363],"study_design_scores_gemma":[0.000019534842,0.0001724359,0.00015418245,0.000003047408,0.000013717973,0.0005315045,0.000011427284,0.00052150624,0.9891516,0.0002980468,0.009109119,0.0000139577],"about_ca_topic_score_codex":0.00030529944,"about_ca_topic_score_gemma":0.000640112,"teacher_disagreement_score":0.0012649737,"about_ca_system_score_codex":0.00033454288,"about_ca_system_score_gemma":0.00050438184,"threshold_uncertainty_score":0.0042316914},"labels":[],"label_agreement":null},{"id":"W2005327851","doi":"10.1002/cncr.24870","title":"A randomized phase 2 trial comparing 3‐hour versus 96‐hour infusion schedules of paclitaxel for the treatment of metastatic breast cancer","year":2010,"lang":"en","type":"article","venue":"Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Mucositis; Metastatic breast cancer; Chemotherapy; myalgia; Paclitaxel; Breast cancer; Neutropenia; Toxicity; Internal medicine; Surgery; Cancer; Gastroenterology","score_opus":0.10300853357009589,"score_gpt":0.4472047981737699,"score_spread":0.34419626460367403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005327851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926386,0.0012688503,0.00055952143,0.0003431324,0.0002610813,0.0034593774,0.00039922397,0.000056250065,0.0010140087],"genre_scores_gemma":[0.9819504,0.0014646966,0.0028734377,0.0012290818,0.00052308704,0.008336668,0.00087718054,0.000031471154,0.0027138707],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99907887,0.00062483136,0.000040875493,0.00010211338,0.000065878376,0.00008750686],"domain_scores_gemma":[0.99851376,0.0005877582,0.0004123866,0.00010010488,0.00004513634,0.0003409015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024516946,0.0011580427,0.0018872621,0.00038509467,0.00031707349,0.00072959403,0.00081157975,0.0014719197,0.00707914],"category_scores_gemma":[0.001788781,0.00046587695,0.0013275507,0.00035806827,0.000999376,0.00071291433,0.00032885597,0.0024615803,0.00078124023],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97474694,0.0091159865,0.00044802207,0.0001780297,0.0003096061,0.000027806811,0.00003259719,0.00026073787,0.00267082,0.000066031,0.00038004635,0.011763355],"study_design_scores_gemma":[0.91045517,0.08697529,0.0011758057,0.000013678064,0.00016101297,0.000029000761,0.000008621375,0.00028422443,0.0003752951,0.00007440497,0.00043974066,0.000007691101],"about_ca_topic_score_codex":0.00049547217,"about_ca_topic_score_gemma":0.001033365,"teacher_disagreement_score":0.00707914,"about_ca_system_score_codex":0.0006862061,"about_ca_system_score_gemma":0.001108568,"threshold_uncertainty_score":0.023682117},"labels":[],"label_agreement":null},{"id":"W2005513578","doi":"10.1016/j.ijpharm.2004.06.025","title":"Characterization of perivascular poly(lactic-co-glycolic acid) films containing paclitaxel","year":2004,"lang":"en","type":"article","venue":"International Journal of Pharmaceutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); University of British Columbia","funders":"","keywords":"PLGA; Glycolic acid; Differential scanning calorimetry; Miscibility; Polymer chemistry; Drug carrier; Aqueous solution; Polymer; Nuclear chemistry; Chemical engineering; Materials science; Chemistry; Lactic acid; Drug delivery; Organic chemistry; Nanoparticle; Nanotechnology","score_opus":0.042433114254306,"score_gpt":0.39925162387110497,"score_spread":0.35681850961679895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005513578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99357224,0.001092613,0.0034492137,0.000041523683,0.00001520774,0.000020464448,0.00006831162,0.000030905667,0.0017095786],"genre_scores_gemma":[0.9939214,0.00060029246,0.002730005,0.00004156776,0.000008358236,0.000021639522,0.00012184049,0.000023112434,0.0025317222],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999261,0.000008783229,0.000006058067,0.000016452212,0.000020876041,0.0000217643],"domain_scores_gemma":[0.99988234,0.000035480538,0.00002989029,0.000009115024,0.000023606075,0.000019553147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009435332,0.00016150669,0.0000913053,0.00013644167,0.00012399103,0.00026293457,0.00012219393,0.00020320421,0.0008617961],"category_scores_gemma":[0.00018472502,0.00011643048,0.00007874606,0.00011619135,0.00009767041,0.0002219575,0.00008016434,0.00019075004,0.00018153265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003080167,0.0000046831933,0.000033195596,0.00000899635,7.0352655e-7,0.000021914264,0.0000067931587,0.000013568896,0.99945265,0.000010617864,0.0000052358373,0.0004106604],"study_design_scores_gemma":[0.0000049523483,0.000084877625,0.0014362219,0.0000035755572,0.000005960242,0.00007405756,0.000013843501,0.00033608958,0.99755776,0.000008655123,0.00047254487,0.0000013289792],"about_ca_topic_score_codex":0.00038030685,"about_ca_topic_score_gemma":0.00058121874,"teacher_disagreement_score":0.0008617961,"about_ca_system_score_codex":0.00011125646,"about_ca_system_score_gemma":0.00007955139,"threshold_uncertainty_score":0.002883017},"labels":[],"label_agreement":null},{"id":"W2006416360","doi":"10.14740/wjon865w","title":"A Retrospective Study of Efficacy and Safety of Albumin-bound paclitaxel in Metastatic Breast Cancer","year":2014,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Neutropenia; Metastatic breast cancer; Paclitaxel; Taxane; Internal medicine; Febrile neutropenia; Breast cancer; Chemotherapy; Toxicity; Oncology; Progressive disease; Docetaxel; Premedication; Surgery; Gastroenterology; Cancer","score_opus":0.02560222401340634,"score_gpt":0.3810440120132287,"score_spread":0.35544178799982235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006416360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99843043,0.0007577186,0.00010900871,0.000017042841,0.0000040601267,0.0000353053,0.00025425444,0.0000034797524,0.00038867106],"genre_scores_gemma":[0.9991792,0.00020207217,0.00007584727,0.000031391755,0.000011633841,0.00002345311,0.00038134473,0.0000027304952,0.00009230317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994406,0.00013345019,0.000091783106,0.00014896702,0.000121301455,0.00006391637],"domain_scores_gemma":[0.99777204,0.0005225752,0.00091805117,0.00016627826,0.00034406356,0.0002769974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008191433,0.00019543472,0.0004212987,0.0006882885,0.00042008137,0.0004269498,0.00021693815,0.00026662476,0.001043131],"category_scores_gemma":[0.0019290504,0.0001991554,0.0003579243,0.0009810812,0.00029916962,0.00028407696,0.00027558347,0.00028864417,0.00024925533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009490803,0.00009343447,0.9937384,0.000051163166,0.00008090384,0.00060372707,0.000102762046,0.00005697738,0.0005481638,0.000017638888,0.0001049927,0.0036528732],"study_design_scores_gemma":[0.000102621394,0.00259739,0.989028,0.000018505396,0.00021205466,0.0053014196,0.0002706448,0.00021151257,0.00053229654,0.000035735527,0.0016786603,0.00001104287],"about_ca_topic_score_codex":0.0017178605,"about_ca_topic_score_gemma":0.0011317569,"teacher_disagreement_score":0.0017178605,"about_ca_system_score_codex":0.0006453764,"about_ca_system_score_gemma":0.00047155088,"threshold_uncertainty_score":0.0046824813},"labels":[],"label_agreement":null},{"id":"W2006689939","doi":"10.1177/1078155206075236","title":"Stability issues of parenteral chemotherapy drugs","year":2007,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency; United States Pharmacopeia","keywords":"Medicine; Chemotherapy; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.06675610146510093,"score_gpt":0.49594687242619134,"score_spread":0.42919077096109043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006689939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33951512,0.28626043,0.2493436,0.03514266,0.005732044,0.0013600283,0.0026971675,0.0033095952,0.07663936],"genre_scores_gemma":[0.79971254,0.04932187,0.12599666,0.005790504,0.002600722,0.00044021616,0.001619474,0.0007773764,0.013740641],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.97848684,0.0075078825,0.0038323386,0.0014908839,0.0083266,0.00035547142],"domain_scores_gemma":[0.9349234,0.034206215,0.014044159,0.003581995,0.012774901,0.00046930954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021894498,0.0004706451,0.0010876645,0.0025764755,0.0012096311,0.0036913392,0.0012703635,0.0016268146,0.00302054],"category_scores_gemma":[0.058827106,0.00044560182,0.0009240108,0.002540682,0.001913791,0.0030835615,0.0014335717,0.0024206708,0.0012902748],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023225376,0.00024254863,0.018310279,0.0039206077,0.00023945345,0.0025057453,0.0035605312,0.003692492,0.08843802,0.02692154,0.021135645,0.8287107],"study_design_scores_gemma":[0.00021614796,0.004657376,0.03375539,0.0026720879,0.0006195644,0.022817075,0.0018171583,0.013030047,0.43423644,0.030911732,0.45487884,0.00038812132],"about_ca_topic_score_codex":0.0017495303,"about_ca_topic_score_gemma":0.0014334884,"teacher_disagreement_score":0.021894498,"about_ca_system_score_codex":0.0021545948,"about_ca_system_score_gemma":0.002074237,"threshold_uncertainty_score":0.115790546},"labels":[],"label_agreement":null},{"id":"W2006732130","doi":"10.1016/j.biomaterials.2007.03.022","title":"A novel trans-lymphatic drug delivery system: Implantable gelatin sponge impregnated with PLGA–paclitaxel microspheres","year":2007,"lang":"en","type":"article","venue":"Biomaterials","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada); University of Toronto","funders":"Canadian Institutes of Health Research; Merck Canada","keywords":"PLGA; Lymphatic system; Drug delivery; Paclitaxel; Gelatin; Materials science; Biomedical engineering; Pharmacology; Medicine; Nanotechnology; Chemistry; Pathology; Surgery; Nanoparticle; Chemotherapy","score_opus":0.01449909306354052,"score_gpt":0.2718709677637713,"score_spread":0.25737187470023076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006732130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9486463,0.007269743,0.03924782,0.0005592296,0.00021723134,0.00017708006,0.00024578802,0.00056626316,0.0030704713],"genre_scores_gemma":[0.97611266,0.0017736587,0.01880003,0.00011696516,0.00005565074,0.00007842057,0.00010448406,0.000048106525,0.0029101025],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986863,0.000021211741,0.000012236906,0.000039140323,0.000030481266,0.000028237408],"domain_scores_gemma":[0.9998203,0.00004180888,0.00006439398,0.000015162692,0.000021143504,0.000037279864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025384157,0.0004381266,0.00031877146,0.0003315728,0.00019612018,0.00036251853,0.0003788549,0.0004490003,0.0006063163],"category_scores_gemma":[0.00021497402,0.0002563777,0.00023390421,0.00016841813,0.00031506634,0.00052455085,0.00026681955,0.00036870578,0.00032357464],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069622416,0.000023983477,0.000047290832,0.000055596465,0.0000043825867,0.00006546674,0.000011225671,0.00009537153,0.9968066,0.00007267388,0.000044510183,0.002703295],"study_design_scores_gemma":[0.000031764426,0.0004155277,0.00074911135,0.000004245966,0.000029299094,0.00027315345,0.0000096133235,0.0012694157,0.9945978,0.00001780216,0.0025894078,0.000012825486],"about_ca_topic_score_codex":0.00067867053,"about_ca_topic_score_gemma":0.0008309607,"teacher_disagreement_score":0.00067867053,"about_ca_system_score_codex":0.00031906788,"about_ca_system_score_gemma":0.0002594183,"threshold_uncertainty_score":0.0023149848},"labels":[],"label_agreement":null},{"id":"W2006998169","doi":"10.1021/np030322r","title":"New Minor Taxane Derivatives from the Needles of <i>Taxus </i><i>c</i><i>anadensis</i>","year":2003,"lang":"en","type":"article","venue":"Journal of Natural Products","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique; McGill University; Queen's University; Université du Québec à Montréal","funders":"","keywords":"Taxane; Taxus; Paclitaxel; Chemistry; Diterpene; Stereochemistry; Botany; Biology; Chemotherapy","score_opus":0.019096833876752022,"score_gpt":0.2788099398506499,"score_spread":0.25971310597389785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006998169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779865,0.007910358,0.0031837865,0.000118935306,0.00008011988,0.00017868579,0.0029357448,0.000059650636,0.007546173],"genre_scores_gemma":[0.96556485,0.00958141,0.0076187663,0.00016121138,0.00005758649,0.000072361254,0.0054402514,0.000032835396,0.011470756],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999753,0.0000020266507,0.0000021306817,0.0000061122323,0.000008399233,0.0000060443767],"domain_scores_gemma":[0.99992776,0.0000073961837,0.000014413375,0.0000056205627,0.00001455818,0.00003020915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000026154627,0.0004520624,0.00020439754,0.0005387862,0.00023870188,0.0001858809,0.00014416086,0.00016229322,0.0021429323],"category_scores_gemma":[0.00007561492,0.00012243023,0.00018356582,0.00036304627,0.00017415517,0.000251074,0.00014820855,0.0005976967,0.00041273359],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001363645,0.0000320309,0.00056935323,0.000114274466,0.000015376056,0.0002893592,0.00005427061,0.000067997156,0.9905916,0.000115548086,0.00007481741,0.007939009],"study_design_scores_gemma":[0.00012881921,0.001879606,0.05714367,0.000081614286,0.00019625302,0.0026232244,0.00035278694,0.0003916828,0.885963,0.0006477273,0.050539255,0.00005233061],"about_ca_topic_score_codex":0.0018483802,"about_ca_topic_score_gemma":0.0064175255,"teacher_disagreement_score":0.0021429323,"about_ca_system_score_codex":0.00017072866,"about_ca_system_score_gemma":0.00036199065,"threshold_uncertainty_score":0.0071688294},"labels":[],"label_agreement":null},{"id":"W2007037292","doi":"10.3816/cbc.2009.n.044","title":"TRIO-012: A Multicenter, Multinational, Randomized, Double-Blind Phase III Study of IMC-1121B Plus Docetaxel Versus Placebo Plus Docetaxel in Previously Untreated Patients With HER2-Negative, Unresectable, Locally Recurrent or Metastatic Breast Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Alberta","funders":"","keywords":"Docetaxel; Medicine; Metastatic breast cancer; Ramucirumab; Placebo; Internal medicine; Oncology; Chemotherapy; Randomized controlled trial; Breast cancer; Phases of clinical research; Cancer; Pathology","score_opus":0.07878283885101223,"score_gpt":0.4425120655689957,"score_spread":0.36372922671798347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007037292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98218954,0.0041170297,0.0011299448,0.0012760282,0.0006967223,0.0048940107,0.0020755394,0.00045581555,0.0031652923],"genre_scores_gemma":[0.9695013,0.004887424,0.003139742,0.0022899534,0.0005868999,0.0078128725,0.0029763367,0.00013212906,0.008673413],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99938667,0.00032704213,0.000026631846,0.00009776798,0.000043866094,0.00011793171],"domain_scores_gemma":[0.9991159,0.00016439,0.00017573948,0.00006645752,0.000049738275,0.0004277034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002389866,0.0027081447,0.0038982523,0.0008484918,0.00075934996,0.0014926433,0.00166512,0.0022203603,0.0069390065],"category_scores_gemma":[0.0015669835,0.0012873092,0.0015840424,0.0008418346,0.0020816976,0.0015170332,0.0004980469,0.0058032167,0.0017819308],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9403726,0.02620127,0.0007639128,0.0006352828,0.0009706594,0.00004449878,0.00011071475,0.0007378211,0.00647918,0.00022768659,0.002181647,0.021274555],"study_design_scores_gemma":[0.9291288,0.06824402,0.00088882423,0.00001598344,0.00027348616,0.00003157248,0.000025548065,0.00034031356,0.00044531343,0.00007327714,0.0005153041,0.000017549386],"about_ca_topic_score_codex":0.0019944638,"about_ca_topic_score_gemma":0.0055448636,"teacher_disagreement_score":0.0069390065,"about_ca_system_score_codex":0.0010255958,"about_ca_system_score_gemma":0.002351221,"threshold_uncertainty_score":0.023213267},"labels":[],"label_agreement":null},{"id":"W2008485928","doi":"10.1111/j.1540-9740.2006.05991.x","title":"Solodyn (Minocycline HCl, USP) Extended‐Release Tablets","year":2006,"lang":"en","type":"article","venue":"SKINmed Dermatology for the Clinician","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Citation; Library science; Computer science","score_opus":0.02240229546156717,"score_gpt":0.3462515459205624,"score_spread":0.3238492504589952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008485928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9287262,0.023175312,0.013023979,0.000745734,0.00063685025,0.0009213738,0.0014571412,0.0011216477,0.030191796],"genre_scores_gemma":[0.9656398,0.0052477145,0.0071425284,0.00023268731,0.00019573543,0.00019902154,0.00041588856,0.000037932594,0.020888673],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998872,0.000031381274,0.000012006216,0.000017894054,0.00004001572,0.0000113544065],"domain_scores_gemma":[0.999863,0.0000336798,0.000038693965,0.000013368564,0.00001633287,0.00003489463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018285519,0.0003072582,0.0003065957,0.00017887013,0.00011457807,0.0001659405,0.00022914483,0.00025988845,0.008269916],"category_scores_gemma":[0.00033378182,0.00009067944,0.00016986123,0.000081454986,0.000109215856,0.00018624193,0.000099020166,0.0003985682,0.0009812238],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011100814,0.0013943132,0.0009020818,0.0019549853,0.000076488155,0.0013321133,0.00015226057,0.00028294776,0.5691224,0.0007847639,0.007324818,0.40557206],"study_design_scores_gemma":[0.014236501,0.07105937,0.042763263,0.00069657323,0.0003399846,0.018712698,0.00040768395,0.0046942914,0.68444216,0.0007580658,0.161778,0.00011144109],"about_ca_topic_score_codex":0.0001603633,"about_ca_topic_score_gemma":0.0006428745,"teacher_disagreement_score":0.008269916,"about_ca_system_score_codex":0.000067774,"about_ca_system_score_gemma":0.00012938546,"threshold_uncertainty_score":0.027665615},"labels":[],"label_agreement":null},{"id":"W2009212934","doi":"10.1111/j.1525-1438.2005.00139.x","title":"Phase II multicenter open-label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies","year":2005,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thames Valley Children's Centre; Université de Montréal; Hôpital Notre-Dame; Hamilton Regional Laboratory Medicine Program; Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Carboplatin; Nausea; Neutropenia; Internal medicine; Adverse effect; Vomiting; Phases of clinical research; Surgery; Chemotherapy; Gastroenterology; Cisplatin","score_opus":0.05852447160272847,"score_gpt":0.4342813146540661,"score_spread":0.3757568430513376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009212934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924103,0.0014931294,0.000746591,0.00042894526,0.00017981368,0.0027123457,0.00072470197,0.00010380283,0.0012004293],"genre_scores_gemma":[0.9871634,0.0018614222,0.0018441678,0.00065375876,0.00025505727,0.003467155,0.001542492,0.000052233758,0.003160218],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99935895,0.00028515983,0.000023254572,0.00012929508,0.00004580139,0.00015764189],"domain_scores_gemma":[0.9988959,0.0002056844,0.00015862682,0.0001325962,0.00005777527,0.00054949796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001903309,0.0020236273,0.0037455894,0.00063606724,0.0007618868,0.0014750473,0.0016159281,0.0019371813,0.0045043714],"category_scores_gemma":[0.0012373652,0.0012128708,0.0013743588,0.0007561924,0.0024608958,0.0017018807,0.0005125844,0.004521501,0.0011248961],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8858579,0.058679633,0.0015131908,0.00040590932,0.00068644964,0.0000929277,0.00026521742,0.0016121372,0.017213915,0.00026403807,0.00178648,0.03162225],"study_design_scores_gemma":[0.79268926,0.2003054,0.0027689068,0.00001353454,0.00023118906,0.00007513208,0.0000646446,0.0008534509,0.0016739671,0.00012518342,0.0011771508,0.000022116214],"about_ca_topic_score_codex":0.002997059,"about_ca_topic_score_gemma":0.005595364,"teacher_disagreement_score":0.0045043714,"about_ca_system_score_codex":0.0017287345,"about_ca_system_score_gemma":0.0032118307,"threshold_uncertainty_score":0.01506865},"labels":[],"label_agreement":null},{"id":"W2009590627","doi":"10.3816/cbc.2005.n.016","title":"Phase II Study of Pemetrexed in Patients Pretreated with an Anthracycline, a Taxane, and Capecitabine for Advanced Breast Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Shaughnessy Hospital","funders":"Eli Lilly and Company","keywords":"Medicine; Pemetrexed; Neutropenia; Internal medicine; Breast cancer; Capecitabine; Taxane; Metastatic breast cancer; Oncology; Leukopenia; Phases of clinical research; Nausea; Cancer; Gastroenterology; Chemotherapy; Surgery; Cisplatin; Colorectal cancer","score_opus":0.03156877664350103,"score_gpt":0.4302681399291997,"score_spread":0.39869936328569866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009590627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950441,0.0010731085,0.00030819897,0.00043467575,0.0001279504,0.001187353,0.00051393954,0.00004335904,0.0012672246],"genre_scores_gemma":[0.9909739,0.0017165497,0.0008860901,0.0005924738,0.00022958049,0.0015302259,0.0013990846,0.000023935705,0.0026482085],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996277,0.00017291808,0.000014242809,0.00006548812,0.00002390644,0.000095646],"domain_scores_gemma":[0.9990422,0.000178161,0.0001172543,0.00007803583,0.00004143602,0.0005427914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011104029,0.0016159273,0.0032029627,0.00043468294,0.00052217825,0.0010228608,0.001043631,0.0013851798,0.004534827],"category_scores_gemma":[0.001214313,0.0007844469,0.0013028199,0.0004743053,0.0011845028,0.0012108057,0.00033649168,0.0046166074,0.0008749882],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8515091,0.08345961,0.0023690977,0.00039364852,0.00085366005,0.0002045541,0.00023737471,0.001809151,0.02277244,0.00022728309,0.0018343894,0.034329657],"study_design_scores_gemma":[0.6649474,0.32476294,0.005789829,0.000018390265,0.00030358628,0.00014305188,0.000065561406,0.00078146515,0.0017518835,0.00012088838,0.0012966862,0.00001826167],"about_ca_topic_score_codex":0.001962854,"about_ca_topic_score_gemma":0.003792924,"teacher_disagreement_score":0.004534827,"about_ca_system_score_codex":0.0010582126,"about_ca_system_score_gemma":0.0018055437,"threshold_uncertainty_score":0.015170574},"labels":[],"label_agreement":null},{"id":"W2010082810","doi":"10.1097/01.coc.0000071464.83271.08","title":"Effect of Capecitabine on Mean Corpuscular Volume in Patients With Metastatic Breast Cancer","year":2004,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Capecitabine; Metastatic breast cancer; Mean corpuscular volume; Breast cancer; Oncology; Internal medicine; Cancer; Colorectal cancer; Hemoglobin","score_opus":0.02125211244019987,"score_gpt":0.4226104372930836,"score_spread":0.40135832485288375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010082810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895918,0.009683858,0.00005284989,0.00009161674,0.000014847958,0.000011746463,0.00008309017,0.0000056001386,0.00046465432],"genre_scores_gemma":[0.99901426,0.0007463555,0.000065959175,0.000036534486,0.000021790496,0.0000038023,0.00006404649,0.0000010372629,0.000046234243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969864,0.0001307875,0.00003467514,0.00004376148,0.00007019597,0.000021933669],"domain_scores_gemma":[0.9983612,0.0008081682,0.0005343782,0.00003833587,0.00009693616,0.00016103244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055701216,0.0001379391,0.0004963502,0.00035026475,0.00015166843,0.00027253968,0.00013096597,0.00017199545,0.00042696384],"category_scores_gemma":[0.0038621123,0.00012076843,0.00021498406,0.00040104668,0.00013853729,0.00018268457,0.00009940654,0.00024617274,0.0000714832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030794842,0.000089059395,0.9687612,0.000099377285,0.00020629763,0.00071128877,0.00006938851,0.00016420397,0.0029174937,0.000022098346,0.00034634568,0.0235337],"study_design_scores_gemma":[0.0000589412,0.0013086322,0.99605644,0.00001750518,0.000107342414,0.0012051346,0.00003439043,0.00023461487,0.00042723666,0.000014680653,0.00053061784,0.000004373578],"about_ca_topic_score_codex":0.0009981338,"about_ca_topic_score_gemma":0.0022527934,"teacher_disagreement_score":0.0009981338,"about_ca_system_score_codex":0.00030971927,"about_ca_system_score_gemma":0.0001843622,"threshold_uncertainty_score":0.0029457808},"labels":[],"label_agreement":null},{"id":"W2010546902","doi":"10.1200/jco.2007.15.9772","title":"Preface to Second Review Issue on Breast Cancer","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Compendium; Cancer; Gerontology; Internal medicine","score_opus":0.22135672072834317,"score_gpt":0.574805088771253,"score_spread":0.35344836804290986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010546902","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013659547,0.030168723,0.00054981763,0.024732582,0.9345452,0.00019942873,0.00044253975,0.00014971606,0.009075327],"genre_scores_gemma":[0.0016028883,0.04475303,0.0015043546,0.04222217,0.80928034,0.000508904,0.0015830701,0.0002126386,0.09833257],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99819046,0.00024908548,0.00021075015,0.00018365063,0.0010396639,0.00012642422],"domain_scores_gemma":[0.9808296,0.0037386627,0.0013615552,0.00046872452,0.011572237,0.002029278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028332747,0.0018324597,0.0023741121,0.004560103,0.00124151,0.0037562521,0.001763646,0.0035215637,0.09213272],"category_scores_gemma":[0.016064148,0.0006583287,0.0018514118,0.002131008,0.00068365515,0.0028601168,0.0015326579,0.005435165,0.06815829],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030415353,0.000017960776,0.000023970399,0.0005864927,0.000008155222,0.0000551846,0.0000075268413,0.000022654844,0.00017804127,0.0002196056,0.9812329,0.017617071],"study_design_scores_gemma":[0.000035608704,0.00007481826,0.0004311969,0.00069132255,0.00002553063,0.0002549461,0.000017154534,0.00006119465,0.00017468582,0.0006537902,0.9975631,0.000016700864],"about_ca_topic_score_codex":0.0012355573,"about_ca_topic_score_gemma":0.0019872664,"teacher_disagreement_score":0.09213272,"about_ca_system_score_codex":0.002195022,"about_ca_system_score_gemma":0.0028560357,"threshold_uncertainty_score":0.30821466},"labels":[],"label_agreement":null},{"id":"W2010677439","doi":"10.1016/j.pain.2013.07.032","title":"Bioenergetic deficits in peripheral nerve sensory axons during chemotherapy-induced neuropathic pain resulting from peroxynitrite-mediated post-translational nitration of mitochondrial superoxide dismutase","year":2013,"lang":"en","type":"article","venue":"Pain","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; School of Medicine, Duke University; Saint Louis University; Leukemia and Lymphoma Research; Leukemia and Lymphoma Society","keywords":"Peroxynitrite; Peroxynitrous acid; Pharmacology; Chemistry; Hyperalgesia; Superoxide dismutase; Superoxide; Mitochondrion; Medicine; Oxidative stress; Nociception; Biochemistry","score_opus":0.01651148511230198,"score_gpt":0.25716442351415814,"score_spread":0.24065293840185614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010677439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99809057,0.0007100754,0.0007688132,0.000025522506,0.000010259261,0.000016143655,0.000057131816,0.000016419994,0.00030501597],"genre_scores_gemma":[0.99860376,0.00034088638,0.00041694837,0.000021967287,0.0000032586784,0.000020389849,0.00008408075,0.0000024450685,0.0005062883],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993277,0.000010474182,0.000006928785,0.000014085524,0.000012816504,0.000022856606],"domain_scores_gemma":[0.99994206,0.0000053464946,0.00002675002,0.0000039155952,0.0000069537655,0.000015036744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010806285,0.00019815586,0.00018960258,0.00009087525,0.00007882307,0.00012048867,0.00009363779,0.00018134616,0.0007749146],"category_scores_gemma":[0.000091920665,0.00009151965,0.00013964673,0.000079245656,0.00014945313,0.0001680926,0.00008668114,0.00032491778,0.00008991576],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005610048,0.000040128394,0.000237956,0.00004843664,0.0000062919285,0.00006380997,0.000018380531,0.000024306211,0.9982212,0.00002534772,0.000013420054,0.0007397175],"study_design_scores_gemma":[0.000057633366,0.0016481056,0.020585297,0.000013198795,0.00003446714,0.0004118078,0.00005655347,0.000836308,0.97582483,0.000053042524,0.0004737149,0.0000052227415],"about_ca_topic_score_codex":0.0004009496,"about_ca_topic_score_gemma":0.00070169446,"teacher_disagreement_score":0.0007749146,"about_ca_system_score_codex":0.00015467677,"about_ca_system_score_gemma":0.00014416498,"threshold_uncertainty_score":0.0025923848},"labels":[],"label_agreement":null},{"id":"W2010922143","doi":"10.1080/13880200701729760","title":"Seasonal Changes in the Concentration of Major Taxanes in the Biomass of Wild Canada Yew (<i>Taxus canadensis</i>. Marsh.)","year":2008,"lang":"en","type":"article","venue":"Pharmaceutical Biology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Fredericton; Natural Resources Canada; Canadian Forest Service","funders":"","keywords":"Taxane; Dry weight; Seasonality; Animal science; Biology; Deciduous; Botany; Biomass (ecology); Taxus; Horticulture; Agronomy; Ecology","score_opus":0.05359541572347494,"score_gpt":0.3452448971791782,"score_spread":0.2916494814557033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010922143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970843,0.00023114243,0.00006775353,0.000014139448,0.000002856894,0.000009110119,0.0017230181,0.000010186788,0.00085746066],"genre_scores_gemma":[0.9927817,0.00023417201,0.00030883687,0.000042037813,0.0000017656838,0.000017577662,0.0031304345,0.00000969748,0.0034738684],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999504,0.0000011558645,0.0000013636281,0.000018181674,0.000016488679,0.00001243767],"domain_scores_gemma":[0.99979895,0.000009424706,0.000041493317,0.0000045606644,0.0000747837,0.00007090777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043561882,0.00021637317,0.00019559002,0.0007263179,0.00061842485,0.00037449755,0.00022134061,0.00016360988,0.0008535112],"category_scores_gemma":[0.00007498403,0.00017765567,0.000092635535,0.0005680732,0.00024539078,0.00013621949,0.0001607661,0.00027851807,0.0001613923],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009235576,0.00008165948,0.34889778,0.00014680508,0.00012416815,0.00034180994,0.0008495434,0.00027185542,0.63286704,0.00011632657,0.00095053745,0.014428788],"study_design_scores_gemma":[0.0000036931408,0.000030436471,0.99585634,0.0000025385805,0.000010496226,0.000036107132,0.00014816197,0.0001146699,0.0028492822,0.000006710247,0.0009365589,0.000005103572],"about_ca_topic_score_codex":0.63119274,"about_ca_topic_score_gemma":0.8893165,"teacher_disagreement_score":0.36880726,"about_ca_system_score_codex":0.003004797,"about_ca_system_score_gemma":0.0009634588,"threshold_uncertainty_score":0.7419585},"labels":[],"label_agreement":null},{"id":"W2011223682","doi":"10.1016/j.ctrv.2008.01.008","title":"Metastatic breast cancer: The role of pegylated liposomal doxorubicin after conventional anthracyclines","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of Ottawa; Ottawa Regional Cancer Foundation; Ottawa Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cardiotoxicity; Anthracycline; Trastuzumab; Doxorubicin; Breast cancer; Metastatic breast cancer; Oncology; Adjuvant; Internal medicine; Regimen; Adjuvant therapy; Chemotherapy; Cancer; Pharmacology","score_opus":0.07097432120529847,"score_gpt":0.42110653563821765,"score_spread":0.3501322144329192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011223682","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002888693,0.9986773,0.000118884374,0.00013866594,0.00010181616,0.00000399467,0.000008197672,0.0000042452134,0.0006579879],"genre_scores_gemma":[0.0014744133,0.9971807,0.0001728088,0.00019439646,0.00011741817,0.0000055131095,0.000022038836,0.0000014890443,0.0008312711],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987674,0.000026367781,0.000015367421,0.000026649326,0.00004257474,0.000012292588],"domain_scores_gemma":[0.9998536,0.00007485871,0.000035143912,0.0000048381507,0.000021989854,0.000009622491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047290177,0.0005830956,0.001418414,0.0008690005,0.00015786273,0.00069189654,0.00060597464,0.0007616433,0.0022888843],"category_scores_gemma":[0.00040333578,0.00019370273,0.00036541006,0.0010368371,0.00034007302,0.00084545085,0.00040110978,0.0012064058,0.0010480309],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021366603,0.000082894854,0.00011386135,0.0075696846,0.00007238282,0.00018185521,0.00003832834,0.00035261453,0.0037369644,0.0020423087,0.015542779,0.9700528],"study_design_scores_gemma":[0.00009540313,0.00034560982,0.0014839713,0.0023919381,0.00019557014,0.0023448495,0.000036348923,0.00018654637,0.0017919213,0.00096256577,0.99014354,0.000021707376],"about_ca_topic_score_codex":0.0008410043,"about_ca_topic_score_gemma":0.0018167945,"teacher_disagreement_score":0.0022888843,"about_ca_system_score_codex":0.000505619,"about_ca_system_score_gemma":0.0005257299,"threshold_uncertainty_score":0.007657051},"labels":[],"label_agreement":null},{"id":"W2011442772","doi":"10.1002/cncr.23189","title":"Combining endocrine agents with chemotherapy: Which patients and what sequence?","year":2007,"lang":"en","type":"article","venue":"Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Chemotherapy; Tamoxifen; Hormone therapy; Oncology; Internal medicine; Breast cancer; Hormonal therapy; Cancer; Randomized controlled trial; Hormone","score_opus":0.030934282053980692,"score_gpt":0.35569558850129496,"score_spread":0.32476130644731427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011442772","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2290607,0.57917637,0.021217512,0.131464,0.00528113,0.004619217,0.0017345314,0.00033281537,0.02711376],"genre_scores_gemma":[0.5147221,0.36532435,0.052658405,0.044815704,0.010745837,0.0037178416,0.0011059932,0.00011302376,0.0067968294],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976584,0.0013990015,0.00034731248,0.00018621917,0.00030708706,0.00010205011],"domain_scores_gemma":[0.997244,0.0012980793,0.00066258194,0.00014515888,0.00022392368,0.00042620685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005106861,0.00047561736,0.0035108344,0.0007404951,0.00051140925,0.0016198425,0.0006777346,0.0020098505,0.004220471],"category_scores_gemma":[0.006794645,0.0003595165,0.0012210296,0.0010052028,0.0008625745,0.00260688,0.0005447096,0.0017335799,0.0014224816],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023164732,0.0026671242,0.013079401,0.004182669,0.0006069006,0.00027159468,0.00023976536,0.0011868244,0.0023629963,0.004510122,0.012557986,0.93516994],"study_design_scores_gemma":[0.09208329,0.16169566,0.06821242,0.026182368,0.008317359,0.0072827013,0.0030232281,0.0075162337,0.013986387,0.11347153,0.4976596,0.00056925707],"about_ca_topic_score_codex":0.0007372533,"about_ca_topic_score_gemma":0.0031138225,"teacher_disagreement_score":0.005106861,"about_ca_system_score_codex":0.001043143,"about_ca_system_score_gemma":0.002322421,"threshold_uncertainty_score":0.027007997},"labels":[],"label_agreement":null},{"id":"W2011567222","doi":"10.1158/0008-5472.sabcs12-p1-13-03","title":"Abstract P1-13-03: Mature analysis of UK Taxotere as Adjuvant Chemotherapy (TACT) trial (CRUK 01/001); effects of treatment and characterisation of patterns of breast cancer relapse.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Docetaxel; Breast cancer; Taxane; Tact; Internal medicine; Oncology; Pertuzumab; Population; Chemotherapy; Trastuzumab; Gynecology; Cancer; Psychology","score_opus":0.04978048749687294,"score_gpt":0.42496220901939524,"score_spread":0.3751817215225223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011567222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819593,0.0032304064,0.00078774814,0.000589653,0.00007989851,0.001895544,0.008785573,0.00008119211,0.0025907396],"genre_scores_gemma":[0.98386127,0.00066433713,0.0013171111,0.00046124143,0.0001368937,0.0014012688,0.0099038305,0.000038578004,0.0022155396],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99900335,0.0007008874,0.00004501439,0.00012384701,0.000065080196,0.00006193382],"domain_scores_gemma":[0.99826497,0.0004216339,0.00050341786,0.00026481156,0.0001189202,0.00042639425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002446009,0.0005774843,0.0012350425,0.00021429642,0.00020492305,0.0008699002,0.000557322,0.0006238293,0.0039238445],"category_scores_gemma":[0.0028541256,0.00031888147,0.000879377,0.00053405436,0.00033826794,0.00040605234,0.00034815507,0.0014879035,0.0006727303],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90042186,0.0033278484,0.029249188,0.00061562704,0.002516806,0.00014582401,0.000120486184,0.0011516421,0.008718265,0.00015089309,0.007610031,0.045971632],"study_design_scores_gemma":[0.5779554,0.12653443,0.2746721,0.00013281827,0.004187669,0.0008377163,0.00008820653,0.0025493493,0.0039837616,0.00040599133,0.008561587,0.000090974056],"about_ca_topic_score_codex":0.0013721439,"about_ca_topic_score_gemma":0.0024199882,"teacher_disagreement_score":0.0039238445,"about_ca_system_score_codex":0.0006213451,"about_ca_system_score_gemma":0.0007776449,"threshold_uncertainty_score":0.013126552},"labels":[],"label_agreement":null},{"id":"W2011675167","doi":"10.1007/s12257-010-0330-6","title":"Separation of taxanes from Taxus canadensis using dynamic pressurized liquid extraction","year":2011,"lang":"en","type":"article","venue":"Biotechnology and Bioprocess Engineering","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Extraction (chemistry); Solvent; Chromatography; Dichloromethane; Methanol; Hexane; Chemistry; Taxane; Chloroform; Solvent polarity; Organic chemistry","score_opus":0.02429583185340939,"score_gpt":0.29497980327888346,"score_spread":0.27068397142547407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011675167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97051126,0.004755874,0.012510079,0.00031998762,0.00009725123,0.00017696153,0.0015227414,0.00015551734,0.009950262],"genre_scores_gemma":[0.96443254,0.0029383276,0.01298552,0.00011737224,0.000023822342,0.000053292053,0.0025081544,0.00005340465,0.016887635],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999347,0.0000036187312,0.000004115059,0.000018217837,0.000024962888,0.0000143948755],"domain_scores_gemma":[0.99995446,0.000010060487,0.000006732645,0.0000064808987,0.000012748444,0.0000095557125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000065076616,0.00036882848,0.0002485536,0.0004990603,0.00039028152,0.00036847475,0.00018732314,0.00020387727,0.0009983259],"category_scores_gemma":[0.000109747874,0.00011331431,0.00019892938,0.00049274776,0.000157893,0.00025339134,0.00024544366,0.00063365814,0.00053218694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006284004,0.00001389371,0.00016695994,0.000029503362,0.0000040845407,0.0000481112,0.000014271575,0.00012478324,0.99437696,0.000054864027,0.000032420478,0.0050713844],"study_design_scores_gemma":[0.000009246425,0.000089847534,0.002447748,0.00001082552,0.000017366472,0.000102792364,0.0000352547,0.00055202935,0.9896276,0.00008237046,0.0070177102,0.0000072459843],"about_ca_topic_score_codex":0.0048416285,"about_ca_topic_score_gemma":0.009640747,"teacher_disagreement_score":0.0048416285,"about_ca_system_score_codex":0.00034587484,"about_ca_system_score_gemma":0.00053159427,"threshold_uncertainty_score":0.009626865},"labels":[],"label_agreement":null},{"id":"W2011760818","doi":"10.1007/s00280-013-2126-9","title":"A phase I trial to determine the safety, pharmacokinetics, and pharmacodynamics of intercalated BMS-690514 with paclitaxel/carboplatin (PC) in advanced or metastatic solid malignancies","year":2013,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Carboplatin; Pharmacokinetics; Neutropenia; Pharmacodynamics; Rash; Febrile neutropenia; Adverse effect; Internal medicine; Nausea; Lung cancer; Gastroenterology; Mucositis; Pharmacology; Chemotherapy","score_opus":0.02949049664627675,"score_gpt":0.38000288019242273,"score_spread":0.350512383546146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011760818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99469745,0.0008038804,0.00044298344,0.00037691617,0.000084719126,0.0015273246,0.00061715255,0.000095477,0.0013541124],"genre_scores_gemma":[0.9905065,0.0009249137,0.002092339,0.0007284257,0.00017986761,0.0016913412,0.0017712995,0.00005140154,0.0020541332],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991773,0.00040746888,0.000038458427,0.00014948187,0.00007448985,0.0001528399],"domain_scores_gemma":[0.99874663,0.00018307532,0.00022328453,0.00010214389,0.000054884003,0.0006900465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018261726,0.0019407388,0.0026927192,0.00066677475,0.0006032429,0.0011441747,0.0012605992,0.0018127796,0.0038084723],"category_scores_gemma":[0.0014811694,0.00075240363,0.0013499234,0.00082823733,0.0020064646,0.001615822,0.0004917676,0.004582922,0.0010304992],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8646362,0.051483676,0.0036480525,0.00026180982,0.00085325283,0.0001708709,0.00021423961,0.0020712414,0.02682746,0.00040499851,0.0019693612,0.047458835],"study_design_scores_gemma":[0.5477063,0.44001105,0.0057363193,0.000014581733,0.00033108666,0.00018835816,0.000036934962,0.001199718,0.0033032678,0.00022243471,0.001222293,0.000027713153],"about_ca_topic_score_codex":0.0016267828,"about_ca_topic_score_gemma":0.003055126,"teacher_disagreement_score":0.0038084723,"about_ca_system_score_codex":0.0014758053,"about_ca_system_score_gemma":0.0023814167,"threshold_uncertainty_score":0.012740612},"labels":[],"label_agreement":null},{"id":"W2012123298","doi":"10.2165/00003495-200262150-00010","title":"Gefitinib","year":2002,"lang":"sl","type":"article","venue":"Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Gefitinib; Pharmacotherapy; Pharmacology; Internal medicine; Cancer; Epidermal growth factor receptor","score_opus":0.03679783711843848,"score_gpt":0.30342954578173936,"score_spread":0.2666317086633009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012123298","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22463587,0.09636315,0.007140567,0.014283368,0.005017564,0.00075510243,0.011358957,0.007353545,0.63309187],"genre_scores_gemma":[0.6524511,0.023203904,0.0051439344,0.003347803,0.00082959404,0.00032860544,0.011786879,0.00026891808,0.30263928],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998004,0.000021150103,0.000010543727,0.000042550586,0.00005734797,0.00006810078],"domain_scores_gemma":[0.9999213,0.000007983246,0.000008577425,0.000012723572,0.000013580153,0.000035849436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019090144,0.0004811413,0.00061792135,0.0006646247,0.00056354934,0.0007232657,0.00042333477,0.00060094777,0.047182042],"category_scores_gemma":[0.00030441993,0.00016964434,0.0004818837,0.00035718802,0.00024585563,0.00045605586,0.0003924013,0.0011652336,0.022977028],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004913954,0.00084622693,0.0036435744,0.000904371,0.00025028907,0.0013678756,0.00008093902,0.0006615552,0.12212225,0.0073294938,0.18866967,0.66920984],"study_design_scores_gemma":[0.0010125485,0.0018867457,0.0068637272,0.000082048704,0.00015664547,0.008672932,0.000031341377,0.0004072952,0.064827316,0.0007938918,0.9152279,0.000037709535],"about_ca_topic_score_codex":0.0008315425,"about_ca_topic_score_gemma":0.0019069576,"teacher_disagreement_score":0.047182042,"about_ca_system_score_codex":0.0006535872,"about_ca_system_score_gemma":0.0007544143,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W2013246214","doi":"10.1159/000048240","title":"Gemcitabine as First-Line Therapy in Patients with Metastatic Breast Cancer: A Phase II Trial","year":2002,"lang":"en","type":"article","venue":"Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); University of Toronto; Mount Sinai Hospital","funders":"Eli Lilly and Company","keywords":"Medicine; Gemcitabine; Neutropenia; Nausea; Metastatic breast cancer; Chemotherapy; Internal medicine; Surgery; Phases of clinical research; Performance status; Breast cancer; Cancer; Vomiting; Gastroenterology","score_opus":0.04271448628610791,"score_gpt":0.3772395463558425,"score_spread":0.3345250600697346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013246214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770284,0.016979948,0.00038056547,0.0009867451,0.00022187586,0.0016858198,0.0006911791,0.00008805519,0.00193734],"genre_scores_gemma":[0.97861403,0.012111145,0.0014699233,0.0014576612,0.00035751206,0.0022193657,0.0018141362,0.000020292526,0.0019358345],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997676,0.00013738885,0.000013812594,0.000029316037,0.00001965121,0.000032244752],"domain_scores_gemma":[0.9995634,0.0000914912,0.00009909346,0.000018533065,0.000017525515,0.00020994277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009796115,0.00080229534,0.0013769501,0.0002586744,0.0002487345,0.00076558,0.000523471,0.0011767755,0.0026599548],"category_scores_gemma":[0.0006669311,0.00024174993,0.0007386467,0.00036029622,0.00035846827,0.00036662433,0.00023350315,0.0021209246,0.0004584383],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6877965,0.033277474,0.011754297,0.0035830433,0.0023539294,0.0007218407,0.00024605813,0.004104285,0.023902593,0.00028406215,0.007704328,0.22427171],"study_design_scores_gemma":[0.79429924,0.18375222,0.011405567,0.00019672688,0.0007187555,0.0005682815,0.000034749864,0.0016357957,0.0025043655,0.00013507399,0.0047263354,0.000022873413],"about_ca_topic_score_codex":0.00042375748,"about_ca_topic_score_gemma":0.0014796687,"teacher_disagreement_score":0.0026599548,"about_ca_system_score_codex":0.0005780937,"about_ca_system_score_gemma":0.0009545584,"threshold_uncertainty_score":0.008898437},"labels":[],"label_agreement":null},{"id":"W2014093910","doi":"10.1158/1535-7163.targ-13-b267","title":"Abstract B267: Inhibition of PLK4 as a therapeutic strategy for genomically unstable cancers deficient for PTEN.","year":2013,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"PTEN; Cancer; Cancer research; Biology; Centrosome; Kinase; Mitosis; Cancer cell; Cell cycle; Apoptosis; PI3K/AKT/mTOR pathway; Cell biology; Genetics","score_opus":0.049749592852205884,"score_gpt":0.34668496005035554,"score_spread":0.29693536719814967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014093910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815285,0.003306354,0.0046711825,0.0005381495,0.00013619362,0.00033618227,0.0014140431,0.00043902584,0.007630348],"genre_scores_gemma":[0.98725605,0.002030494,0.0027838717,0.000114066315,0.000015278607,0.00015029754,0.0011599886,0.00003169081,0.0064582336],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992037,0.000011015744,0.000005301177,0.000012432267,0.00002420012,0.000026731717],"domain_scores_gemma":[0.9999678,0.0000031581162,0.000007646553,0.0000028547915,0.000004303825,0.000014289771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017091025,0.0005955396,0.00027329192,0.0004556014,0.00017544939,0.00027768392,0.0003319938,0.00030585998,0.001847346],"category_scores_gemma":[0.000060687566,0.0001611581,0.00029713154,0.00021566916,0.00021471654,0.0001473608,0.00018837597,0.0007256959,0.0005887033],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007044596,0.00025153134,0.00012305616,0.000086630636,0.000020766243,0.00015682667,0.000012329175,0.00037481365,0.99135065,0.00044381243,0.00047838787,0.0059966957],"study_design_scores_gemma":[0.00029821778,0.0030245595,0.0018229558,0.000011814116,0.000045118588,0.00041484227,0.000020684865,0.0011965764,0.98710424,0.00011652722,0.005935417,0.000009141813],"about_ca_topic_score_codex":0.00079914375,"about_ca_topic_score_gemma":0.0011324892,"teacher_disagreement_score":0.001847346,"about_ca_system_score_codex":0.00032898894,"about_ca_system_score_gemma":0.00040572905,"threshold_uncertainty_score":0.006180048},"labels":[],"label_agreement":null},{"id":"W2014134856","doi":"10.1159/000048244","title":"Weekly Administration of Gemcitabine Plus Docetaxel in Patients with Advanced Breast Cancer: A Phase 1 Study","year":2002,"lang":"en","type":"article","venue":"Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Docetaxel; Medicine; Gemcitabine; Regimen; Toxicity; Internal medicine; Leukopenia; Gastroenterology; Stomatitis; Metastatic breast cancer; Phases of clinical research; Breast cancer; Chemotherapy; Cancer","score_opus":0.02234177178906871,"score_gpt":0.3653930936317798,"score_spread":0.3430513218427111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014134856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99412584,0.0037610373,0.00032367883,0.00020516968,0.000066432294,0.0006789059,0.00021923735,0.000045665038,0.000573915],"genre_scores_gemma":[0.9890215,0.0052691842,0.001808154,0.0006123484,0.0002391685,0.0010451303,0.00103404,0.000025780706,0.00094466767],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995449,0.00021126043,0.00003075444,0.0000779881,0.00005913269,0.00007596249],"domain_scores_gemma":[0.9994092,0.000113898066,0.0001391069,0.00004298634,0.000027425493,0.00026738812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012629036,0.0010659167,0.0020807656,0.00039143566,0.0004081458,0.0006762646,0.0008365247,0.0008980104,0.001697699],"category_scores_gemma":[0.000804555,0.000528461,0.0009112261,0.000557236,0.00059363095,0.00054762047,0.00029951637,0.002287246,0.00048951566],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43208942,0.17118955,0.0273153,0.0024253163,0.0027119312,0.0010647516,0.0006279735,0.005984684,0.0835544,0.00018642464,0.004458844,0.26839134],"study_design_scores_gemma":[0.31087637,0.65039253,0.025744036,0.00007327288,0.0008272286,0.0008978125,0.000048264887,0.00136144,0.005008988,0.00008734601,0.0046473583,0.000035309695],"about_ca_topic_score_codex":0.00061167247,"about_ca_topic_score_gemma":0.0016260048,"teacher_disagreement_score":0.0020807656,"about_ca_system_score_codex":0.00066820387,"about_ca_system_score_gemma":0.0011931554,"threshold_uncertainty_score":0.006678939},"labels":[],"label_agreement":null},{"id":"W2015951140","doi":"10.1097/00004347-200010000-00018","title":"Mitotic Arrest of Endometrial Epithelium After Paclitaxel Therapy for Breast Cancer","year":2000,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Biotech (Canada)","funders":"","keywords":"Paclitaxel; Carcinoma; Endometrium; Breast cancer; Clear cell carcinoma; Biology; Breast carcinoma; Pathology; Cancer; Oncology; Medicine; Internal medicine; Cancer research","score_opus":0.024986378719436476,"score_gpt":0.35609183010171236,"score_spread":0.3311054513822759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015951140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99336994,0.0041649165,0.00032424406,0.00011000404,0.00003647363,0.000030970266,0.000086612185,0.000023589782,0.0018531125],"genre_scores_gemma":[0.9970938,0.0014035691,0.00033264456,0.000069531656,0.000031982807,0.000010183563,0.0001455627,0.0000053651424,0.0009073923],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999398,0.0000095293535,0.000006929547,0.000008178203,0.000016165208,0.000019373218],"domain_scores_gemma":[0.99982435,0.000040466108,0.00005327297,0.00002128659,0.000023033814,0.00003768929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000112521724,0.00020227846,0.00021110555,0.00073844794,0.00039891826,0.00026376036,0.00015451993,0.00044862126,0.0008004783],"category_scores_gemma":[0.000544706,0.00018821008,0.0001725765,0.0002191744,0.00018477504,0.0001294258,0.00022978325,0.00033583195,0.00032020485],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029368682,0.00013765185,0.114764236,0.00026129952,0.000080122714,0.3634238,0.0008071159,0.0001540731,0.4918803,0.00018687453,0.0005557324,0.024811946],"study_design_scores_gemma":[0.00010888785,0.0019294566,0.4274403,0.00004858734,0.00017101048,0.42081743,0.00060530845,0.0006574168,0.13723747,0.0001145967,0.01083318,0.000036423986],"about_ca_topic_score_codex":0.00089241954,"about_ca_topic_score_gemma":0.0011222899,"teacher_disagreement_score":0.00089241954,"about_ca_system_score_codex":0.00018350127,"about_ca_system_score_gemma":0.0001263056,"threshold_uncertainty_score":0.0026779175},"labels":[],"label_agreement":null},{"id":"W2016078871","doi":"10.1271/bbb.80698","title":"Taxusecone, a Novel Taxane with an Unprecedented 11,12-Secotaxane Skeleton, from<i>Taxus cuspidata</i>Needles","year":2009,"lang":"en","type":"article","venue":"Bioscience Biotechnology and Biochemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Hebei Medical University; Hebei University","keywords":"Taxane; Taxus; Skeleton (computer programming); Botany; Biology; Medicine; Internal medicine; Anatomy; Cancer","score_opus":0.011889250572837134,"score_gpt":0.26492502981578375,"score_spread":0.2530357792429466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016078871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97867817,0.007076061,0.0039151045,0.00021346833,0.000060830233,0.00016659466,0.002431035,0.000076617725,0.0073821214],"genre_scores_gemma":[0.9700467,0.0084653115,0.0064072767,0.00022954792,0.000048780075,0.00007545369,0.004420045,0.000026462398,0.0102804415],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99998164,0.0000013394418,0.0000012628285,0.000005377275,0.0000057571688,0.0000046648192],"domain_scores_gemma":[0.9999709,0.0000017348759,0.0000043175937,0.0000020692582,0.0000053292083,0.000015650574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000025527874,0.00047352895,0.00024334164,0.00038267602,0.00023522596,0.00018013566,0.00014016635,0.00022281201,0.001304575],"category_scores_gemma":[0.000046219287,0.000108891516,0.00014822664,0.0003270585,0.00017487568,0.0002740768,0.00020055371,0.00050223974,0.00033711377],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076890065,0.000017008539,0.0005160014,0.00008901398,0.0000065619674,0.00026633454,0.000032730364,0.00007716783,0.9907933,0.00011024871,0.00010425056,0.007910351],"study_design_scores_gemma":[0.00013251857,0.0019838754,0.04213482,0.00006916435,0.00010851857,0.004587207,0.00023493473,0.0005318004,0.8907362,0.00040738983,0.05900636,0.00006721987],"about_ca_topic_score_codex":0.00128174,"about_ca_topic_score_gemma":0.0032361832,"teacher_disagreement_score":0.001304575,"about_ca_system_score_codex":0.00019897052,"about_ca_system_score_gemma":0.00040640493,"threshold_uncertainty_score":0.0043641925},"labels":[],"label_agreement":null},{"id":"W2016664719","doi":"10.1007/s10637-008-9193-5","title":"Pemetrexed combined with paclitaxel: a dose-finding study evaluating three schedules in solid tumors","year":2008,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Pemetrexed; Medicine; Paclitaxel; Neutropenia; Pharmacokinetics; Febrile neutropenia; Mesothelioma; Pharmacology; Toxicity; Internal medicine; Chemotherapy; Oncology; Cisplatin; Pathology","score_opus":0.11158738678637896,"score_gpt":0.3833905561850204,"score_spread":0.2718031693986414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016664719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978466,0.0009785518,0.00026849154,0.00008644771,0.000040501156,0.00027576237,0.00012366516,0.000019715695,0.00036032128],"genre_scores_gemma":[0.99561715,0.0018790499,0.0007435256,0.00011065106,0.00022598189,0.0002397032,0.00023019078,0.000038369737,0.00091537554],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9983923,0.00082188763,0.00010324704,0.0002659846,0.00015626621,0.00026041846],"domain_scores_gemma":[0.9968041,0.0015271301,0.00040571066,0.00042495978,0.00012026801,0.00071782275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026576386,0.0019162028,0.0045432127,0.0020100954,0.0010024995,0.0012442974,0.0020147027,0.0020870594,0.0026729146],"category_scores_gemma":[0.003043759,0.0010600995,0.0023690194,0.0019113863,0.0024947964,0.002059353,0.00062602834,0.0034257176,0.0005060551],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73880666,0.13210309,0.004746203,0.0006138748,0.0015735229,0.0005094768,0.00059342553,0.0036192115,0.05277064,0.00025925893,0.00047002197,0.06393467],"study_design_scores_gemma":[0.11244448,0.8556972,0.008194427,0.000029670575,0.0012873784,0.00034132763,0.00019370648,0.001515424,0.019085027,0.00013542961,0.0010147302,0.000061155195],"about_ca_topic_score_codex":0.0026201224,"about_ca_topic_score_gemma":0.0026973842,"teacher_disagreement_score":0.0045432127,"about_ca_system_score_codex":0.0013577854,"about_ca_system_score_gemma":0.0016302677,"threshold_uncertainty_score":0.014055073},"labels":[],"label_agreement":null},{"id":"W2017016310","doi":"10.1016/j.ijpharm.2003.11.005","title":"Amphiphilic dextran-graft-poly(ε-caprolactone) films for the controlled release of paclitaxel","year":2003,"lang":"en","type":"article","venue":"International Journal of Pharmaceutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Copolymer; Polymer chemistry; Caprolactone; Polymerization; Gel permeation chromatography; Paclitaxel; Amphiphile; Dimethyl sulfoxide; Crystallization; Chemistry; Ring-opening polymerization; Materials science; Nuclear chemistry; Organic chemistry; Polymer; Surgery","score_opus":0.056982591852700853,"score_gpt":0.4042646356945713,"score_spread":0.34728204384187045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017016310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99070215,0.001891926,0.0055642473,0.00013023848,0.000053046308,0.000026373242,0.00007081308,0.000102166574,0.0014589949],"genre_scores_gemma":[0.9929717,0.0009387356,0.00349455,0.00004417459,0.000014766216,0.000014475337,0.000062036845,0.000024403858,0.002435147],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991846,0.000010144482,0.000007343542,0.000015770163,0.000022950791,0.000025227773],"domain_scores_gemma":[0.9999051,0.000022350569,0.000024657385,0.0000063031193,0.000015120209,0.000026436135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001424885,0.00026230633,0.00013920321,0.00019937371,0.00015753176,0.00030258743,0.00016086348,0.00026886552,0.0006795767],"category_scores_gemma":[0.00016094158,0.00018552711,0.00013597915,0.00012958671,0.00014796256,0.00031865173,0.00014725137,0.00038383662,0.00024038786],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005094433,0.000014927668,0.000020503378,0.000019804218,0.0000017822913,0.000029012288,0.000008722241,0.00008165849,0.99848205,0.00005990374,0.000026754557,0.0012040241],"study_design_scores_gemma":[0.00001125739,0.000072242656,0.00026283713,0.0000021944618,0.0000060688994,0.000038777056,0.0000049902983,0.0006709081,0.998237,0.000008240678,0.0006826377,0.000002799349],"about_ca_topic_score_codex":0.0007032211,"about_ca_topic_score_gemma":0.0013749518,"teacher_disagreement_score":0.0007032211,"about_ca_system_score_codex":0.00034890784,"about_ca_system_score_gemma":0.00018799969,"threshold_uncertainty_score":0.0025315285},"labels":[],"label_agreement":null},{"id":"W2017456980","doi":"10.1016/s0968-0896(00)00056-0","title":"Taxus canadensis abundant taxane: conversion to paclitaxel and rearrangements","year":2000,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Queen's University; Armand Frappier Museum; Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Taxane; Paclitaxel; Chemistry; Taxus; Stereochemistry; Pharmacology; Botany; Chemotherapy; Cancer; Internal medicine; Biology","score_opus":0.010472232468410558,"score_gpt":0.2682901490857428,"score_spread":0.2578179166173322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017456980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701974,0.0011017993,0.0020830827,0.00017195326,0.000040464976,0.000077784425,0.00088244537,0.000149267,0.025295788],"genre_scores_gemma":[0.9877807,0.00037112753,0.0008646866,0.00003266276,0.000004974568,0.000016957776,0.00058650447,0.000034582084,0.010307815],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995255,0.000003960878,0.0000024025865,0.000014035276,0.00001103972,0.000016002488],"domain_scores_gemma":[0.9999256,0.000013709728,0.000012113465,0.000021450805,0.00001080554,0.000016245745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045470922,0.00020509663,0.00012013705,0.000316224,0.0003249373,0.0003046978,0.0001961013,0.00022724262,0.0034299316],"category_scores_gemma":[0.00009490268,0.00011177474,0.0001703077,0.00030762752,0.00016772085,0.0002599556,0.00020646695,0.0005178615,0.0006829597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019347173,0.0000562304,0.00045408081,0.000029973706,0.0000068975623,0.00032514078,0.000039874543,0.0004912912,0.9883796,0.00146054,0.00013339553,0.008429555],"study_design_scores_gemma":[0.000011988916,0.00015846221,0.0028031992,0.000002956663,0.000012718372,0.0003988078,0.000054744585,0.00047737308,0.98668635,0.0004595589,0.008926796,0.000007076511],"about_ca_topic_score_codex":0.0027462086,"about_ca_topic_score_gemma":0.0036160338,"teacher_disagreement_score":0.0034299316,"about_ca_system_score_codex":0.0004884839,"about_ca_system_score_gemma":0.00036011357,"threshold_uncertainty_score":0.011474252},"labels":[],"label_agreement":null},{"id":"W2018891796","doi":"10.1158/1535-7163.targ-09-c161","title":"Abstract C161: Modulation of thymidine phosphorylase (TP) expression in breast cancer cell lines exposed to the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839","year":2009,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Thymidine phosphorylase; SKBR3; Pharmacology; Cytidine deaminase; Cell growth; Cancer research; Capecitabine; Epidermal growth factor receptor; Cancer; Growth inhibition; Chemistry; Biology; Cancer cell; Internal medicine; Biochemistry; Medicine; Colorectal cancer; Enzyme","score_opus":0.025792739691510157,"score_gpt":0.3074214845298739,"score_spread":0.28162874483836375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018891796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99618393,0.00070883014,0.0006368821,0.000063267864,0.00003336556,0.0000407492,0.0012254864,0.000033051896,0.0010743138],"genre_scores_gemma":[0.9918262,0.0006842346,0.0012264118,0.000051364994,0.000010620863,0.00010088169,0.0026487124,0.0000141270975,0.0034374746],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998234,0.000023647133,0.000024570703,0.000034613582,0.00005267201,0.00004111347],"domain_scores_gemma":[0.9998871,0.000020523812,0.00002267385,0.000014450224,0.00003073963,0.000024549407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011843678,0.00027827334,0.00036358056,0.00028378106,0.00022192957,0.00028070272,0.00018929207,0.00026438857,0.0018593372],"category_scores_gemma":[0.000110063644,0.00012123758,0.00028522222,0.00048495078,0.0001489099,0.00013889586,0.00013572213,0.00042968008,0.0005207592],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020962996,0.00006954368,0.00042717878,0.000021787748,0.000004770166,0.00003764578,0.0000286897,0.00004106483,0.9985273,0.000023482782,0.00006164579,0.0005471868],"study_design_scores_gemma":[0.000025969775,0.0009158421,0.01674227,0.0000044121994,0.000019518973,0.00019109533,0.000115735194,0.0007281609,0.97950715,0.000015759473,0.001728513,0.000005595726],"about_ca_topic_score_codex":0.0028828103,"about_ca_topic_score_gemma":0.002424009,"teacher_disagreement_score":0.0028828103,"about_ca_system_score_codex":0.00031583745,"about_ca_system_score_gemma":0.00019372712,"threshold_uncertainty_score":0.0062201023},"labels":[],"label_agreement":null},{"id":"W2019289880","doi":"10.1016/s0040-4039(01)01286-2","title":"Synthesis of the racemic tetracyclic core of CP-225,917—a model compound lacking the sidearms of the natural product","year":2001,"lang":"en","type":"article","venue":"Tetrahedron Letters","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chemistry; Ketone; Olefin fiber; Stereochemistry; Sequence (biology); Natural product; Core (optical fiber); Organic chemistry; Catalysis; Biochemistry","score_opus":0.028857703688027325,"score_gpt":0.29662988088482106,"score_spread":0.26777217719679375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019289880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8935833,0.002410031,0.0535182,0.00050182245,0.0004250754,0.0007812247,0.003874682,0.0007578934,0.044147786],"genre_scores_gemma":[0.97350717,0.0013749771,0.016074844,0.00013836153,0.000029020162,0.00014634126,0.0014333398,0.000067274974,0.00722871],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999236,0.000011850496,0.000006597959,0.000018035158,0.000014279099,0.00002569745],"domain_scores_gemma":[0.99993014,0.0000052679716,0.000014492484,0.00001371404,0.000011017817,0.000025352738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018429258,0.00029120038,0.0003349606,0.00024235295,0.00029237266,0.00022717567,0.00059859577,0.00027218836,0.0042309826],"category_scores_gemma":[0.00015374862,0.000155919,0.0002512038,0.00022184134,0.00018556727,0.0003485182,0.00023004477,0.0004698676,0.0014162139],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001130843,0.0003463392,0.00022308069,0.00031958247,0.00005570325,0.0006034114,0.00012877889,0.003383158,0.94252264,0.012949777,0.002511625,0.035825092],"study_design_scores_gemma":[0.00029000558,0.0044218143,0.0008003593,0.000024163315,0.00006644073,0.0005318171,0.000047459504,0.004691972,0.95714456,0.0019232178,0.030005652,0.000052534437],"about_ca_topic_score_codex":0.0008370971,"about_ca_topic_score_gemma":0.0011404228,"teacher_disagreement_score":0.0042309826,"about_ca_system_score_codex":0.00038698167,"about_ca_system_score_gemma":0.00091897557,"threshold_uncertainty_score":0.014154017},"labels":[],"label_agreement":null},{"id":"W2019519157","doi":"10.1021/np000053u","title":"New Taxanes from the Needles of <i>Taxus canadensis</i>","year":2000,"lang":"en","type":"article","venue":"Journal of Natural Products","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut National de la Recherche Scientifique; McGill University; Queen's University; Université du Québec à Montréal","funders":"","keywords":"Taxus; Diterpene; Botany; Taxane; Biology; Stereochemistry; Chemistry","score_opus":0.01363695692924387,"score_gpt":0.27137455134761956,"score_spread":0.2577375944183757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019519157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9604671,0.013327205,0.002358589,0.0002442361,0.0001099422,0.0002497363,0.009642878,0.00015111073,0.013449369],"genre_scores_gemma":[0.9464162,0.009756934,0.0064246305,0.0003106249,0.00006104172,0.000088566594,0.017128639,0.000059441125,0.01975391],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999491,0.0000015449169,0.0000026688529,0.000011947493,0.000020613279,0.0000141782875],"domain_scores_gemma":[0.9998791,0.000008396854,0.000020646423,0.0000073891197,0.000041643685,0.000042872234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003679655,0.0005951608,0.00032041798,0.0011485574,0.00076010363,0.00048606077,0.0001880282,0.00032902628,0.0020145166],"category_scores_gemma":[0.00009874144,0.0001655866,0.00023509726,0.00086649024,0.00032898327,0.00036596382,0.0002481889,0.00075657916,0.0004963663],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031511212,0.000024076173,0.003323566,0.00019002958,0.00002702041,0.0004998078,0.00020621948,0.00008475371,0.98120743,0.0001138394,0.00017653496,0.013831673],"study_design_scores_gemma":[0.00013060922,0.0011356615,0.40081927,0.00013325246,0.00037865946,0.0040397733,0.0016533133,0.00044408048,0.44451717,0.00070106133,0.14591026,0.00013681517],"about_ca_topic_score_codex":0.058442518,"about_ca_topic_score_gemma":0.15907985,"teacher_disagreement_score":0.058442518,"about_ca_system_score_codex":0.00090203446,"about_ca_system_score_gemma":0.0013989786,"threshold_uncertainty_score":0.11620474},"labels":[],"label_agreement":null},{"id":"W2019621848","doi":"10.1016/j.clinthera.2014.10.023","title":"Comparative Effectiveness Analysis of Monotherapy With Cytotoxic Agents in Triple-negative Metastatic Breast Cancer in a Community Setting","year":2014,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"Eisai","keywords":"Medicine; Vinorelbine; Eribulin; Internal medicine; Oncology; Gemcitabine; Capecitabine; Metastatic breast cancer; Breast cancer; Cancer; Chemotherapy; Colorectal cancer","score_opus":0.17232625910111957,"score_gpt":0.5039678140005637,"score_spread":0.33164155489944414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019621848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990395,0.0070838635,0.00015305006,0.00017210917,0.00006489744,0.00032119718,0.00035983798,0.000009497471,0.0014404492],"genre_scores_gemma":[0.9977648,0.0013706991,0.00023175326,0.00007082191,0.00008159485,0.00010201137,0.00020998133,0.0000028901218,0.00016550184],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99472225,0.004018565,0.00029090128,0.0002914314,0.0003683678,0.0003086015],"domain_scores_gemma":[0.9915399,0.004488689,0.001664196,0.0003220945,0.0006078576,0.0013772212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033559562,0.00058173423,0.0019852237,0.0010214268,0.0003347962,0.00077491935,0.0007054291,0.0010545976,0.0039053962],"category_scores_gemma":[0.009658382,0.00025795624,0.0019381599,0.0011307029,0.0006435473,0.0010839568,0.00050047727,0.001045474,0.00018191489],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90898174,0.008927973,0.011128863,0.0016495729,0.004744648,0.00012421972,0.00014760222,0.0014205696,0.001807057,0.00033337812,0.00046941676,0.06026489],"study_design_scores_gemma":[0.16742826,0.7259093,0.08676927,0.00032845736,0.011333757,0.0003381385,0.00070934783,0.0031396844,0.0017101617,0.0005081801,0.0017370491,0.000088282955],"about_ca_topic_score_codex":0.0031414572,"about_ca_topic_score_gemma":0.0059498283,"teacher_disagreement_score":0.0039053962,"about_ca_system_score_codex":0.0019874857,"about_ca_system_score_gemma":0.0016787323,"threshold_uncertainty_score":0.017748177},"labels":[],"label_agreement":null},{"id":"W2020833122","doi":"10.1016/j.pain.2010.10.015","title":"Allopregnanolone prevents and suppresses oxaliplatin-evoked painful neuropathy: Multi-parametric assessment and direct evidence","year":2010,"lang":"en","type":"article","venue":"Pain","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nortel (Canada)","funders":"","keywords":"Medicine; Pharmacology; Allodynia; Neurochemical; Hyperalgesia; Nociception; Endocrinology; Internal medicine; Receptor","score_opus":0.04169945097443233,"score_gpt":0.3664275901289942,"score_spread":0.32472813915456183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020833122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818432,0.005115429,0.01029507,0.00013481003,0.000053371696,0.00009739533,0.0005403748,0.00015450241,0.001765861],"genre_scores_gemma":[0.9888037,0.0026016112,0.0058174874,0.00006783638,0.000025193754,0.00017394006,0.00033581938,0.000021161339,0.002153226],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997993,0.00003435329,0.000018025145,0.00004735385,0.00006080268,0.000040202107],"domain_scores_gemma":[0.99986494,0.0000108753175,0.000053524313,0.000012277703,0.000027385975,0.000030924366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024435486,0.0003764695,0.0003801278,0.00039023298,0.000119047865,0.00015926095,0.00019725572,0.0002686206,0.0008869455],"category_scores_gemma":[0.00014114515,0.00012594517,0.0003194858,0.0003335782,0.0002345599,0.00021621953,0.00021314711,0.00065467757,0.00010522087],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00129688,0.00025432222,0.0011884791,0.00014423698,0.000035677876,0.00011680288,0.00006054559,0.00018658409,0.98540616,0.000059772905,0.000055338503,0.011195137],"study_design_scores_gemma":[0.000102433005,0.0057516545,0.037664283,0.000022727003,0.00018032912,0.0006243046,0.00016823053,0.002277349,0.9509352,0.0001842244,0.0020663997,0.000022896167],"about_ca_topic_score_codex":0.00040066513,"about_ca_topic_score_gemma":0.0006649231,"teacher_disagreement_score":0.0008869455,"about_ca_system_score_codex":0.00014216645,"about_ca_system_score_gemma":0.00019439397,"threshold_uncertainty_score":0.0029671192},"labels":[],"label_agreement":null},{"id":"W2021067098","doi":"10.1016/s0031-9422(01)00305-3","title":"Taxines from the needles of Taxus wallichiana","year":2001,"lang":"en","type":"article","venue":"Phytochemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute; National Research Council Canada","funders":"","keywords":"Stereochemistry; Cancer cell lines; Chemistry; Traditional medicine; Taxus; Botany; Biology; Cancer; Cancer cell; Medicine","score_opus":0.02120331456052698,"score_gpt":0.29733164723402344,"score_spread":0.27612833267349646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021067098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841531,0.0050073154,0.002484307,0.00021359127,0.000057200632,0.00005006277,0.0021280341,0.00006434437,0.005841984],"genre_scores_gemma":[0.9702481,0.003901815,0.002298061,0.00014922782,0.00004945131,0.0000195488,0.0061002388,0.000051846135,0.017181695],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999783,0.000002002799,0.0000012839935,0.000005204198,0.0000066395764,0.0000065577005],"domain_scores_gemma":[0.9998878,0.000026832575,0.000017734252,0.0000109873945,0.000025568856,0.000030974363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035376554,0.00038465,0.0003367028,0.00057844614,0.00039035504,0.00032435576,0.00020556495,0.00033959985,0.001664306],"category_scores_gemma":[0.00013048381,0.00016606634,0.00021570001,0.0004131058,0.00021700248,0.00033432353,0.00021103595,0.0009402081,0.00079216383],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002609696,0.000025978454,0.0005957246,0.00009181781,0.000014626195,0.0003413906,0.000059919774,0.00012943067,0.9933709,0.00013005911,0.00006685643,0.0049123056],"study_design_scores_gemma":[0.00008132858,0.00085836183,0.04060862,0.000081049606,0.00021435504,0.002370776,0.0005360783,0.0008794735,0.9298005,0.0010888063,0.023431195,0.000049462626],"about_ca_topic_score_codex":0.0037947332,"about_ca_topic_score_gemma":0.0043887636,"teacher_disagreement_score":0.0037947332,"about_ca_system_score_codex":0.0001859456,"about_ca_system_score_gemma":0.00039543398,"threshold_uncertainty_score":0.0075452924},"labels":[],"label_agreement":null},{"id":"W2021094196","doi":"10.1078/0944-7113-00010","title":"The influence of ultraviolet radiation on the content of pharmacologically active taxoids in yew tissues","year":2001,"lang":"en","type":"article","venue":"Phytomedicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trent University","funders":"","keywords":"Taxus; Chemistry; Paclitaxel; Chromatography; Wax; High-performance liquid chromatography; Organic chemistry; Botany; Biology","score_opus":0.048724377100539625,"score_gpt":0.35516847161971365,"score_spread":0.30644409451917404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021094196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99749905,0.0010421263,0.00032595932,0.00004482884,0.000010399599,0.0000052942996,0.00019920935,0.0000121208295,0.0008611764],"genre_scores_gemma":[0.9958146,0.00050888344,0.0003134947,0.000039879462,0.0000072939147,0.000012898864,0.00041216376,0.000014495668,0.0028764012],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999312,0.000016348507,0.00000511019,0.000016468624,0.000008050467,0.000022677077],"domain_scores_gemma":[0.9997893,0.0000914352,0.00003039528,0.00002071134,0.000027612366,0.000040540086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010000028,0.00021122354,0.00020604394,0.00027977693,0.00024336345,0.00032446525,0.00012407666,0.00024365043,0.001966845],"category_scores_gemma":[0.00019037937,0.00014807069,0.00022604782,0.00026515697,0.0003434308,0.00029374563,0.0001394353,0.00061292894,0.00029707886],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001392133,0.000025437303,0.0010490287,0.000036410474,0.000012540068,0.000056712925,0.000065731016,0.000028529836,0.9957039,0.00006754451,0.000027432638,0.0015345595],"study_design_scores_gemma":[0.000030071491,0.00072240434,0.056203183,0.000011076407,0.000060052967,0.00022317366,0.00029885274,0.0003676246,0.94046277,0.00011806668,0.0014889393,0.000013740881],"about_ca_topic_score_codex":0.0017591915,"about_ca_topic_score_gemma":0.001709631,"teacher_disagreement_score":0.001966845,"about_ca_system_score_codex":0.00028217095,"about_ca_system_score_gemma":0.00020707952,"threshold_uncertainty_score":0.006579697},"labels":[],"label_agreement":null},{"id":"W2021166818","doi":"10.1016/j.cct.2015.01.012","title":"Rationale and design of a randomized double-blind clinical trial in breast cancer: Dextromethorphan in chemotherapy-induced peripheral neuropathy","year":2015,"lang":"en","type":"article","venue":"Contemporary Clinical Trials","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dextromethorphan; Peripheral neuropathy; Neuropathic pain; Breast cancer; Chemotherapy-induced peripheral neuropathy; Randomized controlled trial; Clinical trial; Anesthesia; McGill Pain Questionnaire; Chemotherapy; Internal medicine; Oncology; Cancer; Visual analogue scale; Diabetes mellitus","score_opus":0.6354221504394105,"score_gpt":0.5579869869232856,"score_spread":0.0774351635161249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021166818","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019968249,0.0047269445,0.023757173,0.0028869025,0.0037431428,0.9394806,0.001449201,0.0003670787,0.0036206592],"genre_scores_gemma":[0.06672184,0.001215456,0.04915325,0.003855976,0.0010532747,0.8761314,0.0003557453,0.00004082128,0.0014722153],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.92363495,0.05668739,0.005958569,0.0059179068,0.0050122347,0.002788899],"domain_scores_gemma":[0.9635898,0.019742964,0.005437111,0.0039372314,0.003707975,0.0035849204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10365529,0.007229056,0.008916093,0.0022510674,0.003361131,0.0041970513,0.003143344,0.008908684,0.015856005],"category_scores_gemma":[0.07860204,0.004111706,0.004680376,0.0018029828,0.010636969,0.0028278208,0.00179371,0.008073531,0.0046999757],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8627665,0.011919109,0.0035149592,0.01978219,0.0045354054,0.0003936342,0.00079193676,0.004099115,0.007188993,0.022183748,0.00906302,0.05376136],"study_design_scores_gemma":[0.88777125,0.053308524,0.0034126353,0.0025520208,0.00323712,0.00022196575,0.00012871211,0.0056146462,0.002439341,0.012342366,0.028752416,0.00021899995],"about_ca_topic_score_codex":0.00066383334,"about_ca_topic_score_gemma":0.0012084127,"teacher_disagreement_score":0.10365529,"about_ca_system_score_codex":0.0027526387,"about_ca_system_score_gemma":0.010205909,"threshold_uncertainty_score":0.54818815},"labels":[],"label_agreement":null},{"id":"W2021291110","doi":"10.1158/1538-7445.am2014-5008","title":"Abstract 5008: The acetylenic tricyclic bis(cyanoeneone), TBE-31 inhibits non-small cell lung cancer cell migration through direct binding with actin","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cell migration; Chemistry; Cell; Actin; Stress fiber; Cancer research; Cancer cell; Cell biology; Cancer; Biochemistry; Biology; Medicine; Internal medicine; Cytoskeleton","score_opus":0.06326090767832017,"score_gpt":0.4001251519401802,"score_spread":0.33686424426186007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021291110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9307785,0.032066982,0.0027485038,0.0007932195,0.00043041175,0.00018747931,0.0020899428,0.0003271731,0.030577736],"genre_scores_gemma":[0.9590633,0.011483191,0.002067551,0.0003235369,0.000059886504,0.00008620614,0.0021196913,0.000027471015,0.024769204],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994385,0.000008168104,0.000004463565,0.000008380405,0.000018606012,0.000016562912],"domain_scores_gemma":[0.99996805,0.0000049605655,0.000006539023,0.000003647687,0.0000061248443,0.000010756358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000067592766,0.00031667957,0.00017664068,0.00023479486,0.000121319914,0.00013958829,0.00022372481,0.00023511497,0.004768191],"category_scores_gemma":[0.000078790006,0.00010851958,0.00012341246,0.0001979451,0.0001231987,0.00010795563,0.00012251198,0.0003571543,0.0010051817],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004075052,0.00010520176,0.00036271234,0.00017522018,0.00001720045,0.00011754901,0.000011697816,0.0001481264,0.9768792,0.00017150877,0.001744665,0.0198594],"study_design_scores_gemma":[0.00014226716,0.0020339116,0.010009621,0.000031252246,0.000045014393,0.0006398052,0.000026833579,0.0006237522,0.9638222,0.000057842306,0.022557924,0.000009575904],"about_ca_topic_score_codex":0.0010685262,"about_ca_topic_score_gemma":0.0023883418,"teacher_disagreement_score":0.004768191,"about_ca_system_score_codex":0.00017825107,"about_ca_system_score_gemma":0.00028136987,"threshold_uncertainty_score":0.015951216},"labels":[],"label_agreement":null},{"id":"W2024177131","doi":"10.1016/j.jpainsymman.2006.11.008","title":"An Open-Label, Multi-Dose Efficacy and Safety Study of Intramuscular Tetrodotoxin in Patients with Severe Cancer-Related Pain","year":2007,"lang":"en","type":"article","venue":"Journal of Pain and Symptom Management","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Western University; Baker Hughes (Canada); Royal University Hospital; Inimex Pharmaceuticals (Canada); Université de Montréal","funders":"University of Alberta; Université de Sherbrooke","keywords":"Medicine; Anesthesia; Analgesic; Cancer pain; Adverse effect; Nausea; Neuropathic pain; Cancer; Internal medicine","score_opus":0.01644011070241777,"score_gpt":0.3279065961283155,"score_spread":0.3114664854258977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024177131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99796057,0.00039692962,0.00043641732,0.00008405007,0.00004734738,0.0005270819,0.00013373813,0.000023577788,0.00039017177],"genre_scores_gemma":[0.9968117,0.0004913558,0.0008478313,0.00023419967,0.00018400048,0.00051345455,0.0002640926,0.000011788013,0.0006416857],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.998993,0.00049321755,0.00007630496,0.00015855918,0.000108284214,0.00017069046],"domain_scores_gemma":[0.9983877,0.00046455287,0.00033166443,0.00023854947,0.000099566336,0.0004778637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016850685,0.0012554796,0.0036404638,0.0004510031,0.0006122814,0.00068873377,0.00086350087,0.0012217113,0.0028592804],"category_scores_gemma":[0.0016334311,0.0006816039,0.001197837,0.00054493424,0.0017831528,0.0015646018,0.00040887212,0.00279548,0.0005521286],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82901937,0.07729426,0.0049826945,0.00040052008,0.00088596815,0.00016988175,0.00026967665,0.0009464023,0.043809123,0.00013393242,0.0004877756,0.04160041],"study_design_scores_gemma":[0.2046598,0.78202844,0.010077783,0.000012637665,0.00026902548,0.00011487587,0.00006136478,0.0006903321,0.0016921485,0.000044143744,0.00032424374,0.000025097977],"about_ca_topic_score_codex":0.0008593615,"about_ca_topic_score_gemma":0.0017614831,"teacher_disagreement_score":0.0036404638,"about_ca_system_score_codex":0.0006684934,"about_ca_system_score_gemma":0.0011454533,"threshold_uncertainty_score":0.009565294},"labels":[],"label_agreement":null},{"id":"W2024302667","doi":"10.1007/s10549-007-9610-z","title":"Gemcitabine in the management of metastatic breast cancer: a systematic review","year":2007,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; McMaster University; Ottawa Hospital","funders":"","keywords":"Gemcitabine; Docetaxel; Medicine; Oncology; Taxane; Metastatic breast cancer; Internal medicine; Breast cancer; Capecitabine; Clinical trial; Randomized controlled trial; Chemotherapy; Anthracycline; Cancer; Colorectal cancer","score_opus":0.20374862271191702,"score_gpt":0.5221446010040509,"score_spread":0.3183959782921339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024302667","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037455477,0.9992816,0.00004113232,0.0000724756,0.000039270748,0.000028018416,0.000046904435,0.0000020957013,0.00011399991],"genre_scores_gemma":[0.004179699,0.9953242,0.00019122372,0.00016361363,0.000033826946,0.000024560437,0.00003214335,8.962346e-7,0.000049884256],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99899036,0.0003837977,0.00030649317,0.00010268536,0.00018144281,0.000035158737],"domain_scores_gemma":[0.9968984,0.0022110732,0.0006160352,0.00003439115,0.00017608544,0.00006390318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018154286,0.0008582919,0.0052205296,0.0025258965,0.00028343013,0.0009067579,0.0010600766,0.001002926,0.0026977654],"category_scores_gemma":[0.0062767123,0.00043732006,0.003053771,0.0038713375,0.0003921081,0.000857951,0.000634302,0.000761545,0.000202478],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009661006,0.00005681879,0.0007709112,0.76271623,0.0119659845,0.00023563855,0.000102905564,0.00040451952,0.00040436778,0.0002602112,0.004774492,0.21734184],"study_design_scores_gemma":[0.0023310008,0.0017304315,0.012635395,0.6399622,0.21732509,0.0021182944,0.00042501919,0.00045555524,0.00087829295,0.0010169907,0.121005796,0.00011585984],"about_ca_topic_score_codex":0.0044202455,"about_ca_topic_score_gemma":0.017602764,"teacher_disagreement_score":0.0052205296,"about_ca_system_score_codex":0.0010098111,"about_ca_system_score_gemma":0.0023493827,"threshold_uncertainty_score":0.009600997},"labels":[],"label_agreement":null},{"id":"W2024641982","doi":"10.1515/hc-2012-0035","title":"Canataxpyran A, a novel 3,8-secotaxane with a 13,17-ether bridge from needles of <i>Taxus canadensis</i>","year":2012,"lang":"en","type":"article","venue":"Heterocyclic Communications","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Japan Society for the Promotion of Science; Hebei Medical University; National Natural Science Foundation of China","keywords":"Chemistry; Bicyclic molecule; Taxane; Ether; Bridge (graph theory); Stereochemistry; Epoxy; Organic chemistry","score_opus":0.06911849081064683,"score_gpt":0.33212529342922176,"score_spread":0.2630068026185749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024641982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790895,0.0064643044,0.002196845,0.00013747314,0.000068426845,0.00013756401,0.0013539351,0.000045738823,0.01050621],"genre_scores_gemma":[0.98282087,0.004343467,0.004173066,0.00014279813,0.000022424705,0.00005292589,0.0014157748,0.000011432084,0.007017298],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99998,0.0000022843033,0.0000014562653,0.000005465666,0.0000061506666,0.000004630708],"domain_scores_gemma":[0.9999752,0.0000018704008,0.000004364484,0.0000022314448,0.000004368523,0.000011817464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000034876568,0.00028961472,0.00012632934,0.0002900491,0.00017959354,0.0001278457,0.00012096782,0.00013720842,0.0012994331],"category_scores_gemma":[0.000035092326,0.000074037045,0.0001310193,0.0002121253,0.00014421999,0.00019642222,0.00016383982,0.00030223542,0.00027524054],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011677851,0.000039550046,0.00042428277,0.0001716939,0.0000146312295,0.00017547073,0.000024101848,0.0002086813,0.990258,0.0002654714,0.00012811221,0.008173212],"study_design_scores_gemma":[0.00011987711,0.0017765475,0.016053881,0.00005476746,0.00009856704,0.0011094859,0.00010109868,0.0008447985,0.93168825,0.0004184809,0.047702976,0.000031270174],"about_ca_topic_score_codex":0.0012700114,"about_ca_topic_score_gemma":0.0030551055,"teacher_disagreement_score":0.0012994331,"about_ca_system_score_codex":0.00017531644,"about_ca_system_score_gemma":0.00028044937,"threshold_uncertainty_score":0.004347086},"labels":[],"label_agreement":null},{"id":"W2025363005","doi":"10.1016/j.ejca.2008.10.031","title":"Lessons learned from independent central review","year":2008,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Ixabepilone; Human services; Food and drug administration; Clinical trial; Lapatinib; Family medicine; Pharmacology; Cancer; Internal medicine; Breast cancer; Political science","score_opus":0.13320688196963348,"score_gpt":0.39239754501226215,"score_spread":0.25919066304262867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025363005","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009079224,0.72732615,0.0018637372,0.18476374,0.07177937,0.00004711095,0.00016012615,0.0001120014,0.013039952],"genre_scores_gemma":[0.027961666,0.5834053,0.0033160085,0.2607694,0.108069554,0.00024648488,0.00028610192,0.00025612512,0.015689332],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9918727,0.0032731453,0.0012313466,0.0012452482,0.0016163626,0.00076120143],"domain_scores_gemma":[0.9209728,0.041232437,0.0042723916,0.004994794,0.023567222,0.004960369],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.031294264,0.00086547085,0.002260388,0.0030613495,0.0015678499,0.008368459,0.00244917,0.008574939,0.010083583],"category_scores_gemma":[0.059311334,0.00061307236,0.0011908165,0.0027311333,0.00398773,0.009433616,0.0047983928,0.011331834,0.004963724],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005059406,0.000086528256,0.0005286671,0.006735805,0.0004072345,0.00054219284,0.00050504087,0.00024701777,0.00034367116,0.036196955,0.64378256,0.31011826],"study_design_scores_gemma":[0.00017452266,0.00011230481,0.00053431344,0.006130501,0.00026832067,0.0006380435,0.00030242134,0.00007927354,0.00033441995,0.020505458,0.9708854,0.00003491602],"about_ca_topic_score_codex":0.00225767,"about_ca_topic_score_gemma":0.0031517926,"teacher_disagreement_score":0.9687057,"about_ca_system_score_codex":0.004663885,"about_ca_system_score_gemma":0.011817941,"threshold_uncertainty_score":0.1655019},"labels":[],"label_agreement":null},{"id":"W2025386509","doi":"10.3816/ccc.2006.n.024","title":"Capecitabine-Induced Cerebellar Toxicity","year":2006,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Capecitabine; Medicine; Toxicity; Neurotoxicity; Cerebellar ataxia; Prodrug; Ataxia; Fluorouracil; Colorectal cancer; Internal medicine; Oncology; Chemotherapy; Pharmacology; Cancer","score_opus":0.05591288314114927,"score_gpt":0.4110532359609091,"score_spread":0.3551403528197598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025386509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728361,0.0067016846,0.0016717787,0.0005291096,0.00009663502,0.00021546392,0.00038699727,0.00012806749,0.017434279],"genre_scores_gemma":[0.9965893,0.001163727,0.00017890203,0.000115525574,0.000015647574,0.000019940337,0.00014286661,0.000007764326,0.0017663515],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.99990344,0.000036120142,0.0000080274285,0.000014642942,0.000016241358,0.000021642021],"domain_scores_gemma":[0.99982435,0.000042768374,0.000056903322,0.000023685612,0.000020816184,0.000031495867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018681532,0.00036649485,0.0003691989,0.00023132552,0.00028073858,0.00019216392,0.00021182172,0.00032138536,0.0024389788],"category_scores_gemma":[0.0005160696,0.00010222867,0.00027732304,0.0002563073,0.00026370957,0.00014418394,0.0001595963,0.00062389206,0.00027042578],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02630517,0.0029797074,0.03557496,0.002315015,0.000793171,0.105071165,0.0004500943,0.0032823894,0.4121266,0.0050196922,0.014916543,0.39116547],"study_design_scores_gemma":[0.008556208,0.07051768,0.32280257,0.00035807645,0.0013077499,0.23492365,0.0003092263,0.006547859,0.268902,0.0022028089,0.08347423,0.00009796691],"about_ca_topic_score_codex":0.0045554414,"about_ca_topic_score_gemma":0.008457535,"teacher_disagreement_score":0.0045554414,"about_ca_system_score_codex":0.0010612195,"about_ca_system_score_gemma":0.0005902028,"threshold_uncertainty_score":0.00905782},"labels":[],"label_agreement":null},{"id":"W2025705843","doi":"10.1016/j.ejon.2004.06.010","title":"Implications of capecitabine (Xeloda®) for cancer nursing practice","year":2004,"lang":"en","type":"review","venue":"European Journal of Oncology Nursing","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Capecitabine; Medicine; Docetaxel; Oncology; Colorectal cancer; Internal medicine; Oncology nursing; Quality of life (healthcare); Chemotherapy; Metastatic breast cancer; Patient education; Breast cancer; Intensive care medicine; Cancer; Nursing; Nurse education","score_opus":0.1255189562843257,"score_gpt":0.5110774936286501,"score_spread":0.3855585373443244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025705843","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00049384404,0.9916788,0.00011098226,0.0040631583,0.00045492506,0.0000064372066,0.0000055463565,0.0000036579659,0.0031826866],"genre_scores_gemma":[0.0059910966,0.9901861,0.00057474937,0.0018146961,0.00025421727,0.000019534953,0.000008516693,0.0000010015646,0.0011501687],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99927264,0.00036863462,0.00007152438,0.000056141947,0.00018963618,0.000041496714],"domain_scores_gemma":[0.9977361,0.0015732241,0.00024858653,0.00002388759,0.00031536628,0.0001029214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001973469,0.0005590466,0.0009358556,0.0009800484,0.0005304888,0.001410139,0.0006862244,0.0018012542,0.004351913],"category_scores_gemma":[0.0039555444,0.00018039056,0.00048416975,0.0014580202,0.0006091101,0.0012589367,0.0006749018,0.0014764597,0.000668746],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009492719,0.00010130729,0.0006648661,0.012479813,0.00005463055,0.0005096752,0.000326492,0.00022377557,0.00038666796,0.0036622814,0.021064797,0.9604307],"study_design_scores_gemma":[0.00014695378,0.0003884791,0.009215765,0.04289388,0.00034603325,0.004067968,0.0017181751,0.00026461497,0.00046012207,0.0057432028,0.93470925,0.000045579287],"about_ca_topic_score_codex":0.005629472,"about_ca_topic_score_gemma":0.022086093,"teacher_disagreement_score":0.005629472,"about_ca_system_score_codex":0.0022737614,"about_ca_system_score_gemma":0.004178032,"threshold_uncertainty_score":0.016497433},"labels":[],"label_agreement":null},{"id":"W2025753970","doi":"10.1177/0960327108090751","title":"N,N-diethyl-2-[4-(phenylmethyl) phenoxy] ethanamine (DPPE; tesmilifene), a chemopotentiating agent with hormetic effects on DNA synthesis in vitro, may improve survival in patients with metastatic breast cancer","year":2008,"lang":"en","type":"article","venue":"Human & Experimental Toxicology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"In vitro; Metastatic breast cancer; Breast cancer; Cancer; Medicine; Internal medicine; Chemistry; DNA; Cancer research; Oncology; Pharmacology; Endocrinology; Biochemistry","score_opus":0.020750888097219762,"score_gpt":0.30167696805283145,"score_spread":0.2809260799556117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025753970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99143785,0.00556508,0.0004507145,0.00035682943,0.000058233552,0.00014407914,0.00015516675,0.00004463759,0.0017874375],"genre_scores_gemma":[0.9947903,0.0026416732,0.00064127584,0.00029569506,0.0000617373,0.0000862812,0.00035313942,0.00000580332,0.0011240705],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999491,0.000021607559,0.0000036420358,0.000007817683,0.00000664305,0.000011057964],"domain_scores_gemma":[0.9999025,0.000027487533,0.000026306296,0.0000048912016,0.0000046389814,0.000034088975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019084173,0.0002804304,0.0003614975,0.00011375624,0.00009744834,0.0001376524,0.00013044948,0.00025096105,0.0016264321],"category_scores_gemma":[0.00021327153,0.00008205388,0.00019673564,0.0000912001,0.00014482578,0.00013323351,0.00010116109,0.0005622344,0.00024224649],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13529032,0.013696249,0.013251357,0.0007527865,0.00038894836,0.00054625084,0.00007452445,0.00094386825,0.4109137,0.00035540538,0.0034901001,0.42029655],"study_design_scores_gemma":[0.086967655,0.58813417,0.1497058,0.00012875955,0.0005869308,0.0036914514,0.0001870691,0.0032051157,0.14038941,0.00042673256,0.026522886,0.00005403557],"about_ca_topic_score_codex":0.00031076156,"about_ca_topic_score_gemma":0.0011814332,"teacher_disagreement_score":0.0016264321,"about_ca_system_score_codex":0.00014861597,"about_ca_system_score_gemma":0.00019250813,"threshold_uncertainty_score":0.0054409504},"labels":[],"label_agreement":null},{"id":"W2025968906","doi":"10.1016/j.expneurol.2011.08.016","title":"Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy","year":2011,"lang":"en","type":"article","venue":"Experimental Neurology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":270,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Neurological Disorders and Stroke; Canada Research Chairs; Health Canada; National Institutes of Health; Louise and Alan Edwards Foundation; Canadian Institutes of Health Research; National Institute for Health and Care Research","keywords":"Peripheral neuropathy; Medicine; Oxaliplatin; Mitochondrion; Sciatic nerve; Chemotherapy; Anesthesia; Neuropathic pain; Peripheral; Paclitaxel; Internal medicine; Cancer; Endocrinology; Biology; Colorectal cancer","score_opus":0.02971140935037471,"score_gpt":0.27147217010471275,"score_spread":0.24176076075433806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025968906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99827147,0.00026915694,0.00063873973,0.00008595392,0.000035023775,0.000021958995,0.00018639173,0.000041102026,0.00045016495],"genre_scores_gemma":[0.99696976,0.00034706548,0.00042092765,0.000029789526,0.0000075558646,0.00004675154,0.00019648382,0.000010207312,0.0019714346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988496,0.00001007638,0.000009710972,0.000027464675,0.000019588326,0.000048247948],"domain_scores_gemma":[0.9997737,0.00001996344,0.00007854297,0.000022112332,0.00003519201,0.00007057925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015392023,0.000641274,0.00048047258,0.00057201425,0.0004042103,0.00023612636,0.00040138938,0.0005832954,0.0029301639],"category_scores_gemma":[0.00021550021,0.0003706153,0.00030414667,0.00031903747,0.0007591144,0.0007890471,0.00027115952,0.0010531865,0.00028204857],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0121502355,0.0005688749,0.0014493325,0.00018456375,0.0000614243,0.00069706386,0.00020471412,0.000275628,0.9792027,0.00039086418,0.00017949931,0.004635087],"study_design_scores_gemma":[0.00037716888,0.0040642684,0.022382693,0.000023432474,0.00020835204,0.000853501,0.00047333434,0.0019389373,0.9683027,0.0004247719,0.0009249362,0.00002600138],"about_ca_topic_score_codex":0.0025977693,"about_ca_topic_score_gemma":0.0025090291,"teacher_disagreement_score":0.0029301639,"about_ca_system_score_codex":0.0005331018,"about_ca_system_score_gemma":0.0005325921,"threshold_uncertainty_score":0.009802401},"labels":[],"label_agreement":null},{"id":"W2026136485","doi":"10.1002/cncr.26579","title":"The use of bevacizumab among women with metastatic breast cancer: A survey on clinical practice and the ongoing controversy","year":2011,"lang":"en","type":"article","venue":"Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bevacizumab; Metastatic breast cancer; Breast cancer; Family medicine; Cancer; Affect (linguistics); Gerontology; Internal medicine","score_opus":0.12954690066752347,"score_gpt":0.40342977059468765,"score_spread":0.27388286992716415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026136485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99701667,0.0003604292,0.000047280635,0.0013788033,0.000011537957,0.000036933016,0.00020864318,0.0000024455235,0.00093729835],"genre_scores_gemma":[0.9982963,0.00060859567,0.00012141589,0.0005836798,0.000018672044,0.00005408926,0.00013265785,0.0000017402259,0.00018276587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99741983,0.0012174727,0.00037016178,0.00019603576,0.0005481651,0.00024840632],"domain_scores_gemma":[0.99135584,0.0027193807,0.003926207,0.00015994474,0.00102806,0.0008105798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037033819,0.000119415556,0.00030474344,0.0010682202,0.00067666784,0.0009444179,0.00045483807,0.0009826813,0.0014405081],"category_scores_gemma":[0.012944456,0.00032302755,0.00031286955,0.001356905,0.00062967185,0.001153096,0.0008594541,0.00078169303,0.0002872153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061787745,0.000112153204,0.9825936,0.00009175073,0.000025684798,0.00013915161,0.009705546,0.000024685145,0.00021177858,0.00005258235,0.0008113078,0.0061700596],"study_design_scores_gemma":[0.000013917677,0.00034409875,0.96243143,0.00011418891,0.00001915375,0.00049967744,0.033488452,0.00021915478,0.0000705995,0.000048430276,0.002734168,0.000016713704],"about_ca_topic_score_codex":0.008533536,"about_ca_topic_score_gemma":0.006967104,"teacher_disagreement_score":0.008533536,"about_ca_system_score_codex":0.0008240356,"about_ca_system_score_gemma":0.0008609388,"threshold_uncertainty_score":0.01958561},"labels":[],"label_agreement":null},{"id":"W2026364548","doi":"10.1158/0008-5472.sabcs-3117","title":"Incidence of postmenopausal symptoms and current mamagement: a survey of 260 breast cancer patients.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Tamoxifen; Incidence (geometry); Menopause; Cancer; Internal medicine; Gynecology; Pediatrics; Obstetrics","score_opus":0.07324103792604446,"score_gpt":0.464679967230813,"score_spread":0.39143892930476853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026364548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99862754,0.0002343537,0.00003643692,0.000041838804,0.000002125956,0.000012491945,0.0006530635,0.000003416903,0.00038870276],"genre_scores_gemma":[0.99907553,0.00018224287,0.000057949124,0.00004434706,0.000004829073,0.000013754754,0.00043745048,0.0000012204291,0.00018260353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964833,0.00008599657,0.000060398972,0.000050465133,0.00010481549,0.00004991174],"domain_scores_gemma":[0.99870765,0.0002680051,0.0006290572,0.00004555736,0.00013778824,0.00021190922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005587808,0.00012728629,0.0002734285,0.00062418706,0.0002944668,0.00035744486,0.00018669014,0.00032799022,0.0013789443],"category_scores_gemma":[0.0015876406,0.0002901791,0.00021480312,0.0009944248,0.00023979293,0.00038711136,0.00025159208,0.0003596233,0.00040585225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046081488,0.000049174803,0.99855024,0.000012796307,0.000010897455,0.000045549317,0.00014303377,0.000014906294,0.00014044755,0.0000034261793,0.00009587259,0.0008875365],"study_design_scores_gemma":[0.000005596215,0.00020582418,0.9989611,0.0000053581416,0.000008514757,0.0002559848,0.00028581664,0.00005372851,0.000037542326,0.0000028762706,0.00017491508,0.0000027580852],"about_ca_topic_score_codex":0.0066197473,"about_ca_topic_score_gemma":0.007214527,"teacher_disagreement_score":0.0066197473,"about_ca_system_score_codex":0.00027185972,"about_ca_system_score_gemma":0.00023956144,"threshold_uncertainty_score":0.013162434},"labels":[],"label_agreement":null},{"id":"W2026670521","doi":"10.1186/1471-2229-13-93","title":"A fungal endophyte induces transcription of genes encoding a redundant fungicide pathway in its host plant","year":2013,"lang":"en","type":"article","venue":"BMC Plant Biology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Agriculture and Agri-Food Canada; University of Guelph","funders":"Ministry of Agriculture, Food and Rural Affairs; Ontario Ministry of Agriculture, Food and Rural Affairs; Washington State University","keywords":"Endophyte; Biology; Taxus; Fungicide; Plant use of endophytic fungi in defense; Botany; Botrytis cinerea; Host (biology); Gene; Biochemistry; Ecology","score_opus":0.05775655091710207,"score_gpt":0.28879852175319964,"score_spread":0.23104197083609757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026670521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99437535,0.000614449,0.0029010088,0.000047189253,0.000017762553,0.000029065302,0.00052211055,0.000102231745,0.0013908027],"genre_scores_gemma":[0.9937289,0.00028296956,0.0020754465,0.000046438254,0.0000066857788,0.000042033083,0.00117014,0.0000353676,0.0026120325],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990463,0.000009630869,0.0000053474723,0.00003135041,0.000024577104,0.00002443571],"domain_scores_gemma":[0.99983954,0.000041198484,0.000036292855,0.000019686126,0.000026587059,0.000036716076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000730524,0.00031508072,0.0001841101,0.000184349,0.00009746563,0.00025521268,0.0001196434,0.00020858971,0.0010416314],"category_scores_gemma":[0.00010491489,0.00012010922,0.0001816724,0.0001428023,0.00013568823,0.00011636321,0.00019519318,0.00045190967,0.00033877898],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023601235,0.0000049721843,0.00014003934,0.0000071210893,8.6859404e-7,0.000011482026,0.000003674008,0.000005902188,0.9995629,0.000017806908,0.0000057192556,0.00021589053],"study_design_scores_gemma":[0.000011321254,0.00015851157,0.022811497,0.000007637206,0.000016769714,0.00030080273,0.00006472461,0.00112713,0.973704,0.00006860616,0.0017248066,0.000004167972],"about_ca_topic_score_codex":0.00039568284,"about_ca_topic_score_gemma":0.0005198744,"teacher_disagreement_score":0.0010416314,"about_ca_system_score_codex":0.00032449156,"about_ca_system_score_gemma":0.0001799566,"threshold_uncertainty_score":0.0034845471},"labels":[],"label_agreement":null},{"id":"W2027376895","doi":"10.1007/s10637-005-2904-2","title":"A phase I study of T900607 given once every 3 weeks in patients with advanced refractory cancers; National Cancer Institute of Canada Clinical Trials Group (NCIC–CTG) IND 130","year":2005,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston Health Sciences Centre; Hôpital Notre-Dame; BC Cancer Agency","funders":"","keywords":"Medicine; Pharmacokinetics; Cmax; Cardiotoxicity; Toxicity; Refractory (planetary science); Cancer; Internal medicine; Lethargy; Neutropenia; Gastroenterology","score_opus":0.07668926564023175,"score_gpt":0.42262326365263103,"score_spread":0.34593399801239927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027376895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97829676,0.0038340928,0.0011209548,0.0016190142,0.00054130715,0.004945455,0.0039475355,0.00033993454,0.005354905],"genre_scores_gemma":[0.9683704,0.0067118895,0.0037613716,0.0020818734,0.0004986038,0.0043311464,0.0054099686,0.000117782496,0.008716983],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994777,0.00021430395,0.000017428778,0.0000901367,0.00005524231,0.00014527216],"domain_scores_gemma":[0.9990877,0.0001275252,0.00012624724,0.000064384796,0.000060112616,0.00053395634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013976916,0.0023465913,0.0031862205,0.0008711419,0.00070199947,0.001214549,0.0017200003,0.0022404823,0.005952872],"category_scores_gemma":[0.0011260669,0.0009444808,0.0022066652,0.00083521765,0.0016952012,0.0010691116,0.0004378162,0.0061615966,0.0017052256],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73564464,0.10290951,0.0029262255,0.001188379,0.0017275739,0.00037782063,0.00041019768,0.0039112954,0.039388996,0.0008381989,0.015192669,0.09548437],"study_design_scores_gemma":[0.67417544,0.31618613,0.004021188,0.000027123426,0.00031075804,0.0001803275,0.000050322302,0.0010028987,0.001630484,0.00016305842,0.0022184108,0.00003380078],"about_ca_topic_score_codex":0.0075749466,"about_ca_topic_score_gemma":0.01668555,"teacher_disagreement_score":0.0075749466,"about_ca_system_score_codex":0.001447972,"about_ca_system_score_gemma":0.003714027,"threshold_uncertainty_score":0.019914329},"labels":[],"label_agreement":null},{"id":"W2028218566","doi":"10.1007/s00520-012-1384-0","title":"Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trials","year":2012,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Hôpital Notre-Dame","funders":"Bristol-Myers Squibb","keywords":"Ixabepilone; Medicine; Common Terminology Criteria for Adverse Events; Internal medicine; Adverse effect; Peripheral neuropathy; Oncology; Breast cancer; Cancer; Metastatic breast cancer; Surgery; Endocrinology","score_opus":0.29298144023505607,"score_gpt":0.5714225348632923,"score_spread":0.27844109462823624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028218566","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10521794,0.83786374,0.0026168672,0.002564897,0.00035808882,0.0026370934,0.038725734,0.00022840552,0.009787354],"genre_scores_gemma":[0.5372476,0.41073176,0.003440662,0.005486218,0.00042936968,0.00370379,0.036137152,0.00019280771,0.0026306622],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99196094,0.003086962,0.0023621137,0.001102269,0.0012308267,0.0002568488],"domain_scores_gemma":[0.9687271,0.0122513,0.014230961,0.0016849707,0.0024471749,0.0006584444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011871152,0.0010707976,0.0036765274,0.0015975168,0.00041575628,0.002129898,0.0009224481,0.0010268497,0.0058798366],"category_scores_gemma":[0.027070208,0.0005254729,0.0055997567,0.005090959,0.000616375,0.0014832873,0.0008476679,0.0014469865,0.00074058573],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1249625,0.00095809274,0.0690229,0.19246462,0.16350149,0.0005342658,0.0004258724,0.0040707723,0.0063068564,0.0008401547,0.03973491,0.39717758],"study_design_scores_gemma":[0.09327592,0.025218297,0.2806686,0.05765347,0.35302344,0.003588463,0.0004652633,0.001818455,0.005399306,0.0026112662,0.17600153,0.00027604002],"about_ca_topic_score_codex":0.0014015003,"about_ca_topic_score_gemma":0.0049790344,"teacher_disagreement_score":0.011871152,"about_ca_system_score_codex":0.0011922619,"about_ca_system_score_gemma":0.0020953554,"threshold_uncertainty_score":0.062781334},"labels":[],"label_agreement":null},{"id":"W2028542413","doi":"10.1021/np030311y","title":"A Yew in Israel, New Taxane Derivatives","year":2003,"lang":"en","type":"article","venue":"Journal of Natural Products","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique; Queen's University","funders":"","keywords":"Taxane; Taxus; Stereochemistry; Diterpene; Chemistry; Biology; Botany; Cancer; Genetics","score_opus":0.027167493220000925,"score_gpt":0.3304553827269324,"score_spread":0.3032878895069315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028542413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806157,0.0045499704,0.000694971,0.00030768645,0.00004900747,0.0000618798,0.0014137578,0.000056859146,0.012250204],"genre_scores_gemma":[0.9613202,0.004708165,0.0028824809,0.00033932115,0.000019432951,0.00004546041,0.0032799228,0.000015053803,0.027389934],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999881,9.599955e-7,5.9607083e-7,0.0000041205835,0.0000030234648,0.0000032177436],"domain_scores_gemma":[0.99999046,5.220324e-7,0.0000019724025,6.7155565e-7,0.0000020837215,0.0000043302466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003357812,0.00020088057,0.00011526263,0.00022144298,0.00033296182,0.00019745444,0.00010938659,0.00016146156,0.0032107837],"category_scores_gemma":[0.000031647138,0.000064067826,0.00009387015,0.00022531944,0.00012879583,0.0001845092,0.00013821086,0.00028514824,0.0005509626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009762737,0.00018261498,0.02209727,0.0003666285,0.000037341968,0.001818346,0.0006424327,0.00034141348,0.87230533,0.0012655826,0.0022084059,0.09775835],"study_design_scores_gemma":[0.00029813137,0.0020532338,0.3203438,0.00015846509,0.00012326558,0.0051402855,0.0031701133,0.0010362596,0.28721824,0.0016775834,0.37872338,0.00005715667],"about_ca_topic_score_codex":0.0027907449,"about_ca_topic_score_gemma":0.0072776205,"teacher_disagreement_score":0.0032107837,"about_ca_system_score_codex":0.00035160416,"about_ca_system_score_gemma":0.00023474246,"threshold_uncertainty_score":0.010741115},"labels":[],"label_agreement":null},{"id":"W2029461912","doi":"10.1007/s10549-015-3345-z","title":"Erratum to: Platinum-based chemotherapy in triple-negative advanced breast cancer","year":2015,"lang":"en","type":"erratum","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Breast cancer; Triple-negative breast cancer; Oncology; Chemotherapy; Medicine; Internal medicine; Triple negative; Platinum; Cancer; Biology","score_opus":0.06377048360085881,"score_gpt":0.42867668471138654,"score_spread":0.36490620111052774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029461912","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016241118,0.0033430764,0.00015696263,0.058099505,0.9354996,0.000022578413,0.00020919977,0.000060496364,0.0024461795],"genre_scores_gemma":[0.0085964175,0.027160034,0.0022573092,0.20671846,0.6170485,0.00012624382,0.0009575584,0.00035321468,0.13678238],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99700767,0.00042040643,0.00089922047,0.0002772372,0.0011594673,0.00023596027],"domain_scores_gemma":[0.98678315,0.0038227334,0.0012481072,0.0005678842,0.00665648,0.00092168484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031229907,0.0019429917,0.0022684182,0.0035712537,0.002345519,0.0027341726,0.0020169385,0.008440557,0.015918773],"category_scores_gemma":[0.027684214,0.0012080013,0.0019916366,0.0017875037,0.0018060602,0.0019738832,0.0011952053,0.0088820355,0.0149113275],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006361827,0.000021331227,0.00015976952,0.00018088623,0.000020508545,0.00070614566,0.000015983682,0.000059675043,0.00005242747,0.00039353914,0.9891495,0.009176565],"study_design_scores_gemma":[0.00008426724,0.000086399865,0.0014794511,0.0007288522,0.0001080638,0.0014761046,0.00007607547,0.00028827818,0.00035941182,0.00081195706,0.9944565,0.000044523982],"about_ca_topic_score_codex":0.008536073,"about_ca_topic_score_gemma":0.014548125,"teacher_disagreement_score":0.015918773,"about_ca_system_score_codex":0.003837258,"about_ca_system_score_gemma":0.004783081,"threshold_uncertainty_score":0.05325359},"labels":[],"label_agreement":null},{"id":"W2031196113","doi":"10.1159/000216901","title":"Therapeutic Use of Low-Molecular-Weight Heparins","year":2009,"lang":"en","type":"review","venue":"Haemostasis","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Heparin; Medicine; Antithrombotic; Deep vein; Thrombosis; Intensive care medicine; Low molecular weight heparin; Clinical trial; Surgery; Internal medicine","score_opus":0.14858017446463584,"score_gpt":0.4188657932321858,"score_spread":0.27028561876755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031196113","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014157598,0.9986713,0.00010290976,0.00014106222,0.00008647493,0.0000040874734,0.000009199806,0.000005798036,0.00083759654],"genre_scores_gemma":[0.0010529074,0.9981996,0.00014042489,0.00015139392,0.000106848056,0.0000062989543,0.0000225382,9.5365453e-7,0.0003190694],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997229,0.000057437283,0.00003646878,0.000045532845,0.00011722379,0.00002037019],"domain_scores_gemma":[0.99975187,0.00011615774,0.000047671903,0.00001034146,0.0000554585,0.00001850226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051192916,0.0008834671,0.0015508366,0.0025033047,0.0002144068,0.00065349287,0.00082091097,0.00083611143,0.0027097615],"category_scores_gemma":[0.0006628329,0.0002271001,0.00059138273,0.0016733499,0.00045951284,0.0007936909,0.00047842468,0.0014710313,0.0015608044],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081445985,0.0000727525,0.0002090373,0.010812075,0.00013050468,0.00017295525,0.000032917513,0.00026250654,0.0015819503,0.0018565366,0.017170362,0.9676169],"study_design_scores_gemma":[0.0000776973,0.00018451008,0.0019613171,0.005177541,0.00023242876,0.0026757095,0.000046890666,0.00017409289,0.0013236114,0.0021654002,0.9859561,0.00002477732],"about_ca_topic_score_codex":0.0009296294,"about_ca_topic_score_gemma":0.0013741696,"teacher_disagreement_score":0.0027097615,"about_ca_system_score_codex":0.0005509786,"about_ca_system_score_gemma":0.00072431477,"threshold_uncertainty_score":0.009065092},"labels":[],"label_agreement":null},{"id":"W2031890665","doi":"10.1159/000225657","title":"In vitro Colony Assay of Peripheral Blood Mononuclear Cells – A Comparison of Breast Cancer Patients and Normal Individuals","year":2009,"lang":"en","type":"article","venue":"Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Peripheral blood mononuclear cell; Breast cancer; In vitro; Stage (stratigraphy); Internal medicine; Cancer; Immunology; Medicine; Peripheral blood; Mammary gland; Biology; Oncology; Biochemistry","score_opus":0.013060222159564995,"score_gpt":0.3405924178679459,"score_spread":0.32753219570838094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031890665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97710264,0.0034332233,0.010742338,0.00012727955,0.00018704691,0.00034556637,0.0015023587,0.00018983308,0.0063697225],"genre_scores_gemma":[0.9734299,0.0017897208,0.014126546,0.00011577327,0.00010421697,0.00042423187,0.0044980426,0.000047934613,0.005463556],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989814,0.0003699288,0.00010545449,0.00011536988,0.00034120856,0.00008659836],"domain_scores_gemma":[0.9990909,0.0003448696,0.00009116269,0.00011618195,0.00021682764,0.00014000111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061001006,0.00042483056,0.000602724,0.0009657849,0.00032570184,0.0003265528,0.00035060116,0.00030142136,0.0022100685],"category_scores_gemma":[0.0010401183,0.00017080648,0.00027452924,0.0006883125,0.00020225301,0.00018408905,0.00038401617,0.00073132076,0.000830072],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022971462,0.0010202843,0.04194944,0.00040239617,0.00014810373,0.00042833175,0.0009880831,0.00018081753,0.9330122,0.0005261739,0.0010374613,0.018009644],"study_design_scores_gemma":[0.00015696594,0.012171213,0.22411072,0.00006898394,0.00027759254,0.0054150047,0.00079867896,0.0028510478,0.74181896,0.00056910183,0.011702709,0.00005901978],"about_ca_topic_score_codex":0.00046736654,"about_ca_topic_score_gemma":0.0005104654,"teacher_disagreement_score":0.0022100685,"about_ca_system_score_codex":0.00012341223,"about_ca_system_score_gemma":0.0001951022,"threshold_uncertainty_score":0.0073934793},"labels":[],"label_agreement":null},{"id":"W2032454683","doi":"10.1097/01.jto.0000283193.48953.cd","title":"C1-06: BO17704: a phase III study of first-line cisplatin and gemcitabine with bevacizumab or placebo in patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC)","year":2007,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Royal Victoria Hospital","funders":"","keywords":"Medicine; Bevacizumab; Gemcitabine; Carboplatin; Internal medicine; Lung cancer; Oncology; Clinical endpoint; Regimen; Placebo; Progression-free survival; Chemotherapy; Cisplatin; Phases of clinical research; Surgery; Randomized controlled trial; Pathology","score_opus":0.020225855283292567,"score_gpt":0.40939970616873156,"score_spread":0.389173850885439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032454683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98280615,0.00531326,0.0005697554,0.0016200015,0.00059575273,0.0035247144,0.002207406,0.00037517113,0.0029878053],"genre_scores_gemma":[0.97257274,0.006728107,0.0024206615,0.0022771934,0.0006706595,0.003997096,0.00458223,0.00012542828,0.006625857],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993331,0.00028331648,0.00003051341,0.00010996289,0.00004978853,0.00019332266],"domain_scores_gemma":[0.99902093,0.00012835205,0.00013267845,0.000059588183,0.00004810811,0.00061029353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002182921,0.002546552,0.005665337,0.0009819574,0.0007613327,0.001602037,0.002185382,0.0026986932,0.007897833],"category_scores_gemma":[0.0012119596,0.0013368928,0.0028504936,0.0008764446,0.0018682273,0.0016265552,0.0006245706,0.008620395,0.002023969],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8601145,0.045057856,0.001957644,0.0010337553,0.0022255555,0.00013141744,0.000171847,0.0013951836,0.014163981,0.0003109647,0.0062191547,0.06721816],"study_design_scores_gemma":[0.8404536,0.15362638,0.002483117,0.000023749093,0.00045717592,0.000089472036,0.000029794515,0.00045344187,0.0010084249,0.00007358555,0.001275893,0.000025352922],"about_ca_topic_score_codex":0.0046170517,"about_ca_topic_score_gemma":0.013248947,"teacher_disagreement_score":0.007897833,"about_ca_system_score_codex":0.0021223216,"about_ca_system_score_gemma":0.004074491,"threshold_uncertainty_score":0.026420832},"labels":[],"label_agreement":null},{"id":"W2032533639","doi":"10.1158/1538-7445.am2012-2790","title":"Abstract 2790: Localization of the binding site for Peloruside A and Laulimalide on beta-tubulin by physical and biological means","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Epothilones; Tubulin; Microtubule; Epothilone; Mutant; Chemistry; Biology; Biochemistry; Cell biology; Stereochemistry; Gene","score_opus":0.15761413907772068,"score_gpt":0.46713093610348977,"score_spread":0.30951679702576906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032533639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887838,0.0007819793,0.005379542,0.00012281189,0.000036429472,0.000036663267,0.0009385626,0.00009619697,0.0038241055],"genre_scores_gemma":[0.9772446,0.00063832727,0.0092819715,0.000086123735,0.00001547429,0.000038567385,0.003368585,0.000067861874,0.009258469],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991274,0.0000103310085,0.000007827895,0.000026685511,0.000027936108,0.000014474925],"domain_scores_gemma":[0.9998796,0.00002737452,0.00003609462,0.000014092351,0.000018499295,0.000024309307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007753603,0.00021261553,0.0001840192,0.00026938153,0.00018179785,0.00020891677,0.00036221935,0.00021265629,0.004167991],"category_scores_gemma":[0.00013005736,0.0001279573,0.00026887323,0.00017135231,0.00022801873,0.00013159802,0.00015209988,0.00026358388,0.0012200844],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056638284,0.000011079159,0.0001409573,0.00001575779,0.000002530984,0.000038497674,0.00000731008,0.000024938332,0.9991092,0.000043320397,0.00003006921,0.0005196725],"study_design_scores_gemma":[0.000011741252,0.00011421693,0.00739909,0.0000049759515,0.000007706948,0.00021018449,0.000034925237,0.00052292144,0.98973876,0.00003389693,0.0019169848,0.00000455271],"about_ca_topic_score_codex":0.0017593883,"about_ca_topic_score_gemma":0.0013851007,"teacher_disagreement_score":0.004167991,"about_ca_system_score_codex":0.0004210064,"about_ca_system_score_gemma":0.00015616987,"threshold_uncertainty_score":0.013943374},"labels":[],"label_agreement":null},{"id":"W2033077240","doi":"10.3747/co.v15i2.263","title":"Managing the Toxicities of the FEC-100 Followed by Docetaxel Regimen: The Price of Success","year":2008,"lang":"en","type":"editorial","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Docetaxel; Medicine; Regimen; Quadrant (abdomen); Oncology; Internal medicine; Gynecology; Family medicine; Surgery; Chemotherapy","score_opus":0.04974530416312795,"score_gpt":0.4061019912894849,"score_spread":0.35635668712635693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033077240","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002371205,0.03740112,0.00053713616,0.10811659,0.85011864,0.00004046947,0.000055993933,0.00012324147,0.0033696862],"genre_scores_gemma":[0.0012732715,0.028486287,0.0004222691,0.070409015,0.89213234,0.000027795135,0.0000398815,0.000037359558,0.007171735],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99821633,0.00037887812,0.00029262333,0.00016494853,0.00084673765,0.00010043465],"domain_scores_gemma":[0.9918228,0.004360858,0.0004545273,0.00018178741,0.0024167702,0.000763317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003307048,0.0021841698,0.002801208,0.0011610675,0.0015302438,0.0032506366,0.003093345,0.0124310125,0.0027771706],"category_scores_gemma":[0.012273356,0.0008455278,0.0015884935,0.00091256975,0.0017688307,0.0035433536,0.0006751891,0.027449947,0.003884659],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004902748,0.000018431003,0.000041587664,0.0003034619,0.000029741266,0.0005155208,0.000015858319,0.000068969464,0.00008169287,0.00045855608,0.97781426,0.020602798],"study_design_scores_gemma":[0.00013406856,0.00011427218,0.00041040903,0.000638737,0.00009176417,0.0020185988,0.000055945042,0.0002728829,0.000179768,0.0009472661,0.99510336,0.00003287099],"about_ca_topic_score_codex":0.0015261308,"about_ca_topic_score_gemma":0.005139565,"teacher_disagreement_score":0.0124310125,"about_ca_system_score_codex":0.0017921047,"about_ca_system_score_gemma":0.0017314291,"threshold_uncertainty_score":0.017489552},"labels":[],"label_agreement":null},{"id":"W2033093363","doi":"10.1016/s0968-0896(02)00347-4","title":"New minor taxanes analogues from the needles of Taxus canadensis","year":2003,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Queen's University; Jewish General Hospital; Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Chemistry; Fast atom bombardment; Paclitaxel; Taxus; High resolution; Stereochemistry; Mass spectrometry; Tubulin; Microtubule; Chromatography; Botany","score_opus":0.018574555355040337,"score_gpt":0.2613475705558914,"score_spread":0.2427730152008511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033093363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92010206,0.024025738,0.0044971094,0.00046929446,0.00033570052,0.0007378192,0.0042324243,0.0002248188,0.045374937],"genre_scores_gemma":[0.96637785,0.012874896,0.0028110929,0.00018806485,0.00007157325,0.00007101579,0.0025135363,0.000025688496,0.015066382],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999752,0.0000017477452,0.0000017556987,0.0000055574537,0.000007652058,0.000008013846],"domain_scores_gemma":[0.9999585,0.0000047974013,0.0000060814764,0.000003990841,0.000006263648,0.00002027184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000040545943,0.00043465436,0.00028019014,0.00060496014,0.00026761775,0.0002007324,0.00024577384,0.00018305023,0.004953353],"category_scores_gemma":[0.000077124256,0.00012488966,0.00021519036,0.0003507583,0.00018248644,0.00024627324,0.00023446982,0.00069760584,0.0007855746],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006280249,0.00024091295,0.00048755968,0.00083319127,0.000052460062,0.0011041971,0.00015751015,0.0014241294,0.9304496,0.001571822,0.0011155511,0.061935045],"study_design_scores_gemma":[0.0006859633,0.007877384,0.021885728,0.00020910545,0.00044360498,0.0039823656,0.00047433184,0.0016037603,0.7947338,0.0028198564,0.16516739,0.000116669864],"about_ca_topic_score_codex":0.0020626679,"about_ca_topic_score_gemma":0.006813747,"teacher_disagreement_score":0.9979373,"about_ca_system_score_codex":0.00017938731,"about_ca_system_score_gemma":0.00031661586,"threshold_uncertainty_score":0.016570628},"labels":[],"label_agreement":null},{"id":"W2033631441","doi":"10.1002/chin.201007163","title":"ChemInform Abstract: A Simple and Efficient Synthesis of 1,4‐ and 1,5‐Dioxepan‐2‐one.","year":2010,"lang":"en","type":"article","venue":"ChemInform","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Chemistry; Simple (philosophy); Service (business); Combinatorial chemistry; Nanotechnology; Epistemology; Business; Marketing","score_opus":0.015727143404826338,"score_gpt":0.2871145182472183,"score_spread":0.27138737484239195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033631441","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26525855,0.057206254,0.32402483,0.0061840317,0.008066797,0.0038071931,0.033328522,0.011525951,0.29059795],"genre_scores_gemma":[0.7129019,0.041046433,0.077733435,0.0023262843,0.0005880694,0.0012969256,0.014214257,0.00084707193,0.14904568],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998235,0.000021288886,0.000012203979,0.000036111465,0.000047708523,0.000059295446],"domain_scores_gemma":[0.99993837,0.0000065389722,0.000009140816,0.0000062852127,0.0000097319335,0.000029819901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024816644,0.0010802308,0.0004701165,0.0007916703,0.00040957468,0.0003212959,0.00086662895,0.00044162868,0.020459326],"category_scores_gemma":[0.00022722507,0.00037100786,0.00031881128,0.00043139458,0.00028363746,0.00074017927,0.0008167517,0.0012733665,0.010006932],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011247086,0.00072205375,0.00025203568,0.0044675674,0.00013947448,0.0014378707,0.00029003032,0.0027726532,0.6774044,0.016409209,0.06879379,0.2261862],"study_design_scores_gemma":[0.00030125436,0.0015460657,0.0009418267,0.00015806743,0.00006824249,0.0012015374,0.000057197205,0.0013597945,0.7455969,0.0046190154,0.2440217,0.00012836068],"about_ca_topic_score_codex":0.00048114106,"about_ca_topic_score_gemma":0.0010640677,"teacher_disagreement_score":0.020459326,"about_ca_system_score_codex":0.00040155626,"about_ca_system_score_gemma":0.0011855294,"threshold_uncertainty_score":0.06844324},"labels":[],"label_agreement":null},{"id":"W2034084175","doi":"10.3747/co.v17i1.437","title":"Capecitabine-Induced Cardiotoxicity: Case Report and Review of the Literature","year":2010,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Capecitabine; Medicine; Cardiotoxicity; Coronary vasospasm; Cardiogenic shock; Adverse effect; Bradycardia; Internal medicine; Cardiology; Angina; Colorectal cancer; Cancer; Chemotherapy; Myocardial infarction; Heart rate","score_opus":0.0694152416841704,"score_gpt":0.4395758298952591,"score_spread":0.3701605882110887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034084175","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3802614,0.55233073,0.011629329,0.008653037,0.0056949565,0.00050626806,0.00069651776,0.0007280241,0.0394997],"genre_scores_gemma":[0.75506246,0.2162722,0.0042891023,0.004396113,0.011468959,0.0001395305,0.0005006047,0.00008876832,0.0077823424],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99942905,0.00007016426,0.00012719218,0.00013716942,0.000095762975,0.00014061421],"domain_scores_gemma":[0.998706,0.0004557678,0.00039379706,0.00009370312,0.000115475865,0.00023523242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039002954,0.0019974236,0.0016834891,0.0033231068,0.0011707252,0.0017955543,0.0018366869,0.004826482,0.0041513504],"category_scores_gemma":[0.0019261863,0.0007064564,0.000892006,0.002615482,0.001416427,0.0024933845,0.0010275025,0.0019338166,0.0028866741],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024063305,0.00007375284,0.0025346498,0.00036868404,0.000026642383,0.98562235,0.000116696,0.0000766042,0.00065866875,0.0001236036,0.0015433135,0.008830953],"study_design_scores_gemma":[0.000010757426,0.000043572563,0.0018223678,0.000092091585,0.00003722185,0.9934541,0.00012726309,0.00009753208,0.00018870285,0.000116671414,0.003996842,0.00001286419],"about_ca_topic_score_codex":0.0010460936,"about_ca_topic_score_gemma":0.0016481432,"teacher_disagreement_score":0.004826482,"about_ca_system_score_codex":0.0008442855,"about_ca_system_score_gemma":0.00080532854,"threshold_uncertainty_score":0.013887644},"labels":[],"label_agreement":null},{"id":"W2034693832","doi":"10.1016/j.clbc.2011.04.001","title":"Concurrent Bevacizumab with a Sequential Regimen of Doxorubicin and Cyclophosphamide Followed by Docetaxel and Capecitabine as Neoadjuvant Therapy for HER2− Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group","year":2011,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Docetaxel; Bevacizumab; Capecitabine; Breast cancer; Mucositis; Internal medicine; Oncology; Cyclophosphamide; Chemotherapy; Metastatic breast cancer; Regimen; Cancer; Surgery; Colorectal cancer","score_opus":0.07746102873287435,"score_gpt":0.44725440114429066,"score_spread":0.3697933724114163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034693832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930166,0.0021903396,0.00046285876,0.0005130709,0.00025994325,0.0011963765,0.00033901373,0.00008487905,0.0019369068],"genre_scores_gemma":[0.98995984,0.0023625507,0.0021077127,0.0005322781,0.00017902635,0.0011786501,0.00095004996,0.00003472342,0.0026951062],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99956256,0.00015717436,0.000024507175,0.000105333056,0.000049222217,0.00010120888],"domain_scores_gemma":[0.99941254,0.000102504644,0.00009569165,0.0000507041,0.000027167996,0.0003114893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014100604,0.0013478943,0.002242643,0.000684187,0.00042908758,0.0010127645,0.0010066576,0.0010179257,0.0033457724],"category_scores_gemma":[0.0010724426,0.00067245925,0.0009674306,0.0007484055,0.0009398284,0.001109065,0.00042224053,0.0030820991,0.000756008],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7390078,0.05926314,0.0041555963,0.00073709874,0.0015632001,0.00012745583,0.00027870885,0.0050784783,0.02258904,0.00061792496,0.0032841088,0.16329752],"study_design_scores_gemma":[0.62992775,0.35147095,0.008540381,0.00006333165,0.0006133928,0.00019799269,0.00009027411,0.0026927195,0.00300188,0.00039029124,0.0029629115,0.000048201873],"about_ca_topic_score_codex":0.0030358804,"about_ca_topic_score_gemma":0.011825981,"teacher_disagreement_score":0.0033457724,"about_ca_system_score_codex":0.0012934709,"about_ca_system_score_gemma":0.0018441508,"threshold_uncertainty_score":0.011192679},"labels":[],"label_agreement":null},{"id":"W2034911302","doi":"10.1139/v02-108","title":"Bakers yeast-catalyzed synthesis of optically pure 4-<i>tert</i>-butyl-3-hydroxy beta-lactam <i>cis</i>-(3<i>R</i>,4<i>S</i>) and <i>trans</i>-(3<i>R</i>,4<i>R</i>) diastereomers","year":2002,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chemistry; Yeast; Saccharomyces cerevisiae; Stereochemistry; Catalysis; Lactam; Side chain; Beta-lactam; Absolute configuration; Organic chemistry; Antibiotics; Polymer; Biochemistry","score_opus":0.01252500284446737,"score_gpt":0.22340551412961776,"score_spread":0.2108805112851504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034911302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9510488,0.004532146,0.02557899,0.00019949925,0.00011068672,0.00025921626,0.0015459599,0.00041025807,0.016314497],"genre_scores_gemma":[0.9712541,0.0035689995,0.015898764,0.000041126812,0.000009400792,0.000071143615,0.0011558923,0.00008626837,0.007914302],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994373,0.000006967651,0.00000510311,0.0000111705,0.000017986878,0.000014980133],"domain_scores_gemma":[0.99996555,0.0000045598326,0.000010999572,0.0000032399184,0.000008622644,0.0000070635856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010049259,0.00052885705,0.00019220515,0.00016507112,0.00010456741,0.00013013714,0.00017071351,0.00012342905,0.0016766398],"category_scores_gemma":[0.00009689636,0.000090140435,0.00014350911,0.00020050534,0.00009623722,0.00013871164,0.00016709193,0.00042987795,0.0006465206],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000104911545,0.000042349948,0.00015854424,0.0001043842,0.00001592813,0.00012837272,0.000049358983,0.00022022777,0.9916037,0.0004024947,0.0001594542,0.0070101866],"study_design_scores_gemma":[0.000022522818,0.00017780767,0.0005075746,0.000004757391,0.00001874844,0.00013754347,0.00002273454,0.0002501235,0.99495125,0.00006397829,0.003836716,0.000006228296],"about_ca_topic_score_codex":0.0013583545,"about_ca_topic_score_gemma":0.0029182269,"teacher_disagreement_score":0.0016766398,"about_ca_system_score_codex":0.00020510446,"about_ca_system_score_gemma":0.00038386587,"threshold_uncertainty_score":0.005608976},"labels":[],"label_agreement":null},{"id":"W2035062443","doi":"10.1016/s0304-3959(02)00047-7","title":"Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy","year":2002,"lang":"en","type":"article","venue":"Pain","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":227,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"National Cancer Institute","keywords":"Nortriptyline; Placebo; Medicine; Dose; Randomization; Anesthesia; Adverse effect; Tolerability; Amitriptyline; Internal medicine; Randomized controlled trial","score_opus":0.07794335937743013,"score_gpt":0.37350707511657216,"score_spread":0.29556371573914203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035062443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899357,0.0027515444,0.0010307438,0.00035031856,0.00020699271,0.0038728262,0.0006941218,0.00015848054,0.0009992771],"genre_scores_gemma":[0.9872866,0.0022878048,0.0019974867,0.0006329329,0.00019507283,0.0041517206,0.0010820226,0.000035749916,0.0023307062],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994722,0.00026821895,0.00003444195,0.00006404098,0.000054528795,0.000106549815],"domain_scores_gemma":[0.9993061,0.0001666378,0.00014893235,0.00007039557,0.00008480433,0.00022314196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013893156,0.0012141983,0.0023844198,0.00035419132,0.00035786218,0.0007961501,0.0010344194,0.0014408928,0.0022365833],"category_scores_gemma":[0.0011185975,0.00065167865,0.0013206984,0.000269539,0.0006383586,0.00048350444,0.00024786542,0.001950578,0.00046905587],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80564666,0.041802153,0.0024097818,0.0012500584,0.0014492478,0.0003170655,0.00029298803,0.001208475,0.07548481,0.00030983577,0.0020067098,0.06782222],"study_design_scores_gemma":[0.64904517,0.33649832,0.005862484,0.000032324268,0.00040252935,0.00016739116,0.00004030358,0.0011240613,0.0056148344,0.00011511101,0.0010762741,0.000021068514],"about_ca_topic_score_codex":0.0011644962,"about_ca_topic_score_gemma":0.0026759123,"teacher_disagreement_score":0.0023844198,"about_ca_system_score_codex":0.0006512431,"about_ca_system_score_gemma":0.0013175807,"threshold_uncertainty_score":0.0074821115},"labels":[],"label_agreement":null},{"id":"W2036145991","doi":"10.3816/cbc.2000.s.012","title":"Epirubicin in Breast Cancer: Present and Future","year":2000,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Epirubicin; Medicine; Anthracycline; Breast cancer; Oncology; Trastuzumab; Taxane; Internal medicine; Cyclophosphamide; Chemotherapy; Metastatic breast cancer; Doxorubicin; Cancer; Pharmacology","score_opus":0.08241764795168283,"score_gpt":0.4870500193305227,"score_spread":0.4046323713788399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036145991","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013374763,0.9982199,0.00013510845,0.00033656906,0.00025762193,0.000005571664,0.000014721579,0.000010256286,0.0008864361],"genre_scores_gemma":[0.0006764952,0.9975452,0.00021819203,0.0003414541,0.0002604912,0.000007318892,0.000020584326,0.0000014666317,0.00092873257],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983346,0.00003449793,0.00002638709,0.00003492869,0.000054595963,0.000016209044],"domain_scores_gemma":[0.9996865,0.00011974438,0.00006907502,0.000009892572,0.000076555894,0.000038235863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007222762,0.0011685798,0.0020070777,0.0019634743,0.00025788174,0.0011273931,0.00084053166,0.0011246959,0.0049504023],"category_scores_gemma":[0.0007042241,0.00035109452,0.0004051972,0.0026908068,0.00053118553,0.0022603697,0.00062096474,0.0017516704,0.0025394051],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019024819,0.00010321591,0.00016169547,0.009396407,0.00007335148,0.00017248772,0.000037314192,0.00038400127,0.0015479465,0.0016494525,0.030696958,0.9555869],"study_design_scores_gemma":[0.00009970878,0.00031058377,0.0010801569,0.0026147652,0.00022421233,0.0012553608,0.000067347726,0.00023610509,0.00045037258,0.0014248427,0.9922151,0.000021488726],"about_ca_topic_score_codex":0.0012238811,"about_ca_topic_score_gemma":0.004513909,"teacher_disagreement_score":0.0049504023,"about_ca_system_score_codex":0.0006433324,"about_ca_system_score_gemma":0.0011579512,"threshold_uncertainty_score":0.016560733},"labels":[],"label_agreement":null},{"id":"W2036335583","doi":"10.1023/a:1006320122711","title":"Liarozole fumarate (R85246): a novel imidazole in the treatment of receptor positive postmenopausal metastatic breast cancer","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre; Alberta Cancer Foundation; Toronto General Hospital","funders":"","keywords":"Metastatic breast cancer; Medicine; Breast cancer; Oncology; Internal medicine; Cancer; Postmenopausal women; Estrogen receptor; Cancer research","score_opus":0.06413388611206063,"score_gpt":0.41164285071278633,"score_spread":0.3475089646007257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036335583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8051414,0.1665536,0.0028876322,0.003980124,0.0005737695,0.00022030668,0.0006810807,0.00072417216,0.019237962],"genre_scores_gemma":[0.94038504,0.049278427,0.0013032806,0.00072577933,0.00024453914,0.000049279384,0.00049513415,0.000019075327,0.0074994657],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9999541,0.000012518516,0.0000042876327,0.000006027233,0.000007797677,0.000015290512],"domain_scores_gemma":[0.9999691,0.000004843132,0.000007834304,0.0000019195893,0.0000041073936,0.000012172998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014089988,0.0002566685,0.00038901152,0.00025785345,0.00018856053,0.00021136558,0.00032949334,0.00035193836,0.0014521402],"category_scores_gemma":[0.00014313398,0.00005725766,0.00022993446,0.00023151062,0.0001337234,0.00014602958,0.00012818628,0.0004934427,0.00043880453],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015824372,0.0011247926,0.004119389,0.0014182721,0.00025230128,0.0025405118,0.00019186402,0.0011963687,0.1727088,0.0018105265,0.012472186,0.78634065],"study_design_scores_gemma":[0.027060995,0.0934929,0.06732712,0.0007267613,0.0020047412,0.022169853,0.0007445808,0.0056656417,0.28948057,0.002200837,0.48891038,0.00021558037],"about_ca_topic_score_codex":0.0015464547,"about_ca_topic_score_gemma":0.005502525,"teacher_disagreement_score":0.0015464547,"about_ca_system_score_codex":0.00028612424,"about_ca_system_score_gemma":0.00029056557,"threshold_uncertainty_score":0.0048578978},"labels":[],"label_agreement":null},{"id":"W2036614336","doi":"10.1158/0008-5472.sabcs11-p1-08-15","title":"P1-08-15: Pattern of Cardiac Monitoring and Risk of Trastuzumab Associated-Cardiac Dysfunction in a Clinical Practice: A Population Based Study.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Medicine; Trastuzumab; Internal medicine; Breast cancer; Ejection fraction; Anthracycline; Population; Cardiology; Incidence (geometry); Oncology; Logistic regression; Cancer; Gynecology; Heart failure","score_opus":0.16977714133355037,"score_gpt":0.5030539515384683,"score_spread":0.33327681020491795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036614336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99937004,0.00007509043,0.000032838572,0.00003455463,0.0000022334998,0.000016763315,0.00024002095,0.0000017933568,0.00022669617],"genre_scores_gemma":[0.99947315,0.00005536426,0.000054161592,0.00004482538,0.0000050611347,0.000020995092,0.00022190672,0.0000013387888,0.00012335136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921,0.00022815954,0.00009872616,0.0001997205,0.00014502219,0.00011841943],"domain_scores_gemma":[0.99752825,0.00035019015,0.0013424776,0.00010294855,0.00020043501,0.00047568258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006717821,0.0002697717,0.00036006654,0.0008486446,0.0005386565,0.0006926259,0.00054340414,0.00063676503,0.0019987072],"category_scores_gemma":[0.0025343976,0.000491923,0.00030821963,0.0017164954,0.00045106377,0.00066428335,0.000619152,0.0007099535,0.000564788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029686264,0.000033210275,0.99942183,0.0000050349418,0.000013799247,0.000051546544,0.00006510336,0.0000072203693,0.000054848562,0.0000031770126,0.000043803757,0.00027080416],"study_design_scores_gemma":[0.00001150336,0.00017670525,0.99884677,0.000005818,0.000010938627,0.00032493446,0.00038183643,0.00011096057,0.000017479178,0.00000802479,0.000101561,0.000003420839],"about_ca_topic_score_codex":0.009656772,"about_ca_topic_score_gemma":0.013371903,"teacher_disagreement_score":0.009656772,"about_ca_system_score_codex":0.0006031078,"about_ca_system_score_gemma":0.0006743364,"threshold_uncertainty_score":0.01920116},"labels":[],"label_agreement":null},{"id":"W2037125902","doi":"10.1023/b:drug.0000047105.38511.2a","title":"Phase I study of Tomudex and Doxorubicin in patients with locally advanced, inoperable or metastatic cancer (IND.98)","year":2004,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; CancerCare Manitoba; Ontario Institute for Cancer Research; AstraZeneca (Canada); Hôpital Notre-Dame; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Doxorubicin; Bolus (digestion); Toxicity; Cancer; Internal medicine; Chemotherapy; Gastroenterology; Surgery","score_opus":0.023312347774086896,"score_gpt":0.33420681025171406,"score_spread":0.31089446247762714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037125902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99022627,0.0018026221,0.0004649152,0.00048323112,0.00013520593,0.0016293086,0.0011068942,0.00012239911,0.0040291464],"genre_scores_gemma":[0.9789507,0.003414767,0.0022461556,0.0008729531,0.00022751774,0.0025138448,0.0032771619,0.000043447624,0.008453346],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998197,0.00009056587,0.0000058989604,0.000023702993,0.000013514823,0.00004671455],"domain_scores_gemma":[0.99960595,0.00008449736,0.00006143668,0.0000306242,0.000019954057,0.0001975011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066403806,0.0010485452,0.0014544375,0.00043499316,0.0003291367,0.000748668,0.0008562947,0.0010679684,0.00627682],"category_scores_gemma":[0.0007166031,0.00047374706,0.0008400829,0.0003568228,0.0006100225,0.00060500484,0.00029997592,0.0026254298,0.0011350963],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73638815,0.06756465,0.006270091,0.00074025145,0.001011485,0.0003327441,0.00034192405,0.0020347224,0.041582245,0.00070428115,0.007038015,0.13599153],"study_design_scores_gemma":[0.5334767,0.44677615,0.009388728,0.00004710528,0.0003558789,0.00037895524,0.00009154556,0.00095100084,0.0033130967,0.00019507465,0.004999112,0.000026666443],"about_ca_topic_score_codex":0.0009052037,"about_ca_topic_score_gemma":0.0022382748,"teacher_disagreement_score":0.00627682,"about_ca_system_score_codex":0.00043185332,"about_ca_system_score_gemma":0.0009977886,"threshold_uncertainty_score":0.02099806},"labels":[],"label_agreement":null},{"id":"W2039310969","doi":"10.1038/sj.bjc.6600261","title":"Randomised, phase II trial comparing oral capecitabine (Xeloda®) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Capecitabine; Medicine; Metastatic breast cancer; Paclitaxel; Oncology; Internal medicine; Breast cancer; Chemotherapy; Phases of clinical research; Cancer; Colorectal cancer","score_opus":0.022443216307930947,"score_gpt":0.3270490110939391,"score_spread":0.30460579478600813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039310969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796983,0.00398765,0.0008379287,0.0009637972,0.0007394152,0.008066513,0.001630608,0.00017089873,0.0039048754],"genre_scores_gemma":[0.966866,0.0042638057,0.002838877,0.002413187,0.000902639,0.010919366,0.003417829,0.000051604202,0.008326642],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993492,0.0003924714,0.000038857634,0.000103907434,0.000037312613,0.00007829705],"domain_scores_gemma":[0.99860805,0.0004509351,0.00030326884,0.00007785284,0.000054044784,0.00050578587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001753852,0.00181949,0.002948682,0.00047595432,0.00034913322,0.0010020718,0.0010493237,0.0018841928,0.009262909],"category_scores_gemma":[0.002324738,0.0007454779,0.0012209354,0.0005126428,0.0010959165,0.0008955029,0.00043308764,0.0028948835,0.0011341464],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9789413,0.00622574,0.000350252,0.00030776192,0.00028738758,0.000050291084,0.000035706027,0.0002626993,0.0035323058,0.00008859596,0.000601729,0.009316088],"study_design_scores_gemma":[0.948104,0.05045126,0.0005367275,0.000012170592,0.00010484989,0.000026374233,0.000007659267,0.00015085905,0.0001884807,0.000051371673,0.00036178023,0.000004349576],"about_ca_topic_score_codex":0.0011569638,"about_ca_topic_score_gemma":0.0027310292,"teacher_disagreement_score":0.009262909,"about_ca_system_score_codex":0.0009071901,"about_ca_system_score_gemma":0.0014824711,"threshold_uncertainty_score":0.03098756},"labels":[],"label_agreement":null},{"id":"W2040048266","doi":"10.1021/np049836w","title":"Taxanes from Rooted Cuttings of <i>Taxus </i><i>c</i><i>anadensis</i>","year":2004,"lang":"en","type":"article","venue":"Journal of Natural Products","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut National de la Recherche Scientifique; McGill University; Queen's University; Université du Québec à Montréal","funders":"","keywords":"Taxus; Cutting; Pharmacognosy; Diterpene; Botany; Stereochemistry; Biology; Chemistry; Biological activity","score_opus":0.01106316156379084,"score_gpt":0.27402822518538067,"score_spread":0.26296506362158983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040048266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98355526,0.0064734425,0.0015888177,0.00007616229,0.000041474086,0.00013219436,0.003495311,0.000053806398,0.004583475],"genre_scores_gemma":[0.9632015,0.0059984494,0.005606807,0.00021024853,0.000042715637,0.00010000286,0.013607958,0.000055227556,0.011177052],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999372,0.00000255703,0.000002814598,0.000016467184,0.000024858087,0.000016014652],"domain_scores_gemma":[0.9998727,0.000011882597,0.000020735399,0.000008418417,0.000036947862,0.000049310558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039778664,0.00066739554,0.00033222654,0.0007316902,0.0005184577,0.00034716722,0.00017094906,0.0003050408,0.001219996],"category_scores_gemma":[0.0001135735,0.0001861892,0.0002568852,0.00071640103,0.0002913595,0.00032813847,0.00021306747,0.0010751325,0.00036722317],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011297537,0.000015894846,0.00084305793,0.000062907915,0.0000108385575,0.00012790048,0.00005301512,0.0000489367,0.9948645,0.00003596105,0.00003422643,0.0037898174],"study_design_scores_gemma":[0.00009419763,0.0011331677,0.14946008,0.00011835894,0.00020251481,0.0015646522,0.00078435923,0.00037114992,0.8151894,0.0003812433,0.030628094,0.00007283098],"about_ca_topic_score_codex":0.016443215,"about_ca_topic_score_gemma":0.040495757,"teacher_disagreement_score":0.016443215,"about_ca_system_score_codex":0.0006244156,"about_ca_system_score_gemma":0.00094269775,"threshold_uncertainty_score":0.032694995},"labels":[],"label_agreement":null},{"id":"W2040951267","doi":"10.1016/j.carrev.2006.03.066","title":"Systemic nanoparticle albumin-bound paclitaxel (nab-paclitaxel) for the prevention of in-stent restenosis (SNAPIST-II): a randomized comparison of single dose and single dose plus repeat dose at 2 months","year":2006,"lang":"en","type":"article","venue":"Cardiovascular revascularization medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Victoria Heart Institute Foundation","funders":"","keywords":"Paclitaxel; Chromatography; Medicine; Protein precipitation; Albumin; Mass spectrometry; Surgery; Chemotherapy; Chemistry; Internal medicine","score_opus":0.033758904035859995,"score_gpt":0.3031790525724021,"score_spread":0.26942014853654206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040951267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940082,0.0015275207,0.00054537907,0.00033760045,0.00044913244,0.001293573,0.00042873688,0.00008229401,0.0013275881],"genre_scores_gemma":[0.9914984,0.0014295048,0.0014204663,0.00061518134,0.0007117842,0.0014581769,0.00058312743,0.000034725355,0.0022486716],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99848866,0.00078665983,0.00010619107,0.0002998991,0.00011070679,0.00020793306],"domain_scores_gemma":[0.9985753,0.00048224037,0.00025318522,0.00016335411,0.00009564915,0.00043014422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022786008,0.0021633222,0.0056616613,0.00071566063,0.0005611069,0.0014648694,0.0013149587,0.002766179,0.005548954],"category_scores_gemma":[0.0019612228,0.0014033882,0.0023564503,0.0006637242,0.0017045067,0.0015804432,0.0005587198,0.004202258,0.0010992917],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9864726,0.005390862,0.000283499,0.000114314455,0.00053901854,0.000015531241,0.000021748014,0.00011756362,0.0012945083,0.000046071822,0.0001481509,0.0055559636],"study_design_scores_gemma":[0.88991714,0.10627657,0.0016851266,0.000017366618,0.0007602254,0.000018541705,0.00002368288,0.00038161137,0.00057822274,0.00009043674,0.00023132248,0.000019903124],"about_ca_topic_score_codex":0.0014648604,"about_ca_topic_score_gemma":0.0027905141,"teacher_disagreement_score":0.0056616613,"about_ca_system_score_codex":0.0010072672,"about_ca_system_score_gemma":0.0012240176,"threshold_uncertainty_score":0.018563092},"labels":[],"label_agreement":null},{"id":"W2041157986","doi":"10.1002/cmdc.200700002","title":"Overcoming Tumor Drug Resistance with High‐Affinity Taxanes: A SAR Study of C2‐Modified 7‐Acyl‐10‐Deacetyl Cephalomannines","year":2007,"lang":"en","type":"article","venue":"ChemMedChem","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Taxoid; Taxane; Paclitaxel; Drug; Drug resistance; Chemistry; Tubulin; Pharmacology; Drug discovery; Stereochemistry; Biology; Biochemistry; Microtubule; Microbiology; Cancer; Cell biology; Genetics","score_opus":0.02507772743041497,"score_gpt":0.3062801525452467,"score_spread":0.28120242511483173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041157986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957052,0.0015858852,0.0007600903,0.0000530327,0.000012046037,0.000047872138,0.0001421507,0.000028079578,0.0016658574],"genre_scores_gemma":[0.99439347,0.0019889781,0.0017044803,0.000052501484,0.000008145354,0.0000184377,0.00034801604,0.000011713146,0.001474223],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999528,0.000010803516,0.0000030596445,0.0000070092087,0.000010673477,0.000015550164],"domain_scores_gemma":[0.9999682,0.000004021896,0.000009845432,0.0000031174213,0.0000039982924,0.000010725251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000082465536,0.00033117284,0.0002863049,0.00010844573,0.00007815916,0.00017021225,0.00018869397,0.00021638618,0.00082451355],"category_scores_gemma":[0.00008262494,0.000098973804,0.00015897132,0.0001124076,0.00014330221,0.0001798283,0.00011630453,0.00030766623,0.00027505506],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002591204,0.00005772871,0.00021169534,0.0000806259,0.000010356457,0.0001562366,0.000026443842,0.0012291374,0.994175,0.00012606487,0.00005556043,0.0036120932],"study_design_scores_gemma":[0.00022808516,0.0034138693,0.0034865313,0.000016536274,0.000040827912,0.00066175923,0.0000348633,0.0019637528,0.9836541,0.000051938187,0.006429592,0.0000181679],"about_ca_topic_score_codex":0.0008042951,"about_ca_topic_score_gemma":0.0018821465,"teacher_disagreement_score":0.00082451355,"about_ca_system_score_codex":0.00028301723,"about_ca_system_score_gemma":0.00016124464,"threshold_uncertainty_score":0.0027582645},"labels":[],"label_agreement":null},{"id":"W2042584309","doi":"10.1097/mph.0b013e318158343b","title":"Vincristine-induced Peripheral Neuropathy and Urinary Bladder Paralysis in a Child With Rhabdomyosarcoma","year":2008,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Peripheral neuropathy; Vincristine; Rhabdomyosarcoma; Peripheral; Electromyography; Urinary system; Urinary bladder; Paralysis; Chemotherapy; Urology; Anesthesia; Internal medicine; Surgery; Pathology; Physical medicine and rehabilitation; Cyclophosphamide; Sarcoma; Endocrinology","score_opus":0.024916555948842244,"score_gpt":0.31418662696045435,"score_spread":0.2892700710116121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042584309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942551,0.0012087724,0.0009020378,0.00055652676,0.00004725704,0.000045599816,0.0001024416,0.000071799645,0.0028104251],"genre_scores_gemma":[0.9977818,0.0006572221,0.00072121836,0.0001814201,0.00004349882,0.000011301069,0.00004593169,0.00001244331,0.0005450969],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99965096,0.000049662358,0.0000433524,0.00006867859,0.00006547972,0.0001218668],"domain_scores_gemma":[0.9991271,0.0002387127,0.00026908488,0.00004305083,0.0000483938,0.0002737716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002764701,0.0008135189,0.000663678,0.0012149445,0.0009701276,0.00044983486,0.00070260983,0.0017810141,0.0012319537],"category_scores_gemma":[0.0016150391,0.00070315343,0.0005148216,0.00066050666,0.001038266,0.0009303901,0.0008027098,0.0014310735,0.0002629115],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029033215,0.000038636692,0.016342318,0.00004989718,0.000007909342,0.9794574,0.00022118387,0.00018004669,0.001704556,0.00021722312,0.00014214613,0.0016097302],"study_design_scores_gemma":[0.000007985471,0.00014130524,0.020455394,0.000018181096,0.000012941022,0.97778165,0.00011995782,0.0002374479,0.000880895,0.000063760235,0.0002725809,0.000007895177],"about_ca_topic_score_codex":0.0033384552,"about_ca_topic_score_gemma":0.0072145746,"teacher_disagreement_score":0.0033384552,"about_ca_system_score_codex":0.0010155472,"about_ca_system_score_gemma":0.0008642561,"threshold_uncertainty_score":0.007368326},"labels":[],"label_agreement":null},{"id":"W2043515009","doi":"10.1021/ac010254i","title":"Detection and Partial Structure Elucidation of Basic Taxoids from <i>Taxus wallichiana</i> by Electrospray Ionization Tandem Mass Spectrometry","year":2001,"lang":"en","type":"article","venue":"Analytical Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Biotechnology Research Institute","funders":"","keywords":"Chemistry; Electrospray ionization; Mass spectrometry; Tandem mass spectrometry; Natural product; Chromatography; Combinatorial chemistry; Organic chemistry","score_opus":0.006508868375626682,"score_gpt":0.25451031219161496,"score_spread":0.2480014438159883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043515009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94875014,0.0027459746,0.043305274,0.00014533693,0.00002945496,0.00016574147,0.0024997364,0.00024827005,0.0021101146],"genre_scores_gemma":[0.89078456,0.0045674127,0.09421358,0.00017184374,0.000031847765,0.00019526634,0.0063173664,0.00013887878,0.0035791972],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999076,0.0000143336365,0.000008305377,0.000020901749,0.00003198787,0.000016806003],"domain_scores_gemma":[0.99979955,0.000048957736,0.00004721961,0.00002286407,0.000048295613,0.000033192933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013885945,0.00055800664,0.00033892886,0.0005260487,0.00024965752,0.00025916664,0.00022162423,0.00027268214,0.0007958695],"category_scores_gemma":[0.0003641366,0.00019621331,0.00023454381,0.0004133898,0.00024629108,0.00032017432,0.0002238998,0.00054411107,0.0004702382],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028067818,0.0000034913826,0.00009538913,0.000015330324,0.0000022085362,0.00003198816,0.00000874149,0.000022493903,0.9987225,0.000022323624,0.000012127539,0.0010353097],"study_design_scores_gemma":[0.000009617652,0.0001263547,0.0024607691,0.000005183517,0.000011795824,0.00045305793,0.000024344417,0.00023468319,0.9946548,0.00008529853,0.0019266552,0.000007606796],"about_ca_topic_score_codex":0.000522818,"about_ca_topic_score_gemma":0.0012496368,"teacher_disagreement_score":0.0007958695,"about_ca_system_score_codex":0.00022339719,"about_ca_system_score_gemma":0.00041144466,"threshold_uncertainty_score":0.0026624799},"labels":[],"label_agreement":null},{"id":"W2044315667","doi":"10.1139/v02-190","title":"Taxanes in rooted cuttings vs. mature Japanese yew","year":2003,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cutting; Taxus; Taxane; Bark (sound); Chemistry; Botany; Metabolite; Stereochemistry; Horticulture; Biology","score_opus":0.008443093429161608,"score_gpt":0.25373224149489587,"score_spread":0.24528914806573426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044315667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99678963,0.0016025541,0.00028296083,0.000014239342,0.0000073836245,0.000018906314,0.00074910687,0.000011304129,0.0005239006],"genre_scores_gemma":[0.9872289,0.002156032,0.002458152,0.00007572435,0.000013749036,0.00005125193,0.004065206,0.000022133632,0.0039288425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995637,0.0000024495341,0.0000040872605,0.000016491844,0.000009378774,0.000011266396],"domain_scores_gemma":[0.9998772,0.00001270263,0.000034369463,0.000007720922,0.000027555474,0.000040440234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050216553,0.00042717185,0.00040251363,0.0006303153,0.0002984947,0.00030880966,0.00011521978,0.0003635925,0.0010537705],"category_scores_gemma":[0.00010849724,0.0002193339,0.0002427894,0.00055395666,0.00018928864,0.00029349004,0.00023578845,0.0006309734,0.00022253407],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022317066,0.000009778251,0.0019187349,0.000051878913,0.000008662671,0.000135253,0.0000724661,0.000009440133,0.99631137,0.000016658765,0.000009305085,0.0012332314],"study_design_scores_gemma":[0.00010346339,0.0020107962,0.60030746,0.000055992805,0.000227518,0.0017675365,0.0011460426,0.00025608068,0.38736856,0.00016520619,0.0065407497,0.00005062471],"about_ca_topic_score_codex":0.0026234128,"about_ca_topic_score_gemma":0.0065231817,"teacher_disagreement_score":0.0026234128,"about_ca_system_score_codex":0.00020873199,"about_ca_system_score_gemma":0.0002269001,"threshold_uncertainty_score":0.00521636},"labels":[],"label_agreement":null},{"id":"W2044987995","doi":"10.3747/co.v17i6.728","title":"Arterial Occlusion Precipitated by Cisplatinbased Chemotherapy","year":2010,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Ototoxicity; Cisplatin; Chemotherapy; Nephrotoxicity; Gangrene; Adverse effect; Neurotoxicity; Internal medicine; Surgery; Toxicity","score_opus":0.04875093538618674,"score_gpt":0.4282600542290483,"score_spread":0.37950911884286154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044987995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97298265,0.0033239287,0.0056025325,0.0010828824,0.00026367162,0.00021890894,0.00008185586,0.00034991358,0.016093608],"genre_scores_gemma":[0.99724126,0.0010186409,0.0003868564,0.00032295208,0.00024400125,0.000014289593,0.0000295547,0.0000076998485,0.0007348414],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997321,0.000053469194,0.000021503283,0.000024989793,0.00004990669,0.000118091],"domain_scores_gemma":[0.9983741,0.00053791265,0.0004454242,0.00014196291,0.00007530546,0.0004251808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016571707,0.0006240101,0.0005546266,0.0011075014,0.00079045596,0.000648716,0.0003256292,0.0011799145,0.001410986],"category_scores_gemma":[0.0021604544,0.0002992826,0.0004324214,0.00088976166,0.000700421,0.00038438424,0.0006131063,0.002032034,0.00044769337],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041075778,0.000110289635,0.017065907,0.00008112681,0.000017908886,0.9670944,0.00017612606,0.00029510507,0.00520343,0.0006458129,0.00041470368,0.008484437],"study_design_scores_gemma":[0.0001092271,0.0006588092,0.023802591,0.00004171445,0.000059821497,0.9617388,0.00012306926,0.0018900175,0.008102603,0.0006578499,0.00279112,0.00002440815],"about_ca_topic_score_codex":0.0009425167,"about_ca_topic_score_gemma":0.0010578991,"teacher_disagreement_score":0.001410986,"about_ca_system_score_codex":0.000586561,"about_ca_system_score_gemma":0.00047159565,"threshold_uncertainty_score":0.004720211},"labels":[],"label_agreement":null},{"id":"W2045259489","doi":"10.3892/ijo.19.4.733","title":"Strategies of medical treatment for metastatic breast cancer (Review)","year":2001,"lang":"en","type":"review","venue":"International Journal of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Vinorelbine; Metastatic breast cancer; Breast cancer; Capecitabine; Oncology; Medicine; Trastuzumab; Gemcitabine; Chemotherapy; Cancer; Internal medicine; Disease; Cisplatin","score_opus":0.1794732844365756,"score_gpt":0.5749174427902647,"score_spread":0.39544415835368907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045259489","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011385456,0.996908,0.0002043693,0.00030383348,0.00049367745,0.0000167321,0.000024592457,0.000012852874,0.0019220033],"genre_scores_gemma":[0.0005502888,0.9972102,0.00042816356,0.00035292585,0.0003289458,0.000017776028,0.00004996653,0.0000016539472,0.0010599479],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975544,0.00005089662,0.00003137911,0.00003501915,0.00010838856,0.000019012165],"domain_scores_gemma":[0.99980277,0.00008537048,0.000037360034,0.000009184698,0.00004401076,0.000021409669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040045852,0.0013232682,0.0015538431,0.0029662128,0.00035692082,0.00083726423,0.0011084893,0.001040721,0.008138962],"category_scores_gemma":[0.00049686123,0.00022893085,0.00063469715,0.0021692642,0.00045774857,0.0012559133,0.00047486374,0.0016419167,0.0055981157],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055119963,0.000109352775,0.00013342028,0.014763095,0.0001021521,0.0003545318,0.00004728565,0.00030771428,0.0010975109,0.0019254173,0.065238774,0.91586566],"study_design_scores_gemma":[0.000040124032,0.00011490385,0.0011148355,0.004257257,0.00010718891,0.0028373594,0.00004699312,0.00007160103,0.00026527818,0.0015996298,0.98953056,0.000014207437],"about_ca_topic_score_codex":0.0009065208,"about_ca_topic_score_gemma":0.0023352148,"teacher_disagreement_score":0.008138962,"about_ca_system_score_codex":0.00060309976,"about_ca_system_score_gemma":0.0008319483,"threshold_uncertainty_score":0.027227521},"labels":[],"label_agreement":null},{"id":"W2045410360","doi":"10.1016/j.neuroscience.2011.10.010","title":"Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat","year":2011,"lang":"en","type":"article","venue":"Neuroscience","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Dorsal root ganglion; Peripheral neuropathy; Spinal cord; Sensory system; Axon; Sensory nerve; Motor neuron; Medicine; Neuropathic pain; Anatomy; Neuroscience; Anesthesia; Biology; Endocrinology","score_opus":0.07447787709038911,"score_gpt":0.31344830045294864,"score_spread":0.23897042336255953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045410360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981431,0.00047476985,0.00048040703,0.00004708683,0.00000943297,0.000007356893,0.00015979694,0.000028525417,0.0006496582],"genre_scores_gemma":[0.9974336,0.00054029195,0.00032588202,0.000017525203,0.0000033059084,0.000010615694,0.00016872743,0.000007689591,0.001492322],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994373,0.0000085498505,0.000005386125,0.000011745219,0.0000122247375,0.000018353203],"domain_scores_gemma":[0.9998777,0.000014392668,0.00005259074,0.000013295704,0.00001578055,0.000026264534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100645164,0.00025783328,0.00018695503,0.0005775787,0.00026726257,0.00022945223,0.00021395588,0.0003782333,0.0016292119],"category_scores_gemma":[0.00011914667,0.00020441916,0.0001941752,0.00030584977,0.00032163365,0.00037212437,0.00011883759,0.00041290952,0.00019790624],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002092048,0.00013446137,0.0011087809,0.00008935754,0.00001968761,0.0005828909,0.0000445249,0.00015324811,0.99299675,0.00026759921,0.00007570214,0.0024350574],"study_design_scores_gemma":[0.00013761413,0.002517061,0.059776064,0.000028183735,0.00013838403,0.002764083,0.00028507054,0.0018379199,0.9311618,0.00039508508,0.000942257,0.000016332837],"about_ca_topic_score_codex":0.0019300542,"about_ca_topic_score_gemma":0.0026996557,"teacher_disagreement_score":0.0019300542,"about_ca_system_score_codex":0.00033774754,"about_ca_system_score_gemma":0.00023829825,"threshold_uncertainty_score":0.0054502487},"labels":[],"label_agreement":null},{"id":"W2046235081","doi":"10.1158/1535-7163.targ-09-a104","title":"Abstract A104: Safety and effectiveness of phase I solid tumor trial designs of molecularly targeted combination therapies","year":2009,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Clinical trial; Cancer; Pharmacology; Oncology; Population; Internal medicine; Pharmacokinetics","score_opus":0.034705481045193866,"score_gpt":0.3695591450582382,"score_spread":0.33485366401304434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046235081","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77358997,0.1401737,0.019195175,0.002893477,0.0012840271,0.02293268,0.017993623,0.0010054223,0.020931832],"genre_scores_gemma":[0.9634539,0.010387671,0.0070685255,0.0012760615,0.0008454695,0.009559743,0.005154024,0.000116360316,0.0021383055],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.971752,0.022889672,0.002495664,0.0010246214,0.0015469227,0.00029115312],"domain_scores_gemma":[0.96890926,0.017886223,0.009517455,0.0014058368,0.0014373556,0.0008438746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020390363,0.0011307515,0.0024246858,0.0015448278,0.00035890372,0.0019517925,0.000672557,0.0011128893,0.006974253],"category_scores_gemma":[0.035150103,0.0004888668,0.003869514,0.0014770419,0.000523149,0.0013020192,0.0005431996,0.0017925629,0.00097380026],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68921626,0.003582836,0.014121434,0.005818579,0.017945442,0.00013426751,0.0001132853,0.004421019,0.0053211534,0.00059086387,0.008092959,0.25064197],"study_design_scores_gemma":[0.49298725,0.3813261,0.0597428,0.0025960654,0.024897309,0.0009163983,0.000113225986,0.008772244,0.008480797,0.0022328969,0.017810961,0.0001239015],"about_ca_topic_score_codex":0.00023137823,"about_ca_topic_score_gemma":0.00036379969,"teacher_disagreement_score":0.020390363,"about_ca_system_score_codex":0.0014695409,"about_ca_system_score_gemma":0.0016430933,"threshold_uncertainty_score":0.10783583},"labels":[],"label_agreement":null},{"id":"W2046345572","doi":"10.1016/s0968-0896(00)00299-6","title":"Biotransformation of a 4(20),11(12)-taxadiene derivative","year":2001,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Queen's University; Jewish General Hospital; Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Chemistry; Biotransformation; Hydroxylation; Stereochemistry; Derivative (finance); Isomerization; Taxane; Organic chemistry; Catalysis; Enzyme","score_opus":0.01948976701641771,"score_gpt":0.28703671716903845,"score_spread":0.26754695015262075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046345572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98201764,0.0014678895,0.0021802546,0.00014499483,0.000056647146,0.00007276545,0.00093361747,0.00006249624,0.013063732],"genre_scores_gemma":[0.9870063,0.001229052,0.0013548814,0.000034761255,0.0000049159407,0.000019407076,0.0004664297,0.000012296869,0.009871883],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999374,0.0000112784155,0.000004593841,0.000010654976,0.000010789973,0.000025201776],"domain_scores_gemma":[0.9999565,0.0000055648015,0.000006864093,0.000008446626,0.000006312858,0.000016308028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100280355,0.00026070318,0.00021949876,0.0002080693,0.00021725298,0.00012871799,0.00021627129,0.00027589343,0.0045210905],"category_scores_gemma":[0.00008848735,0.00009737867,0.00018365249,0.00022538217,0.00012705794,0.00019105348,0.00020648744,0.0003137663,0.000792165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057277747,0.00014956876,0.00047249635,0.00010208978,0.000014768807,0.000509816,0.00015268975,0.0011834019,0.9835977,0.0008863051,0.00022466382,0.012133699],"study_design_scores_gemma":[0.00004005222,0.0013658159,0.0019034414,0.000011226256,0.000019758918,0.00033732256,0.000056874076,0.00046853017,0.98628926,0.000106466054,0.009391476,0.000009870572],"about_ca_topic_score_codex":0.0022487906,"about_ca_topic_score_gemma":0.0047133267,"teacher_disagreement_score":0.0045210905,"about_ca_system_score_codex":0.000320987,"about_ca_system_score_gemma":0.00048245312,"threshold_uncertainty_score":0.015124619},"labels":[],"label_agreement":null},{"id":"W2046705215","doi":"10.1158/0008-5472.sabcs-903","title":"Bevacizumab (BV) maintenance therapy significantly delays disease progression (PD) or death compared with placebo (PL) in the AVADO trial (BV + docetaxel [D] vs D + PL in 1st-line HER2-negative locally recurrent [LR] or metastatic breast cancer [mBC]).","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Bevacizumab; Internal medicine; Discontinuation; Concomitant; Docetaxel; Taxane; Chemotherapy; Oncology; Gastroenterology; Cancer; Urology; Breast cancer","score_opus":0.16377481921600498,"score_gpt":0.477930570792345,"score_spread":0.31415575157634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046705215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949464,0.0025570325,0.0002133639,0.00017900614,0.000095943644,0.00027159476,0.00039746283,0.00003155656,0.0013076849],"genre_scores_gemma":[0.99636024,0.0012028619,0.0003796726,0.00014583759,0.00008018425,0.00023413358,0.00040337193,0.000008511917,0.0011851786],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99964976,0.00020704333,0.000019950821,0.00005683292,0.000022725222,0.00004370729],"domain_scores_gemma":[0.9992372,0.00030317184,0.00019836603,0.00004537291,0.000020419424,0.0001956217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093804323,0.00048125433,0.0009273527,0.00014340733,0.0001005851,0.00053919794,0.00040776763,0.00052703946,0.0031893374],"category_scores_gemma":[0.0011617823,0.00024338736,0.0008664317,0.0001498584,0.00034179387,0.0003956604,0.00020747003,0.0014979579,0.00023885987],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91273355,0.0062089786,0.0024340379,0.00068608555,0.0008443518,0.000038157985,0.00008968106,0.00072224333,0.017484007,0.00015965727,0.001116883,0.0574825],"study_design_scores_gemma":[0.46881008,0.4986428,0.02244136,0.00012007442,0.001321588,0.00013523435,0.000073996176,0.0014790761,0.004170639,0.00023652255,0.0025409176,0.000027623413],"about_ca_topic_score_codex":0.00076761417,"about_ca_topic_score_gemma":0.0022435093,"teacher_disagreement_score":0.0031893374,"about_ca_system_score_codex":0.00038777693,"about_ca_system_score_gemma":0.00046026486,"threshold_uncertainty_score":0.010669351},"labels":[],"label_agreement":null},{"id":"W2047310696","doi":"10.1016/s0968-0896(02)00066-4","title":"Design and syntheses of putative bioactive taxanes","year":2002,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Queen's University; Jewish General Hospital; Institut National de la Recherche Scientifique","funders":"","keywords":"Chemistry; Epoxide; Double bond; Stereochemistry; Acetic acid; Molecular model; Alpha (finance); BETA (programming language); Side chain; Combinatorial chemistry; Biochemistry; Organic chemistry","score_opus":0.05168079949987094,"score_gpt":0.2869162146324074,"score_spread":0.23523541513253646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047310696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85315853,0.023260012,0.074905924,0.0015213841,0.0005581487,0.0017232228,0.0026263006,0.0004487649,0.041797657],"genre_scores_gemma":[0.89765537,0.026337136,0.060019396,0.00025181365,0.000086507964,0.00034322197,0.002010892,0.000082384155,0.0132132955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999107,0.0000162895,0.000011387705,0.000016980353,0.00002091304,0.000023733292],"domain_scores_gemma":[0.9999145,0.000012696164,0.000022436117,0.000011945485,0.0000150857695,0.000023258493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003101394,0.0005449475,0.00031380367,0.00042293422,0.0003618849,0.00055211544,0.0004952434,0.00030160072,0.002815653],"category_scores_gemma":[0.00032198895,0.0002644279,0.0003254287,0.00038599165,0.00032133114,0.0007349114,0.00040221695,0.0009198166,0.0009972806],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008044528,0.00061904173,0.0007834736,0.0014191387,0.000065310516,0.002124968,0.0009379017,0.010587143,0.8491212,0.03075622,0.0019405208,0.10084064],"study_design_scores_gemma":[0.0005542587,0.0028447397,0.0010811778,0.00020423355,0.00009883222,0.0011134553,0.0003502189,0.0037877194,0.86404413,0.0068452065,0.11901855,0.000057455072],"about_ca_topic_score_codex":0.00035528193,"about_ca_topic_score_gemma":0.0013250217,"teacher_disagreement_score":0.002815653,"about_ca_system_score_codex":0.0005375386,"about_ca_system_score_gemma":0.00077197485,"threshold_uncertainty_score":0.009419322},"labels":[],"label_agreement":null},{"id":"W2047759229","doi":"10.1159/000336892","title":"First-Line Bevacizumab-Containing Therapy for Triple-Negative Breast Cancer: Analysis of 585 Patients Treated in the ATHENA Study","year":2012,"lang":"en","type":"article","venue":"Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"GlaxoSmithKline; Pfizer","keywords":"Bevacizumab; Medicine; Triple-negative breast cancer; Internal medicine; Regimen; Metastatic breast cancer; Oncology; Population; Taxane; Breast cancer; Chemotherapy; Progression-free survival; Surgery; Cancer; Gastroenterology","score_opus":0.053962761082142416,"score_gpt":0.40723958135010396,"score_spread":0.35327682026796153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047759229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788886,0.0010962454,0.00005675705,0.000031387382,0.0000071422705,0.00003653515,0.00055212335,0.0000034886214,0.00032746448],"genre_scores_gemma":[0.99776447,0.00032986866,0.00009419393,0.00007114533,0.00002274566,0.000043862477,0.0014442705,0.0000041973203,0.00022522779],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99895775,0.00029958482,0.00013025732,0.00029794167,0.00019648956,0.00011799357],"domain_scores_gemma":[0.9990845,0.00021307943,0.00036242785,0.00011010111,0.00006585381,0.00016404032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010488494,0.00037859692,0.0011186721,0.00083509623,0.00027802592,0.00068389555,0.000565009,0.0005207495,0.0012200013],"category_scores_gemma":[0.001563796,0.00038059917,0.0015008592,0.0010789067,0.00022489959,0.00028545997,0.00053822563,0.00046687055,0.00025177543],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012384249,0.0004220615,0.96928275,0.00019752367,0.00431982,0.0004666347,0.0002116813,0.00036711694,0.0017557108,0.00006161599,0.00081973086,0.00971122],"study_design_scores_gemma":[0.0014647774,0.0014030221,0.99278635,0.00003916177,0.001756043,0.0005007766,0.00017039105,0.00045962894,0.0002059083,0.000037030513,0.0011575122,0.000019449944],"about_ca_topic_score_codex":0.0040799025,"about_ca_topic_score_gemma":0.0077612195,"teacher_disagreement_score":0.0040799025,"about_ca_system_score_codex":0.0006945189,"about_ca_system_score_gemma":0.000472478,"threshold_uncertainty_score":0.008112311},"labels":[],"label_agreement":null},{"id":"W2047837456","doi":"10.1021/jo061339s","title":"Synthesis of Docetaxel and Butitaxel Analogues through Kinetic Resolution of Racemic β-Lactams with 7-<i>O</i>-Triethylsilylbaccatin III","year":2007,"lang":"en","type":"article","venue":"The Journal of Organic Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of New Brunswick","funders":"National Cancer Institute","keywords":"Kinetic resolution; Steric effects; Lactam; Chemistry; Stereochemistry; Resolution (logic); Docetaxel; Beta-lactam; Organic chemistry; Enantioselective synthesis; Catalysis; Antibiotics; Medicine; Biochemistry; Chemotherapy","score_opus":0.010941709479341113,"score_gpt":0.2705639883380366,"score_spread":0.2596222788586955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047837456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97175646,0.004143235,0.015071949,0.00016900133,0.0001052469,0.00029805012,0.00079425785,0.00017444418,0.0074872905],"genre_scores_gemma":[0.9816975,0.002082818,0.008844453,0.0000866396,0.000014456634,0.000095917305,0.0009958653,0.00007177061,0.0061104936],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999874,0.000016645408,0.000018006045,0.000023419361,0.000032196407,0.00003579769],"domain_scores_gemma":[0.9999186,0.000010938571,0.000029292489,0.000014752116,0.000011378372,0.000015132169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001345362,0.00036973148,0.00032159072,0.00013773945,0.000116472336,0.00038790982,0.00025292792,0.00020831348,0.00096297654],"category_scores_gemma":[0.0001753437,0.00017808526,0.00024494593,0.00019484303,0.00017641934,0.0002596955,0.00014515634,0.000580587,0.00055565464],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000104523635,0.000029527097,0.0000861004,0.000031840777,0.000007642974,0.00006993767,0.000025405034,0.00028964152,0.99574846,0.00041361648,0.00005240818,0.0031408796],"study_design_scores_gemma":[0.000024906849,0.00020864794,0.00026787887,0.000002848623,0.000009981566,0.00010813019,0.0000064459045,0.00023892969,0.9963313,0.00003238935,0.0027638134,0.0000046861155],"about_ca_topic_score_codex":0.00055953785,"about_ca_topic_score_gemma":0.0010992629,"teacher_disagreement_score":0.00096297654,"about_ca_system_score_codex":0.00039369112,"about_ca_system_score_gemma":0.0003272372,"threshold_uncertainty_score":0.0032214522},"labels":[],"label_agreement":null},{"id":"W2048627371","doi":"10.1186/bcr3011","title":"Design of RESILIENCE: a phase 3 trial comparing capecitabine in combination with sorafenib or placebo for treatment of locally advanced or metastatic HER2-negative breast cancer","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Capecitabine; Sorafenib; Medicine; Internal medicine; Placebo; Oncology; Breast cancer; Surgical oncology; Hazard ratio; HER2 negative; Metastatic breast cancer; Cancer; Confidence interval; Hepatocellular carcinoma; Colorectal cancer; Pathology; Alternative medicine","score_opus":0.21281598285871361,"score_gpt":0.47633849023620417,"score_spread":0.26352250737749056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048627371","genre_codex":"empirical","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97232383,0.0025756962,0.0020154212,0.002096141,0.001022003,0.014745755,0.0013869974,0.0003027654,0.0035313736],"genre_scores_gemma":[0.9568768,0.0024392456,0.0059003322,0.0022663658,0.00061968894,0.024840271,0.0012955959,0.00006396539,0.005697684],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99912256,0.0004973199,0.000042968928,0.00012705753,0.0000630924,0.00014689803],"domain_scores_gemma":[0.9992854,0.0001408092,0.000201548,0.00006136838,0.000029059896,0.0002818625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002122054,0.0019024867,0.0019576186,0.00068608805,0.00037955405,0.00092730945,0.00088292843,0.0012585555,0.007851709],"category_scores_gemma":[0.0022881157,0.0006271522,0.002031921,0.00035846123,0.0014270582,0.001073178,0.0007861928,0.0027652306,0.0013353531],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9598919,0.011752795,0.0006686324,0.0005960953,0.000907973,0.00008864239,0.00008509459,0.0007017951,0.0076477663,0.0003672314,0.00086970563,0.016422274],"study_design_scores_gemma":[0.9165977,0.080513105,0.0008934659,0.00002240624,0.00029958895,0.00002835985,0.000016257974,0.00019860345,0.00047985505,0.00023750665,0.0006991638,0.000013955339],"about_ca_topic_score_codex":0.00057425996,"about_ca_topic_score_gemma":0.0013697408,"teacher_disagreement_score":0.007851709,"about_ca_system_score_codex":0.0006481428,"about_ca_system_score_gemma":0.0016979664,"threshold_uncertainty_score":0.026266634},"labels":[],"label_agreement":null},{"id":"W2048871140","doi":"10.1271/bbb.70.732","title":"Two New Alkaloidal Taxoids from the Needles of<i>Taxus canadensis</i>","year":2006,"lang":"en","type":"article","venue":"Bioscience Biotechnology and Biochemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"","keywords":"Taxus; Chemistry; Traditional medicine; Botany; Medicine; Biology","score_opus":0.008425782719421106,"score_gpt":0.24973049290683094,"score_spread":0.24130471018740984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048871140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9660045,0.013643791,0.0032652416,0.0002806656,0.00008597771,0.00028037108,0.0050571943,0.00011675762,0.011265438],"genre_scores_gemma":[0.95805895,0.008973476,0.009051059,0.0002658826,0.000049493516,0.00009203962,0.008322084,0.000029938794,0.015157232],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999578,0.0000019246343,0.0000025229838,0.0000093714025,0.00001704071,0.000011354038],"domain_scores_gemma":[0.9999138,0.0000059978506,0.000021352625,0.000005522097,0.000021512504,0.000031849013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030871248,0.0003938586,0.0002784862,0.0006080339,0.00037514843,0.0003190171,0.00017936116,0.00029759054,0.0019088236],"category_scores_gemma":[0.000087328866,0.00013851892,0.00021525973,0.0004820983,0.00030399562,0.00030055962,0.00021635852,0.0006125062,0.0004547542],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024247328,0.000018594554,0.0013003846,0.00013533162,0.0000179863,0.0003354069,0.00005947381,0.00007417499,0.9853393,0.00014795936,0.00010505979,0.012223985],"study_design_scores_gemma":[0.00014238669,0.0011317157,0.09312755,0.00007567193,0.00026023036,0.0035969215,0.0005965293,0.00044584423,0.8158448,0.00044255657,0.08425991,0.00007591566],"about_ca_topic_score_codex":0.012503981,"about_ca_topic_score_gemma":0.028918153,"teacher_disagreement_score":0.012503981,"about_ca_system_score_codex":0.000646593,"about_ca_system_score_gemma":0.0008598235,"threshold_uncertainty_score":0.024862409},"labels":[],"label_agreement":null},{"id":"W2048879818","doi":"10.1016/j.jval.2014.08.119","title":"Abraxane Versus Taxol For Patients with Advanced Breast Cancer: A Prospective Time and Motion Analysis from a Chinese Health Care Perspective","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Premedication; Breast cancer; Paclitaxel; Adverse effect; Cancer; Psychological intervention; Emergency medicine; Internal medicine; Anesthesia","score_opus":0.008759623679871185,"score_gpt":0.329815392597895,"score_spread":0.3210557689180238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048879818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99793494,0.0013598951,0.00010000802,0.000107084416,0.0000069564658,0.000017994587,0.00015137457,9.816285e-7,0.00032080582],"genre_scores_gemma":[0.99913436,0.00039797256,0.00006323638,0.0000559124,0.000016066157,0.000008591855,0.0002222442,0.0000010315827,0.0001005275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995357,0.00015982435,0.000038489063,0.00007585783,0.000056030585,0.00013412727],"domain_scores_gemma":[0.9985374,0.00056399876,0.00056757964,0.000053971118,0.000090915164,0.00018605933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009672596,0.00026151174,0.0007222776,0.00074758683,0.00039979312,0.00063967344,0.00029542542,0.0003459141,0.0020936313],"category_scores_gemma":[0.0022669844,0.00015741886,0.0015637603,0.001326714,0.0003617895,0.0006490221,0.00046587363,0.0007114086,0.000085730695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028360825,0.00046505049,0.94227904,0.00020376238,0.0023684176,0.00032325002,0.0002963221,0.0016847495,0.0008685693,0.0006009225,0.00036379986,0.022185216],"study_design_scores_gemma":[0.0010589749,0.005460772,0.98178816,0.00004011578,0.0038662248,0.00016808181,0.0011237598,0.0050798054,0.00026659525,0.00047132428,0.00063900877,0.0000370686],"about_ca_topic_score_codex":0.010442883,"about_ca_topic_score_gemma":0.014471649,"teacher_disagreement_score":0.010442883,"about_ca_system_score_codex":0.0010033203,"about_ca_system_score_gemma":0.0013270627,"threshold_uncertainty_score":0.020764172},"labels":[],"label_agreement":null},{"id":"W2049005991","doi":"10.1002/ptr.1532","title":"<i>In Vitro</i> culture studies of FlorEssence<sup>®</sup> on human tumor cell lines","year":2005,"lang":"en","type":"article","venue":"Phytotherapy Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Research (Canada); University of British Columbia","funders":"Buddhist Compassion Relief Tzu Chi Foundation; British Columbia Institute of Technology; Lotte and John Hecht Memorial Foundation","keywords":"Jurkat cells; K562 cells; Cisplatin; In vitro; Cell culture; Cell cycle; Medicine; Pharmacology; Immunostimulant; Leukemia; Chemistry; Immunology; Molecular biology; Cancer; Biology; Chemotherapy; Internal medicine; Biochemistry; T cell; Immune system","score_opus":0.14638202588019641,"score_gpt":0.49640080514700397,"score_spread":0.3500187792668076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049005991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9384663,0.013913024,0.014740585,0.0006534144,0.00027452625,0.00027941697,0.0056748516,0.00032765872,0.025670193],"genre_scores_gemma":[0.94377136,0.0081929425,0.016271804,0.00035513556,0.000112635564,0.00054643716,0.013806441,0.00008590791,0.016857402],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99976,0.00006175333,0.000037365917,0.000044589127,0.000052326868,0.000043894073],"domain_scores_gemma":[0.999828,0.000062610714,0.000018438668,0.00003916973,0.0000414373,0.000010281531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030805834,0.00039904207,0.00028237147,0.00026741272,0.0002995872,0.00021923146,0.00033819603,0.0002393523,0.0030017134],"category_scores_gemma":[0.00015531702,0.00013281783,0.00046344966,0.00040859042,0.00016571423,0.00017432494,0.00017573989,0.0003732414,0.0016795348],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034255697,0.00010013321,0.00093281874,0.00017041227,0.0000134730535,0.0002861259,0.00014951426,0.00046111844,0.9915597,0.0002763633,0.00084347563,0.004864366],"study_design_scores_gemma":[0.000015530224,0.00063608703,0.0035828382,0.000017905786,0.000031942564,0.00034025422,0.000057880352,0.0006223267,0.9850684,0.000038673734,0.009581582,0.0000065962604],"about_ca_topic_score_codex":0.003162249,"about_ca_topic_score_gemma":0.002971572,"teacher_disagreement_score":0.003162249,"about_ca_system_score_codex":0.0002593221,"about_ca_system_score_gemma":0.0001991235,"threshold_uncertainty_score":0.010041773},"labels":[],"label_agreement":null},{"id":"W2049141868","doi":"10.1002/chin.200846190","title":"ChemInform Abstract: A New pseudo‐Alkaloid Taxane and a New Rearranged Taxane from the Needles of Taxus canadensis","year":2008,"lang":"en","type":"article","venue":"ChemInform","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Taxane; Taxus; Computer science; Service (business); Biology; Business; Medicine; Botany; Internal medicine; Cancer","score_opus":0.03812313726011836,"score_gpt":0.2701594691624595,"score_spread":0.23203633190234113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049141868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8551988,0.03736777,0.013859213,0.0023852931,0.0015611448,0.0009545732,0.017339705,0.0008131913,0.070520334],"genre_scores_gemma":[0.8749166,0.017534785,0.014891071,0.0008165044,0.0002442825,0.00009727113,0.013382616,0.00016079274,0.07795611],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994767,0.0000039077977,0.0000041990575,0.000016163825,0.000018095168,0.000009931943],"domain_scores_gemma":[0.99993634,0.000008100969,0.00000775577,0.000008587754,0.000012948449,0.000026208847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057118155,0.00059518294,0.000298119,0.000947077,0.00053499464,0.00037064884,0.0003516447,0.0005285275,0.009838465],"category_scores_gemma":[0.000116621486,0.0001803302,0.0002712676,0.0007343744,0.00031523578,0.00075359404,0.00037308823,0.00084020494,0.0022671937],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005051006,0.0001260593,0.00042956258,0.0006163713,0.00004302019,0.0033778548,0.00017792458,0.0005985595,0.9471149,0.0012049886,0.0022452597,0.04356038],"study_design_scores_gemma":[0.00027051958,0.0023626322,0.015874865,0.00015563548,0.00032228988,0.009706345,0.00045909226,0.0012865196,0.6279865,0.0024561267,0.33897632,0.0001430832],"about_ca_topic_score_codex":0.0028488734,"about_ca_topic_score_gemma":0.0036820688,"teacher_disagreement_score":0.009838465,"about_ca_system_score_codex":0.00041480732,"about_ca_system_score_gemma":0.0006143469,"threshold_uncertainty_score":0.03291291},"labels":[],"label_agreement":null},{"id":"W2049213018","doi":"10.1016/j.pain.2006.01.037","title":"Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: Evidence for mitochondrial dysfunction","year":2006,"lang":"en","type":"article","venue":"Pain","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":523,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health; Canada Research Chairs; Bristol-Myers Squibb","keywords":"Paclitaxel; Peripheral neuropathy; Medicine; Allodynia; Peripheral; Neuropathic pain; Hyperalgesia; Myelin; Pathology; Anesthesia; Nociception; Chemotherapy; Internal medicine; Endocrinology; Central nervous system","score_opus":0.110283477296514,"score_gpt":0.38481727115546843,"score_spread":0.27453379385895443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049213018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950636,0.0019158248,0.0013019764,0.000044176817,0.00001382441,0.000030256804,0.00017931052,0.000032844076,0.001418085],"genre_scores_gemma":[0.9930333,0.0022442923,0.0018738777,0.000045604367,0.000008672195,0.000048352187,0.00036442425,0.000010805244,0.0023706893],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999323,0.000011144027,0.0000056913127,0.000009518928,0.000019303488,0.00002201773],"domain_scores_gemma":[0.9998611,0.00001979401,0.00004110933,0.000010931676,0.000033227818,0.000033811488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014627902,0.00022094043,0.00021628324,0.0003293385,0.000208908,0.00017294697,0.00013732216,0.00025015097,0.0015646585],"category_scores_gemma":[0.000112663656,0.00008815442,0.00019042929,0.00024013931,0.00021006468,0.0002907734,0.00012623216,0.00037003314,0.00024854767],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026066907,0.000038616923,0.00058957667,0.000079565194,0.000005586337,0.00015850387,0.000027665204,0.000023324026,0.9977362,0.000031591884,0.000013936166,0.0010346525],"study_design_scores_gemma":[0.000042706695,0.0033413284,0.059824638,0.000037693993,0.00006376565,0.002309264,0.0002678829,0.000627729,0.9317636,0.00012089695,0.0015909731,0.0000095128],"about_ca_topic_score_codex":0.000466377,"about_ca_topic_score_gemma":0.0008390317,"teacher_disagreement_score":0.0015646585,"about_ca_system_score_codex":0.0001541213,"about_ca_system_score_gemma":0.00012761758,"threshold_uncertainty_score":0.005234301},"labels":[],"label_agreement":null},{"id":"W2050360830","doi":"10.3747/co.v17i4.562","title":"Incidence of Taxane-Induced Pain and Distress in Patients Receiving Chemotherapy for Early-Stage Breast Cancer: A Retrospective, Outcomes-Based Survey","year":2010,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Regional Municipality of Durham; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Taxane; Breast cancer; Stage (stratigraphy); Incidence (geometry); Distress; Chemotherapy; Retrospective cohort study; Oncology; Internal medicine; Cancer; Clinical psychology","score_opus":0.05603659427532817,"score_gpt":0.4185789734373806,"score_spread":0.36254237916205245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050360830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990553,0.00013274452,0.000048338567,0.000030693795,0.0000018223674,0.000016647107,0.0004294136,0.000002327103,0.00028270856],"genre_scores_gemma":[0.99932766,0.00011588643,0.00006743242,0.000036285037,0.000003572918,0.000016888516,0.0003582318,7.371987e-7,0.000073383526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993467,0.0002383877,0.00012206823,0.00007045826,0.00013329912,0.00008911033],"domain_scores_gemma":[0.99767774,0.00040667562,0.0013456277,0.0000836914,0.00022451555,0.00026174684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081736373,0.0001342211,0.00022267799,0.0006353399,0.00022411636,0.00038122848,0.00022119905,0.00032133237,0.00093538756],"category_scores_gemma":[0.0024194529,0.00018537292,0.00024398888,0.00091426563,0.00020188058,0.00039693434,0.00036587068,0.0003717012,0.00020657014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029368382,0.00003185978,0.9991372,0.000009912733,0.000011077103,0.000030827538,0.000060593615,0.000014025731,0.000087034234,0.0000025482705,0.000047090954,0.0005385357],"study_design_scores_gemma":[0.0000033908404,0.00014358408,0.99917173,0.0000047723343,0.000007645596,0.00020867164,0.0002330724,0.000051310068,0.00004314725,0.0000023394375,0.00012802093,0.0000022304812],"about_ca_topic_score_codex":0.0026503077,"about_ca_topic_score_gemma":0.003157368,"teacher_disagreement_score":0.0026503077,"about_ca_system_score_codex":0.00025478526,"about_ca_system_score_gemma":0.00026812957,"threshold_uncertainty_score":0.005269766},"labels":[],"label_agreement":null},{"id":"W2050379741","doi":"10.1158/0008-5472.sabcs13-p3-13-03","title":"Abstract P3-13-03: A phase III, open-label, randomized study of eribulin versus capecitabine in patients (pts) with metastatic breast cancer (MBC): Effect of post-progression anti-cancer treatments (PPT) and metastatic progression events on overall survival","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Capecitabine; Internal medicine; Eribulin; Hazard ratio; Anthracycline; Proportional hazards model; Oncology; Progression-free survival; Taxane; Breast cancer; Metastatic breast cancer; Cancer; Confidence interval; Surgery; Chemotherapy; Colorectal cancer","score_opus":0.07583385628773552,"score_gpt":0.4838298686528856,"score_spread":0.40799601236515004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050379741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789949,0.002513075,0.0011948022,0.0011006299,0.00044596114,0.01082084,0.00248421,0.00020103708,0.0022445633],"genre_scores_gemma":[0.9741865,0.001973641,0.0030051267,0.0020102013,0.00052558695,0.011908715,0.0017949112,0.00005663259,0.0045386143],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990765,0.0005661313,0.00004660123,0.00012692536,0.00006001439,0.00012383235],"domain_scores_gemma":[0.9986299,0.00037133577,0.00023393714,0.00009653589,0.000087050044,0.0005812656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028676833,0.0021498727,0.0033965704,0.0004765459,0.0005439389,0.0013511698,0.0013436122,0.001986096,0.009331778],"category_scores_gemma":[0.0020155138,0.00073666155,0.0017756078,0.00071422063,0.0016937436,0.0011605601,0.0004715529,0.0052189026,0.0014816188],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9708055,0.013214271,0.0004835153,0.00034900926,0.0005251103,0.00004090091,0.00004096556,0.00026842652,0.0035455897,0.00010187681,0.00082475686,0.009800084],"study_design_scores_gemma":[0.9151597,0.08278998,0.00082257955,0.000014752624,0.00019349073,0.00002183626,0.000013263586,0.00026498197,0.0003026241,0.00008966742,0.00031926107,0.000007892385],"about_ca_topic_score_codex":0.0013597317,"about_ca_topic_score_gemma":0.0034872452,"teacher_disagreement_score":0.009331778,"about_ca_system_score_codex":0.0009917109,"about_ca_system_score_gemma":0.0027859504,"threshold_uncertainty_score":0.031217933},"labels":[],"label_agreement":null},{"id":"W2051365306","doi":"10.1007/s00280-009-1064-z","title":"A phase II study of biweekly pemetrexed and gemcitabine in patients with metastatic breast cancer","year":2009,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); Ottawa Regional Cancer Foundation; Ottawa Hospital","funders":"Eli Lilly Canada","keywords":"Gemcitabine; Pemetrexed; Medicine; Oncology; Internal medicine; Metastatic breast cancer; Breast cancer; Phases of clinical research; Antimetabolite; Cancer; Chemotherapy; Cisplatin","score_opus":0.016613805612389933,"score_gpt":0.35902117151985685,"score_spread":0.3424073659074669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051365306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935648,0.0017688707,0.0003806177,0.00051372615,0.00017101713,0.0016127991,0.00057398976,0.000068647125,0.0013455299],"genre_scores_gemma":[0.98837215,0.0025019192,0.0015103837,0.0007815598,0.00030765697,0.002412071,0.0012990318,0.000040465107,0.002774804],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992169,0.00039976294,0.000035567606,0.00013986902,0.00004570788,0.00016207044],"domain_scores_gemma":[0.9986947,0.00027086973,0.00016894077,0.00015514177,0.000052996074,0.00065742893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001888938,0.0017255486,0.0037876144,0.00079058815,0.00071415224,0.0012607576,0.0014597629,0.0020517616,0.0053254343],"category_scores_gemma":[0.0014388093,0.001166249,0.0018939539,0.0008285195,0.0015689692,0.0019846947,0.00062262116,0.0058829593,0.0013079105],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87627345,0.07061214,0.0020013184,0.00032844456,0.0007192519,0.00008466776,0.00019753564,0.0012680577,0.010371817,0.00012650831,0.0010509259,0.036965944],"study_design_scores_gemma":[0.67843866,0.31458312,0.004188565,0.000015282369,0.00027445753,0.000073511044,0.000060479437,0.00043974578,0.0008626975,0.000092030794,0.00095100835,0.000020424788],"about_ca_topic_score_codex":0.0019262653,"about_ca_topic_score_gemma":0.0040373392,"teacher_disagreement_score":0.0053254343,"about_ca_system_score_codex":0.0011899337,"about_ca_system_score_gemma":0.0021977047,"threshold_uncertainty_score":0.017815351},"labels":[],"label_agreement":null},{"id":"W2051878959","doi":"10.3816/cbc.2010.n.023","title":"Phase III Trials of Eribulin Mesylate (E7389) in Extensively Pretreated Patients With Locally Recurrent or Metastatic Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada","keywords":"Eribulin; Medicine; Metastatic breast cancer; Capecitabine; Internal medicine; Oncology; Anthracycline; Breast cancer; Taxane; Clinical endpoint; Cancer; Randomized controlled trial; Colorectal cancer","score_opus":0.08561982642156016,"score_gpt":0.46778926604650717,"score_spread":0.382169439624947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051878959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878011,0.004116989,0.000523755,0.00075778033,0.000139532,0.001412309,0.0011446016,0.000118554985,0.003985394],"genre_scores_gemma":[0.98596144,0.0044881715,0.0011950611,0.0008439315,0.00017527546,0.0012205391,0.00223301,0.000046862933,0.0038357924],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999569,0.00023498439,0.000015205329,0.00003518447,0.000025380588,0.00012023778],"domain_scores_gemma":[0.9995808,0.00008838607,0.000074337375,0.00003387,0.000019749528,0.00020279117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012770449,0.0013163653,0.0020160319,0.00048930553,0.00038243827,0.0007077398,0.0008235851,0.000852509,0.0042443653],"category_scores_gemma":[0.00073037005,0.00046284354,0.0008533229,0.0006069237,0.00074862735,0.0006957249,0.00036675893,0.002405059,0.000974905],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6452221,0.040849555,0.007992032,0.00089103746,0.0016489518,0.0003879968,0.00038164703,0.0047506616,0.051200867,0.0009820673,0.008560452,0.2371326],"study_design_scores_gemma":[0.5458852,0.4147562,0.022057164,0.000073052724,0.0007359301,0.0004982791,0.0001697589,0.0015739837,0.006048313,0.0005081262,0.0076552033,0.000038827733],"about_ca_topic_score_codex":0.0016448159,"about_ca_topic_score_gemma":0.006050619,"teacher_disagreement_score":0.0042443653,"about_ca_system_score_codex":0.00071812456,"about_ca_system_score_gemma":0.0010950033,"threshold_uncertainty_score":0.01419878},"labels":[],"label_agreement":null},{"id":"W2053269389","doi":"10.1016/s0968-0896(01)00106-7","title":"Microbial and reducing agents catalyze the rearrangement of taxanes","year":2001,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Queen's University; Jewish General Hospital; Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Chemistry; Taxane; Derivative (finance); Stereochemistry; Double bond; Organic chemistry","score_opus":0.02277994001364311,"score_gpt":0.29191337699412795,"score_spread":0.26913343698048486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053269389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9300272,0.013940046,0.0133062145,0.00089481246,0.00039089803,0.00032260438,0.00085605454,0.00027202905,0.039990194],"genre_scores_gemma":[0.9814703,0.005652702,0.0043019466,0.00014626748,0.00006613769,0.000035642897,0.00048814778,0.000036333757,0.0078025283],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983394,0.000030393157,0.000011474125,0.000030902946,0.00003774238,0.000055533397],"domain_scores_gemma":[0.99984,0.000041721756,0.000047826023,0.000023708315,0.000017745702,0.000028973222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025902683,0.0005691935,0.00020677724,0.00042964568,0.0002694979,0.00028620282,0.0004273309,0.00039132056,0.005867488],"category_scores_gemma":[0.0004244326,0.00018867113,0.00033495648,0.0002678199,0.000307468,0.0006137164,0.00033651557,0.0008301091,0.0013846324],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011299704,0.00047521747,0.0014434636,0.0005855024,0.00011246568,0.0009896593,0.000602892,0.0016364738,0.9256807,0.010120904,0.0015918574,0.0556309],"study_design_scores_gemma":[0.00004699726,0.0007068108,0.0012380292,0.00003285731,0.000034343717,0.0005077224,0.00009508685,0.0005126942,0.98045576,0.00087901595,0.015475047,0.000015569856],"about_ca_topic_score_codex":0.00069932657,"about_ca_topic_score_gemma":0.0021433788,"teacher_disagreement_score":0.005867488,"about_ca_system_score_codex":0.00030636427,"about_ca_system_score_gemma":0.0004118041,"threshold_uncertainty_score":0.019628704},"labels":[],"label_agreement":null},{"id":"W2056593463","doi":"10.1200/jco.2011.36.4281","title":"Tamoxifen Chemoprevention and Cardiac Disease","year":2011,"lang":"en","type":"letter","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Tamoxifen; Disease; Internal medicine; Oncology; Breast cancer; Cancer","score_opus":0.188548134404008,"score_gpt":0.5086288547590361,"score_spread":0.3200807203550281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056593463","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013457921,0.0021078647,0.00007608254,0.9753434,0.013778478,0.000011346329,0.00004417077,0.00001722378,0.007275623],"genre_scores_gemma":[0.017268997,0.004713106,0.00033643705,0.8541348,0.10162536,0.000046684712,0.00006594414,0.000022959339,0.021785773],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991547,0.00030461463,0.00011957014,0.000081654915,0.00019876909,0.00014070517],"domain_scores_gemma":[0.99659854,0.0021919634,0.00028526853,0.00011470514,0.00036440356,0.00044513776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012721113,0.0005397296,0.0010757365,0.0005377403,0.0024635717,0.0018657598,0.0007086567,0.03279596,0.008943228],"category_scores_gemma":[0.012432387,0.00048977917,0.0009243878,0.00053439685,0.0012228843,0.0014879933,0.0008268055,0.019291501,0.0043644453],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019423553,0.00011405056,0.0027336904,0.00012060992,0.000040329778,0.013921752,0.00013526322,0.00017026966,0.0004323592,0.0037445182,0.94371533,0.034677576],"study_design_scores_gemma":[0.00051280065,0.00035110346,0.006669799,0.00077530637,0.00016479446,0.02351333,0.00046734154,0.0013917893,0.0005383805,0.013417157,0.9521234,0.000074801814],"about_ca_topic_score_codex":0.0030046944,"about_ca_topic_score_gemma":0.009949115,"teacher_disagreement_score":0.03279596,"about_ca_system_score_codex":0.002477246,"about_ca_system_score_gemma":0.0021145327,"threshold_uncertainty_score":0.029918075},"labels":[],"label_agreement":null},{"id":"W2057012249","doi":"10.1016/s0040-4039(03)01120-1","title":"A stereoselective intramolecular Diels–Alder strategy for the tricyclo[9.3.1.03,8]pentadecane core of aromatic C-ring taxanes","year":2003,"lang":"en","type":"article","venue":"Tetrahedron Letters","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Chemistry; Pentadecane; Stereoselectivity; Intramolecular force; Ring (chemistry); Diels–Alder reaction; Lewis acids and bases; Stereochemistry; Intramolecular reaction; Yield (engineering); Medicinal chemistry; Organic chemistry; Catalysis","score_opus":0.04668487841272557,"score_gpt":0.3312788759013446,"score_spread":0.284593997488619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057012249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8879967,0.0030984269,0.044100326,0.0006572359,0.00040461446,0.0005976679,0.0009813551,0.00038011878,0.06178363],"genre_scores_gemma":[0.9701967,0.0022136876,0.01268961,0.00021816601,0.000041650303,0.00010887469,0.00036306586,0.000065886874,0.014102376],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998685,0.000019054269,0.000014139407,0.000023593055,0.000022487202,0.00005209289],"domain_scores_gemma":[0.99995077,0.0000063386237,0.000011021795,0.000009527042,0.0000063596344,0.000016058855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019989736,0.0004621703,0.0002453159,0.0002652614,0.00029787552,0.00027118798,0.0003953226,0.0002648409,0.0028103201],"category_scores_gemma":[0.00011281416,0.00026602347,0.00026284708,0.00026548785,0.0002168147,0.00034353478,0.00037969265,0.0006566832,0.0010943172],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034191634,0.0003061236,0.00026165822,0.0003001205,0.000026657286,0.0010753568,0.00032376667,0.001836493,0.9545023,0.007271216,0.0012295854,0.03252486],"study_design_scores_gemma":[0.00014730188,0.0010866576,0.0013434858,0.000029830078,0.000032374843,0.00085332186,0.00008017834,0.001342807,0.9733489,0.000991769,0.020703549,0.000039860184],"about_ca_topic_score_codex":0.0008108693,"about_ca_topic_score_gemma":0.0025219796,"teacher_disagreement_score":0.0028103201,"about_ca_system_score_codex":0.000391097,"about_ca_system_score_gemma":0.0007752905,"threshold_uncertainty_score":0.0094015},"labels":[],"label_agreement":null},{"id":"W2057511062","doi":"10.1158/0008-5472.sabcs10-p6-12-01","title":"Abstract P6-12-01: A Meta Analysis of Risk of Cardiovascular Events in Patients with Metastatic Breast Cancer (MBC) Treated with Anti Vascular Endothelial Growth Factor (VEGF) Therapy — Bevacizumab","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Bevacizumab; Internal medicine; Heart failure; Oncology; Breast cancer; Metastatic breast cancer; Cancer; Cardiology; Chemotherapy","score_opus":0.05645698675753663,"score_gpt":0.36759500238185533,"score_spread":0.3111380156243187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057511062","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.068239644,0.9216163,0.0029356126,0.0009534044,0.0010756222,0.0008849287,0.0029673118,0.00016770318,0.001159454],"genre_scores_gemma":[0.81220424,0.1756559,0.0043768245,0.001522818,0.0006985127,0.0017166146,0.002451865,0.00009109032,0.0012821475],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98884684,0.0073327823,0.0017421495,0.0011040259,0.0007075078,0.00026676053],"domain_scores_gemma":[0.9896151,0.007464198,0.0014422277,0.00046535864,0.0007726373,0.00024053318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011299027,0.0029734548,0.015727371,0.004426278,0.00058997277,0.0037591923,0.0015749391,0.0023827087,0.004542777],"category_scores_gemma":[0.022854054,0.0013951635,0.05493457,0.0049283765,0.0004947881,0.0013597453,0.0014929418,0.0028912548,0.00045935603],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006589442,0.00003395658,0.003628923,0.04166915,0.9439873,0.00010254038,0.00002619723,0.00061445194,0.00024653514,0.00007552422,0.00047166916,0.002554368],"study_design_scores_gemma":[0.0016741387,0.00024231385,0.0029079618,0.0018907705,0.9922044,0.000053248128,0.00001733736,0.00038840994,0.00006939198,0.00011207904,0.00042586378,0.000014144486],"about_ca_topic_score_codex":0.006429342,"about_ca_topic_score_gemma":0.00843681,"teacher_disagreement_score":0.015727371,"about_ca_system_score_codex":0.0018920801,"about_ca_system_score_gemma":0.0014870536,"threshold_uncertainty_score":0.059755683},"labels":[],"label_agreement":null},{"id":"W2057702405","doi":"10.1016/j.phytochem.2004.08.042","title":"Taxanes with C-5-amino-side chains from the needles of Taxus canadensis","year":2004,"lang":"en","type":"article","venue":"Phytochemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McGill University; Jewish General Hospital; Institut National de la Recherche Scientifique","funders":"","keywords":"Taxus; Side chain; Chemistry; Stereochemistry; Botany; Biology; Organic chemistry","score_opus":0.014447830628805983,"score_gpt":0.2616457562135303,"score_spread":0.24719792558472434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057702405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797183,0.0040194215,0.0016746734,0.00019038701,0.00007424393,0.0000982497,0.0020060542,0.00004899598,0.012169701],"genre_scores_gemma":[0.98061,0.0035381413,0.0022294975,0.00013049292,0.000036725836,0.000022822693,0.0032473677,0.000023588293,0.010161389],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999707,0.000002275949,0.0000017151954,0.00000720544,0.000009542189,0.000008613862],"domain_scores_gemma":[0.99993944,0.000010232358,0.000010009901,0.0000063941166,0.000010902941,0.00002311428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035967645,0.00033888023,0.00014132305,0.00039714455,0.0003040136,0.00013911976,0.00017792624,0.00020185344,0.0027371556],"category_scores_gemma":[0.00007821665,0.00010990088,0.00019929426,0.00036038863,0.00014093092,0.00021461726,0.00015437986,0.0006411078,0.0004698569],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025786497,0.000025558695,0.0002880337,0.000079599115,0.000011607526,0.00019755759,0.000023206165,0.00015650522,0.99413174,0.0001684445,0.00008023054,0.0045796977],"study_design_scores_gemma":[0.0000829992,0.00085710216,0.014211911,0.000040987157,0.00012194088,0.00083444,0.000107039166,0.00049950124,0.95577794,0.00051571924,0.026928317,0.000022204566],"about_ca_topic_score_codex":0.0033130902,"about_ca_topic_score_gemma":0.006085861,"teacher_disagreement_score":0.0033130902,"about_ca_system_score_codex":0.00021182052,"about_ca_system_score_gemma":0.00034643718,"threshold_uncertainty_score":0.009156704},"labels":[],"label_agreement":null},{"id":"W2057735943","doi":"10.2147/ott.s63302","title":"Progression-free survival as a potential surrogate for overall survival in metastatic breast cancer","year":2014,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Institut National d'Excellence en Santé et en Services Sociaux; Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Oncology; Metastatic breast cancer; Progression-free survival; Breast cancer; Confidence interval; Population; Surrogate endpoint; Cancer; Overall survival","score_opus":0.02274941579887847,"score_gpt":0.35614130633805935,"score_spread":0.3333918905391809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057735943","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014453306,0.98031473,0.0021025767,0.0007056309,0.00020675661,0.00034346525,0.0009983486,0.000012703397,0.00086246],"genre_scores_gemma":[0.6591575,0.32504615,0.0070760176,0.0017765844,0.00088868116,0.0033757517,0.0022001404,0.000036909005,0.00044216338],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9424441,0.043101467,0.007484692,0.0021768198,0.0044312696,0.0003616095],"domain_scores_gemma":[0.8172206,0.15229273,0.023577573,0.002487948,0.0039549344,0.0004661743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.060500953,0.00088782865,0.0044003595,0.006374618,0.00028969895,0.0021877694,0.0012873712,0.001317892,0.0018165117],"category_scores_gemma":[0.11285554,0.00039248582,0.009669559,0.0064068893,0.0011041136,0.001994779,0.0011263824,0.00160357,0.00018503546],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013405652,0.00013042732,0.100098796,0.4921448,0.1514561,0.00025674643,0.00060001574,0.0056712343,0.0007505817,0.006989026,0.0043616206,0.22413501],"study_design_scores_gemma":[0.0074022375,0.009826687,0.24941365,0.25353333,0.37980163,0.0025283042,0.00087133376,0.009372238,0.0025144813,0.026037687,0.05832799,0.00037041676],"about_ca_topic_score_codex":0.0010639618,"about_ca_topic_score_gemma":0.0018143315,"teacher_disagreement_score":0.060500953,"about_ca_system_score_codex":0.0016406165,"about_ca_system_score_gemma":0.0025472995,"threshold_uncertainty_score":0.31996346},"labels":[],"label_agreement":null},{"id":"W2057805566","doi":"10.1016/s0165-2370(00)00148-0","title":"Challenges in the isolation of taxanes from Taxus canadensis by fast pyrolysis","year":2001,"lang":"en","type":"article","venue":"Journal of Analytical and Applied Pyrolysis","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Pyrolysis; Isolation (microbiology); Taxus; Chemistry; Biology; Botany; Organic chemistry; Microbiology","score_opus":0.03374362426467855,"score_gpt":0.2918198612573437,"score_spread":0.2580762369926652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057805566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.921383,0.015174224,0.050024256,0.006402185,0.0003547428,0.000203501,0.000889936,0.00014639199,0.0054218196],"genre_scores_gemma":[0.92278993,0.01408351,0.05482893,0.00080321333,0.00015732701,0.00008848953,0.0015682079,0.0001253017,0.0055551813],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995202,0.00009853273,0.000040833882,0.00008704078,0.0001765174,0.000076942255],"domain_scores_gemma":[0.9988563,0.00054541236,0.00008302412,0.00016021167,0.00025812272,0.00009693366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012607871,0.00040033297,0.0005154624,0.00051352556,0.0008378584,0.0012698089,0.0005605558,0.0006216007,0.0010238483],"category_scores_gemma":[0.0015308347,0.00031854663,0.00037310354,0.0006391162,0.0005693875,0.0013231207,0.00091938896,0.0024920292,0.0006868208],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003736861,0.00007277452,0.0026436686,0.000275475,0.00004736048,0.00041175014,0.00031892728,0.0008663847,0.95711154,0.0011248387,0.0004387382,0.036314916],"study_design_scores_gemma":[0.000054603435,0.00065285666,0.010058043,0.00011160814,0.00011057718,0.0025070305,0.0028069098,0.003073521,0.94101346,0.00838828,0.031160906,0.0000621328],"about_ca_topic_score_codex":0.001810062,"about_ca_topic_score_gemma":0.007057531,"teacher_disagreement_score":0.9981899,"about_ca_system_score_codex":0.00031274877,"about_ca_system_score_gemma":0.0010216151,"threshold_uncertainty_score":0.006667733},"labels":[],"label_agreement":null},{"id":"W2057932988","doi":"10.1016/s0168-3659(02)00323-1","title":"A lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration","year":2002,"lang":"en","type":"article","venue":"Journal of Controlled Release","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Paclitaxel; Emulsion; Chemistry; Pharmacokinetics; Prodrug; Pharmacology; Excipient; Drug carrier; Chromatography; Drug; Drug delivery; Biochemistry; Organic chemistry; Chemotherapy; Medicine; Surgery","score_opus":0.03384097637251466,"score_gpt":0.320878117615303,"score_spread":0.28703714124278834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057932988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748198,0.0025284113,0.016494175,0.0004022038,0.000106717416,0.00013383855,0.00013137136,0.0002169826,0.005166468],"genre_scores_gemma":[0.9839432,0.0011980275,0.0076311775,0.00006968516,0.000016699176,0.000025771536,0.00008777332,0.000027758231,0.006999952],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99996734,0.0000051790385,0.000002301439,0.0000068623544,0.000009350512,0.000009013301],"domain_scores_gemma":[0.9999685,0.0000056977647,0.000008866061,0.0000028948039,0.000005015745,0.000009031905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008815485,0.00018596901,0.00013827268,0.00015750428,0.000153089,0.00016555282,0.0001268502,0.00021314956,0.0009336638],"category_scores_gemma":[0.00010276653,0.000097339034,0.00011046466,0.000099747806,0.00013786403,0.00020509606,0.00013666744,0.00032384438,0.00038087065],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033344343,0.000049546084,0.000080880876,0.000051724874,0.00000548199,0.00018213059,0.000019163755,0.00017192579,0.9858926,0.00034575828,0.00012558175,0.012741725],"study_design_scores_gemma":[0.00006630277,0.00070606795,0.00046570008,0.000007102778,0.000027725377,0.00031312442,0.0000072292455,0.00073685613,0.9929334,0.000051133273,0.0046797576,0.0000057010843],"about_ca_topic_score_codex":0.0003886125,"about_ca_topic_score_gemma":0.00040952806,"teacher_disagreement_score":0.0009336638,"about_ca_system_score_codex":0.00017831568,"about_ca_system_score_gemma":0.00027227763,"threshold_uncertainty_score":0.0031234622},"labels":[],"label_agreement":null},{"id":"W2058098342","doi":"10.1097/00001813-200210000-00004","title":"Epirubicin/docetaxel regimen in progressive breast cancer—a phase II study","year":2002,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital","funders":"","keywords":"Docetaxel; Epirubicin; Medicine; Regimen; Neutropenia; Metastatic breast cancer; Febrile neutropenia; Internal medicine; Breast cancer; Chemotherapy; Adverse effect; Phases of clinical research; Oncology; Surgery; Gastroenterology; Cancer","score_opus":0.03439308193999131,"score_gpt":0.38094733083647836,"score_spread":0.34655424889648706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058098342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99586076,0.0018257218,0.00024715482,0.00012227934,0.00006285116,0.0008557895,0.00022651257,0.00003335658,0.0007656273],"genre_scores_gemma":[0.98841184,0.004174579,0.0013019473,0.00058613607,0.00024478804,0.0013177848,0.0014332801,0.00002097575,0.002508601],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99969196,0.00014163785,0.00001507088,0.00004165881,0.00004768091,0.00006209714],"domain_scores_gemma":[0.9996736,0.00005147281,0.000058556187,0.000030174699,0.00002071005,0.00016552853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009571904,0.00092339923,0.0018228092,0.00035459283,0.00033260015,0.0005642989,0.00062667,0.00064197724,0.002094847],"category_scores_gemma":[0.0004754691,0.00039307072,0.0006934138,0.00037207917,0.00057510455,0.00037951532,0.00019009114,0.002064451,0.0005268056],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3766032,0.2636712,0.014289959,0.0015480092,0.0013240522,0.0011014482,0.00037304626,0.003338559,0.11266627,0.000296921,0.0030899893,0.2216974],"study_design_scores_gemma":[0.20124288,0.76792985,0.018900251,0.000042712953,0.00035313718,0.00081464165,0.00005425811,0.00097310985,0.0057812184,0.00008464185,0.0038014988,0.00002175477],"about_ca_topic_score_codex":0.0008854767,"about_ca_topic_score_gemma":0.002442133,"teacher_disagreement_score":0.002094847,"about_ca_system_score_codex":0.00044977502,"about_ca_system_score_gemma":0.0009885465,"threshold_uncertainty_score":0.007007897},"labels":[],"label_agreement":null},{"id":"W2059358140","doi":"10.1158/1538-7445.am2012-761","title":"Abstract 761: Phase I interaction study of docetaxel with supplementation of St. John's wort","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Docetaxel; Hyperforin; Hypericum perforatum; Pharmacokinetics; Pharmacology; Medicine; CYP3A4; Midazolam; Cancer; Internal medicine; Metabolism; Cytochrome P450","score_opus":0.20223898097076431,"score_gpt":0.5716591254635875,"score_spread":0.36942014449282323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059358140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930912,0.0023853502,0.0005073057,0.00018032838,0.00018515043,0.0018950384,0.00065965974,0.00006845982,0.001027491],"genre_scores_gemma":[0.9894525,0.0023810328,0.0012737842,0.00027013398,0.00016259414,0.0013167294,0.00086373196,0.000022907472,0.0042566876],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995894,0.00016331305,0.000027250682,0.00009494095,0.00005029712,0.000074823016],"domain_scores_gemma":[0.9996234,0.00006844615,0.00008304137,0.000037239726,0.000033525455,0.00015436292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006362458,0.0010530018,0.0019581264,0.0003733944,0.00027917553,0.00074610685,0.00066337356,0.0008055327,0.0039087515],"category_scores_gemma":[0.00066442735,0.00044483025,0.0012979785,0.00034158345,0.00056316325,0.000449496,0.00019049158,0.0015149019,0.0008134708],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.67535263,0.094025716,0.0031052828,0.0018109274,0.0023077955,0.00031282814,0.00025588134,0.0016346322,0.13863346,0.000336222,0.003403127,0.07882154],"study_design_scores_gemma":[0.17083015,0.8000119,0.0075128963,0.000037133672,0.00089917635,0.00026381147,0.00005754229,0.0010366531,0.015215011,0.000091140726,0.00399827,0.00004635666],"about_ca_topic_score_codex":0.0011230096,"about_ca_topic_score_gemma":0.002847072,"teacher_disagreement_score":0.0039087515,"about_ca_system_score_codex":0.00070822355,"about_ca_system_score_gemma":0.001253482,"threshold_uncertainty_score":0.013076067},"labels":[],"label_agreement":null},{"id":"W2059539152","doi":"10.1517/14656566.1.2.187","title":"Chemotherapy of breast cancer: are the taxanes going to change the natural history of breast cancer?","year":2000,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Breast cancer; Natural history; Oncology; Chemotherapy; Cancer; Internal medicine","score_opus":0.08829158977714896,"score_gpt":0.42387209305990864,"score_spread":0.3355805032827597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059539152","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003757171,0.9146664,0.00059244747,0.07578415,0.0019588717,0.000012713235,0.00006671094,0.000024432667,0.00313704],"genre_scores_gemma":[0.030581243,0.93293446,0.0006451923,0.02597846,0.0060193334,0.00003197998,0.00009907564,0.000022845841,0.0036874416],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990658,0.0004097071,0.00007090235,0.00012226726,0.00025568006,0.00007565099],"domain_scores_gemma":[0.99780077,0.001079837,0.0003055929,0.00010485441,0.00047107082,0.00023790274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024737641,0.00033450781,0.00087233767,0.0005049586,0.0004130554,0.0018751213,0.0006190711,0.0017163769,0.004762919],"category_scores_gemma":[0.005069367,0.00018401183,0.0003367285,0.0008455834,0.0017146416,0.0035274106,0.0006953935,0.003434908,0.0015477623],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000712673,0.00023024954,0.0050644856,0.003878921,0.00012617525,0.00031415184,0.00045058425,0.0005023911,0.003675726,0.0198584,0.069504976,0.8956813],"study_design_scores_gemma":[0.00019011687,0.0012833839,0.011964701,0.003695444,0.00013102566,0.0017115938,0.0008943184,0.00029003547,0.0015169855,0.028785102,0.9494788,0.000058446945],"about_ca_topic_score_codex":0.0011606474,"about_ca_topic_score_gemma":0.0023818281,"teacher_disagreement_score":0.004762919,"about_ca_system_score_codex":0.0011645344,"about_ca_system_score_gemma":0.0014484064,"threshold_uncertainty_score":0.015933573},"labels":[],"label_agreement":null},{"id":"W2059784303","doi":"10.1016/j.critrevonc.2015.01.007","title":"Patients’ satisfaction in early breast cancer treatment: Change in treatment over time and impact of HER2-targeted therapy","year":2015,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Research Society; American Society for Radiation Oncology; American Association for Cancer Research","keywords":"Breast cancer; Medicine; Quality of life (healthcare); Oncology; Adjuvant; Targeted therapy; Adjuvant therapy; Cancer; Internal medicine; Human Epidermal Growth Factor Receptor 2; Nursing","score_opus":0.13091745782011374,"score_gpt":0.5000722111753172,"score_spread":0.3691547533552034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059784303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007607755,0.9984346,0.000042701635,0.00035803523,0.00008399446,0.0000050536246,0.00003549508,0.0000014722955,0.000278015],"genre_scores_gemma":[0.0069928113,0.99195063,0.00018764334,0.00046067222,0.00015212175,0.0000139487975,0.000053338586,0.0000011339984,0.00018771851],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9993649,0.00023050199,0.000091564674,0.000068105925,0.00020145487,0.000043413587],"domain_scores_gemma":[0.99866307,0.0008793771,0.00025562992,0.000011420319,0.00014332386,0.00004718825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013974194,0.00041499166,0.0018088096,0.0007574788,0.00013404666,0.00084551086,0.0006362501,0.0007317042,0.0021534837],"category_scores_gemma":[0.002541232,0.00016255496,0.0010938549,0.0015603134,0.00026953156,0.00062265585,0.00041226856,0.0012176504,0.00023924415],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032846944,0.00013898367,0.0024710847,0.035737075,0.0011402526,0.00007704332,0.00012771532,0.00023112631,0.00029344103,0.00087596447,0.012538862,0.94604003],"study_design_scores_gemma":[0.0007693373,0.0022151768,0.12149033,0.10183285,0.007759842,0.0041025765,0.0016212934,0.0009325224,0.0011023954,0.0040049516,0.7539015,0.00026728632],"about_ca_topic_score_codex":0.0017088188,"about_ca_topic_score_gemma":0.004007904,"teacher_disagreement_score":0.0021534837,"about_ca_system_score_codex":0.00080047175,"about_ca_system_score_gemma":0.0009098684,"threshold_uncertainty_score":0.0073903203},"labels":[],"label_agreement":null},{"id":"W2059854615","doi":"10.1200/jco.2011.37.2326","title":"Reply to C. McCowan et al","year":2011,"lang":"fr","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine","score_opus":0.3615371352753022,"score_gpt":0.5805508081408391,"score_spread":0.21901367286553697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059854615","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012750129,0.0015423414,0.00005562799,0.95239246,0.045220785,0.0000067030537,0.0000605278,0.000024964482,0.0005690806],"genre_scores_gemma":[0.0012105688,0.00096843654,0.00011145972,0.96439946,0.031116161,0.000019424622,0.000030336127,0.000016075252,0.0021279673],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99670035,0.0008530832,0.00046774017,0.00055271015,0.0010176391,0.00040835055],"domain_scores_gemma":[0.98261976,0.008688648,0.0010431295,0.0005873822,0.0051209717,0.001940072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052122157,0.0010835397,0.0017872194,0.0012191737,0.0030261786,0.0037966988,0.0034213383,0.042614806,0.008194806],"category_scores_gemma":[0.040415727,0.0010016718,0.0015166403,0.0011742897,0.003501696,0.004923202,0.0023868256,0.04803885,0.008783691],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026292075,0.0000070175442,0.00013030767,0.00004232565,0.000008448331,0.0002464953,0.000042637683,0.000014218533,0.000040551175,0.00036018802,0.99727315,0.0018084071],"study_design_scores_gemma":[0.00008144839,0.000046650173,0.0012054708,0.00030140378,0.00005208632,0.0023106872,0.00060267875,0.00018938439,0.0004184543,0.004097084,0.9905972,0.0000974487],"about_ca_topic_score_codex":0.004199601,"about_ca_topic_score_gemma":0.00562231,"teacher_disagreement_score":0.042614806,"about_ca_system_score_codex":0.0028588565,"about_ca_system_score_gemma":0.0038431082,"threshold_uncertainty_score":0.027565181},"labels":[],"label_agreement":null},{"id":"W2060483764","doi":"10.1016/j.ijpharm.2003.10.010","title":"The characterization of novel polymeric paste formulations for intratumoral delivery","year":2003,"lang":"en","type":"article","venue":"International Journal of Pharmaceutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); University of British Columbia","funders":"","keywords":"Differential scanning calorimetry; Gel permeation chromatography; Polyethylene glycol; Polymer; Copolymer; Materials science; Dosage form; Polymer chemistry; Paclitaxel; Polycaprolactone; Drug carrier; Chemistry; Nuclear chemistry; Drug delivery; Chemical engineering; Chromatography; Organic chemistry; Composite material; Nanotechnology; Surgery","score_opus":0.05704963008698588,"score_gpt":0.3944571163726115,"score_spread":0.3374074862856256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060483764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.960154,0.0025340545,0.03480846,0.00015513714,0.00006384875,0.0001753666,0.00017525877,0.00012407587,0.0018097863],"genre_scores_gemma":[0.97795105,0.00089084083,0.0182596,0.000057327008,0.00001419288,0.000083265106,0.0001678825,0.000059324542,0.002516491],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999874,0.000018249248,0.000008468837,0.000026588124,0.00005577356,0.000016867463],"domain_scores_gemma":[0.99985766,0.00004464625,0.00003761234,0.000012150324,0.000033231066,0.000014541619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026398656,0.0002443772,0.00018925831,0.00018831938,0.00010451498,0.00022422709,0.0001688634,0.00036989345,0.00093802036],"category_scores_gemma":[0.00043396707,0.00016027142,0.0001873144,0.00010019194,0.00017865808,0.00039576454,0.00010722935,0.00041285477,0.00024310278],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031358373,0.000010604512,0.000027402746,0.000014720632,0.0000012059174,0.000014798414,0.0000048595834,0.000038647235,0.99808145,0.00002412884,0.000012437365,0.0017383464],"study_design_scores_gemma":[0.000006539963,0.00023200239,0.00053705234,0.0000018510448,0.0000064451683,0.000114147835,0.000003821758,0.00069132226,0.9977968,0.000017176253,0.0005907883,0.0000020777406],"about_ca_topic_score_codex":0.00013270795,"about_ca_topic_score_gemma":0.0002159692,"teacher_disagreement_score":0.00093802036,"about_ca_system_score_codex":0.00015030002,"about_ca_system_score_gemma":0.00012921802,"threshold_uncertainty_score":0.0031380057},"labels":[],"label_agreement":null},{"id":"W2061010495","doi":"10.1016/j.bmcl.2011.06.034","title":"Effects of C7 substitutions in a high affinity microtubule-binding taxane on antitumor activity and drug transport","year":2011,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Ministry of Science and Technology; Ministerio de Ciencia e Innovación; National Natural Science Foundation of China; Canadian Cancer Society; Comunidad de Madrid","keywords":"Chemistry; Microtubule; Taxane; Cytotoxicity; Paclitaxel; P-glycoprotein; Affinities; Drug; Binding site; In vitro; Plasma protein binding; Stereochemistry; Biochemistry; Structure–activity relationship; Multiple drug resistance; Pharmacology; Cell biology; Cancer","score_opus":0.01337976189394388,"score_gpt":0.23701707771642486,"score_spread":0.22363731582248098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061010495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99795437,0.00033998865,0.00023866411,0.00009204541,0.000054315187,0.000015749893,0.00020429332,0.00003192748,0.0010687123],"genre_scores_gemma":[0.9981407,0.00022371246,0.0003099968,0.000059551465,0.000015031602,0.000008525063,0.00024118161,0.00003895712,0.00096241076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99956554,0.00012668702,0.000064750835,0.000053367068,0.00008215247,0.000107598506],"domain_scores_gemma":[0.9994599,0.00022682945,0.00008097979,0.00004702546,0.00008345225,0.000101784455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003305404,0.0004003929,0.0004642029,0.00026526494,0.00038903306,0.00039291204,0.0006268979,0.0007965811,0.006351188],"category_scores_gemma":[0.00065609737,0.00024389352,0.0003935371,0.00027145364,0.00054221676,0.00035189185,0.0002612344,0.0008472363,0.0010296789],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005682783,0.0004800648,0.0005428319,0.000056611945,0.00010053228,0.00048120154,0.000050464918,0.0014152003,0.98610395,0.000534161,0.0003263452,0.00422595],"study_design_scores_gemma":[0.00026474058,0.0019922797,0.0018606836,0.000013076876,0.00010547911,0.0004564994,0.000052802992,0.00336696,0.9896938,0.00011213446,0.002048697,0.000032834432],"about_ca_topic_score_codex":0.0049565504,"about_ca_topic_score_gemma":0.003535658,"teacher_disagreement_score":0.006351188,"about_ca_system_score_codex":0.00050521595,"about_ca_system_score_gemma":0.000539071,"threshold_uncertainty_score":0.02124691},"labels":[],"label_agreement":null},{"id":"W2061026641","doi":"10.1097/jto.0000000000000011","title":"Patient-Reported Neuropathy and Taxane-Associated Symptoms in a Phase 3 Trial of nab-Paclitaxel Plus Carboplatin versus Solvent-Based Paclitaxel Plus Carboplatin for Advanced Non–Small-Cell Lung Cancer","year":2013,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Celgene","keywords":"Medicine; Carboplatin; Internal medicine; Taxane; Peripheral neuropathy; Neutropenia; Lung cancer; Peripheral edema; Paclitaxel; Gastroenterology; Cancer; Oncology; Toxicity; Surgery; Chemotherapy; Breast cancer; Adverse effect; Cisplatin; Diabetes mellitus","score_opus":0.02962712005654688,"score_gpt":0.41083622599818354,"score_spread":0.38120910594163665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061026641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982553,0.0006339166,0.000086511405,0.000117714764,0.00004942876,0.00021273231,0.00017253698,0.000010674906,0.00046111483],"genre_scores_gemma":[0.998147,0.00048607393,0.00024100677,0.00018611965,0.000050740786,0.00021984513,0.00030616167,0.0000060321404,0.00035702204],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99937856,0.00034224548,0.000044703407,0.000079503036,0.000053891086,0.00010117683],"domain_scores_gemma":[0.99887913,0.0004211797,0.00019111221,0.000065515014,0.00005244321,0.0003906456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021836192,0.0008069236,0.0017788241,0.00030586318,0.0005123829,0.000763261,0.000762315,0.0010363172,0.002262425],"category_scores_gemma":[0.0018560146,0.0004185155,0.001861185,0.00043726753,0.000747501,0.0009012458,0.00025089885,0.0032452154,0.00025491745],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89610124,0.029994339,0.008825294,0.0005360504,0.002067666,0.0003753435,0.0002600319,0.0018481547,0.011895527,0.00013033072,0.0010801469,0.04688586],"study_design_scores_gemma":[0.4784235,0.47279194,0.041204356,0.000060888815,0.0015955616,0.000535111,0.00015062783,0.0022306459,0.0016136654,0.00031023414,0.0010290609,0.000054391345],"about_ca_topic_score_codex":0.0010560317,"about_ca_topic_score_gemma":0.0047131744,"teacher_disagreement_score":0.002262425,"about_ca_system_score_codex":0.0009251054,"about_ca_system_score_gemma":0.0011211064,"threshold_uncertainty_score":0.011548221},"labels":[],"label_agreement":null},{"id":"W2063601993","doi":"10.1016/j.pain.2011.12.011","title":"Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin","year":2012,"lang":"en","type":"article","venue":"Pain","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Neurological Disorders and Stroke; National Institute for Health and Care Research; Canadian Institutes of Health Research; Health Canada; National Institutes of Health; Louise and Alan Edwards Foundation","keywords":"Neuropathic pain; Medicine; Peripheral neuropathy; Pharmacology; Allodynia; Hyperalgesia; Anesthesia; Auranofin; Pregabalin; Oxaliplatin; Nociception; Internal medicine; Endocrinology; Cancer; Diabetes mellitus","score_opus":0.020762477767600353,"score_gpt":0.2863357563484169,"score_spread":0.26557327858081653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063601993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987801,0.0005273361,0.0001424,0.00002865154,0.0000136228755,0.000016733107,0.000046721154,0.00001745201,0.00042709833],"genre_scores_gemma":[0.99814165,0.00087767415,0.0003403,0.00003118853,0.000010126341,0.00001897002,0.00009087375,0.0000029264381,0.0004863602],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990606,0.000023956422,0.000009762937,0.000013558606,0.000014571754,0.000032105418],"domain_scores_gemma":[0.9997967,0.000043447715,0.000064774395,0.000016691187,0.00001723788,0.00006122858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016943694,0.00037608825,0.00027192454,0.00033814154,0.00018870352,0.0001625266,0.000157105,0.0003029945,0.0009797133],"category_scores_gemma":[0.00029319472,0.00015196564,0.00024131584,0.00018503157,0.00029571963,0.00030235416,0.00013149178,0.00044684662,0.000076860095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008289496,0.0010262912,0.0012487866,0.0002274462,0.000062027466,0.00028274997,0.00008527533,0.00041025734,0.9776148,0.00029718375,0.00011794128,0.010337748],"study_design_scores_gemma":[0.0008979091,0.04419824,0.02834827,0.000067716384,0.00018856862,0.00072456215,0.0001627755,0.0015519318,0.9220363,0.0001730332,0.0016242235,0.000026439006],"about_ca_topic_score_codex":0.0007621693,"about_ca_topic_score_gemma":0.0018784316,"teacher_disagreement_score":0.0009797133,"about_ca_system_score_codex":0.00023162922,"about_ca_system_score_gemma":0.0002374267,"threshold_uncertainty_score":0.0032774806},"labels":[],"label_agreement":null},{"id":"W2063908296","doi":"10.3747/co.22.2210","title":"Use of Bevacizumab as a First-Line Treatment for Metastatic Breast Cancer","year":2015,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Celgene; AstraZeneca","keywords":"Bevacizumab; Medicine; Metastatic breast cancer; Oncology; Breast cancer; Chemotherapy; Disease; Internal medicine; Clinical trial; Cancer","score_opus":0.4695800343564018,"score_gpt":0.5319005441505176,"score_spread":0.0623205097941158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063908296","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003852043,0.9881769,0.0005654641,0.0031079685,0.00029239195,0.000019095938,0.000045299836,0.00001886938,0.0039219037],"genre_scores_gemma":[0.116687655,0.8743594,0.0027098171,0.0035141557,0.0009448436,0.00006078556,0.00019520061,0.0000147754845,0.001513319],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988159,0.00060598017,0.000121395,0.00013156835,0.00027194395,0.0000532333],"domain_scores_gemma":[0.99771607,0.0011290571,0.0005915492,0.00004810217,0.0004300408,0.00008514211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018089837,0.00028483523,0.00066525105,0.0008445692,0.00016601742,0.00070422975,0.0003820367,0.00060783635,0.0017726204],"category_scores_gemma":[0.004368826,0.000095963216,0.00059291476,0.0006733984,0.00030511874,0.00041348144,0.00024913225,0.0007505278,0.00042368984],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009718074,0.00012636335,0.0046624453,0.020829655,0.00086080865,0.00083035737,0.00015667314,0.00072037586,0.009341758,0.0019620324,0.025915692,0.93362194],"study_design_scores_gemma":[0.0005732744,0.0022283765,0.03119594,0.028767787,0.0018626853,0.010715611,0.0002658243,0.00079556205,0.012948572,0.0020292646,0.9085601,0.00005704806],"about_ca_topic_score_codex":0.0012367882,"about_ca_topic_score_gemma":0.0026793121,"teacher_disagreement_score":0.0018089837,"about_ca_system_score_codex":0.0008631101,"about_ca_system_score_gemma":0.0013093014,"threshold_uncertainty_score":0.009566963},"labels":[],"label_agreement":null},{"id":"W2064680741","doi":"10.1016/j.ejca.2011.11.021","title":"Safety of bevacizumab in metastatic breast cancer patients undergoing surgery","year":2011,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Bevacizumab; Surgery; Metastatic breast cancer; Incidence (geometry); Breast cancer; Adverse effect; Complication; Placebo; Breast surgery; Cancer; Chemotherapy; Internal medicine","score_opus":0.04557765805459347,"score_gpt":0.30990334728207297,"score_spread":0.2643256892274795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064680741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99027,0.0071566678,0.00026715925,0.00044898503,0.000048347763,0.000020702146,0.00021057246,0.000012418972,0.0015650871],"genre_scores_gemma":[0.9983059,0.0008711667,0.000081384125,0.0001633493,0.00006547217,0.000008482257,0.00019743411,0.0000034844654,0.00030329655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995054,0.0002328498,0.000034598055,0.000046944435,0.00012141291,0.00005887646],"domain_scores_gemma":[0.9984402,0.0006271782,0.0005795103,0.0000582621,0.00013709225,0.00015768393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062951347,0.0001658924,0.00067495846,0.00019866759,0.0001956027,0.0004965087,0.00014001594,0.00036297832,0.0009198591],"category_scores_gemma":[0.003281208,0.00012009397,0.00054199324,0.00024619294,0.00017014037,0.0002965737,0.00013842386,0.00095531857,0.00014887298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18014178,0.0010745842,0.5003507,0.0007053844,0.0023335645,0.0009796096,0.00031537958,0.0018529525,0.027478795,0.00054119196,0.0024701285,0.28175598],"study_design_scores_gemma":[0.007959267,0.102842964,0.85319585,0.00021874765,0.0029074873,0.0044604056,0.0003245314,0.0048629856,0.0104083,0.0010903062,0.01166588,0.00006319127],"about_ca_topic_score_codex":0.00074684987,"about_ca_topic_score_gemma":0.0013492311,"teacher_disagreement_score":0.0009198591,"about_ca_system_score_codex":0.0005254316,"about_ca_system_score_gemma":0.00047757334,"threshold_uncertainty_score":0.0038122535},"labels":[],"label_agreement":null},{"id":"W2065408496","doi":"10.1017/s0317167100002043","title":"Electronic Case-Report Forms of Symptoms and Impairments of Peripheral Neuropathy","year":2002,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Genentech; National Institute of Neurological Disorders and Stroke; Eli Lilly and Company","keywords":"Medicine; Clinical trial; Peripheral neuropathy; Data entry; Audit; Patient recruitment; Medical record; Physical therapy; Medical physics; Medical emergency; Database; Surgery; Computer science; Internal medicine","score_opus":0.024941183803798735,"score_gpt":0.2872100289015597,"score_spread":0.262268845097761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065408496","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5636085,0.006096554,0.09031479,0.0028812643,0.0013078875,0.06005234,0.13048102,0.0038823243,0.14137524],"genre_scores_gemma":[0.7234148,0.0044344645,0.14418805,0.0021932928,0.0010085856,0.03300182,0.05001117,0.00043479993,0.04131304],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98428357,0.007955982,0.0041387132,0.000970189,0.0023643964,0.0002871631],"domain_scores_gemma":[0.92469895,0.027906807,0.022131331,0.011772707,0.0122524295,0.0012378033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013035764,0.00081407186,0.0006926562,0.004838544,0.00043473535,0.0012693058,0.0016617894,0.0008820599,0.03358046],"category_scores_gemma":[0.046117082,0.00030695982,0.00053323596,0.0031806568,0.0006060234,0.0015836391,0.0015228776,0.0007135077,0.008196212],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069121057,0.002280164,0.30804032,0.0030959523,0.0002070764,0.0027591935,0.0014551302,0.0018355125,0.004361581,0.0030013495,0.09714692,0.5689047],"study_design_scores_gemma":[0.0033180271,0.006432393,0.7245884,0.0025710845,0.00037282336,0.020012058,0.002026941,0.0061391117,0.017999785,0.0042320075,0.21204694,0.00026038164],"about_ca_topic_score_codex":0.00081392715,"about_ca_topic_score_gemma":0.00084112614,"teacher_disagreement_score":0.03358046,"about_ca_system_score_codex":0.0005825809,"about_ca_system_score_gemma":0.0015238973,"threshold_uncertainty_score":0.11233783},"labels":[],"label_agreement":null},{"id":"W2065772375","doi":"10.1271/bbb.110223","title":"Novel Taxa-4(20),12-diene and 2(3→20)<i>Abeo</i>taxane from Needles of<i>Taxus canadensis</i>","year":2011,"lang":"en","type":"article","venue":"Bioscience Biotechnology and Biochemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Hebei Medical University; National Natural Science Foundation of China","keywords":"Taxane; Diene; Stereochemistry; Taxus; Chemistry; Botany; Biology; Organic chemistry","score_opus":0.023150044056059405,"score_gpt":0.24164917574802708,"score_spread":0.21849913169196766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065772375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98130304,0.0061481786,0.0032623243,0.00014574578,0.000071501345,0.00012603469,0.0024463886,0.000046918787,0.0064498824],"genre_scores_gemma":[0.9736309,0.0056980033,0.007885586,0.00014974155,0.00005482311,0.000062384664,0.004103511,0.000018516032,0.00839656],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99997103,0.0000031441823,0.0000022822792,0.000007943634,0.000008829708,0.000006737413],"domain_scores_gemma":[0.99995387,0.000003411227,0.00000933039,0.0000033096944,0.000007902756,0.000022187405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044805452,0.00035073253,0.00020053783,0.00044001904,0.00023521653,0.00017176535,0.00014837271,0.00018464084,0.0020207807],"category_scores_gemma":[0.000068718626,0.00010322371,0.00018268668,0.00032420366,0.00017518994,0.00027459156,0.0001760718,0.0003959653,0.000352983],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021877862,0.00005115913,0.0007793497,0.00017826243,0.000020290205,0.0004803855,0.00007561017,0.00024096906,0.9869048,0.00034820917,0.00012485046,0.010577365],"study_design_scores_gemma":[0.00017490733,0.002212578,0.044829633,0.00007414538,0.00015392389,0.0033893401,0.00044119917,0.0008214118,0.8715408,0.0011565544,0.075108595,0.000096885735],"about_ca_topic_score_codex":0.0011337872,"about_ca_topic_score_gemma":0.0033210765,"teacher_disagreement_score":0.9988662,"about_ca_system_score_codex":0.00020206509,"about_ca_system_score_gemma":0.0003661526,"threshold_uncertainty_score":0.00676018},"labels":[],"label_agreement":null},{"id":"W2066557153","doi":"10.1007/s10637-011-9673-x","title":"A phase II study of the halichondrin B analog eribulin mesylate in gemcitabine refractory advanced pancreatic cancer","year":2011,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Gemcitabine; Eribulin; Medicine; Internal medicine; Pancreatic cancer; Neutropenia; Gastroenterology; Phases of clinical research; Oncology; Progressive disease; Clinical endpoint; Refractory (planetary science); Adverse effect; Cancer; Metastatic breast cancer; Chemotherapy; Breast cancer; Clinical trial","score_opus":0.04866918016163396,"score_gpt":0.34107250550963053,"score_spread":0.29240332534799657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066557153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99474996,0.0015593676,0.0003659733,0.00034556098,0.000088270834,0.0009529833,0.00047339557,0.000043225147,0.0014213852],"genre_scores_gemma":[0.99097097,0.00263449,0.00096736895,0.0005635799,0.00012096899,0.001028304,0.0012184145,0.000031004565,0.002464819],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99962187,0.0002094315,0.000016115038,0.00005206713,0.000023228062,0.000077285746],"domain_scores_gemma":[0.9994436,0.00010264693,0.000075196214,0.00006531311,0.00002547753,0.00028775804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011905126,0.0011593583,0.0022779126,0.00046833637,0.00043367737,0.0008930809,0.0008365808,0.0011068122,0.0031446638],"category_scores_gemma":[0.0006931683,0.0005426839,0.0010028105,0.0004700531,0.0009917959,0.0010351883,0.00034933735,0.0026882295,0.0007296066],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73749495,0.08203226,0.0056531997,0.00086208433,0.0014897599,0.0005624188,0.0003835496,0.0049992804,0.06086393,0.00044563497,0.0032732922,0.10193968],"study_design_scores_gemma":[0.4963288,0.48335332,0.008862546,0.00003409113,0.00051339925,0.00040138935,0.0001427749,0.0014713849,0.0053763418,0.00026277232,0.0032126342,0.000040576055],"about_ca_topic_score_codex":0.0012822364,"about_ca_topic_score_gemma":0.003241423,"teacher_disagreement_score":0.0031446638,"about_ca_system_score_codex":0.00079063897,"about_ca_system_score_gemma":0.0010978088,"threshold_uncertainty_score":0.010519922},"labels":[],"label_agreement":null},{"id":"W2066616838","doi":"10.1158/0008-5472.sabcs10-p6-11-11","title":"Abstract P6-11-11: Trastuzumab beyond Progression in HER2-Positive Advanced Breast Cancer: The Royal Marsden Experience","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Trastuzumab; Breast cancer; Internal medicine; Metastatic breast cancer; Cancer; Oncology; Chemotherapy; Disease; Adjuvant; Surgery","score_opus":0.034655863913858005,"score_gpt":0.4599737779359959,"score_spread":0.4253179140221379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066616838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98013717,0.011471138,0.0004304356,0.0011439286,0.000088431705,0.000065721055,0.0002239332,0.00002703138,0.006412261],"genre_scores_gemma":[0.9856647,0.008539889,0.0007507016,0.0006276601,0.00025610166,0.000035383324,0.0003888124,0.000022030155,0.0037146034],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99899334,0.0005266526,0.00007619105,0.00012355203,0.00016723925,0.00011298332],"domain_scores_gemma":[0.9990891,0.00023887397,0.00016470999,0.00007026787,0.00007003572,0.00036696132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015830976,0.00033184822,0.00028774538,0.00033162368,0.00037213537,0.00092410506,0.0005360714,0.00053526857,0.0022874768],"category_scores_gemma":[0.0015810747,0.00014120035,0.00033767393,0.0005391691,0.00043617384,0.00044358664,0.00090175297,0.00083544286,0.0008116343],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013577976,0.0042203385,0.26274243,0.0009995982,0.00040476857,0.01979676,0.0046731886,0.0020091352,0.018437816,0.0010504347,0.019179177,0.65290844],"study_design_scores_gemma":[0.003350036,0.048112173,0.6991844,0.0007220219,0.00045617067,0.084047414,0.001361199,0.0022915401,0.010051968,0.00040557905,0.14990191,0.00011552857],"about_ca_topic_score_codex":0.00085279014,"about_ca_topic_score_gemma":0.0008913806,"teacher_disagreement_score":0.0022874768,"about_ca_system_score_codex":0.00060985633,"about_ca_system_score_gemma":0.00043739402,"threshold_uncertainty_score":0.008372307},"labels":[],"label_agreement":null},{"id":"W2067500495","doi":"10.1016/j.neuroscience.2011.12.023","title":"Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel","year":2011,"lang":"en","type":"article","venue":"Neuroscience","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health","keywords":"Peripheral neuropathy; Medicine; Allodynia; Oxaliplatin; Neuropathic pain; Hyperalgesia; Gabapentin; Anesthesia; Vinca alkaloid; Internal medicine; Pathology; Endocrinology; Nociception; Chemotherapy; Cancer","score_opus":0.04999451438369151,"score_gpt":0.29342865993493145,"score_spread":0.24343414555123993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067500495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953721,0.0014917414,0.0014913894,0.000039203194,0.00001716541,0.00005893324,0.0004504705,0.000023825356,0.0010551244],"genre_scores_gemma":[0.9891912,0.002814544,0.0018672615,0.000053226482,0.000012420179,0.000082257226,0.0010180706,0.000017703447,0.004943477],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999037,0.000009867676,0.0000054112293,0.000014477582,0.000017577451,0.000049091595],"domain_scores_gemma":[0.9998698,0.000014660965,0.000037299775,0.000014561792,0.00003093478,0.00003265252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019609176,0.0004413806,0.00029758882,0.0007640739,0.00028992497,0.00026393772,0.0002602728,0.00026006566,0.0012242432],"category_scores_gemma":[0.00010572213,0.00017773548,0.00036230587,0.0005081168,0.0003154303,0.00057002495,0.00011879772,0.00058087957,0.00015628607],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011058968,0.00022189568,0.0004533009,0.00008876415,0.000011630571,0.00011259827,0.00002288369,0.00011101266,0.9955669,0.00014062064,0.000030152018,0.00213435],"study_design_scores_gemma":[0.000107370346,0.0043755206,0.024805682,0.000028076518,0.000086436165,0.0005934988,0.00016624722,0.0010256704,0.96729916,0.00012320993,0.0013757619,0.000013416105],"about_ca_topic_score_codex":0.004748268,"about_ca_topic_score_gemma":0.0056335656,"teacher_disagreement_score":0.004748268,"about_ca_system_score_codex":0.0004270153,"about_ca_system_score_gemma":0.0005568017,"threshold_uncertainty_score":0.0094412565},"labels":[],"label_agreement":null},{"id":"W2067505246","doi":"10.14740/jocmr1856w","title":"Risk Factors for Early-Onset Peripheral Neuropathy Caused by Vincristine in Patients With a First Administration of R-CHOP or R-CHOP-Like Chemotherapy","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Vincristine; CHOP; Concomitant; Regimen; Internal medicine; Univariate analysis; Peripheral neuropathy; Logistic regression; Chemotherapy; Surgery; Gastroenterology; Oncology; Multivariate analysis; Endocrinology; Cyclophosphamide","score_opus":0.10216501188593609,"score_gpt":0.48709542254246546,"score_spread":0.3849304106565294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067505246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99906987,0.0004240419,0.00006020408,0.000029040168,0.0000062817658,0.0000080465625,0.000056651992,0.0000036216165,0.00034225252],"genre_scores_gemma":[0.99956554,0.0001574647,0.0000843393,0.000013325516,0.000015679028,0.0000044424505,0.00009101024,0.0000013086727,0.000066771725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975616,0.00003833785,0.000033230066,0.000054893084,0.000051391373,0.000066015455],"domain_scores_gemma":[0.997897,0.00040128623,0.001129898,0.00006957386,0.00012234418,0.00037995877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027991005,0.00029174503,0.0003312259,0.00079200993,0.000533373,0.00049165555,0.00033788118,0.00043193897,0.0018790558],"category_scores_gemma":[0.0019712688,0.00027960306,0.00042203028,0.00093108887,0.00023093303,0.00043493722,0.00030382178,0.000727963,0.00019963183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000526911,0.000017686696,0.99841416,0.0000046386012,0.00000856489,0.0007954924,0.000016709886,0.000026782554,0.00009790058,0.0000037901032,0.00003634048,0.00052539917],"study_design_scores_gemma":[0.0000070849424,0.00010230753,0.9933763,0.000010138863,0.000020707674,0.005832544,0.00015275662,0.00024185368,0.00007822153,0.000013851788,0.0001588875,0.0000052695427],"about_ca_topic_score_codex":0.0020834655,"about_ca_topic_score_gemma":0.0025229934,"teacher_disagreement_score":0.0020834655,"about_ca_system_score_codex":0.0003143933,"about_ca_system_score_gemma":0.00047065073,"threshold_uncertainty_score":0.0062860847},"labels":[],"label_agreement":null},{"id":"W2067776418","doi":"10.1080/01635580701328396","title":"Evaluation of the Antiproliferative Effects of Essiac™ on In Vitro and In Vivo Models of Prostate Cancer Compared to Paclitaxel","year":2007,"lang":"en","type":"article","venue":"Nutrition and Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; British Columbia Institute of Technology; Vancouver General Hospital","funders":"","keywords":"Paclitaxel; In vivo; Cell cycle; Flow cytometry; Toxicity; Apoptosis; In vitro; Distribution (mathematics); Pharmacology; Cancer; Medicine; Chemistry; Biology; Internal medicine; Immunology; Biochemistry; Mathematics","score_opus":0.03945416510199899,"score_gpt":0.3847989550561168,"score_spread":0.34534478995411777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067776418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99564916,0.0022650731,0.0008629349,0.000054200733,0.000028954484,0.00003838514,0.00022501989,0.000039701292,0.0008366046],"genre_scores_gemma":[0.9915413,0.00317321,0.0020699329,0.00004566449,0.00003753021,0.000044862732,0.0006458333,0.000017867247,0.0024236888],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998672,0.000052799947,0.000013185908,0.000016115919,0.000027039709,0.00002361022],"domain_scores_gemma":[0.9998305,0.00005934027,0.000040265248,0.000019301247,0.000025794447,0.000024769894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023884939,0.00043269747,0.0004333939,0.0005486596,0.00016240157,0.00018919048,0.00018102533,0.00019670691,0.0011906435],"category_scores_gemma":[0.00021575575,0.00015327976,0.00031882737,0.00042059485,0.00016745464,0.00020408985,0.00008752311,0.00040996788,0.00013383565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018854949,0.00035005808,0.000403782,0.00012974897,0.00003765658,0.000041903437,0.000031737003,0.00021621499,0.9914909,0.0000330177,0.000046447814,0.005332958],"study_design_scores_gemma":[0.00007465488,0.009518775,0.0059261676,0.0000065439885,0.000099421486,0.00015575775,0.00002676646,0.00045102934,0.98234636,0.0000141881055,0.0013733655,0.000006938472],"about_ca_topic_score_codex":0.0005619132,"about_ca_topic_score_gemma":0.0012898288,"teacher_disagreement_score":0.0011906435,"about_ca_system_score_codex":0.0001863208,"about_ca_system_score_gemma":0.00018720084,"threshold_uncertainty_score":0.0039830804},"labels":[],"label_agreement":null},{"id":"W2068166817","doi":"10.1007/s10555-013-9451-7","title":"Biological insights into effective and antagonistic combinations of targeted agents with chemotherapy in solid tumors","year":2013,"lang":"en","type":"review","venue":"Cancer and Metastasis Reviews","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Regional Municipality of Durham","funders":"","keywords":"Drug; Pharmacology; Medicine; Identification (biology); Antagonism; Computational biology; Biology; Internal medicine","score_opus":0.0806551080847331,"score_gpt":0.42557438261793484,"score_spread":0.34491927453320176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068166817","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045755945,0.9974523,0.0004202008,0.00015881263,0.000120384095,0.000013518783,0.000035739573,0.000011288238,0.0013301143],"genre_scores_gemma":[0.0022567946,0.9963084,0.00046457164,0.00015093973,0.000107216496,0.000013777188,0.000048447993,0.000002127404,0.0006477042],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985313,0.00002533126,0.000018631063,0.000023420034,0.000060176855,0.000019316602],"domain_scores_gemma":[0.9998692,0.00006153432,0.000023027404,0.0000053064146,0.000030883617,0.000010043507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045167084,0.0007947293,0.0013766832,0.0014873927,0.00018245635,0.0007123713,0.00075428205,0.0005572086,0.0031314236],"category_scores_gemma":[0.00042132378,0.0003050056,0.00051589793,0.001344213,0.00034424043,0.0007742104,0.00042873618,0.0014837345,0.0012677979],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022313833,0.0002082329,0.0001637809,0.014533979,0.00014725255,0.00018885994,0.00005301405,0.0008396021,0.013640303,0.003649929,0.016927948,0.94942397],"study_design_scores_gemma":[0.00013048251,0.0005250733,0.0013852195,0.0021773877,0.00038027856,0.0014914422,0.000045902452,0.00033763476,0.0056532375,0.0022174898,0.9856226,0.00003312472],"about_ca_topic_score_codex":0.00059248967,"about_ca_topic_score_gemma":0.00148141,"teacher_disagreement_score":0.0031314236,"about_ca_system_score_codex":0.00040450483,"about_ca_system_score_gemma":0.0005429925,"threshold_uncertainty_score":0.0104756355},"labels":[],"label_agreement":null},{"id":"W2068559390","doi":"10.3816/cbc.2004.n.025","title":"Quality of Life in Women with Advanced Breast Cancer Treated with Docetaxel","year":2004,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Docetaxel; Medicine; Quality of life (healthcare); Nausea; Breast cancer; Internal medicine; Adverse effect; Oncology; Vomiting; Clinical trial; Cancer; Nursing","score_opus":0.0456254794329484,"score_gpt":0.42091801635756826,"score_spread":0.37529253692461984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068559390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99331987,0.004438037,0.000035989517,0.00034016688,0.000028606104,0.000017353672,0.00023782231,0.0000026106122,0.001579453],"genre_scores_gemma":[0.9988613,0.000671141,0.000025412422,0.0000779483,0.000010391818,0.0000071980776,0.00011576145,5.0519543e-7,0.00023023099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998184,0.00007196449,0.000016149565,0.000017756221,0.000035062927,0.000040826206],"domain_scores_gemma":[0.9995572,0.000103817816,0.0001778801,0.000010565226,0.000043266602,0.00010725727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028261897,0.00013051255,0.00037949145,0.00021533917,0.00021807462,0.0004063439,0.00012521794,0.00022801678,0.0008884138],"category_scores_gemma":[0.0015718918,0.00009400882,0.0006256728,0.00043726375,0.00013392424,0.00018969987,0.00018374989,0.0003945854,0.00006480605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007944546,0.00090395624,0.9434919,0.00017882073,0.0008945575,0.00029905967,0.00037749042,0.00060026336,0.0010194798,0.00009112415,0.00096459524,0.04323429],"study_design_scores_gemma":[0.0002863071,0.0028051331,0.99475044,0.000025441439,0.00029183764,0.0002643568,0.00021177526,0.0002948146,0.000115300965,0.00005120618,0.0008955801,0.00000783814],"about_ca_topic_score_codex":0.0052866247,"about_ca_topic_score_gemma":0.009295277,"teacher_disagreement_score":0.0052866247,"about_ca_system_score_codex":0.00076999667,"about_ca_system_score_gemma":0.00031075507,"threshold_uncertainty_score":0.010511696},"labels":[],"label_agreement":null},{"id":"W2068882964","doi":"10.1517/14740338.6.3.315","title":"Managing cardiotoxicity in anthracycline-treated breast cancers","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cardiotoxicity; Medicine; Trastuzumab; Anthracycline; Breast cancer; Oncology; Internal medicine; Metastatic breast cancer; Cancer; Chemotherapy; Malignancy","score_opus":0.06337415341656599,"score_gpt":0.43531622394368896,"score_spread":0.37194207052712297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068882964","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004126935,0.99629754,0.00034802692,0.0006537411,0.00018762992,0.000014004113,0.000011355898,0.000010523714,0.0020645296],"genre_scores_gemma":[0.0019289699,0.9960074,0.0005576238,0.0004979815,0.00026151008,0.000012918129,0.000026918557,0.0000018243098,0.00070497405],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974614,0.00007496762,0.000026578135,0.000023083865,0.000113113536,0.00001617466],"domain_scores_gemma":[0.9997825,0.000091673195,0.000052353404,0.000005112164,0.000054707325,0.000013691956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005984819,0.0005966781,0.0017883017,0.0013465052,0.00021335167,0.00069701474,0.00076225214,0.0011935896,0.0022824535],"category_scores_gemma":[0.00064076664,0.00014580805,0.00042901683,0.001059849,0.00027498428,0.0006772827,0.00039506285,0.0011772672,0.0017819529],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076044664,0.00011736285,0.00018291903,0.014476459,0.000113844,0.00079400203,0.0000785017,0.00035393395,0.0025940891,0.0013606326,0.020897742,0.9589545],"study_design_scores_gemma":[0.00018397826,0.00046666173,0.0030366562,0.008846513,0.00031732768,0.01130868,0.00019652578,0.00033016782,0.0017530608,0.0035395615,0.9699885,0.00003243902],"about_ca_topic_score_codex":0.00070581044,"about_ca_topic_score_gemma":0.0016527522,"teacher_disagreement_score":0.0022824535,"about_ca_system_score_codex":0.00042861482,"about_ca_system_score_gemma":0.00064150593,"threshold_uncertainty_score":0.007635534},"labels":[],"label_agreement":null},{"id":"W2069294590","doi":"10.5586/asbp.2002.025","title":"Influence of extract from shoots of Taxus baccata var. elegantissima on ultrastructure and tubulin cytoskeleton of meristematic cells of Allium cepa L. roots","year":2013,"lang":"en","type":"article","venue":"Acta Societatis Botanicorum Poloniae","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trent University","funders":"","keywords":"Ultrastructure; Meristem; Biology; Botany; Microtubule; Incubation; Taxus; Shoot; Cytoskeleton; Cell plate; Cell biology; Biochemistry; Cell division; Cell; Cytokinesis","score_opus":0.007037299769532706,"score_gpt":0.262217835123966,"score_spread":0.2551805353544333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069294590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99491405,0.0022072622,0.00038855878,0.000118684235,0.000029622288,0.000021221073,0.00068961,0.0000381182,0.0015927376],"genre_scores_gemma":[0.9885821,0.0018371083,0.001275426,0.00013947197,0.000031951324,0.00003579788,0.0031327924,0.00003390216,0.0049315155],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994993,0.000007715065,0.000004812996,0.000012399315,0.0000125817905,0.000012537318],"domain_scores_gemma":[0.9999219,0.000016692817,0.000014193217,0.000007601256,0.000015463174,0.00002408929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054839777,0.00030878463,0.0002792815,0.00021277818,0.00018748146,0.000228435,0.00012341281,0.00018277517,0.0010461689],"category_scores_gemma":[0.00009777151,0.00014446676,0.00018955467,0.00014478186,0.00008646278,0.0001407868,0.00015284469,0.0004687403,0.0002550062],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007384632,0.000012027348,0.00012213204,0.000029190953,0.000003795525,0.000024368774,0.0000114198565,0.000010096083,0.9991856,0.0000072657663,0.00001490213,0.00050529576],"study_design_scores_gemma":[0.0000365977,0.0009891689,0.04149301,0.00002197323,0.000076324395,0.00033331057,0.000109839646,0.00031947898,0.95008194,0.00004688807,0.006479545,0.000011913098],"about_ca_topic_score_codex":0.0016951567,"about_ca_topic_score_gemma":0.0046592103,"teacher_disagreement_score":0.0016951567,"about_ca_system_score_codex":0.00015815864,"about_ca_system_score_gemma":0.00018230437,"threshold_uncertainty_score":0.003499806},"labels":[],"label_agreement":null},{"id":"W2069834221","doi":"10.3747/co.v16i3.377","title":"Optimal Use of Taxanes in Metastatic Breast Cancer","year":2009,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Taxane; Metastatic breast cancer; Breast cancer; Oncology; Guideline; Internal medicine; Anthracycline; Clinical trial; Docetaxel; Cancer; Randomized controlled trial; Intensive care medicine; Pathology","score_opus":0.21199348025233017,"score_gpt":0.49222649042341693,"score_spread":0.28023301017108676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069834221","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14906603,0.6414067,0.023977933,0.083736755,0.0014254126,0.000908577,0.0005925019,0.00019929447,0.09868683],"genre_scores_gemma":[0.71808594,0.2196975,0.041992817,0.014105228,0.0012466804,0.00061457726,0.00036069058,0.00007555339,0.0038210643],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965004,0.0019906925,0.0005000161,0.0001336951,0.0007474286,0.00012780314],"domain_scores_gemma":[0.9982608,0.00080142566,0.00036455356,0.00009314933,0.00036139382,0.000118780175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003955672,0.00019149319,0.0007605412,0.00081740064,0.00034906485,0.00096534425,0.00049040373,0.00071464374,0.001160277],"category_scores_gemma":[0.009553198,0.00016868557,0.00035623717,0.0005507499,0.00034447236,0.00090585207,0.00062079023,0.0013601235,0.00031657994],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001020938,0.0005684603,0.015076001,0.0025888858,0.00022716014,0.0007800037,0.0005812806,0.0050544487,0.0077284356,0.0074046804,0.029511468,0.92945826],"study_design_scores_gemma":[0.0013166033,0.0037066953,0.11144437,0.013647378,0.0006905386,0.004510577,0.0013598127,0.0061358525,0.012477908,0.03307908,0.8115235,0.0001077252],"about_ca_topic_score_codex":0.001483839,"about_ca_topic_score_gemma":0.006248115,"teacher_disagreement_score":0.003955672,"about_ca_system_score_codex":0.0012149452,"about_ca_system_score_gemma":0.001887555,"threshold_uncertainty_score":0.02091986},"labels":[],"label_agreement":null},{"id":"W2070015667","doi":"10.1016/s0968-0896(03)00425-5","title":"Corrigendum to “Design and Syntheses of Putative Bioactive Taxanes” [Bioorg. Med. Chem. (2002) 2387–2395]","year":2003,"lang":"en","type":"erratum","venue":"Bioorganic & Medicinal Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Queen's University; Jewish General Hospital; Institut National de la Recherche Scientifique","funders":"","keywords":"Boulevard; Queen (butterfly); Chemistry; Suite; Library science; Research center; Archaeology; Zoology; History; Political science; Biology; Computer science","score_opus":0.04066035186318156,"score_gpt":0.30169546738533554,"score_spread":0.26103511552215397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070015667","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018999873,0.010518646,0.00077887025,0.017906431,0.96137124,0.000099075754,0.0010268849,0.0003102018,0.0077987],"genre_scores_gemma":[0.011935599,0.08047796,0.0065021357,0.05865803,0.2600437,0.0005426454,0.007605947,0.00090205873,0.57333183],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99687344,0.00034113732,0.00046799882,0.00048042554,0.001250169,0.000586868],"domain_scores_gemma":[0.99252796,0.001273298,0.000599238,0.00050818705,0.0042473413,0.00084392936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022795897,0.0053179553,0.004945986,0.005121386,0.0044010906,0.0028484247,0.006962711,0.0073801302,0.11325743],"category_scores_gemma":[0.013160352,0.002119841,0.0041597285,0.005085716,0.002657736,0.003416006,0.0026168658,0.0063013393,0.08320957],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013397096,0.000036352183,0.00006692773,0.00081547647,0.000043475426,0.0006508205,0.000022300106,0.00015689613,0.00071588036,0.00091070286,0.9846667,0.011780561],"study_design_scores_gemma":[0.00010367445,0.000106886095,0.001334106,0.00025449792,0.00011392026,0.00067670894,0.000051393494,0.00023112113,0.0029321513,0.0013038459,0.99281293,0.00007890145],"about_ca_topic_score_codex":0.019222371,"about_ca_topic_score_gemma":0.02591159,"teacher_disagreement_score":0.11325743,"about_ca_system_score_codex":0.0054456093,"about_ca_system_score_gemma":0.0039805775,"threshold_uncertainty_score":0.3788839},"labels":[],"label_agreement":null},{"id":"W2070634470","doi":"10.1159/000225887","title":"Phase I Toxicologic Study of Lonidamine in Cancer Patients","year":2009,"lang":"en","type":"article","venue":"Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; BC Cancer Agency","funders":"","keywords":"Somnolence; Medicine; Toxicity; Cancer; Chemotherapy; Phases of clinical research; Lung cancer; Breast cancer; Adverse effect; Sarcoma; Internal medicine; Pharmacology; Gastroenterology; Pathology","score_opus":0.056954877794377225,"score_gpt":0.47114051560535686,"score_spread":0.4141856378109796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070634470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964868,0.0009723054,0.00024648113,0.00018986738,0.000030020848,0.000610234,0.00028585875,0.00003007948,0.0011483587],"genre_scores_gemma":[0.99444455,0.0013125683,0.00058921095,0.0006107276,0.0000763412,0.0005316731,0.0011499855,0.000012885712,0.0012719943],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99967766,0.00015379819,0.000015826368,0.00005718578,0.00003630328,0.000059211085],"domain_scores_gemma":[0.99954396,0.00008018878,0.000071641574,0.000038102837,0.00004895843,0.00021715095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071005843,0.00079948566,0.0012760807,0.00035793995,0.00073326007,0.00057890307,0.00044218768,0.00083373825,0.0016912702],"category_scores_gemma":[0.00064327166,0.00036934818,0.00073493033,0.00034998602,0.0005571948,0.00034394863,0.00026603058,0.0014602843,0.00041789442],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3070857,0.17719187,0.08703968,0.0010592808,0.0017533394,0.0020225204,0.0011996151,0.0035807027,0.22462283,0.00032623584,0.004859964,0.18925825],"study_design_scores_gemma":[0.052800138,0.8893307,0.03734501,0.000035344267,0.00047799476,0.0010973051,0.00016833769,0.00085611566,0.011306984,0.00012213108,0.006430872,0.00002918861],"about_ca_topic_score_codex":0.0010262986,"about_ca_topic_score_gemma":0.0024214576,"teacher_disagreement_score":0.0016912702,"about_ca_system_score_codex":0.0006465557,"about_ca_system_score_gemma":0.0010394814,"threshold_uncertainty_score":0.0056579113},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"nonrandomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"nonrandomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2070826508","doi":"10.1158/0008-5472.sabcs-4116","title":"Safety of bevacizumab (BV) plus docetaxel (D) in patients (pts) with locally recurrent (LR) or metastatic breast cancer (mBC) who developed brain metastases during the AVADO phase III study.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"","keywords":"Medicine; Metastatic breast cancer; Bevacizumab; Internal medicine; Clinical endpoint; Hazard ratio; Docetaxel; Population; Neutropenia; Taxane; Placebo; Breast cancer; Oncology; Cancer; Surgery; Chemotherapy; Clinical trial; Confidence interval; Pathology","score_opus":0.08245026851302782,"score_gpt":0.45017309410043804,"score_spread":0.3677228255874102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070826508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906736,0.0058291033,0.00025727227,0.00023897998,0.00007746064,0.00047106712,0.0009163,0.000027837126,0.0015084192],"genre_scores_gemma":[0.99536926,0.0019340235,0.00031167417,0.00034756243,0.00008767881,0.0003278723,0.00092166,0.000008331627,0.0006919349],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9996817,0.00017470705,0.000020480926,0.00005110428,0.000036678153,0.00003528003],"domain_scores_gemma":[0.9993025,0.00015689344,0.00026034407,0.000034394947,0.000034752953,0.00021106341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000955502,0.00044734636,0.0009939569,0.0001357646,0.00014774813,0.0006846625,0.0004395881,0.0005920725,0.0013804553],"category_scores_gemma":[0.0012914189,0.0002695696,0.0008830004,0.00022724111,0.00024167319,0.00032141112,0.00022651728,0.0014451329,0.0002766929],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8023592,0.0092618475,0.030373484,0.0019002383,0.0027025247,0.00019828715,0.00025230946,0.0017458216,0.015871631,0.00021620745,0.0036506953,0.13146766],"study_design_scores_gemma":[0.4791092,0.40839282,0.09827623,0.0002323978,0.0020120977,0.0005238604,0.00013684989,0.0017308642,0.002104017,0.0002680564,0.0071655856,0.000048049373],"about_ca_topic_score_codex":0.0013131202,"about_ca_topic_score_gemma":0.0032791328,"teacher_disagreement_score":0.0013804553,"about_ca_system_score_codex":0.0005796144,"about_ca_system_score_gemma":0.0006676882,"threshold_uncertainty_score":0.005053282},"labels":[],"label_agreement":null},{"id":"W2070855246","doi":"10.1038/sj.bjc.6602304","title":"Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":339,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Medicine; Mastectomy; Term (time); Cancer; Surgery; Oncology; Internal medicine","score_opus":0.009585676431239868,"score_gpt":0.28726506979981525,"score_spread":0.2776793933685754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070855246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990996,0.0003032553,0.000026679096,0.000078770994,0.000009600106,0.000008815285,0.00020473637,0.0000023714526,0.00026618625],"genre_scores_gemma":[0.9992874,0.00014068066,0.000024106903,0.000038614307,0.000009494681,0.000010406031,0.00029648084,6.824504e-7,0.00019213477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996406,0.000073223884,0.000044199616,0.000044015163,0.00009132382,0.00010670688],"domain_scores_gemma":[0.9985568,0.00018664639,0.0005292182,0.00007743109,0.00028498066,0.00036485575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059411547,0.00016733125,0.0005071964,0.000721437,0.00069255027,0.0004948933,0.00032874942,0.0005843987,0.0009963418],"category_scores_gemma":[0.0028138196,0.0002030706,0.00052602735,0.0008755324,0.00020571533,0.00058803736,0.00044639155,0.0008426656,0.0003349322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014884367,0.000078238554,0.9965875,0.000008210892,0.000031088577,0.00028697483,0.00016739334,0.00002039916,0.00016253823,0.0000036452047,0.00008183097,0.002423209],"study_design_scores_gemma":[0.0000051266957,0.00020503001,0.9990146,0.0000053921544,0.000028318798,0.00031902004,0.0002442543,0.000037876132,0.000028873013,0.000006931572,0.00010069142,0.0000038837416],"about_ca_topic_score_codex":0.007182256,"about_ca_topic_score_gemma":0.008350398,"teacher_disagreement_score":0.007182256,"about_ca_system_score_codex":0.00037043038,"about_ca_system_score_gemma":0.00031970855,"threshold_uncertainty_score":0.014280915},"labels":[],"label_agreement":null},{"id":"W2071021499","doi":"10.1016/j.cjca.2011.07.128","title":"181 Prevention of Chemotherapy Induced Cardiac Dysfunction by Renin-angiotensin System Antagonism","year":2011,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Research Manitoba","funders":"","keywords":"Medicine; Antagonism; Renin–angiotensin system; Chemotherapy; Pharmacology; Internal medicine; Cardiac dysfunction; Cardiology; Heart failure; Receptor; Blood pressure","score_opus":0.029821919244161294,"score_gpt":0.26869807773204235,"score_spread":0.23887615848788105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071021499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.939376,0.03263767,0.002092859,0.0026127205,0.00066798116,0.0002840944,0.00033750208,0.00033630317,0.02165492],"genre_scores_gemma":[0.98920727,0.0062057595,0.00069683226,0.00047292313,0.00025925445,0.000045309243,0.00017770544,0.000016955808,0.002918001],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9999411,0.000015241222,0.0000052611413,0.0000053089975,0.000015679238,0.000017363529],"domain_scores_gemma":[0.99988735,0.000025468797,0.00004211893,0.000009889447,0.000010782099,0.000024452165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009283,0.00021733834,0.0004834816,0.00017768565,0.00017955212,0.00022349988,0.0002038452,0.00022678007,0.0022851534],"category_scores_gemma":[0.00032870303,0.00008873062,0.00022108665,0.00012881032,0.0001618943,0.00012475313,0.00013888541,0.00082255644,0.00040959127],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022036087,0.0043409653,0.008332754,0.0010012769,0.00040037843,0.0018969411,0.000119777564,0.0013763265,0.34468287,0.0022743002,0.012233399,0.601305],"study_design_scores_gemma":[0.026324192,0.15318689,0.35504773,0.0006027564,0.001622724,0.014634108,0.00039354147,0.006820648,0.28578362,0.0036370163,0.15176916,0.000177598],"about_ca_topic_score_codex":0.0006313963,"about_ca_topic_score_gemma":0.00174105,"teacher_disagreement_score":0.0022851534,"about_ca_system_score_codex":0.00020971286,"about_ca_system_score_gemma":0.00043284,"threshold_uncertainty_score":0.0076445937},"labels":[],"label_agreement":null},{"id":"W2072882746","doi":"10.1007/bf02967532","title":"The worldwide perspective in the adjuvant treatment of primary lymph node positive breast cancer","year":2001,"lang":"en","type":"review","venue":"Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Epirubicin; Medicine; Breast cancer; Oncology; Anthracycline; Internal medicine; Adjuvant; Taxane; Cancer; Adjuvant therapy; Cyclophosphamide; Chemotherapy","score_opus":0.03421385643421887,"score_gpt":0.37549236438050365,"score_spread":0.3412785079462848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072882746","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000054793338,0.99837935,0.0000601864,0.0005579877,0.00031468904,0.0000015256499,0.0000063097395,0.000002576837,0.0006225661],"genre_scores_gemma":[0.000307814,0.9985067,0.0000998496,0.00037893376,0.00035246988,0.0000019595727,0.000009376348,5.7073004e-7,0.0003423657],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972385,0.000068218025,0.00004129937,0.00004398937,0.0001014979,0.00002107224],"domain_scores_gemma":[0.99932647,0.0003229232,0.00010320123,0.000014647242,0.00018211297,0.00005064281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010738693,0.0009780811,0.0020662546,0.0020180456,0.00032744222,0.0012270561,0.00080744823,0.001633687,0.004784277],"category_scores_gemma":[0.0010535296,0.00026716499,0.00056538696,0.0035861593,0.00054431,0.0019156932,0.00066037005,0.0027582021,0.0022810346],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019504498,0.000094533076,0.00021867845,0.015553129,0.00009264605,0.00029377977,0.00005041322,0.00040108338,0.001244972,0.0030953297,0.038657337,0.94010305],"study_design_scores_gemma":[0.00007753603,0.00025119976,0.001298129,0.0061690235,0.00024175346,0.0017530415,0.0000896234,0.00014827488,0.00022089352,0.0017043846,0.9880262,0.000020036015],"about_ca_topic_score_codex":0.0016137618,"about_ca_topic_score_gemma":0.0047530294,"teacher_disagreement_score":0.004784277,"about_ca_system_score_codex":0.0007738836,"about_ca_system_score_gemma":0.0013445991,"threshold_uncertainty_score":0.01600504},"labels":[],"label_agreement":null},{"id":"W2073325449","doi":"10.1007/s10725-004-2602-7","title":"In vitro stem elongation of stemless carline thistle","year":2004,"lang":"en","type":"article","venue":"Plant Growth Regulation","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Biological Sciences","funders":"","keywords":"Darkness; Elongation; Biology; Botany; Plant stem; photoperiodism; Thistle; Plant physiology; Rosette (schizont appearance); Auxin; Horticulture","score_opus":0.02239550901065059,"score_gpt":0.27905394542035206,"score_spread":0.2566584364097015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073325449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852304,0.0023934953,0.004258261,0.00014030027,0.00009676698,0.000051220908,0.0015017259,0.0001955183,0.0061323284],"genre_scores_gemma":[0.9738356,0.0006518121,0.0028105956,0.00009502546,0.000023724308,0.000036770864,0.0047702244,0.00012341795,0.017652944],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993,0.000008888451,0.000007118828,0.000018337083,0.000018496805,0.000017124361],"domain_scores_gemma":[0.9998325,0.000057146335,0.00002012352,0.000023372295,0.000017833281,0.000048927046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015382472,0.00033603003,0.00029291477,0.00030526365,0.00021216615,0.00025869807,0.00027784336,0.00025837196,0.0021673723],"category_scores_gemma":[0.00009867922,0.00014163605,0.00044920025,0.00018177826,0.00015161782,0.00026722255,0.00026630796,0.00095748954,0.00085208094],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006335512,0.000014997857,0.0000482224,0.000014338254,0.0000017718294,0.00002514434,0.000012980616,0.000034122775,0.99913627,0.000047587015,0.000028002589,0.00057321606],"study_design_scores_gemma":[0.000013900582,0.00035315935,0.0026288787,0.000007842459,0.000012802409,0.00007178122,0.00003664226,0.00048023713,0.9930601,0.000049594477,0.0032793896,0.0000057183993],"about_ca_topic_score_codex":0.002093146,"about_ca_topic_score_gemma":0.0027548112,"teacher_disagreement_score":0.0021673723,"about_ca_system_score_codex":0.0003270532,"about_ca_system_score_gemma":0.0002509474,"threshold_uncertainty_score":0.007250607},"labels":[],"label_agreement":null},{"id":"W2073700935","doi":"10.1038/cdd.2012.11","title":"Thromboxane A2 modulates cisplatin-induced apoptosis through a Siva1-dependent mechanism","year":2012,"lang":"en","type":"article","venue":"Cell Death and Differentiation","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Sherbrooke; Université de Montréal; Université de Sherbrooke","funders":"","keywords":"XIAP; Cisplatin; Cell biology; Apoptosis; HeLa; Chemistry; Receptor; Biology; Caspase; Biochemistry; Programmed cell death; Cell","score_opus":0.0362839232068058,"score_gpt":0.2946398112300573,"score_spread":0.2583558880232515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073700935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992136,0.003177491,0.0017111861,0.0002290388,0.00007308305,0.00008496966,0.00026583966,0.00005498546,0.0022673458],"genre_scores_gemma":[0.99605066,0.0010719259,0.0007163737,0.00005737844,0.000028857967,0.000064685424,0.00020566065,0.000006693888,0.0017977671],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997849,0.00009068725,0.000017238499,0.000024650775,0.000036539765,0.00004588961],"domain_scores_gemma":[0.99986994,0.000024742423,0.000042728003,0.000020479743,0.000018754057,0.000023454537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020590352,0.00026334877,0.00023573832,0.00025092947,0.00022734274,0.00036149198,0.00029482215,0.00033753796,0.0018416765],"category_scores_gemma":[0.00025014908,0.00014264455,0.0003649613,0.00014678008,0.00027276456,0.0003198134,0.00018820542,0.0008823739,0.00034844893],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001389339,0.00026352814,0.00073399115,0.00010207902,0.000041721705,0.00024905012,0.000031730728,0.00017566499,0.9920513,0.00058057887,0.00020580727,0.004175176],"study_design_scores_gemma":[0.00026107585,0.0028183036,0.020597031,0.00003079629,0.000091724774,0.0010153777,0.00008880889,0.0026633511,0.96776897,0.00038002478,0.0042732814,0.000011286488],"about_ca_topic_score_codex":0.0002466224,"about_ca_topic_score_gemma":0.0003198851,"teacher_disagreement_score":0.0018416765,"about_ca_system_score_codex":0.00022547932,"about_ca_system_score_gemma":0.0002539389,"threshold_uncertainty_score":0.0061609745},"labels":[],"label_agreement":null},{"id":"W2073721747","doi":"10.3390/molecules13020360","title":"Design, Synthesis and Applications of Hyaluronic Acid-Paclitaxel Bioconjugates†","year":2008,"lang":"en","type":"review","venue":"Molecules","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fidia Farmaceutici; McGill University","keywords":"Hyaluronic acid; Paclitaxel; Combinatorial chemistry; Chemistry; Nanotechnology; Computational biology; Biology; Materials science; Medicine; Internal medicine; Cancer; Genetics","score_opus":0.05655227694326574,"score_gpt":0.3632363501123435,"score_spread":0.30668407316907775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073721747","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023391861,0.94652075,0.017648509,0.00044424995,0.00031128287,0.00013309119,0.00014074415,0.0001241988,0.011285344],"genre_scores_gemma":[0.049733724,0.9144637,0.016034067,0.0004303204,0.00014872199,0.00020373047,0.00029666332,0.000027070444,0.018661905],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998989,0.000012752963,0.00001270368,0.000026478587,0.00003804036,0.000011020279],"domain_scores_gemma":[0.99996316,0.0000051176885,0.000010830531,0.000002992461,0.000012002125,0.000005845214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024991066,0.00093052565,0.0005161357,0.00070873933,0.00018530824,0.00039882227,0.00048074176,0.0005223505,0.0009052348],"category_scores_gemma":[0.00013756343,0.000379773,0.00019488262,0.00070492376,0.00016559023,0.00047211468,0.00031937467,0.0005014813,0.0014384852],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011961769,0.00014755086,0.00013069228,0.004902721,0.000039604154,0.0006340869,0.0001303347,0.0019483374,0.35246286,0.0066150073,0.0048029874,0.62806624],"study_design_scores_gemma":[0.00004679972,0.0004491421,0.0009289611,0.0004060626,0.00009711165,0.002425075,0.000034755256,0.0011871015,0.30483153,0.001177852,0.68838066,0.00003496413],"about_ca_topic_score_codex":0.0005172961,"about_ca_topic_score_gemma":0.0006733779,"teacher_disagreement_score":0.00093052565,"about_ca_system_score_codex":0.00055567984,"about_ca_system_score_gemma":0.00037099494,"threshold_uncertainty_score":0.0040317774},"labels":[],"label_agreement":null},{"id":"W2074033751","doi":"10.1001/jama.2011.856","title":"Group Releases New Guideline on Options for Treating Painful Diabetic Neuropathy","year":2011,"lang":"en","type":"article","venue":"JAMA","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Guideline; Diabetic neuropathy; Intensive care medicine; Diabetes mellitus; Surgery; Endocrinology","score_opus":0.055092785895766494,"score_gpt":0.32715764294089306,"score_spread":0.27206485704512656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074033751","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013166042,0.22312234,0.00747484,0.46026683,0.060227193,0.0056224284,0.028685752,0.0017240213,0.21155995],"genre_scores_gemma":[0.0069796736,0.26252308,0.05193013,0.45423976,0.021260722,0.008087807,0.06778421,0.0006004307,0.12659426],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99284077,0.0016015446,0.0013987155,0.0003253366,0.0032797568,0.0005538961],"domain_scores_gemma":[0.9847296,0.0029601306,0.0013162252,0.00030649215,0.009376508,0.0013109493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005204463,0.0011080444,0.002405971,0.0045417333,0.0012684653,0.0030479538,0.0043598935,0.0109154,0.014321621],"category_scores_gemma":[0.019892782,0.0008318741,0.0043238522,0.004167071,0.00088450103,0.002253024,0.0020838818,0.010476805,0.012254485],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021597783,0.000033414763,0.00011262253,0.00092799496,0.000028533339,0.00010536138,0.00004317738,0.000057781523,0.00006588074,0.0012232682,0.9537101,0.04367022],"study_design_scores_gemma":[0.00021958159,0.000041754607,0.0008672206,0.008484667,0.000111062785,0.0003073217,0.000040425246,0.00007799843,0.00005570906,0.0013358112,0.9884312,0.000027210928],"about_ca_topic_score_codex":0.052124046,"about_ca_topic_score_gemma":0.11343917,"teacher_disagreement_score":0.052124046,"about_ca_system_score_codex":0.0066916468,"about_ca_system_score_gemma":0.021102116,"threshold_uncertainty_score":0.10364133},"labels":[],"label_agreement":null},{"id":"W2074096414","doi":"10.1016/j.jval.2013.08.589","title":"Stage-Based Utilization of Chemotherapy Agents in a Canadian Breast Cancer Population","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Epirubicin; Medicine; Docetaxel; Breast cancer; Cyclophosphamide; Population; Chemotherapy; Internal medicine; Doxorubicin; Cancer; Stage (stratigraphy); Oncology; Regimen; Surgery","score_opus":0.09369422543786671,"score_gpt":0.40639499045647415,"score_spread":0.31270076501860744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074096414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950147,0.00042285235,0.000042826476,0.0003255714,0.0000075787543,0.000023530956,0.0017542159,0.0000058685396,0.0024027398],"genre_scores_gemma":[0.99832624,0.0003217142,0.00007382806,0.00008766614,0.000005124317,0.0000065251998,0.00063191564,0.0000032285973,0.00054373476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992236,0.00005158249,0.000042531923,0.0000958606,0.00025968428,0.00032681949],"domain_scores_gemma":[0.998374,0.00010438867,0.00041994642,0.000038338847,0.0005993377,0.0004638563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043079458,0.00030068803,0.00039062768,0.0017754508,0.0019426913,0.0011797566,0.0011626984,0.00062518456,0.0033296503],"category_scores_gemma":[0.0021358381,0.00037316047,0.00096064486,0.0039174594,0.0006475488,0.0004353267,0.00070508465,0.0009897335,0.00022336887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009135172,0.000038486618,0.99662435,0.000011579983,0.00003376209,0.000078523255,0.00041017524,0.00008578894,0.00012360784,0.00007007968,0.00050628395,0.001926124],"study_design_scores_gemma":[0.0000047573253,0.000025517062,0.99817264,0.000009612151,0.000023746396,0.00008265975,0.0010654414,0.00019769,0.000026365753,0.0000209269,0.0003601246,0.000010618009],"about_ca_topic_score_codex":0.9881974,"about_ca_topic_score_gemma":0.99325883,"teacher_disagreement_score":0.023840325,"about_ca_system_score_codex":0.023840325,"about_ca_system_score_gemma":0.020235758,"threshold_uncertainty_score":0.17297447},"labels":[],"label_agreement":null},{"id":"W2074599258","doi":"10.1038/nrneurol.2014.77","title":"Mitotoxicity in distal symmetrical sensory peripheral neuropathies","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Neurology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute","keywords":"Medicine; Peripheral neuropathy; Sensory system; Neuropathic pain; Mitochondrion; Sensory nerve; Neurotoxicity; Peripheral; Neuroscience; Diabetes mellitus; Internal medicine; Endocrinology; Pharmacology; Toxicity; Biology","score_opus":0.04774740560998231,"score_gpt":0.409760865844193,"score_spread":0.3620134602342107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074599258","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000083823965,0.9987055,0.000117250114,0.00015878622,0.0002144848,0.000004211364,0.000015913449,0.000007840165,0.00069218746],"genre_scores_gemma":[0.0006197946,0.99813336,0.000116109346,0.00020045046,0.00024350066,0.00000393919,0.00002396703,0.0000011400941,0.0006578604],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998462,0.000024477125,0.00003232827,0.000022391068,0.000058169746,0.000016452563],"domain_scores_gemma":[0.9997079,0.00012132232,0.00006556981,0.000009151617,0.00007219299,0.000023878483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044973922,0.0010784211,0.0017929741,0.0027759653,0.00024439004,0.00094238075,0.0007545071,0.0011328646,0.004221553],"category_scores_gemma":[0.0007073288,0.00031516908,0.0005219927,0.002020617,0.00045571147,0.0012683705,0.0008654873,0.0015263603,0.0020749746],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011176821,0.000057433077,0.00013925972,0.021607745,0.00012038391,0.00035203237,0.000039042407,0.00040018026,0.0019268711,0.0014457564,0.032598563,0.94120085],"study_design_scores_gemma":[0.00005580696,0.00016263218,0.0010544884,0.007807588,0.00037122893,0.0028781889,0.00005692893,0.00014755571,0.00087090797,0.0023305016,0.9842276,0.00003677614],"about_ca_topic_score_codex":0.00094624906,"about_ca_topic_score_gemma":0.002668487,"teacher_disagreement_score":0.004221553,"about_ca_system_score_codex":0.00048302303,"about_ca_system_score_gemma":0.0008390893,"threshold_uncertainty_score":0.014122546},"labels":[],"label_agreement":null},{"id":"W2074605643","doi":"10.1016/j.jep.2013.02.031","title":"Yews (Taxus) along the Hindu Kush-Himalayan region: Exploring the ethnopharmacological relevance among communities of Mongol and Caucasian origins","year":2013,"lang":"en","type":"article","venue":"Journal of Ethnopharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec en Abitibi-Témiscamingue","funders":"National Natural Science Foundation of China; Rural and Environment Science and Analytical Services Division; National Science Foundation","keywords":"Traditional medicine; Ethnobotany; Geography; Hinduism; Medicine; Medicinal plants","score_opus":0.09534192733389656,"score_gpt":0.3445582829851179,"score_spread":0.24921635565122136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074605643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99977154,0.00004903804,0.000015747604,0.000013799403,7.2029985e-7,0.000002878247,0.000016414411,2.7402825e-7,0.00012957957],"genre_scores_gemma":[0.9995153,0.0001230708,0.00008267792,0.000020235606,0.0000016922558,0.000004360484,0.000037747555,4.3130237e-7,0.00021447436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99990463,0.000024960806,0.0000041606536,0.000016770458,0.000008050391,0.00004134633],"domain_scores_gemma":[0.99990165,0.000019309324,0.00003164104,0.000004509667,0.000018451814,0.000024430883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001253295,0.00023002218,0.0001928048,0.0006924697,0.0015269774,0.0005192484,0.00021164065,0.00022237629,0.0010765694],"category_scores_gemma":[0.00018253326,0.00014841743,0.00013562912,0.0010224048,0.00061848905,0.0002914084,0.0004531991,0.00020053516,0.00009847092],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064145186,0.0002105372,0.91560936,0.00013258634,0.00007413556,0.0014344531,0.050958704,0.000047707836,0.014395141,0.0005086022,0.00015849846,0.015828911],"study_design_scores_gemma":[0.000011040092,0.00020103125,0.9501844,0.000027046666,0.000032015807,0.00057993294,0.047733817,0.00007402258,0.00033278664,0.000098160075,0.0007191562,0.0000066740895],"about_ca_topic_score_codex":0.037976224,"about_ca_topic_score_gemma":0.09219745,"teacher_disagreement_score":0.037976224,"about_ca_system_score_codex":0.00054130174,"about_ca_system_score_gemma":0.0005854565,"threshold_uncertainty_score":0.07551038},"labels":[],"label_agreement":null},{"id":"W2074839878","doi":"10.1016/j.ejca.2007.07.034","title":"Endpoints and other considerations in phase I studies of targeted anticancer therapy: Recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies (MDICT)","year":2007,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Task force; Cancer therapy; Medicine; Task (project management); Cancer; Oncology; Medical physics; Internal medicine; Engineering; Systems engineering; Political science","score_opus":0.2556496433220071,"score_gpt":0.49059934637691094,"score_spread":0.2349497030549038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074839878","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013531846,0.0932449,0.69332045,0.10734391,0.018777402,0.046152145,0.0072611207,0.0019588748,0.01840935],"genre_scores_gemma":[0.050129753,0.010423803,0.8163585,0.038699605,0.0036782734,0.07396228,0.0024161928,0.0007235991,0.0036079276],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.2877275,0.6119484,0.059711233,0.0044038203,0.03435655,0.0018524003],"domain_scores_gemma":[0.32573134,0.5136219,0.060789898,0.037603244,0.056557965,0.00569563],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.62113875,0.0046001845,0.013958171,0.0061239097,0.0027584475,0.010899427,0.009070835,0.013446657,0.002582649],"category_scores_gemma":[0.56832564,0.0033263634,0.016289782,0.006997265,0.0060762633,0.0053162407,0.005075809,0.026212161,0.0022672422],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04265141,0.0027890312,0.023533918,0.022268659,0.011079199,0.00094564405,0.0038259667,0.0105648,0.009611717,0.09489796,0.15626313,0.6215686],"study_design_scores_gemma":[0.026159855,0.027003884,0.06284931,0.055385873,0.018075643,0.0024031952,0.0022440623,0.027470268,0.027267242,0.17884906,0.5709704,0.0013212028],"about_ca_topic_score_codex":0.00234968,"about_ca_topic_score_gemma":0.004355648,"teacher_disagreement_score":0.62113875,"about_ca_system_score_codex":0.005610531,"about_ca_system_score_gemma":0.016891038,"threshold_uncertainty_score":0.46720344},"labels":[],"label_agreement":null},{"id":"W2075157026","doi":"10.1097/00002820-200304000-00011","title":"Current Canadian Experience With Capecitabine","year":2003,"lang":"en","type":"review","venue":"Cancer Nursing","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Baker Hughes (Canada)","funders":"","keywords":"Capecitabine; Medicine; Psychological intervention; Intensive care medicine; Colorectal cancer; Metastatic breast cancer; Oncology; Oncology nursing; Cancer; Nursing; Breast cancer; Internal medicine; Nurse education","score_opus":0.10608860096521133,"score_gpt":0.4704851133080228,"score_spread":0.36439651234281145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075157026","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004510594,0.96653414,0.000100305224,0.002427,0.00019796293,0.000013284754,0.00010770235,0.000013033694,0.026096046],"genre_scores_gemma":[0.025385201,0.9665904,0.00022971966,0.00077492726,0.00008619755,0.0000087029375,0.000114135284,0.0000066875346,0.0068040295],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99908876,0.00009709261,0.000058436875,0.00010412355,0.0005442448,0.00010727756],"domain_scores_gemma":[0.99883133,0.00019535696,0.00014485861,0.00001913424,0.0006343026,0.00017495477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009876682,0.00046387222,0.00065157335,0.0016788554,0.001329196,0.0016772092,0.0009070557,0.0006768268,0.009036576],"category_scores_gemma":[0.0023640022,0.00021784207,0.0003300945,0.0070443368,0.00075532607,0.00066891714,0.0006722266,0.0006406252,0.0011968755],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029566482,0.00009891864,0.006417317,0.014375232,0.00010334149,0.002226214,0.002893477,0.0003866083,0.001701397,0.005754347,0.08913761,0.8766098],"study_design_scores_gemma":[0.000022126647,0.00007571547,0.008113871,0.0026919027,0.00010515621,0.0022994648,0.0012777128,0.000044959295,0.00046028767,0.00029791633,0.9845878,0.000023077031],"about_ca_topic_score_codex":0.6894178,"about_ca_topic_score_gemma":0.82806027,"teacher_disagreement_score":0.31058222,"about_ca_system_score_codex":0.014825226,"about_ca_system_score_gemma":0.024731874,"threshold_uncertainty_score":0.6248226},"labels":[],"label_agreement":null},{"id":"W2076065516","doi":"10.2310/7200.2006.033","title":"Do the Dietary Supplements Epigallocatechin Gallate or Vitamin E Cause a Radiomodifying Response on Tumors in Vivo? A Pilot Study with Murine Breast Carcinoma","year":2007,"lang":"en","type":"article","venue":"Journal of the Society for Integrative Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Epigallocatechin gallate; Medicine; Apoptosis; Angiogenesis; In vivo; Vitamin E; Immunohistochemistry; Breast cancer; Cancer; Cancer research; Radiation therapy; Pathology; Internal medicine; Antioxidant; Biology; Biochemistry","score_opus":0.06163069096969403,"score_gpt":0.391528073914909,"score_spread":0.329897382945215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076065516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970939,0.0012386384,0.0008257818,0.00007412259,0.000028991164,0.00009087191,0.00018504856,0.000028149514,0.00043442374],"genre_scores_gemma":[0.992792,0.0019591176,0.0021225063,0.00011062166,0.000036961465,0.00016688071,0.00045293345,0.000025609661,0.0023333358],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996637,0.00010208695,0.000033582266,0.000066207125,0.00005665832,0.00007783145],"domain_scores_gemma":[0.9995586,0.00012292949,0.00010162185,0.00009054559,0.000049741288,0.00007660416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052176556,0.00062992366,0.00069834886,0.000474878,0.00021821812,0.0002531045,0.0004006678,0.00054955174,0.0009971504],"category_scores_gemma":[0.00031918567,0.00024166997,0.00058143045,0.00028570066,0.0004144998,0.00042398012,0.00016758146,0.0009219491,0.00027073847],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027291265,0.001199484,0.00043666063,0.00006940303,0.000024576793,0.00004130714,0.000031333424,0.000099642384,0.9928651,0.00003578082,0.000037543494,0.00243005],"study_design_scores_gemma":[0.00019050104,0.026917007,0.0030999233,0.000006691958,0.000089002766,0.00014539927,0.000044517918,0.00020373947,0.9682653,0.00003006625,0.0010019861,0.0000059215363],"about_ca_topic_score_codex":0.000704459,"about_ca_topic_score_gemma":0.0011794621,"teacher_disagreement_score":0.0009971504,"about_ca_system_score_codex":0.0002675425,"about_ca_system_score_gemma":0.00025905325,"threshold_uncertainty_score":0.0033358335},"labels":[],"label_agreement":null},{"id":"W2078122892","doi":"10.1038/bjc.2014.430","title":"Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Susan G. Komen; Breast Cancer Research Foundation; U.S. Department of Health and Human Services","keywords":"Bevacizumab; Medicine; Genome-wide association study; Internal medicine; Oncology; Blood pressure; SNP; Single-nucleotide polymorphism; Genotype; Biology; Chemotherapy; Genetics","score_opus":0.01655960237681365,"score_gpt":0.28424061643413523,"score_spread":0.2676810140573216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078122892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99863845,0.00016456503,0.00019111703,0.000053856158,0.000010146029,0.0000066684443,0.00048097977,0.000007752709,0.0004464717],"genre_scores_gemma":[0.99910444,0.00003082026,0.00017529474,0.000030119407,0.000009353775,0.0000046320442,0.00050669303,0.0000051282523,0.00013334933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997321,0.00006932407,0.000028255128,0.00009610092,0.000037479935,0.00003680299],"domain_scores_gemma":[0.9990859,0.00033171347,0.0003033894,0.00006415147,0.000048280388,0.00016661761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005108533,0.00040731812,0.0002647687,0.0004265895,0.00029724286,0.00049783237,0.0002542068,0.00066558464,0.0029650566],"category_scores_gemma":[0.0014870472,0.00012699919,0.00065010454,0.0007672386,0.00030654247,0.00013069213,0.0002591679,0.0005243606,0.00034793076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023006967,0.000052630785,0.9889783,0.00002251187,0.00020453347,0.0002967383,0.000035743993,0.00025151257,0.004957307,0.00009232234,0.00025313807,0.0025546274],"study_design_scores_gemma":[0.00013685599,0.00024605528,0.9955585,0.00001387024,0.00026122702,0.0010039504,0.000039908537,0.0013593822,0.0007204583,0.00026194096,0.00038912834,0.0000086980135],"about_ca_topic_score_codex":0.003528319,"about_ca_topic_score_gemma":0.0041546216,"teacher_disagreement_score":0.003528319,"about_ca_system_score_codex":0.0002433145,"about_ca_system_score_gemma":0.0002651663,"threshold_uncertainty_score":0.009919107},"labels":[],"label_agreement":null},{"id":"W2078578614","doi":"10.1158/1535-7163.targ-09-b168","title":"Abstract B168: ANG1005: Results of a phase I study in patients with advanced solid tumors and metastatic brain cancer","year":2009,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Angiochem (Canada)","funders":"","keywords":"Medicine; Tolerability; Neutropenia; Cancer; Internal medicine; Adverse effect; Mucositis; Oncology; Brain metastasis; Metastatic breast cancer; Taxane; Breast cancer; Metastasis; Chemotherapy","score_opus":0.02621273335514649,"score_gpt":0.38129536866898156,"score_spread":0.35508263531383505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078578614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925211,0.0025945539,0.0006433606,0.00045114866,0.00010164939,0.0009771497,0.0012102525,0.00009054552,0.0014102476],"genre_scores_gemma":[0.98830545,0.00254082,0.0015884375,0.0009145609,0.00015870557,0.00085507653,0.0031419871,0.000034727334,0.0024603796],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99969685,0.0001284444,0.000017423856,0.000053442687,0.000047055542,0.000056801568],"domain_scores_gemma":[0.99939525,0.00009179242,0.00008779266,0.000041059044,0.000055310444,0.0003288235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012830006,0.0010083839,0.0015308479,0.00030985303,0.000315854,0.0005658727,0.0005093813,0.0007492826,0.0022081241],"category_scores_gemma":[0.0006958462,0.00035269908,0.0010141766,0.00029846767,0.0004947336,0.0004896956,0.00023471742,0.0025492713,0.00076900783],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43569726,0.1468838,0.029901829,0.001262705,0.0029900826,0.0012714008,0.0004921313,0.004447982,0.12914857,0.00031722971,0.013841028,0.23374604],"study_design_scores_gemma":[0.20184468,0.72721374,0.054253794,0.000060733968,0.00088049774,0.0009493934,0.000102461854,0.0024301978,0.0068658656,0.00023934634,0.005112046,0.00004726783],"about_ca_topic_score_codex":0.0014023387,"about_ca_topic_score_gemma":0.00275824,"teacher_disagreement_score":0.0022081241,"about_ca_system_score_codex":0.0006746224,"about_ca_system_score_gemma":0.001045349,"threshold_uncertainty_score":0.007386863},"labels":[],"label_agreement":null},{"id":"W2079363235","doi":"10.1021/ol015559y","title":"Benzobicyclo[8.4.0.<sup>1,6</sup>0<sup>8,13</sup>]tetradecenones:  Ring CD-Taxoid Models by Planar Tether Controlled Cycloaddition","year":2001,"lang":"en","type":"article","venue":"Organic Letters","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Taxoid; Chemistry; Cycloaddition; Ring (chemistry); Planar; Diol; Adduct; Stereochemistry; Organic chemistry; Catalysis; Paclitaxel","score_opus":0.013777368909596176,"score_gpt":0.24688969276280856,"score_spread":0.23311232385321237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079363235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9100981,0.006968739,0.019378258,0.00047626568,0.00027576854,0.00039460004,0.0022822937,0.0009069684,0.05921904],"genre_scores_gemma":[0.97068566,0.0023283614,0.010251026,0.0000797217,0.000023267006,0.00011225602,0.00068070064,0.00008154759,0.015757525],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99996316,0.000005450168,0.0000020791365,0.000008482492,0.000007398675,0.000013470757],"domain_scores_gemma":[0.99995875,0.0000040475616,0.00001575443,0.000004701706,0.000006065035,0.000010684284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056104705,0.00022393353,0.00012957436,0.000117133604,0.00015543538,0.00022342212,0.00021937177,0.00014504317,0.0057075145],"category_scores_gemma":[0.000072079885,0.00012656579,0.00005378606,0.00020673664,0.00012409169,0.00018059502,0.00013450657,0.00026854145,0.002071208],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036102458,0.000065479086,0.00019154901,0.00018959219,0.000006658197,0.00011390127,0.0000390461,0.00045700086,0.98049253,0.003402592,0.0007155483,0.013965022],"study_design_scores_gemma":[0.0001346723,0.001445377,0.0026874077,0.000020074142,0.00002177939,0.00056299486,0.000043977117,0.0014037351,0.93694925,0.0008875497,0.055820625,0.000022409129],"about_ca_topic_score_codex":0.00045451085,"about_ca_topic_score_gemma":0.0013802823,"teacher_disagreement_score":0.0057075145,"about_ca_system_score_codex":0.00027633965,"about_ca_system_score_gemma":0.00023202818,"threshold_uncertainty_score":0.019093513},"labels":[],"label_agreement":null},{"id":"W2079491315","doi":"10.1246/cl.2006.952","title":"Synthesis of Gemcitabine Analogues as Potential Anti-tumor Agents","year":2006,"lang":"en","type":"article","venue":"Chemistry Letters","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bausch Health (Canada)","funders":"","keywords":"Chemistry; Gemcitabine; Bicyclic molecule; Deoxycytidine; Combinatorial chemistry; Stereochemistry; Derivative (finance); Cytidine deaminase; Organic chemistry; Chemotherapy; Internal medicine","score_opus":0.0076908165723998485,"score_gpt":0.2572107700491941,"score_spread":0.2495199534767943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079491315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91277105,0.02806025,0.021667782,0.00063320075,0.0005877932,0.000937126,0.0019037136,0.00022670501,0.03321238],"genre_scores_gemma":[0.95876646,0.0096996715,0.021673506,0.00019434441,0.00006734823,0.0002838426,0.0010108812,0.00002402007,0.008279966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999198,0.000026475276,0.000009891172,0.000012364001,0.000014352851,0.000017138236],"domain_scores_gemma":[0.9999285,0.000010357353,0.000011215151,0.000008523522,0.000012861189,0.000028564507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001514846,0.0002799202,0.000394548,0.0002657269,0.0002429487,0.00024922114,0.00023900431,0.00034004642,0.0025048926],"category_scores_gemma":[0.00019131141,0.00015289235,0.00014280311,0.00022460475,0.0000970917,0.00019793927,0.00018310365,0.00041653917,0.00074452796],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008076016,0.00023052594,0.00030216703,0.00070765347,0.00003605981,0.0012608774,0.00012824278,0.0032467186,0.9392391,0.005347775,0.0010342478,0.04765909],"study_design_scores_gemma":[0.00033075525,0.0032024086,0.001120511,0.00008267628,0.00009604408,0.0011890321,0.000042023024,0.001986279,0.91655016,0.00081175345,0.074545965,0.00004249957],"about_ca_topic_score_codex":0.00016123541,"about_ca_topic_score_gemma":0.0004056923,"teacher_disagreement_score":0.0025048926,"about_ca_system_score_codex":0.00023637887,"about_ca_system_score_gemma":0.00025375228,"threshold_uncertainty_score":0.008379698},"labels":[],"label_agreement":null},{"id":"W2080049264","doi":"10.1016/j.bmcl.2008.10.010","title":"Synthesis, tubulin assembly, and antiproliferative activity against MCF7 and NCI/ADR-RES cancer cells of 10-O-acetyl-5′-hydroxybutitaxel","year":2008,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of New Brunswick","funders":"National Cancer Institute","keywords":"Chemistry; Paclitaxel; Tubulin; Stereochemistry; Cancer cell lines; Cell growth; Chemical synthesis; In vitro; Kinetic resolution; Cell culture; Biological activity; Cancer cell; Cancer; Microtubule; Biochemistry; Catalysis; Enantioselective synthesis; Cell biology","score_opus":0.0195359295680108,"score_gpt":0.27404566351961523,"score_spread":0.2545097339516044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080049264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99092454,0.00385468,0.00072593946,0.00010856223,0.000058419337,0.000024868194,0.0006778032,0.00005655202,0.0035686088],"genre_scores_gemma":[0.9926928,0.0018865899,0.00049096416,0.00003494203,0.000016114704,0.000020212445,0.0015682962,0.000017710663,0.0032724165],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999145,0.000012342708,0.000008507015,0.000012194549,0.00001708643,0.000035404784],"domain_scores_gemma":[0.99994075,0.0000115539315,0.000010013515,0.000009688092,0.0000069513294,0.00002103655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012852311,0.0002799581,0.00019988517,0.00021996576,0.00017010533,0.00018212055,0.00031194952,0.00019203735,0.0012632675],"category_scores_gemma":[0.00009264331,0.00021674029,0.00019302111,0.00017259724,0.00014594397,0.00017187299,0.00008226377,0.00040197698,0.0003921898],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050675956,0.00006017982,0.00015061485,0.0000361667,0.0000062070267,0.000063204345,0.000020792157,0.00014503053,0.9971294,0.00013054545,0.000090303314,0.0016608102],"study_design_scores_gemma":[0.00004065923,0.0006383371,0.0017596553,0.0000043884042,0.000016098784,0.00006519044,0.00001536567,0.0003167008,0.9953011,0.00001683708,0.0018224246,0.0000031286575],"about_ca_topic_score_codex":0.0023903705,"about_ca_topic_score_gemma":0.0029599413,"teacher_disagreement_score":0.0023903705,"about_ca_system_score_codex":0.00026596288,"about_ca_system_score_gemma":0.00034857832,"threshold_uncertainty_score":0.004752934},"labels":[],"label_agreement":null},{"id":"W2080354842","doi":"10.6000/1927-7229.2014.03.02.1","title":"Evidence for the Conversion of Docetaxel into 7-Epidocetaxel in Patients Receiving Conventional Taxotere® Based Chemotherapy","year":2014,"lang":"en","type":"article","venue":"Journal of Analytical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Docetaxel; Medicine; Paclitaxel; Chemotherapy; Pharmacology; Pharmacokinetics; Metabolite; Urine; Prostate cancer; In vivo; Cancer; Internal medicine; Oncology; Biology","score_opus":0.0694840231192574,"score_gpt":0.404555062201255,"score_spread":0.3350710390819976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080354842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99797755,0.0009826833,0.00011886839,0.000059417955,0.000008232843,0.000008216676,0.00008761905,0.0000066738125,0.0007506368],"genre_scores_gemma":[0.99948114,0.00016748982,0.000058837086,0.00004597807,0.000015649368,0.0000037160444,0.00009584106,0.0000015744104,0.00012988657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996574,0.00007746855,0.000036031583,0.00009474895,0.00009422596,0.000040151765],"domain_scores_gemma":[0.9971137,0.0010021471,0.0011517027,0.00015388435,0.00025019926,0.00032832447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031541256,0.00015934222,0.00032177474,0.0005132713,0.00025015266,0.0004683495,0.00023093459,0.0004767085,0.0035293351],"category_scores_gemma":[0.0028105488,0.00017420764,0.00019423946,0.0005213033,0.00034776196,0.00029744272,0.00017204335,0.00051303924,0.0004418968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001481216,0.00010670859,0.9887398,0.000030066667,0.000047912097,0.00049486465,0.000060974748,0.00003876116,0.00244933,0.000024311836,0.00010737069,0.0064186254],"study_design_scores_gemma":[0.000036879555,0.0010874957,0.99454486,0.000010084494,0.00005917254,0.0028895726,0.00007518451,0.00012448928,0.00059226685,0.00002963997,0.0005453656,0.0000049742553],"about_ca_topic_score_codex":0.00042350512,"about_ca_topic_score_gemma":0.0002979857,"teacher_disagreement_score":0.0035293351,"about_ca_system_score_codex":0.0001645569,"about_ca_system_score_gemma":0.0001913731,"threshold_uncertainty_score":0.011806846},"labels":[],"label_agreement":null},{"id":"W2080598783","doi":"10.1007/s10600-013-0581-5","title":"A new taxane from the needles of Taxus cuspidata","year":2013,"lang":"en","type":"article","venue":"Chemistry of Natural Compounds","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Taxane; Chemistry; Taxus; Botany; Stereochemistry; Biology","score_opus":0.01510131739661412,"score_gpt":0.27490240908803587,"score_spread":0.25980109169142174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080598783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9275441,0.029449565,0.008421344,0.0009578767,0.0005169452,0.0004322723,0.0038587986,0.00018358663,0.028635547],"genre_scores_gemma":[0.9434841,0.023259133,0.007813008,0.0004492559,0.00017042432,0.00006242265,0.0020662479,0.000039102688,0.022656342],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99998236,0.0000014275928,0.0000014499385,0.000006462305,0.000005145354,0.0000031729064],"domain_scores_gemma":[0.99996424,0.0000040984446,0.00000525009,0.0000029418673,0.000005839459,0.000017630442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000028762252,0.00034580578,0.0002396864,0.00055230805,0.0003588382,0.00020381,0.00020723813,0.0002538147,0.0038670613],"category_scores_gemma":[0.000054392076,0.00013432892,0.00020827395,0.00028295192,0.0002573156,0.0004016602,0.00030137852,0.00069075904,0.0005220377],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023476602,0.0000973526,0.00069910276,0.00072895404,0.000025125888,0.0015538093,0.00019408867,0.0003255095,0.95895964,0.0010483777,0.00063188403,0.035501324],"study_design_scores_gemma":[0.00041095566,0.0050327363,0.044848353,0.00039643238,0.0003744894,0.009461581,0.00081800774,0.0013084011,0.6974847,0.003472156,0.23625244,0.00013970332],"about_ca_topic_score_codex":0.0012315108,"about_ca_topic_score_gemma":0.0036918232,"teacher_disagreement_score":0.0038670613,"about_ca_system_score_codex":0.00014980097,"about_ca_system_score_gemma":0.0003470936,"threshold_uncertainty_score":0.012936592},"labels":[],"label_agreement":null},{"id":"W2080856530","doi":"10.1158/1538-7445.am10-3109","title":"Abstract 3109: Myc confers aggressive medulloblastoma phenotypes by regulating cell migration and adhesion genes","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Cancer research; Biology; Cell migration; Cell culture; Phenotype; Cell growth; Gene; Genetics","score_opus":0.045072217860446864,"score_gpt":0.40630516272781025,"score_spread":0.3612329448673634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080856530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963707,0.00033774285,0.0011294298,0.000057113597,0.0000144556525,0.000013066059,0.0008471762,0.000064194945,0.0011661173],"genre_scores_gemma":[0.994649,0.00024781382,0.0010716375,0.00003146651,0.0000068650857,0.000024487032,0.000796037,0.000024314646,0.0031483998],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987626,0.000014619856,0.000008802555,0.000021310283,0.000042998963,0.00003595745],"domain_scores_gemma":[0.99991107,0.000013462248,0.000018860512,0.000007532719,0.0000061042847,0.000042959884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005677901,0.00028993603,0.00020368879,0.0002342555,0.00012247167,0.00021985546,0.00014502561,0.00016279833,0.003047713],"category_scores_gemma":[0.00006501527,0.00013150419,0.00015458197,0.0001158769,0.0001574714,0.00007673575,0.0001781792,0.0005621658,0.0005565945],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006063125,0.000017160955,0.00026045402,0.0000076368815,0.000002089313,0.00003845593,0.0000031891684,0.000025500784,0.9991364,0.000035215555,0.00004192057,0.00037145024],"study_design_scores_gemma":[0.000024149687,0.00038977418,0.029036151,0.0000063284006,0.000013124886,0.00057214446,0.00004742084,0.0017004461,0.9656404,0.00006384306,0.0025017655,0.0000044136946],"about_ca_topic_score_codex":0.0013475477,"about_ca_topic_score_gemma":0.0021670652,"teacher_disagreement_score":0.003047713,"about_ca_system_score_codex":0.00035919194,"about_ca_system_score_gemma":0.00017217791,"threshold_uncertainty_score":0.010195613},"labels":[],"label_agreement":null},{"id":"W2081296457","doi":"10.2147/bctt.s37003","title":"Lapatinib in patients with metastatic breast cancer following initial treatment with trastuzumab: an economic analysis from the Brazilian public health care perspective","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Targets and Therapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"GlaxoSmithKline","keywords":"Medicine; Lapatinib; Capecitabine; Trastuzumab; Breast cancer; Oncology; Internal medicine; Reimbursement; Health care; Cancer","score_opus":0.023805663445978318,"score_gpt":0.33990052430430395,"score_spread":0.3160948608583256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081296457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9223341,0.035241343,0.013310253,0.0081957495,0.00014710487,0.00088128855,0.0027141355,0.00003288482,0.017143236],"genre_scores_gemma":[0.99438703,0.0032272597,0.0012500896,0.00021485434,0.00002635491,0.00009941801,0.00042834293,0.000007045951,0.0003596656],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99732435,0.0018681193,0.00008099941,0.0001466317,0.0002787542,0.00030111065],"domain_scores_gemma":[0.99541736,0.0032176066,0.00073414226,0.000088656576,0.0002973085,0.00024494418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050379843,0.0010200178,0.001289682,0.0012991367,0.00036228358,0.0017779152,0.0008517928,0.0010794521,0.0029771521],"category_scores_gemma":[0.016559038,0.0004897313,0.0033387947,0.0013600528,0.0005370319,0.000917668,0.0010150514,0.001093332,0.000102889004],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005343307,0.001030185,0.08663949,0.0025004582,0.0052016554,0.002507873,0.00026355666,0.82081693,0.001112358,0.015212395,0.0028164284,0.056555454],"study_design_scores_gemma":[0.0020125469,0.0032724421,0.072076224,0.0024088526,0.006491311,0.0022303222,0.00090158207,0.88567877,0.00080837257,0.014158018,0.009826346,0.00013523945],"about_ca_topic_score_codex":0.043123115,"about_ca_topic_score_gemma":0.024316514,"teacher_disagreement_score":0.043123115,"about_ca_system_score_codex":0.0084621105,"about_ca_system_score_gemma":0.005067448,"threshold_uncertainty_score":0.08574426},"labels":[],"label_agreement":null},{"id":"W2081493266","doi":"10.1158/1538-7445.am2011-3576","title":"Abstract 3576: Lapatinib in combination with doxorubicin is highly damaging to cardiac myocytes","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Lapatinib; Dexrazoxane; Cardiotoxicity; Doxorubicin; Pharmacology; Medicine; Myocyte; Trastuzumab; Tyrosine-kinase inhibitor; Cancer; Internal medicine; Breast cancer; Chemotherapy; Anthracycline","score_opus":0.1372126624056593,"score_gpt":0.44257092687625355,"score_spread":0.3053582644705942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081493266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872875,0.005931938,0.0011284216,0.00026515662,0.00023535098,0.00009221453,0.00050249905,0.00009643571,0.004460524],"genre_scores_gemma":[0.9900989,0.0024920446,0.0013533013,0.00014905115,0.0000687229,0.000057627825,0.0010936284,0.000018145474,0.004668538],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998312,0.00003833773,0.00001953459,0.000028495017,0.00004318162,0.000039239472],"domain_scores_gemma":[0.99990976,0.000021906062,0.000016350465,0.000007158776,0.000007708284,0.000037117097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016882636,0.00043743406,0.00049955124,0.0002315292,0.00018873446,0.00022406595,0.00021191304,0.00037041362,0.00456022],"category_scores_gemma":[0.00013034105,0.00014099678,0.00027563312,0.00018630693,0.0001619712,0.00018096752,0.00019228927,0.0005500299,0.00069769257],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010426563,0.00018369373,0.00012508797,0.00010870495,0.000021244066,0.00015594091,0.00001610813,0.00012516782,0.9944478,0.000036138405,0.00032030643,0.003417213],"study_design_scores_gemma":[0.00030975055,0.007932591,0.005305678,0.00002714465,0.000055751196,0.00077534677,0.000029902543,0.0010055731,0.9807175,0.000039610164,0.0037903546,0.000010918245],"about_ca_topic_score_codex":0.00055147795,"about_ca_topic_score_gemma":0.00077890645,"teacher_disagreement_score":0.00456022,"about_ca_system_score_codex":0.00021117704,"about_ca_system_score_gemma":0.00028145866,"threshold_uncertainty_score":0.015255511},"labels":[],"label_agreement":null},{"id":"W2081584264","doi":"10.3816/cbc.2004.n.030","title":"Survival Benefit with Capecitabine/Docetaxel Versus Docetaxel Alone: Analysis of Therapy in a Randomized Phase III Trial","year":2004,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Docetaxel; Capecitabine; Medicine; Chemotherapy; Internal medicine; Oncology; Vinorelbine; Hazard ratio; Randomized controlled trial; Breast cancer; Surgery; Cancer; Confidence interval; Colorectal cancer; Cisplatin","score_opus":0.06626576878013078,"score_gpt":0.4365959759552752,"score_spread":0.3703302071751444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081584264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855359,0.007010443,0.00091606006,0.0010257118,0.0004336506,0.002135501,0.0010606041,0.00008683523,0.0017953204],"genre_scores_gemma":[0.98908615,0.0026576712,0.0015112248,0.0008720278,0.00045290674,0.0020518226,0.001420279,0.00003996383,0.0019078737],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99659365,0.0024175318,0.00012278011,0.0004335706,0.0001348468,0.00029760788],"domain_scores_gemma":[0.9960544,0.0019383811,0.0006818418,0.00035783564,0.000120126904,0.0008473633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062192287,0.002560821,0.0053303647,0.0005796454,0.0006490889,0.0016362274,0.0013187992,0.002007926,0.005171392],"category_scores_gemma":[0.004908537,0.00083440344,0.004332125,0.0008164389,0.0024561503,0.0019482371,0.0006909947,0.0056835837,0.000827093],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9883145,0.0016983591,0.0005493524,0.00016636035,0.0010087985,0.00001931411,0.000029200393,0.00039218398,0.0008547325,0.0000607368,0.0003099206,0.006596596],"study_design_scores_gemma":[0.9409628,0.05409096,0.0019908696,0.00003028603,0.0015597781,0.000032879976,0.00001977929,0.00046344436,0.00026531692,0.00021647269,0.0003524522,0.000014998093],"about_ca_topic_score_codex":0.0010305415,"about_ca_topic_score_gemma":0.0021362281,"teacher_disagreement_score":0.0062192287,"about_ca_system_score_codex":0.001559077,"about_ca_system_score_gemma":0.0017605325,"threshold_uncertainty_score":0.032890797},"labels":[],"label_agreement":null},{"id":"W2083136486","doi":"10.1002/chin.201205099","title":"ChemInform Abstract: Vinylogous Nicholas Reactions in the Synthesis of Icetexane, Faveline, and Related Ring Systems.","year":2012,"lang":"en","type":"article","venue":"ChemInform","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Chemistry; Ring (chemistry); Stereochemistry; Organic chemistry","score_opus":0.02206666910450063,"score_gpt":0.2922474862795188,"score_spread":0.2701808171750182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083136486","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61742646,0.018042501,0.101728514,0.0015736632,0.0013407875,0.00047255412,0.0019293434,0.0010344024,0.25645185],"genre_scores_gemma":[0.92401993,0.007627658,0.025464213,0.00019122266,0.000053842414,0.00009436959,0.00054156425,0.00006945548,0.04193779],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.999923,0.000012954723,0.0000036265556,0.000015730206,0.000022669432,0.000022153252],"domain_scores_gemma":[0.9999709,0.0000065603663,0.0000066305997,0.0000038944727,0.0000046184277,0.000007332115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001663524,0.00032602024,0.00011108281,0.00030797554,0.0002250663,0.00024411012,0.00030187113,0.00021881986,0.0057139313],"category_scores_gemma":[0.00022838492,0.00012103797,0.00011610597,0.0002787024,0.00022960913,0.00039324313,0.00044260608,0.0004680893,0.0011690441],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010793612,0.00021854055,0.0009271321,0.0014451441,0.00011871502,0.001276025,0.00061139744,0.007407606,0.6735502,0.10351851,0.011510745,0.19833657],"study_design_scores_gemma":[0.00013925399,0.00085325737,0.0010209106,0.00011503282,0.000042627304,0.0010094069,0.00009464192,0.0029847447,0.84253865,0.004781956,0.14637527,0.000044346605],"about_ca_topic_score_codex":0.0012768796,"about_ca_topic_score_gemma":0.0024972467,"teacher_disagreement_score":0.0057139313,"about_ca_system_score_codex":0.00047515583,"about_ca_system_score_gemma":0.00045565024,"threshold_uncertainty_score":0.01911503},"labels":[],"label_agreement":null},{"id":"W2083718162","doi":"10.1007/s10549-010-1102-x","title":"Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Université Laval","funders":"Bayer HealthCare","keywords":"Medicine; Breast cancer; Chemotherapy; Oncology; Metastatic breast cancer; Internal medicine; Cancer; Mammary gland; Phases of clinical research","score_opus":0.10599594354823769,"score_gpt":0.46746760014198563,"score_spread":0.3614716565937479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083718162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99642783,0.0005960064,0.00033346986,0.00016986376,0.000047798134,0.0011002906,0.00041074507,0.000032523767,0.00088156987],"genre_scores_gemma":[0.9951846,0.0007004278,0.00056740927,0.00026702046,0.00011243433,0.0010667437,0.00086596765,0.000014264598,0.0012211669],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99970007,0.00015500038,0.000013422528,0.00004134875,0.000023889732,0.00006636865],"domain_scores_gemma":[0.9993198,0.00013828144,0.00009726558,0.00008086904,0.00003976945,0.00032408722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095543644,0.00098077,0.0020755602,0.00037397724,0.00039282514,0.00061080244,0.00075374165,0.0008176441,0.0029699393],"category_scores_gemma":[0.00078333466,0.00040776414,0.0009011298,0.0003813406,0.0010674325,0.00067316904,0.00028015702,0.0029922056,0.0005513855],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8300924,0.07339871,0.004782681,0.00037835128,0.00072295364,0.0002334935,0.0001800355,0.0018365318,0.042783193,0.00027154904,0.0014695955,0.04385056],"study_design_scores_gemma":[0.41599947,0.56736076,0.010018289,0.00001489675,0.00029940222,0.00017116166,0.00004818563,0.00081438554,0.0038635274,0.000115677336,0.0012775036,0.000016737404],"about_ca_topic_score_codex":0.0011510465,"about_ca_topic_score_gemma":0.001796014,"teacher_disagreement_score":0.0029699393,"about_ca_system_score_codex":0.00067831686,"about_ca_system_score_gemma":0.0013350366,"threshold_uncertainty_score":0.009935498},"labels":[],"label_agreement":null},{"id":"W2085063413","doi":"10.1159/000225889","title":"Phase II Study of Lonidamine in Cancer Patients","year":2009,"lang":"en","type":"article","venue":"Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; BC Cancer Agency","funders":"","keywords":"Medicine; Anorexia; Vomiting; Somnolence; Cancer; Nausea; Toxicity; Phases of clinical research; Prednisone; myalgia; Breast cancer; Internal medicine; Anesthesia; Adverse effect; Gastroenterology; Surgery","score_opus":0.0413515949666393,"score_gpt":0.4576175046466559,"score_spread":0.4162659096800166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085063413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99283385,0.0023170246,0.0004913669,0.0005071803,0.00011136932,0.0013969901,0.0004840238,0.000080344784,0.0017779685],"genre_scores_gemma":[0.98838437,0.0026920852,0.0014515511,0.0010828554,0.0001720596,0.0015744675,0.0020334583,0.000027680439,0.0025815726],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996681,0.0001872555,0.000014210848,0.00004223924,0.00002529688,0.00006290574],"domain_scores_gemma":[0.99950445,0.00006545033,0.000055093315,0.000038170907,0.00004092353,0.00029596375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009084932,0.00088615523,0.0019529688,0.00036988343,0.000574529,0.00070116704,0.0006442994,0.0011794678,0.0027659722],"category_scores_gemma":[0.0006238406,0.00046544237,0.000738576,0.00039651073,0.00058303366,0.00046178253,0.0002778685,0.0020474107,0.00072173955],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47716108,0.16796878,0.01826037,0.0010685432,0.0012601922,0.0012033964,0.000741003,0.0025527268,0.14557263,0.00043320746,0.0071577295,0.1766205],"study_design_scores_gemma":[0.25447547,0.71615446,0.013741964,0.00004263452,0.00029581078,0.0008309623,0.000110330824,0.0010039984,0.0071176672,0.00012245058,0.0060748863,0.000029400779],"about_ca_topic_score_codex":0.0008302053,"about_ca_topic_score_gemma":0.001770149,"teacher_disagreement_score":0.0027659722,"about_ca_system_score_codex":0.0005518663,"about_ca_system_score_gemma":0.0010633057,"threshold_uncertainty_score":0.009253144},"labels":[],"label_agreement":null},{"id":"W2085825922","doi":"10.1016/s0828-282x(06)70905-9","title":"Acute coronary syndrome induced by oral capecitabine","year":2006,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Capecitabine; Chest pain; Cardiology; Internal medicine; Acute coronary syndrome; Chemotherapy; ST segment; ST elevation; Electrocardiography; Cancer; Colorectal cancer; Myocardial infarction","score_opus":0.01641145211944604,"score_gpt":0.27297818562515413,"score_spread":0.2565667335057081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085825922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95081437,0.009399646,0.0019419994,0.005286792,0.0007485197,0.00044479268,0.0002969579,0.00017498776,0.030892022],"genre_scores_gemma":[0.9941591,0.0020030309,0.00030490127,0.0010767551,0.0005204318,0.00003940201,0.00017791077,0.0000074548548,0.0017111446],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99973625,0.00008388632,0.000031821255,0.000029269137,0.000044790937,0.00007398115],"domain_scores_gemma":[0.999356,0.00022312351,0.00019173902,0.000055757,0.000028705595,0.00014476907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032213848,0.00085483096,0.0010171158,0.00042566357,0.00071779476,0.00046330213,0.00040607707,0.001530224,0.003553885],"category_scores_gemma":[0.001553221,0.0003086975,0.00097532576,0.00046205972,0.00051369716,0.00038267713,0.0003051784,0.0029421328,0.00051507686],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02531378,0.0010796698,0.044998754,0.0006371261,0.0005006505,0.81863374,0.00020966353,0.0006299875,0.04267879,0.0025126906,0.0049977917,0.05780737],"study_design_scores_gemma":[0.010588413,0.017998286,0.29438186,0.0002659748,0.0012493726,0.62416,0.0003799195,0.0043669045,0.018372059,0.0024519882,0.025648786,0.00013654478],"about_ca_topic_score_codex":0.002117063,"about_ca_topic_score_gemma":0.0034500153,"teacher_disagreement_score":0.003553885,"about_ca_system_score_codex":0.0011591706,"about_ca_system_score_gemma":0.000775826,"threshold_uncertainty_score":0.011888981},"labels":[],"label_agreement":null},{"id":"W2086036058","doi":"10.1007/s10549-010-1152-0","title":"Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Eli Lilly (Canada); University of Alberta; Ottawa Hospital","funders":"Eli Lilly and Company","keywords":"Capecitabine; Medicine; Internal medicine; Metastatic breast cancer; Placebo; Hazard ratio; Breast cancer; Taxane; Oncology; Anthracycline; Cancer; Colorectal cancer; Confidence interval","score_opus":0.07088188007729243,"score_gpt":0.42360677427515525,"score_spread":0.3527248941978628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086036058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844803,0.0036217796,0.0010321302,0.00091815856,0.0014019915,0.005023655,0.0010322415,0.00019727484,0.0022924454],"genre_scores_gemma":[0.9787472,0.0031669955,0.0019766784,0.0013853019,0.00094406604,0.0060191476,0.0011614161,0.000050097984,0.0065491064],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99928826,0.00033125802,0.000043047632,0.00017597107,0.000041627853,0.00011996832],"domain_scores_gemma":[0.9986841,0.00040246636,0.00023904121,0.00012647829,0.00007407135,0.00047387293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019109625,0.0028391276,0.006358998,0.000669839,0.0006701982,0.0013706674,0.0014945968,0.0022649835,0.00927057],"category_scores_gemma":[0.0025170567,0.0014668173,0.001977375,0.00062989065,0.0021068016,0.0017202883,0.0005335995,0.0048090564,0.0015101914],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9902914,0.0041737235,0.00010714158,0.00019470119,0.00029054776,0.000015112635,0.000022109642,0.00014708946,0.0010584065,0.000049211834,0.00022985293,0.0034206288],"study_design_scores_gemma":[0.97178775,0.027249401,0.0003281197,0.000007796235,0.00012972578,0.000008400417,0.0000082178185,0.00016796155,0.00011892507,0.00004997675,0.00013704297,0.0000066548846],"about_ca_topic_score_codex":0.0018384246,"about_ca_topic_score_gemma":0.003710278,"teacher_disagreement_score":0.00927057,"about_ca_system_score_codex":0.0011365236,"about_ca_system_score_gemma":0.0016115193,"threshold_uncertainty_score":0.03101319},"labels":[],"label_agreement":null},{"id":"W2086107711","doi":"10.1002/syn.20825","title":"Antipsychotic drug binding in the substantia nigra: An examination of high metoclopramide binding in the brains of normal, Alzheimer's disease, Huntington's disease, and Multiple Sclerosis patients, and its relation to tardive dyskinesia","year":2010,"lang":"en","type":"article","venue":"Synapse","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Metoclopramide; Tardive dyskinesia; Clozapine; Raclopride; Haloperidol; Olanzapine; Substantia nigra; Dyskinesia; Internal medicine; Endocrinology; Antipsychotic; Chlorpromazine; Pharmacology; Chemistry; Striatum; Psychology; Medicine; Dopaminergic; Dopamine; Schizophrenia (object-oriented programming); Parkinson's disease; Psychiatry; Disease","score_opus":0.025935103665232797,"score_gpt":0.27756960665360103,"score_spread":0.25163450298836826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086107711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99873716,0.0006504588,0.00019158429,0.000019048144,0.0000013025774,0.0000021185465,0.000059207865,0.000006077502,0.00033310225],"genre_scores_gemma":[0.9985884,0.00033001293,0.00045425774,0.000037402446,0.0000036499885,0.0000056545546,0.00019543839,0.0000044925137,0.00038060965],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998467,0.00002257722,0.000013542243,0.000029234207,0.00006108594,0.000026705718],"domain_scores_gemma":[0.9998791,0.000017898346,0.000032616317,0.000009833643,0.00003111152,0.000029363688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017215476,0.00023720654,0.00026246943,0.0006468367,0.00056957203,0.000333507,0.00018616434,0.0004088039,0.0008914584],"category_scores_gemma":[0.00025347952,0.0002883875,0.00024430058,0.00026999865,0.00033043517,0.000118329204,0.00023408649,0.00025613827,0.00020518035],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007734005,0.00008142037,0.10713844,0.00012891857,0.0002903995,0.0012840991,0.0005948201,0.00010483956,0.8828007,0.000112144815,0.00009619655,0.006594739],"study_design_scores_gemma":[0.000016148639,0.000460144,0.96798563,0.000009493783,0.00009785359,0.0052535757,0.0003788972,0.000511585,0.024424847,0.0000669428,0.0007830763,0.000011716461],"about_ca_topic_score_codex":0.007696397,"about_ca_topic_score_gemma":0.0161188,"teacher_disagreement_score":0.007696397,"about_ca_system_score_codex":0.00035763078,"about_ca_system_score_gemma":0.00021513723,"threshold_uncertainty_score":0.0153031945},"labels":[],"label_agreement":null},{"id":"W2087686137","doi":"10.1200/jco.2009.23.0607","title":"Reply to R.S. Mehta et al","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"Medicine","score_opus":0.21334361164083018,"score_gpt":0.5974558753435592,"score_spread":0.384112263702729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087686137","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012534522,0.0015242152,0.000059302696,0.95436424,0.04335627,0.0000066303755,0.000052818054,0.00002399883,0.00048706695],"genre_scores_gemma":[0.0012919911,0.0010290198,0.000119097705,0.96281946,0.032702353,0.000019579524,0.000027444323,0.000015435238,0.0019756749],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966994,0.00094624085,0.0004971017,0.00053326547,0.00096131704,0.00036260442],"domain_scores_gemma":[0.9832025,0.00892097,0.0009844488,0.00053684454,0.00468016,0.0016751325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005422094,0.0010118021,0.0018886647,0.00100398,0.0027629382,0.0034426814,0.0032748452,0.04190403,0.007337209],"category_scores_gemma":[0.039310995,0.0009498038,0.0014966597,0.0010837513,0.0034948776,0.004579395,0.0023228873,0.050986856,0.00829114],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028552888,0.000008432976,0.00012971148,0.000049974573,0.0000105963545,0.00026106683,0.000046015077,0.00001835706,0.000048117956,0.00042352828,0.9967422,0.0022335364],"study_design_scores_gemma":[0.000090413465,0.000049045593,0.0011427307,0.0002806206,0.000056935896,0.0021098633,0.0005787905,0.00021857797,0.00044889597,0.004145459,0.99078816,0.000090591435],"about_ca_topic_score_codex":0.0033162534,"about_ca_topic_score_gemma":0.00446489,"teacher_disagreement_score":0.04190403,"about_ca_system_score_codex":0.0026716844,"about_ca_system_score_gemma":0.0036322712,"threshold_uncertainty_score":0.028675139},"labels":[],"label_agreement":null},{"id":"W2090424972","doi":"10.1007/s10600-014-1033-6","title":"Two New Non-Taxoids from Leaves of Taxus cuspidata","year":2014,"lang":"en","type":"article","venue":"Chemistry of Natural Compounds","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"DEPT; Chemistry; Acetic anhydride; Heteronuclear single quantum coherence spectroscopy; Two-dimensional nuclear magnetic resonance spectroscopy; Stereochemistry; Acetic acid; Organic chemistry; Catalysis","score_opus":0.01543015514092229,"score_gpt":0.30543198112318287,"score_spread":0.2900018259822606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090424972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.926677,0.030383982,0.0159574,0.0011055014,0.00049227005,0.00054319686,0.0032353872,0.0002794228,0.021325802],"genre_scores_gemma":[0.950858,0.011940963,0.011535369,0.0004002194,0.000118131844,0.000117237905,0.002350397,0.00005929922,0.022620438],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99997425,0.0000021552112,0.000002583113,0.0000063193734,0.000007153949,0.000007553222],"domain_scores_gemma":[0.99993753,0.000008291791,0.000009986722,0.0000058225596,0.000009851404,0.000028435714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042703592,0.00037010212,0.00030642533,0.00045810698,0.00025304512,0.0002454343,0.00028194024,0.00033464207,0.0025711786],"category_scores_gemma":[0.00008096872,0.00015660306,0.0003107278,0.00025798206,0.00025294453,0.00040307463,0.00032507363,0.0007916658,0.00057751103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042665543,0.000085001535,0.000335012,0.0005883144,0.000019682651,0.0006983575,0.000111922345,0.00018016565,0.973277,0.0007884193,0.00037536692,0.023114195],"study_design_scores_gemma":[0.00027694576,0.0020823197,0.014467099,0.00006661935,0.0001718574,0.0026130946,0.00024684294,0.00053994806,0.8945332,0.001392693,0.08354718,0.00006210731],"about_ca_topic_score_codex":0.0006691524,"about_ca_topic_score_gemma":0.0014452181,"teacher_disagreement_score":0.0025711786,"about_ca_system_score_codex":0.00023000925,"about_ca_system_score_gemma":0.0003733622,"threshold_uncertainty_score":0.008601427},"labels":[],"label_agreement":null},{"id":"W2091013260","doi":"10.1002/ejoc.200600284","title":"Novel Synthetic Strategy Towards Taxol by Macrocyclization Reaction – Conformational Requirement of Ring A","year":2006,"lang":"en","type":"article","venue":"European Journal of Organic Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Chemistry; Ring (chemistry); Stereochemistry; Combinatorial chemistry; Organic chemistry","score_opus":0.01808994674897337,"score_gpt":0.2647975971216491,"score_spread":0.2467076503726757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091013260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9298915,0.0049531953,0.04178761,0.00071581034,0.0004491462,0.00071396213,0.00081730064,0.00047025856,0.02020133],"genre_scores_gemma":[0.9797799,0.0019754078,0.013256622,0.0001384354,0.00003788636,0.00010606247,0.00023226632,0.00003146262,0.004441975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999193,0.000011364445,0.0000071083177,0.000020804468,0.000010303595,0.000031076474],"domain_scores_gemma":[0.99993634,0.0000071993272,0.000015868267,0.0000077925,0.000008234146,0.00002454097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010109069,0.000373729,0.00026477373,0.00025192645,0.00018639241,0.00022538324,0.0002537218,0.00024909736,0.0014576238],"category_scores_gemma":[0.00007863343,0.00011893293,0.00018170322,0.00017099714,0.00022901947,0.00021291315,0.00029592638,0.0004967826,0.00072800077],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002135932,0.00008510107,0.00019756045,0.00015453242,0.000009715561,0.0009066823,0.000080996186,0.00088227534,0.9789603,0.0027865248,0.00044379183,0.015278969],"study_design_scores_gemma":[0.000092307106,0.0008796752,0.000587859,0.000012930745,0.00001768128,0.0006825012,0.000040608324,0.00080643967,0.97758114,0.00047600098,0.018793548,0.000029243643],"about_ca_topic_score_codex":0.00056468387,"about_ca_topic_score_gemma":0.00070291996,"teacher_disagreement_score":0.0014576238,"about_ca_system_score_codex":0.00023295011,"about_ca_system_score_gemma":0.00053206115,"threshold_uncertainty_score":0.004876256},"labels":[],"label_agreement":null},{"id":"W2091278682","doi":"10.1016/j.freeradbiomed.2010.10.187","title":"Acute Doxorubicin Toxicity Differentially Alters Cytochrome P450 Expression in the Kidney and Liver of Male Sprague Dawley Rats","year":2010,"lang":"en","type":"article","venue":"Free Radical Biology and Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cytochrome P450; Toxicity; Doxorubicin; Liver toxicity; Kidney; Pharmacology; Medicine; Internal medicine; Endocrinology; Chemotherapy; Metabolism","score_opus":0.014838064372053584,"score_gpt":0.3157234499036285,"score_spread":0.3008853855315749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091278682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977003,0.00027236858,0.0008894596,0.00008200644,0.00003211008,0.000012675142,0.0005680499,0.000033768,0.00040927727],"genre_scores_gemma":[0.99008346,0.00065868156,0.0010463593,0.00009028026,0.000013866358,0.000039797575,0.00088693417,0.00004262992,0.0071380185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981695,0.000010487522,0.000012768737,0.00006498416,0.00003536883,0.000059497168],"domain_scores_gemma":[0.99971765,0.00002856366,0.000074810996,0.000033001408,0.000050705607,0.00009522191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009866671,0.00044575433,0.00046381165,0.000822921,0.00028742652,0.00035227535,0.00017586694,0.00034759706,0.0022679295],"category_scores_gemma":[0.00015578273,0.00040169962,0.00035949357,0.00032160422,0.0005362861,0.000488727,0.00019773535,0.0008899842,0.0004199164],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020091299,0.00015938233,0.0021545228,0.000024625882,0.00001775804,0.00008853848,0.00005681386,0.00006691507,0.99357104,0.00009587253,0.00006830907,0.0016870002],"study_design_scores_gemma":[0.000095282674,0.0020825814,0.05887076,0.000007938348,0.00013085573,0.00027287216,0.00029832017,0.00071320595,0.9361904,0.00016946945,0.0011350471,0.00003311704],"about_ca_topic_score_codex":0.0039989576,"about_ca_topic_score_gemma":0.008585899,"teacher_disagreement_score":0.0039989576,"about_ca_system_score_codex":0.00057270785,"about_ca_system_score_gemma":0.00045149305,"threshold_uncertainty_score":0.007951379},"labels":[],"label_agreement":null},{"id":"W2091417780","doi":"10.1097/01.coc.0000258125.97090.3f","title":"Survival Differences Observed in Metastatic Breast Cancer Patients Treated With Capecitabine When Compared With Vinorelbine After Pretreatment With Anthracycline and Taxane","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Statistics Canada; Alberta Cancer Foundation; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Vinorelbine; Capecitabine; Medicine; Anthracycline; Taxane; Metastatic breast cancer; Internal medicine; Oncology; Chemotherapy; Breast cancer; Cancer; Surgery; Colorectal cancer","score_opus":0.0626830552519413,"score_gpt":0.40415889236326363,"score_spread":0.34147583711132234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091417780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993228,0.0003059995,0.000033913126,0.000014485767,0.0000015778583,0.0000048477905,0.00013555124,0.000001473532,0.0001794254],"genre_scores_gemma":[0.99959713,0.0000880414,0.000036247566,0.000008239412,0.0000028237534,0.0000037958496,0.00021554384,5.68471e-7,0.00004759344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997949,0.000033050823,0.000025538773,0.000046315712,0.00005277887,0.000047480575],"domain_scores_gemma":[0.99928844,0.00019363913,0.00033794108,0.000018724106,0.0000740634,0.00008710164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002809691,0.00009999332,0.0001774818,0.00044491867,0.00020315232,0.0002202495,0.00010935863,0.00015610972,0.001071687],"category_scores_gemma":[0.0014555516,0.000065373366,0.00025623353,0.00044254845,0.00016306182,0.00013459817,0.00011860743,0.00017173178,0.00009077262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005581615,0.000029061088,0.9934681,0.000020144007,0.0000532006,0.00031381127,0.00009282925,0.00008628979,0.0010174392,0.000016078686,0.00007256558,0.0042723594],"study_design_scores_gemma":[0.000017153787,0.00030977407,0.9981628,0.000006157203,0.00004104667,0.0007718221,0.000083055376,0.000090524925,0.00028015047,0.000011946003,0.0002230338,0.0000025454017],"about_ca_topic_score_codex":0.0040869107,"about_ca_topic_score_gemma":0.0082526365,"teacher_disagreement_score":0.0040869107,"about_ca_system_score_codex":0.00050709903,"about_ca_system_score_gemma":0.00044311013,"threshold_uncertainty_score":0.008126259},"labels":[],"label_agreement":null},{"id":"W2091911272","doi":"10.1158/1538-7445.am10-3661","title":"Abstract 3661: Vascular changes and potentiating secondary drug delivery in colorectal cancer with Irinophore C","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Colorectal cancer; Irinotecan; Fluorouracil; Toxicity; Pharmacology; Perfusion; Cancer; Pathology; Internal medicine","score_opus":0.035562699177785095,"score_gpt":0.38118300437124364,"score_spread":0.34562030519345854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091911272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945003,0.002019759,0.001415786,0.000107253436,0.00005609861,0.00007285201,0.00016880981,0.00006656971,0.0015926068],"genre_scores_gemma":[0.99438924,0.0012583642,0.0020991615,0.00007024983,0.000032689306,0.000052211362,0.00026529332,0.000012324462,0.0018203781],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991906,0.000015289306,0.0000044140074,0.00001562882,0.000018416253,0.000027303327],"domain_scores_gemma":[0.9999198,0.00001664201,0.000018326004,0.000008665338,0.0000107269925,0.000025873005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001469711,0.00026787227,0.00027950018,0.00021280453,0.000115968316,0.00017142044,0.00017412196,0.00025900782,0.0014647788],"category_scores_gemma":[0.00010650694,0.00009651219,0.00021447876,0.00016169807,0.00019759551,0.0001863151,0.00014138492,0.00053188874,0.00023204678],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007381829,0.00019520469,0.00012944108,0.000111476584,0.000010085377,0.00011083705,0.000017557115,0.0001634266,0.994138,0.000074356576,0.00016345418,0.0041479827],"study_design_scores_gemma":[0.000120028664,0.0056202305,0.0044190227,0.000010340207,0.000036333367,0.00044142225,0.000014523074,0.0011766978,0.9848952,0.00002635697,0.0032319839,0.000007896419],"about_ca_topic_score_codex":0.0006263876,"about_ca_topic_score_gemma":0.00060612336,"teacher_disagreement_score":0.0014647788,"about_ca_system_score_codex":0.00021976681,"about_ca_system_score_gemma":0.0002282332,"threshold_uncertainty_score":0.004900217},"labels":[],"label_agreement":null},{"id":"W2093577168","doi":"10.1158/0008-5472.sabcs10-p3-15-05","title":"Abstract P3-15-05: Muscle and Joint Symptoms in Breast Cancer Patients Receiving Taxane-Based Chemotherapy","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; North York General Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Taxane; Breast cancer; Internal medicine; Cancer; Docetaxel; Joint pain; Chemotherapy; Paclitaxel; Oncology; Physical therapy","score_opus":0.04545014354277371,"score_gpt":0.40371468875381733,"score_spread":0.3582645452110436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093577168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99820924,0.00030351715,0.000029764191,0.000103517945,0.000009532542,0.000039376995,0.00063477503,0.000004055489,0.0006660851],"genre_scores_gemma":[0.9989472,0.00014418925,0.000077662415,0.00007284529,0.000019241943,0.000028368839,0.00048619602,9.599471e-7,0.00022324547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999721,0.000088681234,0.000043600907,0.00003197403,0.000061530605,0.000053218257],"domain_scores_gemma":[0.9987225,0.00024334597,0.0006075425,0.000021111951,0.00009837075,0.00030712044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047595636,0.00015427994,0.00029635607,0.00049916614,0.00038522834,0.00046558835,0.0002516727,0.00041538448,0.0036507985],"category_scores_gemma":[0.0014740117,0.00013248454,0.00025567273,0.00080678327,0.0001986746,0.0002693055,0.00027213877,0.00043363895,0.0003833857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016445231,0.00011164956,0.9955505,0.00003704777,0.000018423367,0.00016518212,0.00008576551,0.000021158477,0.00021402817,0.000005416521,0.0004814362,0.003144863],"study_design_scores_gemma":[0.00002467674,0.0002791473,0.9986565,0.00001197208,0.000013485113,0.00042905408,0.00014320639,0.000057323017,0.00006626158,0.0000061512374,0.00030974642,0.0000024425592],"about_ca_topic_score_codex":0.0016715149,"about_ca_topic_score_gemma":0.0024118437,"teacher_disagreement_score":0.0036507985,"about_ca_system_score_codex":0.0003343372,"about_ca_system_score_gemma":0.00036278734,"threshold_uncertainty_score":0.012213111},"labels":[],"label_agreement":null},{"id":"W2094140813","doi":"10.1016/j.jpain.2011.02.134","title":"Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat","year":2011,"lang":"en","type":"article","venue":"Journal of Pain","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Sensory system; Peripheral neuropathy; Paclitaxel; Medicine; Mitochondrion; Peripheral; Nociception; Neuroscience; Internal medicine; Endocrinology; Chemotherapy; Biology; Receptor","score_opus":0.048817095471229935,"score_gpt":0.30174646784698406,"score_spread":0.25292937237575414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094140813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980908,0.000548321,0.00054713833,0.000051216935,0.000010661326,0.000008191873,0.0001805801,0.000026983615,0.00053598953],"genre_scores_gemma":[0.99779356,0.0005111372,0.0003059809,0.000015711128,0.0000033264882,0.000009740824,0.00016289625,0.0000072865014,0.0011903722],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999336,0.0000104225755,0.000006896303,0.000013282138,0.000014188254,0.000021563623],"domain_scores_gemma":[0.9998592,0.000016824642,0.000059929294,0.00001509449,0.000019809078,0.000029147159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105973755,0.00022336225,0.00018564142,0.00052781566,0.000270596,0.00024199714,0.00020929218,0.00041008473,0.0015260646],"category_scores_gemma":[0.00013582467,0.00020356532,0.00021349819,0.00029740587,0.00029309298,0.0004211058,0.000117922005,0.00041379,0.00022050773],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00207921,0.00011304409,0.0009987678,0.00008417637,0.000018799778,0.00046388316,0.000040994135,0.00011284655,0.99397933,0.00020932835,0.00006162993,0.0018379473],"study_design_scores_gemma":[0.0001557936,0.002399879,0.06013711,0.00003004076,0.00015166016,0.0026423999,0.0003270676,0.0018550276,0.9308809,0.00037563234,0.0010274467,0.000017057717],"about_ca_topic_score_codex":0.0017921577,"about_ca_topic_score_gemma":0.0023239695,"teacher_disagreement_score":0.0017921577,"about_ca_system_score_codex":0.00031770166,"about_ca_system_score_gemma":0.00022753965,"threshold_uncertainty_score":0.0051051974},"labels":[],"label_agreement":null},{"id":"W2094422744","doi":"10.1016/j.addr.2008.10.003","title":"Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy","year":2008,"lang":"en","type":"review","venue":"Advanced Drug Delivery Reviews","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre; Montreal Heart Institute","funders":"","keywords":"Pharmacogenomics; Breast cancer; Vinca; Medicine; Chemotherapy; Pharmacokinetics; Oncology; Docetaxel; Cancer; Vindesine; Pharmacology; Internal medicine; Cyclophosphamide; Vincristine","score_opus":0.046362368245144205,"score_gpt":0.3918706415607305,"score_spread":0.34550827331558626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094422744","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001723262,0.9979528,0.0005203411,0.00033492417,0.00020413115,0.0000075754137,0.000015187667,0.000014760906,0.00077793485],"genre_scores_gemma":[0.00075720786,0.9974126,0.00044593838,0.00025310394,0.00026142737,0.0000081673115,0.00002015108,0.0000020135067,0.0008393574],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997309,0.00006672178,0.000034658835,0.000039677667,0.00010927974,0.00001871504],"domain_scores_gemma":[0.99942136,0.00029469852,0.00011705296,0.000019485582,0.00011907715,0.0000284366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008894751,0.0012175895,0.0024034977,0.0021723846,0.00021224568,0.0010719805,0.00076083984,0.0012207831,0.0033712909],"category_scores_gemma":[0.0010750527,0.00046495924,0.0006202509,0.0024865437,0.0005422082,0.0014178164,0.0005647598,0.0018720415,0.0023675032],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014279073,0.0001510707,0.0001640739,0.010434377,0.000121546254,0.00022617252,0.00003145065,0.0009074457,0.003272119,0.002274599,0.0286114,0.95366293],"study_design_scores_gemma":[0.000097055585,0.00034734208,0.0012975005,0.0031029247,0.00041664875,0.0025012735,0.0000363214,0.0007053379,0.0021960286,0.0027685608,0.9864937,0.0000373533],"about_ca_topic_score_codex":0.00094233087,"about_ca_topic_score_gemma":0.002098858,"teacher_disagreement_score":0.0033712909,"about_ca_system_score_codex":0.00066340895,"about_ca_system_score_gemma":0.001148384,"threshold_uncertainty_score":0.011278093},"labels":[],"label_agreement":null},{"id":"W2094913719","doi":"10.1021/np0004449","title":"New Taxane Analogues from the Needles of <i>Taxus canadensis</i>","year":2001,"lang":"en","type":"article","venue":"Journal of Natural Products","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique; Université du Québec à Montréal","funders":"","keywords":"Taxane; Taxus; Diterpene; Stereochemistry; Chemistry; Botany; Biology; Cancer","score_opus":0.022099713228959622,"score_gpt":0.2877839887193288,"score_spread":0.2656842754903692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094913719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9633208,0.014990959,0.002425389,0.00021154011,0.00013207879,0.00022683147,0.0043692887,0.00013878009,0.014184394],"genre_scores_gemma":[0.964405,0.009507792,0.0058307755,0.00023532471,0.00007086311,0.00006762431,0.008837532,0.000030923657,0.011014202],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99996233,0.000002459434,0.0000029644573,0.000008879121,0.000015105839,0.000008257276],"domain_scores_gemma":[0.99992204,0.000007119396,0.000016392132,0.0000065371755,0.000015054652,0.000032795695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003286744,0.00050437823,0.00025669322,0.00049709145,0.0002544789,0.00027664463,0.00018550076,0.00023506027,0.002510895],"category_scores_gemma":[0.000085535445,0.00011575432,0.00021912446,0.00033094434,0.00018820309,0.00027702865,0.0001763667,0.0007084696,0.00054963265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018008336,0.000025203733,0.00034655104,0.00012981251,0.000013689004,0.00021763505,0.000029429613,0.00007490272,0.9909203,0.000067007786,0.00009299161,0.007902407],"study_design_scores_gemma":[0.00015721435,0.0023299616,0.048725218,0.000072934796,0.00021549649,0.0026125817,0.0002293957,0.0003361598,0.87119466,0.00033693007,0.07373813,0.000051233153],"about_ca_topic_score_codex":0.0023699722,"about_ca_topic_score_gemma":0.0075673754,"teacher_disagreement_score":0.99763,"about_ca_system_score_codex":0.0002488035,"about_ca_system_score_gemma":0.00034369525,"threshold_uncertainty_score":0.008399844},"labels":[],"label_agreement":null},{"id":"W2095108849","doi":"10.1039/b906862g","title":"Enhancement of docetaxel solubility via conjugation of formulation-compatible moieties","year":2009,"lang":"en","type":"article","venue":"Organic & Biomolecular Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs","keywords":"Docetaxel; Chemistry; Prodrug; Conjugate; Solubility; Cytotoxicity; Moiety; Drug; Combinatorial chemistry; Stereochemistry; Organic chemistry; Pharmacology; In vitro; Biochemistry; Cancer","score_opus":0.009149655150587837,"score_gpt":0.2783637329378171,"score_spread":0.2692140777872292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095108849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7615048,0.0009846848,0.216522,0.00022358487,0.000050345876,0.00015760907,0.00018383276,0.00041499478,0.019958122],"genre_scores_gemma":[0.94320935,0.0005058981,0.054529812,0.000030399679,0.000005463133,0.00012256154,0.00013483147,0.00006083425,0.001400786],"study_design_codex":"simulation_or_modeling","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999317,0.000012185458,0.000003131819,0.000008469551,0.000034468005,0.000010111614],"domain_scores_gemma":[0.99993515,0.000030703926,0.000013053997,0.0000046986365,0.000012835421,0.000003430365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023282619,0.00045185428,0.0003234519,0.00023391358,0.00018958614,0.0003919314,0.0003013969,0.00027313747,0.0008686305],"category_scores_gemma":[0.00040947454,0.0002220265,0.00030358348,0.00018532679,0.00022242696,0.00032817383,0.00018412048,0.00026226783,0.00022719603],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019366058,0.00016017511,0.0010599361,0.0003059981,0.000027135653,0.00026139518,0.000053512602,0.7276236,0.23695496,0.014124187,0.0003160239,0.01891934],"study_design_scores_gemma":[0.00003105297,0.00014551077,0.00021273112,0.000008507621,0.000017607264,0.00004080528,0.000009985755,0.9214576,0.075363524,0.0012605651,0.0014424896,0.000009631521],"about_ca_topic_score_codex":0.00081558357,"about_ca_topic_score_gemma":0.0010936799,"teacher_disagreement_score":0.0008686305,"about_ca_system_score_codex":0.00068073696,"about_ca_system_score_gemma":0.00058147643,"threshold_uncertainty_score":0.0049390793},"labels":[],"label_agreement":null},{"id":"W2095584745","doi":"10.1515/znc-2009-1-208","title":"Two New 11(15→1)Abeotaxanes with a 2,20-Epoxy Ring from the Needles of Taxus canadensis","year":2009,"lang":"en","type":"article","venue":"Zeitschrift für Naturforschung C","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"Japan Society for the Promotion of Science; Hebei Medical University; Chiba University","keywords":"Epoxy; Taxus; Ring (chemistry); Composite material; Materials science; Botany; Chemistry; Biology; Organic chemistry","score_opus":0.012534648864048556,"score_gpt":0.29887421295365046,"score_spread":0.28633956408960193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095584745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98098963,0.005427087,0.0021019934,0.00022680277,0.00007025741,0.0001345415,0.0029109379,0.00005841683,0.008080431],"genre_scores_gemma":[0.96830064,0.0052751577,0.006697908,0.0003022886,0.000053400527,0.00008230581,0.0056104003,0.000026347943,0.013651463],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99996984,0.0000026326525,0.0000020609666,0.000006994624,0.000006606771,0.000011942399],"domain_scores_gemma":[0.99993277,0.000005431872,0.000014037247,0.0000040121386,0.00001440894,0.000029338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000342816,0.0005522596,0.00018797764,0.00046518754,0.00029842384,0.00020266535,0.000120630204,0.00023563066,0.0019782297],"category_scores_gemma":[0.00007105435,0.00012771167,0.00020490373,0.0003163238,0.00024528292,0.00026629018,0.00016843018,0.00047048862,0.00047262482],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001989613,0.000032854183,0.0011391543,0.00011760084,0.00001315979,0.0004914318,0.00007591534,0.00014678965,0.98661464,0.00023221389,0.00013111567,0.010806104],"study_design_scores_gemma":[0.00009713377,0.001973862,0.080167495,0.0000690123,0.00014833381,0.0024988235,0.00048554706,0.0002792472,0.845155,0.00054126105,0.0685055,0.00007883346],"about_ca_topic_score_codex":0.0036256195,"about_ca_topic_score_gemma":0.007855238,"teacher_disagreement_score":0.0036256195,"about_ca_system_score_codex":0.00041927863,"about_ca_system_score_gemma":0.00046900313,"threshold_uncertainty_score":0.0072090626},"labels":[],"label_agreement":null},{"id":"W2095704084","doi":"10.1056/nejmoa1111097","title":"Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer","year":2012,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":469,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Docetaxel; Capecitabine; Medicine; Gemcitabine; Bevacizumab; Chemotherapy; Internal medicine; Cyclophosphamide; Breast cancer; Metastatic breast cancer; Oncology; Cancer; Colorectal cancer","score_opus":0.029986808739246255,"score_gpt":0.37093735812574186,"score_spread":0.3409505493864956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095704084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784564,0.013619011,0.0006587881,0.0009449942,0.00092775986,0.0013698547,0.00020793085,0.00005778372,0.0037574994],"genre_scores_gemma":[0.9927234,0.0035360234,0.0012250636,0.0003568533,0.00034452174,0.0005935296,0.00024158547,0.0000061800715,0.00097283575],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991732,0.00046606123,0.000076538345,0.00007893458,0.00014378352,0.00006134605],"domain_scores_gemma":[0.9989479,0.00043245815,0.0002044417,0.00005561323,0.000059526916,0.00029997184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097504054,0.0003296407,0.0013956585,0.00047098738,0.00020063692,0.00051986624,0.00037617265,0.0005818673,0.0035334374],"category_scores_gemma":[0.0022327108,0.00028194615,0.00054128,0.0003776678,0.00047410096,0.00026654673,0.00034527737,0.0014875528,0.0004475993],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68247,0.013516652,0.015269871,0.0030284547,0.0018500333,0.0005837121,0.00017289614,0.005341624,0.028096214,0.0005728901,0.0027222715,0.24637537],"study_design_scores_gemma":[0.36200717,0.5596424,0.026598932,0.00078148756,0.0029005576,0.0018015399,0.000078338584,0.0047142543,0.015231182,0.0007351734,0.025439002,0.00007000247],"about_ca_topic_score_codex":0.00045864482,"about_ca_topic_score_gemma":0.0015689773,"teacher_disagreement_score":0.0035334374,"about_ca_system_score_codex":0.00072058843,"about_ca_system_score_gemma":0.00067555567,"threshold_uncertainty_score":0.011820495},"labels":[],"label_agreement":null},{"id":"W2096107960","doi":"10.1007/s00520-014-2289-x","title":"Management options for established chemotherapy-induced peripheral neuropathy","year":2014,"lang":"en","type":"review","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Nova Scotia","funders":"","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Psychosocial; Pain medicine; Nursing research; Intensive care medicine; Quality of life (healthcare); Psychological intervention; Evidence-based medicine; Alternative medicine; Psychiatry; Nursing","score_opus":0.055134281002700146,"score_gpt":0.4302106633911973,"score_spread":0.37507638238849716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096107960","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011153263,0.99880874,0.00013823116,0.00011556509,0.00008705717,0.0000054006714,0.000012360975,0.0000053979375,0.00071574876],"genre_scores_gemma":[0.0012435503,0.9976179,0.0003534805,0.00023131487,0.00016373438,0.0000070407414,0.000031655567,0.0000012394115,0.00035014199],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985266,0.000027698043,0.00003390219,0.000026483598,0.000045920697,0.0000134128295],"domain_scores_gemma":[0.99971944,0.00015615104,0.00006398093,0.0000060587104,0.000039695078,0.000014694914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003622197,0.00083406793,0.0013749151,0.0019753857,0.0002518998,0.0008768034,0.0008290684,0.0008033545,0.004205767],"category_scores_gemma":[0.0007717663,0.00022760475,0.0007670442,0.0012353049,0.00029346262,0.0010209127,0.0005590413,0.0015668336,0.0009210558],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082958366,0.000068860936,0.00019122622,0.01940781,0.00013038966,0.00032820963,0.000026379063,0.000282717,0.0005250868,0.00089922285,0.011102988,0.96695405],"study_design_scores_gemma":[0.00018859077,0.00041285023,0.0041241916,0.037105143,0.0012976881,0.010955062,0.00017409456,0.00054471864,0.00092704216,0.0041278196,0.94006604,0.000076708086],"about_ca_topic_score_codex":0.0010521755,"about_ca_topic_score_gemma":0.0030977111,"teacher_disagreement_score":0.004205767,"about_ca_system_score_codex":0.00037626486,"about_ca_system_score_gemma":0.00064179796,"threshold_uncertainty_score":0.014069676},"labels":[],"label_agreement":null},{"id":"W2096607288","doi":"10.1517/14656566.3.12.1739","title":"Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapy","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Doxorubicin; Therapeutic index; Metastatic breast cancer; Breast cancer; Pharmacology; Cumulative dose; Anthracycline; Cancer; Cardiotoxicity; Liposome; Therapeutic effect; Chemotherapy; Oncology; Internal medicine; Drug","score_opus":0.1480815675914475,"score_gpt":0.45383212290448716,"score_spread":0.30575055531303963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096607288","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004682148,0.9951939,0.00066045596,0.0008514324,0.00038960326,0.000018768418,0.000015346572,0.000016186734,0.0023861413],"genre_scores_gemma":[0.0013392871,0.9956702,0.00070355285,0.00051772676,0.00029604186,0.0000152402745,0.000029365108,0.000002288147,0.0014263885],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981755,0.000033458975,0.000016734424,0.0000325734,0.00008448616,0.0000152291395],"domain_scores_gemma":[0.9999006,0.00003311894,0.00001818708,0.0000047907324,0.000027826936,0.00001545792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062000647,0.0008736453,0.0014411027,0.0018372255,0.00029256562,0.0009491841,0.0007590536,0.0012686586,0.0034919558],"category_scores_gemma":[0.0002834139,0.00027839278,0.00040039403,0.0018420744,0.0006464201,0.0016541572,0.00055887504,0.0017156091,0.0036014565],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116638614,0.00019632853,0.00011271919,0.0057876445,0.000052549232,0.0005539943,0.000070105576,0.00045630493,0.008590809,0.0045038685,0.019648062,0.9599109],"study_design_scores_gemma":[0.000105173596,0.00034961107,0.0008144065,0.0012436148,0.000074592266,0.0029725302,0.000052396445,0.0002567913,0.0022899962,0.0024176112,0.98939323,0.000030107001],"about_ca_topic_score_codex":0.0008350211,"about_ca_topic_score_gemma":0.0018835193,"teacher_disagreement_score":0.0034919558,"about_ca_system_score_codex":0.00081071095,"about_ca_system_score_gemma":0.00080067007,"threshold_uncertainty_score":0.011681795},"labels":[],"label_agreement":null},{"id":"W2097354398","doi":"10.1200/jco.2009.25.4342","title":"Reply to D.L. Raunig","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine","score_opus":0.20649044368908437,"score_gpt":0.5798411927725939,"score_spread":0.37335074908350957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097354398","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000098289434,0.0027627458,0.000045351,0.97059894,0.025884146,0.000004537953,0.00003869913,0.000018590708,0.0005486182],"genre_scores_gemma":[0.0012002755,0.0015339844,0.00009870871,0.97694117,0.017967578,0.000015549087,0.000020390686,0.000015682013,0.0022066806],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970702,0.0008856968,0.00037731547,0.00055272074,0.0008173428,0.00029665104],"domain_scores_gemma":[0.9843977,0.00869854,0.0008340729,0.0005171436,0.003701912,0.0018506508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005163029,0.0010116233,0.0019501509,0.0011111478,0.0031580701,0.0040786415,0.0030544242,0.037408404,0.0065468554],"category_scores_gemma":[0.04076617,0.001018694,0.001353936,0.0010170194,0.0040447703,0.005963694,0.002804104,0.054246306,0.00781816],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022876731,0.0000064198093,0.00009904445,0.0000429217,0.000008358218,0.00020651279,0.000059217095,0.000014299384,0.000038831222,0.0006791222,0.9966605,0.0021619478],"study_design_scores_gemma":[0.00005311726,0.000036808688,0.0006719744,0.00030917188,0.000029837312,0.0016745104,0.00056271505,0.00011019122,0.00027130326,0.0041040964,0.99210197,0.00007432703],"about_ca_topic_score_codex":0.004370172,"about_ca_topic_score_gemma":0.00607949,"teacher_disagreement_score":0.037408404,"about_ca_system_score_codex":0.003027701,"about_ca_system_score_gemma":0.004622356,"threshold_uncertainty_score":0.027305007},"labels":[],"label_agreement":null},{"id":"W2098169322","doi":"10.1634/theoncologist.8-3-232","title":"Population-Based Pharmacoeconomic Model for Adopting Capecitabine/Docetaxel Combination Treatment for Anthracycline-Pretreated Metastatic Breast Cancer","year":2003,"lang":"en","type":"article","venue":"The Oncologist","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Ottawa Regional Cancer Foundation","funders":"","keywords":"Docetaxel; Medicine; Capecitabine; Taxane; Oncology; Population; Metastatic breast cancer; Internal medicine; Quality-adjusted life year; Anthracycline; Breast cancer; Cost effectiveness; Cancer; Colorectal cancer; Environmental health","score_opus":0.0934897234531395,"score_gpt":0.41733139480526843,"score_spread":0.32384167135212893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098169322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90500575,0.0012354568,0.04766698,0.007532961,0.00017049458,0.0009992181,0.009841724,0.00025912025,0.027288357],"genre_scores_gemma":[0.98482424,0.0003400771,0.004731416,0.0003092275,0.00005004524,0.0005331413,0.0016393038,0.000022399552,0.0075501483],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99878806,0.000687611,0.000032384174,0.00017790297,0.00008701137,0.00022698847],"domain_scores_gemma":[0.99488586,0.0037466309,0.00045687117,0.00007367945,0.00045850535,0.0003785042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030887637,0.0010951776,0.0018755641,0.0016550914,0.0006758477,0.002329085,0.0025745658,0.0026735414,0.010535497],"category_scores_gemma":[0.008416805,0.0010237854,0.0022281108,0.0014405567,0.0010340426,0.00096849026,0.0010551673,0.0022545464,0.0007006804],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036320955,0.0001401639,0.0074679833,0.00003329549,0.00011571018,0.00020525508,0.0000371734,0.9856705,0.00006546004,0.0030036874,0.00094893645,0.001948581],"study_design_scores_gemma":[0.00021886505,0.00013603113,0.0027958225,0.000018062947,0.00012662965,0.000064120955,0.0000755629,0.9944159,0.000021951819,0.0017660243,0.0003444784,0.000016515183],"about_ca_topic_score_codex":0.16752605,"about_ca_topic_score_gemma":0.093782306,"teacher_disagreement_score":0.16752605,"about_ca_system_score_codex":0.009257139,"about_ca_system_score_gemma":0.0050281966,"threshold_uncertainty_score":0.33310193},"labels":[],"label_agreement":null},{"id":"W2098685433","doi":"10.1139/v03-084","title":"Canadensenes: Natural and semi-synthetic analogues","year":2003,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Taxus; Bicyclic molecule; Chemistry; Stereochemistry; Cancer cell lines; Docetaxel; Derivative (finance); Diterpene; Botany; Cancer cell; Cancer; Biology","score_opus":0.010953479958150665,"score_gpt":0.2501579515632487,"score_spread":0.23920447160509806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098685433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8068987,0.06484899,0.013273202,0.0005007637,0.0003491609,0.00079623447,0.006940937,0.00027753162,0.106114544],"genre_scores_gemma":[0.94648033,0.022464912,0.0084728375,0.0001827873,0.000045855777,0.00013175233,0.0025040035,0.000023781837,0.019693762],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995315,0.0000057004813,0.0000036844267,0.00000958486,0.000015750613,0.000012138583],"domain_scores_gemma":[0.99995136,0.0000048182296,0.000006177849,0.000008069562,0.000012022844,0.000017483326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007431666,0.0002921506,0.00013683774,0.00032423457,0.00018063669,0.00021963129,0.00022914834,0.00013658887,0.0046670074],"category_scores_gemma":[0.00011902699,0.00008398427,0.0001318163,0.0003205017,0.00021517088,0.00019212489,0.00023847395,0.00045700785,0.0007621276],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005106468,0.00011950123,0.00040117707,0.0007768748,0.000026689388,0.00040636925,0.00016923883,0.0012314308,0.93670225,0.004097252,0.0006227716,0.054935794],"study_design_scores_gemma":[0.00019623183,0.002877433,0.0059435503,0.00015894294,0.00009250049,0.0017374379,0.0002471799,0.00050438097,0.7154719,0.0016862742,0.27103776,0.00004627643],"about_ca_topic_score_codex":0.002403874,"about_ca_topic_score_gemma":0.008471046,"teacher_disagreement_score":0.0046670074,"about_ca_system_score_codex":0.00039513293,"about_ca_system_score_gemma":0.00048349312,"threshold_uncertainty_score":0.015612721},"labels":[],"label_agreement":null},{"id":"W2098749704","doi":"10.3747/co.v18i1.708","title":"Oxaliplatin: A Review in the Era of Molecularly Targeted Therapy","year":2011,"lang":"en","type":"review","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":424,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Oxaliplatin; Medicine; Pharmacology; Context (archaeology); Clinical trial; Targeted therapy; Pharmacokinetics; Oncology; Cancer; Colorectal cancer; Internal medicine","score_opus":0.33664024914714613,"score_gpt":0.5308158069371451,"score_spread":0.194175557789999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098749704","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000052825468,0.99946076,0.00004994423,0.0001390064,0.00010013745,0.000002766326,0.0000073654037,0.0000020118273,0.00018511247],"genre_scores_gemma":[0.00030956024,0.9992524,0.00013226495,0.00009761064,0.000100222314,0.0000036546835,0.000010980453,5.412985e-7,0.00009272046],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996954,0.0000638235,0.00008079342,0.000043323704,0.00009334327,0.000023316086],"domain_scores_gemma":[0.9993166,0.00033691694,0.00014502312,0.000014020145,0.00014590906,0.000041607796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009027373,0.0009090101,0.0019247779,0.003386917,0.00024308031,0.0011656004,0.0009728882,0.0010045628,0.0030356394],"category_scores_gemma":[0.0012161308,0.00030274125,0.0006119305,0.005729467,0.0004119997,0.0018406475,0.0005739475,0.0012621852,0.0009152671],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015454847,0.00007193474,0.00028211167,0.09412739,0.00020361642,0.0003833847,0.00011401995,0.0004045098,0.001614421,0.003243757,0.029790398,0.86960983],"study_design_scores_gemma":[0.000043231576,0.0001774551,0.0014186157,0.025511812,0.0005404455,0.00238988,0.00011280109,0.00012567968,0.0004884954,0.0017559892,0.96740973,0.000025934529],"about_ca_topic_score_codex":0.0012345503,"about_ca_topic_score_gemma":0.0022551506,"teacher_disagreement_score":0.003386917,"about_ca_system_score_codex":0.0008702402,"about_ca_system_score_gemma":0.0023090115,"threshold_uncertainty_score":0.010155201},"labels":[],"label_agreement":null},{"id":"W2099562503","doi":"10.1200/jco.2009.22.1077","title":"Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Node-Positive or High-Risk Node-Negative Breast Cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); Saskatchewan Cancer Agency; McMaster University; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Amgen; Queen's University; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Epirubicin; Cyclophosphamide; Breast cancer; Internal medicine; Febrile neutropenia; Hazard ratio; Fluorouracil; Chemotherapy; Doxorubicin; Gastroenterology; Oncology; Cancer; Neutropenia; Confidence interval","score_opus":0.04116585421662357,"score_gpt":0.40403025614598265,"score_spread":0.3628644019293591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099562503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596417,0.0019950087,0.0003749567,0.00016224627,0.00015243895,0.00056468777,0.00019654712,0.000027002803,0.000562904],"genre_scores_gemma":[0.9970366,0.0007783481,0.0005644315,0.00018284065,0.00016227219,0.0004933709,0.00021908761,0.0000042918473,0.0005588367],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99824834,0.0012134854,0.00011974169,0.00013288253,0.0000926174,0.00019298153],"domain_scores_gemma":[0.99809045,0.0009571552,0.00046242552,0.00012922162,0.00005142733,0.00030925777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034867001,0.0006291889,0.0019782363,0.00035746905,0.00014707539,0.00042357633,0.00064341974,0.0008703579,0.002358249],"category_scores_gemma":[0.002843625,0.00029570214,0.0024585088,0.0002788861,0.0005235104,0.0004229719,0.00029139756,0.0014061179,0.0002710143],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9658938,0.004683004,0.001718839,0.00030651278,0.0010720337,0.000027548029,0.000019892956,0.00088963157,0.002536388,0.00008057354,0.00021637105,0.022555474],"study_design_scores_gemma":[0.38299668,0.5894026,0.015319258,0.000086482105,0.0030630468,0.00013041022,0.00003972075,0.0032925326,0.0044828793,0.00037690168,0.0007887232,0.000020746324],"about_ca_topic_score_codex":0.00051552436,"about_ca_topic_score_gemma":0.0010328498,"teacher_disagreement_score":0.0034867001,"about_ca_system_score_codex":0.00051576446,"about_ca_system_score_gemma":0.0006663441,"threshold_uncertainty_score":0.01843959},"labels":[],"label_agreement":null},{"id":"W2099712757","doi":"10.1093/annonc/mdr063","title":"Temsirolimus in combination with carboplatin and paclitaxel in patients with advanced solid tumors: a NCIC-CTG, phase I, open-label dose-escalation study (IND 179)","year":2011,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; BC Cancer Agency; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Juravinski Cancer Centre","funders":"","keywords":"Temsirolimus; Carboplatin; Medicine; Tolerability; Paclitaxel; Adverse effect; Neutropenia; Nausea; Chemotherapy; Internal medicine; Toxicity; Common Terminology Criteria for Adverse Events; Pharmacology; Oncology; Urology; Cisplatin","score_opus":0.1238114440220481,"score_gpt":0.438953404819226,"score_spread":0.31514196079717793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099712757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99451447,0.0014406627,0.0002901543,0.00047671946,0.00009889324,0.00070157467,0.0008553938,0.00012338662,0.001498783],"genre_scores_gemma":[0.98811215,0.0024181667,0.0017936869,0.0008429798,0.00023909677,0.0010162301,0.0023486947,0.000055779896,0.0031731518],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996302,0.00017176686,0.000021131342,0.000061278544,0.000043810676,0.00007177188],"domain_scores_gemma":[0.99952936,0.000081683276,0.00009358186,0.000039476105,0.00002216534,0.00023376587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001148645,0.001526792,0.002556902,0.00072591106,0.0003668147,0.00076837017,0.0009154149,0.0008648394,0.0026314026],"category_scores_gemma":[0.00078842096,0.00059796707,0.001476381,0.0008365147,0.00083318626,0.0011395236,0.00033111128,0.0036782678,0.0007218878],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7359763,0.056487795,0.008984998,0.0009998041,0.0025091844,0.00022610607,0.00038678985,0.003932951,0.039597657,0.0003610552,0.007723287,0.14281411],"study_design_scores_gemma":[0.6637471,0.30443507,0.022722902,0.000036619458,0.00074536284,0.00026932868,0.00008099008,0.0019204589,0.0030605502,0.00021127617,0.0027252994,0.00004508912],"about_ca_topic_score_codex":0.0011983515,"about_ca_topic_score_gemma":0.0043238485,"teacher_disagreement_score":0.0026314026,"about_ca_system_score_codex":0.000828216,"about_ca_system_score_gemma":0.0014955065,"threshold_uncertainty_score":0.008802891},"labels":[],"label_agreement":null},{"id":"W2099818449","doi":"10.1093/annonc/mdq430","title":"First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients","year":2010,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Roche","keywords":"Medicine; Bevacizumab; Taxane; Metastatic breast cancer; Internal medicine; Docetaxel; Oncology; Clinical endpoint; Neutropenia; Chemotherapy; Breast cancer; Population; Surgery; Cancer; Clinical trial","score_opus":0.13956061855920757,"score_gpt":0.48037675997332335,"score_spread":0.34081614141411576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099818449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970752,0.0015295381,0.00015774248,0.000061000974,0.000030995823,0.00031167883,0.00033865633,0.000032689913,0.00046254543],"genre_scores_gemma":[0.994639,0.001797201,0.00068493676,0.0002734254,0.00013049552,0.00034295718,0.0012646922,0.000017470935,0.00084981293],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999356,0.00027722184,0.00003559074,0.0001416559,0.00007469697,0.00011483794],"domain_scores_gemma":[0.9991862,0.00016998088,0.00020003026,0.00008501885,0.000046952184,0.00031182382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016478993,0.0011051149,0.0031091177,0.0006965784,0.00047868883,0.001180639,0.00077591796,0.000780221,0.0021229882],"category_scores_gemma":[0.0010667752,0.00060370617,0.0018898282,0.0007134948,0.0010950337,0.0008046907,0.00035097604,0.0024869093,0.00053557655],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8240354,0.04324727,0.021201242,0.00084104907,0.0032765013,0.00022399428,0.00035950958,0.00148149,0.014549208,0.00015665936,0.0017541159,0.08887361],"study_design_scores_gemma":[0.45829794,0.466288,0.06566638,0.00007168062,0.0027402374,0.0004881278,0.00013613596,0.0016606422,0.0023726134,0.00011845601,0.0020917344,0.000067999754],"about_ca_topic_score_codex":0.0024373503,"about_ca_topic_score_gemma":0.0052046254,"teacher_disagreement_score":0.0031091177,"about_ca_system_score_codex":0.0014300689,"about_ca_system_score_gemma":0.0013910434,"threshold_uncertainty_score":0.010375917},"labels":[],"label_agreement":null},{"id":"W2101024529","doi":"10.1634/theoncologist.2014-0059","title":"Investigation of Adverse-Event-Related Costs for Patients With Metastatic Breast Cancer in a Real-World Setting","year":2014,"lang":"en","type":"article","venue":"The Oncologist","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Genentech","keywords":"Medicine; Capecitabine; Metastatic breast cancer; Taxane; Adverse effect; Internal medicine; Cohort; Breast cancer; Cancer; Pharmacy; Leukopenia; Anemia; Chemotherapy; Oncology","score_opus":0.024192563102551974,"score_gpt":0.34294199914562395,"score_spread":0.318749436043072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101024529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924056,0.001727234,0.0003639783,0.0007412164,0.000019093637,0.00014379936,0.0027341496,0.000009254219,0.0018557635],"genre_scores_gemma":[0.9977186,0.00041984505,0.0005145774,0.00010638468,0.0000299059,0.00006412443,0.0010726473,0.0000023798252,0.00007159248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99615437,0.0020703475,0.0005579066,0.00026725465,0.000726478,0.00022360138],"domain_scores_gemma":[0.9823727,0.0039899945,0.010900816,0.00024301135,0.0014760222,0.0010174967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033606405,0.0004085608,0.00046024338,0.001835991,0.00045973234,0.0013052244,0.00067236915,0.00050313363,0.0019381673],"category_scores_gemma":[0.014971453,0.00020908852,0.0009961431,0.0025267068,0.0003068776,0.0009860876,0.0007747134,0.0008675246,0.0002013621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003201811,0.00017087467,0.9915809,0.00015354503,0.00024305932,0.00013714292,0.00004512395,0.0010011832,0.000039616858,0.00011728275,0.00055614865,0.0056348443],"study_design_scores_gemma":[0.000073054165,0.0008599409,0.98868793,0.00010073575,0.0001832498,0.0010670024,0.0004534218,0.0067757093,0.00010423361,0.00022638304,0.0014461582,0.000022170489],"about_ca_topic_score_codex":0.004233732,"about_ca_topic_score_gemma":0.006316513,"teacher_disagreement_score":0.004233732,"about_ca_system_score_codex":0.0027046981,"about_ca_system_score_gemma":0.0014533098,"threshold_uncertainty_score":0.019624054},"labels":[],"label_agreement":null},{"id":"W2101295467","doi":"10.1177/1078155214553143","title":"The effect of race on the CYP3A-mediated metabolism of vincristine in pediatric patients with acute lymphoblastic leukemia","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"International Society of Oncology Pharmacy Practitioners","keywords":"Medicine; Vincristine; Neurotoxicity; Internal medicine; Genotyping; Acute lymphocytic leukemia; Gastroenterology; Incidence (geometry); Leukemia; Chemotherapy; Lymphoblastic Leukemia; Genotype; Toxicity; Gene","score_opus":0.010044189550483045,"score_gpt":0.34122279438766634,"score_spread":0.3311786048371833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101295467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986339,0.000746869,0.000059671533,0.00004181957,0.000004096671,0.0000030436963,0.000051637566,0.0000017976297,0.0004571723],"genre_scores_gemma":[0.9995957,0.00018140773,0.000057580623,0.000022783452,0.000009352218,0.0000026136643,0.00004695208,0.0000017467803,0.00008203071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996024,0.0001915631,0.000036122765,0.000051607556,0.000068106325,0.000050258936],"domain_scores_gemma":[0.99903154,0.00028997255,0.00045285054,0.000035383408,0.000081053375,0.00010923132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003726688,0.00012891268,0.00016138077,0.00021500046,0.0001969616,0.00027395194,0.00010849238,0.00013030079,0.001569738],"category_scores_gemma":[0.0018399293,0.000059551698,0.00014396895,0.00031686167,0.00012575148,0.00018341362,0.00016356308,0.00019420426,0.00021052906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048300746,0.000020977475,0.991642,0.000011407279,0.000037341582,0.0001601564,0.000100555044,0.000035161163,0.0012073403,0.000019520143,0.00007876016,0.0062037697],"study_design_scores_gemma":[0.000010834572,0.000309564,0.9967642,0.00001019097,0.00004569397,0.0014704625,0.00012810559,0.000098318495,0.0005385334,0.000016757947,0.00060554134,0.0000017742736],"about_ca_topic_score_codex":0.00071595534,"about_ca_topic_score_gemma":0.001388729,"teacher_disagreement_score":0.001569738,"about_ca_system_score_codex":0.00018755281,"about_ca_system_score_gemma":0.0001486816,"threshold_uncertainty_score":0.005251348},"labels":[],"label_agreement":null},{"id":"W2101719282","doi":"10.1634/theoncologist.2010-0278","title":"In the End What Matters Most? A Review of Clinical Endpoints in Advanced Breast Cancer","year":2011,"lang":"en","type":"review","venue":"The Oncologist","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; University of Alberta; Bibliographical Society of Canada; Jewish General Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"University of Toronto; Eli Lilly and Company","keywords":"Medicine; Clinical trial; Metastatic breast cancer; Clinical research; Clinical endpoint; Breast cancer; Phases of clinical research; Oncology; Drug; Food and drug administration; Cancer; Internal medicine; Intensive care medicine; Pharmacology","score_opus":0.19286006184339724,"score_gpt":0.5378821186998671,"score_spread":0.3450220568564699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101719282","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006553793,0.99819416,0.00009054383,0.0011035384,0.0003062582,0.000022391943,0.000030420384,0.000003917618,0.00018329226],"genre_scores_gemma":[0.0011417978,0.99584645,0.00060002884,0.0016216091,0.00056138745,0.00008023199,0.000055326265,0.0000058874484,0.00008730522],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.981406,0.009830732,0.00548361,0.0006447588,0.0024611917,0.00017380138],"domain_scores_gemma":[0.93312913,0.051137637,0.00710721,0.0009413445,0.0069580553,0.00072662457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020812126,0.0014053595,0.0063606706,0.012135468,0.00079982786,0.004808452,0.0021443316,0.0021609426,0.0023574838],"category_scores_gemma":[0.054837804,0.00080773945,0.0027530682,0.01741087,0.001967591,0.0058743875,0.0015067281,0.003428701,0.00081418856],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003744215,0.00006269761,0.0010681173,0.30281106,0.0012531531,0.00012976264,0.00043583196,0.0003151932,0.00042631853,0.004244255,0.04457965,0.6442995],"study_design_scores_gemma":[0.00024500696,0.0005735006,0.0088470485,0.47091585,0.0036449172,0.0010722105,0.0007521478,0.00021181109,0.00023384947,0.0072209635,0.5061838,0.00009880641],"about_ca_topic_score_codex":0.0023424325,"about_ca_topic_score_gemma":0.005213323,"teacher_disagreement_score":0.020812126,"about_ca_system_score_codex":0.003284127,"about_ca_system_score_gemma":0.007722387,"threshold_uncertainty_score":0.110066354},"labels":[],"label_agreement":null},{"id":"W2101857408","doi":"10.1081/cnv-100102548","title":"Mitoxantrone and Paclitaxel Combination Chemotherapy in Metastatic Breast Cancer","year":2001,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research & Development Corporation","funders":"Bristol-Myers Squibb","keywords":"Mitoxantrone; Medicine; Chemotherapy; Cardiotoxicity; Metastatic breast cancer; Internal medicine; Neutropenia; Regimen; Oncology; Breast cancer; Nausea; Doxorubicin; Paclitaxel; Cancer; Progressive disease; Surgery","score_opus":0.03761453095331926,"score_gpt":0.3490888451618517,"score_spread":0.31147431420853244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101857408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98822814,0.009555931,0.00035533705,0.00021966087,0.00004498708,0.00011846336,0.000047508845,0.000012675207,0.0014171908],"genre_scores_gemma":[0.9925368,0.0054845056,0.00078658655,0.00012545366,0.00010024278,0.00008221797,0.00018852054,0.0000028550166,0.0006928853],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99974376,0.0001208373,0.000018066701,0.000018263376,0.000056942485,0.000042039646],"domain_scores_gemma":[0.9998789,0.000035107143,0.000027978647,0.0000053967933,0.000010608322,0.000042037907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031687797,0.00019605474,0.00040310383,0.00025183833,0.00025271095,0.00017417873,0.00012331294,0.00017116271,0.0007553192],"category_scores_gemma":[0.0005346434,0.000104198436,0.00021383168,0.00027742036,0.00013657808,0.00014490038,0.00012854002,0.0003128126,0.00014717403],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028627045,0.0051628766,0.13574933,0.00081889227,0.0007045377,0.0034411743,0.0004720498,0.004562408,0.08498393,0.00044572956,0.002530174,0.7325018],"study_design_scores_gemma":[0.022867493,0.2477097,0.59042436,0.00025743898,0.001711555,0.023327693,0.000348087,0.005834908,0.03777799,0.0006604582,0.06900564,0.00007457798],"about_ca_topic_score_codex":0.0005918248,"about_ca_topic_score_gemma":0.0032656328,"teacher_disagreement_score":0.0007553192,"about_ca_system_score_codex":0.00031353274,"about_ca_system_score_gemma":0.0002902848,"threshold_uncertainty_score":0.00252676},"labels":[],"label_agreement":null},{"id":"W2102612417","doi":"10.1158/0008-5472.can-04-0580","title":"A Comparative Analysis of Low-Dose Metronomic Cyclophosphamide Reveals Absent or Low-Grade Toxicity on Tissues Highly Sensitive to the Toxic Effects of Maximum Tolerated Dose Regimens","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Cyclophosphamide; Toxicity; Medicine; Pharmacology; Maximum tolerated dose; Toxicology; Oncology; Internal medicine; Chemotherapy; Biology","score_opus":0.06633478806082845,"score_gpt":0.4347610397646431,"score_spread":0.36842625170381466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102612417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997503,0.00057787186,0.0005945949,0.000010825771,0.0000067207393,0.000020098933,0.00030581682,0.00001916431,0.00096192607],"genre_scores_gemma":[0.9977703,0.0002532901,0.0005001102,0.000018450732,0.000006019269,0.00002877387,0.0007006408,0.000009333751,0.0007130966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998679,0.000030444378,0.00001170286,0.00002153167,0.000031537096,0.000036800062],"domain_scores_gemma":[0.9998292,0.00004624024,0.000030032737,0.00002866561,0.0000222911,0.00004355795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012887163,0.00018387537,0.00028377917,0.00035956607,0.000076009346,0.0001645803,0.00014249679,0.0001890446,0.0013090682],"category_scores_gemma":[0.00020972265,0.00006688929,0.00021080606,0.00025803052,0.00013053745,0.00013454056,0.000077066325,0.0002447041,0.00012894427],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016025451,0.00015110205,0.0011045947,0.000042865147,0.00001700584,0.00005218049,0.000011937793,0.00029808615,0.9919614,0.0000695774,0.000065578766,0.0046229973],"study_design_scores_gemma":[0.00008416918,0.012404607,0.06843273,0.000010302415,0.0000795893,0.00066439103,0.00003853068,0.0020614099,0.9139199,0.000079948135,0.002214042,0.000010285882],"about_ca_topic_score_codex":0.00036606536,"about_ca_topic_score_gemma":0.00053344516,"teacher_disagreement_score":0.0013090682,"about_ca_system_score_codex":0.00017346621,"about_ca_system_score_gemma":0.00011852705,"threshold_uncertainty_score":0.0043792725},"labels":[],"label_agreement":null},{"id":"W2103672719","doi":"10.1177/107815520100600402","title":"Documentation of capecitabine usage as a third-line chemotherapy option for metastatic breast cancer patients","year":2001,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"Capecitabine; Medicine; Taxane; Metastatic breast cancer; Vinorelbine; Internal medicine; Nausea; Oncology; Cancer; Breast cancer; Chemotherapy; Colorectal cancer; Cisplatin","score_opus":0.04922793063149728,"score_gpt":0.47197149728347854,"score_spread":0.42274356665198126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103672719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98679954,0.0048621832,0.00017510672,0.0005454852,0.000021257263,0.00008887273,0.0026018159,0.000030625644,0.004875189],"genre_scores_gemma":[0.995194,0.0019434323,0.00048463058,0.00016379924,0.0000305978,0.000027939275,0.0012835494,0.000005531019,0.0008664802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993556,0.00010181547,0.00009843724,0.00005631505,0.0003072099,0.00008056825],"domain_scores_gemma":[0.99479055,0.0009992693,0.0029158082,0.000082462444,0.0007192602,0.0004926216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000617243,0.0001471078,0.00023958269,0.0014032099,0.0004065578,0.0005469121,0.00040422363,0.00025520002,0.0018771582],"category_scores_gemma":[0.0041950247,0.00011407277,0.00021381782,0.0015625717,0.00019199267,0.00025586394,0.00025257075,0.00042461796,0.00019101723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038358726,0.00003755941,0.9771119,0.00014697181,0.000025822577,0.0007871995,0.0003810934,0.0001548545,0.00057761336,0.00004074598,0.0014629348,0.018889766],"study_design_scores_gemma":[0.00002115781,0.00019648981,0.9913523,0.00012441992,0.000035156256,0.0025353334,0.00040074537,0.00025985306,0.000537401,0.000013665644,0.004514306,0.000009122313],"about_ca_topic_score_codex":0.0801661,"about_ca_topic_score_gemma":0.17038241,"teacher_disagreement_score":0.0801661,"about_ca_system_score_codex":0.0026927898,"about_ca_system_score_gemma":0.0028717304,"threshold_uncertainty_score":0.15939897},"labels":[],"label_agreement":null},{"id":"W2103803683","doi":"10.1139/v03-200","title":"Part 1: Efficient strategies for the construction of variably substituted bicyclo[5.3.1]undecenones (AB taxane ring systems)","year":2004,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; Consejo Nacional de Ciencia y Tecnología; Government of Ontario","keywords":"Chemistry; Intramolecular force; Cycloaddition; Ring (chemistry); Propargyl; Lewis acids and bases; Medicinal chemistry; Bicyclic molecule; Stereochemistry; Boron trifluoride; Taxane; Organic chemistry; Catalysis","score_opus":0.019101733137865038,"score_gpt":0.2614698150398388,"score_spread":0.24236808190197376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103803683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7318102,0.025108244,0.19013102,0.00043994572,0.00040896263,0.001841272,0.0018037824,0.00081107696,0.047645446],"genre_scores_gemma":[0.8443044,0.016930655,0.118759274,0.00018126363,0.0000567138,0.00059320976,0.0017997443,0.000111897265,0.017262865],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986994,0.000022233347,0.000012870313,0.000025418001,0.000039869934,0.00002966388],"domain_scores_gemma":[0.9999428,0.000009675628,0.000017859518,0.0000147960955,0.0000060034386,0.000008898114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021190678,0.0004734757,0.00024400333,0.0003740243,0.00021460989,0.00029461004,0.000501989,0.0002684941,0.0034335307],"category_scores_gemma":[0.0001427032,0.00015980843,0.0002322947,0.0002922191,0.0002897647,0.0004347225,0.00040387674,0.0005683602,0.0010431088],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097391196,0.0001175607,0.0001702933,0.00032697228,0.000017997494,0.00019780798,0.00009058114,0.0010657728,0.9459252,0.0041309926,0.00068154547,0.047177795],"study_design_scores_gemma":[0.000043051972,0.0007320207,0.0009728342,0.000024446597,0.000029310719,0.0006890067,0.00002610069,0.00077314285,0.9568093,0.0005602255,0.03931984,0.000020790381],"about_ca_topic_score_codex":0.0004778445,"about_ca_topic_score_gemma":0.001280499,"teacher_disagreement_score":0.0034335307,"about_ca_system_score_codex":0.00028493954,"about_ca_system_score_gemma":0.00033795237,"threshold_uncertainty_score":0.011486292},"labels":[],"label_agreement":null},{"id":"W2105567212","doi":"10.1186/bcr3231","title":"Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":213,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Surgical oncology; Medicine; Breast cancer; Oncology; Cisplatin; Internal medicine; Chemotherapy; Metastatic breast cancer; Cancer; Randomized controlled trial; Open label","score_opus":0.07042442315505405,"score_gpt":0.46501667705105887,"score_spread":0.39459225389600483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105567212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98996615,0.003409107,0.00059065525,0.00058429746,0.00021387872,0.0032737742,0.0007593833,0.0000475357,0.0011552789],"genre_scores_gemma":[0.9890526,0.0021134878,0.0016815406,0.0009349958,0.00029157713,0.003302323,0.0014310218,0.000022870432,0.0011695755],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99798065,0.001519235,0.000103557635,0.0001688145,0.000121956604,0.000105921165],"domain_scores_gemma":[0.99718887,0.0011579872,0.0006184961,0.00022161608,0.00017100894,0.000642013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039866795,0.0013177615,0.0025104973,0.00035280187,0.00046349145,0.0009529141,0.000792413,0.001239829,0.004946047],"category_scores_gemma":[0.003968811,0.0006497991,0.0012817694,0.00038079047,0.0009939844,0.0010431051,0.00037621876,0.0023283372,0.0006882964],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94029105,0.023074398,0.003228316,0.0005518362,0.0014020237,0.00006327695,0.0000874387,0.00069181155,0.0039857198,0.00007256995,0.0010711821,0.02548042],"study_design_scores_gemma":[0.86625385,0.12856516,0.0032999786,0.000023947325,0.0003987871,0.0000510925,0.000012911763,0.00034284336,0.0004289222,0.00006594486,0.0005465335,0.000009979465],"about_ca_topic_score_codex":0.0004445098,"about_ca_topic_score_gemma":0.0012508412,"teacher_disagreement_score":0.004946047,"about_ca_system_score_codex":0.0007599475,"about_ca_system_score_gemma":0.0013163692,"threshold_uncertainty_score":0.021083891},"labels":[],"label_agreement":null},{"id":"W2105765694","doi":"10.1093/annonc/mdp373","title":"An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer","year":2009,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Durham","funders":"GlaxoSmithKline","keywords":"Capecitabine; Medicine; Lapatinib; Metastatic breast cancer; Oncology; Expanded access; Internal medicine; Breast cancer; Cancer; Trastuzumab; Colorectal cancer","score_opus":0.12627047852334472,"score_gpt":0.49292940128938106,"score_spread":0.36665892276603634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105765694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956227,0.0011702459,0.00021406125,0.00021846399,0.00012904528,0.0007714142,0.0005632108,0.000031018782,0.0012799271],"genre_scores_gemma":[0.9933242,0.0010999468,0.00060462847,0.0004771105,0.0002820777,0.0008253627,0.0008606416,0.000017667287,0.002508405],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99908876,0.00044433694,0.000038391772,0.00018096954,0.00007131521,0.00017618982],"domain_scores_gemma":[0.99876153,0.00034679708,0.00017141443,0.0001154716,0.00006085228,0.00054392335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001685217,0.0014989903,0.0037099114,0.0005783425,0.00064622174,0.0011727359,0.00074764993,0.0015085542,0.008037919],"category_scores_gemma":[0.0015230232,0.00089153484,0.002056794,0.0006067282,0.001409481,0.0022819366,0.0005720162,0.0043227663,0.0010518859],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9552437,0.021489497,0.0025409677,0.00018205038,0.0005530078,0.00010661512,0.000100528654,0.00041356919,0.0028268227,0.000058290876,0.00037819907,0.016106775],"study_design_scores_gemma":[0.7309898,0.25630927,0.009532139,0.00001836617,0.0005937853,0.0000945519,0.000078873025,0.00063635287,0.00050897355,0.00008886142,0.0011130928,0.00003592994],"about_ca_topic_score_codex":0.001938456,"about_ca_topic_score_gemma":0.0053756856,"teacher_disagreement_score":0.008037919,"about_ca_system_score_codex":0.0012503517,"about_ca_system_score_gemma":0.0013641034,"threshold_uncertainty_score":0.026889563},"labels":[],"label_agreement":null},{"id":"W2106155834","doi":"10.1200/jco.2004.01.106","title":"Determining the Relationship Between Toxicity and Quality of Life in an Ovarian Cancer Chemotherapy Clinical Trial","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Lethargy; Quality of life (healthcare); Nausea; Internal medicine; Randomized controlled trial; Clinical trial; Cancer; Ovarian cancer; Vomiting; Chemotherapy; Gynecologic oncology; Oncology","score_opus":0.6171955787318496,"score_gpt":0.6388170291255502,"score_spread":0.02162145039370056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106155834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835323,0.008552189,0.0027302664,0.0010344972,0.00015789572,0.0013396315,0.00071581913,0.00003195035,0.0019053571],"genre_scores_gemma":[0.9964121,0.0003841188,0.0008967639,0.00033181784,0.00008045553,0.0011586935,0.00055363105,0.000007876777,0.00017457712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9242697,0.064411655,0.0046509025,0.0019815122,0.003914841,0.0007713695],"domain_scores_gemma":[0.80653,0.15152429,0.030676749,0.0037323732,0.0034866852,0.004049805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06697248,0.00039187534,0.0016777185,0.00078397535,0.00055124494,0.001706606,0.00065049285,0.001012032,0.0024194599],"category_scores_gemma":[0.113096476,0.00027538175,0.002289125,0.0013683192,0.0010911428,0.0014130574,0.0008570036,0.0020089773,0.00015991116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40983325,0.0022810323,0.51589155,0.0015989051,0.01093615,0.00020019601,0.0002483087,0.0032513866,0.0011454053,0.00056174234,0.0016342335,0.052417777],"study_design_scores_gemma":[0.06414777,0.08808874,0.8169659,0.00035511106,0.0071400553,0.0007373311,0.00016483152,0.012589396,0.0015113744,0.0018126577,0.0063879862,0.00009897096],"about_ca_topic_score_codex":0.00025877802,"about_ca_topic_score_gemma":0.0004086712,"teacher_disagreement_score":0.06697248,"about_ca_system_score_codex":0.0009879327,"about_ca_system_score_gemma":0.001590645,"threshold_uncertainty_score":0.35418856},"labels":[],"label_agreement":null},{"id":"W2109641043","doi":"10.1016/s0968-0896(02)00607-7","title":"Semi-Synthesis of an O-Glycosylated docetaxel analogue","year":2003,"lang":"fi","type":"article","venue":"Bioorganic & Medicinal Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Queen's University; Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Paclitaxel; Docetaxel; Taxane; Chemistry; Cytotoxicity; Potency; Moiety; Cell culture; Pharmacology; Stereochemistry; In vitro; Drug; Biochemistry; Chemotherapy; Cancer; Internal medicine","score_opus":0.017955298851129044,"score_gpt":0.28599597566968915,"score_spread":0.2680406768185601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109641043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9233998,0.0032600572,0.032102425,0.00044386377,0.00034420274,0.00068717304,0.0027186582,0.00031719243,0.03672672],"genre_scores_gemma":[0.97948986,0.0013682051,0.0072296127,0.0000998676,0.000016216225,0.00007570736,0.00066714827,0.00003360766,0.011019711],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994123,0.000005715437,0.000005124096,0.000010400345,0.000009720562,0.000027738166],"domain_scores_gemma":[0.9999666,0.0000039380034,0.0000071788118,0.0000056663566,0.0000047990147,0.000011856783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007820896,0.00028238195,0.00017483867,0.00012340093,0.00017229813,0.00020004227,0.00024121025,0.00017708876,0.0024053885],"category_scores_gemma":[0.00008840824,0.0001015902,0.00020091985,0.00015626551,0.00012707914,0.00021097416,0.00021902526,0.00047347642,0.000760928],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062021584,0.00023586873,0.00029380442,0.0003708592,0.00002228177,0.0010617257,0.00023395888,0.0025883454,0.9565535,0.0040874956,0.0015265138,0.032405492],"study_design_scores_gemma":[0.00015418533,0.0018111872,0.0013592276,0.000029075136,0.000030453108,0.0005640226,0.00005905409,0.0012057166,0.9634385,0.0004404876,0.03087459,0.00003361266],"about_ca_topic_score_codex":0.0012005378,"about_ca_topic_score_gemma":0.0021260867,"teacher_disagreement_score":0.0024053885,"about_ca_system_score_codex":0.00026886608,"about_ca_system_score_gemma":0.000540743,"threshold_uncertainty_score":0.008046806},"labels":[],"label_agreement":null},{"id":"W2110046944","doi":"10.1200/jco.2008.21.0534","title":"Efficacy Does Not Necessarily Translate to Cost Effectiveness: A Case Study in the Challenges Associated With 21st-Century Cancer Drug Pricing","year":2009,"lang":"en","type":"letter","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer drugs; Drug; Drug pricing; Cancer; Intensive care medicine; Oncology; Pharmacology; Internal medicine; Actuarial science","score_opus":0.15994885631993133,"score_gpt":0.5037386611490396,"score_spread":0.3437898048291083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110046944","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40585205,0.051310625,0.02195807,0.37483594,0.002607074,0.0010721729,0.00072386,0.00009042022,0.14154975],"genre_scores_gemma":[0.9162893,0.022007432,0.019355452,0.03034865,0.003677055,0.00041397373,0.00018290243,0.0001484232,0.007576882],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99167484,0.0057623913,0.00053980394,0.00032426638,0.0011067431,0.0005919804],"domain_scores_gemma":[0.9131205,0.076411,0.003963601,0.0015438473,0.002759264,0.0022016445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018018499,0.00052374374,0.0009263574,0.001532396,0.0028523498,0.00505507,0.0012751743,0.006221991,0.00781088],"category_scores_gemma":[0.078134716,0.00034099567,0.002107327,0.002363107,0.0032672568,0.004634291,0.0018173696,0.005592271,0.0006810802],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019868875,0.003309953,0.096910246,0.0027152614,0.00068946864,0.12665609,0.01610254,0.0061573167,0.0010229143,0.32937273,0.16988541,0.24519123],"study_design_scores_gemma":[0.0013608714,0.003924817,0.051688414,0.0072986833,0.001153619,0.20422998,0.034733977,0.029555114,0.0022298864,0.25767955,0.40560564,0.00053946476],"about_ca_topic_score_codex":0.0040176096,"about_ca_topic_score_gemma":0.006558639,"teacher_disagreement_score":0.018018499,"about_ca_system_score_codex":0.0046313927,"about_ca_system_score_gemma":0.0028751022,"threshold_uncertainty_score":0.09529209},"labels":[],"label_agreement":null},{"id":"W2110984210","doi":"10.2217/fon.10.163","title":"Do Anthracyclines Still Have a Role in Adjuvant Chemotherapy of Breast Cancer?","year":2010,"lang":"en","type":"review","venue":"Future Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Anthracycline; Trastuzumab; Cardiotoxicity; Medicine; Breast cancer; Taxane; Oncology; Internal medicine; Chemotherapy; Cancer; Metastatic breast cancer","score_opus":0.029723272581336946,"score_gpt":0.4338935815551031,"score_spread":0.40417030897376616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110984210","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000120839104,0.9986009,0.00005281784,0.00060088973,0.00015194161,0.0000013364778,0.00000482839,0.0000018328021,0.0004646124],"genre_scores_gemma":[0.0008231924,0.99775875,0.00011459875,0.0005036679,0.00024756047,0.000002753405,0.000010693382,0.0000010950532,0.0005376873],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976534,0.000051297826,0.000035913814,0.00003665311,0.00009231328,0.000018505369],"domain_scores_gemma":[0.99931026,0.00031825315,0.000105427054,0.000030598036,0.00018735723,0.000048105983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001142474,0.00052345503,0.001560228,0.0008308958,0.00022765357,0.0009641851,0.00080926844,0.0012328258,0.0026079537],"category_scores_gemma":[0.0011928685,0.0003342005,0.00040497747,0.0014841168,0.0008098381,0.0022983185,0.00043092974,0.0023029153,0.0020865253],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010392536,0.00005757938,0.00022742504,0.006398548,0.000054440192,0.0001324094,0.000058397727,0.00022797076,0.0013238667,0.0034020825,0.018129775,0.9698835],"study_design_scores_gemma":[0.000064475134,0.00015763176,0.001379544,0.0032963906,0.00009379735,0.0012158891,0.00008403499,0.00010941932,0.00041012,0.0027227444,0.9904502,0.00001572491],"about_ca_topic_score_codex":0.0014706433,"about_ca_topic_score_gemma":0.0035739816,"teacher_disagreement_score":0.0026079537,"about_ca_system_score_codex":0.0005791605,"about_ca_system_score_gemma":0.00084768,"threshold_uncertainty_score":0.008724451},"labels":[],"label_agreement":null},{"id":"W2112901840","doi":"10.1200/jco.2006.09.7535","title":"Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, As First-Line Therapy in Patients With Metastatic Breast Cancer Previously Treated With Anthracycline Chemotherapy","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":225,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Ixabepilone; Medicine; Anthracycline; Metastatic breast cancer; Clinical endpoint; Internal medicine; Chemotherapy; Regimen; Adverse effect; Surgery; Breast cancer; Oncology; Cancer; Clinical trial","score_opus":0.13257564656467236,"score_gpt":0.5297732023901652,"score_spread":0.3971975558254929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112901840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99188423,0.0025881159,0.00040034732,0.00050812727,0.00015725683,0.0019111965,0.0005891732,0.000090666224,0.0018707805],"genre_scores_gemma":[0.9880861,0.0021322218,0.0012618367,0.0008902604,0.00024686684,0.0027676243,0.0017920083,0.000022160628,0.0028009107],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997274,0.0001422922,0.000011873589,0.00003945532,0.000023803987,0.00005504363],"domain_scores_gemma":[0.9992706,0.0001189102,0.00014734075,0.000038014903,0.00003392947,0.0003911537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011928004,0.0013827196,0.001711697,0.00028557866,0.00029293823,0.0007678896,0.0007315557,0.0012308377,0.0034093312],"category_scores_gemma":[0.0008201923,0.000430616,0.00072588405,0.0003121283,0.0010329614,0.0005951923,0.0002441064,0.0026713386,0.000710055],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80791575,0.07032742,0.0065283393,0.00074673066,0.0008838064,0.00039834293,0.00024548854,0.0028920595,0.035962947,0.0003189787,0.004654392,0.06912576],"study_design_scores_gemma":[0.64893955,0.3359255,0.008109183,0.000033236436,0.00019530041,0.00027540748,0.000038790982,0.0015244392,0.0027916778,0.000112562084,0.002039824,0.000014557694],"about_ca_topic_score_codex":0.00084477,"about_ca_topic_score_gemma":0.0019397517,"teacher_disagreement_score":0.0034093312,"about_ca_system_score_codex":0.00071514386,"about_ca_system_score_gemma":0.0014370024,"threshold_uncertainty_score":0.011405349},"labels":[],"label_agreement":null},{"id":"W2114358393","doi":"10.1051/medsci/2010265459","title":"Mécanisme d’activation de l’oncogène<i>BRAF</i>","year":2010,"lang":"fr","type":"article","venue":"médecine/sciences","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Chemistry; Cancer research; Medicine","score_opus":0.034466896096121115,"score_gpt":0.36411555551760977,"score_spread":0.32964865942148863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114358393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9101367,0.0019575239,0.019736666,0.0050822194,0.00067949656,0.000114216375,0.00050109957,0.00043619942,0.061355922],"genre_scores_gemma":[0.9899436,0.00041627564,0.0023712139,0.00027754993,0.000066378554,0.00004042653,0.00017408979,0.00003720493,0.006673353],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99947363,0.00008068242,0.00001906219,0.0001327458,0.00016625904,0.0001277242],"domain_scores_gemma":[0.99952185,0.0002615558,0.000050765004,0.000049641552,0.00006122879,0.00005489812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041429006,0.00038297876,0.000367826,0.00035692097,0.0007156173,0.0012032939,0.00049320713,0.0009888912,0.012248034],"category_scores_gemma":[0.0016412069,0.0002604895,0.000510255,0.000117445525,0.0005659445,0.0007274793,0.00057924277,0.0011276309,0.0023142311],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039690587,0.000097731434,0.0020330534,0.00021051004,0.00005429115,0.0007817929,0.00012880105,0.0016070949,0.9609926,0.021331236,0.0019731892,0.010392807],"study_design_scores_gemma":[0.00015773468,0.0007048699,0.008295436,0.000036820464,0.000063573294,0.0033516544,0.0003456982,0.009153367,0.92327726,0.011781958,0.04277137,0.000060198996],"about_ca_topic_score_codex":0.002522547,"about_ca_topic_score_gemma":0.0021798364,"teacher_disagreement_score":0.012248034,"about_ca_system_score_codex":0.0007230079,"about_ca_system_score_gemma":0.00058119936,"threshold_uncertainty_score":0.040973783},"labels":[],"label_agreement":null},{"id":"W2116280772","doi":"10.1634/theoncologist.2008-0070","title":"Anthracyclines in Early-Stage Breast Cancer: Is It the End of an Era?","year":2009,"lang":"en","type":"review","venue":"The Oncologist","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Sanofi; AstraZeneca; Pfizer","keywords":"Anthracycline; Medicine; Breast cancer; Oncology; Internal medicine; Adjuvant; Stage (stratigraphy); Topoisomerase; Cancer; Chemotherapy; Trastuzumab","score_opus":0.11737981977320233,"score_gpt":0.4823295088974135,"score_spread":0.36494968912421116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116280772","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000058446592,0.99930537,0.000030438163,0.00024819354,0.000058623555,0.000001134893,0.000004097604,0.0000020739722,0.00029156654],"genre_scores_gemma":[0.0003990279,0.99904567,0.00006466539,0.00014744842,0.00007379127,0.0000014299492,0.000006413968,4.3083998e-7,0.0002611247],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998467,0.00004211862,0.000022856164,0.000020334666,0.000057385638,0.000010618952],"domain_scores_gemma":[0.9996313,0.000182254,0.000056725792,0.000011908064,0.00009100841,0.000026792351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054415694,0.00054486725,0.0015635273,0.0012191486,0.00022758367,0.0006567007,0.0006709321,0.00089863944,0.0029549988],"category_scores_gemma":[0.0007697406,0.00020497406,0.00032368698,0.001968893,0.00043208292,0.0012864311,0.00035938734,0.0013825432,0.0017984016],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010370297,0.00006522506,0.0001816723,0.019291345,0.00008171091,0.00025263432,0.00006750186,0.00022012243,0.0010183693,0.0021930546,0.034580823,0.9419438],"study_design_scores_gemma":[0.00005471241,0.0001719011,0.0016611734,0.007377788,0.00019116842,0.0026304005,0.00012466691,0.00010130209,0.00046862185,0.0026210153,0.9845785,0.000018759027],"about_ca_topic_score_codex":0.0014643484,"about_ca_topic_score_gemma":0.0037178404,"teacher_disagreement_score":0.0029549988,"about_ca_system_score_codex":0.0005725048,"about_ca_system_score_gemma":0.00097368145,"threshold_uncertainty_score":0.00988543},"labels":[],"label_agreement":null},{"id":"W2119018891","doi":"10.1093/annonc/mdi240","title":"Cyclophosphamide-methotrexate ‘metronomic’ chemotherapy for the palliative treatment of metastatic breast cancer. A comparative pharmacoeconomic evaluation","year":2005,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Associazione Italiana per la Ricerca sul Cancro; Oncosuisse; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Medicine; Cyclophosphamide; Metastatic breast cancer; Breast cancer; Oncology; Chemotherapy; Methotrexate; Internal medicine; Cancer; Nitrogen mustard; Clinical trial; Palliative care; Nursing","score_opus":0.25147634853736733,"score_gpt":0.5328897417986063,"score_spread":0.28141339326123893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119018891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94347596,0.045856208,0.00074702554,0.0009324475,0.00024314779,0.0005005918,0.00031852358,0.000021367407,0.007904736],"genre_scores_gemma":[0.98280865,0.014818625,0.00076903525,0.00027133417,0.00046306988,0.00013217896,0.00015954138,0.0000055983546,0.0005720146],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9983071,0.0013663461,0.00007894035,0.000053795997,0.0001421177,0.000051790194],"domain_scores_gemma":[0.99829525,0.0010681424,0.00028472565,0.00010279276,0.000065424596,0.00018358532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014944922,0.0003262432,0.00094249885,0.0009376728,0.00028195206,0.00039004683,0.00053243176,0.0006493169,0.0046506315],"category_scores_gemma":[0.003036006,0.00017000415,0.00094906293,0.0010915804,0.0006249865,0.0005415349,0.00024154097,0.0010509854,0.00021094277],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52940524,0.012032907,0.002491986,0.0026480495,0.0020858299,0.00036780868,0.00018151062,0.00240478,0.009448551,0.0020174435,0.0009239926,0.4359919],"study_design_scores_gemma":[0.115732595,0.83104336,0.026245443,0.00046079926,0.0035309198,0.0015590206,0.00019751425,0.0021225004,0.006590483,0.0009971715,0.011447203,0.000072940675],"about_ca_topic_score_codex":0.0006325201,"about_ca_topic_score_gemma":0.0025069332,"teacher_disagreement_score":0.0046506315,"about_ca_system_score_codex":0.0006841762,"about_ca_system_score_gemma":0.00042378917,"threshold_uncertainty_score":0.015557885},"labels":[],"label_agreement":null},{"id":"W2119277421","doi":"10.4172/2329-6771.1000103","title":"Current Exercise Behaviors Of Breast Cancer Patients Diagnosed With Chemotherapy-induced Peripheral Neuropathy","year":2012,"lang":"en","type":"article","venue":"Journal of Integrative Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Peripheral neuropathy; Peripheral; Omics; Oncology; Chemotherapy; Internal medicine; Cancer; Bioinformatics; Physical therapy; Endocrinology","score_opus":0.019492661526661254,"score_gpt":0.3638400990499671,"score_spread":0.3443474375233059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119277421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99884593,0.00022404567,0.000014589353,0.000080668055,0.0000046722607,0.0000135214395,0.00024493283,0.0000018101857,0.0005697092],"genre_scores_gemma":[0.9994962,0.00012519129,0.00003320933,0.00004381128,0.000004379509,0.000012398087,0.00016052283,4.3830335e-7,0.00012384763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997516,0.00006427618,0.00003946602,0.000038393875,0.000059857277,0.00004644928],"domain_scores_gemma":[0.99908364,0.00017498093,0.0004894837,0.000020842623,0.00008813164,0.00014290954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037756484,0.00014154585,0.00023173634,0.0005437534,0.0002701964,0.00038758345,0.00018853445,0.0003544034,0.0019404276],"category_scores_gemma":[0.0020392605,0.00013130622,0.0002252683,0.00068801077,0.00012745765,0.00028471305,0.00021622075,0.0003465766,0.0002684936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034360455,0.000056747813,0.9985613,0.000010335334,0.0000109020875,0.00003400522,0.00007342873,0.00001209229,0.000037941863,0.0000022143884,0.00005559542,0.001111051],"study_design_scores_gemma":[0.0000034742454,0.00008166503,0.9994242,0.0000068712825,0.00000937795,0.00010576547,0.00019922377,0.000049643855,0.000013601325,0.0000030527094,0.00010192564,0.0000012145063],"about_ca_topic_score_codex":0.0044560432,"about_ca_topic_score_gemma":0.0077836215,"teacher_disagreement_score":0.0044560432,"about_ca_system_score_codex":0.00031074823,"about_ca_system_score_gemma":0.00024223399,"threshold_uncertainty_score":0.00886023},"labels":[],"label_agreement":null},{"id":"W2119413329","doi":"10.1158/1078-0432.ccr-06-2377","title":"A Randomized, Double-Blind, Phase II Study of Two Doses of Pemetrexed as First-Line Chemotherapy for Advanced Breast Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Pemetrexed; Medicine; Neutropenia; Internal medicine; Breast cancer; Metastatic breast cancer; Oncology; Leukopenia; Population; Gastroenterology; Chemotherapy; Cancer; Phases of clinical research; Surgery","score_opus":0.3282812492929229,"score_gpt":0.6418834965688445,"score_spread":0.31360224727592156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119413329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931652,0.0007068156,0.00071815867,0.00018288453,0.00017571117,0.0039440985,0.0003312492,0.00007009815,0.0007057541],"genre_scores_gemma":[0.984738,0.0009284434,0.003176665,0.00079749385,0.00029526206,0.007409121,0.0007254526,0.000022712886,0.0019067643],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993206,0.0003620809,0.00004195882,0.00013343224,0.000073290204,0.000068724155],"domain_scores_gemma":[0.9988932,0.00033687573,0.00025392315,0.00012334259,0.000050928433,0.00034172973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016306728,0.0013327282,0.0023717224,0.00045233913,0.00031077254,0.0006404772,0.0008147609,0.0014022238,0.0039888155],"category_scores_gemma":[0.0017329191,0.00060207,0.0006896911,0.00033841326,0.0012246753,0.0006992409,0.00028507347,0.0023678038,0.0005786598],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91720384,0.04692642,0.0009628429,0.00029493083,0.0003629206,0.00003864841,0.00005801365,0.0004991096,0.01454323,0.00012302064,0.00047654856,0.018510547],"study_design_scores_gemma":[0.8113202,0.18479945,0.0014693196,0.000008598139,0.000107533706,0.000037939448,0.000009437465,0.00041848855,0.0014195106,0.00007163986,0.0003282592,0.000009514587],"about_ca_topic_score_codex":0.00036351974,"about_ca_topic_score_gemma":0.00059299986,"teacher_disagreement_score":0.0039888155,"about_ca_system_score_codex":0.00062963855,"about_ca_system_score_gemma":0.0011112409,"threshold_uncertainty_score":0.013343871},"labels":[],"label_agreement":null},{"id":"W2120270251","doi":"10.1016/j.mehy.2005.11.005","title":"Tesmilifene may enhance breast cancer chemotherapy by killing a clone of aggressive, multi-drug resistant cells through its action on the p-glycoprotein pump","year":2006,"lang":"en","type":"article","venue":"Medical Hypotheses","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Breast cancer; Oncology; Doxorubicin; Drug resistance; Drug; Medicine; Population; Chemotherapy; Mechanism of action; Paclitaxel; Drug action; Internal medicine; Cancer; Pharmacology; Biology; Genetics; In vitro","score_opus":0.034939394025877764,"score_gpt":0.34055431159334826,"score_spread":0.3056149175674705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120270251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93533957,0.02717976,0.004379598,0.005974244,0.00057564053,0.00019178745,0.00038544266,0.00026371505,0.025710255],"genre_scores_gemma":[0.98048615,0.013751525,0.0013876613,0.0005148714,0.00024814944,0.00003361529,0.0001821834,0.0000108478525,0.0033850502],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999378,0.000030383708,0.0000036777349,0.000005908598,0.0000069492144,0.000015352845],"domain_scores_gemma":[0.99991655,0.000032761847,0.000021415148,0.0000055240926,0.000009320667,0.000014349055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021381924,0.00033922272,0.00031848773,0.00020415544,0.00014043444,0.00038528486,0.00029273191,0.00040757333,0.0036682019],"category_scores_gemma":[0.00029778125,0.00007806865,0.00023746224,0.0001121235,0.00031083947,0.00040557495,0.00011144152,0.000684842,0.00044889678],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017361218,0.0026679435,0.009476088,0.001482735,0.0003252935,0.003510814,0.00019416022,0.0018252335,0.6291522,0.015280816,0.0048929723,0.3138306],"study_design_scores_gemma":[0.0076733315,0.079798736,0.054361057,0.00030015846,0.00083930563,0.016512541,0.00052419596,0.0059104194,0.72748935,0.009164579,0.09731519,0.00011118973],"about_ca_topic_score_codex":0.00022080775,"about_ca_topic_score_gemma":0.000525982,"teacher_disagreement_score":0.0036682019,"about_ca_system_score_codex":0.00017703253,"about_ca_system_score_gemma":0.0002689622,"threshold_uncertainty_score":0.012271285},"labels":[],"label_agreement":null},{"id":"W2120295366","doi":"10.3816/clc.2011.n.002","title":"Classification and Toxicities of Vascular Disrupting Agents","year":2011,"lang":"en","type":"review","venue":"Clinical Lung Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nausea; Vomiting; Headaches; Adverse effect; Pharmacology; Lung cancer; Anesthesia; Oncology; Surgery","score_opus":0.2931588339410363,"score_gpt":0.555318490067568,"score_spread":0.26215965612653164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120295366","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030102176,0.9983486,0.00021052799,0.00014811124,0.00008380544,0.000010185134,0.00004278861,0.000008552982,0.0008464647],"genre_scores_gemma":[0.0012951337,0.99723923,0.0003938357,0.00019120942,0.000116169744,0.000009172914,0.00007253124,0.0000019985018,0.0006807669],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970055,0.000046945945,0.00007198374,0.000042349435,0.00011773969,0.000020509106],"domain_scores_gemma":[0.99957377,0.00016481375,0.00013622413,0.00001276081,0.00009318792,0.000019245053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005908588,0.0009636442,0.0018821518,0.0028221325,0.00018746287,0.00083937874,0.0009200559,0.0005719818,0.0020595628],"category_scores_gemma":[0.00084347295,0.00029516726,0.000945756,0.0027010401,0.0003324987,0.0008201196,0.00044782422,0.0013633982,0.00081344997],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011836993,0.00009281504,0.00032615385,0.012458733,0.00014045654,0.00014494095,0.000025318355,0.00063323666,0.001591336,0.0009725313,0.012795125,0.97070104],"study_design_scores_gemma":[0.00012137016,0.00047752296,0.0035268997,0.008174946,0.0008340484,0.0033743817,0.000059371734,0.0004703264,0.0022381232,0.0016533313,0.9790221,0.000047597096],"about_ca_topic_score_codex":0.0016701055,"about_ca_topic_score_gemma":0.0041316384,"teacher_disagreement_score":0.0028221325,"about_ca_system_score_codex":0.00066825066,"about_ca_system_score_gemma":0.0008207338,"threshold_uncertainty_score":0.0068898797},"labels":[],"label_agreement":null},{"id":"W2120386009","doi":"10.1007/s10549-015-3342-2","title":"Overall survival (OS) endpoint: an incomplete evaluation of metastatic breast cancer (MBC) treatment outcome","year":2015,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Metastatic breast cancer; Clinical trial; Oncology; Progression-free survival; Breast cancer; Chemotherapy; Clinical endpoint; Cancer; Randomized controlled trial","score_opus":0.5563596854227307,"score_gpt":0.5889062232591702,"score_spread":0.03254653783643946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120386009","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053121066,0.9875823,0.0010174336,0.0008791456,0.00030442773,0.00014824416,0.001196446,0.000017406375,0.0035425208],"genre_scores_gemma":[0.079985864,0.90806115,0.0041572754,0.0027040944,0.0005867483,0.0004251256,0.0023373237,0.000015835165,0.0017266079],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979431,0.0008196999,0.00047382442,0.00019879728,0.0004845264,0.000079997684],"domain_scores_gemma":[0.99687874,0.0019707188,0.00063114654,0.0000827386,0.0003753343,0.000061316416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005338919,0.0007627538,0.0035128284,0.0010863768,0.00016005288,0.00090996973,0.0009750498,0.0006362861,0.0020506645],"category_scores_gemma":[0.004763916,0.00015254504,0.0026170376,0.001229208,0.00039343775,0.0007759705,0.0005861991,0.0014717942,0.00031056668],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018993136,0.00015938166,0.0050184964,0.07404088,0.00599191,0.000078603654,0.0000922424,0.0010686382,0.0011876016,0.0026128222,0.014847215,0.8930029],"study_design_scores_gemma":[0.002847677,0.007835169,0.055838913,0.10867358,0.06635927,0.0033103328,0.00071967015,0.002735113,0.0051124715,0.015083567,0.73121893,0.00026534323],"about_ca_topic_score_codex":0.001177321,"about_ca_topic_score_gemma":0.0035869703,"teacher_disagreement_score":0.005338919,"about_ca_system_score_codex":0.00085844076,"about_ca_system_score_gemma":0.0014657653,"threshold_uncertainty_score":0.028235257},"labels":[],"label_agreement":null},{"id":"W2122242131","doi":"10.1136/ebn.12.3.93","title":"Patients with cancer believed that chemotherapy had to “hurt” or “cause side effects” to be effectiveCommentary","year":2009,"lang":"en","type":"letter","venue":"Evidence-Based Nursing","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Fraser Health","funders":"","keywords":"Chemotherapy; Medicine; Cancer; Cancer chemotherapy; Oncology; Internal medicine; Intensive care medicine","score_opus":0.04997426438819863,"score_gpt":0.36416602287555433,"score_spread":0.3141917584873557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122242131","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36643416,0.004186481,0.0002528084,0.5884582,0.00219753,0.00009886541,0.00021615681,0.000031569554,0.038124196],"genre_scores_gemma":[0.82910246,0.004756221,0.0003699092,0.14400749,0.0008197435,0.00008760515,0.00006330866,0.000014594635,0.0207787],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991824,0.00041638152,0.00006616661,0.00004871325,0.00012985332,0.00015651833],"domain_scores_gemma":[0.9974037,0.0012562004,0.00035367158,0.000038041777,0.00045832997,0.0004900144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009698416,0.0001455887,0.00022823666,0.00021718672,0.0034889835,0.0012109078,0.0003114363,0.00243651,0.005782793],"category_scores_gemma":[0.008329773,0.00017903718,0.00015799345,0.00035427386,0.001187138,0.0010520292,0.00039647048,0.0025252094,0.0007679467],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047537187,0.00033275975,0.16602407,0.00074218586,0.000051059666,0.07234366,0.1278654,0.0002535557,0.0016474862,0.0029193286,0.53176874,0.09557647],"study_design_scores_gemma":[0.0001911698,0.00052878953,0.09579718,0.0016017187,0.000075921016,0.085072726,0.33430785,0.0008106324,0.00089964585,0.0026522325,0.47788817,0.00017404217],"about_ca_topic_score_codex":0.05372051,"about_ca_topic_score_gemma":0.08597891,"teacher_disagreement_score":0.05372051,"about_ca_system_score_codex":0.0033097616,"about_ca_system_score_gemma":0.0021510965,"threshold_uncertainty_score":0.106815636},"labels":[],"label_agreement":null},{"id":"W2122381332","doi":"10.1139/v00-010","title":"Efficient method for the preparation of pinacols derived from aromatic and aliphatic ketones by using low-valent titanium reagents in dichloromethane-pivalonitrile","year":2000,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chemistry; Pinacol; Dichloromethane; Zinc; Titanium; Reagent; Chloride; Steric effects; Titanium tetrachloride; Ketone; Coupling reaction; Organic chemistry; Medicinal chemistry; Polymer chemistry; Catalysis; Solvent","score_opus":0.02096639534478933,"score_gpt":0.33322969513729217,"score_spread":0.31226329979250284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122381332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5652171,0.020485274,0.36883742,0.0009941835,0.0005509269,0.0018271311,0.0026807268,0.0016138591,0.037793323],"genre_scores_gemma":[0.8965963,0.01104668,0.078740716,0.00017238737,0.00005764449,0.00056404155,0.0020978563,0.00010186387,0.010622595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975437,0.00003290802,0.000024811723,0.000057296187,0.00008391065,0.000046757898],"domain_scores_gemma":[0.9999237,0.000011384878,0.00001989292,0.000010018053,0.00001572876,0.00001930277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025785813,0.0006875611,0.0003038519,0.00050073187,0.0003076894,0.00023409408,0.00061995094,0.00030084315,0.0018891081],"category_scores_gemma":[0.00021213015,0.00025921213,0.00024774042,0.00028818107,0.00024343493,0.00031861497,0.0004712514,0.00088485674,0.0010191882],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004049196,0.000024592167,0.00009036524,0.00027626773,0.000019950112,0.00024200918,0.000047163565,0.00015318171,0.99148434,0.00054405455,0.00021935887,0.006858065],"study_design_scores_gemma":[0.000026703496,0.00021181184,0.00059102254,0.00001277881,0.000029628125,0.0008096168,0.00002485709,0.00026862844,0.9876825,0.00011132773,0.010211073,0.000019925974],"about_ca_topic_score_codex":0.00092837913,"about_ca_topic_score_gemma":0.0035042264,"teacher_disagreement_score":0.0018891081,"about_ca_system_score_codex":0.00031152926,"about_ca_system_score_gemma":0.0006059853,"threshold_uncertainty_score":0.0063197017},"labels":[],"label_agreement":null},{"id":"W2122766544","doi":"10.1136/aim.24.2.87","title":"Acupuncture Treatment for Chemotherapy-Induced Peripheral Neuropathy – a Case Series","year":2006,"lang":"en","type":"article","venue":"Acupuncture in Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Acupuncture; Chemotherapy-induced peripheral neuropathy; Chemotherapy; Peripheral neuropathy; Traditional Chinese medicine; Anesthesia; Surgery; Diabetes mellitus; Alternative medicine; Pathology","score_opus":0.027450175787195007,"score_gpt":0.3400102092653752,"score_spread":0.3125600334781802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122766544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9740956,0.010560952,0.0031944462,0.00081188243,0.00027084615,0.0003017041,0.000080877886,0.00010220404,0.010581519],"genre_scores_gemma":[0.9942697,0.0024130621,0.0006323118,0.00045408917,0.00031142877,0.000064318156,0.000057673344,0.00000930151,0.00178813],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99947995,0.0000982484,0.00007222997,0.000087713226,0.000118357144,0.00014363191],"domain_scores_gemma":[0.9993808,0.00020999792,0.00013696177,0.00006390975,0.000039427083,0.00016880599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025166693,0.0009785118,0.0008390377,0.000958373,0.0018026514,0.0006351758,0.00060942606,0.0022743791,0.0031555854],"category_scores_gemma":[0.0020192359,0.00037609288,0.0008222947,0.00078931975,0.0007921042,0.00068245764,0.00051332684,0.0009014373,0.00071085227],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012964297,0.0006577951,0.018994238,0.0001524988,0.000077540135,0.9630097,0.00063669164,0.00016076025,0.0016034492,0.00020125162,0.0006441572,0.013732233],"study_design_scores_gemma":[0.00007913533,0.0007719627,0.014222317,0.0000303852,0.00004682072,0.9822066,0.00019394807,0.00032376248,0.0006637903,0.000091982714,0.0013523744,0.000016942697],"about_ca_topic_score_codex":0.0014866847,"about_ca_topic_score_gemma":0.0022960585,"teacher_disagreement_score":0.0031555854,"about_ca_system_score_codex":0.00054734596,"about_ca_system_score_gemma":0.0005840331,"threshold_uncertainty_score":0.010556519},"labels":[],"label_agreement":null},{"id":"W2123732467","doi":"10.1002/1097-0142(20011001)92:7<1759::aid-cncr1691>3.0.co;2-a","title":"Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients","year":2001,"lang":"en","type":"article","venue":"Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":402,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Taxane; Capecitabine; Internal medicine; Adverse effect; Metastatic breast cancer; Docetaxel; Stomatitis; Nausea; Gastroenterology; Chemotherapy; Breast cancer; Oncology; Diarrhea; Anthracycline; Surgery; Cancer","score_opus":0.032040962012839014,"score_gpt":0.3626609404434201,"score_spread":0.3306199784305811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123732467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949233,0.0016711621,0.00022578024,0.00027104147,0.000059272843,0.0015089688,0.0005607886,0.000031504977,0.00074820366],"genre_scores_gemma":[0.9891971,0.0014509577,0.0016117456,0.00090188894,0.00021018369,0.002272312,0.0033014528,0.000022546954,0.0010317917],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995253,0.0002461193,0.000028199891,0.00008274446,0.00005005164,0.00006761442],"domain_scores_gemma":[0.998923,0.00012230026,0.00024653034,0.00006253353,0.00008576798,0.00055986445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019533844,0.0010171317,0.0016014201,0.00026781557,0.00042398137,0.0006042836,0.00057977,0.0007076683,0.0026343574],"category_scores_gemma":[0.0011602041,0.00037809595,0.00053409766,0.00039481622,0.000520034,0.00040274658,0.0003043355,0.0017598858,0.00063287327],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6338047,0.09402031,0.09853008,0.00086244167,0.0019965125,0.0007976023,0.00050862465,0.0021688861,0.05874429,0.00022919278,0.009743663,0.09859381],"study_design_scores_gemma":[0.5786957,0.32895902,0.080790125,0.000058636757,0.0006090545,0.00080182834,0.00009557251,0.0013640614,0.0036513142,0.0001138995,0.00483489,0.000025902498],"about_ca_topic_score_codex":0.0011031821,"about_ca_topic_score_gemma":0.0019386562,"teacher_disagreement_score":0.0026343574,"about_ca_system_score_codex":0.00081766787,"about_ca_system_score_gemma":0.0016698549,"threshold_uncertainty_score":0.010330558},"labels":[],"label_agreement":null},{"id":"W2124456054","doi":"10.3747/co.21.2069","title":"The Trastuzumab and Vinorelbine Combination: An Alternative to Taxane-Based Chemotherapy for Early-Stage and Locally Advanced HER2-Positive Breast Cancer","year":2014,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Vinorelbine; Trastuzumab; Internal medicine; Breast cancer; Oncology; Taxane; Febrile neutropenia; Neutropenia; Docetaxel; Cancer; Chemotherapy; Surgery","score_opus":0.040543246141059384,"score_gpt":0.41651425536986647,"score_spread":0.3759710092288071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124456054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795502,0.018756239,0.0004030182,0.00016575078,0.000022532506,0.000025936808,0.00009533464,0.000011058249,0.0009699048],"genre_scores_gemma":[0.9953146,0.0036463796,0.0005895479,0.00006410655,0.000045689787,0.000008745784,0.00014309173,0.0000020041234,0.00018584036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963486,0.00014904658,0.00004726256,0.000057857505,0.00007548992,0.000035527006],"domain_scores_gemma":[0.99971396,0.00005780241,0.00014242783,0.000019001733,0.000018774252,0.000047967154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058243494,0.00012716497,0.00029928802,0.00052657846,0.00011413001,0.00033627535,0.0001940928,0.00012926965,0.0005942726],"category_scores_gemma":[0.0007588226,0.00006681068,0.00018141947,0.0006914058,0.00015792988,0.00015048044,0.00019606503,0.00022745959,0.00008876811],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071769217,0.00054875953,0.52817535,0.0004682411,0.0005688192,0.0020561526,0.00013062243,0.0011061055,0.022182163,0.00022554147,0.00094423635,0.43641704],"study_design_scores_gemma":[0.0018699138,0.021263156,0.900631,0.0002732072,0.0011116127,0.030544087,0.0002607061,0.0026326969,0.010567054,0.00034665916,0.030459873,0.000040046056],"about_ca_topic_score_codex":0.0003036877,"about_ca_topic_score_gemma":0.0016962731,"teacher_disagreement_score":0.0005942726,"about_ca_system_score_codex":0.0003106499,"about_ca_system_score_gemma":0.00032759146,"threshold_uncertainty_score":0.0030803084},"labels":[],"label_agreement":null},{"id":"W2124648016","doi":"10.1093/carcin/bgn070","title":"Delphinidin, a dietary anthocyanidin, inhibits platelet-derived growth factor ligand/receptor (PDGF/PDGFR) signaling","year":2008,"lang":"en","type":"article","venue":"Carcinogenesis","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université du Québec à Montréal","funders":"Cancer Research Society","keywords":"Platelet-derived growth factor receptor; Delphinidin; Receptor; Growth factor; Anthocyanidin; Platelet-derived growth factor; Chemistry; Signal transduction; Cell biology; Growth factor receptor; Cancer research; Biochemistry; Internal medicine; Endocrinology; Biology; Medicine; Food science","score_opus":0.06176886651418375,"score_gpt":0.2881247859143794,"score_spread":0.22635591940019564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124648016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875866,0.0056596263,0.0042165257,0.000101709215,0.000030351055,0.000034502496,0.00023289754,0.00008762298,0.002050125],"genre_scores_gemma":[0.9892595,0.003598969,0.0042687836,0.00006229928,0.00001831213,0.000031487696,0.00037335715,0.000015719372,0.0023715666],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999584,0.000007902309,0.000002625642,0.000013153688,0.000009349965,0.000008661575],"domain_scores_gemma":[0.999974,0.000004918885,0.000007709396,0.0000024184612,0.0000034772709,0.0000074603836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006634607,0.00040793384,0.00022588127,0.00014298024,0.00010176609,0.00015661845,0.000070047754,0.00015702668,0.00041695152],"category_scores_gemma":[0.000056118726,0.00009512348,0.00012590746,0.00011658824,0.000102525155,0.0001058976,0.0000869337,0.0002721214,0.00012466716],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011119208,0.000024257171,0.00014253524,0.000072845374,0.000005462178,0.000026960808,0.000005660327,0.000059345322,0.9968983,0.000048641636,0.00003947536,0.002565286],"study_design_scores_gemma":[0.000041625546,0.0009455418,0.009636063,0.000007814185,0.0000398383,0.00029089465,0.000011253693,0.00089580845,0.9819903,0.00005205769,0.0060838745,0.0000049333107],"about_ca_topic_score_codex":0.00047544827,"about_ca_topic_score_gemma":0.0008130791,"teacher_disagreement_score":0.00047544827,"about_ca_system_score_codex":0.00017426646,"about_ca_system_score_gemma":0.00014768151,"threshold_uncertainty_score":0.0013948679},"labels":[],"label_agreement":null},{"id":"W2126275851","doi":"10.1056/nejmoa072113","title":"Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer","year":2007,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3053,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Sanofi; Genentech; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Medicine; Paclitaxel; Bevacizumab; Metastatic breast cancer; Oncology; Internal medicine; Breast cancer; Chemotherapy; Cancer","score_opus":0.05956126811358634,"score_gpt":0.39946593754352866,"score_spread":0.3399046694299423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126275851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98839873,0.006642734,0.00042495516,0.000747113,0.0005360332,0.0013594817,0.00033556166,0.00008012803,0.0014753311],"genre_scores_gemma":[0.9904026,0.0033600123,0.0013214863,0.00094739976,0.0006620555,0.0016050474,0.0005491321,0.000015416139,0.0011368574],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99935514,0.0003605559,0.000047404683,0.0000976473,0.00006560365,0.000073588446],"domain_scores_gemma":[0.9989336,0.0004029174,0.0003029205,0.000034260356,0.00004189452,0.00028432033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015742157,0.0008752925,0.0021157719,0.0005222843,0.0002895791,0.0007648268,0.00063810893,0.0010138995,0.0046460913],"category_scores_gemma":[0.0018169632,0.00039351912,0.00093851524,0.0004347333,0.00063638133,0.0006948933,0.0002825271,0.0021105674,0.0006539386],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95116377,0.0064443615,0.00084082666,0.0005137271,0.0007354359,0.000046959638,0.000026907566,0.0006354363,0.002432522,0.000105349594,0.00077216927,0.036282558],"study_design_scores_gemma":[0.84748435,0.14617604,0.0027495136,0.000056899942,0.00063602155,0.00009241553,0.000011730518,0.0009261334,0.0007686978,0.00020561065,0.00087992486,0.000012719496],"about_ca_topic_score_codex":0.00072012085,"about_ca_topic_score_gemma":0.0018955168,"teacher_disagreement_score":0.0046460913,"about_ca_system_score_codex":0.00092767837,"about_ca_system_score_gemma":0.0010774682,"threshold_uncertainty_score":0.015542746},"labels":[],"label_agreement":null},{"id":"W2126386849","doi":"10.1007/s10549-007-9584-x","title":"A Phase 2 study of perifosine in advanced or metastatic breast cancer","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Metastatic breast cancer; Internal medicine; Chemotherapy; Breast cancer; Nausea; Neutropenia; Regimen; Anthracycline; Gastroenterology; Progressive disease; Oncology; Toxicity; Performance status; Surgery; Cancer","score_opus":0.11632199615301068,"score_gpt":0.5141281501004372,"score_spread":0.3978061539474265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126386849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923402,0.0011999885,0.0006032751,0.0007450888,0.00019035827,0.0024654898,0.0008216062,0.000071407434,0.0015625791],"genre_scores_gemma":[0.98037416,0.0030396837,0.0021635066,0.0013898171,0.00036660288,0.005069808,0.0021600516,0.000065957815,0.005370306],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994498,0.00026961087,0.000014780341,0.00007661175,0.00004098292,0.00014818087],"domain_scores_gemma":[0.99917763,0.00015594291,0.00009162255,0.000090802954,0.00005335852,0.0004305804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018322818,0.0018237872,0.0027867164,0.00080929766,0.0006580916,0.0009362717,0.001050626,0.0019126456,0.0055137877],"category_scores_gemma":[0.0011128861,0.0006558316,0.0014476961,0.00050431286,0.0013712961,0.0012637068,0.0004307293,0.0034356443,0.0009823153],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76536137,0.11860378,0.0023080104,0.00066207413,0.0007597388,0.00032264806,0.00034788778,0.002368427,0.045168895,0.0004601077,0.0036723663,0.05996461],"study_design_scores_gemma":[0.4426566,0.54774636,0.0029035374,0.000022277272,0.00023826641,0.00021237355,0.00006922887,0.0004904242,0.0031636597,0.00025274736,0.0022246817,0.000019864747],"about_ca_topic_score_codex":0.0017618765,"about_ca_topic_score_gemma":0.0035568886,"teacher_disagreement_score":0.0055137877,"about_ca_system_score_codex":0.0009057968,"about_ca_system_score_gemma":0.001905272,"threshold_uncertainty_score":0.018445432},"labels":[],"label_agreement":null},{"id":"W2126891371","doi":"10.1211/jpp.59.12.0005","title":"Potentiating effect of β-caryophyllene on anticancer activity of α-humulene, isocaryophyllene and paclitaxel","year":2007,"lang":"en","type":"article","venue":"Journal of Pharmacy and Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":443,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"","keywords":"Paclitaxel; Chemistry; Humulene; Pharmacology; Caryophyllene; Intracellular; Biochemistry; Biology; Chemotherapy; Essential oil; Food science","score_opus":0.017265793381257683,"score_gpt":0.37784785857003655,"score_spread":0.3605820651887789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126891371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98779756,0.006610923,0.0009291935,0.000075942095,0.000026070144,0.000047315236,0.00017059552,0.00003250307,0.0043099546],"genre_scores_gemma":[0.9923935,0.0042208177,0.0013308539,0.00006537717,0.000016640703,0.000029086103,0.00022265653,0.000009346802,0.001711601],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994206,0.000013879237,0.000005514538,0.000010523842,0.00001540615,0.000012666713],"domain_scores_gemma":[0.99993813,0.000017748323,0.0000146813445,0.000007176513,0.000009829581,0.000012491055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006653684,0.00020700233,0.00018254579,0.00021092629,0.000086915046,0.00012723422,0.000104775616,0.00013163943,0.00095967785],"category_scores_gemma":[0.00011627094,0.00007888699,0.00017518277,0.00013917322,0.00008231611,0.0001356674,0.000116633724,0.0002670435,0.00016924414],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016779889,0.000027637445,0.000168428,0.00005065331,0.0000072814655,0.000034459248,0.0000115887715,0.00010097853,0.9964652,0.00003240711,0.000029567293,0.002904027],"study_design_scores_gemma":[0.00001398288,0.0002774847,0.0022745775,0.0000066998837,0.00001590346,0.00011000925,0.000008115051,0.00020593754,0.9951314,0.000010645428,0.0019432274,0.000002054771],"about_ca_topic_score_codex":0.00038128448,"about_ca_topic_score_gemma":0.0009024261,"teacher_disagreement_score":0.00095967785,"about_ca_system_score_codex":0.00014056909,"about_ca_system_score_gemma":0.00011865914,"threshold_uncertainty_score":0.0032104254},"labels":[],"label_agreement":null},{"id":"W2127276650","doi":"10.1158/0008-5472.sabcs13-p3-13-04","title":"Abstract P3-13-04: Effect of age on tolerability and efficacy of eribulin and capecitabine in patients with metastatic breast cancer treated in study 301","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Capecitabine; Eribulin; Internal medicine; Tolerability; Metastatic breast cancer; Adverse effect; Breast cancer; Gastroenterology; Post-hoc analysis; Cancer; Progression-free survival; Incidence (geometry); Toxicity; Oncology; Overall survival","score_opus":0.04003991238900451,"score_gpt":0.41036733114484597,"score_spread":0.37032741875584146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127276650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974974,0.0009212733,0.00013700905,0.000092004935,0.000024288376,0.00022563417,0.0004222809,0.000007704234,0.00067248795],"genre_scores_gemma":[0.9981698,0.00028649182,0.00017851203,0.00013442963,0.00004756216,0.00023225142,0.00057311635,0.000004419803,0.00037343416],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9989122,0.0006783328,0.000105308914,0.00011597631,0.000106204614,0.000081980645],"domain_scores_gemma":[0.99833566,0.0005631182,0.00045482736,0.00013763936,0.00010388306,0.00040487494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00303708,0.0003604256,0.0010677213,0.00017385319,0.00023775449,0.0005547305,0.00030378904,0.0005018492,0.003009612],"category_scores_gemma":[0.0022900214,0.00017235351,0.0013877559,0.00039585962,0.0003025312,0.0005366504,0.000295395,0.0009917619,0.00031214228],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8828537,0.004116289,0.080502704,0.00024438516,0.0018797064,0.0001315103,0.00009222801,0.0005248005,0.005404143,0.00004887549,0.0007807064,0.023420915],"study_design_scores_gemma":[0.16775146,0.32536793,0.49230146,0.000083549836,0.0034101957,0.0004922915,0.00014764076,0.0018693496,0.0042408565,0.00021594907,0.0040739,0.00004544484],"about_ca_topic_score_codex":0.000525655,"about_ca_topic_score_gemma":0.0013697337,"teacher_disagreement_score":0.00303708,"about_ca_system_score_codex":0.00043828244,"about_ca_system_score_gemma":0.000957163,"threshold_uncertainty_score":0.016061783},"labels":[],"label_agreement":null},{"id":"W2127426350","doi":"10.2217/14622416.8.7.803","title":"Pharmacology, Pharmacokinetics and Pharmacogenomics of Paclitaxel","year":2007,"lang":"en","type":"article","venue":"Pharmacogenomics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; American Society of Clinical Oncology","keywords":"Pharmacogenomics; Paclitaxel; Pharmacokinetics; Pharmacology; Medicine; Pharmacodynamics; Drug; Pharmacogenetics; CYP3A4; Cytochrome P450; Internal medicine; Cancer; Biology; Metabolism","score_opus":0.023326303853351642,"score_gpt":0.35500966572802917,"score_spread":0.3316833618746775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127426350","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.064525805,0.9062645,0.011594923,0.004960814,0.00022783286,0.00009616921,0.0006307854,0.00015363825,0.011545469],"genre_scores_gemma":[0.21276689,0.7677102,0.0071992907,0.0017491181,0.0010018157,0.00016684727,0.00066719524,0.000042657186,0.008696015],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99959975,0.000154432,0.000025930394,0.000046742287,0.00015222999,0.000020854543],"domain_scores_gemma":[0.9997955,0.00008228423,0.000052507345,0.000008447756,0.000047945774,0.000013303996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005896872,0.0002890845,0.0008065857,0.0005085461,0.00013627652,0.000588698,0.00020326042,0.00044154664,0.0007156054],"category_scores_gemma":[0.000846654,0.00020963549,0.00043178562,0.0005695525,0.0001485331,0.00032744286,0.00016006693,0.0006611279,0.00039633218],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011644755,0.00033590128,0.011140163,0.0023652082,0.00039922638,0.0010625082,0.00007789523,0.003625219,0.055018183,0.0020719683,0.012928282,0.90981096],"study_design_scores_gemma":[0.00054846745,0.008582915,0.16593397,0.00087042776,0.0019797035,0.027401067,0.00017598322,0.010409602,0.11091986,0.010976203,0.6620427,0.00015911045],"about_ca_topic_score_codex":0.0013114748,"about_ca_topic_score_gemma":0.0019056693,"teacher_disagreement_score":0.0013114748,"about_ca_system_score_codex":0.0005265993,"about_ca_system_score_gemma":0.0005647603,"threshold_uncertainty_score":0.0038207173},"labels":[],"label_agreement":null},{"id":"W2128623632","doi":"10.1007/s00277-011-1348-3","title":"Vincristine-induced vocal cord paralysis in a patient with acute lymphoblastic leukemia","year":2011,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; Stornoway Diamond (Canada); BC Cancer Agency","funders":"","keywords":"Vincristine; Medicine; Lymphoblastic Leukemia; Hematology; Internal medicine; Paralysis; Leukemia; Oncology; Cord; Surgery; Chemotherapy; Cyclophosphamide","score_opus":0.05568088296862699,"score_gpt":0.33949123928127667,"score_spread":0.28381035631264967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128623632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7645483,0.01208867,0.003249903,0.11393194,0.008176776,0.0005009474,0.0007090251,0.00062138564,0.096173055],"genre_scores_gemma":[0.961476,0.003012784,0.0012424488,0.019435057,0.0062263897,0.00004640693,0.00017485522,0.00008971467,0.008296292],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994642,0.00009215339,0.000072042814,0.00009585425,0.000092003575,0.00018371687],"domain_scores_gemma":[0.99805415,0.0008380614,0.00037651582,0.00012236065,0.00012149391,0.00048746655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003384263,0.0012456327,0.00093795377,0.0010473217,0.0018819851,0.0015769777,0.0014220868,0.009700031,0.0028360146],"category_scores_gemma":[0.0059867366,0.0007903388,0.0013106562,0.00081661047,0.0012139786,0.0017898831,0.0008651105,0.0065903277,0.0013052212],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006896925,0.000032267148,0.0024376486,0.000030041605,0.00001269671,0.9935781,0.000085794505,0.000117771975,0.00039994626,0.00021938627,0.0017641125,0.0012533122],"study_design_scores_gemma":[0.00010869398,0.00028522112,0.007753318,0.00007004713,0.00006973172,0.98333955,0.00030393558,0.001606429,0.00085767405,0.00045101112,0.005131986,0.000022359642],"about_ca_topic_score_codex":0.0046830894,"about_ca_topic_score_gemma":0.00863545,"teacher_disagreement_score":0.009700031,"about_ca_system_score_codex":0.0040646633,"about_ca_system_score_gemma":0.0013298208,"threshold_uncertainty_score":0.029491365},"labels":[],"label_agreement":null},{"id":"W2128941584","doi":"10.1200/jco.2005.02.027","title":"Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":547,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Docetaxel; Medicine; Paclitaxel; Metastatic breast cancer; Internal medicine; Regimen; Chemotherapy; Oncology; Taxane; Hazard ratio; Breast cancer; Population; Cancer; Confidence interval","score_opus":0.17264541902181682,"score_gpt":0.5539230823189485,"score_spread":0.38127766329713164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128941584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9707248,0.008433348,0.0017573521,0.0014163252,0.0013644998,0.012174907,0.0018525721,0.00015584585,0.0021203952],"genre_scores_gemma":[0.969402,0.0051350608,0.0038288808,0.0020536538,0.0008347296,0.013781521,0.00148944,0.000046333327,0.0034285309],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998355,0.0012033383,0.00007279517,0.00014902762,0.00011005871,0.00010976844],"domain_scores_gemma":[0.99792707,0.0006856277,0.0005553646,0.00013433964,0.00012820406,0.00056938163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033941905,0.001584971,0.0033511512,0.00043355834,0.0005071957,0.0012765785,0.0011187866,0.0014548288,0.0051987213],"category_scores_gemma":[0.0033602507,0.0007492543,0.0014168479,0.0005781788,0.0013485786,0.00081200525,0.000398439,0.0034008066,0.00085522846],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9735068,0.01043443,0.0007217108,0.00046094548,0.000818642,0.00003563472,0.000043558925,0.00036232025,0.0017407201,0.00010386264,0.0009404336,0.010830919],"study_design_scores_gemma":[0.96344924,0.03497724,0.0005276953,0.000015906167,0.00017137556,0.000016417345,0.000006922208,0.0002084856,0.00018245375,0.00005238821,0.00038675938,0.0000051617117],"about_ca_topic_score_codex":0.001288275,"about_ca_topic_score_gemma":0.0037625725,"teacher_disagreement_score":0.0051987213,"about_ca_system_score_codex":0.0011965476,"about_ca_system_score_gemma":0.0023030853,"threshold_uncertainty_score":0.017950416},"labels":[],"label_agreement":null},{"id":"W2130207808","doi":"10.1634/theoncologist.11-90001-42","title":"The Role of Capecitabine in First-Line Treatment for Patients with Metastatic Breast Cancer","year":2006,"lang":"en","type":"review","venue":"The Oncologist","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Capecitabine; Metastatic breast cancer; Oncology; Internal medicine; Breast cancer; Cancer; Colorectal cancer","score_opus":0.050020701675656275,"score_gpt":0.3936264737207917,"score_spread":0.3436057720451354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130207808","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012386184,0.9989963,0.000046180798,0.00013226435,0.000069434165,0.0000029630821,0.0000057264456,0.0000041569815,0.00061906694],"genre_scores_gemma":[0.0010808274,0.99827313,0.00009596855,0.000101882455,0.000087089014,0.000004215904,0.000012605394,9.476774e-7,0.00034334228],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981445,0.000043878885,0.000022446391,0.000029884643,0.00007771746,0.000011743287],"domain_scores_gemma":[0.9998017,0.00009571503,0.000044697645,0.0000065402673,0.00003528824,0.00001604108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005482391,0.00069303386,0.0017018961,0.0017326543,0.00021954041,0.000654488,0.00068263983,0.0007432388,0.0030087365],"category_scores_gemma":[0.0006371323,0.0002098831,0.00048492834,0.0016282969,0.00033062077,0.00070348824,0.00038095965,0.0014268468,0.0014983553],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116930554,0.00006191377,0.00015570644,0.009276188,0.000085913925,0.00030637192,0.00003887912,0.00020837077,0.0012320684,0.0010143106,0.018453054,0.9690503],"study_design_scores_gemma":[0.00015922908,0.00034816496,0.0026423666,0.0051462287,0.0002306316,0.005008942,0.000043909393,0.00018056978,0.0010793806,0.0013868375,0.9837515,0.000022333581],"about_ca_topic_score_codex":0.0012668563,"about_ca_topic_score_gemma":0.002779282,"teacher_disagreement_score":0.0030087365,"about_ca_system_score_codex":0.00052639755,"about_ca_system_score_gemma":0.00062657474,"threshold_uncertainty_score":0.010065198},"labels":[],"label_agreement":null},{"id":"W2131280296","doi":"10.1177/1078155208096902","title":"Evaluation of osmolality and pH of various concentrations of methotrexate, cytarabine, and thiotepa prepared in normal saline, sterile water for injection, and lactated Ringer's solution for intrathecal administration","year":2008,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Saline; Intrathecal; ThioTEPA; Anesthesia; Sterile water; Methotrexate; Ringer's solution; Surgery; Chemotherapy; Cyclophosphamide; Chemistry","score_opus":0.15626656441589343,"score_gpt":0.5113434548060312,"score_spread":0.35507689039013773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131280296","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6148833,0.37063503,0.0015041799,0.00047870187,0.000093425115,0.0003274789,0.004205831,0.000076653676,0.0077954526],"genre_scores_gemma":[0.84544724,0.14202318,0.008861761,0.00035715054,0.00008988612,0.00022610495,0.0023390877,0.000016352424,0.00063920784],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989128,0.0002961321,0.00031061735,0.00010452772,0.0003307037,0.000045244902],"domain_scores_gemma":[0.99511707,0.0016838703,0.0022232698,0.000064597254,0.0008093534,0.00010172242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015543271,0.00021793557,0.00055463926,0.00534055,0.00023894096,0.0004666792,0.0003712626,0.0003777418,0.0013116885],"category_scores_gemma":[0.0042478633,0.0001277364,0.0004834823,0.0050596762,0.00028338822,0.00062994706,0.00025121623,0.0001811488,0.0002259711],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004748406,0.0003760528,0.34008366,0.07675681,0.0012274274,0.00320122,0.0018185594,0.0006844131,0.09616426,0.0006219185,0.0046456857,0.46967155],"study_design_scores_gemma":[0.00038796716,0.009374415,0.70050716,0.0081413165,0.004009959,0.015630716,0.0041791624,0.00071502227,0.18369645,0.00041304124,0.07274142,0.00020334373],"about_ca_topic_score_codex":0.0014302589,"about_ca_topic_score_gemma":0.0028456391,"teacher_disagreement_score":0.00534055,"about_ca_system_score_codex":0.0005469014,"about_ca_system_score_gemma":0.0008028009,"threshold_uncertainty_score":0.008220136},"labels":[],"label_agreement":null},{"id":"W2131765662","doi":"10.1093/annonc/mdg171","title":"A phase II study of ZD0473 given as a short infusion every 3 weeks to patients with advanced or metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group trial, IND 129","year":2003,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; Jewish General Hospital; BC Cancer Agency","funders":"AstraZeneca Canada","keywords":"Medicine; Neutropenia; Internal medicine; Docetaxel; Metastatic breast cancer; Breast cancer; Carboplatin; Cancer; Clinical trial; Oncology; Phases of clinical research; Chemotherapy; Toxicity; Cisplatin; Surgery","score_opus":0.22710454263369964,"score_gpt":0.540438615129528,"score_spread":0.31333407249582834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131765662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98419803,0.003290919,0.0007036949,0.001665891,0.0003969666,0.0029471514,0.0028680263,0.00027374204,0.003655663],"genre_scores_gemma":[0.97549826,0.004920691,0.002449652,0.0016470945,0.00040318485,0.00296982,0.0035001591,0.000076615055,0.008534562],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996276,0.0001723001,0.0000117820555,0.000052210882,0.00003395331,0.000102159815],"domain_scores_gemma":[0.9992829,0.0001374378,0.00011060756,0.0000539554,0.000039103783,0.00037600865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011479608,0.0017944844,0.0029999057,0.0006233791,0.00067320367,0.001026926,0.0013516776,0.0016054421,0.006202341],"category_scores_gemma":[0.0010961248,0.00071359606,0.0016642524,0.00074797415,0.0014665751,0.0007278617,0.0003279796,0.0043323166,0.0013158513],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90355086,0.023940274,0.0016429832,0.0005334186,0.0009157097,0.0001514644,0.00014314918,0.0015628767,0.008325282,0.00032895358,0.006280597,0.052624457],"study_design_scores_gemma":[0.8939891,0.10056902,0.0026957975,0.00001538132,0.00025549644,0.00008253463,0.000030180541,0.00048359198,0.00048992905,0.000094478,0.0012770834,0.000017459815],"about_ca_topic_score_codex":0.006435535,"about_ca_topic_score_gemma":0.017889585,"teacher_disagreement_score":0.006435535,"about_ca_system_score_codex":0.001354074,"about_ca_system_score_gemma":0.0032635161,"threshold_uncertainty_score":0.020748913},"labels":[],"label_agreement":null},{"id":"W2131784126","doi":"10.1038/bjc.2015.343","title":"A phase I combination dose-escalation study of eribulin mesylate and gemcitabine in patients with advanced solid tumours: a study of the Princess Margaret Consortium","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Gemcitabine; Medicine; Eribulin; Neutropenia; Internal medicine; Cohort; Oncology; Chemotherapy; Metastatic breast cancer; Cancer; Gastroenterology; Breast cancer","score_opus":0.017153020109714832,"score_gpt":0.34147396194387003,"score_spread":0.3243209418341552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131784126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99472696,0.0012921304,0.0002877426,0.0006179568,0.00003124815,0.0015248621,0.00030289535,0.000027754963,0.0011883632],"genre_scores_gemma":[0.98730475,0.00229782,0.0023031621,0.0015188423,0.00017340099,0.0028399585,0.0015797686,0.000024551216,0.0019578773],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9986033,0.00084686157,0.00006063642,0.0001778146,0.00017192306,0.00013953687],"domain_scores_gemma":[0.99799687,0.00027883472,0.00038941443,0.00019077031,0.00017425815,0.0009698368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005192562,0.0011985559,0.0017109627,0.0004903682,0.00056869973,0.00075365516,0.001000738,0.0012463637,0.0023462342],"category_scores_gemma":[0.001467692,0.0005714483,0.001339128,0.00071458553,0.0010924996,0.00083127036,0.00058640423,0.002840163,0.0005911182],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.60932255,0.11376889,0.033053197,0.001070434,0.0038152596,0.00061042985,0.0012288379,0.0037983651,0.05868541,0.00046610122,0.006947687,0.16723289],"study_design_scores_gemma":[0.421223,0.51950693,0.04808042,0.000035625315,0.00072565983,0.0004885721,0.00010823756,0.0010654308,0.0029692212,0.0001745103,0.0055770413,0.000045396537],"about_ca_topic_score_codex":0.0021278346,"about_ca_topic_score_gemma":0.0040210094,"teacher_disagreement_score":0.005192562,"about_ca_system_score_codex":0.0014881861,"about_ca_system_score_gemma":0.0025536765,"threshold_uncertainty_score":0.02746123},"labels":[],"label_agreement":null},{"id":"W2132229544","doi":"10.1093/annonc/mdr043","title":"First-line bevacizumab-containing therapy for breast cancer: results in patients aged ≥70 years treated in the ATHENA study","year":2011,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Western University","funders":"","keywords":"Medicine; Bevacizumab; Tolerability; Proteinuria; Internal medicine; Metastatic breast cancer; Breast cancer; Chemotherapy; Population; Oncology; Cancer; Adverse effect; Surgery","score_opus":0.1655933199108834,"score_gpt":0.42565664014882443,"score_spread":0.260063320237941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132229544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956145,0.002245353,0.000043580785,0.00013659534,0.000040383085,0.000029651426,0.0010563835,0.000005046069,0.00082842866],"genre_scores_gemma":[0.9953532,0.0014046428,0.0001206359,0.00022299071,0.00008723644,0.00004354517,0.0021202406,0.0000060735456,0.0006414154],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999574,0.00014290556,0.000036527603,0.000108503125,0.00005611471,0.00008191292],"domain_scores_gemma":[0.9994337,0.000094934854,0.00019470861,0.00005968812,0.00004413622,0.00017286788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007092989,0.0005345683,0.0012087702,0.00046403345,0.00031855394,0.0009977462,0.00045621372,0.0006511764,0.00090277044],"category_scores_gemma":[0.0011199504,0.0004305815,0.0017428385,0.0009638839,0.00025829684,0.00056500314,0.0006609594,0.0009019923,0.00022218618],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04406978,0.0010731844,0.9292587,0.00029518822,0.0069022225,0.00038140456,0.00020952831,0.00035529464,0.0022534751,0.00012343627,0.0019259504,0.013151922],"study_design_scores_gemma":[0.0035336048,0.0012914516,0.98996335,0.00004018486,0.0031792347,0.00019057325,0.00019130216,0.00014868748,0.00015468647,0.00006562899,0.001218398,0.000022924743],"about_ca_topic_score_codex":0.0068666483,"about_ca_topic_score_gemma":0.01828585,"teacher_disagreement_score":0.0068666483,"about_ca_system_score_codex":0.0005392385,"about_ca_system_score_gemma":0.0005499652,"threshold_uncertainty_score":0.013653338},"labels":[],"label_agreement":null},{"id":"W2133193675","doi":"10.1634/theoncologist.12-7-785","title":"First-Line Treatment Options for Patients with HER-2–Negative Metastatic Breast Cancer: The Impact of Modern Adjuvant Chemotherapy","year":2007,"lang":"en","type":"review","venue":"The Oncologist","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"European Society for Medical Oncology; Pfizer","keywords":"Medicine; Metastatic breast cancer; Breast cancer; Adjuvant; Oncology; Adjuvant therapy; Clinical trial; Quality of life (healthcare); Chemotherapy; Cancer; Randomized controlled trial; Internal medicine; Intensive care medicine","score_opus":0.1131886795486073,"score_gpt":0.466774363464914,"score_spread":0.35358568391630674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133193675","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013357104,0.9988129,0.00008763479,0.0002508315,0.00008200204,0.0000031432437,0.0000069094176,0.0000036705721,0.0006194348],"genre_scores_gemma":[0.0006068835,0.99877435,0.00014945837,0.00013396428,0.00006465098,0.0000037175407,0.00001009912,5.924751e-7,0.00025636592],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981767,0.00004772672,0.000023601036,0.000024480676,0.000074648284,0.00001189014],"domain_scores_gemma":[0.9997156,0.00016146371,0.00004937381,0.0000075318358,0.000050272396,0.000015760665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004551009,0.0006058609,0.0015258938,0.0014273014,0.00020855115,0.0005919518,0.0006168625,0.00072714,0.0027864554],"category_scores_gemma":[0.000672555,0.00016739029,0.0005444888,0.0013563669,0.0002514439,0.0007849838,0.00029692482,0.0012798547,0.001218744],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056649144,0.0000673493,0.00015008361,0.014419992,0.00009586919,0.00017200607,0.00003167242,0.00032740907,0.000782591,0.0013169387,0.016705357,0.965874],"study_design_scores_gemma":[0.00009174877,0.00023225982,0.002831311,0.011403634,0.0003456924,0.0043433122,0.000104074104,0.0002530449,0.0007466571,0.0026187946,0.97700274,0.000026686466],"about_ca_topic_score_codex":0.00093335693,"about_ca_topic_score_gemma":0.0024662062,"teacher_disagreement_score":0.0027864554,"about_ca_system_score_codex":0.0005241253,"about_ca_system_score_gemma":0.00070836063,"threshold_uncertainty_score":0.00932163},"labels":[],"label_agreement":null},{"id":"W2133278615","doi":"10.18433/j3g01p","title":"Emergence of power laws in the pharmacokinetics of paclitaxel due to competing saturable processes.","year":2008,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Lethbridge; University of Alberta","funders":"","keywords":"Exponent; Power law; Cmax; Pharmacokinetics; Power function; Pareto distribution; Law; Mathematics; Nonlinear regression; Power (physics); Nonlinear system; Chemistry; Statistical physics; Statistics; Thermodynamics; Physics; Regression analysis; Mathematical analysis; Pharmacology; Medicine","score_opus":0.10949692229983157,"score_gpt":0.4399396418805712,"score_spread":0.3304427195807397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133278615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5374748,0.005756084,0.44854784,0.0006104353,0.00007842676,0.00040410046,0.00031098063,0.0011746419,0.005642679],"genre_scores_gemma":[0.9759778,0.0016717339,0.01908138,0.0003037809,0.000049081507,0.00024449415,0.00033092158,0.00015619506,0.002184673],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99886703,0.00028184667,0.00006170195,0.00026932033,0.00039347276,0.00012675628],"domain_scores_gemma":[0.99012977,0.0071308846,0.0015188517,0.00067146186,0.00046230078,0.000086755375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027348304,0.0008285378,0.00098923,0.0008884832,0.00030087182,0.0009544521,0.0009161286,0.0008970594,0.0013520258],"category_scores_gemma":[0.020249875,0.0007792625,0.0014321049,0.0007604119,0.0013425645,0.0019974064,0.0006273599,0.0021820902,0.0007106826],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031810761,0.0008078998,0.12673916,0.0030119605,0.0016414584,0.007418324,0.0032763144,0.34819892,0.20193516,0.06442702,0.0051353117,0.23422742],"study_design_scores_gemma":[0.00015883519,0.001517039,0.05122537,0.00014909962,0.00047895053,0.005001848,0.00019270541,0.8275829,0.048605032,0.05542923,0.009480685,0.00017837896],"about_ca_topic_score_codex":0.0020871966,"about_ca_topic_score_gemma":0.0012175014,"teacher_disagreement_score":0.0027348304,"about_ca_system_score_codex":0.0016385706,"about_ca_system_score_gemma":0.0006777036,"threshold_uncertainty_score":0.0144633055},"labels":[],"label_agreement":null},{"id":"W2133324333","doi":"10.1016/j.jpain.2005.01.155","title":"Thalidomide for the treatment of refractory radiculopathic pain: An open label trial","year":2005,"lang":"en","type":"article","venue":"Journal of Pain","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Thalidomide; Refractory (planetary science); Neuropathic pain; Tolerability; Visual analogue scale; Anesthesia; Bedtime; McGill Pain Questionnaire; Opioid; Sedation; Adverse effect; Internal medicine; Multiple myeloma","score_opus":0.11698617502033305,"score_gpt":0.4249907115413579,"score_spread":0.3080045365210249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133324333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9670554,0.023469532,0.0011237434,0.0011724642,0.0006844867,0.0025435975,0.0009214998,0.00011622339,0.002913215],"genre_scores_gemma":[0.97567546,0.014283127,0.0018456947,0.0015163481,0.0007474618,0.0020824063,0.00089267455,0.000026422626,0.0029304111],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99926966,0.00042373536,0.00004439046,0.00009136589,0.000060485472,0.00011033028],"domain_scores_gemma":[0.99894637,0.00044242444,0.00014806727,0.00008270592,0.00006069267,0.00031976704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019178742,0.0016536611,0.0038860894,0.00050814636,0.00063956523,0.0011088606,0.0010114941,0.0021820113,0.004457177],"category_scores_gemma":[0.0019920052,0.0005910514,0.0024319317,0.00056156924,0.0015627905,0.0012620084,0.0003188146,0.0035122074,0.0007534799],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94096744,0.009071683,0.0006860175,0.0016077186,0.0020934676,0.00017619647,0.00016472774,0.0006027338,0.0043260003,0.00031334753,0.0013690726,0.038621616],"study_design_scores_gemma":[0.93104374,0.06530033,0.0012391926,0.0000815196,0.00061449345,0.00009382527,0.00003463975,0.00040564613,0.00025763264,0.00012106257,0.0007858138,0.000022077073],"about_ca_topic_score_codex":0.0015838208,"about_ca_topic_score_gemma":0.003648761,"teacher_disagreement_score":0.004457177,"about_ca_system_score_codex":0.0009217242,"about_ca_system_score_gemma":0.0011973737,"threshold_uncertainty_score":0.014910758},"labels":[],"label_agreement":null},{"id":"W2134169247","doi":"10.1200/jco.2005.03.0981","title":"Phase I Dose-Finding Study of Weekly Single-Agent Patupilone in Patients With Advanced Solid Tumors","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"American Society of Clinical Oncology","keywords":"Medicine; Pharmacokinetics; Urology; Taxane; Dosing; Internal medicine; Surgery; Cancer; Breast cancer","score_opus":0.15033976515414665,"score_gpt":0.517848584346359,"score_spread":0.3675088191922124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134169247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975157,0.0008300588,0.00040728197,0.0001163106,0.000021673748,0.00039890062,0.00021902719,0.000039899645,0.00045110774],"genre_scores_gemma":[0.99731004,0.00041413502,0.0009032781,0.00011553373,0.00003820701,0.00027681343,0.0004784885,0.000009130849,0.00045456598],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998091,0.00007460089,0.000013273305,0.000035374083,0.000033641834,0.000034174256],"domain_scores_gemma":[0.99958247,0.00008782904,0.00010531215,0.000040655814,0.000026148824,0.0001575683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005545946,0.0007912785,0.0010758907,0.0003011482,0.00026510592,0.00047442038,0.0005512297,0.0004899316,0.0017386094],"category_scores_gemma":[0.0005657463,0.00030819024,0.00051366165,0.00032808783,0.00048614165,0.00038925064,0.00016943773,0.0016965,0.0004383129],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30306783,0.06327215,0.037406065,0.0012156346,0.0012325515,0.0009280004,0.00065937126,0.010974492,0.34706968,0.00030635344,0.0036276972,0.23024021],"study_design_scores_gemma":[0.18720238,0.7184351,0.04652879,0.00004148904,0.00045715156,0.0014683957,0.0000754905,0.004778423,0.036704708,0.00015962313,0.004105862,0.000042625128],"about_ca_topic_score_codex":0.00050331035,"about_ca_topic_score_gemma":0.0009320838,"teacher_disagreement_score":0.0017386094,"about_ca_system_score_codex":0.0005747413,"about_ca_system_score_gemma":0.0007199888,"threshold_uncertainty_score":0.0058162212},"labels":[],"label_agreement":null},{"id":"W2134894982","doi":"10.4021/wjon234w","title":"Carboplatin Induced Fatal Autoimmune Hemolytic Anemia: First Reported Case","year":2010,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Carboplatin; Medicine; Autoimmune hemolytic anemia; Anemia; Hemolytic anemia; Chemotherapy; Internal medicine; Gastroenterology; Ovarian cancer; Cancer; Cisplatin","score_opus":0.036702544892686075,"score_gpt":0.36237913384895515,"score_spread":0.32567658895626905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134894982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95831746,0.015450971,0.004797,0.0039907997,0.0012501549,0.00026681888,0.00048962655,0.00061127776,0.014825945],"genre_scores_gemma":[0.99029833,0.0031120013,0.0008673234,0.0014396405,0.0019546654,0.0000406065,0.00019431894,0.00004617073,0.0020468647],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9991961,0.00009618167,0.0001110825,0.0002229602,0.000080410406,0.00029318777],"domain_scores_gemma":[0.99818355,0.0004179589,0.0005064443,0.0002662287,0.00013418889,0.00049162627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003039455,0.0015290502,0.0012618557,0.0011818103,0.0017989452,0.0017927387,0.0011034717,0.0052044676,0.003131784],"category_scores_gemma":[0.0026883932,0.0009368534,0.001142102,0.00082448055,0.0010886857,0.0014262784,0.0011120203,0.0026065127,0.0012215344],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009555914,0.00015763816,0.010799728,0.00007292386,0.000032033375,0.98387027,0.00027244084,0.000082032035,0.00080698077,0.00020799508,0.0011482309,0.0024541982],"study_design_scores_gemma":[0.000035923,0.0001847232,0.005007862,0.00001919584,0.000022958928,0.9922862,0.000102819744,0.00014892653,0.00042175033,0.000119249096,0.0016368646,0.00001348488],"about_ca_topic_score_codex":0.0013389617,"about_ca_topic_score_gemma":0.0012712071,"teacher_disagreement_score":0.0052044676,"about_ca_system_score_codex":0.0009624638,"about_ca_system_score_gemma":0.0005974507,"threshold_uncertainty_score":0.010476828},"labels":[],"label_agreement":null},{"id":"W2136048473","doi":"10.1111/cbdd.12595","title":"Elucidating the Mechanism of Action of the Clinically Approved Taxanes: A Comprehensive Comparison of Local and Allosteric Effects","year":2015,"lang":"en","type":"article","venue":"Chemical Biology & Drug Design","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; Alberta Cancer Foundation; Allard Foundation; Killam Trusts; Alberta Innovates - Technology Futures; University of Alberta","keywords":"Allosteric regulation; Mechanism (biology); Mechanism of action; Computational biology; Chemistry; Pharmacology; Biology; Biochemistry; Receptor; Physics","score_opus":0.10095903343492857,"score_gpt":0.3829406904045022,"score_spread":0.2819816569695736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136048473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976258,0.013784291,0.005422636,0.00022768615,0.000010725095,0.000057349596,0.00022236303,0.00012010008,0.0038969566],"genre_scores_gemma":[0.98577476,0.010501871,0.002678761,0.00008574332,0.000008652231,0.000024277773,0.00024753858,0.000012261957,0.00066612137],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999423,0.000009107854,0.0000036900021,0.000011010482,0.000025101444,0.000008778523],"domain_scores_gemma":[0.99995005,0.00001543956,0.000015232218,0.0000050533276,0.000006365285,0.000007882951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001735448,0.00028677806,0.00044910132,0.0002284544,0.00015917169,0.0003170989,0.00024274728,0.00024275559,0.0014200433],"category_scores_gemma":[0.00019459853,0.00014722765,0.0002903025,0.00017546443,0.00019091308,0.00056633673,0.00015446983,0.00040394242,0.00016711728],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037381196,0.000275882,0.006437427,0.0006638122,0.00009968731,0.00021140669,0.00009689774,0.02923261,0.9063626,0.0030613474,0.00034061732,0.05284389],"study_design_scores_gemma":[0.00035736407,0.0061308453,0.061141066,0.00015950174,0.0005658243,0.001365821,0.00039235238,0.10475685,0.79823136,0.00521679,0.021604685,0.00007744045],"about_ca_topic_score_codex":0.00066790363,"about_ca_topic_score_gemma":0.0016730791,"teacher_disagreement_score":0.0014200433,"about_ca_system_score_codex":0.00026599533,"about_ca_system_score_gemma":0.0003649451,"threshold_uncertainty_score":0.00475055},"labels":[],"label_agreement":null},{"id":"W2136536672","doi":"10.1200/jco.2005.02.106","title":"Objective Response to Chemotherapy As a Potential Surrogate End Point of Survival in Metastatic Breast Cancer Patients","year":2005,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Epirubicin; Internal medicine; Hazard ratio; Breast cancer; Chemotherapy; Metastatic breast cancer; Oncology; Odds ratio; Surrogate endpoint; Cancer; Proportional hazards model; Surgery; Confidence interval","score_opus":0.1327136294108822,"score_gpt":0.5539587784090273,"score_spread":0.42124514899814514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136536672","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3875234,0.59675825,0.008873471,0.0016575549,0.00048554348,0.00044636783,0.0025089486,0.000046303874,0.0017001785],"genre_scores_gemma":[0.976652,0.019247368,0.0017895282,0.00070206093,0.00027547637,0.0003140673,0.00080355734,0.000011125471,0.00020482954],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.96730494,0.027418341,0.0021416605,0.0013291166,0.0015972687,0.00020859597],"domain_scores_gemma":[0.94930947,0.037992828,0.009947813,0.0016975696,0.00080094277,0.00025142403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0335968,0.0009883177,0.0038975002,0.0010228822,0.00017056642,0.0013915793,0.00075294555,0.00110413,0.0008058486],"category_scores_gemma":[0.040510193,0.0003882439,0.0109437825,0.0011663385,0.00071289524,0.0007774323,0.00060983043,0.0015852978,0.000081679624],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08155495,0.00034628375,0.21868403,0.043584555,0.5540002,0.000157665,0.00018812645,0.01140743,0.0013138175,0.0012227831,0.0011398819,0.086400375],"study_design_scores_gemma":[0.029597046,0.024062099,0.319249,0.012363352,0.57306784,0.0011958021,0.0001914802,0.018216483,0.004887383,0.0058963154,0.011055869,0.00021726827],"about_ca_topic_score_codex":0.0006182636,"about_ca_topic_score_gemma":0.00096611853,"teacher_disagreement_score":0.0335968,"about_ca_system_score_codex":0.0007331165,"about_ca_system_score_gemma":0.00065135234,"threshold_uncertainty_score":0.177679},"labels":[],"label_agreement":null},{"id":"W2136970657","doi":"10.1177/1078155214525369","title":"A comparison of toxicity and health care resource use between eribulin, capecitabine, gemcitabine, and vinorelbine in patients with metastatic breast cancer treated in a community oncology setting","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Eribulin; Metastatic breast cancer; Internal medicine; Gemcitabine; Vinorelbine; Neutropenia; Oncology; Breast cancer; Anemia; Capecitabine; Adverse effect; Cancer; Toxicity; Chemotherapy; Colorectal cancer","score_opus":0.06450904396762154,"score_gpt":0.4532250343000936,"score_spread":0.38871599033247206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136970657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99973947,0.00009690581,0.000007733343,0.0000134345955,8.4528955e-7,0.0000076302695,0.000060762286,3.9921036e-7,0.0000728292],"genre_scores_gemma":[0.9997023,0.000052530442,0.000023651688,0.000018707366,0.0000040112063,0.000012142089,0.00016093304,3.869438e-7,0.000025207555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993187,0.00029787686,0.00008197592,0.00010451835,0.00010878932,0.00008814734],"domain_scores_gemma":[0.9977502,0.0006650357,0.0010282872,0.00004020451,0.00012003435,0.0003962435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068474276,0.00019288075,0.00043406678,0.00064403197,0.000372453,0.0005309825,0.00028280012,0.0003398403,0.0011001141],"category_scores_gemma":[0.0033263303,0.00016877502,0.00050701085,0.0010875765,0.00022041817,0.00034335404,0.00035318665,0.0004037051,0.00007442389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031752086,0.00035326224,0.99280244,0.000028996312,0.00019163119,0.00010079135,0.00008580254,0.00016873887,0.00021243765,0.000009651837,0.00008298528,0.0027879684],"study_design_scores_gemma":[0.00022929473,0.0024321105,0.996099,0.00000952598,0.000070929775,0.00022816371,0.00024528048,0.00045506758,0.00008326376,0.00001724192,0.00012341574,0.0000066041953],"about_ca_topic_score_codex":0.004983045,"about_ca_topic_score_gemma":0.007087762,"teacher_disagreement_score":0.004983045,"about_ca_system_score_codex":0.0010501577,"about_ca_system_score_gemma":0.00051259005,"threshold_uncertainty_score":0.00990808},"labels":[],"label_agreement":null},{"id":"W2137677935","doi":"10.1039/b209312j","title":"First example of a taxane-derived propellane in Taxus canadensis needles","year":2002,"lang":"en","type":"article","venue":"Chemical Communications","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Queen's University; Institut National de la Recherche Scientifique","funders":"","keywords":"Propellane; Taxane; Biogenesis; Hertz; Chemistry; Stereochemistry; Biology; Physics; Bicyclic molecule; Biochemistry","score_opus":0.10162737066923415,"score_gpt":0.3108236084796394,"score_spread":0.20919623781040525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137677935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9697873,0.0032283182,0.0074812523,0.000184186,0.00016705533,0.00014059972,0.0018730797,0.00014376713,0.016994458],"genre_scores_gemma":[0.9638421,0.002823764,0.010917058,0.00009345396,0.00003344196,0.000041897878,0.0036347308,0.00004666608,0.018566886],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999435,0.0000044829094,0.000003812659,0.000014890055,0.000018953513,0.0000143905],"domain_scores_gemma":[0.999775,0.000047821362,0.00004218578,0.000027120035,0.000032791184,0.000075065356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035477842,0.00038688094,0.00018068614,0.000586245,0.00049636443,0.0003639757,0.00023374926,0.00047115216,0.00198275],"category_scores_gemma":[0.0001573995,0.00012404674,0.00027169415,0.00044743912,0.00024927745,0.00031076334,0.0005411227,0.0008327807,0.00063297636],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013071063,0.000012649634,0.0006453759,0.000083581755,0.000007251933,0.0014468555,0.00010473787,0.00005660826,0.9934161,0.00026015623,0.00005306106,0.0037829087],"study_design_scores_gemma":[0.000028579385,0.0008296685,0.031404458,0.000053037566,0.00004640592,0.0033917122,0.0007083569,0.00031982877,0.9279207,0.00088264747,0.03437427,0.000040382958],"about_ca_topic_score_codex":0.0012405389,"about_ca_topic_score_gemma":0.00260829,"teacher_disagreement_score":0.00198275,"about_ca_system_score_codex":0.00022594676,"about_ca_system_score_gemma":0.00027659742,"threshold_uncertainty_score":0.0066329837},"labels":[],"label_agreement":null},{"id":"W2138152567","doi":"10.1007/978-0-85729-727-3_3","title":"Chemotherapy in the Management of Cancer","year":2012,"lang":"en","type":"book-chapter","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Medicine; Quarter (Canadian coin); Disease; Cancer; Cure rate; Gynecology; Demography; Internal medicine; History","score_opus":0.03906866153385057,"score_gpt":0.3592225107155671,"score_spread":0.3201538491817165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138152567","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005450504,0.5756362,0.005699317,0.009122351,0.0063918103,0.0000673379,0.00012308141,0.0001461473,0.4022687],"genre_scores_gemma":[0.006174814,0.46189922,0.010583383,0.010989717,0.005045199,0.00013120826,0.00020115444,0.000104979124,0.50487036],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984515,0.000045199027,0.000006608379,0.000014710909,0.000078343524,0.000009998139],"domain_scores_gemma":[0.9998406,0.00010214544,0.000009552767,0.000008409256,0.000025699437,0.000013562297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002920932,0.00069242064,0.0005355589,0.000861036,0.0004944453,0.0011512619,0.00058695895,0.0011402467,0.0154483225],"category_scores_gemma":[0.00055338594,0.00017379303,0.0002454776,0.0009010419,0.000821182,0.0012203383,0.0006613469,0.0023987724,0.0063412855],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029060318,0.00009862664,0.000094683375,0.00094127917,0.000010547086,0.00015518426,0.00031398542,0.00054235937,0.0007191281,0.08218942,0.44434637,0.47055936],"study_design_scores_gemma":[0.0000035382998,0.000011490931,0.00010848019,0.0003435263,0.0000031435827,0.00024412767,0.000026637736,0.00006242743,0.00006780241,0.01079553,0.9883294,0.0000038879675],"about_ca_topic_score_codex":0.0013538445,"about_ca_topic_score_gemma":0.005520035,"teacher_disagreement_score":0.0154483225,"about_ca_system_score_codex":0.0007298135,"about_ca_system_score_gemma":0.0010279929,"threshold_uncertainty_score":0.05167979},"labels":[],"label_agreement":null},{"id":"W2138216054","doi":"10.1200/jco.2012.42.3301","title":"Linking Toxicity to the Target","year":2012,"lang":"en","type":"letter","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Toxicity; Oncology; Internal medicine","score_opus":0.21353725129848272,"score_gpt":0.5256858018184358,"score_spread":0.3121485505199531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138216054","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35342193,0.315608,0.07299231,0.0767849,0.007747192,0.003036824,0.0093509415,0.0008695475,0.16018842],"genre_scores_gemma":[0.8939673,0.04219729,0.0073691863,0.035221543,0.0032580316,0.0010271448,0.002175896,0.0003498147,0.014433844],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9904641,0.005178262,0.00077182223,0.0010869101,0.0020321012,0.0004666989],"domain_scores_gemma":[0.97443986,0.013113471,0.005909306,0.0023320094,0.0032644684,0.00094086386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0102294795,0.00096334954,0.0018267261,0.0014524631,0.00055101165,0.0035530508,0.0015568993,0.0015062583,0.010635639],"category_scores_gemma":[0.031323463,0.0004029127,0.0029354247,0.0020921843,0.001060751,0.0022424774,0.0017712909,0.0042216694,0.0017832172],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011852459,0.0025708831,0.27639896,0.011953214,0.009055396,0.0011470692,0.0010459673,0.010339629,0.008685125,0.06590659,0.06954586,0.5314988],"study_design_scores_gemma":[0.003717374,0.020645216,0.281319,0.007497137,0.013804612,0.0063785464,0.0013731132,0.012603755,0.016505426,0.23989208,0.3959246,0.0003391449],"about_ca_topic_score_codex":0.0007491562,"about_ca_topic_score_gemma":0.0010817817,"teacher_disagreement_score":0.010635639,"about_ca_system_score_codex":0.0025309369,"about_ca_system_score_gemma":0.00213464,"threshold_uncertainty_score":0.05409932},"labels":[],"label_agreement":null},{"id":"W2139515743","doi":"10.1016/j.bbmt.2012.11.196","title":"Impact of Bone Marrow Neuropathy on the Outcome of Autologous Stem Cell Transplantation (ASCT) for Lymphoma","year":2013,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Bone marrow; Stromal cell; Internal medicine; Haematopoiesis; Lymphoma; CD34; Stem cell; Pathology","score_opus":0.0209311755317132,"score_gpt":0.2883212969031479,"score_spread":0.2673901213714347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139515743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99829894,0.000832962,0.000103832186,0.00003715773,0.000008871262,0.0000075367366,0.00004104824,0.000002693659,0.0006670579],"genre_scores_gemma":[0.999584,0.00012013793,0.000028752947,0.000019655174,0.000018384571,0.000003970664,0.000091115275,0.0000011557516,0.00013291856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970204,0.000088661545,0.000040090345,0.00003383785,0.00006413266,0.00007123252],"domain_scores_gemma":[0.9986904,0.0003583981,0.00046339905,0.000046266752,0.000079042766,0.00036257005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051802146,0.00016519455,0.00026993686,0.00025892508,0.00019649733,0.0004797612,0.00012338105,0.00022242864,0.001078207],"category_scores_gemma":[0.001335327,0.000043639964,0.00023090377,0.00016256968,0.00019950738,0.0002541765,0.0002731221,0.0003122426,0.00020259888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061160075,0.00029508717,0.94201744,0.000060788327,0.00014195117,0.0022709914,0.00013301396,0.00045448812,0.008586241,0.00011285174,0.00022267042,0.03958844],"study_design_scores_gemma":[0.00003620603,0.0038642741,0.98951656,0.000027717115,0.00011224083,0.0037969516,0.0001190195,0.00051255204,0.001328969,0.00009280517,0.0005845035,0.0000081719845],"about_ca_topic_score_codex":0.00017274212,"about_ca_topic_score_gemma":0.00036256813,"teacher_disagreement_score":0.001078207,"about_ca_system_score_codex":0.0002548822,"about_ca_system_score_gemma":0.00015477193,"threshold_uncertainty_score":0.003606975},"labels":[],"label_agreement":null},{"id":"W2139995836","doi":"10.1158/1535-7163.mct-07-2217","title":"Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor–induced angiogenesis","year":2008,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Pharmacology; RHOA; Angiogenesis; Vascular endothelial growth factor; Chemistry; Naltrexone; Protein kinase B; Cancer research; Medicine; Receptor; Opioid; Signal transduction; Biochemistry","score_opus":0.026847572037158148,"score_gpt":0.2854884292025764,"score_spread":0.25864085716541824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139995836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904925,0.0051061916,0.00142537,0.00012518036,0.00007211553,0.000090335125,0.00010048917,0.000041627038,0.002546098],"genre_scores_gemma":[0.99551857,0.0015375294,0.0019190427,0.00006408698,0.000020281583,0.000041086718,0.00009930918,0.000003456974,0.00079670525],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998385,0.000043370004,0.000014277802,0.000021757474,0.000038540067,0.00004355624],"domain_scores_gemma":[0.9999236,0.000021569967,0.00002046815,0.0000061639835,0.000006656426,0.000021455713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018834596,0.00035722545,0.00040847395,0.0002339417,0.00009368745,0.00021147625,0.00015501711,0.00021645219,0.00084005244],"category_scores_gemma":[0.0001494795,0.00014924024,0.0003545908,0.00011385305,0.00013641603,0.00016511675,0.00020571417,0.00042539646,0.00012891895],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005893239,0.00018858186,0.00031456235,0.00008729959,0.000030415607,0.000080557336,0.00001770312,0.00032876342,0.9905511,0.0000863175,0.000108176195,0.0076170787],"study_design_scores_gemma":[0.00023292897,0.007749851,0.008678185,0.000021234218,0.00013578129,0.0006286846,0.0000450384,0.0036725602,0.9752774,0.000056012297,0.0034874415,0.000014877039],"about_ca_topic_score_codex":0.00059312617,"about_ca_topic_score_gemma":0.0025110934,"teacher_disagreement_score":0.00084005244,"about_ca_system_score_codex":0.00018534517,"about_ca_system_score_gemma":0.00023911259,"threshold_uncertainty_score":0.0028101802},"labels":[],"label_agreement":null},{"id":"W2140982262","doi":"10.1076/1388-0209(200007)3831-sft192","title":"Paclitaxel in Combination with Coumarin as a Potentially Effective Anticancer Agent","year":2000,"lang":"en","type":"article","venue":"Pharmaceutical Biology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trent University","funders":"","keywords":"Paclitaxel; Clastogen; Coumarin; Pharmacology; Antimitotic Agent; Chemistry; Toxicology; Toxicity; Biology; Genotoxicity; Cancer; Genetics; Tubulin; Organic chemistry","score_opus":0.024577093166481708,"score_gpt":0.38981657160042604,"score_spread":0.36523947843394433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140982262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752101,0.015778638,0.004258973,0.00032751364,0.00009667057,0.000114437884,0.00018350905,0.000118799835,0.0039112624],"genre_scores_gemma":[0.9859,0.006669132,0.004298778,0.000091136135,0.00005497877,0.00004494611,0.00025186426,0.000019512783,0.0026696466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998627,0.000040464336,0.000010970428,0.000023629756,0.000037048085,0.000025219897],"domain_scores_gemma":[0.9999273,0.00002144853,0.000016378717,0.000008303338,0.000010472777,0.000016185646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010181375,0.0003726519,0.0004617209,0.00068094715,0.00021111542,0.00034885076,0.00021761599,0.00033379105,0.00077348517],"category_scores_gemma":[0.00013947014,0.00017447877,0.00016590142,0.0005166321,0.00016763229,0.00019471212,0.00020572457,0.00034563523,0.00023651525],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004270494,0.000103681996,0.0004819105,0.00012783924,0.00002215409,0.00015676596,0.000023301669,0.0004672456,0.9876062,0.00014988385,0.00010455181,0.010329403],"study_design_scores_gemma":[0.000057442077,0.0017025557,0.0020281044,0.000012406252,0.000094719886,0.00037979335,0.000014073767,0.0008615979,0.9864324,0.0000652431,0.0083433,0.000008554018],"about_ca_topic_score_codex":0.00054264563,"about_ca_topic_score_gemma":0.0019738015,"teacher_disagreement_score":0.00077348517,"about_ca_system_score_codex":0.00028824786,"about_ca_system_score_gemma":0.00022635341,"threshold_uncertainty_score":0.0025875568},"labels":[],"label_agreement":null},{"id":"W2141787758","doi":"10.1158/1535-7163.targ-09-b54","title":"Abstract B54: A phase 1 study to assess the safety, tolerability and pharmacokinetics of the ErbB-family inhibitor ARRY-334543 in patients with advanced solid tumors","year":2009,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Juravinski Cancer Centre","funders":"","keywords":"Pharmacokinetics; Medicine; Dosing; Tolerability; Cmax; Capsule; Adverse effect; Pharmacology; Internal medicine; Gastroenterology","score_opus":0.027314768822341542,"score_gpt":0.3634590329814251,"score_spread":0.3361442641590836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141787758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99351406,0.0013404835,0.00045858178,0.00030003296,0.00006950226,0.0017706207,0.0012653832,0.00010643763,0.0011748703],"genre_scores_gemma":[0.98638725,0.0016151696,0.0021187568,0.0008478624,0.00011975292,0.002432027,0.0028431716,0.000054141223,0.0035819055],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996363,0.00016047125,0.000021712865,0.0000718643,0.000041460622,0.00006819175],"domain_scores_gemma":[0.99947613,0.00007595545,0.00010037524,0.00004746381,0.000044972556,0.0002552543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011532711,0.0013896313,0.0020589875,0.00042080018,0.00042332226,0.0007819471,0.0007269879,0.0010055887,0.0057248157],"category_scores_gemma":[0.0007272322,0.0006382674,0.0009665816,0.0003686726,0.0005843839,0.00071246846,0.0003311741,0.0029696373,0.0017143526],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5508303,0.09444934,0.013210535,0.0013793776,0.0013199667,0.0007392884,0.00039300357,0.003033436,0.20225686,0.00028776814,0.007856268,0.12424384],"study_design_scores_gemma":[0.26149634,0.70818055,0.018825108,0.00003882733,0.00037769385,0.0005867479,0.00006165242,0.0012000392,0.005486629,0.00012376648,0.003584572,0.00003821265],"about_ca_topic_score_codex":0.0011098561,"about_ca_topic_score_gemma":0.0019724043,"teacher_disagreement_score":0.0057248157,"about_ca_system_score_codex":0.0008064282,"about_ca_system_score_gemma":0.0014979509,"threshold_uncertainty_score":0.01915145},"labels":[],"label_agreement":null},{"id":"W2142226415","doi":"10.1016/s1470-2045(15)70064-1","title":"Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial","year":2015,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":285,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Fudan University; Natural Science Foundation of Shanghai; Eli Lilly and Company","keywords":"Gemcitabine; Medicine; Internal medicine; Regimen; Metastatic breast cancer; Oncology; Breast cancer; Clinical endpoint; Triple-negative breast cancer; Chemotherapy; Cisplatin; Paclitaxel; Cancer; Clinical trial","score_opus":0.2756851049856489,"score_gpt":0.49839696780858883,"score_spread":0.22271186282293992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142226415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98182124,0.0048006643,0.000905894,0.0015699506,0.001227346,0.004604789,0.0019140557,0.00027977588,0.0028764415],"genre_scores_gemma":[0.97481185,0.004792084,0.002424568,0.0024057995,0.0007384035,0.004599624,0.0026507329,0.00009041167,0.007486457],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992957,0.00038095555,0.000029320316,0.00013021604,0.00005485043,0.0001089997],"domain_scores_gemma":[0.9989209,0.0003070927,0.00019424215,0.000076963915,0.000050093742,0.00045073498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020517674,0.0028346868,0.003940663,0.0006249475,0.0005353145,0.001610868,0.0015759473,0.0025588218,0.011354465],"category_scores_gemma":[0.002216277,0.00094534026,0.0032366293,0.0006771371,0.0016800866,0.0017337062,0.00074642967,0.0062591685,0.0020656234],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9859081,0.0030749259,0.00017683985,0.00035942293,0.00053880725,0.000023278446,0.00003660754,0.0003592541,0.00096629624,0.00008915281,0.0008997852,0.007567499],"study_design_scores_gemma":[0.9672455,0.031331606,0.00046823942,0.000022331773,0.00019798681,0.000017786539,0.000012469266,0.00022205235,0.0001097116,0.000111718735,0.00025012202,0.000010498182],"about_ca_topic_score_codex":0.0020151879,"about_ca_topic_score_gemma":0.0049694763,"teacher_disagreement_score":0.011354465,"about_ca_system_score_codex":0.0014232477,"about_ca_system_score_gemma":0.0016914239,"threshold_uncertainty_score":0.03798449},"labels":[],"label_agreement":null},{"id":"W2143006403","doi":"10.1016/j.breast.2012.05.010","title":"ABC 1 (1st International consensus guidelines for advanced breast cancer): A positive step","year":2012,"lang":"en","type":"editorial","venue":"The Breast","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Scopus; Metastatic breast cancer; Cancer; Disease; Oncology; Internal medicine; Family medicine; MEDLINE","score_opus":0.03580187537947058,"score_gpt":0.4063039905991022,"score_spread":0.3705021152196316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143006403","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00065084995,0.12375554,0.009764883,0.7799196,0.05553385,0.0012350956,0.0017464804,0.00093011936,0.026463555],"genre_scores_gemma":[0.017643848,0.2800764,0.22276956,0.37214485,0.045681957,0.006153644,0.017019784,0.0013967133,0.037113205],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.95528597,0.018369373,0.007360166,0.0011914868,0.015596807,0.0021961266],"domain_scores_gemma":[0.86356497,0.025319366,0.009312186,0.004121981,0.08901112,0.008670356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.053242587,0.0020621389,0.0036336624,0.0059020533,0.0023658674,0.009059099,0.0062754573,0.014562611,0.012980727],"category_scores_gemma":[0.101623,0.0014248231,0.0034567663,0.0051570563,0.0026616189,0.009426169,0.0066669923,0.02177429,0.017457822],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005823283,0.000073159266,0.00034013053,0.0035397236,0.000060959548,0.00011819829,0.0002450074,0.00012837231,0.00016875025,0.004560424,0.88809896,0.10260801],"study_design_scores_gemma":[0.00006369667,0.00006335214,0.0007570637,0.01408409,0.00008270781,0.00041519722,0.00037841505,0.00017357088,0.00013065209,0.0073238215,0.97647333,0.00005404984],"about_ca_topic_score_codex":0.010332101,"about_ca_topic_score_gemma":0.018181408,"teacher_disagreement_score":0.053242587,"about_ca_system_score_codex":0.0057191676,"about_ca_system_score_gemma":0.033400275,"threshold_uncertainty_score":0.28157705},"labels":[],"label_agreement":null},{"id":"W2143498161","doi":"10.1158/0008-5472.sabcs10-p2-16-06","title":"Abstract P2-16-06: Final Overall Survival Results, Including Analysis of Patients with Triple-Negative Disease and Aged ≥70 Years, from the ATHENA Study Evaluating First-Line Bevacizumab-Containing Therapy for Locally Recurrent/Metastatic Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Bevacizumab; Medicine; Taxane; Docetaxel; Internal medicine; Regimen; Chemotherapy; Clinical endpoint; Metastatic breast cancer; Oncology; Population; Chemotherapy regimen; Surgery; Progression-free survival; Anthracycline; Cancer; Breast cancer; Randomized controlled trial","score_opus":0.1836768031969175,"score_gpt":0.47802080924116985,"score_spread":0.29434400604425237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143498161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99112517,0.0008357578,0.00016867966,0.000056099318,0.000017667862,0.00012947286,0.0064828577,0.000018365257,0.0011657887],"genre_scores_gemma":[0.9774161,0.00024744793,0.0002882324,0.00010748623,0.00005715959,0.00019641838,0.020701272,0.000015924226,0.000969849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999526,0.00013726256,0.000055763507,0.0001515591,0.00007358032,0.00005581549],"domain_scores_gemma":[0.9986603,0.00022593235,0.00041348886,0.00014939714,0.00012408913,0.0004267739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019332626,0.00067137316,0.0009818503,0.00064118876,0.0003299806,0.0007491044,0.00061801175,0.0006015065,0.0018590683],"category_scores_gemma":[0.001259089,0.00030307972,0.0016458632,0.00058054936,0.00021677562,0.0005009123,0.00066068006,0.00079185894,0.0006202006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08734445,0.0015496203,0.8785207,0.00034309865,0.0045356886,0.00034156456,0.00011345202,0.0012372435,0.0036539366,0.00004488439,0.003700024,0.01861529],"study_design_scores_gemma":[0.006019067,0.008235782,0.9804586,0.000029311179,0.0015460902,0.0006606,0.00005036183,0.0005240176,0.00063152105,0.000043909236,0.0017761353,0.000024633058],"about_ca_topic_score_codex":0.0010779138,"about_ca_topic_score_gemma":0.0022658352,"teacher_disagreement_score":0.0019332626,"about_ca_system_score_codex":0.0005219103,"about_ca_system_score_gemma":0.000468385,"threshold_uncertainty_score":0.0102241635},"labels":[],"label_agreement":null},{"id":"W2145066018","doi":"10.4021/wjon265w","title":"A Fatal Brain Stroke in Patient with Advanced Breast Cancer Treated with Bevacizumab: A Case Report","year":2010,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Bevacizumab; Medicine; Metastatic breast cancer; Vascular endothelial growth factor; Breast cancer; Internal medicine; Stroke (engine); Paclitaxel; Chemotherapy; Oncology; Proteinuria; Colorectal cancer; Cancer; Surgery; Kidney; VEGF receptors","score_opus":0.01081711343478712,"score_gpt":0.33419057168583255,"score_spread":0.3233734582510454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145066018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732814,0.0032250846,0.003006637,0.0053691184,0.0005286992,0.00023655346,0.00029312927,0.00018238062,0.013877076],"genre_scores_gemma":[0.99239576,0.0018191083,0.0011103682,0.0014996377,0.0015288494,0.000044287754,0.0001384166,0.000027922719,0.0014357321],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99920136,0.00011627116,0.00008601979,0.00020297071,0.00011114656,0.0002822854],"domain_scores_gemma":[0.9981958,0.00049570005,0.00042667022,0.00016370117,0.00014933034,0.0005686802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044658856,0.002287653,0.0016364137,0.0024765285,0.004205196,0.0022976943,0.0013552557,0.00723698,0.002283028],"category_scores_gemma":[0.004004867,0.001480468,0.0014951021,0.0017123839,0.0018974066,0.0025583874,0.0014237175,0.0037266766,0.0009498527],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030744388,0.0000549632,0.005898744,0.000014116565,0.000013504412,0.99279803,0.000119672186,0.000034066783,0.00024206421,0.000084368134,0.00021127274,0.00049847487],"study_design_scores_gemma":[0.000016681797,0.00008659749,0.0034068825,0.000009337769,0.000019927016,0.995669,0.000098623255,0.00017102617,0.00017438504,0.00012239999,0.0002124991,0.000012636858],"about_ca_topic_score_codex":0.0034904843,"about_ca_topic_score_gemma":0.0041779247,"teacher_disagreement_score":0.00723698,"about_ca_system_score_codex":0.0016609716,"about_ca_system_score_gemma":0.0013866264,"threshold_uncertainty_score":0.012051284},"labels":[],"label_agreement":null},{"id":"W2146473694","doi":"10.1200/jco.2004.08.080","title":"Quality of Life in Ovarian Cancer Patients: Comparison of Paclitaxel Plus Cisplatin, With Cyclophosphamide Plus Cisplatin in a Randomized Study","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University; University Health Network","funders":"","keywords":"Cisplatin; Medicine; Paclitaxel; Oncology; Cyclophosphamide; Internal medicine; Randomized controlled trial; Ovarian cancer; Chemotherapy; Cancer; Gynecology","score_opus":0.14607261429325288,"score_gpt":0.5286768606947838,"score_spread":0.3826042464015309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146473694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803137,0.009920645,0.0006304803,0.0008527039,0.0004909423,0.00595201,0.0005919122,0.000053467742,0.0011941843],"genre_scores_gemma":[0.986797,0.003378864,0.0011066323,0.0006363509,0.00050452177,0.006509242,0.00055874075,0.000008772112,0.0004999858],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961357,0.002721829,0.00032046813,0.00032965635,0.00029045608,0.00020189902],"domain_scores_gemma":[0.99556965,0.001899507,0.0012597996,0.00025983728,0.00021943684,0.00079181796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003878472,0.00088275055,0.0027554636,0.0006977588,0.00049106305,0.001196518,0.0008215569,0.0018239929,0.004913988],"category_scores_gemma":[0.0067194435,0.00064668787,0.0031641496,0.0008717552,0.0012019182,0.0007649838,0.00062406535,0.0019274224,0.00039565572],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97507226,0.005160636,0.0017323657,0.00067283947,0.0012423416,0.000019222842,0.000034291766,0.00022303345,0.00041092452,0.000055653276,0.00019775334,0.015178681],"study_design_scores_gemma":[0.937225,0.05868271,0.0026944366,0.000048927814,0.0006644528,0.000016153788,0.000015672473,0.00020274793,0.00011235023,0.000059676837,0.0002704955,0.000007383234],"about_ca_topic_score_codex":0.0009504742,"about_ca_topic_score_gemma":0.0014426585,"teacher_disagreement_score":0.004913988,"about_ca_system_score_codex":0.0012596636,"about_ca_system_score_gemma":0.0018347934,"threshold_uncertainty_score":0.020511568},"labels":[],"label_agreement":null},{"id":"W2146512589","doi":"10.1200/jco.2007.11.8851","title":"Randomized Trial of High-Dose Chemotherapy With Autologous Peripheral-Blood Stem-Cell Support Compared With Standard-Dose Chemotherapy in Women With Metastatic Breast Cancer: NCIC MA.16","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"American Society of Clinical Oncology","keywords":"Medicine; Chemotherapy; Carboplatin; Hazard ratio; Breast cancer; Metastatic breast cancer; Surgery; Internal medicine; ThioTEPA; Oncology; Anthracycline; Autologous stem-cell transplantation; Cyclophosphamide; Cancer; Confidence interval; Cisplatin","score_opus":0.04313492712664521,"score_gpt":0.41637395395101684,"score_spread":0.3732390268243716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146512589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98888624,0.0035151744,0.00037240778,0.0011579517,0.0006083337,0.00341026,0.00064317766,0.00009115502,0.0013153291],"genre_scores_gemma":[0.9888939,0.0011795129,0.0011445077,0.0010889056,0.000683047,0.0042911037,0.000687973,0.000011994938,0.0020190359],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981951,0.0013484374,0.00009126624,0.0001690675,0.00007674564,0.0001193642],"domain_scores_gemma":[0.99762565,0.00088724465,0.00059395906,0.00014764845,0.00011642508,0.000629121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002252892,0.0014654639,0.0026820197,0.0006189679,0.00053986773,0.0011472562,0.0012541089,0.0021720198,0.0079078],"category_scores_gemma":[0.0041977367,0.000584833,0.0016019433,0.00048547896,0.0015254319,0.00078308163,0.0005466601,0.0025699537,0.000857604],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9920773,0.0023290857,0.00043652725,0.00017467578,0.00039180386,0.000013653965,0.000015655827,0.00013041515,0.00046287937,0.00004324625,0.00023176889,0.0036929855],"study_design_scores_gemma":[0.95591474,0.042249355,0.00087102817,0.000017764549,0.0002618735,0.000011778145,0.000007422746,0.00025849152,0.00013733568,0.00005210607,0.00021256425,0.0000055404794],"about_ca_topic_score_codex":0.0016503816,"about_ca_topic_score_gemma":0.0031785802,"teacher_disagreement_score":0.0079078,"about_ca_system_score_codex":0.0010852246,"about_ca_system_score_gemma":0.0015941907,"threshold_uncertainty_score":0.02645427},"labels":[],"label_agreement":null},{"id":"W2147583204","doi":"10.1186/s40064-015-1422-8","title":"Eribulin monotherapy improved survivals in patients with ER-positive HER2-negative metastatic breast cancer in the real world: a single institutional review","year":2015,"lang":"en","type":"article","venue":"SpringerPlus","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada; Eisai","keywords":"Eribulin; Metastatic breast cancer; Medicine; Oncology; Breast cancer; HER2 negative; Internal medicine; Cancer","score_opus":0.030051879067658376,"score_gpt":0.33217868778978177,"score_spread":0.3021268087221234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147583204","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2820413,0.7047723,0.0006980786,0.0013075861,0.00023100435,0.0009463061,0.0039880625,0.00003211835,0.0059832665],"genre_scores_gemma":[0.64292085,0.3495845,0.0011225453,0.0017489344,0.0003620955,0.0006643424,0.002812452,0.000017223107,0.00076712336],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980856,0.0007869372,0.0005965456,0.00012741673,0.00034565767,0.000057801728],"domain_scores_gemma":[0.99408686,0.0015827686,0.0023186163,0.0003230571,0.0015433372,0.00014539399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040240698,0.00012937731,0.00093561714,0.0011523673,0.00021661943,0.0007500037,0.00040442866,0.00035543388,0.00078902114],"category_scores_gemma":[0.006746939,0.00015444568,0.0007828924,0.0024163486,0.00029587952,0.00031869518,0.00023848758,0.0002544282,0.0001870062],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063584344,0.0003835281,0.36065027,0.06849357,0.0092721535,0.0032147088,0.0011115432,0.00021183646,0.006200749,0.0006228685,0.019461196,0.5240192],"study_design_scores_gemma":[0.001371388,0.0033288265,0.8055815,0.01770727,0.017874628,0.00796678,0.0012563128,0.00034474782,0.0039942204,0.00015615932,0.14032978,0.00008842384],"about_ca_topic_score_codex":0.0013154473,"about_ca_topic_score_gemma":0.0030366122,"teacher_disagreement_score":0.0040240698,"about_ca_system_score_codex":0.0006962512,"about_ca_system_score_gemma":0.0018111013,"threshold_uncertainty_score":0.0212816},"labels":[],"label_agreement":null},{"id":"W2148493940","doi":"10.1177/1078155208098584","title":"Economic analysis of albumin-bound paclitaxel for the treatment of metastatic breast cancer","year":2008,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre","funders":"","keywords":"Docetaxel; Medicine; Paclitaxel; Metastatic breast cancer; Oncology; Breast cancer; Internal medicine; Chemotherapy; Toxicity; Nab-paclitaxel; Cancer","score_opus":0.1128865310209775,"score_gpt":0.4903383100464727,"score_spread":0.3774517790254952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148493940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.820865,0.10485138,0.026645033,0.009858526,0.00031257866,0.003385664,0.003982654,0.00007077302,0.03002846],"genre_scores_gemma":[0.98478794,0.008463404,0.004235209,0.0004104942,0.00006700794,0.0005712907,0.00069230085,0.00001115991,0.00076119584],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9891885,0.009361255,0.00021624946,0.00014656053,0.0008103476,0.0002771074],"domain_scores_gemma":[0.9768289,0.020602217,0.0011825056,0.0001622806,0.0008073295,0.00041676033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014114517,0.00071808556,0.0013173097,0.0019282372,0.0002794469,0.0015057693,0.00074478023,0.00074103544,0.0036006267],"category_scores_gemma":[0.03855071,0.00030062094,0.0026353726,0.0020240652,0.00041639863,0.00076559355,0.00056089595,0.001217757,0.000114943236],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04226703,0.0021369138,0.060267545,0.011499086,0.019787537,0.0009768433,0.00038357158,0.57595694,0.001132584,0.028532252,0.011513783,0.24554598],"study_design_scores_gemma":[0.009822994,0.01113572,0.06995782,0.004168041,0.020085819,0.0012408915,0.0011026527,0.80988216,0.0018799566,0.041368615,0.029129228,0.00022616521],"about_ca_topic_score_codex":0.014037811,"about_ca_topic_score_gemma":0.009400881,"teacher_disagreement_score":0.014114517,"about_ca_system_score_codex":0.008696207,"about_ca_system_score_gemma":0.005008416,"threshold_uncertainty_score":0.07464558},"labels":[],"label_agreement":null},{"id":"W2149626092","doi":"10.1200/jco.2003.04.075","title":"Phase III Study of <i>N,N</i>-Diethyl-2-[4-(Phenylmethyl) Phenoxy]Ethanamine (BMS-217380-01) Combined With Doxorubicin Versus Doxorubicin Alone in Metastatic/Recurrent Breast Cancer: National Cancer Institute of Canada Clinical Trials Group Study MA.19","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Medicine; Doxorubicin; Metastatic breast cancer; Breast cancer; Cancer; Internal medicine; Oncology; Chemotherapy","score_opus":0.2747917362226942,"score_gpt":0.5594949828497567,"score_spread":0.28470324662706253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149626092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728299,0.0064076562,0.0009577095,0.0014333689,0.00032960155,0.009054402,0.003146538,0.00023640135,0.0056044604],"genre_scores_gemma":[0.958942,0.0054399245,0.0032080088,0.0024835917,0.0004935075,0.012580331,0.004488584,0.00009230817,0.012271675],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992799,0.00039902935,0.00003078977,0.00010711896,0.00006887921,0.00011434945],"domain_scores_gemma":[0.99881685,0.00018297542,0.00031295005,0.000075795615,0.00007920951,0.00053226977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001958861,0.0019953041,0.0027896436,0.0006506928,0.00051825953,0.0011740627,0.001671214,0.001960536,0.006900194],"category_scores_gemma":[0.0012770152,0.0007021681,0.001670165,0.0005726386,0.0013659103,0.000803593,0.0003949847,0.0034262238,0.0016030822],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8954333,0.042586904,0.0019988343,0.0008538801,0.001906579,0.00014013203,0.00015300738,0.00077726314,0.022732219,0.0002433478,0.0041574663,0.029017141],"study_design_scores_gemma":[0.7761047,0.21617416,0.0028855905,0.00003490313,0.0005312323,0.00008206034,0.000025999863,0.0003673329,0.0019244315,0.000100628095,0.0017522668,0.000016751017],"about_ca_topic_score_codex":0.0041239723,"about_ca_topic_score_gemma":0.0119850375,"teacher_disagreement_score":0.006900194,"about_ca_system_score_codex":0.0019852775,"about_ca_system_score_gemma":0.0032499447,"threshold_uncertainty_score":0.023083448},"labels":[],"label_agreement":null},{"id":"W2150475127","doi":"10.1093/annonc/mdh278","title":"A phase I study of AMD473 and docetaxel given once every 3 weeks in patients with advanced refractory cancer: a National Cancer Institute of Canada-Clinical Trials Group trial, IND 131","year":2004,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Regional Cancer Foundation; BC Cancer Agency","funders":"AstraZeneca Canada","keywords":"Docetaxel; Medicine; Taxane; Neutropenia; Regimen; Internal medicine; Carboplatin; Cancer; Clinical trial; Prostate cancer; Phases of clinical research; Chemotherapy; Oncology; Surgery; Cisplatin; Breast cancer","score_opus":0.19890703960412862,"score_gpt":0.5251946068362316,"score_spread":0.32628756723210306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150475127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797376,0.0054102964,0.0005063647,0.0018022216,0.00047880027,0.003851637,0.0032451872,0.00017670137,0.0047912737],"genre_scores_gemma":[0.97319657,0.0059175584,0.0020947768,0.0019192555,0.00045484002,0.0036754205,0.00358372,0.000063844236,0.009093912],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995389,0.00020853383,0.000015964411,0.00007792288,0.000039775852,0.000118895965],"domain_scores_gemma":[0.9990663,0.00017065059,0.00013797767,0.00006149218,0.000045234254,0.00051830447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013920288,0.0021367446,0.0029814013,0.00058496173,0.00075969705,0.0011507976,0.001283957,0.0017724059,0.006318507],"category_scores_gemma":[0.0013998629,0.00084947026,0.0023179397,0.00074580684,0.0014942574,0.00086458557,0.0003668257,0.004657709,0.0012223084],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89965516,0.029180992,0.0019720118,0.00076086365,0.001176951,0.00015089652,0.00019180654,0.0018242659,0.0072213653,0.0003383382,0.0075091864,0.050018195],"study_design_scores_gemma":[0.8872765,0.10654712,0.0033831631,0.000022758255,0.0002866751,0.00008275468,0.000035640034,0.0004432457,0.00036791386,0.00012103296,0.0014113596,0.000021991893],"about_ca_topic_score_codex":0.008431534,"about_ca_topic_score_gemma":0.027857097,"teacher_disagreement_score":0.008431534,"about_ca_system_score_codex":0.0018447293,"about_ca_system_score_gemma":0.003796228,"threshold_uncertainty_score":0.021137536},"labels":[],"label_agreement":null},{"id":"W2151725702","doi":"10.1093/jncimonographs/lgu041","title":"Clinical Practice Guidelines on the Use of Integrative Therapies as Supportive Care in Patients Treated for Breast Cancer","year":2014,"lang":"en","type":"review","venue":"JNCI Monographs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":270,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian College of Naturopathic Medicine; Ottawa Regional Cancer Foundation; University of Calgary; University of British Columbia","funders":"National Center for Complementary and Integrative Health; University of Texas MD Anderson Cancer Center; Emory University; University of Pennsylvania; University of California, San Francisco; University of Southern California","keywords":"Medicine; Breast cancer; Psychological intervention; Anxiety; Randomized controlled trial; Massage; Quality of life (healthcare); Mood; Physical therapy; Cancer; Intensive care medicine; Alternative medicine; Internal medicine; Psychiatry; Nursing","score_opus":0.20256489049932525,"score_gpt":0.5200536103894381,"score_spread":0.31748871989011285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151725702","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046717855,0.5206454,0.032485995,0.32790658,0.018642016,0.03365645,0.008324931,0.0011819494,0.052484855],"genre_scores_gemma":[0.037141185,0.40283716,0.40348545,0.085988484,0.003922533,0.05057822,0.008565675,0.00033042865,0.0071508237],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.8879633,0.049067523,0.045729216,0.0022750269,0.013326016,0.0016389068],"domain_scores_gemma":[0.6765608,0.14414342,0.04799676,0.006221195,0.1187128,0.006365022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.069397055,0.0019083014,0.0049641994,0.012314507,0.00313515,0.0051484033,0.009357,0.011000536,0.007015309],"category_scores_gemma":[0.2083563,0.0019792928,0.008715292,0.011301929,0.0029592686,0.0044426816,0.005346605,0.008280729,0.0037435421],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044150275,0.00035389385,0.0039984235,0.22220246,0.0015764597,0.0006421429,0.0035644576,0.0013214858,0.0012208151,0.009219569,0.36739567,0.3880631],"study_design_scores_gemma":[0.0011768242,0.00029730186,0.008210521,0.5908516,0.002891038,0.00066324393,0.0017452543,0.00093640917,0.0006498446,0.012379723,0.37994963,0.00024857468],"about_ca_topic_score_codex":0.023364186,"about_ca_topic_score_gemma":0.04306899,"teacher_disagreement_score":0.069397055,"about_ca_system_score_codex":0.009158902,"about_ca_system_score_gemma":0.04426138,"threshold_uncertainty_score":0.36701107},"labels":[],"label_agreement":null},{"id":"W2152362985","doi":"10.4021/wjon314w","title":"Grade III Dermatitis in a Patient Treated With Paclitaxel and Radiotherapy: Case Report and Review of the Literature","year":2011,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Paclitaxel; Radiation therapy; Docetaxel; Adjuvant; Breast cancer; Chemotherapy; Oncology; Adjuvant radiotherapy; Internal medicine; Dermatology; Cancer; Surgery","score_opus":0.022302729540432033,"score_gpt":0.3206446044662794,"score_spread":0.29834187492584735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152362985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7951659,0.14894657,0.006623671,0.0027525108,0.0020179392,0.00041975125,0.00038737728,0.00039386167,0.043292444],"genre_scores_gemma":[0.9483417,0.03918352,0.0017609871,0.002351622,0.0016973624,0.000058561964,0.00016756543,0.000047144706,0.006391625],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994517,0.000084053,0.0001061703,0.0001261454,0.000088503104,0.00014343021],"domain_scores_gemma":[0.99929047,0.00023808643,0.00025544624,0.000067324654,0.00004558834,0.00010304685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031126654,0.0012732744,0.0010863442,0.0013719094,0.0010751678,0.0016475525,0.0009574827,0.0034322012,0.004046069],"category_scores_gemma":[0.0015716105,0.0006811812,0.00080345594,0.0021091788,0.000978978,0.0013136287,0.00066795613,0.0012363589,0.0016398467],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028225457,0.000107221844,0.0071065254,0.00023756694,0.000034587632,0.98338103,0.0001891327,0.00006136575,0.0007597884,0.00010211958,0.0009619369,0.007030534],"study_design_scores_gemma":[0.000008284338,0.000059613456,0.003582548,0.000046371428,0.00002867156,0.9935962,0.00015415247,0.000054109823,0.00012869557,0.00008035787,0.0022539417,0.0000069741495],"about_ca_topic_score_codex":0.0008982594,"about_ca_topic_score_gemma":0.0015134347,"teacher_disagreement_score":0.004046069,"about_ca_system_score_codex":0.0004610568,"about_ca_system_score_gemma":0.00048093701,"threshold_uncertainty_score":0.0135355},"labels":[],"label_agreement":null},{"id":"W2153543895","doi":"10.1093/jat/30.3.202","title":"Hydromorphone-Related Fatalities in Ontario","year":2006,"lang":"en","type":"article","venue":"Journal of Analytical Toxicology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Hydromorphone; Medicine; Internal medicine","score_opus":0.024562890978683125,"score_gpt":0.3060352812723721,"score_spread":0.281472390293689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153543895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869751,0.0028542713,0.00018105491,0.00037654527,0.000020405794,0.00007086326,0.0010955193,0.000026273274,0.00840005],"genre_scores_gemma":[0.9937237,0.0031121785,0.00016906548,0.00012822091,0.000012142324,0.000012124435,0.0005857897,0.0000059408403,0.0022507969],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995536,0.000030674244,0.00003697727,0.000037474532,0.00023960987,0.000101631515],"domain_scores_gemma":[0.99848,0.000105317566,0.0006037486,0.000053961634,0.0005904437,0.00016655946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002724103,0.00022404353,0.00019230963,0.001489833,0.0019812568,0.00057331193,0.0004551881,0.00026158182,0.0016438485],"category_scores_gemma":[0.0014886935,0.000273044,0.00026473487,0.0014178441,0.00072818814,0.00020207973,0.0006585411,0.00023275317,0.00017036925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003030946,0.000034479657,0.9429888,0.0003593109,0.00008078958,0.012423002,0.005507049,0.00032555143,0.0041995225,0.0003075164,0.0028942998,0.030576564],"study_design_scores_gemma":[0.000013739668,0.00007840525,0.98568904,0.00006113117,0.00003250993,0.0041142344,0.001977868,0.00013716292,0.0006574488,0.00007131272,0.007149911,0.000017185776],"about_ca_topic_score_codex":0.92272556,"about_ca_topic_score_gemma":0.97110826,"teacher_disagreement_score":0.07727444,"about_ca_system_score_codex":0.017498355,"about_ca_system_score_gemma":0.011146552,"threshold_uncertainty_score":0.15545899},"labels":[],"label_agreement":null},{"id":"W2154122152","doi":"10.1200/jco.2007.10.8399","title":"Taxanes Alone or in Combination With Anthracyclines As First-Line Therapy of Patients With Metastatic Breast Cancer","year":2008,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":214,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Sanofi; Bristol-Myers Squibb","keywords":"Taxane; Medicine; Docetaxel; Epirubicin; Internal medicine; Oncology; Hazard ratio; Paclitaxel; Cyclophosphamide; Metastatic breast cancer; Breast cancer; Anthracycline; Progression-free survival; Chemotherapy; Cancer; Confidence interval","score_opus":0.2078138191094805,"score_gpt":0.5426035441105482,"score_spread":0.33478972500106774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154122152","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1678465,0.8275568,0.0005813175,0.0007855338,0.00061100506,0.00033987986,0.00080270914,0.00005235187,0.0014239586],"genre_scores_gemma":[0.87500316,0.12124964,0.0007735418,0.00087998505,0.00044600788,0.00019011911,0.00086537644,0.000018365983,0.0005737728],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971517,0.0017399738,0.00038805555,0.00034964693,0.00029636902,0.00007433828],"domain_scores_gemma":[0.99691606,0.001706901,0.0009633461,0.00014704041,0.00013378455,0.00013286501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058685145,0.00094749994,0.0036868702,0.0015437866,0.00017911232,0.0012353332,0.00063808943,0.00081983523,0.0020700742],"category_scores_gemma":[0.0073392023,0.00055155944,0.010948914,0.0013965394,0.0003094542,0.0008401749,0.000409464,0.0013756664,0.00020905942],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13858199,0.00041191053,0.028548962,0.049263306,0.6604846,0.00018671805,0.00009317825,0.005561837,0.0024054672,0.00026238154,0.00255272,0.111646846],"study_design_scores_gemma":[0.08679152,0.022205912,0.052520066,0.0076094423,0.8139087,0.00076997274,0.00013793427,0.0031012893,0.0021847843,0.0011157637,0.009576605,0.00007800329],"about_ca_topic_score_codex":0.0014564673,"about_ca_topic_score_gemma":0.0046748724,"teacher_disagreement_score":0.0058685145,"about_ca_system_score_codex":0.0011225652,"about_ca_system_score_gemma":0.00061323686,"threshold_uncertainty_score":0.03103602},"labels":[],"label_agreement":null},{"id":"W2154472758","doi":"10.1002/mrc.1630","title":"First example of conformational exchange in a natural taxane enolate","year":2005,"lang":"en","type":"article","venue":"Magnetic Resonance in Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Royal Military College of Canada; Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada; Cancer Research Society","keywords":"Chemistry; Taxane; Conformational isomerism; Two-dimensional nuclear magnetic resonance spectroscopy; Stereochemistry; Basis set; Ab initio; Computational chemistry; Nuclear magnetic resonance spectroscopy; Molecule; Density functional theory; Organic chemistry","score_opus":0.016073112674436063,"score_gpt":0.275596492013337,"score_spread":0.25952337933890096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154472758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878044,0.0011357256,0.0041230894,0.000088966706,0.000028983202,0.000037589343,0.00036383135,0.00005553983,0.006361852],"genre_scores_gemma":[0.9930565,0.0004695335,0.0028078842,0.000046863315,0.000004435836,0.000013093881,0.00022760351,0.00000965496,0.0033644647],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99996865,0.000005336255,0.0000012452489,0.000010504509,0.000008256555,0.000006109406],"domain_scores_gemma":[0.9999529,0.000011929823,0.000010782344,0.000009976632,0.0000054978996,0.000008991587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000470931,0.0001293191,0.000106476175,0.00009925972,0.00024577853,0.00011057649,0.00020328484,0.00016213034,0.0021585906],"category_scores_gemma":[0.00009008458,0.000058872363,0.000101150385,0.00011658001,0.00017210224,0.00016506482,0.00013890899,0.00028376025,0.0001858871],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023747153,0.000034956272,0.0006977563,0.00008422794,0.000011643853,0.00058614346,0.00011732654,0.0003358259,0.9917544,0.00071889453,0.00013334087,0.00528805],"study_design_scores_gemma":[0.00003899592,0.0008103259,0.008474635,0.000014635177,0.000024876192,0.0017704902,0.00015360946,0.0022705917,0.9636447,0.00085068465,0.021923231,0.000023260316],"about_ca_topic_score_codex":0.00068465894,"about_ca_topic_score_gemma":0.001224481,"teacher_disagreement_score":0.0021585906,"about_ca_system_score_codex":0.00013410661,"about_ca_system_score_gemma":0.00009773227,"threshold_uncertainty_score":0.0072211623},"labels":[],"label_agreement":null},{"id":"W2154812064","doi":"10.1158/1078-0432.ccr-06-1653","title":"A Phase Ib and Pharmacokinetic Trial of Patupilone Combined with Carboplatin in Patients with Advanced Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Carboplatin; Tolerability; Nausea; Pharmacokinetics; Vomiting; Adverse effect; Phases of clinical research; Area under the curve; Neutropenia; Internal medicine; Urology; Chemotherapy; Oncology; Gastroenterology; Pharmacology; Surgery; Cisplatin","score_opus":0.14233468841941216,"score_gpt":0.5699323937793035,"score_spread":0.42759770535989133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154812064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946642,0.001476156,0.0003067716,0.00032810064,0.000072658484,0.0012819127,0.0004118667,0.00008876227,0.0013695362],"genre_scores_gemma":[0.9947359,0.0009787242,0.0008035788,0.00035470678,0.000101719146,0.0008590329,0.0010712014,0.000019047338,0.0010760304],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99968123,0.00012747446,0.000020072293,0.000065755165,0.000030965304,0.00007448997],"domain_scores_gemma":[0.99943095,0.000059133275,0.00011342782,0.000039888593,0.00002643348,0.00033015784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008469264,0.0014662482,0.0017396061,0.0004835164,0.00039168686,0.0010090495,0.0008749077,0.0010625847,0.0034276294],"category_scores_gemma":[0.000623306,0.00047527882,0.000902356,0.0006439224,0.00089684146,0.00085764856,0.0003565389,0.0034710122,0.0007025265],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73550886,0.07042591,0.008622792,0.00086084247,0.0012645024,0.0004745356,0.00033833706,0.0035906788,0.057266362,0.00028300003,0.0036114713,0.11775262],"study_design_scores_gemma":[0.48931506,0.48701823,0.011682305,0.000040521092,0.00040514197,0.00048233816,0.000059399008,0.0016568308,0.0068161795,0.00012981164,0.0023660418,0.000028080456],"about_ca_topic_score_codex":0.0009420028,"about_ca_topic_score_gemma":0.0017823431,"teacher_disagreement_score":0.0034276294,"about_ca_system_score_codex":0.0011223,"about_ca_system_score_gemma":0.0014648031,"threshold_uncertainty_score":0.011466563},"labels":[],"label_agreement":null},{"id":"W2155388118","doi":"10.1158/0008-5472.can-07-6381","title":"Genetic Variants Contributing to Daunorubicin-Induced Cytotoxicity","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences; National Institutes of Health","keywords":"Daunorubicin; Biology; International HapMap Project; Cytotoxicity; Genotype; Gene; Genetics; Gene expression; Single-nucleotide polymorphism; Molecular biology; In vitro; Leukemia","score_opus":0.1930223636851178,"score_gpt":0.4814117945314891,"score_spread":0.28838943084637125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155388118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985781,0.0001547857,0.0007155173,0.000020525482,0.0000017953603,0.000009361231,0.00035946694,0.000011537835,0.00014899328],"genre_scores_gemma":[0.99892116,0.00008402048,0.00042011024,0.000011302165,0.0000024401097,0.0000117095215,0.00042063586,0.000006225502,0.00012252593],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972695,0.00008867653,0.000025100155,0.00009399762,0.000036132744,0.000029105919],"domain_scores_gemma":[0.9997379,0.00011492631,0.00007913722,0.00003771947,0.000010528479,0.00001981291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032907707,0.00040236133,0.00040290502,0.00032889674,0.0001959656,0.00034743754,0.00017461224,0.00030271497,0.0013393736],"category_scores_gemma":[0.00065302657,0.00019435192,0.00043119807,0.000587263,0.0002518597,0.00007092993,0.0002458214,0.00029649088,0.00015293287],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040260344,0.00019672108,0.7198021,0.00008459827,0.00087672606,0.0017350769,0.0002791755,0.012656542,0.23934175,0.00096177176,0.00045189203,0.019587684],"study_design_scores_gemma":[0.00013046154,0.00034977472,0.97185755,0.000010869167,0.00030728764,0.0011905681,0.00006524692,0.014192293,0.010328535,0.0007005192,0.00084761006,0.000019305722],"about_ca_topic_score_codex":0.0026677002,"about_ca_topic_score_gemma":0.002905174,"teacher_disagreement_score":0.0026677002,"about_ca_system_score_codex":0.00023303385,"about_ca_system_score_gemma":0.00015760434,"threshold_uncertainty_score":0.005304396},"labels":[],"label_agreement":null},{"id":"W2157717971","doi":"10.1093/annonc/mdp328","title":"N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial","year":2009,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Docetaxel; Irinotecan; Metastatic breast cancer; Internal medicine; Regimen; Taxane; Neutropenia; Breast cancer; Oncology; Febrile neutropenia; Cancer; Response Evaluation Criteria in Solid Tumors; Chemotherapy; Surgery; Phases of clinical research; Colorectal cancer","score_opus":0.09833561280837098,"score_gpt":0.44932290861313745,"score_spread":0.35098729580476645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157717971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977785,0.0043210303,0.00048398945,0.0028374733,0.00052958704,0.0020269998,0.002362591,0.00026600927,0.009387504],"genre_scores_gemma":[0.9587291,0.0036756233,0.0026342717,0.0034296375,0.00035573708,0.002769173,0.0045625847,0.00012995373,0.023713883],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996458,0.00018298606,0.000009668595,0.00006017075,0.00003276648,0.00006860623],"domain_scores_gemma":[0.99945134,0.000067458896,0.00008187913,0.000045587898,0.000028528777,0.00032528464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001405215,0.001372689,0.0019578917,0.00036591012,0.0004856449,0.00084743055,0.00089611666,0.0010758754,0.010167905],"category_scores_gemma":[0.0009800354,0.00051962,0.0012754065,0.00043229945,0.0009731946,0.00087875215,0.00043163338,0.003127987,0.0021129698],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7822222,0.021489047,0.0038011952,0.00091051497,0.0014465157,0.0002640522,0.00029086377,0.0027317847,0.014039357,0.0008558233,0.03029895,0.14164966],"study_design_scores_gemma":[0.88028145,0.10079322,0.00902769,0.00006361815,0.0003960618,0.0003101709,0.00006782096,0.0012516493,0.0007436946,0.0005433153,0.006488148,0.000033135006],"about_ca_topic_score_codex":0.0038737105,"about_ca_topic_score_gemma":0.019677848,"teacher_disagreement_score":0.010167905,"about_ca_system_score_codex":0.0015206127,"about_ca_system_score_gemma":0.002236167,"threshold_uncertainty_score":0.034015},"labels":[],"label_agreement":null},{"id":"W2158133583","doi":"10.3747/co.20.1202","title":"Clinical Outcomes of Women with Metastatic Breast Cancer Treated with Nab-Paclitaxel: Experience from a Single Academic Cancer Centre","year":2013,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Breast cancer; Taxane; Paclitaxel; Internal medicine; Metastatic breast cancer; Cancer; Chemotherapy; Oncology; Dosing","score_opus":0.1344135311198215,"score_gpt":0.4759498440927138,"score_spread":0.34153631297289233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158133583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99722123,0.0011386743,0.00008047849,0.00025863157,0.000007859715,0.000037206788,0.00018567537,0.000009144545,0.001061064],"genre_scores_gemma":[0.99807453,0.0009608132,0.00022271376,0.00012092028,0.000020706088,0.000021403339,0.00024399515,0.000008552215,0.00032618784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948823,0.00013859561,0.000044350996,0.0000781085,0.00012595108,0.00012481275],"domain_scores_gemma":[0.9987853,0.00017538689,0.00036981373,0.000046139576,0.00021257586,0.00041081887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056515477,0.00020331683,0.00029255054,0.00039454649,0.00075919944,0.0006119635,0.00042084412,0.00023230999,0.0016154958],"category_scores_gemma":[0.0020966239,0.00018366371,0.00020775726,0.0010728064,0.00038436023,0.00024256932,0.0006109492,0.00029528124,0.00030697766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009701044,0.0003435085,0.94759643,0.00011295551,0.00008818226,0.0021645874,0.0020780049,0.0002848454,0.0014391139,0.00005199445,0.0017736221,0.043096665],"study_design_scores_gemma":[0.00016340963,0.0017335155,0.9820624,0.000057193007,0.00010023537,0.006452359,0.0037211622,0.0003376359,0.00071337336,0.00004667779,0.0045860996,0.00002575959],"about_ca_topic_score_codex":0.018749846,"about_ca_topic_score_gemma":0.028789788,"teacher_disagreement_score":0.018749846,"about_ca_system_score_codex":0.0022139698,"about_ca_system_score_gemma":0.0014907697,"threshold_uncertainty_score":0.037281394},"labels":[],"label_agreement":null},{"id":"W2158353647","doi":"10.1158/0008-5472.can-08-1753","title":"Translymphatic Chemotherapy by Intrapleural Placement of Gelatin Sponge Containing Biodegradable Paclitaxel Colloids Controls Lymphatic Metastasis in Lung Cancer","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Toronto","funders":"","keywords":"Paclitaxel; PLGA; Lymphatic system; Pharmacokinetics; Lymph; Medicine; Lymph node; Lung cancer; Metastasis; Chemotherapy; Pharmacology; Cancer; Urology; Pathology; Surgery; Internal medicine; Chemistry; In vitro","score_opus":0.05950563420338142,"score_gpt":0.4371428807677152,"score_spread":0.3776372465643338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158353647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99714017,0.0009094163,0.0012048923,0.000042137974,0.00001858673,0.000037716512,0.00003895446,0.0000791372,0.0005290364],"genre_scores_gemma":[0.9977629,0.0004302673,0.0010304335,0.000012226564,0.0000084447365,0.00003081571,0.000062279076,0.000018093573,0.00064458384],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999918,0.000022430613,0.0000056079843,0.000014811004,0.000016170654,0.000022972747],"domain_scores_gemma":[0.999889,0.00002200431,0.000039853894,0.000012511018,0.000008273948,0.000028419969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011574969,0.0002782715,0.00026205738,0.0001744327,0.00009469106,0.00020549694,0.00016312992,0.0001738459,0.0007361938],"category_scores_gemma":[0.00017782736,0.00013996534,0.00015499434,0.00009811081,0.0002640545,0.00022175699,0.00012638886,0.00028804128,0.0002562516],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035658976,0.00007672958,0.0001347196,0.000028119279,0.0000031526608,0.00004133684,0.000011023562,0.000097602875,0.9967194,0.000018474624,0.000029315817,0.002483477],"study_design_scores_gemma":[0.00013484318,0.005313256,0.0038134237,0.0000057091047,0.000029625155,0.00035106722,0.000026552802,0.0017782613,0.9871551,0.000021798249,0.001361408,0.000008925284],"about_ca_topic_score_codex":0.000582232,"about_ca_topic_score_gemma":0.0009051554,"teacher_disagreement_score":0.0007361938,"about_ca_system_score_codex":0.00020277165,"about_ca_system_score_gemma":0.00021364827,"threshold_uncertainty_score":0.002462864},"labels":[],"label_agreement":null},{"id":"W2158925468","doi":"10.1634/theoncologist.2009-0219","title":"Commentary: Anthracyclines in Early-Stage Breast Cancer: Is It the End of an Era?","year":2009,"lang":"en","type":"letter","venue":"The Oncologist","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Stage (stratigraphy); Cancer; Oncology; Adjuvant; Adjuvant chemotherapy; Internal medicine","score_opus":0.04782780240256192,"score_gpt":0.3933731187100704,"score_spread":0.3455453163075085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158925468","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023428258,0.0008283122,0.000040135146,0.98333156,0.014051017,0.000009510213,0.00004308247,0.000014819715,0.0014473492],"genre_scores_gemma":[0.0016297345,0.00068312825,0.00012887042,0.97547036,0.018385584,0.000019080162,0.000019246652,0.00001243333,0.0036514904],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99625444,0.0013106404,0.00039237383,0.0004660941,0.0011739343,0.0004024204],"domain_scores_gemma":[0.9906557,0.0056543127,0.0006192858,0.00016313502,0.0018848033,0.0010228103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003454349,0.00089696026,0.0018133991,0.0006512285,0.004613985,0.002701066,0.0028615422,0.073099814,0.0066272984],"category_scores_gemma":[0.02128607,0.00086353254,0.0014245632,0.00094788265,0.0022727696,0.004005782,0.0012057555,0.04941558,0.007253277],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000742172,0.00002550589,0.00024665403,0.000046063924,0.000009983003,0.0009768059,0.000077544915,0.000047803664,0.000109990324,0.0009719205,0.99385625,0.0035571281],"study_design_scores_gemma":[0.00028988003,0.00015975417,0.0014648715,0.0005129218,0.00005755913,0.0031394674,0.00048750534,0.00064937974,0.00036181102,0.007780519,0.9850087,0.000087623346],"about_ca_topic_score_codex":0.011049116,"about_ca_topic_score_gemma":0.019019691,"teacher_disagreement_score":0.073099814,"about_ca_system_score_codex":0.005220752,"about_ca_system_score_gemma":0.006383392,"threshold_uncertainty_score":0.037879407},"labels":[],"label_agreement":null},{"id":"W2160028800","doi":"10.4081/oncol.2014.255","title":"RETRACTION: Challenges of combined everolimus/endocrine therapy in hormone receptor-positive metastatic breast cancer","year":2014,"lang":"en","type":"article","venue":"Oncology Reviews","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Audience measurement; Breast cancer; Clinical Oncology; Oncology; Editorial board; Internal medicine; Metastatic breast cancer; Plagiarism detection; Cancer; Medical education; Library science; Computer science","score_opus":0.06968587968049916,"score_gpt":0.39936712464648183,"score_spread":0.32968124496598267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160028800","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042739217,0.007244418,0.00058476994,0.43894827,0.55061334,0.000037383626,0.00011209276,0.00013475979,0.0018975895],"genre_scores_gemma":[0.007377805,0.01553033,0.0014746571,0.28156447,0.66563356,0.000105762934,0.00014701327,0.00020848004,0.027957894],"study_design_codex":"not_applicable","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9912367,0.0016121435,0.0016370922,0.00066591735,0.004249539,0.0005986827],"domain_scores_gemma":[0.9582516,0.015171387,0.0042834245,0.0011844392,0.018291071,0.002818204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007612704,0.0015195141,0.0015701012,0.0013923111,0.0021619506,0.0044304007,0.002721631,0.014070604,0.010209219],"category_scores_gemma":[0.11281227,0.00063033955,0.0021947497,0.0009982511,0.0028611298,0.0036566833,0.001747795,0.021396875,0.009464791],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020728605,0.0000066218045,0.000089899724,0.00019660618,0.000016050593,0.00039334237,0.00009045795,0.000028162469,0.00010866845,0.0006914578,0.9894462,0.008911842],"study_design_scores_gemma":[0.000029734405,0.0000531001,0.00049392105,0.0006124948,0.000058281134,0.0021095139,0.00020564537,0.00016759621,0.0003959447,0.0011985361,0.994643,0.00003225863],"about_ca_topic_score_codex":0.0021890972,"about_ca_topic_score_gemma":0.0024012101,"teacher_disagreement_score":0.014070604,"about_ca_system_score_codex":0.0035034867,"about_ca_system_score_gemma":0.0057531805,"threshold_uncertainty_score":0.040260315},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["research_integrity"],"domain":null,"study_design":"not_applicable","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W2160250214","doi":"10.4081/hpr.2013.e28","title":"Ten weeks of home-based exercise attenuates symptoms of chemotherapy-induced peripheral neuropathy in breast cancer patients","year":2013,"lang":"en","type":"article","venue":"Health psychology research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Quality of life (healthcare); Peripheral neuropathy; Physical therapy; Chemotherapy-induced peripheral neuropathy; Cancer; Chemotherapy; Analysis of variance; Internal medicine","score_opus":0.06070954127193492,"score_gpt":0.46254278573638935,"score_spread":0.40183324446445445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160250214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994267,0.00020482723,0.000025576059,0.000020885482,0.0000064552964,0.000018982186,0.000010844632,0.0000043424866,0.00028136122],"genre_scores_gemma":[0.9989372,0.00023258387,0.00012402414,0.000055682365,0.0000127922585,0.00003325996,0.000045132278,9.028525e-7,0.00055853196],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9999455,0.000022956383,0.0000029449534,0.000006211037,0.00000724879,0.0000150312635],"domain_scores_gemma":[0.9998945,0.000023159115,0.000026013646,0.0000055442165,0.000009426371,0.00004136042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013656153,0.00015602178,0.00025773793,0.0000859758,0.00013824749,0.00010617666,0.00010382263,0.00015112723,0.0014233685],"category_scores_gemma":[0.00039519297,0.00006840082,0.00010437046,0.00006974981,0.000063342115,0.000075683514,0.00010832336,0.00024437814,0.00011661804],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0656487,0.10061246,0.17748764,0.0009057174,0.00057704496,0.00046703973,0.0008461164,0.0017058288,0.07633895,0.000057631543,0.0019069084,0.57344604],"study_design_scores_gemma":[0.0022323097,0.117142245,0.87498426,0.00005983044,0.00017400023,0.00017078422,0.00031979318,0.0006041093,0.0029516679,0.000042131636,0.0013086884,0.000010057889],"about_ca_topic_score_codex":0.00077908766,"about_ca_topic_score_gemma":0.00267649,"teacher_disagreement_score":0.0014233685,"about_ca_system_score_codex":0.00007772088,"about_ca_system_score_gemma":0.00013615703,"threshold_uncertainty_score":0.0047616363},"labels":[],"label_agreement":null},{"id":"W2160719528","doi":"10.1200/jco.2009.24.0143","title":"Phase I/II Trial of Metronomic Chemotherapy With Daily Dalteparin and Cyclophosphamide, Twice-Weekly Methotrexate, and Daily Prednisone As Therapy for Metastatic Breast Cancer Using Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor Levels As Markers of Response","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Clinical Oncology Group; University of Toronto; Sunnybrook Health Science Centre","funders":"Pfizer","keywords":"Medicine; Cyclophosphamide; Internal medicine; Metastatic breast cancer; Prednisone; Vascular endothelial growth factor; Chemotherapy; Gastroenterology; Clinical endpoint; Breast cancer; Phases of clinical research; Oncology; Progressive disease; Methotrexate; Cancer; Surgery; Clinical trial","score_opus":0.08840411151474677,"score_gpt":0.4399860116120404,"score_spread":0.3515819000972936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160719528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875723,0.0021616102,0.00091048115,0.0006691216,0.00020838862,0.005490791,0.0006734966,0.00015891789,0.0021548332],"genre_scores_gemma":[0.98097426,0.0013095629,0.0030774763,0.0013993932,0.00026315445,0.008090352,0.0017858291,0.000029664734,0.0030702457],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999534,0.00024756519,0.000023400105,0.000078657176,0.000036212245,0.000080263184],"domain_scores_gemma":[0.99911004,0.00011626165,0.00019863078,0.00007362591,0.00003597876,0.00046537048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013465027,0.0017107006,0.0021290518,0.00048451946,0.00044503852,0.00076812785,0.00091379404,0.0013701989,0.002565262],"category_scores_gemma":[0.0008994811,0.0005623585,0.0006974739,0.00044873095,0.0013639599,0.00064922404,0.00032798646,0.0022396105,0.00057226693],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8382556,0.05488527,0.0056915544,0.0004937472,0.00057583535,0.00018963625,0.00019157687,0.0023029307,0.03154421,0.00046569147,0.002758878,0.06264507],"study_design_scores_gemma":[0.65202284,0.33668312,0.004446286,0.000022614375,0.00018644464,0.00019685643,0.00003251877,0.0012851369,0.0031372113,0.00020240422,0.0017680402,0.000016373186],"about_ca_topic_score_codex":0.00051232625,"about_ca_topic_score_gemma":0.0011293143,"teacher_disagreement_score":0.002565262,"about_ca_system_score_codex":0.0008220107,"about_ca_system_score_gemma":0.0012564971,"threshold_uncertainty_score":0.008581638},"labels":[],"label_agreement":null},{"id":"W2161255937","doi":"","title":"Efficacy of S-1 in patients with capecitabine-resistant breast cancer-Japan Breast Cancer Research Network (JBCRN) 04-1 trial.","year":2010,"lang":"en","type":"article","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Capecitabine; Breast cancer; Internal medicine; Nausea; Metastatic breast cancer; Vomiting; Adverse effect; Oncology; Cancer; Population; Surgery","score_opus":0.02927711627484918,"score_gpt":0.3232388542011592,"score_spread":0.29396173792631003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161255937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97602284,0.017831452,0.00019804676,0.0008806461,0.00018375994,0.0011515032,0.0009305141,0.00004726403,0.002753891],"genre_scores_gemma":[0.9833341,0.007688578,0.00086962216,0.00093346497,0.00024433213,0.0012466245,0.002429341,0.000012885944,0.0032410373],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997876,0.0001282596,0.000012581345,0.000023595469,0.00001800813,0.000029927847],"domain_scores_gemma":[0.9997626,0.000037390182,0.00008728219,0.000012990326,0.00001611537,0.000083645355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007448356,0.0005422687,0.001086529,0.00027606104,0.00021411956,0.00038850124,0.0004584007,0.0006033746,0.0020459557],"category_scores_gemma":[0.0005516659,0.00017853854,0.00080115086,0.00028415307,0.00029584905,0.00031103278,0.00017803926,0.0008979792,0.00026890426],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78628117,0.009703767,0.01658464,0.0046649184,0.0024618628,0.0003644026,0.00014470144,0.0016441378,0.011677248,0.00025364355,0.0073871207,0.15883236],"study_design_scores_gemma":[0.79991347,0.14193925,0.04451988,0.0002948128,0.002360379,0.00047758242,0.00006600547,0.0015807201,0.0017957047,0.00018294627,0.0068400544,0.00002926543],"about_ca_topic_score_codex":0.0013544823,"about_ca_topic_score_gemma":0.0061772503,"teacher_disagreement_score":0.0020459557,"about_ca_system_score_codex":0.0006827459,"about_ca_system_score_gemma":0.000990322,"threshold_uncertainty_score":0.0068444014},"labels":[],"label_agreement":null},{"id":"W2162143119","doi":"","title":"Unusual Isomerisation of Cubebene","year":2006,"lang":"es","type":"article","venue":"Redalyc (Universidad Autónoma del Estado de México)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Environment and Climate Change Canada; Université de Moncton","funders":"","keywords":"Chemistry; Isomerization; Methanol; Extraction (chemistry); Chromatography; Microwave irradiation; Solvent; Mass spectrometry; Nuclear chemistry; Organic chemistry","score_opus":0.014694691744423342,"score_gpt":0.2722792719765884,"score_spread":0.2575845802321651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162143119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883774,0.00083135464,0.004119305,0.000075328426,0.000034739733,0.000031928324,0.0005852036,0.00004075917,0.0059040547],"genre_scores_gemma":[0.9895028,0.000550388,0.0030413726,0.00008569493,0.000012311628,0.000023686223,0.00090243574,0.000022570706,0.005858736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995065,0.0000069306006,0.0000018246113,0.000016428785,0.000011140257,0.000013153211],"domain_scores_gemma":[0.9999336,0.000017709559,0.000014844975,0.000011139218,0.0000105482095,0.00001212016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060165552,0.000244288,0.00008326093,0.00022855155,0.00016183396,0.00015812683,0.0001310769,0.00015804647,0.003852475],"category_scores_gemma":[0.00012015045,0.000107368614,0.00014337248,0.00016785027,0.00017930745,0.00026914076,0.00021702815,0.00037020692,0.00040272682],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014858138,0.0000075492344,0.00026182653,0.000030386589,0.000007037143,0.00018798056,0.00005860085,0.00008120117,0.9962089,0.00042784848,0.00004703235,0.002533152],"study_design_scores_gemma":[0.0000066177136,0.0000906641,0.004297738,0.0000043270834,0.0000073218725,0.00039088848,0.000040129293,0.0001961945,0.9907577,0.00022474662,0.003977234,0.000006356271],"about_ca_topic_score_codex":0.00045542856,"about_ca_topic_score_gemma":0.00090201857,"teacher_disagreement_score":0.003852475,"about_ca_system_score_codex":0.00016007821,"about_ca_system_score_gemma":0.00016898596,"threshold_uncertainty_score":0.0128878355},"labels":[],"label_agreement":null},{"id":"W2162200636","doi":"10.1634/theoncologist.2013-0160","title":"Bevacizumab for Advanced Breast Cancer: Hope, Hype, and Hundreds of Headlines","year":2013,"lang":"en","type":"article","venue":"The Oncologist","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; Queen's University; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Bevacizumab; Breast cancer; Newspaper; Headline; Food and drug administration; Family medicine; Clinical trial; Metastatic breast cancer; Cancer; Oncology; Internal medicine; Advertising; Pharmacology; Chemotherapy","score_opus":0.024574839051825687,"score_gpt":0.35788425867525075,"score_spread":0.3333094196234251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162200636","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90195507,0.052045252,0.0024413997,0.016026933,0.0010772141,0.00040688136,0.003794087,0.00015477726,0.0220983],"genre_scores_gemma":[0.9619662,0.02339649,0.0034002245,0.0043555507,0.002028538,0.00027698345,0.0018220366,0.00008091116,0.0026730737],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9904947,0.0037129913,0.0018651424,0.0005059803,0.003110037,0.00031112487],"domain_scores_gemma":[0.84493315,0.087837435,0.05383379,0.0022824388,0.009270593,0.0018425866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010894053,0.00031802442,0.0003695488,0.010545203,0.0010404577,0.0043358845,0.0003517359,0.0005319785,0.0021555403],"category_scores_gemma":[0.04905777,0.00032942646,0.000398808,0.0100311,0.0017623889,0.0035896094,0.0015983118,0.0005717556,0.00052459206],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093986065,0.00012282573,0.520532,0.009190016,0.00044717154,0.0020602373,0.08555444,0.000083105515,0.0047280733,0.003698321,0.034960955,0.337683],"study_design_scores_gemma":[0.000035271747,0.0003060378,0.7596288,0.005754208,0.00041843354,0.0040718936,0.09865356,0.00031127653,0.0016265438,0.0015251584,0.12756509,0.000103728366],"about_ca_topic_score_codex":0.0012583997,"about_ca_topic_score_gemma":0.003296736,"teacher_disagreement_score":0.010894053,"about_ca_system_score_codex":0.0011935658,"about_ca_system_score_gemma":0.0010668458,"threshold_uncertainty_score":0.05761391},"labels":[],"label_agreement":null},{"id":"W2165283639","doi":"10.3747/co.v15i5.285","title":"Vera Peters and the Curability of Hodgkin Disease","year":2008,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Disease; Radiation therapy; Cure rate; Surgery; Internal medicine","score_opus":0.15817710254977507,"score_gpt":0.4499870116427799,"score_spread":0.2918099090930048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165283639","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.046307728,0.6639096,0.0013332721,0.19802326,0.013231909,0.000025533333,0.00006357498,0.000091698,0.0770134],"genre_scores_gemma":[0.5153951,0.39520913,0.0012008593,0.035720035,0.015027228,0.000023122568,0.00005257362,0.000039948096,0.03733195],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975544,0.0000977127,0.0000141190385,0.000035928704,0.000064082284,0.00003275451],"domain_scores_gemma":[0.9995516,0.00026175226,0.00005956567,0.00001887458,0.000044678156,0.000063490406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052069617,0.0001516437,0.00021099468,0.000429231,0.00048739207,0.0011974871,0.00020713283,0.0011342382,0.0016590212],"category_scores_gemma":[0.0014599388,0.000109913984,0.00012190868,0.00023441995,0.0015782334,0.001039678,0.00070287,0.0030323495,0.000393051],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007974712,0.00028233297,0.003217041,0.00091845647,0.00005793778,0.003996977,0.0012546451,0.00078018813,0.013532517,0.27728617,0.15362081,0.5442555],"study_design_scores_gemma":[0.000045999783,0.0003215829,0.0025633704,0.0003006063,0.000024374214,0.0042325486,0.00025289122,0.000354401,0.003112351,0.05734335,0.93141454,0.00003386485],"about_ca_topic_score_codex":0.00082413614,"about_ca_topic_score_gemma":0.00123892,"teacher_disagreement_score":0.0016590212,"about_ca_system_score_codex":0.00055499247,"about_ca_system_score_gemma":0.000510024,"threshold_uncertainty_score":0.005550027},"labels":[],"label_agreement":null},{"id":"W2165819904","doi":"10.1002/cncr.22867","title":"The impact of new chemotherapeutic and hormone agents on survival in a population‐based cohort of women with metastatic breast cancer","year":2007,"lang":"en","type":"article","venue":"Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":464,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Sanofi; Pfizer; Amgen","keywords":"Medicine; Cohort; Metastatic breast cancer; Breast cancer; Internal medicine; Proportional hazards model; Population; Oncology; Cancer; Cohort study; Survival analysis","score_opus":0.03273867528746455,"score_gpt":0.38064044840896855,"score_spread":0.347901773121504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165819904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99933976,0.00012653285,0.00003097546,0.00005120406,0.0000029426865,0.000004747822,0.0002476788,0.0000016500081,0.00019444928],"genre_scores_gemma":[0.9994716,0.00007937392,0.000027602224,0.00002119586,0.0000053968183,0.0000058964624,0.00030922386,0.0000011407672,0.000078662015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995208,0.0001182743,0.00003236309,0.00011093764,0.00009941114,0.0001182071],"domain_scores_gemma":[0.99838996,0.0003505928,0.0005916203,0.00013402401,0.00021028626,0.00032356405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007885709,0.00017290955,0.00026129966,0.00067841704,0.00047167455,0.00067867734,0.0003421913,0.0004112437,0.0011195291],"category_scores_gemma":[0.0032186205,0.00019393484,0.00038659855,0.00081131526,0.00028658344,0.00040381725,0.0004441841,0.0006268603,0.00017225412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001317007,0.000019447189,0.99887425,0.0000020287152,0.000034435,0.00004030385,0.000036633923,0.00004236798,0.00009310716,0.0000066590105,0.00005582768,0.00066320505],"study_design_scores_gemma":[0.0000073480187,0.0000910725,0.9992787,0.0000018603274,0.000020931198,0.00014847645,0.00009621688,0.00018906724,0.00002367129,0.000013240795,0.00012668232,0.0000027807575],"about_ca_topic_score_codex":0.027275119,"about_ca_topic_score_gemma":0.025088206,"teacher_disagreement_score":0.027275119,"about_ca_system_score_codex":0.0007028774,"about_ca_system_score_gemma":0.0006423775,"threshold_uncertainty_score":0.054232717},"labels":[],"label_agreement":null},{"id":"W2166839079","doi":"10.1016/j.jval.2012.08.1244","title":"PCN51 Comprehensive Investigation of Adverse Event (AE)-Related Costs in Patients With Metastatic Breast Cancer (mBC) Treated With First- and Second-Line Chemotherapies","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Capecitabine; Taxane; Medicine; Internal medicine; Docetaxel; Oncology; Pharmacy; Metastatic breast cancer; Adverse effect; Cancer; Breast cancer; Colorectal cancer","score_opus":0.027592431451381228,"score_gpt":0.30222845176798424,"score_spread":0.274636020316603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166839079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949384,0.0016646181,0.00009104668,0.00010910118,0.000006376874,0.00008445912,0.0013926104,0.0000048462393,0.0017085244],"genre_scores_gemma":[0.9976712,0.0005562959,0.00022885448,0.000057970185,0.000015072307,0.00004401055,0.0011001013,0.0000013993129,0.00032498813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945825,0.00019632142,0.000070949885,0.00005608532,0.00015137189,0.00006709813],"domain_scores_gemma":[0.99821067,0.00041732917,0.00093099853,0.00005671891,0.00019148934,0.00019278958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067164196,0.00021896615,0.0005428112,0.00071443303,0.00021438819,0.00034149567,0.0002565418,0.0002506502,0.0013570854],"category_scores_gemma":[0.0023995303,0.00012295062,0.00074918615,0.0012475871,0.00011316184,0.00036287465,0.0002803411,0.0004547832,0.00011142717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008261845,0.00034233832,0.95737743,0.00014584037,0.0006101959,0.00011315808,0.000035294048,0.00077055366,0.00046073511,0.000064014115,0.00053075294,0.031287998],"study_design_scores_gemma":[0.00019407475,0.0020482014,0.9959331,0.000018302877,0.00023104958,0.00019719453,0.000028970007,0.0006497743,0.0001514038,0.000037201637,0.0005042526,0.0000065142403],"about_ca_topic_score_codex":0.004817663,"about_ca_topic_score_gemma":0.01119332,"teacher_disagreement_score":0.004817663,"about_ca_system_score_codex":0.0008964336,"about_ca_system_score_gemma":0.00073549786,"threshold_uncertainty_score":0.009579241},"labels":[],"label_agreement":null},{"id":"W2167714668","doi":"10.1002/chin.200344277","title":"Synthetic Studies Related to CP‐225,917","year":2003,"lang":"en","type":"article","venue":"ChemInform","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chemistry; Combinatorial chemistry","score_opus":0.033175939345156016,"score_gpt":0.35929669059900743,"score_spread":0.3261207512538514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167714668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.768125,0.008853799,0.022402383,0.0013089973,0.00069052033,0.0010501661,0.0035283722,0.00038689625,0.19365382],"genre_scores_gemma":[0.96454275,0.0066198665,0.006271525,0.00047068094,0.00010141487,0.00016255691,0.0016217917,0.00008963215,0.020119714],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999724,0.00008077886,0.000018908882,0.000046790556,0.000049190556,0.000080303405],"domain_scores_gemma":[0.9998591,0.000030104295,0.000023376795,0.00002539316,0.000025098254,0.00003691883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004940948,0.0005852632,0.00036523573,0.00050617545,0.0005868406,0.00044596705,0.0009448702,0.0005061149,0.0065047746],"category_scores_gemma":[0.0004925724,0.00018333511,0.0004956323,0.00041069524,0.00047502588,0.0004633726,0.0003671994,0.0008396163,0.0021657764],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030636254,0.002043849,0.0005950181,0.0025122934,0.00017581147,0.0030461003,0.00065093656,0.0067309802,0.8811067,0.018244933,0.007172341,0.07465744],"study_design_scores_gemma":[0.00033518588,0.00686188,0.0013130755,0.0000911004,0.0001660145,0.0013649622,0.00026600462,0.0015630962,0.93478614,0.0018340223,0.05133877,0.00007966679],"about_ca_topic_score_codex":0.0022101179,"about_ca_topic_score_gemma":0.0015464525,"teacher_disagreement_score":0.0065047746,"about_ca_system_score_codex":0.0004439623,"about_ca_system_score_gemma":0.0007154196,"threshold_uncertainty_score":0.021760643},"labels":[],"label_agreement":null},{"id":"W2167856990","doi":"10.1145/2608628.2608666","title":"Quantifier elimination by cylindrical algebraic decomposition based on regular chains","year":2014,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Natural Science Foundation of China","keywords":"Quantifier elimination; Decomposition; Algebraic number; Quantifier (linguistics); Mathematics; Algebra over a field; Computer science; Discrete mathematics; Pure mathematics; Artificial intelligence; Mathematical analysis; Chemistry","score_opus":0.01181799080922886,"score_gpt":0.3242395777388102,"score_spread":0.31242158692958133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167856990","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010902421,0.00005768378,0.9856537,0.00005314282,0.000019148225,0.00004694894,0.000098039796,0.0016857695,0.0014831823],"genre_scores_gemma":[0.10929075,0.00011211489,0.88680214,0.00007248711,0.000025798205,0.00006274122,0.0005316929,0.0005927366,0.002509624],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99901617,0.00015987891,0.00006926782,0.00019707534,0.00039693434,0.00016060188],"domain_scores_gemma":[0.998754,0.00042997304,0.00009716195,0.00024695197,0.00040272472,0.00006908276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011715378,0.0007200121,0.00080805895,0.0015193722,0.0006818505,0.0013758366,0.0008735924,0.00035768072,0.0055094752],"category_scores_gemma":[0.0030163873,0.00048489159,0.001370967,0.001164854,0.001178273,0.0020174216,0.001933029,0.0012975606,0.0020833514],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041599933,0.0001307499,0.0015071146,0.00044420653,0.00008352494,0.00051982637,0.00045753337,0.058414232,0.068896145,0.40671468,0.007714043,0.4547019],"study_design_scores_gemma":[0.00011989145,0.00019683722,0.0006265457,0.0001197816,0.000083761835,0.00055695977,0.00013017394,0.45372415,0.071379185,0.4361424,0.036809053,0.0001112387],"about_ca_topic_score_codex":0.002179908,"about_ca_topic_score_gemma":0.003064831,"teacher_disagreement_score":0.0055094752,"about_ca_system_score_codex":0.000609248,"about_ca_system_score_gemma":0.0011010314,"threshold_uncertainty_score":0.018431008},"labels":[],"label_agreement":null},{"id":"W2168503278","doi":"10.1080/07357900601063766","title":"A Systematic Review on Drug Interactions in Oncology","year":2006,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Drug; Oncology; Clinical Oncology; Internal medicine; Pharmacology; Medical physics; Cancer","score_opus":0.1370314656954665,"score_gpt":0.47981807028664536,"score_spread":0.3427866045911788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168503278","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005175901,0.99808335,0.00013148967,0.0002624961,0.00014719038,0.0002398052,0.00026142807,0.0000065638765,0.0003502083],"genre_scores_gemma":[0.0052190167,0.9923294,0.001082781,0.00044411694,0.000116286195,0.00040914986,0.00019387827,0.0000027324118,0.00020269498],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9938392,0.0025536995,0.0019339347,0.00033200206,0.001188953,0.00015225564],"domain_scores_gemma":[0.9804419,0.013412167,0.0038147888,0.00019121042,0.0018663601,0.0002736271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049847453,0.0015019809,0.0073758694,0.013113753,0.00057775,0.0015986231,0.0015173149,0.0017403723,0.00665056],"category_scores_gemma":[0.027329559,0.0008262643,0.0030971607,0.014692344,0.00060443627,0.0020317642,0.0010146091,0.000901588,0.0006046664],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016608839,0.000020374575,0.0006484484,0.9128101,0.0043154866,0.0003199191,0.000117874304,0.00013751876,0.00020570803,0.00024519317,0.0061053787,0.07490779],"study_design_scores_gemma":[0.0004225834,0.00034880012,0.0065098726,0.8643997,0.04494847,0.00147862,0.00025000636,0.00012738633,0.00025848913,0.0005340735,0.08067778,0.0000443472],"about_ca_topic_score_codex":0.0058348333,"about_ca_topic_score_gemma":0.02605068,"teacher_disagreement_score":0.013113753,"about_ca_system_score_codex":0.0026301048,"about_ca_system_score_gemma":0.010422611,"threshold_uncertainty_score":0.02636218},"labels":[],"label_agreement":null},{"id":"W2169216883","doi":"10.1158/1078-0432.ccr-06-2385","title":"Dose-Escalating and Pharmacologic Study of Oxaliplatin in Adult Cancer Patients with Impaired Hepatic Function: A National Cancer Institute Organ Dysfunction Working Group Study","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Oxaliplatin; Medicine; Bilirubin; Gastroenterology; Internal medicine; Liver function tests; Liver function; Liver transplantation; Population; Cancer; Colorectal cancer; Transplantation","score_opus":0.21210268984697117,"score_gpt":0.5243792897065563,"score_spread":0.31227659985958517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169216883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99881554,0.00026174667,0.00022657102,0.00007635365,0.000012948696,0.00024896278,0.00013980018,0.000010318039,0.00020775746],"genre_scores_gemma":[0.99720865,0.00040587026,0.0007776065,0.00035513876,0.0000586289,0.0003643312,0.0006125499,0.000005997521,0.00021121698],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99885404,0.0006315046,0.00010228101,0.00013004793,0.00014112801,0.00014100062],"domain_scores_gemma":[0.9983198,0.00023153987,0.00042409208,0.0003156868,0.00010218868,0.00060652953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002651,0.0010698962,0.0017529407,0.00028232517,0.00035472977,0.0005999357,0.00068888965,0.00064709043,0.00088002416],"category_scores_gemma":[0.0015632064,0.00041803345,0.0011143873,0.00061633653,0.0007812469,0.00049731607,0.0003686578,0.0016735068,0.00026657266],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39206257,0.11215237,0.3373158,0.00040861292,0.0032894039,0.00064637343,0.0006759805,0.0031389957,0.0547291,0.00025091268,0.0023055102,0.09302437],"study_design_scores_gemma":[0.13020614,0.47607455,0.37680337,0.000033750297,0.0010979959,0.0013255263,0.00018186113,0.0023920615,0.008338976,0.00016395343,0.0033245545,0.000057276004],"about_ca_topic_score_codex":0.00089617516,"about_ca_topic_score_gemma":0.0009987555,"teacher_disagreement_score":0.002651,"about_ca_system_score_codex":0.0009059069,"about_ca_system_score_gemma":0.0014421352,"threshold_uncertainty_score":0.014020026},"labels":[],"label_agreement":null},{"id":"W2170373770","doi":"10.1200/jco.2009.22.7504","title":"Phase II Multicenter Trial of Anthracycline Rechallenge With Pegylated Liposomal Doxorubicin Plus Cyclophosphamide for First-Line Therapy of Metastatic Breast Cancer Previously Treated With Adjuvant Anthracyclines","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne","funders":"","keywords":"Medicine; Anthracycline; Metastatic breast cancer; Tolerability; Internal medicine; Breast cancer; Regimen; Cyclophosphamide; Cardiotoxicity; Surgery; Doxorubicin; Chemotherapy; Oncology; Neutropenia; Phases of clinical research; Taxane; Cancer; Adverse effect","score_opus":0.13392950609814425,"score_gpt":0.49925669367392583,"score_spread":0.3653271875757816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170373770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938583,0.0016362559,0.0004889716,0.0005199866,0.00011928617,0.0019876736,0.00044770705,0.00007811497,0.00086368184],"genre_scores_gemma":[0.99048376,0.0012339228,0.0015022741,0.0007373428,0.0001911663,0.0023929963,0.0016642025,0.000027091382,0.0017672079],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995091,0.00026970688,0.000021984373,0.00008788878,0.00003260502,0.00007855896],"domain_scores_gemma":[0.9990639,0.00017837365,0.00022596976,0.000064237116,0.000041237403,0.00042637918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020375669,0.0014352978,0.0014121595,0.00027479872,0.0003402363,0.0007740282,0.0008385054,0.001397289,0.0030989293],"category_scores_gemma":[0.0010307555,0.00045579378,0.0008630513,0.00028931556,0.00092955277,0.000609795,0.0003160266,0.0030249662,0.000746476],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8348834,0.054797333,0.005689884,0.00060859043,0.001003844,0.0002948803,0.0002560118,0.0019184368,0.038141575,0.00019750955,0.002875496,0.05933301],"study_design_scores_gemma":[0.69318,0.2949464,0.006528578,0.000027012602,0.00022648089,0.00020416813,0.000026063104,0.00088453456,0.0027979196,0.00007593296,0.001089056,0.000013796069],"about_ca_topic_score_codex":0.00082949596,"about_ca_topic_score_gemma":0.0017514962,"teacher_disagreement_score":0.0030989293,"about_ca_system_score_codex":0.00084494584,"about_ca_system_score_gemma":0.0015262673,"threshold_uncertainty_score":0.0107758045},"labels":[],"label_agreement":null},{"id":"W2170649858","doi":"10.1093/annonc/mdm527","title":"Survival outcome and cost-effectiveness with docetaxel and paclitaxel in patients with metastatic breast cancer: a population-based evaluation","year":2007,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Docetaxel; Medicine; Paclitaxel; Oncology; Hazard ratio; Metastatic breast cancer; Internal medicine; Taxane; Breast cancer; Population; Confidence interval; Chemotherapy; Proportional hazards model; Survival analysis; Cancer","score_opus":0.11243892965338927,"score_gpt":0.48361352427535886,"score_spread":0.3711745946219696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170649858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99747306,0.0013778884,0.00010878969,0.00015650783,0.000012568749,0.000042832908,0.0004763953,0.000005018716,0.00034694595],"genre_scores_gemma":[0.99865,0.00045388454,0.00009519791,0.000054242544,0.000028785122,0.00003420591,0.00060574576,0.000001759647,0.00007615607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979613,0.0012605867,0.00013625753,0.00022828639,0.00026485344,0.00014876627],"domain_scores_gemma":[0.99598545,0.0024040323,0.00086140074,0.00014704891,0.00020547878,0.0003965568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034504905,0.00076397235,0.00172185,0.001098416,0.0004036718,0.00097090245,0.0007039037,0.001247053,0.0016045949],"category_scores_gemma":[0.007677447,0.0004036604,0.0049154735,0.0017104978,0.0006190437,0.0013685576,0.00051365676,0.0013425178,0.00015447322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20214769,0.0050027487,0.7252288,0.00059369544,0.017399313,0.00043599494,0.00021280008,0.015853276,0.0006845121,0.00038704966,0.0010606623,0.030993562],"study_design_scores_gemma":[0.017003672,0.05266849,0.89524573,0.000106723026,0.01370713,0.00092376367,0.0004940438,0.017316768,0.0004452174,0.0009246711,0.0010194763,0.00014434117],"about_ca_topic_score_codex":0.004141212,"about_ca_topic_score_gemma":0.0035534697,"teacher_disagreement_score":0.004141212,"about_ca_system_score_codex":0.0019821443,"about_ca_system_score_gemma":0.0007361436,"threshold_uncertainty_score":0.0182482},"labels":[],"label_agreement":null},{"id":"W2171244965","doi":"10.1016/j.breast.2012.03.003","title":"1st International consensus guidelines for advanced breast cancer (ABC 1)","year":2012,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":299,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Consensus conference; Breast cancer; Medical physics; Family medicine; Cancer; Internal medicine","score_opus":0.08269649930811482,"score_gpt":0.4304189945483469,"score_spread":0.34772249524023213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171244965","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003518729,0.50477266,0.037133496,0.29268205,0.04677217,0.0044085407,0.0097872475,0.0010038946,0.09992118],"genre_scores_gemma":[0.038620636,0.40511814,0.29509258,0.12212912,0.018271696,0.013524096,0.038768042,0.0006783167,0.06779732],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9821898,0.006557339,0.0050858036,0.0005804335,0.0044042915,0.0011823353],"domain_scores_gemma":[0.96674067,0.009151911,0.0058759996,0.0010022669,0.015529232,0.0016999793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019032774,0.0021381788,0.0032323587,0.008604859,0.0021015701,0.003582831,0.006064241,0.0090719275,0.008757462],"category_scores_gemma":[0.037339937,0.0010880812,0.0063926596,0.005610579,0.0016914884,0.0019889097,0.004360135,0.008948373,0.0061100265],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026189492,0.00018336767,0.0024475185,0.010958435,0.0002456142,0.0004885486,0.00032550885,0.0012849409,0.0005959436,0.009030297,0.63248646,0.34169146],"study_design_scores_gemma":[0.00020553188,0.00015325994,0.0038998858,0.0266027,0.00057705323,0.0013235694,0.00026930816,0.0004809332,0.0006290268,0.00543247,0.96037066,0.000055576147],"about_ca_topic_score_codex":0.014490806,"about_ca_topic_score_gemma":0.026150402,"teacher_disagreement_score":0.019032774,"about_ca_system_score_codex":0.0060959496,"about_ca_system_score_gemma":0.018797187,"threshold_uncertainty_score":0.10065615},"labels":[],"label_agreement":null},{"id":"W2174423882","doi":"10.1007/s10549-015-3643-5","title":"Correlation between progression-free survival and overall survival in metastatic breast cancer patients receiving anthracyclines, taxanes, or targeted therapies: a trial-level meta-analysis","year":2015,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Hazard ratio; Metastatic breast cancer; Oncology; Breast cancer; Progression-free survival; Randomized controlled trial; Clinical trial; Meta-analysis; Cancer; Overall survival; Confidence interval","score_opus":0.3655082059876479,"score_gpt":0.5081216217604009,"score_spread":0.142613415772753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2174423882","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034265578,0.96110266,0.0019266657,0.00033781896,0.00039992316,0.00013146929,0.0011467932,0.00006549657,0.0006236797],"genre_scores_gemma":[0.71061844,0.2799935,0.0033587185,0.0015768982,0.0005292788,0.0003622997,0.002040615,0.000095290045,0.001425005],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99597436,0.0021864194,0.0007715274,0.0006197491,0.00028323242,0.00016472692],"domain_scores_gemma":[0.9941532,0.004120308,0.0008310925,0.0004288483,0.00032850177,0.00013795578],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0062050372,0.0022002638,0.008922909,0.0011326623,0.000364239,0.0017541911,0.0015729832,0.001561009,0.0035945894],"category_scores_gemma":[0.012986531,0.0010750362,0.030140245,0.0022906633,0.00042767794,0.0011852336,0.0010844463,0.0027501436,0.000381928],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00782719,0.000035626294,0.010435451,0.033915374,0.9369609,0.00007167797,0.000041362746,0.0007169667,0.0002849235,0.000118640084,0.0006446995,0.0089471685],"study_design_scores_gemma":[0.0010675909,0.00024327992,0.005434515,0.0010774828,0.99053687,0.000047767982,0.000021432035,0.0002486296,0.000074660325,0.00026742474,0.00096372765,0.000016675407],"about_ca_topic_score_codex":0.00394742,"about_ca_topic_score_gemma":0.011059703,"teacher_disagreement_score":0.99107707,"about_ca_system_score_codex":0.0010540396,"about_ca_system_score_gemma":0.00097566086,"threshold_uncertainty_score":0.032815754},"labels":[],"label_agreement":null},{"id":"W2175453042","doi":"10.1007/s10549-015-3633-7","title":"Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute; Medical Research Council; Eisai; Celgene","keywords":"Capecitabine; Medicine; Eribulin; Metastatic breast cancer; Internal medicine; Nausea; Breast cancer; Quality of life (healthcare); Randomized controlled trial; Oncology; Cancer; Surgery; Nursing","score_opus":0.1701282498210228,"score_gpt":0.486875781200225,"score_spread":0.3167475313792022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2175453042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99335915,0.0028239526,0.00020894372,0.00035670915,0.00013081799,0.0018947355,0.00038023965,0.000030413732,0.0008150391],"genre_scores_gemma":[0.99189466,0.00159376,0.00070724665,0.0007282066,0.00017298665,0.0033875508,0.0007385724,0.000008209456,0.0007686936],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992118,0.0004936553,0.00004644439,0.00009568328,0.000055829292,0.000096558986],"domain_scores_gemma":[0.9994099,0.00015086535,0.0001638173,0.000034686487,0.000031580963,0.00020919809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002126532,0.0011258535,0.002563509,0.00033288662,0.0003508093,0.00092192844,0.00051130273,0.001008861,0.0032144408],"category_scores_gemma":[0.0012218759,0.00038185608,0.001747464,0.00045828996,0.0007805229,0.0006595395,0.00031804046,0.0020782582,0.0004716696],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9655637,0.010205929,0.002349023,0.0004328478,0.00070978946,0.00006637898,0.000058539314,0.00036372838,0.0032450526,0.000060426075,0.00048547346,0.016459176],"study_design_scores_gemma":[0.83585805,0.15655577,0.0057739383,0.00002872826,0.00033603818,0.000044124103,0.000024857185,0.0004528257,0.00037940673,0.00010247182,0.00043205573,0.000011791842],"about_ca_topic_score_codex":0.00049614377,"about_ca_topic_score_gemma":0.0016507399,"teacher_disagreement_score":0.0032144408,"about_ca_system_score_codex":0.00079499744,"about_ca_system_score_gemma":0.0010098562,"threshold_uncertainty_score":0.011246324},"labels":[],"label_agreement":null},{"id":"W2186928475","doi":"","title":"A single-institution chart review of breast cancer patients treated with adjuvant chemotherapy","year":2008,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Epirubicin; Cyclophosphamide; Docetaxel; Breast cancer; Chemotherapy; Internal medicine; Cancer; Incidence (geometry); Oncology; Surgery","score_opus":0.023849372199779895,"score_gpt":0.3001158674870531,"score_spread":0.2762664952872732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2186928475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945562,0.0012808511,0.00023317557,0.00010697793,0.000014440147,0.00020475975,0.0021875538,0.000024237555,0.0013917608],"genre_scores_gemma":[0.99674654,0.0008035174,0.00057433784,0.00007798694,0.000017945256,0.000071069626,0.0014674008,0.0000045987003,0.00023658696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984316,0.00039860356,0.00038167517,0.00024783445,0.00039344866,0.00014669009],"domain_scores_gemma":[0.9917333,0.0016883839,0.004130545,0.00034561547,0.0014933756,0.00060882035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009571339,0.00018867743,0.00032166985,0.0026521285,0.0006263061,0.00067175465,0.00034088857,0.00026860446,0.0014526346],"category_scores_gemma":[0.0051097376,0.0002744442,0.0002340336,0.0026032955,0.00029488598,0.00038708147,0.0005117618,0.000291858,0.0002506994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006337141,0.00004596482,0.99189866,0.00008994292,0.000020272613,0.000991079,0.0004446508,0.000033652286,0.0003621915,0.000018281658,0.0006366775,0.0053953896],"study_design_scores_gemma":[0.000010117093,0.00021067029,0.9927816,0.000076784345,0.000030704643,0.0027112097,0.0013677172,0.00014311398,0.0004318537,0.000010266578,0.0022165198,0.000009433783],"about_ca_topic_score_codex":0.011385885,"about_ca_topic_score_gemma":0.020209372,"teacher_disagreement_score":0.011385885,"about_ca_system_score_codex":0.001202158,"about_ca_system_score_gemma":0.0016063054,"threshold_uncertainty_score":0.022639215},"labels":[],"label_agreement":null},{"id":"W2187105577","doi":"10.1016/j.ejca.2015.10.017","title":"Development of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinoma of the pancreas: A subset analysis from a randomised phase III trial (MPACT)","year":2015,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Celgene","keywords":"Medicine; Gemcitabine; Internal medicine; Common Terminology Criteria for Adverse Events; Hazard ratio; Gastroenterology; Peripheral neuropathy; Adverse effect; Pancreatic cancer; Cancer; Surgery; Oncology; Confidence interval","score_opus":0.03435072441050757,"score_gpt":0.3016408263974451,"score_spread":0.26729010198693753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2187105577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983133,0.0008127293,0.0001199137,0.000034654775,0.000010089212,0.00022307105,0.00030262442,0.000005378276,0.00017823557],"genre_scores_gemma":[0.9981693,0.00031231705,0.00022356083,0.000059743394,0.000028130818,0.00022269413,0.0008495554,0.000003578237,0.00013126517],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984162,0.0009993629,0.0001516985,0.00019185634,0.0001423804,0.00009852663],"domain_scores_gemma":[0.99746704,0.00086641544,0.00095476094,0.0002470817,0.00013534546,0.00032948208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004737266,0.00061466027,0.0011567809,0.00037495574,0.00033146123,0.00073074386,0.00048186624,0.00045014368,0.0014247607],"category_scores_gemma":[0.0029150096,0.0002727934,0.0025902735,0.00055597303,0.00045236436,0.00048151062,0.00040963638,0.00087484857,0.00015090042],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58268243,0.003845515,0.359011,0.0010394908,0.008746181,0.00044875944,0.000233397,0.0015348465,0.006702572,0.00007488927,0.0009805524,0.034700315],"study_design_scores_gemma":[0.09362593,0.1475172,0.74063444,0.00015848293,0.008872949,0.001850569,0.00020497365,0.0028179728,0.0021277687,0.00025736194,0.0018612851,0.00007103176],"about_ca_topic_score_codex":0.00046278062,"about_ca_topic_score_gemma":0.001252031,"teacher_disagreement_score":0.004737266,"about_ca_system_score_codex":0.0005288316,"about_ca_system_score_gemma":0.0007396445,"threshold_uncertainty_score":0.025053382},"labels":[],"label_agreement":null},{"id":"W2192078226","doi":"10.1186/s13058-015-0657-1","title":"“New” metastases are associated with a poorer prognosis than growth of pre-existing metastases in patients with metastatic breast cancer treated with chemotherapy","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute; Eisai","keywords":"Eribulin; Medicine; Internal medicine; Metastatic breast cancer; Capecitabine; Oncology; Breast cancer; Chemotherapy; Progression-free survival; Cancer; Metastasis; Colorectal cancer","score_opus":0.07619784674339677,"score_gpt":0.3900244424620759,"score_spread":0.3138265957186791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2192078226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982949,0.0011044894,0.000080629696,0.000044381813,0.000005424258,0.000014635415,0.00014190903,0.0000022074162,0.0003114301],"genre_scores_gemma":[0.9990682,0.00031284435,0.00010134992,0.000050990042,0.000022900396,0.000015267236,0.00027967923,9.578474e-7,0.00014793512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995432,0.00018969331,0.000049559552,0.000088210196,0.000088752604,0.000040547926],"domain_scores_gemma":[0.99660945,0.0013322319,0.0014277559,0.00014392675,0.00011567277,0.0003709023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014358186,0.00018248471,0.00045248854,0.00024853725,0.00015448898,0.00047958925,0.00019518909,0.00039506456,0.0017406804],"category_scores_gemma":[0.0019205861,0.00013761604,0.0005771465,0.0003782497,0.00028800036,0.00035224293,0.00022956141,0.00056651543,0.00009712837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026884397,0.00038089408,0.9520174,0.00017310337,0.00075589045,0.00018335429,0.000059325288,0.00046747315,0.0034320946,0.000040897903,0.00024329674,0.015361844],"study_design_scores_gemma":[0.0005141732,0.005581718,0.99145937,0.000015901107,0.00034078665,0.00053273904,0.000039614537,0.0002672802,0.000670662,0.000051859024,0.00051894475,0.0000069362723],"about_ca_topic_score_codex":0.00027842462,"about_ca_topic_score_gemma":0.001011415,"teacher_disagreement_score":0.0017406804,"about_ca_system_score_codex":0.00030721072,"about_ca_system_score_gemma":0.0002832953,"threshold_uncertainty_score":0.0075933933},"labels":[],"label_agreement":null},{"id":"W2199478144","doi":"10.1016/j.ijrobp.2015.07.583","title":"Ablative Therapy for Metastatic Breast Cancer: A Systematic Review","year":2015,"lang":"en","type":"review","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Medicine; Ablative case; Metastatic breast cancer; Metastasectomy; Radiosurgery; Radiofrequency ablation; Oncology; Breast cancer; Randomized controlled trial; Internal medicine; Cancer; Radiation therapy; Metastasis; Ablation","score_opus":0.09074799598402321,"score_gpt":0.47193643061539403,"score_spread":0.3811884346313708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2199478144","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00051204406,0.9990631,0.00004220305,0.00006828987,0.00003527014,0.000047245074,0.000117380274,0.0000031915633,0.000111351736],"genre_scores_gemma":[0.010013002,0.98904324,0.00025184403,0.0004321454,0.000037352565,0.000052956726,0.00008470075,0.0000023586397,0.00008246255],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99874675,0.00039065085,0.00043119834,0.00016231429,0.00019976674,0.000069258655],"domain_scores_gemma":[0.995852,0.0026707689,0.0011204038,0.00005669811,0.00023015331,0.00006996863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002059168,0.0011459264,0.0055858633,0.0033175098,0.00030589467,0.0012577837,0.001319666,0.0013415195,0.00545614],"category_scores_gemma":[0.0075472593,0.00066634186,0.0057232417,0.0038665233,0.0005118274,0.0012926826,0.001003916,0.0010563129,0.00028284243],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061877776,0.000042101852,0.00075792114,0.9214854,0.021775864,0.00011042184,0.00011639749,0.00018688009,0.00037122823,0.00014866055,0.002460767,0.051925566],"study_design_scores_gemma":[0.0018315633,0.0009280363,0.008547882,0.5868314,0.34698564,0.0009585798,0.0003471284,0.00020465026,0.00042002762,0.00057881646,0.05226677,0.00009956912],"about_ca_topic_score_codex":0.004435207,"about_ca_topic_score_gemma":0.022555957,"teacher_disagreement_score":0.0055858633,"about_ca_system_score_codex":0.0014604694,"about_ca_system_score_gemma":0.0026992015,"threshold_uncertainty_score":0.018252611},"labels":[],"label_agreement":null},{"id":"W2204893626","doi":"10.1016/j.rmr.2015.10.645","title":"Faisabilité d’un programme de téléréadaptation en oncologie pulmonaire","year":2015,"lang":"fr","type":"article","venue":"Revue des Maladies Respiratoires","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire de Cardiologie et de Pneumologie de Québec","funders":"","keywords":"Medicine; Gynecology","score_opus":0.1156381609690303,"score_gpt":0.3508482973574824,"score_spread":0.23521013638845212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2204893626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.876862,0.006084477,0.030261515,0.019817997,0.0027982043,0.0014150671,0.00090864237,0.0013580227,0.060494218],"genre_scores_gemma":[0.9626208,0.0018176168,0.015153069,0.0015503658,0.0008834788,0.00093822053,0.0004306393,0.00012946819,0.016476259],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9952828,0.002581829,0.00023550847,0.00049809524,0.00075919967,0.00064253074],"domain_scores_gemma":[0.98450536,0.008119617,0.0010850176,0.0010154754,0.0025616332,0.002712822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005741551,0.0007321014,0.0005511464,0.0012134693,0.0011570498,0.0024876348,0.0010303092,0.002170075,0.020394012],"category_scores_gemma":[0.02057188,0.00024777965,0.001055203,0.00061399135,0.00065248564,0.001620427,0.0013679549,0.002243773,0.0021706705],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009409217,0.009100516,0.082804106,0.001033944,0.00028053863,0.0017544162,0.0051871976,0.005919408,0.01016161,0.0052519375,0.010924969,0.8581722],"study_design_scores_gemma":[0.006447965,0.03401679,0.64359796,0.0034149522,0.001306051,0.006038085,0.008550344,0.030638194,0.027375247,0.00713545,0.2311458,0.00033321674],"about_ca_topic_score_codex":0.014793127,"about_ca_topic_score_gemma":0.006985292,"teacher_disagreement_score":0.020394012,"about_ca_system_score_codex":0.0037736471,"about_ca_system_score_gemma":0.004506848,"threshold_uncertainty_score":0.06822473},"labels":[],"label_agreement":null},{"id":"W2207022446","doi":"10.1023/a:1008348010437","title":"Liposomal vincristine in relapsed non-Hodgkin's lymphomas: Early results of an ongoing phase II trial","year":2000,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"National Cancer Institute","keywords":"Medicine; Vincristine; Internal medicine; Regimen; Gastroenterology; Lymphoma; Chemotherapy; Surgery; Cyclophosphamide","score_opus":0.07069277781017202,"score_gpt":0.4396739486290902,"score_spread":0.3689811708189182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2207022446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892805,0.0056473305,0.0008251857,0.00063380727,0.00011942265,0.001022305,0.00057930476,0.000088567125,0.0018034907],"genre_scores_gemma":[0.98862666,0.004524674,0.0012393162,0.0007358376,0.00013842517,0.001051504,0.0012859545,0.000043492037,0.0023540964],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995732,0.00019679032,0.000020684223,0.000050680486,0.00004410295,0.00011458586],"domain_scores_gemma":[0.9991642,0.0003095291,0.00010757849,0.00009788969,0.000044941287,0.0002759496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018654552,0.000995167,0.0020264515,0.0003147646,0.00031849928,0.0009873962,0.0007536346,0.0012260122,0.0020807874],"category_scores_gemma":[0.0010369848,0.00026649312,0.00082718366,0.00033862834,0.0010096033,0.0010956931,0.00040835113,0.002480517,0.00066997146],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64720774,0.028502772,0.0035252795,0.0014875473,0.0016059014,0.0003966904,0.00052225986,0.0031222433,0.04541882,0.0005759192,0.0035593484,0.26407546],"study_design_scores_gemma":[0.7369601,0.23991321,0.009023621,0.000110952526,0.00053018145,0.00032441612,0.00012430207,0.0012566,0.006511084,0.00044309074,0.0047643036,0.000038045913],"about_ca_topic_score_codex":0.0009460678,"about_ca_topic_score_gemma":0.0017547313,"teacher_disagreement_score":0.0020807874,"about_ca_system_score_codex":0.0007599189,"about_ca_system_score_gemma":0.00089491403,"threshold_uncertainty_score":0.009865642},"labels":[],"label_agreement":null},{"id":"W2218882637","doi":"10.1017/s1431927602100080","title":"Cytochemical Localization of Fungal Wall Components in Host-Pathogen Interactions: Particular Labeling with Gold-complexed Probes","year":2002,"lang":"en","type":"article","venue":"Microscopy and Microanalysis","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Canadian Forest Service","funders":"","keywords":"Host (biology); Pathogen; Fungal pathogen; Microbiology; Chemistry; Biophysics; Nanotechnology; Materials science; Biology; Genetics","score_opus":0.029383666429726108,"score_gpt":0.2976537404758159,"score_spread":0.26827007404608977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2218882637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6438699,0.010615765,0.32744342,0.001538551,0.00024287202,0.00018828758,0.00024945015,0.0010883425,0.01476343],"genre_scores_gemma":[0.844853,0.0058339755,0.13785736,0.000506104,0.00005683179,0.00021830648,0.00047902574,0.00025804757,0.009937346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997385,0.000086950015,0.000015212274,0.000053045493,0.00003466112,0.000071563314],"domain_scores_gemma":[0.99967396,0.00014272192,0.000035030127,0.00006791052,0.00004001161,0.000040386385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073378294,0.00075898494,0.00035131082,0.00060921034,0.0007488653,0.000574139,0.0007349867,0.0013585913,0.0022728334],"category_scores_gemma":[0.0004682955,0.00056449685,0.0005042941,0.0003430298,0.0007050833,0.00060900336,0.0007684731,0.0012914982,0.0008746973],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000888403,0.000015378337,0.000067079556,0.00007197478,0.000008728534,0.00008430673,0.000034187873,0.00007986432,0.99723,0.0008556233,0.00011680277,0.0013473501],"study_design_scores_gemma":[0.000012319151,0.00010059457,0.0009313788,0.000017692524,0.00001948124,0.00050265447,0.000034652276,0.0018096329,0.9931421,0.0004311906,0.0029902956,0.000007973178],"about_ca_topic_score_codex":0.0011382386,"about_ca_topic_score_gemma":0.0018257708,"teacher_disagreement_score":0.0022728334,"about_ca_system_score_codex":0.0007151759,"about_ca_system_score_gemma":0.00025461309,"threshold_uncertainty_score":0.007603407},"labels":[],"label_agreement":null},{"id":"W2219488898","doi":"10.1200/jco.2012.30.15_suppl.lba671","title":"Open-label phase III randomized controlled trial comparing taxane-based chemotherapy (Tax) with lapatinib (L) or trastuzumab (T) as first-line therapy for women with HER2+ metastatic breast cancer: Interim analysis (IA) of NCIC CTG MA.31/GSK EGF 108919.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Juravinski Cancer Centre; Sunnybrook Health Science Centre; BC Cancer Agency; Interior Health; Ottawa Hospital; Hamilton Health Sciences; University of Toronto","funders":"","keywords":"Medicine; Lapatinib; Trastuzumab; Taxane; Pertuzumab; Oncology; Internal medicine; Metastatic breast cancer; Interim analysis; Breast cancer; Interim; Chemotherapy; Clinical trial; Cancer","score_opus":0.17811336086588878,"score_gpt":0.5349206746260675,"score_spread":0.3568073137601787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2219488898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91899496,0.018946452,0.0033666429,0.004453047,0.005853097,0.025295656,0.00956508,0.0007338984,0.012791203],"genre_scores_gemma":[0.9344909,0.008730716,0.005821932,0.005945675,0.0018538898,0.02456835,0.0058884616,0.0001151562,0.012584923],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993105,0.00036496407,0.000043335403,0.00013842028,0.000050226052,0.000092507325],"domain_scores_gemma":[0.9983891,0.0005146834,0.0003543781,0.00014044714,0.00012395774,0.00047726778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021664796,0.0020450961,0.0036638323,0.0003860776,0.0005957014,0.0013393443,0.001244346,0.0020435192,0.016184116],"category_scores_gemma":[0.0029078284,0.0008077218,0.0017742005,0.0005778422,0.0012719659,0.0018954129,0.0005268842,0.004732529,0.0025760552],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98279244,0.0056284284,0.00015538979,0.00066984224,0.0011211985,0.000022686565,0.000026697322,0.00018389014,0.0007339195,0.00012776349,0.001727007,0.0068107652],"study_design_scores_gemma":[0.98389524,0.014755499,0.00031883398,0.000021119058,0.0002218352,0.000010167961,0.000011227794,0.00014790268,0.00005792516,0.00010565684,0.00044871686,0.0000059335953],"about_ca_topic_score_codex":0.0015079424,"about_ca_topic_score_gemma":0.0048816097,"teacher_disagreement_score":0.016184116,"about_ca_system_score_codex":0.0010475079,"about_ca_system_score_gemma":0.0017115592,"threshold_uncertainty_score":0.054141283},"labels":[],"label_agreement":null},{"id":"W2223234570","doi":"10.1200/jco.2006.24.18_suppl.2078","title":"Dose escalation phase of a phase I/II study of GTI-2501, an antisense to the R1 subunit of ribonucleotide reductase (RNR) and docetaxel in patients with metastatic hormone-refractory prostate cancer","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Docetaxel; Neutropenia; Prostate cancer; Internal medicine; Oncology; Toxicity; Cancer; Febrile neutropenia","score_opus":0.08929568132442707,"score_gpt":0.49107641314776757,"score_spread":0.4017807318233405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2223234570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907362,0.0006040849,0.00041615745,0.00030190035,0.00006239906,0.005137962,0.0010779608,0.0000757005,0.0015876897],"genre_scores_gemma":[0.98743093,0.0006498108,0.002136362,0.0006912881,0.0001039047,0.0042638183,0.0020264694,0.00003440923,0.0026629667],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995621,0.00014918561,0.00001886461,0.000081651604,0.000054240387,0.00013401778],"domain_scores_gemma":[0.9993161,0.00008105389,0.000102499056,0.00005701298,0.00005709476,0.00038636912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011365354,0.0014922894,0.0018396983,0.0006256162,0.000580558,0.000924711,0.0010973732,0.0011531695,0.003272598],"category_scores_gemma":[0.0007561986,0.0007493379,0.0009831411,0.0005537613,0.0011009475,0.00056937744,0.00033179414,0.0035306867,0.000691944],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5780454,0.20191824,0.010482483,0.0006511596,0.0008658504,0.0004746012,0.00091515935,0.006538042,0.09724211,0.00043445034,0.0065498957,0.095882624],"study_design_scores_gemma":[0.3812729,0.5854378,0.018723784,0.00003305534,0.00033251257,0.0002885717,0.000088231514,0.0015042016,0.008478683,0.00020746978,0.0035872255,0.00004557076],"about_ca_topic_score_codex":0.00890501,"about_ca_topic_score_gemma":0.020979503,"teacher_disagreement_score":0.00890501,"about_ca_system_score_codex":0.0026668988,"about_ca_system_score_gemma":0.0041830204,"threshold_uncertainty_score":0.019349873},"labels":[],"label_agreement":null},{"id":"W2225191295","doi":"10.1200/jco.2009.27.15_suppl.e19003","title":"MO19390 (SAiL): Incidence of thromboembolic events and congestive heart failure with first-line bevacizumab (Bv)-based therapy in advanced non-small cell lung cancer (NSCLC)","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Internal medicine; Adverse effect; Heart failure; Myocardial infarction; Clinical endpoint; Deep vein; Incidence (geometry); Cardiology; Pulmonary embolism; Bevacizumab; Surgery; Chemotherapy; Thrombosis; Clinical trial","score_opus":0.04870700257340295,"score_gpt":0.44227736221896935,"score_spread":0.3935703596455664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2225191295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99348736,0.0034517276,0.00028893314,0.00014488345,0.000033398024,0.00035501408,0.0012074352,0.000039505678,0.0009916252],"genre_scores_gemma":[0.9970498,0.00061293464,0.0002912893,0.00011912166,0.00007096851,0.00017467387,0.0012922478,0.000005198853,0.00038381756],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99921715,0.00038986956,0.00006174688,0.00010027175,0.00016673042,0.000064233],"domain_scores_gemma":[0.9985989,0.0003694715,0.0006824955,0.00004233239,0.00007756673,0.00022920998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022335302,0.00047247167,0.0006674834,0.00034200103,0.00015475364,0.00040284605,0.0003927881,0.000589941,0.0018887224],"category_scores_gemma":[0.001586268,0.0001971367,0.0007913796,0.00033524784,0.000173347,0.0003058798,0.00027083888,0.0008374873,0.00019134207],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46919742,0.006819516,0.36054605,0.0013386656,0.0042576147,0.00028393645,0.00008395482,0.002023894,0.019250575,0.00017753094,0.004609974,0.13141097],"study_design_scores_gemma":[0.08942415,0.14506333,0.7418327,0.00010627394,0.0028491286,0.0013217565,0.00004288012,0.004832763,0.009841674,0.00019553353,0.004446367,0.000043555923],"about_ca_topic_score_codex":0.0005163542,"about_ca_topic_score_gemma":0.0010878055,"teacher_disagreement_score":0.0022335302,"about_ca_system_score_codex":0.0005980568,"about_ca_system_score_gemma":0.00059167505,"threshold_uncertainty_score":0.01181221},"labels":[],"label_agreement":null},{"id":"W2225863772","doi":"10.1200/jco.2007.25.18_suppl.550","title":"A phase III adjuvant trial of sequenced EC + filgrastim + epoetin-alpha followed by paclitaxel compared to sequenced AC followed by paclitaxel compared to CEF in women with node-positive or high-risk node-negative breast cancer (NCIC CTG MA.21)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Hazard ratio; Paclitaxel; Gastroenterology; Proportional hazards model; Confidence interval; Cancer","score_opus":0.06350505833528398,"score_gpt":0.4623515918723846,"score_spread":0.39884653353710064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2225863772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99297297,0.0020610627,0.0003459297,0.00049158954,0.00031005213,0.0017413584,0.000607171,0.00006670326,0.0014031207],"genre_scores_gemma":[0.99007916,0.0014743505,0.0011084315,0.0007635012,0.00032010407,0.0022285543,0.0009468149,0.00001919458,0.0030599346],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995721,0.00026304138,0.000020606212,0.0000542386,0.000024964644,0.00006496837],"domain_scores_gemma":[0.99899715,0.00033129417,0.00019795613,0.00008937563,0.00005228036,0.00033203495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016654284,0.0012889643,0.0019364036,0.00038705065,0.0002922793,0.0008320561,0.0008079419,0.0012696038,0.005750391],"category_scores_gemma":[0.0015258663,0.00041284141,0.001432079,0.0003426712,0.0008489863,0.0006681004,0.00028907956,0.0026987123,0.00085215125],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9739127,0.008105611,0.00045816737,0.00024780564,0.00051479525,0.000029678755,0.00003716236,0.00041283382,0.0023203688,0.00008320272,0.00057780964,0.013299892],"study_design_scores_gemma":[0.83878046,0.15698586,0.0018627415,0.000029203124,0.00041129097,0.000048836908,0.00002374435,0.00062332116,0.00052209187,0.00013918619,0.0005626634,0.000010662125],"about_ca_topic_score_codex":0.00090101355,"about_ca_topic_score_gemma":0.001986754,"teacher_disagreement_score":0.005750391,"about_ca_system_score_codex":0.0007170799,"about_ca_system_score_gemma":0.00093854923,"threshold_uncertainty_score":0.019236982},"labels":[],"label_agreement":null},{"id":"W2235582661","doi":"10.1200/jco.2007.25.18_suppl.5084","title":"Combination chemotherapy with gemcitabine, oxaliplatin and paclitaxel in patients with cisplatin-refractory or relapsed germ cell tumors (gct)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Oxaliplatin; Gemcitabine; Cisplatin; Chemotherapy; Refractory (planetary science); Internal medicine; Paclitaxel; Oncology; Progressive disease; Gastroenterology; Toxicity; Progression-free survival; Urology; Surgery; Cancer; Colorectal cancer","score_opus":0.04387084198947501,"score_gpt":0.4158554860321698,"score_spread":0.3719846440426948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2235582661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937597,0.00421535,0.0002846643,0.00020687327,0.000038883496,0.00019602587,0.00012384249,0.00003627328,0.001138477],"genre_scores_gemma":[0.9962411,0.0015089809,0.0008870232,0.00024272517,0.000082415965,0.00019684546,0.00044662302,0.000008270883,0.00038592497],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997229,0.00012535219,0.00002550471,0.00004621183,0.00003587135,0.000044154087],"domain_scores_gemma":[0.9997266,0.00006258527,0.000054209853,0.000020170533,0.000014305629,0.00012205595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000518474,0.00043989264,0.0011212775,0.00039234536,0.0003594696,0.00047617053,0.00037640278,0.00045965414,0.0010199959],"category_scores_gemma":[0.0006138164,0.0002938053,0.00039760253,0.00047297459,0.00027981054,0.0002768882,0.00027617606,0.00066636817,0.0003589405],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10633236,0.011545977,0.28996688,0.0015497911,0.0016169004,0.006017935,0.0007145831,0.008059667,0.06764285,0.00027289707,0.0076463697,0.4986338],"study_design_scores_gemma":[0.048194595,0.3574812,0.5141858,0.0003295617,0.0022189424,0.02103354,0.00028682474,0.009757549,0.017754856,0.0005628938,0.028096333,0.00009803074],"about_ca_topic_score_codex":0.00046551364,"about_ca_topic_score_gemma":0.0015543115,"teacher_disagreement_score":0.0011212775,"about_ca_system_score_codex":0.00054207025,"about_ca_system_score_gemma":0.0005204947,"threshold_uncertainty_score":0.003933072},"labels":[],"label_agreement":null},{"id":"W2236644222","doi":"10.1200/jco.2015.33.15_suppl.9612","title":"The conversion ratio (CR) for opioid rotation (OR) from strong opioids to transdermal fentanyl (TDF) in cancer patients.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Opioid; Fentanyl; Cancer pain; Constipation; Cancer; Anesthesia; Morphine; Internal medicine","score_opus":0.2160608326753055,"score_gpt":0.5227664102218722,"score_spread":0.3067055775465667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2236644222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888094,0.007762859,0.0007551687,0.00016951778,0.000044602715,0.00008762353,0.0009846175,0.000042043226,0.0013441234],"genre_scores_gemma":[0.9985545,0.00045002982,0.00048572893,0.000038145103,0.000015799575,0.000017163366,0.00035030764,0.0000070653596,0.000081157435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99709666,0.0011028892,0.00048488614,0.0003267383,0.0008488213,0.00014006133],"domain_scores_gemma":[0.98688936,0.0044699037,0.0071448814,0.00041152904,0.0007411565,0.00034314205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002826017,0.0002673171,0.0004761324,0.0013574046,0.00019526317,0.00064666104,0.0004755831,0.00034094887,0.0010255743],"category_scores_gemma":[0.018686417,0.00019876384,0.00074298034,0.0014312174,0.0002641998,0.00040542224,0.00035183065,0.00068786956,0.00030722216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006050758,0.000017298487,0.9901024,0.00006965408,0.00012793802,0.000116009745,0.000033026943,0.00010240129,0.00012798853,0.000020270667,0.00023814144,0.008439695],"study_design_scores_gemma":[0.000033449574,0.00041547307,0.99571013,0.000023958306,0.0001394219,0.001944124,0.00010058784,0.00097048085,0.00020193675,0.000036496745,0.0004168771,0.0000070611623],"about_ca_topic_score_codex":0.00224328,"about_ca_topic_score_gemma":0.0022239129,"teacher_disagreement_score":0.002826017,"about_ca_system_score_codex":0.0006327559,"about_ca_system_score_gemma":0.00038560253,"threshold_uncertainty_score":0.014945626},"labels":[],"label_agreement":null},{"id":"W2240443346","doi":"10.1200/jco.2015.33.7_suppl.279","title":"IND 205B: A phase II study of the PI3K inhibitor PX-866 and continued abiraterone/prednisone in patients with recurrent or metastatic castration resistant prostate cancer (CRPC) with PSA progression on abiraterone/prednisone.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; BC Cancer Agency; Princess Margaret Cancer Centre; London Health Sciences Centre; Queen's University; University Health Network; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Abiraterone acetate; Clinical endpoint; Prostate cancer; Internal medicine; Nausea; Prednisone; Adverse effect; Phases of clinical research; Progressive disease; Oncology; Gastroenterology; Chemotherapy; Cancer; Urology; Androgen deprivation therapy; Clinical trial","score_opus":0.14860207523103347,"score_gpt":0.4968250447685502,"score_spread":0.34822296953751675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2240443346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878057,0.0016191807,0.00081888284,0.0005609973,0.00021667538,0.0052218493,0.0012975428,0.000174737,0.0022844104],"genre_scores_gemma":[0.9801618,0.0020074581,0.0029815554,0.0011728264,0.00033054312,0.005184909,0.0033485387,0.000046666868,0.0047656894],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99943477,0.000294029,0.000028226124,0.00007262579,0.000049582773,0.00012074858],"domain_scores_gemma":[0.99917823,0.00012495075,0.0001026189,0.000074081436,0.00004243389,0.00047768097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022601085,0.002022086,0.0022905574,0.0009257244,0.0005795054,0.0011112631,0.001545659,0.001668396,0.006045252],"category_scores_gemma":[0.0010342726,0.0010138269,0.0015838244,0.00078176527,0.0013086013,0.0009910506,0.00053019536,0.0043317303,0.001800452],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.67564756,0.18957363,0.004699795,0.0011956531,0.0010808615,0.0005615367,0.0004360259,0.0030084827,0.03475829,0.00037184468,0.003821098,0.08484519],"study_design_scores_gemma":[0.53123397,0.46061668,0.0040236874,0.000020888663,0.00019853191,0.0002586357,0.000041303898,0.0006356515,0.0015430703,0.000089518726,0.0013173794,0.000020723379],"about_ca_topic_score_codex":0.0014344684,"about_ca_topic_score_gemma":0.0031214503,"teacher_disagreement_score":0.006045252,"about_ca_system_score_codex":0.0008213913,"about_ca_system_score_gemma":0.002627247,"threshold_uncertainty_score":0.02022338},"labels":[],"label_agreement":null},{"id":"W2241038962","doi":"10.1200/jco.2006.24.18_suppl.4557","title":"Quality of life (QOL) of patients (pts) with metastatic hormone refractory prostate cancer (mHRPC) following treatment with docetaxel or mitoxantrone in the TAX-327 study","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Docetaxel; Mitoxantrone; Quality of life (healthcare); Internal medicine; Prostate cancer; Refractory (planetary science); Cancer; Oncology; Chemotherapy","score_opus":0.15289443433840882,"score_gpt":0.5043596204495797,"score_spread":0.3514651861111709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2241038962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99740195,0.0014674005,0.00003836872,0.000105770436,0.0000132582045,0.00004247532,0.0005370949,0.000002584151,0.00039106875],"genre_scores_gemma":[0.998615,0.00039487527,0.00003326877,0.00007708849,0.000017204886,0.000025882751,0.00069537363,8.170566e-7,0.00014032211],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99946374,0.00023157915,0.00005727221,0.000060130307,0.00011842014,0.00006883843],"domain_scores_gemma":[0.9991345,0.000105323095,0.00035176502,0.000036106925,0.000055866087,0.0003165449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000976447,0.00027845753,0.00070310384,0.00029410518,0.0002547287,0.0005992648,0.00028084486,0.00051929447,0.00084449997],"category_scores_gemma":[0.001486754,0.00020313876,0.0010454431,0.00060438615,0.0002265685,0.0003776768,0.0004487898,0.00073787745,0.00013917548],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014316316,0.00088326517,0.97063667,0.00018405783,0.0017102233,0.00021139214,0.00014564588,0.0004894347,0.0009297077,0.000041082287,0.00071476185,0.009737453],"study_design_scores_gemma":[0.0012013053,0.0059490027,0.9908772,0.000026825406,0.0005482292,0.0002685035,0.000066379216,0.00028089053,0.00013949293,0.00002696427,0.0006052251,0.000009943213],"about_ca_topic_score_codex":0.0020548892,"about_ca_topic_score_gemma":0.002438711,"teacher_disagreement_score":0.0020548892,"about_ca_system_score_codex":0.00041513133,"about_ca_system_score_gemma":0.00024739816,"threshold_uncertainty_score":0.0051639676},"labels":[],"label_agreement":null},{"id":"W2241118632","doi":"","title":"Les statines, causes d’impuissance","year":2000,"lang":"fr","type":"article","venue":"Médecine thérapeutique","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Postprandial; Gynecology; Ginseng; Post-prandial; Diabetes mellitus; Endocrinology","score_opus":0.03749533250432504,"score_gpt":0.35550480888038083,"score_spread":0.3180094763760558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2241118632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51027507,0.36598676,0.0044810195,0.017986186,0.001476538,0.0005291116,0.0058185216,0.0002955616,0.09315127],"genre_scores_gemma":[0.9035859,0.06627802,0.0014769861,0.0052595725,0.0007300731,0.0002349277,0.0015220755,0.000049103448,0.020863421],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99850154,0.0004927674,0.000197964,0.00015448817,0.00042780457,0.00022547458],"domain_scores_gemma":[0.9978428,0.0006005417,0.0008080899,0.00017675706,0.00037444854,0.0001974118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014760114,0.0002935628,0.0008616971,0.0006670709,0.00064345927,0.0008606731,0.00022458118,0.0006504909,0.010056526],"category_scores_gemma":[0.0035827954,0.00022317492,0.0011435911,0.00148042,0.00032731643,0.00034149326,0.0004086155,0.0010208309,0.0012489947],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020404216,0.0009037526,0.28084117,0.0069226967,0.004064797,0.0040234374,0.0009534903,0.00066099403,0.012211702,0.008149031,0.030819336,0.63004535],"study_design_scores_gemma":[0.0020268455,0.005866651,0.67257386,0.0023736572,0.0040498134,0.011084405,0.0010689315,0.0009403072,0.013836466,0.0036394186,0.28242376,0.00011595569],"about_ca_topic_score_codex":0.005870312,"about_ca_topic_score_gemma":0.009252111,"teacher_disagreement_score":0.010056526,"about_ca_system_score_codex":0.0011383676,"about_ca_system_score_gemma":0.001099707,"threshold_uncertainty_score":0.03364241},"labels":[],"label_agreement":null},{"id":"W2241202567","doi":"10.1200/jco.2009.27.15_suppl.9640","title":"Placebo and nocebo effects in randomized double-blind clinical trials for fatigue in advanced cancer patients","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Placebo; Nocebo; Nausea; Nocebo Effect; Internal medicine; Randomized controlled trial; Clinical trial; Cancer-related fatigue; Physical therapy; Cancer","score_opus":0.3903949492872185,"score_gpt":0.6278195739453415,"score_spread":0.23742462465812297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2241202567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85786676,0.10806535,0.0063621504,0.0022375395,0.002021836,0.019437907,0.0010239211,0.00033933975,0.0026453324],"genre_scores_gemma":[0.9661176,0.009704242,0.006357455,0.0010946714,0.001148789,0.014525606,0.00040978153,0.000026527443,0.00061521324],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9316323,0.057778496,0.005781646,0.001840727,0.0023013575,0.0006655227],"domain_scores_gemma":[0.9422751,0.03703246,0.015056736,0.0021331317,0.0016340215,0.0018685061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04621777,0.0012122852,0.0050867773,0.001818292,0.00072683237,0.0012979555,0.0007499498,0.0032316917,0.003614847],"category_scores_gemma":[0.06274772,0.0009779591,0.0034044045,0.0013285461,0.0024129327,0.0020180016,0.00068672193,0.0021062153,0.00037382788],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9481953,0.0023939093,0.0038042709,0.0034160002,0.004139803,0.00005699828,0.00015068405,0.00037561276,0.0012551743,0.00018539351,0.00042708858,0.035599742],"study_design_scores_gemma":[0.8613835,0.11869492,0.013666542,0.0004996699,0.0020621207,0.00009781392,0.00005569438,0.0010418714,0.0004927161,0.00047874922,0.001468592,0.00005790814],"about_ca_topic_score_codex":0.0001990117,"about_ca_topic_score_gemma":0.00051864225,"teacher_disagreement_score":0.04621777,"about_ca_system_score_codex":0.00065788964,"about_ca_system_score_gemma":0.0010790491,"threshold_uncertainty_score":0.24442583},"labels":[],"label_agreement":null},{"id":"W2242231555","doi":"10.1200/jco.2009.27.15_suppl.e11556","title":"Trastuzumab and vinorelbine (TV) in early stages of breast cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Vinorelbine; Trastuzumab; Chemotherapy; Regimen; Stage (stratigraphy); Internal medicine; Surgery; Neutropenia; Breast cancer; Cancer; Oncology","score_opus":0.09143339380531963,"score_gpt":0.5095466933966074,"score_spread":0.4181132995912878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2242231555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91931945,0.068323255,0.0005445433,0.0009244651,0.00016522342,0.00006814303,0.000678301,0.00001556259,0.009961018],"genre_scores_gemma":[0.9900205,0.007339333,0.0004652419,0.0002646437,0.00021004131,0.000018013592,0.000547751,0.0000035977087,0.0011309007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962723,0.00013565671,0.00006822398,0.000037772454,0.000071811926,0.000059187772],"domain_scores_gemma":[0.9988104,0.0004244822,0.0004276432,0.000030237272,0.00008998294,0.00021718869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008069121,0.00012305054,0.00037067555,0.00045900064,0.00014140487,0.00050523016,0.00023799331,0.0003872684,0.0013922215],"category_scores_gemma":[0.0021083711,0.00008883679,0.00021395671,0.00070265005,0.00012114928,0.00027847188,0.00026560735,0.0003147952,0.00021166707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00416079,0.00018851858,0.8565437,0.00048595964,0.00016072113,0.0045995605,0.000067951005,0.00046585075,0.0018768526,0.00032745628,0.003065707,0.128057],"study_design_scores_gemma":[0.00031399372,0.0014622929,0.95175004,0.00036421584,0.00023322552,0.01655072,0.000102540536,0.0011277373,0.001692819,0.00032518056,0.026060222,0.0000169361],"about_ca_topic_score_codex":0.0012068196,"about_ca_topic_score_gemma":0.0024271691,"teacher_disagreement_score":0.0013922215,"about_ca_system_score_codex":0.00033982866,"about_ca_system_score_gemma":0.00042920397,"threshold_uncertainty_score":0.0046574473},"labels":[],"label_agreement":null},{"id":"W2242712018","doi":"10.1200/jco.2004.22.90140.6145","title":"Venous thrombosis in breast cancer patients receiving tamoxifen and/or chemotherapy: A systematic review","year":2004,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Tamoxifen; Internal medicine; Chemotherapy; Oncology; Inclusion and exclusion criteria; Cancer; Grading (engineering); Grading scale; Gynecology; Surgery; Pathology; Alternative medicine","score_opus":0.18865759497152587,"score_gpt":0.5531279521266581,"score_spread":0.3644703571551322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2242712018","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038764938,0.9949411,0.00007517581,0.00018102993,0.00006469217,0.00026082984,0.00036995002,0.000004783483,0.00022588208],"genre_scores_gemma":[0.040587056,0.95734555,0.0004148058,0.00049080234,0.000094842784,0.0005673247,0.00038251674,0.0000035157202,0.000113725524],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9926044,0.002337281,0.0032717397,0.0004736371,0.0010936545,0.0002192386],"domain_scores_gemma":[0.97343737,0.018378487,0.005767716,0.00029470003,0.0018439248,0.00027791408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00512519,0.0010194445,0.0066714464,0.009740689,0.0006105373,0.0019419397,0.0013833118,0.0017681909,0.0035705483],"category_scores_gemma":[0.0251353,0.00084067625,0.0056156227,0.0118751675,0.00076799316,0.0018539486,0.0011555711,0.00075888337,0.00022920273],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032076729,0.00001860348,0.003294129,0.9617433,0.011105563,0.00026053583,0.00022743485,0.000057885674,0.00014261504,0.000084571024,0.0009979771,0.021746567],"study_design_scores_gemma":[0.000467151,0.0003635699,0.015012273,0.8668095,0.1049007,0.0010475033,0.00047356752,0.000097581586,0.00017781278,0.00016423852,0.010444236,0.00004185752],"about_ca_topic_score_codex":0.0069371467,"about_ca_topic_score_gemma":0.022657298,"teacher_disagreement_score":0.009740689,"about_ca_system_score_codex":0.00291934,"about_ca_system_score_gemma":0.0072764563,"threshold_uncertainty_score":0.027104974},"labels":[],"label_agreement":null},{"id":"W2243806734","doi":"10.1200/jco.2006.24.18_suppl.4505","title":"Reduced thromboembolic events with DN-101 (high-dose calcitriol) treatment of androgen-independent prostate cancer: Hypothesis for a new class of anticoagulants","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Docetaxel; Calcitriol; Internal medicine; Placebo; Prostate cancer; Adverse effect; Gastroenterology; Oncology; Cancer; Pharmacology; Urology; Vitamin D and neurology; Pathology","score_opus":0.12886978719081835,"score_gpt":0.4588298682468206,"score_spread":0.3299600810560023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2243806734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842718,0.011058995,0.0006957285,0.0006154397,0.00007061271,0.00016400717,0.00010547997,0.00003103588,0.0029870206],"genre_scores_gemma":[0.9957653,0.0023138623,0.00073840335,0.00031435938,0.00011310129,0.00004285298,0.00012852861,0.0000024725534,0.00058109115],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99980015,0.0001077841,0.000012654388,0.000019277815,0.000039870076,0.000020197927],"domain_scores_gemma":[0.9994758,0.00021885085,0.00015079185,0.00003499507,0.0000375015,0.00008208597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007381084,0.0001925836,0.00049664173,0.00018125039,0.000086745225,0.00037343448,0.00033033913,0.0003837874,0.0024873212],"category_scores_gemma":[0.0008538927,0.00010984221,0.00035524246,0.00011471789,0.00038620975,0.00023091037,0.000095208234,0.00043973475,0.0001602913],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16274917,0.0123046925,0.046638396,0.0029589038,0.0019827383,0.00053569145,0.00019598338,0.0020008394,0.24536118,0.003191086,0.0020544368,0.5200269],"study_design_scores_gemma":[0.078460254,0.41260546,0.42102838,0.00036426383,0.0029302097,0.00381133,0.00020497052,0.0039547686,0.045458876,0.0024153066,0.028692598,0.00007367449],"about_ca_topic_score_codex":0.00019071567,"about_ca_topic_score_gemma":0.00039481884,"teacher_disagreement_score":0.0024873212,"about_ca_system_score_codex":0.00019675288,"about_ca_system_score_gemma":0.0002506153,"threshold_uncertainty_score":0.008320928},"labels":[],"label_agreement":null},{"id":"W2243903821","doi":"10.1200/jco.2014.32.4_suppl.109","title":"Cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz + P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D): Analysis by age group.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cabazitaxel; Internal medicine; Docetaxel; Prostate cancer; Discontinuation; Adverse effect; Population; Cohort; Incidence (geometry); Cancer; Androgen deprivation therapy","score_opus":0.06467713322226828,"score_gpt":0.4438116790079496,"score_spread":0.3791345457856813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2243903821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970908,0.00047999856,0.0001976992,0.00007241754,0.000016470998,0.0002687986,0.0012070189,0.000017626351,0.0006491086],"genre_scores_gemma":[0.9956726,0.00025489624,0.00043337877,0.00018616961,0.000032313037,0.00023381072,0.002469252,0.0000057731395,0.0007117911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996,0.00015191532,0.00002208388,0.000082456325,0.00007851788,0.00006504098],"domain_scores_gemma":[0.9992873,0.0001050602,0.00021447451,0.00006648186,0.000037389196,0.00028934889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007976636,0.00029651943,0.00032836193,0.00025630314,0.00019356907,0.00041141864,0.00034578814,0.00031677075,0.0022065372],"category_scores_gemma":[0.0009883002,0.00018905163,0.0006895245,0.0004715774,0.00026348114,0.00031846616,0.00040897093,0.0006473757,0.00022873905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2855713,0.009082584,0.5676324,0.00033772195,0.0015093773,0.00039512492,0.00021817084,0.0014748115,0.00683856,0.00019977131,0.006799865,0.11994029],"study_design_scores_gemma":[0.034244165,0.076669686,0.87468576,0.00006046314,0.0015219986,0.0008554399,0.000114639886,0.0025601143,0.0028511318,0.00016220636,0.006240717,0.000033804852],"about_ca_topic_score_codex":0.0025634079,"about_ca_topic_score_gemma":0.004848991,"teacher_disagreement_score":0.0025634079,"about_ca_system_score_codex":0.00054370984,"about_ca_system_score_gemma":0.0009196325,"threshold_uncertainty_score":0.007381618},"labels":[],"label_agreement":null},{"id":"W2245653899","doi":"10.1200/jco.2007.25.18_suppl.9003","title":"Donepezil for cancer-related fatigue: A double-blind, randomized, placebo-controlled study","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Placebo; Contraindication; Clinical endpoint; Internal medicine; Randomized controlled trial; Donepezil; Randomization; Physical therapy; Nausea; Dementia; Disease","score_opus":0.23903560687445433,"score_gpt":0.5671675735379793,"score_spread":0.32813196666352495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2245653899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96014804,0.014659753,0.0015145701,0.0008941403,0.0013141568,0.015343382,0.002381071,0.0003194537,0.0034254447],"genre_scores_gemma":[0.96532446,0.009925558,0.0024552078,0.0021006975,0.0010856683,0.014069927,0.0013606044,0.000037696762,0.003640135],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990301,0.0004153219,0.00010213917,0.00019419835,0.00011623184,0.00014195233],"domain_scores_gemma":[0.9991116,0.00026913258,0.00015614243,0.000089998655,0.00011284452,0.0002603532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020634346,0.0016207055,0.0048532216,0.0007156258,0.00079119595,0.0010063656,0.0012998619,0.0027879183,0.008546852],"category_scores_gemma":[0.0018162637,0.0009673568,0.00194326,0.0007423084,0.0013225985,0.0010447343,0.00038810069,0.0022750336,0.0014823723],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96262825,0.01575937,0.000294103,0.0019566864,0.0010094256,0.000050648578,0.000055249457,0.000103643826,0.0027574522,0.0000575552,0.0007571504,0.014570669],"study_design_scores_gemma":[0.9663309,0.032211684,0.0006660859,0.000027149801,0.00025173827,0.000013943995,0.000007561542,0.00007958953,0.00014285896,0.000023296565,0.00023784759,0.0000073553933],"about_ca_topic_score_codex":0.001366583,"about_ca_topic_score_gemma":0.0031877158,"teacher_disagreement_score":0.008546852,"about_ca_system_score_codex":0.0006463967,"about_ca_system_score_gemma":0.0016034594,"threshold_uncertainty_score":0.02859211},"labels":[],"label_agreement":null},{"id":"W2246194414","doi":"10.1200/jco.2014.32.26_suppl.157","title":"A comparative effectiveness analysis of single-agent cytotoxics in triple-negative metastatic breast cancer patients.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Internal medicine; Oncology; Metastatic breast cancer; Gemcitabine; Hazard ratio; Eribulin; Vinorelbine; Proportional hazards model; Performance status; Capecitabine; Breast cancer; Discontinuation; Chemotherapy; Cancer; Confidence interval","score_opus":0.15795871854991653,"score_gpt":0.5153220941193895,"score_spread":0.35736337556947295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2246194414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98558503,0.010750343,0.000747095,0.00014290126,0.000065375505,0.00075456116,0.00079107657,0.000008082485,0.0011555024],"genre_scores_gemma":[0.99715495,0.0011373289,0.0006310479,0.00009116618,0.000070388065,0.0002497788,0.00057909836,0.0000024511494,0.000083828185],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9918155,0.005883301,0.0007431992,0.00047406336,0.00079390075,0.00029001528],"domain_scores_gemma":[0.98528004,0.008269493,0.0043081515,0.00050364726,0.00066701043,0.0009716831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009339243,0.00043334079,0.0015444668,0.0014625905,0.00021583024,0.0009231806,0.0005796485,0.00074300764,0.0028349457],"category_scores_gemma":[0.016565127,0.00022917565,0.0036666812,0.0011844294,0.00049616455,0.00082577905,0.00055464957,0.000669576,0.00017314812],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6666763,0.0052138004,0.16933836,0.0038158055,0.03184142,0.00028858546,0.00026801994,0.006045643,0.0022877036,0.0010114292,0.0010259881,0.11218697],"study_design_scores_gemma":[0.12581512,0.4487142,0.36347625,0.0007348076,0.03708606,0.0009738756,0.00069188676,0.01273234,0.0027080532,0.0013579869,0.0055627734,0.00014678293],"about_ca_topic_score_codex":0.000795105,"about_ca_topic_score_gemma":0.001085919,"teacher_disagreement_score":0.009339243,"about_ca_system_score_codex":0.0019480926,"about_ca_system_score_gemma":0.000885423,"threshold_uncertainty_score":0.04939121},"labels":[],"label_agreement":null},{"id":"W2247521924","doi":"10.1200/jco.2006.24.18_suppl.4651","title":"A phase I study of ABT-751 in combination with docetaxel in patients with metastatic hormone-refractory prostate cancer","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada); BC Cancer Agency","funders":"","keywords":"Medicine; Neutropenia; Docetaxel; Febrile neutropenia; Internal medicine; Prostate cancer; Gastroenterology; Chemotherapy; Performance status; Surgery; Cancer","score_opus":0.06767201698211162,"score_gpt":0.4794413760339556,"score_spread":0.411769359051844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2247521924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933943,0.0020623484,0.00029914625,0.00021890225,0.00011111829,0.0016002635,0.0006331444,0.00005603702,0.0016246939],"genre_scores_gemma":[0.9931559,0.0017431481,0.000791055,0.00037058908,0.00011547647,0.0007697239,0.0014519407,0.000014653238,0.0015875064],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99953926,0.00015205944,0.000027621842,0.00009619351,0.000056672663,0.0001281841],"domain_scores_gemma":[0.9994318,0.00004711688,0.000062866646,0.000028224049,0.000026865007,0.0004030941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090240757,0.0015084335,0.0019552836,0.00057621946,0.00064109033,0.00114875,0.00089810067,0.00072181795,0.002855752],"category_scores_gemma":[0.00057768443,0.00061379914,0.0010483239,0.0007654425,0.0008811258,0.00047602036,0.00032023326,0.0022573401,0.0009463829],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5558748,0.15806088,0.019825231,0.0017388456,0.0027219271,0.0010457186,0.00084820413,0.00728099,0.07353002,0.00041018837,0.00614316,0.17252009],"study_design_scores_gemma":[0.26818824,0.6906239,0.029972441,0.00005631167,0.00072787324,0.0005027649,0.000109854904,0.0014029589,0.003475313,0.00008975746,0.0047979974,0.000052527757],"about_ca_topic_score_codex":0.004986654,"about_ca_topic_score_gemma":0.009496692,"teacher_disagreement_score":0.004986654,"about_ca_system_score_codex":0.001650703,"about_ca_system_score_gemma":0.002517763,"threshold_uncertainty_score":0.0119767785},"labels":[],"label_agreement":null},{"id":"W2248113534","doi":"10.1200/jco.2006.24.18_suppl.10640","title":"A population-based study of trastuzumab-mediated cardiotoxicity among early stage breast cancer patients treated with adjuvant trastuzumab","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Trastuzumab; Cardiotoxicity; Internal medicine; Regimen; Ejection fraction; Breast cancer; Oncology; Population; Adjuvant; Chemotherapy; Heart failure; Cancer; Surgery","score_opus":0.043554243560170694,"score_gpt":0.40963950692009754,"score_spread":0.36608526335992686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2248113534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994407,0.00009638521,0.000027825361,0.000018333529,0.0000023318782,0.00001355337,0.00015425759,0.0000016171083,0.00024500297],"genre_scores_gemma":[0.99951494,0.00007630488,0.000033103264,0.000042234176,0.000009553198,0.000013569391,0.0002024167,0.0000010786994,0.00010672482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942684,0.0001683872,0.000046598994,0.00014088114,0.00012462525,0.00009265903],"domain_scores_gemma":[0.99893683,0.00021494263,0.00037936174,0.00008101524,0.00010472671,0.00028310964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059427967,0.00024158519,0.0004920625,0.0008423497,0.0005443056,0.0007198622,0.00030041608,0.00060436194,0.0011286363],"category_scores_gemma":[0.0019618417,0.00038787935,0.0003700319,0.0012066052,0.00030450412,0.0004720461,0.00035635827,0.0008271864,0.0003108644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023806862,0.00015063921,0.99832314,0.0000053933218,0.000041358955,0.00013816934,0.00008187379,0.000018722225,0.0002286939,0.000006230183,0.00006314383,0.0007045007],"study_design_scores_gemma":[0.000032860964,0.00051579863,0.9984792,0.0000029948553,0.000032107062,0.0004898065,0.00014765642,0.00009861436,0.000037681068,0.000008498978,0.00015023004,0.0000045405277],"about_ca_topic_score_codex":0.005380287,"about_ca_topic_score_gemma":0.004988758,"teacher_disagreement_score":0.005380287,"about_ca_system_score_codex":0.0004976158,"about_ca_system_score_gemma":0.00037799144,"threshold_uncertainty_score":0.010697901},"labels":[],"label_agreement":null},{"id":"W2248854698","doi":"10.1200/jco.2007.25.18_suppl.9548","title":"A phase Ib study of oxaliplatin in combination with fluorouracil (5FU) and leucovorin (LV) in pediatric patients (pts) with advanced solid tumors","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Medicine; Oxaliplatin; FOLFOX; Bolus (digestion); Regimen; Tolerability; Toxicity; Pharmacokinetics; Fluorouracil; Internal medicine; Pediatric cancer; Colorectal cancer; Gastroenterology; Chemotherapy; Urology; Oncology; Surgery; Cancer; Adverse effect","score_opus":0.06768361388423799,"score_gpt":0.4851574908015795,"score_spread":0.4174738769173415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2248854698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992714,0.0015992034,0.0007525352,0.00031838843,0.0000844265,0.0027605603,0.0006919079,0.00005463382,0.001024372],"genre_scores_gemma":[0.98638606,0.0029113195,0.0030050382,0.0006242438,0.00019508306,0.0036151896,0.0021181025,0.00003210527,0.0011128179],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99950266,0.0002706306,0.000032794538,0.000064354135,0.000044922483,0.00008463815],"domain_scores_gemma":[0.99916196,0.00011303904,0.00016020324,0.00007227919,0.00005518453,0.0004373563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014070334,0.0015556315,0.0022681085,0.00039921232,0.00050022046,0.0008831027,0.001041631,0.0009742095,0.0026131186],"category_scores_gemma":[0.0009061145,0.0007176186,0.0011716166,0.0006808816,0.0010527235,0.0007590967,0.0004200195,0.0033975597,0.00071780913],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6055028,0.16492295,0.024690753,0.0018426151,0.0021234842,0.0014478792,0.00096686505,0.0058854637,0.06836643,0.0005909764,0.0049846377,0.118675224],"study_design_scores_gemma":[0.2788571,0.69519526,0.016291583,0.00005175947,0.00045144875,0.0008781212,0.00012338991,0.0010883562,0.0035017366,0.00014225896,0.0033969432,0.000021914417],"about_ca_topic_score_codex":0.0016427719,"about_ca_topic_score_gemma":0.00297664,"teacher_disagreement_score":0.0026131186,"about_ca_system_score_codex":0.001254101,"about_ca_system_score_gemma":0.0026013325,"threshold_uncertainty_score":0.009099126},"labels":[],"label_agreement":null},{"id":"W2249291309","doi":"10.1200/jco.2005.23.16_suppl.818","title":"Randomized trial of adjuvant equitoxic dose-escalated anthracycline (A)-containing regimen of doxorubicin, cyclophosphamide (AC) versus cyclophosphamide, methotrexate, 5-FU (CMF) for stage I-II breast cancer (BrCa): Can equitoxicity compensate for agent selection?","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Cyclophosphamide; Anthracycline; Breast cancer; Regimen; Chemotherapy; Internal medicine; Randomized controlled trial; Radiation therapy; Oncology; Surgery; Urology; Cancer","score_opus":0.13803021745123692,"score_gpt":0.49999805762428723,"score_spread":0.3619678401730503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2249291309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98884284,0.0008491403,0.0006555711,0.0007019602,0.00067333895,0.0064529516,0.0005052311,0.000080245416,0.0012388248],"genre_scores_gemma":[0.98109114,0.0008576063,0.0019188459,0.001312468,0.000729129,0.009305061,0.00061646354,0.000023087896,0.0041461894],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99797195,0.0012425154,0.00012230041,0.00027274355,0.00011530387,0.0002752379],"domain_scores_gemma":[0.9960515,0.0013304828,0.0008085351,0.00039200124,0.00019730808,0.0012201647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036048496,0.0022080273,0.003583204,0.0005730729,0.0006579966,0.0015535607,0.0016734813,0.0028976088,0.010132305],"category_scores_gemma":[0.00471031,0.001215517,0.0017453757,0.00052740023,0.0030108728,0.0015896942,0.000861089,0.0055125696,0.0015109752],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9895097,0.0064126183,0.00017920334,0.000096968055,0.00016821052,0.0000129810005,0.000023174483,0.00017617151,0.0008453592,0.00006493163,0.0001503639,0.0023603213],"study_design_scores_gemma":[0.92703897,0.071546674,0.00038313927,0.000009826856,0.00013520093,0.000011797457,0.000011931889,0.000308375,0.00021243555,0.00013467151,0.00019883657,0.000008188601],"about_ca_topic_score_codex":0.0014127662,"about_ca_topic_score_gemma":0.0018521046,"teacher_disagreement_score":0.010132305,"about_ca_system_score_codex":0.001243978,"about_ca_system_score_gemma":0.0019955435,"threshold_uncertainty_score":0.03389597},"labels":[],"label_agreement":null},{"id":"W2250077480","doi":"10.1200/jco.2013.31.31_suppl.48","title":"Health care practitioner prescribing patterns and perspectives on oral chemotherapy management: A survey of cancer centers in Toronto, Canada.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Medical prescription; Family medicine; Nausea; Patient education; Cancer; Nursing; Internal medicine","score_opus":0.11113061659727257,"score_gpt":0.49419965760988194,"score_spread":0.38306904101260936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2250077480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99270916,0.0012126471,0.000052923777,0.0014045906,0.0000111413065,0.00005058665,0.0018842402,0.0000096451795,0.002665194],"genre_scores_gemma":[0.99736124,0.0009031484,0.000119896264,0.00045447703,0.000005884511,0.000017918674,0.00048403358,0.00000382282,0.00064953323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892956,0.00012698564,0.00012785484,0.00010625053,0.00045262126,0.00025667317],"domain_scores_gemma":[0.99549246,0.00047877638,0.0016099898,0.00006417874,0.0010689258,0.0012857019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006429792,0.00015080492,0.00018337007,0.00076564896,0.0017192552,0.0008277443,0.00056820776,0.00038534455,0.0028332327],"category_scores_gemma":[0.0029388098,0.00030431576,0.0002279233,0.0030429445,0.0006262312,0.00036904568,0.0006690399,0.00048359684,0.00025611435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032885888,0.00003462852,0.9863413,0.00013345067,0.000015119597,0.00022759988,0.005215585,0.000059666327,0.00029701018,0.00003247069,0.0019745596,0.005635776],"study_design_scores_gemma":[0.000004085446,0.0000400923,0.9907803,0.00006024959,0.0000066410803,0.00012281987,0.0074904286,0.00011274692,0.000040514096,0.000004069837,0.0013319054,0.000006128023],"about_ca_topic_score_codex":0.95473975,"about_ca_topic_score_gemma":0.9732213,"teacher_disagreement_score":0.04526025,"about_ca_system_score_codex":0.015841153,"about_ca_system_score_gemma":0.014868466,"threshold_uncertainty_score":0.11493617},"labels":[],"label_agreement":null},{"id":"W2256348337","doi":"10.1200/jco.2014.32.31_suppl.177","title":"Association of high symptom burden with oral oncolytic agents.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality of life (healthcare); Internal medicine; Cancer; Intensive care medicine; Physical therapy; Emergency medicine","score_opus":0.09281297926713751,"score_gpt":0.48303408801951325,"score_spread":0.39022110875237576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2256348337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99496907,0.0014616158,0.00011639389,0.00036268105,0.00001377785,0.000034073266,0.0007447954,0.0000090673975,0.002288577],"genre_scores_gemma":[0.9993612,0.0001645077,0.00006857067,0.00004727626,0.000012325647,0.000008140938,0.00023733499,0.0000015441501,0.00009912539],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990701,0.00024059301,0.00015340555,0.00008321351,0.0003365221,0.000116097464],"domain_scores_gemma":[0.99164927,0.0015183354,0.0053110165,0.00015111847,0.0005998945,0.0007703503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061608455,0.00015107334,0.00026682313,0.0005527078,0.0003232241,0.0005354083,0.00022301305,0.0002264661,0.003790424],"category_scores_gemma":[0.0057046684,0.00010437007,0.00033001613,0.001011685,0.00023219528,0.00034149326,0.0004914016,0.00058714946,0.00021418837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009135507,0.000028851995,0.99611723,0.000033190176,0.00004143422,0.000057299807,0.00003719162,0.000033588167,0.00008995649,0.000012231614,0.00027588446,0.003181819],"study_design_scores_gemma":[0.0000051005472,0.00007631441,0.999009,0.0000108792265,0.000018770264,0.00033489562,0.000075952325,0.00012229307,0.000035354475,0.000015227015,0.00029366312,0.000002537023],"about_ca_topic_score_codex":0.0018046036,"about_ca_topic_score_gemma":0.0021734135,"teacher_disagreement_score":0.003790424,"about_ca_system_score_codex":0.00039846275,"about_ca_system_score_gemma":0.0004509391,"threshold_uncertainty_score":0.012680292},"labels":[],"label_agreement":null},{"id":"W2256596578","doi":"10.1200/jco.2005.23.16_suppl.8016","title":"Do women with primary breast cancer who experience chemotherapy-induced menopause have worse symptoms than those due to natural menopause?","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Menopause; Breast cancer; Chemotherapy; Premature Menopause; Surgical Menopause; Adjuvant chemotherapy; Internal medicine; Gynecology; Clinical endpoint; Cancer; Oncology; Clinical trial","score_opus":0.0510057890791539,"score_gpt":0.4475324177660498,"score_spread":0.3965266286868959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2256596578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980319,0.0009921952,0.000021360112,0.00017537229,0.00002767731,0.000012112406,0.0001834828,0.0000016103321,0.00055420224],"genre_scores_gemma":[0.99917775,0.00031827562,0.000022994915,0.00011669577,0.000038606166,0.0000088022725,0.00017394252,6.3271153e-7,0.00014233582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982244,0.00005279366,0.000022488995,0.00003676029,0.000029671437,0.00003584664],"domain_scores_gemma":[0.99876773,0.00026442745,0.0006194759,0.00004373812,0.00009769979,0.00020695417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000586371,0.00016711377,0.00045081464,0.0006210589,0.00021875666,0.0005360157,0.00018371537,0.0006755025,0.0031083773],"category_scores_gemma":[0.0029765181,0.00014641536,0.00039595983,0.00063109153,0.000286631,0.0006443513,0.00019403768,0.00020109233,0.0005248422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011227435,0.00011426291,0.9886634,0.00007948163,0.00013292795,0.00011798741,0.00023446903,0.00001836859,0.00020823562,0.000018145209,0.00034162935,0.008948342],"study_design_scores_gemma":[0.00006347426,0.00058768404,0.99827635,0.000011776592,0.00004147088,0.00032737805,0.00030135846,0.00003317876,0.000024585288,0.00003646213,0.00029260266,0.0000037491752],"about_ca_topic_score_codex":0.00079765636,"about_ca_topic_score_gemma":0.0014860372,"teacher_disagreement_score":0.0031083773,"about_ca_system_score_codex":0.00016103736,"about_ca_system_score_gemma":0.00013447681,"threshold_uncertainty_score":0.010398567},"labels":[],"label_agreement":null},{"id":"W2256921387","doi":"10.1200/jco.2009.27.15_suppl.e20743","title":"The use of cannabinoids (CBs) for the treatment of chemotherapy-induced peripheral neuropathy (CIPN): A retrospective review","year":2009,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Vinca; Peripheral neuropathy; Chemotherapy; Internal medicine; Adverse effect; Retrospective cohort study; Oncology; Pharmacology","score_opus":0.38711644627992725,"score_gpt":0.5653654352153523,"score_spread":0.17824898893542507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2256921387","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.091813,0.90484536,0.0003007267,0.0002509988,0.00006312568,0.00012705984,0.00087139104,0.0000092063,0.0017191115],"genre_scores_gemma":[0.32186335,0.67520124,0.00071855076,0.0005933647,0.00017676836,0.00010802037,0.00096840016,0.000010357981,0.00036001296],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986357,0.0002706203,0.00058971916,0.00016000758,0.00029059776,0.000053345448],"domain_scores_gemma":[0.994915,0.0021615613,0.002317392,0.000109890454,0.00040590338,0.00009025568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013119346,0.0002689204,0.00072009687,0.0030663728,0.00027576773,0.0006327876,0.0005228185,0.00054913235,0.001743362],"category_scores_gemma":[0.0033656834,0.00025423878,0.000927555,0.0058503267,0.0003868197,0.0005821566,0.00029075594,0.00035187544,0.00041935575],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020267572,0.00025989293,0.48770547,0.09443617,0.0036842665,0.020928238,0.00068205973,0.00039536096,0.0027530584,0.0007411492,0.008911883,0.3774758],"study_design_scores_gemma":[0.00029695826,0.0018312593,0.6624052,0.048427228,0.013559805,0.15918788,0.002134058,0.00056840543,0.0026436094,0.00030652032,0.10853328,0.000105910396],"about_ca_topic_score_codex":0.001850012,"about_ca_topic_score_gemma":0.0025882416,"teacher_disagreement_score":0.0030663728,"about_ca_system_score_codex":0.00055862183,"about_ca_system_score_gemma":0.0012092465,"threshold_uncertainty_score":0.006938219},"labels":[],"label_agreement":null},{"id":"W2258401109","doi":"10.1200/jco.2007.25.18_suppl.18092","title":"Costs associated with intravenous (IV) chemotherapy administration in patients with lung cancer","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Chemotherapy; Lung cancer; Route of administration; Internal medicine; Cancer; Administration (probate law); Oncology; Intensive care medicine","score_opus":0.04721964115355841,"score_gpt":0.4744088246118512,"score_spread":0.42718918345829276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2258401109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914507,0.0017075452,0.00030901874,0.0006367048,0.000021433321,0.0000578634,0.0032480087,0.000013124074,0.0025556595],"genre_scores_gemma":[0.9973199,0.0004387535,0.00023977929,0.00008848167,0.000033861976,0.000022396132,0.0016989346,0.000002382925,0.00015555548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988734,0.00037585976,0.00020300184,0.00010543897,0.0002809312,0.00016136031],"domain_scores_gemma":[0.9950847,0.0009284912,0.0032815218,0.000087573695,0.00026910953,0.00034857556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053108984,0.00023177877,0.00027722708,0.0010968001,0.00029166244,0.0008106348,0.0002754332,0.0003031511,0.0017877928],"category_scores_gemma":[0.0053275763,0.00016876342,0.00065561914,0.00189656,0.00020878334,0.0003471404,0.0006709344,0.0006235167,0.00013396525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017908543,0.000070962284,0.98244506,0.00007912965,0.00015229628,0.00021042438,0.000048127844,0.0019219246,0.00011772519,0.00016539602,0.0014751346,0.013134773],"study_design_scores_gemma":[0.00003063247,0.0001749027,0.9924676,0.000096322576,0.000109546345,0.0007209685,0.00018966851,0.003927168,0.00012278851,0.00020970398,0.0019394319,0.000011238104],"about_ca_topic_score_codex":0.012934206,"about_ca_topic_score_gemma":0.013929292,"teacher_disagreement_score":0.012934206,"about_ca_system_score_codex":0.0021070733,"about_ca_system_score_gemma":0.0011000675,"threshold_uncertainty_score":0.025717854},"labels":[],"label_agreement":null},{"id":"W2260518538","doi":"","title":"Vincristine sulfate liposomes injection concentrates vincristine in tumor tissue and bone marrow of tumor-bearing mice","year":2007,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bone marrow; Vincristine; Liposome; Pharmacology; Chemistry; Vinca; Pathology; Medicine; Internal medicine; Chemotherapy; Biochemistry; Cyclophosphamide","score_opus":0.012789799789136752,"score_gpt":0.30142284320880003,"score_spread":0.2886330434196633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2260518538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97801673,0.0023993466,0.006429462,0.00029729516,0.00010180088,0.00076912105,0.003906457,0.0006352318,0.007444524],"genre_scores_gemma":[0.96242756,0.0018505782,0.008283203,0.00024261989,0.00005412456,0.0008448536,0.00470685,0.0001921415,0.02139797],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997118,0.000016892318,0.000017636132,0.00011224677,0.000062995605,0.00007831934],"domain_scores_gemma":[0.99978906,0.0000288154,0.000058156493,0.00002625399,0.00003185221,0.000065881344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025095028,0.0009728131,0.00052507635,0.0011245818,0.0002976172,0.00037855125,0.0004720346,0.0010206992,0.0035091718],"category_scores_gemma":[0.0000959796,0.0003829419,0.00039842873,0.00037217353,0.00037595685,0.00041988702,0.00024870082,0.0016692581,0.0013061657],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007574121,0.00032266328,0.00019785957,0.000055570184,0.000008069348,0.00006275004,0.00003142768,0.00010651779,0.995754,0.00016245402,0.000115824936,0.0024254357],"study_design_scores_gemma":[0.00014989082,0.0030373223,0.0031143064,0.000018804818,0.000030726682,0.00034923278,0.000030536332,0.0011304286,0.98951894,0.00006598082,0.0025433796,0.000010514439],"about_ca_topic_score_codex":0.0011330487,"about_ca_topic_score_gemma":0.0013586986,"teacher_disagreement_score":0.0035091718,"about_ca_system_score_codex":0.00056223274,"about_ca_system_score_gemma":0.00053313735,"threshold_uncertainty_score":0.011739314},"labels":[],"label_agreement":null},{"id":"W2261976279","doi":"10.71781/11202","title":"Progrès vers la synthèse totale de la Pactamycine","year":2008,"lang":"en","type":"dissertation","venue":"Open MIND","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry","score_opus":0.030449082760624285,"score_gpt":0.4096937830550891,"score_spread":0.3792447002944648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2261976279","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012691072,0.91172785,0.008291366,0.00866916,0.0046346346,0.0003274845,0.0028236278,0.00022719264,0.050607722],"genre_scores_gemma":[0.07442373,0.7418376,0.02797977,0.0030426807,0.0019829979,0.0005309987,0.0030505648,0.00028022204,0.14687149],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993716,0.00015767786,0.00006747063,0.00008147923,0.00027711937,0.000044793265],"domain_scores_gemma":[0.9990791,0.00025729294,0.000121573925,0.000060215258,0.0004053844,0.00007638596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015212238,0.0005942845,0.0006447972,0.001715067,0.00041325603,0.0014706119,0.00070458325,0.0005819657,0.02518281],"category_scores_gemma":[0.00318327,0.00027831874,0.00074967754,0.0013864711,0.0004592619,0.0009499427,0.00049656647,0.001299303,0.0036982833],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082580926,0.00016130664,0.00032428856,0.008985391,0.00029907486,0.00032102427,0.0005148705,0.0005476893,0.028013224,0.012406297,0.047651913,0.8999491],"study_design_scores_gemma":[0.00007888788,0.00019361301,0.00091437733,0.0013362548,0.00015822532,0.00028068302,0.000069294205,0.000043987307,0.010776558,0.00092867005,0.98520386,0.000015474534],"about_ca_topic_score_codex":0.019299546,"about_ca_topic_score_gemma":0.039682526,"teacher_disagreement_score":0.02518281,"about_ca_system_score_codex":0.0021693078,"about_ca_system_score_gemma":0.0046151457,"threshold_uncertainty_score":0.08424491},"labels":[],"label_agreement":null},{"id":"W2262014445","doi":"10.1200/jco.2009.27.15_suppl.e11515","title":"Racial differences in acute toxicities of FEC 100 chemotherapy in patients with breast cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Chemotherapy; Epirubicin; Internal medicine; Oncology; Cancer; Cyclophosphamide","score_opus":0.06449901478663041,"score_gpt":0.47127521299723507,"score_spread":0.4067761982106047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2262014445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99897695,0.00017729362,0.00004107886,0.00006398727,0.000004550327,0.000005101872,0.00009842378,9.736073e-7,0.0006318136],"genre_scores_gemma":[0.99959785,0.00007149807,0.00003311055,0.00006807893,0.00000836683,0.000005020206,0.00011995537,0.0000010605376,0.00009506371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996321,0.00012695829,0.00004139119,0.000051772706,0.000060005063,0.00008768509],"domain_scores_gemma":[0.9987865,0.0003439947,0.000570171,0.00004362771,0.00010157542,0.00015412281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004703323,0.00008481096,0.00018037508,0.0002991913,0.00031675355,0.00026648727,0.00011136928,0.00019987926,0.0021664803],"category_scores_gemma":[0.0024446575,0.00008133095,0.00021003665,0.00046162828,0.0001753004,0.0002005059,0.00018853536,0.00023612342,0.00019238575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026904017,0.000041529336,0.996777,0.00000574478,0.000033206332,0.000063891435,0.00007598903,0.00005320809,0.00023870512,0.000026664458,0.00015260423,0.002262322],"study_design_scores_gemma":[0.000011515589,0.00010963586,0.9990318,0.0000044618796,0.00001897291,0.00023736244,0.00009448038,0.00011023188,0.00007234293,0.000027437549,0.00027988997,0.0000020605419],"about_ca_topic_score_codex":0.0023059542,"about_ca_topic_score_gemma":0.004061536,"teacher_disagreement_score":0.0023059542,"about_ca_system_score_codex":0.00027827467,"about_ca_system_score_gemma":0.00021343223,"threshold_uncertainty_score":0.007247627},"labels":[],"label_agreement":null},{"id":"W2262858020","doi":"10.1200/jco.2009.27.15_suppl.2504","title":"Uridine glucuronosyltransferase 2B7 pharmacogenetics predicts epirubicin clearance and myelosuppression","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gastroenterology; Internal medicine; Bilirubin; Population; Tolerability; Pharmacology; Adverse effect","score_opus":0.12026165016198466,"score_gpt":0.5070889860882271,"score_spread":0.3868273359262424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2262858020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994259,0.000076387114,0.00015199739,0.000022451004,0.0000017529279,0.000003954181,0.000094429364,0.0000033449169,0.00021985677],"genre_scores_gemma":[0.99963903,0.000021364598,0.0000815613,0.000015420781,0.0000033387391,0.00000421064,0.000116894815,0.0000026642115,0.000115550574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998412,0.000063183004,0.0000128599195,0.000034073662,0.0000210364,0.000027613274],"domain_scores_gemma":[0.9994715,0.0002026472,0.00018313971,0.0000286673,0.000030098076,0.00008396558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029616288,0.00022525243,0.0002821484,0.00022928294,0.00011556782,0.00036674493,0.000109458786,0.0003261577,0.0024138498],"category_scores_gemma":[0.0010840498,0.00014776179,0.00019623352,0.0002301288,0.00014817959,0.00010386095,0.00012093541,0.00030988466,0.0004202692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018382794,0.00009236188,0.98318267,0.000008498027,0.00006956094,0.00015119443,0.000023921746,0.00035813238,0.010595626,0.000026837628,0.00016733861,0.0034855017],"study_design_scores_gemma":[0.00005783131,0.0006444087,0.99234676,0.0000056687304,0.000088246736,0.0009784213,0.0000338876,0.002570409,0.0028773246,0.00006954133,0.0003234131,0.0000041308244],"about_ca_topic_score_codex":0.0005619408,"about_ca_topic_score_gemma":0.00050785096,"teacher_disagreement_score":0.0024138498,"about_ca_system_score_codex":0.00012721663,"about_ca_system_score_gemma":0.00009491391,"threshold_uncertainty_score":0.008075118},"labels":[],"label_agreement":null},{"id":"W2263012629","doi":"10.1200/jco.2005.23.16_suppl.890","title":"Do clinical trials of neoadjuvant chemotherapy for locally advanced breast cancer (LABC) overestimate the actual response rates observed in clinical practice?","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Anthracycline; Taxane; Breast cancer; Internal medicine; Regimen; Chemotherapy; Oncology; Clinical trial; Inflammatory breast cancer; Neoadjuvant therapy; Chemotherapy regimen; Stage (stratigraphy); Cancer; Surgery","score_opus":0.3706597621708674,"score_gpt":0.637973111732331,"score_spread":0.2673133495614636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2263012629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77849823,0.1462194,0.014555458,0.023794228,0.0031481744,0.0068648546,0.0028316067,0.0002765964,0.023811422],"genre_scores_gemma":[0.97040504,0.006400743,0.0056521897,0.011459906,0.0014803194,0.0027682132,0.0011306088,0.000072844836,0.00063007936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.6206041,0.34031045,0.020174956,0.0065430435,0.011236133,0.0011313367],"domain_scores_gemma":[0.36019078,0.5112687,0.08691698,0.026336882,0.0120687075,0.003217901],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.27704516,0.0006893602,0.0029085614,0.0012675504,0.0005917704,0.0032926197,0.0015674245,0.0030492956,0.0028686887],"category_scores_gemma":[0.41554317,0.0009029394,0.0017648645,0.0026429938,0.003220936,0.0032691923,0.0012554127,0.0016821497,0.0018239979],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06105686,0.00122636,0.73431283,0.0050770966,0.006739531,0.00017734045,0.000989822,0.0029319513,0.0013690073,0.0017580221,0.007920181,0.17644107],"study_design_scores_gemma":[0.026033407,0.06957333,0.8247321,0.004256148,0.0063030203,0.00198966,0.0009870053,0.009318757,0.0023964245,0.0061512706,0.048038926,0.00021987042],"about_ca_topic_score_codex":0.00039620488,"about_ca_topic_score_gemma":0.0007815887,"teacher_disagreement_score":0.72295487,"about_ca_system_score_codex":0.0015196754,"about_ca_system_score_gemma":0.0015360964,"threshold_uncertainty_score":0.89153206},"labels":[],"label_agreement":null},{"id":"W2265087310","doi":"10.1200/jco.2007.25.18_suppl.14535","title":"Effect of hyperthermia on the pharmacokinetic profile of oxaliplatin administered by intraperitoneal route in rats","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Oxaliplatin; Medicine; Peritoneum; Pharmacokinetics; Hyperthermia; Perfusion; Intraperitoneal injection; Mesentery; In vivo; Chemotherapy; Pharmacology; Surgery; Internal medicine; Cancer; Colorectal cancer; Biology","score_opus":0.08793512567251474,"score_gpt":0.5115380316999573,"score_spread":0.42360290602744255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2265087310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693775,0.0008811894,0.0013795978,0.0000537158,0.000026665835,0.00003376553,0.00021827387,0.00007805019,0.00039101855],"genre_scores_gemma":[0.9949234,0.0010352161,0.0019507676,0.000051897034,0.000022742102,0.000093031485,0.0003680063,0.00002137984,0.0015334598],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998362,0.000026572925,0.00000922719,0.0000355427,0.00003908482,0.00005339715],"domain_scores_gemma":[0.99977404,0.000033780503,0.00009780989,0.000026163416,0.00002174738,0.000046491452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002186309,0.00056417845,0.00034606797,0.00040186412,0.00012814229,0.00021886366,0.00016754982,0.0002443572,0.0012136648],"category_scores_gemma":[0.00020082045,0.00021065054,0.00037339385,0.0001755692,0.00037316434,0.00032623482,0.0001569385,0.0007370808,0.00024253906],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028207242,0.0003205564,0.0011919013,0.0000492984,0.000022703154,0.00006052887,0.00005981154,0.00021613676,0.99122953,0.00006741738,0.00009058823,0.0038708528],"study_design_scores_gemma":[0.00008853515,0.0131196845,0.013026379,0.00000877572,0.00007241772,0.000152694,0.000058603495,0.0011587559,0.970899,0.000056621495,0.0013397962,0.000018720444],"about_ca_topic_score_codex":0.0008254597,"about_ca_topic_score_gemma":0.0012130401,"teacher_disagreement_score":0.0012136648,"about_ca_system_score_codex":0.00035493544,"about_ca_system_score_gemma":0.0003280162,"threshold_uncertainty_score":0.004060149},"labels":[],"label_agreement":null},{"id":"W2267133977","doi":"10.1023/a:1008389706725","title":"Retreatment of patients with the same chemotherapy: Implications for clinical mechanisms of drug resistance","year":2001,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chemotherapy; Breast cancer; Internal medicine; Chemotherapy regimen; Disease; Cancer; Surgery; Oncology","score_opus":0.224575961975959,"score_gpt":0.5280030167004287,"score_spread":0.30342705472446974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2267133977","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010869057,0.9957045,0.0002297517,0.0009991073,0.00022441367,0.000006415634,0.000009798564,0.000008848679,0.001730268],"genre_scores_gemma":[0.0071768886,0.9903324,0.000413798,0.0007595368,0.00035975248,0.000011818203,0.00002946985,0.0000020540638,0.0009142329],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997583,0.00008625541,0.00002640308,0.000039815328,0.000070469876,0.000018757652],"domain_scores_gemma":[0.99954766,0.000260122,0.000072762254,0.000014786807,0.000080873906,0.000023712619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007298653,0.0004356378,0.0018798627,0.0007976578,0.00019528887,0.00064153253,0.0008417451,0.0010057981,0.002159922],"category_scores_gemma":[0.0012027158,0.00012120152,0.00047959795,0.0009844679,0.00031052405,0.00086722994,0.00025240803,0.0010839382,0.00079297804],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001395492,0.000093343144,0.00074516947,0.003731853,0.00007409982,0.00046121806,0.00007495148,0.00034617772,0.0012272177,0.0015698246,0.010864177,0.9806724],"study_design_scores_gemma":[0.00023721537,0.0012122705,0.015699225,0.005829863,0.0004852655,0.016009977,0.00031294607,0.0007903636,0.0020434728,0.0056416984,0.9516887,0.000049084967],"about_ca_topic_score_codex":0.0008185097,"about_ca_topic_score_gemma":0.002493979,"teacher_disagreement_score":0.002159922,"about_ca_system_score_codex":0.00050867605,"about_ca_system_score_gemma":0.0006608734,"threshold_uncertainty_score":0.0072256923},"labels":[],"label_agreement":null},{"id":"W2269255206","doi":"10.1200/jco.2006.24.18_suppl.6117","title":"Survival and cost-effectiveness of docetaxel (D) and paclitaxel (P) in patients with metastatic breast cancer (MBC): A population-based evaluation","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Docetaxel; Metastatic breast cancer; Taxane; Confidence interval; Internal medicine; Anthracycline; Population; Breast cancer; Paclitaxel; Log-rank test; Oncology; Chemotherapy; Cancer; Gastroenterology; Urology; Overall survival; Surgery","score_opus":0.10178530269329276,"score_gpt":0.5114907116261588,"score_spread":0.409705408932866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2269255206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942674,0.0041053616,0.00023222363,0.0002216092,0.000021139978,0.00016330654,0.0004434393,0.000008862068,0.0005367218],"genre_scores_gemma":[0.9981573,0.00091983314,0.00019233084,0.00010796605,0.000048102385,0.00008611556,0.000414277,0.0000018526199,0.00007227637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968636,0.0022056876,0.00018606534,0.00025683187,0.0003651863,0.00012266917],"domain_scores_gemma":[0.99439466,0.0033660936,0.0013381327,0.00019839857,0.0002015967,0.00050113694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005193567,0.0007396653,0.0012067375,0.0011922778,0.00023383285,0.0009109744,0.00063119107,0.0010985354,0.001507888],"category_scores_gemma":[0.008668082,0.00043424516,0.004127095,0.0011036862,0.0005607517,0.0008112639,0.00054275396,0.0012195726,0.00016970225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36522168,0.008659355,0.4763671,0.0019520086,0.032650936,0.00042858397,0.00031250075,0.019593095,0.0015547372,0.0006619626,0.0018134947,0.09078459],"study_design_scores_gemma":[0.06349938,0.16780789,0.7037381,0.00047333707,0.024366919,0.0012491052,0.0004316788,0.032371536,0.001236036,0.001308437,0.0032948197,0.00022280401],"about_ca_topic_score_codex":0.0015631604,"about_ca_topic_score_gemma":0.0013868535,"teacher_disagreement_score":0.005193567,"about_ca_system_score_codex":0.0018594771,"about_ca_system_score_gemma":0.0005327699,"threshold_uncertainty_score":0.027466476},"labels":[],"label_agreement":null},{"id":"W2270737067","doi":"10.1200/jco.2009.27.15_suppl.e15634","title":"A phase II study of Halichondrin B analog eribulin mesylate (E7389) as second-line therapy for patients with advanced pancreatic cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre","funders":"","keywords":"Eribulin; Medicine; Gemcitabine; Internal medicine; Gastroenterology; Neutropenia; Pancreatic cancer; Progressive disease; Oncology; Adverse effect; Cancer; Metastatic breast cancer; Toxicity; Surgery; Chemotherapy; Breast cancer","score_opus":0.08946331562877648,"score_gpt":0.5214411670188722,"score_spread":0.43197785139009576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2270737067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921409,0.000994399,0.0005159806,0.0002827281,0.000092675175,0.0037834411,0.0007476765,0.000062974505,0.0013791302],"genre_scores_gemma":[0.9856448,0.001646232,0.0020238915,0.0007375139,0.00013267522,0.0041495985,0.0021557151,0.000026349799,0.0034832775],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997427,0.00012944109,0.000013839253,0.000036732377,0.000023573175,0.000053681695],"domain_scores_gemma":[0.9996495,0.000050702103,0.00005717692,0.000029599443,0.000024370045,0.00018855964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008972731,0.0011852556,0.0019195178,0.00041998006,0.000349179,0.00072148506,0.0007470349,0.0010781634,0.004698584],"category_scores_gemma":[0.0004378713,0.00046091204,0.00084303104,0.0004426472,0.0005712117,0.00057513145,0.00026756444,0.002128757,0.001002265],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5512331,0.16678078,0.011645587,0.0012779734,0.0011388243,0.0008728405,0.00046572427,0.0039521963,0.11693082,0.0004693687,0.0055445544,0.13968815],"study_design_scores_gemma":[0.4791919,0.49771464,0.011840025,0.000037404727,0.00024915565,0.00054048485,0.00007762808,0.0013974666,0.005451488,0.00014327803,0.0033350775,0.000021488948],"about_ca_topic_score_codex":0.00078240916,"about_ca_topic_score_gemma":0.0020728065,"teacher_disagreement_score":0.004698584,"about_ca_system_score_codex":0.0006627732,"about_ca_system_score_gemma":0.0012580341,"threshold_uncertainty_score":0.015718281},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"nonrandomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W2273249800","doi":"10.1200/jco.2009.27.15_suppl.9597","title":"Is patient self-reporting more accurate than clinician reporting of symptoms for predicting survival in patients with cancer? Meta-analysis of 30 closed EORTC randomized controlled trials","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nausea; Constipation; Vomiting; Diarrhea; Internal medicine; Randomized controlled trial; Cancer","score_opus":0.27666963205692885,"score_gpt":0.5480638072808044,"score_spread":0.27139417522387554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2273249800","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06750874,0.9228695,0.004691755,0.00065378635,0.0009457439,0.0008358567,0.0015900651,0.00014442983,0.0007600498],"genre_scores_gemma":[0.864318,0.12313348,0.005405999,0.0018235446,0.00078280666,0.001812891,0.0021147013,0.00012729535,0.000481315],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.93041956,0.050883107,0.009471141,0.0056265183,0.0030023006,0.0005973143],"domain_scores_gemma":[0.84971875,0.124783985,0.01643767,0.00591788,0.0023897917,0.0007519038],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.076563224,0.003816076,0.02051036,0.0039526466,0.00065306015,0.0049314713,0.002606012,0.003295331,0.0021497612],"category_scores_gemma":[0.110282876,0.0019599258,0.06528109,0.004703852,0.001388122,0.0026197273,0.0017022986,0.003548145,0.00029981666],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011370228,0.000028149245,0.008721219,0.019486124,0.9554043,0.000040626244,0.000030246541,0.0005905261,0.00009709809,0.000048664493,0.00015929242,0.004023587],"study_design_scores_gemma":[0.003051589,0.0005573693,0.006162948,0.0017495981,0.9871557,0.00004776851,0.000019298288,0.00049401994,0.000099394565,0.00021825793,0.00041909018,0.000024951843],"about_ca_topic_score_codex":0.003199267,"about_ca_topic_score_gemma":0.0040252297,"teacher_disagreement_score":0.9794896,"about_ca_system_score_codex":0.001630951,"about_ca_system_score_gemma":0.0013959934,"threshold_uncertainty_score":0.40490985},"labels":[],"label_agreement":null},{"id":"W2273887450","doi":"10.1200/jco.2000.18.12.2363","title":"Phase I/II Trial of Cyclophosphamide, Mitoxantrone, and Escalated Doses of Carboplatin Supported by Peripheral-Blood Stem Cells in Women With Metastatic Breast Cancer","year":2000,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Mitoxantrone; Carboplatin; Cyclophosphamide; Metastatic breast cancer; Breast cancer; Peripheral blood; Oncology; Internal medicine; Cancer; Chemotherapy; Cisplatin","score_opus":0.03848341136592249,"score_gpt":0.4150591416245636,"score_spread":0.3765757302586411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2273887450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99456644,0.001859063,0.00026338975,0.00035484866,0.00008067857,0.0013864218,0.000267179,0.00006725126,0.0011548453],"genre_scores_gemma":[0.99054915,0.0018441401,0.0016375864,0.00068862253,0.00016107863,0.0022441735,0.0012626693,0.000020460364,0.001592241],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99972516,0.00013728387,0.000014317933,0.000047615016,0.000021637483,0.000053952925],"domain_scores_gemma":[0.9996308,0.00007194983,0.00008035636,0.000031249365,0.000014848238,0.00017073708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088526023,0.0013238589,0.0015210689,0.00032340197,0.00027129115,0.00062561256,0.0007563305,0.00091238506,0.0030692911],"category_scores_gemma":[0.0006552509,0.00044201594,0.00055767247,0.0003910273,0.0009600061,0.0004710242,0.00029635863,0.0025720997,0.0005726978],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76665246,0.05199678,0.008511562,0.0008904784,0.00084680313,0.0003255797,0.00042556328,0.0032939536,0.044815756,0.00027183865,0.0037688997,0.11820023],"study_design_scores_gemma":[0.68370706,0.29834542,0.009133475,0.00003918127,0.00031084183,0.00028919717,0.000057361907,0.0010376761,0.0040665967,0.00014220514,0.0028573226,0.000013721845],"about_ca_topic_score_codex":0.0006935635,"about_ca_topic_score_gemma":0.0018308739,"teacher_disagreement_score":0.0030692911,"about_ca_system_score_codex":0.0008614529,"about_ca_system_score_gemma":0.001093695,"threshold_uncertainty_score":0.010267794},"labels":[],"label_agreement":null},{"id":"W2274648502","doi":"10.1161/circoutcomes.7.suppl_1.188","title":"Abstract 188: Comparison of Physician- and Patient-Assessed Impressions of Treatment Efficacy: Insights from the TERISA Clinical Trial","year":2014,"lang":"en","type":"article","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Angina; Logistic regression; Clinical trial; Internal medicine; Canadian Cardiovascular Society; Physical therapy; Visual analogue scale; Myocardial infarction","score_opus":0.1484574620663761,"score_gpt":0.4419931448863613,"score_spread":0.2935356828199852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2274648502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9660972,0.013437985,0.002348478,0.0017424383,0.00044301306,0.001390543,0.0043620984,0.0000838805,0.010094289],"genre_scores_gemma":[0.9940387,0.0006599649,0.00101631,0.0005279437,0.00026469576,0.001113032,0.0017771535,0.000021387981,0.00058070465],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9608246,0.032805197,0.0019924792,0.0014611941,0.0024390714,0.00047741385],"domain_scores_gemma":[0.9190864,0.056409087,0.016461676,0.0041861315,0.002717275,0.0011393722],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.038501587,0.00087603385,0.0027198975,0.0008907944,0.00048750802,0.0019545318,0.0010916532,0.001450512,0.0058706566],"category_scores_gemma":[0.07817099,0.0004065169,0.0033568766,0.0014024109,0.0010265015,0.0016932284,0.0010415482,0.0022370343,0.0008007334],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.661301,0.0028903268,0.216182,0.0046372754,0.04461802,0.00022239846,0.0011914087,0.0029685977,0.001304951,0.0014537981,0.007773974,0.055456243],"study_design_scores_gemma":[0.1891258,0.059429105,0.70127994,0.0011862323,0.024723455,0.00057570176,0.0009761302,0.007951765,0.0011373005,0.0040343073,0.009305106,0.00027525163],"about_ca_topic_score_codex":0.00052734045,"about_ca_topic_score_gemma":0.00071407907,"teacher_disagreement_score":0.96149844,"about_ca_system_score_codex":0.0004629748,"about_ca_system_score_gemma":0.00065293506,"threshold_uncertainty_score":0.20361829},"labels":[],"label_agreement":null},{"id":"W2275293745","doi":"10.1200/jco.2005.23.16_suppl.3185","title":"Altered metabolism of cyclophosphamide given in a low-dose metronomic manner does not account for eventual resistance","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Cyclophosphamide; Matrigel; Pharmacology; Cancer; Chemotherapy; Perfusion; Cancer research; Angiogenesis; Internal medicine","score_opus":0.07720551855147771,"score_gpt":0.4686328702862741,"score_spread":0.39142735173479637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2275293745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99630463,0.0008457668,0.001221867,0.00009476877,0.000023997383,0.00003280038,0.0003252308,0.000048062393,0.0011029184],"genre_scores_gemma":[0.9987968,0.000098314194,0.00037484695,0.000025446792,0.000004314741,0.000011314906,0.00031936596,0.000008616289,0.00036099576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998739,0.000016975195,0.000013630487,0.00003072539,0.000030101352,0.000034710338],"domain_scores_gemma":[0.9998416,0.000020288731,0.000058433692,0.000032062107,0.000013702667,0.00003392067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012592511,0.0002794506,0.00034162024,0.00018657002,0.00008909945,0.0003062743,0.00018103949,0.0002921904,0.0021038314],"category_scores_gemma":[0.0002056663,0.00010420022,0.00031006284,0.000119690994,0.00020223796,0.0001923298,0.00012171574,0.0005607492,0.0003037048],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011293301,0.00013231896,0.009817589,0.00004085282,0.000035330188,0.00031436887,0.000008642098,0.00009795279,0.982939,0.00017413049,0.00018757381,0.005122848],"study_design_scores_gemma":[0.00019615058,0.0034127852,0.10795389,0.000024229552,0.00019365562,0.006811616,0.000044274326,0.003901309,0.8718437,0.00032369694,0.005277318,0.000017508488],"about_ca_topic_score_codex":0.00025257148,"about_ca_topic_score_gemma":0.0002888484,"teacher_disagreement_score":0.0021038314,"about_ca_system_score_codex":0.00034483048,"about_ca_system_score_gemma":0.00014444927,"threshold_uncertainty_score":0.007038057},"labels":[],"label_agreement":null},{"id":"W2277293591","doi":"10.1200/jco.2007.25.18_suppl.11072","title":"Adjuvant trastuzumab (T) in early stage breast cancer (EBC): Is cardiac dysfunction (CD) clinically significant?","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Ejection fraction; Trastuzumab; Internal medicine; Anthracycline; Cardiotoxicity; Heart failure; Breast cancer; Regimen; Taxane; Chemotherapy; Cancer; Surgery","score_opus":0.10078801541897237,"score_gpt":0.4937749407274828,"score_spread":0.3929869253085104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2277293591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99864024,0.0007067783,0.00002591109,0.000050359078,0.0000029288997,0.0000068296804,0.00006777763,8.8421876e-7,0.00049818173],"genre_scores_gemma":[0.9995783,0.00023457324,0.000034013054,0.000025254789,0.000011361144,0.000002439313,0.000057882324,3.2296248e-7,0.000055898636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998491,0.000039993174,0.000020399006,0.00002022814,0.000032253098,0.000037979673],"domain_scores_gemma":[0.9992519,0.00021921725,0.00036522257,0.000017579132,0.000048251808,0.00009784975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003912501,0.00007988062,0.00016964434,0.00032868798,0.00019665179,0.00033788697,0.00015525096,0.00016480673,0.0007532642],"category_scores_gemma":[0.0012878237,0.000060859744,0.000080062964,0.000468042,0.00026931733,0.00016413192,0.0001472056,0.00017872489,0.00007951028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038142674,0.000023428176,0.99424064,0.000016005282,0.0000057335787,0.00051882345,0.000031910546,0.000029414254,0.00037585723,0.000011330746,0.000090812144,0.0042746644],"study_design_scores_gemma":[0.000023846445,0.0005121502,0.99473614,0.00002142492,0.000023880379,0.003157429,0.00018577505,0.00021318071,0.00037717086,0.000029431692,0.0007172851,0.0000022773681],"about_ca_topic_score_codex":0.001880558,"about_ca_topic_score_gemma":0.004839704,"teacher_disagreement_score":0.001880558,"about_ca_system_score_codex":0.00039371388,"about_ca_system_score_gemma":0.00030260824,"threshold_uncertainty_score":0.0037392974},"labels":[],"label_agreement":null},{"id":"W2278581713","doi":"10.1200/jco.2013.31.15_suppl.tps664","title":"Human epidermal growth factor receptor 2 (HER2) suppression with the addition of lapatinib to trastuzumab in HER2-positive metastatic breast cancer (HALT: LPT112515).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Lapatinib; Medicine; Trastuzumab; Tolerability; Discontinuation; Internal medicine; Metastatic breast cancer; Clinical endpoint; Oncology; Breast cancer; Chemotherapy; Cancer; Adverse effect; Clinical trial","score_opus":0.07742957421473282,"score_gpt":0.46198266660637854,"score_spread":0.3845530923916457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2278581713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629587,0.001199038,0.00018384914,0.0002227309,0.000069542235,0.0005038106,0.00038169886,0.00007583973,0.0010675389],"genre_scores_gemma":[0.9952916,0.0010256497,0.0005561586,0.00025138535,0.000072898365,0.0006157195,0.0009636061,0.000010429007,0.0012126125],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99976116,0.00008925634,0.00001762747,0.00004104095,0.00003007202,0.00006092457],"domain_scores_gemma":[0.99974674,0.00004268983,0.000066571316,0.000022115533,0.0000087367625,0.00011317252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008198052,0.0008063306,0.001077127,0.000399739,0.0002491767,0.0005765634,0.0007198365,0.0007570068,0.0029899464],"category_scores_gemma":[0.00046401483,0.00033975934,0.0007581504,0.00034462215,0.0007428512,0.0006769497,0.00038513745,0.0022982268,0.0005728479],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49470934,0.083692215,0.0134427175,0.0015964013,0.0010340892,0.00080628163,0.00032823678,0.003209866,0.1503459,0.00058903603,0.006632068,0.24361385],"study_design_scores_gemma":[0.24170154,0.7041474,0.018502822,0.000054322838,0.00049807935,0.0012069307,0.00007157723,0.001498282,0.027159467,0.00021104593,0.004909041,0.00003946154],"about_ca_topic_score_codex":0.0005097431,"about_ca_topic_score_gemma":0.0014422374,"teacher_disagreement_score":0.0029899464,"about_ca_system_score_codex":0.0005672178,"about_ca_system_score_gemma":0.0008882885,"threshold_uncertainty_score":0.010002375},"labels":[],"label_agreement":null},{"id":"W2279192913","doi":"","title":"Vinorelbine liposomes injection results in greater tumor drug exposure compared to conventional vinorelbine in tumor-bearing nude mice","year":2007,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Vinorelbine; Pharmacokinetics; Pharmacology; Liposome; Chemistry; Volume of distribution; Internal medicine; Medicine; Chemotherapy; Biochemistry","score_opus":0.026983872306910076,"score_gpt":0.3224996452426178,"score_spread":0.29551577293570774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2279192913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920878,0.0010274717,0.0024128098,0.00017071878,0.000078670324,0.00010397276,0.0017847336,0.00028664467,0.0020473548],"genre_scores_gemma":[0.98103124,0.0011370304,0.0046232436,0.00011096963,0.000048394697,0.0002372711,0.0025582477,0.00012573678,0.010127869],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99962187,0.000029838906,0.000026836851,0.00014802332,0.000074124575,0.00009935589],"domain_scores_gemma":[0.99975044,0.000041226605,0.00009608125,0.00002481645,0.000018474482,0.00006902558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026964568,0.000774957,0.0005922655,0.0008158513,0.00020192159,0.0003942393,0.00038928515,0.00066221034,0.0027839337],"category_scores_gemma":[0.00013791754,0.00031743493,0.0003880363,0.00033016343,0.00037575833,0.0004632752,0.00019632505,0.0012431234,0.0005541933],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005955868,0.0001785217,0.0000958717,0.00002422782,0.000008600824,0.00002418306,0.000018806933,0.000069213216,0.99784505,0.000048303038,0.000065507076,0.001026075],"study_design_scores_gemma":[0.000089326946,0.0019818929,0.0020404784,0.0000048820716,0.000026097194,0.00014083463,0.000018486526,0.0008371431,0.9937972,0.000021573996,0.0010349521,0.000007196693],"about_ca_topic_score_codex":0.0018552354,"about_ca_topic_score_gemma":0.0019426367,"teacher_disagreement_score":0.0027839337,"about_ca_system_score_codex":0.00070924987,"about_ca_system_score_gemma":0.00036242022,"threshold_uncertainty_score":0.009313166},"labels":[],"label_agreement":null},{"id":"W2279610918","doi":"10.1200/jco.2006.24.18_suppl.13071","title":"Uridine glucuronosyltransferase 2B7 polymorphisms and epirubicin pharmacokinetics","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Glucuronidation; Pharmacokinetics; Anthracycline; Pharmacology; Pharmacogenetics; UGT2B7; Glucuronosyltransferase; SN-38; Genotype; Irinotecan; Colorectal cancer; Cancer; Breast cancer; Chemistry; Biochemistry; In vitro","score_opus":0.09516175521980748,"score_gpt":0.4731237570156215,"score_spread":0.377962001795814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2279610918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992054,0.0002101175,0.0001524945,0.00002628204,0.0000027605017,0.000009635328,0.00012890132,0.0000033438537,0.0002611129],"genre_scores_gemma":[0.9992642,0.000058354184,0.00014363146,0.000023105787,0.00000911495,0.000016595071,0.00016251211,0.0000028610134,0.0003195538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981064,0.00007572465,0.000011823071,0.000037155947,0.000026910919,0.000037813625],"domain_scores_gemma":[0.99958867,0.00017120762,0.000102972175,0.00002399589,0.000023727614,0.00008945039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023952214,0.00027461405,0.0003302201,0.0002523409,0.00014035827,0.00026791927,0.00011563594,0.00040631308,0.0029454639],"category_scores_gemma":[0.0006562937,0.00020816019,0.00019867497,0.0002965791,0.00017346739,0.00015249893,0.000088968955,0.00030425919,0.00035349542],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00781782,0.0003868695,0.96726716,0.000027225055,0.00017701437,0.0005373698,0.00008511997,0.00035716695,0.01673356,0.00008109101,0.00030458168,0.0062250197],"study_design_scores_gemma":[0.00016361663,0.0016019681,0.9928149,0.000005856939,0.00011221048,0.0013130794,0.000033806406,0.0008854918,0.0023921325,0.00006204551,0.00060914614,0.0000057353905],"about_ca_topic_score_codex":0.0008091797,"about_ca_topic_score_gemma":0.00065884436,"teacher_disagreement_score":0.0029454639,"about_ca_system_score_codex":0.00013803845,"about_ca_system_score_gemma":0.00012907835,"threshold_uncertainty_score":0.009853542},"labels":[],"label_agreement":null},{"id":"W2280194506","doi":"10.3747/co.23.2780","title":"Impact of Oxaliplatin-Induced Neuropathy in Patients with Colorectal Cancer: A Prospective Evaluation at a Single Institution","year":2016,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"International Society of Oncology Pharmacy Practitioners","keywords":"Oxaliplatin; Medicine; Colorectal cancer; Cancer; Internal medicine; Prospective cohort study; Oncology; General surgery","score_opus":0.09138890492481176,"score_gpt":0.4341871736735143,"score_spread":0.3427982687487025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2280194506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992316,0.00013876102,0.00005390485,0.000026094489,0.0000022552645,0.00003981098,0.00025991825,0.00000299139,0.00024462907],"genre_scores_gemma":[0.9992374,0.00011937049,0.00010065568,0.000031361356,0.000007775594,0.000029573417,0.00036498206,0.0000022646382,0.000106566746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829537,0.00054711715,0.00024400585,0.0003198187,0.00037727578,0.00021653579],"domain_scores_gemma":[0.9944629,0.0005513027,0.0030044026,0.00033818808,0.0007831721,0.0008601045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019841308,0.00035533088,0.0005482537,0.0010613034,0.0008842735,0.0010830293,0.0005293402,0.00045153074,0.0012965519],"category_scores_gemma":[0.0045173364,0.0005379477,0.0008267376,0.0018172711,0.00045303605,0.0010206753,0.001093745,0.0007100858,0.00038475543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013999625,0.00006194081,0.9990409,0.000005721379,0.00003851421,0.000026311816,0.000040133127,0.000016580829,0.000050695882,0.0000024478868,0.000024135963,0.00055245264],"study_design_scores_gemma":[0.000021822598,0.00054386776,0.9988319,0.0000060665775,0.000043160806,0.00013954328,0.0002070737,0.00006669829,0.00004965017,0.000004476824,0.00008034002,0.000005370355],"about_ca_topic_score_codex":0.0076694083,"about_ca_topic_score_gemma":0.013789547,"teacher_disagreement_score":0.0076694083,"about_ca_system_score_codex":0.00077154906,"about_ca_system_score_gemma":0.00089230685,"threshold_uncertainty_score":0.01524955},"labels":[],"label_agreement":null},{"id":"W2280282551","doi":"10.1200/jco.2007.25.18_suppl.17031","title":"The Oncology Symptom Control and Information Resource (OSCIR): Using information technology to improve the management of cancer treatment-related side effects","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Documentation; Workgroup; Mucositis; Common Terminology Criteria for Adverse Events; Adverse effect; Radiation therapy; Internal medicine; Computer science","score_opus":0.02517999940861822,"score_gpt":0.45291415959047115,"score_spread":0.42773416018185295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2280282551","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40946993,0.005953798,0.24873078,0.012597269,0.0006206213,0.02922529,0.013177981,0.04028717,0.23993716],"genre_scores_gemma":[0.36134574,0.003972905,0.5922481,0.0016791165,0.00031216568,0.008013405,0.011400027,0.0011331944,0.019895336],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965217,0.0018556239,0.0004955246,0.00013707425,0.00085209083,0.00013797935],"domain_scores_gemma":[0.98783547,0.007328326,0.0009842868,0.0007240324,0.0021103595,0.0010175459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008676162,0.0004941372,0.00035932552,0.0022023953,0.00046559126,0.0014574406,0.0009915314,0.00048269972,0.0058605135],"category_scores_gemma":[0.020765165,0.00027883318,0.0005856245,0.0017735638,0.000509661,0.0015677626,0.0018754231,0.00057837804,0.0020956874],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052662013,0.0007750809,0.025193997,0.0018062706,0.000055899516,0.00025286144,0.0014352407,0.001586913,0.004385154,0.0016231294,0.050826494,0.91153234],"study_design_scores_gemma":[0.0014367499,0.0069462704,0.2620764,0.0037060983,0.0005794745,0.004879295,0.002562801,0.029774977,0.031377014,0.0050386013,0.65124345,0.00037897762],"about_ca_topic_score_codex":0.0017627715,"about_ca_topic_score_gemma":0.0034906655,"teacher_disagreement_score":0.008676162,"about_ca_system_score_codex":0.00087771076,"about_ca_system_score_gemma":0.0038683363,"threshold_uncertainty_score":0.04588443},"labels":[],"label_agreement":null},{"id":"W2280900900","doi":"10.1200/jco.2014.32.26_suppl.142","title":"Overall survival (OS) in metastatic breast cancer (MBC): Are we using the right endpoint in the right way?","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Clinical trial; Clinical endpoint; Oncology; Progression-free survival; Metastatic breast cancer; Randomized controlled trial; Cancer; Chemotherapy; Breast cancer","score_opus":0.1726119135008372,"score_gpt":0.5092724751579168,"score_spread":0.33666056165707964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2280900900","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009738547,0.9758974,0.001148639,0.009960595,0.0005542259,0.0003627532,0.0011387387,0.000014151518,0.00118493],"genre_scores_gemma":[0.15580605,0.8148004,0.0084790485,0.0144277625,0.0027807602,0.0017758396,0.0014985113,0.00006287875,0.0003688229],"study_design_codex":"systematic_review","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9421732,0.032070853,0.018640906,0.002231704,0.004412988,0.0004702492],"domain_scores_gemma":[0.7385876,0.21820827,0.030446395,0.0026620307,0.008921037,0.0011746287],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0671154,0.0007558985,0.008665308,0.011367854,0.0005932952,0.004588176,0.0018878093,0.0027598434,0.0038715329],"category_scores_gemma":[0.17282133,0.00064628583,0.0037313534,0.014908612,0.0019805063,0.007045528,0.001792068,0.0021485619,0.0007147364],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004334543,0.000072459865,0.022884008,0.51960355,0.010148307,0.00021878188,0.00090164726,0.0004262156,0.0009280622,0.0035858522,0.012052986,0.4248436],"study_design_scores_gemma":[0.00364634,0.0029416133,0.06911903,0.73784506,0.04013059,0.0014671258,0.0025630174,0.0009717597,0.001000191,0.015996773,0.124034286,0.0002842106],"about_ca_topic_score_codex":0.0012186158,"about_ca_topic_score_gemma":0.0028825894,"teacher_disagreement_score":0.9328846,"about_ca_system_score_codex":0.0021547547,"about_ca_system_score_gemma":0.004751742,"threshold_uncertainty_score":0.3549444},"labels":[],"label_agreement":null},{"id":"W2283778444","doi":"","title":"A phase I and pharmacokinetic (PK) study of vinorelbine liposomes injection in patients with advanced solid tumors, non-Hodgkin’s lymphoma, and Hodgkin’s disease","year":2007,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Vinorelbine; Pharmacokinetics; Medicine; Pharmacology; Lymphoma; Drug; In vivo; Paclitaxel; Internal medicine; Oncology; Cancer; Chemotherapy; Biology","score_opus":0.0105058140867031,"score_gpt":0.3312848075388701,"score_spread":0.320778993452167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2283778444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965501,0.00059473555,0.00044465216,0.0001345905,0.00002907478,0.0012053944,0.0002924872,0.000035343885,0.0007136575],"genre_scores_gemma":[0.99578875,0.0005596882,0.0009094756,0.0002085083,0.00005677713,0.0008288004,0.000640414,0.000011094419,0.0009965344],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996674,0.0001226183,0.000016822472,0.000075455384,0.00004026387,0.000077397766],"domain_scores_gemma":[0.9995401,0.0000828082,0.00007109775,0.000045071527,0.00003545524,0.00022540064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011659364,0.00088234566,0.0012452507,0.00036638218,0.0003629373,0.00065114105,0.00047600653,0.000664414,0.001857729],"category_scores_gemma":[0.0006208958,0.0005525179,0.00069655717,0.00028054192,0.00082621473,0.0006495549,0.0002506772,0.0018680488,0.00059870956],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.434206,0.19447015,0.026376422,0.00067036325,0.0010417048,0.0008988324,0.001184024,0.0033305872,0.21676798,0.0005634908,0.00334055,0.11714983],"study_design_scores_gemma":[0.12935477,0.8197331,0.03434074,0.000017043356,0.00028673687,0.0006159482,0.000118943404,0.001489159,0.010184764,0.00013247158,0.0036912055,0.000035152094],"about_ca_topic_score_codex":0.00087487017,"about_ca_topic_score_gemma":0.0011993273,"teacher_disagreement_score":0.001857729,"about_ca_system_score_codex":0.00076667697,"about_ca_system_score_gemma":0.0010713679,"threshold_uncertainty_score":0.006214738},"labels":[],"label_agreement":null},{"id":"W2286020305","doi":"10.1200/jco.2012.30.15_suppl.e19599","title":"Frequency, indications, outcomes, and factors associated with successful opioid rotation in cancer patients presenting to an outpatient supportive care center.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer pain; Opioid; Ambulatory; Delirium; Cancer; Brief Pain Inventory; Physical therapy; Emergency medicine; Internal medicine; Chronic pain; Intensive care medicine","score_opus":0.11283822869512349,"score_gpt":0.49259876485983006,"score_spread":0.37976053616470656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2286020305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99907035,0.00022594193,0.000020162543,0.00012001871,0.000005410299,0.000011909068,0.0002604815,0.000002503925,0.00028330143],"genre_scores_gemma":[0.99947876,0.00007717974,0.000041758743,0.000044684697,0.000013540978,0.000010267126,0.0002706432,0.0000012903203,0.00006185035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944896,0.00012597509,0.00009759968,0.00007887312,0.00011809899,0.0001305627],"domain_scores_gemma":[0.995006,0.0011383009,0.0028880716,0.000070770104,0.0002721047,0.00062484696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006060769,0.0001761064,0.00024221944,0.0005600242,0.0005035021,0.0006743942,0.00035738386,0.00047337372,0.0028815933],"category_scores_gemma":[0.0047830422,0.00022764163,0.00032583476,0.0009092036,0.00022112545,0.0005244538,0.00046555686,0.00076044915,0.00025681074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040832914,0.000026064345,0.99930775,0.00000434707,0.000006436561,0.00006558746,0.00001785519,0.0000080369055,0.000016342163,0.0000024041371,0.00012089593,0.0003833877],"study_design_scores_gemma":[0.000009156647,0.00010911168,0.99879044,0.000013970769,0.000012107794,0.00048204654,0.00027118984,0.00016562994,0.000018913559,0.000008465857,0.000116560564,0.000002470382],"about_ca_topic_score_codex":0.0043504317,"about_ca_topic_score_gemma":0.006914734,"teacher_disagreement_score":0.0043504317,"about_ca_system_score_codex":0.0005168503,"about_ca_system_score_gemma":0.0006721132,"threshold_uncertainty_score":0.009639859},"labels":[],"label_agreement":null},{"id":"W2286152207","doi":"10.1200/jco.2015.33.7_suppl.141","title":"Final analysis of COMET-2: Cabozantinib (Cabo) versus mitoxantrone/prednisone (MP) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) with moderate to severe pain who were previously treated with docetaxel (D) and abiraterone (A) and/or enzalutamide (E).","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Clinical endpoint; Prostate cancer; Docetaxel; Brief Pain Inventory; Randomization; Mitoxantrone; Internal medicine; Population; Enzalutamide; Cabazitaxel; Cabozantinib; Oncology; Cancer; Randomized controlled trial; Urology; Androgen deprivation therapy; Chemotherapy; Chronic pain; Physical therapy; Androgen receptor","score_opus":0.14749090854508987,"score_gpt":0.4478939216211045,"score_spread":0.3004030130760146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2286152207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9658901,0.0062834937,0.003969393,0.001164994,0.0008175171,0.009791162,0.007877934,0.00038018398,0.003825187],"genre_scores_gemma":[0.97911227,0.0008568753,0.003973007,0.0007731543,0.00036527982,0.005789024,0.00567736,0.00008233541,0.003370606],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.993947,0.0042856093,0.000334161,0.0005348795,0.0005066093,0.0003916994],"domain_scores_gemma":[0.99259514,0.0037640843,0.0011817145,0.0006523514,0.0006309633,0.0011757902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013346819,0.0017216261,0.006333002,0.00065186433,0.0004834957,0.0014912509,0.0013044085,0.002010144,0.009712841],"category_scores_gemma":[0.009969563,0.0007080326,0.008091518,0.00063326303,0.00093249383,0.0011155911,0.00064131554,0.002536069,0.0012301643],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9830702,0.0010798065,0.0014968814,0.00053199026,0.0029130152,0.000042004038,0.00004982393,0.00059641566,0.00200988,0.00008733722,0.0007130092,0.007409726],"study_design_scores_gemma":[0.6279558,0.32401165,0.024813404,0.00010663504,0.009963675,0.00018472387,0.00008035813,0.005090882,0.0035562168,0.00047167065,0.0037054776,0.000059492046],"about_ca_topic_score_codex":0.00071591645,"about_ca_topic_score_gemma":0.0012672752,"teacher_disagreement_score":0.013346819,"about_ca_system_score_codex":0.001214679,"about_ca_system_score_gemma":0.0012936594,"threshold_uncertainty_score":0.07058561},"labels":[],"label_agreement":null},{"id":"W2287841863","doi":"10.1200/jco.2012.30.15_suppl.e13126","title":"Improved 5-year overall survival (OS) in breast cancer (CA) patients from 1994 to 2008.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Vinorelbine; Trastuzumab; Internal medicine; Capecitabine; Cohort; Docetaxel; Breast cancer; Oncology; Hormonal therapy; Metastatic breast cancer; Cancer; Chemotherapy; Overall survival; Aromatase","score_opus":0.0951984904795451,"score_gpt":0.4846176165296104,"score_spread":0.3894191260500653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2287841863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98032296,0.0025093344,0.0001145201,0.0004938426,0.0000339559,0.00003452782,0.013613719,0.000014050693,0.0028630083],"genre_scores_gemma":[0.9928148,0.00030557666,0.00010042723,0.00015306097,0.000013232339,0.000009907049,0.00602639,0.0000026070536,0.0005739634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996086,0.000041198473,0.000024132456,0.000062473824,0.00013337348,0.00013018725],"domain_scores_gemma":[0.99932337,0.000063804735,0.0002081291,0.000028005163,0.00022764769,0.00014910063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072587613,0.0001573345,0.0002443898,0.00060793804,0.0004052592,0.0005292784,0.00040733855,0.0003293941,0.0018729994],"category_scores_gemma":[0.0017473866,0.00009470289,0.0006002042,0.0018014592,0.00020761251,0.0002502006,0.00034439308,0.00046339093,0.00014821478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008769937,0.000020173557,0.9872478,0.00004497469,0.00013757414,0.000043467262,0.00006105351,0.00015825538,0.00012710394,0.00003190796,0.0023945512,0.008856123],"study_design_scores_gemma":[0.00001550788,0.000040194354,0.9990528,0.0000061041833,0.00004461555,0.000030848194,0.000027809441,0.0000620459,0.000018097484,0.000007869736,0.0006922928,0.0000016934256],"about_ca_topic_score_codex":0.55946404,"about_ca_topic_score_gemma":0.7422723,"teacher_disagreement_score":0.55946404,"about_ca_system_score_codex":0.0040493254,"about_ca_system_score_gemma":0.004226748,"threshold_uncertainty_score":0.88626075},"labels":[],"label_agreement":null},{"id":"W2291072211","doi":"10.1177/0840470415607256","title":"L’émergence de la thérapeutique de précision","year":2015,"lang":"fr","type":"review","venue":"Healthcare Management Forum","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; Roche (Canada); Shared Health","funders":"","keywords":"Computer science","score_opus":0.06405395527016826,"score_gpt":0.4568491839326713,"score_spread":0.39279522866250305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2291072211","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007914226,0.92935085,0.0074060243,0.04083512,0.002184264,0.00004551541,0.000046749137,0.000066881956,0.019273166],"genre_scores_gemma":[0.026322689,0.93267465,0.009890184,0.020928903,0.0038540594,0.00015122019,0.00007773444,0.00004137952,0.0060592173],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99066484,0.004773221,0.00066894136,0.00079680904,0.0026885858,0.00040764865],"domain_scores_gemma":[0.9841345,0.011631772,0.001270651,0.00080746156,0.0017355256,0.00042011638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009016035,0.0010291473,0.0020856168,0.0036101285,0.0015602317,0.006689235,0.0015556492,0.0063773524,0.0049217213],"category_scores_gemma":[0.012651802,0.00048720255,0.0018002257,0.0028310083,0.0108616995,0.007538735,0.003780284,0.010720588,0.0016187554],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011747964,0.00012244993,0.000933787,0.016448725,0.00026853275,0.0004801631,0.003530812,0.0005642896,0.0019459279,0.3334107,0.034982987,0.6071942],"study_design_scores_gemma":[0.000034451197,0.00014460066,0.0012250063,0.010680014,0.00011184737,0.0016758149,0.00088697707,0.00021085893,0.0011222705,0.067231625,0.91661775,0.000058766214],"about_ca_topic_score_codex":0.0043820892,"about_ca_topic_score_gemma":0.0039660865,"teacher_disagreement_score":0.009016035,"about_ca_system_score_codex":0.005676867,"about_ca_system_score_gemma":0.010334544,"threshold_uncertainty_score":0.047681928},"labels":[],"label_agreement":null},{"id":"W2300122958","doi":"10.1200/jco.2005.23.16_suppl.4611","title":"First- and second-line chemotherapy with docetaxel or mitoxantrone in patients with hormone-refractory prostate cancer (HRPC): Does sequence matter?","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Docetaxel; Mitoxantrone; Medicine; Internal medicine; Chemotherapy; Oncology; Regimen; Prostate cancer; Performance status; Progression-free survival; Surgery; Gastroenterology; Cancer","score_opus":0.04831283444831135,"score_gpt":0.42675120801868766,"score_spread":0.3784383735703763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300122958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920637,0.005976057,0.000062310224,0.00047384095,0.000016490423,0.000042926968,0.00018401179,0.0000032149999,0.0011773813],"genre_scores_gemma":[0.99835,0.0011794765,0.00006674117,0.0001131366,0.000016279719,0.000008278935,0.00013895895,0.000001132319,0.0001260934],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995078,0.00015849089,0.00005295517,0.00006739506,0.00013857704,0.000074821975],"domain_scores_gemma":[0.9980609,0.0005604249,0.0008972251,0.000048400507,0.00015234204,0.0002807632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008643854,0.00008491835,0.00043910518,0.00033386456,0.00036059105,0.00048819467,0.00027464182,0.000328029,0.0012835719],"category_scores_gemma":[0.0037462,0.000105121784,0.00032306512,0.0007671561,0.00023230223,0.000214162,0.00020392549,0.00040423093,0.00011642337],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005138436,0.00016456516,0.9583453,0.00019403538,0.00014352903,0.00027843472,0.00013595523,0.00020693168,0.00044633646,0.000045190252,0.00050846115,0.034392796],"study_design_scores_gemma":[0.0004022454,0.0022194549,0.99341667,0.00014164989,0.000246391,0.0009975914,0.00029881313,0.0007433115,0.00019003393,0.00011472273,0.0012207165,0.000008467304],"about_ca_topic_score_codex":0.04747636,"about_ca_topic_score_gemma":0.13131136,"teacher_disagreement_score":0.04747636,"about_ca_system_score_codex":0.0017109115,"about_ca_system_score_gemma":0.0032742072,"threshold_uncertainty_score":0.09439999},"labels":[],"label_agreement":null},{"id":"W2303023826","doi":"10.1200/jco.2007.25.18_suppl.1017","title":"Central nervous system (CNS) metastases (mets) in HER2+ metastatic breast cancer (MBC) patients (pts): Patterns of relapse and impact on survival","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Internal medicine; Metastatic breast cancer; Breast cancer; Trastuzumab; Cancer; Oncology","score_opus":0.08275607319581818,"score_gpt":0.47835817984924983,"score_spread":0.39560210665343165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2303023826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99970967,0.00010259919,0.000014710895,0.0000161988,9.305431e-7,0.0000013587115,0.00005415473,6.837017e-7,0.0000995791],"genre_scores_gemma":[0.9997603,0.000072826486,0.000020419091,0.000008598206,0.0000034728428,0.0000017027864,0.00008663432,4.795415e-7,0.000045556266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998704,0.00003329554,0.000015485693,0.00002614541,0.000025918253,0.000028774244],"domain_scores_gemma":[0.9994326,0.000113497474,0.00029119544,0.0000182398,0.000044426586,0.000100046236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022228746,0.000120673576,0.00019239419,0.00044719072,0.00019202726,0.00030720633,0.0001255563,0.00018146637,0.0012062795],"category_scores_gemma":[0.0010239946,0.00008135919,0.00018205545,0.00050901336,0.00019493782,0.00025313682,0.00026371158,0.00019530767,0.0001597481],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012357904,0.000010984163,0.9977423,0.000004650366,0.000011285393,0.0001260895,0.00002274934,0.000026148324,0.0001912493,0.0000028911704,0.000040441573,0.0016976479],"study_design_scores_gemma":[0.0000037565487,0.00011992439,0.9985537,0.0000031038396,0.000013115196,0.00096631364,0.000094415365,0.000100445315,0.00006975756,0.0000120062905,0.00006191917,0.0000015171896],"about_ca_topic_score_codex":0.0020262096,"about_ca_topic_score_gemma":0.004009164,"teacher_disagreement_score":0.0020262096,"about_ca_system_score_codex":0.00018315096,"about_ca_system_score_gemma":0.00014151212,"threshold_uncertainty_score":0.0040354133},"labels":[],"label_agreement":null},{"id":"W2312199392","doi":"10.1515/hc.2011.019","title":"The first taxane peroxide from the rooted cuttings of <i>Taxus canadensis</i>","year":2011,"lang":"en","type":"article","venue":"Heterocyclic Communications","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"Hebei Medical University; National Natural Science Foundation of China","keywords":"Taxane; Chemistry; Cutting; Peroxide; Botany; Organic chemistry; Biology","score_opus":0.06742542710729263,"score_gpt":0.30168422677317625,"score_spread":0.23425879966588362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312199392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885739,0.0018152759,0.0015746419,0.00008448223,0.00003662941,0.00008953738,0.0015963735,0.000038427148,0.0061907596],"genre_scores_gemma":[0.9855914,0.0009897252,0.0017706187,0.00006426957,0.000009424136,0.000023013918,0.0022134804,0.000018246112,0.009319766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999627,0.0000020613686,0.0000012049375,0.000010504035,0.000010408108,0.000013202293],"domain_scores_gemma":[0.9999286,0.000005546378,0.000015768219,0.000005442152,0.00001909569,0.000025555832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000037247184,0.00035765686,0.000127355,0.00034263232,0.00030787423,0.00022123406,0.0001516936,0.0002466055,0.0023411936],"category_scores_gemma":[0.000060663377,0.00010507788,0.00018816485,0.0002516775,0.00023075345,0.00022943538,0.00017355126,0.0006224043,0.00034547265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007699788,0.000009702614,0.00044816773,0.000032130905,0.0000053478625,0.00011313454,0.000035291316,0.00003740297,0.9970323,0.000042575182,0.00003770783,0.002129154],"study_design_scores_gemma":[0.000026332913,0.00081297767,0.04473188,0.000024531168,0.00005255357,0.00039727136,0.0003563766,0.00020860163,0.9409573,0.00020613657,0.0122052645,0.00002071168],"about_ca_topic_score_codex":0.0062274863,"about_ca_topic_score_gemma":0.008566014,"teacher_disagreement_score":0.0062274863,"about_ca_system_score_codex":0.0003359405,"about_ca_system_score_gemma":0.00040671884,"threshold_uncertainty_score":0.012382507},"labels":[],"label_agreement":null},{"id":"W2313563487","doi":"10.1158/0008-5472.sabcs10-p5-10-23","title":"Abstract P5-10-23: Frequency and Cost of Chemotherapy-Related Serious Adverse Effects in a Canadian Population Sample of Women with Estrogen and/or Progesterone Receptor Positive Early Stage Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Breast cancer; Anthracycline; Population; Logistic regression; Chemotherapy; Cancer; Emergency department; Adverse effect; Internal medicine; Stage (stratigraphy); Estrogen receptor; Gynecology; Obstetrics","score_opus":0.017582450444357717,"score_gpt":0.3605277780415742,"score_spread":0.3429453275972165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313563487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888644,0.0005203058,0.000068071255,0.00022823564,0.0000048971633,0.00006241294,0.008916323,0.0000075825756,0.0013276776],"genre_scores_gemma":[0.9954282,0.0003760821,0.00011530353,0.00005642542,0.0000056314484,0.00002099633,0.0036937352,0.000002040167,0.00030162212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994116,0.000049127888,0.00005561883,0.0000896005,0.0002767285,0.00011731365],"domain_scores_gemma":[0.99862576,0.00008923817,0.0005443195,0.000042039115,0.00045749304,0.00024118584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040742764,0.00025936266,0.0002909273,0.0013016869,0.00084461505,0.0005326934,0.0008070601,0.00024138925,0.0015756246],"category_scores_gemma":[0.0025804376,0.00022348156,0.0005285633,0.003195185,0.00026638008,0.00020757373,0.00045924677,0.00037248782,0.00012112319],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037058995,0.0000106413,0.99804854,0.000020262858,0.000040035837,0.00003127765,0.000036878973,0.000061575935,0.000043729513,0.000016118778,0.0004081786,0.0012456102],"study_design_scores_gemma":[0.0000036457038,0.000010210637,0.9994892,0.0000054936413,0.000012828497,0.000038203063,0.000064422966,0.00016846917,0.0000165221,0.0000047045564,0.00018414579,0.0000020506636],"about_ca_topic_score_codex":0.9544445,"about_ca_topic_score_gemma":0.9569196,"teacher_disagreement_score":0.045555472,"about_ca_system_score_codex":0.008562236,"about_ca_system_score_gemma":0.008282914,"threshold_uncertainty_score":0.091647446},"labels":[],"label_agreement":null},{"id":"W2313623943","doi":"10.1200/jco.2006.24.18_suppl.522","title":"Left ventricular function following adjuvant chemotherapy for breast cancer: The NCIC CTG MA5 experience","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Queen's University; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Epirubicin; Ejection fraction; Breast cancer; Internal medicine; Cardiotoxicity; Cyclophosphamide; Cardiac function curve; Cancer; Chemotherapy; Oncology; Cardiology; Heart failure","score_opus":0.07001898704877614,"score_gpt":0.4792698093658994,"score_spread":0.4092508223171233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313623943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821591,0.011892763,0.0001483515,0.0012796781,0.000041740597,0.00010089465,0.00045241436,0.0000111779445,0.0039138263],"genre_scores_gemma":[0.99151915,0.005176866,0.0002237715,0.0010025295,0.00013220977,0.00008512302,0.000974205,0.0000056983095,0.00088047725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995697,0.00022755402,0.00002163457,0.000041955154,0.00006689948,0.00007220325],"domain_scores_gemma":[0.9995408,0.000117659816,0.00006790413,0.000030579537,0.0000296211,0.0002133708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013138991,0.00021516145,0.00026234836,0.00020043518,0.00025906955,0.00042074706,0.00031007468,0.00032810532,0.0011746617],"category_scores_gemma":[0.0012326068,0.00007139498,0.00016695609,0.0005577642,0.00027120917,0.00020129493,0.00037589285,0.0003505597,0.00025387085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012360583,0.0022690145,0.66740316,0.00035831824,0.00026152024,0.0030643677,0.00093014986,0.0009121105,0.0060663777,0.00062219566,0.015119869,0.29063237],"study_design_scores_gemma":[0.0019663684,0.013571455,0.9454759,0.00022024936,0.00020475982,0.005222479,0.00030333863,0.00068980287,0.001427971,0.0001571635,0.030735316,0.000025192674],"about_ca_topic_score_codex":0.005045019,"about_ca_topic_score_gemma":0.009793342,"teacher_disagreement_score":0.005045019,"about_ca_system_score_codex":0.0011331113,"about_ca_system_score_gemma":0.0009208066,"threshold_uncertainty_score":0.0100313425},"labels":[],"label_agreement":null},{"id":"W2315082559","doi":"10.1200/jco.2016.34.3_suppl.157","title":"Management of aromatase inhibitor-associated musculoskeletal symptoms: A systematic review.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Jadad scale; Randomized controlled trial; Psychological intervention; Observational study; Internal medicine; Cohort; Acupuncture; MEDLINE; Physical therapy; Cohort study; Breast cancer; Alternative medicine; Cochrane Library; Cancer; Pathology; Psychiatry","score_opus":0.06270303492056029,"score_gpt":0.48423382119029706,"score_spread":0.4215307862697368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315082559","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013578879,0.996461,0.00014443837,0.00029280406,0.00010633999,0.0009045125,0.0004044825,0.000010341458,0.00031811508],"genre_scores_gemma":[0.017219529,0.97913384,0.00092495297,0.00057887816,0.00007665186,0.0015843295,0.0002632779,0.000004888656,0.00021355959],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9925275,0.002637672,0.0028092791,0.00041496422,0.0013748852,0.00023577118],"domain_scores_gemma":[0.98085886,0.011982546,0.004970096,0.00025896312,0.0016683536,0.00026119288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008548941,0.0014782287,0.008334119,0.007813449,0.00069842534,0.0025960896,0.0017858623,0.002002788,0.005200191],"category_scores_gemma":[0.03237757,0.0011159095,0.006931673,0.010184631,0.00079725095,0.002218788,0.0013173291,0.0011374294,0.00043288045],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017930822,0.000013110571,0.00033955177,0.9783664,0.004445889,0.000060987113,0.0001038914,0.000044503664,0.00008487782,0.0000635457,0.00081044494,0.015487437],"study_design_scores_gemma":[0.0007501195,0.00037955053,0.0041052424,0.92051446,0.061635528,0.00041603894,0.00029791688,0.00009503062,0.00015166616,0.00019164666,0.011429228,0.000033428118],"about_ca_topic_score_codex":0.0068315505,"about_ca_topic_score_gemma":0.024851354,"teacher_disagreement_score":0.008548941,"about_ca_system_score_codex":0.004253658,"about_ca_system_score_gemma":0.013303731,"threshold_uncertainty_score":0.045211673},"labels":[],"label_agreement":null},{"id":"W2315818120","doi":"10.1007/s00520-016-3199-x","title":"A systematic review of patient-reported outcome measures of neuropathy in children, adolescents and young adults","year":2016,"lang":"en","type":"review","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Children's Hospital of Eastern Ontario","funders":"National Cancer Institute","keywords":"Medicine; Pain medicine; Nursing research; Pediatrics; Patient-reported outcome; MEDLINE; Young adult; Quality of Life Research; Physical therapy; Public health; Psychiatry; Gerontology; Quality of life (healthcare); Anesthesiology; Nursing","score_opus":0.042393964371267204,"score_gpt":0.3797277157736475,"score_spread":0.3373337514023803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315818120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018588598,0.9970939,0.00009283827,0.000087836925,0.00006746133,0.0001716187,0.0004894933,0.000003761223,0.00013413934],"genre_scores_gemma":[0.03244304,0.96510446,0.0010337024,0.00048127037,0.000057796053,0.0004171764,0.000365318,0.0000041351973,0.00009313281],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9921985,0.00212155,0.003796078,0.0006584404,0.0010421047,0.00018331545],"domain_scores_gemma":[0.9823026,0.012434098,0.003891324,0.0002123508,0.0009917176,0.00016782302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069932444,0.0013502095,0.00942482,0.0057450393,0.00046111442,0.0020642674,0.001678113,0.0014182796,0.0031692446],"category_scores_gemma":[0.031808887,0.0007677016,0.01188086,0.007226477,0.00073603913,0.0016606965,0.001541267,0.0014126766,0.00015636641],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038578053,0.000024148609,0.0025360037,0.9242061,0.034782548,0.00008131027,0.00014418921,0.00010188151,0.00008883213,0.00012815198,0.0009354092,0.03658567],"study_design_scores_gemma":[0.0008933943,0.00048163303,0.01942009,0.64577824,0.31376648,0.00065628707,0.0004332947,0.0001267174,0.00017637484,0.00039138435,0.017787706,0.00008827102],"about_ca_topic_score_codex":0.008785618,"about_ca_topic_score_gemma":0.03611916,"teacher_disagreement_score":0.00942482,"about_ca_system_score_codex":0.0024899037,"about_ca_system_score_gemma":0.0061488063,"threshold_uncertainty_score":0.036984265},"labels":[],"label_agreement":null},{"id":"W2317767830","doi":"10.1158/0008-5472.sabcs-77","title":"BCIRG 005 main efficacy analysis: a phase III randomized trial comparing docetaxel in combination with doxorubicin and cyclophosphamide (TAC) versus doxorubicin and cyclophosphamide followed by docetaxel (AC→T) in women with Her-2/neu negative axillary lymph node positive early breast cancer.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; William Osler Health System","funders":"","keywords":"Medicine; Docetaxel; Internal medicine; Anthracycline; Febrile neutropenia; Breast cancer; Neutropenia; Cyclophosphamide; Regimen; Mucositis; Clinical endpoint; Metastatic breast cancer; Chemotherapy; Gastroenterology; Doxorubicin; Cancer; Oncology; Surgery; Randomized controlled trial","score_opus":0.02207255447226454,"score_gpt":0.36669337262837537,"score_spread":0.34462081815611084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317767830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9205118,0.02423196,0.0013797334,0.0041233585,0.0014709642,0.013445209,0.008060054,0.0005154542,0.026261408],"genre_scores_gemma":[0.9579361,0.005915748,0.0028426142,0.00427326,0.0007204444,0.00981098,0.0050311172,0.00006500209,0.013404759],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990761,0.00065231737,0.000029860581,0.00008466046,0.00006323981,0.00009373732],"domain_scores_gemma":[0.9993,0.00018144195,0.00016504919,0.000029675852,0.000033682187,0.00029002968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016652872,0.0015069937,0.0018204594,0.00054361345,0.0003490602,0.0009976665,0.0011651148,0.0015049021,0.013852858],"category_scores_gemma":[0.0019810484,0.00045613697,0.0011602974,0.00055447436,0.0007519421,0.0006732136,0.00036140584,0.0031688458,0.001577181],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96319723,0.0043264762,0.0005108239,0.000934162,0.0008085759,0.00004154239,0.000024106832,0.00043951068,0.0018075745,0.00021467464,0.0030424006,0.024653042],"study_design_scores_gemma":[0.96931154,0.027715834,0.0010548343,0.000051205974,0.00030280338,0.00002358081,0.000007356708,0.0002680999,0.00014167308,0.00011362092,0.0010027112,0.000006777692],"about_ca_topic_score_codex":0.0020574841,"about_ca_topic_score_gemma":0.005581817,"teacher_disagreement_score":0.013852858,"about_ca_system_score_codex":0.0011626862,"about_ca_system_score_gemma":0.0015117134,"threshold_uncertainty_score":0.046342432},"labels":[],"label_agreement":null},{"id":"W2319042377","doi":"10.1097/01.cot.0000269629.11781.a7","title":"Advanced Breast Cancer","year":2007,"lang":"en","type":"article","venue":"Oncology Times","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Exemestane; Fulvestrant; Medicine; Breast cancer; Tolerability; Aromatase inhibitor; Aromatase; Internal medicine; Anastrozole; Oncology; Cancer; Clinical trial; Letrozole; Tamoxifen; Gynecology; Adverse effect","score_opus":0.01572584066330776,"score_gpt":0.39040154825276197,"score_spread":0.37467570758945423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319042377","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062545035,0.052684076,0.0015681193,0.022141408,0.012165894,0.00058230787,0.011632527,0.0010291737,0.89194196],"genre_scores_gemma":[0.0422952,0.04486966,0.0044326256,0.02319092,0.005542428,0.0007065925,0.02457207,0.0002307375,0.8541597],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966645,0.000036751157,0.000019132733,0.00008042202,0.0001318875,0.00006529515],"domain_scores_gemma":[0.9996848,0.000018641966,0.000026836902,0.00003769909,0.00013046653,0.00010152182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004249721,0.00075410696,0.0004355743,0.0007287216,0.0007018884,0.0015779764,0.0007297978,0.0008492525,0.16012011],"category_scores_gemma":[0.00063145586,0.00019655749,0.0005208294,0.0007825516,0.00023870688,0.00048620257,0.0009596106,0.0017317614,0.11281354],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020132365,0.00009719835,0.0021899373,0.00027071274,0.000034948054,0.00056972407,0.000036870777,0.000070598086,0.0011658238,0.0035296706,0.74237084,0.24946234],"study_design_scores_gemma":[0.000059256417,0.00006007917,0.0021913694,0.000104524835,0.000009835737,0.0007798359,0.000020841228,0.000037308633,0.00017363063,0.0005704751,0.99598783,0.000004982365],"about_ca_topic_score_codex":0.0022513566,"about_ca_topic_score_gemma":0.0058596996,"teacher_disagreement_score":0.16012011,"about_ca_system_score_codex":0.0012691047,"about_ca_system_score_gemma":0.0011594517,"threshold_uncertainty_score":0.53565514},"labels":[],"label_agreement":null},{"id":"W2320446122","doi":"10.1139/o2012-005","title":"Oroxylin A improves the sensitivity of HT-29 human colon cancer cells to 5-FU through modulation of the COX-2 signaling pathway","year":2012,"lang":"en","type":"article","venue":"Biochemistry and Cell Biology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacology; Chemistry; In vivo; Colorectal cancer; In vitro; Cell growth; Apoptosis; Cancer cell; Cancer research; Cancer; Medicine; Biology; Internal medicine; Biochemistry","score_opus":0.02019605447864938,"score_gpt":0.30091405217028006,"score_spread":0.2807179976916307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320446122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992078,0.004246358,0.0009963403,0.00012045725,0.000065802364,0.000055572666,0.00021710299,0.00007895719,0.0021414058],"genre_scores_gemma":[0.9944463,0.002069403,0.00087909,0.00006595838,0.000014324113,0.000019904213,0.0001781306,0.00000686753,0.0023199292],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999329,0.000016464568,0.000008086337,0.000009226612,0.000017570826,0.000015756726],"domain_scores_gemma":[0.99993,0.0000133894555,0.000015583539,0.000006920841,0.0000119462975,0.000022142465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006913759,0.0003669275,0.00029703186,0.00028626912,0.00013052288,0.00017675204,0.00013619741,0.00019336319,0.001780581],"category_scores_gemma":[0.000097847806,0.00010452205,0.0003083013,0.000109986635,0.0001368701,0.00016504184,0.00014751122,0.0003921457,0.00019411521],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050717394,0.00010968631,0.00023176653,0.0001189349,0.000014190883,0.00007476134,0.000018291532,0.000070799084,0.99609727,0.000036638983,0.000071913455,0.002648636],"study_design_scores_gemma":[0.00014363205,0.004940604,0.012458267,0.000017600018,0.000101373415,0.0002978337,0.000070062844,0.00065082026,0.9754995,0.000048336515,0.005760235,0.000011731646],"about_ca_topic_score_codex":0.00088887993,"about_ca_topic_score_gemma":0.0020423236,"teacher_disagreement_score":0.001780581,"about_ca_system_score_codex":0.00013280529,"about_ca_system_score_gemma":0.00017380249,"threshold_uncertainty_score":0.00595659},"labels":[],"label_agreement":null},{"id":"W2320729463","doi":"10.1097/01.cot.0000310384.88247.39","title":"Integrative Cancer Therapy","year":2007,"lang":"en","type":"article","venue":"Oncology Times","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Medicine; Psychotherapist; Psychology; Internal medicine","score_opus":0.03519439393273268,"score_gpt":0.43218508489836605,"score_spread":0.3969906909656334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320729463","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025447584,0.037272356,0.0044631395,0.041996464,0.013310128,0.00052274467,0.0025020475,0.0016459876,0.8957423],"genre_scores_gemma":[0.026953742,0.050502207,0.009284914,0.046105836,0.007091256,0.0007731129,0.004956239,0.0007077244,0.853625],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987909,0.00024691728,0.0000762776,0.00022208053,0.0005247667,0.0001390345],"domain_scores_gemma":[0.99858606,0.00022519646,0.00008827975,0.00020727815,0.0004914082,0.0004017255],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009717122,0.00075843075,0.00069814886,0.0013720426,0.0017168395,0.004322297,0.0016850565,0.0024360511,0.31313682],"category_scores_gemma":[0.0035115168,0.0002751865,0.0010135479,0.0013924941,0.00079453044,0.002523752,0.0038874056,0.0038537083,0.13785155],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006827326,0.0001461713,0.0005680244,0.0006104316,0.000024222763,0.00022293224,0.00028145808,0.000060116294,0.0004998836,0.011778306,0.6628364,0.32290372],"study_design_scores_gemma":[0.000016267517,0.000026263244,0.0003436083,0.00017986153,0.0000058748155,0.00031824582,0.00008182181,0.000026743133,0.000099802404,0.0019089486,0.9969874,0.000005233837],"about_ca_topic_score_codex":0.0014474584,"about_ca_topic_score_gemma":0.0035343105,"teacher_disagreement_score":0.31313682,"about_ca_system_score_codex":0.0018140889,"about_ca_system_score_gemma":0.0025076545,"threshold_uncertainty_score":0.97972697},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W2320883227","doi":"10.1093/ageing/afw035","title":"66HIGHER LEVELS OF APOMORPHINE AND ROTIGOTINE PRESCRIBING SPEND REDUCE THE TOTAL HEALTHCARE COSTS FOR PARKINSON'S PATIENTS","year":2016,"lang":"en","type":"article","venue":"Age and Ageing","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Rotigotine; Apomorphine; Medicine; Parkinson's disease; Health care; Dopamine; Internal medicine; Dopaminergic","score_opus":0.05992845894006955,"score_gpt":0.3307550363964561,"score_spread":0.27082657745638655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320883227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923625,0.001591484,0.00009653215,0.0005530578,0.000017286988,0.000023305618,0.0019530732,0.000008747127,0.0033940098],"genre_scores_gemma":[0.99805486,0.00034984315,0.00021154585,0.000116866046,0.000024448704,0.000013940537,0.00052211777,0.0000022561392,0.00070423115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988219,0.00028543116,0.00018924035,0.00018573308,0.00033120764,0.00018643388],"domain_scores_gemma":[0.99360234,0.0009168016,0.0043561575,0.0001453808,0.00043809816,0.00054119853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064823206,0.00016370897,0.00023881365,0.00070135813,0.00030799402,0.00095900195,0.00019254081,0.0003319688,0.0084441975],"category_scores_gemma":[0.0056360746,0.00013061987,0.0005321408,0.0015834703,0.00019605174,0.0005024507,0.000534766,0.0004169281,0.0011241747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007906946,0.000063044776,0.9918452,0.00004787123,0.00006981463,0.000048588707,0.000116498566,0.000049932536,0.00008353909,0.000039982657,0.00052212906,0.0070343954],"study_design_scores_gemma":[0.0000064192773,0.000078729994,0.9989091,0.000025734083,0.00003488728,0.00012461784,0.00012811244,0.0000741499,0.00003453596,0.000025330475,0.0005563574,0.0000019718582],"about_ca_topic_score_codex":0.0085552195,"about_ca_topic_score_gemma":0.017162275,"teacher_disagreement_score":0.0085552195,"about_ca_system_score_codex":0.0008506658,"about_ca_system_score_gemma":0.0010681292,"threshold_uncertainty_score":0.028248608},"labels":[],"label_agreement":null},{"id":"W2322706468","doi":"10.1021/ol5029157","title":"PdI<sub>2</sub>-Catalyzed Regioselective Cyclocarbonylation of 2-Allyl Phenols to Dihydrocoumarins","year":2014,"lang":"en","type":"article","venue":"Organic Letters","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Regioselectivity; Chemistry; Phenols; Catalysis; Selectivity; Organic chemistry; Medicinal chemistry; Combinatorial chemistry","score_opus":0.007673690761321302,"score_gpt":0.24181346211561458,"score_spread":0.23413977135429329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322706468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9206562,0.006959395,0.05192201,0.0005658407,0.00013309994,0.00023042392,0.00096552167,0.0007222078,0.01784517],"genre_scores_gemma":[0.9868547,0.001979872,0.006996552,0.00009634095,0.000025656309,0.000049658705,0.00029256404,0.000048630645,0.0036561324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983966,0.00003176282,0.00000868627,0.000034691147,0.000031295083,0.000053814496],"domain_scores_gemma":[0.9999019,0.000018976853,0.00003175371,0.000015454076,0.000012885794,0.000019102723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012751966,0.00044752442,0.000239819,0.00017941554,0.00014844855,0.0001684864,0.00025864184,0.00024779688,0.0011546683],"category_scores_gemma":[0.00017090504,0.00014090378,0.00016634828,0.00022527152,0.0002311401,0.0002891311,0.00028922924,0.0005556441,0.00059564883],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000856714,0.00003266128,0.00012748748,0.00011824942,0.0000098489645,0.00021855939,0.000045634843,0.00036002477,0.99167,0.00032895562,0.00020852458,0.0067944387],"study_design_scores_gemma":[0.000008059354,0.00006674647,0.0002813765,0.0000016372618,0.0000035424569,0.00020157573,0.000008213852,0.00023481183,0.99647164,0.00004011793,0.0026787177,0.000003544978],"about_ca_topic_score_codex":0.00031440557,"about_ca_topic_score_gemma":0.00072708074,"teacher_disagreement_score":0.0011546683,"about_ca_system_score_codex":0.00028570066,"about_ca_system_score_gemma":0.0002792397,"threshold_uncertainty_score":0.0038627386},"labels":[],"label_agreement":null},{"id":"W2323144712","doi":"10.6023/a15010055","title":"Synthesis and Properties of the Poly(<i>ε</i>-caprolactone)-paclitaxel Prodrug","year":2015,"lang":"en","type":"article","venue":"Acta Chimica Sinica","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Education and Child Care","funders":"","keywords":"Chemistry; Caprolactone; Prodrug; Paclitaxel; Combinatorial chemistry; Organic chemistry; Biochemistry; Polymerization; Chemotherapy; Internal medicine","score_opus":0.05667900404789635,"score_gpt":0.29149802987153034,"score_spread":0.23481902582363398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323144712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98908454,0.0012442315,0.005416689,0.00012470972,0.000027977268,0.000091012334,0.00036568983,0.00010202847,0.003543252],"genre_scores_gemma":[0.9905771,0.00046807318,0.003638956,0.000059867438,0.000008561596,0.00004084922,0.00028214065,0.000027994754,0.0048964773],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999491,0.0000065223453,0.000005049527,0.000011251292,0.000014834507,0.0000133325875],"domain_scores_gemma":[0.9999286,0.000015477912,0.000022500652,0.000005522811,0.000015504284,0.000012392477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010809542,0.0001922297,0.00011726268,0.00018318134,0.00016030841,0.00016186821,0.000114242044,0.00016479229,0.001211096],"category_scores_gemma":[0.00018160467,0.0001011282,0.000108668704,0.00014174655,0.00012177355,0.00015712132,0.00007590237,0.00019730632,0.00041625754],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025906583,0.0000385132,0.00018118994,0.00006097809,0.0000039004935,0.00011418889,0.000026288,0.00050303864,0.99227786,0.00017143729,0.00013238541,0.006231126],"study_design_scores_gemma":[0.000022222588,0.00038671854,0.0007013271,0.0000023992247,0.000007642207,0.000065991015,0.000006184977,0.0006277939,0.9966107,0.000016444817,0.0015475993,0.0000049987116],"about_ca_topic_score_codex":0.0006784743,"about_ca_topic_score_gemma":0.00086880394,"teacher_disagreement_score":0.001211096,"about_ca_system_score_codex":0.00024249259,"about_ca_system_score_gemma":0.00023775653,"threshold_uncertainty_score":0.004051566},"labels":[],"label_agreement":null},{"id":"W2323432289","doi":"10.1158/0008-5472.sabcs-1027","title":"Efficacy of bevacizumab (BV) plus docetaxel (D) does not correlate with hypertension (HTN) or G-CSF use in patients (pts) with locally recurrent (LR) or metastatic breast cancer (mBC) in the AVADO phase III study.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Taxane; Metastatic breast cancer; Bevacizumab; Docetaxel; Internal medicine; Population; Gastroenterology; Breast cancer; Oncology; Cancer; Chemotherapy","score_opus":0.12369791208952845,"score_gpt":0.4383749559649993,"score_spread":0.31467704387547085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323432289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974395,0.0011008753,0.00008936572,0.000094832125,0.00002665746,0.00016148742,0.0003196521,0.000011911123,0.00075569854],"genre_scores_gemma":[0.99764156,0.0005838321,0.00027152942,0.00014519833,0.000048042515,0.00013228276,0.0006302633,0.000006556261,0.0005407423],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99969053,0.0001737222,0.00002097054,0.000043948658,0.000037615664,0.000033203403],"domain_scores_gemma":[0.9992238,0.00021937086,0.00021249404,0.000048119535,0.00002872176,0.00026744205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001006135,0.00035951965,0.00077031925,0.00015603502,0.00011335353,0.00050687697,0.0004444835,0.00039294333,0.0013600303],"category_scores_gemma":[0.0010504458,0.0002747125,0.0007284248,0.00024141457,0.00033350414,0.00029820314,0.00022837991,0.0013762265,0.00024111208],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77879834,0.02251755,0.041508403,0.00094905007,0.0019049848,0.00015964516,0.00025631938,0.0015085746,0.04470595,0.00015410178,0.002430837,0.105106235],"study_design_scores_gemma":[0.34094283,0.5008492,0.1446751,0.00008351055,0.0016572792,0.0003708497,0.0001132205,0.0020109776,0.00495291,0.00013363366,0.0041683405,0.00004217813],"about_ca_topic_score_codex":0.0014872256,"about_ca_topic_score_gemma":0.0046093115,"teacher_disagreement_score":0.0014872256,"about_ca_system_score_codex":0.00050109427,"about_ca_system_score_gemma":0.00070485286,"threshold_uncertainty_score":0.005321026},"labels":[],"label_agreement":null},{"id":"W2324247020","doi":"10.1097/01.cot.0000293190.23316.5f","title":"Operable Breast Cancer","year":2004,"lang":"en","type":"article","venue":"Oncology Times","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Chemotherapy; Oncology; Internal medicine; Cancer; Concomitant; Gynecology","score_opus":0.019186749432628197,"score_gpt":0.36792120615651575,"score_spread":0.34873445672388753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324247020","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.050231576,0.14027242,0.00085327635,0.02415639,0.018803937,0.00033840665,0.01659555,0.0005389065,0.74820954],"genre_scores_gemma":[0.14381143,0.077156164,0.0015082756,0.010345719,0.0046289084,0.00021858233,0.010107834,0.00017225613,0.7520508],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989295,0.000011182819,0.0000058130063,0.000022685492,0.000031390133,0.000036011414],"domain_scores_gemma":[0.99989307,0.000010070506,0.000009905229,0.0000075469356,0.00002088192,0.000058555303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016506402,0.00037465378,0.00020490606,0.000623887,0.00029597263,0.0006665934,0.00017836805,0.00030985748,0.101661325],"category_scores_gemma":[0.00030488145,0.00010769407,0.0002462554,0.00048357423,0.00014976384,0.00027137366,0.0004844513,0.00056698185,0.038827784],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041883253,0.00011102615,0.007722045,0.00042142178,0.000034039036,0.0009968587,0.00005370712,0.00007380921,0.0012800072,0.002757533,0.4853944,0.50073636],"study_design_scores_gemma":[0.00006309937,0.00011526046,0.023704506,0.0002609723,0.000017491773,0.002039687,0.0000777635,0.000043731838,0.00039265244,0.0005281925,0.97274786,0.000008641155],"about_ca_topic_score_codex":0.0020107795,"about_ca_topic_score_gemma":0.00571446,"teacher_disagreement_score":0.101661325,"about_ca_system_score_codex":0.0006246783,"about_ca_system_score_gemma":0.00050663325,"threshold_uncertainty_score":0.340091},"labels":[],"label_agreement":null},{"id":"W2324434746","doi":"10.1200/jco.2009.27.15_suppl.589","title":"Evaluation of the incidence and of risk factors associated with trastuzumab-associated cardiac toxicity in routine clinical practice","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Ejection fraction; Trastuzumab; Internal medicine; Tact; Coronary artery disease; Cancer; Surgery; Cardiology; Oncology; Breast cancer; Heart failure","score_opus":0.19299448141732994,"score_gpt":0.537578305884106,"score_spread":0.3445838244667761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324434746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99811685,0.000691985,0.00007302684,0.00010385425,0.0000033419633,0.000020621279,0.00032072506,0.000005775821,0.0006639734],"genre_scores_gemma":[0.99935764,0.0002072552,0.000093992916,0.000027206275,0.000007533807,0.0000092647,0.00022782687,0.000001225055,0.00006811692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986142,0.00034672758,0.00020087857,0.00022184735,0.00044102408,0.00017537121],"domain_scores_gemma":[0.9910998,0.0018300441,0.0049045915,0.00019721537,0.0012698446,0.00069849804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011117862,0.00016554115,0.00032985353,0.0012898294,0.00026358262,0.0006327272,0.00048573193,0.00046576216,0.0011410465],"category_scores_gemma":[0.007589302,0.00020465926,0.00017855711,0.0018324805,0.00030655361,0.00038670452,0.0003017782,0.00041578582,0.00019135392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014256315,0.000007662628,0.9991862,0.00000532294,0.0000060674906,0.000038217204,0.000021485577,0.000007894655,0.000022745728,0.0000019980964,0.000036433426,0.000651709],"study_design_scores_gemma":[0.0000027478984,0.00005065694,0.9992889,0.00000790245,0.0000064260616,0.00025961286,0.00010606871,0.00014648514,0.000026373904,0.00000410395,0.00009896172,0.0000018350185],"about_ca_topic_score_codex":0.025886988,"about_ca_topic_score_gemma":0.026293522,"teacher_disagreement_score":0.025886988,"about_ca_system_score_codex":0.0012432341,"about_ca_system_score_gemma":0.0010970806,"threshold_uncertainty_score":0.051472604},"labels":[],"label_agreement":null},{"id":"W2324535812","doi":"10.1158/1538-7445.am2012-2706","title":"Abstract 2706: Phase 2 study with pharmacokinetics (PK) analysis of sorafenib and vinorelbine in metastatic breast cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Vinorelbine; Capecitabine; Sorafenib; Internal medicine; Pharmacokinetics; Metastatic breast cancer; Oncology; Cancer; Breast cancer; Docetaxel; Chemotherapy; Concomitant; Pharmacology; Gastroenterology; Colorectal cancer; Hepatocellular carcinoma","score_opus":0.1254380671873317,"score_gpt":0.5228773848304897,"score_spread":0.39743931764315804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324535812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672616,0.0004654096,0.0003680994,0.000095769945,0.0000317434,0.0010769349,0.00056214625,0.000044487242,0.0006292363],"genre_scores_gemma":[0.9912334,0.000601228,0.0015944385,0.000223967,0.0001265422,0.0018959659,0.0021076293,0.000027303793,0.0021894602],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994481,0.0002582993,0.00002454249,0.00009250084,0.00007048464,0.00010598186],"domain_scores_gemma":[0.9994561,0.00008172334,0.00007250451,0.00005327702,0.000038759485,0.0002975745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011253168,0.0013107006,0.0018574576,0.00043019874,0.00037864386,0.00071621157,0.0006290547,0.00069861143,0.0036520911],"category_scores_gemma":[0.0009218178,0.0005396609,0.000911227,0.00040216438,0.00070588745,0.0005519657,0.00034247883,0.0018781205,0.00089138665],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.62822616,0.16188887,0.016981207,0.00056127954,0.00082543446,0.0008696925,0.000355365,0.0048281634,0.099977635,0.00035609762,0.003299204,0.0818309],"study_design_scores_gemma":[0.24464397,0.71917284,0.018522466,0.00001714864,0.0002710018,0.00096197176,0.00006804965,0.0022149703,0.0107237175,0.00018067348,0.003187035,0.000036191737],"about_ca_topic_score_codex":0.00095521205,"about_ca_topic_score_gemma":0.00097299716,"teacher_disagreement_score":0.0036520911,"about_ca_system_score_codex":0.00091038784,"about_ca_system_score_gemma":0.0018213547,"threshold_uncertainty_score":0.012217462},"labels":[],"label_agreement":null},{"id":"W2324736805","doi":"10.2174/1573394711309010005","title":"Going Beyond Anthracyclines and Taxanes in Breast Cancer What&amp;#8217;s Next?","year":2013,"lang":"en","type":"article","venue":"Current Cancer Therapy Reviews","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Taxane; Tolerability; Capecitabine; Anthracycline; Medicine; Metastatic breast cancer; Breast cancer; Oncology; Internal medicine; Adjuvant; Cancer; Chemotherapy; Adverse effect; Colorectal cancer","score_opus":0.1182335541980851,"score_gpt":0.43213573654346177,"score_spread":0.3139021823453767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324736805","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005736189,0.9827124,0.00009944165,0.012415706,0.0011152348,0.0000060567595,0.000028294175,0.000008735203,0.0030405184],"genre_scores_gemma":[0.003597799,0.98378307,0.0003000255,0.006593994,0.0021477325,0.000011621453,0.00004229479,0.000006425552,0.003517026],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996815,0.00010335365,0.00003843166,0.00004811018,0.00008831854,0.00004035604],"domain_scores_gemma":[0.9988991,0.0005201666,0.00014963649,0.000031543153,0.00028381313,0.000115683055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008987602,0.00031411374,0.0010622173,0.0010152865,0.00036793327,0.0017017656,0.00049078953,0.0017055431,0.009294334],"category_scores_gemma":[0.001489889,0.00019311445,0.0005527207,0.0013187785,0.0005514756,0.0029740385,0.000548582,0.0019989223,0.0030986657],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031069567,0.00014878299,0.0007002858,0.00987785,0.00009603101,0.0002934035,0.00018579382,0.00028032155,0.0018106602,0.006699846,0.084469914,0.8951264],"study_design_scores_gemma":[0.0000588295,0.00035190617,0.0022047288,0.0072491593,0.00011645876,0.0009014186,0.0003000117,0.000118369906,0.00037621468,0.0060190014,0.9822772,0.000026777137],"about_ca_topic_score_codex":0.003326969,"about_ca_topic_score_gemma":0.011614494,"teacher_disagreement_score":0.009294334,"about_ca_system_score_codex":0.0011031275,"about_ca_system_score_gemma":0.0018516983,"threshold_uncertainty_score":0.031092644},"labels":[],"label_agreement":null},{"id":"W2325065247","doi":"10.1158/0008-5472.sabcs12-p1-13-01","title":"Abstract P1-13-01: A randomized trial of CEF versus dose dense EC followed by paclitaxel versus AC followed by paclitaxel in women with node positive or high risk node negative breast cancer, NCIC CTG MA.21: Results of the final relapse free survival analysis.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; Ottawa Regional Cancer Foundation; Health Sciences Centre; Saint John Regional Hospital; McMaster University; Queen's University; University of Calgary; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Epirubicin; Internal medicine; Paclitaxel; Randomized controlled trial; Taxane; Cyclophosphamide; Gastroenterology; Chemotherapy; Cancer","score_opus":0.05582360208603607,"score_gpt":0.3945439117137432,"score_spread":0.33872030962770716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325065247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791135,0.0039076204,0.00068590784,0.002161045,0.0010972145,0.007165331,0.0021378684,0.00017196122,0.003559538],"genre_scores_gemma":[0.98153573,0.0017170318,0.001292316,0.002124141,0.0006853507,0.0054632295,0.0017480792,0.000031399955,0.0054027233],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990746,0.0006072359,0.00003658739,0.00012096239,0.000042207237,0.0001184985],"domain_scores_gemma":[0.9982558,0.00060876855,0.0003318544,0.000121432495,0.00008233917,0.0005997387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021328693,0.00232222,0.0028643284,0.00056018564,0.00043038742,0.0011372654,0.0013523271,0.002634127,0.010188111],"category_scores_gemma":[0.0028813551,0.00074712466,0.0019968771,0.0005035256,0.0015963331,0.0009948148,0.0005156516,0.0049850885,0.0015484019],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9906275,0.0029781722,0.00019141973,0.00020047037,0.00034878348,0.000020878795,0.000015199008,0.00017115737,0.00085677626,0.000057882826,0.0004701142,0.004061616],"study_design_scores_gemma":[0.95703226,0.04128953,0.00060636253,0.000016851396,0.00029827483,0.000017342996,0.000010297319,0.00025771646,0.00014655227,0.000100391124,0.00021678736,0.000007686673],"about_ca_topic_score_codex":0.0016348812,"about_ca_topic_score_gemma":0.0029986054,"teacher_disagreement_score":0.010188111,"about_ca_system_score_codex":0.0010150104,"about_ca_system_score_gemma":0.0015215585,"threshold_uncertainty_score":0.03408259},"labels":[],"label_agreement":null},{"id":"W2325653118","doi":"10.1158/0008-5472.sabcs11-p5-19-08","title":"P5-19-08: Pooled Analysis of Individual Patient Data from Capecitabine Monotherapy Clinical Trials in Anthracycline-/Taxane-Pretreated Locally Advanced or Metastatic Breast Cancer (LA/MBC).","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Capecitabine; Internal medicine; Taxane; Metastatic breast cancer; Refractory (planetary science); Clinical trial; Anthracycline; Regimen; Oncology; Breast cancer; Cancer","score_opus":0.4927062928935304,"score_gpt":0.5873651864627961,"score_spread":0.09465889356926571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325653118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90736663,0.044914797,0.009048424,0.00029146255,0.0001939002,0.0017864474,0.03393707,0.0002449394,0.0022162888],"genre_scores_gemma":[0.97858024,0.0020020811,0.0028442638,0.00013981492,0.00012781068,0.0011136386,0.014803756,0.000051695468,0.00033662037],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9766921,0.014435169,0.0038633759,0.0024844438,0.0021143907,0.00041054806],"domain_scores_gemma":[0.9725303,0.014837569,0.008746088,0.002110723,0.0011860458,0.0005892194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027209125,0.0012482669,0.004320278,0.0033894966,0.00025808046,0.0017726524,0.0008870647,0.000784974,0.0025508662],"category_scores_gemma":[0.026368646,0.0005464536,0.008145917,0.0041433917,0.00041054652,0.0010262879,0.0010322778,0.00076551404,0.0003578818],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.114613004,0.0005353078,0.3459822,0.0073542804,0.46272177,0.00048328252,0.00023223358,0.006043498,0.004442258,0.00019257229,0.0047903205,0.05260924],"study_design_scores_gemma":[0.014470567,0.021173002,0.65822154,0.00063215505,0.2841813,0.000973675,0.00026179507,0.007584424,0.0030579593,0.00052089937,0.00874787,0.00017482674],"about_ca_topic_score_codex":0.000928318,"about_ca_topic_score_gemma":0.0014580834,"teacher_disagreement_score":0.027209125,"about_ca_system_score_codex":0.0007122325,"about_ca_system_score_gemma":0.000793111,"threshold_uncertainty_score":0.1438973},"labels":[],"label_agreement":null},{"id":"W2325764269","doi":"10.1097/00001813-200303000-00008","title":"Pharmacokinetics of doxorubicin administered i.v. as Myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancer","year":2003,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Doxorubicin; Pharmacokinetics; Metastatic breast cancer; Liposome; Medicine; Breast cancer; Pharmacology; Cyclophosphamide; Cancer; Chemotherapy; Chemistry; Internal medicine; Biochemistry","score_opus":0.013141340336735861,"score_gpt":0.2877310070471609,"score_spread":0.27458966671042506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325764269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99905866,0.0005376161,0.00014063154,0.0000374896,0.0000055580394,0.000012611608,0.000023184353,0.000011563529,0.00017273183],"genre_scores_gemma":[0.99936384,0.00015851205,0.00018771194,0.000050827308,0.000016320639,0.000014682543,0.000058005327,0.0000028731413,0.00014717753],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99979573,0.000079974634,0.000011112643,0.00004510301,0.000039666735,0.000028416693],"domain_scores_gemma":[0.9995764,0.00011882493,0.00013523699,0.000028284074,0.000022060034,0.00011921561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025997244,0.00024957923,0.0006791092,0.00016734976,0.00012539023,0.00041892985,0.00012992734,0.0003499108,0.00042684967],"category_scores_gemma":[0.0013343253,0.00025279264,0.00019961224,0.0001804881,0.00032778239,0.00027925032,0.00013962649,0.00057096564,0.00017039753],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20944448,0.005257959,0.19702713,0.00024466426,0.00079385843,0.0012266462,0.00091209257,0.005579255,0.39926872,0.0002684514,0.0016067654,0.17837001],"study_design_scores_gemma":[0.013118598,0.27882594,0.61201596,0.000041500487,0.00082588656,0.0037319665,0.0002981975,0.015269651,0.07076695,0.00026002302,0.0047425823,0.00010276849],"about_ca_topic_score_codex":0.00044917324,"about_ca_topic_score_gemma":0.0005342988,"teacher_disagreement_score":0.0006791092,"about_ca_system_score_codex":0.0004704103,"about_ca_system_score_gemma":0.00026598977,"threshold_uncertainty_score":0.0034131408},"labels":[],"label_agreement":null},{"id":"W2325803459","doi":"10.1200/jco.2012.30.15_suppl.lba1000","title":"NSABP B-38: Definitive analysis of a randomized adjuvant trial comparing dose-dense (DD) AC followed by paclitaxel (P) plus gemcitabine (G) with DD AC followed by P and with docetaxel, doxorubicin, and cyclophosphamide (TAC) in women with operable, node-positive breast cancer.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Docetaxel; Gemcitabine; Paclitaxel; Adjuvant; Oncology; Internal medicine; Doxorubicin; Randomized controlled trial; Chemotherapy","score_opus":0.03819735924230556,"score_gpt":0.39348291623592246,"score_spread":0.3552855569936169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325803459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9672436,0.013523248,0.00081962434,0.0039443886,0.0014766582,0.0034417617,0.0035655135,0.00015554678,0.0058295485],"genre_scores_gemma":[0.9787749,0.0048634573,0.0020341077,0.0021814916,0.00060965563,0.0024355755,0.002986877,0.000049587838,0.0060643647],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99863166,0.0009371049,0.00008567691,0.000157776,0.00008204363,0.00010566125],"domain_scores_gemma":[0.99776185,0.0007504381,0.0004757622,0.00021537289,0.00011581602,0.00068074244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003731442,0.001995306,0.0026995298,0.00045624087,0.00047653494,0.0012926421,0.0010711837,0.0014883754,0.010212591],"category_scores_gemma":[0.0054124543,0.0007506147,0.002196307,0.00046995076,0.0010691539,0.0016149853,0.00069947145,0.0040218285,0.0016200845],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9759729,0.0017310876,0.00077428215,0.000620489,0.0017253116,0.00005241901,0.000059530885,0.00049399736,0.0013327745,0.00017291703,0.0016337875,0.015430627],"study_design_scores_gemma":[0.9576032,0.03335249,0.0035747266,0.00011765629,0.001878012,0.0000645559,0.00007007885,0.0005589533,0.0002867659,0.0005441017,0.001923708,0.000025820378],"about_ca_topic_score_codex":0.0016053542,"about_ca_topic_score_gemma":0.005806175,"teacher_disagreement_score":0.010212591,"about_ca_system_score_codex":0.0010057962,"about_ca_system_score_gemma":0.0015636545,"threshold_uncertainty_score":0.034164548},"labels":[],"label_agreement":null},{"id":"W2326269621","doi":"10.1097/00001813-200007000-00004","title":"Differential impact of Raf-1 kinase activity on tumor cell resistance to paclitaxel and docetaxel","year":2000,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Cancer Foundation","funders":"","keywords":"Docetaxel; Taxane; Paclitaxel; Cytotoxicity; Kinase; Ovarian cancer; Cancer research; Medicine; Pharmacology; Oncology; Chemotherapy; Internal medicine; Chemistry; Cancer; In vitro; Breast cancer; Biochemistry","score_opus":0.012873713282393347,"score_gpt":0.3305387008184631,"score_spread":0.31766498753606975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326269621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984049,0.00055417937,0.00015259843,0.00002812367,0.0000053839735,0.000007068075,0.00006966313,0.000005748321,0.0007724269],"genre_scores_gemma":[0.9989095,0.00031853747,0.00015113433,0.00001485576,0.0000025384543,0.0000076004567,0.00012296406,0.0000034154727,0.00046950084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977297,0.00006497101,0.000018476025,0.000021725487,0.00006700357,0.00005483676],"domain_scores_gemma":[0.99984705,0.000056594392,0.000020343092,0.000018889632,0.000022934515,0.000034167737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013271693,0.00010505875,0.0002081977,0.00021233798,0.0001409066,0.00038284552,0.000089172805,0.00015414259,0.00087846915],"category_scores_gemma":[0.00036405848,0.00009575225,0.00015277184,0.00016377735,0.00015601612,0.0001571438,0.000093429175,0.0003284017,0.00016761103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007754904,0.00011396036,0.0022156157,0.000027349417,0.000014802781,0.000103803264,0.00004840337,0.0005083223,0.99143255,0.0002703374,0.000079545855,0.004409786],"study_design_scores_gemma":[0.00006417413,0.0020578813,0.03734565,0.00000821957,0.000040182666,0.0010444247,0.000101963975,0.0023394083,0.9544336,0.00012250856,0.0024312858,0.000010739824],"about_ca_topic_score_codex":0.00055598817,"about_ca_topic_score_gemma":0.0010910243,"teacher_disagreement_score":0.00087846915,"about_ca_system_score_codex":0.0003803821,"about_ca_system_score_gemma":0.00017028708,"threshold_uncertainty_score":0.002938807},"labels":[],"label_agreement":null},{"id":"W2326276419","doi":"10.1158/1557-3125.advbc-a050","title":"Abstract A050: ARRY-380, an oral HER2 inhibitor: Final phase 1 results and conclusions","year":2013,"lang":"en","type":"article","venue":"Molecular Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lapatinib; Medicine; Neratinib; Limiting; Pharmacokinetics; Pharmacology; Adverse effect; Clinical trial; Internal medicine; Oncology; Maximum tolerated dose; Trastuzumab; Breast cancer; Cancer","score_opus":0.14719787990537644,"score_gpt":0.5059109550626726,"score_spread":0.3587130751572961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326276419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9241363,0.018442873,0.007138804,0.002339666,0.0005419673,0.008390024,0.019938357,0.001159263,0.017912677],"genre_scores_gemma":[0.91989225,0.01172163,0.008934063,0.003438294,0.00024421074,0.004370373,0.02448525,0.00022981704,0.026684081],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99977344,0.000055181088,0.000012035042,0.00003402232,0.000060064333,0.00006530619],"domain_scores_gemma":[0.9997241,0.000028585264,0.000041365995,0.000016213344,0.000050939598,0.00013890424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010137826,0.0010477668,0.000927951,0.0004152368,0.00029672982,0.0008515587,0.00088796363,0.00084061053,0.006102827],"category_scores_gemma":[0.00047641003,0.00035334495,0.00069840404,0.00028739087,0.0003734094,0.00043097138,0.00027663936,0.0021726803,0.0014563348],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14310895,0.048874702,0.009427167,0.003925012,0.0023943195,0.001359475,0.00060574175,0.011228909,0.2948097,0.0020576715,0.11566534,0.36654305],"study_design_scores_gemma":[0.16003357,0.58578086,0.032918215,0.00039938907,0.0020249535,0.0032231666,0.0001922783,0.009300162,0.1024442,0.0018728874,0.10165433,0.00015607954],"about_ca_topic_score_codex":0.0018033312,"about_ca_topic_score_gemma":0.004254549,"teacher_disagreement_score":0.006102827,"about_ca_system_score_codex":0.00078096334,"about_ca_system_score_gemma":0.0017232856,"threshold_uncertainty_score":0.020416021},"labels":[],"label_agreement":null},{"id":"W2326594858","doi":"10.1249/01.mss.0000401549.15499.a0","title":"Current Exercise Behaviors of Breast Cancer Patients Diagnosed with Chemotherapy-Induced Peripheral Neuropathy","year":2011,"lang":"en","type":"article","venue":"Medicine & Science in Sports & Exercise","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Breast cancer; Quality of life (healthcare); Neuropathic pain; Physical therapy; Peripheral neuropathy; Cancer; Psychological intervention; Rehabilitation; Clinical trial; Internal medicine; Psychiatry","score_opus":0.021349114341791427,"score_gpt":0.3085764803543216,"score_spread":0.2872273660125302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326594858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988524,0.00023871328,0.000013776018,0.00009001993,0.0000046496034,0.00001239277,0.00025775764,0.000002080195,0.00052833476],"genre_scores_gemma":[0.9994844,0.00012570004,0.00003134749,0.000048100286,0.000004409481,0.00001112916,0.00017530155,4.4757067e-7,0.00011910761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977225,0.000056888093,0.00003590509,0.00003385178,0.00005526702,0.000045816614],"domain_scores_gemma":[0.99901783,0.00018108047,0.00052644353,0.000020124407,0.00009074723,0.00016381209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035728302,0.00014813055,0.00023797948,0.00052033644,0.00027242873,0.0004052308,0.00018635561,0.00035791675,0.0019762274],"category_scores_gemma":[0.0021042218,0.00013044562,0.00022767961,0.00065527216,0.00012854798,0.00028689374,0.0002204331,0.00035756856,0.00025527691],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003281396,0.000052620162,0.99865156,0.000009692252,0.000011561486,0.000032586402,0.00005814287,0.0000135492055,0.000032118456,0.000002036794,0.000057096036,0.0010462444],"study_design_scores_gemma":[0.0000039989254,0.00008204359,0.99945897,0.0000069775824,0.000009990561,0.00010697633,0.00016582114,0.0000539219,0.000011998579,0.0000032403254,0.00009488313,0.0000012553883],"about_ca_topic_score_codex":0.0048295837,"about_ca_topic_score_gemma":0.008360241,"teacher_disagreement_score":0.0048295837,"about_ca_system_score_codex":0.0003303596,"about_ca_system_score_gemma":0.00025638603,"threshold_uncertainty_score":0.009602964},"labels":[],"label_agreement":null},{"id":"W2326816428","doi":"10.2512/jspm.9.132","title":"Survey of medical care by oncologists for depression in breast cancer patients","year":2014,"lang":"en","type":"article","venue":"Palliative Care Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Research Foundation","funders":"","keywords":"Medicine; Breast cancer; Depression (economics); Family medicine; Medical care; Oncology; Cancer; Internal medicine","score_opus":0.14728590562528232,"score_gpt":0.5404868676135329,"score_spread":0.3932009619882506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326816428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99038166,0.002769295,0.000056662873,0.0015987431,0.000036400408,0.00004635861,0.0017113179,0.000006946464,0.0033926973],"genre_scores_gemma":[0.9969213,0.0013463423,0.00009962671,0.00052301696,0.00005058852,0.000038495407,0.0006586887,0.0000018737425,0.00036008228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986234,0.00055128336,0.00023917647,0.00010316797,0.0003383009,0.00014471274],"domain_scores_gemma":[0.9941948,0.0011197861,0.0033346605,0.000084223204,0.000560253,0.0007064167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087505905,0.0000627242,0.0001699834,0.0009781674,0.00037552702,0.0003707752,0.00022661212,0.00040011512,0.001549469],"category_scores_gemma":[0.005401607,0.00018304655,0.00028154618,0.0018018279,0.00018574076,0.0003265553,0.0002966727,0.00046542354,0.00023257993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028770519,0.00002983899,0.9971624,0.000029032444,0.000022421038,0.000035794255,0.0001393778,0.00001268659,0.000040150528,0.0000111447325,0.0007073249,0.00178102],"study_design_scores_gemma":[0.000008409464,0.00004903833,0.99851495,0.000027137254,0.000011190146,0.000094756266,0.00046421634,0.00004748446,0.000016818421,0.0000056035296,0.0007581351,0.0000022598026],"about_ca_topic_score_codex":0.023190169,"about_ca_topic_score_gemma":0.038138214,"teacher_disagreement_score":0.023190169,"about_ca_system_score_codex":0.00094051537,"about_ca_system_score_gemma":0.00088220194,"threshold_uncertainty_score":0.04611039},"labels":[],"label_agreement":null},{"id":"W2326976339","doi":"10.6000/1927-7229.2016.05.01.5","title":"A Case of Sigmoid Colon Cancer in which Somatic Pain was Rapidly Alleviated after Panitumumab Administration Despite Tumor Progression","year":2016,"lang":"en","type":"article","venue":"Journal of Analytical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Panitumumab; Oxaliplatin; Abdominal pain; Colorectal cancer; Irinotecan; Adverse effect; Internal medicine; FOLFIRI; Cancer pain; Paronychia; Cancer; Surgery; Gastroenterology; Oncology; Cetuximab","score_opus":0.027616116230245173,"score_gpt":0.39659452619573965,"score_spread":0.36897840996549447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326976339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833741,0.0051242677,0.0025038337,0.0025573955,0.00026943328,0.00013848764,0.00013171854,0.00014197432,0.0057588974],"genre_scores_gemma":[0.9965139,0.0010561062,0.0006959139,0.00061125506,0.00026467396,0.000018766985,0.000058675167,0.000007503963,0.0007732026],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99975914,0.000031923937,0.00002210556,0.000051173254,0.000026181595,0.00010950066],"domain_scores_gemma":[0.99921036,0.00016958342,0.00019626635,0.00007770851,0.00004716681,0.00029882698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020785138,0.0009825821,0.00078489596,0.00070572767,0.0014881139,0.000780925,0.00053232495,0.0029598735,0.0010187232],"category_scores_gemma":[0.0016766049,0.00058844726,0.0008378174,0.00074222416,0.0007831753,0.0007910753,0.00061674346,0.0024143714,0.0003897476],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014759447,0.000027824584,0.0048422045,0.000037492988,0.000009463958,0.9917025,0.000094517956,0.00007670257,0.0016069898,0.00007505648,0.00013009277,0.0012495953],"study_design_scores_gemma":[0.000059942566,0.0003166045,0.009049803,0.000013991379,0.000029816692,0.98776686,0.00007602952,0.00041500974,0.0012694387,0.000104831815,0.0008845932,0.000013017491],"about_ca_topic_score_codex":0.0020498752,"about_ca_topic_score_gemma":0.0032572283,"teacher_disagreement_score":0.0029598735,"about_ca_system_score_codex":0.0008639271,"about_ca_system_score_gemma":0.0004839192,"threshold_uncertainty_score":0.006268263},"labels":[],"label_agreement":null},{"id":"W2327052483","doi":"10.1017/s0317167100018461","title":"Chemotherapy-induced Peripheral Neuropathy Among Paediatric Oncology Patients","year":2014,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"American Society of Pediatric Hematology/Oncology; Leukemia and Lymphoma Society of Canada; Leukemia and Lymphoma Society","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Chemotherapy; Internal medicine; Ataxia; Vinca; Retrospective cohort study; Oncology; Surgery; Pharmacology","score_opus":0.027086059907460793,"score_gpt":0.29332702640349706,"score_spread":0.2662409664960363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327052483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985846,0.00044647852,0.000032259286,0.000031824886,0.000003662901,0.000010856648,0.00020663366,0.000002540532,0.00068101403],"genre_scores_gemma":[0.99910575,0.0004901637,0.00005355329,0.000025849427,0.0000066497264,0.000008352773,0.00022224503,0.0000012318824,0.00008608508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996861,0.000045941255,0.000036855177,0.00005881448,0.00010498602,0.000067277295],"domain_scores_gemma":[0.9985789,0.0001642664,0.000978227,0.000032127173,0.00011507521,0.00013131101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027340738,0.00014389936,0.00024066192,0.0005484652,0.00038575308,0.00042409857,0.00021085852,0.000183489,0.0018656685],"category_scores_gemma":[0.0014831313,0.0001625142,0.0001744134,0.0010273462,0.00026570208,0.0002940634,0.00028370615,0.0003146086,0.0001407099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012718613,0.00000476562,0.99834466,0.000010862147,0.00000477414,0.0003492922,0.000077962824,0.000012787805,0.00007602424,0.0000053612484,0.00007464309,0.0010260973],"study_design_scores_gemma":[0.0000028383383,0.00006426147,0.99497485,0.00002095133,0.00000950141,0.004191268,0.00024998776,0.000030034502,0.00005452978,0.0000066662387,0.00039310302,0.0000020291463],"about_ca_topic_score_codex":0.010027786,"about_ca_topic_score_gemma":0.015167865,"teacher_disagreement_score":0.010027786,"about_ca_system_score_codex":0.00062136585,"about_ca_system_score_gemma":0.000577147,"threshold_uncertainty_score":0.019938827},"labels":[],"label_agreement":null},{"id":"W2327085958","doi":"10.1097/00001813-200008000-00012","title":"Cost-utility analysis of second-line hormonal therapy in advanced breast cancer: a comparison of two aromatase inhibitors to megestrol acetate","year":2000,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Letrozole; Anastrozole; Megestrol acetate; Medicine; Megestrol; Aromatase; Randomized controlled trial; Oncology; Hormonal therapy; Internal medicine; Quality-adjusted life year; Breast cancer; Quality of life (healthcare); Clinical trial; Aromatase inhibitor; Cancer; Gynecology; Cost effectiveness","score_opus":0.03360241873040829,"score_gpt":0.39322030578894535,"score_spread":0.35961788705853703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327085958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97410643,0.0034186505,0.017213933,0.00091310096,0.00008751723,0.00087385665,0.0012077269,0.000060129005,0.0021187],"genre_scores_gemma":[0.9951219,0.0005978186,0.0030662229,0.00012118665,0.000013800838,0.00028600133,0.00038023386,0.0000062474624,0.00040654856],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9930218,0.006161867,0.0001448679,0.00017729386,0.00022337107,0.00027077072],"domain_scores_gemma":[0.9747161,0.023137718,0.0009769647,0.00030384804,0.00045948822,0.0004058225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010198387,0.0014247741,0.002443904,0.0013474553,0.00022424739,0.0012832583,0.0010786827,0.001223384,0.0026317153],"category_scores_gemma":[0.021049213,0.0007243117,0.0051962878,0.0010232491,0.00050326844,0.0009244934,0.0007205025,0.0014777777,0.00010476693],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028508332,0.0010520922,0.0070535853,0.0007494062,0.0031348146,0.00015160823,0.000054566055,0.93927485,0.00059617247,0.0037790209,0.00057308533,0.015072532],"study_design_scores_gemma":[0.0055986242,0.0069949045,0.0061766617,0.00013028411,0.0029232728,0.00009713542,0.00009059207,0.97451186,0.0004779244,0.0023899893,0.0005530085,0.000055812474],"about_ca_topic_score_codex":0.011024374,"about_ca_topic_score_gemma":0.004620867,"teacher_disagreement_score":0.011024374,"about_ca_system_score_codex":0.004750522,"about_ca_system_score_gemma":0.0030623612,"threshold_uncertainty_score":0.053934872},"labels":[],"label_agreement":null},{"id":"W2327509076","doi":"10.1097/01.cot.0000285553.29225.f2","title":"Liposomal Anthracycline Formulations Spare Heart","year":2002,"lang":"en","type":"article","venue":"Oncology Times","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cardiotoxicity; Medicine; Anthracycline; Mucositis; Doxorubicin; Regimen; Breast cancer; Nausea; Internal medicine; Cancer; Oncology; Metastatic breast cancer; Population; Chemotherapy; Surgery","score_opus":0.048546594787928346,"score_gpt":0.3763951281040644,"score_spread":0.32784853331613606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327509076","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49522778,0.1571469,0.08507854,0.01491525,0.0051251743,0.0033073481,0.0029324375,0.0037259297,0.23254061],"genre_scores_gemma":[0.8266955,0.036109783,0.0217512,0.0063747205,0.0011084526,0.001094198,0.0033391195,0.00033363927,0.10319349],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986756,0.000023610814,0.000013100104,0.00003533822,0.000042640502,0.000017747614],"domain_scores_gemma":[0.9998325,0.000027589263,0.00004217876,0.000028131079,0.00003298229,0.0000365244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034751426,0.00036754433,0.0002479023,0.00032324353,0.00021282464,0.0006535717,0.00027226438,0.00061166286,0.010544877],"category_scores_gemma":[0.00036462655,0.00017347632,0.00024056945,0.0001779583,0.00026846057,0.0005300862,0.00040415174,0.0013040234,0.0052646645],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014891338,0.00065221085,0.00063287484,0.00074996374,0.000091874725,0.0007342549,0.00016800105,0.0006758192,0.7108337,0.009285047,0.020411437,0.25427574],"study_design_scores_gemma":[0.002020666,0.005730734,0.0036664403,0.0002688673,0.00019136479,0.004817625,0.000109015265,0.0027953535,0.46931046,0.0023049256,0.5087316,0.000052959826],"about_ca_topic_score_codex":0.0002555621,"about_ca_topic_score_gemma":0.00028378674,"teacher_disagreement_score":0.010544877,"about_ca_system_score_codex":0.0003386887,"about_ca_system_score_gemma":0.00029456033,"threshold_uncertainty_score":0.035276115},"labels":[],"label_agreement":null},{"id":"W2328243021","doi":"10.1097/01.cot.0000315327.46277.02","title":"Metronomic Timing Adds Antiangiogenic Punch","year":2002,"lang":"en","type":"article","venue":"Oncology Times","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cyclophosphamide; Chemotherapy; Docetaxel; Mitoxantrone; Paclitaxel; Lewis lung carcinoma; Oncology; Regimen; Internal medicine; Cancer; Pharmacology; Metastasis","score_opus":0.05168075247852362,"score_gpt":0.34682484796238144,"score_spread":0.29514409548385784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328243021","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.180666,0.07424084,0.12226258,0.26236713,0.0970039,0.0013695325,0.001306675,0.009176747,0.25160652],"genre_scores_gemma":[0.6373172,0.029532949,0.10070459,0.104428954,0.027854776,0.0005282038,0.0006373687,0.0012482537,0.097747676],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99933964,0.00011649038,0.000066362445,0.00011452906,0.00026316787,0.000099772624],"domain_scores_gemma":[0.99814653,0.00073108793,0.00030515352,0.00020432191,0.00028646685,0.00032630347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011842963,0.0004318128,0.0004909671,0.00053085276,0.0005911187,0.0016522629,0.00043695627,0.0014428673,0.016675374],"category_scores_gemma":[0.003439774,0.00039442687,0.00068933656,0.00021760169,0.00060879963,0.0020546918,0.0006534131,0.003120778,0.0029670633],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003751219,0.0012640598,0.0049702143,0.0010050072,0.00015367329,0.0018527921,0.00040354184,0.00091973436,0.06589496,0.022475136,0.19618139,0.7011283],"study_design_scores_gemma":[0.00095213554,0.006787535,0.007045794,0.00029362974,0.00023437772,0.009619008,0.00031071567,0.0013023859,0.05128345,0.012761137,0.9092394,0.00017043392],"about_ca_topic_score_codex":0.00040089551,"about_ca_topic_score_gemma":0.0014687225,"teacher_disagreement_score":0.016675374,"about_ca_system_score_codex":0.0006346536,"about_ca_system_score_gemma":0.00072075386,"threshold_uncertainty_score":0.055784702},"labels":[],"label_agreement":null},{"id":"W2329318802","doi":"10.1158/0008-5472.sabcs11-p5-18-02","title":"P5-18-02: A Population Level Assessment of Emergency Room Visits and Hospitalizations for Women Undergoing Adjuvant Chemotherapy for Early Breast Cancer.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; Credit Valley Hospital; University of Toronto; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Population; Internal medicine; Chemotherapy; Regimen; Cancer; Cancer registry; Chemotherapy regimen; Oncology","score_opus":0.2011688486938001,"score_gpt":0.4988959855576793,"score_spread":0.2977271368638792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329318802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736984,0.00018626747,0.00018245075,0.00010818244,0.000006735081,0.00025107086,0.02424375,0.000017654977,0.0013055245],"genre_scores_gemma":[0.9856067,0.00015183106,0.000428053,0.00006844085,0.00001349872,0.00023020519,0.012897047,0.0000044316453,0.0005998081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99947697,0.0000801854,0.000071527276,0.0000930331,0.00018820158,0.0000900874],"domain_scores_gemma":[0.99771726,0.00013608515,0.0012431784,0.000077099954,0.0004313265,0.000395089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080255297,0.00031134282,0.0002480924,0.0012762224,0.00050524605,0.00061383244,0.0008953643,0.0004346808,0.001856907],"category_scores_gemma":[0.0027667983,0.00031927205,0.0005456289,0.0026114003,0.00018317768,0.00041709503,0.0007106324,0.00044147464,0.00031017017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006197529,0.00001731964,0.9986462,0.000018305576,0.00002439595,0.000025269574,0.000050635514,0.00003506868,0.000037851947,0.000006666048,0.00039814797,0.00067830895],"study_design_scores_gemma":[0.0000064812293,0.00003325738,0.9994753,0.0000044675826,0.000008437677,0.000029831914,0.00007742283,0.0001100839,0.000007823441,0.0000027033557,0.00024269313,0.0000014904566],"about_ca_topic_score_codex":0.40635434,"about_ca_topic_score_gemma":0.4755633,"teacher_disagreement_score":0.40635434,"about_ca_system_score_codex":0.0033763763,"about_ca_system_score_gemma":0.0036729537,"threshold_uncertainty_score":0.80797815},"labels":[],"label_agreement":null},{"id":"W2329585923","doi":"10.1016/j.jval.2014.08.2320","title":"Nab-Paclitaxel or Docetaxel as Alternatives to Solvent-Based Paclitaxel in Metastatic Breast Cancer (Mbc): A Cost Utility Analysis from a Chinese Health Care Perspective","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Docetaxel; Paclitaxel; Medicine; Metastatic breast cancer; Neutropenia; Oncology; Chemotherapy; Febrile neutropenia; Breast cancer; Internal medicine; Cancer; Pharmacology","score_opus":0.050255009929361424,"score_gpt":0.44049519122943914,"score_spread":0.3902401813000777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329585923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94878083,0.029964356,0.0056695575,0.0022305928,0.000110905916,0.00057811645,0.0011453733,0.00003301934,0.011487103],"genre_scores_gemma":[0.9946885,0.0034978269,0.000931516,0.0001322392,0.00003119519,0.000058563273,0.00017263091,0.0000054373977,0.00048200527],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9981591,0.0012116157,0.000066955465,0.000110884066,0.00024430337,0.00020706863],"domain_scores_gemma":[0.99856335,0.0009991709,0.0001982521,0.00002897895,0.00007526345,0.00013504503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021928917,0.00079049804,0.0011993736,0.0018728105,0.00024586477,0.0016327882,0.0008420656,0.000819317,0.003947926],"category_scores_gemma":[0.0050010504,0.00031730725,0.0026075232,0.001804054,0.00070494355,0.0010947839,0.0005582181,0.0010471042,0.00008906131],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059447005,0.0021086447,0.061021194,0.003356849,0.0057096696,0.002067732,0.00033778494,0.4377364,0.0036965364,0.032629143,0.004679228,0.38720977],"study_design_scores_gemma":[0.008319373,0.02620709,0.10514884,0.0013832444,0.026065819,0.0023452602,0.0024015314,0.77424353,0.0040821396,0.034094825,0.015404555,0.00030386657],"about_ca_topic_score_codex":0.012849828,"about_ca_topic_score_gemma":0.011306071,"teacher_disagreement_score":0.012849828,"about_ca_system_score_codex":0.005261027,"about_ca_system_score_gemma":0.0036856462,"threshold_uncertainty_score":0.03817165},"labels":[],"label_agreement":null},{"id":"W2330319273","doi":"10.5114/wo.2011.24435","title":"Opioidy w leczeniu polineuropatii wywołanej chemioterapią","year":2011,"lang":"pl","type":"article","venue":"Współczesna Onkologia","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.13928556748638937,"score_gpt":0.30210465050981256,"score_spread":0.16281908302342318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330319273","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003205691,0.18946013,0.008278368,0.24610145,0.059139553,0.0012838561,0.015645804,0.0038526356,0.47303256],"genre_scores_gemma":[0.015783492,0.19100082,0.008575331,0.030028278,0.012103569,0.0007447404,0.0076364256,0.00096127164,0.7331661],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99643505,0.00053055456,0.00041355783,0.00029044336,0.0021067958,0.00022364112],"domain_scores_gemma":[0.98088396,0.0041134674,0.0016132282,0.0010015897,0.0107700145,0.0016177709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046651647,0.00080652576,0.0012137439,0.0043217526,0.0014923072,0.006530748,0.001801484,0.0024937391,0.19519676],"category_scores_gemma":[0.024954537,0.0006299954,0.00083779654,0.00398437,0.00069033646,0.0045265215,0.001572436,0.0033896384,0.09488958],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007693906,0.00006105798,0.0004639041,0.00053973176,0.000008542924,0.00007033382,0.00006257357,0.00003851617,0.00025914016,0.0014282455,0.8204225,0.17656851],"study_design_scores_gemma":[0.000025056133,0.000068830384,0.0012593345,0.00092621276,0.00002125805,0.00011816389,0.00010661025,0.00007242016,0.0004123202,0.0010712954,0.9959009,0.000017489881],"about_ca_topic_score_codex":0.009471011,"about_ca_topic_score_gemma":0.014475472,"teacher_disagreement_score":0.19519676,"about_ca_system_score_codex":0.0022301057,"about_ca_system_score_gemma":0.006163872,"threshold_uncertainty_score":0.6529982},"labels":[],"label_agreement":null},{"id":"W2330965451","doi":"10.1158/0008-5472.sabcs12-p2-12-07","title":"Abstract P2-12-07: A review of clinical endpoints and use of quality-of-life outcomes in phase III metastatic breast cancer clinical trials","year":2012,"lang":"en","type":"review","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Clinical trial; Clinical endpoint; Quality of life (healthcare); Metastatic breast cancer; Breast cancer; Internal medicine; Cancer; Disease; Oncology; Phases of clinical research; Intensive care medicine; Nursing","score_opus":0.8964209041648008,"score_gpt":0.7636633541804825,"score_spread":0.13275754998431832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330965451","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010287188,0.9956092,0.0005307654,0.00050876226,0.00022749674,0.0010083662,0.0005162332,0.00001829026,0.00055209105],"genre_scores_gemma":[0.027715795,0.96179634,0.0033579494,0.0019199039,0.000298084,0.0038478712,0.00083781575,0.000041016872,0.00018522175],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9288955,0.033524595,0.02597563,0.002092776,0.0090363445,0.00047512652],"domain_scores_gemma":[0.7718926,0.16612314,0.042568315,0.0027335095,0.01531214,0.0013702295],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.065334566,0.0015087841,0.01018389,0.011240585,0.0007311235,0.0048846197,0.0032916227,0.0026647155,0.0035380847],"category_scores_gemma":[0.15731652,0.0010463723,0.007904071,0.015186944,0.0019296922,0.0036845081,0.0020829996,0.002226514,0.00056470674],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018520985,0.00007033689,0.0013913842,0.8654624,0.010566821,0.00007501833,0.0001902838,0.0001878597,0.0004380655,0.00062188937,0.0036496182,0.115494095],"study_design_scores_gemma":[0.0022401954,0.0012614325,0.0080596935,0.89245844,0.047888596,0.00042800672,0.00028284447,0.00031364855,0.0006243088,0.0006816392,0.045683067,0.000078099394],"about_ca_topic_score_codex":0.0014556256,"about_ca_topic_score_gemma":0.0035749397,"teacher_disagreement_score":0.93466544,"about_ca_system_score_codex":0.0042028925,"about_ca_system_score_gemma":0.008034206,"threshold_uncertainty_score":0.34552634},"labels":[],"label_agreement":null},{"id":"W2331094709","doi":"10.1097/00043426-200307000-00008","title":"Phase 1 Study of Paclitaxel Administered Twice Weekly to Children With Refractory Solid Tumors: A Pediatric Oncology Group Study","year":2003,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Medicine; Neutropenia; Dosing; Refractory (planetary science); Paclitaxel; Toxicity; Chemotherapy; Maximum tolerated dose; Limiting; Internal medicine; Gastroenterology; Surgery","score_opus":0.0404686605233346,"score_gpt":0.4053002212812081,"score_spread":0.3648315607578735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331094709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938239,0.0016592116,0.00068010605,0.0005093552,0.00006337692,0.0018732568,0.0006892822,0.000050715513,0.000650782],"genre_scores_gemma":[0.977719,0.0051858607,0.005764057,0.0009936524,0.00028008578,0.0052408185,0.0029097449,0.0000638526,0.0018429948],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99943,0.00033148326,0.000029962286,0.00006506478,0.000073578936,0.00006987219],"domain_scores_gemma":[0.998727,0.0002542075,0.00033271694,0.000105746236,0.0000766851,0.00050355645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015845282,0.001566709,0.0021186974,0.0004006848,0.00042856557,0.0005100962,0.00079811556,0.0011151445,0.00208217],"category_scores_gemma":[0.0011396306,0.0005085616,0.00092415174,0.0005532127,0.000901973,0.00052992353,0.00024199508,0.0035836687,0.00042884465],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5714612,0.14397971,0.04186308,0.0019896054,0.0026491035,0.0021417565,0.0007448419,0.0060874457,0.08137885,0.0007330862,0.008181736,0.13878967],"study_design_scores_gemma":[0.50028,0.46151596,0.021295669,0.00006921893,0.00065035623,0.0011525636,0.000056390636,0.0008337045,0.008866711,0.0001529921,0.0051052063,0.000021308217],"about_ca_topic_score_codex":0.0014076615,"about_ca_topic_score_gemma":0.0025292316,"teacher_disagreement_score":0.0021186974,"about_ca_system_score_codex":0.0011526857,"about_ca_system_score_gemma":0.0030982825,"threshold_uncertainty_score":0.008379877},"labels":[],"label_agreement":null},{"id":"W2331427771","doi":"10.1158/1535-7163.targ-09-c218","title":"Abstract C218: Antitumor activities of a novel oral formulation of SN38","year":2009,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Tolerability; Irinotecan; Pharmacology; Pharmacokinetics; In vivo; Active metabolite; Chemistry; Prodrug; Bioavailability; SN-38; Oral administration; Bioequivalence; Medicine; In vitro; Metabolite; Colorectal cancer; Cancer; Biochemistry; Adverse effect; Internal medicine; Biology","score_opus":0.05436867551825783,"score_gpt":0.3722591213640159,"score_spread":0.3178904458457581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331427771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990961,0.0031690807,0.001974129,0.00011259393,0.000044367946,0.00012768873,0.0004067149,0.000061821775,0.0031425061],"genre_scores_gemma":[0.9900933,0.0018086649,0.0033204206,0.000042441756,0.000027499556,0.00007127484,0.00056798296,0.000016980273,0.0040514395],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999547,0.000006829689,0.000003252412,0.000009942845,0.000016641769,0.000008663921],"domain_scores_gemma":[0.99996424,0.0000044790536,0.000009826503,0.000003098818,0.000007509535,0.000010915291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081187834,0.00035114572,0.00016221462,0.00019867651,0.00009578174,0.0001302439,0.00018344352,0.00019231677,0.0020292606],"category_scores_gemma":[0.00008330493,0.000066538996,0.000112163805,0.00012770071,0.00008644151,0.00014674116,0.000103833125,0.00033788182,0.00037511572],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046899752,0.0003220073,0.00011474507,0.00011287426,0.000009028644,0.000094639276,0.000014783347,0.00030042874,0.9846976,0.000092135735,0.00026600042,0.013506885],"study_design_scores_gemma":[0.00020634227,0.0055481824,0.0016624908,0.000014842141,0.00003696212,0.00049015565,0.000012909583,0.0014894301,0.98091185,0.000037333284,0.009580856,0.000008608268],"about_ca_topic_score_codex":0.00062877894,"about_ca_topic_score_gemma":0.00075195957,"teacher_disagreement_score":0.0020292606,"about_ca_system_score_codex":0.00024603668,"about_ca_system_score_gemma":0.00019320911,"threshold_uncertainty_score":0.0067886114},"labels":[],"label_agreement":null},{"id":"W2331485444","doi":"10.1016/j.jval.2012.08.1226","title":"PCN33 Progression-Free Survival as a Surrogate for Overall Survival in Metastatic Breast Cancer","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Institut National d'Excellence en Santé et en Services Sociaux; Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Metastatic breast cancer; Progression-free survival; Oncology; Breast cancer; Linear regression; Population; Cancer; Overall survival; Statistics; Mathematics","score_opus":0.0920146967092638,"score_gpt":0.43226656311668654,"score_spread":0.3402518664074228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331485444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861558,0.007077737,0.0014843468,0.00054460816,0.00003152724,0.000028225015,0.0007058556,0.000022835004,0.003949062],"genre_scores_gemma":[0.99824667,0.00061497395,0.00043466722,0.000039100134,0.0000106965,0.00001659491,0.00028323827,0.00000390485,0.00035009632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992275,0.00050404586,0.00002891083,0.000035855766,0.00013207826,0.00007150921],"domain_scores_gemma":[0.9984043,0.00066948583,0.00055446936,0.0000728091,0.00013341777,0.00016546236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014001649,0.00021862611,0.0003179695,0.00053565315,0.00014318585,0.0005585366,0.0002384903,0.00028614092,0.0010781157],"category_scores_gemma":[0.0037851213,0.00010109599,0.00027242512,0.0007221682,0.00027290607,0.00030722478,0.0004668425,0.000908926,0.0001957848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017389357,0.000337823,0.7870586,0.00034543773,0.00034978957,0.00054392504,0.00046286857,0.006629248,0.007783182,0.0037989765,0.0046739727,0.1706269],"study_design_scores_gemma":[0.00013772937,0.0037939928,0.96177024,0.00013772922,0.0002296581,0.0017964024,0.00030600105,0.015799556,0.0042277346,0.0036286146,0.008137114,0.00003522334],"about_ca_topic_score_codex":0.0025024607,"about_ca_topic_score_gemma":0.003541482,"teacher_disagreement_score":0.0025024607,"about_ca_system_score_codex":0.001074792,"about_ca_system_score_gemma":0.0005722367,"threshold_uncertainty_score":0.007798195},"labels":[],"label_agreement":null},{"id":"W2331590218","doi":"10.1158/0008-5472.sabcs10-p1-13-01","title":"Abstract P1-13-01: Comparing the Effects of Denosumab and Zoledronic Acid on Pain Interference with Daily Functioning in a Randomized Phase 3 Trial of Patients with Breast Cancer and Bone Metastases","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Denosumab; Brief Pain Inventory; Breast cancer; Internal medicine; Zoledronic acid; Bone pain; Clinical endpoint; Randomized controlled trial; Oncology; Cancer; Physical therapy; Osteoporosis; Chronic pain","score_opus":0.034659930866046525,"score_gpt":0.3834066668880435,"score_spread":0.34874673602199696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331590218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984939,0.0037393868,0.0005959539,0.0010266023,0.00052031653,0.0056822523,0.0017002375,0.00015165444,0.001644676],"genre_scores_gemma":[0.982644,0.002195347,0.0019945502,0.0016940223,0.0006431817,0.0067248484,0.0014560879,0.000036874666,0.0026110976],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988317,0.00076693686,0.000063107356,0.00013150697,0.00007128054,0.00013542791],"domain_scores_gemma":[0.998372,0.00055225054,0.00033802615,0.000092270566,0.00008862436,0.00055678334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030924734,0.0016318664,0.0035459204,0.0005535558,0.0005337333,0.001265713,0.0010180828,0.0018806305,0.0077243056],"category_scores_gemma":[0.0022444755,0.0008266994,0.0022257746,0.00054996565,0.0012702056,0.00091943494,0.00046289118,0.0041604713,0.001052901],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9847438,0.0046284692,0.00030072776,0.00025212104,0.00045098673,0.000025258345,0.000026686552,0.00015980614,0.0018508043,0.00006147874,0.00041340472,0.0070864563],"study_design_scores_gemma":[0.9397876,0.058451958,0.00093564065,0.000012011625,0.00017899563,0.000012575307,0.000008591298,0.00020679692,0.00018349712,0.00005922583,0.00015684297,0.0000062901695],"about_ca_topic_score_codex":0.0011441692,"about_ca_topic_score_gemma":0.0024935377,"teacher_disagreement_score":0.0077243056,"about_ca_system_score_codex":0.00071134896,"about_ca_system_score_gemma":0.0019229569,"threshold_uncertainty_score":0.025840402},"labels":[],"label_agreement":null},{"id":"W2332461257","doi":"10.1158/0008-5472.sabcs-1035","title":"Effect of anticoagulation therapy on bleeding and thromboembolic events (TEs) in the AVADO phase III study of docetaxel (D) ± bevacizumab (BV) in inoperable locally recurrent (LR) or metastatic breast cancer (mBC).","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sudbury Regional Hospital; University of Alberta; BC Cancer Agency","funders":"","keywords":"Medicine; Bevacizumab; Metastatic breast cancer; Concomitant; Docetaxel; Internal medicine; Surgery; Placebo; Phases of clinical research; Gastroenterology; Cancer; Clinical trial; Chemotherapy; Breast cancer","score_opus":0.11909703441275973,"score_gpt":0.5104941023681366,"score_spread":0.3913970679553769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332461257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941718,0.0026993977,0.00016693852,0.00020078145,0.00006506941,0.0005422958,0.0007290279,0.000024220748,0.0014004278],"genre_scores_gemma":[0.99565214,0.0015622189,0.00034567327,0.00025312943,0.00008699931,0.00042608,0.0006608218,0.000007876243,0.0010051319],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99957246,0.00025782958,0.00002598836,0.00005370087,0.00004189086,0.00004809649],"domain_scores_gemma":[0.999151,0.00021908163,0.00027300874,0.000046764897,0.000036611866,0.00027362522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010328714,0.00056707644,0.00086944405,0.00019125051,0.00017521165,0.0007403317,0.000498726,0.00062493054,0.0022888375],"category_scores_gemma":[0.0014717297,0.00030233947,0.0010566612,0.00022792723,0.00033209132,0.0003295169,0.00026413458,0.0017123031,0.00028513954],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.893776,0.01319052,0.012940624,0.0009910321,0.002217402,0.000068225854,0.00015064074,0.000875093,0.009954216,0.00017992288,0.0015158628,0.06414046],"study_design_scores_gemma":[0.61395806,0.319192,0.05872041,0.00013585965,0.0019743242,0.00019161658,0.00008489014,0.0011558449,0.0014112133,0.00020405259,0.002933203,0.000038454964],"about_ca_topic_score_codex":0.0013448981,"about_ca_topic_score_gemma":0.0034810842,"teacher_disagreement_score":0.0022888375,"about_ca_system_score_codex":0.00048706488,"about_ca_system_score_gemma":0.0006555754,"threshold_uncertainty_score":0.007656932},"labels":[],"label_agreement":null},{"id":"W2332743404","doi":"10.1055/s-0030-1250333","title":"A Novel Taxane 13-Glucoside and Other Taxanes from the Leaves of<i>Taxus cuspidata</i>","year":2010,"lang":"en","type":"article","venue":"Planta Medica","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Taxane; Glycosidic bond; Glucoside; Botany; Understory; Stereochemistry; Chemistry; Biology; Medicine; Biochemistry; Canopy; Genetics","score_opus":0.021354728649073305,"score_gpt":0.28920686697144343,"score_spread":0.26785213832237015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332743404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99144113,0.0037605206,0.0011551111,0.000096260774,0.000030175996,0.000051697298,0.0013220737,0.000032566106,0.0021105434],"genre_scores_gemma":[0.97891325,0.005455051,0.005689986,0.00020286703,0.000044679466,0.0000474629,0.003940735,0.000018939687,0.0056870077],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99998343,0.0000016750768,0.000001626269,0.000005234957,0.000004214308,0.0000038408984],"domain_scores_gemma":[0.99996483,0.0000032800992,0.0000075733183,0.0000026204007,0.000005203949,0.000016339798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000031461474,0.0004576853,0.00027640816,0.00049586885,0.00026202563,0.00019519764,0.00010327205,0.00025240105,0.0011583406],"category_scores_gemma":[0.000045903424,0.00013166279,0.00022166205,0.00040589503,0.00018326294,0.00025977226,0.00016197938,0.00041534627,0.00025150838],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013503624,0.000022179678,0.0008325553,0.0000991468,0.000009697654,0.00027079944,0.000060534432,0.00005186008,0.9930494,0.00006608633,0.000043346216,0.005359396],"study_design_scores_gemma":[0.00021793184,0.0024556895,0.11783218,0.00010932477,0.00024703608,0.0038113492,0.00048205635,0.0005326113,0.8310855,0.000533165,0.042614948,0.0000781947],"about_ca_topic_score_codex":0.00087473565,"about_ca_topic_score_gemma":0.001995099,"teacher_disagreement_score":0.0011583406,"about_ca_system_score_codex":0.00012394671,"about_ca_system_score_gemma":0.00030019478,"threshold_uncertainty_score":0.0038750172},"labels":[],"label_agreement":null},{"id":"W2333373145","doi":"10.1097/01.cot.0000289963.81694.73","title":"Metastatic Breast Cancer","year":2005,"lang":"en","type":"article","venue":"Oncology Times","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Cancer; Oncology; Metastatic breast cancer; Internal medicine","score_opus":0.027077208555881655,"score_gpt":0.39018861995654225,"score_spread":0.3631114114006606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333373145","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09071607,0.11407192,0.0015492813,0.013383167,0.0053944862,0.0009944885,0.0054059504,0.00034258683,0.76814204],"genre_scores_gemma":[0.5088823,0.075499736,0.003549458,0.019740058,0.0036319473,0.00071318407,0.009181009,0.00008774936,0.3787146],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998047,0.000026277647,0.000010433344,0.00003611292,0.00007397979,0.00004849529],"domain_scores_gemma":[0.99986553,0.000019530511,0.000020332762,0.000013721015,0.000040804385,0.00004010367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026941363,0.00028571454,0.0003736563,0.00035600885,0.0006483686,0.00053347845,0.0002448019,0.00044969958,0.05306205],"category_scores_gemma":[0.0004978502,0.00008302799,0.00033796445,0.0005033646,0.00014079471,0.00021433443,0.00028759096,0.00046188335,0.010782807],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012643534,0.0003709547,0.024676062,0.0012667603,0.000097691554,0.007127031,0.00021274574,0.00024754507,0.0063968324,0.004397571,0.3600927,0.5938497],"study_design_scores_gemma":[0.00029250522,0.0006693934,0.021361273,0.00028154752,0.00007840154,0.01674198,0.00016737325,0.00014876892,0.0014356828,0.00085909327,0.9579521,0.000011866113],"about_ca_topic_score_codex":0.0018667242,"about_ca_topic_score_gemma":0.00530185,"teacher_disagreement_score":0.05306205,"about_ca_system_score_codex":0.00091637304,"about_ca_system_score_gemma":0.000607929,"threshold_uncertainty_score":0.17751026},"labels":[],"label_agreement":null},{"id":"W2333644254","doi":"10.1158/0008-5472.sabcs11-p4-01-04","title":"P4-01-04: Effects of CYP2D6 Phenotype and Drug Adherence on Tamoxifen Metabolite Levels.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"CYP2D6; Tamoxifen; Metabolite; Medicine; Genotype; Pharmacology; Internal medicine; Active metabolite; Oncology; Pharmacogenetics; Confounding; Breast cancer; Cancer; Biology; Cytochrome P450; Genetics","score_opus":0.1758046066839674,"score_gpt":0.4552985116812434,"score_spread":0.279493904997276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333644254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99850523,0.00014733266,0.00015916777,0.00011791571,0.000012446586,0.000016410859,0.00041119318,0.000010058178,0.000620189],"genre_scores_gemma":[0.998604,0.000029597319,0.00015840723,0.00006944921,0.000012441004,0.000017420916,0.00035948606,0.000004891722,0.00074435613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921846,0.00047776397,0.000047892197,0.00010230096,0.000090322916,0.000063227104],"domain_scores_gemma":[0.9975292,0.0009400613,0.00070896104,0.00017459993,0.00016960855,0.00047755483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011664857,0.00027893635,0.00027682958,0.00022740276,0.00022726558,0.0003429819,0.00030704527,0.00048003974,0.003959469],"category_scores_gemma":[0.002873278,0.00012479085,0.00040324527,0.00035578373,0.00016315762,0.00024508353,0.00024681317,0.0007068154,0.0005875561],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007809756,0.0006549426,0.97659963,0.000034246736,0.00032838402,0.00026655686,0.00006357854,0.00008120056,0.0029246826,0.000033376138,0.00047280916,0.010730942],"study_design_scores_gemma":[0.00015733314,0.00224866,0.99522394,0.0000053705676,0.00014424103,0.00047852678,0.000050540064,0.0006303005,0.0005289965,0.00004627064,0.00048152113,0.0000042325914],"about_ca_topic_score_codex":0.0009270696,"about_ca_topic_score_gemma":0.00071532,"teacher_disagreement_score":0.003959469,"about_ca_system_score_codex":0.000118389704,"about_ca_system_score_gemma":0.00015604186,"threshold_uncertainty_score":0.013245761},"labels":[],"label_agreement":null},{"id":"W2334224680","doi":"10.1158/0008-5472.sabcs11-p5-19-14","title":"P5-19-14: Platinum-Based Chemotherapy in Triple-Negative Breast Cancer.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Credit Valley Hospital; Ottawa Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Vinorelbine; Internal medicine; Triple-negative breast cancer; Oncology; Gemcitabine; Capecitabine; Regimen; Chemotherapy; Breast cancer; Metastatic breast cancer; Cancer; Retrospective cohort study; Cisplatin; Chemotherapy regimen; Surgery; Colorectal cancer","score_opus":0.16560893439651836,"score_gpt":0.4741263035522565,"score_spread":0.30851736915573813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334224680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9662941,0.026522508,0.0004500428,0.0005270465,0.00008513034,0.000116220086,0.0006025036,0.000031189833,0.0053712577],"genre_scores_gemma":[0.9923039,0.005738168,0.00048885006,0.00013952762,0.00006408774,0.000029238934,0.00049607566,0.0000033767983,0.00073674443],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986696,0.000034463803,0.00001964518,0.000020665397,0.00004272881,0.000015502856],"domain_scores_gemma":[0.99978954,0.0000366556,0.00009363434,0.000007743583,0.000024458355,0.0000479668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024245489,0.000108641245,0.00015192463,0.00033601947,0.00018878198,0.00019806765,0.00023483715,0.0001638728,0.0013644035],"category_scores_gemma":[0.0005351158,0.000044504894,0.00009868355,0.0005014949,0.00016628343,0.00011957508,0.00017513582,0.00018180998,0.0002501209],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034202526,0.0004710444,0.6799965,0.00092271634,0.00014430271,0.004642686,0.00009342677,0.00049529725,0.013328029,0.00018142507,0.0043646186,0.2919397],"study_design_scores_gemma":[0.0003574502,0.005305289,0.9414583,0.00024964302,0.00018179645,0.022348775,0.00010955247,0.0007948494,0.009343883,0.00016697605,0.019672861,0.000010641795],"about_ca_topic_score_codex":0.0016095479,"about_ca_topic_score_gemma":0.0025442387,"teacher_disagreement_score":0.0016095479,"about_ca_system_score_codex":0.00043379873,"about_ca_system_score_gemma":0.000490961,"threshold_uncertainty_score":0.0045644045},"labels":[],"label_agreement":null},{"id":"W2334434334","doi":"10.1158/1538-7445.am2013-5515","title":"Abstract 5515: <i>In vivo</i> efficacy of the PARG inhibitor Gallotannin against triple negative breast cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer research; Triple-negative breast cancer; Cancer; Breast cancer; Cell growth; Cyclin D1; In vivo; Cell cycle checkpoint; Cancer cell; Biology; Cell cycle; Medicine; Internal medicine; Oncology; Chemistry; Biochemistry; Genetics","score_opus":0.059339270538116884,"score_gpt":0.4147771849554307,"score_spread":0.3554379144173138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334434334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842077,0.0041654855,0.0013336452,0.00053673884,0.00019591193,0.00023367871,0.0020879922,0.00033529528,0.006903457],"genre_scores_gemma":[0.99180883,0.001448699,0.0011123234,0.00021907101,0.000030846226,0.00014750843,0.0020868268,0.00004455416,0.0031014173],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986005,0.000037146976,0.000010297778,0.000023422966,0.00002201528,0.000047086745],"domain_scores_gemma":[0.9999045,0.000020229745,0.000021866332,0.000012643536,0.000007839859,0.00003294229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002104795,0.00061350083,0.00039758964,0.00043160786,0.0001487603,0.00023277626,0.00029605898,0.00046565296,0.002455366],"category_scores_gemma":[0.0001228381,0.00017306393,0.0003217496,0.00024649312,0.0002518991,0.00022809005,0.00010150857,0.00089740864,0.0004887466],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004494122,0.0011364063,0.00021716677,0.00017045355,0.000048962138,0.00008213711,0.00002925576,0.00037226678,0.9856455,0.00017473688,0.0009485003,0.006680452],"study_design_scores_gemma":[0.0007384738,0.019648412,0.005653429,0.000020723515,0.00010005696,0.00021741673,0.000028939146,0.00126485,0.96904314,0.00007836211,0.0031950923,0.0000110767905],"about_ca_topic_score_codex":0.001519577,"about_ca_topic_score_gemma":0.0014471152,"teacher_disagreement_score":0.002455366,"about_ca_system_score_codex":0.00034981273,"about_ca_system_score_gemma":0.00028769876,"threshold_uncertainty_score":0.008213997},"labels":[],"label_agreement":null},{"id":"W2335344368","doi":"10.1097/ogx.0b013e3182877729","title":"Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer","year":2013,"lang":"en","type":"article","venue":"Obstetrical & Gynecological Survey","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Jewish General Hospital","funders":"","keywords":"Docetaxel; Medicine; Capecitabine; Gemcitabine; Bevacizumab; Breast cancer; Oncology; Cyclophosphamide; Chemotherapy; Internal medicine; Doxorubicin; Cancer; Colorectal cancer","score_opus":0.04641934878625111,"score_gpt":0.35359231772341776,"score_spread":0.30717296893716667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335344368","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97968,0.0123133175,0.00053538993,0.00052906974,0.0007670687,0.0018038885,0.0002723267,0.000054443215,0.004044598],"genre_scores_gemma":[0.99019086,0.004051545,0.0010602897,0.000364738,0.00025988696,0.0010058314,0.0003986429,0.000006658977,0.0026614997],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9994481,0.0003021876,0.00004235829,0.000054501797,0.00009181251,0.000060874016],"domain_scores_gemma":[0.9995739,0.00014291643,0.00006582565,0.000026842012,0.000023920546,0.00016657774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005228459,0.00030041294,0.0017734381,0.00036520473,0.00024570635,0.0003960727,0.00023089538,0.0005348876,0.0034416593],"category_scores_gemma":[0.0012315237,0.00029687726,0.0005405523,0.00038100014,0.0004093912,0.0002607186,0.00022344384,0.0011916835,0.00033771418],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6543684,0.019243233,0.009549884,0.0020574888,0.0012303051,0.0005537651,0.00015685418,0.0025656044,0.03547886,0.0005233596,0.0034829518,0.2707893],"study_design_scores_gemma":[0.2713073,0.65191907,0.03363343,0.00035136088,0.0011178212,0.0010574764,0.00008056068,0.0027226026,0.009959498,0.00063935755,0.027141696,0.00006986483],"about_ca_topic_score_codex":0.00073383155,"about_ca_topic_score_gemma":0.0033639993,"teacher_disagreement_score":0.0034416593,"about_ca_system_score_codex":0.00050846615,"about_ca_system_score_gemma":0.00066816754,"threshold_uncertainty_score":0.011513531},"labels":[],"label_agreement":null},{"id":"W2335421053","doi":"10.1158/1535-7163.targ-11-a95","title":"Abstract A95: The determination of the maximum tolerated dose (MTD) of MGCD265 on an intermittent schedule: Phase I study results (Study 265-102).","year":2011,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Adverse effect; Nausea; Pharmacodynamics; Pharmacokinetics; Tolerability; Internal medicine; Maximum tolerated dose; Pharmacology; Gastroenterology; Oncology","score_opus":0.08630945641426414,"score_gpt":0.38851745837937557,"score_spread":0.30220800196511144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335421053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99332136,0.0008186269,0.0010155388,0.00017457953,0.000048063015,0.0018292734,0.0011489384,0.00011850227,0.0015250123],"genre_scores_gemma":[0.9920854,0.00051765115,0.0019886298,0.0003485635,0.00009318551,0.0011979764,0.0021731164,0.000030936975,0.0015645671],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99967515,0.0001349536,0.000020543937,0.000064389424,0.000042506043,0.00006249724],"domain_scores_gemma":[0.9992933,0.0001303769,0.00015046155,0.000060436803,0.000037009373,0.00032830433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013273333,0.0012999183,0.0010485976,0.0003964053,0.00031220925,0.00081582804,0.00087604386,0.0012069151,0.004104815],"category_scores_gemma":[0.0007909592,0.00044695273,0.000775254,0.00032557175,0.00075921504,0.0005609251,0.00026823004,0.0029239794,0.0009484532],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.59548664,0.09418696,0.010448075,0.0009415597,0.0010071786,0.0008743378,0.0004027181,0.0074983006,0.17237051,0.0007376311,0.00814542,0.10790069],"study_design_scores_gemma":[0.29286575,0.6729344,0.012265281,0.00004491558,0.00027851443,0.0005427506,0.000050682032,0.0026353716,0.014784629,0.00020252696,0.0033609995,0.00003409039],"about_ca_topic_score_codex":0.000997169,"about_ca_topic_score_gemma":0.001473371,"teacher_disagreement_score":0.004104815,"about_ca_system_score_codex":0.00077951164,"about_ca_system_score_gemma":0.001347993,"threshold_uncertainty_score":0.013732016},"labels":[],"label_agreement":null},{"id":"W2337335671","doi":"10.1200/jco.2012.30.15_suppl.539","title":"BOLERO-2: Health-related quality-of-life in metastatic breast cancer patients treated with everolimus and exemestane versus exemestane.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Exemestane; Internal medicine; Breast cancer; Aromatase inhibitor; Quality of life (healthcare); Placebo; Everolimus; Hazard ratio; Oncology; Clinical endpoint; Interim analysis; Proportional hazards model; Cancer; Randomized controlled trial; Confidence interval; Aromatase","score_opus":0.21813842384889356,"score_gpt":0.5185650640622901,"score_spread":0.3004266402133965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337335671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98092574,0.012142423,0.00035726326,0.0005084051,0.00017984159,0.0014968216,0.0018870267,0.000054095548,0.0024484266],"genre_scores_gemma":[0.98547876,0.003342291,0.0019199058,0.0006495028,0.00016879571,0.0030918098,0.0026054212,0.00001862889,0.0027247914],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991584,0.0005218961,0.000045856872,0.000094483716,0.000086134125,0.00009327311],"domain_scores_gemma":[0.99920493,0.00020108827,0.00029842294,0.000032532647,0.000029792462,0.00023333478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026386231,0.00089330133,0.0021158888,0.00047564233,0.00022281286,0.00081140734,0.0008687281,0.000645596,0.0067927362],"category_scores_gemma":[0.0016304215,0.0003972809,0.002383941,0.00036457356,0.0006102898,0.0005698511,0.00065575296,0.0018519607,0.00048052045],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9591201,0.0062351217,0.003268349,0.0008776623,0.0018728935,0.000019777688,0.000046515466,0.00095454784,0.0035987552,0.00007592894,0.0008565325,0.023073774],"study_design_scores_gemma":[0.73583454,0.2254764,0.030497164,0.00017149058,0.0025113318,0.000109372915,0.000043209973,0.0014288287,0.0016086292,0.00016515901,0.0021127234,0.000041151656],"about_ca_topic_score_codex":0.00076538825,"about_ca_topic_score_gemma":0.0026285206,"teacher_disagreement_score":0.0067927362,"about_ca_system_score_codex":0.0010746968,"about_ca_system_score_gemma":0.0009093358,"threshold_uncertainty_score":0.022723913},"labels":[],"label_agreement":null},{"id":"W2337704846","doi":"10.1200/jco.2009.27.15_suppl.1099","title":"Cisplatin chemotherapy in the treatment of BRCA1-positive metastatic breast cancer (MBC)","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Chemotherapy; Internal medicine; Cisplatin; Regimen; Metastatic breast cancer; Anthracycline; Response Evaluation Criteria in Solid Tumors; Oncology; Breast cancer; Chemotherapy regimen; Progressive disease; Cancer; Gastroenterology; Surgery","score_opus":0.13381379519778763,"score_gpt":0.540320516122561,"score_spread":0.4065067209247734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337704846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915378,0.006918389,0.00025340574,0.00024662228,0.00003577759,0.00027702271,0.00007677895,0.000016721524,0.0006374987],"genre_scores_gemma":[0.99589795,0.0028829172,0.0005065152,0.00012134699,0.000053865635,0.00014857596,0.0000958557,0.0000037404245,0.0002892094],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99961674,0.00023359084,0.000029208146,0.000035202662,0.000053688094,0.000031466872],"domain_scores_gemma":[0.99964106,0.00011822403,0.000078260855,0.000017408302,0.000022414008,0.00012257682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007710467,0.00026305165,0.00086054887,0.00028525456,0.00021796735,0.0003395189,0.00032319757,0.00037146208,0.0011497128],"category_scores_gemma":[0.000999635,0.0002030396,0.00022029673,0.00028337957,0.00031940846,0.0002526664,0.00030582934,0.00088826654,0.0001649693],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19961286,0.018924257,0.09490878,0.0026658115,0.0009438439,0.00200415,0.0006335133,0.010198751,0.106956005,0.00060222344,0.004841286,0.55770856],"study_design_scores_gemma":[0.06606322,0.7118946,0.16112573,0.00036146503,0.0008406626,0.004704725,0.00014939568,0.006977844,0.02592872,0.0005326057,0.021368412,0.000052664793],"about_ca_topic_score_codex":0.00051949103,"about_ca_topic_score_gemma":0.0013426961,"teacher_disagreement_score":0.0011497128,"about_ca_system_score_codex":0.00042736428,"about_ca_system_score_gemma":0.0006686026,"threshold_uncertainty_score":0.0040777326},"labels":[],"label_agreement":null},{"id":"W2337771086","doi":"10.1007/s00216-016-9412-4","title":"Phenylbutazone purity challenge","year":2016,"lang":"en","type":"article","venue":"Analytical and Bioanalytical Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada","funders":"","keywords":"Phenylbutazone; Chemistry; Medical laboratory; Environmental chemistry; Biochemical engineering; Chromatography; Engineering; Pharmacology; Medicine","score_opus":0.021560921158375265,"score_gpt":0.2990167133391603,"score_spread":0.27745579218078503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337771086","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08498272,0.009445664,0.65847737,0.088852756,0.007769128,0.0020226857,0.0029209696,0.012394849,0.1331339],"genre_scores_gemma":[0.38340244,0.01379249,0.39461127,0.041208323,0.0038181336,0.0014668654,0.005972418,0.0063760406,0.14935201],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.98638606,0.0022525904,0.00044154542,0.0014965136,0.008477134,0.0009460968],"domain_scores_gemma":[0.98654956,0.0030862235,0.000862411,0.0023405433,0.00634378,0.0008174832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008261497,0.0011409612,0.00090136303,0.0015994986,0.0026445237,0.0036291145,0.0026337148,0.0028329836,0.011904305],"category_scores_gemma":[0.013530812,0.0012817255,0.00058699027,0.00078729715,0.002327024,0.0031851334,0.00520233,0.008480229,0.013813561],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000822358,0.00025897147,0.0017103858,0.000655974,0.00012113649,0.0012375133,0.00064767693,0.00075610087,0.7452151,0.046473183,0.069892466,0.13220914],"study_design_scores_gemma":[0.000051445375,0.0003638682,0.0007936986,0.00017449184,0.000058941256,0.002668979,0.00038926332,0.003245455,0.713603,0.010680977,0.26792267,0.000047156555],"about_ca_topic_score_codex":0.0029615515,"about_ca_topic_score_gemma":0.0030435899,"teacher_disagreement_score":0.011904305,"about_ca_system_score_codex":0.0016399076,"about_ca_system_score_gemma":0.004909984,"threshold_uncertainty_score":0.043691516},"labels":[],"label_agreement":null},{"id":"W2337992458","doi":"10.1093/annonc/mdu329.21","title":"Targeted Chemotherapy with Albumin-Bound Paclitaxel (Nab-Paclitaxel) for Metastatic Breast Cancer (Mbc): Which Benefit for Which Patients? a Real World Multicenter Italian Experience on 150 Women","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Paclitaxel; Metastatic breast cancer; Nab-paclitaxel; Oncology; Chemotherapy; Internal medicine; Breast cancer; Cancer","score_opus":0.04636067163229297,"score_gpt":0.3985789024234224,"score_spread":0.35221823079112946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337992458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975568,0.001044375,0.00013619049,0.00011273986,0.000005973119,0.000064128406,0.00010428046,0.000004885012,0.00097064965],"genre_scores_gemma":[0.99657494,0.0016718918,0.0003760962,0.00029209867,0.00004182052,0.00008424717,0.00035883978,0.000014103223,0.0005858924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995054,0.00029510495,0.000018692948,0.000059198734,0.000043353284,0.000078243],"domain_scores_gemma":[0.9995808,0.00017997307,0.00007445927,0.000045775832,0.000019683397,0.00009933239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011848819,0.00040170536,0.00052924384,0.0002096211,0.0003486568,0.00041364483,0.00024360954,0.00035053233,0.0010535899],"category_scores_gemma":[0.0015523193,0.00014989599,0.00043893297,0.0004451677,0.0006662338,0.00025130442,0.0003472114,0.0003719213,0.00030843334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.062772155,0.015580544,0.52867615,0.0005760309,0.0008937325,0.005017874,0.0069619096,0.005354311,0.04000583,0.0008502629,0.0068405913,0.32647067],"study_design_scores_gemma":[0.0119063435,0.1626652,0.7782315,0.00012589633,0.0013771254,0.0065550185,0.0026174954,0.001353704,0.007667888,0.0006228882,0.026786681,0.00009030483],"about_ca_topic_score_codex":0.002436233,"about_ca_topic_score_gemma":0.002621254,"teacher_disagreement_score":0.002436233,"about_ca_system_score_codex":0.00058317505,"about_ca_system_score_gemma":0.00049224123,"threshold_uncertainty_score":0.006266296},"labels":[],"label_agreement":null},{"id":"W2339221030","doi":"10.1200/jco.2009.27.15_suppl.e14525","title":"Phase I study of daily administration of MGCD265 to patients with advanced malignancies (Study 265–101)","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Neutropenia; Pharmacokinetics; Toxicity; Pharmacodynamics; Internal medicine; Gastroenterology; Tyrosine-kinase inhibitor; Pharmacology; Oncology; Cancer","score_opus":0.09897926098553333,"score_gpt":0.5188007457300592,"score_spread":0.41982148474452585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339221030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946332,0.0006192947,0.00054227153,0.0002168843,0.00006022574,0.0015616921,0.0007578284,0.00009737416,0.0015111149],"genre_scores_gemma":[0.9918407,0.0007482287,0.0012569831,0.00045018955,0.00010577044,0.0011355063,0.0024424696,0.000022621554,0.0019973975],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99970394,0.00013776032,0.000014192735,0.00005185643,0.000030975934,0.000061287275],"domain_scores_gemma":[0.9994006,0.000094685325,0.00011269883,0.000055872653,0.00003843746,0.0002976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011391133,0.0013987602,0.0012184753,0.00038150206,0.00032701765,0.0008953396,0.0007709831,0.0009430386,0.0031295398],"category_scores_gemma":[0.0006287972,0.00049952813,0.0007535208,0.0003395725,0.00084160117,0.0004850518,0.00031125525,0.0024813842,0.00088988873],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5579602,0.13943914,0.014669034,0.0011067045,0.0013094014,0.000730058,0.00066942733,0.009500631,0.14767675,0.0009333649,0.011220842,0.1147845],"study_design_scores_gemma":[0.34166244,0.6282409,0.01644236,0.00003886576,0.00021575078,0.00042838068,0.000070304486,0.0018960857,0.0069215484,0.00017563498,0.0038728626,0.000034891116],"about_ca_topic_score_codex":0.0009638434,"about_ca_topic_score_gemma":0.0021447162,"teacher_disagreement_score":0.0031295398,"about_ca_system_score_codex":0.00081407145,"about_ca_system_score_gemma":0.0015227187,"threshold_uncertainty_score":0.010469377},"labels":[],"label_agreement":null},{"id":"W2339550887","doi":"10.1200/jco.2009.27.15_suppl.5563","title":"A phase II study evaluating the safety and efficacy of patupilone in patients with platinum refractory/resistant ovarian, primary fallopian, or peritoneal cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Medicine; Taxane; Ovarian cancer; Vomiting; Nausea; Refractory (planetary science); Fallopian tube cancer; Surgery; Internal medicine; Adverse effect; Gastroenterology; Urology; Cancer; Breast cancer","score_opus":0.13520955569290882,"score_gpt":0.5222127716911457,"score_spread":0.38700321599823684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339550887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965918,0.00083480525,0.00028149926,0.000119567725,0.000033954693,0.0010359208,0.00035257384,0.000034065197,0.0007158376],"genre_scores_gemma":[0.99544674,0.00069034914,0.0006809169,0.00037910897,0.000076766046,0.00092578016,0.0011404511,0.000010871649,0.0006489378],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99970067,0.00015303433,0.00002018171,0.000046269233,0.000028553834,0.000051347957],"domain_scores_gemma":[0.99921405,0.00017565438,0.00012700206,0.00006494733,0.00003823351,0.00038005554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010747659,0.00077435875,0.0015194156,0.00036689197,0.00035047033,0.00066115725,0.0006223278,0.00075822335,0.0029796115],"category_scores_gemma":[0.0009590504,0.00039534917,0.00075936987,0.00042530362,0.0007035637,0.00047893228,0.00028100045,0.0019397951,0.0005667293],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6524088,0.09176278,0.030630462,0.0012717888,0.0013942621,0.0010487993,0.00069709984,0.0032399006,0.085439384,0.00021424748,0.0029431276,0.1289495],"study_design_scores_gemma":[0.33628383,0.6253092,0.029842136,0.00003492432,0.00042751443,0.0006139474,0.000069037415,0.0014200549,0.0039449246,0.00007680666,0.0019528372,0.000024869825],"about_ca_topic_score_codex":0.0007680518,"about_ca_topic_score_gemma":0.0013304772,"teacher_disagreement_score":0.0029796115,"about_ca_system_score_codex":0.000520096,"about_ca_system_score_gemma":0.0010222961,"threshold_uncertainty_score":0.009967804},"labels":[],"label_agreement":null},{"id":"W2340310616","doi":"10.1200/jco.2006.24.18_suppl.10728","title":"Trends in systemic management (SM) for the treatment of locally advanced breast cancer: Data from a regional cancer centre","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Ottawa Hospital","funders":"","keywords":"Medicine; Anastrozole; Internal medicine; Oncology; Breast cancer; Vinorelbine; Tamoxifen; Docetaxel; Capecitabine; Exemestane; Fulvestrant; Cancer; Letrozole; Epirubicin; Gynecology; Gemcitabine; Chemotherapy; Colorectal cancer","score_opus":0.1761259780921647,"score_gpt":0.5163225580688612,"score_spread":0.3401965799766965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340310616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94958013,0.0036395513,0.00022360687,0.00054421887,0.00001789475,0.000071638824,0.04188912,0.000075151635,0.0039586574],"genre_scores_gemma":[0.972338,0.0017665251,0.00044405714,0.0003028178,0.00003356156,0.00011846487,0.024316244,0.00003583949,0.00064450415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979504,0.00039480274,0.00042605912,0.00044912042,0.0005304525,0.00024930332],"domain_scores_gemma":[0.98920083,0.0014174972,0.006233779,0.00041676997,0.0019623248,0.0007687657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010321627,0.00023225747,0.0005244346,0.0022480194,0.00021794614,0.0006812811,0.0006447152,0.00033336648,0.0023182451],"category_scores_gemma":[0.004009276,0.00022927292,0.00055339833,0.00535564,0.00017524492,0.00044433316,0.0006557457,0.00044411188,0.00092979684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014220993,0.000019780919,0.9919916,0.00012774744,0.00009129785,0.000068080786,0.00010020769,0.00018390159,0.00016506194,0.00003151699,0.0024461003,0.004632622],"study_design_scores_gemma":[0.000014718395,0.000080874626,0.9964386,0.000044083175,0.00004625484,0.0002724962,0.00024325233,0.00017824354,0.000091128066,0.0000067524547,0.00257585,0.000007766536],"about_ca_topic_score_codex":0.049349,"about_ca_topic_score_gemma":0.0731541,"teacher_disagreement_score":0.049349,"about_ca_system_score_codex":0.0014847805,"about_ca_system_score_gemma":0.0015925962,"threshold_uncertainty_score":0.09812355},"labels":[],"label_agreement":null},{"id":"W2342132516","doi":"10.1200/jco.2009.27.15_suppl.1083","title":"Phase II study of sagopilone (ZK-Epo) in patients with recurrent metastatic breast cancer (MBC)","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Taxane; Metastatic breast cancer; Progressive disease; Internal medicine; Clinical endpoint; Adverse effect; Anthracycline; Performance status; Breast cancer; Stage (stratigraphy); Cancer; Surgery; Phases of clinical research; Oncology; Gastroenterology; Chemotherapy; Clinical trial","score_opus":0.13989923692366021,"score_gpt":0.5438389371707747,"score_spread":0.40393970024711445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342132516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971002,0.0008949026,0.00017285763,0.00013001522,0.00002264587,0.0007406755,0.00033472036,0.0000402997,0.00056361925],"genre_scores_gemma":[0.996067,0.00071103557,0.00051536673,0.00020659757,0.00006267251,0.00065411587,0.00085691636,0.000010709737,0.0009155965],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997793,0.000100164296,0.000013309109,0.00003286493,0.000027626946,0.000046652294],"domain_scores_gemma":[0.9997204,0.000038970506,0.000054720465,0.000022242428,0.000020206451,0.00014347097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000757237,0.0009246278,0.0012353031,0.00029809566,0.0002181813,0.0004697364,0.0004224249,0.00060305005,0.0023884894],"category_scores_gemma":[0.00049860624,0.00034398783,0.00059624924,0.0002813181,0.00044735018,0.0003208478,0.00024235043,0.0012617008,0.0006893435],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5806909,0.06479005,0.034784663,0.0011238273,0.0015270172,0.0008041626,0.0007088207,0.0040690238,0.116405435,0.0002785902,0.0052849413,0.18953268],"study_design_scores_gemma":[0.3079978,0.62146765,0.058215197,0.000029450604,0.0004811683,0.0007418419,0.000083922634,0.0015743424,0.0056914506,0.00009882301,0.0035930807,0.000025326484],"about_ca_topic_score_codex":0.0012060157,"about_ca_topic_score_gemma":0.002198673,"teacher_disagreement_score":0.0023884894,"about_ca_system_score_codex":0.0005863436,"about_ca_system_score_gemma":0.0008201513,"threshold_uncertainty_score":0.007990241},"labels":[],"label_agreement":null},{"id":"W2343566398","doi":"10.1007/s10549-016-3808-x","title":"Phase II clinical study of eribulin monotherapy in Japanese patients with metastatic breast cancer who had well-defined taxane resistance","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada; Eisai; Ministry of Health, Labour and Welfare; Japan Agency for Medical Research and Development","keywords":"Medicine; Eribulin; Taxane; Internal medicine; Metastatic breast cancer; Tolerability; Breast cancer; Neutropenia; Febrile neutropenia; Clinical endpoint; Gastroenterology; Progressive disease; Adverse effect; Oncology; Surgery; Chemotherapy; Cancer; Clinical trial","score_opus":0.07258553034229742,"score_gpt":0.4487050927202439,"score_spread":0.37611956237794647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343566398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99602747,0.0013247097,0.00032317822,0.000100630066,0.00003398042,0.0013193853,0.00019730013,0.000025023446,0.00064829795],"genre_scores_gemma":[0.9920515,0.001690462,0.00142761,0.0004449743,0.00007779812,0.002085499,0.0008723639,0.000014504961,0.0013352641],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996867,0.00015070636,0.000016649117,0.000049782502,0.000027860226,0.00006829386],"domain_scores_gemma":[0.9996269,0.00003382782,0.000051804487,0.000035441175,0.000031182557,0.00022078588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011912158,0.00127229,0.0026182712,0.00035361823,0.000427032,0.0004938704,0.00057309854,0.00070927525,0.0018224724],"category_scores_gemma":[0.00049635634,0.00046153236,0.0007017075,0.00039154672,0.00079094863,0.00045540207,0.00031822425,0.0013488496,0.00038574907],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.56812185,0.11494506,0.023838963,0.0011226588,0.001835222,0.00088272634,0.0008966114,0.0032083914,0.18674451,0.0005045294,0.002995222,0.094904184],"study_design_scores_gemma":[0.25552678,0.69987595,0.031105401,0.000033690045,0.00063983625,0.00054992246,0.00016807378,0.0011940321,0.0069373236,0.00014190887,0.0037893844,0.000037709764],"about_ca_topic_score_codex":0.0010498066,"about_ca_topic_score_gemma":0.0031522557,"teacher_disagreement_score":0.0026182712,"about_ca_system_score_codex":0.00064042106,"about_ca_system_score_gemma":0.0014804108,"threshold_uncertainty_score":0.0062997937},"labels":[],"label_agreement":null},{"id":"W2343699346","doi":"10.1177/1534735415627926","title":"Phase 2 Study of Acupuncture-Like Transcutaneous Nerve Stimulation for Chemotherapy-Induced Peripheral Neuropathy","year":2016,"lang":"en","type":"article","venue":"Integrative Cancer Therapies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Acupuncture; Randomization; Peripheral neuropathy; Chemotherapy; Clinical endpoint; Clinical trial; Prospective cohort study; Anesthesia; Surgery; Physical therapy; Internal medicine","score_opus":0.04229508096388666,"score_gpt":0.3831938939705694,"score_spread":0.34089881300668273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343699346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776732,0.00093035575,0.0017533351,0.00026260127,0.0001982606,0.017095435,0.0007584502,0.00009347046,0.0012347776],"genre_scores_gemma":[0.94001603,0.0019858978,0.0073261796,0.0018292983,0.00046787155,0.04070106,0.0022059104,0.000042302243,0.0054255035],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9988925,0.00062429096,0.00004974214,0.00015833382,0.00010266472,0.00017254177],"domain_scores_gemma":[0.99914,0.00019961092,0.00015397166,0.000118920856,0.000095966185,0.0002914621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033672908,0.0023070944,0.002423382,0.00077405217,0.00059831224,0.00083862885,0.0011296248,0.0019548202,0.0043381],"category_scores_gemma":[0.0014091039,0.0008903977,0.0012120664,0.0004825566,0.0010058167,0.00092847954,0.0003928379,0.002229779,0.00057052885],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69506913,0.22204745,0.0029868411,0.0008425995,0.00062782306,0.00031506983,0.00023877303,0.001518349,0.03255456,0.00037280846,0.0014075269,0.042019147],"study_design_scores_gemma":[0.38901678,0.6043548,0.002651517,0.000020686082,0.000115668336,0.00009579608,0.000025493599,0.0005459585,0.0020372593,0.0001238507,0.0009932185,0.000019007526],"about_ca_topic_score_codex":0.0005620313,"about_ca_topic_score_gemma":0.0012965748,"teacher_disagreement_score":0.0043381,"about_ca_system_score_codex":0.0006256805,"about_ca_system_score_gemma":0.0021501305,"threshold_uncertainty_score":0.01780814},"labels":[],"label_agreement":null},{"id":"W2345610352","doi":"10.1007/s00520-016-3256-5","title":"Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer—a systematic review","year":2016,"lang":"en","type":"review","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"","keywords":"Medicine; Taxane; Docetaxel; Breast cancer; Internal medicine; Incidence (geometry); Observational study; Retrospective cohort study; Oncology; Randomized controlled trial; Meta-analysis; Cochrane Library; Cancer","score_opus":0.025940673607040846,"score_gpt":0.39494427933038495,"score_spread":0.3690036057233441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345610352","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009189072,0.9985862,0.000042103246,0.00007306243,0.000048238016,0.00006024085,0.00014229481,0.0000026853554,0.00012636474],"genre_scores_gemma":[0.011189068,0.98800653,0.00024012047,0.00030623842,0.00004381777,0.00006357622,0.00008798487,0.0000013417856,0.000061436636],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9988814,0.00027859758,0.000480582,0.00012551883,0.00018371396,0.000050209084],"domain_scores_gemma":[0.9957605,0.0026872137,0.0011906814,0.000044627748,0.00024321224,0.000073722644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013866205,0.0007977282,0.0038853236,0.0029320535,0.00029001344,0.0011146984,0.0008353792,0.00092717377,0.0032071352],"category_scores_gemma":[0.007955474,0.00050641457,0.0055515356,0.0036896176,0.00039376077,0.00093411043,0.0009714826,0.00096172583,0.00013593922],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005661118,0.000045823603,0.0015360379,0.8943944,0.016875228,0.000114705785,0.000112537484,0.00013775619,0.00028062973,0.00018080877,0.0022901723,0.08346582],"study_design_scores_gemma":[0.0018487691,0.0009416847,0.024208354,0.6695471,0.2448442,0.0013997576,0.00051234436,0.00021102042,0.00034836156,0.0005718515,0.055437177,0.00012939982],"about_ca_topic_score_codex":0.00594753,"about_ca_topic_score_gemma":0.023832139,"teacher_disagreement_score":0.00594753,"about_ca_system_score_codex":0.0010923049,"about_ca_system_score_gemma":0.002632132,"threshold_uncertainty_score":0.0118258},"labels":[],"label_agreement":null},{"id":"W2351438759","doi":"10.1200/jco.2004.22.90140.773","title":"Palliative chemotherapy with vinorelbine or capecitabine in women with anthracycline and taxane refractory metastatic breast cancer","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Vinorelbine; Capecitabine; Medicine; Taxane; Anthracycline; Metastatic breast cancer; Internal medicine; Oncology; Breast cancer; Chemotherapy; Cancer; Surgery; Colorectal cancer","score_opus":0.07887157768887255,"score_gpt":0.4760803488222091,"score_spread":0.3972087711333366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2351438759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782723,0.0015354478,0.000065815424,0.0000616202,0.0000061167175,0.000017040538,0.000078210396,0.0000019370184,0.00040655702],"genre_scores_gemma":[0.99885535,0.00073691923,0.00011019454,0.00004970302,0.000016368402,0.000012727777,0.00014307736,7.3627285e-7,0.000075023134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983704,0.000057039768,0.00002054556,0.000024400642,0.00003303284,0.000027986494],"domain_scores_gemma":[0.9994271,0.00018625442,0.0002514491,0.000015822943,0.00002539277,0.00009403486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003071267,0.000084389765,0.00027934194,0.00025937133,0.00025542348,0.00021006167,0.0001248418,0.0002176986,0.00089502527],"category_scores_gemma":[0.0017142262,0.00010880537,0.00021016464,0.0004005578,0.00021450718,0.00015174814,0.00016803828,0.00018191923,0.00012882998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018775575,0.000108733315,0.9768876,0.00012068379,0.00005349594,0.0031500694,0.00020321363,0.0001904869,0.001546784,0.000030267349,0.00031743106,0.015513725],"study_design_scores_gemma":[0.00021803933,0.0036673348,0.97845334,0.00007924934,0.0001211942,0.013833371,0.00036585404,0.00048096472,0.0007529699,0.000099685836,0.0019183712,0.000009554132],"about_ca_topic_score_codex":0.0011590509,"about_ca_topic_score_gemma":0.0031417843,"teacher_disagreement_score":0.0011590509,"about_ca_system_score_codex":0.00037148266,"about_ca_system_score_gemma":0.00034959553,"threshold_uncertainty_score":0.0029941797},"labels":[],"label_agreement":null},{"id":"W2358919324","doi":"","title":"Efficacy of Local Injection on Cervical 2 Processus Transverses and Stellate Ganglion Block for Cervicogenic Headache","year":2006,"lang":"en","type":"article","venue":"Chinese Journal of Rehabilitation","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cervicogenic headache; Stellate ganglion; Significant difference; Medicine; Anesthesia; Migraine; Internal medicine","score_opus":0.008142605189700334,"score_gpt":0.30410384477267344,"score_spread":0.2959612395829731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2358919324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98709536,0.010657594,0.0006446959,0.00009324068,0.000024726825,0.00007616558,0.000022095757,0.00003127344,0.0013547569],"genre_scores_gemma":[0.99610245,0.0029571843,0.00039287988,0.000053782955,0.00009306945,0.000046358633,0.00003948129,0.0000017271577,0.0003129624],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99981993,0.00007168241,0.0000110038445,0.000019039866,0.000049160666,0.00002925423],"domain_scores_gemma":[0.99980515,0.000072355804,0.00005451409,0.000013814061,0.000011532177,0.00004272768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003317533,0.0002276388,0.00040120078,0.00022048544,0.00014524937,0.00011773022,0.00017362044,0.00020646222,0.0019454465],"category_scores_gemma":[0.00068686006,0.00006395703,0.00019220752,0.00010936301,0.00030486082,0.00015531345,0.00013096546,0.00022731499,0.00018691654],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04795855,0.012297781,0.05797029,0.0030333125,0.00067584956,0.0032344228,0.0006852122,0.0016288053,0.19892946,0.00042781988,0.0015892358,0.67156935],"study_design_scores_gemma":[0.025094228,0.35601047,0.5169211,0.0008082458,0.0019435767,0.013939177,0.0009301735,0.004798909,0.06810775,0.00040564194,0.010958079,0.00008269778],"about_ca_topic_score_codex":0.0006505604,"about_ca_topic_score_gemma":0.001144819,"teacher_disagreement_score":0.0019454465,"about_ca_system_score_codex":0.00014325781,"about_ca_system_score_gemma":0.0002610758,"threshold_uncertainty_score":0.006508112},"labels":[],"label_agreement":null},{"id":"W2368261462","doi":"10.1177/1078155215627502","title":"Taxane-induced arthralgia and myalgia: A literature review","year":2016,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"myalgia; Taxane; Medicine; Docetaxel; Paclitaxel; Internal medicine; Chemotherapy; Oncology; Breast cancer; Cancer","score_opus":0.09835431357604807,"score_gpt":0.5213771832342611,"score_spread":0.423022869658213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2368261462","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003032782,0.99914086,0.000028873248,0.00016053679,0.00007088394,0.00003119243,0.00005790501,0.0000026082578,0.00020374694],"genre_scores_gemma":[0.0020785828,0.99726,0.00012057618,0.00028115258,0.00009811294,0.000045986937,0.000056768145,0.0000011470191,0.000057612808],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976808,0.00049509143,0.0010676009,0.00020756618,0.00047126893,0.000077697885],"domain_scores_gemma":[0.9885306,0.007869993,0.002351984,0.000124377,0.000968461,0.00015460922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002400647,0.0009817474,0.003387128,0.011080523,0.0007340599,0.0016867138,0.0015203513,0.0016337819,0.0050698286],"category_scores_gemma":[0.010383957,0.00056996354,0.002739928,0.011982447,0.0007917126,0.0020992113,0.00093266217,0.0009188421,0.00045567236],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015711783,0.00005886123,0.0012626242,0.80994666,0.0011930646,0.00060118834,0.00027286884,0.00013063019,0.0002886005,0.0006327255,0.00894915,0.17650655],"study_design_scores_gemma":[0.00015779231,0.00034330285,0.01198599,0.83832544,0.017042544,0.0060569057,0.00067725434,0.00012925599,0.00034949716,0.001072262,0.123798326,0.0000615034],"about_ca_topic_score_codex":0.004112157,"about_ca_topic_score_gemma":0.009348469,"teacher_disagreement_score":0.011080523,"about_ca_system_score_codex":0.0019521446,"about_ca_system_score_gemma":0.00673944,"threshold_uncertainty_score":0.016960263},"labels":[],"label_agreement":null},{"id":"W2373695127","doi":"10.1200/jco.2009.27.15_suppl.3558","title":"Phase I study of temsirolimus (CCI-779), carboplatin, and paclitaxel in patients (pts) with advanced solid tumors: NCIC CTG IND 179","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; London Health Sciences Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Carboplatin; Tolerability; Paclitaxel; Temsirolimus; Regimen; Internal medicine; Chemotherapy; Oncology; Ovarian cancer; Urology; Cancer; Adverse effect; Cisplatin","score_opus":0.07709302058253897,"score_gpt":0.5078986007350953,"score_spread":0.4308055801525563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2373695127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99445057,0.0009110003,0.00033431372,0.00033509528,0.000065009,0.0019922876,0.0005666686,0.000060932318,0.0012842803],"genre_scores_gemma":[0.98864114,0.001066275,0.0021169223,0.00073712703,0.0001426531,0.002881963,0.0022546656,0.000026180343,0.0021332235],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99967515,0.00014147995,0.000019115738,0.000053751326,0.00003589815,0.00007464341],"domain_scores_gemma":[0.99937123,0.00007599001,0.00008921371,0.000038299044,0.000027247308,0.00039795076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010834633,0.0013360108,0.0017279463,0.00049942627,0.00043290335,0.0007767447,0.0008946561,0.0010500381,0.0033585841],"category_scores_gemma":[0.00062213506,0.00053263886,0.00091209303,0.00064837444,0.00087810017,0.00058250705,0.00040423826,0.002798632,0.0009431981],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6670872,0.13366401,0.0154825235,0.00091395935,0.0012741297,0.0006529027,0.00058155274,0.0045790067,0.06971416,0.00042815504,0.006015091,0.099607386],"study_design_scores_gemma":[0.43922696,0.537755,0.014344679,0.000033462893,0.0002838396,0.00042504977,0.00006128213,0.0012888118,0.0036694459,0.00015212642,0.0027354881,0.000023932285],"about_ca_topic_score_codex":0.0015275752,"about_ca_topic_score_gemma":0.0030729922,"teacher_disagreement_score":0.0033585841,"about_ca_system_score_codex":0.0010675631,"about_ca_system_score_gemma":0.0021393849,"threshold_uncertainty_score":0.011235535},"labels":[],"label_agreement":null},{"id":"W2376175914","doi":"","title":"Acetyl-L-carnitine prevents and reduces oxaliplation-evoked painful peripheral neuropathy","year":2011,"lang":"en","type":"article","venue":"Zhongguo linchuang yaolixue yu zhiliaoxue","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Anesthesia; Hyperalgesia; Allodynia; Oxaliplatin; Peripheral neuropathy; Peripheral; Nociception; Internal medicine; Endocrinology","score_opus":0.042361287152999284,"score_gpt":0.2864674722174345,"score_spread":0.24410618506443524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2376175914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695635,0.0022422052,0.00029437875,0.00005321624,0.00002004446,0.000039597562,0.00007490764,0.000028528317,0.00029079436],"genre_scores_gemma":[0.99447244,0.0023705391,0.0011696037,0.000061580344,0.000015947393,0.00007381021,0.0002426883,0.000007169636,0.0015861256],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988186,0.000017360562,0.000016130638,0.000016680006,0.00002969865,0.000038262522],"domain_scores_gemma":[0.99983597,0.000013884647,0.00006666869,0.000012063582,0.000023681192,0.000047719946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019559299,0.00049566093,0.00041744948,0.0003241304,0.00015665413,0.00020327498,0.0003896382,0.0003467187,0.00093805965],"category_scores_gemma":[0.0001642102,0.00012766139,0.00021131782,0.00014658915,0.00030211845,0.0003230405,0.0002053013,0.00049990375,0.00015629455],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063307923,0.0015281559,0.0009514727,0.00031653434,0.00004441393,0.000099154524,0.000027633732,0.00014375738,0.9799085,0.00006234797,0.00007934389,0.010507921],"study_design_scores_gemma":[0.0010195242,0.046413492,0.015698154,0.000063939886,0.0001478909,0.00047703544,0.00013058312,0.00068927574,0.93252563,0.00005502178,0.0027616394,0.000017900407],"about_ca_topic_score_codex":0.0010319508,"about_ca_topic_score_gemma":0.0024434784,"teacher_disagreement_score":0.0010319508,"about_ca_system_score_codex":0.00024398517,"about_ca_system_score_gemma":0.0004177554,"threshold_uncertainty_score":0.003138125},"labels":[],"label_agreement":null},{"id":"W2378005634","doi":"","title":"Chemical constituents of Taxus cuspidata from Canada","year":2009,"lang":"en","type":"article","venue":"Zhongcaoyao","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry; Taxon; Epoxy; Stereochemistry; Organic chemistry; Botany; Biology","score_opus":0.013063768458552038,"score_gpt":0.2805364599553843,"score_spread":0.2674726914968322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2378005634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850176,0.0039205,0.00042773294,0.00024665377,0.00002696398,0.000060724065,0.0025102403,0.000041145286,0.00774846],"genre_scores_gemma":[0.9803428,0.0032206164,0.0017366228,0.00025670615,0.000013816631,0.000027566995,0.002910753,0.000021430698,0.011469683],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993277,0.000001479237,0.0000027336935,0.000015977022,0.00003084855,0.000016127555],"domain_scores_gemma":[0.99985254,0.0000062527374,0.000017131528,0.00000249168,0.00008460998,0.000036870802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003974484,0.0003827833,0.00028297515,0.0012285876,0.0013883943,0.00039741647,0.00022898582,0.00021548994,0.0017849284],"category_scores_gemma":[0.00009467968,0.00015024171,0.00015280287,0.0011797498,0.00030789158,0.00018571278,0.00022341018,0.00041714354,0.00024869133],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026176844,0.000025785626,0.0254545,0.0003585171,0.000021603417,0.0007284978,0.00050614664,0.00012322227,0.9538769,0.00012585758,0.00032029976,0.018196851],"study_design_scores_gemma":[0.00002873398,0.00032302924,0.87916183,0.0000929378,0.00011151069,0.0014301421,0.0031179928,0.0004100866,0.077566676,0.00012306037,0.037587926,0.000046018562],"about_ca_topic_score_codex":0.544353,"about_ca_topic_score_gemma":0.7624082,"teacher_disagreement_score":0.455647,"about_ca_system_score_codex":0.002316587,"about_ca_system_score_gemma":0.0035658726,"threshold_uncertainty_score":0.9166608},"labels":[],"label_agreement":null},{"id":"W2380521128","doi":"","title":"Taxane Diterpenoids from the Rooted Cuttings of Taxus canadensis","year":2007,"lang":"en","type":"article","venue":"Tianran chanwu yanjiu yu kaifa","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Taxane; Taxus; Stereochemistry; Cutting; Botany; Geraniaceae; Chemistry; Spectral analysis; Biology; Geranium; Physics; Spectroscopy","score_opus":0.017832618961074954,"score_gpt":0.29953078052853116,"score_spread":0.2816981615674562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2380521128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840285,0.0058932337,0.0016081848,0.00010194736,0.000038934795,0.00011516455,0.0024341398,0.00004104071,0.005738829],"genre_scores_gemma":[0.9784188,0.004214442,0.003414554,0.0001306243,0.00002519323,0.00004918916,0.0061568804,0.000016476633,0.0075738113],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995923,0.0000015540442,0.0000022727781,0.000009774729,0.000017546372,0.0000096130125],"domain_scores_gemma":[0.99993443,0.000006554349,0.000008677431,0.000004012275,0.000018406756,0.000027899596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000037480462,0.000545273,0.0003455273,0.00109703,0.00041610716,0.00021229364,0.00014719718,0.00023207575,0.0012744422],"category_scores_gemma":[0.00009003339,0.00013325969,0.00019156662,0.0008416197,0.00018579426,0.00021798293,0.00018030734,0.00080143224,0.00023637347],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106523905,0.000022028222,0.00080898154,0.00012973994,0.000013508413,0.00028221976,0.000091531896,0.00009698178,0.98906857,0.00006983065,0.00005740952,0.009252756],"study_design_scores_gemma":[0.0001342465,0.0012365509,0.23416187,0.00013122149,0.00043430168,0.0023708756,0.0012346703,0.0009547865,0.70745915,0.00079637964,0.050969925,0.000116013034],"about_ca_topic_score_codex":0.0119004175,"about_ca_topic_score_gemma":0.03541756,"teacher_disagreement_score":0.0119004175,"about_ca_system_score_codex":0.0004315194,"about_ca_system_score_gemma":0.0006317119,"threshold_uncertainty_score":0.023662329},"labels":[],"label_agreement":null},{"id":"W2394573321","doi":"","title":"Docetaxel plus Cyclophosphamide as Adjuvant Therapy for Early, Operable Breast Cancer","year":2012,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Docetaxel; Medicine; Cyclophosphamide; Oncology; Breast cancer; Internal medicine; Adjuvant; Chemotherapy; Cancer","score_opus":0.028999613569090556,"score_gpt":0.3607219206203284,"score_spread":0.33172230705123784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2394573321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.953894,0.036272272,0.0006182715,0.0010162537,0.0005523381,0.00025701546,0.00024246403,0.000083658066,0.0070637004],"genre_scores_gemma":[0.9814889,0.013746561,0.0008598929,0.00023807964,0.00017252131,0.00005027772,0.00016226209,0.000011955211,0.0032695408],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99991894,0.000027296373,0.0000069240386,0.000009791819,0.000011836503,0.000025245332],"domain_scores_gemma":[0.99985814,0.000045091845,0.00001740355,0.000008808309,0.000006205024,0.00006429038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026084264,0.0002511432,0.00070573675,0.00030514286,0.00020009778,0.00037547815,0.00029930516,0.00020727568,0.0015134901],"category_scores_gemma":[0.00048690382,0.000119125325,0.00030325892,0.00030462665,0.00016622523,0.00022219995,0.00016637033,0.00088255585,0.0002368838],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10650446,0.010819075,0.009526199,0.0012676355,0.000531025,0.0022252917,0.00028721124,0.0044026794,0.031513754,0.0010467338,0.005643252,0.8262327],"study_design_scores_gemma":[0.1008016,0.47930247,0.22737601,0.0012512725,0.004488124,0.012760671,0.0007543329,0.009517076,0.051113766,0.002335558,0.11006186,0.0002373494],"about_ca_topic_score_codex":0.0017138247,"about_ca_topic_score_gemma":0.0120562045,"teacher_disagreement_score":0.0017138247,"about_ca_system_score_codex":0.00040793716,"about_ca_system_score_gemma":0.00084602664,"threshold_uncertainty_score":0.0050631166},"labels":[],"label_agreement":null},{"id":"W2396078839","doi":"10.1038/nrclinonc.2016.64","title":"Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Pharmacokinetics; Chemotherapy; Oncology; Clinical trial; Pharmacology; Drug; Colorectal cancer; Intensive care medicine; Cancer; Internal medicine","score_opus":0.1640822111862569,"score_gpt":0.5620383089072559,"score_spread":0.39795609772099905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396078839","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026336993,0.996802,0.0005089056,0.0014244633,0.00019628949,0.0000029615856,0.000020461695,0.00000962728,0.0007718618],"genre_scores_gemma":[0.0040901867,0.9935256,0.00046980457,0.00079649687,0.0005193106,0.000007201173,0.000034944307,0.000005825145,0.00055061135],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99962115,0.00012318717,0.000049602382,0.00006269479,0.00011901001,0.000024276847],"domain_scores_gemma":[0.99894875,0.00062487065,0.0001635577,0.00003572209,0.00018457847,0.000042565665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010084093,0.000539146,0.0018178133,0.0006776678,0.000151496,0.0014068111,0.0007289314,0.0009588261,0.002116682],"category_scores_gemma":[0.0018859296,0.00024338155,0.00043831454,0.00093570095,0.0006177821,0.0017170756,0.0005516778,0.0023542296,0.0009151371],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022773522,0.000058935282,0.00038344087,0.009490258,0.000119728975,0.00016077973,0.000052680127,0.0006041382,0.0035200273,0.0057945102,0.022126619,0.95746124],"study_design_scores_gemma":[0.00006905563,0.0003721045,0.0020106114,0.005033743,0.000338565,0.0027651207,0.000084286425,0.0006488634,0.0030229257,0.006737875,0.97887063,0.000046210087],"about_ca_topic_score_codex":0.0007215377,"about_ca_topic_score_gemma":0.0014939501,"teacher_disagreement_score":0.002116682,"about_ca_system_score_codex":0.0007287807,"about_ca_system_score_gemma":0.0014200264,"threshold_uncertainty_score":0.007080972},"labels":[],"label_agreement":null},{"id":"W2397452357","doi":"10.1385/1-59259-998-2:103","title":"High-Performance Liquid Chromatography Analysis of CYP2C8-Catalyzed Paclitaxel 6α-Hydroxylation","year":2006,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health","keywords":"Hydroxylation; Paclitaxel; Chemistry; CYP2C8; Cytochrome P450; Chromatography; Microsome; Catalysis; High-performance liquid chromatography; Enzyme; Biochemistry; CYP2C9; Biology; Cancer","score_opus":0.026395238111735782,"score_gpt":0.28826371271831674,"score_spread":0.26186847460658097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397452357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7549894,0.018306794,0.18625611,0.0011178483,0.00067088817,0.0023678972,0.007234396,0.0052377684,0.023818834],"genre_scores_gemma":[0.7843911,0.014603987,0.1385258,0.0015376584,0.0005652804,0.0026795627,0.014578915,0.00071566063,0.042402107],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992393,0.00017919549,0.000043060798,0.00013453132,0.0002850346,0.000118935626],"domain_scores_gemma":[0.99929714,0.00016524826,0.00008827313,0.000046141122,0.00028252468,0.00012061664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006006786,0.0013210274,0.0008460984,0.0016750372,0.0010014456,0.00057084404,0.00046746928,0.0007060476,0.0036364237],"category_scores_gemma":[0.0011915682,0.0003239778,0.00041136687,0.0012534353,0.00047213043,0.0003719034,0.00028172662,0.0011344234,0.002340553],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069908856,0.000512872,0.0015879757,0.00012911917,0.000082570645,0.00018992616,0.00005633654,0.00035817214,0.98059386,0.000270111,0.0007053955,0.014814666],"study_design_scores_gemma":[0.00014151279,0.0007501371,0.009423226,0.000017887438,0.00009943337,0.0004853162,0.000036681708,0.0031462035,0.97694105,0.00014449518,0.008776902,0.000037186946],"about_ca_topic_score_codex":0.0031538294,"about_ca_topic_score_gemma":0.0042012585,"teacher_disagreement_score":0.0036364237,"about_ca_system_score_codex":0.0007359911,"about_ca_system_score_gemma":0.0014746696,"threshold_uncertainty_score":0.01216501},"labels":[],"label_agreement":null},{"id":"W2397893479","doi":"10.1158/1538-7445.sabcs15-ot3-01-01","title":"Abstract OT3-01-01: HERMIONE: A phase 2, randomized, open label trial comparing MM-302 plus trastuzumab with chemotherapy of physician's choice plus trastuzumab, in anthracycline naive HER2-positive, locally advanced/metastatic breast cancer patients previously treated with pertuzumab and ado-trastuzumab emtansine (T-DM1)","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Pertuzumab; Trastuzumab; Medicine; Anthracycline; Vinorelbine; Internal medicine; Oncology; Clinical endpoint; Metastatic breast cancer; Capecitabine; Hazard ratio; Breast cancer; Interim analysis; Docetaxel; Chemotherapy; Cancer; Randomized controlled trial; Confidence interval","score_opus":0.057093002480880145,"score_gpt":0.42629622262914296,"score_spread":0.3692032201482628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397893479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808038,0.0023412947,0.00048235006,0.0011573052,0.00064571615,0.0066708415,0.002943278,0.00020459529,0.0047507607],"genre_scores_gemma":[0.96970046,0.0019564165,0.0021795006,0.0022768192,0.00072010653,0.008510854,0.0041926103,0.000049394093,0.010413962],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995765,0.00020548231,0.000018701017,0.00009341917,0.000024684661,0.00008119557],"domain_scores_gemma":[0.9991974,0.0001600521,0.00017109327,0.000053051986,0.000036213863,0.00038226365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017383711,0.0020649198,0.0019615607,0.00042530644,0.0003752153,0.001196734,0.0011314173,0.0019322131,0.011213436],"category_scores_gemma":[0.0012727894,0.00060576556,0.0015366502,0.00037256628,0.0014544161,0.0013053754,0.00044616565,0.0033045919,0.0015101511],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97340727,0.010321969,0.0003978785,0.00035924077,0.00033490034,0.000047630565,0.000054163174,0.00033451695,0.00393471,0.00019693015,0.0015769278,0.009033866],"study_design_scores_gemma":[0.9298307,0.06798671,0.0007700924,0.000021839767,0.00012787072,0.000023580345,0.000015830521,0.0001948946,0.00030989235,0.000091580856,0.0006171335,0.000009747547],"about_ca_topic_score_codex":0.001102702,"about_ca_topic_score_gemma":0.0028685483,"teacher_disagreement_score":0.011213436,"about_ca_system_score_codex":0.0009098727,"about_ca_system_score_gemma":0.0015539541,"threshold_uncertainty_score":0.03751266},"labels":[],"label_agreement":null},{"id":"W2400819691","doi":"","title":"[Evaluation of cancer pain--possibility of biomarkers].","year":2007,"lang":"ja","type":"article","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuropathic pain; Cancer pain; Pain assessment; McGill Pain Questionnaire; Cancer; Medicine; Pain syndrome; Rating scale; Biomarker; Physical therapy; Physical medicine and rehabilitation; Visual analogue scale; Psychology; Pain management; Internal medicine; Anesthesia","score_opus":0.08071281462433393,"score_gpt":0.37721786501529686,"score_spread":0.2965050503909629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400819691","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029506037,0.79087,0.03479355,0.044123862,0.017494999,0.0005980019,0.0019352805,0.000648082,0.080030195],"genre_scores_gemma":[0.3405124,0.49910977,0.054608013,0.033897124,0.008353623,0.00084500073,0.002743359,0.00013549028,0.05979516],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99948114,0.0001691985,0.00005093285,0.00006518345,0.00019523516,0.00003831422],"domain_scores_gemma":[0.9995141,0.00010300162,0.00008362752,0.00003298364,0.0002138587,0.000052337004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012306091,0.00045687714,0.0005273932,0.0016525207,0.0003656688,0.001075943,0.0006057356,0.0014045073,0.0047050486],"category_scores_gemma":[0.0022304794,0.00011389756,0.0003711635,0.0013963631,0.0009256887,0.0017729941,0.0004899652,0.00083533616,0.0025849128],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046468867,0.00018879195,0.01290861,0.00585838,0.0002244602,0.0024122035,0.00036331266,0.00026370352,0.044817053,0.051339973,0.11486528,0.76629347],"study_design_scores_gemma":[0.00016041783,0.0018130052,0.05020221,0.0032474734,0.0003504887,0.028477104,0.00087218866,0.0014424579,0.038571563,0.08028767,0.7943904,0.00018507119],"about_ca_topic_score_codex":0.00079842063,"about_ca_topic_score_gemma":0.0006318794,"teacher_disagreement_score":0.0047050486,"about_ca_system_score_codex":0.0004479935,"about_ca_system_score_gemma":0.00085649744,"threshold_uncertainty_score":0.015739918},"labels":[],"label_agreement":null},{"id":"W2401148735","doi":"","title":"[Angiogenesis: from research to pathology].","year":2000,"lang":"en","type":"editorial","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Angiogenesis; Pathology; Medicine; Anatomical pathology; Immunohistochemistry; Cancer research","score_opus":0.07713436651187099,"score_gpt":0.3889384541180612,"score_spread":0.3118040876061902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401148735","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014410448,0.02671867,0.0001059751,0.018273812,0.9531383,0.000017222821,0.000045194014,0.000044414406,0.0016421512],"genre_scores_gemma":[0.000339486,0.037804615,0.00019951587,0.029020531,0.91979676,0.000036773497,0.000070954186,0.00003444573,0.012696915],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99638927,0.0007696954,0.0006065384,0.000295553,0.0017761396,0.00016290839],"domain_scores_gemma":[0.98202884,0.0072393683,0.0010805186,0.0004641711,0.0071737855,0.0020133294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060541634,0.0042427876,0.0049030203,0.00726088,0.0029082224,0.0070554726,0.0059416946,0.014877997,0.010704024],"category_scores_gemma":[0.02186421,0.0015018951,0.002863803,0.00354113,0.003210515,0.0062510706,0.0017449695,0.021215308,0.014906713],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003190783,0.000005222176,0.000010861831,0.00034617644,0.000015136841,0.000082304134,0.000007263657,0.000014519371,0.000025621359,0.00022556185,0.9922684,0.006967152],"study_design_scores_gemma":[0.00006891998,0.00003749216,0.00023376156,0.001010849,0.000085024505,0.000440837,0.000040055016,0.00010609349,0.000076509976,0.0014540458,0.9964216,0.00002486584],"about_ca_topic_score_codex":0.005135068,"about_ca_topic_score_gemma":0.0139288455,"teacher_disagreement_score":0.014877997,"about_ca_system_score_codex":0.0032386573,"about_ca_system_score_gemma":0.0037061416,"threshold_uncertainty_score":0.035808504},"labels":[],"label_agreement":null},{"id":"W2404165994","doi":"10.1016/j.jval.2016.03.1536","title":"Evaluation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Metastatic Breast Cancer: Systematic Review and Trial Level Meta-Analysis","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Internal medicine; Oncology; Surrogate endpoint; Progression-free survival; Rank correlation; Breast cancer; Spearman's rank correlation coefficient; Hazard ratio; Metastatic breast cancer; Clinical endpoint; Meta-analysis; Proportional hazards model; Randomized controlled trial; Cancer; Overall survival; Confidence interval; Statistics","score_opus":0.34436225851649654,"score_gpt":0.48731588217820454,"score_spread":0.142953623661708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404165994","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023704153,0.970289,0.0031477031,0.00036222534,0.00054008747,0.0004217014,0.00088544143,0.00010022994,0.0005494696],"genre_scores_gemma":[0.74584067,0.24257901,0.005897227,0.002088134,0.000581488,0.001029796,0.0011900569,0.00012903336,0.0006646254],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9781376,0.013912767,0.004049394,0.002136024,0.0013853842,0.00037879043],"domain_scores_gemma":[0.9728664,0.019971045,0.004066943,0.00176022,0.0010260949,0.00030910282],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.023457654,0.0032649857,0.01887788,0.0025531214,0.0005187196,0.0032803877,0.0024412828,0.0027368835,0.0028105152],"category_scores_gemma":[0.049088903,0.0017481111,0.044216137,0.0032249757,0.0010705832,0.002402326,0.0019606657,0.003747745,0.00034440932],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004252129,0.000014224026,0.002693379,0.051474296,0.9374207,0.000037469596,0.00003337602,0.00036042565,0.00012290027,0.00007444233,0.00020784397,0.0033087342],"study_design_scores_gemma":[0.0015852208,0.00030555623,0.0018312791,0.0021767528,0.9930335,0.000045887384,0.000017405795,0.00022897484,0.00007384046,0.00020377722,0.00048101702,0.000016786596],"about_ca_topic_score_codex":0.0037881306,"about_ca_topic_score_gemma":0.009991609,"teacher_disagreement_score":0.98112214,"about_ca_system_score_codex":0.002109981,"about_ca_system_score_gemma":0.001791067,"threshold_uncertainty_score":0.12405747},"labels":[],"label_agreement":null},{"id":"W2405961925","doi":"10.1503/cmaj.150393","title":"Blue man syndrome","year":2016,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Amiodarone; Medicine; Surgery; Internal medicine","score_opus":0.009266852023747897,"score_gpt":0.2741038932650996,"score_spread":0.2648370412413517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405961925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8255572,0.032320954,0.01168894,0.010321757,0.0022155729,0.0004087924,0.0025665774,0.0014763337,0.113443896],"genre_scores_gemma":[0.9751032,0.005753712,0.0022506837,0.0025641,0.0005494863,0.00006984229,0.0004272333,0.00008057219,0.013201212],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996921,0.0000348101,0.000011319627,0.00009167356,0.000072426454,0.000097658434],"domain_scores_gemma":[0.9995035,0.00015002547,0.00007406683,0.000023856304,0.000053587486,0.00019483923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013678308,0.002127787,0.00092902244,0.0013575559,0.0013210431,0.0006272365,0.00074244593,0.0019181189,0.008484457],"category_scores_gemma":[0.0016307739,0.00038458235,0.00044651135,0.0014410121,0.00077271933,0.0008977062,0.00083105726,0.0014169794,0.0014310866],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008351556,0.000048375445,0.0075191325,0.00012259344,0.00003893844,0.9728779,0.0002421385,0.00014055595,0.005175772,0.0014349866,0.0044670077,0.007849059],"study_design_scores_gemma":[0.000026447557,0.00007631893,0.008639503,0.00004103844,0.000027720658,0.9856608,0.0001118167,0.0001393564,0.00043966263,0.00063046877,0.004191829,0.000015120901],"about_ca_topic_score_codex":0.0029968994,"about_ca_topic_score_gemma":0.0033914929,"teacher_disagreement_score":0.008484457,"about_ca_system_score_codex":0.00059978105,"about_ca_system_score_gemma":0.0005870087,"threshold_uncertainty_score":0.028383315},"labels":[],"label_agreement":null},{"id":"W2407635643","doi":"10.1684/bdc.2013.1709","title":"Impact des toxicités cutanées associées aux thérapies ciblées sur la qualité de vie. Résultats d’une étude pilote longitudinale","year":2013,"lang":"fr","type":"article","venue":"Bulletin du Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine","score_opus":0.03498821863418844,"score_gpt":0.35376288428084246,"score_spread":0.318774665646654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407635643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824942,0.009016869,0.0011554587,0.0003119883,0.00008472818,0.0009230236,0.0040020337,0.000027054244,0.0019847103],"genre_scores_gemma":[0.989867,0.0024588653,0.0016543424,0.00023054017,0.000052526626,0.0013787007,0.0017994728,0.000017315926,0.0025412526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939752,0.0032459237,0.00053791155,0.000732971,0.0010468116,0.00046106274],"domain_scores_gemma":[0.9816591,0.007829976,0.004007732,0.0010617336,0.0048047146,0.00063681573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010244893,0.000560718,0.0013117197,0.0007213634,0.00081643614,0.0014640479,0.00046997424,0.0008885865,0.0028332851],"category_scores_gemma":[0.018654443,0.00061914197,0.0024304735,0.0011150201,0.00059474516,0.0010743083,0.00068055984,0.001966916,0.00044437186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03693523,0.0077066496,0.82872206,0.0028044486,0.007596415,0.00020475884,0.0033686282,0.0010648598,0.0054391352,0.00030732754,0.0018612931,0.10398919],"study_design_scores_gemma":[0.0010443691,0.024577761,0.9591543,0.00038909944,0.0033775882,0.00020374077,0.0007523051,0.0003796054,0.0025447144,0.00021272805,0.007300657,0.0000632069],"about_ca_topic_score_codex":0.017939324,"about_ca_topic_score_gemma":0.015893081,"teacher_disagreement_score":0.017939324,"about_ca_system_score_codex":0.0021531938,"about_ca_system_score_gemma":0.001988428,"threshold_uncertainty_score":0.0541808},"labels":[],"label_agreement":null},{"id":"W2409847216","doi":"","title":"Successful treatment of threatening limb loss ischemia of the upper limb caused by ergotamine. A case report and review of the literature.","year":2002,"lang":"en","type":"article","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Ergotamine; Medicine; Ischemia; Limb ischemia; Limb loss; Anesthesia; Lower limb; Upper limb; Surgery; Amputation; Internal medicine; Migraine","score_opus":0.02412641172738947,"score_gpt":0.2723210946053131,"score_spread":0.24819468287792365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409847216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47750005,0.44267985,0.017508969,0.007547099,0.0027939174,0.000634786,0.000708489,0.00076506624,0.049861822],"genre_scores_gemma":[0.85902625,0.11737678,0.005704824,0.004611557,0.002918258,0.00029396865,0.00046642812,0.00009195268,0.009509899],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99959093,0.000074339405,0.00007461755,0.00004696484,0.00008028047,0.00013283685],"domain_scores_gemma":[0.9996383,0.00009521709,0.0001113672,0.000057831774,0.000028153096,0.00006903271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028002268,0.0015131833,0.00084539247,0.0014939351,0.0010520573,0.0009103158,0.0011576451,0.0042900653,0.0023302375],"category_scores_gemma":[0.0010750798,0.0005069731,0.00084507547,0.00089149235,0.0008736032,0.0009299802,0.0005881162,0.0013521397,0.0019384809],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013931977,0.0003039836,0.004512758,0.0005134978,0.000081176906,0.9279594,0.00021473512,0.0001812346,0.005238334,0.00029925595,0.003359298,0.057197113],"study_design_scores_gemma":[0.0000361682,0.00020358461,0.0037144583,0.00007235755,0.000029872464,0.9888786,0.0000846961,0.000093230236,0.00088761805,0.00014214504,0.005843382,0.000013866744],"about_ca_topic_score_codex":0.00075655035,"about_ca_topic_score_gemma":0.001370982,"teacher_disagreement_score":0.0042900653,"about_ca_system_score_codex":0.0005276796,"about_ca_system_score_gemma":0.0007480291,"threshold_uncertainty_score":0.007795453},"labels":[],"label_agreement":null},{"id":"W2411262239","doi":"","title":"Assessing software impact on clinical workflow and resource utilization.","year":2009,"lang":"en","type":"article","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Workflow; Usability; Capecitabine; Computer science; Software; Resource (disambiguation); Medicine; Colorectal cancer; World Wide Web; Cancer; Database; Internal medicine; Operating system","score_opus":0.15687327008463026,"score_gpt":0.4422220902907447,"score_spread":0.28534882020611446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411262239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99573034,0.00025226653,0.0020954397,0.000060061633,0.000023361708,0.00037439668,0.00010103848,0.00006851285,0.0012945728],"genre_scores_gemma":[0.990737,0.00018871747,0.007912021,0.000059387177,0.000018954692,0.00042832518,0.00024927178,0.000020322792,0.00038603935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98263323,0.0111416485,0.0019972934,0.0005864708,0.0031557588,0.00048566618],"domain_scores_gemma":[0.8268645,0.14092277,0.010335203,0.003921585,0.015343475,0.002612558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01652823,0.00059605204,0.00049136556,0.002748491,0.00048535308,0.0011706543,0.0005639548,0.00049845723,0.0014617103],"category_scores_gemma":[0.09390073,0.00029280895,0.0009238911,0.0015032701,0.0004720474,0.0009106081,0.0007746267,0.00047955065,0.000263082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008620791,0.008515235,0.61450505,0.0025621715,0.0010781416,0.0006550844,0.005245428,0.004101465,0.009921239,0.00029456304,0.0012227587,0.34327805],"study_design_scores_gemma":[0.0006417999,0.06470554,0.89589727,0.00048402883,0.0009422437,0.0011124485,0.005965256,0.014554477,0.011607284,0.00041697887,0.0034825983,0.00019005542],"about_ca_topic_score_codex":0.0031050695,"about_ca_topic_score_gemma":0.0031589787,"teacher_disagreement_score":0.01652823,"about_ca_system_score_codex":0.001029161,"about_ca_system_score_gemma":0.0015357272,"threshold_uncertainty_score":0.08741069},"labels":[],"label_agreement":null},{"id":"W2432860777","doi":"10.1200/jco.2013.31.15_suppl.1049","title":"A phase III, open-label, randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes: Subgroup analyses.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Capecitabine; Eribulin; Medicine; Internal medicine; Hazard ratio; Taxane; Metastatic breast cancer; Regimen; Oncology; Chemotherapy; Chemotherapy regimen; Anthracycline; Gastroenterology; Progression-free survival; Breast cancer; Cancer; Confidence interval; Colorectal cancer","score_opus":0.14060218378077016,"score_gpt":0.5207636311247795,"score_spread":0.38016144734400936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2432860777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97634137,0.006840229,0.0012679226,0.0008401138,0.0007615927,0.009509642,0.0023546491,0.00012331286,0.001960988],"genre_scores_gemma":[0.98098147,0.0029814248,0.0015842151,0.0013402601,0.00045518458,0.00827656,0.0014626291,0.000030022276,0.0028883654],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988269,0.0006880077,0.00009748444,0.00014900268,0.0000665081,0.00017197602],"domain_scores_gemma":[0.9986375,0.0004575582,0.0003100559,0.00012331174,0.0000825594,0.00038901644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032736824,0.002363569,0.004408918,0.0006672248,0.00050392986,0.0013700932,0.0010149939,0.001626889,0.0063617076],"category_scores_gemma":[0.0031028942,0.0008119948,0.0041348888,0.00074718194,0.000907608,0.0010441631,0.00055648625,0.0029979143,0.0008991165],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98335534,0.003761947,0.00089271576,0.0004253068,0.0024425506,0.0000448054,0.000052502903,0.0003052558,0.0022883795,0.000055903874,0.00039452093,0.0059808404],"study_design_scores_gemma":[0.935621,0.058907807,0.0020734775,0.000032405624,0.0018195712,0.000035981,0.000042460764,0.00042474899,0.00033508107,0.00016649859,0.00052226457,0.000018693312],"about_ca_topic_score_codex":0.0015115876,"about_ca_topic_score_gemma":0.005206979,"teacher_disagreement_score":0.0063617076,"about_ca_system_score_codex":0.0013599409,"about_ca_system_score_gemma":0.0020008828,"threshold_uncertainty_score":0.021281958},"labels":[],"label_agreement":null},{"id":"W2434551575","doi":"","title":"International Stroke Conference 2009. Translation of high impact targets into clinical trials. 17-20 February 2009, San Diego, CA, USA.","year":2009,"lang":"en","type":"other","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Clinical trial; Stroke (engine); Clinical neurology; Internal medicine; Psychology; Engineering; Neuroscience","score_opus":0.10233105505802366,"score_gpt":0.41123394838021693,"score_spread":0.3089028933221933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2434551575","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012256851,0.24423675,0.010401238,0.15011871,0.05715321,0.0029570311,0.12558438,0.0072233784,0.4010995],"genre_scores_gemma":[0.01368949,0.32581905,0.02866917,0.039600633,0.019839818,0.006759919,0.09201314,0.004040457,0.4695683],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956939,0.0013076474,0.0010419999,0.00017908493,0.0014497694,0.00032751323],"domain_scores_gemma":[0.97570115,0.007256639,0.0032555298,0.0011504842,0.0083163,0.0043199053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011728799,0.002372221,0.0034083026,0.00527518,0.0009941837,0.0062188227,0.0031022339,0.0046047983,0.121776074],"category_scores_gemma":[0.026446335,0.00140268,0.0018075584,0.005416224,0.0009842728,0.0028226343,0.002087979,0.0067034764,0.084613964],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000259097,0.000037166086,0.000058251007,0.0006330801,0.000022340937,0.000028281049,0.000013386376,0.00007635584,0.000106017476,0.0005614811,0.9454442,0.05276025],"study_design_scores_gemma":[0.0006239262,0.0001612395,0.0034467436,0.0023459292,0.00015448006,0.00013474055,0.00006254566,0.00013375843,0.00059169094,0.0024029596,0.9898953,0.000046576853],"about_ca_topic_score_codex":0.013554522,"about_ca_topic_score_gemma":0.032378234,"teacher_disagreement_score":0.121776074,"about_ca_system_score_codex":0.003977025,"about_ca_system_score_gemma":0.014077988,"threshold_uncertainty_score":0.40738153},"labels":[],"label_agreement":null},{"id":"W24563591","doi":"10.1016/j.jyp.2013.10.006","title":"Laurell Ritchie, Doris Anderson Memorial, May 12, 2007","year":2007,"lang":"en","type":"article","venue":"Canadian women's studies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Doris (gastropod); Art; Art history","score_opus":0.030972432325419044,"score_gpt":0.32251857576236215,"score_spread":0.29154614343694313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W24563591","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013073033,0.09646863,0.010582258,0.10656998,0.04543363,0.0009473434,0.0032161162,0.0038621635,0.71984684],"genre_scores_gemma":[0.004687957,0.010389986,0.0014237791,0.001918131,0.0008207488,0.00003439752,0.000499348,0.00007709351,0.9801486],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966943,0.000024634863,0.000009371578,0.000052103085,0.00018444407,0.00006000667],"domain_scores_gemma":[0.99945766,0.000050661823,0.0000144885935,0.000023311719,0.00025958562,0.00019425644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009828841,0.00087625557,0.00057128223,0.00096226664,0.001189169,0.0013173517,0.00080421387,0.0012587095,0.2486532],"category_scores_gemma":[0.0007166666,0.00036133628,0.00040271395,0.0002996749,0.00039484637,0.0004518668,0.0005277525,0.0014484051,0.13333678],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003598925,0.00015200982,0.0005235781,0.0001604821,0.000015988107,0.0002936122,0.000042155203,0.000082719955,0.01292219,0.0010856505,0.8343429,0.15001877],"study_design_scores_gemma":[0.000065547996,0.00017365352,0.0024447255,0.000083842206,0.000014933159,0.00054182304,0.0000720046,0.00015200287,0.0059992997,0.00043388113,0.98999935,0.000018918425],"about_ca_topic_score_codex":0.0054823416,"about_ca_topic_score_gemma":0.026912268,"teacher_disagreement_score":0.2486532,"about_ca_system_score_codex":0.0010171855,"about_ca_system_score_gemma":0.0017340372,"threshold_uncertainty_score":0.8318278},"labels":[],"label_agreement":null},{"id":"W2460310329","doi":"10.4137/bcbcr.s39615","title":"Subgroup Analyses from a Phase 3, Open-Label, Randomized Study of Eribulin Mesylate versus Capecitabine in Pretreated Patients with Advanced or Metastatic Breast Cancer","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Basic and Clinical Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Eribulin; Capecitabine; Medicine; Internal medicine; Metastatic breast cancer; Oncology; Breast cancer; Taxane; Cancer; Colorectal cancer","score_opus":0.2671860688400545,"score_gpt":0.5786689249457595,"score_spread":0.311482856105705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2460310329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9617143,0.014255671,0.0020143576,0.00073245843,0.00059098506,0.011964982,0.0062349956,0.00019200919,0.0023002098],"genre_scores_gemma":[0.97787035,0.0030051675,0.0019325195,0.0012546411,0.00044942662,0.009610035,0.004229484,0.000042137483,0.0016063971],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99601907,0.002804178,0.0003769346,0.00035991817,0.00019848175,0.00024133293],"domain_scores_gemma":[0.9971137,0.0012896552,0.0007790091,0.00030436605,0.00019051753,0.0003226676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066546435,0.0021718433,0.003825859,0.00062422274,0.00046107968,0.0010598737,0.0008893501,0.0013669964,0.0070888195],"category_scores_gemma":[0.006539538,0.00042322316,0.00798796,0.0006883433,0.0006542416,0.00078028755,0.00058122544,0.0021212788,0.00048669966],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9716067,0.0022379481,0.0020328257,0.0014984128,0.010932441,0.00006374017,0.000044778946,0.00049567595,0.0021215288,0.00006171644,0.000849188,0.008055078],"study_design_scores_gemma":[0.9169975,0.058529917,0.008218006,0.00010948071,0.012782789,0.00009117948,0.00004265076,0.0006723441,0.0009927453,0.0003358577,0.0011994613,0.000027981938],"about_ca_topic_score_codex":0.00090511964,"about_ca_topic_score_gemma":0.0038077177,"teacher_disagreement_score":0.0070888195,"about_ca_system_score_codex":0.0014253597,"about_ca_system_score_gemma":0.0019296666,"threshold_uncertainty_score":0.035193563},"labels":[],"label_agreement":null},{"id":"W2462306652","doi":"","title":"Taxol (paclitaxel) involution of articular cartilage destruction in collagen induced arthritis: an ultrastructural demonstration of an increased superficial chondroprotective layer.","year":2000,"lang":"en","type":"article","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Involution (esoterism); Medicine; Articular cartilage; Paclitaxel; Ultrastructure; Cartilage; Arthritis; Glycosaminoglycan; Pathology; Internal medicine; Endocrinology; Anatomy; Chemotherapy; Osteoarthritis; Biology","score_opus":0.02382286524679875,"score_gpt":0.2636449859876192,"score_spread":0.23982212074082046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462306652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970241,0.001183384,0.00093467615,0.000025128806,0.0000103208,0.000030195575,0.00015836024,0.000019672485,0.00061408436],"genre_scores_gemma":[0.99551857,0.0010984346,0.0011692094,0.000024092556,0.0000050414797,0.000028337981,0.00024200985,0.0000054609372,0.0019088505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999944,0.000008366784,0.0000044979943,0.000008492796,0.000016875241,0.000017734637],"domain_scores_gemma":[0.99992967,0.000009569712,0.000029972518,0.0000061884357,0.000009337934,0.000015371343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007046878,0.00016480392,0.00012046007,0.00027527963,0.00012961254,0.0001386709,0.0000845104,0.00019243636,0.00090471614],"category_scores_gemma":[0.00007901859,0.00009199293,0.00011685425,0.00011325468,0.00018743803,0.00013633605,0.0000735618,0.00025290187,0.00024224714],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032701332,0.00003405913,0.0007955667,0.000032962387,0.0000050741587,0.00010547027,0.0000104206665,0.000022490316,0.9967811,0.00003677735,0.000018240782,0.0018308212],"study_design_scores_gemma":[0.000076363795,0.0021268358,0.04580959,0.000011044907,0.000043018674,0.0017271894,0.00007222619,0.0003106823,0.9479923,0.000059181486,0.0017656453,0.000005815374],"about_ca_topic_score_codex":0.0007174586,"about_ca_topic_score_gemma":0.000908558,"teacher_disagreement_score":0.00090471614,"about_ca_system_score_codex":0.00017564373,"about_ca_system_score_gemma":0.00015519251,"threshold_uncertainty_score":0.003026545},"labels":[],"label_agreement":null},{"id":"W2463870580","doi":"10.1200/jco.2012.30.15_suppl.e16547","title":"A review of clinical endpoints and use of quality of life outcomes in phase III metastatic breast cancer clinical trials.","year":2012,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Clinical endpoint; Clinical trial; Quality of life (healthcare); Metastatic breast cancer; Internal medicine; Breast cancer; Disease; Cancer; Oncology; Intensive care medicine","score_opus":0.8346999713139278,"score_gpt":0.7451445904102004,"score_spread":0.08955538090372739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2463870580","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033390804,0.9966691,0.00043685836,0.0007228154,0.00025965602,0.0005315347,0.00052189076,0.000016271337,0.0005078614],"genre_scores_gemma":[0.008473301,0.9837535,0.0027673817,0.0017445128,0.00025770193,0.0020676595,0.000728283,0.000027043852,0.00018065302],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.927244,0.030657439,0.029847587,0.0020506997,0.009714968,0.00048524764],"domain_scores_gemma":[0.77815455,0.16151208,0.04000635,0.0027834072,0.016371166,0.0011724678],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.077956334,0.0017237434,0.010987995,0.014376558,0.00068858836,0.004666057,0.0036518257,0.0027993491,0.0058356854],"category_scores_gemma":[0.1751998,0.00121231,0.006312731,0.018355895,0.0017643035,0.0038227076,0.0023204244,0.0023446532,0.00091030454],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011047556,0.000043443735,0.0011108223,0.7000971,0.0047366843,0.00008208453,0.00019552039,0.00021210586,0.00030203664,0.000978818,0.0090023475,0.28213438],"study_design_scores_gemma":[0.0012540155,0.00070439826,0.00625625,0.8764745,0.019568164,0.00046632797,0.00023144008,0.00026440542,0.00036638582,0.0013502293,0.09298916,0.000074630414],"about_ca_topic_score_codex":0.0017126651,"about_ca_topic_score_gemma":0.0041270796,"teacher_disagreement_score":0.9220437,"about_ca_system_score_codex":0.004996226,"about_ca_system_score_gemma":0.010266824,"threshold_uncertainty_score":0.4122774},"labels":[],"label_agreement":null},{"id":"W2464629114","doi":"10.1007/s10600-013-0765-z","title":"A New Taxane with a 4β,20-Epoxy Ring from the Rooted Cuttings of Taxus canadensis","year":2013,"lang":"en","type":"article","venue":"Chemistry of Natural Compounds","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Hebei Medical University; Hebei University; National Science Foundation","keywords":"Taxane; Chemistry; Cutting; Ring (chemistry); Epoxy; Botany; Stereochemistry; Organic chemistry; Biology","score_opus":0.00904104337953008,"score_gpt":0.2439646613551591,"score_spread":0.23492361797562902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2464629114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93484914,0.02390345,0.0055030677,0.00067066797,0.00032597926,0.0003964794,0.0031911002,0.00019280048,0.030967232],"genre_scores_gemma":[0.9598792,0.013074439,0.0055288374,0.00033539927,0.000070082,0.000057863574,0.0019447592,0.000030530664,0.01907906],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99997616,0.0000020500922,0.000001737657,0.000008044167,0.0000070438164,0.0000048895104],"domain_scores_gemma":[0.9999641,0.000003072334,0.0000048360416,0.000002997828,0.000006123226,0.000018819197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004303403,0.0003661355,0.00019909712,0.00056678226,0.00029627047,0.00017508274,0.00022958923,0.00024168931,0.0030128174],"category_scores_gemma":[0.000045825218,0.00013437349,0.00021356762,0.00031471267,0.00024027674,0.0003569276,0.00025208673,0.0005440214,0.00040373855],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021161081,0.00010699703,0.0005225402,0.00064337044,0.000026612617,0.0010130595,0.00016214137,0.00049494865,0.9708349,0.0012238076,0.0005673911,0.02419257],"study_design_scores_gemma":[0.00031348135,0.0035904862,0.02540853,0.00025791093,0.0003674575,0.0034317197,0.00047919186,0.0010010798,0.7274672,0.0023633337,0.23519889,0.000120744815],"about_ca_topic_score_codex":0.0017665824,"about_ca_topic_score_gemma":0.0056031537,"teacher_disagreement_score":0.99823344,"about_ca_system_score_codex":0.00021730375,"about_ca_system_score_gemma":0.00033878043,"threshold_uncertainty_score":0.010078847},"labels":[],"label_agreement":null},{"id":"W2466901661","doi":"10.7202/1036757ar","title":"Resvératrol et lycopène","year":2016,"lang":"fr","type":"article","venue":"Cahiers franco-canadiens de l Ouest","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.011117036749364867,"score_gpt":0.2879591776094431,"score_spread":0.27684214086007825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466901661","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5108212,0.308746,0.005773545,0.008047277,0.007917606,0.0003577557,0.0032831887,0.0011739299,0.15387945],"genre_scores_gemma":[0.77958876,0.057482168,0.00275864,0.001522568,0.001105326,0.00010722995,0.0021256744,0.000049815266,0.15525979],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998592,0.000042569896,0.000007279309,0.000029839503,0.000036720056,0.000024321473],"domain_scores_gemma":[0.9999372,0.000018054987,0.000010163508,0.000007924782,0.000009280086,0.000017368544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019821784,0.00029852343,0.000304514,0.00030188554,0.00028495825,0.00038132953,0.00021356397,0.0005266891,0.010271641],"category_scores_gemma":[0.00022239896,0.00013243666,0.00021857608,0.00011358627,0.00019832561,0.00030154065,0.00024551363,0.001124399,0.0026738897],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0078082858,0.00072958675,0.0011812033,0.0012076981,0.00027155914,0.000876281,0.00023664586,0.0005544196,0.7929972,0.0072124097,0.014086496,0.1728382],"study_design_scores_gemma":[0.0013358967,0.004839393,0.009982282,0.00013805389,0.00016846089,0.0013390249,0.00011452745,0.00045306943,0.3182836,0.0010100884,0.662287,0.00004855182],"about_ca_topic_score_codex":0.0029212006,"about_ca_topic_score_gemma":0.0041810265,"teacher_disagreement_score":0.010271641,"about_ca_system_score_codex":0.00034498653,"about_ca_system_score_gemma":0.0003463888,"threshold_uncertainty_score":0.034362078},"labels":[],"label_agreement":null},{"id":"W2467528112","doi":"","title":"Current treatment and new therapies for pain management.","year":2004,"lang":"en","type":"other","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pain management; Alternative medicine; Family medicine; Political science; Physical therapy; Pathology","score_opus":0.054540166253946754,"score_gpt":0.3165853205699482,"score_spread":0.26204515431600145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2467528112","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022270509,0.9250272,0.00028825016,0.014156242,0.0027439827,0.000025912794,0.00022548999,0.000056109577,0.05725407],"genre_scores_gemma":[0.003425113,0.9424764,0.0009996624,0.0061845924,0.004323601,0.00009291475,0.00036934062,0.000022063568,0.042106315],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994522,0.00014846952,0.00005201462,0.000050972194,0.00023394161,0.000062270214],"domain_scores_gemma":[0.99935,0.00018218206,0.00009660596,0.000039895593,0.00018894445,0.0001423685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001078187,0.00070373266,0.0006966182,0.0020940497,0.0004820677,0.0017641003,0.0008813131,0.0015202622,0.055534594],"category_scores_gemma":[0.0013103236,0.00018100513,0.00046472772,0.0021011862,0.0008196294,0.0020192368,0.00072691037,0.0024615733,0.018970909],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015114425,0.00012065611,0.00015219943,0.0024838175,0.000017006305,0.00017199872,0.00004893173,0.000052902218,0.00039363242,0.009753024,0.33769017,0.6489646],"study_design_scores_gemma":[0.000050122027,0.000066100285,0.0005314519,0.0011320768,0.000014866429,0.00060544274,0.00004854052,0.000026742251,0.000077360164,0.0029362831,0.99450547,0.0000055054024],"about_ca_topic_score_codex":0.0019155581,"about_ca_topic_score_gemma":0.008223375,"teacher_disagreement_score":0.055534594,"about_ca_system_score_codex":0.0011303825,"about_ca_system_score_gemma":0.0016143526,"threshold_uncertainty_score":0.18578178},"labels":[],"label_agreement":null},{"id":"W2468316166","doi":"10.1016/j.breast.2016.06.013","title":"A prospective study on the neurological complications of breast cancer and its treatment: Updated analysis three years after cancer diagnosis","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"European Regional Development Fund; Fundação para a Ciência e a Tecnologia; Universidade do Porto","keywords":"Medicine; Breast cancer; Prospective cohort study; Taxane; Internal medicine; Peripheral neuropathy; Cancer; Chemotherapy; Odds ratio; Confidence interval; Surgery","score_opus":0.033388218821180156,"score_gpt":0.3313250317947832,"score_spread":0.297936812973603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468316166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973404,0.0006218399,0.000076250544,0.000026762656,0.000008040735,0.000015159655,0.0016137663,0.0000024527933,0.0002951709],"genre_scores_gemma":[0.9973252,0.0003909704,0.00008063054,0.000021199026,0.000011759022,0.000017379669,0.001961466,0.000001615014,0.00018972237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999532,0.000108573506,0.000057421385,0.00012626809,0.00008530098,0.000090497415],"domain_scores_gemma":[0.9985979,0.00014945249,0.0007407948,0.00012096499,0.00020097666,0.00018988806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006712612,0.00027425142,0.0003599833,0.0009175351,0.0003632883,0.0005787266,0.00039576623,0.00049805496,0.0009549637],"category_scores_gemma":[0.0015872068,0.00028503028,0.00082124537,0.0016287961,0.0001191885,0.00046744876,0.00044510936,0.00053244596,0.0002028991],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008447945,0.000021772998,0.999212,0.000005676138,0.000051668,0.00003388073,0.000018192437,0.000011498274,0.00004283836,0.0000020952139,0.000032756627,0.0004829721],"study_design_scores_gemma":[0.000003591927,0.000041208303,0.99968505,0.0000031586144,0.000023824214,0.00009027689,0.0000420462,0.000032650467,0.00000871872,0.0000023521482,0.00006592438,0.000001251038],"about_ca_topic_score_codex":0.017828746,"about_ca_topic_score_gemma":0.016922591,"teacher_disagreement_score":0.017828746,"about_ca_system_score_codex":0.00029141284,"about_ca_system_score_gemma":0.0003679096,"threshold_uncertainty_score":0.035449922},"labels":[],"label_agreement":null},{"id":"W2468405132","doi":"","title":"Development of a very sensitive luminescence assay for the measurement of paclitaxel and related taxanes.","year":2000,"lang":"en","type":"article","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Cegep de Sainte Foy","funders":"","keywords":"Paclitaxel; Taxane; Chemistry; Taxus; Monoclonal antibody; Immunoassay; Pharmacology; Chromatography; Cancer; Antibody; Biology; Medicine; Breast cancer; Immunology; Internal medicine","score_opus":0.04314077197168009,"score_gpt":0.2638961367795593,"score_spread":0.22075536480787922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468405132","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06358678,0.006616323,0.91978264,0.0007269659,0.0005116234,0.0008665664,0.0007406511,0.0024071105,0.004761334],"genre_scores_gemma":[0.22503288,0.004190927,0.7547966,0.00071828824,0.00017569035,0.001625319,0.002151295,0.0001569482,0.011152122],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99754995,0.0007957329,0.00012287484,0.0004813737,0.0008962853,0.0001537888],"domain_scores_gemma":[0.99838567,0.0007109366,0.000206611,0.00014551435,0.00037545635,0.00017577241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020672067,0.0013588824,0.0008377611,0.0016878817,0.0003839898,0.0008897031,0.0014481216,0.0018904839,0.0016934493],"category_scores_gemma":[0.00217882,0.0008711096,0.000735248,0.0006181973,0.0008520619,0.00076396106,0.0010755545,0.0029073874,0.0019330141],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004843313,0.00005449904,0.00022905032,0.000094469746,0.000012870026,0.000028388127,0.000024431705,0.000111157366,0.9901177,0.00024218942,0.00027145408,0.008765379],"study_design_scores_gemma":[0.000052919404,0.0004973042,0.001260824,0.000033243985,0.00003262198,0.0006975356,0.000036586487,0.0045446055,0.98098034,0.00028079338,0.011544439,0.00003871755],"about_ca_topic_score_codex":0.00050143874,"about_ca_topic_score_gemma":0.0008737331,"teacher_disagreement_score":0.0020672067,"about_ca_system_score_codex":0.0007870691,"about_ca_system_score_gemma":0.0007734969,"threshold_uncertainty_score":0.010932565},"labels":[],"label_agreement":null},{"id":"W2474269477","doi":"10.1200/jco.2008.26.15_suppl.550","title":"Triple-negative receptor status and prognosis in the NCIC CTG MA. 21 adjuvant breast cancer trial","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Epirubicin; Internal medicine; Breast cancer; Oncology; Cyclophosphamide; Triple-negative breast cancer; Proportional hazards model; Anthracycline; Chemotherapy; Cancer","score_opus":0.18238580471422888,"score_gpt":0.510368495052706,"score_spread":0.3279826903384771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474269477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9721823,0.016490355,0.000117927426,0.002677055,0.0003015452,0.00044103616,0.0012764098,0.000039394763,0.0064740484],"genre_scores_gemma":[0.9888952,0.0028934453,0.00023509303,0.0019991256,0.00037018175,0.0007815067,0.0020502321,0.000008622239,0.00276665],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99941957,0.00039859084,0.000024904433,0.000048081612,0.00004306988,0.00006579158],"domain_scores_gemma":[0.9990808,0.0002349525,0.0002428464,0.000060164446,0.00003840047,0.000342884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011927583,0.0005460183,0.00096096424,0.00026252074,0.00036358106,0.0007716307,0.00052095676,0.0010327632,0.0034691226],"category_scores_gemma":[0.002377763,0.00015290169,0.0006339345,0.00032006443,0.0004434752,0.0004954269,0.00032905355,0.0013243008,0.00040100675],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8626701,0.004460821,0.023255717,0.0011582534,0.0025625308,0.00024873708,0.0001326799,0.0023597337,0.0033303897,0.0012168677,0.024637649,0.073966525],"study_design_scores_gemma":[0.67260045,0.15523455,0.13441469,0.0011255962,0.0058347015,0.00063531083,0.00015487972,0.0052413377,0.0013372065,0.002433523,0.020880612,0.00010708241],"about_ca_topic_score_codex":0.002506628,"about_ca_topic_score_gemma":0.0070748907,"teacher_disagreement_score":0.0034691226,"about_ca_system_score_codex":0.0010100944,"about_ca_system_score_gemma":0.0010019906,"threshold_uncertainty_score":0.011605322},"labels":[],"label_agreement":null},{"id":"W2475393511","doi":"10.1017/cbo9781139194099","title":"Case Studies in Neurological Pain","year":2012,"lang":"en","type":"book","venue":"Cambridge University Press eBooks","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Disease; Multiple sclerosis; Intensive care medicine; Health professionals; Chronic pain; Physical therapy; Health care; Psychiatry; Pathology","score_opus":0.09143415162308934,"score_gpt":0.3052217439213441,"score_spread":0.21378759229825478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2475393511","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030475974,0.23599397,0.008185455,0.03501699,0.018150091,0.0005445602,0.0003712636,0.00036226818,0.67089945],"genre_scores_gemma":[0.22673263,0.2150203,0.023635495,0.063955314,0.011928625,0.00057380844,0.0008197203,0.00037596162,0.45695814],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99886775,0.00036845784,0.00010075835,0.00014327944,0.00035564415,0.00016417186],"domain_scores_gemma":[0.9988908,0.0006839087,0.00012712683,0.00005729498,0.00010021539,0.0001405819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006307912,0.001111196,0.0007033709,0.0021214595,0.0022346408,0.0018761997,0.0011392909,0.0040436024,0.013467965],"category_scores_gemma":[0.004194278,0.00037113362,0.0007356661,0.0019119149,0.0024940644,0.002718917,0.002408748,0.0048219995,0.0040517147],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010410513,0.0003233969,0.001993878,0.0013441348,0.000046815643,0.33304593,0.008029889,0.0007609528,0.0019200125,0.056306608,0.44706416,0.14906003],"study_design_scores_gemma":[0.000020575675,0.00004960821,0.0011852582,0.0012365152,0.00001914419,0.4805926,0.0017529204,0.0001674734,0.0002446865,0.013078127,0.5016164,0.000036678106],"about_ca_topic_score_codex":0.0017592275,"about_ca_topic_score_gemma":0.0051466743,"teacher_disagreement_score":0.013467965,"about_ca_system_score_codex":0.0014926796,"about_ca_system_score_gemma":0.00093426,"threshold_uncertainty_score":0.045054853},"labels":[],"label_agreement":null},{"id":"W2477533041","doi":"10.1158/1538-7445.am2016-2179","title":"Abstract 2179: Macrolide toxin Mycalolide B is a potent inhibitor of HER2 cancer cell invasion and is the basis of actin targeted therapy for metastatic cancers","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"SKBR3; Cancer research; Trastuzumab; Antibody-drug conjugate; Metastasis; Cancer cell; Cancer; Medicine; Biology; Breast cancer; Antibody; Immunology; Internal medicine; Monoclonal antibody","score_opus":0.11087585323305187,"score_gpt":0.439304725482549,"score_spread":0.32842887224949713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2477533041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96414465,0.016766267,0.006082477,0.0005990407,0.00014709414,0.00016069756,0.0015973322,0.0002298256,0.010272577],"genre_scores_gemma":[0.97918975,0.0072498918,0.00307552,0.00020934627,0.00003063258,0.00009257563,0.0016321188,0.000025058634,0.008495165],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994624,0.000008310895,0.000005235711,0.000009339541,0.000020675021,0.0000102593085],"domain_scores_gemma":[0.99996495,0.0000036942442,0.000010344118,0.0000028818476,0.000007889837,0.000010206635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006982654,0.0002915023,0.00018957023,0.00017776497,0.00011554622,0.00016431465,0.00015507062,0.00023593416,0.0015402276],"category_scores_gemma":[0.000047733603,0.00008966643,0.00014036938,0.00013188142,0.00009239893,0.00008764496,0.00013559926,0.000452643,0.000659902],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110814304,0.000044905377,0.00014222869,0.00004223336,0.000005617893,0.000031242573,0.0000033267013,0.00006815687,0.9960576,0.00008182655,0.00020405326,0.0032080521],"study_design_scores_gemma":[0.000041954387,0.0008337319,0.0031063948,0.000011726402,0.000015359272,0.00035068183,0.000007864486,0.00042188462,0.98361015,0.000028139593,0.011568765,0.000003266995],"about_ca_topic_score_codex":0.0005689014,"about_ca_topic_score_gemma":0.0008384099,"teacher_disagreement_score":0.0015402276,"about_ca_system_score_codex":0.00021508022,"about_ca_system_score_gemma":0.00015242319,"threshold_uncertainty_score":0.0051525235},"labels":[],"label_agreement":null},{"id":"W2480091379","doi":"10.1200/jco.2006.24.18_suppl.550","title":"Updated analysis of NCIC CTG MA.17 (letrozole vs. placebo to letrozole vs placebo) post unblinding","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"Medicine; Letrozole; Tamoxifen; Placebo; Hazard ratio; Internal medicine; Interim analysis; Breast cancer; Oncology; Randomized controlled trial; Chemotherapy; Hormone therapy; Gynecology; Confidence interval; Cancer","score_opus":0.07343197520050578,"score_gpt":0.4740857043753304,"score_spread":0.4006537291748246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2480091379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86041003,0.04843896,0.0064950986,0.0035168268,0.0017230136,0.010354062,0.049144268,0.0012771409,0.01864051],"genre_scores_gemma":[0.9689154,0.0028867326,0.00373452,0.0024619699,0.00061067386,0.0046243565,0.011589262,0.00020327268,0.0049738754],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.97142875,0.022794519,0.0010485207,0.0013325583,0.0026310508,0.0007645695],"domain_scores_gemma":[0.9434534,0.03300019,0.013341085,0.0049963463,0.0030959386,0.0021130748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024702543,0.0012688265,0.004684819,0.0014947278,0.00048949744,0.0014810757,0.0021264378,0.0020242464,0.010865511],"category_scores_gemma":[0.06321376,0.0007432675,0.0075408723,0.0020751166,0.00069119496,0.0011628413,0.0010018641,0.002786919,0.0009559181],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9193622,0.0006627299,0.0080826,0.0014902033,0.015363532,0.00007040319,0.00008590867,0.0013614405,0.0012136215,0.0002658416,0.008471345,0.04357019],"study_design_scores_gemma":[0.5138182,0.15842727,0.20486364,0.0010980442,0.086643346,0.0004311079,0.00011535929,0.006692884,0.0026453026,0.0013268824,0.023756389,0.00018170802],"about_ca_topic_score_codex":0.009164828,"about_ca_topic_score_gemma":0.011952366,"teacher_disagreement_score":0.024702543,"about_ca_system_score_codex":0.0026475112,"about_ca_system_score_gemma":0.0034571572,"threshold_uncertainty_score":0.1306411},"labels":[],"label_agreement":null},{"id":"W2480777294","doi":"10.1017/cbo9781107280250.003","title":"Practical issues in the use of systemic anti-cancer therapy drugs","year":2015,"lang":"en","type":"book-chapter","venue":"Cambridge University Press eBooks","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Compendium; Medicine; Pharmacy; Cancer treatment; Cancer; Alternative medicine; Regimen; Cancer chemotherapy; Systemic therapy; Intensive care medicine; Drug; Family medicine; Pharmacology; Medical physics; Internal medicine; Pathology; Breast cancer","score_opus":0.1603843530878858,"score_gpt":0.3449275385156487,"score_spread":0.18454318542776293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2480777294","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020799171,0.30014557,0.008728938,0.16700824,0.014491501,0.00014969542,0.00014833058,0.00037640097,0.5068714],"genre_scores_gemma":[0.02786408,0.25966477,0.028675348,0.123751014,0.01629887,0.00037008923,0.00024863562,0.00039527018,0.5427319],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99747086,0.0007915031,0.00020100233,0.00022633118,0.0012198181,0.00009048538],"domain_scores_gemma":[0.99612147,0.002910488,0.00015770753,0.00018901023,0.0004929815,0.00012828417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003351247,0.00059709797,0.0005746933,0.0008530039,0.0013612638,0.004820577,0.0016069709,0.0047818418,0.024589403],"category_scores_gemma":[0.006668764,0.000500317,0.00052664924,0.0010871238,0.0037093177,0.007732743,0.0026917895,0.0070578516,0.011158468],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000306348,0.00011034457,0.00015498564,0.0015675626,0.000006462811,0.000651214,0.0025272171,0.00032513443,0.0007166172,0.13588439,0.53879815,0.31922716],"study_design_scores_gemma":[0.0000032584242,0.000015094026,0.00009560028,0.0004950856,0.0000019165393,0.0005793668,0.00018944296,0.000038383092,0.00007700357,0.010696557,0.98780316,0.0000051157253],"about_ca_topic_score_codex":0.0013216925,"about_ca_topic_score_gemma":0.0034597735,"teacher_disagreement_score":0.024589403,"about_ca_system_score_codex":0.0020549519,"about_ca_system_score_gemma":0.0029250933,"threshold_uncertainty_score":0.082259715},"labels":[],"label_agreement":null},{"id":"W2488156982","doi":"10.1158/1538-7445.am2016-3060","title":"Abstract 3060: Molecular mechanisms of the cardiotoxicity of the proteasomal-targeted anticancer drugs bortezomib and carfilzomib","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Carfilzomib; Dexrazoxane; Bortezomib; Cardiotoxicity; Doxorubicin; Pharmacology; Chemistry; Myocyte; Medicine; Toxicity; Cancer; Multiple myeloma; Anthracycline; Internal medicine; Chemotherapy","score_opus":0.037619731588595405,"score_gpt":0.3877342246302499,"score_spread":0.35011449304165454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488156982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9475089,0.031837076,0.006477255,0.0009008245,0.0001953948,0.00028573972,0.0019460324,0.00028642535,0.01056237],"genre_scores_gemma":[0.98174965,0.0053749206,0.0032935976,0.0003454173,0.000054215285,0.00014272796,0.0017035513,0.000018622382,0.0073173856],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998553,0.000026993757,0.000013948568,0.000021386468,0.000051163974,0.000031232183],"domain_scores_gemma":[0.99992573,0.000015823896,0.000020946829,0.0000067115143,0.0000132264795,0.000017502665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020360822,0.0005192959,0.00033930034,0.00025455,0.0001626514,0.0002863655,0.00031834323,0.00060582795,0.0033163165],"category_scores_gemma":[0.00011926706,0.00018015232,0.00030242163,0.00014752276,0.00017479264,0.00025911132,0.00014822792,0.00052110007,0.0010184548],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003702967,0.00008615677,0.0002575114,0.00017354522,0.000017883867,0.00023408563,0.000009993536,0.00020354515,0.9949969,0.00034172987,0.00027414376,0.0030340508],"study_design_scores_gemma":[0.000107671236,0.0013601013,0.01663542,0.00002898496,0.000036508747,0.0014194779,0.000018160184,0.002117253,0.97259146,0.00028823246,0.005384869,0.000011827441],"about_ca_topic_score_codex":0.0004813918,"about_ca_topic_score_gemma":0.00047817643,"teacher_disagreement_score":0.0033163165,"about_ca_system_score_codex":0.00060129556,"about_ca_system_score_gemma":0.0002228394,"threshold_uncertainty_score":0.011094153},"labels":[],"label_agreement":null},{"id":"W2488303827","doi":"10.1016/j.clgc.2016.07.018","title":"A Systematic Review of the Incidence and Risk Factors for Taxane Acute Pain Syndrome in Patients Receiving Taxane-Based Chemotherapy for Prostate Cancer","year":2016,"lang":"en","type":"review","venue":"Clinical Genitourinary Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Public Health; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Taxane; myalgia; Prostate cancer; Incidence (geometry); Internal medicine; Cabazitaxel; Cancer; Clinical trial; Oncology; Chemotherapy; Observational study; Breast cancer; Androgen deprivation therapy","score_opus":0.0528981432978041,"score_gpt":0.4295533392958634,"score_spread":0.3766551959980593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488303827","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008861568,0.99828666,0.00006514654,0.00009165859,0.000057478297,0.00008841275,0.00036843354,0.000004380371,0.00015161924],"genre_scores_gemma":[0.007872112,0.99117744,0.00032116685,0.00026567632,0.000036197453,0.000082123224,0.00016033575,0.0000023466612,0.00008271232],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99792445,0.00045164092,0.0009918315,0.00021462385,0.00034139343,0.00007609901],"domain_scores_gemma":[0.9944518,0.003459312,0.0015031138,0.000074958836,0.00042512538,0.000085678046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002335916,0.0011538387,0.006244696,0.005425785,0.00037168936,0.0015111053,0.0012447087,0.0011349677,0.0041208304],"category_scores_gemma":[0.010683895,0.00075534696,0.008163314,0.0066458397,0.00045374574,0.0012639728,0.0010711576,0.0010377349,0.00024163425],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029360852,0.000022384356,0.0011148317,0.9377459,0.019205173,0.00010468275,0.00011168838,0.00009725297,0.00021850076,0.00012943594,0.0016205134,0.039335918],"study_design_scores_gemma":[0.0006602098,0.00047189632,0.013734435,0.651413,0.2861832,0.00093234674,0.00030299494,0.00011359422,0.00025192706,0.0004108549,0.045430254,0.00009525384],"about_ca_topic_score_codex":0.007540982,"about_ca_topic_score_gemma":0.026212681,"teacher_disagreement_score":0.007540982,"about_ca_system_score_codex":0.0013680701,"about_ca_system_score_gemma":0.0049614,"threshold_uncertainty_score":0.014994144},"labels":[],"label_agreement":null},{"id":"W2488495429","doi":"10.3821/1913-701x-143.sp2.s17a","title":"Hormonothérapie bio-identique: synthèse pratique à l'intention des pharmaciens","year":2010,"lang":"fr","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Humanities; Psychology; Business administration; Business; Art","score_opus":0.023606756511159926,"score_gpt":0.2947688258378267,"score_spread":0.27116206932666675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488495429","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013479496,0.95991796,0.005960558,0.018013889,0.0019441153,0.00009586717,0.00017784869,0.000044642875,0.012497172],"genre_scores_gemma":[0.030346591,0.9312429,0.01527809,0.008372154,0.0025351332,0.00022601344,0.0001808499,0.000031288957,0.011787013],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99720323,0.0011527501,0.00032672152,0.00021054933,0.001007001,0.00009982392],"domain_scores_gemma":[0.9926501,0.005044478,0.000661266,0.00020970534,0.0013251618,0.000109269626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065839374,0.001274072,0.0019014694,0.0028358584,0.00086722954,0.0044323616,0.0013578132,0.0024756147,0.0074738148],"category_scores_gemma":[0.009081612,0.00061270554,0.001078603,0.001933708,0.0027830668,0.0024196368,0.00092687306,0.004762092,0.0015218105],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062200514,0.00023813634,0.00047093746,0.028484339,0.0004916512,0.00040759856,0.001542477,0.0012400465,0.0057546925,0.10782917,0.029208219,0.8237108],"study_design_scores_gemma":[0.00019043782,0.00037022575,0.0014163337,0.016853949,0.00063506217,0.00067537767,0.0004960413,0.00044832236,0.005078753,0.016203925,0.9575588,0.000072651565],"about_ca_topic_score_codex":0.032313008,"about_ca_topic_score_gemma":0.059861414,"teacher_disagreement_score":0.032313008,"about_ca_system_score_codex":0.007225112,"about_ca_system_score_gemma":0.012726081,"threshold_uncertainty_score":0.06424987},"labels":[],"label_agreement":null},{"id":"W2492595798","doi":"10.1200/jco.2016.34.15_suppl.1016","title":"Anthracycline-induced cardiotoxicity in patients with early stage breast cancer: The Canadian cancer trials group (NCIC CTG) MA.21 experience.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saint John Regional Hospital; Sunnybrook Health Science Centre; Queen's University; McMaster University; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Epirubicin; Ejection fraction; Cardiotoxicity; Anthracycline; Heart failure; Breast cancer; Internal medicine; Cyclophosphamide; Cardiology; Randomized controlled trial; Chemotherapy; Cancer; Surgery; Gastroenterology","score_opus":0.16339496123548153,"score_gpt":0.5082006822034575,"score_spread":0.34480572096797596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2492595798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80793804,0.13455613,0.0015253153,0.010277359,0.0006255063,0.0046464824,0.010962353,0.00010977093,0.029359091],"genre_scores_gemma":[0.93460804,0.040663652,0.0020509672,0.005470672,0.00046215614,0.001903723,0.009327064,0.00003905962,0.0054746233],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99876946,0.0007307061,0.000043199656,0.000096313765,0.00020141147,0.00015879805],"domain_scores_gemma":[0.9980842,0.00052831863,0.00022642133,0.00011940422,0.00032503303,0.00071661867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004915289,0.0006436365,0.00095385016,0.00022094253,0.00068298535,0.0005875679,0.0007313476,0.00065801694,0.0025389823],"category_scores_gemma":[0.0029985926,0.00017176585,0.0006489157,0.00095844385,0.0005251705,0.0002732406,0.0003338843,0.0010714267,0.0003504446],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25202194,0.0066752783,0.068870395,0.0023842605,0.0024235526,0.00046062339,0.0006233622,0.0025785558,0.007933582,0.0013220757,0.059440233,0.5952662],"study_design_scores_gemma":[0.21439755,0.15191437,0.429337,0.0012020926,0.004653405,0.0013577186,0.00032667167,0.0019013176,0.0025682368,0.001242967,0.19096403,0.00013457381],"about_ca_topic_score_codex":0.15909082,"about_ca_topic_score_gemma":0.39386734,"teacher_disagreement_score":0.8409092,"about_ca_system_score_codex":0.005327981,"about_ca_system_score_gemma":0.009936353,"threshold_uncertainty_score":0.3163296},"labels":[],"label_agreement":null},{"id":"W2495512985","doi":"10.1200/jco.2016.34.4_suppl.192","title":"Phase III randomized study of sorafenib plus doxorubicin versus sorafenib in patients with advanced hepatocellular carcinoma (HCC): CALGB 80802 (Alliance).","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); Ottawa Hospital; McGill University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Sorafenib; Clinical endpoint; Interim analysis; Hazard ratio; Hepatocellular carcinoma; Internal medicine; Randomized controlled trial; Phases of clinical research; Oncology; Gastroenterology; Progression-free survival; Surgery; Chemotherapy; Confidence interval","score_opus":0.09144095418322526,"score_gpt":0.4539521059192045,"score_spread":0.36251115173597925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2495512985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97308785,0.0024399522,0.0009850028,0.0024854129,0.0007208823,0.0128223365,0.0034206887,0.0002376251,0.0038002904],"genre_scores_gemma":[0.963959,0.0020341594,0.0035449688,0.004110193,0.0005096322,0.014970821,0.0036171873,0.00006183868,0.0071921404],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989592,0.00069191743,0.000033533386,0.00011309696,0.000064339634,0.0001379009],"domain_scores_gemma":[0.9985575,0.00031033074,0.00026367608,0.0001048139,0.00008066991,0.0006829258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042260997,0.0024048223,0.0028870364,0.0007763493,0.00049540657,0.0012095171,0.0011928742,0.0018019591,0.0083388295],"category_scores_gemma":[0.0025711395,0.0010332651,0.0015643105,0.0006510234,0.0017385613,0.000961724,0.000841446,0.0034726984,0.0016246074],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9781058,0.008293581,0.00078793446,0.00023310953,0.00044491346,0.000033961143,0.00004841466,0.0005574087,0.0019066207,0.00010535686,0.0019177819,0.007565152],"study_design_scores_gemma":[0.9714174,0.026581002,0.00080537965,0.000009128209,0.00012032099,0.000017092932,0.000010831832,0.00034923645,0.00012512895,0.00008833457,0.00046851052,0.000007638034],"about_ca_topic_score_codex":0.003395807,"about_ca_topic_score_gemma":0.00797832,"teacher_disagreement_score":0.0083388295,"about_ca_system_score_codex":0.001675246,"about_ca_system_score_gemma":0.0030047928,"threshold_uncertainty_score":0.027896166},"labels":[],"label_agreement":null},{"id":"W2505248710","doi":"10.1177/1078155216660184","title":"Safe administration of docetaxel after weekly paclitaxel-induced acute pancreatitis","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Acute pancreatitis; Docetaxel; Carboplatin; Paclitaxel; Pancreatitis; Adverse effect; Chemotherapy; Pancreatic cancer; Internal medicine; Gastroenterology; Cancer; Cisplatin","score_opus":0.04567577280500804,"score_gpt":0.4385017096093566,"score_spread":0.3928259368043485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2505248710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9569838,0.017936293,0.015632128,0.0016017604,0.0003453432,0.00024379377,0.00011700767,0.00038978836,0.0067500565],"genre_scores_gemma":[0.9948743,0.0018776543,0.001497664,0.00045241995,0.00011334676,0.000029439288,0.000075457276,0.000019617715,0.0010601238],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9997918,0.00006910576,0.000021492246,0.000024623621,0.00006336458,0.000029600804],"domain_scores_gemma":[0.99950445,0.00012301853,0.00018645437,0.00007717341,0.000040616367,0.00006820709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015570507,0.00018232019,0.0004556728,0.00019844552,0.000256739,0.00033306913,0.00018153629,0.00039238256,0.00042850204],"category_scores_gemma":[0.0013019162,0.00009845777,0.00031318975,0.00016075047,0.00017793455,0.00024749938,0.00023323434,0.0007871384,0.00025726165],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006832182,0.0029286218,0.09226934,0.0007097105,0.00040641744,0.10324724,0.0008523884,0.0023594676,0.110322595,0.0021483023,0.008287026,0.66963667],"study_design_scores_gemma":[0.0025451377,0.05230563,0.19028735,0.0007404541,0.0008035991,0.32453173,0.0005424713,0.014881549,0.23597664,0.0053840145,0.17185703,0.00014442272],"about_ca_topic_score_codex":0.00025897892,"about_ca_topic_score_gemma":0.00077363924,"teacher_disagreement_score":0.0004556728,"about_ca_system_score_codex":0.00022950409,"about_ca_system_score_gemma":0.00027744178,"threshold_uncertainty_score":0.001665175},"labels":[],"label_agreement":null},{"id":"W2510092860","doi":"10.1249/01.mss.0000486011.64680.fa","title":"Comparing Indices of Neuromuscular Fatigue with Subjective Fatigue in Cancer Survivors","year":2016,"lang":"en","type":"article","venue":"Medicine & Science in Sports & Exercise","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Isometric exercise; Medicine; Physical medicine and rehabilitation; Cancer-related fatigue; Physical therapy; Rehabilitation; Quality of life (healthcare); Cancer; Muscle fatigue; Internal medicine; Electromyography","score_opus":0.045975488166281955,"score_gpt":0.34462630954375284,"score_spread":0.2986508213774709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2510092860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994906,0.00014187778,0.000046954123,0.0000058251267,0.0000022685217,0.000012382267,0.00009497114,0.0000020959599,0.0002030099],"genre_scores_gemma":[0.999529,0.00005548512,0.00005458595,0.000010884453,0.0000044954204,0.000018890954,0.00019369776,8.937742e-7,0.00013206847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997693,0.00006887812,0.000036171958,0.000040663683,0.00005221385,0.000032754586],"domain_scores_gemma":[0.9987205,0.0002412138,0.0005718644,0.000053252075,0.00019137676,0.00022183542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047817145,0.00018829748,0.00023035074,0.0006207154,0.00014394808,0.00030000965,0.00014387125,0.0002633435,0.0011561398],"category_scores_gemma":[0.00196543,0.000076179516,0.0002619824,0.00039718318,0.00018498853,0.0002323689,0.00040060419,0.00020050992,0.0001494225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008038911,0.00013360035,0.98922616,0.000066274486,0.000111207126,0.000038029466,0.0002982575,0.00007205638,0.0017500828,0.0000075566923,0.00008646559,0.0074064387],"study_design_scores_gemma":[0.0000045282,0.00047388696,0.9991357,0.0000032551698,0.00001468251,0.000048176218,0.00013306245,0.00004547334,0.00008199585,0.000004119302,0.00005326197,0.0000019298718],"about_ca_topic_score_codex":0.00081293884,"about_ca_topic_score_gemma":0.0013116822,"teacher_disagreement_score":0.0011561398,"about_ca_system_score_codex":0.000119443124,"about_ca_system_score_gemma":0.00007520122,"threshold_uncertainty_score":0.0038676858},"labels":[],"label_agreement":null},{"id":"W2513422618","doi":"10.1200/jco.2012.30.15_suppl.e21099","title":"Gene expression combined with gene set enrichment analysis to identify markers of vinorelbine efficacy in breast cancer patients.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Gene; Gene expression; Cancer research; Breast cancer; Gene expression profiling; Biology; Transcription factor; Microarray analysis techniques; Cancer; Medicine; Genetics","score_opus":0.0677473818523388,"score_gpt":0.48026202625263503,"score_spread":0.4125146444002962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513422618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99402726,0.001179701,0.0013693112,0.00008578149,0.000015156662,0.000045579156,0.0023289402,0.00005340103,0.0008947583],"genre_scores_gemma":[0.9939526,0.00023669927,0.0025744198,0.00005783403,0.000012606546,0.000069539565,0.0023572566,0.000009717403,0.0007293264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997985,0.00004391938,0.000012156374,0.00005339656,0.000053119853,0.000038861614],"domain_scores_gemma":[0.99987614,0.00004656218,0.000031172785,0.000007734416,0.000016874614,0.000021442422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028912863,0.000233334,0.0005065174,0.0011894624,0.0001593673,0.0002936465,0.00017190594,0.00019686866,0.0016961205],"category_scores_gemma":[0.0003367274,0.00009004893,0.00030054987,0.0012864517,0.00013120109,0.00008304818,0.00018126197,0.00020225222,0.00028164822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005960333,0.0005282817,0.68643343,0.0003705552,0.0007227482,0.00040250804,0.00015572313,0.0023059996,0.2204851,0.00020024518,0.0019215079,0.08051352],"study_design_scores_gemma":[0.00008030948,0.0009672296,0.97336066,0.000015822865,0.0002642741,0.0006474108,0.00012879715,0.005722244,0.0164822,0.00019619004,0.0021218208,0.000013083707],"about_ca_topic_score_codex":0.00073100894,"about_ca_topic_score_gemma":0.0013581915,"teacher_disagreement_score":0.0016961205,"about_ca_system_score_codex":0.00022014516,"about_ca_system_score_gemma":0.00021899893,"threshold_uncertainty_score":0.005674064},"labels":[],"label_agreement":null},{"id":"W2518518788","doi":"","title":"Development of highly efficacious hydrophobic paclitaxel prodrugs delivered in nanoparticles for fixed-ratio drug combination applications","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Paclitaxel; Prodrug; Drug; Pharmacokinetics; Pharmacology; Drug delivery; Chemistry; In vivo; Bioavailability; Micelle; Drug carrier; Targeted drug delivery; Cancer; Aqueous solution; Medicine; Organic chemistry","score_opus":0.09150125931938934,"score_gpt":0.4202588927023295,"score_spread":0.3287576333829402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518518788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9485108,0.0060231322,0.037352215,0.00030023826,0.0001091754,0.0006662645,0.00025683356,0.0003679199,0.0064133373],"genre_scores_gemma":[0.9431154,0.0040908535,0.04373018,0.00010703286,0.000028869192,0.00024092113,0.00041816474,0.00007255638,0.00819585],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992454,0.000011080293,0.000008013554,0.00001541001,0.000027419805,0.000013596356],"domain_scores_gemma":[0.9999604,0.0000057141465,0.000011501916,0.000004208809,0.000009462301,0.000008782132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022405997,0.00044182915,0.0003168049,0.00028722736,0.00010127189,0.00024224463,0.00020856905,0.0003285855,0.0007812537],"category_scores_gemma":[0.00011014261,0.00024952594,0.00024115552,0.00012465967,0.00012913623,0.00021293464,0.00016739941,0.0003185506,0.00047339406],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004977542,0.00006339019,0.0000591594,0.0000296233,0.000005237727,0.00004198067,0.000010121751,0.00038630285,0.9918805,0.00013807479,0.000103211445,0.007232618],"study_design_scores_gemma":[0.00006899941,0.0006130132,0.00042673,0.0000049324713,0.000024266808,0.00018062606,0.000005329856,0.0027735853,0.9921904,0.000035794517,0.0036714457,0.000004866905],"about_ca_topic_score_codex":0.00041322547,"about_ca_topic_score_gemma":0.0008771419,"teacher_disagreement_score":0.0007812537,"about_ca_system_score_codex":0.00042682572,"about_ca_system_score_gemma":0.00021625725,"threshold_uncertainty_score":0.0030968785},"labels":[],"label_agreement":null},{"id":"W2518731549","doi":"","title":"Comparison of physicochemical characteristics and stability of three novel formulations of paclitaxel: Abraxane, Nanoxel, and Genexol PM","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Paclitaxel; Diluent; Chromatography; Chemistry; Particle size; Nuclear chemistry; Medicine; Surgery; Chemotherapy","score_opus":0.26442089054524215,"score_gpt":0.4898383494715776,"score_spread":0.22541745892633547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518731549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617416,0.0015590987,0.0014476432,0.00004245007,0.000018270523,0.000033895118,0.00013785313,0.000025046902,0.00056154805],"genre_scores_gemma":[0.99487394,0.0010921863,0.0027006683,0.00004397359,0.00001283863,0.00005569496,0.00032468388,0.00001627746,0.0008797545],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982965,0.000033531545,0.00001934022,0.00003134806,0.00006721582,0.00001893118],"domain_scores_gemma":[0.9996723,0.00008256727,0.00011429729,0.000012963659,0.00007975312,0.000038141032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002683503,0.00020597756,0.00012651739,0.00024162894,0.0001308877,0.0002059365,0.00012897428,0.00022241614,0.0007923688],"category_scores_gemma":[0.00048786268,0.00008825856,0.00019055208,0.00017742121,0.0001466304,0.0003181327,0.0001184831,0.00031857184,0.00016605051],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068333634,0.00011699128,0.0009702137,0.00008665164,0.000028250963,0.00008049124,0.000063136926,0.00026061063,0.99153066,0.000039670544,0.00006835837,0.006071587],"study_design_scores_gemma":[0.000050723473,0.0025436175,0.011588104,0.0000086780865,0.00006864915,0.00042755486,0.00005223483,0.0017238639,0.98158115,0.000020230353,0.0019187711,0.000016496831],"about_ca_topic_score_codex":0.0005852891,"about_ca_topic_score_gemma":0.0006165818,"teacher_disagreement_score":0.0007923688,"about_ca_system_score_codex":0.00028199697,"about_ca_system_score_gemma":0.0001648627,"threshold_uncertainty_score":0.0026506782},"labels":[],"label_agreement":null},{"id":"W2520703434","doi":"10.1097/01.jto.0000284321.19705.61","title":"P1-223: Costs associated with intravenous chemotherapy administration in patients with lung cancer","year":2007,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Etoposide; Carboplatin; Chemotherapy; Irinotecan; Lung cancer; Cisplatin; Oncology; Internal medicine; Topotecan; Route of administration; Cancer; Colorectal cancer","score_opus":0.012162735568057003,"score_gpt":0.4152775145712979,"score_spread":0.4031147790032409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520703434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98787737,0.0038172056,0.00045599326,0.001513296,0.00004505632,0.000046336292,0.0010479022,0.00001860998,0.00517821],"genre_scores_gemma":[0.9981515,0.00069128413,0.0002636888,0.00011653033,0.000046663794,0.00001606119,0.0003488089,0.000005919885,0.0003594282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927956,0.00030809987,0.00008269446,0.000045995548,0.00017715462,0.000106594314],"domain_scores_gemma":[0.99592316,0.0017761808,0.0015368558,0.000070550566,0.00027146866,0.00042171218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039059453,0.0002169549,0.00034117143,0.0005192806,0.0002921609,0.0006885664,0.00026226556,0.00040467724,0.0028310646],"category_scores_gemma":[0.009170584,0.00014087235,0.0006905918,0.00092549424,0.00016663769,0.0004272525,0.0004670526,0.0011555738,0.00018566585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075798244,0.00044785155,0.8726985,0.00027377924,0.0005154745,0.0011552888,0.000096234035,0.0043733846,0.0010969556,0.0007447487,0.0027850452,0.10823293],"study_design_scores_gemma":[0.000094753945,0.0012602758,0.9877493,0.00008375454,0.00043277445,0.0018198665,0.00024200004,0.005461084,0.0004419004,0.00032155117,0.0020754875,0.00001734912],"about_ca_topic_score_codex":0.005979778,"about_ca_topic_score_gemma":0.0076644197,"teacher_disagreement_score":0.005979778,"about_ca_system_score_codex":0.001962036,"about_ca_system_score_gemma":0.0011924385,"threshold_uncertainty_score":0.014235616},"labels":[],"label_agreement":null},{"id":"W2520992272","doi":"10.1212/wnl.86.16_supplement.s17.003","title":"Tetrodotoxin (TTX) for Chemotherapy Induced Neuropathic Pain (CINP): A Randomized, Double-Blind, Dose-Finding, Placebo Controlled, Multicenter Study (S17.003)","year":2016,"lang":"en","type":"article","venue":"Neurology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"","keywords":"Neuropathic pain; Medicine; Placebo; Multicenter study; Double blind; Anesthesia; Randomized controlled trial; Multicenter trial; Chemotherapy; Tetrodotoxin; Surgery; Internal medicine; Pathology; Alternative medicine","score_opus":0.048113793392347316,"score_gpt":0.35017559203278814,"score_spread":0.3020617986404408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520992272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859191,0.003207805,0.00089360954,0.00040759766,0.0003114003,0.0075218296,0.0007031851,0.00009062291,0.00094482955],"genre_scores_gemma":[0.976208,0.00440545,0.0032853012,0.0010570857,0.0005688375,0.009798997,0.0010746011,0.0000270927,0.003574648],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993051,0.00038823453,0.00005157706,0.00009862545,0.00008038927,0.0000759781],"domain_scores_gemma":[0.9991615,0.00016643298,0.0003092261,0.00006510986,0.00006984229,0.00022803796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018201927,0.0012219639,0.0020873474,0.0005873255,0.00044856436,0.00070879277,0.0008023313,0.001405142,0.0060864314],"category_scores_gemma":[0.0012673904,0.0006337898,0.0010806528,0.0006045711,0.0010919475,0.0006827946,0.00029510874,0.001716426,0.00064562034],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93832505,0.020693332,0.0010077159,0.00073503976,0.00065285264,0.000051364303,0.0000431896,0.00025281383,0.012959507,0.000102574275,0.00071278994,0.024463883],"study_design_scores_gemma":[0.84767735,0.14951394,0.0013743645,0.000020913001,0.00018658247,0.000028291108,0.000008173599,0.00012525814,0.00069846556,0.000026324153,0.00033310568,0.0000073568526],"about_ca_topic_score_codex":0.00056638883,"about_ca_topic_score_gemma":0.0016990935,"teacher_disagreement_score":0.0060864314,"about_ca_system_score_codex":0.0005665621,"about_ca_system_score_gemma":0.0014554481,"threshold_uncertainty_score":0.020361185},"labels":[],"label_agreement":null},{"id":"W2532290530","doi":"10.1200/jco.2006.24.18_suppl.10627","title":"Pegylated liposomal doxorubicin (PLD) with cyclophosphamide (C) as 1<sup>st</sup>-line chemotherapy for metastatic breast cancer (MBC) patients previously treated with adjuvant anthracyclines","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Cardiotoxicity; Metastatic breast cancer; Anthracycline; Internal medicine; Doxorubicin; Cyclophosphamide; Epirubicin; Mucositis; Gastroenterology; Oncology; Chemotherapy; Neutropenia; Adjuvant; Regimen; Breast cancer; Febrile neutropenia; Discontinuation; Cancer","score_opus":0.042250708226388774,"score_gpt":0.4239758659361589,"score_spread":0.3817251577097701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2532290530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973431,0.00085124245,0.00030584744,0.00010062671,0.000027880345,0.0004524682,0.00011136557,0.00003220431,0.00077520707],"genre_scores_gemma":[0.9973822,0.00042205118,0.0008397257,0.00011218745,0.00002764542,0.0003531103,0.00032217908,0.0000044878784,0.0005364021],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998617,0.000043211854,0.000013110952,0.000027639606,0.000016803902,0.000037545833],"domain_scores_gemma":[0.99979395,0.000024832969,0.000031843312,0.000016364169,0.000007425993,0.00012569186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048050578,0.0003611069,0.0005618797,0.0002057114,0.00022034821,0.00041003918,0.00030253813,0.00034628776,0.0021354954],"category_scores_gemma":[0.00028431782,0.00021734872,0.00024042866,0.0002727817,0.0004224404,0.00036399273,0.00038542174,0.0005691981,0.00047033746],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3011029,0.040459767,0.029973727,0.0012978251,0.0006225243,0.00094318984,0.00053617044,0.008873258,0.33981484,0.0010206108,0.0049665514,0.27038866],"study_design_scores_gemma":[0.20206718,0.58504355,0.0871322,0.0002113947,0.0006471013,0.0023407107,0.0001441504,0.0112642795,0.09201844,0.00038799059,0.018644823,0.00009816854],"about_ca_topic_score_codex":0.00037190306,"about_ca_topic_score_gemma":0.000804716,"teacher_disagreement_score":0.0021354954,"about_ca_system_score_codex":0.0004568051,"about_ca_system_score_gemma":0.00058424636,"threshold_uncertainty_score":0.0071439147},"labels":[],"label_agreement":null},{"id":"W2541318692","doi":"10.1200/jco.2009.27.15_suppl.e16529","title":"Dalteparin low molecular weight heparin (LMWH) in ovarian cancer: A phase II randomized study","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; Ontario Clinical Oncology Group; BC Cancer Agency","funders":"","keywords":"Medicine; Randomized controlled trial; Ovarian cancer; Low molecular weight heparin; Chemotherapy; Heparin; Surgery; Internal medicine; Taxane; Cancer; Gastroenterology; Breast cancer","score_opus":0.08121915640578144,"score_gpt":0.5341580470062968,"score_spread":0.45293889060051534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541318692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97970676,0.00614479,0.0010969279,0.0010017978,0.00035445165,0.008755633,0.0011725557,0.00007593406,0.0016911176],"genre_scores_gemma":[0.9777188,0.004419914,0.002536026,0.0022270181,0.00044470158,0.008304666,0.0014670192,0.000022594602,0.002859421],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99904174,0.0006950942,0.000046869925,0.000081679944,0.000054055363,0.000080427264],"domain_scores_gemma":[0.9988085,0.00040367246,0.00025827682,0.00009142481,0.000065409935,0.00037274061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027134637,0.0010655477,0.0022202062,0.00035829996,0.00027696977,0.00082574645,0.0006725108,0.001292053,0.0053439178],"category_scores_gemma":[0.0020083694,0.00053067034,0.0013389437,0.0004700921,0.0007886307,0.00066693174,0.00037437407,0.0015832062,0.00060937234],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9624812,0.011686642,0.0011660324,0.00075256854,0.0007371632,0.000055350498,0.000050832157,0.00037729114,0.0028156897,0.00012414376,0.00080470776,0.01894845],"study_design_scores_gemma":[0.953223,0.044802416,0.0010157053,0.000019827337,0.00017217643,0.000021549811,0.000009632783,0.00019526898,0.00011298801,0.000060904928,0.00036161474,0.000004956272],"about_ca_topic_score_codex":0.0008651731,"about_ca_topic_score_gemma":0.001938029,"teacher_disagreement_score":0.0053439178,"about_ca_system_score_codex":0.0006585157,"about_ca_system_score_gemma":0.001472935,"threshold_uncertainty_score":0.017877162},"labels":[],"label_agreement":null},{"id":"W2544016569","doi":"10.1016/j.jval.2016.09.1552","title":"A Real-World Outcome Research Study On Quality of Life, Work Productivity And Healthcare Resource Utilization In Metastatic Breast Cancer For Patients And Caregivers","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Centre intégré de santé et de services sociaux de la Montérégie-Centre; Santé Montérégie; Université de Montréal; Pfizer (Canada); Hôpital Maisonneuve-Rosemont; Centre hospitalier universitaire de Québec; Kingston General Hospital","funders":"","keywords":"Medicine; Metastatic breast cancer; Quality of life (healthcare); Work productivity; Cohort; Breast cancer; Internal medicine; Cancer; Prospective cohort study; Disease; Cohort study; Physical therapy; Oncology; Productivity; Nursing","score_opus":0.35795054518969815,"score_gpt":0.5272409181921662,"score_spread":0.16929037300246808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544016569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99909425,0.00019836982,0.000043677624,0.00003834134,0.0000072003677,0.00006740381,0.00038747652,0.0000010948619,0.00016226566],"genre_scores_gemma":[0.99834406,0.00014713423,0.0001373519,0.00005141671,0.000014050354,0.00020186573,0.0009894662,0.0000019294648,0.0001127129],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964933,0.0021200976,0.0004266039,0.00027710025,0.0003323044,0.00035069967],"domain_scores_gemma":[0.9893127,0.003877791,0.0035414572,0.00071138074,0.0012966973,0.0012599175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056677423,0.0007653838,0.0011906255,0.0014322625,0.0017291799,0.0015359026,0.0006769355,0.0010553483,0.0016444386],"category_scores_gemma":[0.012749419,0.00041850054,0.0022777922,0.0026462523,0.001030617,0.0015577815,0.0013433882,0.0013709781,0.0003789674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067462493,0.0025577843,0.9832413,0.00021343815,0.0012440705,0.00017233132,0.0010555716,0.00021110206,0.00013332603,0.00008866314,0.00041756974,0.0039184177],"study_design_scores_gemma":[0.0009460879,0.0048066727,0.98973745,0.00007591141,0.00053913327,0.0002002937,0.0025736766,0.00033156076,0.00009027962,0.00009418235,0.00055788615,0.000046964546],"about_ca_topic_score_codex":0.009848326,"about_ca_topic_score_gemma":0.011667288,"teacher_disagreement_score":0.009848326,"about_ca_system_score_codex":0.0020016504,"about_ca_system_score_gemma":0.0014008618,"threshold_uncertainty_score":0.029974282},"labels":[],"label_agreement":null},{"id":"W2550310472","doi":"10.1182/blood.v118.21.206.206","title":"Venous Thromboembolism (VTE) Prevention with Semuloparin in Cancer Patients Initiating Chemotherapy: Benefit-Risk Assessment by VTE Risk in SAVE-ONCO","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McGill University Health Centre","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Cancer; Pulmonary embolism; Deep vein; Chemotherapy regimen; Surgery; Gastroenterology; Thrombosis; Oncology","score_opus":0.019118421167395414,"score_gpt":0.3078781504209401,"score_spread":0.28875972925354465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550310472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949586,0.003184199,0.00018191281,0.00036167228,0.00004822964,0.00020214396,0.0001927558,0.0000139380245,0.00085663894],"genre_scores_gemma":[0.99760795,0.0010837071,0.00043330697,0.0002226364,0.00006996371,0.00014744418,0.00020204805,0.0000029674732,0.00023],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99934524,0.0003823105,0.00005693537,0.000082297534,0.00007566811,0.000057498655],"domain_scores_gemma":[0.99863344,0.00065175357,0.00032454237,0.000068985806,0.000048511847,0.00027264908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001273733,0.00045856877,0.0017914694,0.00034265258,0.00018615545,0.0006117212,0.0002561429,0.0006555423,0.0023717256],"category_scores_gemma":[0.0021741323,0.00026680683,0.0014747011,0.0004284955,0.00047697418,0.00046952243,0.0004018804,0.0012831338,0.00016861754],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.874067,0.0071912017,0.028070536,0.0007793527,0.0019405665,0.00008281119,0.00009940395,0.0014152451,0.0038991407,0.0003519927,0.00086348417,0.081239276],"study_design_scores_gemma":[0.3973659,0.4662382,0.11747381,0.00027605036,0.006010385,0.00023153907,0.00011407218,0.005681628,0.0023093482,0.001504634,0.0027184666,0.00007604065],"about_ca_topic_score_codex":0.00033901806,"about_ca_topic_score_gemma":0.00072035973,"teacher_disagreement_score":0.0023717256,"about_ca_system_score_codex":0.00035767953,"about_ca_system_score_gemma":0.00057758286,"threshold_uncertainty_score":0.007934213},"labels":[],"label_agreement":null},{"id":"W2554811589","doi":"10.1590/1982-0194201600055","title":"Indução da dor pelo quimioterápico docetaxel em mulheres com câncer de mama","year":2016,"lang":"pt","type":"article","venue":"Acta Paulista de Enfermagem","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Fundação de Amparo à Pesquisa do Estado de Minas Gerais; McGill University","keywords":"Medicine; Docetaxel; Brief Pain Inventory; Gynecology; Internal medicine; Oncology; Cancer; Physical therapy; Chronic pain","score_opus":0.055037812953116313,"score_gpt":0.3600723752270384,"score_spread":0.30503456227392206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554811589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967501,0.002198538,0.00011561509,0.00009734504,0.000008893285,0.0000388349,0.00011226913,0.000004138342,0.00067420484],"genre_scores_gemma":[0.9985586,0.00081191707,0.00016163483,0.00007606731,0.000015440692,0.000033860957,0.00007138546,0.0000012143654,0.00026985694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994917,0.00021327853,0.00005391955,0.00006533543,0.0001019898,0.00007367356],"domain_scores_gemma":[0.9982039,0.00066443323,0.0007523359,0.00005882178,0.00023318862,0.00008732648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060177344,0.00008655642,0.00041234386,0.00025193678,0.00025942796,0.00046134126,0.00008562473,0.00016820821,0.001443681],"category_scores_gemma":[0.0033573252,0.00014442834,0.0003060834,0.00044092519,0.00018335556,0.0002682697,0.00022416253,0.00025659634,0.000120570294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027470728,0.0004105014,0.9246388,0.00047248558,0.0001422588,0.00047518514,0.0016521828,0.00012137952,0.007524461,0.00006860317,0.00050109206,0.06124605],"study_design_scores_gemma":[0.00006548619,0.0041316086,0.9898198,0.000063497486,0.00019042188,0.0009807824,0.0012192157,0.00013536315,0.0014936541,0.000042950167,0.0018473968,0.000009917334],"about_ca_topic_score_codex":0.0015691306,"about_ca_topic_score_gemma":0.0032231263,"teacher_disagreement_score":0.0015691306,"about_ca_system_score_codex":0.00037887655,"about_ca_system_score_gemma":0.00052255567,"threshold_uncertainty_score":0.0048295856},"labels":[],"label_agreement":null},{"id":"W2556113048","doi":"","title":"An Investigation of Selective Galena Recovery Following Its Depression","year":2015,"lang":"en","type":"dissertation","venue":"QSpace (Queen's University Library)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University","keywords":"Depression (economics); Galena; Psychology; Psychiatry; Medicine; Geology; Keynesian economics; Geochemistry; Economics","score_opus":0.011700668803335751,"score_gpt":0.2567573146432211,"score_spread":0.24505664583988535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556113048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968497,0.00046413724,0.0016966008,0.00003187946,0.000009371927,0.00002541841,0.000113664355,0.000031909727,0.0007773422],"genre_scores_gemma":[0.99385756,0.0005187084,0.00168578,0.000048558657,0.000004519959,0.000024092027,0.00021074581,0.00001872853,0.003631275],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998766,0.000012837289,0.000007737709,0.000028269698,0.00004507931,0.000029399003],"domain_scores_gemma":[0.9998865,0.000021440355,0.000030520965,0.000009861655,0.00003686341,0.000014788576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001633181,0.00023273719,0.00027768948,0.00016628263,0.00012751868,0.0003398293,0.00023143628,0.00032657897,0.0011574632],"category_scores_gemma":[0.00028915424,0.00011832446,0.0002500213,0.00018394762,0.00018123016,0.0003644886,0.00022618535,0.0004264326,0.00036679002],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059556125,0.000014080783,0.00019527889,0.000037492293,0.0000028599864,0.00003850087,0.000028479795,0.00003235285,0.99822646,0.000015265405,0.000010463212,0.00133936],"study_design_scores_gemma":[0.0000031630561,0.00028379154,0.0025295126,0.000005419121,0.0000065015806,0.00006738699,0.000051591862,0.00029921264,0.9960407,0.000011584431,0.0006969786,0.000004080612],"about_ca_topic_score_codex":0.00037122684,"about_ca_topic_score_gemma":0.00059952843,"teacher_disagreement_score":0.0011574632,"about_ca_system_score_codex":0.0001306159,"about_ca_system_score_gemma":0.00010027385,"threshold_uncertainty_score":0.0038720965},"labels":[],"label_agreement":null},{"id":"W2556811127","doi":"10.1182/blood.v110.11.3995.3995","title":"Venous Thromboembolism and Non-Small Cell Lung Cancer: A Pooled Analysis of National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) Trials.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; Queen's University; Health Sciences Centre; Sunnybrook Health Science Centre; University Health Network; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Internal medicine; Lung cancer; Vinorelbine; Oncology; Erlotinib; Randomized controlled trial; Cancer; Bevacizumab; Clinical trial; Chemotherapy; Surgery; Cisplatin","score_opus":0.07261791559963969,"score_gpt":0.4240663307849462,"score_spread":0.3514484151853065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556811127","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24275209,0.7324754,0.0025544951,0.0012309379,0.00060000044,0.0023627246,0.015898962,0.0001167844,0.0020085543],"genre_scores_gemma":[0.9115958,0.07278119,0.0028085776,0.0008867104,0.0006355217,0.0019031556,0.008429451,0.00005706774,0.0009023903],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97392344,0.017898567,0.0029354526,0.0017875663,0.002780991,0.00067396846],"domain_scores_gemma":[0.9702228,0.014667294,0.009123003,0.0019749624,0.0029511182,0.001060816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02446165,0.0020198692,0.008552013,0.0027473504,0.00048788174,0.0017547313,0.0010147126,0.0014817789,0.0019076039],"category_scores_gemma":[0.03621655,0.00083554443,0.015490815,0.005300811,0.0005612099,0.00067188044,0.0009381929,0.0014443741,0.00016858715],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.124253705,0.00014502085,0.070994794,0.018326527,0.7581147,0.00017937187,0.00007520383,0.001783697,0.0005707024,0.00018010964,0.0040560844,0.021320133],"study_design_scores_gemma":[0.05240828,0.0033885613,0.12754051,0.0016187542,0.8081968,0.00025773185,0.00007638393,0.0016597366,0.00030933012,0.0003847556,0.004065333,0.00009386687],"about_ca_topic_score_codex":0.052615885,"about_ca_topic_score_gemma":0.1207461,"teacher_disagreement_score":0.052615885,"about_ca_system_score_codex":0.0034555476,"about_ca_system_score_gemma":0.0055298493,"threshold_uncertainty_score":0.12936705},"labels":[],"label_agreement":null},{"id":"W2557455638","doi":"10.1016/j.ejca.2016.11.002","title":"Plasma vascular endothelial growth factor as a predictive biomarker: Door closed?","year":2016,"lang":"en","type":"letter","venue":"European Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Bevacizumab; Medicine; Metastatic breast cancer; Internal medicine; Oncology; Vascular endothelial growth factor; Paclitaxel; Breast cancer; Chemotherapy; Angiogenesis; Progression-free survival; Cancer; Surgery; VEGF receptors","score_opus":0.022528321830941903,"score_gpt":0.29928357593077204,"score_spread":0.27675525409983015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557455638","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009001986,0.005358681,0.00038692256,0.97997814,0.011787497,0.0000089624355,0.000038820486,0.00002267253,0.0015180621],"genre_scores_gemma":[0.029221497,0.010718557,0.002272343,0.72216266,0.23220704,0.000060743554,0.00008538092,0.000037017162,0.003234786],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943005,0.0024308364,0.0009506496,0.0006508715,0.0012878896,0.00037923222],"domain_scores_gemma":[0.9821675,0.011536539,0.0008868079,0.0005138009,0.0031737783,0.0017216512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007477742,0.0008506448,0.0036947709,0.0009999613,0.0020351096,0.005487669,0.002175613,0.027694678,0.0046062036],"category_scores_gemma":[0.038368877,0.0007061192,0.0010740504,0.0007514091,0.00331378,0.0071201343,0.0015994658,0.036673777,0.0040805363],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073661056,0.00026716178,0.01241295,0.0004553642,0.00019795433,0.015662493,0.00038085258,0.00036770586,0.0009780996,0.014798795,0.8285796,0.12516233],"study_design_scores_gemma":[0.0013522073,0.00077158364,0.007831665,0.003151819,0.0005017507,0.045448765,0.002363222,0.006868136,0.001947719,0.13776903,0.7915513,0.0004427968],"about_ca_topic_score_codex":0.0015460263,"about_ca_topic_score_gemma":0.0021378766,"teacher_disagreement_score":0.027694678,"about_ca_system_score_codex":0.002396007,"about_ca_system_score_gemma":0.0025950305,"threshold_uncertainty_score":0.03954655},"labels":[],"label_agreement":null},{"id":"W2558801610","doi":"10.1093/jjco/hyw175","title":"Phase 2 study of eribulin in patients with previously treated advanced or metastatic soft tissue sarcoma†","year":2016,"lang":"en","type":"article","venue":"Japanese Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada","keywords":"Eribulin; Medicine; Soft tissue sarcoma; Trabectedin; Soft tissue; Metastatic breast cancer; Oncology; Sarcoma; Internal medicine; Radiology; Cancer; Pathology; Breast cancer","score_opus":0.08470213998850884,"score_gpt":0.4914355898573078,"score_spread":0.40673344986879895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558801610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963965,0.0007762677,0.00034451432,0.00014663687,0.0000390414,0.0012168427,0.0003143637,0.000030042154,0.00073587877],"genre_scores_gemma":[0.99161834,0.00087580166,0.0013057711,0.0005930211,0.000083192936,0.0020975915,0.0013811566,0.000014317201,0.0020308269],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999723,0.00014843456,0.000012279263,0.000040246414,0.000022113194,0.000053828182],"domain_scores_gemma":[0.9997105,0.000041604868,0.000058281003,0.00002219176,0.000025725858,0.00014165803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012396933,0.001031307,0.0011948899,0.00021271124,0.00022647496,0.0003913618,0.00043341823,0.0005293503,0.0026247692],"category_scores_gemma":[0.00046707242,0.00035016375,0.00064731156,0.00021069152,0.0004210522,0.0003810219,0.00022044507,0.0012989189,0.0005358255],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6454143,0.11172468,0.027915843,0.0009519424,0.0018658045,0.00080701086,0.00049554737,0.0030190195,0.08936254,0.00035191048,0.004793796,0.113297634],"study_design_scores_gemma":[0.49286073,0.4687256,0.026708292,0.000033763317,0.00046133873,0.000531542,0.00007036444,0.0015820672,0.00522394,0.00011766297,0.0036632966,0.000021367146],"about_ca_topic_score_codex":0.00073199574,"about_ca_topic_score_gemma":0.0021307212,"teacher_disagreement_score":0.0026247692,"about_ca_system_score_codex":0.00046017452,"about_ca_system_score_gemma":0.0011718861,"threshold_uncertainty_score":0.008780777},"labels":[],"label_agreement":null},{"id":"W2559295313","doi":"10.1182/blood.v106.11.5171.5171","title":"A Supervised Group Exercise Program for Patients with Multiple Myeloma.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Physical therapy; Aerobic exercise; Depression (economics); Quality of life (healthcare); Anxiety","score_opus":0.011162306660536182,"score_gpt":0.27557070673184675,"score_spread":0.26440840007131056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559295313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937163,0.0005877713,0.0005698103,0.0003299448,0.000047746224,0.0015879289,0.0004338333,0.0002446035,0.0024821518],"genre_scores_gemma":[0.988898,0.0006252906,0.0034676916,0.0005321216,0.00015050071,0.0024908306,0.0011208934,0.00001211591,0.0027025554],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99989104,0.00002799623,0.000008253128,0.000026642085,0.0000150703445,0.00003104692],"domain_scores_gemma":[0.99976164,0.000023137978,0.000035764595,0.000010412438,0.000013009754,0.00015611429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019980666,0.00035390828,0.00037824735,0.00029747564,0.0004972327,0.00014347737,0.00030306727,0.00035166196,0.005635652],"category_scores_gemma":[0.0003888382,0.00012370913,0.00030867013,0.00028607406,0.000080229875,0.00014292885,0.0005627805,0.0005200791,0.0008947111],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029309241,0.13483472,0.08305473,0.0014038768,0.00047805428,0.0009491621,0.00077237864,0.0021436585,0.013293104,0.00010040765,0.014031648,0.719629],"study_design_scores_gemma":[0.03225122,0.1860055,0.7588665,0.00024868487,0.0003763425,0.00090705784,0.00034277167,0.003359446,0.0018598505,0.00025372035,0.015488016,0.000040930587],"about_ca_topic_score_codex":0.0015349026,"about_ca_topic_score_gemma":0.0033315355,"teacher_disagreement_score":0.005635652,"about_ca_system_score_codex":0.00019213404,"about_ca_system_score_gemma":0.0005165144,"threshold_uncertainty_score":0.018853128},"labels":[],"label_agreement":null},{"id":"W2560635244","doi":"10.1093/annonc/mdw544","title":"3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2062,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Oncology; Metastatic breast cancer; Internal medicine; Cancer; Male breast cancer","score_opus":0.2306265813022292,"score_gpt":0.5370334859628867,"score_spread":0.30640690466065745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560635244","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009642661,0.35695505,0.04926145,0.27233848,0.041724518,0.004206997,0.017534254,0.0019510542,0.24638553],"genre_scores_gemma":[0.06965033,0.3089515,0.26939115,0.13206565,0.014879266,0.00940307,0.066963285,0.0010818512,0.12761386],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99274445,0.0023915123,0.001756679,0.0002352809,0.0022448658,0.0006272359],"domain_scores_gemma":[0.98820144,0.0025100901,0.0018780138,0.0003420013,0.0062997076,0.0007687346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010375591,0.0012172827,0.0012601856,0.005429456,0.0009909086,0.0024074912,0.0028995369,0.004445441,0.008380984],"category_scores_gemma":[0.024137327,0.0005304218,0.0035963068,0.002296405,0.00087789894,0.0013212394,0.003532588,0.0036386256,0.0060971603],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017883742,0.000106712556,0.0039059767,0.0041448255,0.00017990981,0.0003989651,0.00020215809,0.00096431444,0.00080772524,0.005877181,0.67032844,0.31290495],"study_design_scores_gemma":[0.00012494053,0.00008319017,0.004654676,0.012926168,0.0003093293,0.0011067034,0.0002163546,0.00044984385,0.0005372106,0.0041328915,0.9754175,0.000041107764],"about_ca_topic_score_codex":0.009397338,"about_ca_topic_score_gemma":0.018180475,"teacher_disagreement_score":0.010375591,"about_ca_system_score_codex":0.0028624632,"about_ca_system_score_gemma":0.0096554225,"threshold_uncertainty_score":0.054872036},"labels":[],"label_agreement":null},{"id":"W2561681743","doi":"10.1055/s-0036-1596315","title":"Anticancer natural products from traditionally used Canadian medicinal plants","year":2016,"lang":"en","type":"article","venue":"Planta Medica","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Moncton; University of New Brunswick","funders":"","keywords":"Medicinal plants; Traditional medicine; Bioassay; Natural product; Drug discovery; Biology; Population; Medicine; Pharmacology; Bioinformatics; Biochemistry","score_opus":0.02608279933613329,"score_gpt":0.2827766905959727,"score_spread":0.25669389125983944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561681743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82533854,0.097579755,0.0068101035,0.001168945,0.00021367935,0.0007077637,0.01453599,0.00037753265,0.05326763],"genre_scores_gemma":[0.8987704,0.057113178,0.014132084,0.0007740081,0.00012611257,0.00012898253,0.010506256,0.00005109935,0.018397886],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991155,0.0000051415564,0.00000336695,0.00001375402,0.00004854541,0.000017692204],"domain_scores_gemma":[0.9999074,0.0000091884785,0.000014517288,0.0000045982874,0.000043915115,0.000020460322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000085838095,0.0007545628,0.00035486708,0.0018000997,0.0010137772,0.00037978042,0.00027952628,0.0002003492,0.0034130272],"category_scores_gemma":[0.00017182695,0.000114281815,0.00028316487,0.0019698264,0.00032017738,0.00019274947,0.00027769903,0.00056125456,0.0004155031],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004685644,0.00014116915,0.002475443,0.0020213844,0.00004931027,0.0007375047,0.00030086975,0.00037797636,0.89855564,0.0007293596,0.0018662963,0.0922766],"study_design_scores_gemma":[0.00015467909,0.001600022,0.19018862,0.0006482336,0.0006741232,0.003695134,0.00077887357,0.00070824986,0.5449913,0.0007776074,0.25566548,0.000117645264],"about_ca_topic_score_codex":0.090174586,"about_ca_topic_score_gemma":0.26373202,"teacher_disagreement_score":0.90982544,"about_ca_system_score_codex":0.0013156089,"about_ca_system_score_gemma":0.0020423129,"threshold_uncertainty_score":0.17929941},"labels":[],"label_agreement":null},{"id":"W2563401770","doi":"10.1371/journal.pone.0167906","title":"Phase I/II Trial of Sorafenib in Combination with Vinorelbine as First-Line Chemotherapy for Metastatic Breast Cancer","year":2016,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"McGill University; Bayer Corporation","keywords":"Medicine; Vinorelbine; Sorafenib; Metastatic breast cancer; Internal medicine; Discontinuation; Neutropenia; Breast cancer; Oncology; Cohort; Surgery; Cancer; Gastroenterology; Chemotherapy; Hepatocellular carcinoma","score_opus":0.05820120234686946,"score_gpt":0.35043232440642885,"score_spread":0.29223112205955937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563401770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915867,0.0018547416,0.0005096953,0.0007431546,0.00020903825,0.002685089,0.00083053025,0.0001233548,0.001457804],"genre_scores_gemma":[0.9868198,0.0018532467,0.0017817196,0.0007804632,0.0002718063,0.003057156,0.0022756888,0.000034516237,0.0031255216],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99961996,0.00016308177,0.000017600792,0.00006563299,0.000038374692,0.00009531564],"domain_scores_gemma":[0.99924207,0.0001051949,0.00012034172,0.00006293443,0.00004043953,0.0004291295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012885561,0.001947958,0.0023113491,0.0005514362,0.00050371327,0.0010432766,0.0010724406,0.0012724034,0.0040058563],"category_scores_gemma":[0.0009251706,0.00068945973,0.0009588731,0.00049971626,0.0009946171,0.0007277816,0.00036711956,0.003489549,0.00086397206],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.70657367,0.12622148,0.004994461,0.0010439403,0.0015053564,0.0005402739,0.0003273296,0.004038517,0.054136094,0.000375835,0.0064664944,0.09377662],"study_design_scores_gemma":[0.6536857,0.33341098,0.005076696,0.000031973384,0.00024589032,0.00029266917,0.000028759983,0.001325411,0.003751596,0.00015195615,0.0019767703,0.000021637163],"about_ca_topic_score_codex":0.0011781119,"about_ca_topic_score_gemma":0.0029842188,"teacher_disagreement_score":0.0040058563,"about_ca_system_score_codex":0.0011525396,"about_ca_system_score_gemma":0.001972854,"threshold_uncertainty_score":0.013400912},"labels":[],"label_agreement":null},{"id":"W2564540330","doi":"10.1182/blood.v116.21.5117.5117","title":"Chemotherapy, but Not Bevacizumab, Increases Tissue Factor Activity Levels In Endothelial Cells, Blood Monocytes, and Non-Small Cell Lung Cancer Cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Lung cancer; Medicine; Carboplatin; Gemcitabine; Bevacizumab; Chemotherapy; Angiogenesis; Tissue factor; Paclitaxel; Cisplatin; Cancer research; Cancer cell; Cancer; Oncology; Pharmacology; Immunology; Internal medicine; Coagulation","score_opus":0.017043797399942454,"score_gpt":0.2901981074395221,"score_spread":0.2731543100395797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564540330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932607,0.004191115,0.00072403305,0.00011313831,0.000060682873,0.000040242958,0.0003773749,0.000022255554,0.0012105191],"genre_scores_gemma":[0.9940544,0.0015423143,0.0011876757,0.00010384211,0.000025584068,0.00008042614,0.0009474469,0.0000042536217,0.0020540506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99974173,0.00006785783,0.000037617447,0.000032737506,0.000047523983,0.00007246003],"domain_scores_gemma":[0.9998665,0.000043020285,0.000025044665,0.000013169624,0.000023228738,0.000028997376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013782432,0.00016384531,0.00026503034,0.00014453594,0.000114818686,0.00023790188,0.00008896242,0.00020265355,0.0019697244],"category_scores_gemma":[0.00016496915,0.00011025356,0.00024247223,0.00020079078,0.00009054654,0.000119342934,0.00010080604,0.00037791883,0.0003812421],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012598203,0.0002462575,0.0019700816,0.00011385154,0.000022531976,0.00011084823,0.000050605122,0.000043191336,0.99207497,0.000042403386,0.00022983733,0.00383538],"study_design_scores_gemma":[0.0003413177,0.0074227,0.07770169,0.000029826597,0.00007168469,0.0007590677,0.00016413422,0.0011728293,0.90756345,0.000057431764,0.004706051,0.000009744707],"about_ca_topic_score_codex":0.0011258873,"about_ca_topic_score_gemma":0.0015558122,"teacher_disagreement_score":0.0019697244,"about_ca_system_score_codex":0.00018154114,"about_ca_system_score_gemma":0.00022481235,"threshold_uncertainty_score":0.0065894127},"labels":[],"label_agreement":null},{"id":"W2564840758","doi":"10.1158/1538-7445.panca16-b83","title":"Abstract B83: Targeting TRPV6 oncochannel for the treatment of pancreatic cancer: A Phase I trial experience","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton; London Health Sciences Centre","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Phases of clinical research; Prostate cancer; Gastroenterology; Cancer; Adverse effect; Urology; Toxicity; Oncology","score_opus":0.25103753202063767,"score_gpt":0.5556311703651444,"score_spread":0.30459363834450676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564840758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829077,0.0067294217,0.0014103011,0.00079340104,0.00014289087,0.0024315657,0.001870301,0.00025544476,0.00345898],"genre_scores_gemma":[0.9831182,0.006106799,0.0023336841,0.001245456,0.00013898658,0.0020419478,0.0019944948,0.0000593988,0.0029611036],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997979,0.000091158756,0.000013031048,0.000032862215,0.000021678654,0.00004346555],"domain_scores_gemma":[0.99970406,0.00005395117,0.000058222184,0.000026668571,0.000029982879,0.00012700642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010422901,0.0008354034,0.0013066105,0.00021121166,0.0003063891,0.00093198713,0.0005738479,0.0009369454,0.0041878084],"category_scores_gemma":[0.00051501184,0.00026622723,0.0008961333,0.00035743395,0.0004641628,0.0005521688,0.00022111936,0.0024053792,0.00085573556],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.513629,0.06612338,0.004953844,0.0042118533,0.0025429532,0.000608537,0.0004940541,0.0045054057,0.1395589,0.00068141345,0.015437764,0.24725293],"study_design_scores_gemma":[0.44910976,0.5151407,0.012389977,0.00025481617,0.00076835736,0.0006638912,0.000119071985,0.002641419,0.009935763,0.00033652055,0.008594054,0.000045598466],"about_ca_topic_score_codex":0.0009022647,"about_ca_topic_score_gemma":0.0019344294,"teacher_disagreement_score":0.0041878084,"about_ca_system_score_codex":0.0005340506,"about_ca_system_score_gemma":0.0011571441,"threshold_uncertainty_score":0.0140096545},"labels":[],"label_agreement":null},{"id":"W2566864507","doi":"10.1158/1538-7445.am2015-524","title":"Abstract 524: Assessing the interaction between acetylenic tricyclic bis-(cyano enone) and cysteine residues of actin to inhibit non-small cell lung cancer cell migration","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Actin; Cell migration; Actin cytoskeleton; Cell biology; Cytoskeleton; MDia1; Actin-binding protein; Lamellipodium; Actin remodeling; Chemistry; Cell; A549 cell; Stress fiber; Biology; Biochemistry","score_opus":0.14258017605746467,"score_gpt":0.4768796802546522,"score_spread":0.33429950419718757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566864507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961349,0.0014220006,0.0012870929,0.00003967761,0.000018467117,0.000040712468,0.00019259703,0.000024203579,0.00084028515],"genre_scores_gemma":[0.9935028,0.0007890453,0.0026408643,0.000046226487,0.0000052355877,0.000049249484,0.0005626413,0.00001274461,0.0023912413],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988604,0.000030916108,0.000009810584,0.00001774239,0.00003331578,0.000022190367],"domain_scores_gemma":[0.99991024,0.000022693846,0.000020816782,0.000008863735,0.000017257438,0.000020013347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015292341,0.00027545632,0.00023375663,0.00014114099,0.00011702274,0.00010175066,0.00016846407,0.0002349702,0.0013880738],"category_scores_gemma":[0.000115446,0.000098256874,0.00017576083,0.00015438751,0.00010695873,0.00008355809,0.00009397027,0.00023563697,0.0002387408],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113698705,0.000029845392,0.00006870737,0.000029517776,0.000005053837,0.000012944709,0.000003566829,0.000058865797,0.9990804,0.000010433524,0.000017371845,0.0005695941],"study_design_scores_gemma":[0.000014201328,0.00048036728,0.0012941413,0.0000027100398,0.000011604191,0.000041692085,0.000005519552,0.0007290226,0.99670875,0.000004358109,0.0007057,0.0000017967259],"about_ca_topic_score_codex":0.00067505875,"about_ca_topic_score_gemma":0.0009770334,"teacher_disagreement_score":0.0013880738,"about_ca_system_score_codex":0.0001650634,"about_ca_system_score_gemma":0.00013249501,"threshold_uncertainty_score":0.0046435595},"labels":[],"label_agreement":null},{"id":"W2567998180","doi":"10.1016/j.clinph.2016.11.022","title":"Corrigendum to “Intracortical inhibition abnormality during the remission phase of multiple sclerosis is related to upper limb dexterity and lesions” [Clin. Neurophysiol. 127 (2016) 1503–1511]","year":2017,"lang":"en","type":"erratum","venue":"Clinical Neurophysiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University; McGill University Health Centre","funders":"","keywords":"Abnormality; Multiple sclerosis; Medicine; Neuroscience; Psychology; Psychiatry","score_opus":0.11365371532675116,"score_gpt":0.4046147410091311,"score_spread":0.2909610256823799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567998180","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008938012,0.0015507397,0.00021413896,0.05279579,0.9419434,0.000033944023,0.00035387863,0.00019868235,0.0028200685],"genre_scores_gemma":[0.0059614303,0.0098398505,0.0014513426,0.195915,0.5940452,0.00020583413,0.0013155676,0.00040859808,0.1908571],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970373,0.00037638698,0.00072156487,0.0004926303,0.0010077067,0.0003644486],"domain_scores_gemma":[0.9861942,0.0038688625,0.00083110796,0.00080807455,0.007568699,0.0007290744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023584946,0.0024678984,0.0032850732,0.0036881506,0.0030390888,0.0027085068,0.004399933,0.012692664,0.042989578],"category_scores_gemma":[0.029325925,0.001473409,0.0029484045,0.0018882873,0.0031946204,0.0023705473,0.0022555238,0.012120015,0.033867784],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034509623,0.000012034795,0.000068959416,0.000089820795,0.000014477869,0.00072289555,0.000016634536,0.000029837634,0.000049678933,0.00029030227,0.9942372,0.0044337404],"study_design_scores_gemma":[0.00011072348,0.000076967095,0.002769533,0.00046840837,0.00007365364,0.0020052425,0.0000882656,0.00033618227,0.00048650548,0.0016717885,0.9918283,0.00008433767],"about_ca_topic_score_codex":0.034730293,"about_ca_topic_score_gemma":0.042856343,"teacher_disagreement_score":0.042989578,"about_ca_system_score_codex":0.0045723645,"about_ca_system_score_gemma":0.0041656606,"threshold_uncertainty_score":0.1438145},"labels":[],"label_agreement":null},{"id":"W2568608113","doi":"10.1016/j.jtho.2016.11.034","title":"ED06.03 Pain Management","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Medicine; Referred pain; Cancer pain; Chronic pain; Palliative care; Nociceptor; Visceral pain; Hyperalgesia; Neuropathic pain; Disease; Cancer; Nociception; Anesthesia; Physical therapy; Internal medicine","score_opus":0.04628104484605768,"score_gpt":0.49795082124000295,"score_spread":0.4516697763939453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568608113","genre_codex":"other","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018665312,0.011629217,0.0038710602,0.012649824,0.0058147027,0.00052868744,0.0060731806,0.001434617,0.9393334],"genre_scores_gemma":[0.13916849,0.01198562,0.015683781,0.02461342,0.006625524,0.0007597812,0.012631775,0.00055439415,0.78797716],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995708,0.00007580727,0.000034508805,0.00003942653,0.00017508128,0.000104352766],"domain_scores_gemma":[0.99913764,0.00010281633,0.000052844614,0.00006851396,0.0002793585,0.00035877698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073125283,0.000392565,0.00038786954,0.0008091203,0.0005210417,0.0012200949,0.00076318317,0.0012839222,0.27069768],"category_scores_gemma":[0.0014450854,0.00014963765,0.0007066527,0.00041259552,0.00022246662,0.0004210542,0.00083319104,0.0012600896,0.08828754],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013561865,0.0012137912,0.0026553248,0.00042315267,0.000056592413,0.00055073993,0.000025152449,0.00016560801,0.0019892936,0.0015151338,0.39254186,0.5975072],"study_design_scores_gemma":[0.00136425,0.0013994294,0.012785631,0.0010112318,0.0000886558,0.0033797824,0.00005213466,0.000508383,0.002002117,0.0014962807,0.9758857,0.000026424916],"about_ca_topic_score_codex":0.00073304004,"about_ca_topic_score_gemma":0.0022503596,"teacher_disagreement_score":0.27069768,"about_ca_system_score_codex":0.0006127149,"about_ca_system_score_gemma":0.0014762292,"threshold_uncertainty_score":0.90557396},"labels":[],"label_agreement":null},{"id":"W2569754140","doi":"10.1139/bcb-2016-0141","title":"Use of substitute Nonidet P-40 nonionic detergents in intracellular tubulin polymerization assays for screening of microtubule targeting agents","year":2017,"lang":"en","type":"article","venue":"Biochemistry and Cell Biology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Microtubule; Intracellular; Tubulin; Polymerization; Chemistry; Biophysics; Biochemistry; Cell biology; Biology; Organic chemistry; Polymer","score_opus":0.03911644318682717,"score_gpt":0.3098415614391623,"score_spread":0.27072511825233514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569754140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91629565,0.012649925,0.056633998,0.00040958813,0.00018358664,0.00073257164,0.0005783039,0.00030356142,0.012212765],"genre_scores_gemma":[0.8477157,0.011596239,0.12301827,0.00015210062,0.000052462805,0.0008064698,0.0025473752,0.00016907009,0.013942312],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894875,0.00032393448,0.00016895747,0.00013707303,0.00034619818,0.000075059994],"domain_scores_gemma":[0.9994184,0.00018017188,0.000105355735,0.0000841828,0.00016207375,0.000049986615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090371276,0.00089355593,0.00047274693,0.0007807673,0.00037411237,0.00043305545,0.00036124673,0.0004438501,0.0013361163],"category_scores_gemma":[0.00072641653,0.00028554382,0.00034117486,0.0005902551,0.00024707097,0.0005138379,0.00040110556,0.0006120335,0.00063659484],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007627292,0.000067316134,0.00019809327,0.00007655297,0.000005765824,0.000038384813,0.00002082584,0.000059092563,0.9969586,0.00005128859,0.00003395294,0.0024137604],"study_design_scores_gemma":[0.000005440934,0.000329258,0.0005063725,0.000009171761,0.000017434948,0.00014143853,0.000015304948,0.00022556465,0.99712723,0.000019281455,0.0015991322,0.000004254061],"about_ca_topic_score_codex":0.0004756949,"about_ca_topic_score_gemma":0.0015119525,"teacher_disagreement_score":0.0013361163,"about_ca_system_score_codex":0.00021508944,"about_ca_system_score_gemma":0.00044454072,"threshold_uncertainty_score":0.004779339},"labels":[],"label_agreement":null},{"id":"W2577893310","doi":"10.71781/11913","title":"Développement de méthodes de synthèse pour les acides aminés indolizidin-9-ones substitués et utilisation des acides aminés azabicycloalcanes en tant que mimes peptidiques","year":2004,"lang":"fr","type":"dissertation","venue":"Open MIND","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; Centre National de la Recherche Scientifique; Fonds Québécois de la Recherche sur la Nature et les Technologies","keywords":"Chemistry; Medicinal chemistry","score_opus":0.09524947472592898,"score_gpt":0.43153302901486695,"score_spread":0.33628355428893797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577893310","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23698774,0.015513233,0.71989363,0.00062351726,0.00094952155,0.0031858708,0.0019257385,0.0019481246,0.018972633],"genre_scores_gemma":[0.23567186,0.016515078,0.6887641,0.00035304573,0.00013721737,0.0025903676,0.0026473356,0.0005858143,0.05273521],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99934655,0.00012146031,0.00004210185,0.0001505778,0.0002589162,0.00008050562],"domain_scores_gemma":[0.99938226,0.00021723077,0.00007985996,0.00010085871,0.00017164042,0.00004818154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010590174,0.0009370119,0.0007900015,0.00069799286,0.0005105951,0.0006224236,0.0007008958,0.00065034186,0.0050508627],"category_scores_gemma":[0.0013757475,0.0005841962,0.00068829313,0.0004778552,0.0004916579,0.00057299423,0.0003811845,0.0021668084,0.003516902],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001461796,0.00008521745,0.00011987048,0.00034933156,0.00004080527,0.0001642249,0.00019239172,0.0003330507,0.95293516,0.0011134837,0.00038220666,0.044138152],"study_design_scores_gemma":[0.000073112395,0.00037504206,0.0005208691,0.0000304262,0.000036556667,0.00034332395,0.000040194158,0.00051206467,0.9694359,0.00024223285,0.0283518,0.000038524584],"about_ca_topic_score_codex":0.0018723559,"about_ca_topic_score_gemma":0.0041514644,"teacher_disagreement_score":0.0050508627,"about_ca_system_score_codex":0.00048651738,"about_ca_system_score_gemma":0.0015443675,"threshold_uncertainty_score":0.016896844},"labels":[],"label_agreement":null},{"id":"W2580256571","doi":"10.18203/2320-6012.ijrms20170141","title":"Preserving of intercostobrachial nerve relieves breast carcinoma patients from postmastectomy pain syndrome","year":2017,"lang":"en","type":"article","venue":"International Journal of Research in Medical Sciences","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Surgery; Mastectomy; Complication; Etiology; Nerve injury; Cancer; Internal medicine","score_opus":0.098177984357611,"score_gpt":0.47246108316360125,"score_spread":0.37428309880599026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580256571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979639,0.0015060656,0.00006515324,0.000031882784,0.000010265084,0.00001137218,0.000013679687,0.0000040522855,0.00039362215],"genre_scores_gemma":[0.9991897,0.00056492875,0.0000833415,0.000020454647,0.000018824268,0.0000071287427,0.000032838096,5.0793443e-7,0.0000823469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999447,0.000014175657,0.000004827907,0.000004633221,0.000016163684,0.000015386971],"domain_scores_gemma":[0.99979144,0.000057782527,0.00006614005,0.000009712416,0.000015931377,0.000058916565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000108306514,0.00014249611,0.00025464126,0.00011571657,0.00013831275,0.00010594345,0.000104027364,0.000105239036,0.0011244826],"category_scores_gemma":[0.0006345344,0.000045417095,0.00015557537,0.0001107129,0.00009138762,0.000104726576,0.000119667144,0.00020205101,0.00009640512],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008403284,0.0028013964,0.6729604,0.0008046626,0.00025689375,0.0045274445,0.0005023573,0.0007208372,0.038232464,0.00006996098,0.000956999,0.26976332],"study_design_scores_gemma":[0.00019811219,0.015218616,0.97195566,0.000089928566,0.00014616767,0.007012222,0.0004908578,0.00030776035,0.0028723115,0.00006865719,0.0016318738,0.000007970105],"about_ca_topic_score_codex":0.00014713881,"about_ca_topic_score_gemma":0.00045192966,"teacher_disagreement_score":0.0011244826,"about_ca_system_score_codex":0.000042736712,"about_ca_system_score_gemma":0.0001237161,"threshold_uncertainty_score":0.0037617087},"labels":[],"label_agreement":null},{"id":"W2581196465","doi":"","title":"Non-pegylated liposomal doxorubicin use in the treatment of bilateral breast cancer","year":2010,"lang":"en","type":"article","venue":"Oncology in Clinical Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cardiotoxicity; Metastatic breast cancer; Breast cancer; Cancer; Adverse effect; Doxorubicin; Regimen; Oncology; Internal medicine; Disease; Chemotherapy; Intensive care medicine","score_opus":0.09959809583881518,"score_gpt":0.5210946399816377,"score_spread":0.42149654414282256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581196465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91100997,0.07293959,0.0018912087,0.0014117325,0.00027436935,0.00022916197,0.00014567575,0.00004798643,0.012050311],"genre_scores_gemma":[0.9857757,0.011255699,0.00061181205,0.00025846995,0.00010095164,0.000048739428,0.00010386535,0.000007497643,0.0018373327],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99991393,0.000036237314,0.000008279096,0.000012152052,0.00001849935,0.000010994829],"domain_scores_gemma":[0.99989843,0.000034070086,0.000025461306,0.000009356719,0.000008199535,0.000024427149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022696328,0.00010677886,0.00030055045,0.00013219933,0.000108742606,0.00014463795,0.0001257889,0.00017036292,0.0018115737],"category_scores_gemma":[0.00044783484,0.00004587896,0.00015061967,0.00014892437,0.00012424609,0.000178306,0.00016813012,0.00031655972,0.00033333534],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016044194,0.0020171818,0.011403145,0.0013210023,0.00024172684,0.0024554932,0.00024261118,0.0008376286,0.06792301,0.0006896482,0.0029565957,0.8938678],"study_design_scores_gemma":[0.016385976,0.14501126,0.34073168,0.0014534119,0.0011597637,0.046226453,0.0004822223,0.0059458404,0.12754704,0.0027253395,0.31220144,0.00012950819],"about_ca_topic_score_codex":0.00025693513,"about_ca_topic_score_gemma":0.0006316777,"teacher_disagreement_score":0.0018115737,"about_ca_system_score_codex":0.00022043499,"about_ca_system_score_gemma":0.00019891647,"threshold_uncertainty_score":0.0060603023},"labels":[],"label_agreement":null},{"id":"W2581392984","doi":"10.1111/jpi.12393","title":"Melatonin prevents mitochondrial dysfunction and promotes neuroprotection by inducing autophagy during oxaliplatin‐evoked peripheral neuropathy","year":2017,"lang":"en","type":"article","venue":"Journal of Pineal Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Medical Association; University of Alberta","funders":"University of Manchester","keywords":"Oxaliplatin; Melatonin; Neuroprotection; Neurotoxicity; Peripheral neuropathy; Pharmacology; Oxidative stress; Medicine; Autophagy; Endocrinology; Internal medicine; Apoptosis; Chemistry; Colorectal cancer; Cancer; Toxicity; Biochemistry","score_opus":0.058519359179111004,"score_gpt":0.4010384903521212,"score_spread":0.3425191311730102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581392984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929073,0.00465538,0.0012357605,0.000119166354,0.00008363253,0.000049028677,0.00012613127,0.00007835374,0.00074523804],"genre_scores_gemma":[0.9958834,0.002255452,0.00066515186,0.000054946413,0.000020205869,0.000056967216,0.00012327424,0.0000064783303,0.0009340671],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999448,0.000007779266,0.000009954759,0.000008012861,0.000009127599,0.00002015809],"domain_scores_gemma":[0.9999716,0.0000017288504,0.000011011078,0.0000026622097,0.000004703363,0.000008345084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009539254,0.00027700886,0.00037564966,0.00026416255,0.00017440192,0.0001463153,0.00018615583,0.00025832222,0.00046943358],"category_scores_gemma":[0.00007596935,0.00010927388,0.00027647984,0.00015788156,0.00016008416,0.00023024337,0.00013003864,0.00049872696,0.00010063854],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019942375,0.0002565255,0.0003807448,0.00026731347,0.000022453545,0.00017460402,0.000043670578,0.00011588143,0.99065745,0.000117572796,0.00015164871,0.005817812],"study_design_scores_gemma":[0.0004518555,0.0060130307,0.020776996,0.000048914415,0.0001318668,0.00043647608,0.000102459955,0.0016008796,0.96668774,0.00021008604,0.00352257,0.000017179107],"about_ca_topic_score_codex":0.00090523995,"about_ca_topic_score_gemma":0.001639521,"teacher_disagreement_score":0.00090523995,"about_ca_system_score_codex":0.00023560844,"about_ca_system_score_gemma":0.00026655232,"threshold_uncertainty_score":0.0017998815},"labels":[],"label_agreement":null},{"id":"W2581498950","doi":"10.2147/bctt.s124646","title":"Docetaxel-associated myalgia&amp;ndash;arthralgia syndrome in patients with breast cancer","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Targets and Therapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Sault Area Hospital","funders":"","keywords":"Docetaxel; Medicine; myalgia; Internal medicine; Breast cancer; Adverse effect; Cancer; Oncology","score_opus":0.013863670213873771,"score_gpt":0.2923748236786982,"score_spread":0.27851115346482447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581498950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963282,0.0022339525,0.00009111649,0.00009833277,0.000013580272,0.000021351996,0.00013152683,0.000005421011,0.0010765101],"genre_scores_gemma":[0.9991246,0.00053392973,0.00007737338,0.00005391491,0.000028197781,0.000008197497,0.000092469134,5.8708105e-7,0.000080798665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981827,0.00003688614,0.000028695085,0.00002794442,0.000040151448,0.000048010425],"domain_scores_gemma":[0.99945456,0.00013126408,0.00028484841,0.000014381652,0.000031455464,0.00008343749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001995525,0.00021283742,0.00030778884,0.0005562588,0.0003908283,0.00027827788,0.00015948221,0.00028811352,0.0014037096],"category_scores_gemma":[0.0012970954,0.00013061191,0.00016467652,0.00078301784,0.00022802917,0.00022694663,0.00020900024,0.00025371552,0.00020175666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117426134,0.000034040633,0.98961604,0.00004062328,0.000015489086,0.0060086898,0.00006179866,0.000028485309,0.0004900879,0.000021845632,0.00020384081,0.003361544],"study_design_scores_gemma":[0.000033127308,0.0003440053,0.9406525,0.000042336942,0.000042226136,0.05739323,0.00028278446,0.0001911732,0.00018510949,0.000065405235,0.0007615677,0.0000064693286],"about_ca_topic_score_codex":0.00077152625,"about_ca_topic_score_gemma":0.0013391855,"teacher_disagreement_score":0.0014037096,"about_ca_system_score_codex":0.00017742494,"about_ca_system_score_gemma":0.00030232215,"threshold_uncertainty_score":0.0046958923},"labels":[],"label_agreement":null},{"id":"W2583561389","doi":"10.1016/s0167-8140(15)41173-9","title":"EP-1181: SBRT in oligometastatic/oligorecurrent NSCLC cancer patients: a new therapeutic approach","year":2015,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Oncology; Internal medicine","score_opus":0.06233108121761415,"score_gpt":0.38355184787345803,"score_spread":0.32122076665584387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583561389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.682801,0.24836385,0.008060021,0.008905042,0.0015647634,0.00048014408,0.0009489163,0.00031773592,0.048558455],"genre_scores_gemma":[0.8785858,0.09337644,0.008522755,0.0024374954,0.00097295415,0.00028205512,0.0012548623,0.00008128061,0.014486368],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9999299,0.000015550166,0.000006710416,0.000014962478,0.000012605884,0.000020266622],"domain_scores_gemma":[0.9999472,0.000010771583,0.00001042573,0.0000048332718,0.000011175579,0.000015587582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002911951,0.00029105437,0.00066171325,0.00030857715,0.00017321597,0.0005935285,0.0004945653,0.00043641802,0.0050672605],"category_scores_gemma":[0.00022753877,0.00012598216,0.00049018057,0.00033245274,0.00018665899,0.0005872916,0.00037743078,0.0011760646,0.00080556184],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071103405,0.0015977394,0.0058669294,0.0013575462,0.0002139135,0.00087391026,0.00009069493,0.0007557684,0.059360757,0.0036503414,0.008059074,0.9110629],"study_design_scores_gemma":[0.016543187,0.09500257,0.14164267,0.0022432148,0.0040848157,0.025239047,0.000756997,0.01409439,0.11848704,0.012655859,0.5689538,0.00029643546],"about_ca_topic_score_codex":0.0004940941,"about_ca_topic_score_gemma":0.0015797993,"teacher_disagreement_score":0.0050672605,"about_ca_system_score_codex":0.00038373636,"about_ca_system_score_gemma":0.0006228633,"threshold_uncertainty_score":0.01695168},"labels":[],"label_agreement":null},{"id":"W2585196464","doi":"10.1016/j.jchromb.2016.12.015","title":"Simultaneous quantification of reparixin and paclitaxel in plasma and urine using ultra performance liquid chromatography-tandem mass spectroscopy (UHPLC–MS/MS): Application to a preclinical pharmacokinetic study in rats","year":2017,"lang":"en","type":"article","venue":"Journal of Chromatography B","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Chemistry; Chromatography; Protein precipitation; Tandem mass spectrometry; Formic acid; Electrospray ionization; Selected reaction monitoring; Mass spectrometry; Sample preparation; Pharmacokinetics; Atmospheric-pressure chemical ionization; Electrospray; Liquid chromatography–mass spectrometry; High-performance liquid chromatography; Chemical ionization; Ionization; Ion; Pharmacology","score_opus":0.03125546455160806,"score_gpt":0.37509444058503233,"score_spread":0.3438389760334243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585196464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9441139,0.0038195716,0.047320448,0.00037667216,0.000117967975,0.000336021,0.0009900122,0.0012128864,0.0017125087],"genre_scores_gemma":[0.9349915,0.0033180106,0.054975238,0.00033695032,0.000067951776,0.00041194502,0.0006708161,0.00016010214,0.005067552],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995634,0.00009908864,0.000027716658,0.00013440565,0.00013224492,0.000043068932],"domain_scores_gemma":[0.9996649,0.000050299383,0.000113295,0.000043274526,0.000084427265,0.000043815875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006275369,0.0005840843,0.0005194192,0.0006427581,0.00043835054,0.00048433634,0.00033004102,0.00066327624,0.00081435655],"category_scores_gemma":[0.0006204265,0.00039846482,0.00039884355,0.00046486888,0.00045793428,0.0006850446,0.00027199613,0.00072633417,0.0004483203],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010467075,0.00015494884,0.00088473083,0.00006359015,0.00005526473,0.000055234905,0.00003552547,0.00022667248,0.9798876,0.00008425957,0.00011564288,0.017389847],"study_design_scores_gemma":[0.000041784795,0.0014020951,0.0041038063,0.000005679088,0.00009642474,0.0003511454,0.000020554206,0.0015349634,0.99113727,0.00005717201,0.0012295005,0.000019648249],"about_ca_topic_score_codex":0.0009948361,"about_ca_topic_score_gemma":0.0017051575,"teacher_disagreement_score":0.0009948361,"about_ca_system_score_codex":0.0004015233,"about_ca_system_score_gemma":0.0010227395,"threshold_uncertainty_score":0.003318727},"labels":[],"label_agreement":null},{"id":"W2586820597","doi":"10.1007/s11240-017-1175-x","title":"Erratum to: Taxol from Corylus avellana: paving the way for a new source of this anti-cancer drug","year":2017,"lang":"en","type":"erratum","venue":"Plant Cell Tissue and Organ Culture (PCTOC)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Drug; Biology; Pharmacology","score_opus":0.02112164512727339,"score_gpt":0.29121745295243834,"score_spread":0.27009580782516496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586820597","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048801745,0.004625617,0.00041312844,0.06510689,0.9262063,0.000032769578,0.00046779134,0.00011872721,0.0025408308],"genre_scores_gemma":[0.018087082,0.05212279,0.006092285,0.22121857,0.36061206,0.00016595003,0.0033183105,0.00074095774,0.33764213],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988174,0.00012899695,0.00028868183,0.0001268939,0.00052726286,0.00011074915],"domain_scores_gemma":[0.99408287,0.0016744874,0.0006213446,0.00029097646,0.0028988004,0.00043152864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013646933,0.0015918238,0.0014718504,0.0020542236,0.0019199224,0.0016653572,0.0016186568,0.006059509,0.013045572],"category_scores_gemma":[0.009243195,0.0009086961,0.0010768074,0.0014050545,0.0016116819,0.002028438,0.0011268815,0.00692219,0.015432534],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001077793,0.000033866974,0.00016393868,0.00027002048,0.000017303151,0.0014308024,0.000031267664,0.00007625747,0.00033122618,0.0006324322,0.98323417,0.013670877],"study_design_scores_gemma":[0.000032704993,0.00005486006,0.0006085246,0.00019454994,0.000044546327,0.0011247045,0.00009120312,0.000123409,0.0008612733,0.0005173882,0.99631727,0.000029468945],"about_ca_topic_score_codex":0.008347221,"about_ca_topic_score_gemma":0.012682634,"teacher_disagreement_score":0.013045572,"about_ca_system_score_codex":0.0025648433,"about_ca_system_score_gemma":0.0038519315,"threshold_uncertainty_score":0.043641806},"labels":[],"label_agreement":null},{"id":"W2586986791","doi":"10.1200/jco.2012.30.30_suppl.87","title":"Biopsy-driven study to identify biomarkers of drug resistance in patients with triple-negative breast cancer.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quebec - Clinical Research Organization in Cancer; Hôtel-Dieu de Montréal; Hôpital du Saint-Sacrement; Hôpital du Sacré-Cœur de Montréal; Royal Victoria Hospital; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Breast cancer; Triple-negative breast cancer; Chemotherapy; Drug resistance; Liquid biopsy; Oncology; Paclitaxel; Biopsy; Internal medicine; Cancer; Cancer research; Pathology; Biology","score_opus":0.07309021360902741,"score_gpt":0.4978080930385941,"score_spread":0.4247178794295667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586986791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99553597,0.00072779966,0.0007962722,0.00006638772,0.000020858013,0.00033351762,0.0011172586,0.000026828797,0.0013750708],"genre_scores_gemma":[0.9920723,0.00044663667,0.0023724507,0.0002400644,0.000026638587,0.0002982204,0.0032412065,0.000013859644,0.0012887103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997677,0.00004994132,0.00001700317,0.00006511228,0.000069977905,0.000030187211],"domain_scores_gemma":[0.9996264,0.00004634272,0.00007086282,0.000026537924,0.00013196626,0.00009783863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004830486,0.000279261,0.000361784,0.00046586563,0.0002839548,0.00047786318,0.0002291479,0.00045027887,0.002098083],"category_scores_gemma":[0.0006913949,0.00018252648,0.00023049682,0.0003739642,0.00015374142,0.00018935543,0.00026537068,0.00031516666,0.00071913813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005529017,0.0011934104,0.8149374,0.0002737533,0.00017404753,0.0020780314,0.00029632048,0.0003170214,0.14614353,0.00011636313,0.001641426,0.027299734],"study_design_scores_gemma":[0.00017513544,0.004871457,0.9613927,0.00003479556,0.00016978514,0.0068128095,0.00039547897,0.0013085054,0.01965845,0.000070079266,0.005095065,0.000015702804],"about_ca_topic_score_codex":0.0011082138,"about_ca_topic_score_gemma":0.0017067371,"teacher_disagreement_score":0.002098083,"about_ca_system_score_codex":0.00025989686,"about_ca_system_score_gemma":0.0002979292,"threshold_uncertainty_score":0.0070188046},"labels":[],"label_agreement":null},{"id":"W2588199706","doi":"10.1093/annonc/mdw390.28","title":"A multi-centre study to investigate the natural history of taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast or prostate cancer","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Taxane; Discontinuation; Prostate cancer; Breast cancer; myalgia; Chemotherapy; Internal medicine; Brief Pain Inventory; Cancer; Oncology; Physical therapy; Chronic pain","score_opus":0.059749570670552574,"score_gpt":0.37985821728456703,"score_spread":0.32010864661401445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588199706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994931,0.000099258716,0.0000536063,0.000023389643,0.0000054676134,0.000037643367,0.00014254921,0.0000013242708,0.0001437137],"genre_scores_gemma":[0.9991103,0.00008268731,0.00014269071,0.000091241,0.000022730119,0.00005098154,0.00032085425,0.000001978087,0.0001764955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994271,0.00021000204,0.000064518004,0.00013760742,0.0000579913,0.00010278493],"domain_scores_gemma":[0.99793756,0.0003712831,0.00079501333,0.00014104196,0.00017335838,0.00058182335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064441666,0.00039887053,0.000612879,0.00062176667,0.0011684257,0.0010257312,0.00043624456,0.00074982253,0.0023302843],"category_scores_gemma":[0.0023775173,0.0005141919,0.00092143496,0.0010434258,0.0005401604,0.0010059098,0.00071773253,0.0010879086,0.00040701788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012682782,0.00054360286,0.99603254,0.00002706478,0.00014724559,0.00024597225,0.0002833114,0.000023466886,0.0005456964,0.000018193581,0.00007595357,0.0007887448],"study_design_scores_gemma":[0.00026340294,0.0028122263,0.99500436,0.00001131359,0.00011228283,0.0006322023,0.0006941259,0.00014001102,0.00006669549,0.000024490222,0.00022359772,0.00001527417],"about_ca_topic_score_codex":0.0059173377,"about_ca_topic_score_gemma":0.008549502,"teacher_disagreement_score":0.0059173377,"about_ca_system_score_codex":0.00074275135,"about_ca_system_score_gemma":0.00089383946,"threshold_uncertainty_score":0.011765778},"labels":[],"label_agreement":null},{"id":"W2588218255","doi":"10.1093/neuonc/now212.478","title":"MPTH-41. MGMT STATUS PREDICTS SURVIVAL OUTCOMES IN NRG ONCOLOGY/RTOG 0424: A PHASE II TRIAL OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY FOR HIGH RISK LOW-GRADE GLIOMAS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Princess Margaret Cancer Centre; University Health Network; London Health Sciences Centre; Western University","funders":"","keywords":"Temozolomide; Oncology; Glioma; Internal medicine; Medicine; Chemoradiotherapy; Hazard ratio; Methyltransferase; Methylation; Proportional hazards model; Biomarker; Radiation therapy; Oligodendroglioma; O-6-methylguanine-DNA methyltransferase; Astrocytoma; Cancer research; Biology; Confidence interval; Gene","score_opus":0.03660164644227795,"score_gpt":0.3806421536693743,"score_spread":0.34404050722709634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588218255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99851054,0.00075144647,0.00007934275,0.000091961985,0.000014437199,0.00011025667,0.00020971184,0.000020617887,0.00021171692],"genre_scores_gemma":[0.9966402,0.0005016372,0.00051770004,0.00013007739,0.000040075152,0.0002518684,0.00076829543,0.000014337873,0.00113582],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995859,0.0002665092,0.000013003027,0.0000456264,0.000041669882,0.00004725105],"domain_scores_gemma":[0.99960226,0.000060138867,0.00014215437,0.000031369964,0.000017352431,0.00014670544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014717004,0.0008025209,0.0009766374,0.00030214095,0.00013828915,0.000609854,0.0005195658,0.00045858274,0.0014745003],"category_scores_gemma":[0.0009244278,0.0002852918,0.0006988325,0.00029309886,0.0003213808,0.00026780102,0.0002725818,0.0009813309,0.0004255106],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5594775,0.02115772,0.14927006,0.0007154801,0.0027360658,0.00026509765,0.0002754766,0.006066599,0.059347276,0.00014113671,0.0038483744,0.19669919],"study_design_scores_gemma":[0.1348888,0.4180544,0.41205534,0.00007151961,0.0025906365,0.00075738743,0.0001543448,0.009092611,0.013580451,0.000383637,0.008284358,0.00008635818],"about_ca_topic_score_codex":0.00084523536,"about_ca_topic_score_gemma":0.0025715246,"teacher_disagreement_score":0.0014745003,"about_ca_system_score_codex":0.0005732395,"about_ca_system_score_gemma":0.0008106952,"threshold_uncertainty_score":0.0077831745},"labels":[],"label_agreement":null},{"id":"W258852898","doi":"","title":"[New regimens for the treatment of gynecologic cancers].","year":2000,"lang":"en","type":"article","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Carboplatin; Medicine; Regimen; Oncology; Internal medicine; Paclitaxel; Gynecologic oncology; Cisplatin; Chemotherapy; Ovarian cancer; Clinical trial; Cyclophosphamide; Cervical cancer; Cancer","score_opus":0.04817056156020977,"score_gpt":0.3049125849131081,"score_spread":0.2567420233528983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W258852898","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00807054,0.4570217,0.00829738,0.021217534,0.023139812,0.0024925137,0.010066672,0.0014699381,0.46822393],"genre_scores_gemma":[0.040214356,0.34347653,0.035447836,0.054800168,0.0062842257,0.0030771059,0.023834001,0.00030304905,0.49256265],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998332,0.000032124823,0.0000145463255,0.000026083297,0.000074998956,0.000019033838],"domain_scores_gemma":[0.99985373,0.000013778155,0.000025544734,0.00001994808,0.000055414774,0.0000315612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000275091,0.00054626004,0.00046181402,0.0009603309,0.00040041882,0.0005593632,0.0008672713,0.0007748315,0.038046267],"category_scores_gemma":[0.00045661026,0.00017403648,0.00046836046,0.0008753659,0.0002516235,0.00073190575,0.0007252016,0.0027303111,0.030542335],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024898443,0.00025058808,0.00024804307,0.0008108588,0.000039007376,0.0002472455,0.000034966586,0.0000869441,0.0025694403,0.0043223826,0.23582494,0.7553166],"study_design_scores_gemma":[0.00018825012,0.00014616945,0.000787933,0.00012829821,0.000017205704,0.0005858733,0.0000068972404,0.000037909365,0.00026105772,0.0010036192,0.99683005,0.0000066387065],"about_ca_topic_score_codex":0.0013723093,"about_ca_topic_score_gemma":0.006128117,"teacher_disagreement_score":0.038046267,"about_ca_system_score_codex":0.000400015,"about_ca_system_score_gemma":0.00073022983,"threshold_uncertainty_score":0.12727743},"labels":[],"label_agreement":null},{"id":"W2588844395","doi":"10.1158/1538-7445.sabcs16-pd4-04","title":"Abstract PD4-04: Effectiveness of myofascial techniques in addition to a standard physical therapy program as postoperative intervention for upper limb pain in breast cancer patients: A randomized controlled trial","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Randomized controlled trial; Breast cancer; Physical therapy; Blinding; Visual analogue scale; Placebo; Surgery; Cancer; Internal medicine","score_opus":0.03877268631580662,"score_gpt":0.492489072785143,"score_spread":0.4537163864693364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588844395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97129446,0.008968119,0.00088057667,0.0007201431,0.0015132459,0.013177725,0.0015573318,0.0002581812,0.0016303399],"genre_scores_gemma":[0.9528243,0.0054050083,0.0043134918,0.0011623986,0.0020225018,0.029217292,0.0012878727,0.00003615471,0.0037309497],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99657404,0.0019794747,0.0004046183,0.00045530504,0.00027764993,0.00030890634],"domain_scores_gemma":[0.9968989,0.0011708842,0.00073518936,0.000245095,0.00027639756,0.000673628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035927678,0.0024857798,0.0066629956,0.0015987935,0.0009345582,0.0017266357,0.002476426,0.004270626,0.013039709],"category_scores_gemma":[0.0049667135,0.0014002962,0.0038096318,0.0012268036,0.0020067808,0.0016131295,0.0009693321,0.0038893912,0.0014196708],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9873121,0.006518481,0.00019495677,0.00081199576,0.00067902816,0.000015407435,0.000013777709,0.000066183406,0.0003980275,0.000024440433,0.00014595072,0.0038196815],"study_design_scores_gemma":[0.95956135,0.039245192,0.0004309912,0.000031522457,0.00038895043,0.0000069613266,0.000008085569,0.000095750525,0.00010417706,0.000023513643,0.00009728723,0.0000062644385],"about_ca_topic_score_codex":0.0015947449,"about_ca_topic_score_gemma":0.0017260286,"teacher_disagreement_score":0.013039709,"about_ca_system_score_codex":0.0013762075,"about_ca_system_score_gemma":0.002494775,"threshold_uncertainty_score":0.043622196},"labels":[],"label_agreement":null},{"id":"W2589081531","doi":"","title":"In vitro combination studies of Troxacitabine (Troxatyl™, SGX-145) against human tumor cell lines.","year":2006,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clonogenic assay; Doxorubicin; Antagonism; Paclitaxel; Pharmacology; Cancer; Combination therapy; Medicine; Breast cancer; Cancer cell; Bone cancer; Cancer research; Bone metastasis; Metastasis; Chemotherapy; In vitro; Chemistry; Internal medicine; Receptor; Biochemistry","score_opus":0.02556507897193268,"score_gpt":0.34218975713007155,"score_spread":0.3166246781581389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589081531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9605917,0.024605587,0.003643985,0.00034957926,0.00043511152,0.00042372514,0.0024154657,0.00017488374,0.0073598307],"genre_scores_gemma":[0.9691186,0.0118415,0.007582117,0.0001718471,0.00010777963,0.00036940217,0.003580348,0.000037506998,0.0071909092],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99947184,0.00015486055,0.000060632585,0.00009168282,0.00015614422,0.00006482285],"domain_scores_gemma":[0.999798,0.0000525478,0.00003102364,0.000026159352,0.000053989286,0.00003831153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006043291,0.0006257366,0.0011293767,0.00050628086,0.0002615494,0.00041481148,0.0003727631,0.00038533777,0.0018872962],"category_scores_gemma":[0.0001996779,0.00027322394,0.0005826853,0.00064078614,0.00015199288,0.00026907353,0.00023145281,0.00068343105,0.00062808953],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010309032,0.0010831101,0.0009075289,0.00054330874,0.00009367586,0.00017331193,0.0001783752,0.00089376105,0.98247993,0.00021110079,0.0010112112,0.011393765],"study_design_scores_gemma":[0.00020123422,0.014653231,0.009208013,0.000037782927,0.0002266327,0.00064583943,0.00011028649,0.0023254864,0.95995206,0.00004705431,0.0125672,0.00002534483],"about_ca_topic_score_codex":0.0026031495,"about_ca_topic_score_gemma":0.004538048,"teacher_disagreement_score":0.0026031495,"about_ca_system_score_codex":0.00037645228,"about_ca_system_score_gemma":0.00045116115,"threshold_uncertainty_score":0.006313622},"labels":[],"label_agreement":null},{"id":"W2589189560","doi":"10.1200/jco.2013.31.15_suppl.e14715","title":"Efficacy and safety of single agent (SA) or combination (CO) adjuvant chemotherapy (AC) in elderly patients with colon cancer: A Canadian Cancer Institute experience.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Discontinuation; Cancer; Internal medicine; Colorectal cancer; Toxicity; Surgery","score_opus":0.10120572763960713,"score_gpt":0.457852425946238,"score_spread":0.35664669830663087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589189560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98139405,0.01156133,0.0001335355,0.0007799467,0.000018451208,0.00014722144,0.001029223,0.0000139268395,0.0049222885],"genre_scores_gemma":[0.9925648,0.0052768025,0.00048572102,0.00028648507,0.000036935533,0.000029784322,0.0008330209,0.0000069517187,0.00047951375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924314,0.00015309316,0.000049800998,0.00006213885,0.00036972063,0.000122059544],"domain_scores_gemma":[0.9975305,0.00042101197,0.0006096621,0.00006583961,0.00087229256,0.00050074235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019331061,0.00017327396,0.00040395086,0.00046466905,0.00078409415,0.00056888786,0.00046223795,0.00024507934,0.0007866619],"category_scores_gemma":[0.0046874853,0.00012193182,0.00035942948,0.0016487389,0.00035106775,0.00021176941,0.000293749,0.000363761,0.00011529902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004922598,0.0005917425,0.87496644,0.00044105022,0.00020178215,0.00031266673,0.0012220467,0.000661445,0.0019466247,0.000114847404,0.0041292207,0.11048964],"study_design_scores_gemma":[0.00027400165,0.0027627423,0.9897967,0.00009704281,0.00019895872,0.00039447137,0.0003767137,0.00049394014,0.00038448072,0.000025361234,0.0051784846,0.000017064165],"about_ca_topic_score_codex":0.7224096,"about_ca_topic_score_gemma":0.81532204,"teacher_disagreement_score":0.7224096,"about_ca_system_score_codex":0.014343689,"about_ca_system_score_gemma":0.012480152,"threshold_uncertainty_score":0.55845034},"labels":[],"label_agreement":null},{"id":"W2589370503","doi":"10.1200/jco.2014.32.4_suppl.222","title":"Pain palliation as an oncology label indication: Lessons learned in custirsen phase III development.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Medicine; Docetaxel; Taxane; Placebo; Cabazitaxel; Internal medicine; Prostate cancer; Regimen; Oncology; Phases of clinical research; Surgery; Clinical trial; Cancer; Breast cancer; Androgen deprivation therapy","score_opus":0.31248239554376095,"score_gpt":0.599375163075988,"score_spread":0.2868927675322271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589370503","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34095892,0.34542048,0.05433221,0.12783171,0.005318804,0.014004101,0.0069165663,0.0016315713,0.103585616],"genre_scores_gemma":[0.56508017,0.1995927,0.13126749,0.05435079,0.002750778,0.009809557,0.009633627,0.0011708837,0.026344026],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997297,0.0015303722,0.000204889,0.00017006771,0.00057782006,0.0002199329],"domain_scores_gemma":[0.9952341,0.0019407433,0.0007031867,0.00029588456,0.00088791404,0.00093818014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021249464,0.0006492371,0.0009853429,0.00045244716,0.0003214847,0.0024366074,0.0016291583,0.001580125,0.005913664],"category_scores_gemma":[0.010867146,0.00042155178,0.0011707201,0.0006186423,0.0011061439,0.0013839001,0.0007469342,0.0046417797,0.0013362896],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011877739,0.0028539484,0.0041620852,0.001916385,0.00034351973,0.0002733674,0.000468798,0.002376148,0.008419868,0.0062092263,0.035395034,0.9257039],"study_design_scores_gemma":[0.06943966,0.11948021,0.024495164,0.0082641225,0.0016081803,0.0021759756,0.0006270047,0.009827713,0.014596034,0.019689158,0.72955126,0.00024558775],"about_ca_topic_score_codex":0.0014497297,"about_ca_topic_score_gemma":0.005266767,"teacher_disagreement_score":0.021249464,"about_ca_system_score_codex":0.0010703717,"about_ca_system_score_gemma":0.004346146,"threshold_uncertainty_score":0.11237919},"labels":[],"label_agreement":null},{"id":"W2589549609","doi":"10.1200/jco.2005.23.16_suppl.695","title":"Phase I-II study of DalCM-P [daily dalteparin (Dal), cyclophosphamide (C) and prednisone (P) and bi-weekly methotrexate (M)] as therapy for metastatic breast cancer (MBC)","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Metastatic breast cancer; Internal medicine; Chemotherapy; Cyclophosphamide; Gastroenterology; Regimen; Breast cancer; Chemotherapy regimen; Progression-free survival; Phases of clinical research; Cancer; Surgery","score_opus":0.15506704465995005,"score_gpt":0.5456303374866971,"score_spread":0.39056329282674707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589549609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98617274,0.0012329567,0.00091058953,0.00064356317,0.0001630809,0.007583183,0.0013019986,0.00011908382,0.001872922],"genre_scores_gemma":[0.97434026,0.0012382413,0.0035130542,0.0013983203,0.00023790279,0.009942734,0.003580321,0.00004158754,0.0057075163],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99940753,0.0002795803,0.000024591796,0.00009742731,0.00005179075,0.0001390995],"domain_scores_gemma":[0.99888355,0.00015234436,0.00018147325,0.000109712775,0.000057616307,0.00061524956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018268549,0.0025708985,0.0023455245,0.00079314696,0.0005301251,0.00092875597,0.0014130769,0.0017134848,0.0053531565],"category_scores_gemma":[0.0012920905,0.001106047,0.0010675056,0.0005167779,0.001347866,0.0011509126,0.0005485736,0.0033657071,0.0014025959],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7409186,0.16605805,0.004464613,0.0004735684,0.0004357091,0.00025800648,0.0002637671,0.0023606902,0.039267093,0.00033161292,0.0030012506,0.042167164],"study_design_scores_gemma":[0.53567755,0.4520773,0.0049909065,0.000016466693,0.00014858815,0.0002131673,0.000043515476,0.00084090885,0.00365076,0.00019993231,0.0021175111,0.000023412773],"about_ca_topic_score_codex":0.00088868174,"about_ca_topic_score_gemma":0.0016406017,"teacher_disagreement_score":0.0053531565,"about_ca_system_score_codex":0.001037176,"about_ca_system_score_gemma":0.0018737644,"threshold_uncertainty_score":0.017908096},"labels":[],"label_agreement":null},{"id":"W2589567505","doi":"10.1200/jco.2014.32.31_suppl.190","title":"The McGill University Health Centre interdisciplinary approach to cancer pain management: Description of treatments and outcomes.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Palliative care; Medical prescription; Opioid; Psychosocial; Brief Pain Inventory; Cancer pain; Morphine; McGill Pain Questionnaire; Cancer; Internal medicine; Physical therapy; Chronic pain; Visual analogue scale; Nursing; Psychiatry","score_opus":0.12629462847540376,"score_gpt":0.47474995244364865,"score_spread":0.34845532396824486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589567505","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23483956,0.42404103,0.016069844,0.034873,0.003340945,0.014938754,0.06585009,0.001705493,0.20434122],"genre_scores_gemma":[0.66427666,0.13788345,0.074330784,0.009789911,0.0018965692,0.014153179,0.03916958,0.0005613208,0.057938594],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99810433,0.00069606706,0.00023054014,0.00013011004,0.0005335453,0.00030536074],"domain_scores_gemma":[0.99702805,0.00037517896,0.0006622382,0.00007810253,0.0008844452,0.0009719929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022791072,0.0006798763,0.00054153835,0.0044622775,0.0006518432,0.0011060344,0.0008871065,0.00047704173,0.011434638],"category_scores_gemma":[0.005034589,0.00028211903,0.0005867374,0.007614685,0.00035745781,0.00078159245,0.001584271,0.0005637973,0.0012444289],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068277,0.00045029158,0.108975954,0.0035321873,0.0001704649,0.00045979812,0.00083304266,0.0008557988,0.0008243226,0.0017537891,0.20562619,0.6758354],"study_design_scores_gemma":[0.00043662635,0.0016815899,0.78180814,0.005168705,0.00020361572,0.0027470659,0.0018167745,0.0013507162,0.0004356568,0.0009367779,0.2032633,0.00015098456],"about_ca_topic_score_codex":0.044202168,"about_ca_topic_score_gemma":0.105287954,"teacher_disagreement_score":0.044202168,"about_ca_system_score_codex":0.007210768,"about_ca_system_score_gemma":0.0081460215,"threshold_uncertainty_score":0.08788979},"labels":[],"label_agreement":null},{"id":"W2589748065","doi":"10.1200/jco.2012.30.34_suppl.249","title":"Quality of systemic cancer therapy in routine care: What are we measuring?","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cancer; Population; MEDLINE; Clinical trial; Family medicine; Internal medicine; Cancer registry; Breast cancer; Intensive care medicine; Oncology","score_opus":0.4384824179354035,"score_gpt":0.5850279326458419,"score_spread":0.14654551471043836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589748065","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031003756,0.9400509,0.0033488907,0.018778272,0.00092182937,0.0007352521,0.0017692195,0.000040081566,0.0033517743],"genre_scores_gemma":[0.44347504,0.53182507,0.014083056,0.0054982184,0.0013111779,0.0020185106,0.0015740565,0.000037877984,0.00017698729],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8858844,0.05918876,0.031516396,0.00378976,0.018295268,0.0013253756],"domain_scores_gemma":[0.5291109,0.32848033,0.08212693,0.0076772403,0.04910389,0.0035007927],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.13079372,0.0010792383,0.00704293,0.013286698,0.001046015,0.009653389,0.003461109,0.0024403203,0.0023451687],"category_scores_gemma":[0.3563771,0.0012939452,0.0064017223,0.024876492,0.003426888,0.014067409,0.0025909904,0.0022249848,0.0003145738],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007477074,0.00018287858,0.2182787,0.29252043,0.014958698,0.00011646163,0.005508687,0.0011049998,0.00020822544,0.0036515244,0.008628921,0.45409265],"study_design_scores_gemma":[0.0007499757,0.0016745005,0.31866089,0.5977154,0.020436116,0.0005471624,0.010712694,0.002491397,0.00073695974,0.009722013,0.036163434,0.00038952654],"about_ca_topic_score_codex":0.013326545,"about_ca_topic_score_gemma":0.01705868,"teacher_disagreement_score":0.8692063,"about_ca_system_score_codex":0.010184654,"about_ca_system_score_gemma":0.015911594,"threshold_uncertainty_score":0.69171154},"labels":[],"label_agreement":null},{"id":"W2590030891","doi":"10.1200/jco.2015.33.29_suppl.182","title":"The Opioid Rotation Ratio (ORR) from transdermal fentanyl (TDF) to strong opioids in cancer patients.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Fentanyl; Opioid; Cancer pain; Cancer; Transdermal; Morphine; Anesthesia; Internal medicine; Pharmacology","score_opus":0.17791441831879826,"score_gpt":0.5153400393633385,"score_spread":0.3374256210445402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590030891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997498,0.0014921527,0.00012657265,0.00005278809,0.0000070642004,0.000031334122,0.0004482253,0.000004337443,0.00033965515],"genre_scores_gemma":[0.9990779,0.00028524658,0.0001958522,0.000037091344,0.000010453237,0.000018787445,0.00032390622,0.0000017635466,0.00004896739],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984767,0.0005618327,0.00030204334,0.0001888627,0.00035830858,0.000112261514],"domain_scores_gemma":[0.99032295,0.0035160906,0.005333907,0.00018330218,0.00037597338,0.00026771575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019559844,0.00019230138,0.0004021069,0.0007900614,0.0001766636,0.00046602442,0.00031509035,0.00022005994,0.0011215433],"category_scores_gemma":[0.007754139,0.00014622674,0.0006165372,0.00094712886,0.00023594158,0.00034172073,0.00035157247,0.0004181803,0.00018405008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039909667,0.000018188905,0.9953056,0.00005762078,0.00007125701,0.000077054836,0.000031915035,0.00005687555,0.0001232556,0.0000076887145,0.00008707334,0.0037643337],"study_design_scores_gemma":[0.000024086405,0.00043769894,0.9978923,0.000014899002,0.000074738804,0.0008072207,0.00010349358,0.0002774205,0.00013380552,0.0000114802515,0.00021902047,0.000003781477],"about_ca_topic_score_codex":0.0010462701,"about_ca_topic_score_gemma":0.0017194066,"teacher_disagreement_score":0.0019559844,"about_ca_system_score_codex":0.00047974035,"about_ca_system_score_gemma":0.00034323471,"threshold_uncertainty_score":0.010344386},"labels":[],"label_agreement":null},{"id":"W2590234373","doi":"10.1200/jco.2014.32.3_suppl.429","title":"Are the cardiovascular side effects of bevacizumab caused by autonomic nervous system toxicity?","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Cancer Care South East; University of Manitoba; Queen's University","funders":"","keywords":"Medicine; Bevacizumab; Internal medicine; Adverse effect; Cardiology; Heart rate variability; Toxicity; Heart rate; Vascular endothelial growth factor; Aldosterone; Autonomic nervous system; Analysis of variance; Heart failure; Sinus rhythm; Plasma renin activity; Hormone; Blood pressure; Endocrinology; Renin–angiotensin system; Chemotherapy; VEGF receptors","score_opus":0.051790235838715636,"score_gpt":0.4022700080996506,"score_spread":0.35047977226093496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590234373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98686606,0.0066503696,0.002025286,0.00054175383,0.00010586394,0.0002755009,0.0001283124,0.00001948266,0.003387383],"genre_scores_gemma":[0.9961824,0.0018214429,0.0007002533,0.00041531192,0.00026099788,0.00011577403,0.00008787337,0.000003586011,0.00041229356],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99952793,0.0002480174,0.00004771216,0.000039243696,0.000096526084,0.00004062705],"domain_scores_gemma":[0.99802005,0.0010730983,0.00056263315,0.000100642894,0.00012539815,0.00011820162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008808185,0.00018668463,0.0005030828,0.00015032712,0.000120756566,0.00028910904,0.00015326354,0.0003685733,0.0028800017],"category_scores_gemma":[0.0026086683,0.000086043474,0.00030473468,0.0001344427,0.0003678232,0.00022927835,0.00010829929,0.0004026073,0.00020904288],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027827581,0.0026479308,0.41622183,0.0011342623,0.00061720435,0.0048619206,0.00021081991,0.00046722466,0.07572365,0.00038800354,0.0012127152,0.46868697],"study_design_scores_gemma":[0.0008422727,0.035077322,0.94217384,0.00016339758,0.00040021783,0.007543736,0.00013106757,0.0006254996,0.0096011255,0.00027214718,0.0031498806,0.000019478988],"about_ca_topic_score_codex":0.00013508793,"about_ca_topic_score_gemma":0.00037673448,"teacher_disagreement_score":0.0028800017,"about_ca_system_score_codex":0.00020130989,"about_ca_system_score_gemma":0.0002453896,"threshold_uncertainty_score":0.009634554},"labels":[],"label_agreement":null},{"id":"W2590373457","doi":"10.1200/jco.2016.34.4_suppl.601","title":"Oxaliplatin associated neurotoxicity outcomes among older adults with colorectal cancer: A population-based study.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Women's College Hospital; Queen's University; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"","keywords":"Oxaliplatin; Medicine; Hazard ratio; Internal medicine; Colorectal cancer; Cohort; Regimen; Cancer registry; Population; Incidence (geometry); Cancer; Surgery; Oncology; Confidence interval","score_opus":0.06502031611701335,"score_gpt":0.46263581986832353,"score_spread":0.39761550375131016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590373457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99734277,0.00034266067,0.000046844376,0.00004024843,0.000006131977,0.000038145787,0.0017310808,0.0000025658678,0.0004495448],"genre_scores_gemma":[0.99820936,0.0002443054,0.000048306523,0.00006638734,0.000009961164,0.00002972403,0.0011888925,0.0000012536142,0.00020178346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959844,0.000044709657,0.000045293666,0.00011646312,0.000106877145,0.00008823594],"domain_scores_gemma":[0.999238,0.000048541217,0.00035334012,0.00005239825,0.00013436357,0.00017337683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000472024,0.0003508526,0.0004642124,0.00069714594,0.0007211379,0.00080032536,0.0003990006,0.0005162644,0.00090987526],"category_scores_gemma":[0.0011395095,0.0004938179,0.0007172101,0.0018492804,0.0002568663,0.0004651605,0.000488284,0.000627163,0.00023090707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086904874,0.000033781187,0.99910223,0.000014676489,0.000070580354,0.000048111662,0.00007940348,0.00001604558,0.00007616956,0.000006220547,0.000101728525,0.00036417757],"study_design_scores_gemma":[0.000018926417,0.00007630897,0.99938464,0.000007659065,0.000053719054,0.00008149251,0.00013568613,0.000063445485,0.000008672164,0.0000067434166,0.00015949279,0.0000030521549],"about_ca_topic_score_codex":0.15217449,"about_ca_topic_score_gemma":0.21056221,"teacher_disagreement_score":0.15217449,"about_ca_system_score_codex":0.0012181638,"about_ca_system_score_gemma":0.0013254333,"threshold_uncertainty_score":0.30257744},"labels":[],"label_agreement":null},{"id":"W2590425344","doi":"10.1200/jco.2014.32.30_suppl.64","title":"Involving patients to improve their care through real-time patient reported outcome (PRO)-CTCAE chemotoxicity surveys in an outpatient chemodaycare (DC) setting: Evaluating patient acceptability.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Dysgeusia; Nausea; Feeling; Patient-reported outcome; Quality of life (healthcare); Family medicine; Constipation; Physical therapy; Vomiting; Nursing; Adverse effect; Surgery; Psychology; Internal medicine","score_opus":0.16592804291243962,"score_gpt":0.49369897234723903,"score_spread":0.3277709294347994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590425344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518496,0.0002457217,0.0008860816,0.0006377646,0.000018458342,0.0009850278,0.00026058045,0.000032956523,0.0017484736],"genre_scores_gemma":[0.99328655,0.0002780212,0.0042380984,0.00044882458,0.00003214013,0.0011326293,0.0002516793,0.0000075454013,0.0003244649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.983165,0.013758327,0.0010507904,0.00039425053,0.0012246547,0.0004069299],"domain_scores_gemma":[0.9681497,0.014300158,0.011305033,0.0013899026,0.0026335297,0.0022217631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016992038,0.0002795604,0.00040083207,0.00044072012,0.0005141797,0.0009945049,0.00040500468,0.00053057424,0.0022320568],"category_scores_gemma":[0.032917995,0.00022652096,0.0005767329,0.0004998661,0.00032002782,0.00067904574,0.0009902267,0.0006788821,0.00040164753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034421321,0.0041633463,0.8360914,0.00070425787,0.0002074038,0.00022490056,0.0055277306,0.00030453023,0.0024895198,0.00009999966,0.003333133,0.14341162],"study_design_scores_gemma":[0.00071190804,0.024657216,0.95922273,0.00020246042,0.0001567408,0.0005489355,0.0054128333,0.0015497773,0.0020353128,0.00010012888,0.005321663,0.000080359576],"about_ca_topic_score_codex":0.0011295285,"about_ca_topic_score_gemma":0.0023164141,"teacher_disagreement_score":0.016992038,"about_ca_system_score_codex":0.000698229,"about_ca_system_score_gemma":0.00111968,"threshold_uncertainty_score":0.08986354},"labels":[],"label_agreement":null},{"id":"W2590660749","doi":"10.1200/jco.2013.31.26_suppl.174","title":"Real-world analysis of eribulin in metastatic breast cancer (MBC): An assessment of time to treatment failure (TTF) in a community oncology setting.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Eribulin; Medicine; Metastatic breast cancer; Anthracycline; Discontinuation; Internal medicine; Oncology; Breast cancer; Toxicity; Cancer; Surgery","score_opus":0.11903135798488274,"score_gpt":0.5668154112911684,"score_spread":0.4477840533062857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590660749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972293,0.00043271927,0.0005973915,0.000071137285,0.0000068693794,0.000069327485,0.0011812791,0.000019903046,0.00039208075],"genre_scores_gemma":[0.99821484,0.00006508951,0.0005020234,0.00002580353,0.000008799452,0.00005090404,0.0010703802,0.0000039166525,0.00005820791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958081,0.0026751657,0.00030760103,0.0004526063,0.0005878263,0.00016869216],"domain_scores_gemma":[0.97678655,0.011171966,0.008304985,0.0012379254,0.0015074317,0.0009910832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007064026,0.00029828446,0.00046541932,0.0013571675,0.00024359536,0.00088870374,0.0005724707,0.0005847126,0.0010905832],"category_scores_gemma":[0.016369523,0.00017419635,0.0006433002,0.0011864167,0.00047158168,0.0007796353,0.0007303436,0.0005535563,0.0002695624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003632432,0.00054994423,0.9685591,0.00017976484,0.0005630994,0.0002604382,0.0002504758,0.005459285,0.00089558307,0.00016147923,0.0009613859,0.018527113],"study_design_scores_gemma":[0.00017982567,0.0037347213,0.9684203,0.000030692398,0.00019477327,0.0010043808,0.0004332464,0.023374945,0.0007884768,0.00022012457,0.0015728766,0.000045458077],"about_ca_topic_score_codex":0.0022874125,"about_ca_topic_score_gemma":0.0020079166,"teacher_disagreement_score":0.007064026,"about_ca_system_score_codex":0.0009695542,"about_ca_system_score_gemma":0.00037602495,"threshold_uncertainty_score":0.037358582},"labels":[],"label_agreement":null},{"id":"W2590746369","doi":"10.1200/jco.2012.30.34_suppl.290","title":"The use of technology to improve the delivery process of ambulatory chemotherapy at the Odette Cancer Centre (OCC).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Chemotherapy; Staffing; Ambulatory; Cancer; Intensive care medicine; Medical emergency; Emergency medicine; Nursing; Internal medicine","score_opus":0.11123374671555956,"score_gpt":0.4987429479297216,"score_spread":0.38750920121416205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590746369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9096443,0.0057322136,0.030917658,0.012572025,0.0004955819,0.003321245,0.0008648061,0.0038062998,0.03264589],"genre_scores_gemma":[0.8273553,0.0027210664,0.15646538,0.0014547356,0.00014951108,0.0010099455,0.000921492,0.00019785363,0.009724633],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9954711,0.0022614049,0.00037387878,0.00038209025,0.001232101,0.00027934706],"domain_scores_gemma":[0.9826903,0.00907892,0.0027295947,0.001307283,0.0024127765,0.0017811987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062136375,0.00034981858,0.00014878243,0.0012790157,0.0009817432,0.0021437316,0.0007957011,0.00053248653,0.003116574],"category_scores_gemma":[0.02702233,0.00028355364,0.00028255483,0.0010982874,0.0005848876,0.0012688441,0.0014734778,0.000613262,0.0006968434],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044128008,0.0008068458,0.06333644,0.000773163,0.00002901664,0.00068283535,0.005099704,0.0011097764,0.008218909,0.0003914565,0.014074652,0.9050359],"study_design_scores_gemma":[0.00049043127,0.005172049,0.7029987,0.001493686,0.00020427961,0.0029141023,0.007175507,0.01646628,0.02012916,0.0008554517,0.24187045,0.00022991115],"about_ca_topic_score_codex":0.019711105,"about_ca_topic_score_gemma":0.020123372,"teacher_disagreement_score":0.019711105,"about_ca_system_score_codex":0.003567345,"about_ca_system_score_gemma":0.009266972,"threshold_uncertainty_score":0.039192736},"labels":[],"label_agreement":null},{"id":"W2590797467","doi":"10.1200/jco.2005.23.16_suppl.8045","title":"Patient controlled methyphenidate [PCM] for cancer-related fatigue [CRF]: A randomized controlled trial","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Placebo; Randomized controlled trial; Somnolence; Nausea; Cancer-related fatigue; Internal medicine; Cancer; Physical therapy; Adverse effect","score_opus":0.12855012789128675,"score_gpt":0.5252281053468183,"score_spread":0.39667797745553157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590797467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.933391,0.029541876,0.0018892153,0.0024129052,0.002183107,0.02095569,0.002834653,0.0004837233,0.0063078045],"genre_scores_gemma":[0.9544686,0.0129456725,0.003468764,0.0029325227,0.001380083,0.019146167,0.0011608283,0.00003082036,0.00446657],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99899036,0.0006297635,0.00008083991,0.00013015725,0.00007845681,0.00009033563],"domain_scores_gemma":[0.9990534,0.00037251855,0.00020686694,0.00007130412,0.00005979705,0.00023605599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020725883,0.0012207377,0.003567694,0.0005616142,0.00055851263,0.0008617628,0.001027543,0.002627241,0.012136807],"category_scores_gemma":[0.0025063704,0.0006768371,0.0018027751,0.000568803,0.0010834391,0.0009850534,0.00037306387,0.0023031346,0.0010883844],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97731984,0.0038815744,0.00023372594,0.0019923141,0.0008521306,0.000033773522,0.00003369085,0.00016149075,0.000972755,0.00014581309,0.0008220107,0.013550855],"study_design_scores_gemma":[0.9848283,0.01413071,0.00035953138,0.000048312915,0.00017421694,0.0000102055665,0.0000056927474,0.00011599308,0.00004820159,0.000040846335,0.00023403221,0.0000039841098],"about_ca_topic_score_codex":0.0011300801,"about_ca_topic_score_gemma":0.0023142486,"teacher_disagreement_score":0.012136807,"about_ca_system_score_codex":0.0005449047,"about_ca_system_score_gemma":0.0012615583,"threshold_uncertainty_score":0.04060167},"labels":[],"label_agreement":null},{"id":"W2590936583","doi":"10.1200/jco.2016.34.2_suppl.340","title":"Metformin (Met): A cost-effective adjunct therapy with enzalutamide (Enza) for metastatic castrate-resistant prostate cancer (mCRPC)?","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Prostate cancer; Quality-adjusted life year; Enzalutamide; Cancer; Actuarial science; Cost effectiveness; Internal medicine; Risk analysis (engineering); Economics","score_opus":0.1878538938582237,"score_gpt":0.5275029001028327,"score_spread":0.33964900624460903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590936583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8874887,0.021740519,0.055066586,0.009971843,0.00022537503,0.0018884166,0.0021771453,0.00018632253,0.0212551],"genre_scores_gemma":[0.9889313,0.0019830544,0.007883769,0.0003767598,0.000029797062,0.0001602248,0.00015869086,0.0000044614485,0.0004718617],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987148,0.0009011924,0.000056431465,0.00011511194,0.00012435013,0.00008821243],"domain_scores_gemma":[0.99774796,0.0016904287,0.0003571297,0.000025607767,0.000055082633,0.0001237872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002440442,0.0005133951,0.0008707913,0.00069577596,0.00020132736,0.00093963626,0.00060479785,0.0010214234,0.0035061166],"category_scores_gemma":[0.006516708,0.00032988185,0.0015331716,0.00037583933,0.00037353524,0.0008639749,0.00055709766,0.0008745485,0.00014422603],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0203397,0.0019074562,0.027803486,0.004139086,0.002159551,0.000726996,0.00017085091,0.6856354,0.0036776948,0.017315008,0.003257143,0.23286758],"study_design_scores_gemma":[0.003886949,0.013102156,0.013304836,0.0025110394,0.0047082193,0.0007750942,0.00028730827,0.92335343,0.0026374813,0.023738163,0.011553843,0.0001414102],"about_ca_topic_score_codex":0.0030127014,"about_ca_topic_score_gemma":0.0055113514,"teacher_disagreement_score":0.0035061166,"about_ca_system_score_codex":0.0019446005,"about_ca_system_score_gemma":0.002283872,"threshold_uncertainty_score":0.014109135},"labels":[],"label_agreement":null},{"id":"W2591022134","doi":"10.1200/jco.2009.27.15_suppl.1033","title":"Safety and efficacy of first-line bevacizumab (B) plus chemotherapy (CT) for locally recurrent or metastatic breast cancer (LR/mBC): Analysis of MO19391 according to CT","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Taxane; Vinorelbine; Metastatic breast cancer; Internal medicine; Docetaxel; Capecitabine; Bevacizumab; Clinical endpoint; Population; Oncology; Trastuzumab; Surgery; Chemotherapy; Gastroenterology; Breast cancer; Cancer; Clinical trial; Colorectal cancer","score_opus":0.12530062789995866,"score_gpt":0.5168701766002968,"score_spread":0.3915695487003381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591022134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99840397,0.00046597898,0.00013848051,0.000031977735,0.0000056432546,0.00008246636,0.00047856724,0.000008020392,0.00038504982],"genre_scores_gemma":[0.998698,0.00009819859,0.00010740674,0.000051426552,0.000011814353,0.000042699212,0.00082019874,0.0000048822403,0.00016544193],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99910647,0.00042914817,0.00007544937,0.00015348282,0.00015873683,0.0000767094],"domain_scores_gemma":[0.99798155,0.0006141982,0.00087153586,0.00014549847,0.00009520362,0.000292031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017268215,0.0003064265,0.0005799903,0.00042661495,0.00015747965,0.00042762165,0.00040195492,0.00048246488,0.0022219233],"category_scores_gemma":[0.0022494702,0.00017569061,0.0010815632,0.00047325416,0.00037077433,0.00031433307,0.00023690592,0.0006429792,0.00043009972],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32918283,0.002771731,0.60470414,0.00023816303,0.0027900725,0.00022579842,0.00015437946,0.0018345198,0.012190558,0.000113290356,0.0009871683,0.0448073],"study_design_scores_gemma":[0.012259779,0.047459636,0.93174726,0.000027616561,0.0011519084,0.00072154595,0.00004404125,0.0029293138,0.002218721,0.0001647527,0.0012499363,0.000025438705],"about_ca_topic_score_codex":0.0011075363,"about_ca_topic_score_gemma":0.00094082777,"teacher_disagreement_score":0.0022219233,"about_ca_system_score_codex":0.0008184707,"about_ca_system_score_gemma":0.0004476266,"threshold_uncertainty_score":0.009132385},"labels":[],"label_agreement":null},{"id":"W2591143777","doi":"10.1200/jco.2016.34.4_suppl.196","title":"A phase Ib/II study of BBI608 combined with weekly paclitaxel in advanced pancreatic cancer.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; St Mary's Hospital Centre","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Gemcitabine; Taxane; Irinotecan; Paclitaxel; Pancreatic cancer; Capecitabine; Gastroenterology; Oncology; Performance status; Cancer; Nausea; Neutropenia; Chemotherapy; Adverse effect; Breast cancer; Colorectal cancer","score_opus":0.12730128512111996,"score_gpt":0.5383634431411422,"score_spread":0.4110621580200222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591143777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863505,0.0021338013,0.00082448067,0.0005250122,0.00028672325,0.0059699956,0.0013248797,0.00019137024,0.0023933034],"genre_scores_gemma":[0.97486067,0.004758711,0.0032741455,0.0013325354,0.00050540594,0.0061755,0.0036596828,0.00007955668,0.005353775],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99942744,0.00023262767,0.000041960742,0.00010980058,0.00006485065,0.00012337937],"domain_scores_gemma":[0.99914575,0.00011426106,0.00015164686,0.000101281454,0.00005344798,0.0004335672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018844977,0.0022505608,0.0031666637,0.0011022661,0.0005665146,0.0013933935,0.0012651333,0.0018395416,0.005051289],"category_scores_gemma":[0.00081333285,0.0013891767,0.0015808864,0.0009858941,0.0011866213,0.0009930591,0.00052219344,0.004489663,0.0017440983],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6309564,0.21305956,0.004219769,0.0011755489,0.0015930663,0.00042778815,0.00028044023,0.002460893,0.056150768,0.00023566459,0.003431361,0.08600876],"study_design_scores_gemma":[0.5427678,0.44586885,0.004463907,0.000029197945,0.00039003245,0.00020947155,0.000035607798,0.0007597232,0.0036400887,0.00010432302,0.00170752,0.000023425056],"about_ca_topic_score_codex":0.0013811574,"about_ca_topic_score_gemma":0.0022039108,"teacher_disagreement_score":0.005051289,"about_ca_system_score_codex":0.0009927257,"about_ca_system_score_gemma":0.0020625296,"threshold_uncertainty_score":0.016898215},"labels":[],"label_agreement":null},{"id":"W2591158495","doi":"10.1200/jco.2014.32.4_suppl.242","title":"Regional analysis of a cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz + P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D).","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cabazitaxel; Medicine; Cohort; Mitoxantrone; Prostate cancer; Population; Interim analysis; Internal medicine; Prednisone; Cancer; Clinical trial; Androgen deprivation therapy; Chemotherapy","score_opus":0.10024579945243786,"score_gpt":0.4656482243335842,"score_spread":0.3654024248811464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591158495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994639,0.00054957566,0.0006010505,0.00007740731,0.00001352664,0.00040917587,0.003040428,0.000040307023,0.00062947214],"genre_scores_gemma":[0.9935091,0.00014550363,0.0010393229,0.00018157678,0.00002381267,0.00039209554,0.004249197,0.000031255557,0.00042812008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801135,0.0011100483,0.00007654017,0.00037187542,0.00019137916,0.00023873556],"domain_scores_gemma":[0.995494,0.0009039355,0.0013608662,0.00057207275,0.0005432582,0.0011259115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034403002,0.0004938297,0.0005676475,0.00043397886,0.00029414077,0.0006847166,0.00071061857,0.00043059178,0.0017206406],"category_scores_gemma":[0.0036054065,0.00032197632,0.0016544035,0.00078654685,0.0004659509,0.00029182152,0.0008772472,0.0007315243,0.00030964546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17889634,0.0055466634,0.7162422,0.0009284905,0.006729598,0.00071597914,0.0008634273,0.0074722343,0.0139632225,0.000244587,0.007531418,0.060865875],"study_design_scores_gemma":[0.007020517,0.023075173,0.9600428,0.00003359163,0.0026151512,0.000445152,0.00023736867,0.0020093783,0.0014435,0.000053311644,0.0029792797,0.000044784207],"about_ca_topic_score_codex":0.010403673,"about_ca_topic_score_gemma":0.013962635,"teacher_disagreement_score":0.010403673,"about_ca_system_score_codex":0.0013002743,"about_ca_system_score_gemma":0.0020190196,"threshold_uncertainty_score":0.02068621},"labels":[],"label_agreement":null},{"id":"W2591241287","doi":"10.1200/jco.2013.31.26_suppl.64","title":"Impact of endocrine therapy in early-stage breast cancer on time to locoregional recurrence.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Statistics Canada; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Lumpectomy; Tamoxifen; Cancer; Lymph node; Internal medicine; Stage (stratigraphy); Oncology; Univariate analysis; Median follow-up; Gynecology; Surgery; Chemotherapy; Mastectomy; Multivariate analysis","score_opus":0.13539720691474938,"score_gpt":0.5325383420881753,"score_spread":0.3971411351734259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591241287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883123,0.009353551,0.00010484471,0.00018474615,0.000013773895,0.000011216203,0.00066184887,0.0000051804,0.0013525306],"genre_scores_gemma":[0.99872285,0.0007695416,0.000047421203,0.000039665985,0.00001702244,0.0000049737746,0.00023555901,0.000001706176,0.00016120158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996068,0.00018014466,0.000048557187,0.000034072233,0.00007171211,0.000058782167],"domain_scores_gemma":[0.9955368,0.002003844,0.0019683775,0.00005121681,0.00021758291,0.00022226106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082557724,0.000079050544,0.00012950147,0.000286818,0.00009054551,0.00028715862,0.00013706223,0.00015626193,0.0013453722],"category_scores_gemma":[0.004175006,0.00005240777,0.00031924836,0.000364838,0.00010713757,0.00016463775,0.00011531705,0.00025848852,0.00014516326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014243,0.00005802366,0.97378796,0.0001237936,0.00009651708,0.00033461524,0.00004009867,0.00033149795,0.00030875424,0.000028039256,0.00031817472,0.023148218],"study_design_scores_gemma":[0.000021817854,0.0005723929,0.99715877,0.000028487751,0.00009769974,0.0009687142,0.00003040115,0.00017917181,0.00021137767,0.000020246878,0.0007072046,0.0000037062466],"about_ca_topic_score_codex":0.0018585585,"about_ca_topic_score_gemma":0.0029132115,"teacher_disagreement_score":0.0018585585,"about_ca_system_score_codex":0.00033815976,"about_ca_system_score_gemma":0.00024065642,"threshold_uncertainty_score":0.004500687},"labels":[],"label_agreement":null},{"id":"W2591450482","doi":"10.1200/jco.2009.27.15_suppl.1032","title":"Tolerability and efficacy of first-line bevacizumab (B) plus chemotherapy (CT) in elderly patients with advanced breast cancer (aBC): Subpopulation analysis of the MO19391 study","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Tolerability; Taxane; Bevacizumab; Internal medicine; Population; Clinical trial; Breast cancer; Cohort; Randomized controlled trial; Oncology; Adverse effect; Cancer; Chemotherapy","score_opus":0.05015774311574187,"score_gpt":0.45404138520252485,"score_spread":0.40388364208678296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591450482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99862516,0.00080093637,0.000049482875,0.000029206038,0.0000039860097,0.000031534986,0.0002486975,0.000003005153,0.00020813609],"genre_scores_gemma":[0.9991899,0.00018273924,0.000042532716,0.00005444009,0.000020016714,0.000025306588,0.00040346783,0.0000022746449,0.000079356316],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99946517,0.00024229614,0.00006186933,0.0000959921,0.00008564969,0.00004905332],"domain_scores_gemma":[0.99890554,0.00020778886,0.0004850302,0.000109992616,0.000075928234,0.000215657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017494414,0.0002832961,0.00083149446,0.00034186523,0.00019405303,0.00042241384,0.00018888207,0.0003410594,0.0007432636],"category_scores_gemma":[0.0015265893,0.00015664652,0.001013655,0.000419293,0.00016506766,0.0003349999,0.0002681866,0.00042262432,0.00016634066],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.073807076,0.001961257,0.8759976,0.00027286157,0.0050996584,0.00043206458,0.00037643302,0.00054819987,0.008927018,0.000053031898,0.0010356164,0.031489108],"study_design_scores_gemma":[0.0034526559,0.018130045,0.97381127,0.000027780992,0.0014737978,0.0005074105,0.000112340516,0.0006295068,0.000596206,0.00005091398,0.0011851686,0.000022968914],"about_ca_topic_score_codex":0.0005435974,"about_ca_topic_score_gemma":0.00079299876,"teacher_disagreement_score":0.0017494414,"about_ca_system_score_codex":0.00025421917,"about_ca_system_score_gemma":0.00021816217,"threshold_uncertainty_score":0.009252012},"labels":[],"label_agreement":null},{"id":"W2591471662","doi":"10.1200/jco.2014.32.3_suppl.423","title":"Dose intensity and survival outcomes with adjuvant FOLFOX for colon cancer.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"FOLFOX; Medicine; Oxaliplatin; Colorectal cancer; Internal medicine; Neutropenia; Oncology; Proportional hazards model; Chemotherapy; Cancer; Surgery","score_opus":0.18572815130798548,"score_gpt":0.5404889401147074,"score_spread":0.3547607888067219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591471662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99802566,0.00087102555,0.0000811334,0.00013969708,0.00000571388,0.000011674638,0.00014419286,0.0000045374913,0.00071636715],"genre_scores_gemma":[0.99941266,0.000105926665,0.000063915926,0.000034090608,0.000008430247,0.0000058608684,0.0002268756,0.0000015123813,0.00014073397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999793,0.00005096439,0.00002159125,0.000034968005,0.00006388625,0.00003564541],"domain_scores_gemma":[0.9983779,0.00028552697,0.0009490039,0.00004341226,0.000090944595,0.00025320155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000552422,0.00009113186,0.00015597223,0.00019681179,0.000121332996,0.0002477539,0.00014376537,0.00019727265,0.001306073],"category_scores_gemma":[0.0024735325,0.000056980894,0.00031256335,0.00039350486,0.0001259149,0.00018736263,0.00017921874,0.00038298554,0.00010345509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018298923,0.00014678777,0.9818703,0.000043098524,0.00011280258,0.000105784966,0.000033561802,0.00053504534,0.0010414725,0.00001800047,0.00027101618,0.01399231],"study_design_scores_gemma":[0.000037231508,0.00074047624,0.99820745,0.000007240512,0.000049685987,0.0002142779,0.000015893838,0.0002461227,0.00014117164,0.000029959157,0.00030844746,0.0000020060152],"about_ca_topic_score_codex":0.0015675088,"about_ca_topic_score_gemma":0.0036699101,"teacher_disagreement_score":0.0015675088,"about_ca_system_score_codex":0.00061840593,"about_ca_system_score_gemma":0.0003938434,"threshold_uncertainty_score":0.0044869184},"labels":[],"label_agreement":null},{"id":"W2591486309","doi":"10.1200/jco.2014.32.3_suppl.644","title":"Patterns of systemic therapy in metastatic colorectal cancer (mCRC): Use of intermittent and stop-and-go strategies in a population-based setting.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; FOLFOX; Bevacizumab; FOLFIRI; Internal medicine; Capecitabine; Population; Colorectal cancer; Systemic therapy; Cancer; Cohort; Oncology; Chemotherapy; Irinotecan; Breast cancer; Oxaliplatin","score_opus":0.12366162210276459,"score_gpt":0.480810905861421,"score_spread":0.3571492837586564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591486309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989888,0.00032932987,0.0000606548,0.000077565426,0.0000025609493,0.000012822466,0.0002818262,0.0000039811384,0.0002423373],"genre_scores_gemma":[0.9995535,0.000112186826,0.00006220043,0.000020301,0.0000038816106,0.00000726028,0.00020011104,0.0000013558821,0.000039205086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990534,0.00027484563,0.000119664095,0.00023212165,0.00018532242,0.00013462834],"domain_scores_gemma":[0.9969009,0.00041327087,0.0020713124,0.000117987925,0.00017700906,0.0003195822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076021004,0.0001386463,0.0003520652,0.0008812455,0.00036466235,0.0006715623,0.00046395976,0.00042532067,0.0009927853],"category_scores_gemma":[0.0031366914,0.00021486028,0.00035428384,0.001650857,0.00033594228,0.0005899053,0.0005666788,0.00043057188,0.00015527525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005321838,0.000014006735,0.99865985,0.000005894534,0.000022196617,0.000029380259,0.000050569077,0.000021589518,0.000054700224,0.000005560671,0.000056394794,0.0010265947],"study_design_scores_gemma":[0.0000051781026,0.000053460746,0.9992072,0.000004331669,0.00001070958,0.00018628946,0.00021275491,0.00020901926,0.000016645019,0.000013273653,0.00007810702,0.0000030101755],"about_ca_topic_score_codex":0.013158928,"about_ca_topic_score_gemma":0.027378356,"teacher_disagreement_score":0.013158928,"about_ca_system_score_codex":0.0006602115,"about_ca_system_score_gemma":0.00057245244,"threshold_uncertainty_score":0.02616465},"labels":[],"label_agreement":null},{"id":"W2591511288","doi":"10.1200/jco.2016.34.7_suppl.63","title":"Quality of life (QoL) by response: An interim analysis of patients (pts) with squamous (SCC) NSCLC treated with <i>nab</i>-paclitaxel/carboplatin (<i>nab</i>-P/C) induction therapy in the phase III ABOUND.sqm study.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Clinical endpoint; Internal medicine; Induction chemotherapy; Interim analysis; Quality of life (healthcare); Carboplatin; Response Evaluation Criteria in Solid Tumors; Maintenance therapy; Oncology; Surgery; Phases of clinical research; Randomized controlled trial; Gastroenterology; Chemotherapy","score_opus":0.15138756162189743,"score_gpt":0.515527758474879,"score_spread":0.36414019685298155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591511288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975325,0.0002144152,0.0002665068,0.000052418476,0.000017099715,0.00034337625,0.0012079584,0.000018063864,0.00034773813],"genre_scores_gemma":[0.9925249,0.0001227826,0.0007467093,0.00017394334,0.000055311164,0.00093678344,0.0047382507,0.000015747064,0.0006856142],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99861526,0.0007371065,0.0000745534,0.00017596563,0.00015569113,0.00024147492],"domain_scores_gemma":[0.99764496,0.0005119821,0.00071272923,0.00038365388,0.00015432634,0.0005922934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052338094,0.0013773002,0.0024166554,0.00050799525,0.00043203306,0.0009887886,0.00076161604,0.0008879907,0.0018362402],"category_scores_gemma":[0.002312654,0.0005301451,0.003949468,0.00064604415,0.0007803359,0.00078704616,0.00075824396,0.0021952584,0.00050981675],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8485708,0.016230699,0.10231601,0.00021286769,0.0030333153,0.00016754816,0.00018469412,0.002658713,0.006250858,0.000075541844,0.0014130347,0.018885868],"study_design_scores_gemma":[0.11196315,0.5299445,0.34126422,0.000037243666,0.004571409,0.000326044,0.00016347176,0.0044272305,0.005023146,0.00024569666,0.0019569444,0.000076968696],"about_ca_topic_score_codex":0.00066588825,"about_ca_topic_score_gemma":0.00086824986,"teacher_disagreement_score":0.0052338094,"about_ca_system_score_codex":0.00083497644,"about_ca_system_score_gemma":0.0013494047,"threshold_uncertainty_score":0.027679384},"labels":[],"label_agreement":null},{"id":"W2591566448","doi":"10.1200/jco.2015.33.29_suppl.181","title":"The Opioid Rotation Ratio (ORR) to transdermal fentanyl (TDF) in cancer patients.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Opioid; Cancer pain; Fentanyl; Cancer; Palliative care; Constipation; Anesthesia; Internal medicine","score_opus":0.1952582740294113,"score_gpt":0.5363013727625947,"score_spread":0.3410430987331834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591566448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936272,0.0047607115,0.00017448296,0.00015420388,0.000018794783,0.000030159208,0.00044506203,0.000012117813,0.00077732233],"genre_scores_gemma":[0.99873644,0.00067616586,0.00023026348,0.000048405655,0.000015665846,0.00001101549,0.00021331603,0.000002846353,0.00006589255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990402,0.00031865115,0.0001795025,0.00012561759,0.00026567437,0.00007030874],"domain_scores_gemma":[0.9950098,0.0013008245,0.0031414542,0.00008840182,0.00028531233,0.00017426892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009893124,0.00019705814,0.00043057842,0.00070974143,0.0002147284,0.0004289831,0.00031849928,0.0002961561,0.0009563631],"category_scores_gemma":[0.0068562375,0.00015107435,0.00040002202,0.0010664739,0.00018422407,0.000355074,0.00026275587,0.0004852555,0.00022511565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002059184,0.000017505652,0.99321014,0.000050833,0.00004767046,0.00015193509,0.000045375687,0.00004757785,0.00015995931,0.0000074541053,0.00014263878,0.0059129973],"study_design_scores_gemma":[0.000013055275,0.00028166646,0.9974452,0.000019844196,0.000048256526,0.0013667525,0.0001022227,0.00031345486,0.00013619811,0.000011380327,0.00025835584,0.0000035288008],"about_ca_topic_score_codex":0.001942818,"about_ca_topic_score_gemma":0.0032707495,"teacher_disagreement_score":0.001942818,"about_ca_system_score_codex":0.00049394317,"about_ca_system_score_gemma":0.0002997955,"threshold_uncertainty_score":0.0052320957},"labels":[],"label_agreement":null},{"id":"W2591643510","doi":"10.1158/1538-7445.sabcs16-s5-06","title":"Abstract S5-06: Randomized, placebo-controlled trial of duloxetine for aromatase inhibitor (AI)-associated musculoskeletal symptoms (AIMSS) in early stage breast cancer (SWOG S1202)","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dr. H. Bliss Murphy Cancer Centre","funders":"","keywords":"Medicine; Duloxetine; Brief Pain Inventory; Breast cancer; Internal medicine; Placebo; Randomized controlled trial; Discontinuation; Aromatase inhibitor; Cancer; Oncology; Physical therapy; Chronic pain; Tamoxifen","score_opus":0.04056827726578983,"score_gpt":0.4423527158761176,"score_spread":0.40178443861032775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591643510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96755445,0.0047844085,0.0006499573,0.0013905907,0.0014898472,0.0148753235,0.00367557,0.00041026552,0.0051695765],"genre_scores_gemma":[0.97138286,0.0023590804,0.0020991422,0.0024024704,0.0008229882,0.011912066,0.0024078311,0.000030234363,0.006583381],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993113,0.00032307973,0.00006553718,0.00012219074,0.000055419314,0.00012251479],"domain_scores_gemma":[0.9992799,0.00015835279,0.00015797796,0.000043792526,0.00006056818,0.00029949602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001409371,0.001826137,0.0037103188,0.0005868686,0.00063100137,0.0012485404,0.001369902,0.0026213476,0.017003233],"category_scores_gemma":[0.0013894453,0.00085212605,0.001946505,0.00040794746,0.0013160525,0.0010456463,0.0004541356,0.0033279415,0.0022481938],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98821867,0.004204774,0.00015245151,0.0005313847,0.00041236702,0.000015954529,0.000019522038,0.00007183925,0.0010208859,0.000061932136,0.00060397066,0.0046862257],"study_design_scores_gemma":[0.9739009,0.025051026,0.0004662555,0.000019636362,0.00013935896,0.00000659534,0.000007452504,0.000106150335,0.000091608854,0.000031595624,0.00017462218,0.0000048149755],"about_ca_topic_score_codex":0.0018021901,"about_ca_topic_score_gemma":0.005045869,"teacher_disagreement_score":0.017003233,"about_ca_system_score_codex":0.0007812641,"about_ca_system_score_gemma":0.0017420058,"threshold_uncertainty_score":0.056881487},"labels":[],"label_agreement":null},{"id":"W2591925750","doi":"10.1200/jco.2013.31.15_suppl.1055","title":"Quality of life (QoL) and content validity in objective tumor response.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Capecitabine; Quality of life (healthcare); Eribulin; Internal medicine; Breast cancer; Metastatic breast cancer; Multivariate analysis; Health related quality of life; Oncology; Cancer; Physical therapy; Disease; Colorectal cancer","score_opus":0.5428370661455958,"score_gpt":0.5661834348095452,"score_spread":0.023346368663949457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591925750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98703057,0.0025091637,0.0038714125,0.00057111535,0.00007680713,0.000766875,0.0017914202,0.000022551103,0.0033601094],"genre_scores_gemma":[0.99680895,0.00016761283,0.001230526,0.00013807468,0.000037512924,0.0006157071,0.0007414977,0.000010284111,0.00024977073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98020303,0.014609466,0.00119666,0.0006768139,0.0028889112,0.00042518583],"domain_scores_gemma":[0.9123889,0.0663084,0.016529571,0.0018555907,0.002181787,0.0007356186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.040309303,0.00032724248,0.00071040285,0.0012233352,0.00021073551,0.0009015533,0.0005833641,0.00053889607,0.0027419913],"category_scores_gemma":[0.052399393,0.00021160634,0.0015328812,0.0014700468,0.0012581145,0.000823075,0.0010592187,0.00088658545,0.00027966252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012425811,0.0005965908,0.91743475,0.00059606304,0.003072303,0.000034063512,0.00036084058,0.0026615486,0.00042224934,0.00046683216,0.0011111122,0.06081771],"study_design_scores_gemma":[0.0014395023,0.0053653996,0.97889996,0.00017136257,0.00082599715,0.00017885542,0.00012413754,0.008439553,0.00089330244,0.001392438,0.0022258684,0.000043592292],"about_ca_topic_score_codex":0.00040227023,"about_ca_topic_score_gemma":0.0004381629,"teacher_disagreement_score":0.040309303,"about_ca_system_score_codex":0.000790312,"about_ca_system_score_gemma":0.00051875843,"threshold_uncertainty_score":0.21317846},"labels":[],"label_agreement":null},{"id":"W2592319793","doi":"10.71781/31184","title":"Effets des polyphénols du thé vert et de la radiothérapie sur la progression et la résistance tumorale dans un modèle in vivo de glioblastome","year":2004,"lang":"fr","type":"dissertation","venue":"Open MIND","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Glioblastoma; Medicine; Nuclear medicine; Cancer research","score_opus":0.014955934240725902,"score_gpt":0.36934725917862943,"score_spread":0.35439132493790354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592319793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96907324,0.0154651925,0.0026461573,0.0009929806,0.00028177723,0.000087075656,0.00063298375,0.000111895686,0.0107087325],"genre_scores_gemma":[0.94118947,0.014645573,0.002191225,0.00020650543,0.00008605185,0.00007313517,0.0007449444,0.000079606056,0.04078344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993587,0.000012223056,0.0000024664173,0.000015275542,0.000017724518,0.00001639197],"domain_scores_gemma":[0.9999174,0.00002974106,0.000011664407,0.0000112186735,0.000013481629,0.000016463779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013982461,0.00025993376,0.00033912167,0.00023808272,0.00020123544,0.0005038362,0.00014272075,0.00035424382,0.0033619297],"category_scores_gemma":[0.0001624036,0.0001410468,0.0003348805,0.0002282023,0.0002843143,0.00024397121,0.00009868552,0.0006947029,0.00030364082],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015106561,0.00019542557,0.00015612456,0.0001387511,0.000037953756,0.00006641688,0.000058648864,0.00018706132,0.9784443,0.00048652856,0.0004980107,0.018220207],"study_design_scores_gemma":[0.00019835804,0.003353168,0.0064117415,0.000034005912,0.0002216743,0.00013731868,0.00005091235,0.0007776956,0.9706778,0.00032538644,0.017789144,0.000022846825],"about_ca_topic_score_codex":0.0043102307,"about_ca_topic_score_gemma":0.007647133,"teacher_disagreement_score":0.0043102307,"about_ca_system_score_codex":0.0003731905,"about_ca_system_score_gemma":0.00034332357,"threshold_uncertainty_score":0.0112468},"labels":[],"label_agreement":null},{"id":"W2592985951","doi":"10.1097/cad.0000000000000493","title":"A systematic review and pooled analysis of retrospective series of eribulin in metastatic breast cancer","year":2017,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sault Area Hospital","funders":"","keywords":"Medicine; Eribulin; Capecitabine; Internal medicine; Breast cancer; Metastatic breast cancer; Oncology; Clinical trial; Confidence interval; Retrospective cohort study; Cancer; Surgery","score_opus":0.04661719267652718,"score_gpt":0.4187347429406821,"score_spread":0.3721175502641549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592985951","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012021656,0.9809265,0.0008985426,0.00018646158,0.00015699423,0.0010533583,0.0041502053,0.0000224828,0.00058377435],"genre_scores_gemma":[0.17817971,0.80984277,0.003076253,0.000909369,0.00022834002,0.003059795,0.004352117,0.000040979772,0.00031069617],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.96637017,0.011392248,0.015605713,0.0025757742,0.0036458303,0.00041019992],"domain_scores_gemma":[0.934274,0.038212698,0.017163068,0.0027596864,0.0071052765,0.00048525893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020540807,0.0017114615,0.011196683,0.016059877,0.0006030164,0.002689305,0.0016698939,0.0012240116,0.0023130774],"category_scores_gemma":[0.0669924,0.0012464107,0.013032015,0.01910822,0.0009841796,0.0016994827,0.0015382869,0.0007844917,0.000377411],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010086026,0.00003152206,0.016118322,0.79236495,0.16143373,0.0003448274,0.00027641773,0.00026272304,0.00034413324,0.0001979591,0.0019501757,0.02566666],"study_design_scores_gemma":[0.00075544935,0.00050414784,0.043397833,0.2421614,0.6959547,0.0010248267,0.0003981392,0.00019701464,0.0004901494,0.00037976512,0.014639835,0.000096772565],"about_ca_topic_score_codex":0.006022828,"about_ca_topic_score_gemma":0.018178562,"teacher_disagreement_score":0.020540807,"about_ca_system_score_codex":0.0027071175,"about_ca_system_score_gemma":0.007054083,"threshold_uncertainty_score":0.10863143},"labels":[],"label_agreement":null},{"id":"W2593744678","doi":"10.1158/1538-7445.sabcs16-p5-14-05","title":"Abstract P5-14-05: Capecitabine in early breast cancer: A meta-analysis of randomized controlled trials","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Capecitabine; Medicine; Internal medicine; Oncology; Breast cancer; Hazard ratio; Triple-negative breast cancer; Anthracycline; Taxane; Fluorouracil; Randomized controlled trial; Chemotherapy; Cancer; Confidence interval; Colorectal cancer","score_opus":0.28977627776189213,"score_gpt":0.5348622269796955,"score_spread":0.2450859492178034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593744678","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01435703,0.9755764,0.0034702176,0.00079262484,0.0008166748,0.0014830822,0.0026256666,0.00016743908,0.00071093265],"genre_scores_gemma":[0.5528587,0.4206363,0.0106353,0.0030594857,0.0011221907,0.0058974195,0.0038596857,0.00018760997,0.0017432732],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97578555,0.01673472,0.0038225935,0.0017726999,0.0014360396,0.00044840688],"domain_scores_gemma":[0.9655034,0.027032131,0.004429659,0.001052637,0.0015124849,0.00046980366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022881731,0.0038733222,0.01964658,0.0051870523,0.00054124364,0.004229679,0.0023765157,0.0028629696,0.0093377745],"category_scores_gemma":[0.04782001,0.0013517342,0.050999146,0.005791888,0.0007617115,0.0022072312,0.0016109892,0.0033049032,0.0006694615],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004470502,0.00002347511,0.00196424,0.13427068,0.8538905,0.000093865434,0.000022889271,0.0005467392,0.00016422744,0.00010262996,0.00067909644,0.0037710976],"study_design_scores_gemma":[0.0025550136,0.00022680259,0.0019423281,0.0068937065,0.9866981,0.00005318741,0.000015558737,0.00034173933,0.00007753497,0.00023343302,0.00094755203,0.000015083811],"about_ca_topic_score_codex":0.0042542596,"about_ca_topic_score_gemma":0.0065830797,"teacher_disagreement_score":0.022881731,"about_ca_system_score_codex":0.0024797868,"about_ca_system_score_gemma":0.0023007307,"threshold_uncertainty_score":0.121011615},"labels":[],"label_agreement":null},{"id":"W2594164534","doi":"10.1182/blood.v104.11.1860.1860","title":"Comparison of the Anticoagulant Effect of Melagatran and Lmwh in an Acquired Antithrombin Deficiency in Children with All Treated with L-Asparaginase.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital","funders":"","keywords":"Ximelagatran; Direct thrombin inhibitor; Asparaginase; Anticoagulant; Medicine; Antithrombin; Thrombosis; Population; Low molecular weight heparin; Warfarin; Discovery and development of direct thrombin inhibitors; Pharmacology; Heparin; Internal medicine; Surgery; Immunology; Thrombin; Leukemia; Lymphoblastic Leukemia; Platelet","score_opus":0.014549307280928167,"score_gpt":0.3135924123303691,"score_spread":0.2990431050494409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594164534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99880946,0.00090370665,0.00004576992,0.000014851143,0.0000036801425,0.00001822742,0.000094253475,0.0000016279218,0.00010842075],"genre_scores_gemma":[0.9993199,0.0003115986,0.00008751137,0.000018619243,0.000007803605,0.000015039834,0.00019112145,9.617194e-7,0.000047418474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990532,0.00040445867,0.000105182036,0.00012188467,0.00020700129,0.00010834446],"domain_scores_gemma":[0.9982993,0.0007307193,0.00061971234,0.000068821464,0.00010852454,0.00017296073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011014601,0.0003790541,0.0008586318,0.0004196555,0.00017587481,0.0003413235,0.0002232145,0.0003962228,0.00072641554],"category_scores_gemma":[0.003038114,0.00016591551,0.00094893813,0.00048760348,0.00031576154,0.0002446607,0.00023363942,0.00045413623,0.00008885627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050270062,0.0009639166,0.9196456,0.0004803599,0.002085491,0.0008013816,0.00045953735,0.00047808912,0.005854007,0.00006845789,0.00027649934,0.018616607],"study_design_scores_gemma":[0.0012429374,0.029293511,0.9628619,0.000038472783,0.00125805,0.0016240524,0.00029510554,0.0003770903,0.0019402904,0.000025639423,0.0010309109,0.000012132742],"about_ca_topic_score_codex":0.0016152568,"about_ca_topic_score_gemma":0.0017302032,"teacher_disagreement_score":0.0016152568,"about_ca_system_score_codex":0.00075961056,"about_ca_system_score_gemma":0.00048137363,"threshold_uncertainty_score":0.005825162},"labels":[],"label_agreement":null},{"id":"W2594239688","doi":"10.1016/j.addr.2017.02.003","title":"The battle of “nano” paclitaxel","year":2017,"lang":"en","type":"review","venue":"Advanced Drug Delivery Reviews","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":397,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Carleton University","keywords":"Paclitaxel; Battle; Nano-; Pharmacology; Chemistry; Medicine; Internal medicine; Chemotherapy; Engineering; Chemical engineering; History; Ancient history","score_opus":0.14799676776173568,"score_gpt":0.4581610657877207,"score_spread":0.310164298025985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594239688","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001420178,0.9943427,0.00029427052,0.0021364726,0.00081663113,0.0000052722903,0.000015514886,0.000012589947,0.0022346552],"genre_scores_gemma":[0.0012031758,0.9939919,0.0003053749,0.0020006169,0.0005847211,0.000007955228,0.000025123229,0.0000041033272,0.0018771183],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997224,0.00006971762,0.000023942725,0.00003049306,0.000117472526,0.000035873287],"domain_scores_gemma":[0.9997068,0.00015073513,0.00003139857,0.000012194108,0.00006760916,0.000031266252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083876785,0.0006261703,0.0010060429,0.0011313899,0.0003561474,0.001520811,0.0006858181,0.0013669287,0.0046712887],"category_scores_gemma":[0.0008078615,0.00024223191,0.00042529852,0.00097515626,0.0009733212,0.0028712458,0.0011880933,0.0031686288,0.0020541667],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008595658,0.00006148414,0.00008108125,0.008163427,0.000049852053,0.00013232307,0.00008806239,0.00027820677,0.0022656329,0.025444278,0.08353216,0.8798174],"study_design_scores_gemma":[0.000011114391,0.000033680775,0.00010244434,0.0014910987,0.000022644312,0.0002624679,0.000037699498,0.000056555935,0.00032910806,0.0042265565,0.99341923,0.0000074301925],"about_ca_topic_score_codex":0.00096048473,"about_ca_topic_score_gemma":0.0028453495,"teacher_disagreement_score":0.0046712887,"about_ca_system_score_codex":0.0007633876,"about_ca_system_score_gemma":0.0014413869,"threshold_uncertainty_score":0.015626967},"labels":[],"label_agreement":null},{"id":"W2594425395","doi":"10.1145/3055282.3055299","title":"Fermat benchmarks for rational expressionals in maple","year":2017,"lang":"en","type":"article","venue":"ACM communications in computer algebra","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Maple; Fermat's Last Theorem; Benchmark (surveying); Set (abstract data type); Undo; Factor (programming language); Computer science; Fermat number; Mathematics; Algebra over a field; Discrete mathematics; Programming language; Pure mathematics","score_opus":0.10578383142872837,"score_gpt":0.43353890776434156,"score_spread":0.3277550763356132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594425395","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06904588,0.0021312255,0.5415829,0.001780225,0.0008303937,0.00042721344,0.009293788,0.21916401,0.15574434],"genre_scores_gemma":[0.33148283,0.0009156859,0.5845236,0.0009765397,0.00034033312,0.00072998606,0.020413797,0.03397217,0.026645077],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9943321,0.0012485413,0.00049784774,0.00066440215,0.0024408957,0.00081624446],"domain_scores_gemma":[0.9910657,0.004720628,0.00036158925,0.0020379538,0.001562719,0.0002513562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039490326,0.002283495,0.001370687,0.0024657864,0.0016228983,0.003987814,0.0037855403,0.0013597951,0.05397853],"category_scores_gemma":[0.019044796,0.00093869405,0.002047969,0.004191025,0.0012729622,0.0075840713,0.0031551667,0.0030764926,0.02128711],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023688974,0.00054418505,0.003232754,0.0018979384,0.00013970045,0.00058201526,0.00060036563,0.026832473,0.015939446,0.23240739,0.33269385,0.38276106],"study_design_scores_gemma":[0.0009282623,0.00057704735,0.0021294234,0.00040164942,0.0001283622,0.0008140816,0.00041846585,0.33729655,0.10230051,0.2256218,0.32914302,0.00024089773],"about_ca_topic_score_codex":0.002385856,"about_ca_topic_score_gemma":0.0046473723,"teacher_disagreement_score":0.05397853,"about_ca_system_score_codex":0.0024643652,"about_ca_system_score_gemma":0.002283254,"threshold_uncertainty_score":0.1805762},"labels":[],"label_agreement":null},{"id":"W2595403935","doi":"10.1200/jco.2012.30.15_suppl.9131","title":"Prevalence of cancer-related fatigue in a population-based sample of colorectal, breast, and prostate cancer survivors.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cancer; Breast cancer; Survivorship curve; Population; Quality of life (healthcare); Internal medicine; Prostate cancer; Depression (economics); Colorectal cancer; Physical therapy; Disease; Oncology","score_opus":0.10282846162688326,"score_gpt":0.4932229183544065,"score_spread":0.39039445672752326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595403935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994363,0.000051315776,0.000028854887,0.000017878123,0.0000014682103,0.000013273812,0.00033100898,0.000002176226,0.00011777661],"genre_scores_gemma":[0.9992902,0.00005116955,0.00003667967,0.000022114227,0.000003267132,0.000027418173,0.00045032875,8.7894165e-7,0.00011790605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99947673,0.00015913784,0.00006362044,0.00010316066,0.00012331392,0.00007400243],"domain_scores_gemma":[0.9992256,0.00016804754,0.0002934034,0.000045666708,0.00010137208,0.00016596544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006389304,0.00019350558,0.000282905,0.00096301874,0.00034495906,0.00041967427,0.00026337613,0.00042004228,0.0015119115],"category_scores_gemma":[0.0019879625,0.00030701718,0.00027400366,0.0008658193,0.000255546,0.00047317636,0.00048111676,0.0003443985,0.00038292914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004062792,0.000041452986,0.99893194,0.000007804787,0.000017071428,0.000039824932,0.00012505584,0.00001082061,0.00013301618,0.0000034504103,0.000065625536,0.0005832205],"study_design_scores_gemma":[0.0000034606726,0.00010687079,0.99946946,0.0000018169661,0.0000057648595,0.00014152222,0.00016704886,0.000042482217,0.000015490736,0.0000024721394,0.000041942425,0.0000018009964],"about_ca_topic_score_codex":0.008303582,"about_ca_topic_score_gemma":0.007947094,"teacher_disagreement_score":0.008303582,"about_ca_system_score_codex":0.000255404,"about_ca_system_score_gemma":0.00024932713,"threshold_uncertainty_score":0.016510487},"labels":[],"label_agreement":null},{"id":"W2596486877","doi":"10.1200/jco.2004.22.90140.630","title":"A multi-centre phase II trial of pegylated liposomal doxorubicin and trastuzumab in HER-2 over-expressing metastatic breast cancer (MBC)","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Metastatic breast cancer; Anthracycline; Trastuzumab; Ejection fraction; Cardiotoxicity; Doxorubicin; Internal medicine; Breast cancer; Cancer; Heart failure; Oncology; Chemotherapy","score_opus":0.1422473115020502,"score_gpt":0.5265052184546788,"score_spread":0.3842579069526286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596486877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925575,0.0008343243,0.0002757832,0.00028142805,0.000058846683,0.004096824,0.0007070638,0.00005044476,0.0011378006],"genre_scores_gemma":[0.98863864,0.0010332685,0.0016945868,0.00066885917,0.00013171873,0.003313865,0.0022955097,0.000019303241,0.0022041274],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994648,0.00019599701,0.000024766905,0.00009358376,0.0000771315,0.00014372922],"domain_scores_gemma":[0.9991059,0.00006484251,0.00009780289,0.000050003207,0.000054072134,0.0006274287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020478053,0.00166029,0.0016453807,0.00041785437,0.00079508376,0.0008984139,0.0012219307,0.0012590411,0.003452124],"category_scores_gemma":[0.00076024735,0.00067675975,0.00081120396,0.00057444826,0.0010605135,0.0004856754,0.00051953905,0.0022904747,0.0007255068],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8085489,0.083964795,0.008895046,0.0005811716,0.0007645297,0.00036147333,0.00047708288,0.0018579338,0.031220548,0.00013702137,0.00422033,0.058971144],"study_design_scores_gemma":[0.6747915,0.2942178,0.024901928,0.000029350354,0.00031591312,0.0002857068,0.00006495684,0.00083838904,0.0021471593,0.00007240718,0.0023056932,0.00002915232],"about_ca_topic_score_codex":0.029295914,"about_ca_topic_score_gemma":0.061727475,"teacher_disagreement_score":0.029295914,"about_ca_system_score_codex":0.003919715,"about_ca_system_score_gemma":0.006109642,"threshold_uncertainty_score":0.058250785},"labels":[],"label_agreement":null},{"id":"W2596681760","doi":"10.1200/jco.2013.31.15_suppl.e20568","title":"Differences in pain, symptom burden, and opioid use among cancer pain patients with active versus non-active disease.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Disease; Opioid; Anxiety; Cancer pain; Depression (economics); Cancer; Internal medicine; Physical therapy; Psychiatry","score_opus":0.0815141294209158,"score_gpt":0.42356041457200744,"score_spread":0.34204628515109164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596681760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993217,0.00016802366,0.000012894516,0.000030710326,0.0000032369433,0.0000068203813,0.00019942857,5.9987855e-7,0.00025654532],"genre_scores_gemma":[0.999483,0.000055953733,0.000021050635,0.000026202737,0.000008230327,0.000006558704,0.0002638918,5.120134e-7,0.00013448829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997551,0.000057158042,0.00003634226,0.000035756446,0.00006697196,0.000048728343],"domain_scores_gemma":[0.99871695,0.00031113214,0.0005603631,0.000026350059,0.00009836007,0.0002868181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036076282,0.000116098774,0.00024328481,0.0006252582,0.00025691555,0.0004614974,0.0001664003,0.00025219924,0.0033817496],"category_scores_gemma":[0.0014067836,0.000118000644,0.00024884075,0.0006400531,0.00018635349,0.00045898484,0.00034179632,0.00035777947,0.0003538877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022950662,0.000077604476,0.9978727,0.0000113746655,0.000021429032,0.00004463724,0.000059998245,0.0000118519,0.00014655136,0.0000063558427,0.00006427529,0.0014538808],"study_design_scores_gemma":[0.000012925578,0.00019574666,0.9993931,0.0000026404953,0.000006657363,0.00014251171,0.00011239691,0.00003540144,0.000013836644,0.0000053650415,0.000078029756,0.0000013088064],"about_ca_topic_score_codex":0.0014309005,"about_ca_topic_score_gemma":0.0031464023,"teacher_disagreement_score":0.0033817496,"about_ca_system_score_codex":0.00022400635,"about_ca_system_score_gemma":0.00016844641,"threshold_uncertainty_score":0.01131314},"labels":[],"label_agreement":null},{"id":"W2596927554","doi":"","title":"Professor Hope S. Rugo: Reversing resistance and hormone therapy for metastatic breast cancer","year":2013,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian College of Osteopathy","funders":"","keywords":"Reversing; Metastatic breast cancer; Medicine; Breast cancer; Cancer; Acquired resistance; Hormone therapy; Oncology; Internal medicine; Engineering","score_opus":0.03014076374366816,"score_gpt":0.3482695949574836,"score_spread":0.31812883121381547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596927554","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020522021,0.10377515,0.00070649886,0.77036273,0.10381485,0.00011739269,0.00013928128,0.0001084247,0.018923445],"genre_scores_gemma":[0.028205067,0.15428495,0.0024563007,0.3701395,0.17903656,0.0001593909,0.00021959146,0.00018808796,0.2653105],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99887604,0.00025680265,0.00006927515,0.0001900114,0.00048105838,0.00012682997],"domain_scores_gemma":[0.9984073,0.00030898742,0.00010748777,0.000045504246,0.0004858922,0.0006449656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00181476,0.0006368191,0.0008352848,0.0007345564,0.00083508226,0.0016315791,0.0009661295,0.00400699,0.009811235],"category_scores_gemma":[0.0039986065,0.00020965708,0.00059769413,0.00055066467,0.00084545126,0.0016003129,0.0009703208,0.007139361,0.0044877604],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011690028,0.000050617167,0.0005236387,0.0001263487,0.00001565862,0.0004193304,0.000069143374,0.00005130216,0.00056585454,0.0021802722,0.9468608,0.049020052],"study_design_scores_gemma":[0.00007173726,0.0001248104,0.0009611824,0.00018357595,0.000019481575,0.001101251,0.00008491247,0.000090001355,0.00048143754,0.0012972776,0.9955623,0.000022154838],"about_ca_topic_score_codex":0.0031381007,"about_ca_topic_score_gemma":0.007031534,"teacher_disagreement_score":0.009811235,"about_ca_system_score_codex":0.0013692603,"about_ca_system_score_gemma":0.0019838165,"threshold_uncertainty_score":0.032821834},"labels":[],"label_agreement":null},{"id":"W2597223639","doi":"10.1200/jco.2007.25.18_suppl.1099","title":"Randomized phase II study of biweekly gemcitabine (gem)-paclitaxel (pac), gem-carboplatin (carb) and gem-cisplatin (cis) as first-line treatments in metastatic breast cancer (MBC) after anthracycline failure","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Clinical endpoint; Metastatic breast cancer; Interim analysis; Internal medicine; Carboplatin; Gemcitabine; Anthracycline; Breast cancer; Phases of clinical research; Surgery; Performance status; Chemotherapy; Oncology; Urology; Cancer; Randomized controlled trial; Gastroenterology; Cisplatin","score_opus":0.09059287299246062,"score_gpt":0.5155515087569532,"score_spread":0.4249586357644926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597223639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797204,0.0013995132,0.0012084929,0.00085573905,0.000585314,0.012059152,0.001844356,0.0002243907,0.002102604],"genre_scores_gemma":[0.9668502,0.0018918733,0.0040404503,0.0022800292,0.0005404977,0.015917527,0.0026183242,0.0000891083,0.0057721143],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99884903,0.00072558696,0.00005531824,0.0001330622,0.000058483674,0.00017844843],"domain_scores_gemma":[0.99756706,0.0005986029,0.00041281254,0.00023790667,0.000115735565,0.0010680194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038881428,0.002172552,0.0039237104,0.0007639883,0.0006075097,0.0014813944,0.0016159681,0.002294734,0.007859993],"category_scores_gemma":[0.0025654912,0.0012993972,0.0015451147,0.00075196,0.0019251022,0.0014990139,0.00062836317,0.00513089,0.0016747621],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93688095,0.0435634,0.0009961228,0.00024530818,0.00049179216,0.00006204173,0.00008975084,0.00058215007,0.005395005,0.000112902104,0.0011653006,0.0104153715],"study_design_scores_gemma":[0.87053686,0.12649135,0.0012423374,0.0000101092855,0.00017329406,0.000035362926,0.000019994808,0.0004061249,0.00048721436,0.000090534006,0.00049483264,0.000012059258],"about_ca_topic_score_codex":0.0010638401,"about_ca_topic_score_gemma":0.0027133063,"teacher_disagreement_score":0.007859993,"about_ca_system_score_codex":0.0010242971,"about_ca_system_score_gemma":0.0025381213,"threshold_uncertainty_score":0.02629435},"labels":[],"label_agreement":null},{"id":"W2597562859","doi":"10.1200/jco.2017.35.5_suppl.219","title":"A preliminary evaluation of the TrueNTH androgen deprivation therapy educational program.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; University Health Network; Baker Hughes (Canada); Prostate Cancer Canada; University of British Columbia","funders":"","keywords":"Medicine; Androgen deprivation therapy; Prostate cancer; Quality of life (healthcare); Adverse effect; Internal medicine; Oncology; Cancer; Physical therapy; Nursing","score_opus":0.3617694813062418,"score_gpt":0.6086548668789356,"score_spread":0.24688538557269374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597562859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.941191,0.0012608387,0.00070686796,0.002150227,0.00060925714,0.025720017,0.004572428,0.00015461746,0.023634799],"genre_scores_gemma":[0.90028226,0.0048906943,0.018978013,0.003240541,0.000536673,0.034606088,0.00891559,0.00010474006,0.028445255],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969272,0.0016582935,0.00016579338,0.0001810056,0.000736479,0.0003312181],"domain_scores_gemma":[0.99521184,0.0017894763,0.00026791522,0.00019038025,0.00088915805,0.0016511861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004477642,0.0004870159,0.0005321765,0.00046597046,0.0009929314,0.00095610984,0.0012200263,0.00080326304,0.012701187],"category_scores_gemma":[0.007687008,0.00023668398,0.0012478187,0.000592046,0.00032754557,0.00065996766,0.00071386545,0.0010478027,0.0011842083],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0426688,0.18611182,0.01853355,0.0025517964,0.00044994874,0.00028686077,0.0026717666,0.0006784576,0.0015503569,0.0007149568,0.010870571,0.73291117],"study_design_scores_gemma":[0.091037124,0.51022494,0.31915414,0.0015649373,0.0013366317,0.00032915192,0.005021723,0.002197957,0.0029324654,0.00066541357,0.065379724,0.00015578522],"about_ca_topic_score_codex":0.027980922,"about_ca_topic_score_gemma":0.05442044,"teacher_disagreement_score":0.027980922,"about_ca_system_score_codex":0.0024102447,"about_ca_system_score_gemma":0.00862389,"threshold_uncertainty_score":0.055636108},"labels":[],"label_agreement":null},{"id":"W2597837743","doi":"10.1200/jco.2013.31.15_suppl.e13503","title":"Development of a new equation to estimate GFR in cancer patients.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Carboplatin; Medicine; Renal function; Body surface area; Urology; Dosing; Lung cancer; Creatinine; Pharmacokinetics; Lean body mass; Internal medicine; Oncology; Nuclear medicine; Chemotherapy; Cisplatin; Body weight","score_opus":0.2701873512720473,"score_gpt":0.5754353173007194,"score_spread":0.3052479660286721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597837743","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.083130695,0.003816479,0.8940155,0.003564731,0.0010764633,0.0008139318,0.0038242177,0.0034845578,0.0062734634],"genre_scores_gemma":[0.32140878,0.0018044349,0.6636488,0.0009787899,0.0002962629,0.00124103,0.004378146,0.0003352283,0.0059086992],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988544,0.00036994793,0.00013014562,0.00017508316,0.0004417823,0.000028688835],"domain_scores_gemma":[0.99795604,0.000720692,0.0002069967,0.00012511633,0.00094371807,0.000047350102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025173991,0.00059970503,0.0010056606,0.0012250049,0.0001947277,0.0006856312,0.00072597293,0.0009625468,0.0023724684],"category_scores_gemma":[0.009387086,0.00039959326,0.00079385506,0.0008600746,0.00016186404,0.0009938495,0.0005776497,0.0011983333,0.001985218],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007919596,0.00026459058,0.18819205,0.0004010812,0.00053669955,0.0005628564,0.00018889048,0.046608113,0.0062823724,0.005633729,0.046772122,0.7037655],"study_design_scores_gemma":[0.0005103589,0.0006984746,0.08691818,0.00023880723,0.0005231158,0.003791228,0.00008968082,0.80515754,0.0072886986,0.0047255526,0.08993949,0.00011887148],"about_ca_topic_score_codex":0.0037786663,"about_ca_topic_score_gemma":0.0037143838,"teacher_disagreement_score":0.0037786663,"about_ca_system_score_codex":0.00093335164,"about_ca_system_score_gemma":0.0012065943,"threshold_uncertainty_score":0.013313472},"labels":[],"label_agreement":null},{"id":"W2598128017","doi":"10.1200/jco.2013.31.15_suppl.e14556","title":"Are XELOX and FOLFOX equivalent in colorectal cancer? Dose intensity, toxicity, and treatment duration in clinical practice.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"","keywords":"FOLFOX; Oxaliplatin; Medicine; Capecitabine; Internal medicine; Nausea; Colorectal cancer; Cumulative dose; Gastroenterology; Surgery; Oncology; Cancer","score_opus":0.20942390221721394,"score_gpt":0.5424612950939143,"score_spread":0.3330373928767003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598128017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9388349,0.051974386,0.0010983571,0.0031487748,0.00006734749,0.00012100326,0.0004896171,0.000010569941,0.0042550014],"genre_scores_gemma":[0.9971083,0.0015667068,0.00039226393,0.0005189033,0.00006734146,0.000030841456,0.00016060518,0.000004515582,0.00015043381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99356294,0.0035614271,0.00096636807,0.00047566826,0.0012046505,0.0002289283],"domain_scores_gemma":[0.9494802,0.02419039,0.022806892,0.00076643087,0.0012944436,0.0014616984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011157311,0.00007770947,0.00051197235,0.00047837998,0.00018684934,0.0009176422,0.00040893894,0.0006409938,0.0026459303],"category_scores_gemma":[0.049615096,0.00013411172,0.0007646161,0.0014342928,0.0004924191,0.001299886,0.0005426368,0.0006869353,0.00019345687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006406628,0.00015002301,0.8774734,0.00045053905,0.0007673464,0.000121465695,0.00023359442,0.0006587231,0.00040299687,0.00039741586,0.00068716105,0.112250745],"study_design_scores_gemma":[0.00046380333,0.0029432958,0.98953736,0.00027415596,0.0004037136,0.00073073193,0.00024637976,0.0011548793,0.0002296155,0.0006530186,0.003347052,0.000015915599],"about_ca_topic_score_codex":0.00072505616,"about_ca_topic_score_gemma":0.0011982385,"teacher_disagreement_score":0.011157311,"about_ca_system_score_codex":0.0010981377,"about_ca_system_score_gemma":0.0007422571,"threshold_uncertainty_score":0.059006155},"labels":[],"label_agreement":null},{"id":"W2598143957","doi":"10.1200/jco.2013.31.15_suppl.6595","title":"Patient perceptions about potential side effects and benefits from chemotherapy agents.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; McGill University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Nausea; Medicine; Mucositis; Side effect (computer science); Vomiting; Quality of life (healthcare); Chemotherapy; Internal medicine; Surgery","score_opus":0.06326017516239979,"score_gpt":0.4419449892995883,"score_spread":0.3786848141371885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598143957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99466383,0.00057424314,0.00007943268,0.0005405564,0.0000072044672,0.000027551201,0.0002721772,0.000004186951,0.003830888],"genre_scores_gemma":[0.99891925,0.00026480548,0.000111041765,0.00019425608,0.0000044088956,0.000009106278,0.00009962874,0.0000011464759,0.0003963869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899167,0.0003076626,0.000074700794,0.000046185913,0.00044257048,0.00013725513],"domain_scores_gemma":[0.99806696,0.0006283842,0.0006239816,0.000025659916,0.00028252613,0.00037248162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010880013,0.00013106003,0.00018345735,0.00034395585,0.00055208727,0.000647747,0.00018241181,0.00034190516,0.005402307],"category_scores_gemma":[0.004693797,0.0000859731,0.00037296058,0.00039839742,0.00044042655,0.00030986458,0.00035590483,0.0004891092,0.0003109981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000979176,0.00024068175,0.9396103,0.00023099035,0.00015392985,0.0004085008,0.0063400646,0.00038940928,0.0012981609,0.00014842078,0.0031164272,0.04708379],"study_design_scores_gemma":[0.00006256501,0.0009106147,0.98051214,0.000113809074,0.000099164994,0.0010846443,0.010842457,0.0006258754,0.00029629038,0.00015086314,0.005264278,0.00003716071],"about_ca_topic_score_codex":0.0742403,"about_ca_topic_score_gemma":0.10653416,"teacher_disagreement_score":0.0742403,"about_ca_system_score_codex":0.001940699,"about_ca_system_score_gemma":0.0013135924,"threshold_uncertainty_score":0.14761633},"labels":[],"label_agreement":null},{"id":"W2598864615","doi":"10.1200/jco.2012.30.15_suppl.e13598","title":"Pharmacodynamic evaluation of pCDC2 as the target engagement biomarker to assess activity of MK-1775 a Wee1 tyrosine kinase inhibitor.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Carboplatin; Gemcitabine; Wee1; Pharmacodynamics; Pharmacology; Oncology; Chemotherapy; Cisplatin; Biomarker; Tolerability; Internal medicine; Urology; Pharmacokinetics; Cancer; Cyclin-dependent kinase 1; Adverse effect","score_opus":0.39022315236694166,"score_gpt":0.585126215296599,"score_spread":0.19490306292965737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598864615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915234,0.0023209415,0.0025917839,0.00013821133,0.000034299243,0.00052355125,0.00078873895,0.00006653179,0.0020126177],"genre_scores_gemma":[0.99723685,0.00024855224,0.0010958812,0.000057873756,0.000014993262,0.00016268507,0.0004999901,0.000012544997,0.0006705482],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996424,0.00013876382,0.00001552966,0.000058515503,0.00010713186,0.000037759808],"domain_scores_gemma":[0.99958485,0.00011162196,0.00013263099,0.000037052876,0.000057744644,0.00007605462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096301455,0.0003817722,0.0005238406,0.00028498462,0.00011799512,0.0005189078,0.00027531665,0.00033360333,0.0015789196],"category_scores_gemma":[0.0009523786,0.00017000998,0.0003142791,0.0003315848,0.00026616937,0.00032686867,0.00016189323,0.0008404116,0.00030444548],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09141979,0.009005415,0.06017766,0.00082917983,0.0009521756,0.00029257612,0.00019107728,0.013730656,0.66302305,0.0005440462,0.003038841,0.15679552],"study_design_scores_gemma":[0.00996518,0.23351085,0.16513686,0.00005334371,0.0014878523,0.0019996224,0.00018202282,0.037877653,0.5327041,0.00041377818,0.016580947,0.00008772407],"about_ca_topic_score_codex":0.0004983432,"about_ca_topic_score_gemma":0.00086945447,"teacher_disagreement_score":0.0015789196,"about_ca_system_score_codex":0.0005966079,"about_ca_system_score_gemma":0.0004292193,"threshold_uncertainty_score":0.0052820444},"labels":[],"label_agreement":null},{"id":"W2599063392","doi":"10.1200/jco.2017.35.4_suppl.789","title":"ECOG performance status as a predictor of adjuvant chemotherapy (AC) toxicities in stage III colorectal cancer (CRC) patients.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Capecitabine; Nausea; Performance status; FOLFOX; Cohort; Anemia; Cancer; Adjuvant therapy; Vomiting; Univariate analysis; Colorectal cancer; Gastroenterology; Oncology; Surgery; Oxaliplatin; Multivariate analysis","score_opus":0.08958946198783549,"score_gpt":0.48544376314409,"score_spread":0.39585430115625453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599063392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970092,0.0013710235,0.00008347277,0.00014527424,0.000015788219,0.000011333597,0.0005914098,0.0000049059577,0.00076764077],"genre_scores_gemma":[0.99932945,0.00013788968,0.000044617816,0.000022918273,0.000011547694,0.000004536418,0.0003399053,0.0000014889862,0.00010769946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969935,0.00009144127,0.000032096796,0.00005282402,0.000067330235,0.000057023153],"domain_scores_gemma":[0.99764925,0.00060419337,0.001020626,0.00006934093,0.00020368428,0.00045282167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009865494,0.00023183823,0.0002138482,0.0006525195,0.00023434532,0.00044657348,0.00024725974,0.00041599927,0.0014042191],"category_scores_gemma":[0.0029243757,0.000117773,0.0004494313,0.0011045234,0.0002754054,0.00029193342,0.0002775746,0.0006058086,0.00022843806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015079831,0.0000063886587,0.9984534,0.0000070924702,0.000023759758,0.000030395597,0.000008560621,0.00004718212,0.000043010234,0.000003796742,0.00010330744,0.0011222844],"study_design_scores_gemma":[0.000006057737,0.000067903806,0.99932253,0.000006424709,0.00002871397,0.00012178413,0.00002555272,0.00021031135,0.000019613111,0.000012488022,0.00017677995,0.0000018266189],"about_ca_topic_score_codex":0.0045512286,"about_ca_topic_score_gemma":0.007492709,"teacher_disagreement_score":0.0045512286,"about_ca_system_score_codex":0.0003445653,"about_ca_system_score_gemma":0.0004380982,"threshold_uncertainty_score":0.009049475},"labels":[],"label_agreement":null},{"id":"W2599371299","doi":"10.1200/jco.2013.31.15_suppl.e11597","title":"Bevacizumab for advanced breast cancer: Hope, hype, and hundreds of headlines.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital; Queen's University; University of Toronto","funders":"","keywords":"Medicine; Bevacizumab; Breast cancer; Newspaper; Headline; Food and drug administration; Family medicine; Clinical trial; Cancer; Oncology; Internal medicine; Advertising; Pharmacology; Chemotherapy","score_opus":0.10516201181284197,"score_gpt":0.5141664109434135,"score_spread":0.40900439913057157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599371299","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40177462,0.32215852,0.0016648232,0.1376943,0.0076473816,0.00064281933,0.025664598,0.00027586147,0.102477096],"genre_scores_gemma":[0.74473274,0.15083979,0.003942133,0.043234367,0.0066849203,0.0004512978,0.00991834,0.00024220588,0.039954238],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997681,0.00067921885,0.0005489328,0.00011752527,0.0008588981,0.00011442329],"domain_scores_gemma":[0.9458153,0.031660296,0.014109575,0.00046100887,0.0065940595,0.0013597447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049137715,0.0002453573,0.00030941144,0.005467273,0.0006659926,0.0024567028,0.000342169,0.00067748665,0.012726045],"category_scores_gemma":[0.031673256,0.00029042267,0.0003590199,0.0075922837,0.0008780207,0.0028334833,0.00072827766,0.00045901025,0.0026962596],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011962459,0.0001020247,0.23273848,0.011533411,0.0002294208,0.0020660278,0.007720105,0.00006030812,0.0015060145,0.0018258091,0.2922437,0.44877845],"study_design_scores_gemma":[0.00007516875,0.0002198833,0.49449533,0.011467741,0.0003803147,0.00549675,0.020987237,0.00025031413,0.0009470299,0.00089267443,0.46473983,0.000047808102],"about_ca_topic_score_codex":0.0026144115,"about_ca_topic_score_gemma":0.0101118665,"teacher_disagreement_score":0.012726045,"about_ca_system_score_codex":0.0010724309,"about_ca_system_score_gemma":0.0013536859,"threshold_uncertainty_score":0.042572856},"labels":[],"label_agreement":null},{"id":"W2599456777","doi":"10.1200/jco.2006.24.18_suppl.14513","title":"Randomized phase II trial of irofulven (IROF)/prednisone (P), IROF/capecitabine (C)/P or mitoxantrone (M)/P in docetaxel-pretreated hormone refractory prostate cancer (HRPC) patients (pts)","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Docetaxel; Mitoxantrone; Clinical endpoint; Capecitabine; Internal medicine; Prostate cancer; Urology; Refractory (planetary science); Gastroenterology; Phases of clinical research; Chemotherapy; Randomized controlled trial; Surgery; Oncology; Cancer","score_opus":0.07944983119989771,"score_gpt":0.4741449583049285,"score_spread":0.39469512710503074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599456777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843612,0.002003062,0.00093584455,0.0006229914,0.00044873843,0.0069835503,0.0014563606,0.00020300568,0.0029852586],"genre_scores_gemma":[0.98185617,0.0017205172,0.0019808367,0.0013537373,0.00033614476,0.0061970875,0.002099683,0.00004212259,0.004413694],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995432,0.00023312125,0.00001943547,0.00009246501,0.00002680328,0.00008496289],"domain_scores_gemma":[0.9992787,0.00011068412,0.00011430538,0.000055115448,0.000031843178,0.00040931947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014468293,0.0023739494,0.002913221,0.0004943042,0.00045824365,0.0012236382,0.00096445845,0.001332652,0.008345259],"category_scores_gemma":[0.0010424197,0.00089581835,0.0014073806,0.0006229322,0.0014391348,0.0009249221,0.00049807824,0.0031477069,0.0016615576],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.965724,0.011481157,0.00084941153,0.00029558476,0.0004072817,0.00005863016,0.000070424605,0.00047729147,0.003724138,0.00016754778,0.0013119996,0.015432569],"study_design_scores_gemma":[0.92478704,0.07238557,0.0011564225,0.000014073901,0.00016333604,0.000045026478,0.000016586904,0.00034021965,0.00029618503,0.00011767403,0.00066695997,0.000010810384],"about_ca_topic_score_codex":0.0013742502,"about_ca_topic_score_gemma":0.003327755,"teacher_disagreement_score":0.008345259,"about_ca_system_score_codex":0.0009423452,"about_ca_system_score_gemma":0.0017465757,"threshold_uncertainty_score":0.027917624},"labels":[],"label_agreement":null},{"id":"W2599524623","doi":"10.1200/jco.2012.30.15_suppl.587","title":"Endocrine therapy in early breast cancer: Encouraging observations in a nontrial setting.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Letrozole; Exemestane; Tamoxifen; Breast cancer; Internal medicine; Cancer; Aromatase inhibitor; Metastatic breast cancer; Surgery; Oncology; Gynecology","score_opus":0.20944872204652545,"score_gpt":0.5267936544192303,"score_spread":0.3173449323727049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599524623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95059013,0.030881926,0.0022571827,0.0021444238,0.0002798355,0.0012638178,0.0009962172,0.00004632505,0.011540145],"genre_scores_gemma":[0.98602444,0.0072573493,0.0023945905,0.0013262796,0.00030396951,0.000679239,0.0008548695,0.000027672662,0.0011315335],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9940899,0.00449205,0.0006333694,0.00017659008,0.0004954651,0.00011250523],"domain_scores_gemma":[0.9589353,0.027686378,0.0060243467,0.002908785,0.0031771108,0.0012679873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015879782,0.00022286405,0.00053822383,0.000244411,0.0004595816,0.00097418635,0.0003944882,0.0007645783,0.0018790157],"category_scores_gemma":[0.031880274,0.00015324615,0.00046278973,0.0008903116,0.0006356987,0.0007260608,0.0003490963,0.0013448398,0.00043161423],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10180534,0.017164243,0.29980528,0.003990446,0.0016740701,0.0031117443,0.003351907,0.0012873716,0.010685523,0.00258657,0.007744403,0.54679316],"study_design_scores_gemma":[0.04454114,0.33299905,0.49298263,0.0023672518,0.0021281578,0.013434418,0.002011123,0.0038797553,0.012121215,0.0027672162,0.09065113,0.00011696565],"about_ca_topic_score_codex":0.00065809477,"about_ca_topic_score_gemma":0.0013853038,"teacher_disagreement_score":0.015879782,"about_ca_system_score_codex":0.00053619104,"about_ca_system_score_gemma":0.0010716394,"threshold_uncertainty_score":0.083981335},"labels":[],"label_agreement":null},{"id":"W2600242980","doi":"10.1200/jco.2012.30.15_suppl.1099","title":"Phase II trial of sorafenib (S) and vinorelbine (V) in metastatic breast cancer (mBC) with pharmacokinetics (PK) analysis.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Pharmacokinetics; Tolerability; Metastatic breast cancer; Vinorelbine; Internal medicine; Toxicity; Gastroenterology; Neutropenia; Urology; Pharmacology; Cancer; Breast cancer; Oncology; Chemotherapy; Adverse effect","score_opus":0.15162748440593077,"score_gpt":0.5508904711779373,"score_spread":0.39926298677200656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600242980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941962,0.001461448,0.00036693754,0.0003305234,0.000081873586,0.0015859957,0.00080082007,0.000060938917,0.0011152523],"genre_scores_gemma":[0.99088097,0.0008559528,0.000991334,0.00048432738,0.000111078094,0.0019679791,0.0021494294,0.000019495157,0.0025394661],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996346,0.0001841364,0.000015099133,0.000055431905,0.00003465672,0.00007603157],"domain_scores_gemma":[0.99939716,0.00010121577,0.00010429236,0.00003935162,0.000029292434,0.00032873478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010326663,0.0011980662,0.0015651345,0.00033113686,0.0002970038,0.000795645,0.00058418565,0.0011111175,0.004350731],"category_scores_gemma":[0.000833681,0.00053786946,0.00081369723,0.00032132532,0.0006023992,0.00056574814,0.00032969855,0.0018693828,0.00082773797],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83736634,0.039360017,0.0065463767,0.0005864232,0.0008265998,0.00048149267,0.00024249042,0.0027979594,0.045130927,0.0002779058,0.003603401,0.06278005],"study_design_scores_gemma":[0.5349052,0.44328558,0.011125232,0.000029850702,0.00026535123,0.00054443337,0.000050650848,0.0018796859,0.004235611,0.00022362849,0.0034288785,0.000025810703],"about_ca_topic_score_codex":0.00082972675,"about_ca_topic_score_gemma":0.0016730282,"teacher_disagreement_score":0.004350731,"about_ca_system_score_codex":0.0009571521,"about_ca_system_score_gemma":0.0015024072,"threshold_uncertainty_score":0.01455462},"labels":[],"label_agreement":null},{"id":"W2600898566","doi":"10.1200/jco.2012.30.15_suppl.540","title":"BOLERO-2: Everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone receptor-positive breast cancer.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Exemestane; Medicine; Everolimus; Internal medicine; Dysgeusia; Letrozole; Aromatase inhibitor; Anastrozole; Breast cancer; Oncology; Clinical endpoint; Adverse effect; Placebo; Population; Progression-free survival; Cancer; Clinical trial; Aromatase; Chemotherapy; Pathology","score_opus":0.05317573863883323,"score_gpt":0.4219023762950248,"score_spread":0.36872663765619157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600898566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470055,0.0035974318,0.00012338594,0.000211372,0.000071124035,0.00020881742,0.00016731236,0.000017307239,0.0009026545],"genre_scores_gemma":[0.99615234,0.0017959533,0.00043318977,0.00035673002,0.0001044065,0.00023609556,0.00030482223,0.0000051672664,0.00061127404],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99963033,0.000203722,0.000036593956,0.00005242222,0.000030444402,0.000046545898],"domain_scores_gemma":[0.9995141,0.00011580861,0.00015843476,0.000030107658,0.00001467155,0.00016687432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013897973,0.0006092135,0.0015445107,0.00031175982,0.0001869053,0.0006281015,0.0004723269,0.00048804784,0.0023927074],"category_scores_gemma":[0.00092640024,0.00029549302,0.001361516,0.000318146,0.000463398,0.00077376683,0.00044235593,0.001370471,0.00033004666],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8893479,0.008719686,0.010515688,0.00072469487,0.0024115625,0.000128609,0.00016046043,0.00093541,0.008971167,0.00012770433,0.0006800581,0.077277035],"study_design_scores_gemma":[0.41914472,0.5172964,0.049409233,0.00014032981,0.0041330815,0.00045624754,0.00017433103,0.0022530882,0.003490841,0.00027339224,0.0031790503,0.000049312293],"about_ca_topic_score_codex":0.0004205189,"about_ca_topic_score_gemma":0.0018903076,"teacher_disagreement_score":0.0023927074,"about_ca_system_score_codex":0.00048564858,"about_ca_system_score_gemma":0.000722886,"threshold_uncertainty_score":0.008004427},"labels":[],"label_agreement":null},{"id":"W2601214088","doi":"10.1200/jco.2012.30.15_suppl.7590","title":"Weekly nab-paclitaxel in combination with carboplatin as first-line therapy in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Medicine; Internal medicine; Carboplatin; non-small cell lung cancer (NSCLC); Clinical endpoint; Gastroenterology; Lung cancer; Population; Paclitaxel; Performance status; Cancer; Surgery; Chemotherapy; Oncology; Randomized controlled trial; Cisplatin","score_opus":0.04936182536150489,"score_gpt":0.43175248352997503,"score_spread":0.3823906581684701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601214088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977704,0.0013310792,0.00013108227,0.000057009438,0.000022587994,0.00017266413,0.00012724742,0.000013907487,0.00037392965],"genre_scores_gemma":[0.9978604,0.0008475343,0.00034951442,0.00016233147,0.000049107945,0.00013355495,0.00025917054,0.0000029891369,0.00033540055],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99982965,0.0000805685,0.000016314578,0.00002807477,0.000019222098,0.000026183967],"domain_scores_gemma":[0.99977666,0.000040718198,0.00006758622,0.000012138338,0.00000769947,0.00009519476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065157085,0.00034206608,0.0007429463,0.0002384103,0.00015329904,0.00035827284,0.00028236958,0.00029024965,0.0008432737],"category_scores_gemma":[0.00047048705,0.0002271001,0.00056549936,0.00030126507,0.000243215,0.00024171027,0.00021002983,0.0005464087,0.00021040885],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5442573,0.027668197,0.11576711,0.001061861,0.0022269632,0.000847638,0.00035730161,0.004406453,0.04992662,0.00019922135,0.0030523497,0.25022906],"study_design_scores_gemma":[0.15500355,0.55274165,0.27131015,0.000114325216,0.0017898044,0.0013052747,0.0001232567,0.004208767,0.0066318675,0.00022097814,0.0065120175,0.000038420574],"about_ca_topic_score_codex":0.00072700455,"about_ca_topic_score_gemma":0.0021583645,"teacher_disagreement_score":0.0008432737,"about_ca_system_score_codex":0.00048471487,"about_ca_system_score_gemma":0.0004820307,"threshold_uncertainty_score":0.0035169125},"labels":[],"label_agreement":null},{"id":"W2601596974","doi":"10.1200/jco.2013.31.15_suppl.6585","title":"Identification of knowledge translation opportunities in the treatment of locally advanced breast cancer: Results of a national survey of physicians.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Health Sciences Centre; Sunnybrook Health Science Centre; St. Michael's Hospital; University of Toronto; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Knowledge translation; Psychological intervention; Family medicine; Clinical Practice; Medical physics; Cancer; Internal medicine; Nursing; Knowledge management","score_opus":0.36150451644383275,"score_gpt":0.5286172422382871,"score_spread":0.16711272579445435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601596974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99223435,0.000671352,0.0000993305,0.0010987374,0.000009673224,0.00020144286,0.003396986,0.000008691089,0.0022794632],"genre_scores_gemma":[0.9965454,0.00059995026,0.0003190803,0.00047886223,0.0000062535896,0.00009032671,0.0013856735,0.0000031504667,0.00057125516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99672616,0.00064816675,0.0003672638,0.00026886255,0.0014342435,0.00055524934],"domain_scores_gemma":[0.9857713,0.002661987,0.003358895,0.0002494171,0.005692681,0.002265767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00376999,0.00016038654,0.00026690427,0.00097634114,0.0014794152,0.00086486037,0.0005352114,0.0004678223,0.0017836662],"category_scores_gemma":[0.014148503,0.00032756277,0.0003511782,0.0030019945,0.00063099834,0.00043628615,0.000819954,0.0006543348,0.00028724625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008006755,0.000073557676,0.9859568,0.00017752821,0.000027258633,0.00006253658,0.005131813,0.000062540996,0.0001578827,0.000025632015,0.0020455823,0.0061988407],"study_design_scores_gemma":[0.0000080110785,0.00005293962,0.994005,0.00005043909,0.0000073856154,0.00002841,0.004683232,0.0001230585,0.000032667765,0.000004590287,0.0009987368,0.000005352799],"about_ca_topic_score_codex":0.9011225,"about_ca_topic_score_gemma":0.9245631,"teacher_disagreement_score":0.9011225,"about_ca_system_score_codex":0.012315579,"about_ca_system_score_gemma":0.020895177,"threshold_uncertainty_score":0.19891953},"labels":[],"label_agreement":null},{"id":"W2601703087","doi":"10.1200/jco.2012.30.15_suppl.6083","title":"Chemotherapy in the oldest old: The feasibility of cytotoxic therapy in the 80+ population.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Discontinuation; Cancer; Lung cancer; Population; Internal medicine; Performance status; Chemotherapy; Surgery; Retrospective cohort study","score_opus":0.293374716593269,"score_gpt":0.5595872208055418,"score_spread":0.26621250421227277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601703087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99006164,0.0052538263,0.00005258337,0.0010096767,0.000020678808,0.000014561671,0.0003566712,0.0000022769816,0.0032280413],"genre_scores_gemma":[0.9970143,0.002148627,0.000051201914,0.0002994926,0.00004634866,0.000008382271,0.00018819641,0.0000015182046,0.00024194483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996885,0.00007910168,0.00003687931,0.00003115493,0.00010088462,0.00006351315],"domain_scores_gemma":[0.99821377,0.0003213793,0.00097154,0.000035278994,0.00014470748,0.00031336537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007483392,0.00006747195,0.00016262455,0.00033886603,0.00030840246,0.0005676686,0.00015801482,0.00020239635,0.001399509],"category_scores_gemma":[0.0024860152,0.00008036756,0.00018474052,0.00042904625,0.00020207123,0.00048077633,0.0003777036,0.00032602338,0.00023806047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016534672,0.000026580834,0.98671305,0.000025274581,0.000009467227,0.0002379204,0.00009932309,0.00002864671,0.00013045881,0.000036387173,0.00042576468,0.012101848],"study_design_scores_gemma":[0.000012672375,0.00027710616,0.99474466,0.0000686645,0.000028045053,0.0012532726,0.0004583618,0.000089996836,0.0001077493,0.00006511268,0.0028903089,0.000004100193],"about_ca_topic_score_codex":0.0040841517,"about_ca_topic_score_gemma":0.009943678,"teacher_disagreement_score":0.0040841517,"about_ca_system_score_codex":0.0005346144,"about_ca_system_score_gemma":0.00062535115,"threshold_uncertainty_score":0.008120716},"labels":[],"label_agreement":null},{"id":"W2602364135","doi":"10.1200/jco.2013.31.15_suppl.e14595","title":"Retrospective analysis of dose intensity, toxicity, and clinical outcomes in 5-fluorouracil based regimens in the treatment of metastatic colorectal cancer.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Oxaliplatin; Capecitabine; Internal medicine; Colorectal cancer; Oncology; Retrospective cohort study; Fluorouracil; Toxicity; Progression-free survival; Chemotherapy; Cancer","score_opus":0.1454874759263934,"score_gpt":0.5129613173902648,"score_spread":0.3674738414638714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602364135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985447,0.00054624357,0.000084052444,0.000021415379,0.000002999108,0.00001715526,0.00046986097,0.0000024436652,0.00031127728],"genre_scores_gemma":[0.9990736,0.00009768676,0.000059453898,0.000026340045,0.0000054335233,0.0000105692125,0.0006588086,0.0000012531916,0.000066662215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99937755,0.00013791367,0.0001039886,0.00011225634,0.00018995948,0.00007838272],"domain_scores_gemma":[0.998159,0.00039711947,0.0009129737,0.00009431362,0.00024141201,0.00019515918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079275627,0.0001270285,0.00024392422,0.00064732454,0.00023482775,0.00039349773,0.00018983123,0.00024650086,0.0006683493],"category_scores_gemma":[0.0019703244,0.00014862773,0.00029321262,0.001491753,0.00023698229,0.00024163128,0.00024249927,0.00022879314,0.00012326545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002521746,0.000018503699,0.99744475,0.000014318785,0.000033921064,0.0001339191,0.000026239182,0.000051267813,0.00018397428,0.000008945552,0.000091433285,0.0017405989],"study_design_scores_gemma":[0.000009748024,0.00019104253,0.9988073,0.000004282973,0.000022139215,0.00045765174,0.000052400796,0.00008763221,0.0000970088,0.000005858257,0.00026260185,0.000002312995],"about_ca_topic_score_codex":0.006656248,"about_ca_topic_score_gemma":0.009468234,"teacher_disagreement_score":0.006656248,"about_ca_system_score_codex":0.0007805776,"about_ca_system_score_gemma":0.00046973597,"threshold_uncertainty_score":0.013235033},"labels":[],"label_agreement":null},{"id":"W2602386620","doi":"10.1016/j.jpain.2017.02.267","title":"(417) The use of the Edmonton Classification system for Cancer Pain adds clinical complexity to the Breakthrough Cancer Pain assessment","year":2017,"lang":"en","type":"article","venue":"Journal of Pain","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer pain; Addiction; Morphine; Cancer; Lung cancer; Neuropathic pain; Observational study; Distress; Physical therapy; Internal medicine; Anesthesia; Psychiatry; Clinical psychology","score_opus":0.3948974510212561,"score_gpt":0.5161124588866398,"score_spread":0.1212150078653837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602386620","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33753195,0.013709558,0.037279088,0.025884029,0.0074576787,0.0011546421,0.011277756,0.00034812684,0.5653571],"genre_scores_gemma":[0.8746611,0.011834004,0.048116993,0.012006002,0.002940719,0.0006668181,0.0069123907,0.00017136041,0.042690527],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979341,0.00037600374,0.00034551654,0.00009468282,0.0010546818,0.0001950516],"domain_scores_gemma":[0.9972596,0.00058783987,0.00047241896,0.00011073746,0.001413303,0.00015601315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023016077,0.00034667508,0.0004436913,0.0012961248,0.0007536451,0.0014518622,0.0005697029,0.0006120717,0.0077839275],"category_scores_gemma":[0.0057728086,0.00013753497,0.00047586203,0.0018206864,0.0005326348,0.00088959286,0.00084848044,0.0013502788,0.0025413674],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006875753,0.00037316713,0.281664,0.0007426419,0.00016525398,0.0030185808,0.00092406187,0.0007724917,0.0059152734,0.026152661,0.116178446,0.56340575],"study_design_scores_gemma":[0.00014508303,0.0008600158,0.6604091,0.0014443083,0.00020120361,0.023212614,0.002955594,0.0043705245,0.0027542915,0.019317584,0.2840979,0.00023184337],"about_ca_topic_score_codex":0.011486294,"about_ca_topic_score_gemma":0.031177437,"teacher_disagreement_score":0.011486294,"about_ca_system_score_codex":0.0008366972,"about_ca_system_score_gemma":0.0018058126,"threshold_uncertainty_score":0.02603978},"labels":[],"label_agreement":null},{"id":"W2603056587","doi":"10.1200/jco.2014.32.15_suppl.1058","title":"Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel (WP) or eribulin (E) followed by doxorubicin and cyclophosphamide (AC) in women with locally advanced HER2-negative breast cancer (LABC): NSABP FB-9.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Eribulin; Taxane; Febrile neutropenia; Mucositis; Neutropenia; Anthracycline; Clinical endpoint; Cyclophosphamide; Gastroenterology; Chemotherapy; Surgery; Oncology; Cancer; Metastatic breast cancer; Clinical trial","score_opus":0.05818724985628228,"score_gpt":0.4897362801187247,"score_spread":0.43154903026244246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603056587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757675,0.0014998208,0.00076353765,0.0011030093,0.00077095197,0.0153314,0.0013678214,0.00012219306,0.0032736864],"genre_scores_gemma":[0.96298295,0.0017494874,0.0026456683,0.0021777,0.00059452193,0.021468658,0.0021887338,0.000031103653,0.006161086],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99938536,0.00036044748,0.000029042052,0.000094652016,0.000036142348,0.00009431061],"domain_scores_gemma":[0.99841404,0.00036711837,0.00034142248,0.00011547239,0.000076726596,0.0006851434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022426727,0.0019509911,0.0022815121,0.00047401467,0.00047202758,0.00094465597,0.0011322588,0.0017568249,0.011218269],"category_scores_gemma":[0.00222857,0.0008761266,0.0009960604,0.0004517841,0.001570772,0.0011943243,0.00053835,0.0035686588,0.0015070022],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96741176,0.022172865,0.00052690564,0.00018517289,0.00018005398,0.00003381959,0.000034308236,0.0003639046,0.0018646609,0.00009532183,0.0006969702,0.006434347],"study_design_scores_gemma":[0.90300983,0.095189914,0.00061984983,0.000013006209,0.00009105895,0.000020116458,0.00001500297,0.00033138707,0.00022966982,0.00009021816,0.00038361005,0.0000062794074],"about_ca_topic_score_codex":0.0010345125,"about_ca_topic_score_gemma":0.0026393284,"teacher_disagreement_score":0.011218269,"about_ca_system_score_codex":0.0010878785,"about_ca_system_score_gemma":0.0021437807,"threshold_uncertainty_score":0.037528872},"labels":[],"label_agreement":null},{"id":"W2603068525","doi":"10.1200/jco.2012.30.15_suppl.e19527","title":"Palliative inpatient chemotherapy: Clinical benefit or harm?","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Palliative care; Lung cancer; Performance status; Cancer; Regimen; Chemotherapy; Internal medicine","score_opus":0.35669271422426807,"score_gpt":0.5980000917517748,"score_spread":0.24130737752750675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603068525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43280128,0.14157459,0.0018855877,0.29797015,0.0035236138,0.00030246234,0.0028059483,0.00006020149,0.11907618],"genre_scores_gemma":[0.9397385,0.031498816,0.0006140573,0.020775778,0.0041595837,0.00007332235,0.00056933064,0.000015100176,0.0025554593],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978471,0.0013478651,0.00029104724,0.00006756935,0.00031387105,0.00013244536],"domain_scores_gemma":[0.9818464,0.011107291,0.005128388,0.00028327818,0.0009483795,0.0006863068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035029475,0.00015196795,0.00051241147,0.0004469523,0.00025551752,0.0013909467,0.0004181375,0.0012939606,0.015529885],"category_scores_gemma":[0.022576902,0.00012421292,0.0003990915,0.001086983,0.001076392,0.001390942,0.00050048373,0.00095781486,0.0012816241],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046649794,0.0003805153,0.41548347,0.0064620823,0.00049343717,0.00571734,0.00068652973,0.0005068655,0.00041595602,0.013878229,0.08552776,0.46578276],"study_design_scores_gemma":[0.0027601318,0.0034992802,0.5565415,0.031210057,0.0020630166,0.041508753,0.0118819345,0.0027462696,0.0018381936,0.055857103,0.2899268,0.00016697666],"about_ca_topic_score_codex":0.00022838775,"about_ca_topic_score_gemma":0.0006820058,"teacher_disagreement_score":0.015529885,"about_ca_system_score_codex":0.00053323066,"about_ca_system_score_gemma":0.00062662945,"threshold_uncertainty_score":0.0519526},"labels":[],"label_agreement":null},{"id":"W2603191492","doi":"10.1200/jco.2012.30.15_suppl.1025","title":"NSABP FB-6: Phase II trial of weekly paclitaxel (WP) and pazopanib following doxorubicin and cyclophosphamide (AC) as neoadjuvant therapy for HER2-negative locally advanced breast cancer (LABC).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Montreal General Hospital; Ottawa Hospital; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Pazopanib; Medicine; Internal medicine; Breast cancer; Clinical endpoint; Regimen; Oncology; Phases of clinical research; Chemotherapy; Tyrosine-kinase inhibitor; Cancer; Urology; Gastroenterology; Clinical trial","score_opus":0.08320078400952502,"score_gpt":0.5089545598580594,"score_spread":0.42575377584853435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603191492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98946464,0.0026394262,0.00041463814,0.00056643627,0.00016771976,0.0024691666,0.0012437329,0.00013347054,0.0029006803],"genre_scores_gemma":[0.9791531,0.003193484,0.0025472175,0.0009610274,0.0001856099,0.003035853,0.004810424,0.000027798596,0.0060856505],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99978155,0.00009764668,0.000011293296,0.000033002132,0.000030951407,0.000045549063],"domain_scores_gemma":[0.99968433,0.000043238524,0.00006117179,0.000015634752,0.000013254434,0.00018247866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012805948,0.0012090275,0.00123119,0.000444994,0.00031544713,0.0006540359,0.00080266886,0.0010643181,0.0050168424],"category_scores_gemma":[0.0006798419,0.00048418978,0.00067374477,0.0003495747,0.0009004257,0.0006398845,0.0004181281,0.0030012652,0.0011632711],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.75944686,0.04030121,0.0057525146,0.0015393778,0.0010176258,0.0005107802,0.00025459868,0.0039182026,0.039822415,0.000530861,0.0075616855,0.1393438],"study_design_scores_gemma":[0.75478715,0.2230482,0.008924398,0.00008168793,0.0003446859,0.00073980907,0.00004225041,0.0022216383,0.0042923125,0.00020048073,0.005286373,0.000031027103],"about_ca_topic_score_codex":0.0009805644,"about_ca_topic_score_gemma":0.0032841365,"teacher_disagreement_score":0.0050168424,"about_ca_system_score_codex":0.00083835964,"about_ca_system_score_gemma":0.0012764254,"threshold_uncertainty_score":0.016782999},"labels":[],"label_agreement":null},{"id":"W2603575264","doi":"10.1200/jco.2012.30.15_suppl.3047","title":"Clinical and correlative science results in a phase II study of UCN-01in combination with irinotecan in recurrent triple-negative breast cancer (TNBC).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Triple-negative breast cancer; Irinotecan; Taxane; Neutropenia; Internal medicine; Oncology; Phases of clinical research; Cancer; Vomiting; Peripheral blood mononuclear cell; Breast cancer; Gastroenterology; Chemotherapy","score_opus":0.1677929814383985,"score_gpt":0.5610055274139666,"score_spread":0.3932125459755681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603575264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940058,0.0015430186,0.0003177698,0.00036503712,0.0000687765,0.0014698165,0.00051383796,0.00003546745,0.0016805494],"genre_scores_gemma":[0.98714113,0.0018732894,0.0014281389,0.0008049624,0.00021418172,0.0020326513,0.0034621337,0.000028544275,0.003014987],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99879456,0.0007558895,0.0000632431,0.00011050006,0.00012703169,0.00014876174],"domain_scores_gemma":[0.99873406,0.00028363205,0.00022454096,0.00011363198,0.00009013967,0.00055402966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037544325,0.0016046888,0.0015697522,0.00048979267,0.0006777895,0.0011395491,0.0010836724,0.0015498062,0.0027503017],"category_scores_gemma":[0.0015088883,0.0006017181,0.00092593033,0.00044692718,0.001403983,0.0007136318,0.00039900155,0.0033227706,0.0008569105],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44865984,0.28224012,0.019091249,0.001017092,0.0020124149,0.0013620881,0.0011297106,0.0043387315,0.10785414,0.0003728585,0.007401224,0.12452059],"study_design_scores_gemma":[0.19952458,0.76375365,0.02102598,0.000043196993,0.00065460795,0.00080893596,0.000086787935,0.0010867639,0.008823632,0.00010401747,0.0040584523,0.000029411725],"about_ca_topic_score_codex":0.0014713864,"about_ca_topic_score_gemma":0.003111705,"teacher_disagreement_score":0.0037544325,"about_ca_system_score_codex":0.0012421033,"about_ca_system_score_gemma":0.0017708611,"threshold_uncertainty_score":0.019855618},"labels":[],"label_agreement":null},{"id":"W2603616054","doi":"10.1200/jco.2012.30.15_suppl.tps7618","title":"Weekly <i>nab</i>-paclitaxel in combination with carboplatin as first-line therapy in patients (pts) with advanced non-small cell lung cancer (NSCLC): Analysis of patient-reported neuropathy and taxane-associated symptoms.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Medicine; Taxane; Internal medicine; Tolerability; Carboplatin; Common Terminology Criteria for Adverse Events; Clinical endpoint; Paclitaxel; Oncology; Lung cancer; Adverse effect; Peripheral neuropathy; Gastroenterology; Cancer; Chemotherapy; Clinical trial; Breast cancer; Diabetes mellitus","score_opus":0.027568258179016925,"score_gpt":0.38018836991791655,"score_spread":0.3526201117388996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603616054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982881,0.0009411888,0.00011335604,0.000085145846,0.000016840519,0.00016679143,0.0001346912,0.000016628552,0.00023723528],"genre_scores_gemma":[0.99729747,0.00084668346,0.0006592456,0.00014503174,0.00005195478,0.00016623246,0.00042908278,0.000005848565,0.00039856447],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99965894,0.00017562586,0.000025660605,0.000053810876,0.000045848967,0.00004009841],"domain_scores_gemma":[0.99954224,0.00011377285,0.00014965446,0.000027802058,0.000019431505,0.00014717151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092624367,0.0005088222,0.0012114351,0.0003544651,0.0002441804,0.00058907236,0.00047380192,0.00061271316,0.00097097503],"category_scores_gemma":[0.0008479923,0.0003427694,0.0007878183,0.0005273238,0.00044302078,0.00032854482,0.00021232726,0.0010860323,0.00024206753],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5831416,0.029928066,0.09542002,0.0012941201,0.0022705495,0.0008021672,0.00047628928,0.004665319,0.08985302,0.00013838975,0.0021577927,0.18985263],"study_design_scores_gemma":[0.11577219,0.6256084,0.23035951,0.000078870245,0.0023448109,0.0019466353,0.00015283636,0.0048179342,0.013968959,0.00021219064,0.0046759252,0.00006186937],"about_ca_topic_score_codex":0.0007587582,"about_ca_topic_score_gemma":0.0019737564,"teacher_disagreement_score":0.0012114351,"about_ca_system_score_codex":0.00070141366,"about_ca_system_score_gemma":0.0006342608,"threshold_uncertainty_score":0.005089104},"labels":[],"label_agreement":null},{"id":"W2604055952","doi":"10.1016/j.clcc.2017.03.013","title":"Neurotoxicity Outcomes in a Population-based Cohort of Elderly Patients Treated With Adjuvant Oxaliplatin for Colorectal Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"","keywords":"Oxaliplatin; Medicine; Colorectal cancer; Oncology; Internal medicine; Neurotoxicity; Adjuvant; Cohort; Population; Cancer; Toxicity; Environmental health","score_opus":0.05068831074772731,"score_gpt":0.416747593082448,"score_spread":0.36605928233472074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604055952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994098,0.0001677888,0.000027724454,0.00002017653,0.000003021394,0.000003921308,0.00014820845,0.0000012228602,0.00021818996],"genre_scores_gemma":[0.9994553,0.000120925884,0.000018728839,0.000025843998,0.000007874769,0.0000039836013,0.0002680252,9.282847e-7,0.00009844368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997743,0.00003561318,0.000032201267,0.00006741097,0.000036443886,0.000054019216],"domain_scores_gemma":[0.99953604,0.00005640762,0.00020103755,0.0000328089,0.00007326512,0.00010052927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002703072,0.00024004662,0.0005339213,0.00057644746,0.00060519454,0.00076509285,0.0002046255,0.00031074556,0.00086848193],"category_scores_gemma":[0.0011182986,0.00023471942,0.00057503657,0.00093218515,0.0002641769,0.0005396987,0.0004466963,0.0005023125,0.00013458946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029758038,0.000044864802,0.99810326,0.000006367748,0.00011093159,0.00017993408,0.00005485697,0.000043117845,0.00019511349,0.00001212372,0.000061153674,0.000890676],"study_design_scores_gemma":[0.000018618073,0.0002624176,0.9985026,0.0000039069655,0.000094824885,0.00054463034,0.00023741642,0.000116008276,0.000038594764,0.000036412282,0.00013927766,0.0000052944633],"about_ca_topic_score_codex":0.0073174774,"about_ca_topic_score_gemma":0.008150815,"teacher_disagreement_score":0.0073174774,"about_ca_system_score_codex":0.00048353992,"about_ca_system_score_gemma":0.00043119065,"threshold_uncertainty_score":0.014549792},"labels":[],"label_agreement":null},{"id":"W2604489617","doi":"10.1200/jco.2004.22.14_suppl.624","title":"Risk of radiation pneumonitis in breast cancer patients treated with adjuvant taxanes and radiation","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Pneumonitis; Paclitaxel; Internal medicine; Adjuvant; Cancer; Oncology; Retrospective cohort study; Concomitant; Chemotherapy; Radiation Pneumonitis; Surgery; Lung","score_opus":0.03415493484110391,"score_gpt":0.41780437077431004,"score_spread":0.3836494359332061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604489617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99318707,0.005417065,0.00020268296,0.00013259963,0.000011503267,0.000019456626,0.00014222036,0.000004500141,0.000882914],"genre_scores_gemma":[0.99814487,0.0013488209,0.00014885607,0.000062430794,0.000025006908,0.0000108862905,0.00013810766,0.0000015358331,0.00011950056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995018,0.0001874103,0.0000700843,0.000062858155,0.00012525325,0.00005262655],"domain_scores_gemma":[0.99778444,0.0006526745,0.0011878369,0.00008158548,0.00013878291,0.00015478322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006648106,0.00011094086,0.00030848832,0.00065079046,0.00024770666,0.0003414651,0.00015430157,0.00031062946,0.0014819709],"category_scores_gemma":[0.0028895563,0.00015980599,0.00041565739,0.00069199374,0.00015730811,0.00023009458,0.00022747218,0.0003363985,0.00015663593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013132625,0.000013857308,0.9953609,0.00001935031,0.000037002508,0.0002412326,0.000024074867,0.000018324665,0.00014866106,0.0000074612904,0.00006569541,0.0039321412],"study_design_scores_gemma":[0.000026838197,0.00052424386,0.9891719,0.00004903952,0.00018561337,0.007950951,0.00014958897,0.00018008977,0.00033373278,0.00004608937,0.0013769425,0.000004927831],"about_ca_topic_score_codex":0.0009398226,"about_ca_topic_score_gemma":0.0013285638,"teacher_disagreement_score":0.0014819709,"about_ca_system_score_codex":0.0001977791,"about_ca_system_score_gemma":0.00025872645,"threshold_uncertainty_score":0.0049577355},"labels":[],"label_agreement":null},{"id":"W2604716799","doi":"10.1200/jco.2013.31.15_suppl.555","title":"A prognostic factor (PF) index for overall survival in a HER2-negative endocrine-resistant metastatic breast cancer (MBC) population: Analysis from the ATHENA trial.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Metastatic breast cancer; Population; Breast cancer; Taxane; Progression-free survival; Clinical endpoint; Anthracycline; Cancer; Chemotherapy; Clinical trial","score_opus":0.16179686464203244,"score_gpt":0.4976812030909953,"score_spread":0.3358843384489628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604716799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99246866,0.004175755,0.00042386085,0.00019778253,0.000037175567,0.0001045203,0.0018207676,0.000013969451,0.0007576045],"genre_scores_gemma":[0.99523634,0.0004702779,0.00032313532,0.00011138072,0.00007676322,0.00013500468,0.0033662834,0.000008945729,0.00027191913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822944,0.0010492721,0.00014558235,0.00030418692,0.0001685705,0.00010298329],"domain_scores_gemma":[0.9958548,0.001965245,0.0012426401,0.00043341427,0.00011691522,0.00038700958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065362887,0.0006472755,0.0012867104,0.00069916726,0.0002005254,0.0009169827,0.0006499048,0.00068964675,0.0020510033],"category_scores_gemma":[0.0059786974,0.00024879212,0.0028650628,0.0008847551,0.00039844454,0.00078402803,0.0008219386,0.0010253115,0.0002761447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19890676,0.0004940933,0.742011,0.0009604235,0.022270903,0.0003910928,0.00018145276,0.0036570388,0.0014734648,0.00031803537,0.0038242757,0.02551154],"study_design_scores_gemma":[0.024516769,0.009618551,0.9318389,0.00018618132,0.01952296,0.0008591524,0.00017276526,0.008003516,0.00042671498,0.0010014228,0.0037607881,0.000092293616],"about_ca_topic_score_codex":0.00090777926,"about_ca_topic_score_gemma":0.0012938534,"teacher_disagreement_score":0.0065362887,"about_ca_system_score_codex":0.0003926533,"about_ca_system_score_gemma":0.00038799713,"threshold_uncertainty_score":0.034567595},"labels":[],"label_agreement":null},{"id":"W2604888638","doi":"10.1200/jco.2004.22.90140.706","title":"Trastuzumab (T) and docetaxel (D) for the treatment of HER2 metastatic breast cancer (MBC): A literature based (LB) and individual patient data (IPD) meta-analysis (MA) of phase II trial","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Docetaxel; Internal medicine; Metastatic breast cancer; Oncology; Trastuzumab; Breast cancer; Meta-analysis; Clinical trial; Cochrane Library; MEDLINE; CINAHL; Cancer","score_opus":0.41150323797398336,"score_gpt":0.5572722318948445,"score_spread":0.14576899392086118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604888638","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.068158634,0.9233929,0.0031869144,0.000689327,0.0005271999,0.0018547229,0.0011005711,0.00010356757,0.0009861896],"genre_scores_gemma":[0.7102724,0.27408212,0.007768568,0.0017466072,0.0005901415,0.003265285,0.001332409,0.000084477084,0.0008580274],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.970038,0.022344347,0.0040552896,0.0016450925,0.00156439,0.00035300702],"domain_scores_gemma":[0.97579104,0.017756471,0.0039657583,0.001007499,0.0010750075,0.00040415893],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.034609955,0.0030734406,0.014703094,0.0072766524,0.0005561411,0.003604132,0.0020352625,0.0020021047,0.0025614458],"category_scores_gemma":[0.040140036,0.001601655,0.048251845,0.006317321,0.00069911,0.0022207184,0.0019346578,0.0020221919,0.00026873458],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014215295,0.00005713249,0.003921569,0.057596136,0.9122333,0.00009345708,0.000063288295,0.0011080378,0.0003330013,0.00011438278,0.00027526647,0.009989112],"study_design_scores_gemma":[0.004680168,0.0010530127,0.0025492022,0.003288312,0.98688614,0.0000611497,0.00003135089,0.0005114465,0.000119411845,0.00018247383,0.0006171626,0.000020093235],"about_ca_topic_score_codex":0.003946233,"about_ca_topic_score_gemma":0.008197485,"teacher_disagreement_score":0.9852969,"about_ca_system_score_codex":0.0025152555,"about_ca_system_score_gemma":0.0022016778,"threshold_uncertainty_score":0.18303716},"labels":[],"label_agreement":null},{"id":"W2605117686","doi":"10.1200/jco.2017.35.8_suppl.190","title":"Utilizing patient reported outcomes for patients recieving oral chemotherapy.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Capecitabine; Chemotherapy; Quality of life (healthcare); Intensive care medicine; Physical therapy; Internal medicine; Cancer; Nursing; Colorectal cancer","score_opus":0.30154577000438787,"score_gpt":0.5701173914839619,"score_spread":0.26857162147957403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605117686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9509476,0.0043436824,0.0027504256,0.00450083,0.00019673163,0.0019497005,0.013184347,0.0002019692,0.021924771],"genre_scores_gemma":[0.98940116,0.0007498146,0.0034566633,0.0005197515,0.00006511232,0.0011723209,0.0038739236,0.000017363476,0.0007439029],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933936,0.0031813076,0.0013995358,0.00035715723,0.0012696264,0.00039884314],"domain_scores_gemma":[0.97560775,0.0047386573,0.013671437,0.0006699407,0.0034300343,0.0018821396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008601472,0.000302614,0.0004587957,0.0013891687,0.00050653575,0.0013563754,0.00045625068,0.00034599655,0.00267173],"category_scores_gemma":[0.024003087,0.00011333063,0.0010559558,0.0018809403,0.00021517374,0.00083989353,0.0012058871,0.00096438633,0.0004877448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039414008,0.00038264098,0.9103069,0.00027844467,0.00016562312,0.000045747434,0.000449313,0.00019261749,0.0000783268,0.0001774665,0.0039576874,0.083571196],"study_design_scores_gemma":[0.00008592837,0.0014489093,0.9882434,0.00022274525,0.00016822772,0.00021652532,0.0008220695,0.0011097048,0.00030341462,0.00027521898,0.007075134,0.000028716158],"about_ca_topic_score_codex":0.0019141356,"about_ca_topic_score_gemma":0.0030828333,"teacher_disagreement_score":0.008601472,"about_ca_system_score_codex":0.0009794137,"about_ca_system_score_gemma":0.001367977,"threshold_uncertainty_score":0.04548949},"labels":[],"label_agreement":null},{"id":"W2605305617","doi":"10.1200/jco.2012.30.15_suppl.6619","title":"Initial characterization of the toxicity and efficacy of elacytarabine (CP-4055), a novel antileukemic agent, using a multidimensional exposure-response relationship model.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Pharmacokinetics; Medicine; Toxicity; Dosing; Pharmacology; Population; Pharmacodynamics; Oncology; Internal medicine","score_opus":0.265419063122809,"score_gpt":0.5002150856960331,"score_spread":0.23479602257322413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605305617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9581027,0.00037102966,0.03901861,0.0001113963,0.000005609951,0.00013428183,0.00065952743,0.00014768536,0.0014491938],"genre_scores_gemma":[0.9956934,0.00006318776,0.003407725,0.000016128197,0.0000018099358,0.00007904514,0.00034417785,0.000008157512,0.0003864407],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997619,0.00012849995,0.000010629185,0.00004723702,0.000026615435,0.000025200188],"domain_scores_gemma":[0.99793494,0.0017419327,0.00014153247,0.00005010184,0.00010235661,0.000029164175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013822431,0.00052507635,0.0005248359,0.0003287679,0.00012714519,0.0004894772,0.00047868793,0.00058758556,0.0012563464],"category_scores_gemma":[0.0032855775,0.00026142225,0.00097636814,0.00020630499,0.00016538668,0.00023855832,0.00025787632,0.00066529546,0.0001450552],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009060804,0.00017414961,0.013676137,0.000094983305,0.00014350822,0.000106674124,0.00006538219,0.9728644,0.004836855,0.0004707343,0.00025275385,0.006408418],"study_design_scores_gemma":[0.000043510943,0.00046890645,0.0076100943,0.0000058218493,0.00006028833,0.00009351193,0.000014633545,0.9885161,0.0026035109,0.0002502719,0.00032332042,0.000009961325],"about_ca_topic_score_codex":0.0064156037,"about_ca_topic_score_gemma":0.0022905588,"teacher_disagreement_score":0.0064156037,"about_ca_system_score_codex":0.0014410389,"about_ca_system_score_gemma":0.00081720325,"threshold_uncertainty_score":0.0127565265},"labels":[],"label_agreement":null},{"id":"W2605718406","doi":"10.71781/11823","title":"Progrès dans la synthèse de l'analogue [Val₆ (6S)-Mel²aa₄₋₅] de l'auréobasidine B","year":2004,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Chemistry; Physics","score_opus":0.0062520766491072025,"score_gpt":0.21535318497763914,"score_spread":0.20910110832853193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605718406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88962805,0.0160573,0.03347975,0.0013996011,0.0014522631,0.000449657,0.0010243241,0.0005037913,0.056005273],"genre_scores_gemma":[0.9456479,0.006800967,0.013378941,0.00026511736,0.00017512495,0.00012348212,0.0006828868,0.00008113214,0.032844424],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997899,0.00006214967,0.000013884127,0.0000497491,0.00004249604,0.00004187401],"domain_scores_gemma":[0.99986076,0.000042588887,0.000025019148,0.000018370889,0.000024244486,0.000029011151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043019236,0.00037049325,0.00035557183,0.00018326119,0.00034752287,0.00038476844,0.00053932256,0.0006040259,0.004237889],"category_scores_gemma":[0.0004825302,0.0001862533,0.0002714153,0.00016021902,0.0003176559,0.0004076681,0.00024206362,0.00086038565,0.001684605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013664728,0.00022681872,0.00021668474,0.000490964,0.00004197778,0.0005517283,0.00031254662,0.0017528355,0.9614953,0.0040897555,0.001673749,0.027781133],"study_design_scores_gemma":[0.00017888926,0.0020366444,0.00077114295,0.000041271265,0.000034035435,0.00049427187,0.000053056974,0.0009905534,0.93996567,0.00032461935,0.05506877,0.00004107157],"about_ca_topic_score_codex":0.0028066237,"about_ca_topic_score_gemma":0.0021354367,"teacher_disagreement_score":0.004237889,"about_ca_system_score_codex":0.00044519466,"about_ca_system_score_gemma":0.000504441,"threshold_uncertainty_score":0.014177144},"labels":[],"label_agreement":null},{"id":"W2605759430","doi":"10.2217/fon-2017-0062","title":"ESAS and FACT-B in eribulin-treated metastatic breast cancer patients: a multicenter, prospective and observational study","year":2017,"lang":"en","type":"article","venue":"Future Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Eribulin; Metastatic breast cancer; Observational study; Internal medicine; Quality of life (healthcare); Oncology; Breast cancer; Prospective cohort study; Cancer; Nursing","score_opus":0.05307339089581799,"score_gpt":0.408731362008138,"score_spread":0.35565797111232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605759430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990233,0.00052818045,0.000041190568,0.000018181454,0.000003661314,0.00002150858,0.00022099963,0.0000012437644,0.00014159037],"genre_scores_gemma":[0.9989172,0.00024267215,0.00010953989,0.000039259947,0.000020294481,0.00003960539,0.0005429409,0.0000010587344,0.00008750297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992963,0.00034116735,0.00006943343,0.00012113586,0.00010524325,0.00006670244],"domain_scores_gemma":[0.99845266,0.0002915946,0.0007921235,0.00010398534,0.0001002064,0.00025938917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012805564,0.00033734704,0.0006583805,0.0005087439,0.00040864124,0.00051125744,0.0002411562,0.00046084676,0.0008779421],"category_scores_gemma":[0.0018351863,0.000223302,0.0005067354,0.00097273575,0.00026553267,0.00038770892,0.00032790363,0.0005513416,0.00017201563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003436872,0.0004835298,0.99310356,0.000040851013,0.00017974549,0.00011862167,0.00007010235,0.000054196946,0.00043685196,0.000014866243,0.00010778514,0.0019531108],"study_design_scores_gemma":[0.00034348635,0.003026947,0.994948,0.000012505299,0.00019205209,0.00053434796,0.00014053215,0.00020082519,0.0001551885,0.000013529282,0.0004248531,0.000007627333],"about_ca_topic_score_codex":0.0011545956,"about_ca_topic_score_gemma":0.0011538079,"teacher_disagreement_score":0.0012805564,"about_ca_system_score_codex":0.00027001614,"about_ca_system_score_gemma":0.00028893325,"threshold_uncertainty_score":0.0067723393},"labels":[],"label_agreement":null},{"id":"W2607020465","doi":"10.1016/s0016-5085(17)31573-1","title":"No Increase in Immunomodulator Use in Combination with Anti-TNF Therapy in the Post Sonic ERA","year":2017,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Tumor necrosis factor alpha; Medicine; Pharmacology; Immunology","score_opus":0.017411025760797293,"score_gpt":0.2900728645555634,"score_spread":0.27266183879476613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607020465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9529275,0.026082609,0.00065600435,0.0011994411,0.0004957661,0.000060694787,0.002397892,0.00009789241,0.016082237],"genre_scores_gemma":[0.988971,0.0044547236,0.00037311728,0.00052202377,0.00034408204,0.000034896646,0.0011874594,0.000021906182,0.00409084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905425,0.0002064999,0.00011954808,0.00013626777,0.00027084321,0.00021260027],"domain_scores_gemma":[0.9965863,0.0012358516,0.0010062774,0.00022491207,0.00040322382,0.0005434634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006315326,0.00024215294,0.00067586283,0.0005273693,0.00030406,0.0007246151,0.00027310307,0.0006231878,0.0060424567],"category_scores_gemma":[0.0037976403,0.00013033832,0.0007322713,0.0009064271,0.00025590538,0.000577989,0.00041720556,0.0012845491,0.0011203453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04964574,0.0012746418,0.6565861,0.001406378,0.0010871881,0.0019799783,0.00037732118,0.00024002869,0.025124745,0.0007899557,0.0037883515,0.25769955],"study_design_scores_gemma":[0.00016821579,0.006059726,0.96878403,0.00017128132,0.0012077661,0.002286138,0.00037288587,0.00017618123,0.0031290432,0.00021852377,0.017408649,0.000017491815],"about_ca_topic_score_codex":0.00106619,"about_ca_topic_score_gemma":0.002204598,"teacher_disagreement_score":0.0060424567,"about_ca_system_score_codex":0.00054421846,"about_ca_system_score_gemma":0.0010000684,"threshold_uncertainty_score":0.020214021},"labels":[],"label_agreement":null},{"id":"W2607070724","doi":"","title":"Quantifying and predicting upper limb capability and dysfunction of breast cancer survivors","year":2014,"lang":"en","type":"dissertation","venue":"UWSpace (University of Waterloo)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Medicine; Cancer; Oncology; Physical medicine and rehabilitation; Internal medicine","score_opus":0.01527177311949994,"score_gpt":0.25501806065362914,"score_spread":0.2397462875341292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607070724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973162,0.00021406186,0.00025844414,0.00006209365,0.0000053584026,0.000038311744,0.000786488,0.000009504034,0.0013096051],"genre_scores_gemma":[0.99616796,0.0004984032,0.001086103,0.00003426424,0.000008467223,0.000055298915,0.0012127281,0.000002974935,0.0009339171],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980074,0.000037810874,0.00002495921,0.000028700902,0.00007042382,0.000037468788],"domain_scores_gemma":[0.99959844,0.00007562451,0.00013894586,0.000023546632,0.0000985521,0.0000649032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057804765,0.00032331934,0.00019695597,0.0010288728,0.0002205647,0.0006265216,0.0002709644,0.00030611522,0.0015102812],"category_scores_gemma":[0.0018730706,0.00011989535,0.00028079504,0.0004939667,0.00015654632,0.00025844589,0.0006361961,0.0002722478,0.0005827453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025288862,0.000060395367,0.9850454,0.000019997105,0.000015370846,0.000024241537,0.00015525619,0.00019143627,0.00030118474,0.00002137795,0.00038287634,0.013757154],"study_design_scores_gemma":[0.0000019585746,0.00016028086,0.99790394,0.000021251257,0.000016454715,0.00010200292,0.00042250316,0.0005050917,0.0003010358,0.00004287643,0.00051799015,0.000004692089],"about_ca_topic_score_codex":0.0054206774,"about_ca_topic_score_gemma":0.010037939,"teacher_disagreement_score":0.0054206774,"about_ca_system_score_codex":0.00019617779,"about_ca_system_score_gemma":0.00025286883,"threshold_uncertainty_score":0.010778248},"labels":[],"label_agreement":null},{"id":"W2607528826","doi":"","title":"Preclinical assessment of a fixed dose combination of novel liposome formulations of idarubicin and gemcitabine showing improved antitumor activity","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Gemcitabine; Pharmacology; Drug; Idarubicin; Medicine; Liposome; Therapeutic index; Pharmacokinetics; Chemotherapy; Cytarabine; Chemistry; Internal medicine","score_opus":0.2040143750113472,"score_gpt":0.5404268104338324,"score_spread":0.3364124354224852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607528826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951283,0.00085309806,0.0028242536,0.0000607184,0.00002756785,0.0001486942,0.00016923371,0.000045590492,0.0007426731],"genre_scores_gemma":[0.9931131,0.00084092875,0.0046228925,0.00003222266,0.00001208926,0.00011588961,0.00040312583,0.000014902981,0.0008448196],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986804,0.00003143971,0.000014857429,0.000025974237,0.000034878904,0.0000247445],"domain_scores_gemma":[0.9998852,0.000025363062,0.000028787075,0.000010873483,0.000023536188,0.000026182724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044611437,0.0003899931,0.0002894745,0.00026728984,0.000097850425,0.00022146114,0.0002916783,0.0003336819,0.00075716124],"category_scores_gemma":[0.00019391433,0.00014022262,0.0002475402,0.00017152786,0.00019641884,0.00026720396,0.00014621935,0.00060986326,0.00018314991],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053261296,0.00057623937,0.00016147876,0.000055009008,0.000016478765,0.000029290695,0.0000183002,0.00056018535,0.99486095,0.000059015038,0.00005989359,0.0030705505],"study_design_scores_gemma":[0.000113596056,0.013418015,0.0010130341,0.0000068277272,0.000060800285,0.00008859036,0.0000109686625,0.0018389869,0.9822712,0.000018122197,0.0011536304,0.000006292613],"about_ca_topic_score_codex":0.00035677588,"about_ca_topic_score_gemma":0.00041702465,"teacher_disagreement_score":0.00075716124,"about_ca_system_score_codex":0.00030913868,"about_ca_system_score_gemma":0.00028415062,"threshold_uncertainty_score":0.002532959},"labels":[],"label_agreement":null},{"id":"W2610037390","doi":"10.1021/acs.bioconjchem.7b00165","title":"Comparison of Tumor Penetration of Podophyllotoxin–Carboxymethylcellulose Conjugates with Various Chemical Compositions in Tumor Spheroid Culture and In Vivo Solid Tumor","year":2017,"lang":"en","type":"article","venue":"Bioconjugate Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of British Columbia","funders":"Canadian Institutes of Health Research; National Institutes of Health; Natural Sciences and Engineering Research Council of Canada; University of British Columbia","keywords":"In vivo; Chemistry; Conjugate; Podophyllotoxin; Penetration (warfare); Polyethylene glycol; Spheroid; PEG ratio; Biophysics; Drug delivery; Carboxymethyl cellulose; Nanoparticle; In vitro; Chromatography; Stereochemistry; Biochemistry; Nanotechnology; Organic chemistry; Materials science","score_opus":0.017564636617805725,"score_gpt":0.32496209587121255,"score_spread":0.30739745925340684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610037390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951534,0.0010195695,0.002816142,0.000032615084,0.0000148603485,0.000027905091,0.000110206376,0.000039756942,0.00078540616],"genre_scores_gemma":[0.99338055,0.0010742617,0.0035922276,0.000023683404,0.0000070228275,0.000040905958,0.0002741004,0.000026611338,0.001580621],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998498,0.00003378345,0.000018111421,0.000030450912,0.000044759985,0.000023016615],"domain_scores_gemma":[0.9998191,0.00006186893,0.000044312907,0.000017736213,0.000027010728,0.00002995109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020437066,0.00040467354,0.00027640947,0.00018451923,0.00007926848,0.00019188451,0.00010202922,0.00022832374,0.00042616602],"category_scores_gemma":[0.00019226178,0.000120684395,0.00018817867,0.00016386234,0.00012494814,0.00026591445,0.0000888678,0.00033179953,0.00013101306],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041073006,0.000020276882,0.0000938591,0.000014092372,0.000003984474,0.000012408184,0.000013731582,0.00008807842,0.99910706,0.000014249571,0.0000057228817,0.0005855608],"study_design_scores_gemma":[0.0000038603766,0.00030427508,0.0012471377,0.0000011798976,0.0000129705295,0.000030961266,0.0000072821313,0.0007690731,0.9973968,0.000005167519,0.00021986391,0.0000015393699],"about_ca_topic_score_codex":0.00082081626,"about_ca_topic_score_gemma":0.0008632133,"teacher_disagreement_score":0.00082081626,"about_ca_system_score_codex":0.00026422198,"about_ca_system_score_gemma":0.00018353782,"threshold_uncertainty_score":0.0019171238},"labels":[],"label_agreement":null},{"id":"W2610690192","doi":"10.25011/cim.v31i4.4827","title":"THE DYNACTOME: INVESTIGATING DYNAMIC KINASE NETWORKS IN CELLULAR DECISION-MAKING","year":2008,"lang":"en","type":"article","venue":"Clinical and investigative medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Kinase; Phosphorylation; Context (archaeology); Cell biology; Annexin; Apoptosis; Signal transduction; Biology; Carcinogenesis; Chemistry; Cancer research; Computational biology; Biochemistry; Gene","score_opus":0.12688458924266033,"score_gpt":0.40422873931195386,"score_spread":0.2773441500692935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610690192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8789136,0.011150153,0.098191366,0.001768565,0.00018151705,0.00010725707,0.0014157989,0.00024267253,0.008029047],"genre_scores_gemma":[0.95120645,0.00577007,0.039837718,0.0001507034,0.00006894699,0.00012805886,0.0005962903,0.000032090862,0.0022097055],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985445,0.000035356057,0.0000066336725,0.000040186576,0.000038488233,0.000024806825],"domain_scores_gemma":[0.9996953,0.00013143063,0.000073033036,0.000021427957,0.000021998998,0.00005677348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040803457,0.0003205497,0.0003993861,0.0006658524,0.000435928,0.0010622304,0.000376007,0.0005091905,0.0019382068],"category_scores_gemma":[0.0006799543,0.0002379486,0.00022541097,0.00052208843,0.0005954465,0.0020841942,0.000626316,0.000826349,0.00034269507],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010486648,0.00020500114,0.014908343,0.0011843321,0.0002218509,0.00038625693,0.00032335625,0.043594852,0.8012267,0.04866351,0.0020871127,0.08615],"study_design_scores_gemma":[0.00017350027,0.00064425194,0.11674396,0.00016908739,0.00014366748,0.0017691493,0.0007882643,0.5123991,0.24182737,0.085466065,0.03968373,0.00019182308],"about_ca_topic_score_codex":0.0006872313,"about_ca_topic_score_gemma":0.00084672746,"teacher_disagreement_score":0.0019382068,"about_ca_system_score_codex":0.0007621657,"about_ca_system_score_gemma":0.00033350315,"threshold_uncertainty_score":0.0064839125},"labels":[],"label_agreement":null},{"id":"W2613801984","doi":"10.1200/jco.2013.31.15_suppl.7071","title":"Quality of life (QOL) and physical function in one-year adult and elderly survivors of acute myeloid leukemia (AML).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Quality of life (healthcare); Grip strength; Prospective cohort study; Internal medicine; Myeloid leukemia; Longitudinal study; Physical therapy; Pathology","score_opus":0.10019789548511553,"score_gpt":0.4559775932760604,"score_spread":0.35577969779094487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613801984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999012,0.00045726012,0.000024810519,0.00004846609,0.0000041870308,0.000007014324,0.00027085684,0.0000014749702,0.00017386905],"genre_scores_gemma":[0.99930656,0.00015738427,0.00003520728,0.000049082497,0.000008344315,0.0000099061235,0.0003345331,4.5829088e-7,0.00009857322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997224,0.000080534126,0.00002565487,0.000035963818,0.000068930756,0.000066522094],"domain_scores_gemma":[0.99922717,0.00008964738,0.00039214385,0.00002042557,0.00006464643,0.00020599684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007518009,0.0001904066,0.000283638,0.0004049726,0.00026162722,0.00037067273,0.00017182317,0.0003123891,0.0011144228],"category_scores_gemma":[0.0016980239,0.000117004325,0.00036037818,0.0005111502,0.00016695338,0.00041265925,0.00037830343,0.00045209622,0.000205733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002714612,0.00008441206,0.9961647,0.000016770053,0.00005530712,0.000054472614,0.00008927832,0.000042049804,0.000120689125,0.0000051419947,0.00014645672,0.002949301],"study_design_scores_gemma":[0.000011719244,0.00031658908,0.9992244,0.00000450666,0.00002120671,0.00011939524,0.00006427814,0.00007135967,0.00002371802,0.000006835983,0.00013385744,0.0000019787751],"about_ca_topic_score_codex":0.0023348671,"about_ca_topic_score_gemma":0.003333821,"teacher_disagreement_score":0.0023348671,"about_ca_system_score_codex":0.00027922186,"about_ca_system_score_gemma":0.00019892368,"threshold_uncertainty_score":0.004642606},"labels":[],"label_agreement":null},{"id":"W2613988704","doi":"10.71781/3705","title":"Caractérisation moléculaire de la mPGES-1 canine et son expression dans les carcinomes spinocellulaires","year":2006,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Molecular biology; Biology","score_opus":0.00701282763369151,"score_gpt":0.2224989457946554,"score_spread":0.21548611816096389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613988704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924936,0.0019965605,0.0018060037,0.00022486981,0.000029613246,0.000019853805,0.0006270281,0.000056858433,0.0027456346],"genre_scores_gemma":[0.9891556,0.00083886465,0.002029348,0.00004843583,0.0000139667845,0.000035116776,0.0007844705,0.000018162467,0.0070760655],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998568,0.000010380829,0.0000055239634,0.000035208395,0.000041574072,0.000050478113],"domain_scores_gemma":[0.9998615,0.000033960867,0.000026743246,0.000013622703,0.000037613347,0.000026559308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019803403,0.00019804688,0.0001466473,0.00070522877,0.0005626391,0.0005234413,0.00019174477,0.00037853594,0.0034538337],"category_scores_gemma":[0.00027688846,0.00018788823,0.00031474687,0.00026425222,0.00039986172,0.0002935872,0.00019664447,0.000739814,0.00062136643],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117673226,0.000019326788,0.008728539,0.000032938737,0.000016132435,0.00032755875,0.00023326112,0.000091453934,0.9853182,0.00029543153,0.00014475848,0.004674738],"study_design_scores_gemma":[0.000029727773,0.0003208893,0.2875344,0.000023277742,0.00007458026,0.0037558256,0.0010964235,0.0010843216,0.6907461,0.00021275986,0.015104239,0.000017373495],"about_ca_topic_score_codex":0.008895155,"about_ca_topic_score_gemma":0.008647386,"teacher_disagreement_score":0.008895155,"about_ca_system_score_codex":0.00052500854,"about_ca_system_score_gemma":0.0003443893,"threshold_uncertainty_score":0.017686784},"labels":[],"label_agreement":null},{"id":"W2615601352","doi":"10.3390/cancers9050052","title":"Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways","year":2017,"lang":"en","type":"review","venue":"Cancers","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1973,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; University of Alberta","keywords":"Cyclin-dependent kinase 8; Cancer research; Epidermal growth factor receptor; Signal transduction; Protein kinase B; MAPK/ERK pathway; ERBB3; Receptor tyrosine kinase; Biology; PI3K/AKT/mTOR pathway; Growth factor receptor; Cell cycle; Cell biology; Cancer; Notch signaling pathway","score_opus":0.15740548245471456,"score_gpt":0.3949922547634476,"score_spread":0.23758677230873307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615601352","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005397857,0.98961776,0.00039208087,0.0003959297,0.00037815492,0.000020492653,0.00013351654,0.00003133793,0.008490896],"genre_scores_gemma":[0.0023558338,0.992543,0.00027892037,0.00022042921,0.00014245723,0.000015715123,0.00015705872,0.0000026093792,0.0042839386],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999869,0.000014242986,0.000015974178,0.000021954173,0.00006128938,0.000017530403],"domain_scores_gemma":[0.9999417,0.0000138938385,0.000009137524,0.0000024335486,0.000024982759,0.00000777047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018915026,0.0007098016,0.0007018961,0.0012729537,0.00025513483,0.00080611894,0.0005768893,0.00052430364,0.0063630096],"category_scores_gemma":[0.00018477558,0.00017145592,0.00041591187,0.000999207,0.0002203564,0.00064690976,0.000504795,0.0013880209,0.0039419658],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008358866,0.00009493948,0.00018998302,0.012785717,0.00008684397,0.00027929718,0.00006544426,0.00043227337,0.009541883,0.0070471666,0.041597947,0.92779505],"study_design_scores_gemma":[0.000011150788,0.00005086442,0.0004026223,0.00082057517,0.00003759187,0.00071980763,0.000021651276,0.00006092285,0.001900332,0.0010179395,0.9949469,0.0000095982805],"about_ca_topic_score_codex":0.00089208205,"about_ca_topic_score_gemma":0.0013015213,"teacher_disagreement_score":0.0063630096,"about_ca_system_score_codex":0.00056261366,"about_ca_system_score_gemma":0.00070900423,"threshold_uncertainty_score":0.021286368},"labels":[],"label_agreement":null},{"id":"W2625687193","doi":"10.1158/1078-0432.ccr-16-3224","title":"Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Common Fund; National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; National Cancer Institute; NIH Office of the Director; National Human Genome Research Institute; National Institute of Mental Health; National Heart, Lung, and Blood Institute; National Institutes of Health; Université de Genève; University of Pennsylvania; RIKEN; Broad Institute; Harvard University; National Institute on Drug Abuse; University of Miami","keywords":"Medicine; Internal medicine; Cancer; Imputation (statistics); Peripheral neuropathy; Cisplatin; Genome-wide association study; Oncology; Diabetes mellitus; Body mass index; Single-nucleotide polymorphism; Genotype; Chemotherapy; Endocrinology; Genetics; Gene; Biology","score_opus":0.28480858156993494,"score_gpt":0.5834587144445557,"score_spread":0.2986501328746207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625687193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99861264,0.00021798642,0.00012494244,0.000020126281,0.0000026327025,0.000007855264,0.00087784167,0.0000042162037,0.00013168667],"genre_scores_gemma":[0.99877685,0.00007506189,0.000094967516,0.000025369352,0.0000038439175,0.000009917278,0.0009174223,0.0000023464167,0.00009418966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995946,0.00012494846,0.000038835165,0.00014373336,0.0000623372,0.000035535475],"domain_scores_gemma":[0.9990338,0.00016041123,0.00041502964,0.00014260836,0.00013538804,0.00011268595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060099876,0.00018310398,0.0002569822,0.0003645181,0.0002629135,0.00039377657,0.00030014126,0.00021924463,0.0013177904],"category_scores_gemma":[0.0015463539,0.00013192192,0.00028164554,0.0010479875,0.00018387221,0.0001663513,0.00035215667,0.00031835565,0.00013813087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048254427,0.00002267905,0.99607396,0.000023936816,0.00018275874,0.000038576603,0.000026031013,0.00008209514,0.00079288305,0.000012837982,0.00017779472,0.002084001],"study_design_scores_gemma":[0.000018379737,0.000105866675,0.99922967,0.0000041186095,0.0000809996,0.00010892163,0.000034080564,0.00016012856,0.000093082665,0.000017554232,0.00014540755,0.0000017094269],"about_ca_topic_score_codex":0.0043977047,"about_ca_topic_score_gemma":0.00620554,"teacher_disagreement_score":0.0043977047,"about_ca_system_score_codex":0.00020792948,"about_ca_system_score_gemma":0.0002680299,"threshold_uncertainty_score":0.00874418},"labels":[],"label_agreement":null},{"id":"W2630601502","doi":"10.1200/jco.2017.35.15_suppl.e12030","title":"Rates of trastuzumab-associated cardiotoxicity in patients with HER2-positive breast cancer at a tertiary cancer centre.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Trastuzumab; Cardiotoxicity; Internal medicine; Oncology; Breast cancer; Clinical trial; Discontinuation; Cancer; Disease; Metastatic breast cancer; Chemotherapy","score_opus":0.057735540386877116,"score_gpt":0.46763188812585477,"score_spread":0.40989634773897765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2630601502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953094,0.00072990323,0.000044616172,0.00034736955,0.000007706083,0.00004966568,0.0014803817,0.000017930239,0.0020129667],"genre_scores_gemma":[0.99888796,0.00021455059,0.00003867116,0.00016219364,0.000011449022,0.000013255437,0.00045087852,0.0000038201515,0.00021726395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880016,0.00016267259,0.00019152129,0.00019163932,0.00041267215,0.00024127973],"domain_scores_gemma":[0.9942638,0.00074038527,0.00334316,0.0001567637,0.0005560666,0.0009397815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005655748,0.00015498606,0.00026909378,0.0008941082,0.0005569344,0.00077914627,0.0005273447,0.00052974775,0.0035054986],"category_scores_gemma":[0.0037881793,0.0002502452,0.00027210533,0.0018823015,0.00037756108,0.00037318695,0.0006167476,0.0006483813,0.00029753862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007217507,0.000025522711,0.99691224,0.000021957743,0.0000119351,0.00039396255,0.000081073194,0.000035489596,0.00011843298,0.000014323047,0.00050052506,0.0018123962],"study_design_scores_gemma":[0.000012970609,0.000101240454,0.99803764,0.000016720542,0.000011085181,0.0010045322,0.00026148022,0.00012703304,0.00009516866,0.000013294239,0.0003135145,0.0000053043113],"about_ca_topic_score_codex":0.053222317,"about_ca_topic_score_gemma":0.07696518,"teacher_disagreement_score":0.053222317,"about_ca_system_score_codex":0.0028596052,"about_ca_system_score_gemma":0.0018995164,"threshold_uncertainty_score":0.10582507},"labels":[],"label_agreement":null},{"id":"W2637410905","doi":"10.1634/theoncologist.2017-0235","title":"Pregabalin for the Prevention of Oxaliplatin-Induced Painful Neuropathy: A Randomized, Double-Blind Trial","year":2017,"lang":"en","type":"article","venue":"The Oncologist","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pregabalin; Neuropathic pain; Oxaliplatin; Anesthesia; Allodynia; Placebo; Analgesic; Chronic pain; Duloxetine; Peripheral neuropathy; Randomized controlled trial; Nociception; Internal medicine; Colorectal cancer; Hyperalgesia; Cancer; Physical therapy","score_opus":0.2068603240696497,"score_gpt":0.45655941135312983,"score_spread":0.24969908728348014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2637410905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94837135,0.023009147,0.001558148,0.0016703117,0.0026946,0.016607212,0.0017166388,0.00034423496,0.004028514],"genre_scores_gemma":[0.9565313,0.012683446,0.0031111024,0.0026046888,0.001823327,0.016254997,0.00095443026,0.00003444353,0.0060022934],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992748,0.0003653166,0.00006799686,0.00012810741,0.000059749018,0.00010392318],"domain_scores_gemma":[0.99929166,0.00020665537,0.0001660966,0.00006607572,0.00006963084,0.0001998767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015575412,0.0016211362,0.0039028467,0.000533731,0.00047215942,0.0009612042,0.0011400426,0.0025638847,0.008147897],"category_scores_gemma":[0.0015155395,0.00069159793,0.0020113804,0.0005119892,0.0011329412,0.0009962298,0.00040523717,0.0025624488,0.0010230327],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9820747,0.005114284,0.00013678409,0.0010386157,0.00059678726,0.000018592958,0.000015739466,0.00008811121,0.0009863946,0.000057135385,0.00033781052,0.009534942],"study_design_scores_gemma":[0.9823231,0.016765025,0.00031560403,0.00003097003,0.00019398645,0.000007487296,0.00000431206,0.00007472392,0.00008725037,0.000038741346,0.00015441114,0.000004287636],"about_ca_topic_score_codex":0.0010480888,"about_ca_topic_score_gemma":0.0020566413,"teacher_disagreement_score":0.008147897,"about_ca_system_score_codex":0.000617823,"about_ca_system_score_gemma":0.0013180005,"threshold_uncertainty_score":0.027257442},"labels":[],"label_agreement":null},{"id":"W2640351411","doi":"10.1200/jco.2017.35.15_suppl.2534","title":"Validation of RECIST 1.1 for use with cytotoxic agents and targeted cancer agents (TCA): Results of a RECIST Working Group analysis of a 50 clinical trials pooled individual patient database.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Response Evaluation Criteria in Solid Tumors; Clinical trial; Progressive disease; Lung cancer; Cancer; Oncology; Target lesion; Internal medicine; Placebo; Clinical endpoint; Lesion; Chemotherapy; Radiology; Phases of clinical research; Pathology","score_opus":0.5320876877449999,"score_gpt":0.5820127522052523,"score_spread":0.049925064460252355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2640351411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86453116,0.021533357,0.061065648,0.0010826237,0.0002984329,0.010881517,0.032715876,0.00091942743,0.0069719288],"genre_scores_gemma":[0.9457006,0.0009530936,0.020622393,0.0005452364,0.00013785945,0.0054483227,0.02598076,0.00028633792,0.0003254771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.7597887,0.18290487,0.024305487,0.012326078,0.019551273,0.0011236231],"domain_scores_gemma":[0.69586635,0.1898177,0.055018358,0.042011455,0.015329731,0.0019564407],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.25480238,0.0013194147,0.004159583,0.004140062,0.00047726868,0.0030421445,0.0028231337,0.0011542827,0.0012082596],"category_scores_gemma":[0.27829143,0.00079916196,0.005760189,0.0057391804,0.0007387854,0.0016226278,0.0024745374,0.0012154244,0.00047261265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10061964,0.00088302046,0.6515673,0.0033405605,0.05328895,0.00029197425,0.0012496854,0.021211151,0.0032590898,0.0011130673,0.01292732,0.1502483],"study_design_scores_gemma":[0.012429509,0.012840108,0.86852527,0.00073037716,0.0326698,0.0015956799,0.00045351146,0.04388411,0.0040004556,0.0013225636,0.02123148,0.0003171602],"about_ca_topic_score_codex":0.0014025391,"about_ca_topic_score_gemma":0.0012979839,"teacher_disagreement_score":0.25480238,"about_ca_system_score_codex":0.002166703,"about_ca_system_score_gemma":0.0026254323,"threshold_uncertainty_score":0.91896135},"labels":[],"label_agreement":null},{"id":"W2702220459","doi":"10.1200/jco.2016.34.15_suppl.1014","title":"Disease-free (DFS) and overall survival (OS) at 3.4 years (yrs) for neoadjuvant bevacizumab (Bev) added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide (D-FEC), for women with HER2 negative early breast cancer: The ARTemis trial.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Docetaxel; Internal medicine; Epirubicin; Fluorouracil; Hazard ratio; Breast cancer; Neoadjuvant therapy; Oncology; Bevacizumab; Gastroenterology; Chemotherapy; Cancer; Confidence interval","score_opus":0.049282086248313914,"score_gpt":0.40586575050859663,"score_spread":0.3565836642602827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2702220459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964006,0.0018727701,0.00012014346,0.00017228442,0.00005745347,0.00019301914,0.0005648606,0.0000073261067,0.00061149226],"genre_scores_gemma":[0.9958626,0.00070424436,0.00023133526,0.00018657147,0.00010181815,0.00037871127,0.0013168665,0.0000041562976,0.0012136375],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99931383,0.00040358925,0.000044176108,0.00008937481,0.000051838517,0.000097136064],"domain_scores_gemma":[0.99912935,0.000322789,0.00021952864,0.000059574984,0.00003162188,0.00023723535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027594287,0.00050131977,0.00079814484,0.00023451608,0.00019487798,0.0006457225,0.00037404214,0.0008746706,0.0025156694],"category_scores_gemma":[0.0016051166,0.0002627028,0.001239943,0.00025421384,0.0005585699,0.00062483374,0.0003801269,0.0013563146,0.00031673242],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9556643,0.0036114934,0.013633787,0.00026547213,0.0006324396,0.00007279842,0.00006698712,0.0010447297,0.0026947865,0.000077582394,0.0008175292,0.021418266],"study_design_scores_gemma":[0.28698313,0.5991689,0.10190317,0.00012397992,0.0024532662,0.00034510906,0.00010233344,0.0019052399,0.0028283964,0.00046211967,0.003674998,0.00004925705],"about_ca_topic_score_codex":0.0005526319,"about_ca_topic_score_gemma":0.0013732531,"teacher_disagreement_score":0.0027594287,"about_ca_system_score_codex":0.00084592664,"about_ca_system_score_gemma":0.0004962708,"threshold_uncertainty_score":0.014593422},"labels":[],"label_agreement":null},{"id":"W2724602822","doi":"10.1007/s10637-017-0486-4","title":"Safety and effectiveness of eribulin in Japanese patients with locally advanced or metastatic breast cancer: a post-marketing observational study","year":2017,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada; Eisai","keywords":"Eribulin; Medicine; Observational study; Metastatic breast cancer; Oncology; Internal medicine; Breast cancer; Cancer","score_opus":0.03159839853472978,"score_gpt":0.33611036699038593,"score_spread":0.30451196845565615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2724602822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983047,0.0008971008,0.00007758361,0.000049972736,0.000005458904,0.00005567259,0.0002933475,0.0000028259583,0.00031320867],"genre_scores_gemma":[0.9985007,0.00040928173,0.00010085608,0.00015958032,0.00004222433,0.00006986131,0.00057125214,0.0000022934528,0.00014386416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841213,0.0006267521,0.00026716213,0.00027020695,0.0002834784,0.00014013982],"domain_scores_gemma":[0.99155384,0.0011910042,0.005422106,0.0004719542,0.00077010435,0.0005910369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002500732,0.000327387,0.00096074084,0.00045702522,0.0004769694,0.0008251101,0.00034198552,0.00048663025,0.0014317564],"category_scores_gemma":[0.00417088,0.000283288,0.0011676658,0.0009913278,0.0004705072,0.00057863636,0.00035389443,0.0007921352,0.0002699348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048398953,0.0005953641,0.98630303,0.0002453687,0.0009823288,0.00018931371,0.0001741455,0.00009662395,0.00060576864,0.000021372078,0.00025647116,0.005690371],"study_design_scores_gemma":[0.0006385362,0.0042625726,0.9918018,0.000026372898,0.001046673,0.0003990975,0.00017192942,0.00038732076,0.00023545056,0.000027137732,0.0009844325,0.000018757286],"about_ca_topic_score_codex":0.0020481385,"about_ca_topic_score_gemma":0.002161539,"teacher_disagreement_score":0.002500732,"about_ca_system_score_codex":0.0007342551,"about_ca_system_score_gemma":0.0008000988,"threshold_uncertainty_score":0.013225257},"labels":[],"label_agreement":null},{"id":"W2725508151","doi":"10.1080/10833196.2017.1343539","title":"Measurement of objective shoulder function following breast cancer surgery: a scoping review protocol","year":2017,"lang":"en","type":"review","venue":"Physical Therapy Reviews","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Saskatchewan","funders":"","keywords":"Medicine; Breast cancer; Protocol (science); Quality of life (healthcare); Physical therapy; Range of motion; Narrative review; Cancer; Physical medicine and rehabilitation; Breast surgery; Medical physics; Alternative medicine; Intensive care medicine; Pathology; Internal medicine; Nursing","score_opus":0.35073191356258687,"score_gpt":0.5373454591521603,"score_spread":0.18661354558957338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2725508151","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00050968485,0.0029509705,0.0012584901,0.00032427325,0.00011804856,0.99089795,0.003051058,0.000049873583,0.0008397351],"genre_scores_gemma":[0.00049618154,0.0032866502,0.0037734816,0.00016356604,0.000018842798,0.9911952,0.00066944753,0.0000058736864,0.00039072186],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.96747977,0.011653427,0.012630714,0.0019830286,0.0048031486,0.0014498645],"domain_scores_gemma":[0.94485927,0.01919218,0.009953174,0.004478481,0.019639488,0.001877385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08078051,0.004279464,0.010584807,0.014545904,0.00485898,0.0060340143,0.0059080715,0.008451954,0.050684534],"category_scores_gemma":[0.07206248,0.0044199117,0.011781268,0.011498845,0.0038853015,0.006101598,0.0055716364,0.0044408096,0.009733158],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002563084,0.00045648555,0.0008387971,0.90653795,0.0012067117,0.0008218585,0.0031724882,0.0008158,0.001875491,0.003401075,0.019424852,0.058885366],"study_design_scores_gemma":[0.006824684,0.0016899471,0.007705897,0.7286832,0.006961489,0.0008418789,0.0030063107,0.000611532,0.00226921,0.004251183,0.23679386,0.0003608125],"about_ca_topic_score_codex":0.006836907,"about_ca_topic_score_gemma":0.017227342,"teacher_disagreement_score":0.08078051,"about_ca_system_score_codex":0.0123067135,"about_ca_system_score_gemma":0.08910435,"threshold_uncertainty_score":0.4272133},"labels":[],"label_agreement":null},{"id":"W2730598197","doi":"10.1159/000477841","title":"Chronic Oxaliplatin-Based Chemotherapy in a Primary Ampullary Adenocarcinoma Patient without Significant Peripheral Neuropathy: Case Report and Literature Review","year":2017,"lang":"en","type":"article","venue":"Case Reports in Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Oxaliplatin; Medicine; Peripheral neuropathy; FOLFIRINOX; Irinotecan; Chemotherapy; Adenocarcinoma; Chemotherapy-induced peripheral neuropathy; Internal medicine; Oncology; Peripheral; Surgery; Cancer; Colorectal cancer","score_opus":0.02013752150172025,"score_gpt":0.3431272344386827,"score_spread":0.32298971293696244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2730598197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5875548,0.37161937,0.0073745437,0.0056991926,0.0020843768,0.00042335698,0.0006658321,0.00026209635,0.024316404],"genre_scores_gemma":[0.8528246,0.13428706,0.0024891486,0.0028010479,0.0034923428,0.000074610674,0.000438825,0.000040592942,0.0035517921],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996464,0.000043007123,0.00009305561,0.000089360736,0.00005146052,0.00007664027],"domain_scores_gemma":[0.9990742,0.0002869842,0.00031999833,0.000069778005,0.00010677527,0.00014215721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025389701,0.0009847357,0.000990507,0.001797675,0.0012543752,0.001556651,0.0011259302,0.0030031276,0.0021731239],"category_scores_gemma":[0.0013388022,0.0005548999,0.0005709893,0.002329565,0.0011406031,0.0018124828,0.00090174144,0.0013842771,0.0010299153],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033849665,0.000061789,0.007650791,0.00048337175,0.000025087566,0.98173964,0.00019425656,0.00006719059,0.0008610408,0.00012789089,0.0013879574,0.0073670326],"study_design_scores_gemma":[0.000005595306,0.000033950506,0.0029566048,0.000110846515,0.000033586344,0.99331117,0.00016815256,0.000057728237,0.00019650551,0.00009358867,0.0030230524,0.000009242219],"about_ca_topic_score_codex":0.0009457894,"about_ca_topic_score_gemma":0.001632541,"teacher_disagreement_score":0.0030031276,"about_ca_system_score_codex":0.00050883484,"about_ca_system_score_gemma":0.0006273387,"threshold_uncertainty_score":0.0072698593},"labels":[],"label_agreement":null},{"id":"W2732921111","doi":"10.1093/annonc/mdx261.301","title":"Incidence of oxaliplatin-induced peripheral sensory neuropathy in patients with colorectal cancer treated by FOLFOX regimen at a regional community hospital in Québec","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Université de Sherbrooke","funders":"","keywords":"Medicine; Oxaliplatin; FOLFOX; Bevacizumab; Regimen; Internal medicine; Discontinuation; Colorectal cancer; Peripheral neuropathy; Surgery; Fluorouracil; Chemotherapy; Gastroenterology; Cancer; Diabetes mellitus","score_opus":0.06442179793898725,"score_gpt":0.3751321489538139,"score_spread":0.3107103510148267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2732921111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976375,0.0003333062,0.00004656155,0.000103389415,0.000006399121,0.000017152643,0.00073574076,0.000008848457,0.0011109847],"genre_scores_gemma":[0.99918145,0.00013333365,0.000036099704,0.00004890596,0.0000039032843,0.000004506023,0.00026491968,0.0000019312267,0.00032492864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996119,0.000052956693,0.000034134657,0.000064739266,0.00008022337,0.00015615165],"domain_scores_gemma":[0.9986507,0.000120656165,0.00037779612,0.000031817977,0.00045666404,0.00036237415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023665669,0.00022252176,0.00032924247,0.0007472104,0.00094384677,0.00082650216,0.0008370852,0.0004984116,0.0026657246],"category_scores_gemma":[0.0011404076,0.00024019246,0.0004466942,0.0012543538,0.00041981094,0.00030633243,0.00038438002,0.00056759315,0.00016789415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009680102,0.0000300727,0.99702066,0.000014052192,0.00004273015,0.00018652125,0.00012718917,0.000097001284,0.00024140406,0.000018267834,0.0002843095,0.0018409917],"study_design_scores_gemma":[0.0000074876316,0.00005869097,0.99897015,0.0000098549845,0.000017352097,0.00013694362,0.0004443662,0.0001930662,0.00003028797,0.0000043210744,0.0001218348,0.0000057561356],"about_ca_topic_score_codex":0.9125808,"about_ca_topic_score_gemma":0.94571334,"teacher_disagreement_score":0.08741921,"about_ca_system_score_codex":0.010118904,"about_ca_system_score_gemma":0.0059287506,"threshold_uncertainty_score":0.17586803},"labels":[],"label_agreement":null},{"id":"W2734560446","doi":"10.1200/jco.2013.31.15_suppl.e12031","title":"Quality of life (QoL) and symptoms evaluation in metastatic breast cancer (MBC) patients (pts) treated with eribulin: Preliminary results of a prospective observational study.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Eribulin; Tolerability; Internal medicine; Taxane; Metastatic breast cancer; Capecitabine; Anthracycline; Neutropenia; Breast cancer; Adverse effect; Surgery; Gastroenterology; Chemotherapy; Cancer","score_opus":0.2666592212623247,"score_gpt":0.5288009329294016,"score_spread":0.26214171166707684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734560446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991978,0.0002586558,0.00005450748,0.000022243632,0.0000028519892,0.000049496426,0.00025787306,0.0000010949053,0.00015547473],"genre_scores_gemma":[0.99900204,0.00015269058,0.000133109,0.000045221892,0.000011957369,0.000080153935,0.0004795394,7.5248767e-7,0.00009466219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995372,0.00024369296,0.000041593456,0.000057404653,0.00006583429,0.000054234173],"domain_scores_gemma":[0.99864787,0.0003052049,0.0006229773,0.000052505624,0.00008527366,0.00028618544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010185805,0.00029896206,0.00045213845,0.0003458625,0.0003879629,0.0004631977,0.00023681448,0.00044715812,0.0014961575],"category_scores_gemma":[0.0017850915,0.00022836488,0.0005585752,0.0008116026,0.00026530796,0.00043909746,0.00035564875,0.00062955485,0.00024727438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054450417,0.0014366147,0.98767895,0.000077537174,0.00019014199,0.00015852196,0.00013075011,0.00009178249,0.00048765232,0.000013790112,0.00017417454,0.0041150907],"study_design_scores_gemma":[0.0006412544,0.007681108,0.9901922,0.00001520288,0.000111969995,0.00046348988,0.00013973562,0.00023972214,0.00013602874,0.000017581744,0.0003534142,0.000008344405],"about_ca_topic_score_codex":0.0011159286,"about_ca_topic_score_gemma":0.0013658499,"teacher_disagreement_score":0.0014961575,"about_ca_system_score_codex":0.000343672,"about_ca_system_score_gemma":0.00028149545,"threshold_uncertainty_score":0.0053868294},"labels":[],"label_agreement":null},{"id":"W2734681090","doi":"10.1200/jco.2016.34.15_suppl.4543","title":"Genome-wide association study of cisplatin-induced peripheral neuropathy (CIPN) in testicular cancer survivors.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Internal medicine; Genome-wide association study; Imputation (statistics); Single-nucleotide polymorphism; Cumulative dose; Oncology; Sensory neuropathy; Cancer; Cisplatin; Chemotherapy; Genotype; Gene; Genetics; Endocrinology; Diabetes mellitus","score_opus":0.1284873427186085,"score_gpt":0.47914271761906174,"score_spread":0.35065537490045323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734681090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952544,0.001377566,0.00041401215,0.00010517184,0.000025357871,0.0000163679,0.0022259848,0.00001945359,0.00056179415],"genre_scores_gemma":[0.9982058,0.00021438791,0.00021160103,0.00006026426,0.000016095553,0.000019484689,0.00090411655,0.000009249637,0.00035902328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933404,0.0002089515,0.000055461394,0.0002418606,0.00008341819,0.00007617801],"domain_scores_gemma":[0.99920624,0.00020238603,0.00021760176,0.000121865676,0.00008941224,0.00016239454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007710444,0.00022422153,0.0004829441,0.00047732898,0.00064907066,0.00049562217,0.00032919255,0.0004817971,0.0029506553],"category_scores_gemma":[0.0015551968,0.0002633563,0.0007796457,0.0016058672,0.00016977024,0.00016356699,0.0003811347,0.00062133215,0.00025666607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046743226,0.000037602316,0.9931924,0.00005243392,0.0009424758,0.00016063549,0.00010199956,0.00008683894,0.0013645412,0.00004819538,0.00049198966,0.0030536873],"study_design_scores_gemma":[0.000017714085,0.00010213486,0.998645,0.0000068985983,0.00036086055,0.00015728953,0.000042450378,0.00015833491,0.00006616471,0.000026289377,0.00041369826,0.0000030542153],"about_ca_topic_score_codex":0.007814946,"about_ca_topic_score_gemma":0.008893259,"teacher_disagreement_score":0.007814946,"about_ca_system_score_codex":0.00017834968,"about_ca_system_score_gemma":0.00035146557,"threshold_uncertainty_score":0.015538931},"labels":[],"label_agreement":null},{"id":"W2734686113","doi":"10.1016/j.ctrv.2017.06.007","title":"Influence of non-measurable disease on progression-free survival in patients with metastatic breast cancer","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Metastatic breast cancer; Hazard ratio; Oncology; Chemotherapy; Disease; Cancer; Clinical trial; Confidence interval; Bone disease; Progression-free survival; Osteoporosis","score_opus":0.10435938010052802,"score_gpt":0.45080077233445087,"score_spread":0.34644139223392284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734686113","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045394528,0.9990508,0.000029839413,0.000103418846,0.00004696136,0.0000025512206,0.000024082676,0.0000018981461,0.00028654592],"genre_scores_gemma":[0.0068267267,0.99251986,0.000102271486,0.0002143315,0.00011339428,0.000005966561,0.000049969836,0.0000010106321,0.00016654166],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99980634,0.000054355198,0.000036173027,0.00002766065,0.00005981627,0.000015556458],"domain_scores_gemma":[0.9995421,0.0002923521,0.00009690822,0.0000063195644,0.00004767313,0.000014660716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046340242,0.0003972059,0.0013228429,0.0006547865,0.00008673364,0.0005004119,0.00043188734,0.00036942848,0.0016930599],"category_scores_gemma":[0.0011708781,0.00016176746,0.0008908415,0.0007498033,0.00017694209,0.00036323047,0.0002576286,0.0010066676,0.00022318133],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049689226,0.000089664914,0.002538818,0.027963817,0.0012081878,0.000095720454,0.00004434978,0.00043196406,0.00069383223,0.0007406261,0.00989701,0.9557991],"study_design_scores_gemma":[0.0011972745,0.0027472654,0.09093404,0.05674093,0.0213109,0.0039861277,0.0003266345,0.0014806894,0.0019061284,0.004588458,0.8146007,0.00018082857],"about_ca_topic_score_codex":0.0012113901,"about_ca_topic_score_gemma":0.00401661,"teacher_disagreement_score":0.0016930599,"about_ca_system_score_codex":0.00029688404,"about_ca_system_score_gemma":0.0005821979,"threshold_uncertainty_score":0.0056638718},"labels":[],"label_agreement":null},{"id":"W2734944762","doi":"10.3821/1913-701x-143.sp2.s17b","title":"Définition de l'hormonothérapie bio-identique","year":2010,"lang":"fr","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Geography; Humanities; Philosophy","score_opus":0.02217914826354529,"score_gpt":0.2913826089282291,"score_spread":0.2692034606646838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734944762","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015419544,0.11492628,0.42200407,0.055593837,0.009079241,0.0010846966,0.0026876957,0.0008416512,0.3783629],"genre_scores_gemma":[0.3545333,0.07453551,0.38431618,0.024147162,0.008764396,0.0027724553,0.002790235,0.00024252768,0.14789826],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928231,0.002273764,0.0006390834,0.00078560744,0.0030641018,0.00041436622],"domain_scores_gemma":[0.99566346,0.0022284803,0.00043544,0.0002449601,0.00125743,0.0001701386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005049303,0.0016014659,0.0015066292,0.0038577598,0.0022107416,0.007326027,0.0019439602,0.0034529967,0.005605814],"category_scores_gemma":[0.0048864996,0.00040688599,0.0015598914,0.0023140325,0.007327685,0.0024612057,0.0018197302,0.0051911213,0.00231398],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110888934,0.00016361558,0.0010430815,0.001028748,0.00010263887,0.00053040445,0.00082016044,0.002132194,0.0034421254,0.8445003,0.016656077,0.12946971],"study_design_scores_gemma":[0.00007208397,0.00020696875,0.0015015003,0.0010785613,0.00014433198,0.001533172,0.00040045142,0.004453408,0.0054044966,0.1091176,0.8760092,0.00007822642],"about_ca_topic_score_codex":0.029786492,"about_ca_topic_score_gemma":0.017956765,"teacher_disagreement_score":0.029786492,"about_ca_system_score_codex":0.007299384,"about_ca_system_score_gemma":0.008635254,"threshold_uncertainty_score":0.059226215},"labels":[],"label_agreement":null},{"id":"W2735078344","doi":"10.1097/01.cot.0000521885.70331.34","title":"Less Chemotherapy Recommended After Surgery for Low-Risk Colon Cancer","year":2017,"lang":"en","type":"article","venue":"Oncology Times","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oxaliplatin; FOLFOX; Capecitabine; Colorectal cancer; Discontinuation; Internal medicine; Chemotherapy; Surgery; Oncology; Cancer","score_opus":0.047280403653568656,"score_gpt":0.400188093446682,"score_spread":0.3529076897931133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735078344","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34469432,0.19375893,0.0036727437,0.28186095,0.027907697,0.0011750594,0.010173715,0.0010577759,0.1356988],"genre_scores_gemma":[0.6466571,0.041926924,0.006672388,0.23335288,0.016653974,0.0006131415,0.0109534655,0.00017674633,0.042993315],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992841,0.00021737708,0.00007701906,0.00009148474,0.00022581383,0.00010419477],"domain_scores_gemma":[0.9970272,0.00037873565,0.0010376803,0.00015276881,0.0005332695,0.00087021856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011190221,0.00020945208,0.00042653183,0.00058194355,0.00058324233,0.00086169626,0.00028653292,0.0008644892,0.012629109],"category_scores_gemma":[0.0031067908,0.000099791665,0.00057803,0.0005951475,0.0003148243,0.0005827656,0.00038973126,0.0010941244,0.0014579389],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048042135,0.000653358,0.081559785,0.0024802363,0.00047457774,0.0003538895,0.00018520073,0.00019134441,0.0062865796,0.001690327,0.43294838,0.4683721],"study_design_scores_gemma":[0.0024490578,0.0046299654,0.41612887,0.0020056854,0.00054696307,0.0024056889,0.00034277156,0.00020515235,0.0022185177,0.0010101035,0.56796795,0.00008917885],"about_ca_topic_score_codex":0.0062454245,"about_ca_topic_score_gemma":0.027706806,"teacher_disagreement_score":0.012629109,"about_ca_system_score_codex":0.0011547881,"about_ca_system_score_gemma":0.0015473157,"threshold_uncertainty_score":0.042248607},"labels":[],"label_agreement":null},{"id":"W2735604277","doi":"10.1016/s0167-8140(17)31634-1","title":"EP-1198: Low risk breast cancer patients’ supportive care needs and perceptions of follow-up care options","year":2017,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Breast cancer; Medicine; Perception; Risk perception; Oncology; Family medicine; Nursing; Intensive care medicine; Gynecology; Cancer; Internal medicine; Psychology","score_opus":0.01174667352165648,"score_gpt":0.34309083865636325,"score_spread":0.33134416513470677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735604277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99569196,0.00008019017,0.000029348364,0.0005210538,0.000023524144,0.000018726845,0.00014244193,0.0000019274173,0.003490998],"genre_scores_gemma":[0.99751866,0.000093097755,0.00010023303,0.00041042824,0.000010305851,0.000021358088,0.000121585625,0.0000027748722,0.0017216664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950385,0.00013430872,0.00005679797,0.0000323668,0.0001179542,0.00015465239],"domain_scores_gemma":[0.9959602,0.0011260575,0.0010795739,0.000059640624,0.00042196884,0.001352584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090539386,0.0001241072,0.00023102376,0.0004068941,0.0008094172,0.001308273,0.0002727856,0.00057210226,0.010000154],"category_scores_gemma":[0.0063139875,0.00012588514,0.00034326222,0.0003099207,0.00039685995,0.00073635345,0.0009215526,0.0013461047,0.00073092326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007504698,0.0012214521,0.9518434,0.00014582078,0.0001302561,0.00078124524,0.012497397,0.00008261338,0.0010406898,0.00045757976,0.004979517,0.026069513],"study_design_scores_gemma":[0.000075634714,0.00063226314,0.93242645,0.000111261004,0.00008418485,0.001065642,0.058525324,0.00026591346,0.00033660198,0.00040580754,0.006032073,0.00003881845],"about_ca_topic_score_codex":0.0043504504,"about_ca_topic_score_gemma":0.0078022485,"teacher_disagreement_score":0.010000154,"about_ca_system_score_codex":0.0005674009,"about_ca_system_score_gemma":0.00086848525,"threshold_uncertainty_score":0.033453822},"labels":[],"label_agreement":null},{"id":"W2737376100","doi":"10.1186/s40780-017-0089-4","title":"Objective evaluation of chemotherapy-induced peripheral neuropathy using quantitative pain measurement system (Pain Vision®), a pilot study","year":2017,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Health Care and Sciences","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Japan Society for the Promotion of Science","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Common Terminology Criteria for Adverse Events; Cancer pain; Chemotherapy; Visual analogue scale; McGill Pain Questionnaire; Adverse effect; Anesthesia; Physical therapy; Internal medicine; Cancer","score_opus":0.36647353161493473,"score_gpt":0.5416819143141665,"score_spread":0.17520838269923172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737376100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658465,0.0004047519,0.0014793635,0.000011091793,0.000013965597,0.00070191297,0.000093942144,0.000010989231,0.0006992835],"genre_scores_gemma":[0.99653155,0.00022590683,0.0018740376,0.000054961514,0.000031798365,0.0006879241,0.00019324123,0.0000037788639,0.00039682697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919397,0.0004438907,0.00007007742,0.00008950363,0.00014318783,0.000059488113],"domain_scores_gemma":[0.99820983,0.0006638668,0.00048297454,0.00012137736,0.000342459,0.00017942517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018881093,0.0005673754,0.00041006654,0.00032825267,0.00016372192,0.0001994473,0.00019821842,0.0002508979,0.0014104681],"category_scores_gemma":[0.0019604268,0.00014271843,0.00027052662,0.00023465071,0.00030241557,0.00029175088,0.00023548111,0.00038157628,0.00017910839],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031103907,0.028220676,0.6594593,0.0013366701,0.00052125443,0.0016622101,0.0010902188,0.0010451413,0.15498638,0.00019436966,0.0005928073,0.11978702],"study_design_scores_gemma":[0.0015456612,0.32677245,0.6554115,0.0000343949,0.00018716321,0.002204041,0.0002987218,0.0014238701,0.01108104,0.000050712188,0.000955182,0.000035280398],"about_ca_topic_score_codex":0.00022420229,"about_ca_topic_score_gemma":0.00032563633,"teacher_disagreement_score":0.0018881093,"about_ca_system_score_codex":0.00011065106,"about_ca_system_score_gemma":0.00021683084,"threshold_uncertainty_score":0.009985387},"labels":[],"label_agreement":null},{"id":"W2737551266","doi":"10.1007/s00520-017-3836-z","title":"A prospective study of docetaxel-associated pain syndrome","year":2017,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; North York General Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Pain medicine; Docetaxel; Nursing research; Prospective cohort study; Oncology; Internal medicine; Cancer; Anesthesia; Anesthesiology; Nursing","score_opus":0.031177374636377958,"score_gpt":0.394488387934553,"score_spread":0.36331101329817506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737551266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99899477,0.00040667964,0.0000409838,0.000018081062,0.000008358052,0.000028671147,0.000106654625,0.000001110776,0.00039471043],"genre_scores_gemma":[0.99922574,0.00019279357,0.000042093743,0.000029981082,0.000013843657,0.000017033382,0.00019057671,0.0000011268297,0.00028683865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945706,0.00020140295,0.00006329096,0.00010502765,0.00008338249,0.000089887704],"domain_scores_gemma":[0.9986527,0.00026523747,0.00048264585,0.000096640535,0.00013544175,0.0003672413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005837988,0.00037648386,0.0004232034,0.0005979628,0.0008704657,0.0009576438,0.00031649452,0.0005538574,0.0024906832],"category_scores_gemma":[0.0019355319,0.00042397671,0.00051103503,0.0009053645,0.00045917105,0.0005606544,0.00044303827,0.0007191748,0.00050747715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015429606,0.00075188716,0.9949391,0.00002231343,0.000102141246,0.00050930766,0.0001358668,0.00001820728,0.0005734319,0.00004044573,0.00006305247,0.0013012611],"study_design_scores_gemma":[0.00010057032,0.002252821,0.9960962,0.000009122763,0.00007490713,0.0007930172,0.00029539314,0.000048884052,0.000050457595,0.000021160005,0.00024953336,0.0000079094725],"about_ca_topic_score_codex":0.0036822173,"about_ca_topic_score_gemma":0.004380612,"teacher_disagreement_score":0.0036822173,"about_ca_system_score_codex":0.0004949063,"about_ca_system_score_gemma":0.0006497409,"threshold_uncertainty_score":0.008332133},"labels":[],"label_agreement":null},{"id":"W2739249765","doi":"","title":"The Role of Albumin-bound Paclitaxel (Abraxane) in the Treatment of Metastatic Breast Cancer","year":2012,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Metastatic breast cancer; Paclitaxel; Cancer; Breast cancer; Oncology; Family medicine; Internal medicine","score_opus":0.0280889884611054,"score_gpt":0.3565047013326134,"score_spread":0.328415712871508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739249765","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008891419,0.98091084,0.00033597424,0.005190829,0.00042119515,0.00008174403,0.00015664594,0.000015489917,0.0039959215],"genre_scores_gemma":[0.13023049,0.85949963,0.0029253233,0.0030902657,0.000862388,0.00010457728,0.00033356666,0.000018911964,0.0029348133],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99756145,0.0016185094,0.00024765008,0.00012396892,0.00038708767,0.000061266015],"domain_scores_gemma":[0.9941176,0.003412887,0.0012659191,0.000094995325,0.0009161711,0.00019242783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006081692,0.0002795127,0.00080459676,0.0011715172,0.00015111353,0.0009608334,0.00035001372,0.00052502856,0.0030494565],"category_scores_gemma":[0.010095246,0.00012345942,0.0008148673,0.0009795247,0.00025126344,0.0005721773,0.0003383913,0.0007339515,0.00048125276],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055043865,0.00013878982,0.0012450815,0.016729647,0.0008786041,0.000112554284,0.00005217371,0.00038462688,0.0014313216,0.00096287613,0.011394064,0.9611658],"study_design_scores_gemma":[0.015307789,0.034733962,0.08508054,0.0678468,0.015270593,0.0041184346,0.00047690733,0.0026304857,0.008547665,0.0060572806,0.7597668,0.00016270364],"about_ca_topic_score_codex":0.0018914903,"about_ca_topic_score_gemma":0.006750886,"teacher_disagreement_score":0.006081692,"about_ca_system_score_codex":0.0008569158,"about_ca_system_score_gemma":0.0016538603,"threshold_uncertainty_score":0.03216338},"labels":[],"label_agreement":null},{"id":"W2741428492","doi":"10.1158/1538-7445.am2017-ct055","title":"Abstract CT055: A randomized, double-blinded, controlled study of tucatinib (ONT-380) vs. placebo in combination with capecitabine (C) and trastuzumab (Tz) in patients with pretreated HER2+ unresectable locally advanced or metastatic breast carcinoma (MBC) (HER2CLIMB)","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Capecitabine; Internal medicine; Rash; Trastuzumab; Placebo; Taxane; Gastroenterology; Adverse effect; Population; Diarrhea; Oncology; Pertuzumab; Progression-free survival; Cancer; Chemotherapy; Breast cancer; Colorectal cancer; Pathology","score_opus":0.05602476690837405,"score_gpt":0.39824079362522813,"score_spread":0.3422160267168541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741428492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.969764,0.006526088,0.001287668,0.0008014875,0.0012497072,0.014364104,0.0024345417,0.00028959147,0.0032828753],"genre_scores_gemma":[0.97908837,0.0023166551,0.001803955,0.0011865816,0.00065629865,0.009764121,0.0013895624,0.000024375218,0.0037700748],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99879885,0.0006709667,0.00010155196,0.00020487492,0.000080176396,0.00014360742],"domain_scores_gemma":[0.9987078,0.00035694864,0.00028227243,0.00008525746,0.00011108287,0.00045671192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002555144,0.0021838166,0.0041456944,0.0007029916,0.00071441225,0.0013614447,0.0012410879,0.0024769385,0.009688573],"category_scores_gemma":[0.0023558226,0.00090578647,0.002094552,0.000681869,0.0017130589,0.0013997876,0.0004220904,0.0033506178,0.0016183602],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98978686,0.0040964317,0.00013854784,0.00037222102,0.00041494766,0.00001535018,0.000017151428,0.00007886369,0.0011830694,0.000041426913,0.00025919147,0.003595898],"study_design_scores_gemma":[0.9457527,0.052787814,0.00052585464,0.000020263953,0.00028487822,0.000010603927,0.000008695809,0.00018290126,0.0001736528,0.000040097806,0.00020494698,0.0000076013384],"about_ca_topic_score_codex":0.0014276257,"about_ca_topic_score_gemma":0.0030055742,"teacher_disagreement_score":0.009688573,"about_ca_system_score_codex":0.0010098327,"about_ca_system_score_gemma":0.0017943879,"threshold_uncertainty_score":0.032411575},"labels":[],"label_agreement":null},{"id":"W2746271885","doi":"","title":"Pharmacokinetics of once daily IV busulfan: Implications of fixed-infusion rate dosing","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Busulfan; Dosing; Pharmacokinetics; Body surface area; Medicine; Pharmacology; Urology; Transplantation; Dose rate; Hematopoietic stem cell transplantation; Chemistry; Internal medicine","score_opus":0.12647436966958656,"score_gpt":0.507927610903224,"score_spread":0.38145324123363744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2746271885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893678,0.0028245272,0.006532029,0.0001617232,0.000018693987,0.000088936955,0.00012538533,0.00007507327,0.00080575363],"genre_scores_gemma":[0.99739337,0.0005571869,0.0016730462,0.00004551564,0.000011137463,0.00003199867,0.00010076845,0.000022837166,0.00016413523],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991942,0.00040944727,0.00004075848,0.0000933058,0.0002157438,0.000046620196],"domain_scores_gemma":[0.99879164,0.00053851836,0.00045310767,0.00008142435,0.000061325074,0.000073969415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014237108,0.00035799167,0.000988871,0.00022119946,0.000117951924,0.000807607,0.00030702536,0.00030879906,0.0005323272],"category_scores_gemma":[0.0036805787,0.00021639875,0.00036700463,0.00032246846,0.00025182415,0.00034222004,0.00013872882,0.00081256946,0.00015295534],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.065730736,0.0019360994,0.14360443,0.0005763944,0.0010633304,0.0006743838,0.0010263139,0.08511136,0.2934195,0.0016468563,0.001812814,0.40339777],"study_design_scores_gemma":[0.003765464,0.106890105,0.5149451,0.00023655513,0.0014470936,0.0045946976,0.00035963033,0.21672083,0.1362131,0.0018617747,0.012774643,0.00019098219],"about_ca_topic_score_codex":0.00085044256,"about_ca_topic_score_gemma":0.0005427946,"teacher_disagreement_score":0.0014237108,"about_ca_system_score_codex":0.0007084129,"about_ca_system_score_gemma":0.000442076,"threshold_uncertainty_score":0.0075294375},"labels":[],"label_agreement":null},{"id":"W2747379890","doi":"10.1093/jnci/djx162","title":"Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30","year":2017,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Docetaxel; Taxane; Chemotherapy-induced peripheral neuropathy; Oncology; Peripheral neuropathy; Internal medicine; Breast cancer; Chemotherapy; Cancer; Quality of life (healthcare); Adjuvant","score_opus":0.03815278462749991,"score_gpt":0.3711577391902169,"score_spread":0.33300495456271695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2747379890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993972,0.0051365294,0.00006889961,0.00018474486,0.000017101685,0.000068430156,0.00020291608,0.0000028741536,0.00034645016],"genre_scores_gemma":[0.9972253,0.0017839611,0.00016090291,0.00020252391,0.000025274949,0.00007046369,0.0003992219,8.286601e-7,0.00013146184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910116,0.00049359404,0.00010190261,0.00008883942,0.00015008455,0.000064464],"domain_scores_gemma":[0.99799037,0.000565094,0.0010427649,0.00004490262,0.00010137216,0.00025550375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023895237,0.00021559413,0.00050288404,0.00021299944,0.00020825448,0.00041088794,0.0002894008,0.0003800566,0.0008596145],"category_scores_gemma":[0.00352767,0.0001296244,0.00050228334,0.0006518771,0.00020784068,0.00032225763,0.00028730542,0.00047786458,0.000086107415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022311332,0.0012071742,0.92982113,0.00081523706,0.0009592113,0.00016011504,0.000086682725,0.0004634848,0.0008182069,0.0000411273,0.00087700546,0.042439267],"study_design_scores_gemma":[0.0026146905,0.013407248,0.9798973,0.00028899082,0.0007771799,0.0006059481,0.000103905215,0.00065040396,0.00021141367,0.000102432554,0.0013276993,0.000012617774],"about_ca_topic_score_codex":0.0011805322,"about_ca_topic_score_gemma":0.0032183668,"teacher_disagreement_score":0.0023895237,"about_ca_system_score_codex":0.00043595166,"about_ca_system_score_gemma":0.00077317865,"threshold_uncertainty_score":0.012637138},"labels":[],"label_agreement":null},{"id":"W2748791006","doi":"10.1200/jco.2012.30.15_suppl.1557","title":"A comparison of simple single-item measures and the NCI Common Toxicity Criteria version 3.0 measure of peripheral neuropathy.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Common Terminology Criteria for Adverse Events; Clinical trial; Physical therapy; Adverse effect; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Patient-reported outcome; Psychological intervention; Randomized controlled trial; Quality of life (healthcare); Internal medicine","score_opus":0.26279268825581004,"score_gpt":0.5315475255132972,"score_spread":0.26875483725748717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2748791006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94951284,0.015409539,0.01078787,0.00039783245,0.0004988769,0.0063659297,0.009815555,0.00014259774,0.0070689525],"genre_scores_gemma":[0.9770114,0.0015408064,0.0077482336,0.00027826196,0.00012205595,0.0065983236,0.0056999703,0.000039099214,0.00096195715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9555167,0.029272327,0.0044431044,0.0022474392,0.008148498,0.0003718465],"domain_scores_gemma":[0.9202871,0.053963352,0.01828973,0.0024146968,0.0039487956,0.0010963941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031399503,0.0007791771,0.0024484352,0.0037132208,0.0003216999,0.0010778182,0.0014305613,0.0008705972,0.0029280458],"category_scores_gemma":[0.06509902,0.00051739917,0.003388986,0.004094808,0.0007510594,0.0016564155,0.0015507273,0.0011107768,0.00039983197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07686971,0.0015577595,0.768963,0.0044989823,0.034741364,0.000096518364,0.00051632937,0.004028219,0.0012918375,0.0013814553,0.0044201175,0.10163471],"study_design_scores_gemma":[0.006881528,0.020013101,0.95514196,0.0003237307,0.0032065376,0.0003543834,0.00028127097,0.008449411,0.0003892122,0.0011750753,0.0036676186,0.00011626152],"about_ca_topic_score_codex":0.0014027795,"about_ca_topic_score_gemma":0.0022921872,"teacher_disagreement_score":0.031399503,"about_ca_system_score_codex":0.0014293555,"about_ca_system_score_gemma":0.00094934506,"threshold_uncertainty_score":0.16605842},"labels":[],"label_agreement":null},{"id":"W2749034238","doi":"10.14740/wjon1043w","title":"Visceral Crisis Means Short Survival Among Patients With Luminal A Metastatic Breast Cancer: A Retrospective Cohort Study","year":2017,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Metastatic breast cancer; Retrospective cohort study; Breast cancer; Chemotherapy; Internal medicine; Cancer; Cohort; Oncology","score_opus":0.021866324517359596,"score_gpt":0.3615178261924824,"score_spread":0.3396515016751228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749034238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99948835,0.00015878525,0.00004027167,0.00001860612,0.000003189568,0.000008201694,0.00014751643,0.0000011173994,0.00013387544],"genre_scores_gemma":[0.99962604,0.00009105551,0.000031561594,0.000014385327,0.0000070266856,0.000007690518,0.00017203762,8.3974794e-7,0.000049333714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997023,0.000060060287,0.00004024174,0.00008922215,0.000049723916,0.000058452748],"domain_scores_gemma":[0.9993,0.00011713454,0.00029463356,0.00006955019,0.00005383256,0.00016483337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004639907,0.00021628036,0.0003085792,0.0007126368,0.000556197,0.00059837045,0.000244535,0.00031312948,0.0018668302],"category_scores_gemma":[0.0010259965,0.00028030315,0.00038242986,0.00080684706,0.00025731538,0.00049176737,0.0004140117,0.0005129488,0.0002090391],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068567606,0.000019006862,0.99938035,0.000004264674,0.00001752981,0.00011689577,0.000031360072,0.000008708809,0.000058816455,0.000007133463,0.00003279741,0.00025469932],"study_design_scores_gemma":[0.0000128788815,0.00027876746,0.9970751,0.000008311838,0.000060683575,0.0016181276,0.00047573363,0.00013326555,0.00005221049,0.000025161531,0.00025377443,0.0000061241903],"about_ca_topic_score_codex":0.0017957148,"about_ca_topic_score_gemma":0.0023364495,"teacher_disagreement_score":0.0018668302,"about_ca_system_score_codex":0.00023494443,"about_ca_system_score_gemma":0.00032838166,"threshold_uncertainty_score":0.0062451363},"labels":[],"label_agreement":null},{"id":"W2752175334","doi":"10.1007/s12282-017-0798-4","title":"Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study","year":2017,"lang":"en","type":"article","venue":"Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Chugai Pharmaceutical; Eisai Canada; Japan Society of Clinical Oncology","keywords":"Capecitabine; Eribulin; Medicine; Metastatic breast cancer; Dosing; Internal medicine; Pharmacokinetics; Breast cancer; Neutropenia; Taxane; Anthracycline; Oncology; Gastroenterology; Toxicity; Pharmacology; Cancer; Urology; Colorectal cancer","score_opus":0.07959678551480229,"score_gpt":0.4405309141356356,"score_spread":0.3609341286208333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752175334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98898435,0.0033079514,0.00053694885,0.00062936934,0.00010263203,0.0035658446,0.0008388938,0.00010907498,0.0019248775],"genre_scores_gemma":[0.977094,0.004626512,0.0032940945,0.002132153,0.0001996692,0.0045382786,0.0027083743,0.000059132868,0.0053477534],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99962366,0.00015246638,0.000015300056,0.000063027066,0.00005338957,0.00009219683],"domain_scores_gemma":[0.9994492,0.00006958042,0.00009857347,0.0000393542,0.000037986752,0.00030528032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013125569,0.0019744968,0.0026506772,0.00072603347,0.00047777736,0.0008713279,0.0012523857,0.0015990842,0.0032240867],"category_scores_gemma":[0.0007985972,0.0007004988,0.0008787786,0.00052238884,0.0009012591,0.0005138705,0.000312415,0.0031185448,0.00085401273],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4742367,0.14886399,0.013098318,0.002005713,0.001557999,0.0014726022,0.0006574276,0.005219315,0.16592662,0.00094095845,0.012557975,0.17346244],"study_design_scores_gemma":[0.58105487,0.39198896,0.011390157,0.00007472981,0.00035275423,0.00068561034,0.00004704161,0.0010151514,0.0066540604,0.00019083092,0.006507675,0.000038002927],"about_ca_topic_score_codex":0.001284521,"about_ca_topic_score_gemma":0.0037128367,"teacher_disagreement_score":0.0032240867,"about_ca_system_score_codex":0.0011512723,"about_ca_system_score_gemma":0.0018957738,"threshold_uncertainty_score":0.01078558},"labels":[],"label_agreement":null},{"id":"W2752563952","doi":"10.1200/jco.2017.73.3246","title":"First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seagen (Canada)","funders":"National Cancer Institute; Pfizer; Eli Lilly and Company","keywords":"Medicine; Tamoxifen; Fulvestrant; Internal medicine; Metastatic breast cancer; Breast cancer; Oncology; Pharmacokinetics; Cancer; Gastroenterology; Pharmacology; Urology","score_opus":0.12391452297016595,"score_gpt":0.5287560360576353,"score_spread":0.4048415130874694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752563952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906579,0.0024754095,0.0009216385,0.00048086955,0.000093165974,0.0029667544,0.0008876016,0.000076316945,0.0014402793],"genre_scores_gemma":[0.9893791,0.0019333274,0.0017044592,0.0007641862,0.00014212138,0.0021102573,0.0011330987,0.000026612905,0.0028068663],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999642,0.0001893921,0.000013913949,0.000050896084,0.000030774154,0.000072956325],"domain_scores_gemma":[0.99956316,0.000075072356,0.000070168724,0.000042687934,0.00002693563,0.00022197116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011778027,0.00097434275,0.0014612421,0.0002659208,0.00035510873,0.0005004503,0.0004658123,0.00063286966,0.0024438913],"category_scores_gemma":[0.00066583743,0.00045921048,0.00065017893,0.00022490347,0.0007310023,0.00045986773,0.0002393085,0.0016386714,0.0005328714],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46825597,0.10271912,0.023936415,0.0015898389,0.0015019276,0.001331237,0.0007293491,0.003258871,0.21911924,0.00048744824,0.0071644005,0.16990617],"study_design_scores_gemma":[0.24518307,0.71309036,0.020052977,0.000035037203,0.0004583079,0.00075561774,0.000103341634,0.0009683535,0.012490585,0.00025784835,0.0065778806,0.000026711215],"about_ca_topic_score_codex":0.00063232245,"about_ca_topic_score_gemma":0.0021840741,"teacher_disagreement_score":0.0024438913,"about_ca_system_score_codex":0.00060285954,"about_ca_system_score_gemma":0.0011183892,"threshold_uncertainty_score":0.0081756115},"labels":[],"label_agreement":null},{"id":"W2753082865","doi":"10.1182/blood.v128.22.4991.4991","title":"Efficacy of Dabigatran Etexilate in a Murine Model of Cancer Associated Thrombosis","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Dabigatran; Cancer; Pulmonary embolism; Rivaroxaban; Direct thrombin inhibitor; Thrombosis; Low molecular weight heparin; Warfarin; Discovery and development of direct thrombin inhibitors; Lung cancer; Apixaban; Intensive care medicine; Internal medicine; Thrombin; Atrial fibrillation","score_opus":0.04375751817295521,"score_gpt":0.3513237967834105,"score_spread":0.3075662786104553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753082865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91466564,0.02864549,0.022128083,0.0032004938,0.0026450031,0.0010143139,0.011426844,0.0009503957,0.015323704],"genre_scores_gemma":[0.955875,0.01133443,0.0073253824,0.00090633635,0.00021857604,0.0013071547,0.004626494,0.00008154569,0.018325027],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988637,0.00025570637,0.00013848285,0.00018313694,0.0003361971,0.00022286775],"domain_scores_gemma":[0.9993333,0.00010396118,0.00014844026,0.00009790962,0.00013278185,0.0001835445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010270992,0.00087745616,0.0010429532,0.001255259,0.00040151717,0.00081790943,0.000558821,0.0012537277,0.004406758],"category_scores_gemma":[0.0005066004,0.00039948855,0.001288026,0.00055583747,0.00045972026,0.0006929193,0.00030178393,0.0034117831,0.0014392909],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069061597,0.004438409,0.0015638405,0.0013768084,0.00022677393,0.00081563165,0.00022296364,0.0015860393,0.9636074,0.0018109736,0.0034517432,0.013993251],"study_design_scores_gemma":[0.0012808862,0.030052543,0.006902115,0.0003010146,0.00059147005,0.0018774172,0.00038651208,0.007845841,0.9152717,0.0013381088,0.034049794,0.000102480815],"about_ca_topic_score_codex":0.001542731,"about_ca_topic_score_gemma":0.0013065869,"teacher_disagreement_score":0.004406758,"about_ca_system_score_codex":0.0006450164,"about_ca_system_score_gemma":0.000715853,"threshold_uncertainty_score":0.014742076},"labels":[],"label_agreement":null},{"id":"W2757511999","doi":"10.1016/j.breast.2016.10.001","title":"3rd ESO–ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3)","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":232,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Metastatic breast cancer; Overall survival; Cancer","score_opus":0.06115132011510013,"score_gpt":0.41052325189541666,"score_spread":0.34937193178031656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757511999","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0063481247,0.4791287,0.044863865,0.26637787,0.037578627,0.004548012,0.017297307,0.0014446274,0.14241293],"genre_scores_gemma":[0.047314372,0.39824373,0.2547043,0.13054596,0.015541276,0.012434447,0.05387093,0.00093116047,0.08641389],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9881931,0.00386585,0.00289529,0.00037828018,0.0037532405,0.0009141579],"domain_scores_gemma":[0.9816684,0.004212653,0.0031463571,0.0005605229,0.0092352005,0.0011769227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01460144,0.0017265223,0.0021478238,0.007290609,0.0014000515,0.0030366902,0.004297445,0.006896336,0.0069559324],"category_scores_gemma":[0.028955694,0.0008121015,0.0056807874,0.003357295,0.0011798723,0.0014997593,0.0044820253,0.0056579923,0.005623931],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002911409,0.0001807059,0.0032586507,0.0076086638,0.00035364373,0.00042836444,0.0002292451,0.0015130885,0.00087360886,0.0074341567,0.6500341,0.3277946],"study_design_scores_gemma":[0.00019321256,0.0001107259,0.0046341443,0.020143447,0.00058417965,0.0010650757,0.00020039988,0.00055082934,0.0007067708,0.004655419,0.96709865,0.000057119352],"about_ca_topic_score_codex":0.013290374,"about_ca_topic_score_gemma":0.02321098,"teacher_disagreement_score":0.01460144,"about_ca_system_score_codex":0.0042537567,"about_ca_system_score_gemma":0.014334396,"threshold_uncertainty_score":0.07722074},"labels":[],"label_agreement":null},{"id":"W2757829418","doi":"10.1200/jco.2009.27.15_suppl.557","title":"Cost-effectiveness of zoledronic (ZOL) acid plus endocrine therapy (ET) in premenopausal women with early breast cancer (EBC) from a Canadian perspective","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Anastrozole; Breast cancer; Tamoxifen; Cost effectiveness; Gynecology; Goserelin; Internal medicine; Randomized controlled trial; Quality-adjusted life year; Oncology; Cancer","score_opus":0.10414754638523868,"score_gpt":0.49166512905062587,"score_spread":0.38751758266538716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757829418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94484735,0.016083317,0.0039536273,0.006568517,0.000093182076,0.0006481666,0.011945195,0.000074604126,0.015786065],"genre_scores_gemma":[0.99473333,0.0020233875,0.0012970574,0.00022996713,0.000012139694,0.000060473132,0.0010932906,0.000006373882,0.0005440945],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9991818,0.00033446998,0.000034747765,0.000076037795,0.00015194941,0.00022093921],"domain_scores_gemma":[0.99866056,0.00069450965,0.00019468756,0.000028081175,0.00018218212,0.00024008099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00135896,0.0006152897,0.0008660916,0.0010132288,0.00074042444,0.0014700035,0.0010725938,0.0011277212,0.0029462916],"category_scores_gemma":[0.0050696004,0.0005190458,0.0020874657,0.001386759,0.00052870583,0.0005396056,0.00058037404,0.00085992756,0.00012046295],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009898608,0.00034599073,0.062495586,0.0010469984,0.0034555183,0.0005491915,0.00020417922,0.86746645,0.0008975245,0.012021757,0.005068207,0.036550008],"study_design_scores_gemma":[0.004105782,0.0022848186,0.096865036,0.00071862,0.0053387596,0.00069609936,0.0006474341,0.86943924,0.00069969706,0.009958766,0.009010214,0.00023552577],"about_ca_topic_score_codex":0.88000077,"about_ca_topic_score_gemma":0.8711582,"teacher_disagreement_score":0.11999923,"about_ca_system_score_codex":0.036896646,"about_ca_system_score_gemma":0.02781367,"threshold_uncertainty_score":0.26770514},"labels":[],"label_agreement":null},{"id":"W2761819177","doi":"10.1093/annonc/mdx365.080","title":"IMpassion131: Phase III study comparing 1L atezolizumab with paclitaxel vs placebo with paclitaxel in treatment-naive patients with inoperable locally advanced or metastatic triple negative breast cancer (mTNBC)","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Atezolizumab; Paclitaxel; Triple-negative breast cancer; Oncology; Placebo; Internal medicine; Breast cancer; Chemotherapy; Cancer; Immunotherapy; Pathology; Pembrolizumab","score_opus":0.09233901511981349,"score_gpt":0.44344857244973124,"score_spread":0.3511095573299178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761819177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98286855,0.0040747733,0.0008898045,0.0012207831,0.0006016075,0.003054303,0.0026129237,0.00023432483,0.004442944],"genre_scores_gemma":[0.9770588,0.0032760105,0.0023634245,0.0021415397,0.00065615727,0.0031262732,0.0044795694,0.00008605195,0.0068122386],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995403,0.0002350162,0.000022122904,0.0000832399,0.000034169636,0.000085074134],"domain_scores_gemma":[0.9991947,0.00021135747,0.00013857156,0.00007417583,0.00003786042,0.00034342334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015725602,0.001593359,0.002742694,0.00048740066,0.00043973184,0.0012739847,0.0016088217,0.0018780705,0.0070818346],"category_scores_gemma":[0.0013719787,0.00080498174,0.0024169094,0.00048502933,0.0012611726,0.0010857726,0.00055202935,0.0052657556,0.001624455],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9214734,0.024182396,0.0012701743,0.0006403579,0.001320982,0.00006705593,0.00009451704,0.00080511445,0.009130392,0.00020622225,0.0020719785,0.03873742],"study_design_scores_gemma":[0.7989928,0.19379894,0.0033661553,0.000034445224,0.0006187337,0.00008442264,0.00003217968,0.00047113985,0.0010563922,0.0001583536,0.0013616718,0.000024782956],"about_ca_topic_score_codex":0.0011940695,"about_ca_topic_score_gemma":0.0038544938,"teacher_disagreement_score":0.0070818346,"about_ca_system_score_codex":0.000987075,"about_ca_system_score_gemma":0.0017128215,"threshold_uncertainty_score":0.023691118},"labels":[],"label_agreement":null},{"id":"W2765099943","doi":"10.1016/s0960-9776(17)30667-7","title":"Creating a Novel Drug Navigation Tool for Metastatic Breast Cancer Drugs in Canada","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Drug; Metastatic breast cancer; Breast cancer; Oncology; Cancer drugs; Cancer; Internal medicine; Medical physics; Intensive care medicine; Pharmacology","score_opus":0.022026568746454204,"score_gpt":0.329341557099641,"score_spread":0.3073149883531868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765099943","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19050214,0.0049212333,0.14796627,0.04271556,0.0016588158,0.0019096476,0.04062031,0.14390151,0.42580453],"genre_scores_gemma":[0.39358,0.0064231437,0.3756441,0.0044164513,0.0002926022,0.0004188921,0.01504153,0.005763226,0.19842012],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993685,0.00010121943,0.00004987089,0.000072988,0.0003049941,0.000102387],"domain_scores_gemma":[0.99680483,0.0011246718,0.00017027989,0.0001912397,0.0012235041,0.00048555483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011990091,0.0005625541,0.0003659218,0.00214793,0.0019416949,0.002780548,0.001026995,0.001032028,0.030428067],"category_scores_gemma":[0.0048750546,0.00037344426,0.0005333061,0.001988939,0.00043521237,0.0015017728,0.0014303705,0.00082743674,0.0052027446],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065998494,0.0003392283,0.021012334,0.00059544656,0.00006983909,0.0012923935,0.0017941097,0.0066726776,0.0058354745,0.012578211,0.4093983,0.53975195],"study_design_scores_gemma":[0.00018796582,0.00014166259,0.010401354,0.00030775386,0.000117016556,0.0005612846,0.0015263591,0.031755466,0.006583758,0.0043838024,0.9438124,0.00022130157],"about_ca_topic_score_codex":0.68663114,"about_ca_topic_score_gemma":0.84076095,"teacher_disagreement_score":0.31336886,"about_ca_system_score_codex":0.0073335557,"about_ca_system_score_gemma":0.02640474,"threshold_uncertainty_score":0.6304287},"labels":[],"label_agreement":null},{"id":"W2765390782","doi":"10.1007/s11103-017-0674-9","title":"Correction to: CYP79 P450 monooxygenases in gymnosperms: CYP79A118 is associated with the formation of taxiphyllin in Taxus baccata","year":2017,"lang":"en","type":"erratum","venue":"Plant Molecular Biology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Taxus; Biology; Monooxygenase; Botany; Computational biology; Biochemistry; Enzyme; Cytochrome P450","score_opus":0.018032710405198816,"score_gpt":0.30772900941034637,"score_spread":0.28969629900514754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765390782","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004200625,0.0015417644,0.001061858,0.03791324,0.9553234,0.000020422924,0.00083643355,0.00038278726,0.0024999795],"genre_scores_gemma":[0.027965816,0.01991141,0.011116944,0.092538014,0.43103924,0.0001691439,0.005339879,0.0025446303,0.4093749],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976707,0.0002765649,0.00045000945,0.00036785036,0.001044422,0.00019031661],"domain_scores_gemma":[0.98738897,0.0034254708,0.0011056863,0.00067841366,0.006680918,0.0007205798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019259902,0.0016063941,0.0011848892,0.0023484486,0.0021814643,0.0021708575,0.0020150898,0.0046492917,0.04060731],"category_scores_gemma":[0.02261346,0.00081003143,0.0012201518,0.0014115121,0.0018713715,0.0019467246,0.0015113545,0.007173152,0.023275506],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075546835,0.000013173558,0.00013650078,0.0002250822,0.000014279853,0.00086474395,0.000057292957,0.00006618175,0.00035088358,0.0009286493,0.9851184,0.012149346],"study_design_scores_gemma":[0.000028952332,0.000032488377,0.0007425271,0.00027649506,0.000034649624,0.0017587848,0.000079410645,0.00017155908,0.0008190891,0.0009860295,0.9950341,0.00003593797],"about_ca_topic_score_codex":0.00810946,"about_ca_topic_score_gemma":0.008824679,"teacher_disagreement_score":0.04060731,"about_ca_system_score_codex":0.002246559,"about_ca_system_score_gemma":0.0031911358,"threshold_uncertainty_score":0.13584495},"labels":[],"label_agreement":null},{"id":"W2766182174","doi":"10.1016/j.jval.2017.08.2594","title":"Supporting Individual Reflection and Patient-Clinician Shared Decision-Making on GEP-NET Management Options Using Reflective Multi-Criteria Decision Analysis","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Decision quality; Lanreotide; Watchful waiting; Population; Actuarial science; Family medicine; Psychology; Nursing; Patient satisfaction; Internal medicine; Business","score_opus":0.1712701435847904,"score_gpt":0.5248776480838744,"score_spread":0.35360750449908396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766182174","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09729196,0.00047003917,0.87298954,0.008713467,0.00024626276,0.0017481581,0.00027924337,0.0014001171,0.016861262],"genre_scores_gemma":[0.46502134,0.00015742703,0.53205997,0.0006138973,0.00006175859,0.00074535946,0.000223948,0.00016523106,0.00095106126],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.8985829,0.085888796,0.003882855,0.0031687852,0.006492322,0.0019844018],"domain_scores_gemma":[0.74917525,0.21833701,0.0080905855,0.009945429,0.010100683,0.004351037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06261105,0.0016526128,0.001701423,0.0025466539,0.0021335597,0.008757885,0.0033982105,0.002639543,0.008356055],"category_scores_gemma":[0.19366828,0.0009917595,0.0023068246,0.0013812016,0.0025728643,0.006533812,0.009630286,0.004639903,0.0013802679],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031747737,0.002284548,0.021844905,0.0017593163,0.001330114,0.0016688975,0.028014507,0.15519157,0.0053865686,0.06491965,0.016631579,0.69779354],"study_design_scores_gemma":[0.00069946214,0.0008994074,0.0033359863,0.0015106603,0.00041519714,0.0005839083,0.010109975,0.6848047,0.008625212,0.2692798,0.019390147,0.00034559512],"about_ca_topic_score_codex":0.0016819262,"about_ca_topic_score_gemma":0.0036427751,"teacher_disagreement_score":0.06261105,"about_ca_system_score_codex":0.003148828,"about_ca_system_score_gemma":0.010379225,"threshold_uncertainty_score":0.33112288},"labels":[],"label_agreement":null},{"id":"W2766393924","doi":"","title":"Squalene protects mice bone marrow hematopoietic and mesenchymal stem cells against high-dose cisplatin in vivo by restoring antioxidant balance: implications in cancer chemotherapy","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cisplatin; Bone marrow; Pharmacology; Toxicity; In vivo; Medicine; Stem cell; Squalene; Mesenchymal stem cell; Cancer research; Chemotherapy; Chemistry; Immunology; Pathology; Biology; Internal medicine; Biochemistry","score_opus":0.042422883180788885,"score_gpt":0.3845504276158072,"score_spread":0.3421275444350183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766393924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883874,0.0058646607,0.0029260616,0.0003279846,0.00006545999,0.00008637457,0.0005956433,0.00016356754,0.0015828937],"genre_scores_gemma":[0.9917887,0.0030854885,0.001770912,0.00010610748,0.0000183731,0.00007739187,0.0006846552,0.000015528822,0.0024529484],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992573,0.000012904253,0.000008729406,0.000013930567,0.000019944002,0.000018799066],"domain_scores_gemma":[0.9999292,0.000006022716,0.00002253148,0.00000797891,0.0000094716115,0.00002486543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012084411,0.000497323,0.00027172707,0.00042438024,0.00011741463,0.00017207353,0.00021074153,0.00030999695,0.0018164271],"category_scores_gemma":[0.00006514622,0.00014519636,0.00027037886,0.0001611936,0.00024662336,0.00026669214,0.00012984806,0.0006361542,0.00031444276],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035329635,0.00012011387,0.00017210147,0.000053260428,0.000007976103,0.00002661692,0.000007276869,0.000042190968,0.9974825,0.000062362175,0.000039171864,0.001633252],"study_design_scores_gemma":[0.00006813091,0.0021928893,0.0044608135,0.000015400796,0.000038891896,0.00017144615,0.000022292754,0.0003071743,0.9910033,0.00007959608,0.0016353165,0.000004750241],"about_ca_topic_score_codex":0.00048875174,"about_ca_topic_score_gemma":0.00092532183,"teacher_disagreement_score":0.0018164271,"about_ca_system_score_codex":0.00019606896,"about_ca_system_score_gemma":0.00026705343,"threshold_uncertainty_score":0.0060765147},"labels":[],"label_agreement":null},{"id":"W2767214300","doi":"10.1093/neuonc/nox168.247","title":"DDIS-11. TTI-2341: A NOVEL, ORALLY BIOAVAILABLE, BRAIN-PENETRANT, COVALENT EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITOR FOR TREATMENT OF GLIOBLASTOMA MULTIFORME (GBM) AND BRAIN METASTASES OF NON-SMALL CELL LUNG CANCER (NSCLC)","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"Erlotinib; Afatinib; Epidermal growth factor receptor; Pharmacology; Bioavailability; EGFR inhibitors; Blood–brain barrier; Cancer research; Gefitinib; Medicine; Cancer; Central nervous system; Internal medicine","score_opus":0.03715621773001542,"score_gpt":0.34614006948822057,"score_spread":0.30898385175820514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767214300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89128315,0.05334811,0.01655096,0.0013175367,0.000609018,0.00074822217,0.006659724,0.0009738626,0.028509388],"genre_scores_gemma":[0.94271064,0.02018666,0.0061067548,0.000362123,0.00007403414,0.0002018415,0.0061227907,0.00004138283,0.024193855],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999897,0.000010330708,0.00000912295,0.000026050853,0.000036420563,0.000020977213],"domain_scores_gemma":[0.9999783,0.00000194735,0.000007631153,0.0000014695389,0.0000035904252,0.000007132043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010202075,0.00052062643,0.00035469496,0.00032882902,0.00018356513,0.00027213048,0.00032047604,0.00039741688,0.0016005978],"category_scores_gemma":[0.000090030735,0.0001442131,0.0002541082,0.00035307353,0.0001722014,0.00023465832,0.00020589371,0.00062647683,0.00073762785],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011326427,0.0004163854,0.0009803645,0.0010346442,0.00005798807,0.0009784647,0.00007190666,0.0014358393,0.86785495,0.0014908378,0.00509945,0.11944647],"study_design_scores_gemma":[0.0005273872,0.0040253326,0.004862273,0.000035408706,0.000101943864,0.006448537,0.00002860907,0.0017103029,0.9147852,0.00025047702,0.06718571,0.000038688104],"about_ca_topic_score_codex":0.001104325,"about_ca_topic_score_gemma":0.002389752,"teacher_disagreement_score":0.0016005978,"about_ca_system_score_codex":0.00062395894,"about_ca_system_score_gemma":0.00050158193,"threshold_uncertainty_score":0.0053545237},"labels":[],"label_agreement":null},{"id":"W2767766110","doi":"10.1093/neuonc/nox168.1104","title":"SCDT-21. CEREBRAL INTRAARTERIAL CHEMOTHERAPY IN THE TREATMENT OF MALIGNANT GLIOMAS: READY TO RISE AGAIN","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Temozolomide; Carboplatin; Chemotherapy; Complication; Glioma; Concomitant; Cohort; Surgery; Radiation therapy; Oncology; Internal medicine; Cisplatin","score_opus":0.04201072693010514,"score_gpt":0.3734141479719171,"score_spread":0.3314034210418119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767766110","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.510581,0.4457945,0.0033736655,0.00893753,0.0013440956,0.00023713522,0.0010160038,0.00031791566,0.028398182],"genre_scores_gemma":[0.8435042,0.13092719,0.005249953,0.0022063733,0.0011224819,0.00012882966,0.0023049267,0.00009998361,0.014456121],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997857,0.00007575649,0.000019331588,0.000027529155,0.000055981676,0.000035634923],"domain_scores_gemma":[0.99979514,0.000027013506,0.000046050493,0.000018115577,0.00003827534,0.0000754551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042374153,0.00020183364,0.00030963306,0.00047209059,0.00014492041,0.0003710006,0.00020200305,0.00035554098,0.0016886708],"category_scores_gemma":[0.0003292836,0.0000687933,0.0002674354,0.0007563121,0.00023434708,0.00016673321,0.00021384085,0.00049226725,0.00086749025],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021252157,0.00027216706,0.012653596,0.0008086431,0.00010441347,0.0015972907,0.00009550001,0.0008316613,0.019724177,0.0013188034,0.010010334,0.95045817],"study_design_scores_gemma":[0.0016451288,0.0144461095,0.1374651,0.00053183635,0.0004497249,0.024902984,0.00013097817,0.0017327811,0.05202974,0.0020666,0.76450944,0.000089634144],"about_ca_topic_score_codex":0.00091198744,"about_ca_topic_score_gemma":0.0028175132,"teacher_disagreement_score":0.0016886708,"about_ca_system_score_codex":0.0006150883,"about_ca_system_score_gemma":0.0008215107,"threshold_uncertainty_score":0.0056491494},"labels":[],"label_agreement":null},{"id":"W2769968157","doi":"10.1200/jco.2017.35.31_suppl.119","title":"Impact of pharmacy interventions on pain management in an oncology palliative medicine (PM) outpatient clinic.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clinical endpoint; Pharmacy; McNemar's test; Pharmacist; Regimen; Palliative care; Physical therapy; Psychological intervention; Quality of life (healthcare); Cancer pain; Internal medicine; Outpatient clinic; Performance status; Cancer; Clinical trial; Family medicine; Nursing","score_opus":0.48154132006747746,"score_gpt":0.6737666908397559,"score_spread":0.19222537077227847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769968157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890119,0.0025426217,0.00012563379,0.0020022686,0.000089895664,0.00076766836,0.00019612692,0.0000479497,0.005215999],"genre_scores_gemma":[0.9967794,0.0008774066,0.00051760767,0.0007680811,0.00009637042,0.00028268714,0.00014371974,0.000004397157,0.0005303195],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99800116,0.0010391567,0.00011910633,0.00013356765,0.00032839773,0.0003787011],"domain_scores_gemma":[0.99589074,0.0010274412,0.0010564962,0.00008804416,0.00020481717,0.0017324181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013951801,0.0002494089,0.0004254944,0.0003156797,0.0008433958,0.0007272041,0.00048974366,0.00071242533,0.0051126694],"category_scores_gemma":[0.0093431305,0.00019596989,0.00060300005,0.00030980018,0.00016070236,0.000466562,0.0009591258,0.0009039195,0.00032793925],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01537425,0.061392978,0.16451582,0.001922863,0.0006611326,0.00069195044,0.0009291687,0.00091786816,0.0015030606,0.00017578535,0.009718025,0.7421971],"study_design_scores_gemma":[0.009982648,0.06595665,0.90890944,0.0009890691,0.0005694395,0.00074962963,0.0012413398,0.0023020166,0.00058760843,0.00018287757,0.008489193,0.000040020182],"about_ca_topic_score_codex":0.0047338903,"about_ca_topic_score_gemma":0.012115637,"teacher_disagreement_score":0.0051126694,"about_ca_system_score_codex":0.0013420448,"about_ca_system_score_gemma":0.0024125066,"threshold_uncertainty_score":0.017103612},"labels":[],"label_agreement":null},{"id":"W2771979038","doi":"10.1016/j.jpba.2017.12.002","title":"HPLC–MS/MS analysis of mesupron and its application to a pharmacokinetic study in rats","year":2017,"lang":"en","type":"article","venue":"Journal of Pharmaceutical and Biomedical Analysis","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Ministry of Trade, Industry and Energy","keywords":"Chemistry; Chromatography; Protein precipitation; Pharmacokinetics; Bioanalysis; Selected reaction monitoring; Tandem mass spectrometry; High-performance liquid chromatography; Formic acid; Acetonitrile; Analyte; Mass spectrometry; Pharmacology","score_opus":0.04355072442007977,"score_gpt":0.43860806719783585,"score_spread":0.39505734277775606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771979038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94964606,0.007343899,0.03364671,0.0005708351,0.00022058733,0.00039545415,0.0019451834,0.0007676497,0.005463571],"genre_scores_gemma":[0.9630678,0.005026649,0.023466531,0.00055325794,0.00010806675,0.0002759226,0.00082148076,0.00014073783,0.0065394985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996815,0.000060938426,0.000027901824,0.00008903076,0.000092805225,0.000047846308],"domain_scores_gemma":[0.9997087,0.000060884493,0.00006142742,0.000035617497,0.000071621274,0.000061756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005139719,0.0005931044,0.0005408301,0.0007720617,0.0006819753,0.00047033658,0.0002491009,0.0007222982,0.0019487629],"category_scores_gemma":[0.00070441165,0.00033877703,0.00049167074,0.0005881568,0.0004626038,0.0005700945,0.00026292854,0.00086576235,0.00069497176],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018573523,0.00018392647,0.0011448786,0.00016544078,0.000082361556,0.00019379192,0.00008622449,0.00037185184,0.97532016,0.00027931726,0.0002681906,0.020046588],"study_design_scores_gemma":[0.00007180969,0.0021465186,0.006192461,0.000018567393,0.00019366626,0.00065998756,0.000046947265,0.0018040658,0.9823286,0.00011929533,0.006367407,0.000050695144],"about_ca_topic_score_codex":0.0014220258,"about_ca_topic_score_gemma":0.0017670897,"teacher_disagreement_score":0.0019487629,"about_ca_system_score_codex":0.00036441057,"about_ca_system_score_gemma":0.0012383154,"threshold_uncertainty_score":0.0065193176},"labels":[],"label_agreement":null},{"id":"W2772380982","doi":"","title":"Tamoxifen and Turmeric","year":2017,"lang":"en","type":"article","venue":"Ars Medica","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Internal medicine; Cancer","score_opus":0.024947650332301882,"score_gpt":0.36027469349740054,"score_spread":0.33532704316509865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772380982","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29265958,0.47446847,0.0015779688,0.018960744,0.002773574,0.00019845889,0.0019226748,0.0005992368,0.20683934],"genre_scores_gemma":[0.7625651,0.12374256,0.001003978,0.0048074927,0.00088794925,0.00008194105,0.0011031107,0.00003694993,0.105770886],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985266,0.000057007266,0.000011772779,0.000018092622,0.000027153248,0.0000332608],"domain_scores_gemma":[0.9998809,0.000025268408,0.000038979884,0.000012095505,0.000016009964,0.00002673344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020263462,0.00028762224,0.00025694643,0.00043394166,0.00022783769,0.00035560824,0.00025779838,0.0005966978,0.015542174],"category_scores_gemma":[0.00033260998,0.00012796803,0.0002958062,0.00023285414,0.00025976458,0.00023410546,0.0003089678,0.0005001399,0.0031688095],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011170307,0.0007375451,0.0063816463,0.003152225,0.0007152467,0.0030528586,0.00040726623,0.0006848782,0.2338032,0.019055678,0.053207476,0.6676317],"study_design_scores_gemma":[0.001270932,0.010649164,0.028095745,0.00047425853,0.0006003801,0.0077602244,0.00040266884,0.0003555393,0.0709265,0.0023344872,0.8770678,0.00006233229],"about_ca_topic_score_codex":0.00093069376,"about_ca_topic_score_gemma":0.003091565,"teacher_disagreement_score":0.015542174,"about_ca_system_score_codex":0.0002829986,"about_ca_system_score_gemma":0.00034815507,"threshold_uncertainty_score":0.051993787},"labels":[],"label_agreement":null},{"id":"W2779612734","doi":"10.1097/fpc.0000000000000318","title":"Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci","year":2017,"lang":"en","type":"review","venue":"Pharmacogenetics and Genomics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Taxane; Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Internal medicine; Oncology; Odds ratio; Common Terminology Criteria for Adverse Events; Breast cancer; Genome-wide association study; Confidence interval; Cancer; Pharmacogenetics; Diabetes mellitus; Genetics; Single-nucleotide polymorphism; Genotype; Biology; Gene; Endocrinology","score_opus":0.44997370352963967,"score_gpt":0.48725786600588017,"score_spread":0.0372841624762405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2779612734","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6217152,0.35454655,0.010374134,0.0026579686,0.0005706555,0.00011919473,0.007219701,0.00047705293,0.002319498],"genre_scores_gemma":[0.9756085,0.019863747,0.0017730942,0.00044691126,0.00013881167,0.00007336924,0.0016570876,0.00005689414,0.00038151938],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99652666,0.0017178241,0.00027953554,0.0009549326,0.00030879915,0.00021228132],"domain_scores_gemma":[0.9948872,0.0033118369,0.00076937693,0.0005891276,0.000255328,0.000187175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048216404,0.0014869693,0.0027783767,0.0020063787,0.00052157737,0.0020230715,0.0011302641,0.0012107557,0.0025409686],"category_scores_gemma":[0.008584033,0.00062080234,0.014882645,0.0034106227,0.00036393895,0.00046056573,0.0009930743,0.001302594,0.00018040554],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006070947,0.000053448584,0.3756467,0.004798888,0.5854459,0.0005742693,0.000087571236,0.00434717,0.0029396627,0.00037669792,0.0021574523,0.017501319],"study_design_scores_gemma":[0.0009961512,0.0005925332,0.40049368,0.0010657683,0.58521783,0.00061402656,0.00012807918,0.004794318,0.00091746356,0.0012746261,0.0038585898,0.000046897225],"about_ca_topic_score_codex":0.007363877,"about_ca_topic_score_gemma":0.010635333,"teacher_disagreement_score":0.007363877,"about_ca_system_score_codex":0.0005399732,"about_ca_system_score_gemma":0.0007477286,"threshold_uncertainty_score":0.025499582},"labels":[],"label_agreement":null},{"id":"W2781298674","doi":"","title":"[Pierre Famel, his pharmacy, laboratories and pharmaceutical products].","year":2010,"lang":"en","type":"article","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemist; Exhibition; Management; Pharmacy; Art history; Library science; Political science; Art; Law; Chemistry","score_opus":0.037106036409613484,"score_gpt":0.32841157260984505,"score_spread":0.2913055362002316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781298674","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002130322,0.187714,0.003680487,0.21040076,0.038540725,0.00010284095,0.0009998683,0.0009859207,0.5554451],"genre_scores_gemma":[0.022966899,0.05388317,0.003481773,0.06438449,0.0077529075,0.00009286348,0.00044816046,0.00026356336,0.8467261],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983506,0.00029565083,0.000066615175,0.00035146964,0.00071457465,0.00022111215],"domain_scores_gemma":[0.9990344,0.00016742485,0.000134143,0.000047654277,0.00030421655,0.00031231987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093010603,0.00097035227,0.00038433255,0.0012449749,0.00380764,0.005558047,0.00085597974,0.004490117,0.054597728],"category_scores_gemma":[0.0036690354,0.0003720513,0.00028110255,0.001403741,0.0021213172,0.0041163145,0.0021444855,0.0042846487,0.03142603],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017698061,0.000009636302,0.00015023568,0.000090224705,0.0000036231859,0.0003310595,0.0004916028,0.00003455503,0.000096197145,0.025604816,0.90186095,0.071309395],"study_design_scores_gemma":[0.0000014836065,0.00000374387,0.000098121294,0.00004214675,5.6450017e-7,0.00022655785,0.000050463692,0.0000091458105,0.000020447145,0.0010962812,0.9984479,0.0000031312063],"about_ca_topic_score_codex":0.019162258,"about_ca_topic_score_gemma":0.02901987,"teacher_disagreement_score":0.054597728,"about_ca_system_score_codex":0.003384359,"about_ca_system_score_gemma":0.0059500146,"threshold_uncertainty_score":0.18264765},"labels":[],"label_agreement":null},{"id":"W2782518332","doi":"10.5152/ejbh.2017.3563","title":"A Systematic Review and Pooled Analysis of Studies of Oral Etoposide in Metastatic Breast Cancer","year":2018,"lang":"en","type":"review","venue":"European Journal of Breast Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sault Area Hospital; NOSM University","funders":"","keywords":"Medicine; Etoposide; Metastatic breast cancer; Oncology; Breast cancer; Internal medicine; Cancer; Population; Chemotherapy","score_opus":0.10476779183695265,"score_gpt":0.46854089920727754,"score_spread":0.36377310737032487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782518332","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036473821,0.9929096,0.00053309073,0.0001698667,0.00012192384,0.00086334394,0.0013643283,0.000015942096,0.00037442468],"genre_scores_gemma":[0.087098256,0.904515,0.00285256,0.000517835,0.00018975914,0.0031187017,0.0014131448,0.00002381088,0.00027093902],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9692552,0.01508423,0.010107188,0.0018747482,0.0031961817,0.00048247556],"domain_scores_gemma":[0.9512097,0.032725178,0.01020567,0.0010307436,0.0044263355,0.00040239986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022110702,0.0026424883,0.020620367,0.017731473,0.00063734036,0.0034361652,0.0020085818,0.001860441,0.0036486553],"category_scores_gemma":[0.06553519,0.0012611275,0.021229025,0.017232971,0.00093610043,0.0019796488,0.0018717491,0.0011476524,0.00034739284],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006781798,0.000013873922,0.001850903,0.8410713,0.14122131,0.0001498388,0.0000943415,0.00026339368,0.000176546,0.00013354521,0.00069072156,0.013655969],"study_design_scores_gemma":[0.0007369377,0.00035100663,0.0064430214,0.2318734,0.75324523,0.00027874176,0.00017142462,0.0001742363,0.00022507268,0.00030666712,0.0061528836,0.000041387982],"about_ca_topic_score_codex":0.005872572,"about_ca_topic_score_gemma":0.015851408,"teacher_disagreement_score":0.022110702,"about_ca_system_score_codex":0.004016728,"about_ca_system_score_gemma":0.00860207,"threshold_uncertainty_score":0.11693394},"labels":[],"label_agreement":null},{"id":"W2788763033","doi":"10.1007/s12035-018-0920-4","title":"Rosmarinic Acid Mitigates Mitochondrial Dysfunction and Spinal Glial Activation in Oxaliplatin-induced Peripheral Neuropathy","year":2018,"lang":"en","type":"article","venue":"Molecular Neurobiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women and Children’s Health Research Institute","funders":"","keywords":"Oxaliplatin; Neuroprotection; Medicine; Neuroinflammation; Pharmacology; Oxidative stress; Peripheral neuropathy; Colorectal cancer; Internal medicine; Endocrinology; Cancer; Inflammation","score_opus":0.016117479649149852,"score_gpt":0.29154537907418376,"score_spread":0.27542789942503393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788763033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99534297,0.002117198,0.0010153194,0.00014692995,0.00007830497,0.0000747405,0.00010653751,0.000111071975,0.0010069406],"genre_scores_gemma":[0.9968797,0.0012926626,0.0005483214,0.00004684925,0.000013404089,0.00003973137,0.00013986148,0.0000068070503,0.0010327452],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990535,0.000019464886,0.000013530619,0.00001069253,0.000013180225,0.00003768418],"domain_scores_gemma":[0.9999393,0.0000035906965,0.000022278107,0.000007950067,0.000008652427,0.000018085255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018465775,0.0005012689,0.0006083669,0.00026866182,0.00025727806,0.0002635492,0.00041762798,0.00040594258,0.0018266384],"category_scores_gemma":[0.0001978551,0.00015537434,0.00043845293,0.00023103875,0.000269557,0.0004916094,0.00023619617,0.0010307432,0.0001978734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053239457,0.006699386,0.0014355318,0.0014282342,0.00042012797,0.00064938335,0.00016996945,0.0014615497,0.8435569,0.00092632277,0.001179426,0.088833764],"study_design_scores_gemma":[0.0076197246,0.05659705,0.022152068,0.0001870558,0.001372077,0.0012934835,0.00037045177,0.00589142,0.8939826,0.000826081,0.009629644,0.00007832789],"about_ca_topic_score_codex":0.001129009,"about_ca_topic_score_gemma":0.0022101472,"teacher_disagreement_score":0.0018266384,"about_ca_system_score_codex":0.00022160246,"about_ca_system_score_gemma":0.0006131072,"threshold_uncertainty_score":0.006110728},"labels":[],"label_agreement":null},{"id":"W2789053561","doi":"10.1007/s00520-018-4071-y","title":"Physical interventions for patients suffering from chemotherapy-induced polyneuropathy","year":2018,"lang":"en","type":"letter","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Pain medicine; Polyneuropathy; Chemotherapy; Nursing research; Psychological intervention; Physical therapy; Intensive care medicine; Internal medicine; Nursing; Pathology; Anesthesiology","score_opus":0.048538357206483494,"score_gpt":0.4007359995306597,"score_spread":0.3521976423241762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789053561","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022040155,0.017925674,0.00035141103,0.9256322,0.009561881,0.00006340915,0.000042308497,0.000040564093,0.024342444],"genre_scores_gemma":[0.24212673,0.021988802,0.0015004904,0.6615004,0.055930834,0.00017238839,0.00007878693,0.000024139734,0.016677503],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997286,0.0001006202,0.00004285152,0.000021639291,0.000047000165,0.000059281792],"domain_scores_gemma":[0.99906176,0.0005071099,0.00011498295,0.000018004515,0.000085806234,0.00021247924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033795042,0.0002827772,0.0004884376,0.00026116992,0.0015459248,0.00062222994,0.00038886155,0.00856422,0.0045517255],"category_scores_gemma":[0.0045548594,0.00013819266,0.00048650044,0.0002506901,0.0007132093,0.00072994176,0.00052783574,0.006368049,0.0010692745],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009472711,0.0008282438,0.019016648,0.0012495545,0.00012952056,0.24528156,0.00093768217,0.0006554215,0.0025720429,0.0062448415,0.53781,0.18432724],"study_design_scores_gemma":[0.0019783103,0.0020248692,0.03280922,0.0030793133,0.0001916412,0.29358867,0.002172289,0.0019297056,0.0010451402,0.019517673,0.64156526,0.00009794435],"about_ca_topic_score_codex":0.0010625791,"about_ca_topic_score_gemma":0.0034862543,"teacher_disagreement_score":0.00856422,"about_ca_system_score_codex":0.0012014323,"about_ca_system_score_gemma":0.0008558464,"threshold_uncertainty_score":0.015227079},"labels":[],"label_agreement":null},{"id":"W2791622018","doi":"10.1158/1538-7445.sabcs17-p3-17-02","title":"Abstract P3-17-02: Influence of non-measurable disease on progression-free survival in patients with metastatic breast cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Metastatic breast cancer; Breast cancer; Meta-analysis; Confidence interval; Oncology; Clinical endpoint; Randomized controlled trial; Cancer; Progression-free survival; Clinical trial; Disease; Chemotherapy","score_opus":0.05747750975229474,"score_gpt":0.4432716736565262,"score_spread":0.38579416390423144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791622018","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018761136,0.97445256,0.00073362835,0.001157081,0.0006295742,0.00091213145,0.0017561526,0.000043384807,0.001554427],"genre_scores_gemma":[0.56245416,0.42427993,0.0022620428,0.0032958116,0.0019791427,0.0022109465,0.002163135,0.000066081106,0.0012887939],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9884393,0.0072386614,0.002201255,0.0007709826,0.0011685583,0.00018129933],"domain_scores_gemma":[0.9697178,0.023391763,0.004893824,0.00048722277,0.0010970074,0.0004123824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013189298,0.0017276256,0.007825913,0.0017420597,0.00030351666,0.0030872414,0.0012022875,0.002592874,0.007858074],"category_scores_gemma":[0.033986334,0.00049831095,0.019758262,0.0025352691,0.0007714233,0.0015793766,0.00090059853,0.00345452,0.00063808734],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0483364,0.00018703016,0.006583229,0.5679412,0.31710985,0.00024896886,0.00012674829,0.000779023,0.0008506131,0.00056132406,0.0032656582,0.054010015],"study_design_scores_gemma":[0.073843084,0.0077856597,0.030141722,0.10508365,0.76588833,0.0006799045,0.00014621296,0.0010325813,0.0009193656,0.0025479952,0.011846171,0.0000852725],"about_ca_topic_score_codex":0.0019257391,"about_ca_topic_score_gemma":0.0026384261,"teacher_disagreement_score":0.013189298,"about_ca_system_score_codex":0.0015327856,"about_ca_system_score_gemma":0.0017996174,"threshold_uncertainty_score":0.069752514},"labels":[],"label_agreement":null},{"id":"W2791921511","doi":"10.1007/s00520-018-4161-x","title":"Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center study","year":2018,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ottawa Regional Cancer Foundation; Ontario Clinical Oncology Group; University of Alberta; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Taxane; Common Terminology Criteria for Adverse Events; Docetaxel; Prostate cancer; Breast cancer; Chemotherapy; Internal medicine; Prospective cohort study; Cancer; Oncology; myalgia","score_opus":0.01928164644181161,"score_gpt":0.37467566867815427,"score_spread":0.35539402223634264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791921511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994487,0.0002070167,0.00004181555,0.0000168573,0.000005257322,0.00002649543,0.000118755604,0.0000010338813,0.00013400527],"genre_scores_gemma":[0.9990896,0.00021861862,0.00007742669,0.000049783757,0.000023223443,0.000028093777,0.0003700128,0.0000011251225,0.00014210503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999432,0.00017987541,0.00006715796,0.000120578974,0.000088642424,0.00011165492],"domain_scores_gemma":[0.9985368,0.00020706287,0.0006626558,0.00008562238,0.00011523201,0.00039261565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070463493,0.0005999042,0.00067139784,0.0007855278,0.0010292007,0.001123572,0.00044655643,0.0008018215,0.0019208904],"category_scores_gemma":[0.0015294293,0.0006013795,0.001073962,0.0012717611,0.0005965479,0.0010972692,0.000953405,0.0011315483,0.00029271794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087800395,0.0003090783,0.9974712,0.000017020118,0.0001537161,0.00013165061,0.000078042816,0.000021433485,0.00029927486,0.000014602059,0.000038690036,0.0005874302],"study_design_scores_gemma":[0.00010085972,0.0010103633,0.9979007,0.000008418858,0.000098475764,0.0003336069,0.00032644693,0.00006414201,0.00003811664,0.000014320223,0.0000964219,0.000008081456],"about_ca_topic_score_codex":0.0029524346,"about_ca_topic_score_gemma":0.004618194,"teacher_disagreement_score":0.0029524346,"about_ca_system_score_codex":0.000469458,"about_ca_system_score_gemma":0.0006322357,"threshold_uncertainty_score":0.0064259768},"labels":[],"label_agreement":null},{"id":"W2792339230","doi":"10.1016/j.bmcl.2018.01.053","title":"Pharmacology and in vivo efficacy of pyridine-pyrimidine amides that inhibit microtubule polymerization","year":2018,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"ADME; Chemistry; In vivo; Pharmacology; Pharmacokinetics; Bioavailability; Microtubule polymerization; Microtubule; In vitro; Biochemistry; Tubulin; Biology; Cell biology","score_opus":0.01528710306998185,"score_gpt":0.2838546049290552,"score_spread":0.2685675018590733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792339230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955052,0.0011584974,0.00053771754,0.00014869081,0.00007984147,0.00005823644,0.00035792225,0.00008261972,0.0020712381],"genre_scores_gemma":[0.99475205,0.0013667635,0.00044874882,0.000051480765,0.00006494064,0.00006220488,0.0006539695,0.00002318533,0.0025765458],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984956,0.000041538577,0.000009306045,0.000021302765,0.000019771443,0.000058551803],"domain_scores_gemma":[0.99974614,0.00007063117,0.000047225014,0.00003321339,0.000017251843,0.00008547595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034307686,0.0005131679,0.00045067153,0.00045076478,0.0003106964,0.0002918527,0.0005199678,0.00048038445,0.0023858855],"category_scores_gemma":[0.00037179777,0.00030524647,0.00044671292,0.00026853377,0.00043665105,0.0004683687,0.000096645446,0.0014833736,0.0003929527],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020731442,0.007117652,0.00068228325,0.00016897434,0.00015948614,0.00032883545,0.00012958862,0.0022414355,0.9489131,0.00070352847,0.0009591617,0.017864507],"study_design_scores_gemma":[0.0021029334,0.048706718,0.0062458487,0.000022619151,0.00021563873,0.0003418815,0.00007462894,0.0025891915,0.937083,0.0002395386,0.0023498284,0.000028217426],"about_ca_topic_score_codex":0.0013155662,"about_ca_topic_score_gemma":0.0021932966,"teacher_disagreement_score":0.0023858855,"about_ca_system_score_codex":0.0003177838,"about_ca_system_score_gemma":0.00045119642,"threshold_uncertainty_score":0.007981598},"labels":[],"label_agreement":null},{"id":"W2793337941","doi":"10.1158/1538-7445.sabcs17-p6-12-26","title":"Abstract P6-12-26: The axonal damage marker, serum phosphorylated neurofilament heavy subunit, as a potential marker of chemotherapy-induced neuropathy","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chemotherapy; Breast cancer; Peripheral neuropathy; Internal medicine; Oncology; Biomarker; Cancer; Gastroenterology; Endocrinology","score_opus":0.06557520019117179,"score_gpt":0.40540570186538544,"score_spread":0.33983050167421364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793337941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99855524,0.0008516238,0.00019049116,0.00001529483,0.000007345556,0.000010091965,0.000115854295,0.000008039075,0.00024592964],"genre_scores_gemma":[0.99922717,0.00017652121,0.00022274695,0.000009592637,0.0000056516683,0.00000827281,0.00012070255,7.717547e-7,0.00022871443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99992776,0.000015768732,0.000009152808,0.000014680562,0.00002092856,0.000011602188],"domain_scores_gemma":[0.9997112,0.000041650474,0.00014422496,0.000008723822,0.000037526792,0.00005662509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001892116,0.00025476827,0.00018305109,0.00042792343,0.00013634918,0.00024648488,0.00012466013,0.0001863892,0.0014740911],"category_scores_gemma":[0.00040521016,0.00008311798,0.000120424134,0.0003132465,0.00012176496,0.00015025576,0.0001444114,0.00022286341,0.00017061799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003952639,0.00028345187,0.9359276,0.00015454178,0.000105004794,0.00058635545,0.00006494254,0.000291345,0.04093994,0.000020056137,0.0002931927,0.017380847],"study_design_scores_gemma":[0.00004378356,0.0019107929,0.98386556,0.00001255412,0.000064312495,0.002387884,0.00006661491,0.00079261744,0.0104003595,0.000036803405,0.00041139143,0.000007318969],"about_ca_topic_score_codex":0.00041262168,"about_ca_topic_score_gemma":0.0005126401,"teacher_disagreement_score":0.0014740911,"about_ca_system_score_codex":0.00013102168,"about_ca_system_score_gemma":0.00009149025,"threshold_uncertainty_score":0.004931271},"labels":[],"label_agreement":null},{"id":"W2793419309","doi":"10.1158/1538-7445.sabcs17-p3-14-06","title":"Abstract P3-14-06: The prevention and management of chemotherapy-induced peripheral neuropathy in breast cancer patients: A systematic review","year":2018,"lang":"en","type":"review","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Breast cancer; Internal medicine; Observational study; Adverse effect; Systematic review; Peripheral neuropathy; Randomized controlled trial; Cancer; Oncology; Physical therapy; MEDLINE","score_opus":0.11496525183868346,"score_gpt":0.4825476662749586,"score_spread":0.36758241443627515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793419309","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016886769,0.99450785,0.00022121362,0.00043674724,0.00017634046,0.0014797708,0.0009900519,0.000021376802,0.00047794558],"genre_scores_gemma":[0.021928046,0.97273284,0.0008829928,0.0010288563,0.00014617061,0.0023971328,0.00051807234,0.0000099815015,0.00035586648],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99396354,0.002111756,0.0021586025,0.00044238628,0.0011006868,0.00022307131],"domain_scores_gemma":[0.98476124,0.0096154325,0.0034580664,0.00018627766,0.0017139628,0.00026509402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00653527,0.0015601997,0.009631851,0.0074768933,0.0006642159,0.0030200449,0.0020544962,0.0025220562,0.010077877],"category_scores_gemma":[0.029919786,0.0008510241,0.007266901,0.008432172,0.00082268927,0.002585444,0.0015538875,0.00132131,0.00059180934],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001224731,0.00000967487,0.00024099727,0.9866882,0.0037704066,0.000031214542,0.00006265571,0.000033599128,0.00006871776,0.00006296942,0.0006999359,0.008209069],"study_design_scores_gemma":[0.0004135498,0.00019616216,0.0020992951,0.94139946,0.0479264,0.00015074624,0.00015011315,0.000079769816,0.00010896267,0.00015836686,0.0072952737,0.000021971331],"about_ca_topic_score_codex":0.0075735776,"about_ca_topic_score_gemma":0.018648343,"teacher_disagreement_score":0.010077877,"about_ca_system_score_codex":0.004437418,"about_ca_system_score_gemma":0.01093165,"threshold_uncertainty_score":0.03456229},"labels":[],"label_agreement":null},{"id":"W2793551130","doi":"10.5858/arpa.2017-0401-ed","title":"The Lifecycle of an Evidence-Based Laboratory Practice Guideline: Origin, Update, Affirmation, and Impact!","year":2018,"lang":"en","type":"article","venue":"Archives of Pathology & Laboratory Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Guideline; Medicine; Business; Pathology","score_opus":0.02259983158137919,"score_gpt":0.3903342743051524,"score_spread":0.3677344427237732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793551130","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006036377,0.039231624,0.0153492475,0.9043707,0.024886789,0.001236655,0.00048025468,0.0006365922,0.01320451],"genre_scores_gemma":[0.024517726,0.10279657,0.45169857,0.36482158,0.030452464,0.0056348923,0.0043856716,0.0013424552,0.01435014],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.7679279,0.10679796,0.04024427,0.004339837,0.07549116,0.0051988675],"domain_scores_gemma":[0.47884512,0.15745637,0.035722483,0.029801184,0.26290873,0.035266183],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.20266579,0.002183297,0.0038644224,0.010345186,0.0048322207,0.031469617,0.0074465433,0.023674747,0.013292806],"category_scores_gemma":[0.4588985,0.0028076796,0.00389649,0.0076627303,0.00907673,0.028586125,0.01468647,0.03431297,0.015613549],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066163004,0.00020949058,0.0011481781,0.0035401017,0.00013736135,0.00034445737,0.0016383185,0.00027175766,0.00033598772,0.020240512,0.67978835,0.2922792],"study_design_scores_gemma":[0.00015592478,0.00022949553,0.0014065192,0.035952814,0.00020703516,0.00077704294,0.001977864,0.0010701147,0.0004946558,0.029623939,0.92787224,0.00023240679],"about_ca_topic_score_codex":0.009572307,"about_ca_topic_score_gemma":0.013484194,"teacher_disagreement_score":0.7973342,"about_ca_system_score_codex":0.013526651,"about_ca_system_score_gemma":0.086487316,"threshold_uncertainty_score":0.983255},"labels":[],"label_agreement":null},{"id":"W2800423321","doi":"10.1016/j.lfs.2018.04.058","title":"Therapeutic potential of patupilone in epithelial ovarian cancer and future directions","year":2018,"lang":"en","type":"review","venue":"Life Sciences","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Department of Medical Biophysics, University of Toronto","keywords":"Epothilones; Ixabepilone; Epothilone; Ovarian cancer; Taxane; In vivo; Cancer research; Cancer; Medicine; Microtubule; Paclitaxel; Pharmacology; Drug; Malignancy; Oncology; Biology; Internal medicine; Chemistry; Breast cancer; Metastatic breast cancer; Cell biology","score_opus":0.06182321546841823,"score_gpt":0.4048664378634616,"score_spread":0.34304322239504337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800423321","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021406094,0.9983777,0.000104514475,0.0003123045,0.0001455969,0.0000054098027,0.00003250748,0.0000072156604,0.00080073485],"genre_scores_gemma":[0.0011694714,0.9976355,0.0001797258,0.00028235523,0.00015777259,0.0000069293933,0.000036720874,0.000001497355,0.00052998995],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988866,0.000020376521,0.00002023886,0.000022141234,0.00003296804,0.00001549815],"domain_scores_gemma":[0.9997676,0.000114642695,0.000042917647,0.000007467427,0.00004487807,0.000022478542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005079836,0.0006957206,0.0013841433,0.0016669584,0.00020810403,0.0010818244,0.00089123496,0.00083266885,0.006067049],"category_scores_gemma":[0.000674481,0.00025725135,0.0006328585,0.0014463803,0.00045271614,0.0012594116,0.0006252388,0.0020834634,0.0014408489],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029268028,0.0001492581,0.00022386176,0.018864488,0.00015507455,0.00028506506,0.00005398671,0.00045531528,0.002075987,0.0031492815,0.01894287,0.95535225],"study_design_scores_gemma":[0.00016290904,0.00037529645,0.00102835,0.0046567386,0.00043475363,0.0015106105,0.00007922489,0.00021156298,0.0009057519,0.0024979792,0.988103,0.000033902314],"about_ca_topic_score_codex":0.0008485812,"about_ca_topic_score_gemma":0.0021788618,"teacher_disagreement_score":0.006067049,"about_ca_system_score_codex":0.00036647636,"about_ca_system_score_gemma":0.0009060054,"threshold_uncertainty_score":0.020296276},"labels":[],"label_agreement":null},{"id":"W2801860620","doi":"10.1021/acschemneuro.8b00013","title":"Protective Effect of a Mitochondria-Targeted Peptide against the Development of Chemotherapy-Induced Peripheral Neuropathy in Mice","year":2018,"lang":"en","type":"article","venue":"ACS Chemical Neuroscience","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"National Institute on Drug Abuse; Japan Society for the Promotion of Science; Canadian Institutes of Health Research","keywords":"Oxaliplatin; Peripheral neuropathy; Medicine; Neuropathic pain; Chemotherapy; Sciatic nerve; Chemotherapy-induced peripheral neuropathy; Mitochondrion; Cancer; Peripheral; Pharmacology; Internal medicine; Endocrinology; Colorectal cancer; Biology","score_opus":0.016252643737455042,"score_gpt":0.299004097311289,"score_spread":0.28275145357383397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801860620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99432796,0.0018667335,0.0016996778,0.00018647079,0.00009239304,0.00008910326,0.00035424257,0.00011699051,0.0012665027],"genre_scores_gemma":[0.9908862,0.002658565,0.0027896177,0.00017549835,0.000035134897,0.00014516074,0.00057641737,0.000019849156,0.0027136763],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998863,0.000018428247,0.000012104063,0.000025822887,0.000022424681,0.000034924975],"domain_scores_gemma":[0.9998561,0.000012745366,0.000048072903,0.000011801158,0.000016836468,0.00005452139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022223023,0.0006005229,0.00037302138,0.00058169535,0.00017748501,0.00022441978,0.0002893429,0.0005234116,0.0013992531],"category_scores_gemma":[0.00011710567,0.00019674444,0.00035405642,0.00020718695,0.00031556564,0.00047666606,0.00016254271,0.0010577827,0.00021097698],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015773696,0.0007123747,0.0002444765,0.00012647522,0.000021412216,0.0000760605,0.000029617722,0.00019274229,0.9920001,0.00015982857,0.000112270536,0.0047472287],"study_design_scores_gemma":[0.0005101563,0.019488845,0.0064569404,0.000059624002,0.0001252532,0.00036274164,0.00007057079,0.0019813625,0.9677739,0.00017670878,0.0029733353,0.000020509497],"about_ca_topic_score_codex":0.0004943793,"about_ca_topic_score_gemma":0.00061832136,"teacher_disagreement_score":0.0013992531,"about_ca_system_score_codex":0.00020488886,"about_ca_system_score_gemma":0.00038912133,"threshold_uncertainty_score":0.0046809316},"labels":[],"label_agreement":null},{"id":"W2802054964","doi":"10.1200/jco.2018.36.4_suppl.685","title":"Platinum deposition in skin as a possible mechanism for peripheral sensory neuropathy (PSN) in patients (pts) with colorectal cancer (CRC) following oxaliplatin-based therapy.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fluidigm (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Oxaliplatin; Medicine; FOLFOX; Internal medicine; Colorectal cancer; Gastroenterology; Peripheral neuropathy; Cancer; Cetuximab; Oncology; Urology; Endocrinology","score_opus":0.06722822838202357,"score_gpt":0.440695205084386,"score_spread":0.3734669767023624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802054964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989359,0.00046035234,0.00012090696,0.000026442316,0.000003596976,0.00001653295,0.000036804486,0.0000037222328,0.00039583893],"genre_scores_gemma":[0.9996617,0.00010245483,0.000078798854,0.000021771413,0.000004402682,0.000004102178,0.00003240755,4.5453478e-7,0.00009386823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989367,0.000034139102,0.000012121283,0.0000221447,0.000022449112,0.000015489317],"domain_scores_gemma":[0.9997254,0.00005746482,0.00014528226,0.000008332565,0.000021860978,0.0000417571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002684401,0.00014329825,0.00018299665,0.00034056487,0.00025063156,0.00031446465,0.00013424734,0.00026786665,0.0014064634],"category_scores_gemma":[0.00050201145,0.00013171414,0.00017470302,0.00031615194,0.00017074803,0.00021775237,0.00018585466,0.00023343769,0.0001428268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013021011,0.00009625041,0.9770231,0.00008560958,0.000041562573,0.004586343,0.0001019401,0.00009849685,0.007516442,0.000020998787,0.00011856358,0.00900865],"study_design_scores_gemma":[0.000043356715,0.0015904204,0.9824942,0.000016653305,0.00007824509,0.0126735475,0.0001813571,0.00058443163,0.0018879955,0.000047429858,0.00039816764,0.000004218718],"about_ca_topic_score_codex":0.00043068067,"about_ca_topic_score_gemma":0.00085854426,"teacher_disagreement_score":0.0014064634,"about_ca_system_score_codex":0.00021926805,"about_ca_system_score_gemma":0.00013227045,"threshold_uncertainty_score":0.0047050714},"labels":[],"label_agreement":null},{"id":"W2803060236","doi":"10.1200/jco.2018.36.4_suppl.414","title":"Folfirinox (FFX) versus gemcitabine with nab‐paclitaxel (GNP) in the first line treatment (1LTx) of metastatic pancreatic cancer (mPC): A tertiary center experience.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Gemcitabine; Internal medicine; Pancreatic cancer; Gastroenterology; Neutropenia; Discontinuation; Progression-free survival; Surgery; Chemotherapy; Cancer","score_opus":0.1971894995990235,"score_gpt":0.521799951063017,"score_spread":0.32461045146399353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803060236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980716,0.0011876288,0.000111678106,0.00006580945,0.000011619327,0.00006639927,0.00006334576,0.000009285963,0.00041266697],"genre_scores_gemma":[0.9981749,0.000890714,0.00023947295,0.000091511916,0.000039251805,0.000030178175,0.0001948915,0.000003146957,0.00033596958],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996841,0.00014054282,0.000031809162,0.00004967405,0.000032232714,0.000061734994],"domain_scores_gemma":[0.9993057,0.00020802482,0.00020885395,0.00003717148,0.000028809764,0.00021137753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013569006,0.0003150519,0.0006289602,0.0002502359,0.0003348278,0.00048538827,0.00039267333,0.0003142806,0.002244245],"category_scores_gemma":[0.0012512143,0.00012014267,0.0005678889,0.00033773883,0.00027574276,0.00043264427,0.0003879459,0.00060640706,0.0002578938],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27027318,0.030303987,0.22276367,0.0016077094,0.002134669,0.0015011254,0.0015630431,0.005412675,0.018749805,0.00042214902,0.003964987,0.44130296],"study_design_scores_gemma":[0.03475323,0.51076627,0.42374286,0.00034097236,0.0022206388,0.0047766315,0.0005695377,0.004998068,0.011902476,0.00031240142,0.0055538244,0.00006302568],"about_ca_topic_score_codex":0.0012428884,"about_ca_topic_score_gemma":0.003920316,"teacher_disagreement_score":0.002244245,"about_ca_system_score_codex":0.0013818943,"about_ca_system_score_gemma":0.0007267593,"threshold_uncertainty_score":0.010026336},"labels":[],"label_agreement":null},{"id":"W2803537745","doi":"10.5603/gp.a2018.0034","title":"Effectiveness of gabapentin pharmacotherapy in chemotherapy-induced peripheral neuropathy","year":2018,"lang":"en","type":"article","venue":"Ginekologia Polska","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gabapentin; Peripheral neuropathy; Chemotherapy-induced peripheral neuropathy; Chemotherapy; Neuropathic pain; Discontinuation; Internal medicine; Carboplatin; Exacerbation; Quality of life (healthcare); Ovarian cancer; Neurotoxicity; Anesthesia; Oncology; Cancer; Toxicity; Cisplatin; Diabetes mellitus","score_opus":0.021844470987754175,"score_gpt":0.34842249194884056,"score_spread":0.3265780209610864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803537745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98731405,0.011146066,0.00020325439,0.00012253723,0.00002765579,0.00005973679,0.000054878816,0.000021710177,0.0010502647],"genre_scores_gemma":[0.9964677,0.0028044768,0.00029499896,0.00006992208,0.00001674865,0.00003189226,0.00006545765,0.000001706034,0.0002470763],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99992526,0.00003615367,0.000008757519,0.000007461905,0.000010782786,0.000011742303],"domain_scores_gemma":[0.9998884,0.000030434234,0.000046666915,0.0000054077523,0.000010146404,0.000018859686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000121868696,0.00012671396,0.0003431261,0.00015225529,0.00010358075,0.00012616694,0.00010898553,0.00011891932,0.0007536691],"category_scores_gemma":[0.00032128367,0.000034369292,0.00019326844,0.000118352895,0.00007666926,0.00009114359,0.00009377067,0.00026085958,0.000073646734],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046509,0.0073315967,0.060187202,0.0022087581,0.0008541467,0.0010878008,0.00014073362,0.0030468714,0.061626997,0.0002505386,0.0012327426,0.8155236],"study_design_scores_gemma":[0.009429462,0.17231843,0.7362148,0.0011415756,0.0015988711,0.006664273,0.00033479783,0.006568437,0.04802328,0.00046494268,0.017190123,0.00005104734],"about_ca_topic_score_codex":0.00026588174,"about_ca_topic_score_gemma":0.0007652117,"teacher_disagreement_score":0.0007536691,"about_ca_system_score_codex":0.00015603412,"about_ca_system_score_gemma":0.00017206665,"threshold_uncertainty_score":0.0025212765},"labels":[],"label_agreement":null},{"id":"W2808815218","doi":"10.1016/j.bulcan.2018.04.012","title":"Nouvelles définitions de la maladie oligométastatique et nouveaux concepts de prise en charge globale de la maladie métastatique","year":2018,"lang":"fr","type":"review","venue":"Bulletin du Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ablative case; Systemic therapy; Quality of life (healthcare); Metastasis; Disease; Oncology; Ablation; Radiation therapy; Internal medicine; Cancer","score_opus":0.02022754080206572,"score_gpt":0.38122237195670516,"score_spread":0.36099483115463943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808815218","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023622655,0.9879447,0.0012260955,0.0052738762,0.0011320139,0.000011921722,0.000055134526,0.000010362829,0.0041097514],"genre_scores_gemma":[0.004999885,0.986337,0.0017589686,0.003158649,0.0015331926,0.00003593477,0.00011206567,0.000007924937,0.002056328],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989868,0.0003257759,0.00015412417,0.00015777747,0.00027926653,0.00009633822],"domain_scores_gemma":[0.99801433,0.0013201173,0.00020680181,0.00006956645,0.00031124015,0.000077966695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030672592,0.0011570978,0.0015369493,0.0033787927,0.0007883391,0.0030405961,0.0012694745,0.00223044,0.0045983098],"category_scores_gemma":[0.00433607,0.0003959785,0.001139128,0.0036786557,0.005352958,0.004457696,0.001969804,0.005378807,0.0010998988],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011185329,0.00007957809,0.001056579,0.025674151,0.00020911818,0.0003827709,0.001797035,0.0007183932,0.0013035084,0.28374904,0.07047182,0.614446],"study_design_scores_gemma":[0.000016531689,0.000047744103,0.000910743,0.0065467185,0.00009429742,0.0013399293,0.00050113467,0.000091592425,0.00031086485,0.021771485,0.9683358,0.000033148735],"about_ca_topic_score_codex":0.0055284468,"about_ca_topic_score_gemma":0.0067263115,"teacher_disagreement_score":0.0055284468,"about_ca_system_score_codex":0.0028941983,"about_ca_system_score_gemma":0.0062071253,"threshold_uncertainty_score":0.020998955},"labels":[],"label_agreement":null},{"id":"W2810376202","doi":"10.1097/01.reo.0000000000000111","title":"Physical Therapy–Based Interventions Improve Balance, Function, Symptoms, and Quality of Life in Patients With Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review","year":2018,"lang":"en","type":"review","venue":"Rehabilitation Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Psychological intervention; Physical therapy; Quality of life (healthcare); Balance (ability); Physical medicine and rehabilitation; Peripheral neuropathy; Randomized controlled trial; Observational study; Internal medicine; Psychiatry","score_opus":0.04313003745739118,"score_gpt":0.4036203973133361,"score_spread":0.3604903598559449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810376202","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002350964,0.9963684,0.0000857535,0.00014570463,0.00008143327,0.00045646893,0.00020892132,0.000008543314,0.00029374537],"genre_scores_gemma":[0.026834637,0.9708085,0.00056909485,0.0005394776,0.00008544115,0.00083552505,0.00018856367,0.0000042880297,0.00013437986],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.996759,0.0011461267,0.0011713664,0.00022062745,0.00057004066,0.00013294065],"domain_scores_gemma":[0.9907053,0.006486644,0.0018041298,0.00010245749,0.00076360453,0.00013787489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003617646,0.0011525467,0.00776137,0.004643472,0.00058203615,0.0018117635,0.0015463856,0.0019073843,0.0043154354],"category_scores_gemma":[0.016410105,0.0007580416,0.0068589402,0.0052632433,0.0004964787,0.0012880818,0.0008789929,0.0010131467,0.00026596594],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039681085,0.000049591636,0.0006075153,0.957718,0.012411952,0.00007582959,0.00011267081,0.00007334615,0.00013294694,0.0000796039,0.00074728543,0.02759447],"study_design_scores_gemma":[0.0011522204,0.00070117455,0.0065709073,0.86517644,0.11476215,0.00033707672,0.00025315364,0.00013862233,0.00021836263,0.000170334,0.010482055,0.000037520647],"about_ca_topic_score_codex":0.006348967,"about_ca_topic_score_gemma":0.01984835,"teacher_disagreement_score":0.00776137,"about_ca_system_score_codex":0.002837203,"about_ca_system_score_gemma":0.006347135,"threshold_uncertainty_score":0.020585418},"labels":[],"label_agreement":null},{"id":"W2810686894","doi":"10.1017/cjn.2018.154","title":"P.052 Case Report: Brentuximab associated toxic neuropathy","year":2018,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Saskatoon Medical Imaging","funders":"","keywords":"Medicine; Brentuximab vedotin; Vincristine; Pathology; Internal medicine; Oncology; Lymphoma; Cyclophosphamide; Chemotherapy","score_opus":0.04705391630050084,"score_gpt":0.3241820456953859,"score_spread":0.27712812939488507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810686894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89140975,0.0348926,0.0057209004,0.0057311337,0.0014632731,0.00035284995,0.00092942116,0.0005079077,0.05899207],"genre_scores_gemma":[0.9885074,0.003967882,0.0010342059,0.0012189102,0.00091710093,0.000036677142,0.0002047715,0.000030573327,0.0040824646],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995622,0.000049180722,0.000076409626,0.0001163653,0.000075417374,0.000120429766],"domain_scores_gemma":[0.9991677,0.000281361,0.0002640514,0.00008116158,0.00007420432,0.00013153588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026340352,0.001184249,0.00079670374,0.0016724534,0.001301522,0.0012532288,0.00082525326,0.0033551385,0.006198939],"category_scores_gemma":[0.0015540984,0.000509197,0.00084906234,0.0014462472,0.0008379108,0.0015160388,0.0007478601,0.0016302973,0.0020222208],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024647099,0.000019576628,0.0026979547,0.000057665588,0.000009375911,0.9940905,0.000048653346,0.00003178764,0.00037476936,0.00009749595,0.00035260068,0.002194968],"study_design_scores_gemma":[0.000009691755,0.000039815623,0.0020041203,0.000035344154,0.000013897434,0.9961719,0.00006598059,0.000099763194,0.0002546838,0.00013158936,0.0011686631,0.0000046985615],"about_ca_topic_score_codex":0.0012201634,"about_ca_topic_score_gemma":0.001447459,"teacher_disagreement_score":0.006198939,"about_ca_system_score_codex":0.00067374314,"about_ca_system_score_gemma":0.00057836814,"threshold_uncertainty_score":0.020737529},"labels":[],"label_agreement":null},{"id":"W2814722636","doi":"","title":"Metronomic ABI-007 therapy: antiangiogenic and antitumor activity of a nanoparticle albumin-bound paclitaxel","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Paclitaxel; Medicine; Pharmacology; Chemotherapy; Angiogenesis; Cancer; Toxicity; Cancer research; Internal medicine","score_opus":0.11926687460562532,"score_gpt":0.46720650383466705,"score_spread":0.34793962922904176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2814722636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99406695,0.0012974803,0.002165431,0.00006934768,0.000024807554,0.000040804585,0.000065500346,0.00007260135,0.00219718],"genre_scores_gemma":[0.9964994,0.00038933754,0.0016337918,0.000028694305,0.000008803225,0.000024050903,0.000112545524,0.000009278669,0.0012939977],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999329,0.000011011785,0.0000055482797,0.000009322223,0.00002471231,0.000016459546],"domain_scores_gemma":[0.999969,0.0000064455453,0.000005806135,0.0000033894448,0.0000056931067,0.0000095815385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106614345,0.0001926183,0.00019887438,0.00021891584,0.00008923575,0.00021217424,0.00016093375,0.00023350601,0.00084894913],"category_scores_gemma":[0.000087800305,0.00008185865,0.00011659424,0.00013219063,0.00013267771,0.00014439556,0.00008336397,0.0003963777,0.00027294015],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008082682,0.0003708957,0.00035165477,0.00009130404,0.000011751661,0.000106763364,0.000029401928,0.0004185216,0.98063385,0.00021252608,0.00029625537,0.016668737],"study_design_scores_gemma":[0.000097140575,0.0028278579,0.0024587149,0.000005544441,0.000027707483,0.00047810844,0.000012670708,0.0027566294,0.9888011,0.000043751417,0.002485179,0.000005549461],"about_ca_topic_score_codex":0.00049215887,"about_ca_topic_score_gemma":0.00088930567,"teacher_disagreement_score":0.00084894913,"about_ca_system_score_codex":0.0002570356,"about_ca_system_score_gemma":0.00022527797,"threshold_uncertainty_score":0.002840042},"labels":[],"label_agreement":null},{"id":"W2834973095","doi":"10.1002/cpt.1179","title":"Pharmacogenomics of Vincristine‐Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; BC Children’s Hospital Foundation; BC Children's Hospital; Children's Hospital Foundation; London Health Sciences Centre","keywords":"Pharmacogenomics; Peripheral neuropathy; Pharmacokinetics; Medicine; Pharmacogenetics; Pharmacology; Vincristine; Gene; Bioinformatics; Internal medicine; Genetics; Biology; Chemotherapy; Genotype; Endocrinology","score_opus":0.24322484068939612,"score_gpt":0.5059146346413825,"score_spread":0.26268979395198644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2834973095","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9380394,0.050811317,0.0038347994,0.0011018378,0.0000478342,0.000025041722,0.0039635114,0.000045876317,0.0021303678],"genre_scores_gemma":[0.9917066,0.0056401147,0.0009159692,0.00025452435,0.000038860457,0.000013709407,0.0009887835,0.000014891074,0.0004265097],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991689,0.00034927466,0.00006318883,0.00023897461,0.00014097847,0.000038621216],"domain_scores_gemma":[0.99846715,0.00084862934,0.00041366776,0.00014299554,0.00008815054,0.000039441107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010764598,0.00035287166,0.0005428647,0.0005335977,0.00015840691,0.0006593739,0.00018715908,0.00029956322,0.0015893528],"category_scores_gemma":[0.0022981546,0.00012735598,0.0009703319,0.0015544365,0.0001948986,0.00019521196,0.0002852192,0.00042654626,0.00011266999],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037965113,0.00010417322,0.8363957,0.0017328031,0.026237233,0.0007237644,0.000162463,0.0043966575,0.019386861,0.0014405578,0.0023146858,0.103308596],"study_design_scores_gemma":[0.00019460804,0.0004499865,0.9628664,0.00020582187,0.017805954,0.0013713543,0.00008343887,0.0038699037,0.0042119124,0.0023917768,0.00652286,0.000025885009],"about_ca_topic_score_codex":0.0024049927,"about_ca_topic_score_gemma":0.003695254,"teacher_disagreement_score":0.0024049927,"about_ca_system_score_codex":0.00030381745,"about_ca_system_score_gemma":0.0002708004,"threshold_uncertainty_score":0.005692959},"labels":[],"label_agreement":null},{"id":"W2883308915","doi":"10.1016/j.ijpharm.2018.07.046","title":"Drug metabolites and their effects on the development of adverse reactions: Revisiting Lipinski’s Rule of Five","year":2018,"lang":"en","type":"review","venue":"International Journal of Pharmaceutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":230,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Adverse effect; Lipinski's rule of five; Drug; Cancer; Pharmacology; Breast cancer; Drug reaction; Medicine; Anticancer drug; Bioinformatics; Intensive care medicine; Chemistry; Internal medicine; Biology","score_opus":0.07611744742011885,"score_gpt":0.4324239561494103,"score_spread":0.3563065087292915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883308915","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008246182,0.9885295,0.0042034416,0.0030128881,0.0007927539,0.000049841947,0.00005339932,0.000028135304,0.0025054314],"genre_scores_gemma":[0.012202878,0.9792636,0.0039477753,0.0024839656,0.0010786778,0.00006556199,0.00007067476,0.000008145075,0.00087866664],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99662304,0.0010844182,0.0009557142,0.00030437906,0.0008846948,0.00014768346],"domain_scores_gemma":[0.9932841,0.005028752,0.0008444282,0.00015718589,0.0005751815,0.00011034978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068415026,0.0016064415,0.003699538,0.0028653978,0.000465208,0.0024099066,0.002768163,0.0026880188,0.002616262],"category_scores_gemma":[0.0066929655,0.0005304054,0.0024902155,0.0015132035,0.0028008136,0.004993838,0.0020752412,0.006570207,0.00082004257],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003879772,0.00019838985,0.0015992213,0.031433515,0.0006193316,0.0014665457,0.00031979685,0.0013544745,0.0012269164,0.060640626,0.016736913,0.8840163],"study_design_scores_gemma":[0.0002973569,0.0011352238,0.0033938647,0.030739067,0.0014023377,0.009518411,0.000511544,0.0022642862,0.0024275188,0.10028874,0.84780675,0.00021485139],"about_ca_topic_score_codex":0.00083416735,"about_ca_topic_score_gemma":0.0012802882,"teacher_disagreement_score":0.0068415026,"about_ca_system_score_codex":0.0009796782,"about_ca_system_score_gemma":0.0024404677,"threshold_uncertainty_score":0.036181748},"labels":[],"label_agreement":null},{"id":"W2883816907","doi":"10.2147/ott.s166399","title":"Outcome of eribulin as a late treatment line for Thai metastatic breast cancer patients","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Association of Emergency Physicians","funders":"","keywords":"Eribulin; Medicine; Metastatic breast cancer; Breast cancer; Oncology; Internal medicine; Radiomics; Cancer; Radiology","score_opus":0.04725875636328954,"score_gpt":0.3979276726502522,"score_spread":0.3506689162869627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883816907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957491,0.0031809239,0.00017318357,0.00008451351,0.000012152879,0.000013939538,0.00013085353,0.000004442581,0.00065094046],"genre_scores_gemma":[0.99847454,0.00075902825,0.00009162786,0.000088619505,0.000021909027,0.000016287666,0.0003488877,0.0000018161462,0.00019727812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985707,0.00004891295,0.000016306376,0.000018041905,0.000031892614,0.000027690796],"domain_scores_gemma":[0.99925786,0.00012069394,0.00040261023,0.000018333358,0.00006018653,0.00014029145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030596583,0.00013291108,0.0002561959,0.00012557677,0.00019330549,0.00030959025,0.000096298274,0.00013830564,0.0005911382],"category_scores_gemma":[0.0008307307,0.000040750812,0.0002876719,0.00019862724,0.00011755422,0.00017393759,0.00016540418,0.00032456053,0.00007676509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017713688,0.0008380497,0.82696456,0.0007869535,0.00039949457,0.0033950205,0.00043239535,0.0013024918,0.014315643,0.00019231476,0.001706544,0.13195288],"study_design_scores_gemma":[0.000997316,0.042286087,0.9096246,0.00025750764,0.00074543926,0.020617032,0.00063435134,0.0029213978,0.008346435,0.00031163642,0.013223987,0.000034283174],"about_ca_topic_score_codex":0.00037280293,"about_ca_topic_score_gemma":0.0006392746,"teacher_disagreement_score":0.0005911382,"about_ca_system_score_codex":0.00032092826,"about_ca_system_score_gemma":0.00025298336,"threshold_uncertainty_score":0.002328515},"labels":[],"label_agreement":null},{"id":"W2883844854","doi":"10.1007/s00520-018-4361-4","title":"Letter to the editor—comments on Kleckner et al. (2018) “Effects of exercise during chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial”","year":2018,"lang":"en","type":"letter","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Athabasca University","funders":"","keywords":"Medicine; Pain medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Randomized controlled trial; Peripheral; Chemotherapy; Nursing research; Physical therapy; Internal medicine; Anesthesia; Anesthesiology; Pathology; Diabetes mellitus; Endocrinology","score_opus":0.014082505227358391,"score_gpt":0.33399141967379414,"score_spread":0.31990891444643577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883844854","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027384673,0.0010712289,0.00006032056,0.971229,0.026423775,0.000016209624,0.00017095087,0.000048675567,0.0007060081],"genre_scores_gemma":[0.0019633677,0.0008497771,0.00014219631,0.94889545,0.04612,0.00005717887,0.000057502002,0.000027529075,0.0018869651],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954798,0.001938236,0.0007100741,0.00055538834,0.0009640678,0.00035227917],"domain_scores_gemma":[0.97727627,0.013328799,0.0021424731,0.00047226108,0.0047919312,0.0019883094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062768254,0.00088359334,0.0021907652,0.00084569975,0.0023867392,0.0031099631,0.0024420342,0.030498685,0.0083906995],"category_scores_gemma":[0.05484052,0.00076090515,0.0013263386,0.0010315247,0.001875024,0.0032292092,0.0010435247,0.027737916,0.009232646],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014091763,0.000026693018,0.00027108734,0.00007001883,0.000017140012,0.00034788708,0.000037249334,0.000026057996,0.000052973846,0.00030597087,0.9946049,0.0040992247],"study_design_scores_gemma":[0.001180184,0.00033701226,0.002205791,0.00093318586,0.00017365864,0.0024265775,0.00039487693,0.0006159417,0.00060538185,0.00620823,0.98478067,0.00013848681],"about_ca_topic_score_codex":0.003091746,"about_ca_topic_score_gemma":0.0042819437,"teacher_disagreement_score":0.030498685,"about_ca_system_score_codex":0.0033667933,"about_ca_system_score_gemma":0.0039234143,"threshold_uncertainty_score":0.033195436},"labels":[],"label_agreement":null},{"id":"W2884184285","doi":"10.5737/23688076283178183","title":"Potential mediators of improvement in painful chemotherapy-induced peripheral neuropathy via a web-based cognitive behavioural intervention","year":2018,"lang":"en","type":"article","venue":"Canadian Oncology Nursing Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases; University of Michigan; Damon Runyon Cancer Research Foundation; U.S. Department of Defense","keywords":"Medicine; Anxiety; Depression (economics); Cognition; Intervention (counseling); Chronic pain; Peripheral neuropathy; Physical therapy; Cognitive behavioral therapy; Sleep disorder; Randomized controlled trial; Psychiatry; Internal medicine","score_opus":0.016934642626548594,"score_gpt":0.32965668123580405,"score_spread":0.31272203860925546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884184285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973048,0.00028623836,0.00028782792,0.00023182321,0.000015007674,0.0005309814,0.00008629643,0.0000222053,0.0012348061],"genre_scores_gemma":[0.9962674,0.0003423769,0.0017350421,0.00015026481,0.000018644618,0.0008188481,0.00007552569,0.0000016379506,0.00059031637],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994438,0.00028377437,0.00003456733,0.000049503986,0.00010974501,0.00007860464],"domain_scores_gemma":[0.9990313,0.00057118706,0.00019303274,0.000031426258,0.000044413915,0.00012856864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095758535,0.00024558246,0.00038412964,0.0002738621,0.00022760234,0.00024584556,0.0003751438,0.000268414,0.005140684],"category_scores_gemma":[0.003442701,0.00011323653,0.00035896138,0.00021146557,0.00019531698,0.00019021607,0.00032749437,0.0006153481,0.00016139707],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06309105,0.13170478,0.093622684,0.0057686605,0.0016159588,0.00023683204,0.0023913546,0.0016503074,0.009312615,0.00060412247,0.0018623142,0.6881393],"study_design_scores_gemma":[0.038750928,0.15338203,0.79001635,0.00086539006,0.0029183612,0.0001848483,0.0008991526,0.004864768,0.004228836,0.0009085658,0.0029343525,0.000046337984],"about_ca_topic_score_codex":0.0027483944,"about_ca_topic_score_gemma":0.0041744527,"teacher_disagreement_score":0.005140684,"about_ca_system_score_codex":0.00038609267,"about_ca_system_score_gemma":0.000997918,"threshold_uncertainty_score":0.01719731},"labels":[],"label_agreement":null},{"id":"W2884248669","doi":"10.5737/23688076283184190","title":"Médiateurs potentiels d’amélioration de la neuropathie périphérique chimio-induite douloureuse par une intervention cognitivocomportementale en ligne","year":2018,"lang":"fr","type":"article","venue":"Canadian Oncology Nursing Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine","score_opus":0.013454360155232025,"score_gpt":0.3647698676303381,"score_spread":0.35131550747510604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884248669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787102,0.0051387562,0.0015461182,0.00054462143,0.0001481406,0.00071234826,0.00069250225,0.000059938186,0.012447389],"genre_scores_gemma":[0.9852223,0.0026347926,0.00240386,0.00034193398,0.00007764236,0.0017240561,0.00051567354,0.00001530732,0.007064468],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99971634,0.000097484095,0.000023886407,0.000064440734,0.000054988872,0.000042946845],"domain_scores_gemma":[0.998978,0.00057303155,0.00020657651,0.000053272008,0.00011403528,0.00007494818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007822318,0.0003402574,0.00063675956,0.00020104671,0.00030121682,0.00070497853,0.0003601369,0.00058346364,0.022467637],"category_scores_gemma":[0.0024171015,0.0002162119,0.000519437,0.00014788697,0.00031479128,0.00039121447,0.00037554133,0.0005919314,0.00092894846],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12867449,0.010749728,0.07336033,0.017052885,0.0036573543,0.0010242264,0.00905203,0.001195509,0.19124553,0.0043070666,0.00924919,0.55043167],"study_design_scores_gemma":[0.011386899,0.06959499,0.82051194,0.0025549338,0.005357016,0.0013432576,0.0029251368,0.0014316429,0.05035978,0.0037899432,0.030594423,0.00015005599],"about_ca_topic_score_codex":0.001668965,"about_ca_topic_score_gemma":0.0026774728,"teacher_disagreement_score":0.022467637,"about_ca_system_score_codex":0.0003817036,"about_ca_system_score_gemma":0.00088284863,"threshold_uncertainty_score":0.075161755},"labels":[],"label_agreement":null},{"id":"W2885680330","doi":"10.1158/1538-7445.am2018-ct096","title":"Abstract CT096: Trastuzumab emtansine (T-DM1) + capecitabine in HER2-positive metastatic breast cancer (mBC) and HER2-positive locally advanced (LA)/metastatic gastric cancer (mGC): Results from the phase I/randomized phase II TRAXHER2 study","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Capecitabine; Medicine; Metastatic breast cancer; Internal medicine; Trastuzumab; Gastroenterology; Breast cancer; Cancer; Phases of clinical research; Trastuzumab emtansine; Oncology; Toxicity; Colorectal cancer","score_opus":0.05435336479656514,"score_gpt":0.4505987041799581,"score_spread":0.39624533938339296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885680330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987061,0.005214274,0.0005082456,0.00067971094,0.00019372176,0.0012429133,0.0020719816,0.00016781634,0.0028604062],"genre_scores_gemma":[0.9862969,0.0028730587,0.0012341802,0.00066749385,0.0001858968,0.00089991995,0.004121409,0.000033135817,0.0036880428],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996637,0.0001831454,0.000022708424,0.000049244896,0.00004016052,0.000040952305],"domain_scores_gemma":[0.999546,0.00007934463,0.00007863389,0.000021438083,0.00002468977,0.0002498618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010840662,0.0008652209,0.0012662393,0.0004083361,0.0002499605,0.00052600756,0.00066275964,0.0006274717,0.0052996348],"category_scores_gemma":[0.00063846994,0.00032942707,0.0007894149,0.00043406987,0.00049264607,0.00057977886,0.0002971573,0.0020174598,0.00078151654],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8471471,0.016850702,0.0038992106,0.0007346315,0.0011609273,0.00022571936,0.000069446636,0.0022726168,0.041731235,0.0002878173,0.0065635787,0.079057105],"study_design_scores_gemma":[0.64210236,0.33013833,0.013089679,0.00005933261,0.0008202019,0.00040710924,0.000027624585,0.0018986174,0.0069637722,0.00016593066,0.004301881,0.000025264935],"about_ca_topic_score_codex":0.00087673205,"about_ca_topic_score_gemma":0.0024276737,"teacher_disagreement_score":0.0052996348,"about_ca_system_score_codex":0.00070736115,"about_ca_system_score_gemma":0.0009532161,"threshold_uncertainty_score":0.017729044},"labels":[],"label_agreement":null},{"id":"W2888335003","doi":"10.1200/jco.2007.25.18_suppl.1047","title":"A phase II study of pemetrexed and doxorubicin in patients with advanced or metastatic breast cancer (MBC)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Metastatic breast cancer; Pemetrexed; Doxorubicin; Neutropenia; Breast cancer; Internal medicine; Chemotherapy; Phases of clinical research; Febrile neutropenia; Oncology; Gastroenterology; Surgery; Cancer; Cisplatin","score_opus":0.11186106138756197,"score_gpt":0.5453082906213601,"score_spread":0.43344722923379814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888335003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938737,0.001204192,0.0003294468,0.00030951406,0.00009282288,0.00293291,0.00031508997,0.000027949933,0.000914402],"genre_scores_gemma":[0.9879078,0.0017680818,0.0017554589,0.0009894685,0.00024473201,0.0044560623,0.0011606239,0.000016927626,0.0017008343],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994209,0.00035193263,0.000026165202,0.00006982712,0.000042779255,0.00008842832],"domain_scores_gemma":[0.99904746,0.00018845416,0.00012126808,0.00006444947,0.000054979024,0.00052330556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020675864,0.0010913886,0.0019514877,0.0004448313,0.0003863007,0.00070815335,0.0007593695,0.0011356696,0.004394802],"category_scores_gemma":[0.0010546544,0.0007003433,0.0008804007,0.00044173983,0.0009041068,0.00066257425,0.00043062936,0.0028617708,0.0008441102],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6940107,0.18329848,0.013996605,0.00086912175,0.0012651805,0.00040479825,0.00052548107,0.0016794511,0.030247048,0.00025354733,0.0029699837,0.07047973],"study_design_scores_gemma":[0.58037823,0.40573558,0.009923406,0.000025329708,0.00025331555,0.00021170717,0.000061819475,0.00069882354,0.001030468,0.00007562451,0.0015919143,0.0000138292735],"about_ca_topic_score_codex":0.0007490498,"about_ca_topic_score_gemma":0.0012788202,"teacher_disagreement_score":0.004394802,"about_ca_system_score_codex":0.00072195724,"about_ca_system_score_gemma":0.0015858972,"threshold_uncertainty_score":0.014702082},"labels":[],"label_agreement":null},{"id":"W2888793209","doi":"10.1016/s1470-2045(18)30418-2","title":"Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review","year":2018,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"European Organisation for Research and Treatment of Cancer; Boehringer Ingelheim","keywords":"Medicine; Breast cancer; Randomized controlled trial; Sample size determination; MEDLINE; Systematic review; Clinical trial; Quality of life (healthcare); Meta-analysis; Missing data; Data quality; Medical physics; Alternative medicine; Cancer; Family medicine; Internal medicine; Pathology; Statistics","score_opus":0.23198629264013598,"score_gpt":0.520737163619044,"score_spread":0.288750870978908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888793209","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022829722,0.9934487,0.0018008313,0.00032958144,0.00035007525,0.0009441041,0.0005680456,0.000040699873,0.00023497606],"genre_scores_gemma":[0.17622039,0.8033565,0.011359986,0.0024797232,0.0006218899,0.00441259,0.0011274295,0.00008696822,0.00033449152],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.8665941,0.08638501,0.03244791,0.0050641196,0.008460786,0.0010481563],"domain_scores_gemma":[0.7074474,0.25406593,0.028538086,0.0046332385,0.0046425336,0.00067281205],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06682053,0.0022933849,0.021515166,0.005532003,0.0005499424,0.004316151,0.003583291,0.0032854665,0.0058817435],"category_scores_gemma":[0.2556437,0.0017994548,0.027940411,0.005645358,0.0022970133,0.0038021076,0.0023719324,0.00455068,0.00033192165],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002416867,0.000027337528,0.0013067989,0.7758487,0.19534607,0.000052447143,0.00012500936,0.00036544452,0.0001307235,0.00046094085,0.0010137802,0.022905916],"study_design_scores_gemma":[0.0074560186,0.0008586838,0.005874962,0.21764477,0.7537889,0.00021006819,0.00022939248,0.0006583845,0.00029326932,0.0030512393,0.0098174205,0.00011688499],"about_ca_topic_score_codex":0.0031535325,"about_ca_topic_score_gemma":0.007822714,"teacher_disagreement_score":0.9331795,"about_ca_system_score_codex":0.004111337,"about_ca_system_score_gemma":0.007115379,"threshold_uncertainty_score":0.35338497},"labels":[],"label_agreement":null},{"id":"W2889295856","doi":"10.1007/s00520-018-4424-6","title":"Wireless transcutaneous electrical nerve stimulation device for chemotherapy-induced peripheral neuropathy: an open-label feasibility study","year":2018,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; School of Medicine and Dentistry, University of Rochester; McGill University; University of Rochester; Foundation for Neuromuscular Reconstruction","keywords":"Chemotherapy-induced peripheral neuropathy; Medicine; Transcutaneous electrical nerve stimulation; Peripheral neuropathy; Neuropathic pain; Quality of life (healthcare); Chemotherapy; Anesthesia; Physical therapy; Physical medicine and rehabilitation; Internal medicine; Nursing","score_opus":0.11121526679803206,"score_gpt":0.46079997560637165,"score_spread":0.3495847088083396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889295856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99201536,0.0010189763,0.0042979196,0.000076945864,0.000072149654,0.0017993533,0.00010609044,0.000024474377,0.00058873155],"genre_scores_gemma":[0.9916785,0.0016625923,0.0037211832,0.00020956784,0.00013192894,0.0016503347,0.00016153672,0.000010728056,0.00077359437],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993512,0.0003243887,0.00005184337,0.00010239187,0.00009501596,0.00007517499],"domain_scores_gemma":[0.9992823,0.00035565285,0.00012427031,0.00010411562,0.00005517823,0.000078548626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014959687,0.00092514337,0.001004157,0.00022922416,0.00033521492,0.0005608064,0.00053064735,0.00075130095,0.0028908153],"category_scores_gemma":[0.0012206556,0.00027784388,0.0007372891,0.0002488932,0.0014150692,0.0011302221,0.0002581883,0.0011257955,0.00044178028],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30263162,0.22975862,0.007185073,0.0028933017,0.0010808737,0.001743398,0.0010178445,0.0021351518,0.23482299,0.0011113711,0.0012866381,0.21433322],"study_design_scores_gemma":[0.030181034,0.9403396,0.008090524,0.000082212544,0.00067120953,0.0011262168,0.0004696483,0.002640899,0.013722262,0.00035244322,0.0022766907,0.0000472506],"about_ca_topic_score_codex":0.0003348687,"about_ca_topic_score_gemma":0.000452984,"teacher_disagreement_score":0.0028908153,"about_ca_system_score_codex":0.0003045375,"about_ca_system_score_gemma":0.0007781287,"threshold_uncertainty_score":0.009670794},"labels":[],"label_agreement":null},{"id":"W2889309405","doi":"","title":"UJI DIAGNOSTIK TORONTO CLINICAL SCORING SYSTEM TERHADAP DIAGNOSIS NEUROPATI PERIFER TERINDUKSI KEMOTERAPI","year":2014,"lang":"id","type":"article","venue":"Neurona (Majalah Kedokteran Neuro Sains Perhimpunan Dokter Spesialis Saraf Indonesia)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Chemotherapy; Oncology; Adverse effect; Intensive care medicine; Internal medicine; Physical therapy; Diabetes mellitus","score_opus":0.03264343874443765,"score_gpt":0.31949612912851016,"score_spread":0.2868526903840725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889309405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67716455,0.038081694,0.03506319,0.0048329774,0.0017651905,0.005638454,0.03364209,0.0017977029,0.20201422],"genre_scores_gemma":[0.8710584,0.016358694,0.03971318,0.0006916746,0.00035426574,0.0022857036,0.020127306,0.00011282763,0.049297865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990778,0.0000952287,0.00017444558,0.00008465011,0.00044910176,0.00011865267],"domain_scores_gemma":[0.99873894,0.000098661556,0.0003248814,0.00004062712,0.000660222,0.00013663345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005713282,0.00073434715,0.00067046966,0.002498531,0.0006375089,0.00088329375,0.0006330042,0.0003535026,0.008729124],"category_scores_gemma":[0.0019462272,0.00014216061,0.0006254531,0.0016665576,0.0003246933,0.00043042432,0.000821101,0.00059961557,0.001987027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001684553,0.00039072195,0.52246976,0.0016717808,0.0005019855,0.0037121575,0.0007816895,0.002281167,0.01832891,0.0022064918,0.092601314,0.35336944],"study_design_scores_gemma":[0.00023186783,0.0010136517,0.87695116,0.0007730955,0.00042447,0.017107222,0.0009541385,0.0058627245,0.009968523,0.0018343889,0.084676765,0.00020194441],"about_ca_topic_score_codex":0.018573947,"about_ca_topic_score_gemma":0.022273146,"teacher_disagreement_score":0.018573947,"about_ca_system_score_codex":0.0012866479,"about_ca_system_score_gemma":0.0016880698,"threshold_uncertainty_score":0.036931634},"labels":[],"label_agreement":null},{"id":"W2889620472","doi":"10.1200/jco.2017.35.15_suppl.10123","title":"Trastuzumab-related subclinical cardiotoxicity in patients with early stage HER2-positive breast cancer: A retrospective single-center cohort study.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Ejection fraction; Internal medicine; Breast cancer; Asymptomatic; Cardiotoxicity; Cancer; Surgery; Heart failure; Chemotherapy","score_opus":0.05702956444858435,"score_gpt":0.44346861963295403,"score_spread":0.38643905518436966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889620472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991617,0.00016110731,0.000036096615,0.000012726777,0.0000032842606,0.000016433178,0.0004153826,0.0000017832136,0.00019155354],"genre_scores_gemma":[0.99920976,0.00010127065,0.000036912028,0.000033721954,0.000007753861,0.000020846526,0.00045569014,0.0000017600155,0.00013218175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999537,0.000077100216,0.00005905743,0.00014697536,0.000093177114,0.00008664306],"domain_scores_gemma":[0.99908745,0.00011535802,0.000387176,0.00011017076,0.00009535449,0.0002044377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006084748,0.00029318858,0.00039105004,0.0006383513,0.0005756321,0.00075730885,0.00038190433,0.0003924544,0.0019071113],"category_scores_gemma":[0.0012149799,0.00048358206,0.00047503237,0.0012492411,0.00020438993,0.0003971039,0.0004401126,0.00046608775,0.000499402],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009270061,0.00002868887,0.9992167,0.0000055401615,0.000032462278,0.00010462804,0.000039093662,0.000008508857,0.00010120658,0.0000039117176,0.000053637494,0.00031308905],"study_design_scores_gemma":[0.000019791922,0.00017879053,0.998657,0.000006283256,0.000042153,0.000597188,0.00016331654,0.00009132136,0.000041538122,0.0000074035056,0.00019161752,0.0000035322994],"about_ca_topic_score_codex":0.010939406,"about_ca_topic_score_gemma":0.013042784,"teacher_disagreement_score":0.010939406,"about_ca_system_score_codex":0.00054978096,"about_ca_system_score_gemma":0.0004393181,"threshold_uncertainty_score":0.021751463},"labels":[],"label_agreement":null},{"id":"W2889735799","doi":"10.1096/fasebj.30.1_supplement.1107.6","title":"Delivery of paclitaxel and cetuximab by nanodiamond enhances mitotic catastrophe and tumor inhibition in colorectal cancer","year":2016,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Mitotic catastrophe; Cetuximab; Cancer research; Paclitaxel; Colorectal cancer; Apoptosis; Mitosis; Growth inhibition; Cancer cell; Cancer; Medicine; Chemistry; Biology; Cell biology; Internal medicine; Biochemistry","score_opus":0.009571856826938036,"score_gpt":0.2627064195749662,"score_spread":0.25313456274802815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889735799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99496895,0.0013992223,0.0018375152,0.00011648559,0.000027783593,0.000038724596,0.00009613073,0.00005853651,0.0014566749],"genre_scores_gemma":[0.99498874,0.0006523344,0.0021285666,0.00003077939,0.0000052594096,0.000025559804,0.00010076556,0.0000068250574,0.002061267],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99996674,0.000005727265,0.000003084114,0.000005794981,0.0000091627635,0.000009416056],"domain_scores_gemma":[0.9999782,0.0000044355875,0.0000062786157,0.0000019283186,0.000002838313,0.0000062970307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005860769,0.00017892967,0.000137412,0.00012882371,0.00008361029,0.00012245381,0.000096193915,0.0001946219,0.0005888405],"category_scores_gemma":[0.00006147794,0.0000939692,0.00015248527,0.00006565069,0.00009940587,0.00012791046,0.000100093486,0.00025373147,0.00010812191],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014287361,0.000038582442,0.000058445843,0.000037499347,0.0000029658381,0.000026576692,0.0000064617407,0.00011447113,0.99796873,0.00009122571,0.000040149094,0.0014720289],"study_design_scores_gemma":[0.000027370024,0.00026321155,0.0007374665,0.0000018494572,0.000006419945,0.00006517765,0.00000324325,0.00082241977,0.9969914,0.000013847496,0.0010658244,0.000001769402],"about_ca_topic_score_codex":0.0009761959,"about_ca_topic_score_gemma":0.001796568,"teacher_disagreement_score":0.0009761959,"about_ca_system_score_codex":0.00042150056,"about_ca_system_score_gemma":0.00021809542,"threshold_uncertainty_score":0.003058195},"labels":[],"label_agreement":null},{"id":"W2889855746","doi":"10.1200/jco.2017.35.15_suppl.e18297","title":"Strategies to minimize wastage of expensive drugs in expensive times: Cabazitaxel, a single center experience.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cabazitaxel; Vial; Medicine; Prostate cancer; Drug; Cancer; Internal medicine; Pharmacology; Androgen deprivation therapy","score_opus":0.19456911130182628,"score_gpt":0.533104279183883,"score_spread":0.33853516788205673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889855746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899844,0.0034704208,0.0017018609,0.00096470694,0.000064684085,0.00041461448,0.00018908933,0.00008282615,0.0031274217],"genre_scores_gemma":[0.9870367,0.002987888,0.006579679,0.00071268884,0.00013466175,0.00018492133,0.00042835553,0.000040112784,0.0018949962],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99970263,0.00009964034,0.000030090168,0.000056115456,0.000045698704,0.00006594523],"domain_scores_gemma":[0.9992661,0.00009164909,0.00014688552,0.00003393449,0.00006334335,0.00039802125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079371815,0.00049781386,0.00023975749,0.00039284216,0.0006025574,0.000707131,0.00064000214,0.00047935024,0.003763343],"category_scores_gemma":[0.0012868157,0.0001786501,0.0004983169,0.00042825047,0.00025053622,0.0006652862,0.00054632616,0.00056454155,0.0005892004],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009606969,0.021050818,0.098633006,0.0006006669,0.00026234187,0.005273965,0.0013522342,0.0018914646,0.009711076,0.0004752867,0.011632416,0.8395097],"study_design_scores_gemma":[0.022353593,0.1543989,0.6316897,0.0009908801,0.0011566882,0.07611753,0.0046161395,0.013347664,0.0205419,0.0012046935,0.07316737,0.00041482583],"about_ca_topic_score_codex":0.0020447876,"about_ca_topic_score_gemma":0.0046744025,"teacher_disagreement_score":0.003763343,"about_ca_system_score_codex":0.00093881885,"about_ca_system_score_gemma":0.001530619,"threshold_uncertainty_score":0.012589633},"labels":[],"label_agreement":null},{"id":"W2891363159","doi":"10.1200/jco.2017.35.15_suppl.e18237","title":"Baseline characteristics as predictors of adjuvant chemotherapy (AC) toxicities in stage III colorectal cancer (CRC) patients.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Baker Hughes (Canada); University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; FOLFOX; Capecitabine; Anemia; Cohort; Univariate analysis; Cancer; Colorectal cancer; Population; Oncology; Gastroenterology; Multivariate analysis; Oxaliplatin","score_opus":0.08234248336522221,"score_gpt":0.48125398293434235,"score_spread":0.39891149956912014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891363159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978461,0.00046841236,0.00006302933,0.00008694325,0.000009323481,0.000012625983,0.0010798681,0.0000038114679,0.00042986986],"genre_scores_gemma":[0.9990976,0.000079617625,0.000059253976,0.00003319127,0.000009173222,0.000010319585,0.00058599375,0.0000016573224,0.00012314109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967325,0.00009075499,0.000044224802,0.000059820057,0.0000711433,0.000060799535],"domain_scores_gemma":[0.99736446,0.00084379077,0.0011646894,0.00008437866,0.00022098054,0.00032162847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007164027,0.00018477206,0.00028424113,0.0005266249,0.00026205287,0.0005013434,0.00024146105,0.00052851916,0.00211774],"category_scores_gemma":[0.003145212,0.00015058593,0.0004365886,0.0012167819,0.00018704847,0.00031460737,0.0002350446,0.0006490883,0.0002811658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011641626,0.000011274249,0.9990877,0.000006276794,0.00002431309,0.000026802616,0.0000072228854,0.000035289715,0.000037872363,0.000003831333,0.00009053427,0.0005523958],"study_design_scores_gemma":[0.000009908094,0.00008134642,0.99918705,0.000007110134,0.000027288022,0.00014100995,0.000042189295,0.00027578857,0.000022483902,0.000013233117,0.00019043272,0.0000021032233],"about_ca_topic_score_codex":0.0060861,"about_ca_topic_score_gemma":0.009588382,"teacher_disagreement_score":0.0060861,"about_ca_system_score_codex":0.00033899737,"about_ca_system_score_gemma":0.0005747979,"threshold_uncertainty_score":0.012101352},"labels":[],"label_agreement":null},{"id":"W2891861168","doi":"10.1038/s41571-018-0101-4","title":"Why patients receive treatments that are minimally effective?","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; University Health Network; Queen's University","funders":"","keywords":"Medicine; MEDLINE; Medical physics; Intensive care medicine; General surgery; Family medicine","score_opus":0.17794357545937708,"score_gpt":0.5473828599332276,"score_spread":0.36943928447385044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891861168","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030212247,0.985341,0.00025667832,0.010777785,0.0008372091,0.000009242884,0.000044055272,0.0000114999275,0.002420329],"genre_scores_gemma":[0.0058371047,0.9736213,0.0007906049,0.016044019,0.002310773,0.000041698302,0.00006082072,0.000008899392,0.0012848963],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99892825,0.000458195,0.00017740522,0.00011461584,0.00025893006,0.00006264619],"domain_scores_gemma":[0.9970042,0.0022305928,0.0003716311,0.000057342684,0.00027064056,0.00006561643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019668438,0.0004130266,0.001577305,0.0007345523,0.00023218685,0.0013959701,0.00063872983,0.0019886722,0.0054260297],"category_scores_gemma":[0.006523689,0.00024186245,0.00073126605,0.00064416276,0.0012085151,0.0018487665,0.000639465,0.0030538435,0.0015433986],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002925338,0.000072891904,0.0004240694,0.024008358,0.00034750084,0.00013283157,0.00010019579,0.000124352,0.00086521456,0.013305929,0.07591402,0.88441217],"study_design_scores_gemma":[0.00029354493,0.00022565827,0.0017774687,0.020308819,0.00065321947,0.0010759784,0.0001666601,0.00008084644,0.00050901686,0.015330156,0.95954543,0.000033183896],"about_ca_topic_score_codex":0.000688762,"about_ca_topic_score_gemma":0.0023603938,"teacher_disagreement_score":0.0054260297,"about_ca_system_score_codex":0.00073611876,"about_ca_system_score_gemma":0.0016956959,"threshold_uncertainty_score":0.01815182},"labels":[],"label_agreement":null},{"id":"W2891887155","doi":"10.1200/jco.18.00242","title":"National Cancer Institute Breast Cancer Steering Committee Working Group Report on Meaningful and Appropriate End Points for Clinical Trials in Metastatic Breast Cancer","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Achieve Life Sciences (Canada)","funders":"AstraZeneca","keywords":"Medicine; Breast cancer; Clinical trial; Metastatic breast cancer; Cancer; Oncology; Internal medicine; Family medicine; Medical physics","score_opus":0.4241682816083695,"score_gpt":0.5935647420298819,"score_spread":0.16939646042151235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891887155","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038063035,0.321829,0.07799282,0.28355783,0.054842457,0.14757484,0.052681837,0.0020075734,0.055707287],"genre_scores_gemma":[0.026073668,0.105317146,0.37331808,0.1439741,0.012357185,0.29710063,0.030071132,0.0018634731,0.009924671],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.40254015,0.37948576,0.13324289,0.008798676,0.06956753,0.006364956],"domain_scores_gemma":[0.28362486,0.3582701,0.09251879,0.030506587,0.21804067,0.01703906],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.53723246,0.004702468,0.014396856,0.011798656,0.0053000543,0.016719295,0.014859369,0.018983426,0.00742289],"category_scores_gemma":[0.5597544,0.0036361767,0.02503839,0.016007682,0.004690492,0.008305906,0.012589132,0.02625939,0.007471986],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056969593,0.00032628156,0.004823148,0.1787934,0.011616165,0.0002337431,0.001503068,0.002291714,0.0012228903,0.013447351,0.552934,0.2271114],"study_design_scores_gemma":[0.008202263,0.000714993,0.009983044,0.3072587,0.016156316,0.00023692765,0.0007338132,0.0014654672,0.0025228118,0.018665854,0.6336213,0.00043861681],"about_ca_topic_score_codex":0.009407091,"about_ca_topic_score_gemma":0.010112405,"teacher_disagreement_score":0.46276754,"about_ca_system_score_codex":0.016458817,"about_ca_system_score_gemma":0.06772392,"threshold_uncertainty_score":0.5706748},"labels":[],"label_agreement":null},{"id":"W2892272740","doi":"10.1200/jco.2016.34.15_suppl.e16540","title":"Effect of abiraterone acetate (AA) and enzalutamide (EZ) administration on chemotherapy-naïve metastatic castration-resistant prostate cancer (CN-mCRPC) patient’s symptom burden.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Enzalutamide; Prostate cancer; Internal medicine; Multivariate analysis; Abiraterone acetate; Univariate analysis; Cancer; Chemotherapy; Oncology; Androgen deprivation therapy","score_opus":0.0626399407867444,"score_gpt":0.47133645379068634,"score_spread":0.40869651300394194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892272740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99811137,0.0013645632,0.000020522893,0.000048416252,0.000014569659,0.000018961016,0.000056572007,0.000004474512,0.00036065243],"genre_scores_gemma":[0.9992506,0.00037839927,0.00008401446,0.000031624208,0.000019434267,0.000008553112,0.00007700958,6.164951e-7,0.00014968001],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9997973,0.000091007554,0.000026054267,0.000022171602,0.000036832498,0.000026673959],"domain_scores_gemma":[0.99949026,0.0001690049,0.0001430171,0.000019235264,0.000024039977,0.00015442671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036563218,0.00018024837,0.00037913074,0.00016863875,0.00012768415,0.00016421317,0.0001325917,0.00013462667,0.0005629905],"category_scores_gemma":[0.0013226093,0.00006928054,0.00037949,0.00018640199,0.00012809732,0.00015346549,0.00014552083,0.0003882626,0.000068020425],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26995617,0.013583913,0.2675721,0.0008621512,0.0016296847,0.0008891559,0.00061238266,0.0034747298,0.024963656,0.00013468666,0.0011743644,0.415147],"study_design_scores_gemma":[0.005531683,0.10941467,0.8770879,0.000059353573,0.000624975,0.000677493,0.00017769066,0.001711497,0.0023059081,0.000075833115,0.0023089338,0.000024187888],"about_ca_topic_score_codex":0.001288247,"about_ca_topic_score_gemma":0.0039131674,"teacher_disagreement_score":0.001288247,"about_ca_system_score_codex":0.00019882887,"about_ca_system_score_gemma":0.0003580149,"threshold_uncertainty_score":0.00256145},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2893222431","doi":"10.1097/dss.0000000000001652","title":"Deoxycholic Acid for Submental Fullness and More: Real-World Experience With 202 Patients","year":2018,"lang":"en","type":"letter","venue":"Dermatologic Surgery","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Deoxycholic acid; Medicine; Internal medicine; Bile acid","score_opus":0.04052946934720248,"score_gpt":0.322874403195509,"score_spread":0.2823449338483065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893222431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.948745,0.007565128,0.0005937498,0.022041293,0.0004889337,0.00010130242,0.00018655624,0.000034327328,0.020243775],"genre_scores_gemma":[0.97755957,0.005067487,0.00072583405,0.010442367,0.000490449,0.000038475246,0.00016342399,0.000024535733,0.0054878383],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9997228,0.000106531916,0.000024609079,0.000023722043,0.000039827624,0.00008256388],"domain_scores_gemma":[0.999252,0.00029360235,0.00007905456,0.00002544623,0.000048867874,0.0003009972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003711644,0.00036001488,0.00028481567,0.00016303384,0.0018505456,0.00083761656,0.00027123166,0.0016176607,0.0031940918],"category_scores_gemma":[0.0026964236,0.00017138058,0.00052046665,0.0004074929,0.00038612983,0.0006708372,0.0005731461,0.001197356,0.0007759413],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019423408,0.0030804493,0.18740913,0.00040109386,0.00018229721,0.5630527,0.014284421,0.0008417079,0.004867919,0.0014563493,0.072363555,0.15011807],"study_design_scores_gemma":[0.00085122103,0.008244257,0.16197106,0.00037866266,0.00020180979,0.6939476,0.025164446,0.0015764654,0.0024856809,0.002340761,0.10267343,0.00016461672],"about_ca_topic_score_codex":0.001327966,"about_ca_topic_score_gemma":0.0034487727,"teacher_disagreement_score":0.0031940918,"about_ca_system_score_codex":0.0007615747,"about_ca_system_score_gemma":0.0005528273,"threshold_uncertainty_score":0.010685325},"labels":[],"label_agreement":null},{"id":"W2894254476","doi":"10.1200/jco.2018.36.30_suppl.151","title":"Assessment of scheduled pharmacy follow-up for patients receiving oral chemotherapy.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacist; Pharmacy; Psychological intervention; Chemotherapy; Patient education; Audit; Intervention (counseling); Intensive care medicine; Physical therapy; Family medicine; Internal medicine; Nursing","score_opus":0.18655034475399465,"score_gpt":0.5783130633114408,"score_spread":0.39176271855744615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894254476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9677765,0.0014843907,0.002498088,0.0016194904,0.00010465713,0.0015899049,0.0056591197,0.00044474044,0.018823246],"genre_scores_gemma":[0.98865193,0.00063946913,0.006258428,0.0003826815,0.00007531925,0.0005616335,0.001863797,0.00003295432,0.0015338422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967002,0.0012007698,0.0007504876,0.0002779577,0.00084647705,0.00022417669],"domain_scores_gemma":[0.9806989,0.0034543334,0.010425346,0.0006333509,0.0030594375,0.0017285699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026906072,0.00028019762,0.00043125768,0.0017739919,0.0008620569,0.0010969328,0.00068715465,0.00034305544,0.0038304613],"category_scores_gemma":[0.013902654,0.0002123957,0.00054645824,0.00152712,0.00016589192,0.00053349446,0.0007987375,0.0008301095,0.00083238794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005941997,0.00063223485,0.88266534,0.00047028155,0.00010395577,0.0005232751,0.0011342944,0.00036316153,0.0007030073,0.00006216997,0.0049698926,0.10777819],"study_design_scores_gemma":[0.000055250675,0.001305066,0.98842686,0.00014684767,0.00008196893,0.000831957,0.0012864029,0.0012866857,0.00094757334,0.000070171605,0.0055324887,0.000028799275],"about_ca_topic_score_codex":0.004574824,"about_ca_topic_score_gemma":0.009936076,"teacher_disagreement_score":0.004574824,"about_ca_system_score_codex":0.0009019695,"about_ca_system_score_gemma":0.0017671097,"threshold_uncertainty_score":0.014229476},"labels":[],"label_agreement":null},{"id":"W2897563735","doi":"","title":"Metilfenidato para aliviar astenia de pacientes con cáncer avanzado. Ensayo clínico aleatorizado, estratificado, doble ciego, controlado con placebo y multicéntrico","year":2018,"lang":"es","type":"dissertation","venue":"Deposito Adademico Digital Universidad De Navarra (University of Navarra)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Humanities; Gynecology; Philosophy","score_opus":0.014018352460871825,"score_gpt":0.27221276155654095,"score_spread":0.25819440909566915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897563735","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20919827,0.74516606,0.004190559,0.0076622996,0.0020103704,0.0028428608,0.004172063,0.00020275789,0.024554754],"genre_scores_gemma":[0.73992974,0.21562023,0.00793862,0.0073386733,0.0014935012,0.0033909671,0.0038748635,0.000045677432,0.02036764],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990859,0.000539698,0.000089934394,0.00009859385,0.00012998586,0.000055951772],"domain_scores_gemma":[0.99886465,0.00035634756,0.00047334202,0.0000580496,0.00017462454,0.000072998235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018222695,0.00038135643,0.00080235803,0.00044115554,0.00019127238,0.00046061008,0.00029542064,0.00067301217,0.0070487605],"category_scores_gemma":[0.0018878253,0.00015676486,0.0011766388,0.000518984,0.00024339245,0.00034802812,0.00022320538,0.0006990803,0.0005018246],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09687511,0.0018544465,0.011138189,0.017292673,0.0034306825,0.00023014756,0.00016223805,0.0007949642,0.01551273,0.0013919343,0.022019431,0.8292975],"study_design_scores_gemma":[0.11673997,0.18729037,0.17065424,0.014211816,0.016657984,0.0034556673,0.0005255835,0.0027285812,0.03700629,0.0030661095,0.447456,0.00020747195],"about_ca_topic_score_codex":0.0015610021,"about_ca_topic_score_gemma":0.0039665313,"teacher_disagreement_score":0.0070487605,"about_ca_system_score_codex":0.0008528794,"about_ca_system_score_gemma":0.001084683,"threshold_uncertainty_score":0.023580432},"labels":[],"label_agreement":null},{"id":"W2900133207","doi":"10.1093/neuonc/noy148.1135","title":"TMOD-23. DYNAMIC PATTERNS OF GLIOBLASTOMA CLONAL EVOLUTION IN RESPONSE TO CHEMORADIOTHERAPY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Temozolomide; Chemoradiotherapy; Radiation therapy; Somatic evolution in cancer; Oncology; Glioblastoma; Medicine; Stem cell; Biology; Cancer research; Bioinformatics; Internal medicine; Cancer; Genetics","score_opus":0.013840688834285457,"score_gpt":0.3489778122568107,"score_spread":0.3351371234225252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900133207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953022,0.00069577276,0.0015509856,0.000050331284,0.000011103729,0.000024644054,0.0005648544,0.00009601411,0.0017040973],"genre_scores_gemma":[0.99668485,0.0003201269,0.0011545569,0.000049660714,0.0000030274773,0.000034158333,0.0004970902,0.00002002643,0.0012366687],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99988747,0.000011184838,0.0000062248305,0.000025565067,0.00004125865,0.000028342567],"domain_scores_gemma":[0.9999026,0.000012681479,0.000028120956,0.00000958838,0.00002673012,0.000020316767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011430436,0.00009338891,0.00016543479,0.0002294555,0.00011271201,0.00028601705,0.000107059655,0.00013788097,0.0010036262],"category_scores_gemma":[0.00019989964,0.00007821859,0.00011073349,0.00016486694,0.0001173158,0.00011179371,0.00010827967,0.00023025193,0.00019279284],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018301432,0.000033819397,0.003064377,0.00003498624,0.000011107279,0.000049927614,0.000042235435,0.000741974,0.9820448,0.00017105877,0.00025114746,0.013371552],"study_design_scores_gemma":[0.000015433146,0.00086478255,0.05716649,0.000009421308,0.00003642633,0.0004596162,0.00008488871,0.0062314835,0.9284951,0.00014887739,0.006473214,0.00001425227],"about_ca_topic_score_codex":0.0019310077,"about_ca_topic_score_gemma":0.0029947604,"teacher_disagreement_score":0.0019310077,"about_ca_system_score_codex":0.00039864017,"about_ca_system_score_gemma":0.00018196936,"threshold_uncertainty_score":0.0038395524},"labels":[],"label_agreement":null},{"id":"W2900342617","doi":"10.1093/neuonc/noy148.313","title":"DRES-06. PREVENTING THE EMERGENCE OF TEMOZOLOMIDE RESISTANCE IN GLIOBLASTOMA BY PARP-1 INHIBITION","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Temozolomide; MSH6; Cancer research; Biology; PARP inhibitor; DNA repair; Synthetic lethality; MSH2; Methyltransferase; Poly ADP ribose polymerase; MLH1; DNA mismatch repair; Molecular biology; Gene; Genetics; Methylation; Polymerase; Glioblastoma","score_opus":0.01949112033093168,"score_gpt":0.3336514222823488,"score_spread":0.3141603019514171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900342617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793465,0.006647812,0.002557213,0.00044528095,0.00016143304,0.00019152227,0.0022551555,0.0008680546,0.0075270594],"genre_scores_gemma":[0.98327404,0.0034800842,0.0028428119,0.00024790064,0.000020836553,0.000119201235,0.0041875727,0.00004045057,0.005787029],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999112,0.000013374922,0.000009224776,0.00001665044,0.000017884606,0.00003177227],"domain_scores_gemma":[0.99994767,0.000004961657,0.0000120636305,0.000006579186,0.000007112032,0.00002157631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016609153,0.00040739172,0.000491828,0.00037190097,0.00013325612,0.0002728704,0.00038726802,0.00032689513,0.0030438025],"category_scores_gemma":[0.00011057817,0.00014711887,0.00034186477,0.0002742237,0.0001560496,0.00013576265,0.00014230939,0.00096118444,0.0010058024],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020189998,0.0012263734,0.0007208212,0.00033414265,0.000061615254,0.0002770684,0.000043335705,0.0007053789,0.9532844,0.00060389313,0.002151987,0.038571984],"study_design_scores_gemma":[0.001091736,0.013680333,0.012986942,0.000057815207,0.00012782,0.0016416085,0.00006418961,0.0030408597,0.94318,0.00022890186,0.023866093,0.00003374548],"about_ca_topic_score_codex":0.00075891084,"about_ca_topic_score_gemma":0.0018154512,"teacher_disagreement_score":0.0030438025,"about_ca_system_score_codex":0.0002457532,"about_ca_system_score_gemma":0.00029045145,"threshold_uncertainty_score":0.0101825},"labels":[],"label_agreement":null},{"id":"W2901231757","doi":"10.7759/cureus.3625","title":"Phenytoin Toxicity During Neoadjuvant Concurrent Capecitabine and Radiation Therapy for Rectal Adenocarcinoma: Case Report of a Drug Interaction","year":2018,"lang":"en","type":"article","venue":"Cureus","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Capecitabine; Medicine; Phenytoin; Toxicity; Colorectal cancer; Drug; Internal medicine; Oncology; Pharmacology; Cancer; Epilepsy","score_opus":0.028584153908152766,"score_gpt":0.34697019951457675,"score_spread":0.318386045606424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901231757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757533,0.007719494,0.0036744853,0.0048514213,0.0005363337,0.00021483742,0.0002013401,0.00016883074,0.0068799066],"genre_scores_gemma":[0.99331254,0.0022482937,0.0010683683,0.0011052109,0.00085821573,0.000024441797,0.000081208134,0.000028850467,0.0012728155],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99925274,0.00010415067,0.00011781463,0.00017828932,0.00012775321,0.0002193381],"domain_scores_gemma":[0.9975394,0.00071484805,0.00070492714,0.00015185987,0.00014730573,0.0007416274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035018378,0.0019184793,0.0015486836,0.0020063673,0.0025513808,0.0017082944,0.0009886854,0.00550567,0.0014284416],"category_scores_gemma":[0.0031449925,0.0013741989,0.0016914891,0.0013137276,0.0015284212,0.002067119,0.0014088182,0.004350081,0.00067949924],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026733385,0.000025717658,0.0026243846,0.0000144680735,0.0000077102295,0.9963408,0.00009080102,0.000039449333,0.00031294118,0.000036799764,0.00009778853,0.00038249572],"study_design_scores_gemma":[0.000008642107,0.0000734853,0.0023851648,0.00000926422,0.000016997394,0.99652797,0.000074126314,0.00017928316,0.00035899624,0.000048901,0.000307718,0.000009515116],"about_ca_topic_score_codex":0.0038713764,"about_ca_topic_score_gemma":0.005764708,"teacher_disagreement_score":0.00550567,"about_ca_system_score_codex":0.001616383,"about_ca_system_score_gemma":0.0011289992,"threshold_uncertainty_score":0.01172775},"labels":[],"label_agreement":null},{"id":"W2903040004","doi":"10.1200/jco.2018.36.34_suppl.216","title":"Prediction of hospitalizations in patients with cancer age 70 and older receiving chemotherapy.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sault Area Hospital","funders":"","keywords":"Medicine; Chemotherapy; Multivariate analysis; Internal medicine; Cancer; Univariate analysis; Population; Exact test; Disease; Surgery","score_opus":0.0690542074008144,"score_gpt":0.4530315156451838,"score_spread":0.3839773082443694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903040004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985139,0.00038340292,0.00006294064,0.000069879876,0.000012445591,0.0000102218055,0.0004626195,0.000004707264,0.00047994038],"genre_scores_gemma":[0.9992017,0.00014239925,0.00008125457,0.000013078429,0.000012057734,0.0000056122303,0.00047872702,8.526165e-7,0.00006436605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997919,0.00004459983,0.000044786342,0.000027666792,0.00004709279,0.000043903845],"domain_scores_gemma":[0.99859005,0.00021432956,0.00078762026,0.000025741028,0.000101776786,0.00028044792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003618416,0.0002173025,0.00022513025,0.0010152599,0.0002852358,0.00035084225,0.00020083923,0.0002673069,0.0016063534],"category_scores_gemma":[0.0021493195,0.00013350781,0.00046812766,0.000877789,0.00014716855,0.0002838877,0.00035483547,0.00048132663,0.00022740451],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025238245,0.000008898867,0.9994143,0.000004400279,0.0000062768345,0.000028394938,0.000010411849,0.000026352092,0.000020391884,0.0000029274909,0.000049258677,0.00040314643],"study_design_scores_gemma":[0.0000019449146,0.000064756,0.99911636,0.000007740701,0.000011633897,0.0002506707,0.00010408562,0.00029056022,0.000022782517,0.000011109572,0.00011655858,0.0000018235323],"about_ca_topic_score_codex":0.005140255,"about_ca_topic_score_gemma":0.0053422246,"teacher_disagreement_score":0.005140255,"about_ca_system_score_codex":0.0002902566,"about_ca_system_score_gemma":0.00034719234,"threshold_uncertainty_score":0.010220647},"labels":[],"label_agreement":null},{"id":"W2903375916","doi":"10.1139/cjc-2018-0455","title":"A three-step synthesis of estra-4,9-diene-3,17-dione","year":2018,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Sichuan University; Opening Project of Key Laboratory of Green Chemistry of Sichuan Institutes of Higher Education","keywords":"Chemistry; Diene; Yield (engineering); Lactone; Reagent; Domino; Combinatorial chemistry; Stereochemistry; Organic chemistry; Catalysis","score_opus":0.017228609708923506,"score_gpt":0.2725648644479866,"score_spread":0.25533625473906313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903375916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7981272,0.021401193,0.08832608,0.0011363036,0.0012817115,0.0033074806,0.0078008175,0.0014807225,0.07713855],"genre_scores_gemma":[0.89611006,0.010577047,0.05498521,0.00038413197,0.000052601164,0.0005056066,0.0019833562,0.00008952189,0.03531244],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987924,0.000009634115,0.00001022463,0.000024670482,0.000033686865,0.000042492546],"domain_scores_gemma":[0.9998982,0.000008065071,0.00000807771,0.0000104242945,0.000025065077,0.000050195766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021057203,0.0006141069,0.0005362531,0.00062018493,0.00032514834,0.00024871432,0.0004569837,0.00038421917,0.0046097515],"category_scores_gemma":[0.00017738873,0.0002531216,0.00028545453,0.00044005914,0.0001895948,0.00029244038,0.0005007128,0.000665008,0.0023616676],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018577014,0.00023685094,0.00032562288,0.0008075473,0.000044621374,0.0015508028,0.0001935689,0.0012357447,0.945325,0.0032236082,0.0011424863,0.045728523],"study_design_scores_gemma":[0.00012668353,0.0017361911,0.0018863205,0.00007708472,0.00007027069,0.0015101223,0.00008009132,0.0007166606,0.91957057,0.0009405002,0.07319218,0.00009327749],"about_ca_topic_score_codex":0.0005782788,"about_ca_topic_score_gemma":0.0020723103,"teacher_disagreement_score":0.0046097515,"about_ca_system_score_codex":0.00026119803,"about_ca_system_score_gemma":0.0010104943,"threshold_uncertainty_score":0.015421212},"labels":[],"label_agreement":null},{"id":"W2907322496","doi":"10.1200/jco.2014.32.15_suppl.e17674","title":"Does the side of surgery and treatment have an effect on cardiovascular measurements in breast cancer survivors?","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Medicine; Radiation therapy; Chemotherapy; Surgery; Blood pressure; Side effect (computer science); Hormone therapy; Cancer; Breast cancer; Internal medicine","score_opus":0.17804367442507127,"score_gpt":0.47283594077418845,"score_spread":0.29479226634911715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907322496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980901,0.00067622465,0.0000372266,0.00016020807,0.000020316214,0.0000045286542,0.00022399871,0.0000012166513,0.00078616093],"genre_scores_gemma":[0.9992884,0.0002198582,0.00004313826,0.00008804586,0.000051213927,0.000005120946,0.0001706156,0.0000014825375,0.00013226984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999405,0.0002800506,0.000057900055,0.0000652858,0.000105429615,0.000086326465],"domain_scores_gemma":[0.9959623,0.0017107256,0.0014978007,0.00013773683,0.00019491717,0.0004964795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092350575,0.000121192956,0.00034698474,0.00040483254,0.0002315252,0.00033543888,0.00019130833,0.00040683962,0.0038621542],"category_scores_gemma":[0.003159151,0.00010009301,0.0007129116,0.00057401863,0.00024290053,0.00029150955,0.00028447673,0.00045396676,0.00029901337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007819,0.000039119335,0.9959919,0.000014382857,0.00006985324,0.000040018578,0.00002944101,0.00001093463,0.00012713743,0.000008021413,0.00006584999,0.002821398],"study_design_scores_gemma":[0.000006954699,0.00036756953,0.99918014,0.0000074363684,0.000042950185,0.00010901973,0.00010826597,0.000029775785,0.000034825032,0.000012798909,0.000098436474,0.0000019175554],"about_ca_topic_score_codex":0.00085471076,"about_ca_topic_score_gemma":0.0019818812,"teacher_disagreement_score":0.0038621542,"about_ca_system_score_codex":0.00013984567,"about_ca_system_score_gemma":0.00022738957,"threshold_uncertainty_score":0.012920141},"labels":[],"label_agreement":null},{"id":"W2907871591","doi":"10.1200/jco.2014.32.15_suppl.e14627","title":"Treatment patterns and progression-free survival (PFS) in first-line metastatic colorectal (mCRC) patients (pts) on an oxaliplatin-based chemotherapy (OX-t): A Canadian retrospective chart review.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Bevacizumab; Oxaliplatin; FOLFIRI; FOLFOX; Internal medicine; Progression-free survival; Colorectal cancer; Irinotecan; Oncology; Retrospective cohort study; Chemotherapy; Capecitabine; Surgery; Cancer","score_opus":0.07739181201287954,"score_gpt":0.46429319807991426,"score_spread":0.3869013860670347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907871591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.959312,0.0058455067,0.00025804277,0.0002091714,0.000010099893,0.0003650497,0.032077473,0.000022337887,0.0019003162],"genre_scores_gemma":[0.98500156,0.0033143687,0.0004644994,0.000103583945,0.0000087578055,0.00011223597,0.010556871,0.0000070508245,0.00043110613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999099,0.000088457185,0.00018828316,0.0001927441,0.00031485793,0.00011660281],"domain_scores_gemma":[0.99429613,0.0005437915,0.003103914,0.00017503771,0.0015637034,0.00031741156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086125225,0.00019317964,0.00034678433,0.0028385967,0.0008189872,0.00076027244,0.0005952893,0.0003225124,0.0017843355],"category_scores_gemma":[0.003601058,0.00030325312,0.00044949492,0.0070431964,0.00033578297,0.00040042534,0.0004236555,0.00026959224,0.00026398426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012477723,0.000017891089,0.992462,0.00031046197,0.000055906003,0.00026336004,0.00027657734,0.00005835684,0.00015555056,0.000027403676,0.0011314133,0.0051163617],"study_design_scores_gemma":[0.000013618163,0.00006342255,0.99669755,0.00011616712,0.000050589464,0.0005253155,0.00036449643,0.00012179772,0.00011485381,0.0000070545348,0.0019145852,0.000010534086],"about_ca_topic_score_codex":0.6180166,"about_ca_topic_score_gemma":0.6673298,"teacher_disagreement_score":0.3819834,"about_ca_system_score_codex":0.005407213,"about_ca_system_score_gemma":0.008137257,"threshold_uncertainty_score":0.76846594},"labels":[],"label_agreement":null},{"id":"W2908002421","doi":"10.1200/jco.2014.32.15_suppl.e14576","title":"The impact of dose reduction on survival for colon cancer patients treated with adjuvant FOLFOX.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Baker Hughes (Canada)","funders":"","keywords":"Medicine; Oxaliplatin; FOLFOX; Colorectal cancer; Internal medicine; Gastroenterology; Cancer; Chemotherapy; Stage (stratigraphy); Surgery","score_opus":0.1290869723939355,"score_gpt":0.5346742928818136,"score_spread":0.40558732048787804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908002421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977984,0.0014231913,0.000051298364,0.00013206228,0.0000052965147,0.0000051289976,0.0000746132,0.000004187052,0.0005056101],"genre_scores_gemma":[0.9995691,0.00015764436,0.000055401317,0.000038466867,0.0000046433383,0.0000016752484,0.00008344005,8.9327835e-7,0.00008879064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998154,0.00006345813,0.000013179141,0.00001711484,0.00005789329,0.000032851985],"domain_scores_gemma":[0.9990159,0.00027867392,0.0005003828,0.000023711218,0.000058255064,0.00012302127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041847044,0.000091708185,0.00016042615,0.00018050842,0.00012579693,0.00026452544,0.00012573997,0.00014874882,0.0008804645],"category_scores_gemma":[0.0015442652,0.00005836146,0.0002992204,0.00029067587,0.00013386755,0.00012194227,0.00014883408,0.00028769078,0.000082118066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031199357,0.0001612345,0.95689857,0.00007415538,0.00019927391,0.00020366404,0.000050121656,0.0008041832,0.001742939,0.000034426364,0.0003587507,0.036352832],"study_design_scores_gemma":[0.000050100774,0.0014844865,0.9964928,0.000013874666,0.0001069773,0.00047202982,0.000035949455,0.00041610806,0.0003759164,0.000026744121,0.0005217602,0.0000032558146],"about_ca_topic_score_codex":0.0027508156,"about_ca_topic_score_gemma":0.00902508,"teacher_disagreement_score":0.0027508156,"about_ca_system_score_codex":0.0007665524,"about_ca_system_score_gemma":0.0004645583,"threshold_uncertainty_score":0.0055617094},"labels":[],"label_agreement":null},{"id":"W2910524550","doi":"10.1152/ajpcell.00384.2018","title":"Altered skeletal muscle microtubule-mitochondrial VDAC2 binding is related to bioenergetic impairments after paclitaxel but not vinblastine chemotherapies","year":2019,"lang":"en","type":"article","venue":"American Journal of Physiology-Cell Physiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada; James H. Cummings Foundation","keywords":"Vinblastine; Microtubule; Paclitaxel; Bioenergetics; Mitochondrion; Skeletal muscle; Cell biology; Chemistry; Internal medicine; Biology; Endocrinology; Medicine; Chemotherapy","score_opus":0.0059626385892648515,"score_gpt":0.2639500062040378,"score_spread":0.2579873676147729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910524550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99850875,0.0005230157,0.00039177312,0.000030442046,0.000010312774,0.000011313693,0.00015663926,0.000022689675,0.00034510758],"genre_scores_gemma":[0.9982418,0.0002966882,0.00015505485,0.000030725212,0.0000036301697,0.000016693366,0.00021456234,0.0000039799866,0.0010368465],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999263,0.000008741625,0.000008265187,0.000021824684,0.000013191166,0.000021602658],"domain_scores_gemma":[0.9999089,0.000008490725,0.000044536995,0.0000059639524,0.000008854785,0.000023260049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005648732,0.00020114872,0.00026354167,0.00019774366,0.00011522275,0.00015398777,0.00009120514,0.00028167423,0.00095487863],"category_scores_gemma":[0.00009386263,0.00011024652,0.00012106383,0.00013529793,0.00013986234,0.000093992596,0.00010259097,0.0003072034,0.0001023627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000437615,0.00003631062,0.0016244978,0.000030330444,0.000015363334,0.00011859762,0.000010268258,0.000060381277,0.99663913,0.000015464337,0.00003301315,0.0009790153],"study_design_scores_gemma":[0.000044787237,0.0011711087,0.14023697,0.000009593291,0.000056201072,0.000688851,0.000060931263,0.0009929582,0.8552921,0.0000338947,0.0014068617,0.00000589604],"about_ca_topic_score_codex":0.00070826337,"about_ca_topic_score_gemma":0.0011248533,"teacher_disagreement_score":0.00095487863,"about_ca_system_score_codex":0.00029811787,"about_ca_system_score_gemma":0.000063319465,"threshold_uncertainty_score":0.0031943321},"labels":[],"label_agreement":null},{"id":"W2913056912","doi":"10.1177/1534735419828823","title":"Impaired Postural Control and Altered Sensory Organization During Quiet Stance Following Neurotoxic Chemotherapy: A Preliminary Study","year":2019,"lang":"en","type":"article","venue":"Integrative Cancer Therapies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Division of Graduate Education; National Cancer Institute; Ministère de l'Économie, de la Science et de l'Innovation - Québec","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Balance (ability); Physical medicine and rehabilitation; Vestibular system; Balance problems; Peripheral neuropathy; Somatosensory system; Physical therapy; Audiology; Psychiatry","score_opus":0.011433277197377346,"score_gpt":0.30279037667263625,"score_spread":0.2913570994752589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913056912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99967563,0.00009671295,0.000042255153,0.00000512168,0.0000017534528,0.000018781948,0.000023099632,6.871238e-7,0.00013599411],"genre_scores_gemma":[0.9994758,0.00012721353,0.00010872686,0.000013101567,0.0000067780634,0.000022707902,0.00008350588,4.2560507e-7,0.00016182219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999089,0.000021512276,0.000008282616,0.000015260337,0.000025254396,0.000020779386],"domain_scores_gemma":[0.99962306,0.00004496377,0.00011914503,0.00002321945,0.00008323337,0.00010637845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023081791,0.0002927696,0.00022419308,0.00039305928,0.00030459877,0.00022444397,0.00013130008,0.00023303408,0.0010928478],"category_scores_gemma":[0.00060443825,0.00010204897,0.00016373162,0.00025023424,0.0002173027,0.0001690385,0.00031275503,0.00024804415,0.00017136929],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053832945,0.0036018735,0.92706287,0.00017495784,0.00013179799,0.0016764882,0.0009694242,0.000102457474,0.030457843,0.000025576754,0.00014587108,0.030267589],"study_design_scores_gemma":[0.000028790266,0.0074810176,0.9904669,0.000007850101,0.0000365402,0.00081781606,0.00033878593,0.00009847168,0.0005415937,0.000014182794,0.00016398265,0.000004070319],"about_ca_topic_score_codex":0.0018934708,"about_ca_topic_score_gemma":0.0038980278,"teacher_disagreement_score":0.0018934708,"about_ca_system_score_codex":0.00012038039,"about_ca_system_score_gemma":0.00021697124,"threshold_uncertainty_score":0.0037648678},"labels":[],"label_agreement":null},{"id":"W2914802774","doi":"10.1158/1538-7445.sabcs18-p3-11-05","title":"Abstract P3-11-05: Predictive gene signatures of adjuvant capecitabine benefit in triple negative breast cancer in the FinXX trial","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Capecitabine; Epirubicin; Medicine; Oncology; Internal medicine; Docetaxel; Breast cancer; Triple-negative breast cancer; Hazard ratio; Cyclophosphamide; Fluorouracil; Cancer; Gene signature; Chemotherapy; Confidence interval; Gene expression; Colorectal cancer; Biology","score_opus":0.053868755868043065,"score_gpt":0.41678518531308084,"score_spread":0.36291642944503777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914802774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99271905,0.0025475905,0.00030913,0.00040748093,0.000082134466,0.0002679817,0.0014824831,0.000035450263,0.0021487067],"genre_scores_gemma":[0.9948043,0.0004216353,0.00038999596,0.0003139356,0.00007117474,0.00024567198,0.0023982213,0.0000075013127,0.0013475497],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9996841,0.00018086802,0.000018875984,0.000060598282,0.000026758298,0.000028794053],"domain_scores_gemma":[0.9995359,0.00017423586,0.00010305378,0.000039613522,0.000031752323,0.000115535346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015867657,0.0005517861,0.00085023354,0.000110976944,0.00017691661,0.00054273015,0.00026274912,0.0004332873,0.0027410344],"category_scores_gemma":[0.0010707629,0.000119427634,0.00080556184,0.00016189861,0.0003072749,0.0003156797,0.00018481998,0.0009797809,0.0002188263],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8717529,0.0010417602,0.05405118,0.0008979618,0.0025134736,0.0001375755,0.00004963238,0.002409682,0.008400347,0.00024564177,0.004427552,0.054072358],"study_design_scores_gemma":[0.41117772,0.15834191,0.38892543,0.00045168854,0.0095593305,0.0009012086,0.00015183781,0.009331482,0.007959631,0.0019069362,0.0111823995,0.000110438654],"about_ca_topic_score_codex":0.0004547015,"about_ca_topic_score_gemma":0.0009984128,"teacher_disagreement_score":0.0027410344,"about_ca_system_score_codex":0.00033956324,"about_ca_system_score_gemma":0.00037233392,"threshold_uncertainty_score":0.009169698},"labels":[],"label_agreement":null},{"id":"W2915409618","doi":"10.1158/1538-7445.sabcs15-p4-14-20","title":"Abstract P4-14-20: A phase 1b study of ONT 380, an oral HER2-specific inhibitor, combined with ado trastuzumab emtansine (T DM1), in HER2+ metastatic breast cancer (MBC)","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Lapatinib; Tolerability; Internal medicine; Metastatic breast cancer; Pertuzumab; Trastuzumab; Trastuzumab emtansine; Taxane; Capecitabine; Oncology; Context (archaeology); Cancer; Breast cancer; Gastroenterology; Adverse effect; Pharmacology","score_opus":0.12941939372273326,"score_gpt":0.47064189096229636,"score_spread":0.3412224972395631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915409618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945427,0.00072938093,0.00042942382,0.00018045474,0.000038075676,0.0011807209,0.0008264693,0.00008683477,0.0019858733],"genre_scores_gemma":[0.9873267,0.0011329609,0.0015336294,0.00044213468,0.000069009766,0.0012140606,0.002899232,0.00004399423,0.005338351],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99982065,0.000057304194,0.00001066589,0.00003725919,0.000026717047,0.00004747872],"domain_scores_gemma":[0.99975055,0.000023881506,0.000038876427,0.000020415153,0.00002006733,0.00014627216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006761173,0.0011275245,0.0009575543,0.00032637353,0.0002930899,0.0006982374,0.00081516086,0.00075668195,0.0041603255],"category_scores_gemma":[0.00038067228,0.0004197025,0.000562983,0.0002856143,0.0006375773,0.0005283313,0.00028938506,0.002157925,0.000843258],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38426432,0.1464171,0.008945331,0.0013634639,0.0013759817,0.0006827678,0.00046104786,0.0061959676,0.2547464,0.0006475289,0.011351182,0.18354894],"study_design_scores_gemma":[0.21369378,0.7377326,0.015843032,0.000052210788,0.0005300842,0.0006804491,0.00008443565,0.002214122,0.022728337,0.00026396548,0.006136972,0.000040134688],"about_ca_topic_score_codex":0.0015319815,"about_ca_topic_score_gemma":0.0032519116,"teacher_disagreement_score":0.0041603255,"about_ca_system_score_codex":0.00087882247,"about_ca_system_score_gemma":0.0014946972,"threshold_uncertainty_score":0.013917625},"labels":[],"label_agreement":null},{"id":"W2915509041","doi":"","title":"Le cancer un combat qui pourrait aussi etre le votre - Tome 1","year":2016,"lang":"fr","type":"book","venue":"Presses Académiques Francophones eBooks","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology; Humanities; Art","score_opus":0.018596204044243534,"score_gpt":0.296659477816777,"score_spread":0.2780632737725334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915509041","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023742116,0.34278634,0.003471108,0.04386005,0.029951358,0.00010669254,0.0003451079,0.00027914645,0.576826],"genre_scores_gemma":[0.013969195,0.115107305,0.0027717338,0.01497548,0.00599629,0.00006192523,0.00022393008,0.00016301611,0.84673107],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99959916,0.00008772703,0.000018411081,0.000070288195,0.00017325055,0.000051100305],"domain_scores_gemma":[0.9995672,0.00020147451,0.000037955462,0.000027252729,0.00009750749,0.00006859423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036670157,0.0006607264,0.0005485004,0.000863456,0.0014329016,0.003605735,0.0005549129,0.002185931,0.03789991],"category_scores_gemma":[0.0010922856,0.00029410404,0.00059286534,0.0008636132,0.002216297,0.002432943,0.0012092354,0.0034554654,0.015346272],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009169068,0.00003642351,0.00041589836,0.0012649858,0.00001621471,0.0004452291,0.0012311478,0.00022031434,0.0025479097,0.08013855,0.7129474,0.20064406],"study_design_scores_gemma":[0.00000273931,0.0000150903625,0.00013093148,0.00016403015,0.000003119259,0.00042450838,0.00010268289,0.000014638934,0.00014472546,0.001764674,0.9972293,0.0000035647051],"about_ca_topic_score_codex":0.0047698906,"about_ca_topic_score_gemma":0.011303022,"teacher_disagreement_score":0.03789991,"about_ca_system_score_codex":0.0024962113,"about_ca_system_score_gemma":0.0022766113,"threshold_uncertainty_score":0.12678784},"labels":[],"label_agreement":null},{"id":"W2916799720","doi":"10.3747/co.v13i3.88","title":"Natural Health Products That Inhibit Angiogenesis: A Potential Source for Investigational New Agents to Treat Cancer—Part 2","year":2006,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Traditional medicine; Scutellaria baicalensis; Pharmacology; Salvia officinalis; Ginseng; Camellia sinensis; Andrographolide; Biology; Officinalis; Traditional Chinese medicine; Botany","score_opus":0.17549476162861025,"score_gpt":0.44993683313735894,"score_spread":0.27444207150874866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916799720","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.050571512,0.8317274,0.009384122,0.016417788,0.005608155,0.0009473081,0.0012372553,0.000356785,0.08374971],"genre_scores_gemma":[0.1501482,0.7286355,0.011190521,0.010458836,0.011170208,0.00074054673,0.0019877187,0.00011441385,0.085554026],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989295,0.000024810193,0.0000074091136,0.000012763316,0.000041435727,0.000020625808],"domain_scores_gemma":[0.99985826,0.00003425494,0.000023030334,0.000012264655,0.000037614765,0.000034562472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004651266,0.0005790093,0.00029506514,0.0009998331,0.00022768092,0.00081667077,0.0003646902,0.0007327323,0.012357324],"category_scores_gemma":[0.0002575073,0.00015767873,0.00040652172,0.0005050325,0.00029951954,0.0008856091,0.00051249453,0.0009167542,0.0025068473],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008370149,0.0012986771,0.00080208457,0.0038552142,0.00006848258,0.00055785215,0.0000905765,0.0004476451,0.13158318,0.010250321,0.08056149,0.7696475],"study_design_scores_gemma":[0.00033410784,0.0027982336,0.008641546,0.000904602,0.00011492501,0.0022973607,0.00009101475,0.0006666816,0.047255695,0.0055438327,0.9313217,0.000030389749],"about_ca_topic_score_codex":0.00023857696,"about_ca_topic_score_gemma":0.0005828114,"teacher_disagreement_score":0.012357324,"about_ca_system_score_codex":0.00032208257,"about_ca_system_score_gemma":0.00044857763,"threshold_uncertainty_score":0.041339397},"labels":[],"label_agreement":null},{"id":"W2920021859","doi":"10.1158/1538-7445.sabcs18-p1-13-08","title":"Abstract P1-13-08: A prospective non-randomized clinical trial of adjuvant carboplatin chemotherapy in triple negative breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Carboplatin; Medicine; Regimen; Internal medicine; Oncology; Triple-negative breast cancer; Taxane; Breast cancer; Docetaxel; Chemotherapy; Anthracycline; Cancer; Cisplatin","score_opus":0.08622547739423342,"score_gpt":0.503429888189596,"score_spread":0.4172044107953626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920021859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98694825,0.0016185051,0.00042587737,0.0011377761,0.00038228373,0.0071332497,0.0007079733,0.00007795854,0.0015682154],"genre_scores_gemma":[0.9778165,0.0014830907,0.0018964008,0.0018105042,0.00066292565,0.011010117,0.0014353963,0.000025668676,0.0038592939],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99867177,0.0009058742,0.00006819955,0.00015574509,0.00008143096,0.00011693304],"domain_scores_gemma":[0.99820244,0.00049848174,0.0003569227,0.0001323637,0.00010756804,0.00070229324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034650876,0.0018076324,0.002601471,0.00044071212,0.0006070229,0.0012732896,0.0009856757,0.0018308077,0.0074046925],"category_scores_gemma":[0.0023301234,0.0006966176,0.0012056516,0.0005151972,0.0015089076,0.0009995097,0.0006443832,0.004104295,0.0011167013],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98231035,0.008273933,0.0008811869,0.00021983648,0.00031360085,0.00003426676,0.000026182961,0.00016272052,0.0011493634,0.00006312781,0.00050741533,0.0060579875],"study_design_scores_gemma":[0.93454057,0.063314304,0.0011692338,0.000017668497,0.00014690665,0.000025481315,0.00001039586,0.00025954776,0.00018282725,0.00006558722,0.00026138866,0.000006026091],"about_ca_topic_score_codex":0.00082629104,"about_ca_topic_score_gemma":0.0013584249,"teacher_disagreement_score":0.0074046925,"about_ca_system_score_codex":0.00074305746,"about_ca_system_score_gemma":0.0021496231,"threshold_uncertainty_score":0.024771154},"labels":[],"label_agreement":null},{"id":"W2920981862","doi":"10.1590/1518-8345.2959.3126","title":"Acupuncture in adults with Chemotherapy-Induced Peripheral Neuropathy: a systematic review","year":2019,"lang":"en","type":"review","venue":"Revista Latino-Americana de Enfermagem","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chemotherapy-induced peripheral neuropathy; Medicine; Acupuncture; Peripheral neuropathy; Cochrane Library; MEDLINE; Systematic review; Physical therapy; Meta-analysis; Chemotherapy; Randomized controlled trial; Alternative medicine; Scopus; Internal medicine; Pathology","score_opus":0.043430650564915525,"score_gpt":0.3696948508644634,"score_spread":0.3262642002995479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920981862","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00092826516,0.99849856,0.00006684168,0.00009723933,0.000070298775,0.00016011366,0.000054709544,0.0000028463073,0.000121109246],"genre_scores_gemma":[0.011027989,0.987768,0.00044405425,0.0002541766,0.00009255604,0.00027722007,0.000062462284,0.0000016561016,0.00007182464],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9965978,0.001243783,0.0011135327,0.0002455335,0.0006904929,0.000108879736],"domain_scores_gemma":[0.9901923,0.006779066,0.0018412409,0.00012783206,0.00094277906,0.000116902134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004525346,0.0013990658,0.006872085,0.006010406,0.00052357675,0.0018951982,0.0012157804,0.0019990327,0.0038397706],"category_scores_gemma":[0.016835203,0.000722584,0.0059888028,0.0055029006,0.0004783194,0.0014464457,0.00083828694,0.0009284557,0.00024774185],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021326289,0.000041709372,0.000616933,0.94924456,0.008153708,0.000092824346,0.00011861211,0.00005866128,0.00018846012,0.00009744946,0.0006727233,0.040501103],"study_design_scores_gemma":[0.00063490146,0.0008287996,0.008331761,0.85310733,0.1194582,0.00081831025,0.0003739451,0.00016332044,0.00031167708,0.0002580237,0.015670424,0.000043308304],"about_ca_topic_score_codex":0.004275445,"about_ca_topic_score_gemma":0.011936148,"teacher_disagreement_score":0.006872085,"about_ca_system_score_codex":0.0019207816,"about_ca_system_score_gemma":0.0060380762,"threshold_uncertainty_score":0.023932636},"labels":[],"label_agreement":null},{"id":"W2923959553","doi":"","title":"[A Survey to Compare the Specifications and Stability of Anticancer Drugs in Japan, the United States, Canada, and Australia].","year":2018,"lang":"en","type":"article","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vial; Pharmacy; Anticancer drug; Medicine; Drug; Pharmacology; Family medicine; Chemistry; Chromatography","score_opus":0.1396361872470051,"score_gpt":0.3311849594508765,"score_spread":0.1915487722038714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923959553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8012481,0.07204811,0.0027258229,0.0032219868,0.00020414272,0.00047282354,0.043274716,0.00042345526,0.07638099],"genre_scores_gemma":[0.9145043,0.047225975,0.0057851598,0.0027462125,0.00006234723,0.00015825976,0.01966529,0.00007849301,0.009773926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828964,0.00016293512,0.0003404982,0.00012678477,0.00093984086,0.0001403065],"domain_scores_gemma":[0.9925222,0.00082549924,0.0024886292,0.000108032524,0.003660187,0.00039555907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014743058,0.0002255335,0.00023565654,0.0031685352,0.0004502173,0.0005921947,0.00031146186,0.00025532075,0.0026739673],"category_scores_gemma":[0.0043861787,0.00014797668,0.00039935907,0.006318432,0.00023572372,0.0005265983,0.00035429196,0.0002945255,0.00061699335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042095638,0.00012563703,0.6426258,0.0035250462,0.00018616104,0.0004223207,0.0011571842,0.00022211748,0.0068925107,0.00073994236,0.033129245,0.31055316],"study_design_scores_gemma":[0.000008991843,0.00017339697,0.8950697,0.00037763073,0.000117317635,0.0010036638,0.0011572092,0.00017359204,0.0020531956,0.000043517328,0.09979373,0.000028159964],"about_ca_topic_score_codex":0.20425649,"about_ca_topic_score_gemma":0.23538539,"teacher_disagreement_score":0.7957435,"about_ca_system_score_codex":0.002428287,"about_ca_system_score_gemma":0.00510059,"threshold_uncertainty_score":0.40613514},"labels":[],"label_agreement":null},{"id":"W2924827988","doi":"10.3332/ecancer.2019.ed88","title":"Drug interactions and oncological outcomes: a hidden adversary","year":2019,"lang":"en","type":"editorial","venue":"ecancermedicalscience","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Drug; Capecitabine; Intensive care medicine; Disease; Cancer drugs; Drug repositioning; Pharmacology; Cancer; Bioinformatics; Internal medicine; Colorectal cancer","score_opus":0.015977283763105744,"score_gpt":0.37735467005400375,"score_spread":0.361377386290898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924827988","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006237325,0.06270509,0.0001450588,0.067591205,0.86782384,0.000011005627,0.000039534447,0.000042277206,0.00157972],"genre_scores_gemma":[0.0004534085,0.032098852,0.00009378701,0.02622489,0.9377943,0.0000098882,0.000018963889,0.000021175347,0.0032846117],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958818,0.0011641653,0.00060749165,0.00043351678,0.0016961216,0.00021688998],"domain_scores_gemma":[0.96867543,0.021163644,0.001344328,0.0004858634,0.006477721,0.0018530606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005573296,0.0021489062,0.003114403,0.002401275,0.001961305,0.005900283,0.0021031587,0.011491644,0.008573699],"category_scores_gemma":[0.026739633,0.00074527255,0.0018119203,0.0013881543,0.002795356,0.0051319,0.0015035364,0.01771055,0.005394695],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043196535,0.000012363523,0.00005122842,0.00068392855,0.00003441082,0.0001223355,0.000030836953,0.00003144036,0.000048389546,0.0008849191,0.97822237,0.019834729],"study_design_scores_gemma":[0.000040449875,0.000036861828,0.00024905204,0.0016775996,0.000073115385,0.0004443145,0.000071176604,0.00008790613,0.00006224069,0.0025460413,0.9946871,0.000024172941],"about_ca_topic_score_codex":0.0011340891,"about_ca_topic_score_gemma":0.002604633,"teacher_disagreement_score":0.011491644,"about_ca_system_score_codex":0.0025915364,"about_ca_system_score_gemma":0.0029701572,"threshold_uncertainty_score":0.029474795},"labels":[],"label_agreement":null},{"id":"W2929448861","doi":"","title":"Synergistic antineoplastic activity of amonafide malate (Xanafide) with docetaxel and paclitaxel in human prostate cells","year":2005,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Irinotecan; Oxaliplatin; Etoposide; Medicine; Docetaxel; Colorectal cancer; Paclitaxel; Camptothecin; Pharmacology; Drug; Oncology; Cancer research; Cancer; Chemotherapy; Internal medicine; Chemistry","score_opus":0.008967955918337695,"score_gpt":0.2820612816458084,"score_spread":0.2730933257274707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2929448861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98529994,0.0074019646,0.00088739075,0.00014507449,0.000064200336,0.00008818417,0.00034813612,0.000071236995,0.005693892],"genre_scores_gemma":[0.9923758,0.0028525128,0.0013153042,0.000046694327,0.00001646446,0.000027522186,0.00068432395,0.000010852973,0.002670501],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985325,0.000038488994,0.000009331995,0.000017052338,0.00004124685,0.000040647283],"domain_scores_gemma":[0.9999521,0.000011140443,0.00000854786,0.00000635689,0.0000064667825,0.000015397889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015019086,0.0003276861,0.00031190494,0.0004646571,0.00017272038,0.00036960127,0.00022546192,0.00017342852,0.0020973205],"category_scores_gemma":[0.00009598802,0.00023407178,0.00037229396,0.00028700207,0.00011432978,0.00014825109,0.00022595108,0.00032167445,0.00059950043],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008174298,0.0004636143,0.0010594525,0.0001436215,0.00007091611,0.0002194706,0.00004735669,0.0006208643,0.9787405,0.0002740318,0.00065919146,0.016883496],"study_design_scores_gemma":[0.00014683654,0.003634437,0.009444514,0.000015177463,0.000070800226,0.001285544,0.000055120185,0.0014310551,0.9731311,0.000051557945,0.010723476,0.000010342365],"about_ca_topic_score_codex":0.0018214717,"about_ca_topic_score_gemma":0.0059701907,"teacher_disagreement_score":0.0020973205,"about_ca_system_score_codex":0.00039729205,"about_ca_system_score_gemma":0.0003694172,"threshold_uncertainty_score":0.007016182},"labels":[],"label_agreement":null},{"id":"W2941757790","doi":"10.1093/neuonc/noz036.059","title":"DIPG-38. DIANHYDROGALACTITOL (VAL-083) WITH AZD1775 INCREASES SURVIVAL IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG), IN VIVO","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"In vivo; Cancer research; Wee1; DNA damage; Cell cycle checkpoint; Cancer; IC50; Cell cycle; Chemistry; Medicine; Pharmacology; In vitro; Internal medicine; Biology; DNA; Cyclin-dependent kinase 1; Biochemistry; Genetics","score_opus":0.013355405510796867,"score_gpt":0.29550850844423965,"score_spread":0.28215310293344276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941757790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99667114,0.0012666755,0.00041149277,0.0000871874,0.000026506648,0.000025203728,0.0003057784,0.00007820252,0.0011278575],"genre_scores_gemma":[0.9966028,0.0007005127,0.0007187212,0.000034059725,0.000008143257,0.000024451832,0.00050117535,0.0000109667835,0.0013991562],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998772,0.000021088641,0.000009156563,0.000022134878,0.00003684911,0.00003353784],"domain_scores_gemma":[0.9999348,0.000007902302,0.000016547132,0.000005870208,0.000004705487,0.000030185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009918573,0.00044676723,0.00034580298,0.0002830553,0.00010551838,0.00017214508,0.00022932405,0.00020339304,0.0010410065],"category_scores_gemma":[0.000070756774,0.00012478989,0.0002266255,0.00023895077,0.00021011957,0.00016888062,0.00014582934,0.000665389,0.00023091058],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010845995,0.00035586496,0.0003494865,0.000065725806,0.00002365935,0.00009009951,0.000027418013,0.00022185339,0.992737,0.000076164346,0.00019285327,0.0047752927],"study_design_scores_gemma":[0.00012539559,0.006789086,0.006967,0.000005603651,0.00004303035,0.00038131562,0.00003334232,0.00094234245,0.9820531,0.00003319463,0.002620403,0.0000061427377],"about_ca_topic_score_codex":0.0015123053,"about_ca_topic_score_gemma":0.002571756,"teacher_disagreement_score":0.0015123053,"about_ca_system_score_codex":0.00028304124,"about_ca_system_score_gemma":0.00029595062,"threshold_uncertainty_score":0.003482461},"labels":[],"label_agreement":null},{"id":"W2942660786","doi":"10.3747/co.26.4261","title":"A Systematic Review of Acupuncture for Chemotherapy-Induced Peripheral Neuropathy","year":2019,"lang":"en","type":"review","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; University of British Columbia","funders":"","keywords":"Medicine; Acupuncture; Chemotherapy-induced peripheral neuropathy; CINAHL; Randomized controlled trial; MEDLINE; Peripheral neuropathy; Alternative medicine; Quality of life (healthcare); Physical therapy; Clinical trial; Systematic review; Internal medicine; Psychiatry; Pathology; Psychological intervention","score_opus":0.23998888864208157,"score_gpt":0.5243745583293208,"score_spread":0.2843856696872392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942660786","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006440561,0.9978982,0.00010039115,0.00020548562,0.00014050075,0.00045629928,0.00020702774,0.000006233253,0.0003416696],"genre_scores_gemma":[0.00825728,0.9895536,0.00055977475,0.00047172856,0.000087840875,0.00075675966,0.00014630202,0.0000042307056,0.00016248069],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9922368,0.003100627,0.0024881568,0.00048008867,0.0014998809,0.00019460259],"domain_scores_gemma":[0.9853565,0.009406974,0.0030171187,0.0002046035,0.0018025938,0.00021211317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006415656,0.001604863,0.009231215,0.010104194,0.0008312976,0.00268339,0.0018446626,0.0020137124,0.0072061126],"category_scores_gemma":[0.02935485,0.0009271627,0.0068545854,0.010490671,0.0008713125,0.0022536134,0.0013638234,0.0012569227,0.00047379648],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011271419,0.000011138578,0.00018964526,0.972742,0.0036953525,0.000076199205,0.00012857777,0.000044558943,0.00009030594,0.00014008724,0.0011122699,0.021657249],"study_design_scores_gemma":[0.00029335677,0.00020278415,0.0022768965,0.94221604,0.038584005,0.00034904288,0.00020141226,0.000066798515,0.00009108002,0.00023476758,0.015457608,0.00002615431],"about_ca_topic_score_codex":0.007816103,"about_ca_topic_score_gemma":0.026788155,"teacher_disagreement_score":0.010104194,"about_ca_system_score_codex":0.004405453,"about_ca_system_score_gemma":0.012820001,"threshold_uncertainty_score":0.033929586},"labels":[],"label_agreement":null},{"id":"W2942952407","doi":"","title":"Conception d'un dosimètre à fibre scintillante pour la curiethérapie","year":2008,"lang":"fr","type":"article","venue":"Corpus Université Laval (Université Laval)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Nuclear medicine; Surgery","score_opus":0.012547243761325417,"score_gpt":0.22693290349075318,"score_spread":0.21438565972942777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942952407","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61963457,0.045423206,0.2746346,0.0032867875,0.00087312696,0.0012669115,0.00056043273,0.0006737779,0.053646673],"genre_scores_gemma":[0.7171534,0.021986052,0.20389467,0.00069192535,0.0001808487,0.0006138915,0.0004269202,0.0002060918,0.054846257],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995468,0.00007555407,0.000020518177,0.00008938566,0.00021078247,0.000056877005],"domain_scores_gemma":[0.99953413,0.0001080081,0.00008355354,0.000045045992,0.0001733047,0.00005601068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012852057,0.00042718163,0.0004556174,0.0005583442,0.0004268523,0.0009284746,0.00053522165,0.0008331434,0.0024072588],"category_scores_gemma":[0.00064388075,0.00023871554,0.0004235071,0.00034522294,0.00073218025,0.000737379,0.0004912115,0.0009756655,0.00055968534],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028018127,0.00008698927,0.0005335924,0.00041828104,0.000020383572,0.00009404383,0.00034191643,0.0011887178,0.9296594,0.009346892,0.0003832839,0.057646334],"study_design_scores_gemma":[0.000042477484,0.0013888391,0.0018774496,0.00008371842,0.000043610147,0.00033922264,0.00011733142,0.0016131002,0.9223558,0.0007239221,0.07136135,0.000053140167],"about_ca_topic_score_codex":0.002898547,"about_ca_topic_score_gemma":0.0039231926,"teacher_disagreement_score":0.002898547,"about_ca_system_score_codex":0.0016947857,"about_ca_system_score_gemma":0.001433062,"threshold_uncertainty_score":0.012296557},"labels":[],"label_agreement":null},{"id":"W2943425953","doi":"10.1016/j.clon.2019.04.008","title":"Neurotoxicity Among Survivors of Testicular Cancer: A Population-based Study","year":2019,"lang":"en","type":"article","venue":"Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of Calgary; Queen's University","funders":"PTC Therapeutics","keywords":"Medicine; Testicular cancer; Chemotherapy; Orchiectomy; Neurotoxicity; Cancer; Retrospective cohort study; Population; Cancer registry; Cohort; Internal medicine; Surgery; Toxicity; Environmental health","score_opus":0.08663527472442592,"score_gpt":0.48032696541173353,"score_spread":0.3936916906873076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943425953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993305,0.00019208883,0.000038890863,0.000013958728,0.0000023662164,0.000008291042,0.00016656243,0.0000016680326,0.00024562326],"genre_scores_gemma":[0.9994326,0.00017664676,0.000028646155,0.000021362672,0.0000066687976,0.0000068926115,0.00017960179,0.000001148601,0.00014637606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966526,0.000092872164,0.00003469112,0.00008797312,0.00006157219,0.00005757535],"domain_scores_gemma":[0.9992828,0.000096249474,0.00026908575,0.000060431208,0.00014462475,0.00014680352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033129347,0.0003043323,0.0005502431,0.0010237776,0.0008434919,0.0008054494,0.0002798991,0.00056481926,0.0012153294],"category_scores_gemma":[0.0010990012,0.0004087893,0.000627298,0.0021264085,0.00033350094,0.00063658727,0.00038636365,0.00056868454,0.00020920979],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011193425,0.0000747241,0.99872977,0.000007695817,0.00008649534,0.000089706125,0.000103667786,0.000017103823,0.0001419665,0.000005822336,0.000027273141,0.0006038659],"study_design_scores_gemma":[0.00001118919,0.00032678782,0.99863523,0.0000038691155,0.00010232192,0.00034370457,0.00038984843,0.000042627893,0.000028028266,0.00001559471,0.00009628907,0.0000044463573],"about_ca_topic_score_codex":0.011456709,"about_ca_topic_score_gemma":0.014019879,"teacher_disagreement_score":0.011456709,"about_ca_system_score_codex":0.00042998287,"about_ca_system_score_gemma":0.0004555536,"threshold_uncertainty_score":0.022780001},"labels":[],"label_agreement":null},{"id":"W2946249472","doi":"10.1007/s00520-019-04845-7","title":"Pain descriptors of taxane acute pain syndrome (TAPS) in breast cancer patients—a prospective clinical study","year":2019,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Health Sciences Centre; University of Toronto; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; myalgia; Taxane; Pain medicine; Docetaxel; Breast cancer; Prospective cohort study; Cancer pain; Brief Pain Inventory; McGill Pain Questionnaire; Neuropathic pain; Chemotherapy; Chronic pain; Internal medicine; Cancer; Physical therapy; Anesthesia; Visual analogue scale; Anesthesiology","score_opus":0.018560946720652068,"score_gpt":0.3752612564688225,"score_spread":0.35670030974817046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946249472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99888414,0.00031795126,0.00005506469,0.000013292566,0.000006822774,0.000073255826,0.00025564525,0.0000011768594,0.00039273908],"genre_scores_gemma":[0.99857056,0.00026638957,0.00008854777,0.00003523944,0.0000216045,0.00008489973,0.00064618094,0.0000013021613,0.00028535473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994106,0.00016769167,0.00009121152,0.000098114615,0.00013834175,0.00009402229],"domain_scores_gemma":[0.998451,0.00027000933,0.00077315053,0.000058479218,0.00017228532,0.0002750283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063992804,0.0004602076,0.0005450101,0.0009082806,0.00052986137,0.0007813981,0.0003662434,0.00060513685,0.002089271],"category_scores_gemma":[0.002407135,0.00031640462,0.0008959097,0.0011794262,0.000398203,0.0006834356,0.00068387704,0.0008729484,0.0004083951],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010294402,0.00036902248,0.99622935,0.000040276485,0.00010866233,0.00012816172,0.00011238934,0.000035264206,0.00031324237,0.000018494797,0.000059488804,0.0015562244],"study_design_scores_gemma":[0.00005651361,0.00089371443,0.99826944,0.000008052325,0.000047714522,0.00024212977,0.00023736528,0.00005403377,0.000030941428,0.000015390813,0.00013835824,0.000006201839],"about_ca_topic_score_codex":0.0014859713,"about_ca_topic_score_gemma":0.0022998094,"teacher_disagreement_score":0.002089271,"about_ca_system_score_codex":0.00042484267,"about_ca_system_score_gemma":0.00042288646,"threshold_uncertainty_score":0.0069893003},"labels":[],"label_agreement":null},{"id":"W2946893188","doi":"10.1200/jco.2019.37.15_suppl.2602","title":"Safety profile of INT230-6, a novel intratumoral (IT) formulation, during injections into a variety of refractory deep and superficial tumors with evidence of tumor regression and immune activation.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Tolerability; Adverse effect; Common Terminology Criteria for Adverse Events; Pharmacokinetics; Leukopenia; Refractory (planetary science); Cancer; Internal medicine; Gastroenterology; Pharmacology; Pathology; Urology; Toxicity","score_opus":0.06102023954126988,"score_gpt":0.42982169381317836,"score_spread":0.36880145427190847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946893188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99544406,0.001508938,0.0017527658,0.000050025617,0.000018478067,0.000095693846,0.00019927617,0.000060056624,0.00087066484],"genre_scores_gemma":[0.99813557,0.0005048179,0.00048286884,0.00003679078,0.000010869414,0.000046016514,0.00020044805,0.000013115081,0.00056944543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991953,0.000025551995,0.000003943553,0.00001602722,0.000022342134,0.000012677473],"domain_scores_gemma":[0.99987876,0.00001908866,0.000055284716,0.000010680536,0.000011478799,0.000024737214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002530275,0.0002441581,0.00018782304,0.00009601814,0.00010397382,0.00027326794,0.00017245377,0.00023258368,0.0009518815],"category_scores_gemma":[0.0002196958,0.00008661529,0.00018510639,0.00011827641,0.00014037995,0.00023260278,0.000058645375,0.0005839315,0.0003407841],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023810295,0.0030826242,0.004969333,0.00035910236,0.00012715782,0.00045483132,0.00018734999,0.0022129447,0.8620456,0.00019909305,0.0013298724,0.10122189],"study_design_scores_gemma":[0.002971026,0.23560405,0.0389812,0.000056586265,0.00043428602,0.0054754694,0.0001682782,0.0084511805,0.68928796,0.00016581597,0.018360198,0.00004401335],"about_ca_topic_score_codex":0.0003343608,"about_ca_topic_score_gemma":0.00045539666,"teacher_disagreement_score":0.0009518815,"about_ca_system_score_codex":0.00019092328,"about_ca_system_score_gemma":0.00021893358,"threshold_uncertainty_score":0.0031843781},"labels":[],"label_agreement":null},{"id":"W2946984441","doi":"10.1134/s1607672919020145","title":"Detection of Taxuyunnanin C in Suspension Cell Culture of Taxuscanadensis","year":2019,"lang":"en","type":"article","venue":"Doklady Biochemistry and Biophysics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Taxoid; Suspension culture; Chemistry; Suspension (topology); Botany; Cell culture; Stereochemistry; Biology; Paclitaxel; Genetics; Cancer","score_opus":0.0051824330514105305,"score_gpt":0.23597985677889424,"score_spread":0.2307974237274837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946984441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98882127,0.0018171435,0.0047933054,0.000051941053,0.00004833291,0.0000676448,0.0010390979,0.00007620299,0.003285024],"genre_scores_gemma":[0.98406065,0.0014441767,0.0060451706,0.000054084292,0.000020028889,0.00004666063,0.0026349407,0.000022714825,0.0056716325],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994636,0.000003502983,0.000002663958,0.000016566853,0.000019560199,0.00001141375],"domain_scores_gemma":[0.99991715,0.0000148955005,0.000013626163,0.000009747416,0.000023033428,0.000021660757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000046520203,0.00031230063,0.0001974697,0.00043756294,0.0002708216,0.0002761903,0.00012846576,0.00023352407,0.0007040519],"category_scores_gemma":[0.00008549826,0.000069716625,0.00013572705,0.00028197412,0.00016443896,0.00017009008,0.00022732648,0.00036674686,0.00041853386],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014702816,0.0000036439808,0.00041982305,0.0000067679894,0.0000014402035,0.00002651208,0.000014928512,0.0000070262545,0.9988053,0.000008182288,0.0000052694622,0.00068642315],"study_design_scores_gemma":[0.0000072517364,0.00036122455,0.023968711,0.000009382895,0.000025863139,0.00050075026,0.0002510065,0.0005045697,0.97042817,0.00006113815,0.003870698,0.000011197175],"about_ca_topic_score_codex":0.003612982,"about_ca_topic_score_gemma":0.0039995257,"teacher_disagreement_score":0.003612982,"about_ca_system_score_codex":0.0001520439,"about_ca_system_score_gemma":0.00023217822,"threshold_uncertainty_score":0.0071839094},"labels":[],"label_agreement":null},{"id":"W2947217282","doi":"10.1200/jco.2019.37.15_suppl.1002","title":"Neratinib + capecitabine versus lapatinib + capecitabine in patients with HER2+ metastatic breast cancer previously treated with ≥ 2 HER2-directed regimens: Findings from the multinational, randomized, phase III NALA trial.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Capecitabine; Medicine; Lapatinib; Internal medicine; Neratinib; Metastatic breast cancer; Gastroenterology; Clinical endpoint; Randomized controlled trial; Breast cancer; Oncology; Cancer; Trastuzumab; Colorectal cancer","score_opus":0.05348833309670203,"score_gpt":0.41720628720842934,"score_spread":0.3637179541117273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947217282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899889,0.0053148316,0.00027156246,0.0008827932,0.00034726746,0.0011301467,0.0005910252,0.000040328025,0.0014330214],"genre_scores_gemma":[0.99320024,0.0020955051,0.00057471014,0.00080595224,0.00022179823,0.00109194,0.0006506984,0.000009575713,0.0013496787],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993037,0.0004334927,0.00004949393,0.00008972781,0.000040873303,0.00008280007],"domain_scores_gemma":[0.99894255,0.0003330948,0.00027123452,0.000055018198,0.000038217724,0.00035982832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002624286,0.0010893081,0.0017853301,0.0003236999,0.00029442247,0.00090291287,0.0006550536,0.0009819785,0.0044911555],"category_scores_gemma":[0.0018787704,0.00045141045,0.0019513079,0.0003510952,0.0006843435,0.0009171557,0.0003871538,0.00260245,0.0005604802],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9689883,0.0054536783,0.0014434501,0.00044134053,0.0012019331,0.000034417306,0.00004620331,0.00053814455,0.0017226406,0.00007607155,0.00082187954,0.019232044],"study_design_scores_gemma":[0.8785201,0.11244374,0.0056096036,0.00005791873,0.00093660626,0.000075854805,0.00003414583,0.0007279155,0.00039937746,0.00019334379,0.0009849279,0.00001657122],"about_ca_topic_score_codex":0.0011677035,"about_ca_topic_score_gemma":0.004883732,"teacher_disagreement_score":0.0044911555,"about_ca_system_score_codex":0.0011625411,"about_ca_system_score_gemma":0.0011984634,"threshold_uncertainty_score":0.015024424},"labels":[],"label_agreement":null},{"id":"W2947888232","doi":"10.1200/jco.2019.37.15_suppl.3142","title":"Effects of immune architecture on response to adjuvant capecitabine in triple-negative breast cancer (FinXX trial).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Capecitabine; Medicine; Epirubicin; Docetaxel; Triple-negative breast cancer; Internal medicine; Oncology; Cyclophosphamide; Breast cancer; Gene signature; Chemotherapy; Adjuvant; Cancer; Colorectal cancer; Gene expression","score_opus":0.04443171687605387,"score_gpt":0.47001652870276767,"score_spread":0.4255848118267138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947888232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99556434,0.002511295,0.000108315086,0.00014376293,0.000044803033,0.00012608993,0.00039189606,0.000019970159,0.0010894954],"genre_scores_gemma":[0.9971494,0.00047786903,0.00022930003,0.00016812337,0.000038678147,0.00011873759,0.0009327845,0.0000045514553,0.00088059943],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99979585,0.00010425191,0.000010652938,0.000039260543,0.000018328275,0.000031725856],"domain_scores_gemma":[0.99974793,0.0000820123,0.000072462004,0.00001904536,0.0000134995935,0.00006502641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011231744,0.00053601654,0.0007800166,0.00018880951,0.00016918218,0.0004431082,0.0002785563,0.00047552105,0.0021454254],"category_scores_gemma":[0.000738411,0.0001428911,0.00068114157,0.00015902088,0.0002932417,0.0003391165,0.00021490002,0.00064655324,0.00019259643],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8181479,0.0020443066,0.049239233,0.0009125658,0.0019024909,0.00013337217,0.000073748444,0.0028727879,0.011262983,0.00022334333,0.0024992595,0.11068797],"study_design_scores_gemma":[0.28926316,0.26017594,0.42058676,0.00035085125,0.0059744655,0.0011238831,0.0001282177,0.0067814644,0.006240875,0.0012532676,0.008035586,0.00008549078],"about_ca_topic_score_codex":0.000711389,"about_ca_topic_score_gemma":0.001700087,"teacher_disagreement_score":0.0021454254,"about_ca_system_score_codex":0.00048588702,"about_ca_system_score_gemma":0.0002922322,"threshold_uncertainty_score":0.0071772337},"labels":[],"label_agreement":null},{"id":"W2949372190","doi":"10.1016/s0040-4020(01)00121-1","title":"The transannular Diels–Alder strategy: applications to total synthesis","year":2001,"lang":"en","type":"article","venue":"Tetrahedron","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Chemistry; Diels–Alder reaction; Total synthesis; Organic chemistry; Catalysis","score_opus":0.027185079799771156,"score_gpt":0.3382062996872534,"score_spread":0.31102121988748227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949372190","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21078636,0.07528895,0.49943492,0.005348737,0.0044450723,0.000541121,0.0013648053,0.001791288,0.20099874],"genre_scores_gemma":[0.69885033,0.08064683,0.14585796,0.0022136746,0.0004529724,0.0004216218,0.0007497107,0.00036511038,0.07044177],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999778,0.0000504506,0.000013832932,0.000048246882,0.000056911264,0.000052601197],"domain_scores_gemma":[0.9999274,0.000016224809,0.000009527564,0.000015926265,0.000015599766,0.000015322568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006335763,0.00068665034,0.0006316626,0.00069879094,0.0004914056,0.000594521,0.0004622018,0.00060231105,0.0034038562],"category_scores_gemma":[0.00025334905,0.00032072698,0.00065307354,0.0006821264,0.0005237205,0.0007802035,0.00079750543,0.0015451581,0.0023625754],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010574594,0.0003899625,0.0002281082,0.0016322769,0.00017303259,0.0009857583,0.00066921243,0.009472778,0.5353884,0.1440726,0.017377097,0.2885534],"study_design_scores_gemma":[0.00036064468,0.003374291,0.0008367881,0.0002496566,0.00021574824,0.0016216736,0.00021511503,0.012348678,0.6511869,0.06810337,0.26123405,0.00025308944],"about_ca_topic_score_codex":0.0007092026,"about_ca_topic_score_gemma":0.0015099447,"teacher_disagreement_score":0.0034038562,"about_ca_system_score_codex":0.0005932932,"about_ca_system_score_gemma":0.00067892217,"threshold_uncertainty_score":0.011386991},"labels":[],"label_agreement":null},{"id":"W2949565469","doi":"10.1002/chin.200221136","title":"ChemInform Abstract: Taxines from the Needles of Taxus wallichiana.","year":2002,"lang":"en","type":"article","venue":"ChemInform","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute","funders":"","keywords":"Chemistry; Service (business); Nanotechnology; World Wide Web; Business; Marketing; Computer science","score_opus":0.03146296645399282,"score_gpt":0.2748375510935088,"score_spread":0.243374584639516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949565469","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11268996,0.14756328,0.022810774,0.017749783,0.009553644,0.0010854348,0.04688466,0.005169125,0.63649344],"genre_scores_gemma":[0.17863032,0.05488265,0.014372671,0.0030243117,0.0007566838,0.00018690985,0.020769414,0.00094076665,0.7264364],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99993515,0.0000049826526,0.000003886598,0.000016165348,0.000026996788,0.000012826561],"domain_scores_gemma":[0.9999287,0.000008131064,0.00001393797,0.0000067643678,0.00001184824,0.000030601936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008706104,0.0007927884,0.000513095,0.001874048,0.0010065027,0.00087994954,0.0004353001,0.00065482355,0.08425493],"category_scores_gemma":[0.00022796613,0.00026305192,0.00021452866,0.0015364424,0.00049125944,0.0011905732,0.0008093602,0.0015691806,0.038898923],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016219831,0.00022332055,0.0010639285,0.0020534648,0.000081620565,0.0068119443,0.0004053303,0.0006813397,0.17672168,0.009895778,0.22437781,0.5760618],"study_design_scores_gemma":[0.00004507039,0.00015988367,0.0017152843,0.0001988629,0.0000520838,0.0031563472,0.00014282146,0.0000818908,0.040381573,0.0018041201,0.9522386,0.000023376166],"about_ca_topic_score_codex":0.0027583411,"about_ca_topic_score_gemma":0.0049655,"teacher_disagreement_score":0.08425493,"about_ca_system_score_codex":0.0003981258,"about_ca_system_score_gemma":0.0007871399,"threshold_uncertainty_score":0.28186077},"labels":[],"label_agreement":null},{"id":"W2950436633","doi":"10.1055/s-2000-6291","title":"A Carbometallation-Intramolecular Cycloaddition Strategy for the AB-Taxane Ring and an Enone Accelerated Cope Rearrangement to Bicyclo[2.2.2]octanones","year":2000,"lang":"en","type":"article","venue":"Synthesis","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada; Government of Ontario","keywords":"Chemistry; Bicyclic molecule; Enone; Cycloaddition; Ketone; Isomerization; Intramolecular force; Lewis acids and bases; Medicinal chemistry; Stereochemistry; Ring (chemistry); Organic chemistry; Catalysis","score_opus":0.04904171598865918,"score_gpt":0.34985185732806845,"score_spread":0.30081014133940925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950436633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92949027,0.0040769232,0.035967514,0.00021608446,0.00017042772,0.00039747317,0.00045904244,0.0002900478,0.028932188],"genre_scores_gemma":[0.9679326,0.00187687,0.019855713,0.00007390432,0.000023603314,0.00011677297,0.00033725088,0.00004139035,0.009741872],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991226,0.000009334246,0.00000872155,0.000020304065,0.000024792978,0.00002459502],"domain_scores_gemma":[0.9999641,0.0000033904078,0.000009362047,0.000006027868,0.000005209,0.000011774899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007715369,0.00036918608,0.00018661913,0.0002531559,0.00015906457,0.00017263755,0.00021616324,0.00013953664,0.0014458706],"category_scores_gemma":[0.00007416466,0.00015384746,0.00017133597,0.00018687324,0.00014574523,0.00024948455,0.00025782984,0.00039627418,0.0004956793],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007955307,0.0000725978,0.00017734135,0.00009565352,0.000007665966,0.0002870097,0.0000630348,0.00035972966,0.98567444,0.0014642143,0.000146234,0.011572548],"study_design_scores_gemma":[0.00003338094,0.00052888796,0.001277271,0.0000107898695,0.000013044417,0.0007699173,0.000032774275,0.0005111625,0.97694325,0.00020806717,0.019656098,0.000015264088],"about_ca_topic_score_codex":0.0003964476,"about_ca_topic_score_gemma":0.0016720837,"teacher_disagreement_score":0.0014458706,"about_ca_system_score_codex":0.00022240322,"about_ca_system_score_gemma":0.00030803308,"threshold_uncertainty_score":0.0048368573},"labels":[],"label_agreement":null},{"id":"W2950463097","doi":"10.7164/antibiotics.57.97","title":"ICM0301s, New Angiogenesis Inhibitors from Aspergillus sp. F-1491: I. Taxonomy, Fermentation, Isolation and Biological Activities","year":2004,"lang":"en","type":"article","venue":"The Journal of Antibiotics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"","keywords":"Angiogenesis; Umbilical vein; Microbiology; Cytotoxicity; Fermentation; Aspergillus; Pharmacology; Chemistry; Basic fibroblast growth factor; Angiogenesis inhibitor; Biology; Biochemistry; In vitro; Growth factor; Cancer research","score_opus":0.041888110378928804,"score_gpt":0.2870594799529177,"score_spread":0.24517136957398888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950463097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96223015,0.021612152,0.005493398,0.00021513674,0.00009363084,0.00040465215,0.003139281,0.00027451038,0.0065370044],"genre_scores_gemma":[0.9737637,0.006126495,0.010584877,0.00022826306,0.000044134238,0.00013892814,0.006185401,0.00001992639,0.0029082524],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999447,0.0000073255833,0.0000063916514,0.000009844431,0.00001696947,0.000014795616],"domain_scores_gemma":[0.99992764,0.0000067438577,0.00001782933,0.000005289515,0.000014602367,0.000027806836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008025245,0.00061988505,0.00033315422,0.0005308735,0.0001464063,0.00021306096,0.00023333644,0.0002868847,0.00069271],"category_scores_gemma":[0.0001015965,0.000083614446,0.0002959605,0.0003887079,0.00012999414,0.00015099988,0.00010809325,0.00035573356,0.0004146172],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029576724,0.00020775778,0.0012286113,0.00016701451,0.000015345775,0.0002482133,0.00001548628,0.00036138113,0.9708872,0.00014598778,0.0003245516,0.026102738],"study_design_scores_gemma":[0.000114224196,0.0032382847,0.0151509475,0.000044559085,0.00006440909,0.0020336933,0.00003598343,0.0008890035,0.9658224,0.00010859497,0.012478416,0.000019597855],"about_ca_topic_score_codex":0.00085948105,"about_ca_topic_score_gemma":0.0012856452,"teacher_disagreement_score":0.00085948105,"about_ca_system_score_codex":0.00025100866,"about_ca_system_score_gemma":0.00035219846,"threshold_uncertainty_score":0.0023173094},"labels":[],"label_agreement":null},{"id":"W2950479189","doi":"10.1002/chin.200020205","title":"ChemInform Abstract: Antimitotic Diterpenes from Erythropodium caribaeorum Test Pharmacophore Models for Microtubule Stabilization.","year":2000,"lang":"en","type":"article","venue":"ChemInform","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Chemistry; Pharmacophore; Test (biology); Combinatorial chemistry; Stereochemistry","score_opus":0.022407291451047355,"score_gpt":0.2925089192109869,"score_spread":0.2701016277599395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950479189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8768148,0.014327645,0.021319985,0.0015397171,0.00044268087,0.0006794467,0.018699752,0.0011345093,0.06504153],"genre_scores_gemma":[0.94874245,0.0062742373,0.008368327,0.00027265793,0.000040616327,0.00014732883,0.012965136,0.00007085856,0.023118366],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999485,0.000009372718,0.0000033480642,0.000007845081,0.000021339973,0.000009647728],"domain_scores_gemma":[0.99995875,0.0000102355225,0.0000065160784,0.0000033916572,0.000008717922,0.000012391977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105627405,0.00035030246,0.00030630062,0.00035191266,0.00014902366,0.00019799099,0.00028248536,0.00022793635,0.0071076257],"category_scores_gemma":[0.00012986269,0.000096169155,0.00017093096,0.00028915232,0.00010273469,0.00021822084,0.00015649499,0.00041975334,0.0011942049],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011292584,0.00029104933,0.00025163157,0.00059029466,0.000050904924,0.00033523559,0.00004042961,0.0048583318,0.9549265,0.002845645,0.00584129,0.028839495],"study_design_scores_gemma":[0.00028170124,0.0021074358,0.00097561633,0.000032503784,0.000072292925,0.00018988141,0.000027890472,0.0044977074,0.9589067,0.00057797594,0.032311443,0.000019012068],"about_ca_topic_score_codex":0.0011352126,"about_ca_topic_score_gemma":0.0019699333,"teacher_disagreement_score":0.0071076257,"about_ca_system_score_codex":0.00031267124,"about_ca_system_score_gemma":0.00027465282,"threshold_uncertainty_score":0.023777366},"labels":[],"label_agreement":null},{"id":"W2950763902","doi":"10.1002/chin.200146265","title":"ChemInform Abstract: Synthesis of the Racemic Tetracyclic Core (I) of CP‐225,917 — A Model Compound Lacking the Sidearms of the Natural Product.","year":2001,"lang":"en","type":"article","venue":"ChemInform","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chemistry; Core (optical fiber); Natural product; Product (mathematics); Natural (archaeology); Service (business); Stereochemistry; Combinatorial chemistry; Computer science; Business; Telecommunications; Marketing","score_opus":0.03201229355811482,"score_gpt":0.30036701439082686,"score_spread":0.26835472083271206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950763902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61080796,0.008516775,0.10032625,0.0013870734,0.0019180783,0.0015444407,0.02821987,0.003536302,0.24374327],"genre_scores_gemma":[0.92586285,0.005053193,0.019832546,0.00052785565,0.00014899386,0.00027510503,0.008990165,0.00035532413,0.038954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999335,0.000005886043,0.000004642011,0.000018854404,0.0000150921705,0.000022004617],"domain_scores_gemma":[0.99995506,0.0000028472832,0.00000971281,0.0000061784854,0.0000071895947,0.00001915628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011942137,0.00049308274,0.0003139632,0.00030882497,0.00025685332,0.00025332515,0.00064991653,0.00025457158,0.014447832],"category_scores_gemma":[0.000116397845,0.00016983709,0.00031401048,0.0002992124,0.00017097969,0.00054062315,0.00025241333,0.00050732144,0.005033297],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013873534,0.0003104886,0.00020619869,0.000979284,0.000075757,0.00061392266,0.0001047064,0.0027326415,0.9007288,0.011265661,0.019701572,0.061893575],"study_design_scores_gemma":[0.00027668665,0.002914635,0.0009509957,0.00005578629,0.00008807043,0.0006234974,0.000031106414,0.0023026918,0.9333578,0.0016937954,0.057651427,0.000053534462],"about_ca_topic_score_codex":0.0010596507,"about_ca_topic_score_gemma":0.0011702084,"teacher_disagreement_score":0.014447832,"about_ca_system_score_codex":0.00043067653,"about_ca_system_score_gemma":0.0009920846,"threshold_uncertainty_score":0.04833281},"labels":[],"label_agreement":null},{"id":"W2951516539","doi":"10.1002/chin.200519063","title":"A Convenient Method of the Conversion of Hindered Carboxylic Acids to N‐Methoxy‐N‐methyl (Weinreb) Amides.","year":2005,"lang":"en","type":"article","venue":"ChemInform","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Chemistry; Citation; Library science; Stereochemistry; Computer science","score_opus":0.022171263548899648,"score_gpt":0.33331651534491985,"score_spread":0.3111452517960202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951516539","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27892068,0.021275593,0.6028714,0.0009110854,0.001740545,0.002442282,0.0058583166,0.0048527727,0.08112733],"genre_scores_gemma":[0.7667791,0.01740393,0.15375647,0.0006179646,0.00019941875,0.0017370032,0.00589846,0.00051010563,0.053097513],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997036,0.00005158434,0.000025812875,0.00008793238,0.00006903958,0.00006206459],"domain_scores_gemma":[0.9998629,0.000018752888,0.000036341913,0.000043921707,0.000016004105,0.000022024225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045271055,0.000938238,0.00033392917,0.00056777144,0.00036072123,0.00030565387,0.0008429503,0.0005130292,0.004974541],"category_scores_gemma":[0.0004274564,0.00037687313,0.00037132046,0.0003986548,0.00028094955,0.0005242684,0.00061816117,0.0012073461,0.0040256316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012969747,0.00014084353,0.00015486543,0.000614,0.000053987165,0.0004675028,0.000099448655,0.00049818546,0.955661,0.0029559713,0.0038752796,0.035349254],"study_design_scores_gemma":[0.00005007404,0.00052132737,0.00064553716,0.000026586766,0.000035509434,0.0015426229,0.000020269053,0.0007054477,0.936792,0.00042981666,0.059187997,0.00004277863],"about_ca_topic_score_codex":0.0006879252,"about_ca_topic_score_gemma":0.0019205031,"teacher_disagreement_score":0.004974541,"about_ca_system_score_codex":0.0003358883,"about_ca_system_score_gemma":0.00069684966,"threshold_uncertainty_score":0.016641498},"labels":[],"label_agreement":null},{"id":"W2951793178","doi":"10.1139/v03-086","title":"Synthetic studies related to CP-225,917","year":2003,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chemistry; Cope rearrangement; Furan; Ruthenium; Core (optical fiber); Olefin fiber; Stereochemistry; Strain (injury); Combinatorial chemistry; Organic chemistry; Catalysis; Internal medicine","score_opus":0.022384864914018043,"score_gpt":0.31641641560383993,"score_spread":0.2940315506898219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951793178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.942302,0.002682079,0.0160421,0.0005293012,0.00018766879,0.0013517437,0.001947131,0.00015941892,0.034798503],"genre_scores_gemma":[0.9683005,0.004814945,0.012687282,0.00029508982,0.00006062451,0.00043068436,0.0018107535,0.000060350732,0.01153979],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980074,0.00004400811,0.000016032101,0.000029821145,0.000056190423,0.00005318729],"domain_scores_gemma":[0.99987817,0.000021471114,0.000021083737,0.000023018167,0.000027102044,0.000029153965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004044674,0.0003974794,0.00033135852,0.00029344557,0.000466562,0.00021384534,0.00055096624,0.00036510258,0.0031414605],"category_scores_gemma":[0.00036044655,0.00013453505,0.00033472027,0.00035672213,0.00033092257,0.00040894092,0.0002981716,0.00080780295,0.00094636757],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008107324,0.0005034889,0.0002511312,0.0005262607,0.000041349107,0.0011067552,0.000272228,0.0021399152,0.96537393,0.0035977322,0.0011562465,0.024220305],"study_design_scores_gemma":[0.0002377096,0.0055636363,0.0010636466,0.000027823804,0.00006825689,0.001329093,0.000115708965,0.00064299034,0.9629183,0.0005693212,0.027415575,0.00004791032],"about_ca_topic_score_codex":0.001149421,"about_ca_topic_score_gemma":0.0010807228,"teacher_disagreement_score":0.0031414605,"about_ca_system_score_codex":0.00034313573,"about_ca_system_score_gemma":0.0005879825,"threshold_uncertainty_score":0.010509253},"labels":[],"label_agreement":null},{"id":"W2951832268","doi":"10.1515/znb-2008-0814","title":"A New pseudo-Alkaloid Taxane and a New Rearranged Taxane from the Needles of Taxus canadensis","year":2008,"lang":"en","type":"article","venue":"Zeitschrift für Naturforschung B","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"Hebei Medical University","keywords":"Taxane; Chemistry; Stereochemistry; Double bond; Taxus; Tetrahydrofuran; Botany; Biology; Organic chemistry","score_opus":0.026863947021318658,"score_gpt":0.2886093429611346,"score_spread":0.26174539593981594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951832268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874368,0.0046046427,0.0019032076,0.00009453039,0.000049546325,0.000067571425,0.0020956967,0.00004178303,0.003706265],"genre_scores_gemma":[0.9740606,0.0041282075,0.00752523,0.00011096527,0.000029992974,0.00003948168,0.0052066045,0.000018175115,0.008880707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999639,0.0000022655263,0.0000031886152,0.000014208521,0.000010478875,0.000005989554],"domain_scores_gemma":[0.999938,0.0000052958994,0.000011514565,0.000007729024,0.0000150957085,0.000022223374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000028193528,0.0002621918,0.00018132021,0.00046393127,0.0002848328,0.000208575,0.00016410688,0.00027588027,0.0017507485],"category_scores_gemma":[0.00007482374,0.00010047285,0.00019227057,0.00038765548,0.00022770806,0.00033189476,0.00016885083,0.00034640267,0.00036947054],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001637123,0.000015639895,0.00080961664,0.000100239806,0.00000870536,0.0004424062,0.00007237126,0.00008311907,0.9908428,0.00013606103,0.000044784247,0.0072805523],"study_design_scores_gemma":[0.00023596776,0.0018966242,0.15761949,0.00009400245,0.0002679665,0.012294837,0.0010893717,0.0013246192,0.6839295,0.0012380464,0.13987584,0.0001337481],"about_ca_topic_score_codex":0.0028945394,"about_ca_topic_score_gemma":0.006529638,"teacher_disagreement_score":0.0028945394,"about_ca_system_score_codex":0.0002901495,"about_ca_system_score_gemma":0.00038696764,"threshold_uncertainty_score":0.005856812},"labels":[],"label_agreement":null},{"id":"W2951978011","doi":"10.1515/znb-2015-0074","title":"Two new taxane-glycosides from the needles of <i>Taxus canadensis</i>","year":2015,"lang":"en","type":"article","venue":"Zeitschrift für Naturforschung B","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Japan Society for the Promotion of Science; Natural Science Foundation of Hebei Province; Youth Foundation of Hebei Educational Committee; Hebei Medical University; National Natural Science Foundation of China","keywords":"Taxane; Glycoside; Taxus; Chemistry; Stereochemistry; High resolution; Diterpene; Fast atom bombardment; Mass spectrometry; Botany; Chromatography; Biology; Geography","score_opus":0.034653872556819336,"score_gpt":0.3348569677313767,"score_spread":0.30020309517455734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951978011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872084,0.0028869223,0.001428051,0.0001039812,0.000042653613,0.00008392754,0.0020888974,0.000037289887,0.0061198086],"genre_scores_gemma":[0.97979647,0.00345822,0.004307929,0.00013976645,0.00003950445,0.00004006874,0.004430297,0.000018956649,0.0077688317],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999788,0.0000015834237,0.0000015309032,0.0000060462426,0.0000067543274,0.0000052270957],"domain_scores_gemma":[0.9999243,0.0000055188066,0.000015053753,0.0000047296876,0.000014436835,0.000036019344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000026981625,0.0005051365,0.00017881455,0.00059894845,0.00030494368,0.00024473653,0.00014521532,0.00022069094,0.001626508],"category_scores_gemma":[0.000058390797,0.00010458447,0.00024016037,0.00047772314,0.00019233239,0.00023740565,0.00014033337,0.00049190986,0.0003069054],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015503836,0.000025161311,0.0008875481,0.00009026076,0.000014633166,0.00027832194,0.000043649412,0.00007721737,0.99263567,0.00008993433,0.000058050908,0.005644578],"study_design_scores_gemma":[0.00016385877,0.0014783212,0.14906481,0.00008354207,0.00029056423,0.0022816623,0.0006338177,0.0008818893,0.79587436,0.00067777035,0.048497774,0.00007161034],"about_ca_topic_score_codex":0.0031481723,"about_ca_topic_score_gemma":0.00534071,"teacher_disagreement_score":0.0031481723,"about_ca_system_score_codex":0.00025291392,"about_ca_system_score_gemma":0.00033958122,"threshold_uncertainty_score":0.00625968},"labels":[],"label_agreement":null},{"id":"W2952638306","doi":"10.1002/chin.200429166","title":"First Three Examples of Taxane‐Derived Di‐propellanes in Taxus canadensis Needles.","year":2004,"lang":"en","type":"article","venue":"ChemInform","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Armand Frappier Museum","funders":"","keywords":"Chemistry; Taxane; Taxus; Stereochemistry; Botany","score_opus":0.028090808818259313,"score_gpt":0.2653163155665519,"score_spread":0.23722550674829257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952638306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80433965,0.0153456,0.019697094,0.0011817203,0.00088299403,0.0005405665,0.018740768,0.001135412,0.13813609],"genre_scores_gemma":[0.8979171,0.0049034823,0.014047352,0.0004525846,0.00004789598,0.000099920944,0.008570521,0.00008937997,0.07387189],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999926,0.0000033134866,0.0000028893082,0.000015180544,0.000024951674,0.000027723541],"domain_scores_gemma":[0.9998627,0.000025695741,0.00002366945,0.000017914923,0.000021427048,0.000048560585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000398353,0.00034570147,0.00014413337,0.0006213064,0.0004820622,0.00027379894,0.00038405732,0.0005715074,0.009972906],"category_scores_gemma":[0.00010126706,0.00012538461,0.0003664063,0.00048473815,0.000312454,0.00033070083,0.0004266676,0.0011280285,0.0019236276],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040536816,0.00007596353,0.0006675798,0.0002179134,0.000022697419,0.0016137401,0.000084601954,0.0004592258,0.98076576,0.0016324688,0.0011845864,0.012870189],"study_design_scores_gemma":[0.00006606718,0.00097339123,0.022296952,0.00007050315,0.0000655526,0.002293725,0.00054003054,0.0012182955,0.85365474,0.0027490293,0.11600565,0.000066129454],"about_ca_topic_score_codex":0.0045606554,"about_ca_topic_score_gemma":0.009135634,"teacher_disagreement_score":0.99543935,"about_ca_system_score_codex":0.0004400132,"about_ca_system_score_gemma":0.00029157486,"threshold_uncertainty_score":0.033362687},"labels":[],"label_agreement":null},{"id":"W2952693279","doi":"10.1139/v99-240","title":"A new short synthetic approach to chlorocyclopentenones related to cryptosporiopsin via a ring expansion strategy: first synthesis of a fungitoxic metabolite from <i>Sporormia affinis</i>","year":2000,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chemistry; Cycloaddition; Stereochemistry; Metabolite; Cyclopentene; Ring (chemistry); Yield (engineering); Total synthesis; Claisen rearrangement; Organic chemistry; Catalysis","score_opus":0.011236229308644171,"score_gpt":0.23876528724434778,"score_spread":0.2275290579357036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952693279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8812472,0.007680013,0.08455245,0.00048860104,0.00039935237,0.000735467,0.0012763429,0.00055307645,0.023067536],"genre_scores_gemma":[0.94915694,0.0047088093,0.03871055,0.00015575769,0.00005622479,0.0001682232,0.0007860948,0.000038607814,0.006218759],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999304,0.000009713895,0.000008081291,0.000016753178,0.00001352897,0.000021621561],"domain_scores_gemma":[0.99993634,0.0000087250955,0.000014345425,0.000008762412,0.000010422365,0.00002145832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011173233,0.0005231742,0.00021972532,0.00017960418,0.00017639546,0.00014889569,0.00026920773,0.00027046652,0.0017299833],"category_scores_gemma":[0.00008785977,0.00013470011,0.00024549724,0.00016444805,0.00017478666,0.00025822764,0.00027494706,0.000495569,0.00050016254],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098773126,0.000056668945,0.00012359742,0.00016780144,0.000009618523,0.0003517628,0.00004813611,0.00032154232,0.98673916,0.000543237,0.00014552672,0.011394161],"study_design_scores_gemma":[0.000054531352,0.0016105508,0.0010985883,0.000009745403,0.00002291552,0.0009665177,0.000037640933,0.00028866928,0.98269135,0.00016536728,0.013037528,0.000016611484],"about_ca_topic_score_codex":0.0003838485,"about_ca_topic_score_gemma":0.0009928175,"teacher_disagreement_score":0.0017299833,"about_ca_system_score_codex":0.0002038489,"about_ca_system_score_gemma":0.00046417522,"threshold_uncertainty_score":0.005787432},"labels":[],"label_agreement":null},{"id":"W2952768401","doi":"10.1002/chin.200007166","title":"ChemInform Abstract: Novel Taxanes from the Needles of Taxus canadensis","year":2000,"lang":"en","type":"article","venue":"ChemInform","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Armand Frappier Museum","funders":"","keywords":"Chemistry; Service (business); World Wide Web; Business; Computer science; Marketing","score_opus":0.022305774250084284,"score_gpt":0.2731788700655872,"score_spread":0.25087309581550293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952768401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62401015,0.112006806,0.01532675,0.0044015376,0.0035604779,0.002403333,0.034251288,0.0018991797,0.20214048],"genre_scores_gemma":[0.7829626,0.05607848,0.011824704,0.0013694349,0.0005051029,0.00019269245,0.02766928,0.00020693748,0.11919072],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999486,0.000003071847,0.0000030106285,0.000010716178,0.000023115772,0.000011512426],"domain_scores_gemma":[0.9999602,0.0000043353466,0.000005229172,0.0000043742025,0.0000085623205,0.000017274571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006199189,0.0008641795,0.00041631906,0.0012079553,0.0005423912,0.0004391389,0.00031390722,0.0004347538,0.018551316],"category_scores_gemma":[0.00012872535,0.00018662734,0.00031033673,0.0007825113,0.00022862348,0.00050333556,0.0004167455,0.0009832788,0.004964303],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010891007,0.00033521606,0.000631947,0.0014551238,0.00010348592,0.0021957825,0.000105155996,0.001403844,0.8373748,0.0021392156,0.014729568,0.13843684],"study_design_scores_gemma":[0.00045849007,0.0028381415,0.008161474,0.00024092656,0.00041865723,0.005373041,0.0001679021,0.0011278096,0.5340075,0.0018318258,0.44528705,0.000087219094],"about_ca_topic_score_codex":0.0029634263,"about_ca_topic_score_gemma":0.0063261366,"teacher_disagreement_score":0.018551316,"about_ca_system_score_codex":0.00042253706,"about_ca_system_score_gemma":0.00056837295,"threshold_uncertainty_score":0.062060356},"labels":[],"label_agreement":null},{"id":"W2952789992","doi":"10.1200/jco.2013.31.15_suppl.5055","title":"Interim safety analysis of a compassionate-use program (CUP) and early-access program (EAP) providing cabazitaxel (Cbz) plus prednisone (P) to patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cabazitaxel; Prostate cancer; Internal medicine; Adverse effect; Docetaxel; Interim analysis; Mitoxantrone; Febrile neutropenia; Surgery; Cancer; Toxicity; Neutropenia; Clinical trial; Chemotherapy; Androgen deprivation therapy","score_opus":0.12189504773126325,"score_gpt":0.48449588118517356,"score_spread":0.3626008334539103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952789992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9659097,0.0021245016,0.0056366213,0.00071153167,0.00018680678,0.003404257,0.011883049,0.0004336515,0.0097098565],"genre_scores_gemma":[0.9834147,0.0003989809,0.0027829392,0.000594393,0.00012186241,0.002065771,0.008006568,0.00004760146,0.002567238],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99797946,0.0011632235,0.00010692754,0.00023513261,0.00027597198,0.0002392008],"domain_scores_gemma":[0.99460113,0.0018147792,0.0015864783,0.00061430375,0.00052225153,0.0008610292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051540677,0.00065390876,0.0008410633,0.00043404443,0.00032856702,0.00106352,0.000619124,0.000854609,0.0053884787],"category_scores_gemma":[0.005945464,0.00029253855,0.0016837216,0.00044130237,0.00042616198,0.00045702743,0.0004010614,0.0013885662,0.00077845866],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73055893,0.017258182,0.04323962,0.0010690183,0.0035857984,0.0005687696,0.00022212161,0.012031469,0.019868797,0.0008866328,0.020905202,0.14980537],"study_design_scores_gemma":[0.093939476,0.7204182,0.12412485,0.00016087957,0.0060542873,0.0015484623,0.00012129129,0.016136566,0.016124118,0.0013085026,0.01997582,0.00008761114],"about_ca_topic_score_codex":0.0005217467,"about_ca_topic_score_gemma":0.000701279,"teacher_disagreement_score":0.0053884787,"about_ca_system_score_codex":0.00096026267,"about_ca_system_score_gemma":0.0017194574,"threshold_uncertainty_score":0.02725768},"labels":[],"label_agreement":null},{"id":"W2952970180","doi":"10.1002/chin.200320204","title":"First Example of a Taxane‐Derived Propellane in Taxus canadensis Needles.","year":2003,"lang":"en","type":"article","venue":"ChemInform","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Armand Frappier Museum","funders":"","keywords":"Chemistry; Taxane; Propellane; Terpene; Stereochemistry; Bicyclic molecule; Internal medicine","score_opus":0.028486562438362777,"score_gpt":0.2651354889410099,"score_spread":0.23664892650264713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952970180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8724579,0.008426244,0.015791805,0.0014481815,0.0009245906,0.00045737196,0.01573799,0.00057324854,0.08418269],"genre_scores_gemma":[0.9089247,0.0027671268,0.0136290975,0.00042610816,0.000055391607,0.00006603832,0.008507982,0.0000724494,0.06555107],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991643,0.000005181275,0.0000029155983,0.000020576841,0.000029549574,0.000025385247],"domain_scores_gemma":[0.99978393,0.000050565202,0.000030481098,0.00002955073,0.000035472105,0.00006992474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050407027,0.00034761464,0.00018508839,0.00067641184,0.00066519337,0.00035662946,0.00040539753,0.000876958,0.0065407585],"category_scores_gemma":[0.00014150442,0.00013292134,0.00039631026,0.000469458,0.00032245004,0.00033160285,0.00061291317,0.0012267043,0.0019041047],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033373857,0.00005804791,0.00081341265,0.00013728211,0.00001854247,0.0033138576,0.0000871222,0.00022587071,0.9867676,0.00071553997,0.00065718684,0.0068717757],"study_design_scores_gemma":[0.00007094316,0.0013374164,0.04138464,0.00008349841,0.00010615202,0.007438128,0.0011541735,0.0013269123,0.83206064,0.0026073367,0.11235803,0.00007218113],"about_ca_topic_score_codex":0.0051567894,"about_ca_topic_score_gemma":0.007953887,"teacher_disagreement_score":0.0065407585,"about_ca_system_score_codex":0.00044964987,"about_ca_system_score_gemma":0.000363382,"threshold_uncertainty_score":0.021880984},"labels":[],"label_agreement":null},{"id":"W2953000066","doi":"10.1002/chin.201340267","title":"ChemInform Abstract: Interactions of Laulimalide, Peloruside, and Their Derivatives with the Isoforms of β‐Tubulin","year":2013,"lang":"en","type":"article","venue":"ChemInform","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chemistry; Tubulin; Gene isoform; Stereochemistry; Microtubule; Computational chemistry; Biochemistry; Cell biology","score_opus":0.016693532007706725,"score_gpt":0.2766161309997846,"score_spread":0.25992259899207787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953000066","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001270344,0.9632896,0.0007300122,0.002148256,0.004578792,0.00005271348,0.00051802484,0.00009850297,0.027313836],"genre_scores_gemma":[0.005673912,0.9518477,0.000514992,0.001494538,0.0015710585,0.000037879825,0.0009138468,0.000018538958,0.037927527],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982613,0.000018501005,0.000012279498,0.000031488475,0.00009308086,0.000018509212],"domain_scores_gemma":[0.9997905,0.00004800982,0.000032595268,0.000007507686,0.00009446219,0.000026900267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004261774,0.0008888211,0.00074743264,0.001191734,0.00038238012,0.0010234899,0.0007955267,0.0010699017,0.021539941],"category_scores_gemma":[0.00049268245,0.00026235537,0.0003394291,0.0014463706,0.00032105984,0.00096457836,0.0006195026,0.0012136406,0.012047779],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026348772,0.00008544801,0.00021678902,0.011390514,0.00011041608,0.00022102884,0.000057115096,0.00050977035,0.014537152,0.0059628645,0.36922365,0.59742177],"study_design_scores_gemma":[0.000023976872,0.00011203326,0.0003788878,0.00064347597,0.0000696692,0.00030132313,0.0000238841,0.000065292166,0.007038467,0.00051385025,0.990815,0.000014151455],"about_ca_topic_score_codex":0.0015243102,"about_ca_topic_score_gemma":0.0027128214,"teacher_disagreement_score":0.021539941,"about_ca_system_score_codex":0.000987099,"about_ca_system_score_gemma":0.0011116978,"threshold_uncertainty_score":0.07205832},"labels":[],"label_agreement":null},{"id":"W2953404073","doi":"10.1158/1538-7445.am2019-3904","title":"Abstract 3904: Pharmacokinetic modeling of serum platinum reveals extent of long-term exposure and associated comorbidities after cisplatin treatment","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cisplatin; Medicine; Pharmacokinetics; Internal medicine; Oncology; Confidence interval; Adverse effect; Chemotherapy; Endocrinology; Urology","score_opus":0.09839875122151723,"score_gpt":0.43082938252517256,"score_spread":0.33243063130365536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953404073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822841,0.00008315699,0.016179686,0.000111672365,0.000005990428,0.000029614848,0.0006635418,0.00009230273,0.0005499882],"genre_scores_gemma":[0.9970777,0.000034552355,0.0018888249,0.00001576628,0.0000033173785,0.000024225772,0.00046255699,0.000016133272,0.00047681204],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.999806,0.000071125476,0.000011513078,0.000058715214,0.00003086797,0.00002180504],"domain_scores_gemma":[0.99904984,0.0005158215,0.00020320641,0.00009601547,0.00009188154,0.000043257383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073497096,0.00026753204,0.00030892625,0.00029919358,0.00012310289,0.000452728,0.00032237105,0.00030712347,0.0017204357],"category_scores_gemma":[0.0037523783,0.0001581211,0.00062841404,0.000322849,0.00015744993,0.00024376147,0.0002690794,0.0003892573,0.00033849038],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007556106,0.0003433501,0.6485478,0.000086021995,0.0003406099,0.00044123412,0.00016286057,0.305163,0.015055861,0.0011476001,0.0012774048,0.026678601],"study_design_scores_gemma":[0.00004271508,0.00042576925,0.17412364,0.000009208256,0.000085648906,0.00045817395,0.000061033137,0.82008237,0.0027812205,0.0010915056,0.0008193259,0.000019374706],"about_ca_topic_score_codex":0.008249242,"about_ca_topic_score_gemma":0.0032887955,"teacher_disagreement_score":0.008249242,"about_ca_system_score_codex":0.00055967754,"about_ca_system_score_gemma":0.00059142784,"threshold_uncertainty_score":0.016402483},"labels":[],"label_agreement":null},{"id":"W2954238247","doi":"10.2147/jpr.s213912","title":"&lt;p&gt;Rational treatment of chemotherapy-induced peripheral neuropathy with capsaicin 8% patch: from pain relief towards disease modification&lt;/p&gt;","year":2019,"lang":"en","type":"article","venue":"Journal of Pain Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Astellas Pharma; Astellas Pharma Europe; Imperial College London; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Capsaicin; Neuropathic pain; Peripheral neuropathy; Anesthesia; Chemotherapy-induced peripheral neuropathy; McGill Pain Questionnaire; Chemotherapy; Peripheral; Neuralgia; Visual analogue scale; Internal medicine","score_opus":0.0697280344784218,"score_gpt":0.37918776645444113,"score_spread":0.30945973197601934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954238247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.850075,0.113103814,0.010242411,0.0057548024,0.0006424573,0.0007474736,0.00033305952,0.00046104673,0.018639933],"genre_scores_gemma":[0.97086674,0.017003,0.006831675,0.000917163,0.00030880392,0.00017066885,0.00021998952,0.000020186091,0.0036618256],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99995446,0.000012780471,0.0000044998,0.0000064396327,0.000012790115,0.00000900206],"domain_scores_gemma":[0.9999542,0.00000793434,0.000016057027,0.000004245067,0.00000918424,0.000008356772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014461672,0.00022813267,0.00022222241,0.00013963607,0.00009131183,0.0001846384,0.00017063555,0.00023532823,0.002117758],"category_scores_gemma":[0.00019328007,0.000055340486,0.00016542153,0.000101290054,0.00020478712,0.00018723171,0.0001177246,0.00045480276,0.0005038235],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052441866,0.0015472005,0.011971475,0.0019048594,0.00008037605,0.0013726129,0.00009730271,0.001407271,0.106426336,0.0010837612,0.011436139,0.8574285],"study_design_scores_gemma":[0.013271499,0.116853796,0.32066843,0.0024178384,0.0010904019,0.03697517,0.00056629843,0.02716369,0.26518965,0.007276792,0.20836245,0.00016404744],"about_ca_topic_score_codex":0.0003424196,"about_ca_topic_score_gemma":0.0004706678,"teacher_disagreement_score":0.002117758,"about_ca_system_score_codex":0.0001428817,"about_ca_system_score_gemma":0.00020379388,"threshold_uncertainty_score":0.007084608},"labels":[],"label_agreement":null},{"id":"W2955206262","doi":"10.1249/01.mss.0000563124.62055.c0","title":"Impact of Aerobic and Resistance Exercise on Global Shoulder Function in Breast Cancer Survivors","year":2019,"lang":"en","type":"article","venue":"Medicine & Science in Sports & Exercise","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Breast cancer; Physical therapy; Dash; Isometric exercise; Aerobic exercise; Randomized controlled trial; Range of motion; Mastectomy; Cancer; Internal medicine","score_opus":0.01361829212379172,"score_gpt":0.33156020032522193,"score_spread":0.3179419082014302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955206262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99826485,0.0011202468,0.000028024418,0.0000689345,0.000013980408,0.00012391608,0.000054369975,0.0000035561563,0.00032228063],"genre_scores_gemma":[0.99828535,0.00086355413,0.0001358638,0.000107667096,0.000024087874,0.00025585678,0.00009419611,8.668876e-7,0.00023263611],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996604,0.00018734156,0.000029379782,0.000028372257,0.000038199298,0.00005626232],"domain_scores_gemma":[0.9995778,0.00015443715,0.000097186836,0.000020515976,0.000025441204,0.00012446506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008081887,0.000299051,0.00046805674,0.00021073932,0.00019386939,0.00017726277,0.00017413821,0.00028535875,0.0020370046],"category_scores_gemma":[0.0011932617,0.000103116276,0.00043132302,0.00021012958,0.00022671046,0.00013373118,0.00027618158,0.00034247478,0.0001412402],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26446787,0.08400136,0.23896861,0.005480644,0.004457783,0.00025688743,0.0008440854,0.0014746868,0.013870488,0.0001394881,0.0015102766,0.38452783],"study_design_scores_gemma":[0.023679206,0.31780037,0.6526801,0.00033899574,0.00148426,0.0001509016,0.00038784576,0.00051919674,0.0014666306,0.00012594336,0.0013481922,0.000018353938],"about_ca_topic_score_codex":0.000764272,"about_ca_topic_score_gemma":0.0014295038,"teacher_disagreement_score":0.0020370046,"about_ca_system_score_codex":0.00011416831,"about_ca_system_score_gemma":0.00034656105,"threshold_uncertainty_score":0.00681448},"labels":[],"label_agreement":null},{"id":"W2955569507","doi":"10.21873/anticanres.13471","title":"A Systematic Review and Meta-analysis of the Combination of Vinorelbine and Lapatinib in Patients With Her2-positive Metastatic Breast Cancer","year":2019,"lang":"en","type":"review","venue":"Anticancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Essar Steel Algoma (Canada); Sault Area Hospital","funders":"","keywords":"Vinorelbine; Lapatinib; Medicine; Metastatic breast cancer; Oncology; Internal medicine; Breast cancer; Cancer; Trastuzumab; Chemotherapy","score_opus":0.15644854051951979,"score_gpt":0.4910211439907729,"score_spread":0.3345726034712531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955569507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018444165,0.99717075,0.00015888926,0.00011523668,0.00006506553,0.00009047551,0.00033185424,0.000008047936,0.00021525742],"genre_scores_gemma":[0.04602476,0.95206547,0.0005972071,0.00038495634,0.00009015967,0.00021558885,0.0004420743,0.000008990847,0.00017073636],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9965939,0.0014602859,0.0010709203,0.00033297276,0.0004256586,0.000116261755],"domain_scores_gemma":[0.99307936,0.004871147,0.0011261795,0.00015405171,0.0006638854,0.00010537705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005283293,0.001543983,0.010396705,0.00458886,0.0004241837,0.0018379854,0.0011903198,0.0011548811,0.0030539872],"category_scores_gemma":[0.012478349,0.00077089795,0.016454063,0.006806371,0.00040758442,0.0010540973,0.0008702223,0.0009909123,0.00026146587],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014938421,0.000029830904,0.0021141744,0.7220971,0.24032786,0.00016680827,0.00007640361,0.00048653773,0.0003321193,0.00018179572,0.0015943368,0.031099143],"study_design_scores_gemma":[0.00055297586,0.0002603277,0.005095645,0.06623686,0.92048126,0.00021613315,0.000053160282,0.00018989378,0.00018619729,0.00026442096,0.0064321067,0.00003108768],"about_ca_topic_score_codex":0.006492928,"about_ca_topic_score_gemma":0.016951546,"teacher_disagreement_score":0.010396705,"about_ca_system_score_codex":0.0018062209,"about_ca_system_score_gemma":0.0035600387,"threshold_uncertainty_score":0.027941048},"labels":[],"label_agreement":null},{"id":"W2956136764","doi":"10.1158/1538-7445.am2019-1282","title":"Abstract 1282: Understanding the kinomic contributions to tyrosine kinase inhibitor resistance in triple negative breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cabozantinib; Erlotinib; Triple-negative breast cancer; Cancer research; Epidermal growth factor receptor; EGFR inhibitors; Kinome; Receptor tyrosine kinase; Tyrosine-kinase inhibitor; Cancer; Tyrosine kinase; Medicine; Pharmacology; Breast cancer; Kinase; Biology; Internal medicine; Receptor; Cell biology","score_opus":0.08987593085900725,"score_gpt":0.4458685232074839,"score_spread":0.35599259234847663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956136764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94801754,0.04133659,0.003135647,0.0012513126,0.00006709115,0.000051573294,0.0006856225,0.000049878647,0.0054046754],"genre_scores_gemma":[0.9830194,0.012452579,0.0012082248,0.00021071071,0.00004962897,0.00002304581,0.0005028868,0.0000052416162,0.002528132],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999583,0.000005654682,0.0000026508976,0.000007663124,0.000014217061,0.000011593584],"domain_scores_gemma":[0.99996686,0.000004869757,0.000012220405,0.0000014792578,0.0000074292752,0.000007168087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014733901,0.00024597804,0.00026350372,0.00024771516,0.000102608086,0.00040872907,0.00017933037,0.00030019908,0.0018439904],"category_scores_gemma":[0.00009270862,0.00009520333,0.00018405727,0.00015942824,0.00013074212,0.00037074482,0.00014781747,0.00048159232,0.00033513375],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006743048,0.000120079894,0.0040131765,0.00052358065,0.000027425724,0.0003095651,0.000054957607,0.00063623575,0.9699981,0.00040877715,0.0005659961,0.022667801],"study_design_scores_gemma":[0.00014323648,0.0025521251,0.24234334,0.00021435495,0.00021887537,0.0070281094,0.0004899923,0.012521017,0.702101,0.0025535286,0.029790979,0.000043459233],"about_ca_topic_score_codex":0.0008835298,"about_ca_topic_score_gemma":0.0009568303,"teacher_disagreement_score":0.0018439904,"about_ca_system_score_codex":0.0004221013,"about_ca_system_score_gemma":0.00020346149,"threshold_uncertainty_score":0.0061687827},"labels":[],"label_agreement":null},{"id":"W2956139542","doi":"10.1016/j.clbc.2019.05.013","title":"Effect of Exercise on Taxane Chemotherapy–Induced Peripheral Neuropathy in Women With Breast Cancer: A Randomized Controlled Trial","year":2019,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of Alberta; University of British Columbia","funders":"University of British Columbia","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Taxane; Breast cancer; Randomized controlled trial; Oncology; Peripheral neuropathy; Internal medicine; Chemotherapy; Cancer; Physical therapy; Endocrinology; Diabetes mellitus","score_opus":0.011403874610716057,"score_gpt":0.355187699852125,"score_spread":0.34378382524140894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956139542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97780675,0.012590171,0.0007771736,0.0010575559,0.0011008888,0.0036460583,0.0007862814,0.00009319774,0.0021418226],"genre_scores_gemma":[0.98526114,0.005739993,0.0009896111,0.0011235151,0.0007351445,0.0030708106,0.0005556395,0.000014606099,0.0025095742],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992292,0.00038941958,0.000064613094,0.00016162203,0.000041998137,0.000113199836],"domain_scores_gemma":[0.9989504,0.00040084915,0.00023012597,0.000082387895,0.00006680144,0.00026951885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013645678,0.0017318414,0.0035908972,0.00043359553,0.00063334784,0.00091686606,0.0009899782,0.0026753866,0.008346002],"category_scores_gemma":[0.002300141,0.0008342309,0.0025532076,0.0005718711,0.0014743353,0.0010592297,0.00058371143,0.003227607,0.0007465311],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9873246,0.0037520686,0.00045337965,0.0008549724,0.0014342775,0.000021102296,0.000023693729,0.00010741945,0.0005323418,0.000039040144,0.00020992351,0.00524722],"study_design_scores_gemma":[0.9586309,0.037185732,0.0018896353,0.00008018869,0.0015540434,0.000012106531,0.000024894469,0.00016116309,0.00009389055,0.000078209014,0.000278629,0.000010625378],"about_ca_topic_score_codex":0.0019133223,"about_ca_topic_score_gemma":0.0028941184,"teacher_disagreement_score":0.008346002,"about_ca_system_score_codex":0.000673815,"about_ca_system_score_gemma":0.00083925563,"threshold_uncertainty_score":0.027920127},"labels":[],"label_agreement":null},{"id":"W2956941920","doi":"10.5430/jnep.v9n10p29","title":"Chemotherapy-induced peripheral neuropathy and its association with quality of life among cancer patients","year":2019,"lang":"en","type":"article","venue":"Journal of Nursing Education and Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Quality of life (healthcare); Cancer; Chemotherapy; Internal medicine; Complication; Physical therapy; Diabetes mellitus","score_opus":0.05768906473336144,"score_gpt":0.4372225270331339,"score_spread":0.3795334622997725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956941920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99732095,0.0012832913,0.000048211183,0.00014571143,0.000008697985,0.000017113298,0.00022898674,0.0000015491888,0.00094538735],"genre_scores_gemma":[0.99937147,0.0003119542,0.000049063223,0.00003057121,0.000005607384,0.00000923046,0.00011930377,3.996728e-7,0.00010248167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995377,0.00013014712,0.00007942059,0.000050869425,0.00013570924,0.00006616659],"domain_scores_gemma":[0.9982541,0.00036126978,0.00093579036,0.00003344593,0.00021148317,0.00020386491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048510288,0.00008601172,0.00018295652,0.00045246724,0.0002732109,0.00039315055,0.0001342174,0.00019156716,0.0020408556],"category_scores_gemma":[0.0027642616,0.00006106514,0.0002578837,0.0007071276,0.00015338298,0.0002512306,0.00032264285,0.00035069627,0.000105413485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055891767,0.000082959676,0.99559987,0.00006141479,0.000033404656,0.000052962805,0.00012619788,0.000030236753,0.00007171917,0.000016192564,0.00014428864,0.0037248605],"study_design_scores_gemma":[0.0000039406887,0.00021123787,0.99862075,0.00003606211,0.000024331968,0.00030094132,0.00032891607,0.0000811824,0.000037804086,0.000030942487,0.0003207334,0.0000031526413],"about_ca_topic_score_codex":0.0010331962,"about_ca_topic_score_gemma":0.001842854,"teacher_disagreement_score":0.0020408556,"about_ca_system_score_codex":0.00025473352,"about_ca_system_score_gemma":0.0002837459,"threshold_uncertainty_score":0.0068273544},"labels":[],"label_agreement":null},{"id":"W2962866878","doi":"10.1177/1545968319860486","title":"Neuropathic Pain in Taxane-Induced Peripheral Neuropathy: Evidence for Exercise in Treatment","year":2019,"lang":"en","type":"review","venue":"Neurorehabilitation and neural repair","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Peripheral neuropathy; Taxane; Neuropathic pain; Breast cancer; Adverse effect; Cancer; Oncology; Internal medicine; Anesthesia; Diabetes mellitus; Endocrinology","score_opus":0.17973320562789144,"score_gpt":0.44013948205369635,"score_spread":0.26040627642580494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962866878","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000071544804,0.9991406,0.000029888264,0.00019874165,0.000094654104,0.00000243446,0.000008617824,0.0000024009266,0.00045104933],"genre_scores_gemma":[0.00051523757,0.9990181,0.00006371035,0.0001519274,0.00007822984,0.0000039752417,0.000011901973,6.6096635e-7,0.00015635235],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99983716,0.000037152753,0.00003214524,0.000029661916,0.000051404015,0.000012464353],"domain_scores_gemma":[0.99960357,0.00025978428,0.000049397528,0.000008027975,0.00005977683,0.000019314615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005085316,0.0005244921,0.0012654273,0.0014639818,0.00020959771,0.00084708416,0.0007206313,0.0010238761,0.0052623698],"category_scores_gemma":[0.00082286884,0.00017889641,0.0006989654,0.0013318171,0.00039719,0.0007195899,0.00053463626,0.0015240278,0.001079701],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013234235,0.00007995362,0.00017375367,0.032413855,0.00015418726,0.00011718925,0.00005157003,0.00017345729,0.0005256948,0.0026235757,0.016131036,0.9474234],"study_design_scores_gemma":[0.000098056174,0.00027791975,0.0025451258,0.033326346,0.00051867164,0.0015767488,0.00011773239,0.00015838185,0.00031186655,0.0033317532,0.9577084,0.000028950319],"about_ca_topic_score_codex":0.001205933,"about_ca_topic_score_gemma":0.002403379,"teacher_disagreement_score":0.0052623698,"about_ca_system_score_codex":0.00042839156,"about_ca_system_score_gemma":0.0007681227,"threshold_uncertainty_score":0.01760441},"labels":[],"label_agreement":null},{"id":"W2963208685","doi":"10.1200/jco.2006.24.18_suppl.3564","title":"Patient-reported neurotoxicity with FULV versus FLOX in patients with stage II or III carcinoma of the colon: Results of NSABP Protocol C-07","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Oxaliplatin; Neurotoxicity; Internal medicine; Bolus (digestion); Gastroenterology; Colorectal cancer; Logistic regression; Surgery; Cancer; Toxicity","score_opus":0.09326442666147912,"score_gpt":0.4403192307235135,"score_spread":0.34705480406203437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963208685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997001,0.00043520302,0.00018359629,0.00016228961,0.000013643164,0.001187429,0.0005457909,0.000008749388,0.000462168],"genre_scores_gemma":[0.99363166,0.00045565164,0.0007636775,0.00026728172,0.000045040644,0.003101365,0.0013172419,0.0000063676734,0.00041178596],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9969152,0.0025205335,0.0001670262,0.00009170201,0.00016471201,0.00014083796],"domain_scores_gemma":[0.996824,0.0014323879,0.0007716139,0.00022014286,0.00018263787,0.0005692374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00601443,0.0003984267,0.0010024899,0.00035816475,0.00052323577,0.0004936831,0.00049755484,0.00073178473,0.0014643052],"category_scores_gemma":[0.0063322303,0.00023873852,0.0013177526,0.00045783803,0.00056270347,0.00037659748,0.00044890319,0.00093875977,0.00015940513],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87544787,0.015037607,0.052925363,0.00042473784,0.0014912161,0.00013349084,0.00025468974,0.0031120945,0.0035402924,0.00012183308,0.001577068,0.04593373],"study_design_scores_gemma":[0.24849841,0.58482254,0.15682578,0.00011695818,0.0013730052,0.00023354265,0.00014868777,0.0021416084,0.003079236,0.00025544994,0.0024571149,0.00004762796],"about_ca_topic_score_codex":0.0012805344,"about_ca_topic_score_gemma":0.0027728716,"teacher_disagreement_score":0.00601443,"about_ca_system_score_codex":0.0012007917,"about_ca_system_score_gemma":0.0020929738,"threshold_uncertainty_score":0.03180778},"labels":[],"label_agreement":null},{"id":"W2964348195","doi":"10.1200/jco.2006.24.18_suppl.10063","title":"Active <i>c</i>-Src has prognostic and therapeutic value in ER-negative breast cancer","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Proto-oncogene tyrosine-protein kinase Src; Oncology; Internal medicine; Tissue microarray; Trastuzumab; Immunohistochemistry; Chemotherapy; Grading (engineering); Tamoxifen; Immunostaining; Cancer; Pathology; Receptor","score_opus":0.12691142869742486,"score_gpt":0.48829145841286997,"score_spread":0.36138002971544514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964348195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998847,0.00062371185,0.00006604934,0.000041256888,0.000004076435,0.000003952234,0.00010365801,0.0000032754544,0.0003070644],"genre_scores_gemma":[0.9995054,0.0001606079,0.000067582,0.0000071427426,0.000011518851,0.000003259015,0.00017430665,8.081836e-7,0.000069294605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989486,0.000021160371,0.000013013969,0.00001976668,0.000020997402,0.000030262136],"domain_scores_gemma":[0.9992453,0.00020024173,0.00026051668,0.000034313693,0.00008874266,0.0001709824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040680575,0.0001689892,0.00020109542,0.00050568715,0.00022072859,0.00034606946,0.0001804081,0.00030131618,0.0012787929],"category_scores_gemma":[0.0010877951,0.000096896445,0.00016471797,0.00059892645,0.0002421414,0.00018539043,0.000159947,0.0002737253,0.00021870658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005797253,0.00002540528,0.99296534,0.000011356332,0.000016118207,0.00015160198,0.000021313095,0.00007038304,0.0016772293,0.000007800219,0.000100645164,0.00437313],"study_design_scores_gemma":[0.000011052338,0.00012601196,0.9979279,0.000003910668,0.00002583494,0.0009476448,0.000033108747,0.0002318579,0.0004010247,0.000021584849,0.00026762582,0.000002422],"about_ca_topic_score_codex":0.00092613767,"about_ca_topic_score_gemma":0.0014795907,"teacher_disagreement_score":0.0012787929,"about_ca_system_score_codex":0.00026137067,"about_ca_system_score_gemma":0.00015184208,"threshold_uncertainty_score":0.0042779446},"labels":[],"label_agreement":null},{"id":"W2964521989","doi":"10.1200/jco.2009.27.15_suppl.9607","title":"The predictive accuracy of survival between patient-reported versus clinician-reported pain in a cohort of 1,214 patients with metastatic cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cancer; Cohort; Prostate cancer; Breast cancer; Cancer pain; Logistic regression; Wilcoxon signed-rank test; Internal medicine; Performance status; Colorectal cancer; Randomized controlled trial; Lung cancer; Physical therapy; Mann–Whitney U test","score_opus":0.14912415074415636,"score_gpt":0.5031426434159173,"score_spread":0.35401849267176094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964521989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7290654,0.26270267,0.002412275,0.0006173342,0.00041663466,0.0002514944,0.003279765,0.00006744333,0.0011869858],"genre_scores_gemma":[0.99121195,0.006896945,0.00044650518,0.00017126864,0.00011297474,0.000115862735,0.0009135238,0.000012458484,0.000118510165],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9805288,0.012883964,0.00254683,0.0023386234,0.0014076272,0.0002940457],"domain_scores_gemma":[0.94322866,0.043134883,0.00817206,0.0035295621,0.0015807053,0.0003541368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030720696,0.0010420325,0.0043233554,0.0015495,0.00044047568,0.0020017447,0.0014468548,0.0014179292,0.0010035296],"category_scores_gemma":[0.05070092,0.00085892394,0.017094232,0.00220089,0.00055822026,0.00091204135,0.0007808294,0.0012936625,0.00013718252],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037235435,0.00010581456,0.3909802,0.007909752,0.54553366,0.00017030966,0.00016880181,0.0018823161,0.0005240167,0.00012150214,0.0006378812,0.014730239],"study_design_scores_gemma":[0.005798057,0.0034717238,0.33269215,0.0016555513,0.6497987,0.00039933043,0.00015050947,0.0033333218,0.0005557059,0.0005589039,0.0015068591,0.00007926195],"about_ca_topic_score_codex":0.0028915382,"about_ca_topic_score_gemma":0.0031483353,"teacher_disagreement_score":0.030720696,"about_ca_system_score_codex":0.00061895844,"about_ca_system_score_gemma":0.0004930412,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W2964631730","doi":"10.1200/jco.2013.31.15_suppl.e13013","title":"Using ANG4043, a brain-penetrant anti-HER2 mab, to increase survival in a murine intracranial breast tumor model.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Angiochem (Canada)","funders":"","keywords":"Transcytosis; Medicine; Brain tumor; Blood–brain barrier; Radioimmunotherapy; Receptor; Breast cancer; LRP1; Cancer research; Human brain; Monoclonal antibody; Internal medicine; Pharmacology; Immunology; Antibody; Pathology; Central nervous system; Cancer; Lipoprotein; LDL receptor","score_opus":0.14273372103139548,"score_gpt":0.4914529120257182,"score_spread":0.34871919099432275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964631730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949911,0.0010426475,0.0015983429,0.00013343674,0.00004767149,0.000099823475,0.0005072801,0.00013218183,0.0014475059],"genre_scores_gemma":[0.991742,0.00096322777,0.0037262212,0.000072463336,0.00001677791,0.00009679776,0.0006756609,0.000027639237,0.0026792446],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987745,0.000020598382,0.0000074864456,0.00002544053,0.00002967358,0.000039322353],"domain_scores_gemma":[0.999899,0.000018876513,0.000038701743,0.0000074472136,0.000009440323,0.000026488038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019866115,0.000496763,0.00027118227,0.00036726435,0.00011943162,0.00020755215,0.0002340481,0.00042825396,0.0008673452],"category_scores_gemma":[0.00007124018,0.00013660452,0.0002243691,0.00020222082,0.00022229699,0.00018870296,0.00010222438,0.0006441446,0.00022852715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003450836,0.00022421133,0.0001281387,0.00003793553,0.0000073252563,0.000051442512,0.000017451732,0.00016763595,0.99700826,0.000060586353,0.00014115688,0.0018107039],"study_design_scores_gemma":[0.0001026006,0.0038386388,0.0019915744,0.0000066144976,0.00002821818,0.0002939903,0.0000151304,0.0010478039,0.99074286,0.000024272478,0.0019027648,0.0000055092173],"about_ca_topic_score_codex":0.0010784186,"about_ca_topic_score_gemma":0.0018180558,"teacher_disagreement_score":0.0010784186,"about_ca_system_score_codex":0.00036835042,"about_ca_system_score_gemma":0.0002483776,"threshold_uncertainty_score":0.002901554},"labels":[],"label_agreement":null},{"id":"W2964957864","doi":"10.1007/s10549-019-05360-3","title":"A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancer","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; Genentech; F. Hoffmann-La Roche","keywords":"Docetaxel; Taxane; Paclitaxel; Medicine; Adverse effect; Breast cancer; Lung cancer; Cancer; Metastatic breast cancer; Internal medicine; Pharmacology; Oncology","score_opus":0.05230859694138998,"score_gpt":0.42508213895852676,"score_spread":0.37277354201713675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964957864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99439925,0.0008869108,0.0005378342,0.0003147675,0.0001263126,0.0015403243,0.00075225177,0.00009940236,0.001342814],"genre_scores_gemma":[0.9899346,0.0013535155,0.0016764993,0.0007356158,0.00019199734,0.0017132622,0.0015314021,0.000054976586,0.00280816],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993549,0.00028269735,0.000025304345,0.0001335085,0.000061927196,0.0001417306],"domain_scores_gemma":[0.99903655,0.00012458868,0.00018097734,0.00013263106,0.000048961258,0.0004763339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015718709,0.0019616578,0.0029864758,0.00077234383,0.0005452714,0.0013040426,0.0010457988,0.001405199,0.003869422],"category_scores_gemma":[0.0011181117,0.0010590471,0.0016686933,0.0008766956,0.0018838313,0.0015239931,0.00042425303,0.005699364,0.0010721122],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7932309,0.107324906,0.0032393457,0.00040938327,0.0011428375,0.00013255894,0.00030083835,0.0027384814,0.03167188,0.00034862215,0.0023644452,0.05709579],"study_design_scores_gemma":[0.56852454,0.41939783,0.0058088847,0.000018128101,0.00035057237,0.00014210123,0.00006448981,0.0012551576,0.0025019336,0.00022488837,0.001675439,0.00003598989],"about_ca_topic_score_codex":0.0017529199,"about_ca_topic_score_gemma":0.0040710713,"teacher_disagreement_score":0.003869422,"about_ca_system_score_codex":0.001495374,"about_ca_system_score_gemma":0.0022690042,"threshold_uncertainty_score":0.01294446},"labels":[],"label_agreement":null},{"id":"W2965042402","doi":"10.1200/jco.2012.30.15_suppl.3082","title":"A phase I study of R04929097, an oral gamma secretase inhibitor, in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gemcitabine; Tolerability; Nausea; Vomiting; Internal medicine; Pharmacokinetics; Gastroenterology; Adverse effect; Toxicity; Oncology; Pharmacology; Cancer","score_opus":0.07258309049514548,"score_gpt":0.4835584636050948,"score_spread":0.4109753731099493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965042402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98992366,0.00198263,0.00063006685,0.00049213006,0.00012976064,0.0033798912,0.0012181011,0.00013173734,0.0021119867],"genre_scores_gemma":[0.9851527,0.002345604,0.0021296937,0.0009575011,0.00018854586,0.0033868433,0.002961819,0.00004603309,0.0028313007],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99951494,0.00020831854,0.000028989005,0.00009711013,0.00005036484,0.000100317506],"domain_scores_gemma":[0.9993186,0.000088493514,0.00012828504,0.000057117613,0.000028500677,0.00037903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011857947,0.0018108848,0.00252474,0.00067855965,0.0004178219,0.0012355931,0.0013317321,0.0014369012,0.003737332],"category_scores_gemma":[0.00087686564,0.0007775298,0.0012452068,0.0006526125,0.0010777357,0.0010580729,0.0004495547,0.003633728,0.0011949001],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.67298704,0.13506961,0.0060421936,0.0011463423,0.0015651094,0.0006120356,0.00048370176,0.004084228,0.065789245,0.0004400718,0.005887208,0.10589316],"study_design_scores_gemma":[0.4751501,0.51003665,0.007230557,0.00003300589,0.0003763978,0.00033756573,0.00007036524,0.0011807679,0.0030508423,0.00015451467,0.002348082,0.000031155734],"about_ca_topic_score_codex":0.0012264234,"about_ca_topic_score_gemma":0.0028626975,"teacher_disagreement_score":0.003737332,"about_ca_system_score_codex":0.0011459214,"about_ca_system_score_gemma":0.0019638427,"threshold_uncertainty_score":0.012502611},"labels":[],"label_agreement":null},{"id":"W2965053910","doi":"10.1200/jco.2012.30.15_suppl.8587","title":"A phase II, multicenter, open-label study of YM155 plus docetaxel in subjects with stage III (unresectable) or stage IV melanoma.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Docetaxel; Medicine; Tolerability; Clinical endpoint; Internal medicine; Phases of clinical research; Oncology; Melanoma; Gastroenterology; Survivin; Survival rate; Progression-free survival; Surgery; Chemotherapy; Adverse effect; Clinical trial; Cancer; Cancer research","score_opus":0.28348017463377767,"score_gpt":0.5572430561771021,"score_spread":0.27376288154332445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965053910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908931,0.001842717,0.0005618199,0.00029550766,0.00021068387,0.0039214618,0.0008139526,0.00008743948,0.0013731862],"genre_scores_gemma":[0.9866152,0.0019026936,0.0015060182,0.00097106746,0.0003291286,0.00356034,0.0016769504,0.000029199571,0.003409335],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995179,0.00024908606,0.000021722182,0.00008069308,0.000036469373,0.000094150295],"domain_scores_gemma":[0.9993482,0.00009143758,0.00011200153,0.00003766854,0.000045178545,0.0003654724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018242777,0.0018059363,0.0024337324,0.00053922134,0.00051561475,0.000827542,0.00094841886,0.0010999595,0.004313396],"category_scores_gemma":[0.00095808954,0.00080468104,0.0009854406,0.0004327614,0.00093867973,0.0007878401,0.00034230013,0.0024489593,0.001381118],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80990213,0.09513813,0.0075174947,0.0008237037,0.0011318336,0.0003085974,0.0003994545,0.001214135,0.026867298,0.00017731721,0.003781249,0.05273864],"study_design_scores_gemma":[0.6178979,0.3677035,0.010314387,0.00002650936,0.00034557268,0.00011547462,0.0000610153,0.0005877636,0.001190664,0.00009132346,0.0016464404,0.000019402634],"about_ca_topic_score_codex":0.0014984908,"about_ca_topic_score_gemma":0.0034101754,"teacher_disagreement_score":0.004313396,"about_ca_system_score_codex":0.0008794713,"about_ca_system_score_gemma":0.0015140364,"threshold_uncertainty_score":0.014429808},"labels":[],"label_agreement":null},{"id":"W2965081956","doi":"10.1007/s00520-019-04987-8","title":"Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview","year":2019,"lang":"en","type":"review","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Pain medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Nursing research; Chemotherapy; Internal medicine; Oncology; Intensive care medicine; Physical therapy; Nursing; Psychiatry; Anesthesiology; Diabetes mellitus","score_opus":0.18063192063616412,"score_gpt":0.43423922164166107,"score_spread":0.25360730100549694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965081956","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012541692,0.99913615,0.000089817884,0.00019719377,0.00008012572,0.0000075703774,0.000060652,0.0000042510137,0.0002987968],"genre_scores_gemma":[0.00086495513,0.9983694,0.00020103091,0.00018879722,0.00010433356,0.000012788964,0.000103017184,9.783281e-7,0.00015467941],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997546,0.000040778697,0.00006445654,0.00004960039,0.00006663167,0.000023880102],"domain_scores_gemma":[0.9992428,0.0003892762,0.00017626489,0.000011570416,0.00013720102,0.000042892458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010511767,0.0009347987,0.001888243,0.002206705,0.00018775267,0.0009432197,0.0008664853,0.0008444484,0.0022449454],"category_scores_gemma":[0.001356708,0.0002892367,0.0014765469,0.002019404,0.00022479541,0.0006382877,0.0006833594,0.0013409007,0.0006413553],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018056725,0.000083109226,0.0011000511,0.02900165,0.00047917178,0.00007911158,0.000028123115,0.00054963364,0.00041681083,0.0011547538,0.01740394,0.949523],"study_design_scores_gemma":[0.00030503815,0.0007710546,0.01909943,0.07874528,0.0052576344,0.0023458572,0.00019022322,0.0008666348,0.0009305803,0.0038917367,0.8874688,0.00012774284],"about_ca_topic_score_codex":0.0039985855,"about_ca_topic_score_gemma":0.0064645004,"teacher_disagreement_score":0.0039985855,"about_ca_system_score_codex":0.0007042959,"about_ca_system_score_gemma":0.0021584344,"threshold_uncertainty_score":0.007950604},"labels":[],"label_agreement":null},{"id":"W2965901058","doi":"10.1101/19003467","title":"Patient Benefit and Risk in Anticancer Drug Development: A Systematic Review of the Ixabepilone Trial Portfolio","year":2019,"lang":"en","type":"review","venue":"medRxiv","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Ixabepilone; Medicine; Observational study; Clinical endpoint; Clinical trial; Adverse effect; Internal medicine; Interim analysis; Oncology; Intensive care medicine; Breast cancer; Cancer; Metastatic breast cancer","score_opus":0.0377960817767039,"score_gpt":0.3443438914266322,"score_spread":0.3065478096499283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965901058","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014355845,0.9968606,0.0002547187,0.00040967952,0.00009610486,0.0003511051,0.0003949533,0.000006105491,0.00019103185],"genre_scores_gemma":[0.050313033,0.9435627,0.0022319038,0.00108263,0.0002823369,0.0018457547,0.0005248874,0.000017297654,0.00013955061],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9549067,0.018357238,0.01883813,0.0021051113,0.005386061,0.0004068069],"domain_scores_gemma":[0.8239247,0.13365746,0.030347848,0.00254304,0.008687701,0.0008392136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.036549967,0.0015049601,0.011020839,0.01467795,0.00062927714,0.003444547,0.001663008,0.0016511101,0.0033884435],"category_scores_gemma":[0.12708853,0.0011944028,0.0086920895,0.015407377,0.0013670577,0.0028301037,0.0021528946,0.0013892773,0.00023435471],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006153287,0.000017438926,0.0021737015,0.9231081,0.03021162,0.000088428314,0.00029369115,0.00012911281,0.00012807458,0.00030363872,0.001308018,0.041622918],"study_design_scores_gemma":[0.0007625607,0.0003359061,0.0078088786,0.8267642,0.1459739,0.00038323726,0.00041477007,0.00016092684,0.00017645187,0.0008008176,0.016349804,0.00006845635],"about_ca_topic_score_codex":0.002831054,"about_ca_topic_score_gemma":0.009587083,"teacher_disagreement_score":0.036549967,"about_ca_system_score_codex":0.0032563382,"about_ca_system_score_gemma":0.010087877,"threshold_uncertainty_score":0.19329703},"labels":[],"label_agreement":null},{"id":"W2966099035","doi":"10.1136/ijgc-00009577-200409001-00134","title":"134 Phase I Study of Patupilone Plus Carboplatin in Patients With Advanced Malignancies","year":2004,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Carboplatin; Oncology; Internal medicine; Urology; Chemotherapy; Cisplatin","score_opus":0.020496997130148475,"score_gpt":0.360257502046621,"score_spread":0.3397605049164725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966099035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910766,0.0017781565,0.0005008705,0.0006146115,0.00016656154,0.002239915,0.0013873241,0.00018908738,0.0020468526],"genre_scores_gemma":[0.98722154,0.0022478004,0.001486102,0.0006187157,0.00019842293,0.0019884277,0.0024636888,0.00004890037,0.003726358],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995813,0.00019485125,0.0000145803215,0.000060612798,0.0000353945,0.000113351874],"domain_scores_gemma":[0.99946135,0.000090356836,0.00007444285,0.000053060634,0.000026579155,0.00029423067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008508567,0.0018063388,0.0027508445,0.0007953224,0.00049177505,0.0009939437,0.0012753427,0.0010382576,0.004803503],"category_scores_gemma":[0.000683166,0.000813164,0.0017597049,0.00067323254,0.0009827197,0.0007462238,0.00037084715,0.004020574,0.0010694672],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8140301,0.05536598,0.0034835238,0.0008795779,0.0014987653,0.0002189667,0.00021859052,0.0030507543,0.036449578,0.00034014447,0.004341911,0.08012205],"study_design_scores_gemma":[0.64499485,0.3429255,0.006356158,0.000018991712,0.00043790656,0.00014244668,0.000030138208,0.000775268,0.0025291622,0.00008918065,0.0016731741,0.000027216569],"about_ca_topic_score_codex":0.002811995,"about_ca_topic_score_gemma":0.005666858,"teacher_disagreement_score":0.004803503,"about_ca_system_score_codex":0.0011968098,"about_ca_system_score_gemma":0.002268864,"threshold_uncertainty_score":0.016069353},"labels":[],"label_agreement":null},{"id":"W2967695014","doi":"","title":"In vitro screening of anticancer drug penetration into tumor tissue: taxanes","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"","keywords":"Paclitaxel; Docetaxel; Penetration (warfare); Spheroid; Tissue culture; Drug; In vitro; Cell; Cell culture; Pharmacology; Biology; Chemistry; Cancer research; Chemotherapy; Internal medicine; Medicine; Biochemistry","score_opus":0.07811166090812563,"score_gpt":0.490811470373672,"score_spread":0.4126998094655464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967695014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98459136,0.004888544,0.0058180117,0.00008143832,0.00003557176,0.0001372664,0.0011265551,0.00008297844,0.0032382621],"genre_scores_gemma":[0.9788602,0.0050779926,0.009628795,0.000049161437,0.00001892198,0.00013074082,0.0014165402,0.00004499238,0.0047725574],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99974304,0.0000692925,0.000029242747,0.000048270093,0.000076977325,0.00003315012],"domain_scores_gemma":[0.9997917,0.000085316475,0.00003503552,0.000024097364,0.000041379328,0.000022473148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023380943,0.00039164207,0.0004524763,0.00027272242,0.00017844664,0.00031949952,0.00024359026,0.00031861832,0.0014224795],"category_scores_gemma":[0.00021412976,0.000209069,0.00024593488,0.00033169007,0.00013489228,0.00018295895,0.00017671396,0.00051577965,0.00040279632],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000538977,0.000051075574,0.00013973282,0.000046470428,0.000004284253,0.0000148974,0.000025620397,0.00014097537,0.998718,0.000013092658,0.000020296124,0.000771647],"study_design_scores_gemma":[0.000008894859,0.0011005327,0.0028513544,0.0000050637805,0.000021573702,0.0000693362,0.000024837525,0.00093414326,0.99379224,0.000008892255,0.0011791958,0.0000039822216],"about_ca_topic_score_codex":0.0023571465,"about_ca_topic_score_gemma":0.0038357147,"teacher_disagreement_score":0.0023571465,"about_ca_system_score_codex":0.00027695048,"about_ca_system_score_gemma":0.00018519466,"threshold_uncertainty_score":0.0047585964},"labels":[],"label_agreement":null},{"id":"W2968566719","doi":"10.1200/jco.2013.31.15_suppl.e16082","title":"Cabazitaxel in docetaxel-pretreated metastatic castration resistant prostate cancer (mCRPC): Canadian experience.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; Université de Montréal; Université Laval; Sanofi (Canada); Sunnybrook Health Science Centre; University of Toronto; Moncton Hospital; Grand River Hospital; London Health Sciences Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Docetaxel; Cabazitaxel; Prostate cancer; Adverse effect; Internal medicine; Neutropenia; Febrile neutropenia; Prednisone; Surgery; Cancer; Chemotherapy; Androgen deprivation therapy","score_opus":0.16341291541713204,"score_gpt":0.5157864465834574,"score_spread":0.35237353116632536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968566719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8585799,0.09000538,0.00088277727,0.0058725225,0.00031225174,0.0005480055,0.002881213,0.00011099325,0.040807065],"genre_scores_gemma":[0.9215977,0.060156293,0.00151127,0.002092637,0.00018923303,0.00007640917,0.0033116722,0.000048419424,0.011016439],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99972874,0.000040584437,0.000012914069,0.000032157757,0.00010639355,0.00007924146],"domain_scores_gemma":[0.9996105,0.000035416404,0.000043452306,0.000011589021,0.00012036898,0.0001787465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062837277,0.00047084596,0.00035782057,0.00033813785,0.0009067532,0.00061183167,0.00050602155,0.00041833505,0.0036191002],"category_scores_gemma":[0.00065022317,0.00015730826,0.00029332054,0.0014501252,0.00044909987,0.00024275003,0.00029768163,0.0005368392,0.0006443758],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009540979,0.0023674478,0.113966905,0.0018650602,0.00030171731,0.0041396697,0.0018432894,0.0016314302,0.010122755,0.0014597793,0.054703712,0.7980573],"study_design_scores_gemma":[0.0061595733,0.01345937,0.55391115,0.000842998,0.0008794266,0.011879904,0.0013825726,0.0019641486,0.003918012,0.00040136438,0.4050829,0.00011850986],"about_ca_topic_score_codex":0.66803354,"about_ca_topic_score_gemma":0.8402142,"teacher_disagreement_score":0.66803354,"about_ca_system_score_codex":0.0059840614,"about_ca_system_score_gemma":0.00975768,"threshold_uncertainty_score":0.6678429},"labels":[],"label_agreement":null},{"id":"W2969150729","doi":"","title":"Comparative in vitro analysis of C1311 activity in a panel of colorectal cell lines against standard colon cancer chemotherapies.","year":2004,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Colorectal cancer; Medicine; Capecitabine; Cancer research; In vivo; Cancer; Mitoxantrone; Oxaliplatin; Internal medicine; Oncology; Ovarian cancer; Pharmacology; Chemotherapy; Biology","score_opus":0.04042104460862335,"score_gpt":0.35794298216887205,"score_spread":0.3175219375602487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969150729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96802974,0.00911862,0.0032996351,0.00029363477,0.00015106275,0.00026159492,0.0068806773,0.00023122289,0.011733798],"genre_scores_gemma":[0.9471009,0.008344767,0.008719985,0.00021930989,0.000050969753,0.00027438742,0.024336807,0.00006313215,0.010889757],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999705,0.00008330135,0.000034246616,0.00003654856,0.00009947063,0.00004143217],"domain_scores_gemma":[0.9997454,0.00006957489,0.00002783318,0.000029853467,0.00008451028,0.00004274624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003035256,0.00066251715,0.0004124156,0.0005522657,0.00026229932,0.00024972134,0.00020975986,0.00035336884,0.0019117165],"category_scores_gemma":[0.00018896279,0.00014451622,0.00038081894,0.0009624431,0.00016529241,0.00014011824,0.00017141587,0.00043611045,0.0007892979],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025425258,0.00016372847,0.0003771543,0.00014609858,0.000016019543,0.00006330248,0.00003726649,0.00027126443,0.9955509,0.00006967929,0.00031293381,0.0027374108],"study_design_scores_gemma":[0.00004984643,0.0035301591,0.010399782,0.000022279779,0.000058453887,0.0004021818,0.00006800813,0.0009480644,0.9786245,0.000028505458,0.005852185,0.000016070895],"about_ca_topic_score_codex":0.005732067,"about_ca_topic_score_gemma":0.009346596,"teacher_disagreement_score":0.005732067,"about_ca_system_score_codex":0.0003776847,"about_ca_system_score_gemma":0.00041135724,"threshold_uncertainty_score":0.011397362},"labels":[],"label_agreement":null},{"id":"W2972352807","doi":"10.1080/24740527.2019.1665992","title":"Quantitative sensory profiles of upper extremity chemotherapy induced peripheral neuropathy: Are there differences in sensory profiles for neuropathic versus nociceptive pain?","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Pain","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"CancerCare Manitoba Foundation","keywords":"Neuropathic pain; Quantitative sensory testing; Medicine; Peripheral neuropathy; Sensory system; Confidence interval; Odds ratio; Neuralgia; Nociception; Internal medicine; Physical therapy; Anesthesia; Psychology; Neuroscience","score_opus":0.06323877215973088,"score_gpt":0.3132347724412353,"score_spread":0.24999600028150443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972352807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918459,0.0019463578,0.0029445125,0.00019361034,0.000041003714,0.0000934245,0.00082190125,0.00004637493,0.0020668814],"genre_scores_gemma":[0.9983639,0.00030869918,0.00059106573,0.000083165956,0.000011128426,0.000034849225,0.00026055862,0.0000070671376,0.0003394791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952626,0.0001258532,0.000057247074,0.00005786788,0.00017633995,0.00005652252],"domain_scores_gemma":[0.997912,0.00050345896,0.0005006222,0.00010366769,0.000838277,0.00014191818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015868767,0.00030130785,0.00037008605,0.0007987474,0.00017111016,0.00038601412,0.00033639962,0.00031015745,0.0029828714],"category_scores_gemma":[0.0033689637,0.000093297946,0.00025050374,0.00070892385,0.00037545917,0.0006271671,0.00025167942,0.00038956877,0.00044565002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075664744,0.00074907317,0.549677,0.0015572024,0.0007514149,0.0008320023,0.0010426454,0.0005870511,0.262627,0.00029840745,0.0012475109,0.17306419],"study_design_scores_gemma":[0.000023248507,0.0015673682,0.9884798,0.00006247356,0.00008193127,0.0008746894,0.0003459462,0.0003181987,0.0076646153,0.00017219427,0.0003947257,0.000014884694],"about_ca_topic_score_codex":0.0015203789,"about_ca_topic_score_gemma":0.0021894034,"teacher_disagreement_score":0.0029828714,"about_ca_system_score_codex":0.00024320828,"about_ca_system_score_gemma":0.00018792333,"threshold_uncertainty_score":0.009978771},"labels":[],"label_agreement":null},{"id":"W2973076369","doi":"10.1007/s00280-019-03956-6","title":"Skin platinum deposition in colorectal cancer patients following oxaliplatin-based therapy","year":2019,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Fluidigm (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Oxaliplatin; FOLFOX; Medicine; Peripheral neuropathy; Cumulative dose; Colorectal cancer; Internal medicine; Neurotoxicity; Gastroenterology; Chemotherapy; Cancer; Oncology; Toxicity; Endocrinology","score_opus":0.012279270525962987,"score_gpt":0.3243970405063564,"score_spread":0.3121177699803934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973076369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970204,0.00046875956,0.00006599442,0.00004410685,0.000010704521,0.000011473679,0.000067047935,0.000005407793,0.0023061342],"genre_scores_gemma":[0.99941707,0.00013991774,0.000032095748,0.000027878754,0.000009428882,0.0000017707663,0.000041936662,0.0000022699735,0.0003277174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978524,0.00004611917,0.000022862412,0.000034160315,0.00006030151,0.000051273564],"domain_scores_gemma":[0.9992329,0.00017865752,0.00031782754,0.000032773438,0.000100978374,0.00013682374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018716443,0.00013475934,0.00035048905,0.0006439022,0.00039294653,0.0004940496,0.00014078102,0.00034120103,0.0023174733],"category_scores_gemma":[0.0011539755,0.0001868335,0.00040440957,0.0005766884,0.00018477469,0.00030848038,0.00024947716,0.00044933576,0.00024305876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021745896,0.0001938612,0.9657634,0.000081689665,0.00013203124,0.011962353,0.00026744758,0.00016422984,0.0064370492,0.000033338918,0.00024630647,0.012543894],"study_design_scores_gemma":[0.000014342208,0.00051063404,0.98736703,0.000008141148,0.00008142177,0.010292657,0.000260137,0.0001987918,0.0008385649,0.00003156458,0.00038972002,0.000006968661],"about_ca_topic_score_codex":0.0019368108,"about_ca_topic_score_gemma":0.0027586704,"teacher_disagreement_score":0.0023174733,"about_ca_system_score_codex":0.00034987295,"about_ca_system_score_gemma":0.000185835,"threshold_uncertainty_score":0.007752657},"labels":[],"label_agreement":null},{"id":"W2978060560","doi":"10.1093/annonc/mdz242.077","title":"CONTESSA TRIO: A multinational, multicenter, phase II study of tesetaxel plus 3 different PD-(L)1 inhibitors in patients with metastatic triple negative breast cancer (TNBC) and tesetaxel monotherapy in elderly patients with her2- metastatic breast cancer (MBC)","year":2019,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Atezolizumab; Pembrolizumab; Internal medicine; Tolerability; Taxane; Oncology; Cohort; Triple-negative breast cancer; Metastatic breast cancer; Breast cancer; Nivolumab; Cancer; Adverse effect; Immunotherapy","score_opus":0.03578482217766499,"score_gpt":0.37684929556269836,"score_spread":0.3410644733850334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978060560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98991895,0.0020708607,0.00052441907,0.0008342262,0.00020455704,0.0016649865,0.0021840995,0.00020502381,0.0023929412],"genre_scores_gemma":[0.9785891,0.0029710997,0.002424477,0.0016515375,0.00030579985,0.0027587435,0.0057960683,0.00010181519,0.0054013757],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99968696,0.00013081392,0.000012613486,0.00005806117,0.000028233033,0.00008325624],"domain_scores_gemma":[0.9993643,0.00008107481,0.000104814695,0.00005065816,0.000034072153,0.0003650662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014317299,0.001344138,0.0020436642,0.0005136514,0.00047474564,0.0011954216,0.0009724795,0.0010620437,0.004266425],"category_scores_gemma":[0.0007917571,0.0005293488,0.0016939105,0.000512453,0.0010284631,0.0009277853,0.00042468155,0.00358412,0.001167455],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7947903,0.06409783,0.009053745,0.00076406496,0.0025564686,0.00016780903,0.0003736927,0.0028952386,0.04112296,0.00050031865,0.007566422,0.076111175],"study_design_scores_gemma":[0.7220956,0.25305066,0.015465316,0.000043632543,0.0010559858,0.00023234333,0.000104936094,0.0013559702,0.002195147,0.00025507048,0.004090261,0.0000550912],"about_ca_topic_score_codex":0.0022928647,"about_ca_topic_score_gemma":0.0068970774,"teacher_disagreement_score":0.004266425,"about_ca_system_score_codex":0.0009124737,"about_ca_system_score_gemma":0.0020078677,"threshold_uncertainty_score":0.014272571},"labels":[],"label_agreement":null},{"id":"W2979559101","doi":"10.1182/blood.v118.21.3359.3359","title":"A Novel Polymer Based Antidote for Reversing the Anticoagulation Effect of Clinically Used Heparins,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Heparin; Pharmacology; Medicine; Antidote; Fondaparinux; Partial thromboplastin time; Platelet; Chemistry; Surgery; Immunology; Thrombosis; Internal medicine; Toxicity; Venous thromboembolism","score_opus":0.05991873752565248,"score_gpt":0.3479533794754216,"score_spread":0.28803464194976913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979559101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9561679,0.01378259,0.024605531,0.00030854286,0.0002284203,0.00018106015,0.00020324977,0.0003059112,0.0042168144],"genre_scores_gemma":[0.97492564,0.003239168,0.017566366,0.00017945461,0.000032438635,0.000054929114,0.0001677591,0.000011849123,0.00382241],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995553,0.000007364687,0.000003093612,0.0000104448345,0.00001621914,0.0000072840385],"domain_scores_gemma":[0.9999571,0.0000062909735,0.000016365246,0.0000027668264,0.000008600964,0.000008969734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000076920514,0.00020371734,0.00010504903,0.00014128641,0.00007377881,0.000115300776,0.00016694033,0.00031561046,0.00053123897],"category_scores_gemma":[0.00008815409,0.000063815685,0.00009384276,0.000083220446,0.00011672506,0.0001589304,0.0001136463,0.00026975782,0.00019674237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007269562,0.000031982978,0.00011685775,0.000106061816,0.0000040616533,0.00007385986,0.0000070089372,0.00007640935,0.9921147,0.00017555228,0.00011529844,0.007105452],"study_design_scores_gemma":[0.000017528335,0.0005900628,0.0008318967,0.00000694785,0.00000936682,0.00042539663,0.0000047179124,0.0009049602,0.99218565,0.0000219855,0.004996774,0.000004873207],"about_ca_topic_score_codex":0.00015364208,"about_ca_topic_score_gemma":0.00013910954,"teacher_disagreement_score":0.00053123897,"about_ca_system_score_codex":0.00010169507,"about_ca_system_score_gemma":0.00015222233,"threshold_uncertainty_score":0.0017771125},"labels":[],"label_agreement":null},{"id":"W2982238418","doi":"10.1016/j.jtho.2019.08.543","title":"MA06.07 E1505: Adjuvant Chemotherapy +/- Bevacizumab for Early Stage NSCLC: Updated Chemotherapy Subset Analysis","year":2019,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Docetaxel; Bevacizumab; Gemcitabine; Regimen; Vinorelbine; Internal medicine; Chemotherapy; Pemetrexed; Histology; Oncology; Stage (stratigraphy); Adjuvant; Chemotherapy regimen; Cisplatin; Biology","score_opus":0.022987012161067022,"score_gpt":0.4307940233050613,"score_spread":0.40780701114399426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982238418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7067794,0.040399965,0.011020245,0.0047559715,0.0010726706,0.0014460835,0.19367127,0.0007045443,0.040149838],"genre_scores_gemma":[0.7379607,0.013103681,0.0096129775,0.005020374,0.001117053,0.0012695357,0.21749724,0.00054754055,0.013870984],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991953,0.000254124,0.0001175957,0.00015465567,0.00017690046,0.00010151566],"domain_scores_gemma":[0.9985127,0.00046491888,0.00033873098,0.00022411236,0.00030165262,0.00015789986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017706393,0.00054860313,0.0012606094,0.00073300715,0.00022475449,0.0011212726,0.00091672014,0.00047326635,0.007745163],"category_scores_gemma":[0.0028916674,0.00028961638,0.00309985,0.0011991349,0.00012538007,0.000865418,0.0006750675,0.0010374221,0.0017387966],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.065269075,0.0007700669,0.31144994,0.0037683835,0.02036831,0.0005026126,0.00015830726,0.008106384,0.014091104,0.002275468,0.13225546,0.4409849],"study_design_scores_gemma":[0.010078536,0.0064506563,0.7204049,0.0014211014,0.043991342,0.0022549673,0.00025805502,0.008480885,0.005184358,0.0044646356,0.19685085,0.00015960792],"about_ca_topic_score_codex":0.0041461885,"about_ca_topic_score_gemma":0.014303936,"teacher_disagreement_score":0.007745163,"about_ca_system_score_codex":0.000706847,"about_ca_system_score_gemma":0.0009888004,"threshold_uncertainty_score":0.025910199},"labels":[],"label_agreement":null},{"id":"W2982249510","doi":"10.1093/jnci/djz211","title":"A Systematic Review and Meta-Analysis of Bevacizumab in First-Line Metastatic Breast Cancer: Lessons for Research and Regulatory Enterprises","year":2019,"lang":"en","type":"review","venue":"JNCI Journal of the National Cancer Institute","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Harvard-MIT Center for Regulatory Science; Arnold Ventures","keywords":"Bevacizumab; Medicine; Hazard ratio; Internal medicine; Oncology; Metastatic breast cancer; Meta-analysis; Proportional hazards model; Clinical trial; Breast cancer; Progression-free survival; Cancer; Confidence interval; Overall survival; Chemotherapy","score_opus":0.4801933040482415,"score_gpt":0.5622275174975023,"score_spread":0.08203421344926082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982249510","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015624997,0.9964504,0.0005350234,0.00061930506,0.00017233774,0.00015657805,0.0002599283,0.000018246872,0.00022574133],"genre_scores_gemma":[0.12875152,0.86146414,0.004415687,0.0024055252,0.0005492165,0.0012978443,0.00076748175,0.000051758896,0.0002968101],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9595636,0.027126536,0.0076722037,0.0021263533,0.002874556,0.00063665217],"domain_scores_gemma":[0.89872503,0.0824818,0.009569254,0.0029267871,0.0057161474,0.0005810068],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0478841,0.0025738543,0.018230028,0.007582349,0.00059783686,0.0041025546,0.002431121,0.002380709,0.0033278135],"category_scores_gemma":[0.114291124,0.0014156502,0.031367872,0.008685469,0.0009166363,0.0026891208,0.0015602851,0.0022020997,0.0003462706],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013244658,0.00001923959,0.003538824,0.39698336,0.5710379,0.00018468586,0.00011368969,0.00095877715,0.00018881727,0.00050826144,0.0020730174,0.023068927],"study_design_scores_gemma":[0.00069226336,0.00018956335,0.004618303,0.09740603,0.88998616,0.00013108659,0.00007428966,0.0004074884,0.00011700843,0.0010951374,0.0052485373,0.000034074492],"about_ca_topic_score_codex":0.009676301,"about_ca_topic_score_gemma":0.02083036,"teacher_disagreement_score":0.9521159,"about_ca_system_score_codex":0.004527587,"about_ca_system_score_gemma":0.007461413,"threshold_uncertainty_score":0.25323832},"labels":[],"label_agreement":null},{"id":"W2984735937","doi":"10.1097/01.reo.0000000000000189","title":"Neuromuscular Electrical Stimulation (NMES) in the Management of Glioblastoma Multiforme: A Case Report","year":2019,"lang":"en","type":"article","venue":"Rehabilitation Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Queen's University Belfast; European Commission","keywords":"Medicine; Quality of life (healthcare); Adverse effect; Psychosocial; Physical therapy; Aerobic exercise; Intervention (counseling); Glioblastoma; Rehabilitation; Physical medicine and rehabilitation; Internal medicine; Nursing","score_opus":0.01198335727705173,"score_gpt":0.3594155886429487,"score_spread":0.34743223136589696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984735937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9539022,0.019923808,0.0068945778,0.0074454015,0.00054925104,0.00030637498,0.00023885528,0.00026283978,0.010476864],"genre_scores_gemma":[0.99065524,0.0034869944,0.0022510646,0.001329642,0.00068941363,0.00004867201,0.000084000465,0.000021917805,0.0014329359],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994405,0.00008019685,0.00008016564,0.000114344264,0.0001020446,0.00018283317],"domain_scores_gemma":[0.99894935,0.00027582818,0.00038922424,0.00005938921,0.00005985364,0.00026645273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032969442,0.0016361255,0.0009628302,0.0017293056,0.0024955762,0.0009630421,0.0013729701,0.0051758103,0.0012907394],"category_scores_gemma":[0.0022514788,0.0006997512,0.0011431065,0.0015701221,0.0013819081,0.0014803411,0.0012325658,0.0027098907,0.0006464947],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012483992,0.000023371953,0.0021747071,0.000029196364,0.0000068936115,0.9958402,0.00012834705,0.00006913676,0.00030123256,0.000076148775,0.00019056768,0.0011478041],"study_design_scores_gemma":[0.0000047808694,0.000038722108,0.0015611136,0.0000141906,0.000008949994,0.99750525,0.000084073356,0.00017135548,0.00015858661,0.00006908184,0.00037822063,0.0000056800113],"about_ca_topic_score_codex":0.0036202883,"about_ca_topic_score_gemma":0.006039387,"teacher_disagreement_score":0.0051758103,"about_ca_system_score_codex":0.0015209971,"about_ca_system_score_gemma":0.00097267085,"threshold_uncertainty_score":0.011035621},"labels":[],"label_agreement":null},{"id":"W2986452922","doi":"10.1182/blood-2019-127917","title":"Meta-Analysis and Cost-Effectiveness Analysis of Low-Dose Direct Oral Anticoagulant for the Prevention of Cancer Associated Thrombosis","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Apixaban; Meta-analysis; Rivaroxaban; Relative risk; Randomized controlled trial; Internal medicine; Placebo; Subgroup analysis; Warfarin; Confidence interval; Atrial fibrillation","score_opus":0.11367015810697412,"score_gpt":0.4163979681811051,"score_spread":0.30272781007413097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986452922","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012349913,0.97892284,0.004540308,0.0006486678,0.0004563691,0.00065643864,0.0014725664,0.00010019641,0.0008527862],"genre_scores_gemma":[0.46338832,0.51410854,0.013306963,0.0014414748,0.0009013033,0.0031462596,0.0027193418,0.000119849865,0.00086790975],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97542155,0.016547188,0.004048733,0.0016418963,0.0019424645,0.00039821144],"domain_scores_gemma":[0.96558994,0.02864119,0.0030518929,0.0010706697,0.0013691065,0.00027722356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.033873543,0.0042377664,0.023732923,0.012109464,0.00053461996,0.0056162886,0.0027931065,0.002676718,0.0041231224],"category_scores_gemma":[0.061696008,0.0018083069,0.07382554,0.008373929,0.0006027805,0.0023837946,0.0016128685,0.0028074847,0.00036528517],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002120155,0.000024256875,0.0021311524,0.062327884,0.9243786,0.00008889685,0.000020542808,0.0027809932,0.00010112865,0.00023801038,0.00032775078,0.0054605757],"study_design_scores_gemma":[0.0005897772,0.00013903412,0.0014993835,0.005183883,0.98983115,0.00006341912,0.000013892762,0.0013088005,0.000102209924,0.0005883169,0.00066009373,0.00002005272],"about_ca_topic_score_codex":0.004641595,"about_ca_topic_score_gemma":0.005064242,"teacher_disagreement_score":0.033873543,"about_ca_system_score_codex":0.003795002,"about_ca_system_score_gemma":0.003022531,"threshold_uncertainty_score":0.17914253},"labels":[],"label_agreement":null},{"id":"W2990384780","doi":"10.1182/blood-2019-126306","title":"Enhanced VTE Risk Stratification in Ambulatory Patients with Cancer","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Internal medicine; Ambulatory; Hazard ratio; Framingham Risk Score; Apixaban; Proportional hazards model; Incidence (geometry); Placebo; Confidence interval; Disease; Warfarin; Atrial fibrillation; Pathology","score_opus":0.006589515201571565,"score_gpt":0.2688415012112273,"score_spread":0.2622519860096557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990384780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921457,0.0042849304,0.0008525089,0.00026821543,0.000035185265,0.00016175592,0.00049150793,0.000021702082,0.0017385443],"genre_scores_gemma":[0.99754685,0.00062779,0.0010682454,0.00009324424,0.000066387656,0.0000542154,0.0004433255,0.000002133645,0.00009788039],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990675,0.0004721382,0.00010664042,0.00011755869,0.0001770618,0.00005920486],"domain_scores_gemma":[0.99793196,0.0006216669,0.000890563,0.000072520044,0.0002238494,0.0002593773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001207111,0.00022095749,0.0007171507,0.00050031254,0.00016176638,0.00053287117,0.00016450827,0.00029440646,0.0015963187],"category_scores_gemma":[0.003873488,0.000081928854,0.0004439819,0.0005277055,0.00012501249,0.00024883886,0.00033865287,0.00035446137,0.00012244633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017540887,0.00064114825,0.85001564,0.00064592453,0.00088432105,0.00020192843,0.000110016015,0.0013218331,0.0022803068,0.00020572817,0.0020362935,0.12411587],"study_design_scores_gemma":[0.0019153485,0.007037973,0.98022604,0.0001754535,0.00076228793,0.00084076164,0.00008425532,0.0057256008,0.00051401544,0.00051010994,0.0021859377,0.00002217184],"about_ca_topic_score_codex":0.000691218,"about_ca_topic_score_gemma":0.0014305754,"teacher_disagreement_score":0.0015963187,"about_ca_system_score_codex":0.00027937125,"about_ca_system_score_gemma":0.00037841147,"threshold_uncertainty_score":0.006383896},"labels":[],"label_agreement":null},{"id":"W2992699933","doi":"10.1200/jco.2009.27.15_suppl.5139","title":"A phase II study of patupilone in patients (pts) with metastatic castration- resistant prostate cancer (CRPC) who have progressed after docetaxel","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; London Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Docetaxel; Internal medicine; Clinical endpoint; Adverse effect; Taxane; Prostate cancer; Progression-free survival; Gastroenterology; Nausea; Chemotherapy; Surgery; Cancer; Oncology; Clinical trial; Breast cancer","score_opus":0.0965500528240619,"score_gpt":0.5084327799756414,"score_spread":0.4118827271515795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992699933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955687,0.00073008216,0.00031305852,0.0001860341,0.00005313761,0.0018391629,0.00050549646,0.000046607096,0.00075760455],"genre_scores_gemma":[0.9916516,0.0011660726,0.0011798876,0.0005217718,0.00012442011,0.0021480315,0.0015399081,0.000016906897,0.0016514754],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999729,0.00012944461,0.00001340998,0.00004340154,0.000027716545,0.000056953595],"domain_scores_gemma":[0.99932146,0.00010166975,0.00009501766,0.000049183695,0.00003680068,0.00039577557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011690514,0.0010129242,0.0015840529,0.0003138605,0.00033021852,0.0007608141,0.00072976167,0.00089188863,0.00327824],"category_scores_gemma":[0.0007358459,0.00048852956,0.0008226106,0.00046463514,0.00072351354,0.00059812615,0.00028399815,0.0022209128,0.0006731729],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7093848,0.11708072,0.012720927,0.00096410123,0.0008686222,0.0006804169,0.00052064424,0.0030973717,0.06152829,0.00025391337,0.003569782,0.0893304],"study_design_scores_gemma":[0.41443276,0.56416744,0.016235469,0.000020554096,0.0002257485,0.0003587254,0.000051278446,0.00096092647,0.001922897,0.00008746957,0.0015166622,0.000020083764],"about_ca_topic_score_codex":0.0008690858,"about_ca_topic_score_gemma":0.0020488824,"teacher_disagreement_score":0.00327824,"about_ca_system_score_codex":0.00060431904,"about_ca_system_score_gemma":0.001229687,"threshold_uncertainty_score":0.010966778},"labels":[],"label_agreement":null},{"id":"W2999546558","doi":"10.1016/s0923-7534(20)32889-1","title":"Progression-Free Survival as a Surrogate for Overall Survival in Metastatic Breast Cancer","year":2012,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National d'Excellence en Santé et en Services Sociaux; Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"Medicine; Metastatic breast cancer; Oncology; Surrogate endpoint; Internal medicine; Breast cancer; Overall survival; Progression-free survival; Cancer","score_opus":0.14704478219920217,"score_gpt":0.4943423350120266,"score_spread":0.3472975528128245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999546558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720979,0.013973265,0.0056942613,0.0009340191,0.00014817802,0.000041504216,0.0013869754,0.000089239584,0.0056346264],"genre_scores_gemma":[0.9963044,0.0011394189,0.0010756233,0.00010483884,0.000074824966,0.00003785102,0.00060829194,0.000013332385,0.0006414487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998665,0.00092077634,0.00008564922,0.00007296841,0.00018262703,0.000073048264],"domain_scores_gemma":[0.9965436,0.0018763734,0.00094932585,0.000153188,0.00020136988,0.00027614154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033928244,0.00032366905,0.000546196,0.0006923302,0.00020387494,0.0006703831,0.00029739708,0.0004020649,0.0007772967],"category_scores_gemma":[0.0059678764,0.00012572942,0.00055037654,0.0005733799,0.00030576406,0.00053398235,0.000604914,0.0012644768,0.0001820478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022969585,0.0005439494,0.7928701,0.000888497,0.0011328654,0.0006143274,0.000554193,0.01191437,0.007948259,0.0038824389,0.0044151037,0.15226635],"study_design_scores_gemma":[0.00023900051,0.00849176,0.9527179,0.00016245624,0.00075503543,0.0029785468,0.00029921485,0.018067578,0.0034988446,0.0045221406,0.008214041,0.000053418775],"about_ca_topic_score_codex":0.00065455935,"about_ca_topic_score_gemma":0.0014402508,"teacher_disagreement_score":0.0033928244,"about_ca_system_score_codex":0.0006443804,"about_ca_system_score_gemma":0.00047819284,"threshold_uncertainty_score":0.017943203},"labels":[],"label_agreement":null},{"id":"W3000956560","doi":"10.1177/1545968319899918","title":"An Exploratory Randomized Trial of Physical Therapy for the Treatment of Chemotherapy-Induced Peripheral Neuropathy","year":2020,"lang":"en","type":"article","venue":"Neurorehabilitation and neural repair","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"CancerCare Manitoba Foundation","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Breast cancer; Randomized controlled trial; Peripheral neuropathy; Physical therapy; Odds ratio; Internal medicine; Taxane; Confidence interval; Population; Chemotherapy; Clinical trial; Cancer","score_opus":0.045389436860392506,"score_gpt":0.3545396141668244,"score_spread":0.3091501773064319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000956560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92316425,0.0136995055,0.0027169192,0.002792465,0.0044850954,0.042573217,0.003135817,0.0004610647,0.0069717052],"genre_scores_gemma":[0.9320874,0.0038444293,0.005774266,0.0029819768,0.0013684948,0.047029816,0.0015102046,0.00004833765,0.0053550107],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966904,0.0022700524,0.00020362128,0.00042017226,0.00019082498,0.0002248725],"domain_scores_gemma":[0.99689984,0.0012901609,0.00077696505,0.0002941056,0.00023832462,0.00050061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003849455,0.002357835,0.0048711854,0.00076744374,0.0007119166,0.0014455272,0.0013262825,0.003112652,0.015670318],"category_scores_gemma":[0.006817804,0.0008754314,0.0028996265,0.0006162323,0.0017374496,0.0014152466,0.0008573846,0.002858318,0.001362389],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9933089,0.0023288967,0.000093875395,0.00039961722,0.0005086997,0.000012584765,0.000012465626,0.00007098288,0.00028416395,0.000064124084,0.00021576551,0.0026999526],"study_design_scores_gemma":[0.9799423,0.01909584,0.00026205485,0.000029755978,0.00023909545,0.0000075370403,0.0000074230497,0.00010905293,0.000038330534,0.00009775992,0.00016679778,0.000004011368],"about_ca_topic_score_codex":0.0009992451,"about_ca_topic_score_gemma":0.0019975805,"teacher_disagreement_score":0.015670318,"about_ca_system_score_codex":0.0009621832,"about_ca_system_score_gemma":0.0019657754,"threshold_uncertainty_score":0.052422464},"labels":[],"label_agreement":null},{"id":"W3004486659","doi":"","title":"Clustering of anthracycline-containing lysosomes in drug-resistant MCF-7 cells in response to tesmilifene","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Laurentian University; Sudbury Regional Hospital","funders":"","keywords":"Doxorubicin; Epirubicin; Cytotoxicity; Anthracycline; Cancer research; Cytoplasm; Biology; Daunorubicin; Cancer cell; Clonogenic assay; Pharmacology; Cancer; Chemotherapy; Medicine; Apoptosis; In vitro; Cell biology; Internal medicine; Biochemistry; Breast cancer","score_opus":0.11304269958126131,"score_gpt":0.4622375099017531,"score_spread":0.3491948103204918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004486659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918685,0.002154997,0.0015493222,0.00019876423,0.000054350625,0.00007095191,0.00081077084,0.00008337041,0.0032088575],"genre_scores_gemma":[0.99197376,0.000924156,0.0026499578,0.000112941954,0.000016553371,0.00009623821,0.0012380015,0.00002637337,0.0029620891],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997713,0.000053094907,0.000018797902,0.000033765984,0.000066583685,0.000056392066],"domain_scores_gemma":[0.99988747,0.000022394788,0.000022746673,0.000017432398,0.000029299987,0.000020575479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021919487,0.0003175324,0.000750428,0.00030832543,0.00024582868,0.00039686603,0.00019320821,0.00036363586,0.0016412869],"category_scores_gemma":[0.00014289614,0.00028537124,0.00040448285,0.00021410792,0.0001924692,0.00016976263,0.00018016984,0.0004344242,0.00073125487],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027674623,0.000048546095,0.00036350038,0.000035765723,0.0000091979055,0.00008465484,0.000030118705,0.000068873924,0.9977957,0.00004127034,0.000063754975,0.0011818672],"study_design_scores_gemma":[0.00006557155,0.0008572937,0.019933261,0.000012109429,0.000021152116,0.00061188015,0.00014648521,0.0022236665,0.9740986,0.00004438177,0.001973223,0.000012339296],"about_ca_topic_score_codex":0.0016362547,"about_ca_topic_score_gemma":0.0019967174,"teacher_disagreement_score":0.0016412869,"about_ca_system_score_codex":0.00047672985,"about_ca_system_score_gemma":0.00023060368,"threshold_uncertainty_score":0.005490601},"labels":[],"label_agreement":null},{"id":"W3005429575","doi":"10.1016/j.actbio.2020.01.042","title":"Corrigendum to ‘Recent advances in musculoskeletal local drug delivery’ [Acta Biomaterialia 2019, 93, 135–151]","year":2020,"lang":"en","type":"erratum","venue":"Acta Biomaterialia","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Drug delivery; Materials science; Drug; Biomedical engineering; Medicine; Nanotechnology; Pharmacology","score_opus":0.017357174707034812,"score_gpt":0.3101460149195151,"score_spread":0.2927888402124803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005429575","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000026522905,0.0045795823,0.00018449318,0.028368099,0.9602385,0.000024738645,0.00039195566,0.00013775848,0.006048413],"genre_scores_gemma":[0.0023028133,0.03171076,0.0024195416,0.1278535,0.43967953,0.00021711674,0.0021541573,0.000717132,0.39294544],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947396,0.00054038776,0.0006983947,0.0007376314,0.0027478696,0.00053608685],"domain_scores_gemma":[0.98225385,0.0035498212,0.00087883044,0.0009899902,0.011039284,0.0012883007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043702386,0.003028883,0.003274624,0.0061632907,0.004550576,0.0060268342,0.0044737454,0.009773903,0.10148829],"category_scores_gemma":[0.029329576,0.0015465292,0.0027816934,0.004108253,0.0025923906,0.0031372702,0.0034461746,0.010771014,0.07380399],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000092281725,0.000004973481,0.000010737721,0.00009179043,0.0000034710295,0.00004404157,0.000005477015,0.000011797712,0.000022335322,0.00022911123,0.9955657,0.0040014167],"study_design_scores_gemma":[0.000017775696,0.000018256771,0.00041189397,0.00022993865,0.000025466734,0.00011755793,0.000021716787,0.0000660468,0.00012096398,0.00076190033,0.9981877,0.00002078233],"about_ca_topic_score_codex":0.04555547,"about_ca_topic_score_gemma":0.09071458,"teacher_disagreement_score":0.10148829,"about_ca_system_score_codex":0.006723069,"about_ca_system_score_gemma":0.009096133,"threshold_uncertainty_score":0.33951217},"labels":[],"label_agreement":null},{"id":"W3005908190","doi":"10.1158/1538-7445.sabcs19-gs1-01","title":"Abstract GS1-01: Tucatinib vs placebo, both combined with capecitabine and trastuzumab, for patients with pretreated HER2-positive metastatic breast cancer with and without brain metastases (HER2CLIMB)","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Capecitabine; Medicine; Trastuzumab; Metastatic breast cancer; Internal medicine; Clinical endpoint; Oncology; Pertuzumab; Breast cancer; Neratinib; Regimen; Palbociclib; Cancer; Clinical trial; Colorectal cancer","score_opus":0.048273422772037035,"score_gpt":0.38689826831232316,"score_spread":0.3386248455402861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005908190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870228,0.0030661873,0.00033621793,0.0010352723,0.00092661683,0.0027652513,0.0016052364,0.000217418,0.0030250903],"genre_scores_gemma":[0.98879516,0.0016089366,0.0006486036,0.0010293736,0.0006069756,0.0019431757,0.0012998395,0.000023570443,0.004044363],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990885,0.00047694848,0.000058091086,0.00014462753,0.000052573345,0.00017922826],"domain_scores_gemma":[0.99883646,0.0003252504,0.00021938917,0.00006382963,0.000051980547,0.0005029651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018223729,0.0022391684,0.0034950122,0.0009976232,0.00040837328,0.0016647577,0.0012694891,0.0026048238,0.013901607],"category_scores_gemma":[0.0019243411,0.0007814301,0.0026977821,0.0006073589,0.0016700816,0.0017202572,0.0006428699,0.004259523,0.0016855395],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9843583,0.0051092673,0.00017018196,0.00025454725,0.00033650652,0.000015742355,0.000020441445,0.00023719444,0.0014548292,0.0000706625,0.00048337597,0.0074888663],"study_design_scores_gemma":[0.82362425,0.17301449,0.0014061666,0.000030738625,0.00039714112,0.000024813593,0.000022257613,0.00039603788,0.00049741974,0.00015008904,0.00042063717,0.000015966894],"about_ca_topic_score_codex":0.0012425677,"about_ca_topic_score_gemma":0.002719547,"teacher_disagreement_score":0.013901607,"about_ca_system_score_codex":0.0011608208,"about_ca_system_score_gemma":0.0015470934,"threshold_uncertainty_score":0.04650557},"labels":[],"label_agreement":null},{"id":"W3006085704","doi":"10.1016/j.jocn.2020.01.020","title":"Pilot study of repetitive transcranial magnetic stimulation in patients with chemotherapy-induced peripheral neuropathy","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Neuroscience","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Ministry of Health, Labour and Welfare","keywords":"Dysesthesia; Medicine; Chemotherapy-induced peripheral neuropathy; Transcranial magnetic stimulation; Neuropathic pain; Visual analogue scale; Peripheral neuropathy; McGill Pain Questionnaire; Adverse effect; Common Terminology Criteria for Adverse Events; Anesthesia; Neurostimulation; Internal medicine; Stimulation","score_opus":0.09715323459683775,"score_gpt":0.39305435766762004,"score_spread":0.2959011230707823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006085704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99878246,0.000117042735,0.00014456805,0.000029179871,0.000015288626,0.00023822834,0.000041730247,0.000006938829,0.0006245784],"genre_scores_gemma":[0.99903834,0.00011951038,0.00023781921,0.000072750845,0.000052008407,0.00013832755,0.00009123731,0.000001880684,0.00024808725],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99960023,0.00020653434,0.00003029017,0.000062438936,0.0000341916,0.000066388995],"domain_scores_gemma":[0.9992624,0.00029348,0.000063926316,0.00007275134,0.000063033855,0.0002444228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000820715,0.00073027995,0.000950514,0.00030619316,0.00067475234,0.00030956132,0.00029699446,0.0005573725,0.002784813],"category_scores_gemma":[0.0014559999,0.00018544063,0.00048440765,0.00027852444,0.00061615265,0.0004195911,0.00023160117,0.0007266963,0.00044707244],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39173028,0.16229312,0.2011855,0.0006802293,0.00076879543,0.012287366,0.0032449614,0.0018094783,0.119504124,0.00044668632,0.0010242338,0.1050253],"study_design_scores_gemma":[0.018960021,0.79979354,0.17292546,0.00002033593,0.00032259288,0.0023654953,0.0006104545,0.0009990241,0.0029901078,0.00011662856,0.00085890567,0.000037507623],"about_ca_topic_score_codex":0.0009605711,"about_ca_topic_score_gemma":0.001086675,"teacher_disagreement_score":0.002784813,"about_ca_system_score_codex":0.00026444325,"about_ca_system_score_gemma":0.00066546537,"threshold_uncertainty_score":0.009316146},"labels":[],"label_agreement":null},{"id":"W3006388526","doi":"","title":"Rapport de stage en chimie au Canada - Synthèse d'un analogue de la deltorphine I ayant pour cible le récepteur delta","year":2020,"lang":"fr","type":"article","venue":"Publications Rapport de Stage","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Humanities; Chemistry; Art","score_opus":0.030175079722662278,"score_gpt":0.29539920909049316,"score_spread":0.2652241293678309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006388526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8234391,0.014540663,0.031470556,0.00097193505,0.00069509115,0.00064532965,0.0019317665,0.00034598715,0.1259596],"genre_scores_gemma":[0.91432637,0.0054899585,0.00805136,0.00019941849,0.00002772378,0.00008081476,0.0005076624,0.00008850045,0.07122824],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998171,0.000019482035,0.0000047437156,0.000035245124,0.00006408867,0.000059367547],"domain_scores_gemma":[0.99988544,0.000029572453,0.000011729144,0.000013010197,0.00003514,0.000025068774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002695578,0.000346066,0.00029091816,0.00025672995,0.000444994,0.00044758007,0.00040721992,0.00029205452,0.0071126684],"category_scores_gemma":[0.0003083219,0.00019292303,0.00033033313,0.00023693487,0.00045336434,0.00026582775,0.00024832477,0.00092715834,0.0009823528],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055794744,0.000052868843,0.00037486173,0.0003156017,0.00003317139,0.0004059754,0.0004876337,0.0021736517,0.9703653,0.004109362,0.001483626,0.019639984],"study_design_scores_gemma":[0.000051034043,0.00066512404,0.0011348651,0.000031293268,0.000027184096,0.00014988444,0.00011490833,0.00062600034,0.9484158,0.00020067737,0.048553817,0.000029530636],"about_ca_topic_score_codex":0.05660615,"about_ca_topic_score_gemma":0.07229509,"teacher_disagreement_score":0.9433938,"about_ca_system_score_codex":0.0016212496,"about_ca_system_score_gemma":0.002294461,"threshold_uncertainty_score":0.1125533},"labels":[],"label_agreement":null},{"id":"W3007043352","doi":"10.4103/1735-5362.278710","title":"Development of a RP-HPLC method for analysis of docetaxel in tumor-bearing mice plasma and tissues following injection of docetaxel-loaded pH responsive targeting polymeric micelles","year":2020,"lang":"en","type":"article","venue":"Research in Pharmaceutical Sciences","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chromatography; High-performance liquid chromatography; Docetaxel; Chemistry; Polyethylene glycol; Extraction (chemistry); Micelle; Biochemistry","score_opus":0.24752554995896492,"score_gpt":0.5306112159141528,"score_spread":0.2830856659551879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007043352","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25693834,0.017404415,0.7148292,0.000691474,0.00042550088,0.001100887,0.001301551,0.0028620977,0.0044464525],"genre_scores_gemma":[0.55013067,0.009839064,0.42835107,0.0011545735,0.0001769981,0.0016525178,0.001184459,0.00015335818,0.0073573077],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992192,0.00015173772,0.000049398834,0.00019730102,0.0003344573,0.00004781105],"domain_scores_gemma":[0.99963796,0.00006944048,0.00010441762,0.000022236034,0.00013772956,0.000028153676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006962433,0.00086711184,0.00048244858,0.00072595285,0.00027725272,0.00038325213,0.0005383467,0.00083164783,0.0005825296],"category_scores_gemma":[0.00071443233,0.00037145324,0.00037215985,0.0003092967,0.00042432078,0.00035369056,0.00024120358,0.0009023095,0.0008200325],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065939246,0.000042342817,0.00030887706,0.00013960044,0.000015840882,0.00008010916,0.000017025248,0.00020158869,0.99018466,0.00010436383,0.00014387287,0.008695742],"study_design_scores_gemma":[0.000022374192,0.00036826293,0.0016517902,0.00002053175,0.00003548049,0.0008261003,0.000011045922,0.0024415331,0.99152476,0.000054844986,0.0030187839,0.000024546916],"about_ca_topic_score_codex":0.00073316856,"about_ca_topic_score_gemma":0.0015684388,"teacher_disagreement_score":0.00086711184,"about_ca_system_score_codex":0.00057059573,"about_ca_system_score_gemma":0.0008100611,"threshold_uncertainty_score":0.00413996},"labels":[],"label_agreement":null},{"id":"W3007141125","doi":"10.1158/1538-7445.sabcs19-ot1-08-08","title":"Abstract OT1-08-08: CONTESSA TRIO: A multinational, multicenter, phase 2 study of tesetaxel plus 3 different PD-(L)1 inhibitors in patients with metastatic triple-negative breast cancer (TNBC) and tesetaxel monotherapy in elderly patients with HER2- metastatic breast cancer (MBC)","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Atezolizumab; Pembrolizumab; Tolerability; Internal medicine; Taxane; Oncology; Metastatic breast cancer; Cohort; Triple-negative breast cancer; Breast cancer; Chemotherapy; Clinical endpoint; Cancer; Clinical trial; Adverse effect; Immunotherapy","score_opus":0.05992016180778357,"score_gpt":0.40329152375285165,"score_spread":0.34337136194506807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007141125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988991,0.0015791878,0.0003370243,0.00089674693,0.00015462005,0.0031103068,0.0022592451,0.000121716985,0.0025501605],"genre_scores_gemma":[0.97628105,0.0018479768,0.00219365,0.0018929354,0.00043523687,0.0042299153,0.006755835,0.00007685391,0.0062864684],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995745,0.00021207494,0.000017486776,0.000075654294,0.00003761234,0.00008258257],"domain_scores_gemma":[0.99882096,0.0001638984,0.0002157677,0.00007021144,0.00007817123,0.0006509044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021464906,0.0016267999,0.0015472664,0.0004527893,0.00054149004,0.0010377512,0.0010144521,0.001572415,0.0055176197],"category_scores_gemma":[0.0010131602,0.00056271744,0.0014623251,0.00046008368,0.0010695292,0.0011213031,0.00046720178,0.0031646758,0.0012279103],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8432051,0.06479063,0.009426379,0.0006076595,0.0011512019,0.00023983775,0.0002709054,0.0015488936,0.02580636,0.00031927778,0.008199603,0.044434175],"study_design_scores_gemma":[0.6962416,0.28740555,0.010629981,0.000037150094,0.00041224988,0.00019924335,0.000052226802,0.0009380169,0.0016574296,0.00013443464,0.0022583893,0.00003369444],"about_ca_topic_score_codex":0.0017839676,"about_ca_topic_score_gemma":0.0042893137,"teacher_disagreement_score":0.0055176197,"about_ca_system_score_codex":0.0009185843,"about_ca_system_score_gemma":0.0021136345,"threshold_uncertainty_score":0.018458307},"labels":[],"label_agreement":null},{"id":"W3009722442","doi":"10.1200/jco.2007.25.18_suppl.4028","title":"Bevacizumab (Bev) in combination with XELOX or FOLFOX4: Updated efficacy results from XELOX-1/ NO16966, a randomized phase III trial in first-line metastatic colorectal cancer","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Oxaliplatin; Medicine; FOLFOX; Capecitabine; Bevacizumab; Internal medicine; Oncology; Regimen; Colorectal cancer; Chemotherapy; Fluorouracil; Chemotherapy regimen; Cancer","score_opus":0.1315895413467038,"score_gpt":0.5133118688873759,"score_spread":0.3817223275406721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009722442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.962712,0.025415733,0.001249438,0.0012315537,0.00034854593,0.002424805,0.0031372083,0.00012718054,0.0033536684],"genre_scores_gemma":[0.9722962,0.011227565,0.002216249,0.0013286592,0.00040801175,0.0016369751,0.008408604,0.000050040773,0.0024277726],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998727,0.00083378656,0.00006496063,0.000100899335,0.00016598437,0.0001072776],"domain_scores_gemma":[0.9986796,0.00036820982,0.00041110383,0.00006544067,0.000072823,0.00040277536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004012509,0.001157337,0.0019653225,0.00040161004,0.000231754,0.00087104604,0.0007917503,0.0008009761,0.0024343403],"category_scores_gemma":[0.002188448,0.00043907526,0.0014312937,0.00046827496,0.0004965741,0.00054042786,0.00042012864,0.00208931,0.0004225234],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8050282,0.01282751,0.0069387998,0.0024038088,0.0037327,0.00015118651,0.00013082793,0.002613414,0.014187004,0.0003051542,0.0055026645,0.14617874],"study_design_scores_gemma":[0.8258559,0.14722402,0.016610863,0.00015114006,0.0022019583,0.00029440827,0.000030503645,0.001038566,0.0015054474,0.00024783224,0.0047962847,0.000043070315],"about_ca_topic_score_codex":0.00078957964,"about_ca_topic_score_gemma":0.0023354902,"teacher_disagreement_score":0.004012509,"about_ca_system_score_codex":0.00065579574,"about_ca_system_score_gemma":0.0010587333,"threshold_uncertainty_score":0.021220446},"labels":[],"label_agreement":null},{"id":"W3009814258","doi":"10.1158/1538-7445.sabcs19-p6-03-21","title":"Abstract P6-03-21: Identification of mechanisms driving acquired chemoresistance in preclinical breast cancer models of taxane resistance","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Taxane; Paclitaxel; Docetaxel; Cancer research; Cancer; Protein kinase B; PI3K/AKT/mTOR pathway; Breast cancer; Medicine; Biology; Pharmacology; Signal transduction; Internal medicine; Genetics","score_opus":0.16886145998551766,"score_gpt":0.47063370405509486,"score_spread":0.3017722440695772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009814258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98763275,0.00084369245,0.003968118,0.00028491422,0.000066464214,0.00016086757,0.0040098177,0.00022623267,0.0028070952],"genre_scores_gemma":[0.96393085,0.0012670122,0.006980703,0.00018126382,0.000026450289,0.00039886922,0.012939235,0.00009613051,0.014179576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99974054,0.000030138037,0.000021111757,0.00004101447,0.000115393916,0.000051843595],"domain_scores_gemma":[0.9998461,0.000023442237,0.00003696806,0.000024146802,0.00002785404,0.00004149373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020415272,0.00042346434,0.0003289635,0.00040321314,0.00018573349,0.0003502135,0.00028327398,0.00035872223,0.004306338],"category_scores_gemma":[0.00014947566,0.00016369164,0.00037504025,0.00026459963,0.00021733712,0.00018879978,0.00017611109,0.001205131,0.0012163016],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010438519,0.00009237826,0.00012937326,0.000025159901,0.0000039437973,0.000034606055,0.0000062082995,0.000048742637,0.99879396,0.000041877956,0.0001052068,0.0006140906],"study_design_scores_gemma":[0.000024400753,0.0011847203,0.0064635654,0.000008155111,0.000015339921,0.00046158096,0.000031071482,0.0008101724,0.98812616,0.00004390025,0.0028270409,0.000003896499],"about_ca_topic_score_codex":0.00040724434,"about_ca_topic_score_gemma":0.0005549711,"teacher_disagreement_score":0.004306338,"about_ca_system_score_codex":0.00036728373,"about_ca_system_score_gemma":0.00024794033,"threshold_uncertainty_score":0.014406145},"labels":[],"label_agreement":null},{"id":"W3009982165","doi":"10.1200/jco.2007.25.18_suppl.2554","title":"Pharmacokinetic (PK) interactions between capecitabine (X), oxaliplatin (O) and bevacizumab (A) when used in combination for first-line treatment of metastatic colorectal cancer (MCRC)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Capecitabine; Oxaliplatin; Irinotecan; Bevacizumab; Internal medicine; Colorectal cancer; Regimen; FOLFOX; Gastroenterology; Pharmacokinetics; Oncology; Cancer; Chemotherapy","score_opus":0.21257378462741217,"score_gpt":0.5383188680677896,"score_spread":0.32574508344037745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009982165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99711776,0.0012684807,0.0007157029,0.000071665054,0.000014933937,0.00012346516,0.00014275206,0.000033110307,0.0005120855],"genre_scores_gemma":[0.99805933,0.00051813334,0.00076651335,0.000049177263,0.000034755365,0.00008401151,0.0001740324,0.000008696318,0.00030541568],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9995017,0.00025336162,0.000021202784,0.00006826898,0.00009932964,0.000056050754],"domain_scores_gemma":[0.9996145,0.00012620472,0.00017546421,0.000019462954,0.000012860487,0.00005159027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006985352,0.0004379389,0.00084797974,0.00024017206,0.00025449367,0.00068940653,0.00030349524,0.00034100914,0.0012333691],"category_scores_gemma":[0.001240711,0.0003877246,0.00045650188,0.00026269627,0.00049853965,0.00051369984,0.00021377114,0.0010156579,0.00020712435],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.098846324,0.013356498,0.043898247,0.0007160071,0.0011881317,0.0009446851,0.00045910713,0.01941297,0.65997386,0.0002976578,0.0029493566,0.15795708],"study_design_scores_gemma":[0.023712782,0.41662514,0.22932364,0.0000790084,0.0019269738,0.008738386,0.0003107292,0.04682339,0.2535912,0.000727051,0.01795545,0.00018624603],"about_ca_topic_score_codex":0.000921018,"about_ca_topic_score_gemma":0.0016475,"teacher_disagreement_score":0.0012333691,"about_ca_system_score_codex":0.0009064629,"about_ca_system_score_gemma":0.00063563336,"threshold_uncertainty_score":0.0065768957},"labels":[],"label_agreement":null},{"id":"W3010161595","doi":"10.1200/jco.2007.25.18_suppl.1003","title":"A randomized, double-blind phase II study of the oral tyrosine kinase inhibitor (TKI) axitinib (AG-013736) in combination with docetaxel (DOC) compared to DOC plus placebo (PL) in metastatic breast cancer (MBC)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Docetaxel; Internal medicine; Taxane; Adverse effect; Gastroenterology; Placebo; Nausea; Neutropenia; Febrile neutropenia; Stomatitis; Metastatic breast cancer; Anthracycline; Chemotherapy; Breast cancer; Pharmacology; Oncology; Cancer; Pathology","score_opus":0.17119473350791267,"score_gpt":0.5148333912451809,"score_spread":0.3436386577372682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010161595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836653,0.0018205296,0.0009144495,0.0005422927,0.000826182,0.009090373,0.0012075605,0.00017671273,0.001756583],"genre_scores_gemma":[0.9750518,0.0022116234,0.0024280378,0.0009365768,0.00081194384,0.012354505,0.0011911436,0.00005038309,0.0049639735],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99908304,0.00051356497,0.00005554781,0.00014203637,0.00006789601,0.0001379738],"domain_scores_gemma":[0.99834776,0.0004916406,0.00031825455,0.00014494099,0.00009519878,0.00060224085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023170267,0.0024465118,0.003934925,0.00063919905,0.0006263374,0.0012866546,0.0014160852,0.0019767813,0.008489011],"category_scores_gemma":[0.0022953989,0.00133293,0.0014667511,0.0006670223,0.0022975893,0.0012697878,0.0005197037,0.0037142693,0.001669847],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97603273,0.014573144,0.00021553399,0.00024004273,0.00022307436,0.000019340185,0.000034589088,0.00015755663,0.0029960952,0.000053503085,0.00033361805,0.0051207724],"study_design_scores_gemma":[0.8961126,0.102304034,0.0005767835,0.000009977193,0.00012883153,0.000015763204,0.000011249649,0.00022235204,0.00030538524,0.0000719319,0.00023271158,0.000008350197],"about_ca_topic_score_codex":0.0010935585,"about_ca_topic_score_gemma":0.0023460288,"teacher_disagreement_score":0.008489011,"about_ca_system_score_codex":0.0010483674,"about_ca_system_score_gemma":0.0023173133,"threshold_uncertainty_score":0.028398573},"labels":[],"label_agreement":null},{"id":"W3010522503","doi":"10.1158/1538-7445.sabcs19-ot1-08-07","title":"Abstract OT1-08-07: CONTESSA 2: A multinational, multicenter, phase 2 study of tesetaxel plus a reduced dose of capecitabine in patients with HER2-, HR+ metastatic breast cancer (MBC) who have not previously received a taxane","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; McGill University Health Centre","funders":"","keywords":"Capecitabine; Medicine; Taxane; Regimen; Internal medicine; Metastatic breast cancer; Clinical endpoint; Chemotherapy; Oncology; Dosing; Phases of clinical research; Chemotherapy regimen; Breast cancer; Cancer; Clinical trial","score_opus":0.10674752161737866,"score_gpt":0.4428524557434013,"score_spread":0.33610493412602266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010522503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99017334,0.0015387068,0.00035075872,0.0008982883,0.00013997171,0.0026623781,0.0016023451,0.000110705514,0.0025235247],"genre_scores_gemma":[0.9805053,0.0016186583,0.002144597,0.0013170397,0.00033794873,0.0029933206,0.0052255816,0.00005780072,0.005799732],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99966204,0.00016077669,0.000014626778,0.00006306641,0.000032698015,0.00006685291],"domain_scores_gemma":[0.99919516,0.00014034474,0.00013500823,0.000047533347,0.00005648516,0.0004255195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019674029,0.0018093331,0.0012142273,0.00044800737,0.00050821976,0.0010297445,0.0010569647,0.0014900693,0.0054554753],"category_scores_gemma":[0.00094919535,0.0005297761,0.0010678656,0.000442221,0.0009955387,0.0011052924,0.0003850552,0.0033841934,0.0009917255],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71266586,0.112003766,0.013086323,0.001005025,0.0016251148,0.0005191178,0.00050572306,0.003994895,0.056153387,0.00055451697,0.012640449,0.08524584],"study_design_scores_gemma":[0.5584521,0.42018372,0.012522967,0.000046148918,0.0003704471,0.00034404508,0.00006927701,0.0016075781,0.002999181,0.0001758259,0.003191925,0.000036674755],"about_ca_topic_score_codex":0.0017862039,"about_ca_topic_score_gemma":0.0046095396,"teacher_disagreement_score":0.0054554753,"about_ca_system_score_codex":0.0010197578,"about_ca_system_score_gemma":0.0018867913,"threshold_uncertainty_score":0.018250346},"labels":[],"label_agreement":null},{"id":"W3011242490","doi":"10.1200/jco.2013.31.15_suppl.1050","title":"Quality of life (QoL) in patients (pts) with locally advanced or metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes who received eribulin mesylate or capecitabine: A phase III, open-label, randomized study.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Eribulin; Capecitabine; Internal medicine; Metastatic breast cancer; Clinical endpoint; Taxane; Quality of life (healthcare); Anthracycline; Breast cancer; Adverse effect; Oncology; Phases of clinical research; Progression-free survival; Cancer; Clinical trial; Chemotherapy","score_opus":0.12441381449430199,"score_gpt":0.5084301453302427,"score_spread":0.38401633083594067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011242490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99838257,0.0006807029,0.0001037144,0.00009699318,0.000026016754,0.00031924964,0.0001631616,0.0000074486666,0.0002201471],"genre_scores_gemma":[0.9974312,0.0005260302,0.0003516392,0.00024373556,0.000056254066,0.0007290238,0.00031880496,0.0000020427833,0.0003412227],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99964106,0.0001969248,0.000024186744,0.000046313533,0.000034707617,0.00005681454],"domain_scores_gemma":[0.99933213,0.00013634519,0.0002175802,0.0000219181,0.00002561071,0.0002663861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013829521,0.000791372,0.0012583181,0.00024288177,0.00033608917,0.0005754264,0.00037204314,0.0008931159,0.0024203162],"category_scores_gemma":[0.0010157954,0.0004220518,0.0012617313,0.00042170894,0.000625268,0.0005225315,0.00038979534,0.0014496559,0.00028209377],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82697195,0.03887765,0.07364914,0.00085760665,0.0024398149,0.00020801034,0.00022598417,0.0015540979,0.007315966,0.00012424053,0.0012099165,0.04656565],"study_design_scores_gemma":[0.31081358,0.5668272,0.11653901,0.00006435979,0.0012520473,0.00022642582,0.00010681842,0.001920279,0.0009320815,0.00014169345,0.001148931,0.000027626762],"about_ca_topic_score_codex":0.00078610296,"about_ca_topic_score_gemma":0.0012802478,"teacher_disagreement_score":0.0024203162,"about_ca_system_score_codex":0.0005576536,"about_ca_system_score_gemma":0.00065686693,"threshold_uncertainty_score":0.008096755},"labels":[],"label_agreement":null},{"id":"W3011568629","doi":"10.1016/j.annonc.2020.01.028","title":"19O A phase Ib trial of CFI-402257 in combination with weekly paclitaxel in patients with advanced HER2-negative (HER2-) breast cancer (aBC)","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Ottawa Hospital; Canadian Partnership Against Cancer; Princess Margaret Cancer Centre","funders":"Ontario Institute for Cancer Research; Canadian Cancer Society; Stand Up To Cancer Canada; Government of Ontario","keywords":"Medicine; Neutropenia; Internal medicine; Taxane; Breast cancer; Adverse effect; Nausea; Tolerability; Febrile neutropenia; Paclitaxel; Oncology; Cancer; Metastatic breast cancer; Chemotherapy; Response Evaluation Criteria in Solid Tumors; Gastroenterology; Phases of clinical research","score_opus":0.05386763053986506,"score_gpt":0.4132210440111539,"score_spread":0.35935341347128885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011568629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746242,0.004009605,0.0007215975,0.0016842957,0.0005541139,0.0031907829,0.0036084864,0.00030844496,0.011298555],"genre_scores_gemma":[0.96498436,0.0048197033,0.0028204117,0.0026268791,0.0004452613,0.0026857995,0.0065635005,0.0000804086,0.014973653],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99980134,0.000062184714,0.000009433047,0.000028711076,0.000016298083,0.00008198486],"domain_scores_gemma":[0.9997253,0.000037921556,0.000028862625,0.000016999791,0.000013660836,0.00017727268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058337214,0.00096767157,0.0014817105,0.000575867,0.0004117896,0.00097018905,0.00064995553,0.001228025,0.009923161],"category_scores_gemma":[0.00044987065,0.00038653586,0.0010450154,0.0004287834,0.0005397095,0.00050996226,0.00030133745,0.002772124,0.0017819564],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.54070795,0.05297782,0.0078192325,0.0013605864,0.00209173,0.00068136415,0.00026804366,0.0033884197,0.05663254,0.0012342149,0.022771088,0.3100671],"study_design_scores_gemma":[0.63179827,0.33257535,0.011738401,0.00011799964,0.00069929374,0.0005729502,0.00008342138,0.0016432136,0.005818882,0.00042448018,0.014478022,0.000049708684],"about_ca_topic_score_codex":0.0023397272,"about_ca_topic_score_gemma":0.0067746458,"teacher_disagreement_score":0.009923161,"about_ca_system_score_codex":0.00071702455,"about_ca_system_score_gemma":0.0015183837,"threshold_uncertainty_score":0.03319627},"labels":[],"label_agreement":null},{"id":"W3011656614","doi":"","title":"Mammalian Target of Rapamycin Inhibition Synergistically Increases Cytotoxicity of Vinorelbine in Breast Cancer Cells.","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"PI3K/AKT/mTOR pathway; Protein kinase B; Vinorelbine; RPTOR; Chemistry; Kinase; Cancer research; Phosphorylation; Pharmacology; Signal transduction; Biology; Cell biology; Biochemistry","score_opus":0.03415952101981392,"score_gpt":0.38252770423928323,"score_spread":0.34836818321946933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011656614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888099,0.0043278844,0.0006759286,0.00020715344,0.0001950787,0.00008732225,0.00091109704,0.00014522008,0.004640417],"genre_scores_gemma":[0.9901626,0.0026460835,0.0015018494,0.00009918607,0.000040157433,0.00011162015,0.0013568829,0.000018246426,0.0040634656],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99976295,0.000049135273,0.000024163774,0.000042140404,0.000055034667,0.000066492954],"domain_scores_gemma":[0.9998951,0.000025354606,0.000020099233,0.000017630182,0.0000116413985,0.000030130654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014985212,0.00042094503,0.00066794374,0.00032105495,0.00017892814,0.00027344387,0.0002145393,0.00030521475,0.0020494666],"category_scores_gemma":[0.00012957436,0.0002163247,0.0003858557,0.00035266348,0.00015371255,0.00016139892,0.00019627488,0.0005122725,0.0005064872],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001376819,0.00055086316,0.0005335689,0.00018129773,0.00005685261,0.00013323294,0.000049839287,0.0003330879,0.98673624,0.00010649581,0.0007370073,0.009204763],"study_design_scores_gemma":[0.00013995108,0.0048237513,0.011766247,0.000015242214,0.00006445745,0.0005155113,0.000037376227,0.00075814006,0.97580385,0.000029680908,0.006033558,0.000012338495],"about_ca_topic_score_codex":0.0013510868,"about_ca_topic_score_gemma":0.004277997,"teacher_disagreement_score":0.0020494666,"about_ca_system_score_codex":0.00045490786,"about_ca_system_score_gemma":0.000330722,"threshold_uncertainty_score":0.006856203},"labels":[],"label_agreement":null},{"id":"W3011815213","doi":"10.1200/jco.2006.24.18_suppl.6019","title":"Measuring chemotherapy safety in a community oncology practice: Results of a three-year prospective study","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chemotherapy; Internal medicine; Cancer; Prospective cohort study; Lung cancer; Breast cancer; Neutropenia; Intensive care medicine; Oncology","score_opus":0.20793970800131584,"score_gpt":0.5302978625886811,"score_spread":0.3223581545873652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011815213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99902105,0.00014276167,0.0000838096,0.000072962204,0.000005243743,0.00010222088,0.00025028418,0.000004937804,0.00031673274],"genre_scores_gemma":[0.99873894,0.00017442748,0.00023469365,0.00011058742,0.000011858681,0.00012185655,0.0004671678,0.0000058080473,0.0001346015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939831,0.002823881,0.0007349619,0.0006886727,0.0011312849,0.0006381476],"domain_scores_gemma":[0.9746483,0.005761735,0.01031884,0.001580961,0.0042291773,0.0034610226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008296694,0.00046800586,0.0005280114,0.0025204697,0.0015453722,0.0018097683,0.0008439742,0.0010960648,0.0015021404],"category_scores_gemma":[0.019048551,0.0008737552,0.001083276,0.003779776,0.0010357843,0.001970493,0.0019648287,0.0013904202,0.0006193305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012717542,0.00046205908,0.9969215,0.00001540944,0.00004740262,0.000047074613,0.00064072653,0.000022432707,0.00003202208,0.0000070725987,0.00012676154,0.001550434],"study_design_scores_gemma":[0.00006387725,0.0010186132,0.99638087,0.000021596035,0.00003431601,0.00011440699,0.0018362459,0.00019332979,0.000028048727,0.000011097629,0.00028529353,0.000012323052],"about_ca_topic_score_codex":0.020405537,"about_ca_topic_score_gemma":0.019864276,"teacher_disagreement_score":0.020405537,"about_ca_system_score_codex":0.001755388,"about_ca_system_score_gemma":0.002129659,"threshold_uncertainty_score":0.04387766},"labels":[],"label_agreement":null},{"id":"W3011863200","doi":"10.1200/jco.2006.24.18_suppl.6129","title":"Drug interactions in ambulatory cancer patients receiving cancer-directed therapy","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cancer; Internal medicine; Ambulatory; Drug; Chemotherapy; Logistic regression; Breast cancer; Epidemiology; Pharmacology","score_opus":0.12448327550527227,"score_gpt":0.5302975286402103,"score_spread":0.405814253134938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011863200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98793614,0.0056622853,0.00035068416,0.00078316644,0.000027585946,0.000058336158,0.0014284048,0.00003785331,0.003715734],"genre_scores_gemma":[0.9977214,0.0010670255,0.00029990426,0.00019007959,0.00005118114,0.000014958462,0.00047534335,0.0000033701328,0.00017671315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982015,0.00046130264,0.0003556009,0.00019222072,0.0006744285,0.000114963404],"domain_scores_gemma":[0.98431975,0.003141429,0.010831503,0.00018087856,0.000634823,0.0008916584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007860576,0.00015507122,0.00041499935,0.0011190546,0.00046249756,0.00055091374,0.00020341865,0.00035444717,0.0029625415],"category_scores_gemma":[0.0067046415,0.00014966106,0.00050143566,0.0020827043,0.00019120309,0.00046409885,0.00051815924,0.00079788436,0.00027776838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005350672,0.00003448623,0.9928726,0.00005259791,0.000041176325,0.00022972836,0.000046112084,0.000036041994,0.00006221045,0.000015207906,0.00036470094,0.0061915405],"study_design_scores_gemma":[0.000010361934,0.00019367384,0.99563557,0.000050857558,0.000045527813,0.0023680665,0.000110953,0.000258479,0.000053714495,0.00004130859,0.0012265494,0.000004997732],"about_ca_topic_score_codex":0.0025990065,"about_ca_topic_score_gemma":0.0038297772,"teacher_disagreement_score":0.0029625415,"about_ca_system_score_codex":0.0004333441,"about_ca_system_score_gemma":0.00041677328,"threshold_uncertainty_score":0.009910643},"labels":[],"label_agreement":null},{"id":"W3012324339","doi":"10.1200/jco.2012.30.15_suppl.604","title":"Lapatinib in HER2+ early breast cancer: Quality of life analysis.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Lapatinib; Medicine; Placebo; Quality of life (healthcare); Population; Clinical endpoint; Internal medicine; Breast cancer; Randomized controlled trial; Adverse effect; Oncology; Cancer; Alternative medicine; Trastuzumab","score_opus":0.25999208827237974,"score_gpt":0.5899869266895392,"score_spread":0.3299948384171595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012324339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838537,0.0077296714,0.0006096073,0.00018783916,0.000023112401,0.00031415286,0.005894719,0.000020598434,0.0013665728],"genre_scores_gemma":[0.992714,0.00084866094,0.0005058432,0.000087216045,0.000022193066,0.0002819786,0.0051405113,0.000004349543,0.00039512117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889636,0.000535354,0.00010402351,0.000093870636,0.00025867225,0.00011169761],"domain_scores_gemma":[0.9985392,0.000286836,0.00080915727,0.000043256226,0.00011502346,0.0002065677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028978789,0.00039548037,0.00069026876,0.00094559253,0.00017139284,0.0005647514,0.0003626955,0.00029829954,0.0028738598],"category_scores_gemma":[0.002173249,0.00016132061,0.0016480782,0.0014059325,0.00015427846,0.000313415,0.000576242,0.0005287885,0.0002731221],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037933525,0.0008337519,0.9093786,0.0009782367,0.004383141,0.00008008439,0.000065982385,0.0011307143,0.0007539533,0.00007408383,0.0018507876,0.042537168],"study_design_scores_gemma":[0.002624641,0.0037846912,0.9886149,0.0000680757,0.0011880326,0.00025365246,0.000054815086,0.0015925462,0.00027018628,0.00011394425,0.0014171918,0.000017379882],"about_ca_topic_score_codex":0.0010395932,"about_ca_topic_score_gemma":0.0013052064,"teacher_disagreement_score":0.0028978789,"about_ca_system_score_codex":0.00071463047,"about_ca_system_score_gemma":0.00033099137,"threshold_uncertainty_score":0.015325606},"labels":[],"label_agreement":null},{"id":"W3013899227","doi":"10.1158/1538-7445.sabcs19-p4-14-09","title":"Abstract P4-14-09: Platinum-based chemotherapy in early-stage triple negative breast cancer: A meta-analysis","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Oncology; Triple-negative breast cancer; Breast cancer; Taxane; Anthracycline; Chemotherapy; Confidence interval; Meta-analysis; Cancer; Surgery","score_opus":0.22982111868810523,"score_gpt":0.4780810175425407,"score_spread":0.24825989885443545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013899227","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018259255,0.974358,0.002301626,0.00060896727,0.000571532,0.0006896546,0.0021696342,0.0001429048,0.0008983985],"genre_scores_gemma":[0.63183844,0.35308814,0.004652743,0.002362352,0.00082451786,0.0021774943,0.0030832777,0.00015120242,0.0018218405],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9904578,0.005558979,0.0017987636,0.0010815047,0.00081015105,0.00029280927],"domain_scores_gemma":[0.9874685,0.008934847,0.0018625942,0.0005151522,0.00094439223,0.0002744231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01244848,0.0034418148,0.017025666,0.004391394,0.0006163271,0.0042344118,0.0023469655,0.0025735826,0.008052959],"category_scores_gemma":[0.02297874,0.0012925399,0.0592267,0.0053336876,0.00067240954,0.0019099313,0.0016395195,0.0031924725,0.0008602352],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002819754,0.000021132852,0.002547076,0.08100788,0.90942657,0.00009373734,0.000020443242,0.00048229698,0.00021451249,0.00006183423,0.00049951766,0.0028052633],"study_design_scores_gemma":[0.0007278292,0.0001288593,0.001985762,0.0034718104,0.99266726,0.000043284603,0.000012704089,0.00020962021,0.00005966534,0.00011704946,0.00056539435,0.000010815228],"about_ca_topic_score_codex":0.0054052183,"about_ca_topic_score_gemma":0.007885472,"teacher_disagreement_score":0.017025666,"about_ca_system_score_codex":0.0018079861,"about_ca_system_score_gemma":0.0019723573,"threshold_uncertainty_score":0.06583464},"labels":[],"label_agreement":null},{"id":"W3015494016","doi":"","title":"L'applicazione della Edmonton Symptom Assessment System (ESAS) nel paziente oncologico. Indagine presso l'Unità Operativa di Oncologia dell'Azienda ULSS 18 di Rovigo.","year":2018,"lang":"it","type":"article","venue":"Rivista Italiana di Cure Palliative","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.04018332912185468,"score_gpt":0.3678559698070109,"score_spread":0.3276726406851562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015494016","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29771236,0.39100635,0.024831424,0.06911753,0.010509354,0.002589975,0.013885217,0.00109548,0.18925229],"genre_scores_gemma":[0.71901166,0.12006843,0.09299871,0.009307057,0.0037702015,0.0023386271,0.0071574547,0.00033686878,0.045011032],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985323,0.00079432613,0.000107520806,0.00012612424,0.00034673652,0.00009296218],"domain_scores_gemma":[0.9969562,0.0015907143,0.0003437939,0.00018813521,0.00065320864,0.0002678882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004141405,0.0003772921,0.0005494658,0.0011779334,0.00025180617,0.0014091295,0.0004159319,0.00055487826,0.006173428],"category_scores_gemma":[0.007175417,0.00017542513,0.0004895563,0.0007540801,0.00048008413,0.000721916,0.0011033986,0.0014179811,0.0016185512],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004817263,0.00027572058,0.07934112,0.0009490454,0.0001809441,0.00018643684,0.00042393798,0.00038608274,0.0032306293,0.0021626456,0.056357734,0.85602397],"study_design_scores_gemma":[0.00049267866,0.0021803651,0.51283795,0.0035818894,0.00035712303,0.0038332057,0.00067129114,0.0015075939,0.0037379055,0.004143028,0.46650302,0.00015398266],"about_ca_topic_score_codex":0.003539376,"about_ca_topic_score_gemma":0.010373652,"teacher_disagreement_score":0.006173428,"about_ca_system_score_codex":0.00075134577,"about_ca_system_score_gemma":0.0022529252,"threshold_uncertainty_score":0.021902084},"labels":[],"label_agreement":null},{"id":"W3023616387","doi":"","title":"PCN143 – Pcodr – the pointless canadian oncology drug review?","year":2015,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Drug; Oncology; Pharmacology","score_opus":0.07922609922640306,"score_gpt":0.4003947621710844,"score_spread":0.3211686629446813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023616387","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044931818,0.7330909,0.00058495015,0.20999283,0.023324843,0.000048914073,0.0005065746,0.00013011959,0.03187153],"genre_scores_gemma":[0.00905004,0.7964503,0.0018733778,0.15115361,0.012223836,0.000048066755,0.0004862925,0.00007962428,0.028634917],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973116,0.0005934935,0.00018772026,0.00023888871,0.0011822573,0.00048607556],"domain_scores_gemma":[0.9914452,0.0014207198,0.00059632736,0.00025820467,0.004675472,0.001603998],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0056226593,0.0010571289,0.0020097548,0.0023098378,0.0017369766,0.0055922153,0.0024360537,0.0048344294,0.02628278],"category_scores_gemma":[0.011837677,0.0004786124,0.001084168,0.0032300993,0.003494869,0.005370181,0.0023508563,0.008133751,0.006919057],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003010985,0.000043136188,0.00018211539,0.0017508145,0.00007351582,0.000097446624,0.00006235988,0.00015342893,0.00028599202,0.019102355,0.67511225,0.3028355],"study_design_scores_gemma":[0.00007514297,0.000055731278,0.0002128266,0.0015405209,0.000052064308,0.000076798926,0.000056195113,0.000049591166,0.000053895474,0.0021759684,0.9956318,0.000019569658],"about_ca_topic_score_codex":0.2536352,"about_ca_topic_score_gemma":0.56903255,"teacher_disagreement_score":0.9943773,"about_ca_system_score_codex":0.015859839,"about_ca_system_score_gemma":0.05438199,"threshold_uncertainty_score":0.50431776},"labels":[],"label_agreement":null},{"id":"W3026445041","doi":"10.1139/cjpp-2019-0380","title":"History of the Pharmacological Society of Canada 1956–2008","year":2020,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Queen's University; Dalhousie University","funders":"","keywords":"Clinical pharmacology; Political science; Public administration; Medicine; Pharmacology","score_opus":0.031073046022360846,"score_gpt":0.27002696406131776,"score_spread":0.2389539180389569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026445041","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002944886,0.18024942,0.0009983972,0.12387219,0.03839605,0.00025707795,0.0034312957,0.0002699546,0.6495807],"genre_scores_gemma":[0.043430645,0.20110074,0.0016547935,0.05010909,0.013743325,0.00019530799,0.0022923255,0.00028076582,0.6871929],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99558985,0.00034348777,0.00021840469,0.0004018583,0.0026731282,0.00077327946],"domain_scores_gemma":[0.9910618,0.00044348493,0.00026941852,0.0002190827,0.0059309932,0.0020752684],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0027144083,0.0008070981,0.000587145,0.005120998,0.009325467,0.006927886,0.0012791326,0.0037665481,0.037830632],"category_scores_gemma":[0.0064858478,0.0005199505,0.0003878721,0.0068537383,0.004758331,0.0021997143,0.0029512192,0.0067673535,0.01366756],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006557958,0.00006269809,0.000853924,0.0005122809,0.000016484275,0.00031756444,0.0010272689,0.000110788205,0.00032527855,0.051162995,0.8278613,0.11768379],"study_design_scores_gemma":[0.0000015336858,0.0000030105818,0.0004498812,0.00008229562,0.0000014896867,0.000026285183,0.000042366766,0.0000049031023,0.000029599456,0.00020234231,0.99915147,0.0000047613453],"about_ca_topic_score_codex":0.77045137,"about_ca_topic_score_gemma":0.82998365,"teacher_disagreement_score":0.99067456,"about_ca_system_score_codex":0.050950848,"about_ca_system_score_gemma":0.10052931,"threshold_uncertainty_score":0.46180093},"labels":[],"label_agreement":null},{"id":"W3028662611","doi":"10.3760/cma.j.issn.0254-1416.2011.06.011","title":"Efficacy of destruction of dorsal root ganglia with local doxorubicin Injection under the guidance of CT for postherpetic neuralgia involving thoracic back region","year":2011,"lang":"en","type":"article","venue":"Zhonghua mazuixue zazhi","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Postherpetic neuralgia; Medicine; Anesthesia; Lidocaine; Gabapentin; Neuralgia; Local anesthetic; Oxycodone; Surgery; Neuropathic pain; Opioid; Internal medicine","score_opus":0.043161060224063165,"score_gpt":0.3071492744596878,"score_spread":0.26398821423562463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028662611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99492115,0.0039508063,0.00042860385,0.000031529435,0.000012833424,0.00007806558,0.00001860462,0.0000133005615,0.00054515095],"genre_scores_gemma":[0.9977316,0.0015243061,0.00040285266,0.000030258067,0.000029139135,0.000037274254,0.000026546088,0.000001311587,0.00021675431],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998709,0.000047324145,0.000009051752,0.000015656413,0.000032851927,0.000024198416],"domain_scores_gemma":[0.9998178,0.00007061521,0.000051189145,0.00001646729,0.0000133889735,0.000030636766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025116524,0.00024027466,0.0003650394,0.00017461575,0.00009203337,0.00011133615,0.00016764987,0.00019124558,0.0010062184],"category_scores_gemma":[0.00048007478,0.00006894146,0.00019586229,0.000091643575,0.0001910901,0.00014361438,0.00009723837,0.00024523452,0.000117830845],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058918614,0.012840156,0.049292225,0.0025971602,0.00055471354,0.0024316728,0.0004437831,0.0019395853,0.42965385,0.0001684523,0.00063715264,0.4405226],"study_design_scores_gemma":[0.008864093,0.56012696,0.29908165,0.0004105355,0.0011525442,0.0066497047,0.00044232226,0.004251211,0.1143887,0.00010411797,0.0044773067,0.00005092873],"about_ca_topic_score_codex":0.00027345849,"about_ca_topic_score_gemma":0.00065739546,"teacher_disagreement_score":0.0010062184,"about_ca_system_score_codex":0.00008505515,"about_ca_system_score_gemma":0.0001088992,"threshold_uncertainty_score":0.0033661127},"labels":[],"label_agreement":null},{"id":"W3029233318","doi":"10.1200/jco.2020.38.15_suppl.e14012","title":"Systematic analysis of chemotherapy agents for home-based administration.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chemotherapy; Continuous infusion; Emergency medicine; Intensive care medicine; Internal medicine","score_opus":0.23374951722622045,"score_gpt":0.5476316261068798,"score_spread":0.3138821088806593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029233318","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.092943184,0.8477336,0.0029474688,0.002332019,0.00065192225,0.009144269,0.03948567,0.00020365568,0.0045581614],"genre_scores_gemma":[0.51913595,0.4182513,0.02087313,0.0037821897,0.00045858425,0.009561542,0.026341513,0.00013508963,0.0014606804],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9658494,0.008048701,0.016083546,0.0019825606,0.0076071536,0.000428629],"domain_scores_gemma":[0.86917216,0.05153467,0.05212636,0.00396966,0.021742443,0.0014547849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017214011,0.00085997465,0.003829892,0.017853964,0.00061576115,0.001187324,0.0010410061,0.00088300003,0.0022219666],"category_scores_gemma":[0.07548553,0.0006233111,0.005114117,0.01490644,0.000707781,0.0012621563,0.0016580344,0.00069030595,0.0004280801],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022153354,0.00013460589,0.15363075,0.5712143,0.015886303,0.0007983434,0.001629415,0.0004437407,0.0014083021,0.00055959815,0.019951796,0.23212738],"study_design_scores_gemma":[0.0017455858,0.0016457286,0.40050787,0.4395142,0.04656687,0.0030644692,0.0025957425,0.0013730547,0.002374266,0.0009183987,0.099429734,0.00026415195],"about_ca_topic_score_codex":0.01196192,"about_ca_topic_score_gemma":0.03497868,"teacher_disagreement_score":0.017853964,"about_ca_system_score_codex":0.0027563612,"about_ca_system_score_gemma":0.012188632,"threshold_uncertainty_score":0.09103751},"labels":[],"label_agreement":null},{"id":"W3031809543","doi":"10.1200/jco.2020.38.15_suppl.1088","title":"Clinical predictors of long-term response to capecitabine in metastatic breast cancer (MBC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital; University of Alberta; Baker Hughes (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Capecitabine; Internal medicine; Metastatic breast cancer; Breast cancer; Cohort; Oncology; Cancer; Docetaxel; Proportional hazards model; Stage (stratigraphy); Hormonal therapy; Surgery","score_opus":0.18164664771792685,"score_gpt":0.5443573413343225,"score_spread":0.36271069361639563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031809543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99815124,0.0006425251,0.000053829885,0.000092374736,0.000005007465,0.00001436742,0.000597187,0.000003537737,0.00043988964],"genre_scores_gemma":[0.9992642,0.000098054596,0.000044992015,0.000015220595,0.000008720353,0.0000074283603,0.00043769373,0.0000010840228,0.00012267548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999759,0.000050367773,0.000034876895,0.00003454296,0.000075161726,0.000046005815],"domain_scores_gemma":[0.9976094,0.0005707196,0.001177052,0.000038737307,0.00021055755,0.00039352902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006058926,0.00014050196,0.00018753027,0.0004176415,0.00022760063,0.0004140808,0.00025307288,0.00031381624,0.0018493138],"category_scores_gemma":[0.0022289017,0.00008915299,0.00020641502,0.0007293403,0.00018019597,0.00027138635,0.00025198245,0.0004514808,0.0002824167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016292179,0.000015669762,0.9987079,0.000009508433,0.0000097451675,0.00005571043,0.000011018663,0.00003123951,0.00007731743,0.000003409034,0.00007418786,0.0008413315],"study_design_scores_gemma":[0.0000063952493,0.00013745058,0.99908507,0.0000062439585,0.000014531643,0.0002849164,0.000047072605,0.0001569187,0.000048431513,0.000007618921,0.00020394998,0.0000014976714],"about_ca_topic_score_codex":0.0061187,"about_ca_topic_score_gemma":0.009993218,"teacher_disagreement_score":0.0061187,"about_ca_system_score_codex":0.0004942997,"about_ca_system_score_gemma":0.0004795125,"threshold_uncertainty_score":0.012166202},"labels":[],"label_agreement":null},{"id":"W3032371821","doi":"10.1200/jco.2020.38.15_suppl.tps1111","title":"CONTESSA TRIO: A multinational, multicenter, phase (P) II study of tesetaxel (T) plus three different PD-(L)1 inhibitors in patients (Pts) with metastatic triple-negative breast cancer (TNBC) and tesetaxel monotherapy in elderly pts with HER2-metastatic breast cancer (MBC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Atezolizumab; Pembrolizumab; Taxane; Internal medicine; Tolerability; Oncology; Cohort; Chemotherapy; Nivolumab; Metastatic breast cancer; Breast cancer; Cancer; Immunotherapy; Adverse effect","score_opus":0.09154226995387651,"score_gpt":0.4490843375037694,"score_spread":0.35754206754989293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032371821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97827554,0.0031502547,0.00081346615,0.001799819,0.00030304008,0.0067511527,0.0038979796,0.00023584205,0.004772865],"genre_scores_gemma":[0.962689,0.0031539847,0.003700603,0.0027972031,0.0005359642,0.010754657,0.008806825,0.00015333922,0.0074085896],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99933016,0.00033545122,0.000025500816,0.00010379265,0.00007416354,0.00013085069],"domain_scores_gemma":[0.9984353,0.0002181332,0.00029575068,0.00011293173,0.00008282877,0.0008550173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026279006,0.0021207035,0.0016543202,0.00080372737,0.0006636739,0.001427292,0.0016473816,0.001976108,0.005698073],"category_scores_gemma":[0.001435753,0.00076144736,0.0018603534,0.00073250436,0.0014659131,0.0013113223,0.0007669557,0.0038819755,0.0016449639],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73307246,0.10094396,0.017127426,0.0013079131,0.0020729012,0.0005931906,0.0006828442,0.0036709397,0.045689,0.0007784968,0.01721995,0.07684091],"study_design_scores_gemma":[0.69218737,0.28492504,0.012179923,0.00006082644,0.00064253865,0.00047364956,0.00008960088,0.0010492953,0.0021757158,0.00029099736,0.005871579,0.00005346911],"about_ca_topic_score_codex":0.0022737181,"about_ca_topic_score_gemma":0.0048358585,"teacher_disagreement_score":0.005698073,"about_ca_system_score_codex":0.0012515987,"about_ca_system_score_gemma":0.0030665041,"threshold_uncertainty_score":0.019061983},"labels":[],"label_agreement":null},{"id":"W3034300226","doi":"10.2337/db20-543-p","title":"543-P: A Randomised Control Trial to Evaluate the Efficacy of Chinese Traditional Medicine for the Treatment of Diabetic Peripheral Neuropathy","year":2020,"lang":"en","type":"article","venue":"Diabetes","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Diabetes mellitus; Adverse effect; Internal medicine; Peripheral neuropathy; Randomized controlled trial; Clinical trial; Traditional Chinese medicine; Surgery; Diabetic neuropathy; Alternative medicine","score_opus":0.04734966850464823,"score_gpt":0.33069419984538767,"score_spread":0.28334453134073945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034300226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97249526,0.007937796,0.0008882642,0.0011264015,0.0011982349,0.012366016,0.0010732342,0.0001971348,0.002717657],"genre_scores_gemma":[0.97317636,0.0034534484,0.00190751,0.0014221199,0.0005935309,0.015427017,0.0007659246,0.000016720158,0.003237256],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99885106,0.00061854464,0.00009522961,0.00020389502,0.00008431116,0.00014690083],"domain_scores_gemma":[0.99900824,0.0002757676,0.00026814023,0.0000713677,0.00007530818,0.00030124735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002009967,0.0019517962,0.004002834,0.0007526511,0.000705334,0.00093593355,0.0013019199,0.0029793198,0.011996596],"category_scores_gemma":[0.0024977396,0.00070346514,0.002517962,0.0007132126,0.0014826688,0.001195413,0.0007097871,0.0024980712,0.0010456413],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9883102,0.0026971677,0.0002441271,0.0012219716,0.0007371319,0.00003068868,0.000027863407,0.000088042725,0.0007117329,0.000078555146,0.0002486887,0.005603904],"study_design_scores_gemma":[0.97233564,0.02608663,0.0006686694,0.000049270253,0.00044825007,0.00000956015,0.000011061776,0.00010525411,0.00007767845,0.000059100792,0.000142851,0.000005977849],"about_ca_topic_score_codex":0.002325842,"about_ca_topic_score_gemma":0.0028812536,"teacher_disagreement_score":0.011996596,"about_ca_system_score_codex":0.0012917449,"about_ca_system_score_gemma":0.002108033,"threshold_uncertainty_score":0.04013264},"labels":[],"label_agreement":null},{"id":"W3043096450","doi":"10.1200/jco.20.00147","title":"Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":609,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Puma Biotechnology; American Society of Clinical Oncology","keywords":"Capecitabine; Medicine; Lapatinib; Internal medicine; Neratinib; Hazard ratio; Metastatic breast cancer; Clinical endpoint; Gastroenterology; Oncology; Cancer; Breast cancer; Trastuzumab; Randomized controlled trial; Confidence interval; Colorectal cancer","score_opus":0.12862131070580513,"score_gpt":0.467998518340425,"score_spread":0.33937720763461987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043096450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857437,0.0058276406,0.00045362583,0.00083204365,0.00049500755,0.002754722,0.0009033884,0.00009775464,0.0028921072],"genre_scores_gemma":[0.9858791,0.003590112,0.0010774954,0.0011642817,0.00034720483,0.0026507003,0.0011486589,0.00001894482,0.00412348],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99963844,0.00016571747,0.000030766056,0.00007101773,0.00003306977,0.000060977716],"domain_scores_gemma":[0.9995153,0.000104486084,0.0000940595,0.00002900616,0.000027629267,0.00022956061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013995869,0.0011550571,0.0023228808,0.00028237954,0.00031392963,0.0010892438,0.0007766474,0.0009474041,0.0038461706],"category_scores_gemma":[0.0010662565,0.0003715588,0.0015534194,0.00027751562,0.0006478847,0.00082002115,0.0003431238,0.0021935042,0.0006582462],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93350995,0.013087793,0.00090713316,0.0009876717,0.0011564078,0.000093742616,0.00007673373,0.0011081701,0.007087073,0.00016576383,0.0017222187,0.04009729],"study_design_scores_gemma":[0.8802244,0.1137568,0.0026407521,0.000054924454,0.00044552088,0.000105378786,0.00002802333,0.0006868563,0.00065368466,0.00018234651,0.0012028308,0.00001840365],"about_ca_topic_score_codex":0.0008271099,"about_ca_topic_score_gemma":0.0033581804,"teacher_disagreement_score":0.0038461706,"about_ca_system_score_codex":0.00081992225,"about_ca_system_score_gemma":0.0012666858,"threshold_uncertainty_score":0.012866735},"labels":[],"label_agreement":null},{"id":"W3046679789","doi":"10.1002/macp.202000216","title":"The Next 100 Years of Polymer Science","year":2020,"lang":"en","type":"article","venue":"Macromolecular Chemistry and Physics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université Laval; University of Prince Edward Island","funders":"","keywords":"Polymer science; Polymer; Polymerization; Polymer chemistry; Macromolecule; Chemistry; Nanotechnology; Materials science; Organic chemistry","score_opus":0.020340171021888804,"score_gpt":0.28696466615670974,"score_spread":0.26662449513482095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046679789","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035875314,0.525452,0.004320698,0.22446872,0.13161364,0.00008195597,0.0005048985,0.0003754045,0.10959524],"genre_scores_gemma":[0.044674676,0.5150544,0.007887733,0.12043421,0.077717796,0.00020115405,0.0010114975,0.00027578455,0.23274271],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99774384,0.0003558262,0.00013844347,0.00029335835,0.0010769046,0.0003916056],"domain_scores_gemma":[0.996494,0.0005403176,0.00020372061,0.0002796157,0.0010049356,0.0014773533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005426982,0.0009920704,0.0007328298,0.0014831624,0.0019070822,0.00563394,0.0008631998,0.003906538,0.03576127],"category_scores_gemma":[0.00611303,0.0004049902,0.00065930164,0.0012252984,0.0026377072,0.00717518,0.0042915787,0.0071635554,0.01759857],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012470152,0.00012869973,0.0004109971,0.0008721332,0.00003193718,0.00014167356,0.00027473437,0.00022003979,0.003888603,0.0625669,0.63221043,0.29912922],"study_design_scores_gemma":[0.0000037794407,0.000039772418,0.00018672389,0.0001741607,0.0000038384387,0.00007601381,0.00007277331,0.000035056953,0.00027120093,0.0083963275,0.9907342,0.0000061403384],"about_ca_topic_score_codex":0.00077955064,"about_ca_topic_score_gemma":0.0013090799,"teacher_disagreement_score":0.03576127,"about_ca_system_score_codex":0.00247628,"about_ca_system_score_gemma":0.0038057289,"threshold_uncertainty_score":0.11963338},"labels":[],"label_agreement":null},{"id":"W3083735926","doi":"10.1158/1538-7445.am2020-4130","title":"Abstract 4130: Improvement of drug efficacy of polo-like kinase 4 inhibitor in the treatment of uterine leiomyosarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Mitosis; Mitotic catastrophe; Cancer research; Cell cycle; Kinase; Cell growth; Apoptosis; Cell biology","score_opus":0.10802873920770342,"score_gpt":0.45531401868136095,"score_spread":0.3472852794736575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083735926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96504986,0.026002476,0.0013099272,0.00048786946,0.00025932663,0.00020153819,0.0011111379,0.0001908207,0.00538717],"genre_scores_gemma":[0.97797465,0.0108247055,0.0025163528,0.00022996159,0.000065196306,0.00012783127,0.0020060102,0.000024762086,0.006230486],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999498,0.0000097699585,0.000006560998,0.000011054461,0.000012261661,0.000010549567],"domain_scores_gemma":[0.9999658,0.0000066559583,0.000006272618,0.000002885557,0.0000066283524,0.000011712637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001336399,0.00023797809,0.00035518236,0.00030822642,0.000092793176,0.00017099666,0.0002480205,0.0002143794,0.003553451],"category_scores_gemma":[0.000102195525,0.00008499613,0.00024593747,0.00022329944,0.0000999387,0.0001586279,0.00013692885,0.0005953259,0.00045787208],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073557366,0.0016935999,0.0016448991,0.0014330078,0.00013554472,0.0005824021,0.00008858131,0.0010220194,0.8274298,0.0004370337,0.0037089703,0.15446842],"study_design_scores_gemma":[0.00439757,0.0484982,0.032970298,0.0002109607,0.0006377005,0.0034054443,0.00012140499,0.004625974,0.84144133,0.00031515447,0.06331533,0.000060589282],"about_ca_topic_score_codex":0.00061653747,"about_ca_topic_score_gemma":0.0010578563,"teacher_disagreement_score":0.003553451,"about_ca_system_score_codex":0.00019092583,"about_ca_system_score_gemma":0.00029133062,"threshold_uncertainty_score":0.011887491},"labels":[],"label_agreement":null},{"id":"W3088311877","doi":"10.1016/j.annonc.2020.08.377","title":"275O Impact of tucatinib on health-related quality of life (HRQoL) in patients with HER2+ metastatic breast cancer (MBC) with and without brain metastases (BM)","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; BC Cancer Agency; Jewish General Hospital","funders":"","keywords":"Medicine; Quality of life (healthcare); Capecitabine; Internal medicine; Visual analogue scale; Metastatic breast cancer; Placebo; Oncology; Depression (economics); Clinical trial; Breast cancer; Trastuzumab; Anxiety; Cancer; Surgery; Psychiatry; Alternative medicine; Pathology; Nursing","score_opus":0.13965578588046457,"score_gpt":0.4710488251463778,"score_spread":0.33139303926591324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088311877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960901,0.0018571991,0.000024771995,0.00019755184,0.000033081073,0.000008046877,0.0004203383,0.0000026991115,0.0013660422],"genre_scores_gemma":[0.99900454,0.00028385152,0.000021269583,0.0000751419,0.00001715398,0.0000060370917,0.00032316326,6.2619137e-7,0.00026828452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997671,0.000060879745,0.000018174771,0.000031707492,0.000030202684,0.00009206701],"domain_scores_gemma":[0.9997491,0.00006630523,0.00007994567,0.000009313207,0.00002585071,0.00006937512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034192,0.00015386022,0.00040207393,0.00019676337,0.0002722649,0.00064880966,0.00012433736,0.00028751395,0.0023952378],"category_scores_gemma":[0.0010206918,0.00006706244,0.0009472896,0.00031792678,0.00017075487,0.0003464801,0.00033028147,0.00048201534,0.00018407096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038632255,0.0015641326,0.83983296,0.00038420106,0.0020723573,0.00027799947,0.00019330149,0.0012410593,0.0025780883,0.00022302357,0.0022244551,0.11077608],"study_design_scores_gemma":[0.00043960425,0.0036119071,0.9919574,0.000053468768,0.00079867657,0.00022029139,0.0002966135,0.000925548,0.00034379523,0.00011522267,0.0012202313,0.000017273935],"about_ca_topic_score_codex":0.0042179986,"about_ca_topic_score_gemma":0.00906064,"teacher_disagreement_score":0.0042179986,"about_ca_system_score_codex":0.0005856923,"about_ca_system_score_gemma":0.00038501646,"threshold_uncertainty_score":0.00838691},"labels":[],"label_agreement":null},{"id":"W3088392406","doi":"10.1016/j.annonc.2020.08.451","title":"349TiP EPIK-B3: A phase III, randomised, double-blind (DB), placebo (PBO)-controlled study of alpelisib (ALP) + nab-paclitaxel (nab-PTX) in advanced triple-negative breast cancer (TNBC) with either PIK3CA mutation or phosphatase and tensin homolog (PTEN) loss without PIK3CA mutation","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Genentech; Ipsen; Daiichi Sankyo Europe; Servier; European Society for Medical Oncology; Chugai Pharmaceutical; Vifor Pharma; Oncolytics Biotech; Novo Nordisk; Astellas Pharma; Eisai; Seagen; Daiichi-Sankyo; MacroGenics; Japan Surgical Society; Puma Biotechnology; Pfizer; Incyte; Menarini Silicon Biosystems; Mylan; Clovis Oncology; Teva Pharmaceutical Industries; Sanofi; Foundation Medicine; Genomic Health; GlaxoSmithKline; Amgen; Novartis Pharmaceuticals Corporation; G1 Therapeutics; Jounce Therapeutics; Celgene; AstraZeneca; ImmunoMedics; Eli Lilly and Company; Samsung; Bristol-Myers Squibb","keywords":"Medicine; Triple-negative breast cancer; PTEN; Internal medicine; Oncology; Breast cancer; Population; Fulvestrant; Cancer; Cancer research; PI3K/AKT/mTOR pathway; Tamoxifen","score_opus":0.07964210492149927,"score_gpt":0.4290398262502009,"score_spread":0.3493977213287016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088392406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977715,0.0060798516,0.0017947643,0.00088311906,0.00077394187,0.0053814,0.002410646,0.00065218704,0.004309119],"genre_scores_gemma":[0.9763441,0.0046357918,0.002431622,0.0017103623,0.00041404605,0.005237161,0.002314544,0.00010869242,0.006803737],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996526,0.00015023342,0.000019941252,0.000072581664,0.000024206129,0.00008043632],"domain_scores_gemma":[0.99963796,0.000082372615,0.000051734314,0.000028471311,0.000023769167,0.00017576512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010591908,0.0019374294,0.0028783947,0.00055693864,0.00038543477,0.0009363493,0.0010797246,0.0017228543,0.009011068],"category_scores_gemma":[0.00089944643,0.00074958464,0.0011310945,0.00050020806,0.001129728,0.0009877943,0.00034783987,0.003293297,0.0018146149],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96918184,0.0065776855,0.00021900999,0.00061940047,0.00048104493,0.000028057026,0.000024974508,0.00024093511,0.0066728573,0.00010989255,0.00079941825,0.015044832],"study_design_scores_gemma":[0.94543463,0.051976766,0.0007996347,0.000017707524,0.00023087052,0.00002392686,0.000011807144,0.00024068398,0.00061608246,0.00007629873,0.00056073937,0.000010906917],"about_ca_topic_score_codex":0.0011412416,"about_ca_topic_score_gemma":0.0021156338,"teacher_disagreement_score":0.009011068,"about_ca_system_score_codex":0.00051559095,"about_ca_system_score_gemma":0.0011602753,"threshold_uncertainty_score":0.03014499},"labels":[],"label_agreement":null},{"id":"W3088957710","doi":"10.1016/j.annonc.2020.08.376","title":"274O Health-related quality of life (HRQoL) changes with veliparib in patients (pts) with metastatic or locally advanced breast cancer in the phase III BROCADE 3 study","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"AbbVie","keywords":"Medicine; Veliparib; Internal medicine; Breast cancer; Carboplatin; Brief Pain Inventory; Quality of life (healthcare); Oncology; Cancer; Metastatic breast cancer; Placebo; Hazard ratio; PARP inhibitor; Adverse effect; Paclitaxel; Physical therapy; Chemotherapy; Poly ADP ribose polymerase; Confidence interval; Chronic pain; Pathology","score_opus":0.17107674004817533,"score_gpt":0.47661155909900943,"score_spread":0.3055348190508341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088957710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941696,0.0018698239,0.00016152636,0.0001608506,0.000049029535,0.0002208591,0.001786826,0.000013900129,0.0015675423],"genre_scores_gemma":[0.99528426,0.0007496892,0.0002014771,0.0003024616,0.000042699852,0.00021826458,0.0022503356,0.0000046397854,0.0009460727],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996964,0.00013890967,0.000016492919,0.000042255746,0.000033949884,0.00007203509],"domain_scores_gemma":[0.9997818,0.0000450768,0.000066137574,0.000018496745,0.00001929545,0.000069241025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008414204,0.00046219147,0.0009653281,0.00012562612,0.0002743163,0.0007432402,0.0003079582,0.00040096717,0.00219191],"category_scores_gemma":[0.00046535477,0.00019586155,0.001608174,0.00038188323,0.00021941193,0.00029851234,0.00025481443,0.0012813922,0.00033385627],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.75039357,0.009653435,0.13630776,0.0007945983,0.0063438592,0.00020104677,0.00011405309,0.0025916833,0.013109817,0.00023009804,0.0044981656,0.07576178],"study_design_scores_gemma":[0.21319245,0.14795268,0.62000126,0.0001333114,0.00485108,0.000289768,0.00019714478,0.002078994,0.0043021487,0.0003398204,0.006589661,0.00007174437],"about_ca_topic_score_codex":0.00125561,"about_ca_topic_score_gemma":0.0025687548,"teacher_disagreement_score":0.00219191,"about_ca_system_score_codex":0.00050842564,"about_ca_system_score_gemma":0.00051018206,"threshold_uncertainty_score":0.007332623},"labels":[],"label_agreement":null},{"id":"W3090064455","doi":"10.24095/hpcdp.29.2.06f","title":"Thérapies complémentaires pour les patients cancéreux :évaluer les besoins d'information et l'utilisation de l'information","year":2009,"lang":"fr","type":"article","venue":"Maladies chroniques au Canada","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"Fondation pour la Recherche Médicale","keywords":"Medicine; Political science; Humanities; Gynecology; Philosophy","score_opus":0.01331057341557329,"score_gpt":0.27465247136509724,"score_spread":0.26134189794952395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090064455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8746022,0.067186095,0.0035551898,0.008951805,0.0002097113,0.0016752123,0.003599609,0.00007143135,0.040148772],"genre_scores_gemma":[0.9449782,0.031950384,0.010823496,0.0023126982,0.00018103504,0.0016836185,0.001600733,0.000020482865,0.0064494223],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9871793,0.0071866564,0.0013859969,0.000573042,0.0032797677,0.0003952518],"domain_scores_gemma":[0.9580046,0.03198444,0.0050810836,0.00065825257,0.0037186237,0.00055299007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012904786,0.00034419054,0.0010199876,0.0017375347,0.00094049034,0.0023426153,0.00045849773,0.0010884709,0.00764566],"category_scores_gemma":[0.046644557,0.00020659203,0.0010347244,0.0027300904,0.00060270814,0.0017064534,0.00090364437,0.0010218658,0.0007129761],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060714516,0.0011587777,0.29259542,0.016528886,0.0016205444,0.00070211507,0.017348524,0.0010639897,0.0024530552,0.0028077222,0.009362811,0.64828676],"study_design_scores_gemma":[0.0012966017,0.013190944,0.7386882,0.016441628,0.005382923,0.004323189,0.021071902,0.0020134484,0.008442433,0.004160894,0.18468773,0.0003002157],"about_ca_topic_score_codex":0.009081548,"about_ca_topic_score_gemma":0.013988255,"teacher_disagreement_score":0.99091846,"about_ca_system_score_codex":0.002805619,"about_ca_system_score_gemma":0.0046256064,"threshold_uncertainty_score":0.068247795},"labels":[],"label_agreement":null},{"id":"W3090590949","doi":"10.1016/j.bcp.2020.114255","title":"The active second-generation proteasome inhibitor oprozomib reverts the oxaliplatin-induced neuropathy symptoms","year":2020,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Università degli Studi di Firenze; Università di Bologna; Ministero dell’Istruzione, dell’Università e della Ricerca","keywords":"Oxaliplatin; Neuropathic pain; Medicine; Proteasome; Allodynia; Pharmacology; Proteasome inhibitor; Oxidative stress; Downregulation and upregulation; Adverse effect; Peripheral neuropathy; Nociception; Internal medicine; Hyperalgesia; Endocrinology; Cancer; Chemistry; Colorectal cancer; Biology; Cell biology; Receptor","score_opus":0.03942767462896317,"score_gpt":0.3113601735748303,"score_spread":0.27193249894586713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090590949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866682,0.0060465047,0.0016273721,0.00038888617,0.00023969598,0.00005836545,0.00029123784,0.00045996002,0.00421977],"genre_scores_gemma":[0.9948974,0.0019859592,0.00043744806,0.00012480593,0.000018492667,0.000015217964,0.00030276703,0.000013143537,0.002204826],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995685,0.000004955583,0.0000032493124,0.0000057877437,0.000012301312,0.00001686394],"domain_scores_gemma":[0.99995697,0.000004759879,0.000011263093,0.000004922828,0.000006362246,0.000015849884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008346038,0.00036638515,0.00038748037,0.000255892,0.00012008368,0.00016423133,0.00023072175,0.000202601,0.0016271523],"category_scores_gemma":[0.00011737678,0.00008296847,0.00023988371,0.000112587084,0.00013755569,0.00018155637,0.000100964106,0.00086358725,0.00025868329],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075140735,0.0016842617,0.001602928,0.00046543637,0.00015684521,0.0011624608,0.000039725077,0.00056672917,0.8313092,0.00072143355,0.0023969149,0.15237993],"study_design_scores_gemma":[0.004510915,0.04474838,0.08238906,0.00013741064,0.00061005703,0.008800439,0.00019087497,0.004297475,0.81472933,0.0012695204,0.038235288,0.00008138135],"about_ca_topic_score_codex":0.0008774754,"about_ca_topic_score_gemma":0.0014543558,"teacher_disagreement_score":0.0016271523,"about_ca_system_score_codex":0.00019878034,"about_ca_system_score_gemma":0.0002671418,"threshold_uncertainty_score":0.0054433346},"labels":[],"label_agreement":null},{"id":"W3091560225","doi":"10.1158/1078-0432.ccr-20-2682","title":"Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer Survivors","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health; University of Chicago","keywords":"Cisplatin; Medicine; Cancer; Oncology; Internal medicine; Chemotherapy","score_opus":0.3250167528719663,"score_gpt":0.5483750320847276,"score_spread":0.2233582792127613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091560225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99880326,0.00030726945,0.0001232901,0.000026501184,0.0000048738225,0.0000050945387,0.00055697554,0.0000051939,0.0001675209],"genre_scores_gemma":[0.99923396,0.00009348499,0.00007640974,0.000017241722,0.000005420244,0.000004717857,0.00043157802,0.0000024204242,0.00013466769],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977165,0.000047306097,0.000029799154,0.00009308982,0.000031744792,0.000026423331],"domain_scores_gemma":[0.99937063,0.00009559114,0.0002682705,0.00007298933,0.000080851096,0.00011163805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030976324,0.00024691885,0.0003093498,0.00050706015,0.00034821616,0.0004313979,0.00024856473,0.00033966426,0.0014712842],"category_scores_gemma":[0.0008446854,0.00018402709,0.0005257597,0.0010397859,0.00015598592,0.00016948686,0.00033102417,0.0003639686,0.0001490521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000239692,0.000017697721,0.99667263,0.000014700371,0.00022765699,0.00010473306,0.00003065308,0.000045100835,0.00126716,0.000013308154,0.00012374617,0.0012427986],"study_design_scores_gemma":[0.0000047803,0.000041386487,0.9994031,0.0000019272375,0.00007663777,0.00014094995,0.000029270435,0.00010122594,0.00008601271,0.000012866905,0.00010029146,0.0000015694919],"about_ca_topic_score_codex":0.0031208494,"about_ca_topic_score_gemma":0.0041627935,"teacher_disagreement_score":0.0031208494,"about_ca_system_score_codex":0.00011539725,"about_ca_system_score_gemma":0.00016936746,"threshold_uncertainty_score":0.0062053204},"labels":[],"label_agreement":null},{"id":"W3093241270","doi":"10.1007/s00520-020-05791-5","title":"A randomized clinical trial comparing physician-directed or fixed-dose steroid replacement strategies for incomplete dexamethasone dosing prior to docetaxel chemotherapy","year":2020,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Docetaxel; Dexamethasone; Chemotherapy; Dosing; Randomized controlled trial; Internal medicine; Clinical trial; Oncology","score_opus":0.1663864591283641,"score_gpt":0.47502973690779965,"score_spread":0.30864327777943557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093241270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98233736,0.007336717,0.00082216127,0.000807995,0.0012079525,0.0043490003,0.00052583,0.00008442118,0.0025285834],"genre_scores_gemma":[0.9901799,0.0021761383,0.0017223136,0.0007908225,0.00041562936,0.0021864355,0.0003206249,0.000015969415,0.0021921855],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99877805,0.0006534332,0.00008980933,0.00025635707,0.00008118372,0.00014121312],"domain_scores_gemma":[0.99732447,0.0012536814,0.0005034261,0.00016333787,0.00012259369,0.0006324735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017114939,0.001238092,0.0036764108,0.00046420994,0.0004572976,0.0010143071,0.001041308,0.0018227553,0.008549139],"category_scores_gemma":[0.003912842,0.0006262586,0.0015757604,0.00047245683,0.0013288365,0.001159692,0.00043389012,0.0036775216,0.0008034096],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9861313,0.0043017715,0.00018292069,0.00027536272,0.0005133333,0.000010258343,0.000023347064,0.0001692813,0.00042367572,0.0000677121,0.00018244958,0.007718442],"study_design_scores_gemma":[0.9361649,0.06140772,0.0008928232,0.00004514382,0.000491249,0.000013909207,0.000023932069,0.00030975908,0.00014672353,0.00010925957,0.0003818208,0.000012652249],"about_ca_topic_score_codex":0.0016914151,"about_ca_topic_score_gemma":0.003988611,"teacher_disagreement_score":0.008549139,"about_ca_system_score_codex":0.0013121795,"about_ca_system_score_gemma":0.001569945,"threshold_uncertainty_score":0.02859968},"labels":[],"label_agreement":null},{"id":"W3096869953","doi":"10.2217/pgs-2020-0056","title":"Unraveling Heterogeneity of the Clinical Pharmacogenomic Guidelines in Oncology Practice Among Major Regulatory Bodies","year":2020,"lang":"en","type":"review","venue":"Pharmacogenomics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Clinical Oncology; Medicine; Clinical Practice; Personalized medicine; Drug response; Drug; Oncology; Intensive care medicine; Internal medicine; Pharmacology; Bioinformatics; Cancer; Family medicine; Genotype; Biology; Genetics","score_opus":0.2497313678221193,"score_gpt":0.5320333608091322,"score_spread":0.2823019929870129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096869953","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009203377,0.97951424,0.002070913,0.01170591,0.0006069234,0.00007660029,0.00019970578,0.000028685141,0.0048765815],"genre_scores_gemma":[0.014569412,0.9728703,0.0044948882,0.006381869,0.00053585327,0.00013491864,0.0003680371,0.000026764952,0.000618034],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99110377,0.004131818,0.0016335403,0.00071942253,0.002159469,0.00025198003],"domain_scores_gemma":[0.96374166,0.027883008,0.0031174629,0.0007817447,0.004088303,0.0003878674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016288826,0.00047644528,0.0012416265,0.0032755549,0.00043921047,0.0032081783,0.0015607377,0.001836859,0.003203977],"category_scores_gemma":[0.039862048,0.00036260337,0.0011698656,0.0036961841,0.0011580184,0.0027799294,0.001414434,0.002901015,0.0007664695],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061918734,0.00004665735,0.0010804732,0.038488787,0.0003508884,0.00015403514,0.0005423014,0.00050398876,0.00051896507,0.01842554,0.021920886,0.9179055],"study_design_scores_gemma":[0.000052607666,0.00013371387,0.004395969,0.08096463,0.0008709258,0.000911369,0.00064792857,0.0003220312,0.0006068722,0.010821103,0.9002211,0.000051720537],"about_ca_topic_score_codex":0.0032238844,"about_ca_topic_score_gemma":0.006587272,"teacher_disagreement_score":0.016288826,"about_ca_system_score_codex":0.0022041649,"about_ca_system_score_gemma":0.012215035,"threshold_uncertainty_score":0.086144626},"labels":[],"label_agreement":null},{"id":"W3102553708","doi":"10.1093/oso/9780190200794.003.0028","title":"Reactions Involving Carbon–Carbon Bond Cleavage","year":2015,"lang":"en","type":"book-chapter","venue":"Oxford University Press eBooks","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry; Rhodium; Pyridine; Catalysis; Bond cleavage; Regioselectivity; Stereochemistry; Medicinal chemistry; Organic chemistry","score_opus":0.0595270012034639,"score_gpt":0.26693390514510124,"score_spread":0.20740690394163733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3102553708","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21728022,0.16069192,0.18662299,0.0063417554,0.010698476,0.0018233381,0.0023152488,0.0011480527,0.413078],"genre_scores_gemma":[0.8340334,0.08063474,0.028562903,0.0028111953,0.00066774635,0.00074244617,0.001219054,0.00015550187,0.051173057],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99896944,0.00011519577,0.000071579634,0.0002372157,0.00029027794,0.00031627718],"domain_scores_gemma":[0.99967754,0.0000985551,0.00007034166,0.00004543128,0.000071352544,0.00003676429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074626185,0.0010697749,0.0003496707,0.00057179236,0.00079842063,0.00069164764,0.0009320764,0.0013251284,0.008687025],"category_scores_gemma":[0.001058581,0.00046643242,0.00058372895,0.0007040144,0.0007328399,0.0019013399,0.0013098626,0.0029944242,0.004360955],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003295724,0.0005003629,0.00088638125,0.0061835377,0.00030052898,0.002467531,0.00085564255,0.0021252434,0.6554777,0.13391827,0.02777846,0.16917679],"study_design_scores_gemma":[0.00006057918,0.00051402056,0.00072676514,0.000278984,0.00004696109,0.001609103,0.00013553865,0.0009831588,0.7500191,0.0061513726,0.2393972,0.00007713426],"about_ca_topic_score_codex":0.0010185568,"about_ca_topic_score_gemma":0.0019121851,"teacher_disagreement_score":0.008687025,"about_ca_system_score_codex":0.0010169132,"about_ca_system_score_gemma":0.00068893103,"threshold_uncertainty_score":0.02906096},"labels":[],"label_agreement":null},{"id":"W3103925870","doi":"10.1161/atvb.39.suppl_1.514","title":"Abstract 514: Treatment of Mice with ApoA1 Protects Them Against Doxorubicin Induced Cardiotoxicity in a Scavenger Receptor Class B Type I Dependent Manner","year":2019,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Cardiotoxicity; Doxorubicin; Scavenger receptor; Pharmacology; Apoptosis; Scavenger; Medicine; Receptor; Biology; Cancer research; Chemistry; Chemotherapy; Internal medicine; Biochemistry; Cholesterol; Antioxidant","score_opus":0.05007935317821518,"score_gpt":0.29747930145923096,"score_spread":0.24739994828101577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103925870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852822,0.0025752399,0.0035940907,0.0010212539,0.000269572,0.00018543813,0.0030535802,0.00076361565,0.003255039],"genre_scores_gemma":[0.95422053,0.0024957696,0.0052477946,0.0007581344,0.0001433709,0.0005126222,0.0055671576,0.00023035351,0.030824298],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997328,0.000032929158,0.00003077501,0.00007492566,0.00005119524,0.00007736408],"domain_scores_gemma":[0.99966586,0.000025670968,0.00011205883,0.00004037797,0.000034369306,0.00012174676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000264473,0.0009211202,0.00082412123,0.00081985706,0.00034690386,0.00041981591,0.00046407766,0.0010336431,0.005130761],"category_scores_gemma":[0.00015981986,0.00038846603,0.0005203377,0.00020602666,0.00051435054,0.000512743,0.00022746308,0.0018067361,0.0020008322],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015316494,0.00055508444,0.00022716835,0.00007027978,0.000019377045,0.000070120106,0.000019009438,0.000053127627,0.9943731,0.00009886069,0.00038639706,0.0025959243],"study_design_scores_gemma":[0.00065332453,0.007945388,0.008680625,0.000048426147,0.00008668005,0.0005202931,0.000042148866,0.00095027516,0.9752749,0.00017955009,0.005595327,0.000022952445],"about_ca_topic_score_codex":0.000571585,"about_ca_topic_score_gemma":0.000567729,"teacher_disagreement_score":0.005130761,"about_ca_system_score_codex":0.00042350468,"about_ca_system_score_gemma":0.00037131552,"threshold_uncertainty_score":0.017164111},"labels":[],"label_agreement":null},{"id":"W3104220556","doi":"10.29289/259453942019v29s1cp03","title":"AXILLARY SURGICAL APPROACH IN METASTATIC BREAST CANCER PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS","year":2019,"lang":"en","type":"review","venue":"Mastology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Research Foundation","funders":"","keywords":"Breast cancer; Meta-analysis; Medicine; Metastatic breast cancer; Oncology; Cancer; Internal medicine","score_opus":0.12416491287155289,"score_gpt":0.4138942868391872,"score_spread":0.2897293739676343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3104220556","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004395981,0.9946944,0.000179075,0.00008987315,0.000078347286,0.00005837955,0.00033842848,0.000010256552,0.00015535459],"genre_scores_gemma":[0.16057688,0.83584374,0.001165263,0.0011212702,0.00018941514,0.00018784827,0.00050173624,0.00001966883,0.00039411563],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9975197,0.00082956,0.00082838524,0.00039692287,0.0002813221,0.00014407688],"domain_scores_gemma":[0.99504155,0.003177077,0.0012294208,0.00016529966,0.00029442512,0.000092167684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034570324,0.001715418,0.009475025,0.002795097,0.00041011345,0.0018089525,0.0014945769,0.0017307642,0.0045622117],"category_scores_gemma":[0.009599769,0.0011018655,0.020539124,0.00431144,0.0005287648,0.0012871039,0.0013290371,0.0015959737,0.00034844445],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025869936,0.00005491984,0.008800514,0.434733,0.53286576,0.00017015832,0.00013122582,0.00041375076,0.00036855284,0.00013164626,0.0011276361,0.018615762],"study_design_scores_gemma":[0.00075902493,0.0002170556,0.0075732693,0.020917682,0.9674557,0.000135534,0.00008066405,0.00010620223,0.000073774136,0.00015861267,0.0024886543,0.000033898854],"about_ca_topic_score_codex":0.0055368687,"about_ca_topic_score_gemma":0.02547889,"teacher_disagreement_score":0.009475025,"about_ca_system_score_codex":0.0011880107,"about_ca_system_score_gemma":0.0017200843,"threshold_uncertainty_score":0.018282771},"labels":[],"label_agreement":null},{"id":"W3105020049","doi":"10.1016/s0167-8140(20)31044-6","title":"152: Toxicity Assessment of Individualized Dosimetry Adjusted PRRT - Interim Report of the Ontario Consortium Trial OZM 067","year":2020,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Interim; Interim analysis; Medicine; Medical physics; Dosimetry; Toxicity; Nuclear medicine; Internal medicine; Clinical trial; Political science","score_opus":0.06600208622586254,"score_gpt":0.4013407703297132,"score_spread":0.3353386841038507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105020049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8982913,0.00644773,0.0042938385,0.0025191589,0.00027110783,0.0055900803,0.036631312,0.00046842382,0.045486998],"genre_scores_gemma":[0.9447289,0.0024686016,0.007350766,0.002731387,0.00013323255,0.0028478769,0.023158338,0.0005065121,0.016074294],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99782014,0.0011186586,0.000066908484,0.00021070571,0.00049692084,0.00028663542],"domain_scores_gemma":[0.99875104,0.00016406424,0.00038519912,0.00027445474,0.00019061702,0.00023459783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031971114,0.00089588575,0.0016267024,0.00026586629,0.00057894556,0.0014319427,0.0013057349,0.00074849185,0.0069905],"category_scores_gemma":[0.0030965141,0.00047759223,0.002221692,0.000883803,0.0006830755,0.00043655906,0.0006884122,0.0018387152,0.0010303397],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.59010124,0.005618661,0.041148856,0.002272161,0.007976519,0.00015980344,0.0008489069,0.01570573,0.014318424,0.002747306,0.063275084,0.2558273],"study_design_scores_gemma":[0.25657347,0.09913902,0.5052258,0.00071001245,0.011790475,0.00047318992,0.00051585183,0.008868552,0.004842134,0.0024328353,0.10914788,0.00028086503],"about_ca_topic_score_codex":0.19205764,"about_ca_topic_score_gemma":0.442612,"teacher_disagreement_score":0.19205764,"about_ca_system_score_codex":0.009398835,"about_ca_system_score_gemma":0.012914667,"threshold_uncertainty_score":0.3818795},"labels":[],"label_agreement":null},{"id":"W3112162239","doi":"10.1016/j.cct.2020.106242","title":"Recruitment strategies and design considerations in a trial of resistance training to prevent dose-limiting toxicities in colon cancer patients undergoing chemotherapy","year":2020,"lang":"en","type":"article","venue":"Contemporary Clinical Trials","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Limiting; Colorectal cancer; Chemotherapy; Cancer; Oncology; Internal medicine; Clinical trial; Intensive care medicine; Surgery","score_opus":0.6837395647107228,"score_gpt":0.5331751885168329,"score_spread":0.15056437619388996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112162239","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37313715,0.0104973735,0.102247946,0.097477235,0.008357934,0.37207392,0.00089768594,0.0004026851,0.03490812],"genre_scores_gemma":[0.49179378,0.0024151762,0.16085741,0.020310674,0.003192303,0.31706634,0.00017397961,0.00007986224,0.004110525],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.76667917,0.21905822,0.006872136,0.001814834,0.0037122578,0.0018633642],"domain_scores_gemma":[0.92589134,0.054308437,0.007318432,0.004303017,0.0041974233,0.0039813654],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.2044591,0.0012485285,0.002347077,0.0008928831,0.0028415218,0.003928837,0.0023546661,0.0068025975,0.009806733],"category_scores_gemma":[0.14917813,0.0015522726,0.0021732303,0.0009819972,0.002505232,0.0030623262,0.0018356406,0.0055424217,0.0018053433],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33675578,0.030705577,0.029067442,0.0062821205,0.0027039894,0.00086521753,0.0048696226,0.01014678,0.006361087,0.027387615,0.021066975,0.5237878],"study_design_scores_gemma":[0.42828983,0.34779707,0.04382118,0.0066079576,0.0040498995,0.001093333,0.0029985453,0.029580854,0.004662686,0.035369225,0.095206715,0.0005226218],"about_ca_topic_score_codex":0.0012550522,"about_ca_topic_score_gemma":0.0035986002,"teacher_disagreement_score":0.2044591,"about_ca_system_score_codex":0.0020964455,"about_ca_system_score_gemma":0.008527535,"threshold_uncertainty_score":0.9810436},"labels":[],"label_agreement":null},{"id":"W3115338232","doi":"10.3389/fneur.2020.604688","title":"Impact of Cryotherapy on Sensory, Motor, and Autonomic Neuropathy in Breast Cancer Patients Receiving Paclitaxel: A Randomized, Controlled Trial","year":2020,"lang":"en","type":"article","venue":"Frontiers in Neurology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Singapore General Hospital; Terry Fox Foundation; Singapore Cancer Society","keywords":"Medicine; Tolerability; Cryotherapy; Randomized controlled trial; Chemotherapy-induced peripheral neuropathy; Clinical endpoint; Paclitaxel; Breast cancer; Chemotherapy; Peripheral neuropathy; Anesthesia; Surgery; Internal medicine; Cancer; Adverse effect","score_opus":0.011007693837429411,"score_gpt":0.2908498823704286,"score_spread":0.2798421885329992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115338232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9587188,0.029325426,0.00076750206,0.0011272612,0.0010728044,0.005956928,0.0009606772,0.0001011873,0.0019693805],"genre_scores_gemma":[0.9830155,0.00697418,0.0009378258,0.00092047016,0.00065049203,0.005961158,0.00050755055,0.000010950751,0.0010218141],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988102,0.0007066711,0.00011512469,0.00016895257,0.00008190701,0.00011718001],"domain_scores_gemma":[0.998459,0.0006145609,0.00050752313,0.00009250823,0.00010259404,0.00022381004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023161783,0.0009259348,0.0026983698,0.00035220128,0.00041042833,0.0008430358,0.00081048004,0.0014349499,0.006115088],"category_scores_gemma":[0.0026716413,0.00044484108,0.0022494583,0.00053633796,0.0008121348,0.0006657061,0.00028234103,0.0015716353,0.00050702365],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9826751,0.0022796432,0.00075782795,0.0017305317,0.001997404,0.000031622527,0.000024395178,0.00015850368,0.00076847547,0.00004620883,0.00031380646,0.00921648],"study_design_scores_gemma":[0.96764416,0.028693281,0.0016002337,0.00009914236,0.0012888773,0.000019450832,0.0000106755115,0.00014281838,0.00012886383,0.00005241748,0.00031352832,0.0000065839326],"about_ca_topic_score_codex":0.00077008916,"about_ca_topic_score_gemma":0.0016775117,"teacher_disagreement_score":0.006115088,"about_ca_system_score_codex":0.00067503314,"about_ca_system_score_gemma":0.00092480885,"threshold_uncertainty_score":0.02045697},"labels":[],"label_agreement":null},{"id":"W3118992528","doi":"10.32539/bsm.v5i1.162","title":"Efficacy of Alpha Lipoic Acid Supplementation In Chemotherapy-Induced Peripheral Neuropathy","year":2020,"lang":"en","type":"article","venue":"Bioscientia Medicina Journal of Biomedicine and Translational Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Peripheral neuropathy; Chemotherapy; Internal medicine; Clinical trial; Placebo; Alpha-Lipoic Acid; Hematology; Quality of life (healthcare); Double blind; Gastroenterology; Pathology; Diabetes mellitus; Oxidative stress; Alternative medicine; Nursing; Endocrinology","score_opus":0.11162516317728718,"score_gpt":0.43267608271011326,"score_spread":0.32105091953282605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118992528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99415874,0.0051392885,0.00011687236,0.000050989485,0.000040160205,0.000098736215,0.00003580336,0.00000761046,0.00035186048],"genre_scores_gemma":[0.995773,0.0031006755,0.0003484767,0.00005439629,0.00004017929,0.00008537945,0.000070865666,0.0000016487605,0.00052534277],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99988246,0.000055127766,0.000014354547,0.0000134008005,0.000017010978,0.000017595394],"domain_scores_gemma":[0.99983406,0.00003675504,0.00005237753,0.000012890206,0.000017757786,0.00004623341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030718,0.00030396722,0.0005179911,0.0002693656,0.00014850746,0.0002142911,0.0001432697,0.00024463717,0.0015186808],"category_scores_gemma":[0.00034679772,0.00008141623,0.00021410506,0.00017345614,0.00023437927,0.000198462,0.0001709145,0.00041060775,0.00010902211],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3562429,0.049221195,0.00962251,0.0034439021,0.00062693295,0.0003326718,0.00026795315,0.0005949232,0.29859507,0.00026381813,0.00077355147,0.28001457],"study_design_scores_gemma":[0.03635645,0.78934747,0.060207184,0.00044736164,0.0012486681,0.00050195766,0.00026811636,0.0014411801,0.102720454,0.00026842233,0.0071593327,0.00003343582],"about_ca_topic_score_codex":0.00025152997,"about_ca_topic_score_gemma":0.00044594536,"teacher_disagreement_score":0.0015186808,"about_ca_system_score_codex":0.00012030568,"about_ca_system_score_gemma":0.00028763074,"threshold_uncertainty_score":0.0050804615},"labels":[],"label_agreement":null},{"id":"W3120723698","doi":"10.1016/j.esmoop.2020.100019","title":"Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)","year":2021,"lang":"en","type":"article","venue":"ESMO Open","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada; European Society for Medical Oncology; Eisai; Eli Lilly and Company; Takeda Pharmaceutical Company; Roche; Teva Pharmaceutical Industries; Les Laboratories Pierre Fabre; AstraZeneca","keywords":"Eribulin; Gemcitabine; Medicine; Internal medicine; Metastatic breast cancer; Triple-negative breast cancer; Oncology; Neutropenia; Regimen; Clinical endpoint; Phases of clinical research; Febrile neutropenia; Breast cancer; Adverse effect; Clinical trial; Cancer; Toxicity","score_opus":0.08808522107393496,"score_gpt":0.45142079871338525,"score_spread":0.3633355776394503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120723698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889924,0.0044011963,0.0005672098,0.00056685985,0.00014158811,0.0018311588,0.0011635004,0.00008255108,0.002253479],"genre_scores_gemma":[0.98368895,0.0033316421,0.0019788505,0.001208597,0.00023781408,0.0025683127,0.0033393817,0.00004172038,0.003604813],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99964726,0.00020693423,0.000011331023,0.00004675075,0.000030652725,0.000057144625],"domain_scores_gemma":[0.99972147,0.000038289203,0.0000859122,0.000022881259,0.000016784441,0.00011462473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001526664,0.0012615619,0.0016323358,0.00035023637,0.00023387276,0.0008526199,0.0006976889,0.0010983653,0.0026245345],"category_scores_gemma":[0.0006065322,0.00046639392,0.0008566191,0.0003021006,0.00047460356,0.000502128,0.0003581219,0.0017350701,0.0007939462],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7852326,0.046300054,0.011840967,0.0008218942,0.0025583121,0.0004290183,0.00028792268,0.0032759653,0.03317155,0.00039914527,0.006760056,0.1089225],"study_design_scores_gemma":[0.6889688,0.26987493,0.02564891,0.000081483,0.0010619293,0.0008406839,0.00008832067,0.0017907807,0.0036849466,0.00029251972,0.007627839,0.000038963608],"about_ca_topic_score_codex":0.0007190288,"about_ca_topic_score_gemma":0.0018172736,"teacher_disagreement_score":0.0026245345,"about_ca_system_score_codex":0.0007011096,"about_ca_system_score_gemma":0.0007784156,"threshold_uncertainty_score":0.008779943},"labels":[],"label_agreement":null},{"id":"W3122730376","doi":"10.1016/j.eclinm.2021.100730","title":"A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer","year":2021,"lang":"en","type":"article","venue":"EClinicalMedicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Arnold Ventures","keywords":"Medicine; Surrogate endpoint; Breast cancer; Overall survival; Oncology; Correlation; Survival analysis; Event (particle physics); Internal medicine; Cancer","score_opus":0.14350677167944517,"score_gpt":0.45889658549403006,"score_spread":0.31538981381458486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3122730376","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.139268,0.42126963,0.35738814,0.0061811986,0.0030253564,0.022544414,0.03387063,0.0011764308,0.015276238],"genre_scores_gemma":[0.854859,0.019920198,0.08552476,0.002176009,0.0007712948,0.02793484,0.0064235106,0.00030380502,0.0020865933],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.65645814,0.28897026,0.025324311,0.012782287,0.015083545,0.0013815267],"domain_scores_gemma":[0.3212541,0.57612073,0.065227546,0.02626262,0.010098695,0.0010362648],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.22778434,0.0017022096,0.0058946135,0.009719279,0.000593276,0.0026829792,0.0018046517,0.0016648734,0.008596021],"category_scores_gemma":[0.39588675,0.00086537556,0.020438872,0.010175751,0.0017891804,0.002759572,0.0030499946,0.0023951489,0.0011226193],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01818919,0.00029072977,0.25316527,0.16137429,0.37303314,0.00043860427,0.0011241009,0.010158006,0.00090443256,0.017447308,0.011363147,0.15251185],"study_design_scores_gemma":[0.009853408,0.01176832,0.21165815,0.04159377,0.55685145,0.0015003546,0.00067398965,0.04782563,0.0022135847,0.047760203,0.06767726,0.0006239012],"about_ca_topic_score_codex":0.0011701175,"about_ca_topic_score_gemma":0.0022438725,"teacher_disagreement_score":0.9941054,"about_ca_system_score_codex":0.0019363841,"about_ca_system_score_gemma":0.0049456647,"threshold_uncertainty_score":0.9522794},"labels":[],"label_agreement":null},{"id":"W3126523341","doi":"10.1186/s13007-021-00714-9","title":"A hybrid model based on general regression neural network and fruit fly optimization algorithm for forecasting and optimizing paclitaxel biosynthesis in Corylus avellana cell culture","year":2021,"lang":"en","type":"article","venue":"Plant Methods","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Paclitaxel; Elicitor; Cell culture; Artificial neural network; Extracellular; Algorithm; Botany; Biology; Chemistry; Mathematics; Biochemistry; Computer science; Machine learning; Chemotherapy","score_opus":0.06050506789970764,"score_gpt":0.3522622749619371,"score_spread":0.2917572070622295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126523341","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40823627,0.0020401839,0.5792218,0.00047085204,0.00013424017,0.00015867926,0.0004121939,0.0016511375,0.0076746517],"genre_scores_gemma":[0.9398936,0.00032182588,0.055834282,0.000084687796,0.000016911525,0.00017711848,0.00033993565,0.000034904675,0.00329677],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998072,0.000038303333,0.000015801272,0.00006834132,0.000037937392,0.00003248462],"domain_scores_gemma":[0.99966824,0.00017804532,0.000037840633,0.00001153678,0.00009371294,0.000010654444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006166382,0.001004994,0.00085390196,0.0006016521,0.00031419372,0.0007200945,0.00079001696,0.0010979144,0.0010415174],"category_scores_gemma":[0.0009071749,0.0003639242,0.0009437087,0.00049762265,0.00021667831,0.00042752118,0.00030735898,0.0006815763,0.0001989178],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036948466,0.000031905194,0.0010027158,0.000031890442,0.00003279821,0.000033254553,0.000012531509,0.9834657,0.0012892857,0.00017695577,0.00015103213,0.013735085],"study_design_scores_gemma":[0.0000015474538,0.000012443993,0.00013470875,0.000001597352,0.0000037928335,0.0000025737322,0.000001904341,0.9995623,0.00019311618,0.00004092196,0.000043476615,0.0000015633582],"about_ca_topic_score_codex":0.03041919,"about_ca_topic_score_gemma":0.018497022,"teacher_disagreement_score":0.03041919,"about_ca_system_score_codex":0.00080829766,"about_ca_system_score_gemma":0.0007628821,"threshold_uncertainty_score":0.06048429},"labels":[],"label_agreement":null},{"id":"W3127026655","doi":"10.14740/jh771","title":"A Pilot Phase II Study of the Feasibility and Efficacy of Vincristine Sulfate Liposome Injection in Patients With Relapsed or Refractory Acute Myeloid Leukemia","year":2021,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Refractory (planetary science); Vincristine; Internal medicine; Myeloid leukemia; Pharmacology; Phases of clinical research; Toxicity; Clinical trial; Oncology; Chemotherapy; Cyclophosphamide","score_opus":0.031236258482425106,"score_gpt":0.34116056460276234,"score_spread":0.3099243061203372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127026655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99442357,0.00042851004,0.0004778094,0.0001988567,0.000042955075,0.0030078944,0.0004827112,0.000049137092,0.00088856264],"genre_scores_gemma":[0.9949602,0.00033664666,0.0010200129,0.00026474436,0.000060617433,0.0017241649,0.00087600295,0.00001568345,0.000742055],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995153,0.00021420064,0.000028085891,0.00009931829,0.000042706328,0.00010037831],"domain_scores_gemma":[0.9991534,0.00015288583,0.00014348136,0.000114554234,0.000058931768,0.0003766696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018798752,0.0012430737,0.0014674859,0.00032904634,0.00040953545,0.00090736424,0.00079029397,0.0009205987,0.0033977602],"category_scores_gemma":[0.0011062999,0.00044982156,0.00091527053,0.00037499593,0.001209035,0.0007306221,0.00042421036,0.0028063168,0.0008794206],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52148366,0.23536876,0.015657209,0.00080711395,0.0013026171,0.0006515272,0.0007992223,0.0039669294,0.08978943,0.00038141763,0.0037303527,0.12606183],"study_design_scores_gemma":[0.22052886,0.76043147,0.011868841,0.000014940231,0.00022434437,0.00020828795,0.00007168993,0.0009167822,0.0042642807,0.00008899775,0.0013627972,0.000018650584],"about_ca_topic_score_codex":0.0010433695,"about_ca_topic_score_gemma":0.0017657452,"teacher_disagreement_score":0.0033977602,"about_ca_system_score_codex":0.0010666898,"about_ca_system_score_gemma":0.00177515,"threshold_uncertainty_score":0.011366665},"labels":[],"label_agreement":null},{"id":"W3129274860","doi":"10.32553/ijmbs.v5i2.1746","title":"RANDOMIZED PHASE III TRIAL COMPARING EPIRUBICIN/ DOXORUBICIN PLUS DOCETAXEL AND EPIRUBICIN/ DOXORUBICIN PLUS PACLITAXEL AS FIRST LINE TREATMENT IN WOMEN WITH ADVANCED BREAST CANCER","year":2021,"lang":"en","type":"article","venue":"International Journal of Medical and Biomedical Studies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lions Gate Hospital","funders":"","keywords":"Epirubicin; Medicine; Docetaxel; Anthracycline; Doxorubicin; Regimen; Chemotherapy; Paclitaxel; Internal medicine; Breast cancer; Neutropenia; Gastroenterology; Urology; Cancer","score_opus":0.04402779330855026,"score_gpt":0.41228444571505113,"score_spread":0.36825665240650085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129274860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747994,0.006643266,0.00089743553,0.0015208964,0.0012414806,0.008449876,0.0021963553,0.0001559086,0.0040953257],"genre_scores_gemma":[0.9687017,0.0045989105,0.0031061645,0.003228126,0.0009433094,0.009493946,0.0030690366,0.00004688616,0.0068119173],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991761,0.00054134784,0.00004716047,0.00010155012,0.000049276674,0.000084504456],"domain_scores_gemma":[0.9986211,0.00045846577,0.00027534235,0.00008408236,0.00006818081,0.00049282826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002112604,0.0013090046,0.002924206,0.0005085742,0.0004267449,0.0010708955,0.0010752128,0.0014310866,0.008322797],"category_scores_gemma":[0.0020038805,0.0006900287,0.0013708527,0.0005166681,0.0010455697,0.00080728973,0.000436757,0.002995243,0.0011843516],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9795991,0.0062478776,0.00048620225,0.00031998064,0.00048593272,0.00002800144,0.00002515746,0.0002377432,0.001579713,0.00007456874,0.00063800067,0.0102777565],"study_design_scores_gemma":[0.9613535,0.036872253,0.0006996486,0.000015610709,0.00018092127,0.000023345829,0.000008469827,0.00016692,0.00017676209,0.000052441126,0.00044551835,0.0000046618065],"about_ca_topic_score_codex":0.0009835679,"about_ca_topic_score_gemma":0.0032363893,"teacher_disagreement_score":0.008322797,"about_ca_system_score_codex":0.0010032017,"about_ca_system_score_gemma":0.0018463791,"threshold_uncertainty_score":0.027842581},"labels":[],"label_agreement":null},{"id":"W3130823265","doi":"10.1158/1538-7445.sabcs20-gs4-01","title":"Abstract GS4-01: Results from CONTESSA: A phase 3 study of tesetaxel plus a reduced dose of capecitabine versus capecitabine alone in patients with HER2-, hormone receptor + (HR+) metastatic breast cancer (MBC) who have previously received a taxane","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Capecitabine; Medicine; Taxane; Metastatic breast cancer; Regimen; Internal medicine; Breast cancer; Chemotherapy; Cancer; Oncology; Chemotherapy regimen; Fluorouracil; Gastroenterology; Urology; Colorectal cancer","score_opus":0.08037823029429043,"score_gpt":0.4083962176252598,"score_spread":0.3280179873309694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130823265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98483384,0.0029755118,0.00043543163,0.0011397928,0.0003416706,0.0024691832,0.0036015422,0.00023024064,0.0039728805],"genre_scores_gemma":[0.97335386,0.0022410268,0.002142416,0.0020118766,0.000588321,0.0024309591,0.01025121,0.00012895124,0.0068513905],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99936956,0.00032271454,0.000026801741,0.00010329884,0.000077206576,0.000100470075],"domain_scores_gemma":[0.9984444,0.00032287082,0.00026926852,0.00013337361,0.00011434333,0.00071576034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002285846,0.0024582678,0.0026485287,0.0008767646,0.00071735505,0.0013741441,0.0015516629,0.002122032,0.0075562466],"category_scores_gemma":[0.001846742,0.00071183994,0.0032524574,0.0008359402,0.0020797749,0.0012261975,0.00046701788,0.0046609687,0.0013997382],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8521264,0.050944574,0.003840975,0.0007958146,0.0022300684,0.000225592,0.00024614893,0.0027645566,0.027463702,0.00037208732,0.009724722,0.049265202],"study_design_scores_gemma":[0.6077998,0.37648216,0.009470119,0.000044656394,0.000529154,0.00023239826,0.000060640723,0.00087009795,0.0019031139,0.0002856798,0.0022722182,0.000049988517],"about_ca_topic_score_codex":0.0027789327,"about_ca_topic_score_gemma":0.0063608363,"teacher_disagreement_score":0.0075562466,"about_ca_system_score_codex":0.0016840743,"about_ca_system_score_gemma":0.002656304,"threshold_uncertainty_score":0.02527821},"labels":[],"label_agreement":null},{"id":"W3134332329","doi":"10.1016/j.annonc.2021.01.053","title":"38MO IND.236: A Canadian Cancer Trial Group (CCTG) phase Ib trial of combined CFI-402257 and weekly paclitaxel (Px) in patients with HER2-negative (HER2-) advanced breast cancer (BC)","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University Health Network; Queen's University; Ottawa Hospital; Princess Margaret Cancer Centre","funders":"Ontario Institute for Cancer Research; Canadian Cancer Society; Stand Up To Cancer Canada; Government of Ontario","keywords":"Medicine; Taxane; Internal medicine; Neutropenia; Febrile neutropenia; Chemotherapy; Breast cancer; Nausea; Adverse effect; Gastroenterology; Cancer; Oncology","score_opus":0.04667935103306406,"score_gpt":0.40746208288190044,"score_spread":0.36078273184883636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134332329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9072313,0.007886668,0.00062977173,0.00595355,0.0012174099,0.004919374,0.020140942,0.001059207,0.05096176],"genre_scores_gemma":[0.9023964,0.005419215,0.002165222,0.004695583,0.0004993746,0.0030109393,0.01937417,0.00014229352,0.062296726],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99981123,0.000044755183,0.000004952159,0.00002630028,0.000022172777,0.00009054368],"domain_scores_gemma":[0.999742,0.000017945884,0.000020720869,0.000010718111,0.000011106027,0.0001974967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042230636,0.0012997716,0.0013399624,0.00046894207,0.00056156924,0.0010218131,0.00083070534,0.0013012859,0.024850387],"category_scores_gemma":[0.00048668456,0.00035738965,0.0009887943,0.0004311993,0.0005803967,0.00039711126,0.00036341368,0.0028515565,0.003965007],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.59944993,0.019407406,0.005469878,0.0014616895,0.0012514988,0.00059297506,0.00020928602,0.0031713343,0.022401877,0.0021170466,0.08447785,0.2599893],"study_design_scores_gemma":[0.7854676,0.14370835,0.019069077,0.0001682275,0.00068169745,0.00067081995,0.000095470525,0.0022390645,0.0030340212,0.0010163749,0.043768223,0.000081052916],"about_ca_topic_score_codex":0.013347158,"about_ca_topic_score_gemma":0.05927125,"teacher_disagreement_score":0.024850387,"about_ca_system_score_codex":0.0016943612,"about_ca_system_score_gemma":0.0034589763,"threshold_uncertainty_score":0.08313286},"labels":[],"label_agreement":null},{"id":"W3135671961","doi":"10.1016/j.clbc.2021.03.001","title":"Uridine Glucuronosyltransferase 2B7 Polymorphism-Based Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy for Early-Stage Breast Cancer","year":2021,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alberta Innovates - Health Solutions; Alberta Cancer Foundation","keywords":"Medicine; Epirubicin; Breast cancer; Pharmacogenetics; Oncology; Chemotherapy; Internal medicine; Dosing; Stage (stratigraphy); Glucuronosyltransferase; Cancer; Genotype; Genetics; Gene; Biology","score_opus":0.05108618909565029,"score_gpt":0.42020743389212056,"score_spread":0.3691212447964703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135671961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99509466,0.0015996842,0.00081120676,0.00040046967,0.00006624663,0.000039794075,0.00016457844,0.000019753716,0.0018036894],"genre_scores_gemma":[0.9988945,0.00021880012,0.00031021793,0.00012019447,0.000017466415,0.0000178068,0.00008694143,0.0000054640045,0.00032871202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995198,0.00025539333,0.000032204895,0.00007095825,0.0000718266,0.000049855516],"domain_scores_gemma":[0.9996947,0.00013656622,0.00007809171,0.000024305182,0.000024895946,0.000041459643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047532498,0.00021881025,0.0005089714,0.00021291393,0.0001295762,0.00033636883,0.00022697302,0.0004106749,0.0012804498],"category_scores_gemma":[0.0015486245,0.00010928326,0.00031665422,0.0002980343,0.00017037868,0.00021642186,0.00012436,0.0005074704,0.00015659635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08248244,0.002884832,0.48230925,0.00030180567,0.0032146587,0.0008392746,0.00030473515,0.0065087155,0.05094651,0.0016100962,0.0033080347,0.3652897],"study_design_scores_gemma":[0.004051557,0.020283569,0.90535986,0.00017569277,0.0036470238,0.0017937238,0.00026995584,0.027666852,0.019090014,0.0034351915,0.0141491415,0.00007743671],"about_ca_topic_score_codex":0.0006062378,"about_ca_topic_score_gemma":0.0012427222,"teacher_disagreement_score":0.0012804498,"about_ca_system_score_codex":0.00035350464,"about_ca_system_score_gemma":0.00031446465,"threshold_uncertainty_score":0.0042835474},"labels":[],"label_agreement":null},{"id":"W3137566720","doi":"10.1007/s00520-021-06142-8","title":"A prospective multi-centre, randomized study comparing the addition of tapering dexamethasone to other standard of care therapies for taxane-associated pain syndrome (TAPS) in breast cancer patients","year":2021,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"Cancer Care Ontario","keywords":"Medicine; Taxane; Dexamethasone; Docetaxel; Discontinuation; Randomized controlled trial; Clinical endpoint; Premedication; Anesthesia; Internal medicine; Breast cancer; Chemotherapy; Surgery; Cancer","score_opus":0.020252400871443164,"score_gpt":0.3464352647913625,"score_spread":0.32618286391991935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137566720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931271,0.002621389,0.0003172292,0.00027005514,0.00051748706,0.002169741,0.00030494516,0.00002674852,0.00064538914],"genre_scores_gemma":[0.99336654,0.0013910112,0.0013165359,0.00063171145,0.0004586606,0.0016189552,0.00043717,0.000009154544,0.0007703399],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980261,0.0010672782,0.00020133048,0.00038571836,0.00012604972,0.0001935604],"domain_scores_gemma":[0.996221,0.001360043,0.00086096505,0.000302087,0.00024247964,0.0010134112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020409955,0.0014709668,0.003539043,0.0004429435,0.00073968293,0.001420117,0.0012157926,0.0021634726,0.0054315263],"category_scores_gemma":[0.004332378,0.00089649804,0.0027398043,0.000664822,0.0016516965,0.0013254554,0.0007460827,0.0040270826,0.00066447107],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9893026,0.005470175,0.00057164114,0.00017899333,0.0006461455,0.000013896815,0.00002237755,0.00008880617,0.00053092494,0.000023108021,0.00007450829,0.0030768062],"study_design_scores_gemma":[0.8678569,0.12770613,0.0029018607,0.000032403837,0.0008822725,0.000019895118,0.00003394449,0.00018985731,0.00013078215,0.00006132384,0.00016994726,0.000014613691],"about_ca_topic_score_codex":0.0023383175,"about_ca_topic_score_gemma":0.0047672903,"teacher_disagreement_score":0.0054315263,"about_ca_system_score_codex":0.0012671171,"about_ca_system_score_gemma":0.0018369132,"threshold_uncertainty_score":0.018170297},"labels":[],"label_agreement":null},{"id":"W3138402725","doi":"10.36076/ppj.2008/11/863","title":"Pulsed Radiofrequency for Metastatic PainTreatment","year":2008,"lang":"en","type":"article","venue":"Pain Physician","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baylis Medical (Canada)","funders":"","keywords":"Cannula; Medicine; Zygapophyseal Joint; Neurolysis; Fluoroscopy; Imaging phantom; Image stitching; Lesion; Surgery; Radiology; Nuclear medicine; Biomedical engineering; Lumbar; Facet joint","score_opus":0.047764122951220164,"score_gpt":0.3242966672286543,"score_spread":0.2765325442774341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138402725","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31539965,0.41359043,0.083002426,0.00960298,0.0024926164,0.0010672649,0.0015396025,0.0021318546,0.17117319],"genre_scores_gemma":[0.8790426,0.07317056,0.016860893,0.0032568136,0.0010424427,0.00046636892,0.00095018005,0.00016156258,0.025048625],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9999336,0.000008689159,0.000004113504,0.000012677422,0.00002649618,0.000014434505],"domain_scores_gemma":[0.9999074,0.000023224173,0.000023260924,0.000010410719,0.000019470606,0.000016280703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015421817,0.0002461169,0.00030898134,0.00050632114,0.0002773598,0.0003659914,0.00029156153,0.00040332618,0.017288717],"category_scores_gemma":[0.00033445455,0.00008598852,0.0003684637,0.000437884,0.00031856698,0.0002883567,0.0003267895,0.0005946091,0.0032531843],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009835871,0.0005130509,0.0057142405,0.002417743,0.00012144885,0.011929415,0.0001431536,0.00080177427,0.07440927,0.0036322544,0.025944274,0.8733897],"study_design_scores_gemma":[0.0017732792,0.006766221,0.046065237,0.0033593755,0.0007423604,0.32764015,0.00030186668,0.0062552495,0.09109272,0.010139203,0.505759,0.000105331426],"about_ca_topic_score_codex":0.00058453734,"about_ca_topic_score_gemma":0.001164027,"teacher_disagreement_score":0.017288717,"about_ca_system_score_codex":0.00040345424,"about_ca_system_score_gemma":0.00034260668,"threshold_uncertainty_score":0.057836533},"labels":[],"label_agreement":null},{"id":"W3139800722","doi":"","title":"Chemotherapy: managing side effects and safe handling.","year":2009,"lang":"en","type":"article","venue":"The Canadian veterinary journal = La revue veterinaire canadienne","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Chemotherapy; Business; Risk analysis (engineering); Intensive care medicine; Computer science; Medicine; Surgery","score_opus":0.015654418868362673,"score_gpt":0.26560364698624495,"score_spread":0.24994922811788228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139800722","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08943549,0.5528436,0.078433044,0.08709307,0.0030625006,0.00095966505,0.0006145629,0.0014623491,0.18609574],"genre_scores_gemma":[0.5151949,0.32438508,0.079671316,0.012154821,0.0032808199,0.00039896573,0.0006209296,0.00036868328,0.06392456],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991615,0.00025895788,0.000054332726,0.00004572675,0.0004250347,0.00005452047],"domain_scores_gemma":[0.9990988,0.00022410364,0.0002169038,0.00006189763,0.00026626853,0.00013206642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009586297,0.0003649999,0.00048024437,0.00055120443,0.00055553816,0.00096533226,0.0006254179,0.0011482227,0.005179263],"category_scores_gemma":[0.0024321896,0.00010743661,0.00016609326,0.0004913854,0.00064092386,0.0009271155,0.00058400637,0.0010413314,0.0018826303],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039474556,0.0002715591,0.0051839533,0.0017264468,0.00004789684,0.0009979717,0.00040416353,0.0006370344,0.018293686,0.0050079604,0.06275652,0.90427786],"study_design_scores_gemma":[0.00017179475,0.0021290656,0.033681564,0.001325649,0.00011687107,0.022339318,0.0010158085,0.001286303,0.017600713,0.011879273,0.9083841,0.00006962045],"about_ca_topic_score_codex":0.0032432845,"about_ca_topic_score_gemma":0.007585281,"teacher_disagreement_score":0.005179263,"about_ca_system_score_codex":0.0007612747,"about_ca_system_score_gemma":0.0019529539,"threshold_uncertainty_score":0.017326355},"labels":[],"label_agreement":null},{"id":"W3140545115","doi":"10.3390/toxins13040235","title":"Tetrodotoxin for Chemotherapy-Induced Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Dose Finding Trial","year":2021,"lang":"en","type":"article","venue":"Toxins","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"","keywords":"Placebo; Medicine; Neuropathic pain; Anesthesia; Adverse effect; Randomized controlled trial; Cohort; Pregabalin; Internal medicine; Pathology","score_opus":0.0721859294665846,"score_gpt":0.35824726107672694,"score_spread":0.28606133161014236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3140545115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808139,0.0053631724,0.0011328575,0.0006850946,0.00090857584,0.0088471845,0.0007061724,0.00015899756,0.0013840314],"genre_scores_gemma":[0.9723355,0.0052223606,0.002969655,0.0015424275,0.00090262055,0.012046452,0.0008047739,0.000035879613,0.004140382],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991416,0.0004154986,0.000079837984,0.00016391926,0.00009056764,0.000108627704],"domain_scores_gemma":[0.99904746,0.00023795773,0.0002786843,0.00008901945,0.00009947158,0.00024738497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00211762,0.0014289512,0.0032350973,0.0005760119,0.0005365044,0.0010037333,0.00097031204,0.0022386059,0.004784927],"category_scores_gemma":[0.0018637646,0.0007621501,0.0014076415,0.0004892395,0.0013405534,0.0010602494,0.0003649486,0.0021635827,0.00088492],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96987915,0.011603842,0.0002661799,0.00069668284,0.0004452821,0.00003871224,0.000037175694,0.00015365696,0.0048926272,0.00008985753,0.0003975722,0.011499324],"study_design_scores_gemma":[0.93856925,0.060117275,0.00045494942,0.000018948525,0.00014089375,0.000015882672,0.000007259712,0.000145189,0.00024923775,0.000044166565,0.00022971064,0.0000072228904],"about_ca_topic_score_codex":0.0005088513,"about_ca_topic_score_gemma":0.0012938023,"teacher_disagreement_score":0.004784927,"about_ca_system_score_codex":0.00065278384,"about_ca_system_score_gemma":0.001100678,"threshold_uncertainty_score":0.016007125},"labels":[],"label_agreement":null},{"id":"W3142109413","doi":"10.6000/1929-2279.2012.01.01.16","title":"Treatment of Chemotherapy - Induced Peripheral Neuropathy: The Physicians Need Guidelines, the Patients Need Help","year":2012,"lang":"en","type":"article","venue":"Journal of cancer research updates","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Group B; Allodynia; Peripheral neuropathy; Group A; Chemotherapy-induced peripheral neuropathy; Amitriptyline; Gabapentin; Anesthesia; Oxycodone; Pregabalin; Internal medicine; Hyperalgesia; Opioid; Nociception","score_opus":0.11638956256335735,"score_gpt":0.461953186034648,"score_spread":0.34556362347129066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3142109413","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8416746,0.0831887,0.0037241136,0.03296756,0.0013058537,0.0013368754,0.000312768,0.0001353931,0.035354067],"genre_scores_gemma":[0.93791556,0.022169564,0.015683224,0.014939791,0.0014393252,0.0010433032,0.0004086547,0.00002143067,0.0063790563],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994783,0.00027484325,0.000049810104,0.000043409487,0.00011316414,0.000040472936],"domain_scores_gemma":[0.99915874,0.0002296935,0.00020839568,0.00004538787,0.00014688821,0.00021084516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007384532,0.00014339476,0.00038071294,0.00017926557,0.0004240246,0.0004226374,0.00018082143,0.00075687666,0.00440215],"category_scores_gemma":[0.0028019955,0.000061035214,0.00017389763,0.0002332459,0.00018898927,0.00056653895,0.00027032397,0.0005235548,0.00065598736],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029929848,0.005525428,0.13241714,0.003062692,0.00012547686,0.0022520118,0.0007592423,0.00036405434,0.0065548066,0.001041061,0.021228584,0.8236764],"study_design_scores_gemma":[0.00435444,0.03041445,0.63379586,0.004887525,0.0006331508,0.0240229,0.004765022,0.0018947937,0.0054264395,0.0029179498,0.2867577,0.0001298016],"about_ca_topic_score_codex":0.0004448141,"about_ca_topic_score_gemma":0.0012362889,"teacher_disagreement_score":0.00440215,"about_ca_system_score_codex":0.00025637378,"about_ca_system_score_gemma":0.0007969983,"threshold_uncertainty_score":0.014726698},"labels":[],"label_agreement":null},{"id":"W3145070328","doi":"10.5430/jst.v10n2p30","title":"A pilot study to evaluate the efficacy of PEC blocks in minimising chronic post-mastectomy pain","year":2021,"lang":"en","type":"article","venue":"Journal of Solid Tumors","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Mastectomy; Blockade; Chronic pain; Prospective cohort study; Anesthesia; Block (permutation group theory); Surgery; Physical therapy; Internal medicine; Breast cancer; Cancer","score_opus":0.03725739247321615,"score_gpt":0.36790837557810724,"score_spread":0.3306509831048911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3145070328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969008,0.00028319325,0.0005011208,0.00007756809,0.000058519927,0.0015826267,0.00010280593,0.00001640657,0.00047696847],"genre_scores_gemma":[0.99305916,0.00046011206,0.0021603315,0.00034040128,0.0002961036,0.002441893,0.00032479642,0.000011369998,0.00090595084],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9991948,0.0004117115,0.00006651692,0.000080998,0.0000829935,0.00016300821],"domain_scores_gemma":[0.9968554,0.0016273905,0.00029681064,0.0003530219,0.00020602359,0.0006612388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002370817,0.0011340308,0.0017173453,0.00027719405,0.0006172853,0.0004101952,0.0006618498,0.00081945286,0.0044104797],"category_scores_gemma":[0.0027830019,0.0004042743,0.0009835454,0.00021138976,0.0013074939,0.000769308,0.00039241643,0.0018658014,0.0007037917],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4202119,0.36088404,0.032689955,0.0010800123,0.0008539768,0.0021067637,0.0012192774,0.0011407252,0.09669394,0.0003185327,0.0011530364,0.08164789],"study_design_scores_gemma":[0.019955227,0.9710141,0.00721113,0.0000066561915,0.00006543059,0.00019376553,0.00005774245,0.00010743952,0.001142567,0.000022265924,0.00021565454,0.00000809275],"about_ca_topic_score_codex":0.00052215415,"about_ca_topic_score_gemma":0.0006487429,"teacher_disagreement_score":0.0044104797,"about_ca_system_score_codex":0.00016041055,"about_ca_system_score_gemma":0.0010845507,"threshold_uncertainty_score":0.014754534},"labels":[],"label_agreement":null},{"id":"W3150802936","doi":"10.22033/esgf/cmip6.1305","title":"CCCma CanESM5 model output prepared for CMIP6 DAMIP","year":2019,"lang":"en","type":"dataset","venue":"Earth System Grid Federation","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Environmental science","score_opus":0.05460404728949472,"score_gpt":0.33625416784027073,"score_spread":0.281650120550776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3150802936","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001225615,0.0001287949,0.0028221249,0.0006951831,0.0004754485,0.000094510324,0.9797323,0.0038872592,0.010938919],"genre_scores_gemma":[0.015268368,0.00017132708,0.00889091,0.0004259902,0.000116746254,0.0005771959,0.96173096,0.0032976463,0.009520854],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9994056,0.00010351795,0.00004129607,0.00018493057,0.00016505593,0.000099613404],"domain_scores_gemma":[0.99849737,0.00015559513,0.00005450715,0.00021271735,0.00096878136,0.000111067835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011611948,0.0013305708,0.0012815484,0.0015026769,0.0009603039,0.0019673964,0.0038502319,0.0020289547,0.11564926],"category_scores_gemma":[0.0036999546,0.000943017,0.0019740786,0.004261809,0.0003116077,0.002576728,0.0010987222,0.0032071704,0.051365025],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084024876,0.000018203726,0.0009984608,0.00024285643,0.00009984122,0.00002743532,0.000024508714,0.016200097,0.0003097626,0.0026259306,0.9744401,0.004928863],"study_design_scores_gemma":[0.0005342244,0.000019220553,0.0062231207,0.00022403586,0.00011974267,0.000034873898,0.00011203496,0.04396452,0.0015599423,0.007031704,0.9400469,0.00012959402],"about_ca_topic_score_codex":0.2523209,"about_ca_topic_score_gemma":0.14040662,"teacher_disagreement_score":0.2523209,"about_ca_system_score_codex":0.0028920565,"about_ca_system_score_gemma":0.004975582,"threshold_uncertainty_score":0.50170445},"labels":[],"label_agreement":null},{"id":"W3155627233","doi":"10.2196/27502","title":"Chemotherapy-Induced Peripheral Neuropathy Detection via a Smartphone App: Cross-sectional Pilot Study","year":2021,"lang":"en","type":"article","venue":"JMIR mhealth and uhealth","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Peripheral neuropathy; Preprint; Medicine; Cross-sectional study; Smartphone app; mHealth; Computer science; Internet privacy; World Wide Web; Psychological intervention; Psychiatry; Pathology","score_opus":0.07611310804354308,"score_gpt":0.41649403263922335,"score_spread":0.34038092459568026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155627233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988826,0.00008917714,0.00017819219,0.000024320876,0.000010281474,0.00044183564,0.00011838888,0.000002962067,0.00025222547],"genre_scores_gemma":[0.9974152,0.00018088467,0.0005778166,0.00023827051,0.000021574582,0.0007718323,0.00025291377,0.0000029750684,0.0005384477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990945,0.0002696796,0.000097899385,0.00022168073,0.00017234425,0.00014391322],"domain_scores_gemma":[0.9978089,0.00044385236,0.00052902,0.00013940378,0.0007086375,0.00037018754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017101371,0.00055175874,0.0005360589,0.0005020916,0.00086858,0.0006234124,0.00027937896,0.00060657295,0.0023242692],"category_scores_gemma":[0.002574021,0.0004833623,0.00065465947,0.00035449179,0.00039315334,0.00076764566,0.0006033059,0.001022508,0.0006739117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024435339,0.015454396,0.96202636,0.0003953673,0.000267448,0.0007407918,0.003634366,0.000068180605,0.0028753355,0.0000611139,0.00065156893,0.01138147],"study_design_scores_gemma":[0.00042247027,0.046898235,0.9431381,0.000088375135,0.00038719169,0.0011285369,0.0052713994,0.00041929455,0.0007009124,0.000054679876,0.0014573196,0.000033393597],"about_ca_topic_score_codex":0.0019842708,"about_ca_topic_score_gemma":0.0036576474,"teacher_disagreement_score":0.0023242692,"about_ca_system_score_codex":0.00035481752,"about_ca_system_score_gemma":0.0007065028,"threshold_uncertainty_score":0.00904417},"labels":[],"label_agreement":null},{"id":"W3159181549","doi":"10.14283/cw.2021.1","title":"Psychological Disorders, Cognitive Impairment, and Quality of Life with Chemotherapy-induced Neuropathy in Colon and Rectal Carcinoma Patients","year":2021,"lang":"en","type":"article","venue":"Care weekly","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oxaliplatin; Medicine; Internal medicine; Colorectal cancer; Chemotherapy; Quality of life (healthcare); Anxiety; Montreal Cognitive Assessment; Hospital Anxiety and Depression Scale; Depression (economics); Oncology; Gastroenterology; Cancer; Psychiatry; Cognitive impairment; Disease","score_opus":0.02942125168895163,"score_gpt":0.3358955092688345,"score_spread":0.30647425757988284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159181549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994381,0.00027931808,0.000012727068,0.00002225229,0.0000030785939,0.0000063560706,0.00006577906,7.054701e-7,0.00017168063],"genre_scores_gemma":[0.99971837,0.000083643885,0.000024495386,0.000017528999,0.0000039169518,0.0000053861436,0.00008481609,1.7501522e-7,0.000061562365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977225,0.00006243646,0.000033224587,0.000031411797,0.00005449338,0.000046240697],"domain_scores_gemma":[0.99939966,0.00005488795,0.00032421175,0.000015830266,0.000057984955,0.00014742499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003221738,0.00021045319,0.0002786676,0.0005203,0.0003923186,0.0004356968,0.00015813044,0.0002628135,0.0008969051],"category_scores_gemma":[0.0012130522,0.00012709756,0.0004296676,0.00063577696,0.00019213185,0.00024640333,0.00031146957,0.00039671775,0.000098099874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012722124,0.00008059534,0.9983273,0.000012207909,0.00005004555,0.00006075347,0.000051186344,0.000030235937,0.000092769886,0.0000038575126,0.000040071467,0.0011237668],"study_design_scores_gemma":[0.000008860938,0.00016669897,0.9993345,0.000004000327,0.000020550298,0.00020492614,0.000102903694,0.000071667346,0.000022267051,0.000005615782,0.0000557767,0.0000021753506],"about_ca_topic_score_codex":0.002512398,"about_ca_topic_score_gemma":0.0040213303,"teacher_disagreement_score":0.002512398,"about_ca_system_score_codex":0.0002880204,"about_ca_system_score_gemma":0.00018742195,"threshold_uncertainty_score":0.004995525},"labels":[],"label_agreement":null},{"id":"W3159637394","doi":"10.21037/pcm-20-69","title":"A narrative review of chemotherapy in advanced triple negative breast cancer","year":2021,"lang":"en","type":"review","venue":"Precision Cancer Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Eribulin; Medicine; Oncology; Internal medicine; Triple-negative breast cancer; Breast cancer; Anthracycline; Taxane; Olaparib; Gemcitabine; Chemotherapy; Capecitabine; Metastatic breast cancer; Cancer; Colorectal cancer","score_opus":0.05870134318040379,"score_gpt":0.4804741947722393,"score_spread":0.42177285159183553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159637394","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000120218116,0.9979074,0.000059666007,0.00059618655,0.00031873668,0.000022614828,0.000085421816,0.0000032132602,0.0008865322],"genre_scores_gemma":[0.0011884063,0.9970752,0.00017861753,0.0007375682,0.00041595456,0.000042407704,0.00009678518,0.000002466596,0.00026260788],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99881727,0.0004227163,0.00039022267,0.00011957171,0.00020447074,0.00004583746],"domain_scores_gemma":[0.9946406,0.0039967075,0.000753144,0.000057272682,0.00047411514,0.00007810827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011671886,0.000845666,0.0015280902,0.0044807657,0.0004726602,0.0019605462,0.0008071728,0.001423643,0.0071396925],"category_scores_gemma":[0.0070252945,0.00036229947,0.0012427126,0.00447526,0.00050983176,0.0018000004,0.0009146341,0.0012900967,0.001173759],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018230852,0.000051837655,0.00046860706,0.35507816,0.00041759855,0.00090168486,0.0007433652,0.00036450004,0.00049520854,0.0055949283,0.09542999,0.5402719],"study_design_scores_gemma":[0.000029796889,0.00011500052,0.0013058641,0.23756811,0.00089555315,0.003246431,0.0003287734,0.00008002691,0.0001371652,0.0011877323,0.7550771,0.000028331055],"about_ca_topic_score_codex":0.0025061236,"about_ca_topic_score_gemma":0.004177316,"teacher_disagreement_score":0.0071396925,"about_ca_system_score_codex":0.0014866649,"about_ca_system_score_gemma":0.003239507,"threshold_uncertainty_score":0.023884594},"labels":[],"label_agreement":null},{"id":"W3160630885","doi":"10.3389/fphar.2021.642820","title":"Modulation of Pathological Pain by Epidermal Growth Factor Receptor","year":2021,"lang":"en","type":"review","venue":"Frontiers in Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University; St. Michael's Hospital; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; International Anesthesia Research Society","keywords":"Medicine; Epidermal growth factor receptor; Chronic pain; ErbB; Signal transduction; Bioinformatics; Cancer; Biology; Internal medicine; Psychiatry","score_opus":0.04597651062640735,"score_gpt":0.37699184041235384,"score_spread":0.3310153297859465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160630885","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023537558,0.9977054,0.00011858035,0.00023293152,0.00017723843,0.000005493877,0.00002652469,0.000009234188,0.0014893229],"genre_scores_gemma":[0.0011325988,0.997552,0.00011177112,0.00017207538,0.00011481269,0.0000050026024,0.00003619608,0.0000010386191,0.00087451574],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999905,0.0000157277,0.000011551889,0.000014951936,0.00004023474,0.000012469301],"domain_scores_gemma":[0.9999074,0.000038719783,0.00001391905,0.0000030948145,0.000027314101,0.000009585208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025807283,0.00051265623,0.0007363605,0.0012182919,0.00015616912,0.0006209435,0.00048816905,0.0006404226,0.0035753695],"category_scores_gemma":[0.00029835984,0.00014603513,0.0004180221,0.00085314165,0.0002345465,0.000680905,0.00039455568,0.0012981755,0.0017822846],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008815939,0.00008573793,0.00016517736,0.016275376,0.00007847305,0.00019937498,0.00004773368,0.00032411327,0.0047282376,0.004252272,0.025802907,0.9479525],"study_design_scores_gemma":[0.00002272698,0.00014622006,0.0011189157,0.0028447877,0.00008893035,0.0013048395,0.000041816667,0.000115370574,0.0012667747,0.0017377115,0.9912956,0.000016221204],"about_ca_topic_score_codex":0.00058122573,"about_ca_topic_score_gemma":0.0011806492,"teacher_disagreement_score":0.0035753695,"about_ca_system_score_codex":0.00036447644,"about_ca_system_score_gemma":0.00053018954,"threshold_uncertainty_score":0.011960745},"labels":[],"label_agreement":null},{"id":"W3163182274","doi":"10.1016/j.ajem.2021.05.043","title":"Cardiotoxicity in yew berry poisoning","year":2021,"lang":"en","type":"article","venue":"The American Journal of Emergency Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Emergency department; Intensive care medicine; Psychological intervention; Intensive care unit; Refractory (planetary science)","score_opus":0.05165285271487655,"score_gpt":0.4033168906754099,"score_spread":0.3516640379605333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163182274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927239,0.0022717628,0.0002324228,0.00026497105,0.000025123647,0.0000323576,0.000070306756,0.000015916617,0.0043632095],"genre_scores_gemma":[0.99790657,0.0008583368,0.000115557974,0.00014149051,0.00004117934,0.0000052965233,0.00006410949,0.0000048094403,0.0008627027],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9998832,0.000047124046,0.000013354129,0.000012398771,0.000018607436,0.00002535237],"domain_scores_gemma":[0.9997563,0.00006728721,0.00007807627,0.00001800293,0.000042795076,0.00003758178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028266534,0.0002669562,0.00026990884,0.0006557879,0.0006236762,0.0004050435,0.0001427447,0.00077085383,0.0026051744],"category_scores_gemma":[0.0008038875,0.00016067355,0.0002109611,0.0004527011,0.00036714075,0.0002936006,0.00026636713,0.0005049752,0.0003449048],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012412387,0.00061695906,0.71111494,0.0005773196,0.00023626011,0.17301756,0.0009154214,0.00033266292,0.053224526,0.00082114676,0.002376994,0.04435383],"study_design_scores_gemma":[0.00019821478,0.0041697193,0.8681873,0.00009920825,0.00019770092,0.11062587,0.0011540203,0.0007673912,0.008469433,0.00043404681,0.005664837,0.000032328495],"about_ca_topic_score_codex":0.0024213546,"about_ca_topic_score_gemma":0.0029240435,"teacher_disagreement_score":0.0026051744,"about_ca_system_score_codex":0.00046020848,"about_ca_system_score_gemma":0.00026105836,"threshold_uncertainty_score":0.008715153},"labels":[],"label_agreement":null},{"id":"W3166882697","doi":"10.1200/jco.2021.39.15_suppl.12018","title":"Long-term results from a randomized blinded sham- and waitlist-controlled trial of acupuncture for joint symptoms related to aromatase inhibitors in early stage breast cancer (S1200).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institutes of Health","keywords":"Medicine; Acupuncture; Brief Pain Inventory; Randomized controlled trial; Breast cancer; Physical therapy; Internal medicine; WOMAC; Osteoarthritis; Cancer; Chronic pain","score_opus":0.07492004897205339,"score_gpt":0.4576652551877509,"score_spread":0.3827452062156975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166882697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99012613,0.0036516069,0.00036566964,0.00038537383,0.0005220128,0.002602333,0.0011004254,0.000077414734,0.0011689689],"genre_scores_gemma":[0.9853662,0.0017918582,0.0013202364,0.0010947519,0.0005409785,0.0059557627,0.0014472904,0.000020761985,0.0024621433],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986512,0.0007398011,0.00011975712,0.00021316604,0.00008880661,0.00018728065],"domain_scores_gemma":[0.99832743,0.00047280014,0.00042628637,0.00014578534,0.00016570324,0.00046204115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027766663,0.0012429381,0.0029974538,0.00039247423,0.0005910678,0.0009877661,0.0008180053,0.0023484074,0.0064869844],"category_scores_gemma":[0.0029882067,0.00057598884,0.0021123455,0.00035987454,0.0009074529,0.0009487076,0.00045271445,0.00214998,0.00089295115],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9828052,0.0073114303,0.0003105734,0.0003572717,0.00092168554,0.000019581877,0.00003304648,0.00007635567,0.0010737532,0.000031020976,0.0003640942,0.006695868],"study_design_scores_gemma":[0.92907584,0.06754933,0.0020350728,0.000026484815,0.00078149175,0.000012539998,0.000014473228,0.00011350005,0.00013975358,0.000058569585,0.00018487804,0.000008070913],"about_ca_topic_score_codex":0.0009373802,"about_ca_topic_score_gemma":0.0022118979,"teacher_disagreement_score":0.0064869844,"about_ca_system_score_codex":0.0006171142,"about_ca_system_score_gemma":0.00095026987,"threshold_uncertainty_score":0.021701097},"labels":[],"label_agreement":null},{"id":"W3167076087","doi":"10.1200/jco.2021.39.15_suppl.1061","title":"Results from CONTESSA 2: A multinational, multicenter, phase 2 study of tesetaxel (T) plus a reduced dose of capecitabine (C) in patients (pts) with hormone receptor + (HR+), HER2- metastatic breast cancer (MBC) not previously treated with a taxane.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Taxane; Capecitabine; Metastatic breast cancer; Clinical endpoint; Internal medicine; Breast cancer; Phases of clinical research; Cancer; Oncology; Gastroenterology; Chemotherapy; Clinical trial","score_opus":0.09543072615978272,"score_gpt":0.4480371251360116,"score_spread":0.3526063989762289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167076087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98125654,0.0042913584,0.0006179256,0.0018261394,0.0003103325,0.0029086478,0.0040077567,0.00016974715,0.0046116197],"genre_scores_gemma":[0.962085,0.0042810086,0.0033453307,0.0028517146,0.00054828636,0.00427454,0.013763852,0.00015323366,0.008696961],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99923205,0.00041325673,0.00003081873,0.00013326465,0.00008655601,0.00010397593],"domain_scores_gemma":[0.99848264,0.000384375,0.0002775706,0.00011628652,0.00008547415,0.00065363507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030873134,0.002443502,0.0018929273,0.0006250848,0.0006381165,0.0013371604,0.0012875746,0.0018709155,0.005220012],"category_scores_gemma":[0.0023148563,0.00071077707,0.00227077,0.0005981817,0.0012285408,0.0013062622,0.0005224389,0.004326325,0.0012190128],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7605565,0.07334906,0.010819298,0.0010230097,0.0028771532,0.00033138288,0.00058636407,0.0033191994,0.031018527,0.00047309327,0.013397581,0.10224886],"study_design_scores_gemma":[0.6616041,0.3105251,0.017902194,0.00007629706,0.0009815866,0.0003671106,0.00008442908,0.0010747822,0.0021235214,0.00025959846,0.004944743,0.00005651443],"about_ca_topic_score_codex":0.0026394415,"about_ca_topic_score_gemma":0.007695716,"teacher_disagreement_score":0.005220012,"about_ca_system_score_codex":0.0015426559,"about_ca_system_score_gemma":0.0023136826,"threshold_uncertainty_score":0.01746273},"labels":[],"label_agreement":null},{"id":"W3167816205","doi":"","title":"糖尿病性腎臓病(DKD)Basic & Clinical up-to-date2020~進化するDKD治療~II 糖尿病性腎臓病Clinical2020~Current and Future Therapeutic Strategies~ミネラルコルチコイド受容体拮抗薬への期待","year":2020,"lang":"ja","type":"article","venue":"Pharma Medica","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Current (fluid); Computer science; Internal medicine; Intensive care medicine; Engineering","score_opus":0.13313184280741894,"score_gpt":0.4615322600267572,"score_spread":0.3284004172193382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167816205","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014333471,0.098999545,0.011585325,0.1546764,0.032317452,0.0011021645,0.005631677,0.0010119993,0.6803421],"genre_scores_gemma":[0.19980177,0.14373995,0.04153797,0.060116127,0.015746942,0.0010739823,0.008895911,0.00047635453,0.528611],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982291,0.0003379217,0.00017287931,0.00017941117,0.0007056675,0.0003750303],"domain_scores_gemma":[0.994517,0.00052365684,0.00039765157,0.000624513,0.0021609543,0.0017762376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039187786,0.00043092648,0.00050060876,0.0010219481,0.0011474268,0.004460854,0.0009798995,0.0016721883,0.10289807],"category_scores_gemma":[0.0045876405,0.00029451877,0.00057629036,0.0010302166,0.001178044,0.0023014105,0.0026438234,0.0026514323,0.06252926],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005282294,0.0006039592,0.0046326923,0.0014187277,0.000051461964,0.00039268454,0.00015295912,0.00021262476,0.0071528344,0.030891288,0.28648952,0.6674731],"study_design_scores_gemma":[0.00007299611,0.0001984225,0.0028799386,0.00038940806,0.000030711693,0.00082944,0.00016078034,0.00010964276,0.004179139,0.005422692,0.98570675,0.000020122867],"about_ca_topic_score_codex":0.0018022672,"about_ca_topic_score_gemma":0.002740663,"teacher_disagreement_score":0.10289807,"about_ca_system_score_codex":0.0032170147,"about_ca_system_score_gemma":0.009297464,"threshold_uncertainty_score":0.34422833},"labels":[],"label_agreement":null},{"id":"W3169033212","doi":"10.1200/jco.2021.39.15_suppl.7016","title":"A mixed methods study exploring the role of perceived side effects on treatment decision-making in older adults with acute myeloid leukemia (AML).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada); Princess Margaret Cancer Centre","funders":"Pfizer","keywords":"Medicine; Myeloid leukemia; Internal medicine; Chemotherapy; Family medicine; Intensive care medicine","score_opus":0.0943905675052841,"score_gpt":0.500058440569318,"score_spread":0.40566787306403396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169033212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963456,0.00048831775,0.0005561653,0.00036787186,0.000019964646,0.0011637666,0.00022412662,0.0000031573627,0.00083108403],"genre_scores_gemma":[0.9890759,0.0010106261,0.0034443343,0.0010609421,0.000038443366,0.0041570915,0.00027436856,0.000004856423,0.0009335183],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9901916,0.0072924877,0.0008401257,0.00044408353,0.0005599591,0.00067176577],"domain_scores_gemma":[0.9697779,0.020822933,0.004957374,0.00065365736,0.002407622,0.0013805435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018212704,0.00047005262,0.00077868643,0.0017630217,0.0029571238,0.0022607031,0.0008601717,0.0010871167,0.0028176676],"category_scores_gemma":[0.029239407,0.0006832233,0.00075049023,0.001769624,0.001078155,0.0018997362,0.001802038,0.0014076119,0.00029539727],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010554465,0.0038743797,0.27165002,0.0020749513,0.00023680434,0.0011885397,0.6730298,0.0001781856,0.00096011,0.0010150404,0.0014533823,0.043283414],"study_design_scores_gemma":[0.00036061212,0.005524328,0.13847803,0.0011243885,0.00015895664,0.0005313622,0.8451623,0.0010758935,0.0005069027,0.0005536618,0.006439114,0.00008459847],"about_ca_topic_score_codex":0.006069509,"about_ca_topic_score_gemma":0.016323574,"teacher_disagreement_score":0.018212704,"about_ca_system_score_codex":0.003151784,"about_ca_system_score_gemma":0.003593157,"threshold_uncertainty_score":0.09631914},"labels":[],"label_agreement":null},{"id":"W3171111042","doi":"10.1007/978-3-030-71155-9_18","title":"Vascular Endothelial Growth Factor (VEGF) Bevacizumab and Hypertension","year":2021,"lang":"en","type":"book-chapter","venue":"Clinical cases in cardiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University","funders":"","keywords":"Medicine; Bevacizumab; Blood pressure; Ramipril; Amlodipine; Folinic acid; Vascular endothelial growth factor; FOLFIRI; Ambulatory blood pressure; Sunitinib; Internal medicine; Chemotherapy; Fluorouracil; Urology; Cancer; VEGF receptors; Irinotecan; Colorectal cancer","score_opus":0.12113909535247906,"score_gpt":0.38361257241213387,"score_spread":0.2624734770596548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171111042","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018289337,0.15618086,0.0042440905,0.013716951,0.0114068845,0.000045717323,0.00006246416,0.00014982802,0.81236434],"genre_scores_gemma":[0.009994805,0.06903848,0.0031181993,0.0072663464,0.0049938913,0.000036643,0.00005953052,0.000078671175,0.9054135],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999199,0.00001985416,0.0000041556054,0.000007569043,0.000039879455,0.0000085686],"domain_scores_gemma":[0.9998877,0.00007570926,0.0000067246237,0.0000042509664,0.000011293977,0.000014346247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018491675,0.00044806523,0.00021839903,0.00053088233,0.00045653933,0.0012547582,0.00034811258,0.0011025361,0.023738436],"category_scores_gemma":[0.0004682089,0.00015621039,0.0002125537,0.000343237,0.0005969959,0.0011002593,0.0006053068,0.0018613507,0.0066875843],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029977486,0.000112624555,0.00013095426,0.00027517715,0.000005866461,0.0013876144,0.00027946365,0.00034607912,0.0012977688,0.094969265,0.6055689,0.2955963],"study_design_scores_gemma":[0.000004504527,0.00001590402,0.00015193135,0.0001420457,0.000003001266,0.0023112046,0.000049644754,0.00012878147,0.00015513357,0.010138581,0.9868955,0.000003797742],"about_ca_topic_score_codex":0.0011306335,"about_ca_topic_score_gemma":0.004084441,"teacher_disagreement_score":0.023738436,"about_ca_system_score_codex":0.00051567645,"about_ca_system_score_gemma":0.00038710912,"threshold_uncertainty_score":0.079413},"labels":[],"label_agreement":null},{"id":"W3171740981","doi":"10.1200/jco.2021.39.15_suppl.e24080","title":"A randomized double-blind pilot study comparing cetirizine with diphenhydramine in the prevention of paclitaxel-associated infusion-related reactions.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Diphenhydramine; Cetirizine; Premedication; Placebo; Anesthesia; Adverse effect; Randomized controlled trial; Sedative; Paclitaxel; Context (archaeology); Chemotherapy; Internal medicine","score_opus":0.26571369849716064,"score_gpt":0.5104193089121388,"score_spread":0.24470561041497818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171740981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97011393,0.0017034732,0.002076829,0.00039159838,0.0006069945,0.023045916,0.00068576843,0.0001318948,0.0012436435],"genre_scores_gemma":[0.9615503,0.001518555,0.008725357,0.00087879464,0.0006542576,0.023844229,0.0006596371,0.000027620004,0.0021412158],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981989,0.0011170424,0.00017285776,0.00023501257,0.00011008737,0.00016612807],"domain_scores_gemma":[0.996696,0.001247755,0.0007411799,0.00032913947,0.00023871737,0.00074721186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044671306,0.0014710719,0.0028433343,0.0006965529,0.0006571709,0.0007008848,0.0013708821,0.002074382,0.007821719],"category_scores_gemma":[0.0038764074,0.0010663555,0.00128238,0.00047195182,0.0019185351,0.0012962779,0.0005814462,0.0023845762,0.0010047585],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94526654,0.03727959,0.00032640673,0.00036911934,0.00020381217,0.000032767064,0.000042908523,0.00009152683,0.0055680745,0.00006120853,0.00019348865,0.0105645],"study_design_scores_gemma":[0.75623363,0.24221489,0.0006957845,0.0000100225125,0.00009378979,0.00001661288,0.000010466755,0.00011464176,0.00041992762,0.00003041815,0.00015421498,0.0000056130875],"about_ca_topic_score_codex":0.0004914899,"about_ca_topic_score_gemma":0.00088492286,"teacher_disagreement_score":0.007821719,"about_ca_system_score_codex":0.0004846617,"about_ca_system_score_gemma":0.0021459523,"threshold_uncertainty_score":0.0261662},"labels":[],"label_agreement":null},{"id":"W3172027519","doi":"10.1200/jco.2021.39.15_suppl.5025","title":"Factors associated with use of medications for anxiety and depression in testicular cancer survivors after cisplatin-based chemotherapy.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"National Institutes of Health","keywords":"Medicine; Anxiety; Common Terminology Criteria for Adverse Events; Depression (economics); Testicular cancer; Internal medicine; Quality of life (healthcare); Adverse effect; Cancer; Psychiatry","score_opus":0.1767086377752125,"score_gpt":0.48501139322897313,"score_spread":0.3083027554537606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172027519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986248,0.0004956601,0.000029082426,0.00008564594,0.000006096205,0.000014406156,0.00036561975,0.0000024389576,0.00037621695],"genre_scores_gemma":[0.99953914,0.00013178395,0.000026691088,0.000032048218,0.000005652522,0.0000064006517,0.00018913654,4.1581313e-7,0.000068888156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998202,0.000036273294,0.000030470112,0.00002445598,0.00004885669,0.00003969832],"domain_scores_gemma":[0.9989969,0.00013294365,0.00059362,0.000020175428,0.00008112079,0.00017516575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022554897,0.000093181996,0.00013542609,0.00041553497,0.0002564985,0.00026066665,0.00014497044,0.00020391868,0.00130379],"category_scores_gemma":[0.0014300974,0.00009830926,0.0003319745,0.0006606564,0.00011649689,0.00017435089,0.00023220855,0.00041504603,0.000089752655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020253301,0.000018577022,0.9989993,0.000007166494,0.000015309293,0.000026401407,0.000019504734,0.000013465706,0.000033058488,0.0000025930603,0.00006264426,0.0007816931],"study_design_scores_gemma":[0.0000018521183,0.00005252525,0.9996283,0.0000043892705,0.000013000181,0.000094378796,0.00007129325,0.000060223832,0.000010735644,0.0000035601713,0.000058509042,0.0000011990664],"about_ca_topic_score_codex":0.007117782,"about_ca_topic_score_gemma":0.012709866,"teacher_disagreement_score":0.007117782,"about_ca_system_score_codex":0.0002339555,"about_ca_system_score_gemma":0.00032924683,"threshold_uncertainty_score":0.014152706},"labels":[],"label_agreement":null},{"id":"W3172478157","doi":"10.1200/jco.2021.39.15_suppl.12004","title":"Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus and peripheral sensory neuropathy.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"National Institutes of Health","keywords":"Medicine; Tinnitus; Cisplatin; Internal medicine; Hearing loss; Peripheral neuropathy; Pharmacogenomics; Ototoxicity; Confounding; Neurotoxicity; Oncology; Auditory neuropathy; Cohort; Gastroenterology; Chemotherapy; Endocrinology; Toxicity; Pharmacology; Diabetes mellitus; Audiology","score_opus":0.22732918067206553,"score_gpt":0.4978560729158356,"score_spread":0.2705268922437701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172478157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917446,0.0028604611,0.0012972507,0.00026824127,0.000011533607,0.000029327848,0.0028717376,0.000023719247,0.00089302886],"genre_scores_gemma":[0.9968094,0.0007179501,0.0005916554,0.00008995979,0.000016903232,0.000019762938,0.0013389749,0.0000045492784,0.00041075645],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997154,0.00010372319,0.000026364103,0.00007243298,0.000058177,0.000023925917],"domain_scores_gemma":[0.99882203,0.0003510492,0.00054686575,0.00007233651,0.000109172484,0.00009848043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053846114,0.00019381173,0.00029657004,0.00067883806,0.00017750464,0.00037799397,0.00021198459,0.00026086604,0.0016464203],"category_scores_gemma":[0.0015994476,0.000098442935,0.00049608323,0.0013755937,0.00016483926,0.0001599743,0.00029528237,0.0003000008,0.000173432],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045014214,0.000054015225,0.9840739,0.00010662009,0.0005532124,0.0001641103,0.000028254746,0.00031436223,0.003763863,0.00006396922,0.0002676712,0.0101597505],"study_design_scores_gemma":[0.000009017083,0.00012422298,0.9980142,0.0000060371904,0.00018799785,0.0003172093,0.000017683624,0.00045847564,0.0004229615,0.0001103471,0.0003292289,0.0000026101065],"about_ca_topic_score_codex":0.0025280542,"about_ca_topic_score_gemma":0.0026364005,"teacher_disagreement_score":0.0025280542,"about_ca_system_score_codex":0.00019780682,"about_ca_system_score_gemma":0.0003278427,"threshold_uncertainty_score":0.005507827},"labels":[],"label_agreement":null},{"id":"W3174581043","doi":"10.1096/fasebj.2019.33.1_supplement.700.19","title":"Myotube Morphology and Protein Metabolism are Negatively Regulated by Chemotherapy Drugs","year":2019,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"York University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"mTORC1; Myogenesis; Ribosomal protein s6; Cachexia; Myofibril; Myosin; P70-S6 Kinase 1; Pharmacology; Chemotherapy; Endocrinology; Internal medicine; Biology; Chemistry; Cancer research; Phosphorylation; Protein kinase B; Medicine; Cancer; Myocyte; Cell biology","score_opus":0.009943037844000623,"score_gpt":0.2654006455240268,"score_spread":0.2554576076800262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174581043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923044,0.0034986918,0.0006278036,0.00016676326,0.000050035997,0.00004491336,0.00064721267,0.00004718385,0.0026129638],"genre_scores_gemma":[0.9910687,0.0019019262,0.0010623562,0.00012214486,0.000012160271,0.0001090764,0.00096330256,0.000016545368,0.004743703],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997485,0.000040316125,0.000028093544,0.00004581203,0.00008802535,0.00004914234],"domain_scores_gemma":[0.9998282,0.000018829223,0.000052453004,0.00001372494,0.00003527807,0.00005148269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011869219,0.0002589271,0.0004131432,0.00021591649,0.0002650743,0.00031252136,0.000121535166,0.00025212183,0.0012992765],"category_scores_gemma":[0.00013787231,0.00017842128,0.0003805016,0.00020722765,0.00018856376,0.0001500071,0.00019947354,0.0004953617,0.0003222303],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047670762,0.000059582206,0.0012272616,0.000045658344,0.000014169151,0.00007296544,0.000022627515,0.000031596795,0.99615806,0.000025595431,0.00010247033,0.0017634147],"study_design_scores_gemma":[0.000077015764,0.0020156638,0.24484736,0.000021087431,0.000068382724,0.0004786286,0.00015472164,0.0011133039,0.74669677,0.00004394185,0.004469415,0.000013741417],"about_ca_topic_score_codex":0.0012641498,"about_ca_topic_score_gemma":0.0031171634,"teacher_disagreement_score":0.0012992765,"about_ca_system_score_codex":0.00028215832,"about_ca_system_score_gemma":0.00022160647,"threshold_uncertainty_score":0.00434649},"labels":[],"label_agreement":null},{"id":"W3174706170","doi":"10.1016/j.ejca.2021.05.025","title":"Preservation of quality of life in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial)","year":2021,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; BC Cancer Agency; Jewish General Hospital","funders":"Daiichi Sankyo Europe; EMD Serono; Genentech; European Society for Medical Oncology; Eisai; Seagen; G1 Therapeutics; MacroGenics; Silverback Therapeutics; Pfizer; NuCana; Regeneron Pharmaceuticals; Mylan; Unum Therapeutics; Helsinn Therapeutics; Amgen; Radius Health; Syndax Pharmaceuticals; Clovis Oncology; Teva Pharmaceutical Industries; Helsinn; Les Laboratories Pierre Fabre; Taiho Pharmaceutical; Eli Lilly and Company; AstraZeneca; Foundation Medicine; National Cancer Research Institute; Genomic Health; Mersana Therapeutics; Karyopharm Therapeutics; Puma Biotechnology","keywords":"Capecitabine; Trastuzumab; Metastatic breast cancer; Oncology; Medicine; Human Epidermal Growth Factor Receptor 2; Internal medicine; Placebo; Breast cancer; Cancer; Pathology; Colorectal cancer","score_opus":0.05052952878100639,"score_gpt":0.3440817760243052,"score_spread":0.29355224724329876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174706170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925166,0.0047031743,0.00013307201,0.0005123071,0.00023922713,0.00014384439,0.0004995364,0.00003250944,0.001219757],"genre_scores_gemma":[0.99635446,0.0015321291,0.00018698665,0.00028358787,0.00014828176,0.00014941767,0.0005831606,0.0000053811928,0.0007566658],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997744,0.00011562972,0.000013097784,0.00003989427,0.0000114362565,0.000045486056],"domain_scores_gemma":[0.99982613,0.000045872337,0.000041361774,0.000009200534,0.000008215576,0.000069237496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006373321,0.00076556986,0.0017090905,0.0001993087,0.00021500824,0.0007821774,0.00038171868,0.0006730388,0.0030686564],"category_scores_gemma":[0.0006988735,0.00024350644,0.0015024836,0.00024224253,0.00042783286,0.000529148,0.0002654934,0.0018285156,0.0002892116],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9378827,0.0027801637,0.0031042162,0.00077739434,0.0020867083,0.000107936336,0.0000618654,0.0013752495,0.0060393633,0.0001495501,0.0017087662,0.043925982],"study_design_scores_gemma":[0.76363415,0.1819226,0.043132745,0.00016365119,0.003576508,0.0002959358,0.000113161484,0.0019075474,0.0018587249,0.00041096218,0.002940132,0.000043928743],"about_ca_topic_score_codex":0.00090092554,"about_ca_topic_score_gemma":0.0023346005,"teacher_disagreement_score":0.0030686564,"about_ca_system_score_codex":0.00052270264,"about_ca_system_score_gemma":0.0004228264,"threshold_uncertainty_score":0.010265648},"labels":[],"label_agreement":null},{"id":"W3175511275","doi":"10.1186/s12885-021-08446-8","title":"Network meta-analysis of eribulin versus other chemotherapies used as second- or later-line treatment in locally advanced or metastatic breast cancer","year":2021,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Eisai Incorporated; Eisai","keywords":"Medicine; Internal medicine; Oncology; Metastatic breast cancer; Vinorelbine; Eribulin; Breast cancer; Hazard ratio; Gemcitabine; Ixabepilone; Cancer; Chemotherapy; Confidence interval","score_opus":0.1584458835225617,"score_gpt":0.4188219669357842,"score_spread":0.2603760834132225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3175511275","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02690194,0.9595713,0.0063314545,0.0011208535,0.0008188871,0.0008868884,0.0026457794,0.00016979397,0.0015531345],"genre_scores_gemma":[0.75922,0.22183971,0.008774267,0.002046974,0.00052178104,0.0028277272,0.003320652,0.00014845096,0.001300425],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97456497,0.019757884,0.0021857265,0.0018526798,0.0012611873,0.00037753436],"domain_scores_gemma":[0.9676992,0.026561504,0.0030307001,0.0011567016,0.0011888964,0.00036294584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030387873,0.0037883124,0.014170294,0.005629654,0.00050798967,0.0032301943,0.0023600145,0.002403738,0.0043496327],"category_scores_gemma":[0.055560246,0.0014180426,0.059706334,0.004974265,0.0005592635,0.001954479,0.0016432672,0.002758501,0.0003972955],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036560062,0.00002340883,0.0028307093,0.034587372,0.951713,0.00005735943,0.000023308361,0.0025985688,0.0001007917,0.00014774728,0.00036306214,0.003898647],"study_design_scores_gemma":[0.0009258953,0.00019328819,0.001930522,0.0025108627,0.9920774,0.00003702119,0.000013713304,0.0011507275,0.000072209434,0.0003708683,0.00070181186,0.000015618667],"about_ca_topic_score_codex":0.010052478,"about_ca_topic_score_gemma":0.011729705,"teacher_disagreement_score":0.030387873,"about_ca_system_score_codex":0.0033184956,"about_ca_system_score_gemma":0.0023823222,"threshold_uncertainty_score":0.16070837},"labels":[],"label_agreement":null},{"id":"W3176123402","doi":"10.1096/fasebj.2018.32.1_supplement.536.14","title":"The Dose‐Related Effects of Doxorubicin Chemotherapy on Interstitial Amino Acid Concentrations in Skeletal Muscle","year":2018,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Laurentian University; NOSM University","funders":"","keywords":"Microdialysis; Amino acid; Interstitial space; Doxorubicin; Pharmacology; Chemistry; Skeletal muscle; Saline; Metabolism; Chemotherapy; Medicine; Internal medicine; Extracellular; Biochemistry","score_opus":0.011109856655565775,"score_gpt":0.29898922838865394,"score_spread":0.28787937173308814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176123402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99515873,0.0028947373,0.0006145482,0.00008023127,0.000058551355,0.000035517933,0.00022064032,0.000022939057,0.0009141015],"genre_scores_gemma":[0.99370354,0.0017414027,0.0011536498,0.00006667541,0.000024814784,0.00007445369,0.00029085597,0.000008093044,0.0029366324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998888,0.000025981268,0.00001010446,0.00002598506,0.000022869946,0.00002619648],"domain_scores_gemma":[0.9997781,0.0000552888,0.000083610124,0.000023773273,0.000025097228,0.000034037243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001314172,0.00023704782,0.0002470632,0.0001873578,0.00009830092,0.00015031564,0.00012603468,0.00026268975,0.0012129326],"category_scores_gemma":[0.00020350826,0.00016022802,0.00020858158,0.0001505967,0.00022393117,0.00024599375,0.000116152914,0.00061617733,0.0001795023],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002802564,0.00017853426,0.00090807234,0.0000886488,0.000014820015,0.000054337466,0.00003586397,0.00009109425,0.9915631,0.000036541485,0.000051135998,0.004175285],"study_design_scores_gemma":[0.0000715728,0.0090442635,0.030202271,0.000014623585,0.000052517866,0.00013533708,0.00007516878,0.00072902883,0.95855606,0.00004584588,0.0010615783,0.000011674805],"about_ca_topic_score_codex":0.00053928397,"about_ca_topic_score_gemma":0.0015126092,"teacher_disagreement_score":0.0012129326,"about_ca_system_score_codex":0.00026894914,"about_ca_system_score_gemma":0.00020810978,"threshold_uncertainty_score":0.004057646},"labels":[],"label_agreement":null},{"id":"W3178326122","doi":"10.1038/s41477-021-00963-5","title":"The Taxus genome provides insights into paclitaxel biosynthesis","year":2021,"lang":"en","type":"article","venue":"Nature Plants","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":243,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Wuhan University; Chinese Academy of Agricultural Sciences; Agricultural Science and Technology Innovation Program; Hunan Agricultural University; Chinese Academy of Sciences","keywords":"Taxus; Genome; Biology; Gene; Paclitaxel; Gene cluster; Biosynthesis; Gene duplication; Computational biology; Genetics; Botany; Cancer","score_opus":0.010124761287408907,"score_gpt":0.2943140098066403,"score_spread":0.2841892485192314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178326122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92492557,0.009500673,0.014762276,0.0009401084,0.00011460616,0.00009488064,0.034686234,0.001120865,0.013854776],"genre_scores_gemma":[0.89918214,0.0098429555,0.03300626,0.0002641613,0.00006927584,0.000054032298,0.048435215,0.0002356894,0.008910204],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99996364,0.0000032823953,0.0000021990459,0.00001241501,0.000010732722,0.000007805825],"domain_scores_gemma":[0.99993324,0.000012006928,0.000009917385,0.000008974798,0.000017258857,0.00001858563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007553751,0.00042939777,0.000249748,0.0008412295,0.0004217823,0.00038317233,0.00016784052,0.00027854223,0.002176607],"category_scores_gemma":[0.00013457623,0.0001233767,0.00035448704,0.0009538875,0.00014632604,0.00030936926,0.00025880415,0.00047657016,0.0007954543],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003318557,0.000020559899,0.0041120797,0.00026691868,0.000029099812,0.0003309569,0.00010779718,0.00042066394,0.9661727,0.00080736476,0.0005816253,0.026818337],"study_design_scores_gemma":[0.00010789643,0.0004306598,0.24050826,0.00018809433,0.00067377003,0.0035472286,0.0007106585,0.007986404,0.5243125,0.0061668525,0.2152329,0.00013482283],"about_ca_topic_score_codex":0.004968981,"about_ca_topic_score_gemma":0.009952488,"teacher_disagreement_score":0.004968981,"about_ca_system_score_codex":0.00040652213,"about_ca_system_score_gemma":0.0007739872,"threshold_uncertainty_score":0.0098801255},"labels":[],"label_agreement":null},{"id":"W3178613530","doi":"10.1158/1538-7445.am2021-1377","title":"Abstract 1377: Volume scanning, a rational approach to covalent PI3Kα inhibitors","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"PI3K/AKT/mTOR pathway; Chemistry; Covalent bond; Selectivity; Rational design; Combinatorial chemistry; Biochemistry; Kinase; Target protein; Stereochemistry; Biophysics; Nanotechnology; Signal transduction; Biology; Materials science; Organic chemistry","score_opus":0.1462639111395096,"score_gpt":0.4690487802446619,"score_spread":0.3227848691051523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178613530","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77638346,0.012466549,0.15344483,0.0011270705,0.00037724528,0.0011199422,0.0012125236,0.0015047377,0.052363686],"genre_scores_gemma":[0.9577868,0.005752282,0.026776223,0.00022804263,0.00006167667,0.00020646799,0.0003480264,0.000094690615,0.008745887],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998385,0.0000202014,0.000009134978,0.000040802734,0.000067614645,0.000023768587],"domain_scores_gemma":[0.9999571,0.000008672341,0.000015804182,0.000005822346,0.000006810895,0.0000057680845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019249858,0.00050918054,0.00029745125,0.0002095108,0.00016145695,0.00031780225,0.00054474134,0.00019759758,0.003600986],"category_scores_gemma":[0.000166272,0.00017571005,0.00018275026,0.00023386073,0.00026191698,0.0003991756,0.00036059658,0.00056586217,0.001066357],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003516067,0.00030779434,0.00026057762,0.0004937788,0.000033989956,0.0002622702,0.00007143218,0.013169369,0.91648006,0.01259214,0.0019840617,0.053993],"study_design_scores_gemma":[0.00011349796,0.0017883223,0.00031705105,0.000026125424,0.00003052252,0.00029748108,0.0000177332,0.008518653,0.9580942,0.0015444005,0.029231073,0.000020953166],"about_ca_topic_score_codex":0.00026300427,"about_ca_topic_score_gemma":0.0005431481,"teacher_disagreement_score":0.003600986,"about_ca_system_score_codex":0.0003571124,"about_ca_system_score_gemma":0.00028550296,"threshold_uncertainty_score":0.012046516},"labels":[],"label_agreement":null},{"id":"W3183886430","doi":"10.3390/curroncol28040239","title":"Patterns and Predictors of First-Line Taxane Use in Patients with Metastatic Triple-Negative Breast Cancer in US Clinical Practice","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Triple-negative breast cancer; Taxane; Triple negative; Oncology; Metastatic breast cancer; Paclitaxel; Internal medicine; Breast cancer; Cancer; Clinical Practice; Family medicine","score_opus":0.1069257443243616,"score_gpt":0.46140730406580466,"score_spread":0.3544815597414431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183886430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981824,0.0006383643,0.000054617634,0.00019386268,0.000003917848,0.0000073853016,0.00052169146,0.000004498196,0.00039331353],"genre_scores_gemma":[0.9991678,0.00027414437,0.000082619066,0.0000538678,0.000006698699,0.000005068136,0.00033950043,0.000002329428,0.00006798523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994042,0.00013484307,0.0000984088,0.00013820939,0.00013866328,0.00008573222],"domain_scores_gemma":[0.9972946,0.0004957515,0.0015941272,0.00009823797,0.00021161666,0.00030563428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048440747,0.00011964181,0.00024051349,0.0008632429,0.0002682531,0.00051747245,0.00035285734,0.00036804294,0.0011956175],"category_scores_gemma":[0.0037662294,0.00024064542,0.0002477558,0.0014299327,0.00021492483,0.00038065307,0.00036218966,0.00054854195,0.00016610514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019968098,0.000011704232,0.9986223,0.000006263068,0.0000118688695,0.00003655796,0.000035952282,0.000027762751,0.000045125493,0.0000088883135,0.00013041603,0.0010432212],"study_design_scores_gemma":[0.0000047955414,0.000037822192,0.9984237,0.000020430996,0.000012702395,0.00042853274,0.0002494725,0.00038497118,0.00006145533,0.000020100533,0.00035262716,0.0000034473262],"about_ca_topic_score_codex":0.02140581,"about_ca_topic_score_gemma":0.040264882,"teacher_disagreement_score":0.02140581,"about_ca_system_score_codex":0.0006787103,"about_ca_system_score_gemma":0.00074529886,"threshold_uncertainty_score":0.042562425},"labels":[],"label_agreement":null},{"id":"W3187178237","doi":"10.1017/cjn.2019.122","title":"P.022 Myasthenia gravis following dabrafenib and trametinib for metastatic melanoma","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Trametinib; Dabrafenib; Medicine; Myasthenia gravis; MEK inhibitor; Pyridostigmine; Melanoma; Internal medicine; Gastroenterology; MAPK/ERK pathway; Cancer research; Vemurafenib; Kinase; Metastatic melanoma; Biology","score_opus":0.04194767816253712,"score_gpt":0.3206121343342226,"score_spread":0.27866445617168545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187178237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92774653,0.0071351216,0.00073305616,0.006781407,0.000649344,0.0001111294,0.0002213491,0.00013958236,0.05648247],"genre_scores_gemma":[0.993697,0.00060697633,0.0001532629,0.00094047276,0.0006930102,0.000012937743,0.00011278233,0.000009076244,0.003774557],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99978894,0.000030086681,0.000015912918,0.000027174574,0.000044384524,0.00009345524],"domain_scores_gemma":[0.9994892,0.00011930348,0.0001551339,0.000022527516,0.0000516813,0.000162084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021892544,0.0003611534,0.00029236512,0.00038961595,0.00073278544,0.00051348715,0.00038377423,0.0015302546,0.008080568],"category_scores_gemma":[0.001092815,0.00015117666,0.00042062814,0.00026694883,0.00041806852,0.0004144672,0.0003250411,0.0012292068,0.0016350532],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044993468,0.00016138457,0.08844201,0.00009264292,0.000055909284,0.88679075,0.00015014375,0.00014828445,0.0015569619,0.0004628578,0.0056624897,0.016026562],"study_design_scores_gemma":[0.00012261872,0.0005958696,0.10187289,0.00010102552,0.00005076594,0.8855639,0.00015737394,0.0010307768,0.00068106706,0.00040941726,0.009399859,0.000014375152],"about_ca_topic_score_codex":0.0015516373,"about_ca_topic_score_gemma":0.0019114882,"teacher_disagreement_score":0.008080568,"about_ca_system_score_codex":0.0006604213,"about_ca_system_score_gemma":0.00040550574,"threshold_uncertainty_score":0.027032197},"labels":[],"label_agreement":null},{"id":"W3193530660","doi":"10.3390/curroncol28040273","title":"Chemotherapy-Induced Neuropathy and Diabetes: A Scoping Review","year":2021,"lang":"en","type":"review","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Peripheral neuropathy; Diabetes mellitus; Chemotherapy-induced peripheral neuropathy; Chemotherapy; Diabetic neuropathy; Internal medicine; Regimen; Cancer; Surgery; Endocrinology","score_opus":0.3235678917286284,"score_gpt":0.5553974951440349,"score_spread":0.23182960341540654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193530660","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041575,0.998776,0.0000457604,0.00016961482,0.00010380863,0.00007007509,0.00010929288,0.0000029652074,0.0003067341],"genre_scores_gemma":[0.0019496533,0.99744225,0.00011656342,0.00016695537,0.00006180461,0.00008161523,0.000096996686,0.0000014294334,0.00008282075],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9972077,0.0006272151,0.0012958508,0.00021013903,0.00052788435,0.00013116174],"domain_scores_gemma":[0.9833108,0.012433152,0.0026697246,0.00017410351,0.0012465415,0.00016569291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035392884,0.001223066,0.0037631015,0.013382747,0.0008055814,0.0029369213,0.0012288896,0.002096609,0.0052545127],"category_scores_gemma":[0.018090872,0.00078492396,0.0038822943,0.01823325,0.0006459339,0.0019016224,0.0013317892,0.0011076744,0.0004739706],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016015446,0.000048798905,0.00116059,0.8632448,0.0020295791,0.00040861982,0.0003482713,0.00014174399,0.00020582683,0.0005126339,0.0051044878,0.12663452],"study_design_scores_gemma":[0.00004865877,0.000100904304,0.0035238198,0.9323496,0.011308348,0.0010492349,0.00034595784,0.000059924074,0.00012125065,0.0003601651,0.05070496,0.00002716717],"about_ca_topic_score_codex":0.007098243,"about_ca_topic_score_gemma":0.011918429,"teacher_disagreement_score":0.013382747,"about_ca_system_score_codex":0.0026266673,"about_ca_system_score_gemma":0.0079681855,"threshold_uncertainty_score":0.01905793},"labels":[],"label_agreement":null},{"id":"W3200457141","doi":"10.1101/2021.09.13.21263539","title":"Factors associated with chemotherapy-induced peripheral neuropathy-related reduced taxane dose or premature discontinuation in women with early-stage breast cancer","year":2021,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Waterloo; The Quebec Population Health Research Network; Centre for Interdisciplinary Research in Rehabilitation; Montreal Council on Foreign Relations; York University; University of Toronto; Université de Sherbrooke; Université de Montréal; Université Laval","funders":"Astellas Pharma; Disarm Therapeutics; Fondation du cancer du sein du Québec; GW Pharmaceuticals; National Institutes of Health; Boston Scientific Corporation; Biogen; AstraZeneca; Pfizer","keywords":"Medicine; Taxane; Peripheral neuropathy; Chemotherapy-induced peripheral neuropathy; Discontinuation; Breast cancer; Internal medicine; Odds ratio; Cancer; Physical therapy","score_opus":0.03265870034546732,"score_gpt":0.30180671114309104,"score_spread":0.26914801079762374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200457141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985857,0.00072704296,0.000040661584,0.00013319889,0.000007741351,0.000009904777,0.000118345,0.0000017021505,0.000375646],"genre_scores_gemma":[0.99963415,0.00016002265,0.000034292163,0.00003204222,0.000006016858,0.0000047281433,0.00004642164,3.7686826e-7,0.00008201455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962056,0.00016887982,0.00003985577,0.00006211154,0.0000674736,0.00004113281],"domain_scores_gemma":[0.9978179,0.00054731534,0.0013111657,0.00006177701,0.00009865079,0.00016325481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006109302,0.00013328751,0.00015947505,0.0002663877,0.00025966798,0.0003404131,0.0001956691,0.00028665067,0.0016715308],"category_scores_gemma":[0.00464651,0.00013884979,0.0003157459,0.00041937217,0.00013680734,0.00019568589,0.00021269644,0.00053273584,0.0001013835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052279633,0.00003791155,0.9983699,0.000013798665,0.00002144711,0.00003709908,0.000029787441,0.000018723458,0.000031407337,0.000004689045,0.000050860308,0.0013322276],"study_design_scores_gemma":[0.000004965664,0.00009490378,0.9992943,0.000014810689,0.000019435467,0.00018160243,0.00014545787,0.00011521609,0.00001612562,0.0000129537775,0.00009831674,0.000001931843],"about_ca_topic_score_codex":0.0033316556,"about_ca_topic_score_gemma":0.0050937277,"teacher_disagreement_score":0.0033316556,"about_ca_system_score_codex":0.0002041284,"about_ca_system_score_gemma":0.00031184248,"threshold_uncertainty_score":0.00662452},"labels":[],"label_agreement":null},{"id":"W3202121966","doi":"10.1016/j.annonc.2021.08.728","title":"1840P Impact of age, comorbidities and polypharmacy on survival in advanced cancers","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Polypharmacy; Comorbidity; Oncology; Gerontology; Internal medicine; Overall survival; Intensive care medicine","score_opus":0.13906244305785645,"score_gpt":0.49876909455505103,"score_spread":0.3597066514971946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202121966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840757,0.0034836244,0.00020454089,0.0012779766,0.00011752753,0.000009219049,0.0031353293,0.000016503811,0.0076795057],"genre_scores_gemma":[0.9969463,0.0005724043,0.00011068071,0.00018688319,0.00011503322,0.000004779808,0.0007982523,0.0000069600933,0.0012586454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997373,0.000069715,0.000023128969,0.000034082303,0.00006847249,0.00006721782],"domain_scores_gemma":[0.9981987,0.00053273235,0.0005592486,0.00009598647,0.00018902164,0.00042434502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038050415,0.00012542981,0.00028483142,0.00037832564,0.00025604208,0.0006164103,0.00017188447,0.00035486135,0.007173668],"category_scores_gemma":[0.0031758333,0.00010505864,0.00074445026,0.0007812067,0.00013484611,0.00046416902,0.00050997373,0.00077438453,0.00054356136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012400211,0.00008594722,0.96951354,0.000050649607,0.0003288155,0.00016103673,0.00003839745,0.0002745845,0.00029904806,0.000112295966,0.0015552489,0.026340432],"study_design_scores_gemma":[0.000013887733,0.0001248013,0.99816966,0.00001206272,0.00008308731,0.00016123925,0.000038821137,0.00026612522,0.00004076743,0.0001376691,0.00094747444,0.000004256129],"about_ca_topic_score_codex":0.0054041413,"about_ca_topic_score_gemma":0.009656513,"teacher_disagreement_score":0.007173668,"about_ca_system_score_codex":0.00033309677,"about_ca_system_score_gemma":0.00043619177,"threshold_uncertainty_score":0.02399826},"labels":[],"label_agreement":null},{"id":"W3206196696","doi":"10.1016/j.clinbiomech.2021.105512","title":"Influence of intermittent pneumatic compression on foot sensation and balance control in chemotherapy-induced peripheral neuropathy patients","year":2021,"lang":"en","type":"article","venue":"Clinical Biomechanics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Institute for Aging; University of Waterloo","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Medicine; Intermittent pneumatic compression; Peripheral neuropathy; Sensation; Massage; Balance (ability); Physical medicine and rehabilitation; Peripheral; Context (archaeology); Physical therapy; Surgery; Internal medicine; Psychology","score_opus":0.028541812671102385,"score_gpt":0.35208981141745077,"score_spread":0.3235479987463484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206196696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991086,0.0003318814,0.000020079095,0.000018552779,0.000005852345,0.000005443724,0.000021406866,0.0000013979733,0.0004868237],"genre_scores_gemma":[0.9997147,0.000098956865,0.000017473305,0.000012921268,0.0000061285737,0.0000028973002,0.000029217135,2.5564964e-7,0.00011748304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999294,0.00001964206,0.000007572242,0.0000104465735,0.000012559438,0.000020283278],"domain_scores_gemma":[0.99979967,0.00006836048,0.000046252815,0.000006034538,0.000014972133,0.00006471914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009030373,0.00013786559,0.00021971611,0.00014154478,0.00017184136,0.0001959118,0.00008056722,0.00017806474,0.0015178315],"category_scores_gemma":[0.00069270737,0.00004232238,0.00016299373,0.00018369418,0.00011584012,0.00010206814,0.00009410757,0.00022993797,0.000058570648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0704164,0.004404438,0.7335865,0.00037729015,0.0005671239,0.004460064,0.0005574809,0.0008483108,0.02712236,0.00015628617,0.0006525769,0.15685116],"study_design_scores_gemma":[0.00026474558,0.0120406,0.9849969,0.000019795569,0.00017451883,0.0007292077,0.00016170582,0.00037699324,0.0008731907,0.00003901145,0.0003153288,0.000008108124],"about_ca_topic_score_codex":0.0012217287,"about_ca_topic_score_gemma":0.0018087331,"teacher_disagreement_score":0.0015178315,"about_ca_system_score_codex":0.0001531442,"about_ca_system_score_gemma":0.00018208982,"threshold_uncertainty_score":0.00507766},"labels":[],"label_agreement":null},{"id":"W3206895537","doi":"","title":"The effects of exercise training on antitumor efficacy of doxorubicin in MDA-MB-231 breast cancer xenografts","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Chemotherapy; Breast cancer; Cancer; Doxorubicin; Internal medicine; Urology; Oncology; Surgery","score_opus":0.07046813172707168,"score_gpt":0.45713557103825403,"score_spread":0.38666743931118236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206895537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974203,0.0013752076,0.00016147754,0.00007126975,0.000030601946,0.000022129248,0.00020066444,0.000019774823,0.00069849164],"genre_scores_gemma":[0.9959765,0.0016681525,0.0003231638,0.000055383807,0.00001720334,0.000051954787,0.00051152846,0.0000062253384,0.0013898566],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990904,0.000020738647,0.000008346487,0.000012195273,0.000015391795,0.000034324992],"domain_scores_gemma":[0.99992466,0.000021917675,0.000013227197,0.000007481617,0.0000065003214,0.000026161319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014919955,0.00023449642,0.00035915204,0.00013710941,0.000089069465,0.00019368001,0.00013301212,0.00016986966,0.0009875594],"category_scores_gemma":[0.00012783095,0.000091006186,0.00018120061,0.000115943,0.00014561313,0.00016508558,0.000109566565,0.0005961501,0.00014654359],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048701605,0.0021153064,0.0011707577,0.00015868794,0.000031964242,0.000047817546,0.00004706153,0.0003092533,0.9767423,0.00007671444,0.00033384116,0.014095985],"study_design_scores_gemma":[0.0005947798,0.062623054,0.060545016,0.000047664653,0.00014468704,0.0002098293,0.0001305163,0.0035959855,0.86790186,0.000104761035,0.0040742047,0.00002772954],"about_ca_topic_score_codex":0.00078513345,"about_ca_topic_score_gemma":0.0018049104,"teacher_disagreement_score":0.0009875594,"about_ca_system_score_codex":0.00013261496,"about_ca_system_score_gemma":0.00016665515,"threshold_uncertainty_score":0.0033037066},"labels":[],"label_agreement":null},{"id":"W3207701638","doi":"10.1002/cnr2.1577","title":"Diagnostic tools should be used for the diagnosis of chemotherapy induced peripheral neuropathy in breast cancer patients receiving taxanes","year":2021,"lang":"en","type":"article","venue":"Cancer Reports","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Peripheral neuropathy; Breast cancer; Internal medicine; Docetaxel; Chemotherapy-induced peripheral neuropathy; Taxane; Oncology; Paclitaxel; Cancer; Chemotherapy","score_opus":0.062239493270620186,"score_gpt":0.35982611819895977,"score_spread":0.2975866249283396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207701638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99268216,0.0023834673,0.00072440156,0.0005472308,0.00007913271,0.00010855697,0.00064022664,0.000029834951,0.0028049045],"genre_scores_gemma":[0.9971723,0.00043286706,0.0013845961,0.00022138827,0.000043357973,0.00008062541,0.00041378132,0.0000021474493,0.0002489617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914145,0.00021472786,0.00014724543,0.00009071173,0.0002643559,0.00014161872],"domain_scores_gemma":[0.99619246,0.0009312652,0.0017652846,0.00012474238,0.00068957877,0.00029656946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011791633,0.00040697734,0.00040111874,0.00064209435,0.00050474325,0.00049826485,0.00034011502,0.00084249943,0.0011805828],"category_scores_gemma":[0.004445112,0.00011380528,0.0005036175,0.000811869,0.00027718188,0.00045497355,0.0002834312,0.0008146616,0.00048751637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016273913,0.00012538358,0.9881197,0.0000435641,0.000012124966,0.00019120793,0.000053580883,0.000039649763,0.0008703487,0.000015850688,0.00033322346,0.010032562],"study_design_scores_gemma":[0.000015623047,0.000625203,0.9955369,0.000051521136,0.00004330215,0.0012379533,0.00019820526,0.00023206975,0.0008849439,0.00007277537,0.0010947182,0.0000068384165],"about_ca_topic_score_codex":0.0012071829,"about_ca_topic_score_gemma":0.0016462159,"teacher_disagreement_score":0.0012071829,"about_ca_system_score_codex":0.00036141844,"about_ca_system_score_gemma":0.00059464626,"threshold_uncertainty_score":0.0062360764},"labels":[],"label_agreement":null},{"id":"W3207704344","doi":"10.1177/17151635211050029","title":"Pharmacy, we have an image problem . . . (and here’s a solution)","year":2021,"lang":"en","type":"editorial","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacy; Image (mathematics); Computer science; Computer vision; Medicine; Nursing","score_opus":0.030612910968947724,"score_gpt":0.3198254235975019,"score_spread":0.28921251262855413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207704344","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017673605,0.0041785673,0.000079747035,0.13979992,0.8543762,0.0000123546715,0.000031865347,0.000052272302,0.0014513668],"genre_scores_gemma":[0.0005020534,0.0061522997,0.0001663552,0.16617069,0.812827,0.000029532135,0.00003550879,0.000059725888,0.014056831],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9894722,0.0016174624,0.00087528746,0.0008253196,0.0065898905,0.0006198173],"domain_scores_gemma":[0.961839,0.014143982,0.0013939008,0.0008496694,0.016092561,0.0056808223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010256451,0.0029642717,0.003002768,0.0028100181,0.005668637,0.012044079,0.003853595,0.024922479,0.018903421],"category_scores_gemma":[0.055152815,0.0012080185,0.0032784175,0.0015396321,0.0049379147,0.008786332,0.0019900694,0.043166738,0.013599526],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000056381896,0.000003086322,0.000007180829,0.00006607078,0.0000067457904,0.000024126568,0.000008969679,0.0000061286546,0.000008358173,0.00021605878,0.9978676,0.0017801817],"study_design_scores_gemma":[0.000035029196,0.000015534819,0.00012701291,0.00041265917,0.000032007887,0.0001778161,0.00008025041,0.000060087295,0.000039664104,0.0012884837,0.99771214,0.000019303807],"about_ca_topic_score_codex":0.011927962,"about_ca_topic_score_gemma":0.030696418,"teacher_disagreement_score":0.024922479,"about_ca_system_score_codex":0.0069128023,"about_ca_system_score_gemma":0.00976334,"threshold_uncertainty_score":0.06323826},"labels":[],"label_agreement":null},{"id":"W3214344627","doi":"10.1182/blood-2021-154311","title":"Bleeding Outcomes in Patients with Gastrointestinal Malignancies Treated with Distally Absorbed Versus Proximally Absorbed Direct Oral Anticoagulants","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Rivaroxaban; Edoxaban; Apixaban; Dabigatran; Internal medicine; Cancer; Gastroenterology; Malignancy; Warfarin; Atrial fibrillation","score_opus":0.01688496194765079,"score_gpt":0.26532386837195676,"score_spread":0.24843890642430597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214344627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99657863,0.0016878736,0.000105377876,0.00013931932,0.000018111245,0.000027126222,0.0008907338,0.0000032992275,0.00054955465],"genre_scores_gemma":[0.99874914,0.00033307128,0.000074193194,0.00006509025,0.00002629756,0.000021329974,0.0006531277,8.828843e-7,0.000076755205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940896,0.00014927432,0.000093112685,0.00019537621,0.00008600518,0.00006723112],"domain_scores_gemma":[0.9989177,0.00017526934,0.00066595234,0.00003250956,0.000064885106,0.00014377992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051245664,0.00018790006,0.0003860303,0.00045985112,0.00024440122,0.0004851921,0.00023538682,0.00029240668,0.0016441708],"category_scores_gemma":[0.001987549,0.000106840285,0.0008624077,0.00081530155,0.00020032952,0.00023159145,0.00026514585,0.00041268914,0.00009779995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020623738,0.00011300412,0.9914233,0.000102151585,0.0004884053,0.000076346114,0.000032312862,0.000129592,0.00022630274,0.00007516542,0.00042151337,0.004849681],"study_design_scores_gemma":[0.0004550763,0.00081204076,0.9966156,0.00004691534,0.00041280402,0.0003966881,0.00006177376,0.00043518416,0.00016489162,0.00011408656,0.0004767331,0.000008196289],"about_ca_topic_score_codex":0.0021944281,"about_ca_topic_score_gemma":0.0025297801,"teacher_disagreement_score":0.0021944281,"about_ca_system_score_codex":0.0005014892,"about_ca_system_score_gemma":0.00040452814,"threshold_uncertainty_score":0.005500257},"labels":[],"label_agreement":null},{"id":"W3215368970","doi":"10.1161/res.129.suppl_1.p425","title":"Abstract P425: Sirtuin 3 Attenuates Doxorubicin Induced Cardiac Dysfunction By Regulating The Mitochondrial Acetylome And Alterations Of The Cardiac Lipidome","year":2021,"lang":"en","type":"article","venue":"Circulation Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital; University of Manitoba; Children's Hospital Research Institute of Manitoba","funders":"","keywords":"SIRT3; Sirtuin; Cardiac function curve; Pharmacology; Mitochondrion; Cardiac fibrosis; Endocrinology; Chemistry; Internal medicine; Biology; Acetylation; Biochemistry; Medicine; Fibrosis; Heart failure","score_opus":0.06650778107713613,"score_gpt":0.37495808531434033,"score_spread":0.3084503042372042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215368970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98092574,0.00321049,0.005317928,0.0012911576,0.0004796064,0.00014651222,0.0032735693,0.00081671524,0.0045384145],"genre_scores_gemma":[0.9810724,0.0013455226,0.002452946,0.00045679498,0.00008412405,0.0001730321,0.0023633346,0.00011190805,0.011939985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998567,0.000018195129,0.000013878608,0.00003572879,0.000033284763,0.000042206495],"domain_scores_gemma":[0.9998927,0.0000064146934,0.000033350876,0.000010740327,0.000010580481,0.00004609089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014830058,0.00057696056,0.00057015376,0.00025407402,0.00021775963,0.00034121712,0.00038843215,0.0005245846,0.0076289787],"category_scores_gemma":[0.000113616494,0.00017226758,0.00035614378,0.00019692499,0.00045100227,0.00034791135,0.0002003878,0.0015935434,0.0013718584],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040310533,0.00047824794,0.0003404458,0.00013848014,0.000036016074,0.0001124888,0.000027178268,0.00010385739,0.9873899,0.00020953876,0.0009129337,0.0062198243],"study_design_scores_gemma":[0.0010541691,0.0072922744,0.009212296,0.000044445416,0.00012243344,0.00054864766,0.000105458595,0.001386352,0.97075605,0.00025058826,0.009210363,0.000016980288],"about_ca_topic_score_codex":0.00069589267,"about_ca_topic_score_gemma":0.0009788073,"teacher_disagreement_score":0.0076289787,"about_ca_system_score_codex":0.00030961592,"about_ca_system_score_gemma":0.0004050004,"threshold_uncertainty_score":0.025521457},"labels":[],"label_agreement":null},{"id":"W32676954","doi":"10.1023/a:1013050330608","title":"Drug-Drug Interactions Arising From the Use of Liposomal Vincristine in Combination with Other Anticancer Drugs","year":2001,"lang":"en","type":"article","venue":"Pharmaceutical Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Drug; Anticancer drug; Pharmacology; Vincristine; Liposome; Medicine; Drug interaction; Approved drug; Chemistry; Chemotherapy; Internal medicine","score_opus":0.27231962334222193,"score_gpt":0.5117446603891239,"score_spread":0.239425037046902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W32676954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815092,0.009938178,0.0027388749,0.00042747502,0.00008335402,0.00012217967,0.00012243113,0.00004351135,0.005014669],"genre_scores_gemma":[0.996846,0.0015612696,0.00067317614,0.00010780477,0.00004083337,0.000013186296,0.000055147742,0.000011450346,0.00069106644],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992853,0.000370325,0.00006242665,0.00005151021,0.0001723586,0.000058157962],"domain_scores_gemma":[0.9986265,0.000877655,0.00031859428,0.00004782586,0.000059749444,0.00006979105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094114954,0.00020957075,0.00044803513,0.00043892986,0.00038268513,0.00045944515,0.00016721817,0.00045374766,0.002394028],"category_scores_gemma":[0.0021381686,0.00014061171,0.00046529132,0.00041568352,0.00022312919,0.00029874267,0.000382256,0.0005805165,0.00037676393],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020207476,0.0009775392,0.070691675,0.0013933453,0.0014557258,0.017401142,0.0005687134,0.003058489,0.5981947,0.0017591671,0.0022249962,0.2820669],"study_design_scores_gemma":[0.00095930946,0.01845895,0.17019925,0.00021145261,0.0025073374,0.055059846,0.00058641186,0.013005495,0.67556816,0.0014818559,0.06186536,0.000096591684],"about_ca_topic_score_codex":0.00029276626,"about_ca_topic_score_gemma":0.00079005345,"teacher_disagreement_score":0.002394028,"about_ca_system_score_codex":0.0004091008,"about_ca_system_score_gemma":0.00020871029,"threshold_uncertainty_score":0.008008778},"labels":[],"label_agreement":null},{"id":"W39492073","doi":"10.1016/j.vaccine.2023.10.058","title":"Effets cellulaires de substances naturelles et synthétiques : identification des activités cytoprotectrices liées au stress oxydant en chimiothérapie","year":2008,"lang":"en","type":"dissertation","venue":"Vaccine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Molecular biology; Chemistry; Biology","score_opus":0.012347686330247297,"score_gpt":0.3276260767230536,"score_spread":0.3152783903928063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W39492073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844428,0.00862066,0.00061506516,0.0004924575,0.00003651338,0.00009409989,0.00021334058,0.000016198634,0.0054689357],"genre_scores_gemma":[0.9908556,0.0045119147,0.0008474621,0.00022367293,0.000026161524,0.000048785634,0.00016586696,0.0000054544616,0.0033151838],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99955744,0.00011078946,0.000012868917,0.000068824535,0.00015710102,0.00009304546],"domain_scores_gemma":[0.9990792,0.00030885733,0.00030949948,0.000028032358,0.00017195074,0.00010230504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009773467,0.0002578456,0.00028104254,0.0006281404,0.00050439703,0.0010265455,0.00021973098,0.0004452339,0.0025549924],"category_scores_gemma":[0.0018968876,0.00013470718,0.00028421945,0.0005167011,0.00067541504,0.00026032637,0.00032730895,0.0004843906,0.00017779192],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074620377,0.0013253995,0.45037147,0.002052971,0.0005000081,0.0016322234,0.016193321,0.00055773335,0.17843036,0.0013946042,0.0024726752,0.33760726],"study_design_scores_gemma":[0.00009861177,0.0022939374,0.9499008,0.00030389804,0.00026143217,0.0007628886,0.0062400503,0.000732153,0.023646994,0.00049070915,0.015222992,0.0000455085],"about_ca_topic_score_codex":0.07275333,"about_ca_topic_score_gemma":0.10141347,"teacher_disagreement_score":0.07275333,"about_ca_system_score_codex":0.0018512346,"about_ca_system_score_gemma":0.0014014769,"threshold_uncertainty_score":0.14465976},"labels":[],"label_agreement":null},{"id":"W416563081","doi":"10.1016/b978-2-294-08855-1.50177-7","title":"10.1016/b978-2-294-08855-1.50177-7","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Philosophy","score_opus":0.0143094062707754,"score_gpt":0.23222719033937933,"score_spread":0.21791778406860393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W416563081","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015237817,0.0005032399,0.00068945164,0.00025760147,0.00015705738,0.00003667351,0.00053123897,0.00071992975,0.9969524],"genre_scores_gemma":[0.00038761552,0.00025934147,0.00031062917,0.00009843125,0.000029669614,0.000024247385,0.00031692168,0.00016516802,0.998408],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999637,0.000022326385,0.00002091292,0.0001186926,0.00013535381,0.00006568595],"domain_scores_gemma":[0.99878925,0.00039132038,0.00008466514,0.00015013175,0.00022661586,0.00035806544],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00068931194,0.0018819387,0.0011643897,0.0016073373,0.0012631869,0.0041026054,0.0023816626,0.0036100156,0.97760713],"category_scores_gemma":[0.001384082,0.0007042882,0.00075565366,0.0016801155,0.0009780048,0.0038635854,0.0029396608,0.0020033189,0.98801416],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012303205,0.00010757399,0.00028521716,0.00038145352,0.000012782205,0.00011145951,0.00007613719,0.00029412966,0.0020023421,0.006602114,0.37098315,0.61902064],"study_design_scores_gemma":[0.000012299733,0.000035248686,0.0003581356,0.00022880449,0.0000052731157,0.00015859558,0.000056321875,0.00008873714,0.00025053162,0.0010464134,0.9977501,0.000009440197],"about_ca_topic_score_codex":0.002566742,"about_ca_topic_score_gemma":0.0028649168,"teacher_disagreement_score":0.022392869,"about_ca_system_score_codex":0.0008329318,"about_ca_system_score_gemma":0.00074223406,"threshold_uncertainty_score":0.03194064},"labels":[],"label_agreement":null},{"id":"W4200155196","doi":"10.14740/jmc3819","title":"High-Dose Gabapentin and Amitriptyline in the Treatment of Refractory Chemotherapy-Induced Peripheral Neuropathy in a Toddler","year":2021,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gabapentin; Peripheral neuropathy; Chemotherapy-induced peripheral neuropathy; Refractory (planetary science); Discontinuation; Pregabalin; Amitriptyline; Anesthesia; Internal medicine","score_opus":0.04247216451385996,"score_gpt":0.35377974673570267,"score_spread":0.31130758222184274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200155196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.952544,0.03552275,0.0015995638,0.003946437,0.00018460366,0.00009657576,0.00006286528,0.00009168372,0.0059514744],"genre_scores_gemma":[0.9838076,0.0116240885,0.0024369794,0.0011013871,0.00014745815,0.00002614997,0.000047007863,0.000009261634,0.0008000766],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9999218,0.000025368754,0.0000129945765,0.000008002955,0.00001280229,0.000019113708],"domain_scores_gemma":[0.99986076,0.000030619973,0.000035906593,0.0000059610725,0.000008999243,0.000057690173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014489942,0.00025716945,0.000379802,0.00029316903,0.000468569,0.0002084917,0.00030804865,0.00061481167,0.00042590205],"category_scores_gemma":[0.00047375992,0.00010829402,0.00026408295,0.00021766724,0.00028271627,0.00017824445,0.0002585112,0.00088512234,0.00013225709],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021176504,0.0010813517,0.08092736,0.00089616515,0.00021654523,0.6741481,0.00049893564,0.001153604,0.023128869,0.0010734462,0.0058417385,0.20891616],"study_design_scores_gemma":[0.00037171264,0.006569549,0.15460244,0.00041249936,0.00018618442,0.8126749,0.00062407134,0.0017408535,0.0063350773,0.0006399263,0.015802532,0.00004024693],"about_ca_topic_score_codex":0.0015827118,"about_ca_topic_score_gemma":0.0049493806,"teacher_disagreement_score":0.0015827118,"about_ca_system_score_codex":0.0003811698,"about_ca_system_score_gemma":0.00036546754,"threshold_uncertainty_score":0.0031469464},"labels":[],"label_agreement":null},{"id":"W4200404431","doi":"10.17504/protocols.io.b2xbqfin","title":"[RETRACTED] HempLeafz CBD Gummies | &amp;#34;Scam Alert&amp;#34; v1","year":2021,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Product (mathematics); Order (exchange); Internet privacy; Ideal (ethics); Health professionals; Psychology; Business; Health care; Advertising; Medicine; Computer science; Law; Political science","score_opus":0.07772776466948145,"score_gpt":0.3819838712468033,"score_spread":0.3042561065773218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200404431","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00066692644,0.00096430216,0.0019248715,0.012328803,0.027553275,0.0007409941,0.004881549,0.013974808,0.93696445],"genre_scores_gemma":[0.0017688826,0.0003425442,0.0004890508,0.006890116,0.0017878026,0.00014166595,0.0012913503,0.0016393146,0.9856491],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99902546,0.00007818947,0.000066299515,0.00010958363,0.0005333486,0.00018708086],"domain_scores_gemma":[0.99595934,0.00055878714,0.00012790563,0.0004064069,0.0023226545,0.0006249334],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012111546,0.0011289412,0.0010690901,0.0013192262,0.0029961686,0.004112528,0.0024150512,0.0068851113,0.8675284],"category_scores_gemma":[0.010099941,0.0009174017,0.0012607703,0.00090750214,0.0008349677,0.0040233955,0.0022418918,0.0050950446,0.7872323],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002607104,0.000027830692,0.000037712893,0.000039400613,0.0000014286862,0.000062447965,0.000011204398,0.000010093153,0.00008527748,0.0001830595,0.9852631,0.014252406],"study_design_scores_gemma":[0.000027136508,0.000029546067,0.00038416247,0.00007599996,0.0000027644412,0.00016359855,0.000033974247,0.00005689757,0.00015016111,0.00024086011,0.9988218,0.000013158261],"about_ca_topic_score_codex":0.0100795375,"about_ca_topic_score_gemma":0.015113598,"teacher_disagreement_score":0.8675284,"about_ca_system_score_codex":0.001028617,"about_ca_system_score_gemma":0.0013869936,"threshold_uncertainty_score":0.18895471},"labels":[],"label_agreement":null},{"id":"W4205376135","doi":"10.1200/jco.2022.40.4_suppl.078","title":"Adjuvant oxaliplatin and fall-related injury in patients with colorectal cancer.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Institute of Health Services and Policy Research; Sunnybrook Health Science Centre; Mount Sinai Hospital; University of Toronto","funders":"Physicians' Services Incorporated Foundation","keywords":"Medicine; Oxaliplatin; Colorectal cancer; Cohort; Hazard ratio; Internal medicine; Proportional hazards model; Population; Retrospective cohort study; Adjuvant chemotherapy; Oncology; Cancer; Surgery; Confidence interval","score_opus":0.04708204055723457,"score_gpt":0.44939695461691265,"score_spread":0.40231491405967806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205376135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972465,0.0008146641,0.00005249649,0.0000873387,0.0000126046125,0.000023894843,0.0012120449,0.0000032994776,0.00054721255],"genre_scores_gemma":[0.99861705,0.00021777106,0.000065499386,0.00005016551,0.000012230065,0.00001699193,0.0007514592,0.000001211325,0.000267538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997204,0.000040379866,0.000038037564,0.00006728557,0.000061576524,0.00007230331],"domain_scores_gemma":[0.99928135,0.000057877325,0.00046380656,0.000037762842,0.000054767315,0.00010448445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033545695,0.00017372328,0.00024507628,0.00038170614,0.00033550203,0.00040469225,0.00025465412,0.00032486577,0.0013172921],"category_scores_gemma":[0.0013708586,0.00023612748,0.0005584406,0.00094374106,0.00013332909,0.00019831823,0.00027225426,0.00045109517,0.00014698203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043494705,0.000038272257,0.9979657,0.000021434687,0.000069270456,0.000042963118,0.000014960013,0.000039806037,0.0000581322,0.000009091697,0.00015080199,0.0011545825],"study_design_scores_gemma":[0.00005161949,0.00023676359,0.99875855,0.000013259384,0.000082112536,0.00016402402,0.00004354776,0.00021005078,0.000027829077,0.000018784449,0.0003904661,0.000002905038],"about_ca_topic_score_codex":0.025995634,"about_ca_topic_score_gemma":0.04648375,"teacher_disagreement_score":0.025995634,"about_ca_system_score_codex":0.0006093294,"about_ca_system_score_gemma":0.00077993184,"threshold_uncertainty_score":0.05168867},"labels":[],"label_agreement":null},{"id":"W4206240957","doi":"10.1093/ww/9780199540884.013.u13564","title":"Deslongchamps, Prof. Pierre, (born 8 May 1938), Professor of Organic Chemistry, Université de Sherbrooke, Canada, 1972–2006, now Emeritus; Executive Scientific Advisor, OmegaChem Inc., since 2008; Associate Professor, Laval University, Quebec, since 2008","year":2007,"lang":"en","type":"reference-entry","venue":"Who's Who","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Library science; Engineering; Engineering physics; Computer science","score_opus":0.013908111053815906,"score_gpt":0.25652482481397687,"score_spread":0.24261671376016097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206240957","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002183821,0.10017125,0.0017215367,0.13746151,0.04552036,0.00020630237,0.008855617,0.0009325957,0.70294696],"genre_scores_gemma":[0.002201106,0.013316794,0.00028884673,0.004068295,0.0007843346,0.000020279374,0.00059898145,0.00007534673,0.978646],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991333,0.00008776487,0.000037757247,0.00017293196,0.0004197263,0.00014852834],"domain_scores_gemma":[0.9982324,0.00024899788,0.000111243025,0.00004659069,0.00082540594,0.00053536467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010291287,0.00095640006,0.0006404717,0.0012808449,0.0016530802,0.0022019162,0.00080867094,0.0017695382,0.19573566],"category_scores_gemma":[0.0020971647,0.00040834662,0.0002404995,0.0016782344,0.00076203933,0.00167673,0.0008730602,0.0024823004,0.11724823],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028442559,0.000006367356,0.00013442677,0.00007240951,0.000001664562,0.00008785456,0.00006783839,0.000027791399,0.00012665035,0.0019098745,0.96822786,0.029308759],"study_design_scores_gemma":[0.0000035408093,0.000006626556,0.00018391511,0.00003291434,8.8602064e-7,0.00007845279,0.000034336135,0.00000604866,0.00011083449,0.00015712845,0.99938214,0.0000031784532],"about_ca_topic_score_codex":0.09106796,"about_ca_topic_score_gemma":0.22610727,"teacher_disagreement_score":0.19573566,"about_ca_system_score_codex":0.005204776,"about_ca_system_score_gemma":0.008475609,"threshold_uncertainty_score":0.654801},"labels":[],"label_agreement":null},{"id":"W4206834628","doi":"10.21203/rs.3.rs-1254626/v1","title":"The effect of trastuzumab on taxane-induced peripheral neuropathy in women with breast cancer: a population-based cohort study","year":2022,"lang":"en","type":"preprint","venue":"Research Square","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Kingston Health Sciences Centre; Queen's University","funders":"Queen's University; Cancer Care Ontario","keywords":"Medicine; Taxane; Docetaxel; Trastuzumab; Internal medicine; Breast cancer; Population; Peripheral neuropathy; Oncology; Cohort; Cancer; Diabetes mellitus","score_opus":0.028280602293816685,"score_gpt":0.4117375393122459,"score_spread":0.3834569370184292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206834628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983315,0.00029616614,0.00005032507,0.00004228975,0.0000078632365,0.00001683868,0.000879179,0.0000020161287,0.00037397814],"genre_scores_gemma":[0.9990664,0.00016551197,0.00004687019,0.000038873026,0.000010220967,0.000014354449,0.0005204835,0.0000015765315,0.00013561084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921775,0.00014771096,0.0000813172,0.00025940084,0.00015253462,0.00014123382],"domain_scores_gemma":[0.9986656,0.00016030962,0.0005865825,0.00018304632,0.00019098955,0.00021358425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008644702,0.00027036623,0.00037600525,0.0006842395,0.0006558569,0.0008998391,0.00053662976,0.0004496314,0.0014793954],"category_scores_gemma":[0.0024274578,0.0003752566,0.00069455296,0.0016567411,0.00022557007,0.0005186539,0.00046041343,0.00063382665,0.00024616078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009491334,0.000021758793,0.9992719,0.000004804992,0.00009065707,0.000043176937,0.00003555759,0.000008242184,0.00005849845,0.0000068066824,0.00005697704,0.0003067957],"study_design_scores_gemma":[0.000017215281,0.00008053231,0.9992681,0.0000057403463,0.000081418606,0.00015289125,0.00011761381,0.00008329869,0.000020566735,0.000011698183,0.00015819953,0.000002693162],"about_ca_topic_score_codex":0.025957396,"about_ca_topic_score_gemma":0.029253336,"teacher_disagreement_score":0.025957396,"about_ca_system_score_codex":0.00060795975,"about_ca_system_score_gemma":0.00065529183,"threshold_uncertainty_score":0.051612616},"labels":[],"label_agreement":null},{"id":"W4206848609","doi":"","title":"Docetaxel-associated myalgia&ndash;arthralgia syndrome in patients with breast cancer","year":2017,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"myalgia; Docetaxel; Medicine; Breast cancer; Oncology; Internal medicine; Dermatology; Cancer","score_opus":0.14566794732261912,"score_gpt":0.5450446510712325,"score_spread":0.39937670374861334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206848609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99767905,0.0013183617,0.0000740759,0.0000701588,0.000010298115,0.000021537156,0.0000959571,0.000003912923,0.0007265644],"genre_scores_gemma":[0.9992186,0.0004808683,0.000062647676,0.00003855943,0.000021344496,0.000008871562,0.0000983772,6.800593e-7,0.00007005108],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9997149,0.00005271966,0.00004604803,0.0000475228,0.00007565742,0.00006316412],"domain_scores_gemma":[0.9992205,0.00022206314,0.00037240164,0.000022780156,0.000048402522,0.000113957176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028096887,0.0002532534,0.00042186174,0.00075400993,0.00043841297,0.00040017732,0.00023055838,0.0003519452,0.0012705347],"category_scores_gemma":[0.0018765149,0.00024618543,0.00021984961,0.0008966082,0.0002960683,0.00031804806,0.00028106477,0.00031064337,0.00018891036],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117824944,0.000029502653,0.9922132,0.00002547791,0.000015434633,0.00446748,0.00008555736,0.000027029195,0.0004055039,0.000018906581,0.00012920327,0.0024648947],"study_design_scores_gemma":[0.000031734184,0.00027137954,0.9701952,0.000036568694,0.000031286945,0.028386315,0.0003208498,0.00018888518,0.00013163719,0.00003078832,0.0003683699,0.000007038371],"about_ca_topic_score_codex":0.0016454416,"about_ca_topic_score_gemma":0.0027749848,"teacher_disagreement_score":0.0016454416,"about_ca_system_score_codex":0.0002348253,"about_ca_system_score_gemma":0.00034501796,"threshold_uncertainty_score":0.0042503476},"labels":[],"label_agreement":null},{"id":"W4210602537","doi":"10.3917/pls.497.0072","title":"Pilules Orientales pour poitrine idéale","year":2019,"lang":"fr","type":"article","venue":"Pour la Science","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Society for the History of Medicine","funders":"","keywords":"Art","score_opus":0.013302565286484587,"score_gpt":0.3319507151853574,"score_spread":0.3186481498988728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210602537","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16364205,0.12700488,0.07327553,0.027006833,0.009375593,0.00029430725,0.00049489323,0.0014709486,0.5974349],"genre_scores_gemma":[0.7344792,0.04119462,0.039925206,0.0051064384,0.002298638,0.0002910153,0.00025973248,0.0004585624,0.17598656],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99924684,0.00021055991,0.00001812762,0.00007061502,0.0003049113,0.00014895435],"domain_scores_gemma":[0.99963284,0.0001338593,0.000039056868,0.000037028793,0.000087653636,0.00006943635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006275797,0.0008628383,0.0007588797,0.0011372697,0.0014085734,0.0025284367,0.00038657515,0.0013606695,0.018185057],"category_scores_gemma":[0.0014891259,0.00020902813,0.0006455145,0.0004946801,0.0017844526,0.001513274,0.0014857994,0.004537609,0.004190587],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011542983,0.00027088667,0.0005974932,0.0008812466,0.00007743194,0.0016290188,0.0007494451,0.0021094736,0.08087061,0.7034611,0.017647076,0.19055188],"study_design_scores_gemma":[0.00026065466,0.0004907423,0.001312648,0.00045116013,0.00007835391,0.004270171,0.0009810902,0.0021590225,0.05783925,0.14388296,0.78819263,0.00008132868],"about_ca_topic_score_codex":0.0013388839,"about_ca_topic_score_gemma":0.0013364557,"teacher_disagreement_score":0.018185057,"about_ca_system_score_codex":0.0012533278,"about_ca_system_score_gemma":0.00073281967,"threshold_uncertainty_score":0.060835063},"labels":[],"label_agreement":null},{"id":"W4210625548","doi":"10.1038/s41408-021-00602-4","title":"Patient-reported outcome measures are associated with health care utilization in patients with transplant ineligible multiple myeloma: a population-based study","year":2022,"lang":"en","type":"editorial","venue":"Blood Cancer Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"Hamilton Health Sciences Foundation; Cancer Care Ontario; Hamilton Health Sciences","keywords":"Multiple myeloma; Medicine; Outcome (game theory); Population; Internal medicine; MEDLINE; Health care; Intensive care medicine; Environmental health; Biology","score_opus":0.03334740798546452,"score_gpt":0.329829562829504,"score_spread":0.29648215484403945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210625548","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022726195,0.12732661,0.0006026925,0.099506795,0.74030757,0.00012638773,0.0043434645,0.00014014523,0.0049200887],"genre_scores_gemma":[0.0687346,0.051843807,0.001070392,0.086174965,0.7796096,0.0002717111,0.0020125539,0.00011501341,0.010167297],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9962528,0.0014007104,0.0006359608,0.00044847766,0.0010821054,0.00017987493],"domain_scores_gemma":[0.96687263,0.023791017,0.0019201131,0.0007149113,0.0053572203,0.0013441904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0078030345,0.0012374246,0.0027836596,0.0017406597,0.0007500609,0.004044319,0.0013631644,0.00422296,0.0026816435],"category_scores_gemma":[0.023993349,0.0007523345,0.0019366458,0.00207247,0.0008101769,0.0011318912,0.0004894112,0.0045268177,0.0010436047],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020173183,0.00025290798,0.03595925,0.0033702934,0.0025110561,0.00065336394,0.00013424862,0.000090644266,0.00027807758,0.0003755077,0.92405474,0.030302513],"study_design_scores_gemma":[0.004825538,0.0015898221,0.46351463,0.0071077654,0.012026775,0.0027938273,0.0011984892,0.0018832869,0.00072202855,0.0024904057,0.50144416,0.00040337493],"about_ca_topic_score_codex":0.0022299064,"about_ca_topic_score_gemma":0.0048948545,"teacher_disagreement_score":0.0078030345,"about_ca_system_score_codex":0.0007637005,"about_ca_system_score_gemma":0.001479711,"threshold_uncertainty_score":0.04126692},"labels":[],"label_agreement":null},{"id":"W4210847582","doi":"10.21203/rs.3.rs-1289285/v1","title":"Neuro Protective Effect of Baicalein Against Oxaliplatin-Induced Peripheral Neuropathy: Impact on Oxidative Stress, Neuro-inflammation and WNT/β-Catenin Signaling","year":2022,"lang":"en","type":"preprint","venue":"Research Square","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Pharmaceutical Education and Research, Raebareli","keywords":"Baicalein; Oxidative stress; Oxaliplatin; Inflammation; Peripheral neuropathy; Wnt signaling pathway; Medicine; Catenin; Pharmacology; Immunology; Signal transduction; Internal medicine; Biology; Cell biology; Endocrinology; Cancer; Colorectal cancer","score_opus":0.05062817158793939,"score_gpt":0.41599832477808835,"score_spread":0.365370153190149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210847582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99090415,0.0048591406,0.00065623136,0.00031533054,0.00014779839,0.000053210508,0.0007758844,0.00010528098,0.0021829023],"genre_scores_gemma":[0.99350476,0.0020877584,0.00094546616,0.00008341355,0.000024091078,0.000046850637,0.0005078331,0.00001540759,0.0027844135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999654,0.0000030588576,0.0000021402343,0.000008316454,0.0000065107056,0.000014457421],"domain_scores_gemma":[0.9999765,0.0000020200787,0.000005420652,0.000001818769,0.0000031831319,0.000011048063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006220875,0.00032661852,0.0004444418,0.00015974505,0.00016890977,0.00020118497,0.00012306121,0.00023302517,0.0026505725],"category_scores_gemma":[0.000099067576,0.00007836357,0.00020396692,0.00015375199,0.00017036147,0.00024742648,0.00012846601,0.0005665044,0.00019792852],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007629226,0.00035860747,0.00043200955,0.0004644724,0.00006442459,0.00015530377,0.00003956496,0.00016819316,0.9781838,0.00031559143,0.0007818833,0.011407032],"study_design_scores_gemma":[0.0010402009,0.003551411,0.017536985,0.000051025247,0.00018663048,0.00042083548,0.000089945985,0.0012023052,0.9684628,0.00022542526,0.0072090453,0.000023298762],"about_ca_topic_score_codex":0.0016981321,"about_ca_topic_score_gemma":0.0034913006,"teacher_disagreement_score":0.0026505725,"about_ca_system_score_codex":0.000262518,"about_ca_system_score_gemma":0.00044089765,"threshold_uncertainty_score":0.008867025},"labels":[],"label_agreement":null},{"id":"W4210926374","doi":"10.21203/rs.3.rs-1321818/v1","title":"Tolerability of Eribulin and Correlation Between Polymorphisms and Neuropathy in an Unselected Population of Female Patients with Metastatic Breast Cancer: Results of The Multicenter, Single Arm, Phase IV PAINTER Study","year":2022,"lang":"en","type":"preprint","venue":"Research Square","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Tolerability; Eribulin; Internal medicine; Neutropenia; Metastatic breast cancer; Gastroenterology; Breast cancer; Adverse effect; Febrile neutropenia; Oncology; Surgery; Cancer; Toxicity","score_opus":0.06823118358957378,"score_gpt":0.41629658134092973,"score_spread":0.3480653977513559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210926374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995334,0.00013255398,0.00003676155,0.000010505085,0.000001644504,0.0000136723675,0.000114592236,0.0000016815654,0.00015529677],"genre_scores_gemma":[0.99935514,0.000063995925,0.000040101975,0.000047423495,0.0000105296485,0.000021742477,0.0002724262,0.0000015603889,0.0001871651],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99965334,0.00015108181,0.00002660062,0.00007816464,0.00005550727,0.00003535043],"domain_scores_gemma":[0.99918276,0.00017138766,0.00035072217,0.00006294822,0.0000824908,0.00014972096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088471005,0.0003553092,0.00043286517,0.00028788095,0.00022375085,0.00043264386,0.00016149359,0.00031753816,0.0013234231],"category_scores_gemma":[0.0010882963,0.0001789382,0.00035951688,0.00032969727,0.00015515626,0.00025002056,0.00016940785,0.00025830226,0.00027467508],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010062329,0.00081304996,0.97862625,0.00003456358,0.00033333965,0.00029682356,0.00014165703,0.000173402,0.0032467148,0.000013324508,0.0002526454,0.0060058697],"study_design_scores_gemma":[0.0005775731,0.007037743,0.99081707,0.000005151516,0.0001281073,0.00050401303,0.000079086996,0.00022329723,0.00031399034,0.000018445508,0.00028850383,0.0000069206553],"about_ca_topic_score_codex":0.00043993478,"about_ca_topic_score_gemma":0.00045708084,"teacher_disagreement_score":0.0013234231,"about_ca_system_score_codex":0.00018855513,"about_ca_system_score_gemma":0.00011310132,"threshold_uncertainty_score":0.0046788454},"labels":[],"label_agreement":null},{"id":"W4211009850","doi":"10.1007/978-3-319-07311-8_18","title":"Toxic Neuropathies","year":2014,"lang":"en","type":"book-chapter","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"","keywords":"Medicine","score_opus":0.027986202431647303,"score_gpt":0.2902252503081626,"score_spread":0.2622390478765153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211009850","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021782753,0.06982244,0.0048447563,0.0056924233,0.0043321555,0.00007094003,0.00028107755,0.00028552185,0.91249233],"genre_scores_gemma":[0.010479667,0.055498667,0.0024081073,0.0038075077,0.0012651185,0.000056523535,0.00026249874,0.00013213283,0.92608964],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983394,0.000026158272,0.000007689813,0.000023460403,0.00008285949,0.00002585559],"domain_scores_gemma":[0.99987066,0.000029631809,0.0000132024625,0.00001839623,0.00004883633,0.00001923176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022522922,0.0010168717,0.0003922674,0.001404849,0.0007995878,0.0014024162,0.0006468599,0.0009124681,0.048937105],"category_scores_gemma":[0.00042586873,0.00023091676,0.0004369669,0.0007468317,0.0010582276,0.0012467478,0.0014374063,0.0022637437,0.013724082],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006718187,0.000104601124,0.0002021062,0.0007013562,0.000021868722,0.0017475045,0.0003278065,0.0005734416,0.00381576,0.118337564,0.47756812,0.39653274],"study_design_scores_gemma":[0.000004029327,0.000017835962,0.00015962802,0.00030591653,0.000008097007,0.0023505592,0.00006585171,0.000052166324,0.0007378588,0.020409968,0.9758817,0.0000063735984],"about_ca_topic_score_codex":0.0018575364,"about_ca_topic_score_gemma":0.004868819,"teacher_disagreement_score":0.048937105,"about_ca_system_score_codex":0.0010794598,"about_ca_system_score_gemma":0.0009881416,"threshold_uncertainty_score":0.16371095},"labels":[],"label_agreement":null},{"id":"W4211210620","doi":"10.1007/s00520-022-06891-0","title":"Pre-medication protocols for the prevention of paclitaxel-induced infusion related reactions: a systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Discontinuation; Meta-analysis; Observational study; Relative risk; Adverse effect; Randomized controlled trial; Internal medicine; MEDLINE; Clinical endpoint; Systematic review; Cochrane Library; Confidence interval","score_opus":0.20743111679492188,"score_gpt":0.5192020584243411,"score_spread":0.3117709416294192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211210620","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0060249907,0.9927234,0.00035920585,0.00008508291,0.00013521317,0.00024890454,0.00017291403,0.000015015104,0.00023526694],"genre_scores_gemma":[0.1476966,0.84791803,0.0021511016,0.00080974353,0.00016594176,0.0005261331,0.00036995107,0.000018628363,0.00034389013],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9963678,0.001614853,0.0010859543,0.000386185,0.00040433556,0.0001408017],"domain_scores_gemma":[0.9932433,0.0047826516,0.0013693316,0.00020105434,0.0003020383,0.00010158841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057147522,0.0017692661,0.01051782,0.0020414393,0.0004172239,0.0019587276,0.001603747,0.0017965706,0.0041943835],"category_scores_gemma":[0.014116587,0.0009844674,0.021675447,0.0024718835,0.00054622936,0.0013929842,0.0009851983,0.0023015945,0.00029119232],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009591612,0.0002026216,0.0024391792,0.5293667,0.40594143,0.00011299649,0.0001130465,0.0007772444,0.00042531439,0.00019212114,0.00081860204,0.050019063],"study_design_scores_gemma":[0.0049348655,0.0013060241,0.0048306123,0.042719655,0.94225764,0.00012030125,0.000082921426,0.00026140342,0.0002650956,0.00028562677,0.0028898553,0.000045960078],"about_ca_topic_score_codex":0.00407589,"about_ca_topic_score_gemma":0.011634672,"teacher_disagreement_score":0.01051782,"about_ca_system_score_codex":0.0014929262,"about_ca_system_score_gemma":0.0020857172,"threshold_uncertainty_score":0.030222893},"labels":[],"label_agreement":null},{"id":"W4211244322","doi":"10.32920/ryerson.14655858","title":"The Influence Of The Epidermal Growth Factor Receptor On The DNA Damage Response As Examined Through Clathrin Affiliated Signalling Complexes","year":2021,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"","keywords":"Cisplatin; Epidermal growth factor receptor; DNA damage; DNA repair; Cancer research; Context (archaeology); PI3K/AKT/mTOR pathway; Cancer; Cell biology; Biology; Signal transduction; DNA; Medicine; Internal medicine; Chemotherapy; Genetics","score_opus":0.053627716346361945,"score_gpt":0.33384774716136295,"score_spread":0.280220030815001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211244322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98765695,0.003830823,0.0019838638,0.00022937793,0.000057095538,0.000013478511,0.00019049096,0.000034187626,0.0060036643],"genre_scores_gemma":[0.9912149,0.0016600379,0.0010941647,0.000052750558,0.000008392933,0.000008634482,0.00018514937,0.000015357613,0.0057606823],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999324,0.000008149522,0.0000022705983,0.000012422321,0.000021562817,0.00002318649],"domain_scores_gemma":[0.99995244,0.000012627249,0.000007648617,0.0000059215804,0.0000065917775,0.000014856671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011071997,0.00012487751,0.00010552955,0.0000933679,0.00011618338,0.00038013307,0.00013366246,0.00018227656,0.0015403535],"category_scores_gemma":[0.0001162164,0.00009607905,0.00015026679,0.0000681677,0.00022711007,0.00031660558,0.00017779175,0.00038236205,0.00033383878],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018333222,0.000011255034,0.00034052343,0.000051219682,0.0000060470707,0.000106529274,0.000027456581,0.00007211343,0.99674404,0.0005676866,0.000076396034,0.0018133429],"study_design_scores_gemma":[0.00001267333,0.00015135112,0.013769313,0.000011921763,0.000010854039,0.00022067454,0.00007121869,0.0012788855,0.9811483,0.00022714598,0.003089823,0.000007866657],"about_ca_topic_score_codex":0.0011857705,"about_ca_topic_score_gemma":0.0014184025,"teacher_disagreement_score":0.0015403535,"about_ca_system_score_codex":0.00033426422,"about_ca_system_score_gemma":0.00022842237,"threshold_uncertainty_score":0.0051530004},"labels":[],"label_agreement":null},{"id":"W4212810043","doi":"10.17504/protocols.io.b5ebq3an","title":"[RETRACTED] Nerve Rejuv Amazon: UK, USA, Australia, South Africa, Canada, NZ (Ingredients Updates) v1","year":2022,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Amazon rainforest; Business; Medicine; Advertising; Geography; Biology","score_opus":0.06591995734518499,"score_gpt":0.3319415243283123,"score_spread":0.2660215669831273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212810043","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007404315,0.0033840053,0.0020412086,0.01957823,0.027629735,0.0007395655,0.029534293,0.01439009,0.90196234],"genre_scores_gemma":[0.0021263347,0.0012454526,0.0009412948,0.0070042145,0.0014726392,0.00013557458,0.0068318592,0.0036040563,0.9766385],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99928683,0.00004827255,0.000041420913,0.00006651284,0.00042091802,0.00013610817],"domain_scores_gemma":[0.99710315,0.00039376997,0.00012253656,0.00027061164,0.0015682301,0.00054172095],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012802868,0.0008306753,0.0010748182,0.0012773668,0.0016679078,0.0034879874,0.002101307,0.0038731808,0.81517506],"category_scores_gemma":[0.007350021,0.00082032004,0.0011424882,0.0012551437,0.0006567843,0.0028435518,0.0015219237,0.0034567774,0.6232192],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048015718,0.000017538188,0.000024885128,0.00007482278,0.0000022836975,0.000021188425,0.0000072031717,0.000008939,0.0001558639,0.00024095066,0.9853334,0.014065027],"study_design_scores_gemma":[0.000030783864,0.000017245848,0.00022809862,0.00005440397,0.0000036109395,0.000030225407,0.000010327284,0.000024005334,0.00014871567,0.00020429476,0.9992424,0.0000058597698],"about_ca_topic_score_codex":0.022246478,"about_ca_topic_score_gemma":0.054974325,"teacher_disagreement_score":0.9777535,"about_ca_system_score_codex":0.0014794075,"about_ca_system_score_gemma":0.0023150546,"threshold_uncertainty_score":0.26363027},"labels":[],"label_agreement":null},{"id":"W4212963976","doi":"10.3390/curroncol29020105","title":"Front-Line Bevacizumab plus Chemotherapy with or without Maintenance Therapy for Metastatic Breast Cancer: An Observational Study by the Hellenic Oncology Research Group","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"China Academy of Building Research","keywords":"Medicine; Bevacizumab; Internal medicine; Oncology; Maintenance therapy; Metastatic breast cancer; Neutropenia; Chemotherapy; Discontinuation; Breast cancer; Hormonal therapy; Adverse effect; Cancer; Surgery","score_opus":0.4896111016687083,"score_gpt":0.5627094855712466,"score_spread":0.07309838390253826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212963976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99880683,0.00078588526,0.00006343185,0.000031660154,0.000010421022,0.000024796907,0.00019049428,0.0000013402831,0.00008503927],"genre_scores_gemma":[0.9987947,0.00039437177,0.00010175144,0.00007646259,0.00002982687,0.000030738684,0.00048569127,0.0000018659491,0.000084587955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886453,0.00051023136,0.00011717566,0.0002701521,0.00012263004,0.00011528786],"domain_scores_gemma":[0.99820364,0.0003892853,0.0008611147,0.00017428014,0.000091138994,0.00028044957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014734827,0.00028033764,0.00066709,0.000335876,0.0003649493,0.0007827217,0.000361099,0.0006092919,0.0009245679],"category_scores_gemma":[0.0027071587,0.00035200713,0.0011345326,0.0007918137,0.00025747292,0.0004929559,0.00036187022,0.0008227944,0.00015891145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021023454,0.001803694,0.96652216,0.0002100839,0.0025179074,0.00022409197,0.00016964476,0.00012258925,0.00095938775,0.000045940862,0.00048925116,0.0059119593],"study_design_scores_gemma":[0.002718064,0.008201039,0.9842234,0.00006552295,0.0019030645,0.0005222107,0.00024742898,0.0007815027,0.00020231132,0.000060537255,0.0010516548,0.000023159793],"about_ca_topic_score_codex":0.003604642,"about_ca_topic_score_gemma":0.0032927603,"teacher_disagreement_score":0.003604642,"about_ca_system_score_codex":0.0006680756,"about_ca_system_score_gemma":0.000636391,"threshold_uncertainty_score":0.0077926517},"labels":[],"label_agreement":null},{"id":"W4212986327","doi":"10.1093/jac/47.suppl_2.38-a","title":"Pharmacokinetics (Abstracts P88-P93)","year":2001,"lang":"en","type":"article","venue":"Journal of Antimicrobial Chemotherapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; University of Toronto; Hamilton Health Sciences; Dalhousie University; McMaster University; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Pharmacokinetics; Pharmacology; Medicine","score_opus":0.018754747333220245,"score_gpt":0.3230575385151151,"score_spread":0.30430279118189485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212986327","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5376898,0.07836828,0.034476195,0.009877435,0.0047465255,0.0070794513,0.03712167,0.00604167,0.28459898],"genre_scores_gemma":[0.88991183,0.007882662,0.005469948,0.0023506063,0.0010217859,0.0013752064,0.006540078,0.00035567486,0.08509208],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99947685,0.00015516349,0.00004010652,0.0000658636,0.00018992473,0.000072058494],"domain_scores_gemma":[0.9994722,0.00017391732,0.000105558436,0.00007445075,0.00007787586,0.00009593028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058640755,0.0009223559,0.0007497661,0.00051331,0.0003223772,0.0006021406,0.00029092815,0.0008799805,0.024282027],"category_scores_gemma":[0.0024468247,0.00034787838,0.00071659184,0.0003500284,0.00020347469,0.00029407683,0.00020263984,0.0015142579,0.009067848],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08707448,0.0066868635,0.015592625,0.002103142,0.0010263169,0.0035585468,0.000630418,0.005956299,0.13980787,0.0025476061,0.13178077,0.60323507],"study_design_scores_gemma":[0.03254483,0.11638241,0.19754739,0.0007492834,0.002431265,0.018089635,0.00035383654,0.01645675,0.1347488,0.0054662554,0.47487897,0.00035050086],"about_ca_topic_score_codex":0.0013998288,"about_ca_topic_score_gemma":0.0016135029,"teacher_disagreement_score":0.024282027,"about_ca_system_score_codex":0.00048660825,"about_ca_system_score_gemma":0.000530663,"threshold_uncertainty_score":0.081231534},"labels":[],"label_agreement":null},{"id":"W4213064176","doi":"10.1200/jco.2022.40.6_suppl.082","title":"Daily symptom monitoring commonly leads to treatment modification in older adults receiving treatment for metastatic prostate cancer (mPC).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Prostate Cancer Canada","keywords":"Medicine; Prostate cancer; Docetaxel; Internal medicine; Prospective cohort study; Quality of life (healthcare); Androgen deprivation therapy; Cancer; Cohort; Physical therapy","score_opus":0.20375292736056624,"score_gpt":0.5337860924145994,"score_spread":0.33003316505403313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213064176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731785,0.000911663,0.000059141094,0.00015519791,0.00001190506,0.00004185668,0.0004638119,0.0000060953494,0.001032462],"genre_scores_gemma":[0.99889106,0.00034764913,0.000103133745,0.00011183708,0.000016655073,0.000017399556,0.0003213831,0.000001215414,0.00018966521],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928457,0.00019671513,0.000092851835,0.00009361303,0.00023529779,0.00009712117],"domain_scores_gemma":[0.99788314,0.00026251454,0.0014123584,0.000052145868,0.00015713132,0.00023265596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077310967,0.00014308853,0.00030901431,0.00033114728,0.0004487273,0.0004047565,0.0002227313,0.0002652384,0.0016602885],"category_scores_gemma":[0.003451348,0.00012320527,0.00036552554,0.0007629516,0.00019307945,0.0002773315,0.000401428,0.00037451883,0.00014923952],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017431854,0.00007608117,0.9899087,0.00007623879,0.000036276,0.00011303427,0.00026832137,0.000020079127,0.00025169013,0.00000958337,0.00041114353,0.008654598],"study_design_scores_gemma":[0.0000063526004,0.00014577841,0.9991229,0.00001791342,0.00001831648,0.00018982797,0.00015740893,0.00003591467,0.000032694912,0.000006194468,0.00026416752,0.0000023787334],"about_ca_topic_score_codex":0.0103682345,"about_ca_topic_score_gemma":0.02899444,"teacher_disagreement_score":0.0103682345,"about_ca_system_score_codex":0.0006212936,"about_ca_system_score_gemma":0.00067814585,"threshold_uncertainty_score":0.020615757},"labels":[],"label_agreement":null},{"id":"W4213114293","doi":"10.26226/morressier.5cdbe0a8618793e647b12537","title":"13 - MEDICAL CANNABIS IMPROVES APPETITE AND STABILIZES WEIGHT IN CANCER PATIENTS","year":2019,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Appetite; Cannabis; Medicine; Medical cannabis; Internal medicine; Environmental health; Psychiatry","score_opus":0.013269203478115159,"score_gpt":0.32622283913583294,"score_spread":0.3129536356577178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213114293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950133,0.0018660901,0.000048306218,0.00033848887,0.00002998675,0.00010877652,0.00027955804,0.000027992526,0.0022874968],"genre_scores_gemma":[0.9979539,0.0007023065,0.00023134952,0.00017392608,0.000023240756,0.000039603892,0.00022825268,0.0000026768407,0.00064481416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998679,0.0000376166,0.000011383549,0.000012525582,0.00003952508,0.000030889736],"domain_scores_gemma":[0.9997011,0.000051239625,0.00008874826,0.000011579576,0.000045290064,0.000101967686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026998192,0.00011331658,0.00031657543,0.00020754838,0.00023931739,0.0002295566,0.00016627755,0.00019189916,0.0048215142],"category_scores_gemma":[0.00089500356,0.000077645695,0.00029023527,0.0002821056,0.0001361164,0.00016899144,0.00024830157,0.00029331076,0.00048405342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02537362,0.0072124815,0.51276165,0.001579142,0.000622722,0.00075578474,0.00044911387,0.00035655353,0.017794007,0.00010684555,0.006768198,0.42622],"study_design_scores_gemma":[0.0025319404,0.025602095,0.96274734,0.00014884297,0.00023727719,0.0010328557,0.00031957953,0.00051808805,0.0019809366,0.00008475238,0.0047778445,0.000018427558],"about_ca_topic_score_codex":0.0021784243,"about_ca_topic_score_gemma":0.00705016,"teacher_disagreement_score":0.0048215142,"about_ca_system_score_codex":0.000353269,"about_ca_system_score_gemma":0.0004881502,"threshold_uncertainty_score":0.016129553},"labels":[],"label_agreement":null},{"id":"W4214591090","doi":"10.3390/curroncol18030002","title":"In this issue of Current Oncology","year":2011,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Epirubicin; Docetaxel; Medicine; Cyclophosphamide; Fluorouracil; Regimen; Oncology; Internal medicine; Breast cancer; Cancer research; Chemotherapy; Cancer","score_opus":0.29259579014025716,"score_gpt":0.5149666930386047,"score_spread":0.2223709028983475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214591090","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005702256,0.0217334,0.000747571,0.091311395,0.84899145,0.0001723861,0.00060023664,0.00062346435,0.03524987],"genre_scores_gemma":[0.0019174265,0.02664544,0.0009908498,0.08816378,0.73693043,0.0001446438,0.001447611,0.00020755737,0.14355227],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99903405,0.00012120286,0.00012186617,0.000108105305,0.0004802374,0.00013469187],"domain_scores_gemma":[0.99521565,0.0011419461,0.0004459706,0.00030893955,0.0016345583,0.0012528673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018730912,0.0016088563,0.0019240141,0.0026260978,0.0020034276,0.00631836,0.0024408544,0.0068544587,0.08240877],"category_scores_gemma":[0.006421369,0.00091376744,0.0016380931,0.0017710895,0.0012338514,0.0035365166,0.0014478844,0.008401862,0.0481945],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006967604,0.00007599362,0.0002499339,0.00028003976,0.00001441904,0.00009130078,0.000011590865,0.000042682055,0.00014475109,0.0004468809,0.9576457,0.040926963],"study_design_scores_gemma":[0.000023255578,0.000023384924,0.0005205549,0.00011444449,0.000015490195,0.000101366284,0.000021872924,0.000056671477,0.00006326316,0.00032999658,0.9987208,0.000008816693],"about_ca_topic_score_codex":0.0013878966,"about_ca_topic_score_gemma":0.005450691,"teacher_disagreement_score":0.08240877,"about_ca_system_score_codex":0.0014295303,"about_ca_system_score_gemma":0.0018745663,"threshold_uncertainty_score":0.27568477},"labels":[],"label_agreement":null},{"id":"W4214668728","doi":"10.51731/cjht.2021.146","title":"Semaglutide (Rybelsus)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Semaglutide; Reimbursement; Medicine; Metformin; Glycemic; Drug; Type 2 diabetes; Family medicine; Diabetes mellitus; Pharmacology; Political science; Health care; Endocrinology","score_opus":0.03820972258412177,"score_gpt":0.34213541595885694,"score_spread":0.3039256933747352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214668728","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.041574452,0.6586211,0.005678269,0.010913588,0.0032359106,0.00048971426,0.0076669464,0.0020091394,0.2698109],"genre_scores_gemma":[0.29587227,0.42388853,0.011833516,0.01881911,0.00087816815,0.00030092552,0.0127618555,0.00021430333,0.23543142],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998155,0.00003683342,0.000021952388,0.00003757028,0.00006370323,0.000024482937],"domain_scores_gemma":[0.9998734,0.000018528508,0.000028210196,0.000006542196,0.00004724855,0.000026029078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037401414,0.00033242136,0.00035535614,0.00067509734,0.0002087971,0.00069927855,0.00036069166,0.00051067077,0.018580945],"category_scores_gemma":[0.0003546586,0.00009427364,0.00051278406,0.0005256254,0.00025968012,0.00039466872,0.0003384602,0.0008250822,0.0071786526],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013241229,0.00016224544,0.00074391515,0.0048324754,0.0001501202,0.00042413414,0.000049905313,0.0002994322,0.014638413,0.00470759,0.116198175,0.85646945],"study_design_scores_gemma":[0.00078480743,0.0009363026,0.0038728097,0.0014929633,0.00022256831,0.0016477542,0.000063389576,0.00028189656,0.008518444,0.0007687095,0.9813805,0.000029885829],"about_ca_topic_score_codex":0.01140682,"about_ca_topic_score_gemma":0.036358178,"teacher_disagreement_score":0.018580945,"about_ca_system_score_codex":0.000817784,"about_ca_system_score_gemma":0.0015464363,"threshold_uncertainty_score":0.06215942},"labels":[],"label_agreement":null},{"id":"W4220847074","doi":"10.5281/zenodo.5903087","title":"Antibody Characterization Report for Syntaxin-4","year":2022,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Antibody; Virology; Immunology; Medicine","score_opus":0.04077874315487583,"score_gpt":0.3199088571871349,"score_spread":0.27913011403225907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220847074","genre_codex":"methods","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32118443,0.026802642,0.5313002,0.004466671,0.0037902037,0.005804564,0.06353759,0.0028992055,0.040214546],"genre_scores_gemma":[0.22794029,0.03617734,0.25361428,0.0033967549,0.0012107921,0.006617119,0.39526612,0.0013187238,0.07445857],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991442,0.00012673825,0.00015914119,0.00020321223,0.00019349638,0.0001731286],"domain_scores_gemma":[0.99884295,0.00021238548,0.00010430612,0.00019742394,0.00048986357,0.00015306936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009524681,0.0016093495,0.00076841115,0.0016889483,0.0012413622,0.0008782759,0.0013137045,0.00082759565,0.018451627],"category_scores_gemma":[0.001431171,0.00085572497,0.0011142503,0.001115502,0.00025949994,0.00083040935,0.00071125984,0.0019488957,0.017505523],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020634064,0.00011837309,0.00028133654,0.00035292475,0.000051976906,0.00022314319,0.0000699131,0.00010150899,0.9855437,0.00074270164,0.0056449655,0.0066632163],"study_design_scores_gemma":[0.00018614647,0.00082928065,0.007718718,0.00015133731,0.00029547574,0.0044268533,0.00015779525,0.0018222482,0.621387,0.00069079344,0.36225396,0.00008038613],"about_ca_topic_score_codex":0.0014938747,"about_ca_topic_score_gemma":0.0022590978,"teacher_disagreement_score":0.018451627,"about_ca_system_score_codex":0.00068154844,"about_ca_system_score_gemma":0.0014575134,"threshold_uncertainty_score":0.06172687},"labels":[],"label_agreement":null},{"id":"W4220872739","doi":"10.1158/1538-7445.sabcs21-ot1-11-02","title":"Abstract OT1-11-02: A pragmatic, randomised, multicentre trial evaluating the dose timing (morning vs evening) of endocrine therapy and its effects on tolerability and compliance (REaCT-CHRONO Study)","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; McMaster University; Thunder Bay Regional Health Sciences Centre; University of Ottawa","funders":"","keywords":"Tolerability; Medicine; Evening; Clinical endpoint; Breast cancer; Morning; Internal medicine; Cancer; Clinical trial; Oncology; Adverse effect","score_opus":0.2686467496825231,"score_gpt":0.5216192358242293,"score_spread":0.2529724861417062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220872739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9695616,0.006048789,0.0013793507,0.0018953487,0.0013748283,0.013208268,0.0023890263,0.00019740307,0.003945359],"genre_scores_gemma":[0.9677283,0.0020283563,0.004913125,0.002514195,0.0010147335,0.015438517,0.0017195182,0.00004863922,0.0045945146],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99758697,0.0017470256,0.00012955551,0.00024832383,0.00011498623,0.00017316332],"domain_scores_gemma":[0.99693334,0.0010421682,0.00080683763,0.00021222663,0.00015564637,0.0008497643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042053736,0.0018715924,0.003319273,0.00038370874,0.0005084014,0.0012448154,0.0010963168,0.0022006114,0.013423789],"category_scores_gemma":[0.0051282765,0.0006463511,0.0024003945,0.00052903936,0.0016089373,0.0013320614,0.0007690225,0.0032297554,0.0011562179],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9811508,0.006583893,0.00025837944,0.0011576788,0.00054577156,0.000032992426,0.000048789603,0.00019727384,0.0011953677,0.00015689706,0.00076583494,0.0079062795],"study_design_scores_gemma":[0.9443179,0.0540542,0.0006234884,0.000049634644,0.00027041291,0.000017654673,0.000020440657,0.0001216568,0.00008029101,0.00009852707,0.00033540855,0.000010447027],"about_ca_topic_score_codex":0.000985527,"about_ca_topic_score_gemma":0.0018655688,"teacher_disagreement_score":0.013423789,"about_ca_system_score_codex":0.0007939511,"about_ca_system_score_gemma":0.001636106,"threshold_uncertainty_score":0.044907093},"labels":[],"label_agreement":null},{"id":"W4220978230","doi":"10.1158/1538-7445.sabcs21-p4-10-15","title":"Abstract P4-10-15: Whole-body vibration combined with physical exercise to treat aromatase inhibitor-induced musculoskeletal symptoms in breast cancer women: Results of a pilot randomized controlled study","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Physical therapy; Whole body vibration; Randomized controlled trial; WOMAC; Cancer; Aromatase inhibitor; Osteoarthritis; Internal medicine; Physical medicine and rehabilitation; Tamoxifen; Alternative medicine; Pathology","score_opus":0.028336843282527033,"score_gpt":0.3870256262619594,"score_spread":0.35868878297943235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220978230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728064,0.0038494852,0.00085257547,0.00041986507,0.0006002561,0.019717572,0.00090325874,0.00009701638,0.00075354305],"genre_scores_gemma":[0.94119465,0.0050426363,0.0047673355,0.0012844909,0.0011825878,0.04192538,0.0012345739,0.000027374339,0.0033410226],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99872893,0.0006456129,0.00015774516,0.0001866791,0.00013266181,0.00014844332],"domain_scores_gemma":[0.9987091,0.00030344797,0.00026831517,0.00012242518,0.00016259601,0.00043407182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002683417,0.0015724719,0.0044164974,0.0006066586,0.0006212019,0.00078980275,0.001431704,0.002025185,0.009201512],"category_scores_gemma":[0.0020344686,0.0008635782,0.002265459,0.0007265671,0.0015218374,0.00093020656,0.0006533194,0.001969862,0.00101171],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9328434,0.051317073,0.00061016396,0.0013726731,0.00091781083,0.00004914416,0.000050726994,0.000096300755,0.0032298516,0.000039458064,0.0002986522,0.00917487],"study_design_scores_gemma":[0.7607427,0.23625374,0.0016606712,0.00003965344,0.00056111516,0.00001390433,0.000027212793,0.000102048405,0.0002815941,0.000033744676,0.00027344414,0.000010195585],"about_ca_topic_score_codex":0.00095464673,"about_ca_topic_score_gemma":0.0013977741,"teacher_disagreement_score":0.009201512,"about_ca_system_score_codex":0.00055273436,"about_ca_system_score_gemma":0.002080226,"threshold_uncertainty_score":0.030782044},"labels":[],"label_agreement":null},{"id":"W4223629792","doi":"10.1136/bmjopen-2021-057950","title":"Evaluation of the psychometric properties of patient-reported and clinician-reported outcome measures of chemotherapy-induced peripheral neuropathy: a COSMIN systematic review protocol","year":2022,"lang":"en","type":"article","venue":"BMJ Open","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université de Montréal; Université Laval","funders":"National Cancer Institute; Fondation Jean-Louis Lévesque","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; PsycINFO; MEDLINE; Prom; Checklist; Protocol (science); CINAHL; Patient-reported outcome; Quality of life (healthcare); Physical therapy; Alternative medicine; Peripheral neuropathy; Psychiatry; Pathology; Psychological intervention","score_opus":0.379683212875548,"score_gpt":0.4985042766355723,"score_spread":0.11882106376002427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223629792","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008417114,0.0029469111,0.0015469058,0.0005032986,0.00012786582,0.9891663,0.0041275737,0.00006824012,0.00067125325],"genre_scores_gemma":[0.00089813146,0.0012073122,0.0026079589,0.00016845965,0.000015450581,0.99428284,0.00061898306,0.000007162638,0.00019370882],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.95815176,0.019277213,0.012981321,0.0028785227,0.0051958794,0.0015153027],"domain_scores_gemma":[0.9505412,0.020497076,0.010423118,0.004188725,0.012774252,0.001575594],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.09041027,0.004256929,0.012207529,0.010808712,0.0031750556,0.0056700534,0.004694766,0.0062600346,0.04270317],"category_scores_gemma":[0.095026866,0.0035329775,0.0147256935,0.010680403,0.0039424472,0.005923096,0.0043297317,0.003983528,0.005486245],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008544829,0.00040423527,0.0020901538,0.90254664,0.005755224,0.00036673984,0.0017496378,0.001444535,0.0013000134,0.0038059175,0.025801137,0.04619094],"study_design_scores_gemma":[0.040845904,0.0036999374,0.020369437,0.7079327,0.03333128,0.000761638,0.002238697,0.0035352623,0.0027819788,0.009519754,0.17439176,0.0005916332],"about_ca_topic_score_codex":0.004875987,"about_ca_topic_score_gemma":0.0124632325,"teacher_disagreement_score":0.9095897,"about_ca_system_score_codex":0.012701516,"about_ca_system_score_gemma":0.051211383,"threshold_uncertainty_score":0.47814095},"labels":[],"label_agreement":null},{"id":"W4224095649","doi":"10.1016/j.neurol.2022.02.414","title":"Les effets de l’évobrutinib, un inhibiteur de la tyrosine kinase de Bruton, sur les lésions à expansion lente : un nouveau marqueur d’imagerie de la perte tissulaire chronique dans la sclérose en plaques","year":2022,"lang":"fr","type":"article","venue":"Revue Neurologique","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada)","funders":"","keywords":"Chemistry; Molecular biology; Biology","score_opus":0.009699167280697777,"score_gpt":0.28257369329930127,"score_spread":0.2728745260186035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224095649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93051505,0.05390169,0.0009962015,0.0019397325,0.0007131291,0.00010208251,0.00040788052,0.0001070289,0.011317249],"genre_scores_gemma":[0.97353065,0.016271422,0.00092016725,0.0006551798,0.0003499885,0.00008996801,0.00040714437,0.000027005723,0.0077484683],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99984026,0.000056141114,0.000011067807,0.00001749059,0.0000371016,0.000037939368],"domain_scores_gemma":[0.9998036,0.000092219234,0.000029541114,0.000011155735,0.000026572769,0.000036906433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000349183,0.00042684376,0.00077340775,0.00028577694,0.0002146807,0.00078382704,0.00018369223,0.00085178105,0.0036977755],"category_scores_gemma":[0.00055943814,0.00021078193,0.00042342857,0.00019797306,0.00032645944,0.00048035194,0.000104907886,0.0013811219,0.00049050775],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051122017,0.004028234,0.0029686196,0.0017079307,0.00053913624,0.0014428337,0.0002687825,0.0012854025,0.6607883,0.0010762225,0.005457227,0.2693153],"study_design_scores_gemma":[0.026014676,0.14130768,0.058110222,0.0005077936,0.002193038,0.008261609,0.0005291414,0.0058038547,0.6399643,0.0017837418,0.11534133,0.0001825625],"about_ca_topic_score_codex":0.0013651593,"about_ca_topic_score_gemma":0.002975389,"teacher_disagreement_score":0.0036977755,"about_ca_system_score_codex":0.0003049047,"about_ca_system_score_gemma":0.00028594208,"threshold_uncertainty_score":0.012370288},"labels":[],"label_agreement":null},{"id":"W4224305302","doi":"10.17504/protocols.io.8epv59n44g1b/v1","title":"[RETRACTED] Lisa Laflamme CBD Gummies Canada RESULT REVIEWS, 100% SAFE &amp;amp; RISK FREE! v1","year":2022,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sadness; Unrest; Key (lock); Computer science; Economics; Operations management; Psychology; Political science; Computer security; Social psychology; Law","score_opus":0.06408073193083959,"score_gpt":0.35314889745859734,"score_spread":0.28906816552775777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224305302","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031667887,0.0054792636,0.0025333378,0.13429505,0.18473324,0.00030361488,0.0038172035,0.009072426,0.6594493],"genre_scores_gemma":[0.00080340053,0.0014679306,0.0005528915,0.025555866,0.008189998,0.00006374369,0.0008047451,0.0015415371,0.9610199],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99703467,0.00022502143,0.00021305981,0.00028648632,0.0019270455,0.00031374954],"domain_scores_gemma":[0.9847733,0.0018552159,0.00045100518,0.0009607465,0.010212606,0.0017471192],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0024711462,0.0010721684,0.0012096087,0.0022148073,0.0030233474,0.005983534,0.0027481122,0.008035479,0.5346253],"category_scores_gemma":[0.023796305,0.0007806903,0.0010412352,0.0021262567,0.0013580247,0.0039461865,0.0019109315,0.006450993,0.5390599],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000029082705,0.0000031439693,0.000009125757,0.000014334339,5.2147584e-7,0.000015832886,0.0000053844074,0.0000035303522,0.000018138802,0.00018713599,0.99488574,0.004854214],"study_design_scores_gemma":[0.0000027300266,0.000004187967,0.000073508374,0.000030676474,8.7194337e-7,0.000045541383,0.000012997303,0.000011063781,0.000026314106,0.000105192805,0.9996835,0.000003434896],"about_ca_topic_score_codex":0.025259893,"about_ca_topic_score_gemma":0.06330558,"teacher_disagreement_score":0.4653747,"about_ca_system_score_codex":0.0030479464,"about_ca_system_score_gemma":0.0049702,"threshold_uncertainty_score":0.66380054},"labels":[],"label_agreement":null},{"id":"W4226287808","doi":"10.46747/cfp.6801e5","title":"Principes de base de la chimiothérapie à l’intention des médecins de famille","year":2022,"lang":"fr","type":"article","venue":"Canadian Family Physician","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology; Humanities; Philosophy","score_opus":0.020901111847830577,"score_gpt":0.2853805636465879,"score_spread":0.26447945179875737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226287808","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027205812,0.039913967,0.11835589,0.44184333,0.004941623,0.0009643816,0.0006439173,0.0006177247,0.36551338],"genre_scores_gemma":[0.6023656,0.049133994,0.1719509,0.09751393,0.0037378797,0.0018766492,0.00056974037,0.00025347117,0.0725978],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935474,0.0027946702,0.0003308194,0.0005743439,0.0022997144,0.0004529907],"domain_scores_gemma":[0.99178153,0.0023595893,0.00081545813,0.0008108061,0.0032138312,0.0010188718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010522828,0.00072851096,0.0006129514,0.0013000347,0.003403471,0.0048125423,0.0013466803,0.002914486,0.0064378735],"category_scores_gemma":[0.015806533,0.00040248927,0.0007986546,0.00062883133,0.007771636,0.0016640059,0.0022103135,0.0064748535,0.0022166956],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025783794,0.0006243069,0.013082826,0.0018573903,0.00037035494,0.0011781283,0.010144141,0.0023232563,0.0071514426,0.59093904,0.10577117,0.2663001],"study_design_scores_gemma":[0.00021791882,0.00054215244,0.01632444,0.0033998743,0.00024218317,0.0019515004,0.002776567,0.000951775,0.005344055,0.18392862,0.78417504,0.00014584615],"about_ca_topic_score_codex":0.024326572,"about_ca_topic_score_gemma":0.037731286,"teacher_disagreement_score":0.024326572,"about_ca_system_score_codex":0.007120893,"about_ca_system_score_gemma":0.024685076,"threshold_uncertainty_score":0.05565071},"labels":[],"label_agreement":null},{"id":"W4226399799","doi":"","title":"Managing 5FU Cardiotoxicity in Colorectal Cancer Treatment","year":2022,"lang":"en","type":"review","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Cardiotoxicity; Medicine; Colorectal cancer; Chemotherapy; Oncology; Internal medicine; Cancer; Intensive care medicine","score_opus":0.44285396380527514,"score_gpt":0.6403797302577987,"score_spread":0.19752576645252357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226399799","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008299471,0.96978164,0.0021074056,0.009463774,0.00079940166,0.000057095498,0.000060276805,0.000055859327,0.009375125],"genre_scores_gemma":[0.07565835,0.90832335,0.0038379172,0.00589139,0.0034438386,0.00005304967,0.00018667929,0.000020952868,0.002584462],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99954,0.00018466022,0.00008218446,0.00003208479,0.00012175012,0.00003930121],"domain_scores_gemma":[0.9991817,0.00037111493,0.00022809717,0.000013574081,0.00012713329,0.00007836983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081129716,0.00021503694,0.00040445218,0.00077034236,0.00027906164,0.00089774095,0.00032375395,0.0007824099,0.0012399649],"category_scores_gemma":[0.0020889721,0.00009427257,0.0002896658,0.0006423931,0.0002697231,0.00075961335,0.0005929772,0.0010241269,0.00045672126],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021742324,0.000074794785,0.0048111756,0.0055163684,0.00009547814,0.003385217,0.00030002347,0.00054486,0.0012001831,0.0019499444,0.04412264,0.9377819],"study_design_scores_gemma":[0.00014625932,0.0008350737,0.023150489,0.014704906,0.00032318194,0.059927102,0.0012081272,0.0011457708,0.0020205998,0.0065558725,0.8899142,0.00006835751],"about_ca_topic_score_codex":0.0009516848,"about_ca_topic_score_gemma":0.003338414,"teacher_disagreement_score":0.0012399649,"about_ca_system_score_codex":0.0007140767,"about_ca_system_score_gemma":0.0009968152,"threshold_uncertainty_score":0.0051810145},"labels":[],"label_agreement":null},{"id":"W4229367461","doi":"10.1007/s12035-022-02858-8","title":"Neuroprotective Effect of Baicalein Against Oxaliplatin-Induced Peripheral Neuropathy: Impact on Oxidative Stress, Neuro-inflammation and WNT/β-Catenin Signaling","year":2022,"lang":"en","type":"article","venue":"Molecular Neurobiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"","keywords":"Oxaliplatin; Baicalein; Neuroprotection; Oxidative stress; Medicine; Pharmacology; Peripheral neuropathy; Wnt signaling pathway; Internal medicine; Endocrinology; Cancer; Chemistry; Signal transduction; Colorectal cancer; Biochemistry","score_opus":0.009142419085627998,"score_gpt":0.2795402926725754,"score_spread":0.2703978735869474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229367461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907996,0.0059207394,0.00046658306,0.00025546562,0.00013879372,0.00006722176,0.0004210028,0.00008500586,0.0018454527],"genre_scores_gemma":[0.9945458,0.0025682112,0.00065825944,0.00008645353,0.000023455243,0.0000631792,0.00029298972,0.0000065396075,0.0017552028],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999949,0.0000051024936,0.0000042910433,0.000010031307,0.000009371346,0.000022165028],"domain_scores_gemma":[0.99997234,0.0000018196183,0.0000060684674,0.000001891007,0.000004456125,0.000013427836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000840486,0.0004187913,0.0005898004,0.00019225976,0.00023721083,0.00019805405,0.00015249822,0.00026415297,0.002068402],"category_scores_gemma":[0.00009574833,0.00009240192,0.00024916197,0.00016829677,0.00022795699,0.00033646185,0.00012769256,0.00065844983,0.00012964035],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010184543,0.00076878065,0.00059984345,0.00068159116,0.00010482072,0.00019285145,0.0000643887,0.00016165567,0.97428447,0.00032039586,0.0007671924,0.011869354],"study_design_scores_gemma":[0.0018028897,0.0075370385,0.025218647,0.00008294043,0.0003409673,0.000518582,0.00020562558,0.0014544047,0.956071,0.00021772266,0.006515209,0.000034996156],"about_ca_topic_score_codex":0.002004428,"about_ca_topic_score_gemma":0.005546163,"teacher_disagreement_score":0.002068402,"about_ca_system_score_codex":0.00031708166,"about_ca_system_score_gemma":0.00058696006,"threshold_uncertainty_score":0.006919503},"labels":[],"label_agreement":null},{"id":"W4229664019","doi":"10.5489/cuaj.1324","title":"Moderated Poster Session 3: Oncology 2","year":2011,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Session (web analytics); Medicine; Internal medicine; Oncology; Psychology; Medical physics; Computer science; World Wide Web","score_opus":0.04464806038405039,"score_gpt":0.29980741598361843,"score_spread":0.25515935559956804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229664019","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007943173,0.007657426,0.0016922862,0.043689065,0.09344848,0.0024406088,0.015687725,0.0020504228,0.8253908],"genre_scores_gemma":[0.018743556,0.003996119,0.0008781742,0.009097611,0.038214155,0.0006871373,0.0044649537,0.0005889921,0.92332935],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99899703,0.00022748938,0.0000550591,0.00018528456,0.00031457155,0.00022067032],"domain_scores_gemma":[0.99572974,0.0004112094,0.00023101098,0.00018879559,0.0011837493,0.0022554644],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0014743368,0.0008848141,0.0008485157,0.0012525533,0.0017674168,0.0031390302,0.0010613181,0.002702776,0.6391839],"category_scores_gemma":[0.0031308075,0.0002776728,0.00078683475,0.00079696724,0.00042173953,0.0011458653,0.0027951687,0.0026295173,0.35055006],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016986736,0.000077259465,0.0005366016,0.00017134844,0.000005627168,0.00007410629,0.000023346107,0.00002696493,0.00014125486,0.0001935306,0.9797504,0.018829808],"study_design_scores_gemma":[0.00006517,0.00013750202,0.004415014,0.00031633562,0.000010731451,0.00022016726,0.00009101442,0.0000708936,0.00021406605,0.00050791906,0.9939412,0.000009963681],"about_ca_topic_score_codex":0.0014350702,"about_ca_topic_score_gemma":0.005079184,"teacher_disagreement_score":0.36081612,"about_ca_system_score_codex":0.0013804974,"about_ca_system_score_gemma":0.0022080494,"threshold_uncertainty_score":0.51466036},"labels":[],"label_agreement":null},{"id":"W4230163924","doi":"10.1200/jco.2004.22.14_suppl.706","title":"Trastuzumab (T) and docetaxel (D) for the treatment of HER2 metastatic breast cancer (MBC): A literature based (LB) and individual patient data (IPD) meta-analysis (MA) of phase II trial","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Docetaxel; Internal medicine; Metastatic breast cancer; Oncology; Trastuzumab; Meta-analysis; Breast cancer; Clinical trial; MEDLINE; Cochrane Library; CINAHL; Systematic review; Cancer","score_opus":0.41150323797398336,"score_gpt":0.5572722318948445,"score_spread":0.14576899392086118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230163924","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.068158634,0.9233929,0.0031869144,0.000689327,0.0005271999,0.0018547229,0.0011005711,0.00010356757,0.0009861896],"genre_scores_gemma":[0.7102724,0.27408212,0.007768568,0.0017466072,0.0005901415,0.003265285,0.001332409,0.000084477084,0.0008580274],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.970038,0.022344347,0.0040552896,0.0016450925,0.00156439,0.00035300702],"domain_scores_gemma":[0.97579104,0.017756471,0.0039657583,0.001007499,0.0010750075,0.00040415893],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.034609955,0.0030734406,0.014703094,0.0072766524,0.0005561411,0.003604132,0.0020352625,0.0020021047,0.0025614458],"category_scores_gemma":[0.040140036,0.001601655,0.048251845,0.006317321,0.00069911,0.0022207184,0.0019346578,0.0020221919,0.00026873458],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014215295,0.00005713249,0.003921569,0.057596136,0.9122333,0.00009345708,0.000063288295,0.0011080378,0.0003330013,0.00011438278,0.00027526647,0.009989112],"study_design_scores_gemma":[0.004680168,0.0010530127,0.0025492022,0.003288312,0.98688614,0.0000611497,0.00003135089,0.0005114465,0.000119411845,0.00018247383,0.0006171626,0.000020093235],"about_ca_topic_score_codex":0.003946233,"about_ca_topic_score_gemma":0.008197485,"teacher_disagreement_score":0.9852969,"about_ca_system_score_codex":0.0025152555,"about_ca_system_score_gemma":0.0022016778,"threshold_uncertainty_score":0.18303716},"labels":[],"label_agreement":null},{"id":"W4230571109","doi":"10.1515/iupac.87.0518","title":"Peripheral Neuropathy","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Chemical nomenclature; Relation (database); Computer science; Psychology; Medicine; Chemistry; Linguistics; Philosophy; Data mining; Organic chemistry","score_opus":0.0183244224904887,"score_gpt":0.44372992708496123,"score_spread":0.4254055045944725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230571109","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007117574,0.0007316656,0.00013697564,0.00011504174,0.00006286939,0.000081172955,0.99395657,0.0001813392,0.004022601],"genre_scores_gemma":[0.0026549373,0.0009954491,0.00058337505,0.00034533383,0.00003883646,0.0003371203,0.9917902,0.000045018915,0.0032097013],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99911004,0.00011614906,0.000245817,0.00026788688,0.00016102126,0.00009908971],"domain_scores_gemma":[0.99703884,0.0007926946,0.00068165833,0.00049006083,0.0008194024,0.00017735867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007255884,0.0011914627,0.0013551165,0.0024199432,0.0005712381,0.0019756856,0.0016769249,0.0012822425,0.092030086],"category_scores_gemma":[0.0072580418,0.00037079272,0.0016666156,0.00394742,0.00023268195,0.0012566539,0.0012443276,0.001471652,0.040394716],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011324649,0.00006799897,0.0095884325,0.007489127,0.00027011582,0.00015763022,0.000035120403,0.000488779,0.00018893575,0.00092444866,0.94782346,0.031833526],"study_design_scores_gemma":[0.0013337757,0.00013642265,0.04099034,0.0064973966,0.00036943285,0.0010074048,0.00014806718,0.0006124532,0.0005631679,0.0032310034,0.94503725,0.00007343781],"about_ca_topic_score_codex":0.0105685545,"about_ca_topic_score_gemma":0.022596061,"teacher_disagreement_score":0.092030086,"about_ca_system_score_codex":0.0012415621,"about_ca_system_score_gemma":0.0020895465,"threshold_uncertainty_score":0.30787128},"labels":[],"label_agreement":null},{"id":"W4230623844","doi":"10.1139/v00-080","title":"Synthesis of dimeric and tetrameric macrolactams with cytotoxic activity<sup>1</sup>","year":2000,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chemistry; Taxoid; Stereochemistry; Taxane; Cytotoxicity; Docetaxel; Cytotoxic T cell; Side chain; Paclitaxel; In vitro; Organic chemistry; Biochemistry","score_opus":0.0065285490804004725,"score_gpt":0.2302413065696946,"score_spread":0.22371275748929415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230623844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96969116,0.005117323,0.016408652,0.00018311325,0.000090468435,0.0003455181,0.001215126,0.00021777552,0.006730784],"genre_scores_gemma":[0.95921427,0.0019196415,0.03385294,0.00011088751,0.000016524735,0.00015819201,0.001550426,0.000038015427,0.003139062],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989235,0.000017212571,0.000015735244,0.000023802397,0.000023075707,0.000027761713],"domain_scores_gemma":[0.9998679,0.000010280913,0.000039734306,0.000016543045,0.00002243471,0.000043141383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015561869,0.00031546006,0.0002754734,0.00018610276,0.00010476923,0.0002232739,0.00021398035,0.00023700285,0.0011393032],"category_scores_gemma":[0.00022015795,0.00012676629,0.00018331133,0.0002427565,0.00012933931,0.00015957849,0.00020692578,0.0004039218,0.00048741206],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018336078,0.00006674736,0.00027484295,0.00007711319,0.000013939199,0.00009990996,0.00003342807,0.00031676554,0.984237,0.00028500488,0.00019266341,0.014219231],"study_design_scores_gemma":[0.00010130261,0.0013726742,0.0024521023,0.0000138900505,0.000033295975,0.0005581065,0.000023663899,0.0006657075,0.97779125,0.00008280523,0.016891895,0.0000132603],"about_ca_topic_score_codex":0.00026539143,"about_ca_topic_score_gemma":0.0006547325,"teacher_disagreement_score":0.0011393032,"about_ca_system_score_codex":0.0002334101,"about_ca_system_score_gemma":0.00031917528,"threshold_uncertainty_score":0.0038113594},"labels":[],"label_agreement":null},{"id":"W4231003726","doi":"10.1515/iupac.88.1076","title":"Morula","year":2017,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Terminology; Relation (database); Computer science; Linguistics; Philosophy; Data mining","score_opus":0.03012265849020757,"score_gpt":0.5193382229373927,"score_spread":0.48921556444718517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231003726","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007981143,0.00016612824,0.00010360843,0.00009416955,0.0000307108,0.000023477745,0.99782866,0.00043497566,0.0012385007],"genre_scores_gemma":[0.00030713758,0.00021094586,0.0003930538,0.00015667766,0.000015152959,0.00013357139,0.99765503,0.00014288646,0.0009854363],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981887,0.00039370576,0.00037502192,0.00054146006,0.00030635996,0.00019466349],"domain_scores_gemma":[0.99584144,0.0013712452,0.00056795054,0.0009172497,0.0009926889,0.00030944083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016529685,0.0015484279,0.0016454911,0.0043946537,0.000862192,0.003683575,0.0026953674,0.0016793542,0.14736412],"category_scores_gemma":[0.012943054,0.000679633,0.001963096,0.006689888,0.00041583236,0.0024041266,0.0027225527,0.0017708188,0.18582103],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014921966,0.000015952779,0.001123195,0.0025082147,0.00007092021,0.000028124097,0.0000398938,0.00019532234,0.00011484467,0.0012192586,0.9877221,0.0068129255],"study_design_scores_gemma":[0.00019367451,0.000018334871,0.0020529237,0.00094180816,0.000041160052,0.000058392543,0.000050358212,0.00017837861,0.00016197027,0.001447898,0.99483323,0.000021742944],"about_ca_topic_score_codex":0.013397405,"about_ca_topic_score_gemma":0.026161551,"teacher_disagreement_score":0.14736412,"about_ca_system_score_codex":0.0014369129,"about_ca_system_score_gemma":0.00326151,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4231306758","doi":"10.7748/cnp.14.5.15.s17","title":"Assessment of DN4 pain grading tool shows its reliability","year":2015,"lang":"en","type":"article","venue":"Cancer Nursing Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Grading (engineering); Medicine; Neuropathic pain; Physical therapy; Medical physics; Surgery; Engineering; Anesthesia","score_opus":0.09331572823394925,"score_gpt":0.47854005034899183,"score_spread":0.3852243221150426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231306758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91365355,0.007485409,0.015531938,0.0015568299,0.0007231502,0.0014493471,0.003964103,0.00016645505,0.055469047],"genre_scores_gemma":[0.9750249,0.0019248425,0.016158447,0.00031813196,0.00010257812,0.00045095175,0.0013752446,0.00004051388,0.004604318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98891103,0.0030343335,0.0015227074,0.00081963226,0.0052868263,0.00042550822],"domain_scores_gemma":[0.98201925,0.0069414782,0.0024204503,0.0009412595,0.0073070014,0.00037048574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010639679,0.00038114018,0.0006041943,0.0013945278,0.00041209316,0.0010165719,0.00090806175,0.0006024718,0.0034494493],"category_scores_gemma":[0.027313748,0.00019339951,0.001180494,0.0009501342,0.00076527003,0.0007661219,0.0010858363,0.000604769,0.00081084965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00127595,0.00036395903,0.7596487,0.0012966435,0.0007692722,0.00017746456,0.0018892493,0.0013315417,0.004356362,0.0011245143,0.00488381,0.2228825],"study_design_scores_gemma":[0.00006531071,0.00082443526,0.97845924,0.00036870583,0.00021091888,0.00040431073,0.0009948893,0.0019537266,0.0014955889,0.00075037766,0.014390004,0.00008252718],"about_ca_topic_score_codex":0.027135085,"about_ca_topic_score_gemma":0.05220496,"teacher_disagreement_score":0.027135085,"about_ca_system_score_codex":0.0012123592,"about_ca_system_score_gemma":0.0017900519,"threshold_uncertainty_score":0.056268692},"labels":[],"label_agreement":null},{"id":"W4232388491","doi":"10.1139/cjc-79-9-1381","title":"Reanalysis of the biotransformation of 4(20),11(12)-taxadiene derivatives","year":2001,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chemistry; Biotransformation; Organic chemistry; Stereochemistry","score_opus":0.01406355443019332,"score_gpt":0.2578501507101483,"score_spread":0.24378659627995494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232388491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715152,0.0047530932,0.010536528,0.00021005668,0.00022230523,0.000111300855,0.007260223,0.00034338408,0.005047799],"genre_scores_gemma":[0.9564055,0.0050531854,0.009200134,0.00011978153,0.000021464097,0.00009088822,0.0099966135,0.00019492849,0.0189175],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979216,0.000023446806,0.000010630683,0.000038439874,0.00009275719,0.00004263798],"domain_scores_gemma":[0.9997991,0.000025387762,0.000025369149,0.0000395054,0.000082701394,0.000027992051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024974084,0.000810991,0.00061169436,0.0007879579,0.0005197783,0.00048071652,0.00046437123,0.00036665823,0.0052633085],"category_scores_gemma":[0.00049881014,0.00026279344,0.00063967623,0.0007759953,0.00026271932,0.00032464438,0.00026896605,0.0007240025,0.0016554688],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002246597,0.00010707125,0.0050298087,0.00028787693,0.00022891129,0.0005203891,0.00024000132,0.0021514748,0.953153,0.00046168116,0.0009218691,0.034651376],"study_design_scores_gemma":[0.00004133402,0.000455569,0.020514345,0.000023822875,0.00018826142,0.00063015526,0.00016623933,0.002825701,0.95916975,0.0001629225,0.01578371,0.00003830169],"about_ca_topic_score_codex":0.014985622,"about_ca_topic_score_gemma":0.023116805,"teacher_disagreement_score":0.014985622,"about_ca_system_score_codex":0.00075798604,"about_ca_system_score_gemma":0.0019690748,"threshold_uncertainty_score":0.02979678},"labels":[],"label_agreement":null},{"id":"W4232434482","doi":"10.1200/jco.2004.22.14_suppl.633","title":"Patterns of trastuzumab (T) use in three Canadian provinces","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke; McMaster University; BC Cancer Agency","funders":"","keywords":"Medicine; Vinorelbine; Trastuzumab; Taxane; Breast cancer; Cancer; Family medicine; Metastatic breast cancer; Cancer registry; Internal medicine; Chemotherapy","score_opus":0.18032151794858894,"score_gpt":0.4878412718449584,"score_spread":0.30751975389636943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232434482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903566,0.0011671705,0.00010660518,0.0007594366,0.000010718865,0.00006765918,0.0040352144,0.000018068888,0.003478473],"genre_scores_gemma":[0.99770975,0.0005620386,0.00013217756,0.00014794816,0.0000032416551,0.000017268847,0.00094975356,0.00000552509,0.00047229877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983204,0.00013911392,0.00014852587,0.0002349856,0.0005812575,0.000575656],"domain_scores_gemma":[0.994676,0.00042589128,0.0015608153,0.00012995604,0.0021637517,0.0010435756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006529317,0.0003405696,0.00040463114,0.0020318,0.002336674,0.0010871167,0.0015061199,0.0005252598,0.0015404167],"category_scores_gemma":[0.0036393583,0.00038464466,0.0005002887,0.0059552453,0.0009529837,0.0002513557,0.0008270261,0.0005214785,0.00013187388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020474843,0.000026478112,0.9848065,0.000078790516,0.00006195111,0.0002410102,0.0013263111,0.00029813,0.00038445744,0.00016035707,0.0018419074,0.010569344],"study_design_scores_gemma":[0.000018007355,0.00004136251,0.99502677,0.00005195056,0.000030028306,0.00019054752,0.001962747,0.0004563016,0.00019563633,0.000017956801,0.0019897097,0.000019103545],"about_ca_topic_score_codex":0.9960782,"about_ca_topic_score_gemma":0.99720556,"teacher_disagreement_score":0.047765467,"about_ca_system_score_codex":0.047765467,"about_ca_system_score_gemma":0.049799196,"threshold_uncertainty_score":0.3465643},"labels":[],"label_agreement":null},{"id":"W4232564297","doi":"10.1200/jco.2004.22.90140.624","title":"Risk of radiation pneumonitis in breast cancer patients treated with adjuvant taxanes and radiation","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Pneumonitis; Paclitaxel; Internal medicine; Cancer; Oncology; Retrospective cohort study; Adjuvant; Concomitant; Chemotherapy; Surgery; Lung","score_opus":0.03415493484110391,"score_gpt":0.41780437077431004,"score_spread":0.3836494359332061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232564297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99318707,0.005417065,0.00020268296,0.00013259963,0.000011503267,0.000019456626,0.00014222036,0.000004500141,0.000882914],"genre_scores_gemma":[0.99814487,0.0013488209,0.00014885607,0.000062430794,0.000025006908,0.0000108862905,0.00013810766,0.0000015358331,0.00011950056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995018,0.0001874103,0.0000700843,0.000062858155,0.00012525325,0.00005262655],"domain_scores_gemma":[0.99778444,0.0006526745,0.0011878369,0.00008158548,0.00013878291,0.00015478322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006648106,0.00011094086,0.00030848832,0.00065079046,0.00024770666,0.0003414651,0.00015430157,0.00031062946,0.0014819709],"category_scores_gemma":[0.0028895563,0.00015980599,0.00041565739,0.00069199374,0.00015730811,0.00023009458,0.00022747218,0.0003363985,0.00015663593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013132625,0.000013857308,0.9953609,0.00001935031,0.000037002508,0.0002412326,0.000024074867,0.000018324665,0.00014866106,0.0000074612904,0.00006569541,0.0039321412],"study_design_scores_gemma":[0.000026838197,0.00052424386,0.9891719,0.00004903952,0.00018561337,0.007950951,0.00014958897,0.00018008977,0.00033373278,0.00004608937,0.0013769425,0.000004927831],"about_ca_topic_score_codex":0.0009398226,"about_ca_topic_score_gemma":0.0013285638,"teacher_disagreement_score":0.0014819709,"about_ca_system_score_codex":0.0001977791,"about_ca_system_score_gemma":0.00025872645,"threshold_uncertainty_score":0.0049577355},"labels":[],"label_agreement":null},{"id":"W4232634311","doi":"10.5489/cuaj.1291","title":"Moderated Posters 5: Oncology-General 2","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Psychology; Oncology; Medical physics; Internal medicine","score_opus":0.017160850454919205,"score_gpt":0.27673711489584024,"score_spread":0.259576264440921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232634311","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014367495,0.0033460124,0.0007918285,0.012112436,0.050621815,0.00067577226,0.004858665,0.0016146355,0.92454207],"genre_scores_gemma":[0.0051910495,0.002838588,0.00034815926,0.0055551734,0.018853853,0.00017086875,0.0024866804,0.00064185867,0.9639137],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992993,0.000115419905,0.000045867495,0.00014704569,0.00021346516,0.0001788888],"domain_scores_gemma":[0.9967926,0.0002374562,0.00014947937,0.00015725926,0.00075017614,0.001912971],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006696854,0.0010661783,0.0007947304,0.0013990313,0.0011744435,0.002800574,0.0011421248,0.0033222528,0.833784],"category_scores_gemma":[0.0024287375,0.00047523328,0.00093072304,0.00085356156,0.0003873345,0.00205679,0.002703267,0.0032068626,0.7002586],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003854417,0.000040853374,0.00019593263,0.00012541864,0.0000033989868,0.000084458086,0.0000088173,0.000042747633,0.00010542481,0.00028062577,0.9700019,0.029072085],"study_design_scores_gemma":[0.000025313797,0.000035202895,0.0010374782,0.00021477284,0.0000030780898,0.00017426356,0.000025033107,0.00004301634,0.000070398775,0.00040917099,0.9979564,0.000005981293],"about_ca_topic_score_codex":0.0009837361,"about_ca_topic_score_gemma":0.0029212323,"teacher_disagreement_score":0.833784,"about_ca_system_score_codex":0.0010765042,"about_ca_system_score_gemma":0.0012219744,"threshold_uncertainty_score":0.23708689},"labels":[],"label_agreement":null},{"id":"W4232961824","doi":"10.1007/978-3-662-44185-5_5236","title":"Suboxic","year":2015,"lang":"en","type":"book-chapter","venue":"Encyclopedia of Astrobiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Geology","score_opus":0.031986307379685164,"score_gpt":0.3054732787949637,"score_spread":0.27348697141527856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232961824","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026611485,0.02714172,0.016047318,0.0023649745,0.003490905,0.0002073486,0.0018988902,0.0013713737,0.92086595],"genre_scores_gemma":[0.10557518,0.024753496,0.0063593155,0.0029927618,0.00077608164,0.00017086892,0.001967969,0.00028043287,0.857124],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998628,0.00001064102,0.0000062086515,0.000032081076,0.0000658234,0.000022449403],"domain_scores_gemma":[0.9999378,0.000006572799,0.000010254281,0.000012378666,0.000020579888,0.000012405646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013173072,0.00075602747,0.00027793716,0.0006492275,0.00053246674,0.0008831671,0.0005342672,0.00053562864,0.051413804],"category_scores_gemma":[0.00021147866,0.00013609783,0.0002923395,0.00042144532,0.00055880874,0.00082458154,0.0010035626,0.0012702377,0.016741524],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064456294,0.00039181538,0.0009240482,0.002012086,0.00004734067,0.0012243157,0.0005456481,0.00061007316,0.2758138,0.13645841,0.12881003,0.45251787],"study_design_scores_gemma":[0.000014789306,0.00023981056,0.0010665045,0.00017084472,0.000022512257,0.0012886719,0.00012321031,0.00012754451,0.05160195,0.012675839,0.93265533,0.000013104435],"about_ca_topic_score_codex":0.0009080531,"about_ca_topic_score_gemma":0.0014683987,"teacher_disagreement_score":0.051413804,"about_ca_system_score_codex":0.0004355282,"about_ca_system_score_gemma":0.0005948543,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4233084556","doi":"10.3747/co.6","title":"Current Oncology","year":2020,"lang":"en","type":"paratext","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Clinical Oncology; Oncology; Internal medicine; Computational biology; Bioinformatics; Medical physics; Cancer; Biology","score_opus":0.23650474993072657,"score_gpt":0.5251220920733896,"score_spread":0.288617342142663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233084556","genre_codex":"other","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039030233,0.0052299025,0.00062106806,0.015918268,0.025394104,0.0001298297,0.0012999716,0.00047689106,0.9505397],"genre_scores_gemma":[0.0019948923,0.004630118,0.00045785934,0.0069481316,0.006191116,0.00007113346,0.0012098651,0.00012339333,0.9783735],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991984,0.00011383712,0.000038403345,0.00008850885,0.00042948715,0.00013136918],"domain_scores_gemma":[0.995256,0.00046084152,0.00017163939,0.00032703092,0.0016711527,0.0021132734],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011786141,0.0007819937,0.00052624755,0.0017535893,0.0013128427,0.0048064715,0.00090271025,0.0025298272,0.64181805],"category_scores_gemma":[0.0055773305,0.0003253713,0.00050372747,0.00093523477,0.0007684573,0.0020603323,0.0019932655,0.0032635273,0.46517646],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022896755,0.00004099335,0.00011155268,0.00010366675,0.0000020453072,0.00003831356,0.000010718913,0.00002806469,0.0001567245,0.003773869,0.8738555,0.12185563],"study_design_scores_gemma":[0.0000071038853,0.000013038436,0.00014161831,0.00010250343,0.0000016378156,0.00007404911,0.000012391392,0.000022258377,0.00004350529,0.0014421585,0.9981376,0.0000021169394],"about_ca_topic_score_codex":0.001246432,"about_ca_topic_score_gemma":0.00395904,"teacher_disagreement_score":0.35818195,"about_ca_system_score_codex":0.0017494722,"about_ca_system_score_gemma":0.0046637077,"threshold_uncertainty_score":0.51090306},"labels":[],"label_agreement":null},{"id":"W4233437458","doi":"10.1200/jco.2012.30.27_suppl.129","title":"A review of clinical endpoints and use of quality-of-life outcomes in phase III metastatic breast cancer clinical trials.","year":2012,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Clinical endpoint; Clinical trial; Quality of life (healthcare); Metastatic breast cancer; Internal medicine; Breast cancer; Cancer; Disease; Oncology; Intensive care medicine","score_opus":0.8390301528975707,"score_gpt":0.7464270069315143,"score_spread":0.09260314596605634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233437458","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039529684,0.9970214,0.00037803286,0.00050912297,0.00020526415,0.00062932906,0.00043794775,0.000014479447,0.00040921275],"genre_scores_gemma":[0.009909584,0.9827336,0.0026058103,0.0012842967,0.00022281524,0.002407449,0.0006660026,0.000024279558,0.00014622895],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.92209834,0.032641612,0.032729283,0.0021478604,0.00987899,0.0005039608],"domain_scores_gemma":[0.79249877,0.14570396,0.04309092,0.0026935213,0.014741485,0.0012713257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07881943,0.0017638686,0.011934738,0.015368797,0.00076377107,0.0051829745,0.003439962,0.002649087,0.004035593],"category_scores_gemma":[0.16040339,0.001322096,0.0069431243,0.01877718,0.0018011729,0.0034482712,0.0022302342,0.0021192902,0.0006869815],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011364851,0.000045674053,0.0011289649,0.7801874,0.0060027423,0.00008546246,0.00020704245,0.00018934275,0.00034701786,0.00073780474,0.0053704833,0.20456149],"study_design_scores_gemma":[0.0014743506,0.0010062695,0.0070386278,0.8870938,0.029310575,0.0005164627,0.00025615594,0.00027192713,0.00043100704,0.0011446376,0.07137523,0.00008114896],"about_ca_topic_score_codex":0.0019062017,"about_ca_topic_score_gemma":0.0047648163,"teacher_disagreement_score":0.07881943,"about_ca_system_score_codex":0.0055032894,"about_ca_system_score_gemma":0.012347021,"threshold_uncertainty_score":0.41684198},"labels":[],"label_agreement":null},{"id":"W4234129648","doi":"10.1002/jcph.72","title":"Issue Information","year":2013,"lang":"en","type":"paratext","venue":"The Journal of Clinical Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; University of Manitoba","funders":"","keywords":"Citation; Computer science; Information retrieval; World Wide Web","score_opus":0.07487596288625405,"score_gpt":0.4982250255603367,"score_spread":0.4233490626740827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234129648","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032713113,0.00053445075,0.0008124918,0.003795714,0.008954751,0.00043212518,0.021807972,0.0023365044,0.96099883],"genre_scores_gemma":[0.0006174067,0.00023940814,0.00026013443,0.00072239136,0.00059746136,0.00010124464,0.0057522706,0.00043685784,0.99127275],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986551,0.00018544597,0.00008317767,0.00013851363,0.00077835534,0.00015937744],"domain_scores_gemma":[0.9943189,0.0008703113,0.00022590643,0.00042707627,0.0026889408,0.0014688766],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0015837966,0.0011564251,0.0011971957,0.00467273,0.001985559,0.0076086265,0.0017278501,0.002117898,0.9035238],"category_scores_gemma":[0.009913941,0.0005266992,0.00059521216,0.004574574,0.00071657,0.004309003,0.0028046865,0.0022567657,0.86516637],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014563746,0.000017040176,0.00003243714,0.000074673866,6.522935e-7,0.000009007589,0.000008559225,0.000018163651,0.000057330984,0.0007772295,0.9808126,0.018177813],"study_design_scores_gemma":[0.000022126007,0.000018625464,0.00035982966,0.000117408454,0.0000017709779,0.000022099879,0.000053146614,0.000068917805,0.00010567451,0.0011716512,0.9980515,0.000007214087],"about_ca_topic_score_codex":0.0031380455,"about_ca_topic_score_gemma":0.006258445,"teacher_disagreement_score":0.0964762,"about_ca_system_score_codex":0.001710787,"about_ca_system_score_gemma":0.0034159853,"threshold_uncertainty_score":0.13761151},"labels":[],"label_agreement":null},{"id":"W4234258422","doi":"10.1200/jco.2009.27.15_suppl.571","title":"Randomized, blinded, placebo-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Acupuncture; Breast cancer; Randomized controlled trial; Discontinuation; Adverse effect; Joint pain; Placebo; Physical therapy; Internal medicine; Aromatase inhibitor; Brief Pain Inventory; Osteoarthritis; WOMAC; Body mass index; Exemestane; Cancer; Tamoxifen; Chronic pain","score_opus":0.05758300344351331,"score_gpt":0.42965069926841143,"score_spread":0.3720676958248981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234258422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753745,0.006929876,0.00088154833,0.000868754,0.001394205,0.011438511,0.0008547589,0.00015072411,0.0021071017],"genre_scores_gemma":[0.97386825,0.003178602,0.0025160525,0.0013064654,0.0008334055,0.015108932,0.0005082718,0.000016238007,0.0026636529],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990508,0.0005096794,0.000098999204,0.00016810246,0.00007525445,0.00009718702],"domain_scores_gemma":[0.99853694,0.0006409321,0.00027312344,0.00010749998,0.0001355435,0.00030598528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019218671,0.0011990366,0.003969352,0.0004993539,0.00068457995,0.00091779034,0.0010870643,0.0024497164,0.00869509],"category_scores_gemma":[0.0033982317,0.0007281937,0.0012361322,0.00036590052,0.0012307637,0.0009271367,0.0004249328,0.0021171998,0.0008077048],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98501146,0.005523342,0.00019621802,0.00077116885,0.00051203254,0.000024734372,0.000038331127,0.0000713892,0.0011576394,0.000051017076,0.0002562621,0.006386228],"study_design_scores_gemma":[0.9675798,0.0314336,0.0004524349,0.000023297951,0.00015296774,0.0000074187647,0.000008958771,0.00009026026,0.000087082284,0.00004299833,0.0001172775,0.0000039812885],"about_ca_topic_score_codex":0.00088398793,"about_ca_topic_score_gemma":0.0021144424,"teacher_disagreement_score":0.00869509,"about_ca_system_score_codex":0.0005479499,"about_ca_system_score_gemma":0.0013341868,"threshold_uncertainty_score":0.02908802},"labels":[],"label_agreement":null},{"id":"W4234971132","doi":"10.2165/00128415-200510380-00011","title":"Apotex updates Canadian Apo-Mefloquine patient leaflet","year":2005,"lang":"en","type":"article","venue":"Reactions Weekly","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mefloquine; Leaflet (botany); Pharmacology; Medicine; Biology; Malaria; Immunology; Chloroquine","score_opus":0.014968951024025607,"score_gpt":0.2930518241767922,"score_spread":0.2780828731527666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234971132","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0072412756,0.0058004693,0.0010572682,0.31409082,0.116932735,0.0005967191,0.0039767125,0.0017305965,0.54857343],"genre_scores_gemma":[0.015800135,0.0044539473,0.0018133826,0.092564836,0.038317572,0.00018604363,0.0019854282,0.000244158,0.84463465],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99944896,0.00005193688,0.00003532865,0.000021942584,0.00033605628,0.00010563222],"domain_scores_gemma":[0.9952507,0.0008017685,0.00032496918,0.000161906,0.0022968282,0.0011637766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007957117,0.0005431232,0.0006007302,0.0008199477,0.0015452582,0.001376859,0.0008016767,0.0055457316,0.17353956],"category_scores_gemma":[0.0053438414,0.00027504616,0.0005935104,0.00047916998,0.00031890915,0.00051225035,0.00053140655,0.0030602042,0.03414774],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005103684,0.000024116765,0.00018198433,0.000019704528,0.0000013798068,0.00020113595,0.0000044124854,0.000013651103,0.00007574871,0.000078001554,0.9867011,0.012647713],"study_design_scores_gemma":[0.00007879859,0.000033547098,0.0013794606,0.00004670479,0.0000052029,0.00028900456,0.000020308997,0.00007075326,0.00008853306,0.0001214389,0.9978592,0.0000070655183],"about_ca_topic_score_codex":0.058265895,"about_ca_topic_score_gemma":0.20400561,"teacher_disagreement_score":0.9417341,"about_ca_system_score_codex":0.0029031013,"about_ca_system_score_gemma":0.004257909,"threshold_uncertainty_score":0.5805477},"labels":[],"label_agreement":null},{"id":"W4236026480","doi":"10.1016/j.jcjd.2013.03.432","title":"Neuropathie","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.013318773781377139,"score_gpt":0.2442167782382103,"score_spread":0.23089800445683317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236026480","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014556676,0.043905288,0.010007649,0.01224166,0.011163769,0.0002724867,0.00681401,0.004313852,0.8967246],"genre_scores_gemma":[0.072160885,0.03501416,0.011676311,0.0082918815,0.0024665939,0.00033335478,0.0043774326,0.0014691096,0.8642103],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994898,0.000059111724,0.00003397266,0.0001255026,0.00016185733,0.00012981934],"domain_scores_gemma":[0.9995152,0.000060978975,0.000038369533,0.00009713488,0.00019387194,0.00009449554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049999595,0.0017978462,0.00074696273,0.0031784019,0.002463621,0.0027260454,0.000908768,0.0015516763,0.25089273],"category_scores_gemma":[0.0018271252,0.00047317165,0.000959049,0.0016768044,0.0010104202,0.0012345514,0.0026384564,0.0038216398,0.14722045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005893684,0.00012904953,0.0023582382,0.0008884917,0.000119684024,0.01025804,0.00044439855,0.00060246343,0.0075094174,0.027766624,0.33531883,0.6140154],"study_design_scores_gemma":[0.0000360506,0.00006346173,0.0021049718,0.0004677142,0.000052982257,0.014980786,0.0002574717,0.00018554083,0.0018762994,0.005265927,0.97468364,0.00002510591],"about_ca_topic_score_codex":0.010815704,"about_ca_topic_score_gemma":0.013813859,"teacher_disagreement_score":0.25089273,"about_ca_system_score_codex":0.002035613,"about_ca_system_score_gemma":0.0019095006,"threshold_uncertainty_score":0.8393198},"labels":[],"label_agreement":null},{"id":"W4236114868","doi":"10.1200/jco.2004.22.14_suppl.6052","title":"Does supportive-expressive group therapy for metastatic breast cancer patients lower health care services resource utilization","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Breast cancer; Mood; Psychosocial; Profile of mood states; Physical therapy; Quality of life (healthcare); Randomized controlled trial; Patient satisfaction; Metastatic breast cancer; Health care; Cancer; Family medicine; Internal medicine; Nursing; Psychiatry","score_opus":0.09892220443071154,"score_gpt":0.5150214318762829,"score_spread":0.4160992274455714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236114868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928296,0.0022193536,0.00006684627,0.0014900689,0.00010922717,0.00015801315,0.00014511238,0.000019571778,0.0029621562],"genre_scores_gemma":[0.99831885,0.0006132192,0.00016766496,0.00032897375,0.000085725085,0.00009359617,0.0001382009,0.0000017598488,0.00025207878],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996575,0.00017060702,0.000030800526,0.000032326207,0.000057116285,0.000051767453],"domain_scores_gemma":[0.9989625,0.00046646825,0.00024946837,0.000037676735,0.000039069924,0.00024479587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006144477,0.00016283218,0.00066697877,0.00036822612,0.00021425434,0.0003754436,0.0002513389,0.00080850144,0.00964332],"category_scores_gemma":[0.004325719,0.00007621985,0.0007041583,0.0003368001,0.00023170409,0.00035899816,0.00022202439,0.0004181612,0.0003405748],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1539965,0.036035817,0.07958959,0.0022217652,0.0025076764,0.000430266,0.00043049362,0.0016638379,0.0025433688,0.0006634676,0.0071022916,0.7128149],"study_design_scores_gemma":[0.13827012,0.1732347,0.6614516,0.0012094976,0.0042310413,0.00072120404,0.0008448019,0.0057742395,0.0021582919,0.001967705,0.010049599,0.000087141554],"about_ca_topic_score_codex":0.0011074329,"about_ca_topic_score_gemma":0.0022123693,"teacher_disagreement_score":0.00964332,"about_ca_system_score_codex":0.00039256722,"about_ca_system_score_gemma":0.00046177884,"threshold_uncertainty_score":0.03226012},"labels":[],"label_agreement":null},{"id":"W4237000794","doi":"10.2165/00151234-201106310-00025","title":"Febuxostat, dexlansoprazole reimbursed in Quebec","year":2011,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Febuxostat; Quality of Life Research; Business; Medicine; Public health; Internal medicine; Nursing","score_opus":0.04945966627069039,"score_gpt":0.36785061744353953,"score_spread":0.31839095117284916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237000794","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2998433,0.0423394,0.0007006609,0.45220718,0.0074704317,0.00016201033,0.028929822,0.00036831398,0.16797881],"genre_scores_gemma":[0.7449577,0.0234392,0.0014316367,0.06593207,0.0021160156,0.00008576961,0.008226704,0.00010394882,0.15370695],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995479,0.000056869143,0.000030651197,0.00004074376,0.00016889011,0.00015499188],"domain_scores_gemma":[0.997255,0.00037249536,0.00026711705,0.00005115249,0.0010666987,0.0009874491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054967747,0.00011235307,0.00019194745,0.00040181875,0.0012122495,0.0014037866,0.00054701924,0.0010176193,0.014681675],"category_scores_gemma":[0.0030631982,0.00012644938,0.0002871187,0.00094048807,0.00038303976,0.0004549968,0.0002672636,0.001317671,0.00045875265],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001298533,0.00019003697,0.10463474,0.00036019195,0.00015387856,0.001957734,0.00026617918,0.0011171903,0.001603615,0.0071714506,0.73621523,0.14503114],"study_design_scores_gemma":[0.0006931279,0.00016436483,0.40929502,0.0004066366,0.00013541276,0.0005715119,0.0007666858,0.0019007587,0.00068546186,0.00045602242,0.58486223,0.00006281372],"about_ca_topic_score_codex":0.9786647,"about_ca_topic_score_gemma":0.99046385,"teacher_disagreement_score":0.025333758,"about_ca_system_score_codex":0.025333758,"about_ca_system_score_gemma":0.044752173,"threshold_uncertainty_score":0.18381017},"labels":[],"label_agreement":null},{"id":"W4237242270","doi":"10.1016/s0009-9236(01)70992-7","title":"Red wine decreases cyclosporine bioavailability","year":2001,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North","funders":"","keywords":"Wine; Ciclosporin; Pharmacology; Bioavailability; CYP3A4; Pharmacokinetics; Crossover study; Chemistry; Grapefruit juice; Whole blood; Fluorescence polarization immunoassay; Medicine; Placebo; Chromatography; Cytochrome P450; Internal medicine; Food science; Biochemistry; Chemotherapy; Metabolism","score_opus":0.14501065618878375,"score_gpt":0.4814705665912841,"score_spread":0.33645991040250034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237242270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961169,0.002410922,0.00030400552,0.00013872416,0.0000666089,0.000020573994,0.00008265038,0.000062061816,0.00079767837],"genre_scores_gemma":[0.99573475,0.0015684656,0.00057918864,0.00019229561,0.00008071974,0.000017195194,0.00015212358,0.000015579013,0.0016596478],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998821,0.00003402592,0.000009818613,0.000022986274,0.000028893013,0.000022255384],"domain_scores_gemma":[0.9997414,0.00006922298,0.000082970815,0.000021402393,0.000031470852,0.000053549044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014639444,0.00028083092,0.00032696963,0.000113349,0.00012441064,0.00029279946,0.00011971164,0.00023882571,0.0028030346],"category_scores_gemma":[0.00036084262,0.00011089506,0.0002149564,0.000085040556,0.00010760455,0.00015098766,0.00014469506,0.0004322415,0.00029766234],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018664833,0.0017765019,0.008091605,0.00046075325,0.0002384869,0.0002986205,0.00006510151,0.0002676993,0.88948363,0.00016905158,0.0012296307,0.07925414],"study_design_scores_gemma":[0.0032394086,0.0714414,0.17642766,0.0001582866,0.0007647706,0.0029204811,0.00016786632,0.0032543845,0.7163875,0.00041625838,0.024775544,0.000046451838],"about_ca_topic_score_codex":0.00033889187,"about_ca_topic_score_gemma":0.00042710063,"teacher_disagreement_score":0.0028030346,"about_ca_system_score_codex":0.0001571465,"about_ca_system_score_gemma":0.00014101964,"threshold_uncertainty_score":0.009377062},"labels":[],"label_agreement":null},{"id":"W4237273614","doi":"10.1515/iupac.79.1146","title":"Dimercaprol","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glossary; Chemical nomenclature; Toxicology; Computer science; Chemistry; Philosophy; Biology; Linguistics","score_opus":0.020189134738199783,"score_gpt":0.46837368076732955,"score_spread":0.44818454602912977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237273614","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020869102,0.00046380734,0.000089928675,0.00008241788,0.000032522457,0.000029904058,0.99736696,0.00033717384,0.0013885912],"genre_scores_gemma":[0.0005197589,0.00030479528,0.00029669647,0.00015277781,0.000012895835,0.00011408642,0.99758244,0.000058180744,0.0009583541],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987299,0.00022185,0.0001983716,0.00044649004,0.00026410917,0.00013933486],"domain_scores_gemma":[0.99800926,0.0005849723,0.0003297844,0.00047460524,0.0004107509,0.0001905705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010076045,0.002284686,0.002071915,0.0029847964,0.00082391006,0.0028617475,0.003239267,0.0020629908,0.09364157],"category_scores_gemma":[0.00633185,0.0006514653,0.0022269345,0.004538098,0.00035834167,0.0017045335,0.0017355507,0.0019248347,0.12477279],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045177163,0.000059769303,0.0016915074,0.0036004726,0.00013253649,0.00004545561,0.000021968552,0.0005197267,0.0003168712,0.00062952493,0.981217,0.011313341],"study_design_scores_gemma":[0.0005198337,0.00006142889,0.0036622128,0.0007238904,0.00013225105,0.00013401356,0.000038153452,0.0003779417,0.0005417889,0.0013610619,0.9924097,0.00003762435],"about_ca_topic_score_codex":0.011132438,"about_ca_topic_score_gemma":0.023916282,"teacher_disagreement_score":0.09364157,"about_ca_system_score_codex":0.0012620469,"about_ca_system_score_gemma":0.0026256158,"threshold_uncertainty_score":0.31326228},"labels":[],"label_agreement":null},{"id":"W4237709015","doi":"10.1200/jco.2004.22.14_suppl.630","title":"A multi-centre phase II trial of pegylated liposomal doxorubicin and trastuzumab in HER-2 over-expressing metastatic breast cancer (MBC)","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Anthracycline; Metastatic breast cancer; Ejection fraction; Cardiotoxicity; Trastuzumab; Doxorubicin; Internal medicine; Heart failure; Breast cancer; Cancer; Oncology; Chemotherapy; Gastroenterology; Urology","score_opus":0.1422473115020502,"score_gpt":0.5265052184546788,"score_spread":0.3842579069526286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237709015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925575,0.0008343243,0.0002757832,0.00028142805,0.000058846683,0.004096824,0.0007070638,0.00005044476,0.0011378006],"genre_scores_gemma":[0.98863864,0.0010332685,0.0016945868,0.00066885917,0.00013171873,0.003313865,0.0022955097,0.000019303241,0.0022041274],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994648,0.00019599701,0.000024766905,0.00009358376,0.0000771315,0.00014372922],"domain_scores_gemma":[0.9991059,0.00006484251,0.00009780289,0.000050003207,0.000054072134,0.0006274287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020478053,0.00166029,0.0016453807,0.00041785437,0.00079508376,0.0008984139,0.0012219307,0.0012590411,0.003452124],"category_scores_gemma":[0.00076024735,0.00067675975,0.00081120396,0.00057444826,0.0010605135,0.0004856754,0.00051953905,0.0022904747,0.0007255068],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8085489,0.083964795,0.008895046,0.0005811716,0.0007645297,0.00036147333,0.00047708288,0.0018579338,0.031220548,0.00013702137,0.00422033,0.058971144],"study_design_scores_gemma":[0.6747915,0.2942178,0.024901928,0.000029350354,0.00031591312,0.0002857068,0.00006495684,0.00083838904,0.0021471593,0.00007240718,0.0023056932,0.00002915232],"about_ca_topic_score_codex":0.029295914,"about_ca_topic_score_gemma":0.061727475,"teacher_disagreement_score":0.029295914,"about_ca_system_score_codex":0.003919715,"about_ca_system_score_gemma":0.006109642,"threshold_uncertainty_score":0.058250785},"labels":[],"label_agreement":null},{"id":"W4237936247","doi":"10.3410/f.718426882.793495799","title":"Faculty Opinions recommendation of A high throughput screen identifies Nefopam as targeting cell proliferation in β-catenin driven neoplastic and reactive fibroproliferative disorders.","year":2014,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Catenin; Cancer research; Cell growth; Throughput; Cell biology; Chemistry; Biology; Computer science; Wnt signaling pathway; Signal transduction; Biochemistry; Telecommunications","score_opus":0.017741187366115144,"score_gpt":0.3469871396183872,"score_spread":0.32924595225227204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237936247","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00070674194,0.00031324537,0.000091661386,0.00030925398,0.000050375533,0.00003044279,0.99681866,0.0003600862,0.0013195188],"genre_scores_gemma":[0.0018700657,0.00027317522,0.00045102593,0.00035914918,0.000024621739,0.00008803587,0.99511635,0.000065673004,0.0017519441],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99916446,0.000120192446,0.00008374205,0.0002412078,0.00026602182,0.00012442084],"domain_scores_gemma":[0.9975809,0.0007844152,0.00031946215,0.0003268213,0.0006548221,0.00033363997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010850742,0.0015748723,0.0014898018,0.0022760448,0.00071732193,0.0022414227,0.0021230653,0.0024403203,0.05817371],"category_scores_gemma":[0.006195843,0.0004986604,0.0021243193,0.002590143,0.00028340175,0.0008775335,0.0011131231,0.0014536516,0.03446843],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040692877,0.000066592394,0.00418901,0.0015518572,0.00020123571,0.000049807575,0.000012094713,0.00028730943,0.0007327893,0.00024743873,0.9868281,0.00542685],"study_design_scores_gemma":[0.0018680895,0.00017515919,0.026485493,0.00071144564,0.00077442086,0.00026535895,0.00006309286,0.001630338,0.0031657417,0.0012363902,0.9635518,0.00007264908],"about_ca_topic_score_codex":0.020776168,"about_ca_topic_score_gemma":0.05682195,"teacher_disagreement_score":0.05817371,"about_ca_system_score_codex":0.0013506835,"about_ca_system_score_gemma":0.0032464894,"threshold_uncertainty_score":0.19461048},"labels":[],"label_agreement":null},{"id":"W4238325746","doi":"10.1515/iupac.87.0313","title":"Hypophysectomy","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Relation (database); Psychology; Computer science; Linguistics; Philosophy; Data mining","score_opus":0.020433534492741823,"score_gpt":0.46240867790457796,"score_spread":0.44197514341183614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238325746","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013744833,0.0019381723,0.00046026628,0.00024351837,0.0001327443,0.000112776426,0.98990995,0.00028060243,0.005547558],"genre_scores_gemma":[0.0059202034,0.002022952,0.0012812744,0.00086483837,0.00009587072,0.00047511232,0.98496616,0.00014776111,0.004225898],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989619,0.0001651125,0.00026205502,0.00032743605,0.00016566803,0.00011775148],"domain_scores_gemma":[0.99732983,0.00097081525,0.000533982,0.00060179434,0.00041259592,0.00015112791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010181032,0.0011966451,0.0013627723,0.0018241553,0.0004983998,0.0019577127,0.0013406861,0.0011515042,0.075936586],"category_scores_gemma":[0.006493171,0.00043033817,0.0028609708,0.0026733684,0.0003198372,0.0012748847,0.0012965513,0.001836685,0.03769583],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003527906,0.00011350271,0.012288158,0.01003991,0.001003679,0.0002621426,0.0000520157,0.001172093,0.00061180186,0.0016392352,0.913303,0.055986427],"study_design_scores_gemma":[0.0020667973,0.0001965225,0.0326739,0.0039178254,0.000618558,0.0011298665,0.00010792973,0.000592327,0.0009751285,0.0055435235,0.95209163,0.00008614301],"about_ca_topic_score_codex":0.009656139,"about_ca_topic_score_gemma":0.01882071,"teacher_disagreement_score":0.075936586,"about_ca_system_score_codex":0.001562101,"about_ca_system_score_gemma":0.0023567327,"threshold_uncertainty_score":0.2540332},"labels":[],"label_agreement":null},{"id":"W4238430268","doi":"10.1515/iupac.78.0335","title":"Glucuronides","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Glossary; Chemical nomenclature; Relation (database); Computer science; Management science; Data science; Environmental chemistry; Chemistry; Engineering; Data mining; Linguistics","score_opus":0.020763071778345896,"score_gpt":0.47012580560311734,"score_spread":0.44936273382477143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238430268","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016226871,0.00042420853,0.000063350984,0.00006299343,0.0000146911,0.000016085176,0.99792755,0.00009638045,0.0012323698],"genre_scores_gemma":[0.00069181557,0.0006599173,0.00036931506,0.00016645431,0.000011422188,0.0001064496,0.99670357,0.00005084064,0.0012402323],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99891186,0.00017974152,0.00027830095,0.0003025931,0.00024776222,0.000079674064],"domain_scores_gemma":[0.99774796,0.0007055127,0.0005715658,0.0003430411,0.0004999692,0.0001319359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072811113,0.0015431988,0.001595101,0.0035130053,0.00051520526,0.0019768267,0.0017221613,0.0012906584,0.07997033],"category_scores_gemma":[0.0056311493,0.00042081345,0.0014854613,0.0070172427,0.00030688316,0.0012930459,0.0011657492,0.0013701343,0.06730466],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036234295,0.00003506873,0.0026260433,0.0053831544,0.00011110679,0.00007078257,0.000031283478,0.000348457,0.0003528674,0.0011181856,0.97368854,0.01587213],"study_design_scores_gemma":[0.0001916144,0.000026993384,0.0057880864,0.0010000292,0.000078025005,0.00011696867,0.00003264132,0.00011502572,0.0002894445,0.0010377145,0.9913003,0.00002318155],"about_ca_topic_score_codex":0.015016483,"about_ca_topic_score_gemma":0.030959131,"teacher_disagreement_score":0.07997033,"about_ca_system_score_codex":0.0012854218,"about_ca_system_score_gemma":0.002313817,"threshold_uncertainty_score":0.2675274},"labels":[],"label_agreement":null},{"id":"W4238890016","doi":"10.21203/rs.2.11805/v3","title":"The efficacy and safety of electro-acupuncture for alleviating chemotherapy-induced peripheral neuropathy in colorectal cancer patients: study protocol for a single-blinded, randomized sham-controlled trial","year":2019,"lang":"en","type":"preprint","venue":"Research Square","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Hospital Authority; Hong Kong Baptist University","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Acupuncture; Randomized controlled trial; Colorectal cancer; Protocol (science); Chemotherapy; Internal medicine; Cancer; Oncology; Peripheral; Physical therapy; Alternative medicine; Pathology","score_opus":0.08049126825956275,"score_gpt":0.46635391430938405,"score_spread":0.3858626460498213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238890016","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32163253,0.0036742017,0.0069229286,0.0008142183,0.0014588292,0.6562623,0.0034530088,0.00048317865,0.005298879],"genre_scores_gemma":[0.27943352,0.0019916275,0.012568844,0.0015305124,0.0009730129,0.69704694,0.00108387,0.000066392764,0.0053053056],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9951586,0.0023831928,0.0006628062,0.0006553858,0.00050271046,0.0006372164],"domain_scores_gemma":[0.99663997,0.0009367968,0.00082736975,0.00054025865,0.00044168532,0.00061384833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007561258,0.003928662,0.0075809816,0.0014328026,0.0017612468,0.0017247645,0.0018802644,0.004779977,0.019979814],"category_scores_gemma":[0.007423266,0.0017457072,0.003104619,0.0012087679,0.0034116097,0.0017732034,0.0009489074,0.0039845724,0.0035612974],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9836675,0.0070253727,0.00013894851,0.0007870423,0.00032259055,0.00001824693,0.000040582312,0.00019541153,0.001244116,0.00014652492,0.00034744616,0.006066241],"study_design_scores_gemma":[0.9635869,0.03455942,0.00040518717,0.000054673823,0.00023788781,0.000008051287,0.000009791041,0.00018896617,0.00023721406,0.00013959919,0.00055608957,0.000016233102],"about_ca_topic_score_codex":0.0011350721,"about_ca_topic_score_gemma":0.001772466,"teacher_disagreement_score":0.019979814,"about_ca_system_score_codex":0.001561993,"about_ca_system_score_gemma":0.0043165423,"threshold_uncertainty_score":0.0668391},"labels":[],"label_agreement":null},{"id":"W4239858202","doi":"10.1515/iupac.76.0199","title":"Cytochrome P450","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glossary; Toxicokinetics; Relation (database); Hazard; Computer science; Toxicology; Medicine; Chemistry; Pharmacology; Data mining; Biology; Linguistics; Philosophy","score_opus":0.02079004407645341,"score_gpt":0.4711151561286404,"score_spread":0.450325112052187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239858202","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014882079,0.00049723545,0.0001326536,0.000056116758,0.000018130775,0.00001852966,0.9978865,0.0001930104,0.0010490356],"genre_scores_gemma":[0.0005436254,0.00052527495,0.0004211154,0.00010835073,0.0000115457115,0.000096732474,0.9975268,0.0000531721,0.0007134242],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998451,0.000260921,0.0003417684,0.0005099965,0.0003170387,0.000119250275],"domain_scores_gemma":[0.9968746,0.0010827591,0.0005837177,0.000639207,0.0006198884,0.00019980781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096626714,0.0015240577,0.0017102773,0.003970944,0.00066547014,0.0022262894,0.0015272349,0.0011379637,0.08317453],"category_scores_gemma":[0.0076446077,0.0006303432,0.0013446477,0.0090109585,0.00029520047,0.0014108152,0.001360772,0.0016971026,0.079611234],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018606128,0.000026433787,0.0026453822,0.0037439382,0.00011096514,0.00006887046,0.00003225979,0.0002730793,0.00034375646,0.0008091037,0.9756631,0.016097128],"study_design_scores_gemma":[0.00015316728,0.000024492558,0.0076799477,0.0008131112,0.000097128766,0.00020395705,0.000029046463,0.00014272294,0.00031266033,0.0012721182,0.98924315,0.000028417364],"about_ca_topic_score_codex":0.012146729,"about_ca_topic_score_gemma":0.018223304,"teacher_disagreement_score":0.08317453,"about_ca_system_score_codex":0.0012388881,"about_ca_system_score_gemma":0.0023690737,"threshold_uncertainty_score":0.27824652},"labels":[],"label_agreement":null},{"id":"W4239887008","doi":"10.1016/s1701-2163(16)30697-1","title":"Archivée: Recours à l’hormonothérapie substitutive après un traitement contre le cancer du sein","year":2004,"lang":"fr","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology; Humanities","score_opus":0.024272845638380426,"score_gpt":0.2581612399536119,"score_spread":0.23388839431523148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239887008","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.044997245,0.1422857,0.0066907443,0.19380814,0.3061732,0.00054185,0.026347626,0.0024634835,0.27669197],"genre_scores_gemma":[0.13324095,0.05707082,0.0067307507,0.0322345,0.096370935,0.00035088486,0.0110948235,0.0011648446,0.66174144],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9989396,0.0002030327,0.00011188977,0.0000819295,0.00052084686,0.00014261599],"domain_scores_gemma":[0.9934742,0.0023254377,0.0006783535,0.0007486248,0.0020891293,0.00068425736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001522405,0.00054883456,0.0007651493,0.0022262968,0.0015848564,0.0034071594,0.00086902495,0.0022305513,0.08450415],"category_scores_gemma":[0.0106297955,0.0003621695,0.00091384316,0.0011813545,0.00088498776,0.0013673713,0.0012049616,0.002879925,0.024264889],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015285766,0.00017913658,0.0026826984,0.0010674708,0.00008383009,0.0031648148,0.0006579084,0.00029715986,0.002581745,0.0029340123,0.76494914,0.21987352],"study_design_scores_gemma":[0.0000662699,0.00010921529,0.0036508553,0.00028838572,0.000031880085,0.002155934,0.00015587376,0.00008834846,0.0020639845,0.0005865332,0.990777,0.000025631325],"about_ca_topic_score_codex":0.008485395,"about_ca_topic_score_gemma":0.010661133,"teacher_disagreement_score":0.08450415,"about_ca_system_score_codex":0.002050121,"about_ca_system_score_gemma":0.0032999683,"threshold_uncertainty_score":0.28269458},"labels":[],"label_agreement":null},{"id":"W4240203973","doi":"10.1515/iupac.87.0123","title":"Carpel Tunnel Syndrome (CTS)","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Chemical nomenclature; Relation (database); Computer science; Psychology; Linguistics; Chemistry; Philosophy; Data mining; Organic chemistry","score_opus":0.02026787650016847,"score_gpt":0.4440031669268697,"score_spread":0.4237352904267012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240203973","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009797143,0.0009918781,0.00016245164,0.0001329976,0.000048338985,0.0000733122,0.99524397,0.000102414284,0.0022649993],"genre_scores_gemma":[0.003153925,0.0012920275,0.00050949753,0.00022614746,0.000032036165,0.00034700806,0.99320835,0.000040931096,0.001190083],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99848807,0.00018555806,0.0006282984,0.000324566,0.00025351922,0.00011991137],"domain_scores_gemma":[0.99488753,0.0016935366,0.0015014667,0.00074199867,0.0009266364,0.00024887218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009604695,0.0010987755,0.0015374713,0.004201328,0.0005266884,0.0016533486,0.0014800627,0.0012269615,0.043658555],"category_scores_gemma":[0.010053071,0.0004166315,0.0015924188,0.0069365688,0.00035430273,0.0012368737,0.0013352927,0.0016326212,0.01736117],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085497845,0.000037532474,0.015856978,0.008233265,0.00034632196,0.00029581267,0.00005793336,0.00051692076,0.00020235081,0.001281843,0.94970363,0.022612337],"study_design_scores_gemma":[0.0012628504,0.00010211685,0.08784605,0.0114163915,0.0004932113,0.0022256912,0.00026039375,0.00079081743,0.00063179166,0.0039014106,0.8909255,0.00014373068],"about_ca_topic_score_codex":0.012799325,"about_ca_topic_score_gemma":0.024655988,"teacher_disagreement_score":0.043658555,"about_ca_system_score_codex":0.0012394884,"about_ca_system_score_gemma":0.00261188,"threshold_uncertainty_score":0.14605242},"labels":[],"label_agreement":null},{"id":"W4241025105","doi":"10.1002/cncr.20897","title":"Author reply","year":2005,"lang":"en","type":"article","venue":"Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Hazard ratio; Medicine; Proportional hazards model; Confounding; Sample size determination; Observational study; Statistics; Constant (computer programming); Confidence interval; Event (particle physics); Trastuzumab; Internal medicine; Oncology; Cancer; Mathematics; Breast cancer; Computer science","score_opus":0.0476644770768043,"score_gpt":0.4159754248623061,"score_spread":0.3683109477855018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241025105","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028091227,0.0032391904,0.00030709978,0.8715064,0.12189638,0.000023518945,0.0001964153,0.00013395766,0.0024162065],"genre_scores_gemma":[0.002182087,0.0017017514,0.0003370263,0.939443,0.048122242,0.00005975438,0.00008949295,0.00008844054,0.00797618],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945327,0.0014792645,0.0006379505,0.00091696286,0.0018144968,0.00061861734],"domain_scores_gemma":[0.95205134,0.018790718,0.0026366904,0.0017324537,0.021322897,0.0034659072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006859814,0.00093819696,0.0014645152,0.0011719179,0.0025806907,0.0051777815,0.0034601206,0.024142684,0.03102367],"category_scores_gemma":[0.09698081,0.00069195754,0.001488444,0.00090473203,0.003168043,0.006494143,0.0037791743,0.034529023,0.025802419],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021253398,0.0000051747816,0.00017083996,0.00006408307,0.0000064811416,0.00022929757,0.00009534446,0.000017564254,0.000044264172,0.00085876003,0.99443793,0.0040491014],"study_design_scores_gemma":[0.000022172742,0.000017847013,0.00032053245,0.00024562015,0.000012825259,0.0011009197,0.0003243717,0.00005920569,0.00016330776,0.0017682737,0.9959299,0.000035078712],"about_ca_topic_score_codex":0.00259146,"about_ca_topic_score_gemma":0.002618011,"teacher_disagreement_score":0.03102367,"about_ca_system_score_codex":0.0030886405,"about_ca_system_score_gemma":0.0055833263,"threshold_uncertainty_score":0.10378456},"labels":[],"label_agreement":null},{"id":"W4241164232","doi":"10.1515/iupac.79.1689","title":"Neurotoxic","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glossary; Chemical nomenclature; Computer science; Toxicology; Chemistry; Philosophy; Biology; Linguistics; Organic chemistry","score_opus":0.0224309372106804,"score_gpt":0.47067368241760194,"score_spread":0.44824274520692153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241164232","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036322096,0.0008498508,0.00010836223,0.00010251636,0.00006582431,0.00003347158,0.99615234,0.0001234745,0.0022007609],"genre_scores_gemma":[0.0014566844,0.000875271,0.00046184545,0.0003038211,0.000041578405,0.00019270797,0.9942887,0.00004779957,0.0023316287],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998728,0.00018539002,0.0002939164,0.00040927046,0.00025575914,0.000127653],"domain_scores_gemma":[0.99689215,0.0008047653,0.0006597822,0.0005865477,0.0008437307,0.00021302002],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010414083,0.0016898079,0.0017699358,0.0032554746,0.0007310218,0.0023645386,0.0018680051,0.0012950875,0.090817325],"category_scores_gemma":[0.008686224,0.00046585253,0.002138136,0.003996985,0.00028932162,0.0014385626,0.0016077383,0.0017263422,0.06479502],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006875512,0.000049431223,0.00728558,0.006773977,0.00031284726,0.000100845944,0.00004317734,0.00043669084,0.0002694228,0.0010785498,0.9567692,0.026192734],"study_design_scores_gemma":[0.0005426371,0.000070703354,0.016759858,0.0022232549,0.0004003873,0.00042335448,0.00007787738,0.0002525996,0.00037623954,0.0024627184,0.97636557,0.000044754157],"about_ca_topic_score_codex":0.013292062,"about_ca_topic_score_gemma":0.035815753,"teacher_disagreement_score":0.90918267,"about_ca_system_score_codex":0.0014815913,"about_ca_system_score_gemma":0.0028151218,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4241188965","doi":"10.1016/b0-12-369400-0/00746-8","title":"Pharmacokinetics/Toxicokinetics","year":2005,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Toxicokinetics; Pharmacokinetics; Pharmacology; Medicine","score_opus":0.0256362844768887,"score_gpt":0.3077204251711355,"score_spread":0.2820841406942468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241188965","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015925763,0.18899,0.029270941,0.0035605754,0.004396043,0.00010659009,0.0010254633,0.0014194768,0.7696384],"genre_scores_gemma":[0.0027785155,0.049050126,0.0055221478,0.0015080582,0.00079508504,0.00007394914,0.00038835508,0.00019676243,0.93968695],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981564,0.000021655916,0.000008840425,0.000025576252,0.00011793294,0.000010472696],"domain_scores_gemma":[0.999864,0.00005213818,0.000011169193,0.000021341239,0.00003904999,0.000012179242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035860157,0.0014327678,0.0011130748,0.0015769642,0.00034015698,0.0015410798,0.0006970722,0.0013697109,0.076009266],"category_scores_gemma":[0.00042899413,0.00053115236,0.00042721644,0.0011531019,0.00044354243,0.0012643184,0.00082587154,0.0023918778,0.07103945],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005961613,0.00013852312,0.00010682617,0.0007023007,0.000013352349,0.00026193203,0.000084172185,0.0009692161,0.010829652,0.014386636,0.21680611,0.7556417],"study_design_scores_gemma":[0.000007837043,0.00005282883,0.00015156723,0.00018402621,0.00001055809,0.0006494904,0.000012941694,0.00026945028,0.002276113,0.0060689454,0.99030846,0.0000077584245],"about_ca_topic_score_codex":0.0010606105,"about_ca_topic_score_gemma":0.001876089,"teacher_disagreement_score":0.076009266,"about_ca_system_score_codex":0.0006049772,"about_ca_system_score_gemma":0.00061982154,"threshold_uncertainty_score":0.25427634},"labels":[],"label_agreement":null},{"id":"W4241365950","doi":"10.2165/00128413-200514760-00056","title":"Ethinylestradiol/drospirenone [Yasmin; Berlex Canada] has been launched in Canada,","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drospirenone; Medicine; Launched; Ethinylestradiol; Gynecology; Environmental health; Population; Research methodology; Engineering","score_opus":0.030514620886917497,"score_gpt":0.2804845569241142,"score_spread":0.24996993603719672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241365950","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1839812,0.11279161,0.0042912485,0.042493533,0.005231459,0.0017082233,0.022594826,0.0030056313,0.62390226],"genre_scores_gemma":[0.2953762,0.029652104,0.0038215714,0.00613008,0.00043745205,0.00013329617,0.0079860445,0.00016401245,0.6562993],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99957556,0.00003029185,0.000015500333,0.000047981513,0.00022013372,0.00011059997],"domain_scores_gemma":[0.9993549,0.000037848367,0.00005168234,0.000021420292,0.00027852374,0.0002556309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005016407,0.00045233438,0.0004471398,0.0005932545,0.0018074138,0.0008802178,0.0005011105,0.0008858416,0.030932117],"category_scores_gemma":[0.00050439796,0.00018752045,0.00030839717,0.0005480455,0.00074385066,0.00018844027,0.00044629924,0.0010048557,0.0048713987],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005662964,0.0010540312,0.016377142,0.0014268579,0.00016064341,0.0020428856,0.00028600992,0.0009929793,0.06456023,0.011284574,0.30773404,0.58841765],"study_design_scores_gemma":[0.0006640388,0.0011509393,0.028787468,0.00011750696,0.00007007707,0.0007124762,0.00027648167,0.0002665787,0.014221287,0.0003252827,0.9533728,0.000035077635],"about_ca_topic_score_codex":0.6268881,"about_ca_topic_score_gemma":0.88426274,"teacher_disagreement_score":0.3731119,"about_ca_system_score_codex":0.0061180354,"about_ca_system_score_gemma":0.025981085,"threshold_uncertainty_score":0.75061846},"labels":[],"label_agreement":null},{"id":"W4241390578","doi":"10.2165/00128415-200711570-00003","title":"New Avastin safety info issued in Canada","year":2007,"lang":"en","type":"article","venue":"Reactions Weekly","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Business; Medicine","score_opus":0.015253657974784465,"score_gpt":0.30515369602394743,"score_spread":0.289900038049163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241390578","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020793078,0.020170283,0.0022229294,0.10398939,0.029008713,0.0006031264,0.03104454,0.002756712,0.7894111],"genre_scores_gemma":[0.025280148,0.0051670573,0.0007465525,0.008635386,0.0018720248,0.00003114962,0.0054226983,0.0002153041,0.9526296],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987318,0.000041612762,0.00004405356,0.00004322667,0.0009899728,0.00014937505],"domain_scores_gemma":[0.9950531,0.00042901325,0.00031870976,0.000111428526,0.0030193015,0.001068422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091166643,0.00040995868,0.00050101185,0.0017244682,0.0018831822,0.0034818074,0.0007127227,0.0024890797,0.08842441],"category_scores_gemma":[0.0037235585,0.00044355594,0.0004845825,0.0013623721,0.0005449091,0.00048167177,0.00044384523,0.0028578422,0.016577164],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008354659,0.000036678433,0.001607991,0.00006240754,0.0000071098693,0.0001462169,0.00002624236,0.00008394032,0.00046150078,0.000536999,0.9678904,0.029057179],"study_design_scores_gemma":[0.000034450277,0.00004418515,0.011925743,0.00006975179,0.000015695525,0.0001081801,0.000059861348,0.00023632514,0.00047829677,0.00015793867,0.9868548,0.000014725891],"about_ca_topic_score_codex":0.7259303,"about_ca_topic_score_gemma":0.89161974,"teacher_disagreement_score":0.27406973,"about_ca_system_score_codex":0.0118860565,"about_ca_system_score_gemma":0.027884606,"threshold_uncertainty_score":0.5513675},"labels":[],"label_agreement":null},{"id":"W4241423121","doi":"10.1139/cjc-78-2-270","title":"A new short synthetic approach to chlorocyclopentenones related to cryptosporiopsin via a ring expansion strategy: first synthesis of a fungitoxic metabolite from &lt;i&gt;Sporormia affinis&lt;/i&gt;","year":2000,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chemistry; Cycloaddition; Stereochemistry; Cyclopentene; Metabolite; Ring (chemistry); Yield (engineering); Total synthesis; Organic chemistry; Catalysis","score_opus":0.011170288474983213,"score_gpt":0.23545235474117987,"score_spread":0.22428206626619665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241423121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8685154,0.008633333,0.089436375,0.0006179855,0.0005016643,0.00088822877,0.0014941742,0.0005638551,0.029349068],"genre_scores_gemma":[0.9477669,0.005305081,0.03831948,0.00017091408,0.00006111905,0.00018167529,0.0007968136,0.00003928217,0.0073588397],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999244,0.000009658322,0.000008946076,0.000018893528,0.000014163991,0.00002390827],"domain_scores_gemma":[0.99993813,0.00000821333,0.000013018529,0.000009084447,0.000010355912,0.000021172753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011732185,0.0005329407,0.00023137515,0.00019873354,0.00018602364,0.00015238542,0.00030126274,0.0002778611,0.0019589085],"category_scores_gemma":[0.00009186643,0.00013983154,0.0002471676,0.00018402078,0.00018442654,0.0002794421,0.00030594744,0.00053188746,0.00056730566],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011895065,0.000084251435,0.00013499729,0.00020404148,0.000011501115,0.00046482985,0.00006794897,0.0004174169,0.9820223,0.0008056375,0.00022014667,0.015448073],"study_design_scores_gemma":[0.00007208215,0.0020694942,0.0012502067,0.000013128662,0.000028076194,0.0011512925,0.000052146792,0.00038477505,0.9764797,0.00024244766,0.018234665,0.000022056707],"about_ca_topic_score_codex":0.00044236518,"about_ca_topic_score_gemma":0.0011933885,"teacher_disagreement_score":0.0019589085,"about_ca_system_score_codex":0.0002290328,"about_ca_system_score_gemma":0.0005307412,"threshold_uncertainty_score":0.006553173},"labels":[],"label_agreement":null},{"id":"W4241484909","doi":"10.1200/jco.2004.22.14_suppl.6145","title":"Venous thrombosis in breast cancer patients receiving tamoxifen and/or chemotherapy: A systematic review","year":2004,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Tamoxifen; Breast cancer; Chemotherapy; Venous thrombosis; Oncology; Cancer; Internal medicine; Venous thromboembolism; Thrombosis","score_opus":0.18865759497152587,"score_gpt":0.5531279521266581,"score_spread":0.3644703571551322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241484909","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038764938,0.9949411,0.00007517581,0.00018102993,0.00006469217,0.00026082984,0.00036995002,0.000004783483,0.00022588208],"genre_scores_gemma":[0.040587056,0.95734555,0.0004148058,0.00049080234,0.000094842784,0.0005673247,0.00038251674,0.0000035157202,0.000113725524],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9926044,0.002337281,0.0032717397,0.0004736371,0.0010936545,0.0002192386],"domain_scores_gemma":[0.97343737,0.018378487,0.005767716,0.00029470003,0.0018439248,0.00027791408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00512519,0.0010194445,0.0066714464,0.009740689,0.0006105373,0.0019419397,0.0013833118,0.0017681909,0.0035705483],"category_scores_gemma":[0.0251353,0.00084067625,0.0056156227,0.0118751675,0.00076799316,0.0018539486,0.0011555711,0.00075888337,0.00022920273],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032076729,0.00001860348,0.003294129,0.9617433,0.011105563,0.00026053583,0.00022743485,0.000057885674,0.00014261504,0.000084571024,0.0009979771,0.021746567],"study_design_scores_gemma":[0.000467151,0.0003635699,0.015012273,0.8668095,0.1049007,0.0010475033,0.00047356752,0.000097581586,0.00017781278,0.00016423852,0.010444236,0.00004185752],"about_ca_topic_score_codex":0.0069371467,"about_ca_topic_score_gemma":0.022657298,"teacher_disagreement_score":0.009740689,"about_ca_system_score_codex":0.00291934,"about_ca_system_score_gemma":0.0072764563,"threshold_uncertainty_score":0.027104974},"labels":[],"label_agreement":null},{"id":"W4241592018","doi":"10.1007/978-3-642-27833-4_5236-1","title":"Suboxic","year":2014,"lang":"en","type":"book-chapter","venue":"Encyclopedia of Astrobiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Geology","score_opus":0.011430834373929666,"score_gpt":0.2654768365959707,"score_spread":0.25404600222204105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241592018","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02692334,0.024378562,0.015552583,0.002343931,0.0032781821,0.0002000797,0.0017928308,0.0013125496,0.92421794],"genre_scores_gemma":[0.10344741,0.022980263,0.006198575,0.0028292101,0.00074326235,0.0001630746,0.0018397613,0.00027447482,0.861524],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998617,0.000010849135,0.0000060800176,0.00003208545,0.00006656818,0.00002278632],"domain_scores_gemma":[0.9999361,0.0000066843854,0.000010362244,0.000012738292,0.00002148809,0.000012587774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012918857,0.0007440946,0.00027530378,0.00065620523,0.0005457462,0.00088875665,0.0005478977,0.0005381341,0.052925408],"category_scores_gemma":[0.00021015805,0.00013818147,0.00028359634,0.00042590045,0.00056506717,0.0008277316,0.0010068954,0.001269564,0.016795589],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006438651,0.0004123258,0.00095402834,0.0019561425,0.000046785215,0.0012365099,0.0005666869,0.0006115344,0.27867785,0.13738802,0.13022536,0.44728088],"study_design_scores_gemma":[0.000014601666,0.00024017377,0.0010867297,0.00016685927,0.000022510347,0.0012940931,0.0001312752,0.00012862173,0.052604504,0.012814425,0.9314829,0.000013301905],"about_ca_topic_score_codex":0.0009117146,"about_ca_topic_score_gemma":0.0014740616,"teacher_disagreement_score":0.052925408,"about_ca_system_score_codex":0.00043339696,"about_ca_system_score_gemma":0.00059886684,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4241933606","doi":"10.26434/chemrxiv.14195207","title":"Strategy for Lead Identification for Understudied Kinases","year":2021,"lang":"en","type":"preprint","venue":"ChemRxiv","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novartis Pharma; Genentech; National Institutes of Health; Ministero dello Sviluppo Economico; Genome Canada; Fundação de Amparo à Pesquisa do Estado de São Paulo; Ontario Ministry of Economic Development and Innovation; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Gillings School of Public Health; North Carolina Biotechnology Center; Pfizer","keywords":"Kinase; Function (biology); Protein-Serine-Threonine Kinases; Pyrimidine; Identification (biology); Computational biology; Cancer research; Biology; Cell biology; Chemistry; Biochemistry; Protein kinase A; Botany","score_opus":0.18260391781741228,"score_gpt":0.42329379374983117,"score_spread":0.2406898759324189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241933606","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10568777,0.01696782,0.76997155,0.007840874,0.0029569145,0.0029349038,0.0057631307,0.008177362,0.07969964],"genre_scores_gemma":[0.5064228,0.021092854,0.37863606,0.0064572315,0.0005478885,0.0029140045,0.0052962573,0.0018725459,0.07676037],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99932635,0.0001044235,0.000043056298,0.0001533773,0.0002739171,0.000098995246],"domain_scores_gemma":[0.99955946,0.00008430516,0.000049427676,0.0001415185,0.000104322135,0.00006083704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011627831,0.00087874715,0.00094841706,0.0007670475,0.00067992066,0.001402489,0.0009954675,0.000883292,0.012167734],"category_scores_gemma":[0.0012456357,0.00051994924,0.0005763565,0.0006608989,0.000672281,0.001140407,0.0015951305,0.0030844326,0.007966862],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010177363,0.0004678275,0.0005710829,0.0016066366,0.00016242989,0.0011340046,0.00046211618,0.005725815,0.67799133,0.06429647,0.047987673,0.19857682],"study_design_scores_gemma":[0.00032613846,0.0011119773,0.00031005114,0.00012457908,0.00009492474,0.0012580925,0.000131024,0.012001962,0.65478504,0.01893713,0.31082115,0.00009801683],"about_ca_topic_score_codex":0.0004225099,"about_ca_topic_score_gemma":0.00121679,"teacher_disagreement_score":0.012167734,"about_ca_system_score_codex":0.00068051287,"about_ca_system_score_gemma":0.001120719,"threshold_uncertainty_score":0.040705085},"labels":[],"label_agreement":null},{"id":"W4241951868","doi":"10.1200/jco.2013.31.26_suppl.155","title":"Patient-reported physical, emotional, and social functioning in advanced breast cancer: Insights from BOLERO-2.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Cambridge Memorial Hospital","funders":"","keywords":"Medicine; Exemestane; Discontinuation; Quality of life (healthcare); Breast cancer; Internal medicine; Adverse effect; Clinical endpoint; Cancer; Oncology; Randomized controlled trial; Physical therapy; Tamoxifen","score_opus":0.07385496028442555,"score_gpt":0.44321140298550005,"score_spread":0.3693564427010745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241951868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9485352,0.035474285,0.00021307386,0.0009258817,0.000045243938,0.0002891,0.0070404387,0.000015810212,0.007460966],"genre_scores_gemma":[0.97978896,0.008905234,0.0011298032,0.0007192861,0.00009480946,0.00044442806,0.007413962,0.000010977462,0.0014925064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994349,0.0002624235,0.00004406314,0.000060957915,0.0001385553,0.000059006477],"domain_scores_gemma":[0.99935895,0.00018895895,0.0002732865,0.0000249843,0.000072995375,0.0000807754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023548175,0.00031374444,0.00052356254,0.0007687609,0.00020670432,0.0005745958,0.00039179315,0.00029401798,0.0014004717],"category_scores_gemma":[0.0019616839,0.00013174379,0.00057361467,0.0007283766,0.00016067385,0.00022106472,0.00059173035,0.00043025636,0.00026763615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009029076,0.0019263563,0.8605473,0.0011834697,0.0009510997,0.00023509443,0.0008662004,0.00049169065,0.0015661239,0.00014353747,0.0048336373,0.11822647],"study_design_scores_gemma":[0.00046150733,0.0011350807,0.9928773,0.00016596892,0.00017345884,0.00024500722,0.00012630633,0.00014812346,0.00009915996,0.000050420127,0.004503585,0.000014136783],"about_ca_topic_score_codex":0.0040795812,"about_ca_topic_score_gemma":0.009570222,"teacher_disagreement_score":0.0040795812,"about_ca_system_score_codex":0.00087479356,"about_ca_system_score_gemma":0.0003747404,"threshold_uncertainty_score":0.012453616},"labels":[],"label_agreement":null},{"id":"W4242467441","doi":"10.1155/2011/412617","title":"Modeling of cytochrome P450 (Cyt P450, CYP) channels","year":2011,"lang":"en","type":"article","venue":"Spectroscopy An International Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton","funders":"European Regional Development Fund; Université de Moncton","keywords":"Heme; Substrate (aquarium); Cytochrome P450; Chemistry; Hydroxylation; Cytochrome; Stereochemistry; Biophysics; Biological system; Crystallography; Biochemistry; Biology; Enzyme","score_opus":0.0674365193036656,"score_gpt":0.38238389485374724,"score_spread":0.3149473755500816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242467441","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4125571,0.0006612894,0.57006526,0.00055332895,0.00005087716,0.00009456497,0.0007781452,0.0014896916,0.013749778],"genre_scores_gemma":[0.9368941,0.000741829,0.05758235,0.000043832006,0.00001554016,0.00013575058,0.00046831788,0.00013521245,0.0039830734],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9999162,0.000026473263,0.0000035432186,0.000014145812,0.000025270458,0.000014314252],"domain_scores_gemma":[0.99985945,0.00007144895,0.000015636551,0.000011519339,0.000022885728,0.000019010717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020387415,0.00030596263,0.00044595049,0.00023975156,0.0002550745,0.0004997091,0.00055971835,0.000700384,0.0013206111],"category_scores_gemma":[0.0005192202,0.00017718437,0.00058341277,0.00029633997,0.00028786284,0.000523152,0.000307279,0.00036747832,0.00027642818],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010056366,0.000025292977,0.0009609062,0.00006506267,0.000016497803,0.00017549623,0.0000716772,0.96323913,0.014458703,0.014783891,0.00049456325,0.0056081833],"study_design_scores_gemma":[0.000010673086,0.000016281374,0.00014340493,0.000002180787,0.0000033925382,0.00003444933,0.0000106085645,0.99488914,0.0019094227,0.0021275335,0.000848326,0.0000045885417],"about_ca_topic_score_codex":0.0030781166,"about_ca_topic_score_gemma":0.0017781834,"teacher_disagreement_score":0.0030781166,"about_ca_system_score_codex":0.00031651746,"about_ca_system_score_gemma":0.000761664,"threshold_uncertainty_score":0.0061203837},"labels":[],"label_agreement":null},{"id":"W4242714632","doi":"10.2165/00128415-200510380-00004","title":"Canadian Ezetrol label change reflects adverse event reports","year":2005,"lang":"en","type":"article","venue":"Reactions Weekly","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adverse effect; Event (particle physics); Medicine; Pharmacology","score_opus":0.048737922076682594,"score_gpt":0.36131843402236347,"score_spread":0.3125805119456809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242714632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5376749,0.011811033,0.005430393,0.009466986,0.0016881418,0.0029881394,0.025501207,0.001382716,0.40405655],"genre_scores_gemma":[0.9487061,0.002002941,0.005196321,0.0031668153,0.00031540132,0.0003577539,0.00718237,0.0001814714,0.03289089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9885279,0.0020040935,0.00069213496,0.00043065628,0.0076541076,0.00069127965],"domain_scores_gemma":[0.9747796,0.0041481736,0.0049892906,0.0010868971,0.013912966,0.0010830553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003942187,0.00026528642,0.0005101823,0.001590667,0.0010563305,0.0012598959,0.0007204102,0.00051549973,0.009528951],"category_scores_gemma":[0.02037613,0.0001659451,0.0005803439,0.0021519207,0.00051372533,0.00045190146,0.00039047914,0.0013399796,0.0012804484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074175205,0.00065144204,0.47914532,0.0010469841,0.00049737835,0.00060991064,0.0010859749,0.00049450085,0.0065766247,0.0025537577,0.12672997,0.37319058],"study_design_scores_gemma":[0.00037073993,0.00071406265,0.87317383,0.00010853046,0.00024815215,0.00073684537,0.00044472647,0.0006763047,0.003986889,0.00035448573,0.11913659,0.00004878597],"about_ca_topic_score_codex":0.36918864,"about_ca_topic_score_gemma":0.65000296,"teacher_disagreement_score":0.63081133,"about_ca_system_score_codex":0.010352366,"about_ca_system_score_gemma":0.0065946775,"threshold_uncertainty_score":0.7340795},"labels":[],"label_agreement":null},{"id":"W4243125367","doi":"10.3109/14733400410001728456","title":"Phase III study of N, N-Diethyl-2-[4-(Phenylmethyl) Phenoxyl] Ethanamine (BMS-2173801-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA-19","year":2004,"lang":"en","type":"article","venue":"The Women s Oncology Review","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Doxorubicin; Breast cancer; Medicine; Metastatic breast cancer; Cancer; Internal medicine; Oncology; Chemotherapy","score_opus":0.1757692435539034,"score_gpt":0.5063471901154966,"score_spread":0.3305779465615932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243125367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8176389,0.14261666,0.001334399,0.006948743,0.001298209,0.0069968337,0.005402108,0.000253131,0.017511036],"genre_scores_gemma":[0.8808652,0.07789951,0.0036470804,0.006952432,0.00086764735,0.0047055045,0.0049562487,0.00007432753,0.020032028],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996692,0.0001869759,0.000014164238,0.00003946066,0.000042006293,0.000048200152],"domain_scores_gemma":[0.999419,0.0001175451,0.00013783286,0.000023638651,0.00006672705,0.00023526077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013092278,0.00090112607,0.002064128,0.0003081955,0.00044390935,0.00067998254,0.0010282206,0.0015317795,0.004123483],"category_scores_gemma":[0.0010732281,0.00043083276,0.0010212351,0.00047770859,0.00051850925,0.00043832525,0.00023478163,0.0019505565,0.00070995826],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6803095,0.025737243,0.004184774,0.0035653005,0.004207522,0.00029423914,0.00028068814,0.0011986846,0.03196641,0.00066261034,0.033697177,0.21389596],"study_design_scores_gemma":[0.6733353,0.27804968,0.015001182,0.00033196114,0.002709587,0.0004298339,0.00014233206,0.00062867446,0.0040861717,0.0003250627,0.024917576,0.000042518266],"about_ca_topic_score_codex":0.013972583,"about_ca_topic_score_gemma":0.0520656,"teacher_disagreement_score":0.013972583,"about_ca_system_score_codex":0.0016349863,"about_ca_system_score_gemma":0.0036748215,"threshold_uncertainty_score":0.0277825},"labels":[],"label_agreement":null},{"id":"W4243402845","doi":"10.1139/cjm-46-2-143","title":"Is &lt;i&gt;Fusarium culmorum&lt;/i&gt; isotrichodermin-15-hydroxylase different from other fungal species?","year":2000,"lang":"en","type":"article","venue":"Canadian Journal of Microbiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Fusarium culmorum; Fusarium; Biology; Microbiology; Chemistry; Botany","score_opus":0.01703712716056224,"score_gpt":0.2480154688350384,"score_spread":0.23097834167447615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243402845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980409,0.009235913,0.0022533892,0.001533376,0.00014074813,0.000014623959,0.0010338668,0.000097633696,0.0052814167],"genre_scores_gemma":[0.99241793,0.0025803577,0.00073227787,0.00030027094,0.000037527516,0.000004454342,0.0012179911,0.000012626949,0.0026966694],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99983335,0.000010187167,0.00001013567,0.00003829513,0.00003364708,0.000074408],"domain_scores_gemma":[0.99984336,0.000017624481,0.00005643137,0.0000135129385,0.000026375828,0.000042790234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015906259,0.00030023168,0.00046277538,0.00031527877,0.00020622792,0.0006905826,0.0002999213,0.00062164635,0.0010347748],"category_scores_gemma":[0.00022963037,0.00013637051,0.00033395336,0.00030466384,0.00049175863,0.00069457485,0.00013439631,0.0003825887,0.00056349405],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003765827,0.00002790462,0.0060886056,0.00010720065,0.000025989137,0.00046330027,0.000076710014,0.000050946994,0.9800925,0.0008003405,0.0003094936,0.011580431],"study_design_scores_gemma":[0.000052271953,0.00046620058,0.25363463,0.000045869034,0.00014566837,0.0068301596,0.0010138649,0.0006246341,0.7063936,0.0013843424,0.029362237,0.000046454355],"about_ca_topic_score_codex":0.0048829117,"about_ca_topic_score_gemma":0.004067562,"teacher_disagreement_score":0.0048829117,"about_ca_system_score_codex":0.0005365369,"about_ca_system_score_gemma":0.00035714425,"threshold_uncertainty_score":0.009708941},"labels":[],"label_agreement":null},{"id":"W4243585785","doi":"10.1142/9789812701848_0069","title":"SNOLAB","year":2005,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University","funders":"","keywords":"Computer science","score_opus":0.017773306614777152,"score_gpt":0.3532266986803868,"score_spread":0.33545339206560965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243585785","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005562616,0.008954158,0.00400945,0.006628887,0.0033347588,0.0003718027,0.0037266817,0.0037214982,0.9636902],"genre_scores_gemma":[0.007826984,0.0026375367,0.0016151286,0.0015862216,0.00030516245,0.000087738474,0.0027844699,0.00022113201,0.98293567],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995561,0.000040632338,0.000018342624,0.00009915126,0.00022013657,0.000065631546],"domain_scores_gemma":[0.99958545,0.00003460885,0.000029483617,0.000051995667,0.00013568427,0.00016279628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005245781,0.00087742816,0.0006671317,0.0014263509,0.00094854855,0.0014812421,0.0010298471,0.0014920066,0.515867],"category_scores_gemma":[0.0008093478,0.00031443138,0.00054978434,0.0006204702,0.00037914954,0.0006993918,0.0009654712,0.0020117078,0.34647414],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008738104,0.00040442805,0.0005452954,0.00038832126,0.000032491516,0.00043246604,0.000049437356,0.00011967772,0.015258079,0.0076546716,0.43148625,0.5427551],"study_design_scores_gemma":[0.000101916674,0.00012258865,0.00063374086,0.000065452805,0.000016992188,0.00044073522,0.000017154882,0.00010977266,0.0032305887,0.00094203063,0.9943131,0.0000058942137],"about_ca_topic_score_codex":0.0012542647,"about_ca_topic_score_gemma":0.0033553776,"teacher_disagreement_score":0.515867,"about_ca_system_score_codex":0.00073985214,"about_ca_system_score_gemma":0.0017281948,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4243637855","doi":"10.1016/j.annonc.2020.08.518","title":"407P Long-term effect of peripheral sensory neuropathy (PSN) of 3 or 6 months oxaliplatin-based adjuvant chemotherapy for high-risk stage II colon cancer: ACHIEVE-2 as part of the IDEA collaboration","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Foundation Medicine; Sierra Oncology; INCLIVA Instituto de Investigación Sanitaria; European Society for Medical Oncology; BeiGene; Genentech; Les Laboratories Pierre Fabre; FibroGen; Eli Lilly and Company; Servier; Instituto de Salud Carlos III; Amgen","keywords":"Medicine; Oxaliplatin; FOLFOX; Incidence (geometry); Colorectal cancer; Surgery; Stage (stratigraphy); Internal medicine; Cancer; Randomization; Gastroenterology; Randomized controlled trial","score_opus":0.04931255489397637,"score_gpt":0.3929471690141371,"score_spread":0.3436346141201608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243637855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891746,0.0022870048,0.00033393872,0.0014656867,0.0004946688,0.00065127807,0.0014935789,0.00008382774,0.00401552],"genre_scores_gemma":[0.98593163,0.0022167524,0.0014991346,0.0011267924,0.00035150463,0.00086394994,0.0016111198,0.000044308817,0.0063546854],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9995369,0.00025632587,0.000026049196,0.00004296675,0.00004702809,0.00009073777],"domain_scores_gemma":[0.99907863,0.0002127884,0.00015643447,0.0001190907,0.000081108315,0.00035194535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017998369,0.00044284365,0.0011951227,0.00025698144,0.00037434034,0.00085870014,0.00050885737,0.0009065286,0.007469628],"category_scores_gemma":[0.0013263342,0.0001890264,0.0021290367,0.00029643718,0.0004146725,0.00056799554,0.0006855939,0.0019797252,0.0008431423],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7545493,0.029312598,0.005953421,0.00065797823,0.0021974263,0.00013705326,0.00019707852,0.0011052182,0.012098485,0.0006083044,0.0072664283,0.18591663],"study_design_scores_gemma":[0.28169048,0.66822106,0.034034286,0.00017789085,0.001659049,0.00019103714,0.0002065466,0.0007625383,0.0047611375,0.00061926857,0.0076238955,0.00005279377],"about_ca_topic_score_codex":0.0011041525,"about_ca_topic_score_gemma":0.0032881922,"teacher_disagreement_score":0.007469628,"about_ca_system_score_codex":0.0006016157,"about_ca_system_score_gemma":0.0020120265,"threshold_uncertainty_score":0.024988353},"labels":[],"label_agreement":null},{"id":"W4243727353","doi":"10.31857/s0869-56524853374-376","title":"Detection of taxuyunnanin c in suspension cell culture of Taxus canadensis","year":2019,"lang":"en","type":"article","venue":"Доклады Академии наук","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Taxoid; Suspension culture; Taxus; Chemistry; Biomass (ecology); Botany; Suspension (topology); Cell culture; Stereochemistry; Biology; Paclitaxel; Genetics; Ecology","score_opus":0.008737153768554513,"score_gpt":0.26621866271397027,"score_spread":0.25748150894541577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243727353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98800683,0.001961818,0.0048612636,0.000055631634,0.000053535692,0.00008918425,0.0012957664,0.00007956159,0.0035963352],"genre_scores_gemma":[0.9841133,0.0015358565,0.0063665495,0.000054528657,0.000017415032,0.00004407417,0.0026121926,0.000020861498,0.0052352906],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993503,0.0000044364792,0.0000035573837,0.000017027342,0.000026293583,0.00001359515],"domain_scores_gemma":[0.99990976,0.000019114208,0.000014526686,0.000010924192,0.000024397787,0.000021272703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005694939,0.00030121853,0.00020317496,0.00047324222,0.00027037112,0.0002685376,0.00012317322,0.000237195,0.00060143566],"category_scores_gemma":[0.00010932787,0.00006931233,0.0001494594,0.00033903876,0.00016323684,0.00015767454,0.00023065755,0.00036428188,0.00034101648],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015522815,0.0000037569873,0.00040935454,0.000008535624,0.0000017668176,0.000029023679,0.000015488746,0.000009513635,0.9988017,0.00000796938,0.0000056995127,0.0006917236],"study_design_scores_gemma":[0.0000073225647,0.0003650253,0.023067204,0.0000090619815,0.000028757777,0.0004098028,0.00026735335,0.00057971687,0.97094554,0.000052878568,0.0042547863,0.000012573939],"about_ca_topic_score_codex":0.0055789095,"about_ca_topic_score_gemma":0.0067258812,"teacher_disagreement_score":0.0055789095,"about_ca_system_score_codex":0.00016709848,"about_ca_system_score_gemma":0.00025756648,"threshold_uncertainty_score":0.011092842},"labels":[],"label_agreement":null},{"id":"W4243925059","doi":"10.1515/iupac.73.0185","title":"Cycloartenol","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Okanagan College","funders":"","keywords":"Chemistry; Table (database); Food science; Organic chemistry; Product (mathematics); Biochemistry; Computer science; Mathematics; Data mining","score_opus":0.019051045532076073,"score_gpt":0.4618151053569599,"score_spread":0.4427640598248838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243925059","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00074607757,0.0011489056,0.0000939144,0.00012723423,0.000035257654,0.000041711435,0.99602616,0.00018766022,0.0015930572],"genre_scores_gemma":[0.002010294,0.00087627105,0.00030538198,0.00019651953,0.000020860973,0.00016519119,0.9951532,0.00003996849,0.0012324059],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990237,0.0001763493,0.0001601568,0.00033701127,0.00018772681,0.0001150435],"domain_scores_gemma":[0.99864787,0.0004174407,0.00030211036,0.00026655733,0.00024759184,0.00011838172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066475925,0.0013643262,0.001513795,0.0026670964,0.0005079473,0.0020188582,0.0018032719,0.0014427573,0.04603524],"category_scores_gemma":[0.0049114935,0.0003501479,0.0017230657,0.004680039,0.00030409216,0.0009918252,0.0010767304,0.0012993996,0.042484127],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002299013,0.00018894616,0.008387974,0.01206469,0.00054911716,0.00016888426,0.000051173556,0.0012996183,0.001125901,0.0017738265,0.9325325,0.039558474],"study_design_scores_gemma":[0.0010139109,0.00014220201,0.011666142,0.0014752998,0.0003956586,0.0002608998,0.000051220366,0.00047472285,0.0011857318,0.0017112667,0.98157734,0.000045557725],"about_ca_topic_score_codex":0.010220354,"about_ca_topic_score_gemma":0.020699572,"teacher_disagreement_score":0.04603524,"about_ca_system_score_codex":0.0012373368,"about_ca_system_score_gemma":0.002225188,"threshold_uncertainty_score":0.1540032},"labels":[],"label_agreement":null},{"id":"W4244170236","doi":"10.3747//co.19.1041","title":"E-manuscript Article Summaries","year":2012,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Citation; Download; Library science; World Wide Web; Computer science","score_opus":0.20311511197018953,"score_gpt":0.4693588786729594,"score_spread":0.26624376670276984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244170236","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009490625,0.0028380693,0.0036015462,0.02026701,0.13991506,0.0014950897,0.026048634,0.007464328,0.7974212],"genre_scores_gemma":[0.0023487643,0.0013000324,0.0012514939,0.003447791,0.020439204,0.00019680803,0.007138391,0.0015422895,0.9623352],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99755317,0.000372868,0.00026149212,0.00020689618,0.0014002613,0.0002052724],"domain_scores_gemma":[0.9782472,0.0034466642,0.0011028625,0.0014474316,0.012086838,0.0036690002],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0022701242,0.0012694643,0.0010053641,0.003194737,0.0012666453,0.0047164997,0.0014374712,0.0023542852,0.8876704],"category_scores_gemma":[0.023054054,0.0005026569,0.0009576132,0.0019967232,0.0004041629,0.0022036037,0.0022483082,0.0017831543,0.7657197],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025840185,0.000017281765,0.00004201851,0.00007533737,0.00000177815,0.00003133041,0.0000059926724,0.000010296822,0.000057129033,0.00014247182,0.98066,0.018930553],"study_design_scores_gemma":[0.000018036913,0.000020803385,0.00015613108,0.00005774278,0.0000022946936,0.000051303796,0.000020997426,0.00003282187,0.000126427,0.00035576997,0.99915147,0.0000062808654],"about_ca_topic_score_codex":0.00073205575,"about_ca_topic_score_gemma":0.0014738721,"teacher_disagreement_score":0.1123296,"about_ca_system_score_codex":0.0010079402,"about_ca_system_score_gemma":0.0018696329,"threshold_uncertainty_score":0.16022444},"labels":[],"label_agreement":null},{"id":"W4244352323","doi":"10.32920/ryerson.14655858.v1","title":"The Influence Of The Epidermal Growth Factor Receptor On The DNA Damage Response As Examined Through Clathrin Affiliated Signalling Complexes","year":2021,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"","keywords":"Cisplatin; Epidermal growth factor receptor; DNA damage; DNA repair; Cancer research; Context (archaeology); PI3K/AKT/mTOR pathway; Cancer; Cell biology; Signal transduction; Biology; DNA; Medicine; Internal medicine; Chemotherapy; Genetics","score_opus":0.053627716346361945,"score_gpt":0.33384774716136295,"score_spread":0.280220030815001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244352323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98765695,0.003830823,0.0019838638,0.00022937793,0.000057095538,0.000013478511,0.00019049096,0.000034187626,0.0060036643],"genre_scores_gemma":[0.9912149,0.0016600379,0.0010941647,0.000052750558,0.000008392933,0.000008634482,0.00018514937,0.000015357613,0.0057606823],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999324,0.000008149522,0.0000022705983,0.000012422321,0.000021562817,0.00002318649],"domain_scores_gemma":[0.99995244,0.000012627249,0.000007648617,0.0000059215804,0.0000065917775,0.000014856671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011071997,0.00012487751,0.00010552955,0.0000933679,0.00011618338,0.00038013307,0.00013366246,0.00018227656,0.0015403535],"category_scores_gemma":[0.0001162164,0.00009607905,0.00015026679,0.0000681677,0.00022711007,0.00031660558,0.00017779175,0.00038236205,0.00033383878],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018333222,0.000011255034,0.00034052343,0.000051219682,0.0000060470707,0.000106529274,0.000027456581,0.00007211343,0.99674404,0.0005676866,0.000076396034,0.0018133429],"study_design_scores_gemma":[0.00001267333,0.00015135112,0.013769313,0.000011921763,0.000010854039,0.00022067454,0.00007121869,0.0012788855,0.9811483,0.00022714598,0.003089823,0.000007866657],"about_ca_topic_score_codex":0.0011857705,"about_ca_topic_score_gemma":0.0014184025,"teacher_disagreement_score":0.0015403535,"about_ca_system_score_codex":0.00033426422,"about_ca_system_score_gemma":0.00022842237,"threshold_uncertainty_score":0.0051530004},"labels":[],"label_agreement":null},{"id":"W4244525316","doi":"10.21203/rs.2.11805/v2","title":"The efficacy and safety of electro-acupuncture for alleviating chemotherapy-induced peripheral neuropathy in colorectal cancer patients: study protocol for a pilot single-blinded, randomized sham-controlled trial","year":2019,"lang":"en","type":"preprint","venue":"Research Square","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Hospital Authority; Hong Kong Baptist University","keywords":"Chemotherapy-induced peripheral neuropathy; Medicine; Peripheral neuropathy; Acupuncture; Randomized controlled trial; Colorectal cancer; Chemotherapy; Protocol (science); Single blind; Peripheral; Cancer; Internal medicine; Oncology; Physical therapy; Alternative medicine; Pathology","score_opus":0.09526413833963833,"score_gpt":0.4650187963612227,"score_spread":0.36975465802158436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244525316","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016677672,0.00047236457,0.0013284481,0.00021588952,0.00032647347,0.97949255,0.000723994,0.00008912376,0.00067361846],"genre_scores_gemma":[0.015152614,0.00026232438,0.0024527868,0.0003177863,0.00011258323,0.9810466,0.00018409012,0.0000061518526,0.00046503366],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99123526,0.0047219647,0.0011324887,0.00095225516,0.0009556576,0.0010022612],"domain_scores_gemma":[0.9927194,0.0014739829,0.0017465444,0.00091219833,0.0014966581,0.0016512045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016133122,0.0047190767,0.009655929,0.0015845734,0.0026278207,0.002062292,0.0028293247,0.004743135,0.028539747],"category_scores_gemma":[0.01368236,0.0022198723,0.0036696678,0.0016880849,0.0032123837,0.0026261965,0.0012491049,0.0044952976,0.0045473613],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9534676,0.025074663,0.0005165783,0.0048339334,0.000916123,0.000086499414,0.00013258001,0.00053512154,0.0019363543,0.00044640733,0.0019940764,0.010060046],"study_design_scores_gemma":[0.9336851,0.061288055,0.00094074546,0.00027755473,0.00042299344,0.00002074593,0.00003521733,0.00042185557,0.00032317042,0.0003334235,0.0022191869,0.000031992164],"about_ca_topic_score_codex":0.0010307545,"about_ca_topic_score_gemma":0.0024854299,"teacher_disagreement_score":0.028539747,"about_ca_system_score_codex":0.0024945152,"about_ca_system_score_gemma":0.010821561,"threshold_uncertainty_score":0.09547496},"labels":[],"label_agreement":null},{"id":"W4244887701","doi":"10.2307/j.ctv1h0p09w.12","title":"PROFESSEUR DES DEUX ÉCOLES DE MÉDECINE FRANCOPHONES DE MONTRÉAL","year":2019,"lang":"fr","type":"book-chapter","venue":"Presses de l'Université Laval eBooks","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Art","score_opus":0.015884483847986866,"score_gpt":0.24241384290247853,"score_spread":0.22652935905449167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244887701","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12600964,0.066272244,0.001693657,0.15590492,0.0048185564,0.00022325879,0.005563184,0.0005250494,0.63898945],"genre_scores_gemma":[0.11706684,0.0077435593,0.00073717255,0.0023108297,0.0003596557,0.000040083924,0.000375394,0.00006933282,0.8712972],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986243,0.00020239764,0.00002399218,0.00015292395,0.00045668118,0.000539604],"domain_scores_gemma":[0.99793833,0.00021638034,0.000094454415,0.000033750875,0.000407528,0.001309487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010970164,0.00062188227,0.00027964276,0.0017125601,0.0049243513,0.0039879973,0.0006568738,0.0014481464,0.05300245],"category_scores_gemma":[0.0016742504,0.0004836623,0.0002805954,0.0021886076,0.0018956664,0.0007697128,0.0015615975,0.001484967,0.002833684],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026897757,0.000116602976,0.024194354,0.00027981075,0.000051410836,0.0011784006,0.0101499455,0.0007653164,0.0022547822,0.11460345,0.65288454,0.19325238],"study_design_scores_gemma":[0.000017805183,0.000023444034,0.04446475,0.000071121496,0.00000501607,0.00011098341,0.0014571496,0.00010653107,0.00017344269,0.00035340592,0.95319706,0.000019254692],"about_ca_topic_score_codex":0.91704565,"about_ca_topic_score_gemma":0.9740568,"teacher_disagreement_score":0.91704565,"about_ca_system_score_codex":0.03943516,"about_ca_system_score_gemma":0.055391643,"threshold_uncertainty_score":0.28612345},"labels":[],"label_agreement":null},{"id":"W4244999708","doi":"10.1200/jco.2014.32.15_suppl.e17648","title":"A comparative effectiveness analysis of single-agent cytotoxics in triple-negative metastatic breast cancer (TN-MBC) patients.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Internal medicine; Metastatic breast cancer; Oncology; Hazard ratio; Vinorelbine; Gemcitabine; Eribulin; Proportional hazards model; Performance status; Breast cancer; Discontinuation; Capecitabine; Chemotherapy; Surgery; Cancer; Confidence interval; Colorectal cancer","score_opus":0.16355271133825136,"score_gpt":0.5159438887030333,"score_spread":0.352391177364782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244999708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876714,0.009519979,0.0005426656,0.00015267647,0.000049796872,0.0004983044,0.0006250849,0.0000059960125,0.000934196],"genre_scores_gemma":[0.9976376,0.0009852726,0.0005408665,0.00009875938,0.00005153589,0.00016549212,0.00044152467,0.0000020717669,0.000076978744],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9942092,0.0041899555,0.00049164816,0.00036641918,0.000520067,0.0002227786],"domain_scores_gemma":[0.98911613,0.006032881,0.0033072676,0.0003329196,0.00047485964,0.00073588075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008311041,0.0003652648,0.0011647991,0.0012352561,0.0002036348,0.0008070001,0.0005143694,0.000692251,0.0027748991],"category_scores_gemma":[0.013088038,0.0001887674,0.0030611951,0.0010185393,0.00050119986,0.00076034816,0.000574941,0.0006135713,0.00015363329],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.55502784,0.005358004,0.26635095,0.0034368327,0.025907088,0.00033914563,0.00029582076,0.0069740107,0.0029227247,0.0011135843,0.0012328135,0.13104112],"study_design_scores_gemma":[0.09953743,0.3946275,0.4464885,0.00071548735,0.032535523,0.0011454683,0.0008269609,0.013362536,0.003032728,0.001299066,0.006300791,0.00012794859],"about_ca_topic_score_codex":0.0007862628,"about_ca_topic_score_gemma":0.0012331664,"teacher_disagreement_score":0.008311041,"about_ca_system_score_codex":0.0016514474,"about_ca_system_score_gemma":0.0007555086,"threshold_uncertainty_score":0.043953538},"labels":[],"label_agreement":null},{"id":"W4245447381","doi":"10.1200/jco.2012.30.18_suppl.lba1000","title":"NSABP B-38: Definitive analysis of a randomized adjuvant trial comparing dose-dense (DD) AC→paclitaxel (P) plus gemcitabine (G) with DD AC→P and with docetaxel, doxorubicin, and cyclophosphamide (TAC) in women with operable, node-positive breast cancer.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Docetaxel; Internal medicine; Cyclophosphamide; Gastroenterology; Breast cancer; Gemcitabine; Adjuvant; Paclitaxel; Urology; Cancer; Chemotherapy","score_opus":0.05828094261182096,"score_gpt":0.4145853904945108,"score_spread":0.3563044478826899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245447381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98202616,0.0066244164,0.00056126376,0.0017563514,0.00050212996,0.003644449,0.0020697936,0.0000940412,0.0027214836],"genre_scores_gemma":[0.9839505,0.0027068935,0.0019525025,0.0013657117,0.00034588212,0.0034415075,0.002411435,0.000024878755,0.003800716],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983041,0.0012779058,0.00007568645,0.00014373384,0.0000840847,0.000114389106],"domain_scores_gemma":[0.9976331,0.00066738453,0.00057286123,0.00017645098,0.00008963847,0.00086047157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039263745,0.001952966,0.0024460603,0.00047794633,0.00039419418,0.000976971,0.0012503642,0.0015586629,0.009119896],"category_scores_gemma":[0.0040063374,0.00077183545,0.0019549783,0.0004433336,0.0012878856,0.0011416794,0.00062961306,0.003259508,0.0012747955],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98563504,0.001899273,0.00056060596,0.00030604546,0.0007090905,0.000030259578,0.000031451567,0.0003538447,0.000978733,0.00007244662,0.0005831999,0.0088399695],"study_design_scores_gemma":[0.9483974,0.046598893,0.002139724,0.000051581956,0.00076512364,0.00004815754,0.00002639314,0.00035835325,0.00025128934,0.000247339,0.0011026342,0.000013017196],"about_ca_topic_score_codex":0.0016090774,"about_ca_topic_score_gemma":0.004839493,"teacher_disagreement_score":0.009119896,"about_ca_system_score_codex":0.0014146098,"about_ca_system_score_gemma":0.0018362402,"threshold_uncertainty_score":0.030509114},"labels":[],"label_agreement":null},{"id":"W4245795169","doi":"10.1515/iupac.87.0463","title":"Neurotoxin","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Chemical nomenclature; Relation (database); Computer science; Chemistry; Linguistics; Philosophy; Organic chemistry; Data mining","score_opus":0.022210281135016125,"score_gpt":0.4695049975641064,"score_spread":0.4472947164290903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245795169","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017444171,0.000344429,0.00009919446,0.00009431366,0.00003854917,0.000022590983,0.99750286,0.0001409808,0.0015827105],"genre_scores_gemma":[0.0005119684,0.00037496776,0.00042352086,0.00015539906,0.0000110469,0.00007956895,0.9971973,0.000039596063,0.0012066592],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985551,0.00020306316,0.0003722106,0.00037730558,0.00035101298,0.00014122309],"domain_scores_gemma":[0.9965976,0.000817066,0.0006312295,0.00068686635,0.0010511104,0.00021623536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011983584,0.0013066087,0.0013510609,0.0038936166,0.00070793036,0.0024127925,0.0019202543,0.0015056868,0.065486625],"category_scores_gemma":[0.0075826007,0.0005497309,0.0016399053,0.006318133,0.00035095867,0.0014896806,0.0017655267,0.0019809927,0.064367965],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002713226,0.000032182572,0.003974739,0.004394058,0.00011493399,0.00006165806,0.00003816144,0.0003603935,0.00035701098,0.0015452886,0.97494966,0.013900748],"study_design_scores_gemma":[0.0001925094,0.00002562612,0.0071948,0.0010090774,0.00006896647,0.0001398495,0.000042448144,0.00014888337,0.00029310933,0.0011020227,0.98976177,0.000020937083],"about_ca_topic_score_codex":0.016283013,"about_ca_topic_score_gemma":0.02980027,"teacher_disagreement_score":0.065486625,"about_ca_system_score_codex":0.0018963694,"about_ca_system_score_gemma":0.0033097018,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4245921256","doi":"10.1016/s0985-0562(11)70059-0","title":"O55 Impact des thérapies ciblées en cancérologie sur la masse musculaire et le tissu adipeux","year":2011,"lang":"fr","type":"article","venue":"Nutrition Clinique et Métabolisme","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Descriptive statistics; Statistics; Humanities; Medicine; Mathematics; Philosophy","score_opus":0.07568821206725736,"score_gpt":0.4081656790115094,"score_spread":0.33247746694425206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245921256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55294895,0.38941315,0.00096246216,0.0080918195,0.002564892,0.00019913258,0.0017020454,0.000063727224,0.04405388],"genre_scores_gemma":[0.8388481,0.12523995,0.0018865938,0.003220015,0.0012716813,0.00013174822,0.0014783181,0.000029497063,0.027894009],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99953485,0.00017201963,0.0000352803,0.000055910226,0.00011013561,0.000091913076],"domain_scores_gemma":[0.99926907,0.0003742419,0.000099521174,0.000036397483,0.0001102466,0.00011059136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009826504,0.00038641505,0.0008017409,0.00043399085,0.0003544541,0.0013926798,0.00025553553,0.00068189105,0.011631596],"category_scores_gemma":[0.0012972325,0.000121554294,0.0009912777,0.000523593,0.00056445465,0.00042755523,0.0003346992,0.0010030776,0.0013139498],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06335262,0.003916544,0.026368517,0.0040107453,0.002158645,0.00062806014,0.00032510082,0.0019783638,0.11795483,0.0043172576,0.009396169,0.7655932],"study_design_scores_gemma":[0.012010015,0.13206741,0.31908602,0.003385013,0.007053674,0.001914621,0.0018587377,0.001812539,0.13316512,0.0029050687,0.38459495,0.00014684367],"about_ca_topic_score_codex":0.004234908,"about_ca_topic_score_gemma":0.006656699,"teacher_disagreement_score":0.011631596,"about_ca_system_score_codex":0.0006413458,"about_ca_system_score_gemma":0.0011002403,"threshold_uncertainty_score":0.03891158},"labels":[],"label_agreement":null},{"id":"W4246008022","doi":"10.1200/jco.2004.22.14_suppl.773","title":"Palliative chemotherapy with vinorelbine or capecitabine in women with anthracycline and taxane refractory metastatic breast cancer","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Vinorelbine; Capecitabine; Medicine; Anthracycline; Taxane; Metastatic breast cancer; Internal medicine; Oncology; Breast cancer; Chemotherapy; Cancer; Colorectal cancer","score_opus":0.07887157768887255,"score_gpt":0.4760803488222091,"score_spread":0.3972087711333366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246008022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782723,0.0015354478,0.000065815424,0.0000616202,0.0000061167175,0.000017040538,0.000078210396,0.0000019370184,0.00040655702],"genre_scores_gemma":[0.99885535,0.00073691923,0.00011019454,0.00004970302,0.000016368402,0.000012727777,0.00014307736,7.3627285e-7,0.000075023134],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99983704,0.000057039768,0.00002054556,0.000024400642,0.00003303284,0.000027986494],"domain_scores_gemma":[0.9994271,0.00018625442,0.0002514491,0.000015822943,0.00002539277,0.00009403486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003071267,0.000084389765,0.00027934194,0.00025937133,0.00025542348,0.00021006167,0.0001248418,0.0002176986,0.00089502527],"category_scores_gemma":[0.0017142262,0.00010880537,0.00021016464,0.0004005578,0.00021450718,0.00015174814,0.00016803828,0.00018191923,0.00012882998],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018775575,0.000108733315,0.9768876,0.00012068379,0.00005349594,0.0031500694,0.00020321363,0.0001904869,0.001546784,0.000030267349,0.00031743106,0.015513725],"study_design_scores_gemma":[0.00021803933,0.0036673348,0.97845334,0.00007924934,0.0001211942,0.013833371,0.00036585404,0.00048096472,0.0007529699,0.000099685836,0.0019183712,0.000009554132],"about_ca_topic_score_codex":0.0011590509,"about_ca_topic_score_gemma":0.0031417843,"teacher_disagreement_score":0.0011590509,"about_ca_system_score_codex":0.00037148266,"about_ca_system_score_gemma":0.00034959553,"threshold_uncertainty_score":0.0029941797},"labels":[],"label_agreement":null},{"id":"W4246038120","doi":"10.1007/978-0-387-39940-9_4091","title":"XPDL","year":2009,"lang":"en","type":"book-chapter","venue":"Encyclopedia of Database Systems","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Computer science","score_opus":0.02360826194090945,"score_gpt":0.2925866381306791,"score_spread":0.26897837618976966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246038120","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017002887,0.0010809682,0.4234104,0.0011113285,0.0006801196,0.0005544459,0.03884135,0.28024048,0.25238067],"genre_scores_gemma":[0.012233138,0.0023940806,0.20031661,0.0017263825,0.0001739089,0.000619289,0.12623824,0.05986386,0.5964345],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99865603,0.00015387828,0.00018974124,0.0002584128,0.00063244975,0.00010942116],"domain_scores_gemma":[0.99824286,0.00039812972,0.000059627007,0.0007201141,0.00048645545,0.000092861344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012142388,0.0016658844,0.00089397404,0.0022376955,0.0006696351,0.005543318,0.0037945835,0.0012391089,0.2185924],"category_scores_gemma":[0.0042896536,0.0013711101,0.0011662602,0.002347467,0.00046216347,0.0052144337,0.0031834305,0.0026771163,0.27986762],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120925724,0.00011330879,0.00035255568,0.0006575128,0.000027841761,0.00012941666,0.00017027145,0.00088673964,0.0034119226,0.029468851,0.57588506,0.3887756],"study_design_scores_gemma":[0.00003134131,0.000016468259,0.00018658626,0.00012283979,0.00001461451,0.00021667164,0.000038758677,0.0024145425,0.006153355,0.008907736,0.9818726,0.000024489827],"about_ca_topic_score_codex":0.0030973505,"about_ca_topic_score_gemma":0.002743713,"teacher_disagreement_score":0.2185924,"about_ca_system_score_codex":0.00085934065,"about_ca_system_score_gemma":0.0014218396,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4246797495","doi":"10.1016/j.annonc.2020.10.024","title":"3MO IMpassion031: Results from a phase III study of neoadjuvant (neoadj) atezolizumab + chemo in early triple-negative breast cancer (TNBC)","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"EMD Serono; Samsung; Genentech; PharmaMar; Chugai Pharmaceutical; Vifor Pharma; Astellas Pharma; Eisai; Bayer HealthCare; G1 Therapeutics; Silverback Therapeutics; OncoSec Medical; Mersana Therapeutics; Amgen; Radius Health; Syndax Pharmaceuticals; Queen Mary University of London; Clovis Oncology; Daiichi Sankyo Europe; Servier; Calithera Biosciences; Mylan; MacroGenics; Celldex Therapeutics; Teva Pharmaceutical Industries; Les Laboratories Pierre Fabre; F. Hoffmann-La Roche; Ariad Pharmaceuticals; Exelixis; Sanofi; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company; Baxalta; Flatiron Health; Genomic Health; GlaxoSmithKline","keywords":"Medicine; Atezolizumab; Taxane; Internal medicine; Clinical endpoint; Anthracycline; Breast cancer; Cyclophosphamide; Triple-negative breast cancer; Oncology; Placebo; Phases of clinical research; Neoadjuvant therapy; Gastroenterology; Chemotherapy; Surgery; Cancer; Randomized controlled trial; Pathology; Immunotherapy; Nivolumab","score_opus":0.11921368673131624,"score_gpt":0.4494909992734035,"score_spread":0.33027731254208725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246797495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98322856,0.004619055,0.0008747187,0.0013742084,0.00027902206,0.0014567297,0.0036047327,0.00023673521,0.004326178],"genre_scores_gemma":[0.9683511,0.0046020886,0.0033094427,0.003106339,0.00034586986,0.0020735317,0.010567763,0.0001715202,0.007472318],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996387,0.00015291575,0.000015239868,0.00005743135,0.000033260847,0.0001024645],"domain_scores_gemma":[0.9993411,0.00011305143,0.00008099487,0.00006283025,0.00003725993,0.00036471928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013418146,0.0010534589,0.0015543901,0.0003347059,0.00041761188,0.0011982808,0.0010610356,0.0012559055,0.0050180517],"category_scores_gemma":[0.00076791266,0.000438938,0.001751943,0.00037966785,0.0007574683,0.00083737075,0.00045147975,0.0035830885,0.0014348973],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5907012,0.06682761,0.013011702,0.0012701162,0.0024990744,0.00031989327,0.00032358628,0.0032781383,0.06874449,0.00042036705,0.012021509,0.24058238],"study_design_scores_gemma":[0.40140948,0.53925,0.03337245,0.00012293858,0.002028541,0.0006854453,0.00016043746,0.0018651751,0.008726798,0.00042694868,0.011880618,0.000071115915],"about_ca_topic_score_codex":0.0013161559,"about_ca_topic_score_gemma":0.0059652263,"teacher_disagreement_score":0.0050180517,"about_ca_system_score_codex":0.0007166598,"about_ca_system_score_gemma":0.0013741506,"threshold_uncertainty_score":0.016787052},"labels":[],"label_agreement":null},{"id":"W4246866429","doi":"10.1371/annotation/4a6a7d2c-e898-481c-b1e1-f6f1ad7fc6e2","title":"Correction: The Physical Interaction of Myoblasts with the Microenvironment during Remodeling of the Cytoarchitecture","year":2013,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Fonds Québécois de la Recherche sur la Nature et les Technologies; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs","keywords":"Cytoarchitecture; Myocyte; Cell biology; Biology; Neuroscience; Computational biology","score_opus":0.01744442296971446,"score_gpt":0.23430797532081385,"score_spread":0.2168635523510994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246866429","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00078869023,0.0018653802,0.0013903285,0.025465218,0.9651747,0.000056307472,0.0014316749,0.00062028517,0.00320748],"genre_scores_gemma":[0.054876413,0.012493585,0.007973148,0.040940363,0.6475087,0.00045682825,0.0052901963,0.00254182,0.22791904],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963175,0.00051510637,0.0006920451,0.0006272504,0.0014508329,0.0003972341],"domain_scores_gemma":[0.98080975,0.003250877,0.0012108431,0.0011300246,0.012320025,0.0012785045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027456642,0.0020800577,0.001651272,0.003657837,0.0017933693,0.0025956328,0.0029644407,0.004311344,0.08267232],"category_scores_gemma":[0.038122457,0.00066554913,0.0015164915,0.0016232552,0.0017997083,0.0020591863,0.0018039665,0.005748306,0.029428918],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014229583,0.000013614262,0.00035844304,0.0008079002,0.00004591414,0.00093300355,0.000075500495,0.00009359984,0.00047127253,0.0009977254,0.9782361,0.017824687],"study_design_scores_gemma":[0.00005998383,0.00006038054,0.0022887082,0.0005836848,0.000075058626,0.0026620405,0.00016131463,0.0005135357,0.0013192473,0.0013310476,0.99088,0.00006489653],"about_ca_topic_score_codex":0.0064427285,"about_ca_topic_score_gemma":0.0054481225,"teacher_disagreement_score":0.08267232,"about_ca_system_score_codex":0.00258058,"about_ca_system_score_gemma":0.0034404607,"threshold_uncertainty_score":0.2765665},"labels":[],"label_agreement":null},{"id":"W4246954367","doi":"10.1515/iupac.84.1027","title":"Phytohemagglutinin (PHA)","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Immunotoxicology; Immunology; Medicine; Immune system; Philosophy; Linguistics","score_opus":0.022622351271312638,"score_gpt":0.4702252628590205,"score_spread":0.4476029115877079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246954367","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012750934,0.00017914292,0.000055523262,0.000066696004,0.000018716195,0.000016154216,0.99877006,0.000106509484,0.0006597573],"genre_scores_gemma":[0.00043819702,0.00024058089,0.00028534996,0.00011312431,0.000008001189,0.00009642284,0.99811316,0.000032047974,0.0006731537],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981279,0.0003631283,0.0004865451,0.00049617275,0.00035930352,0.00016695689],"domain_scores_gemma":[0.99478096,0.0018377568,0.0009859758,0.0010281723,0.0010314462,0.00033563402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016184788,0.0014595712,0.0015015362,0.0038826393,0.00065369345,0.0025792562,0.0023483157,0.001752491,0.05606956],"category_scores_gemma":[0.011416509,0.0006129818,0.0016267542,0.0072934157,0.00038228135,0.0014545808,0.001602929,0.002123239,0.055518776],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035458285,0.000045268418,0.0026972813,0.0039754673,0.000117160635,0.00004446861,0.000024141635,0.00037157594,0.000256938,0.00078231026,0.98384154,0.0074892403],"study_design_scores_gemma":[0.00044483293,0.000040710824,0.008206311,0.0011803198,0.000094907955,0.00012577184,0.00005195674,0.00025441064,0.00045961858,0.0012766123,0.9878313,0.000033129938],"about_ca_topic_score_codex":0.01628173,"about_ca_topic_score_gemma":0.025406597,"teacher_disagreement_score":0.05606956,"about_ca_system_score_codex":0.0018471404,"about_ca_system_score_gemma":0.003136061,"threshold_uncertainty_score":0.18757135},"labels":[],"label_agreement":null},{"id":"W4247460059","doi":"10.1186/isrctn83324925","title":"A Randomised Comparative Trial of Infusional ECF versus Conventional FEC as Adjuvant Chemotherapy in Patients with Poor Prognosis Breast Cancer","year":2013,"lang":"en","type":"dataset","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research","keywords":"Medicine; Oncology; Adjuvant; Chemotherapy; Breast cancer; Internal medicine; Adjuvant chemotherapy; Randomized controlled trial; Cancer","score_opus":0.027790521497617196,"score_gpt":0.3443023051578943,"score_spread":0.3165117836602771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247460059","genre_codex":"empirical","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5536287,0.032158054,0.004168925,0.0064431382,0.0019223572,0.01842843,0.3638588,0.00062257354,0.018769026],"genre_scores_gemma":[0.78264475,0.0109587675,0.006001288,0.0053265784,0.0006259858,0.025195638,0.15052629,0.0001832739,0.018537506],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99827147,0.0011506013,0.00014557487,0.00020650898,0.00010776709,0.000118026925],"domain_scores_gemma":[0.9978277,0.00081415346,0.0006236214,0.0002762976,0.000165846,0.00029239783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025565445,0.0013418116,0.003210848,0.0005155113,0.00036478092,0.0008231602,0.0018182141,0.0014244838,0.022591181],"category_scores_gemma":[0.0057818554,0.0004988106,0.0034804428,0.0009245279,0.00062715367,0.00088325667,0.00086511666,0.0020544669,0.002201294],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9519519,0.0013711243,0.00224329,0.0036271978,0.0059132357,0.000070768954,0.000030168412,0.0010825106,0.00060578296,0.00030076707,0.0209752,0.011828197],"study_design_scores_gemma":[0.97076786,0.0067884806,0.00695445,0.00037955763,0.0046806,0.00007597004,0.00003725084,0.0006358935,0.00016953835,0.0005197709,0.008959218,0.000031395168],"about_ca_topic_score_codex":0.004705515,"about_ca_topic_score_gemma":0.010882046,"teacher_disagreement_score":0.022591181,"about_ca_system_score_codex":0.0018333958,"about_ca_system_score_gemma":0.0022259515,"threshold_uncertainty_score":0.075574994},"labels":[],"label_agreement":null},{"id":"W4247634389","doi":"10.1016/j.jcjd.2013.07.028","title":"Neuropathie","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology; Medical screening","score_opus":0.013318773781377139,"score_gpt":0.2442167782382103,"score_spread":0.23089800445683317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247634389","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014556676,0.043905288,0.010007649,0.01224166,0.011163769,0.0002724867,0.00681401,0.004313852,0.8967246],"genre_scores_gemma":[0.072160885,0.03501416,0.011676311,0.0082918815,0.0024665939,0.00033335478,0.0043774326,0.0014691096,0.8642103],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994898,0.000059111724,0.00003397266,0.0001255026,0.00016185733,0.00012981934],"domain_scores_gemma":[0.9995152,0.000060978975,0.000038369533,0.00009713488,0.00019387194,0.00009449554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049999595,0.0017978462,0.00074696273,0.0031784019,0.002463621,0.0027260454,0.000908768,0.0015516763,0.25089273],"category_scores_gemma":[0.0018271252,0.00047317165,0.000959049,0.0016768044,0.0010104202,0.0012345514,0.0026384564,0.0038216398,0.14722045],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005893684,0.00012904953,0.0023582382,0.0008884917,0.000119684024,0.01025804,0.00044439855,0.00060246343,0.0075094174,0.027766624,0.33531883,0.6140154],"study_design_scores_gemma":[0.0000360506,0.00006346173,0.0021049718,0.0004677142,0.000052982257,0.014980786,0.0002574717,0.00018554083,0.0018762994,0.005265927,0.97468364,0.00002510591],"about_ca_topic_score_codex":0.010815704,"about_ca_topic_score_gemma":0.013813859,"teacher_disagreement_score":0.25089273,"about_ca_system_score_codex":0.002035613,"about_ca_system_score_gemma":0.0019095006,"threshold_uncertainty_score":0.8393198},"labels":[],"label_agreement":null},{"id":"W4247765498","doi":"10.1200/jco.2017.35.15_suppl.tps1107","title":"A randomized, double-blinded, controlled study of tucatinib (ONT-380) vs. placebo in combination with capecitabine (C) and trastuzumab (Tz) in patients with pretreated HER2+ unresectable locally advanced or metastatic breast carcinoma (mBC) (HER2CLIMB).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Capecitabine; Internal medicine; Rash; Taxane; Oncology; Placebo; Adverse effect; Trastuzumab; Pertuzumab; Population; Gastroenterology; Cancer; Breast cancer; Colorectal cancer; Pathology","score_opus":0.07203960633910661,"score_gpt":0.4295408083241917,"score_spread":0.3575012019850851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247765498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736168,0.0061356644,0.0012858954,0.0006417979,0.0014123074,0.012644904,0.0014729042,0.00020685248,0.0025829305],"genre_scores_gemma":[0.9780694,0.0026869217,0.002130807,0.0011788708,0.0007594243,0.011040689,0.0008431247,0.00002853927,0.0032622602],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99877316,0.00066822773,0.00008454589,0.00024936115,0.00008169593,0.00014298441],"domain_scores_gemma":[0.9984226,0.00051238196,0.00034198107,0.00013374443,0.0001453278,0.00044393988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027690793,0.0019138076,0.004668288,0.00057559204,0.00061538274,0.0011144897,0.0012071714,0.0023158388,0.0069000763],"category_scores_gemma":[0.0026942613,0.0008883435,0.0017876831,0.000579269,0.001617442,0.0012855944,0.00043987733,0.0032095232,0.0012316217],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98770916,0.005888573,0.00014989906,0.0003370555,0.00036977782,0.000014567471,0.00002161695,0.000075371245,0.0009905035,0.000032115517,0.00021201378,0.004199329],"study_design_scores_gemma":[0.9323995,0.06609486,0.0005821405,0.000016582952,0.00026162082,0.000010983054,0.000010133939,0.00018535089,0.00013964079,0.00005127705,0.0002398063,0.000008080537],"about_ca_topic_score_codex":0.0011457338,"about_ca_topic_score_gemma":0.0023249106,"teacher_disagreement_score":0.0069000763,"about_ca_system_score_codex":0.00089010794,"about_ca_system_score_gemma":0.0015768381,"threshold_uncertainty_score":0.023083031},"labels":[],"label_agreement":null},{"id":"W4247767630","doi":"10.1515/iupac.79.1688","title":"Neuropathy","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glossary; Chemical nomenclature; Computer science; Toxicology; Library science; Chemistry; Philosophy; Biology; Linguistics; Organic chemistry","score_opus":0.019746120641801,"score_gpt":0.45738067472048716,"score_spread":0.4376345540786862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247767630","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014172735,0.00013128378,0.00011025512,0.00009624954,0.00004395347,0.00003355659,0.9973935,0.00025964336,0.0017897973],"genre_scores_gemma":[0.00044662235,0.000113149974,0.00035214412,0.00017884659,0.000015551648,0.00014911218,0.9970884,0.00006673481,0.0015893987],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977107,0.0004076888,0.00038881486,0.00083595456,0.00042564573,0.00023122632],"domain_scores_gemma":[0.99563724,0.001118354,0.00046226548,0.0010669444,0.0013991103,0.00031605965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015675282,0.0016777784,0.0014629707,0.0029268377,0.00083782175,0.0030617295,0.0026461266,0.0016537705,0.15238814],"category_scores_gemma":[0.012760557,0.00050718145,0.002002139,0.0047978438,0.00032652417,0.0019305658,0.0016517186,0.0016738671,0.18795009],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017747005,0.000025963118,0.001769168,0.0010231208,0.000058564394,0.000021225833,0.000017495699,0.00016725117,0.00008130775,0.00060310966,0.9880355,0.008019819],"study_design_scores_gemma":[0.0002677206,0.000028310862,0.0040273922,0.0006159859,0.0000636672,0.00008621864,0.000061827406,0.0002508054,0.00022158887,0.001392429,0.99295855,0.000025537298],"about_ca_topic_score_codex":0.014061552,"about_ca_topic_score_gemma":0.02899305,"teacher_disagreement_score":0.15238814,"about_ca_system_score_codex":0.001538046,"about_ca_system_score_gemma":0.0030607835,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4248036055","doi":"10.1016/b978-0-12-386454-3.00419-x","title":"Pharmacokinetics","year":2014,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Intrinsik (Canada)","funders":"","keywords":"Xenobiotic; ADME; Pharmacokinetics; Biotransformation; Distribution (mathematics); Chemistry; Computational biology; Pharmacology; Biology; Mathematics; Biochemistry","score_opus":0.023453847220345492,"score_gpt":0.30453725080683064,"score_spread":0.28108340358648515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248036055","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0068983184,0.082911804,0.035377283,0.006609839,0.00314653,0.0005062804,0.0049008015,0.0035717748,0.85607743],"genre_scores_gemma":[0.027918871,0.03212916,0.008983672,0.0030466528,0.00075016014,0.00035138716,0.0020615302,0.0004987983,0.92425984],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99958295,0.00007969231,0.000018078446,0.00008658071,0.0001980454,0.00003466769],"domain_scores_gemma":[0.9998084,0.000045778743,0.000021807713,0.00003662568,0.00006153023,0.000025938825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063983444,0.0010198021,0.0007708619,0.0011639922,0.0004170251,0.0016283907,0.0006239177,0.0010533083,0.101649255],"category_scores_gemma":[0.0009767583,0.0004529508,0.00058292504,0.0008131399,0.00046465397,0.0009715136,0.0007220395,0.002049325,0.07110961],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045321888,0.00021460914,0.000311041,0.0007233782,0.00004201152,0.0002616142,0.00008624645,0.0006186402,0.025170632,0.012858272,0.15537404,0.8038863],"study_design_scores_gemma":[0.000094420495,0.00031979984,0.0010461188,0.00020387008,0.000038511655,0.0014891789,0.000024264895,0.0005832167,0.013324151,0.0045228745,0.9783279,0.000025702144],"about_ca_topic_score_codex":0.0014189996,"about_ca_topic_score_gemma":0.0020782542,"teacher_disagreement_score":0.101649255,"about_ca_system_score_codex":0.00090971397,"about_ca_system_score_gemma":0.0014119773,"threshold_uncertainty_score":0.34005064},"labels":[],"label_agreement":null},{"id":"W4248055982","doi":"10.1515/iupac.87.0437","title":"Neurofibroma","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Chemical nomenclature; Relation (database); Computer science; Psychology; Chemistry; Linguistics; Philosophy; Data mining; Organic chemistry","score_opus":0.02020853640667629,"score_gpt":0.4585340919253211,"score_spread":0.43832555551864477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248055982","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007157059,0.00081354694,0.00013269205,0.00015077779,0.00006232606,0.000056773526,0.9937476,0.00020472833,0.004115827],"genre_scores_gemma":[0.0026788164,0.00085238134,0.00060470484,0.00029229914,0.000036277354,0.00023840093,0.9933009,0.00006211757,0.001934119],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99922585,0.000073670475,0.00020980064,0.00023184175,0.00014805206,0.00011084474],"domain_scores_gemma":[0.99733835,0.00076289923,0.0005445523,0.0004637527,0.0006805982,0.00020981552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058488065,0.0009443801,0.0012369056,0.003932894,0.0006900718,0.0019958073,0.001263726,0.0013331915,0.07067674],"category_scores_gemma":[0.007891074,0.00037448545,0.0012407859,0.00475631,0.0002528322,0.0014281791,0.001145677,0.0012110192,0.040766805],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003812811,0.000022365322,0.006092625,0.0034029947,0.00012713291,0.00023461883,0.000025750162,0.00026848385,0.00018783919,0.0007444674,0.9665973,0.021915223],"study_design_scores_gemma":[0.00052008464,0.00003693836,0.025572984,0.0047789603,0.00020337579,0.0020270194,0.00012812506,0.00042704892,0.00047953354,0.0030010608,0.9627714,0.00005348081],"about_ca_topic_score_codex":0.010588327,"about_ca_topic_score_gemma":0.026312506,"teacher_disagreement_score":0.07067674,"about_ca_system_score_codex":0.0011700507,"about_ca_system_score_gemma":0.0020109871,"threshold_uncertainty_score":0.23643726},"labels":[],"label_agreement":null},{"id":"W4248196662","doi":"10.1021/np020361n","title":"New Taxanes from the Needles of <i>Taxus canadensis</i>","year":2003,"lang":"en","type":"article","venue":"Journal of Natural Products","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut National de la Recherche Scientifique; McGill University; Queen's University; Université du Québec à Montréal","funders":"","keywords":"Taxane; Chemistry; Stereochemistry; Biology; Cancer; Genetics; Breast cancer","score_opus":0.017772080633307246,"score_gpt":0.2776186363002226,"score_spread":0.25984655566691534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248196662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9516463,0.01973309,0.0031665396,0.00029162114,0.00015320834,0.00027574267,0.0076738135,0.00015310755,0.016906548],"genre_scores_gemma":[0.92379284,0.018956095,0.010424248,0.00049987674,0.00011905375,0.00013866607,0.021813119,0.000048606413,0.024207508],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99996316,0.0000017394267,0.000002338635,0.0000092332475,0.000013273894,0.000010290181],"domain_scores_gemma":[0.9999316,0.0000054720153,0.0000105561785,0.000003329508,0.00001889687,0.000030089139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036136415,0.00063252257,0.00024763274,0.00094045716,0.00048637544,0.0003521545,0.00018821133,0.00025892857,0.0020402991],"category_scores_gemma":[0.00007781974,0.0001588857,0.00026922493,0.00058842765,0.00024554078,0.00027477278,0.00021345381,0.00068022305,0.00049626036],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027578825,0.00005126589,0.0020813302,0.00029407663,0.00004022045,0.0005295356,0.0001334313,0.00023449546,0.97691786,0.00015892682,0.00026061997,0.01902245],"study_design_scores_gemma":[0.00029286058,0.0016395731,0.22449926,0.000247194,0.0004593574,0.00364388,0.0011192231,0.00096227106,0.57229275,0.0007976378,0.1939192,0.00012683748],"about_ca_topic_score_codex":0.014148775,"about_ca_topic_score_gemma":0.039539784,"teacher_disagreement_score":0.014148775,"about_ca_system_score_codex":0.0005762277,"about_ca_system_score_gemma":0.000623541,"threshold_uncertainty_score":0.028132856},"labels":[],"label_agreement":null},{"id":"W4248288235","doi":"10.1002/jcph.70","title":"Issue Information","year":2013,"lang":"en","type":"paratext","venue":"The Journal of Clinical Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Impact","funders":"","keywords":"Citation; Computer science; Information retrieval; World Wide Web","score_opus":0.07487596288625405,"score_gpt":0.4982250255603367,"score_spread":0.4233490626740827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248288235","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032713113,0.00053445075,0.0008124918,0.003795714,0.008954751,0.00043212518,0.021807972,0.0023365044,0.96099883],"genre_scores_gemma":[0.0006174067,0.00023940814,0.00026013443,0.00072239136,0.00059746136,0.00010124464,0.0057522706,0.00043685784,0.99127275],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986551,0.00018544597,0.00008317767,0.00013851363,0.00077835534,0.00015937744],"domain_scores_gemma":[0.9943189,0.0008703113,0.00022590643,0.00042707627,0.0026889408,0.0014688766],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0015837966,0.0011564251,0.0011971957,0.00467273,0.001985559,0.0076086265,0.0017278501,0.002117898,0.9035238],"category_scores_gemma":[0.009913941,0.0005266992,0.00059521216,0.004574574,0.00071657,0.004309003,0.0028046865,0.0022567657,0.86516637],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014563746,0.000017040176,0.00003243714,0.000074673866,6.522935e-7,0.000009007589,0.000008559225,0.000018163651,0.000057330984,0.0007772295,0.9808126,0.018177813],"study_design_scores_gemma":[0.000022126007,0.000018625464,0.00035982966,0.000117408454,0.0000017709779,0.000022099879,0.000053146614,0.000068917805,0.00010567451,0.0011716512,0.9980515,0.000007214087],"about_ca_topic_score_codex":0.0031380455,"about_ca_topic_score_gemma":0.006258445,"teacher_disagreement_score":0.0964762,"about_ca_system_score_codex":0.001710787,"about_ca_system_score_gemma":0.0034159853,"threshold_uncertainty_score":0.13761151},"labels":[],"label_agreement":null},{"id":"W4248674962","doi":"10.21203/rs.2.11805/v1","title":"The efficacy and safety of acupuncture for alleviating chemotherapy-induced peripheral neuropathy in colorectal cancer patients: study protocol for a pilot single-blinded, randomized sham-controlled trial","year":2019,"lang":"en","type":"preprint","venue":"Research Square","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Hospital Authority; Hong Kong Baptist University","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Acupuncture; Colorectal cancer; Randomized controlled trial; Chemotherapy; Protocol (science); Cancer; Internal medicine; Oncology; Peripheral; Physical therapy; Alternative medicine; Pathology","score_opus":0.11118557132805269,"score_gpt":0.47289813011174675,"score_spread":0.36171255878369407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248674962","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015939677,0.00045776254,0.0011422125,0.00021177276,0.00029747377,0.98058015,0.00068463315,0.00007597016,0.0006102924],"genre_scores_gemma":[0.0153295975,0.00026528604,0.0023254277,0.00031944292,0.00010832488,0.98099893,0.0001724439,0.000005374668,0.00047513974],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9918304,0.004238447,0.0010206286,0.0009309313,0.0009573885,0.0010222292],"domain_scores_gemma":[0.9932081,0.001378067,0.0016226451,0.00081501977,0.0013751828,0.0016009473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015462413,0.0047067367,0.010235508,0.0015634194,0.0027548817,0.0021241282,0.0027705296,0.0049295486,0.029720824],"category_scores_gemma":[0.012895599,0.002236382,0.003671855,0.0017010632,0.0032422722,0.0026148541,0.0012405213,0.004566237,0.004295175],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95230854,0.026447738,0.00056730566,0.0052583087,0.0009456313,0.00009614291,0.00015240007,0.0005371158,0.0017367825,0.0004933568,0.0019569667,0.009499632],"study_design_scores_gemma":[0.93774647,0.05734559,0.0009290229,0.00029858123,0.0004461337,0.000018626515,0.00003956572,0.00040282434,0.00029054887,0.00034406746,0.002106473,0.000032123295],"about_ca_topic_score_codex":0.0012508759,"about_ca_topic_score_gemma":0.0029620612,"teacher_disagreement_score":0.029720824,"about_ca_system_score_codex":0.0026907697,"about_ca_system_score_gemma":0.011072322,"threshold_uncertainty_score":0.09942603},"labels":[],"label_agreement":null},{"id":"W4248712378","doi":"10.2165/00128413-200515060-00051","title":"Safety updates to Canadian labelling for Duragesic","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Labelling; Medicine; Pharmacy; Medical emergency; Family medicine; Criminology; Psychology","score_opus":0.02394607577086246,"score_gpt":0.3393357333737358,"score_spread":0.31538965760287335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248712378","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012312569,0.015379473,0.006911206,0.23007365,0.040780585,0.00077496003,0.008814961,0.0030406942,0.68191195],"genre_scores_gemma":[0.074029505,0.011107385,0.018091079,0.1708759,0.0057749897,0.00032595586,0.0068280455,0.00095721375,0.7120099],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98875415,0.0012526754,0.00058925967,0.00047387145,0.0076158517,0.0013141754],"domain_scores_gemma":[0.9583477,0.0044211075,0.0012445913,0.0012813282,0.03218897,0.0025163817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006984204,0.0006868718,0.00073230756,0.003414406,0.005547418,0.004243118,0.0035018292,0.010090463,0.040163063],"category_scores_gemma":[0.024197198,0.00063906744,0.0015752744,0.0024850802,0.0018346405,0.0011078392,0.0010593311,0.008022418,0.009749432],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015601628,0.00007489007,0.0009373653,0.00027697848,0.000013950023,0.0002548304,0.00028226126,0.00013706017,0.0013485285,0.007105141,0.93766195,0.051751044],"study_design_scores_gemma":[0.00001857142,0.00003915234,0.0019757065,0.00016128152,0.000022083697,0.0001553863,0.00011434741,0.00007568966,0.0006773729,0.0004280659,0.9963103,0.000021966365],"about_ca_topic_score_codex":0.6898334,"about_ca_topic_score_gemma":0.8148617,"teacher_disagreement_score":0.3101666,"about_ca_system_score_codex":0.020381259,"about_ca_system_score_gemma":0.06250339,"threshold_uncertainty_score":0.6239865},"labels":[],"label_agreement":null},{"id":"W4249072217","doi":"10.1200/jco.2012.30.27_suppl.125","title":"BOLERO-2: Health-related quality-of-life (HRQoL) in metastatic breast cancer patients treated with everolimus and exemestane versus exemestane.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cambridge Memorial Hospital","funders":"","keywords":"Medicine; Exemestane; Internal medicine; Breast cancer; Hazard ratio; Aromatase inhibitor; Everolimus; Placebo; Oncology; Clinical endpoint; Quality of life (healthcare); Proportional hazards model; Interim analysis; Cancer; Randomized controlled trial; Confidence interval; Aromatase; Pathology","score_opus":0.21684305128424827,"score_gpt":0.5177775195784704,"score_spread":0.3009344682942221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249072217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720309,0.019036489,0.0004666593,0.0006353915,0.00021615085,0.0018490391,0.002377927,0.000076200886,0.0033112895],"genre_scores_gemma":[0.98450893,0.004119375,0.001971354,0.0007413994,0.00017839803,0.0029012156,0.0027403166,0.000018963,0.0028200662],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989503,0.00068719033,0.00005822286,0.00011442036,0.00009054953,0.00009938502],"domain_scores_gemma":[0.999193,0.0002239323,0.00032419205,0.00003731724,0.000031476036,0.00019002729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034376956,0.0008993796,0.0018756256,0.0004827798,0.00020959692,0.0009314283,0.0007887269,0.0006591757,0.006801718],"category_scores_gemma":[0.0020339852,0.00038528984,0.0025411823,0.00036990372,0.0005485903,0.00057768717,0.0006910639,0.0017867985,0.0004942394],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9487504,0.0058030155,0.0043607187,0.0014104455,0.0026293357,0.000020578165,0.000058465463,0.0011888078,0.0027066737,0.00012136366,0.0011717791,0.03177842],"study_design_scores_gemma":[0.7650265,0.18407235,0.04117782,0.0003154165,0.0029754594,0.000119638935,0.000049292266,0.0017868573,0.0013587568,0.00022027706,0.0028501444,0.000047529298],"about_ca_topic_score_codex":0.00076261326,"about_ca_topic_score_gemma":0.0025832069,"teacher_disagreement_score":0.006801718,"about_ca_system_score_codex":0.0010889849,"about_ca_system_score_gemma":0.00087875046,"threshold_uncertainty_score":0.022754014},"labels":[],"label_agreement":null},{"id":"W4249137086","doi":"10.1097/fpc.0b013e3283335277","title":"Taxane pathway","year":2009,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"National Institute of General Medical Sciences","keywords":"Taxane; Biology; Genetics; Cancer; Breast cancer","score_opus":0.01899387428273902,"score_gpt":0.3110434663305991,"score_spread":0.2920495920478601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249137086","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2207577,0.1374215,0.026361959,0.022661628,0.0049718814,0.0011498694,0.04431212,0.0026857355,0.5396775],"genre_scores_gemma":[0.43109375,0.09357767,0.008468475,0.0024146722,0.00045797264,0.00026851537,0.020396542,0.00019381287,0.44312862],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998834,0.000008533516,0.0000062675213,0.00002945817,0.000050245457,0.000021980528],"domain_scores_gemma":[0.99993134,0.0000042593047,0.0000129441,0.000007717983,0.000022806147,0.000020895312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009715968,0.000479215,0.00027823594,0.0004787023,0.00051229744,0.0010640165,0.00039006822,0.00038240783,0.039214883],"category_scores_gemma":[0.00018618883,0.00013738424,0.00040717467,0.00027537125,0.00013050508,0.0005150889,0.0005424951,0.0008816285,0.009635149],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012549537,0.00029920044,0.0040372615,0.0014348266,0.00012579882,0.0016165163,0.00022334042,0.00080091076,0.39763957,0.04916431,0.11972996,0.42367336],"study_design_scores_gemma":[0.00017841879,0.0003366042,0.009688041,0.00025206068,0.00010965709,0.0033011339,0.00013950067,0.0008114115,0.15317605,0.00805861,0.82392114,0.000027392347],"about_ca_topic_score_codex":0.001986007,"about_ca_topic_score_gemma":0.0029120771,"teacher_disagreement_score":0.039214883,"about_ca_system_score_codex":0.00085757824,"about_ca_system_score_gemma":0.0009928874,"threshold_uncertainty_score":0.13118684},"labels":[],"label_agreement":null},{"id":"W4249550597","doi":"10.1515/iupac.76.0106","title":"Active Metabolite","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glossary; Toxicokinetics; Relation (database); Toxicology; Computer science; Medicine; Pharmacology; Biology; Data mining; Linguistics; Philosophy","score_opus":0.020066851033998818,"score_gpt":0.4712057248539894,"score_spread":0.4511388738199906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249550597","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013113717,0.00036133575,0.00011641046,0.00004529845,0.000023428136,0.000025513888,0.9980742,0.00018912049,0.0010335067],"genre_scores_gemma":[0.00045380392,0.00034865967,0.0005068481,0.00012910452,0.000011687532,0.00013637701,0.99730587,0.000066973174,0.0010406697],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99878854,0.00020092457,0.00026756377,0.00040185545,0.00025215145,0.00008896302],"domain_scores_gemma":[0.9974268,0.0008810838,0.00048297137,0.00050654367,0.000540861,0.00016168384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093964254,0.0016556161,0.0016297254,0.0031733252,0.00056870707,0.002065526,0.0018714793,0.0013573432,0.111338004],"category_scores_gemma":[0.0067458716,0.00057665986,0.0017295841,0.005151638,0.0003091036,0.00155302,0.0014332305,0.0015867309,0.10282376],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003687937,0.000051856776,0.0020664255,0.0053596543,0.00012596395,0.000064429,0.00003446104,0.00040947352,0.0005288523,0.0008919371,0.9729074,0.017190704],"study_design_scores_gemma":[0.0002138586,0.000036082754,0.0038127273,0.00077005214,0.00009004156,0.000121681434,0.000031032567,0.00016214918,0.00038386183,0.0010700658,0.9932829,0.000025612431],"about_ca_topic_score_codex":0.008944402,"about_ca_topic_score_gemma":0.017772023,"teacher_disagreement_score":0.111338004,"about_ca_system_score_codex":0.0011204238,"about_ca_system_score_gemma":0.002245406,"threshold_uncertainty_score":0.37246275},"labels":[],"label_agreement":null},{"id":"W4249976545","doi":"10.1515/iupac.78.0472","title":"Pharmacodynamics","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Glossary; Computer science; Chemical nomenclature; Management science; Data science; Chemistry; Engineering","score_opus":0.01873516103566293,"score_gpt":0.47759721047744524,"score_spread":0.4588620494417823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249976545","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012702939,0.0006831188,0.00015278062,0.00016501827,0.000026008482,0.00003137587,0.9963552,0.000176288,0.0022832472],"genre_scores_gemma":[0.0012562529,0.0011732233,0.0008083048,0.0005651389,0.000035423443,0.0002454786,0.9935719,0.00009262079,0.002251765],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987255,0.00025008392,0.00029294487,0.00034282779,0.00029179527,0.00009676303],"domain_scores_gemma":[0.9956326,0.0018184959,0.0008992242,0.0006065013,0.0008351546,0.00020803903],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011488539,0.0014766726,0.0016539296,0.0031694344,0.00054142193,0.002329691,0.0020894015,0.001712842,0.13251458],"category_scores_gemma":[0.010051126,0.00045441615,0.0019206271,0.005616046,0.00030975233,0.0014853807,0.001320694,0.0018886431,0.07800929],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002782872,0.000033518754,0.0020143308,0.0058057336,0.00015169206,0.00006172384,0.000023250312,0.00042282708,0.00018756156,0.001568375,0.97146565,0.017987022],"study_design_scores_gemma":[0.00035740467,0.000033219916,0.0046136817,0.0015499307,0.00015205133,0.00019193887,0.000021535252,0.00022562263,0.00020094869,0.0024268092,0.9902006,0.00002638041],"about_ca_topic_score_codex":0.011575666,"about_ca_topic_score_gemma":0.021180298,"teacher_disagreement_score":0.8674854,"about_ca_system_score_codex":0.0017835381,"about_ca_system_score_gemma":0.0028869237,"threshold_uncertainty_score":0.44330543},"labels":[],"label_agreement":null},{"id":"W4250262361","doi":"10.1186/isrctn12237417","title":"Venlafaxine and gabapentin for the management of hot flashes in breast cancer survivors: a randomized crossover trial","year":2013,"lang":"en","type":"dataset","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Cancer Society","keywords":"Venlafaxine; Gabapentin; Crossover study; Randomized controlled trial; Medicine; Breast cancer; Oncology; Internal medicine; Anesthesia; Cancer; Antidepressant; Alternative medicine; Placebo","score_opus":0.02545339971309443,"score_gpt":0.34835253991839926,"score_spread":0.32289914020530486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250262361","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41283965,0.037696082,0.004246712,0.004284128,0.0010217603,0.013476146,0.5109925,0.00075103575,0.014691916],"genre_scores_gemma":[0.7098834,0.01928948,0.0072034886,0.0041868817,0.00046970986,0.026621094,0.21555099,0.00023033978,0.016564589],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99916494,0.0004474428,0.00008952014,0.00013767187,0.000094081595,0.00006632396],"domain_scores_gemma":[0.9986053,0.00051818293,0.00040087543,0.00015346218,0.00015685472,0.00016534646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016563872,0.0011932492,0.0026638743,0.00042973497,0.00034084762,0.0007467687,0.0013781565,0.0010466275,0.015833037],"category_scores_gemma":[0.004269866,0.00044026767,0.0029166816,0.0008714649,0.00035150044,0.0005358957,0.0005509234,0.0016926377,0.0018283231],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8328968,0.0027772717,0.009402994,0.01081921,0.0167007,0.00013906264,0.00006018349,0.0015767986,0.001301686,0.00055110623,0.09328575,0.03048831],"study_design_scores_gemma":[0.9427369,0.0042390656,0.020096302,0.00078802154,0.010814717,0.00014072319,0.000051432962,0.0011612603,0.00038851195,0.0007000178,0.018820427,0.000062656356],"about_ca_topic_score_codex":0.0049911467,"about_ca_topic_score_gemma":0.011534645,"teacher_disagreement_score":0.015833037,"about_ca_system_score_codex":0.0011842123,"about_ca_system_score_gemma":0.0019252121,"threshold_uncertainty_score":0.052966833},"labels":[],"label_agreement":null},{"id":"W4250599156","doi":"10.1200/jco.2012.30.18_suppl.lba671","title":"Open-label phase III randomized controlled trial comparing taxane-based chemotherapy (Tax) with lapatinib (L) or trastuzumab (T) as first-line therapy for women with HER2+ metastatic breast cancer: Interim analysis (IA) of NCIC CTG MA.31/GSK EGF 108919.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Juravinski Cancer Centre; Sunnybrook Health Science Centre; BC Cancer Agency; Interior Health; Ottawa Hospital; Hamilton Health Sciences; University of Toronto","funders":"","keywords":"Medicine; Docetaxel; Metastatic breast cancer; Internal medicine; Taxane; Clinical endpoint; Trastuzumab; Lapatinib; Breast cancer; Oncology; Pertuzumab; Interim analysis; Surgery; Chemotherapy; Cancer; Randomized controlled trial","score_opus":0.17811336086588878,"score_gpt":0.5349206746260675,"score_spread":0.3568073137601787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250599156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93986666,0.009564005,0.002145957,0.0027099615,0.0029671662,0.028209707,0.00648009,0.00061274925,0.0074436753],"genre_scores_gemma":[0.94319135,0.0038376357,0.004438473,0.0039021662,0.001086508,0.030932643,0.004117265,0.000095940835,0.008398009],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988727,0.0006708873,0.00006326614,0.00016733073,0.00006249163,0.0001633652],"domain_scores_gemma":[0.99791497,0.00064890704,0.0005245611,0.00018667022,0.00013802227,0.0005868903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030519497,0.0025632214,0.0044189696,0.00049283606,0.00057043316,0.0015992207,0.0013837228,0.0024535393,0.01165752],"category_scores_gemma":[0.003652367,0.000919065,0.0022217403,0.0006099592,0.0016245687,0.0017051738,0.00060280354,0.004545415,0.0022005527],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99062145,0.0035600725,0.00014343233,0.00037010846,0.0006586458,0.000017871078,0.000019953195,0.00014192457,0.0005907293,0.00005711953,0.00074040896,0.003078469],"study_design_scores_gemma":[0.9743823,0.02423942,0.00038329864,0.000019391904,0.0002231387,0.0000100189,0.0000095027,0.00018286887,0.00008829975,0.00007926363,0.0003764107,0.000006206566],"about_ca_topic_score_codex":0.0014831716,"about_ca_topic_score_gemma":0.004728064,"teacher_disagreement_score":0.01165752,"about_ca_system_score_codex":0.0013442328,"about_ca_system_score_gemma":0.0022095395,"threshold_uncertainty_score":0.038998246},"labels":[],"label_agreement":null},{"id":"W4250793702","doi":"10.1200/jco.2013.31.18_suppl.lba509","title":"Correlation of molecular alterations with efficacy of everolimus in hormone receptor–positive, HER2-negative advanced breast cancer: Results from BOLERO-2.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"","keywords":"Exemestane; Medicine; Everolimus; PTEN; Oncology; Internal medicine; Breast cancer; Population; Progression-free survival; Hormone receptor; Cancer; Genetics; Tamoxifen; PI3K/AKT/mTOR pathway; Biology; Overall survival","score_opus":0.03618967590298205,"score_gpt":0.4164349621592653,"score_spread":0.38024528625628323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250793702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923994,0.0040557515,0.00017883009,0.00012353151,0.000010609917,0.00005289505,0.0022903024,0.000020068583,0.00086859555],"genre_scores_gemma":[0.9900122,0.0011583401,0.000671777,0.00018361096,0.00002824059,0.000054803746,0.007133731,0.000018436467,0.0007388648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950993,0.0001764597,0.00004142147,0.00011823287,0.00011793489,0.00003595261],"domain_scores_gemma":[0.9989108,0.0004251735,0.00034189582,0.00013928543,0.000065537024,0.000117414544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025270828,0.00029003693,0.0004974958,0.00042182594,0.00015519414,0.0004900955,0.0003190831,0.0003154044,0.0009864804],"category_scores_gemma":[0.0016341116,0.0001953725,0.0005562641,0.0003715177,0.00027911883,0.00020265878,0.00027598417,0.00045132052,0.00020688235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08479647,0.0020744875,0.74639446,0.0007083186,0.0031349855,0.00036932374,0.00031131992,0.004352102,0.047112,0.00013884211,0.0029226854,0.10768496],"study_design_scores_gemma":[0.0024692526,0.0077072796,0.9780341,0.00004392054,0.0010622042,0.00055912667,0.00003823339,0.001799469,0.0046018455,0.000094204894,0.0035667666,0.000023734581],"about_ca_topic_score_codex":0.0014326915,"about_ca_topic_score_gemma":0.0027709233,"teacher_disagreement_score":0.0025270828,"about_ca_system_score_codex":0.0006367262,"about_ca_system_score_gemma":0.00034449174,"threshold_uncertainty_score":0.013364673},"labels":[],"label_agreement":null},{"id":"W4251283077","doi":"10.4081/hpr.2013.1450","title":"Ten weeks of home-based exercise attenuates symptoms of chemotherapy-induced peripheral neuropathy in breast cancer patients","year":2013,"lang":"en","type":"article","venue":"Health psychology research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Quality of life (healthcare); Peripheral neuropathy; Physical therapy; Chemotherapy-induced peripheral neuropathy; Cancer; Analysis of variance; Chemotherapy; Internal medicine","score_opus":0.06070954127193492,"score_gpt":0.46254278573638935,"score_spread":0.40183324446445445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251283077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99945563,0.00018107452,0.00002385118,0.000021175396,0.000006537068,0.000017484297,0.000011168796,0.0000046356263,0.00027839537],"genre_scores_gemma":[0.99904424,0.00020091505,0.000107643464,0.000057662193,0.000014124099,0.000032299195,0.00004860791,9.830133e-7,0.00049340545],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9999472,0.000021303767,0.0000028494069,0.0000057950224,0.0000069010684,0.000015982681],"domain_scores_gemma":[0.9998963,0.000022931446,0.000024274777,0.000005940649,0.0000093348,0.000041261846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013832093,0.000156166,0.00024656527,0.000086348504,0.00013943875,0.000114462964,0.0001045704,0.00015243018,0.0015190953],"category_scores_gemma":[0.0004206243,0.00007443156,0.0001152378,0.00006765686,0.0000650518,0.00007716811,0.00010218335,0.00025410842,0.00013270795],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05754187,0.09853191,0.17074633,0.0008856461,0.0006113488,0.00048044338,0.000932666,0.001799471,0.07388885,0.000054559587,0.0022360825,0.5922908],"study_design_scores_gemma":[0.0021959487,0.10463154,0.8878028,0.00006247794,0.00016741025,0.00016332943,0.0003012083,0.0006243848,0.0027532708,0.000040785693,0.0012466735,0.000010161806],"about_ca_topic_score_codex":0.0007833779,"about_ca_topic_score_gemma":0.0024800096,"teacher_disagreement_score":0.0015190953,"about_ca_system_score_codex":0.000077666795,"about_ca_system_score_gemma":0.00012837404,"threshold_uncertainty_score":0.0050818324},"labels":[],"label_agreement":null},{"id":"W4252594977","doi":"10.1021/ol016581u","title":"Syn−Anti Isomerization of Aldols by Enolization","year":2001,"lang":"en","type":"article","venue":"Organic Letters","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Keto–enol tautomerism; Isomerization; Chemistry; Adduct; Aldol reaction; Imidazole; Stereochemistry; Medicinal chemistry; Organic chemistry; Catalysis","score_opus":0.009603610595018474,"score_gpt":0.26401395046963094,"score_spread":0.2544103398746125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252594977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95228165,0.003209076,0.01862635,0.0003108808,0.000213727,0.00013215937,0.0003805081,0.00049192715,0.024353575],"genre_scores_gemma":[0.9884067,0.0016740339,0.002805583,0.000090425936,0.00002946218,0.000026476153,0.00022967116,0.000046787703,0.0066908505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979943,0.000048166727,0.000011675875,0.000033505945,0.000032904984,0.00007430096],"domain_scores_gemma":[0.99986327,0.00002143401,0.000037681915,0.000021581363,0.000026750668,0.00002935303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042848286,0.00079691067,0.00020491818,0.00034955857,0.0002844718,0.00030959083,0.0003609992,0.00018205267,0.0044625294],"category_scores_gemma":[0.00023136368,0.0001521341,0.00015967393,0.00021357657,0.00030558073,0.00046713985,0.00034470134,0.00049415295,0.0012763481],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007656418,0.00014544654,0.0005525503,0.00019486187,0.000031196276,0.0004062709,0.00028769404,0.00041784765,0.97938627,0.0050118896,0.00073752,0.012062791],"study_design_scores_gemma":[0.000018303044,0.0002835157,0.00037602594,0.000004328151,0.000009800371,0.00032146153,0.000032597974,0.0003001814,0.9933564,0.00019019555,0.0050972686,0.000009714317],"about_ca_topic_score_codex":0.00045928705,"about_ca_topic_score_gemma":0.00064296735,"teacher_disagreement_score":0.0044625294,"about_ca_system_score_codex":0.00024408054,"about_ca_system_score_gemma":0.0002837467,"threshold_uncertainty_score":0.014928699},"labels":[],"label_agreement":null},{"id":"W4252976727","doi":"10.1515/iupac.87.0266","title":"Giant Axonal Neuropathy","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Relation (database); Chemical nomenclature; Computer science; Psychology; Engineering ethics; Neuroscience; Chemistry; Linguistics; Engineering; Philosophy; Organic chemistry; Data mining","score_opus":0.020723497908299252,"score_gpt":0.44275415375141586,"score_spread":0.4220306558431166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252976727","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040500684,0.00047583887,0.00008150874,0.00010166918,0.00004123514,0.00005111136,0.9968297,0.00012273871,0.0018911422],"genre_scores_gemma":[0.0012704257,0.0006084479,0.0004076147,0.00021985472,0.00002431476,0.00024594538,0.9956768,0.000037286918,0.0015092392],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99898964,0.00013300075,0.00031530933,0.00026045277,0.00018501638,0.00011642815],"domain_scores_gemma":[0.9963135,0.0010356923,0.00090434455,0.000585658,0.00089396164,0.0002668539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008910673,0.001167579,0.0015525143,0.0033785915,0.000584089,0.0019911844,0.0017609466,0.0015311671,0.07426893],"category_scores_gemma":[0.00819073,0.00039885155,0.0015450704,0.005012017,0.0002849618,0.0013274299,0.0014885404,0.001479425,0.035057217],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000612077,0.00004248792,0.0058375145,0.006070776,0.00019254322,0.00012502122,0.000029125009,0.00034476272,0.00017255974,0.00081958325,0.9690773,0.016676342],"study_design_scores_gemma":[0.0010844589,0.000077472076,0.030083876,0.005913394,0.00029210036,0.0007422549,0.00012886358,0.00043515023,0.00046236915,0.0027511066,0.95796365,0.000065359716],"about_ca_topic_score_codex":0.011892178,"about_ca_topic_score_gemma":0.030253608,"teacher_disagreement_score":0.07426893,"about_ca_system_score_codex":0.0014685378,"about_ca_system_score_gemma":0.0027790437,"threshold_uncertainty_score":0.24845433},"labels":[],"label_agreement":null},{"id":"W4253119700","doi":"10.1200/jco.2012.30.5_suppl.172","title":"A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cabazitaxel; Prednisone; Docetaxel; Prostate cancer; Cohort; Internal medicine; Interim analysis; Mitoxantrone; Abiraterone acetate; Cancer; Surgery; Oncology; Androgen deprivation therapy; Clinical trial; Chemotherapy","score_opus":0.16491443993143304,"score_gpt":0.509163103084779,"score_spread":0.3442486631533459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253119700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97979456,0.0009564255,0.0015229206,0.00087870884,0.00017833982,0.0055233617,0.006394551,0.00023250295,0.004518715],"genre_scores_gemma":[0.9650525,0.0011000494,0.0057244925,0.0017132721,0.00033422175,0.0064267376,0.013925934,0.000056176075,0.0056667286],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99948645,0.0002246739,0.00001991506,0.00008455666,0.00007624312,0.00010818335],"domain_scores_gemma":[0.9983169,0.00015092069,0.00029483027,0.00021897872,0.00010045933,0.0009180332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017506141,0.0006779882,0.00047475108,0.0003543497,0.00048378797,0.0007134693,0.00079495646,0.0005557291,0.0063762646],"category_scores_gemma":[0.0015168923,0.0002535825,0.0012357391,0.0004915255,0.0003898671,0.00057570013,0.00076079887,0.0012092694,0.0010014843],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5004003,0.073559076,0.056704767,0.00042677711,0.0018643454,0.00037217807,0.00033930028,0.004277465,0.016248155,0.00039393737,0.02034654,0.3250671],"study_design_scores_gemma":[0.44016227,0.34679195,0.18398675,0.00008579138,0.0015765902,0.00051246816,0.00013556915,0.00405168,0.005065016,0.000459017,0.017113572,0.000059359107],"about_ca_topic_score_codex":0.003917768,"about_ca_topic_score_gemma":0.006924036,"teacher_disagreement_score":0.0063762646,"about_ca_system_score_codex":0.0010416702,"about_ca_system_score_gemma":0.0027799003,"threshold_uncertainty_score":0.021330714},"labels":[],"label_agreement":null},{"id":"W4253323776","doi":"10.1200/jco.2013.31.15_suppl.2053","title":"Phase II study of PX-866 in recurrent glioblastoma.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Manitoba; BC Cancer Agency; University of Alberta; Queen Elizabeth II Health Sciences Centre; University of Toronto; University Health Network; Dalhousie University; Cancer Care Ontario; Queen's University","funders":"","keywords":"Medicine; Temozolomide; Nausea; Internal medicine; Gastroenterology; Phases of clinical research; Adverse effect; Oncology; PTEN; Surgery; Toxicity; Chemotherapy; PI3K/AKT/mTOR pathway; Signal transduction","score_opus":0.17804300974857967,"score_gpt":0.5697458970082092,"score_spread":0.39170288725962954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253323776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943381,0.0010857526,0.00051086524,0.00017750113,0.00006560988,0.0021906518,0.0006552424,0.000099248755,0.00087691494],"genre_scores_gemma":[0.98788583,0.0014657412,0.001734015,0.00037733113,0.00009592949,0.0028703718,0.0023972702,0.000033471588,0.0031399732],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996063,0.00018355245,0.00002604765,0.00004753323,0.000041416853,0.000095086085],"domain_scores_gemma":[0.9996283,0.000040020317,0.00007805436,0.000040113242,0.000029563073,0.00018398727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012919897,0.0015610534,0.0017739605,0.0005995293,0.0003133666,0.0005256878,0.0008084298,0.00091323,0.003597836],"category_scores_gemma":[0.0004721014,0.00053757755,0.00090024463,0.000441866,0.0006746842,0.0004252037,0.0004472749,0.0020495544,0.0011663112],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5529043,0.109254636,0.01152272,0.0016946264,0.0012509245,0.0006903349,0.00060314377,0.0045058117,0.13032182,0.000615879,0.0062821065,0.18035369],"study_design_scores_gemma":[0.20186317,0.76999253,0.014706425,0.000042358366,0.00032591607,0.0006665302,0.00006528549,0.001345079,0.008282427,0.00017195073,0.002514986,0.000023445846],"about_ca_topic_score_codex":0.0012496808,"about_ca_topic_score_gemma":0.0027192635,"teacher_disagreement_score":0.003597836,"about_ca_system_score_codex":0.00064459175,"about_ca_system_score_gemma":0.0016324151,"threshold_uncertainty_score":0.012035906},"labels":[],"label_agreement":null},{"id":"W4253819800","doi":"10.1200/jco.2016.34.15_suppl.e18034","title":"Oxaliplatin associated neurotoxicity outcomes among older adults with colorectal cancer: a population-based study.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Women's College Hospital; Queen's University; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"","keywords":"Oxaliplatin; Medicine; Hazard ratio; Internal medicine; Regimen; Colorectal cancer; Cancer registry; Cumulative incidence; Population; Cohort; Incidence (geometry); Cancer; Surgery; Oncology; Confidence interval","score_opus":0.06502031611701335,"score_gpt":0.46263581986832353,"score_spread":0.39761550375131016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253819800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959377,0.0004769564,0.000061996354,0.000070337555,0.000008256166,0.000045138422,0.002822049,0.0000035379257,0.00057390705],"genre_scores_gemma":[0.9976382,0.00028656135,0.0000669211,0.00009972775,0.000013784082,0.00003895281,0.0015636737,0.0000018347708,0.0002903039],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964964,0.00004940268,0.0000393143,0.000093916075,0.00008270031,0.00008503355],"domain_scores_gemma":[0.99914753,0.00007302518,0.00041262852,0.000059108726,0.00015663158,0.00015107363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004942295,0.00035935378,0.00043788485,0.0006221487,0.0006669241,0.0007441406,0.00044369744,0.00054619653,0.0012529817],"category_scores_gemma":[0.0013580847,0.00049392035,0.00082192104,0.0021939687,0.00024839368,0.0005305727,0.0004890621,0.00062123383,0.0002202035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008417868,0.00003000779,0.9990206,0.000015564317,0.00007411419,0.000051748433,0.000058640948,0.000018194518,0.00004997143,0.000009017494,0.00017778306,0.00041023237],"study_design_scores_gemma":[0.00002453278,0.00005703335,0.999268,0.000011208118,0.00006522619,0.000075107826,0.00012954432,0.0000953638,0.0000068523254,0.000010445241,0.00025302448,0.0000036993526],"about_ca_topic_score_codex":0.19373482,"about_ca_topic_score_gemma":0.2762869,"teacher_disagreement_score":0.19373482,"about_ca_system_score_codex":0.0012225553,"about_ca_system_score_gemma":0.0015055779,"threshold_uncertainty_score":0.38521433},"labels":[],"label_agreement":null},{"id":"W4254182661","doi":"10.1200/jco.2013.31.26_suppl.142","title":"Correlation of molecular alterations with efficacy of everolimus in hormone-receptor–positive, HER2-negative advanced breast cancer: Results from BOLERO-2.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"","keywords":"Exemestane; Medicine; Everolimus; Oncology; Internal medicine; PTEN; Breast cancer; Population; Hormone receptor; Progression-free survival; Cancer; Genetics; PI3K/AKT/mTOR pathway; Biology; Aromatase; Overall survival","score_opus":0.034563522283415374,"score_gpt":0.4159951434199039,"score_spread":0.38143162113648854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254182661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931242,0.003974946,0.00016654139,0.000100934754,0.000010248049,0.000056711946,0.0017326578,0.000016913427,0.0008168109],"genre_scores_gemma":[0.99150777,0.0011371496,0.00063860475,0.00016155237,0.000027255463,0.00005673369,0.005781386,0.000014825279,0.00067470496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999526,0.00016863066,0.00004394855,0.00011212589,0.00011584014,0.00003347127],"domain_scores_gemma":[0.99892884,0.0004333834,0.0003196279,0.00012601283,0.0000707867,0.00012144695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023759198,0.00027389944,0.00053896336,0.00040098358,0.000155014,0.00045749318,0.00029951695,0.00030482333,0.0009948612],"category_scores_gemma":[0.001623906,0.00018672273,0.00052045553,0.00034947426,0.0002732195,0.0001958188,0.0002669432,0.00044320917,0.00019313359],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09238122,0.0025321194,0.7303662,0.0008041266,0.002739625,0.000376796,0.00034976003,0.0033151174,0.055823028,0.0001322368,0.0025338174,0.10864606],"study_design_scores_gemma":[0.0030543797,0.010863036,0.97392964,0.000043155997,0.00093208335,0.00061818375,0.000038689654,0.0013458459,0.005639822,0.000082210645,0.0034305556,0.000022400867],"about_ca_topic_score_codex":0.0010630975,"about_ca_topic_score_gemma":0.0020497795,"teacher_disagreement_score":0.0023759198,"about_ca_system_score_codex":0.000581028,"about_ca_system_score_gemma":0.00030394722,"threshold_uncertainty_score":0.012565196},"labels":[],"label_agreement":null},{"id":"W4254247034","doi":"10.1515/iupac.87.0214","title":"Dystonia","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Chemical nomenclature; Relation (database); Computer science; Psychology; Engineering ethics; Chemistry; Linguistics; Engineering; Philosophy; Organic chemistry; Data mining","score_opus":0.018849080549440164,"score_gpt":0.4704113973277275,"score_spread":0.45156231677828734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254247034","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044567545,0.0003809511,0.00010550923,0.00010309833,0.000047088513,0.000057428635,0.9959812,0.00016323334,0.0027158286],"genre_scores_gemma":[0.0016721785,0.00045779167,0.00043433774,0.000269852,0.000026277221,0.0002630953,0.9942907,0.000044844783,0.0025409802],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99905854,0.00016114261,0.00028102082,0.00023943228,0.00016159596,0.000098212964],"domain_scores_gemma":[0.99670815,0.0011178735,0.0006763953,0.00055694807,0.00075083686,0.00018982646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007888993,0.0012212528,0.0011645539,0.0025988445,0.00053858024,0.0018320882,0.0015842597,0.0013912899,0.1156852],"category_scores_gemma":[0.009592181,0.0003494859,0.0015924588,0.0030065335,0.0002613348,0.0010472385,0.0015644439,0.0011253961,0.072327405],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053000666,0.00003481384,0.0049378006,0.0039762864,0.00013132453,0.00010779616,0.000031374453,0.00024392318,0.000143081,0.0006467393,0.96980995,0.019406872],"study_design_scores_gemma":[0.00065885513,0.00008508695,0.027395494,0.0037659379,0.00018621919,0.00070064404,0.00014064218,0.00044224522,0.00045135902,0.0026780984,0.9634281,0.00006722066],"about_ca_topic_score_codex":0.010322432,"about_ca_topic_score_gemma":0.027738282,"teacher_disagreement_score":0.1156852,"about_ca_system_score_codex":0.0012099561,"about_ca_system_score_gemma":0.0017112235,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4254601055","doi":"10.3410/f.734552032.793578452","title":"Faculty Opinions recommendation of Apixaban to Prevent Venous Thromboembolism in Patients with Cancer.","year":2020,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Apixaban; Venous thromboembolism; Medicine; Cancer; Internal medicine; Business; General surgery; Warfarin; Atrial fibrillation; Thrombosis","score_opus":0.02837011613257942,"score_gpt":0.3753954030679569,"score_spread":0.3470252869353775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254601055","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013143178,0.00017250648,0.000043243046,0.0002766477,0.00004106879,0.000018603907,0.9981627,0.00013108316,0.0010227788],"genre_scores_gemma":[0.0011709676,0.0003278016,0.00038497502,0.00047975546,0.000039580125,0.00009817237,0.9959901,0.00006291401,0.0014458112],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987783,0.00023866964,0.00022433451,0.00034073534,0.00029006772,0.00012795452],"domain_scores_gemma":[0.9944706,0.0020375038,0.00094517984,0.00071918796,0.001164754,0.0006627612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012784738,0.0015338669,0.001719648,0.0020055186,0.00051765225,0.0021412494,0.002398866,0.0028390558,0.121178],"category_scores_gemma":[0.015847793,0.00060826086,0.0022728334,0.0034377542,0.00022987726,0.0012462373,0.0012464978,0.0019816784,0.06810597],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021037161,0.00002731548,0.001759291,0.001433899,0.00010478316,0.000016275142,0.000005638922,0.00015207451,0.000052405798,0.00020969138,0.9919906,0.0040376484],"study_design_scores_gemma":[0.0026797992,0.00008674765,0.01517051,0.0019427161,0.0003920048,0.00014155595,0.000033011525,0.0013270214,0.00043529883,0.0017297382,0.9760039,0.000057766774],"about_ca_topic_score_codex":0.02604593,"about_ca_topic_score_gemma":0.05951607,"teacher_disagreement_score":0.121178,"about_ca_system_score_codex":0.0014846468,"about_ca_system_score_gemma":0.0036617406,"threshold_uncertainty_score":0.4053808},"labels":[],"label_agreement":null},{"id":"W4254787778","doi":"10.3410/f.1004615.76511","title":"Faculty Opinions recommendation of Combinatorial computational method gives new picomolar ligands for a known enzyme.","year":2002,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Computational biology; Enzyme; Computer science; Combinatorial chemistry; Chemistry; Data science; Biochemistry; Biology","score_opus":0.05165685488720307,"score_gpt":0.4176720180765428,"score_spread":0.36601516318933974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254787778","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004109677,0.0005974246,0.0013949414,0.00036333577,0.00014682733,0.00012613492,0.98578984,0.0034478193,0.0040241433],"genre_scores_gemma":[0.0035110805,0.00019360094,0.0034933817,0.00014519482,0.000019523131,0.00013697552,0.9904479,0.00014243499,0.0019099601],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986162,0.00024384112,0.00010229333,0.0005236924,0.00038054134,0.0001334434],"domain_scores_gemma":[0.99816495,0.0005863598,0.00014576105,0.00045277542,0.00044130225,0.0002088309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001319663,0.005011585,0.0024424712,0.0026224959,0.00094489136,0.0026471675,0.0047518183,0.004191455,0.026656503],"category_scores_gemma":[0.0051202155,0.0011378115,0.0027505623,0.004022182,0.00040624748,0.00106154,0.00093442464,0.0027756407,0.03232478],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080440356,0.0004103755,0.0029995122,0.0016160592,0.00020996151,0.00007134784,0.000014996595,0.0050194813,0.0015851079,0.0007115439,0.97268134,0.013876022],"study_design_scores_gemma":[0.0039450303,0.00042443193,0.0152869765,0.00035965774,0.00056966254,0.00033532418,0.00011361524,0.06415471,0.020868175,0.00429486,0.8894636,0.00018389257],"about_ca_topic_score_codex":0.022508623,"about_ca_topic_score_gemma":0.055711593,"teacher_disagreement_score":0.026656503,"about_ca_system_score_codex":0.0020006904,"about_ca_system_score_gemma":0.0030266964,"threshold_uncertainty_score":0.08917493},"labels":[],"label_agreement":null},{"id":"W4254984560","doi":"10.1515/iupac.81.0686","title":"Phytochelatin","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glossary; Ecotoxicology; Environmental risk assessment; Relation (database); Computer science; Ecology; Risk assessment; Biology; Data mining; Philosophy; Linguistics","score_opus":0.021362877524451797,"score_gpt":0.47079564697214543,"score_spread":0.4494327694476936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254984560","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033558765,0.00041761014,0.000074198266,0.00009591344,0.000022807915,0.000011261992,0.99772364,0.00015671921,0.0011622263],"genre_scores_gemma":[0.000589235,0.0002603412,0.00022680634,0.000083271094,0.0000044071794,0.000035190435,0.9980562,0.00002591004,0.0007186472],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99911374,0.00010974685,0.00013569307,0.00029780323,0.00022272166,0.000120268094],"domain_scores_gemma":[0.99868363,0.00033558253,0.00025657253,0.00030791436,0.00029226902,0.00012399715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063547766,0.0015705155,0.001546678,0.0034522521,0.0008381911,0.0024753355,0.00205839,0.0018186336,0.047868297],"category_scores_gemma":[0.0035514964,0.0006038645,0.0014495034,0.005946622,0.00034113793,0.0014746042,0.001649228,0.0021005205,0.059200976],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032921397,0.000048061618,0.005155881,0.0035443234,0.00010961304,0.00009361191,0.000046582078,0.00057370286,0.00076495897,0.0011842704,0.9778967,0.010253127],"study_design_scores_gemma":[0.00018812691,0.000028322393,0.008165204,0.00048779335,0.00007807954,0.00022522222,0.00005168332,0.00026469142,0.0007078971,0.0012385533,0.9885394,0.000025005866],"about_ca_topic_score_codex":0.0187567,"about_ca_topic_score_gemma":0.039047312,"teacher_disagreement_score":0.047868297,"about_ca_system_score_codex":0.001738837,"about_ca_system_score_gemma":0.002581319,"threshold_uncertainty_score":0.16013533},"labels":[],"label_agreement":null},{"id":"W4255159404","doi":"10.1385/1592599982","title":"Cytochrome P450 Protocols","year":2005,"lang":"en","type":"book","venue":"Humana Press eBooks","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Faculty of Pharmaceutical Sciences, University of British Columbia; Institute of Molecular and Cell Biology; School of Medicine, Vanderbilt University; Directorate for Biological Sciences; University of Ioannina; Vrije Universiteit Brussel; University of Surrey; Chiang Mai University; Karolinska Institutet; Institut National de la Santé et de la Recherche Médicale; Newcastle University; University College London; University of Dundee; University of Washington; Queen Mary University of London; Imperial College London; Showa Pharmaceutical University; University of Connecticut; Vanderbilt University; Sanofi","keywords":"Cytochrome P450; Computer science; Computational biology; Medicine; Biology; Internal medicine","score_opus":0.13918846533216817,"score_gpt":0.4007187621992431,"score_spread":0.2615302968670749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255159404","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040122685,0.11054113,0.28898364,0.008668542,0.018688194,0.0067982697,0.026317133,0.014381856,0.52160895],"genre_scores_gemma":[0.016644415,0.06879459,0.09552684,0.00530961,0.0025448664,0.005709419,0.02496322,0.0023442104,0.7781628],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99811625,0.00029315735,0.00015472442,0.00027970655,0.0010263274,0.00012990368],"domain_scores_gemma":[0.9991553,0.000115800605,0.00004723389,0.00027141313,0.0003436219,0.000066600616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017961072,0.0012941937,0.0011175382,0.0024914558,0.0015855446,0.0018036154,0.0018308015,0.0016206824,0.10031064],"category_scores_gemma":[0.0021703143,0.0009961103,0.00094096665,0.0020816093,0.00089860783,0.001901651,0.0017054636,0.005399433,0.12762722],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002671482,0.00016969591,0.00014956173,0.0022778097,0.0000467052,0.00035666907,0.00022523204,0.00031379456,0.10667799,0.038882673,0.56935316,0.28127956],"study_design_scores_gemma":[0.000013418196,0.000062457,0.00010231578,0.00006371,0.000007881271,0.00026687476,0.000014128205,0.00005108021,0.01529118,0.0020123979,0.98209965,0.000014875242],"about_ca_topic_score_codex":0.0009631252,"about_ca_topic_score_gemma":0.0020216107,"teacher_disagreement_score":0.10031064,"about_ca_system_score_codex":0.00094960793,"about_ca_system_score_gemma":0.0011670241,"threshold_uncertainty_score":0.33557254},"labels":[],"label_agreement":null},{"id":"W4255993023","doi":"10.1200/jco.2017.35.15_suppl.tps1119","title":"SANDPIPER: Phase III study of the PI3-kinase (PI3K) inhibitor taselisib (GDC-0032) plus fulvestrant in patients (pts) with estrogen receptor (ER)-positive, HER2-negative locally advanced or metastatic breast cancer (BC) enriched for pts with <i>PIK3CA-</i>mutant tumors.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Fulvestrant; Medicine; Metastatic breast cancer; Aromatase inhibitor; Internal medicine; Cancer; Estrogen receptor; Placebo; Palbociclib; PI3K/AKT/mTOR pathway; Clinical endpoint; Oncology; Breast cancer; Cancer research; Randomized controlled trial; Aromatase; Biology; Pathology; Apoptosis; Genetics","score_opus":0.05892864188827659,"score_gpt":0.4421185958734921,"score_spread":0.38318995398521555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255993023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98548895,0.0015809166,0.00090593786,0.000575781,0.00015249712,0.005363227,0.0026689002,0.00044577473,0.0028181488],"genre_scores_gemma":[0.97433156,0.0019871858,0.0037797182,0.0012876239,0.00018612854,0.0073766396,0.0052418443,0.00005125447,0.005758106],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997385,0.000109989254,0.000010962697,0.000046687335,0.000025599462,0.00006823594],"domain_scores_gemma":[0.99955577,0.0000675981,0.00009460831,0.000036523903,0.000023913635,0.0002215328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000916116,0.0016942056,0.0014480526,0.00055845466,0.0003419073,0.00088872196,0.0012190929,0.0014256883,0.005098069],"category_scores_gemma":[0.00072562817,0.0005938448,0.0012498165,0.00048640443,0.0010100987,0.0009156705,0.00036491224,0.0022772397,0.0009918058],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84410167,0.044158082,0.0026285537,0.0010919418,0.0014213858,0.00017097857,0.00017301645,0.0034378842,0.03878694,0.0004909412,0.005328525,0.058210045],"study_design_scores_gemma":[0.7312883,0.2560878,0.0050863707,0.00003296595,0.00045048483,0.00015582137,0.00003716982,0.0014342781,0.0033082594,0.00021471013,0.0018769844,0.00002681166],"about_ca_topic_score_codex":0.0020620674,"about_ca_topic_score_gemma":0.0054302285,"teacher_disagreement_score":0.005098069,"about_ca_system_score_codex":0.0011055345,"about_ca_system_score_gemma":0.002213678,"threshold_uncertainty_score":0.017054737},"labels":[],"label_agreement":null},{"id":"W4256035456","doi":"10.2165/00128413-200715930-00041","title":"New Avastin safety info issued in Canada","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Traditional medicine; Family medicine; Optometry; Ophthalmology","score_opus":0.014390874321892982,"score_gpt":0.30848279498024395,"score_spread":0.294091920658351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256035456","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014343864,0.014337941,0.0017708878,0.09018544,0.020355472,0.00061116694,0.043001186,0.002211116,0.813183],"genre_scores_gemma":[0.018798681,0.004011157,0.00066904014,0.008913349,0.0014795389,0.00003627405,0.0068786936,0.00017199553,0.95904124],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985428,0.000042167474,0.000039935854,0.000049318714,0.0011249091,0.00020104263],"domain_scores_gemma":[0.994429,0.000408928,0.00022746816,0.000098747325,0.0036991374,0.0011367379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009318619,0.000456498,0.0006124419,0.0020268895,0.0025764916,0.0042006318,0.00079338084,0.0030929307,0.095555015],"category_scores_gemma":[0.003541746,0.0004966981,0.00055551913,0.0015937178,0.0006098377,0.0005524879,0.00052177976,0.0029201824,0.017574767],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008782913,0.000038735863,0.0012377268,0.00006583985,0.0000072300068,0.00014381156,0.000025636364,0.00009543104,0.00034020693,0.000805761,0.97298145,0.024170306],"study_design_scores_gemma":[0.000038541864,0.000041064828,0.007952723,0.000064865555,0.000014927431,0.000078693745,0.000050473616,0.00023172164,0.00045403696,0.0002269898,0.9908303,0.00001565138],"about_ca_topic_score_codex":0.8057409,"about_ca_topic_score_gemma":0.9205989,"teacher_disagreement_score":0.1942591,"about_ca_system_score_codex":0.016224708,"about_ca_system_score_gemma":0.051823787,"threshold_uncertainty_score":0.39080626},"labels":[],"label_agreement":null},{"id":"W4256256284","doi":"10.1515/iupac.73.0187","title":"Cyclopropene Acid","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Okanagan College","funders":"","keywords":"Cyclopropene; Table (database); Chemistry; Product (mathematics); Organic chemistry; Fatty acid; Food science; Biochemistry; Commission; Polymer science; Computer science; Mathematics; Political science; Database; Law","score_opus":0.020537468530122255,"score_gpt":0.4578025510725623,"score_spread":0.43726508254244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256256284","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00061970495,0.0009764532,0.000078106794,0.000093909235,0.000032417756,0.000026321437,0.99679524,0.00013090034,0.0012469977],"genre_scores_gemma":[0.0016659623,0.0008944935,0.0002965315,0.00013023835,0.000017004477,0.00010596374,0.99586475,0.000028363684,0.0009966916],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991955,0.00011346687,0.00012239478,0.00030304384,0.00016151936,0.000104073915],"domain_scores_gemma":[0.9988549,0.00035270327,0.00024973645,0.00021025042,0.00023534155,0.00009713275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005301198,0.0017185123,0.0014337746,0.002864327,0.0006494187,0.0019178304,0.0015826803,0.0015300185,0.04782369],"category_scores_gemma":[0.004152504,0.000389607,0.0016725775,0.0054868385,0.00030959587,0.0010834809,0.0011255619,0.0014688651,0.043155063],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017561849,0.0001436414,0.010654126,0.010910746,0.0004335527,0.00019304913,0.00005646491,0.0012527211,0.0011939289,0.0018149449,0.9376782,0.03391244],"study_design_scores_gemma":[0.0005746498,0.00008221361,0.013996296,0.0012656609,0.00027432595,0.00027979363,0.000054290103,0.00038789824,0.000975511,0.0015275502,0.98054266,0.000039207167],"about_ca_topic_score_codex":0.012844241,"about_ca_topic_score_gemma":0.021086775,"teacher_disagreement_score":0.04782369,"about_ca_system_score_codex":0.0010890679,"about_ca_system_score_gemma":0.0021890441,"threshold_uncertainty_score":0.1599862},"labels":[],"label_agreement":null},{"id":"W4256299223","doi":"10.1002/ange.200250681","title":"The Total Synthesis of Racemic Teucvin and 12‐<i>epi</i>‐Teucvin","year":2003,"lang":"en","type":"article","venue":"Angewandte Chemie","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Science Council","keywords":"Total synthesis; Chemistry; Stereochemistry","score_opus":0.014831391551486795,"score_gpt":0.2716549413335883,"score_spread":0.25682354978210153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256299223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8650258,0.008191852,0.083879076,0.00027424286,0.00040571424,0.00046085956,0.0053244275,0.00046997427,0.035968088],"genre_scores_gemma":[0.9540365,0.0036307801,0.019389953,0.000079595724,0.00001971858,0.00015270484,0.0027108318,0.00009899956,0.019880971],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988663,0.000014135118,0.000009573234,0.000023654991,0.000022457369,0.000043647327],"domain_scores_gemma":[0.99989486,0.000013366569,0.000014894458,0.00002379347,0.000028386003,0.000024714975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020623166,0.00055738183,0.00037462558,0.000296494,0.00024796659,0.00034455134,0.00040207946,0.00031650809,0.0025129882],"category_scores_gemma":[0.00024603127,0.00016644997,0.00030516848,0.0004449562,0.00020276314,0.00034546654,0.00029423053,0.0005598734,0.00079638005],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037720718,0.00005284723,0.00012984997,0.00019416666,0.000023240998,0.00019014855,0.0001125124,0.0016046738,0.9706312,0.0044462043,0.00025303444,0.021984996],"study_design_scores_gemma":[0.000050396447,0.00062474125,0.00040174898,0.000019259762,0.000032745967,0.00017258817,0.000029993758,0.00046487685,0.975342,0.0007270049,0.02211529,0.000019433417],"about_ca_topic_score_codex":0.0009990861,"about_ca_topic_score_gemma":0.0016689665,"teacher_disagreement_score":0.0025129882,"about_ca_system_score_codex":0.00044811735,"about_ca_system_score_gemma":0.0009245957,"threshold_uncertainty_score":0.008406818},"labels":[],"label_agreement":null},{"id":"W4281652688","doi":"10.1200/jco.2022.40.16_suppl.7561","title":"Analysis of peripheral neuropathy (PN) using clinician- and patient-reported outcomes (ClinRO and PRO) in the POLARIX study.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Internal medicine; Vincristine; CHOP; Placebo; Incidence (geometry); Progression-free survival; Gastroenterology; Oncology; Lymphoma; Chemotherapy; Cyclophosphamide; Pathology","score_opus":0.20937681960913465,"score_gpt":0.5324843172641304,"score_spread":0.3231074976549957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281652688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826684,0.0031478791,0.0008295119,0.00013733435,0.00004374125,0.0007036493,0.01013906,0.000016747206,0.0023136903],"genre_scores_gemma":[0.983267,0.00054506067,0.00086587126,0.00019258389,0.000054355758,0.00089647115,0.01335821,0.000009578765,0.0008107597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959596,0.0026512821,0.00023129777,0.0005405477,0.00045841228,0.00015889634],"domain_scores_gemma":[0.9936494,0.0016936888,0.0031441005,0.00039698483,0.0005212605,0.00059448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00897734,0.0008680873,0.000666554,0.0008430222,0.0002772662,0.000988986,0.0006752184,0.00065843476,0.0022398608],"category_scores_gemma":[0.004483517,0.00027123865,0.0012190017,0.0012769774,0.00036063918,0.0008718793,0.00119554,0.0010845341,0.0003334825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10905617,0.0013411267,0.85675395,0.0009969013,0.007075148,0.00014596336,0.00017645153,0.0009726758,0.0013617289,0.00022295184,0.0024257356,0.019471232],"study_design_scores_gemma":[0.007762461,0.011295066,0.9744673,0.000102534505,0.0017180963,0.0002949519,0.00018792231,0.0013177582,0.0003165033,0.0001719247,0.0023232943,0.000042127136],"about_ca_topic_score_codex":0.0011348455,"about_ca_topic_score_gemma":0.0021186944,"teacher_disagreement_score":0.00897734,"about_ca_system_score_codex":0.0005337783,"about_ca_system_score_gemma":0.0005377303,"threshold_uncertainty_score":0.047477245},"labels":[],"label_agreement":null},{"id":"W4281684131","doi":"10.1200/jco.2022.40.16_suppl.e12523","title":"Telehealth delivered Tai Chi intervention for managing aromatase inhibitor-induced arthralgia in breast cancer patients: <i>TaiChi4Joint</i> during the COVID-19 pandemic a Pilot study.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Brief Pain Inventory; Physical therapy; Breast cancer; Quality of life (healthcare); Pittsburgh Sleep Quality Index; WOMAC; Attendance; Internal medicine; Cancer; Osteoarthritis; Alternative medicine; Chronic pain; Psychiatry","score_opus":0.14073534185881623,"score_gpt":0.4863820886847931,"score_spread":0.34564674682597685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281684131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951696,0.00021373051,0.000106490304,0.00019363638,0.000057795056,0.0032500252,0.00028512857,0.0000148642175,0.0007087059],"genre_scores_gemma":[0.9849969,0.0004957045,0.001205368,0.0005146473,0.00016470972,0.010989166,0.00036614767,0.0000059669696,0.001261358],"study_design_codex":"nonrandomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994779,0.0002336629,0.000029611358,0.000055278266,0.000037123613,0.00016628146],"domain_scores_gemma":[0.9991653,0.0001902193,0.00010536292,0.000046917,0.00008027659,0.0004118894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011825198,0.0005071515,0.0007475274,0.00028277934,0.0007150675,0.000451768,0.00048820418,0.000891294,0.0061274227],"category_scores_gemma":[0.001401188,0.00026919311,0.0011288195,0.00024719397,0.0003561788,0.0004123859,0.00047525275,0.0012863918,0.0005499515],"study_design_candidate":"nonrandomized_trial","study_design_consensus":"nonrandomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21145113,0.56255794,0.029613521,0.0023398625,0.0006914088,0.00042487122,0.0022969623,0.0006124293,0.009403326,0.00014880001,0.0034583597,0.17700146],"study_design_scores_gemma":[0.044058207,0.9097967,0.043201704,0.00008469704,0.00020900677,0.00004791909,0.00066466257,0.0002219504,0.00050113146,0.000034763645,0.0011603103,0.000018831664],"about_ca_topic_score_codex":0.0046623624,"about_ca_topic_score_gemma":0.008519536,"teacher_disagreement_score":0.0061274227,"about_ca_system_score_codex":0.00057993527,"about_ca_system_score_gemma":0.0018765248,"threshold_uncertainty_score":0.020498276},"labels":[],"label_agreement":null},{"id":"W4281727653","doi":"10.1200/jco.2022.40.16_suppl.e24066","title":"Building a model to predict the risk of multiple severe neurotoxicities in cancer survivors after cisplatin treatment.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto","funders":"National Institutes of Health","keywords":"Medicine; Internal medicine; Oncology; Head and neck cancer; Concordance; Cancer","score_opus":0.13518160812579472,"score_gpt":0.4799018621242025,"score_spread":0.3447202539984078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281727653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6686904,0.0029879923,0.29656002,0.006489794,0.00054280745,0.00042434165,0.016294619,0.002372632,0.0056374194],"genre_scores_gemma":[0.9460312,0.0006036831,0.0323425,0.00070418837,0.0001735071,0.00074007706,0.012562025,0.000115814124,0.0067269243],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.999416,0.00024783783,0.000027277778,0.00018027422,0.000033420478,0.00009520317],"domain_scores_gemma":[0.9966543,0.002743405,0.00019102491,0.00005387231,0.00021628087,0.00014120208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029092487,0.0012416473,0.0012609919,0.0013503142,0.00057571055,0.0012180263,0.0013592701,0.0018255248,0.008828504],"category_scores_gemma":[0.005123795,0.0006327779,0.0016384334,0.00070487807,0.00047666783,0.0006040481,0.0010067708,0.0021678787,0.0010857597],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094482617,0.0003480138,0.10997914,0.00017444123,0.00052303553,0.00054986327,0.0001451336,0.83651155,0.0005336263,0.0026707344,0.008964941,0.038654756],"study_design_scores_gemma":[0.000056209414,0.00009279286,0.0033832905,0.000032092525,0.00007390265,0.00006301901,0.000026750175,0.99371064,0.000080949736,0.0018009292,0.0006671711,0.000012274752],"about_ca_topic_score_codex":0.025353242,"about_ca_topic_score_gemma":0.014594197,"teacher_disagreement_score":0.025353242,"about_ca_system_score_codex":0.0008359071,"about_ca_system_score_gemma":0.0017498403,"threshold_uncertainty_score":0.050411344},"labels":[],"label_agreement":null},{"id":"W4282037661","doi":"10.1200/jco.2022.40.16_suppl.1545","title":"Impact of proactive symptom monitoring on quality of life (QoL) and treatment toxicity in patients with cancer receiving chemotherapy: A meta-analysis of randomized clinical trials.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Meta-analysis; Randomized controlled trial; Minimal clinically important difference; Quality of life (healthcare); Clinical trial; MEDLINE; Strictly standardized mean difference; Internal medicine; Odds ratio; Cancer; Physical therapy","score_opus":0.42822123247110955,"score_gpt":0.6059991463496031,"score_spread":0.1777779138784935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282037661","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028785082,0.96691996,0.0013098561,0.00039423208,0.00043703648,0.0008273102,0.0008051278,0.00006544896,0.00045597262],"genre_scores_gemma":[0.6391347,0.34858263,0.0049303975,0.0014664908,0.00051717967,0.0031615326,0.0015077211,0.000073160874,0.0006261587],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9856129,0.008569066,0.0031939473,0.0012938774,0.0009897785,0.00034038728],"domain_scores_gemma":[0.97989094,0.01443869,0.003717659,0.00078092044,0.00083277526,0.0003390739],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.021650944,0.002888783,0.01740618,0.0044270833,0.000635412,0.0034304203,0.0019566389,0.002657373,0.0032131104],"category_scores_gemma":[0.034127418,0.0016499031,0.061972797,0.004733158,0.0009144843,0.001981896,0.0014289756,0.0027820729,0.00033350158],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011809172,0.000055932902,0.0033211175,0.07490484,0.9040499,0.00005395692,0.000031474294,0.0005797041,0.00015244691,0.00006189254,0.0002202067,0.0047593345],"study_design_scores_gemma":[0.0033226968,0.0005198774,0.0023055773,0.0034630063,0.9895341,0.000039430746,0.000018650171,0.00019847769,0.00008382511,0.00011946967,0.00037959544,0.000015359716],"about_ca_topic_score_codex":0.004023961,"about_ca_topic_score_gemma":0.0068410034,"teacher_disagreement_score":0.98259383,"about_ca_system_score_codex":0.0024684526,"about_ca_system_score_gemma":0.0023241742,"threshold_uncertainty_score":0.11450249},"labels":[],"label_agreement":null},{"id":"W4283022221","doi":"10.1093/oncolo/oyac106","title":"The Value of In Vivo Reflectance Confocal Microscopy as an Assessment Tool in Chemotherapy-Induced Peripheral Neuropathy: A Pilot Study","year":2022,"lang":"en","type":"article","venue":"The Oncologist","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; RWTH Aachen University; Bundesministerium für Bildung und Forschung; Medical Research Foundation; Melville Charitable Trust","keywords":"Medicine; Peripheral neuropathy; Chemotherapy-induced peripheral neuropathy; In vivo; Confocal microscopy; Chemotherapy; Confocal; Pathology; Peripheral; Radiology; Internal medicine; Optics","score_opus":0.04574533894228266,"score_gpt":0.4373136524696243,"score_spread":0.3915683135273416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283022221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998823,0.00016557219,0.00048399673,0.000012341692,0.000005428287,0.00025470246,0.000030832038,0.000006155285,0.00021790969],"genre_scores_gemma":[0.99828845,0.00013983705,0.0010794785,0.00003624011,0.000018480498,0.00019131404,0.00007241337,0.0000028806946,0.00017100024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988611,0.0006978878,0.00006094023,0.00015637625,0.00012002733,0.00010368201],"domain_scores_gemma":[0.9966222,0.0014557054,0.0005296269,0.00044328775,0.00060029415,0.00034880053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003348292,0.00074495375,0.00043844996,0.00042126395,0.00036967438,0.00032740788,0.0003392219,0.00048890593,0.0016625315],"category_scores_gemma":[0.003065596,0.00020983467,0.0003988949,0.00022727078,0.00072464236,0.0005369451,0.00042167434,0.0004929364,0.00033010994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.097271696,0.06859405,0.45890087,0.00080626085,0.00047595348,0.0029784453,0.0020966085,0.0010686896,0.27808988,0.00018428208,0.00045410777,0.08907909],"study_design_scores_gemma":[0.003157807,0.5595851,0.40439484,0.00004411947,0.00042797046,0.0030700562,0.00065165624,0.0024692027,0.025145402,0.0000941879,0.00090930535,0.00005042991],"about_ca_topic_score_codex":0.0009885111,"about_ca_topic_score_gemma":0.0008791793,"teacher_disagreement_score":0.003348292,"about_ca_system_score_codex":0.00036181646,"about_ca_system_score_gemma":0.00044471453,"threshold_uncertainty_score":0.017707646},"labels":[],"label_agreement":null},{"id":"W4283325379","doi":"10.26355/eurrev_202206_28973","title":"Risk factors for oxaliplatin-induced peripheral neuropathy: a systematic review and meta-analysis.","year":2022,"lang":"en","type":"review","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Oxaliplatin; Odds ratio; Internal medicine; MEDLINE; Body mass index; Peripheral neuropathy; Oncology; Observational study; Regimen; Diabetes mellitus; Cancer; Colorectal cancer","score_opus":0.23999662731645166,"score_gpt":0.3869768595827417,"score_spread":0.14698023226629003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283325379","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021252544,0.9967179,0.00029530586,0.00014742774,0.000100037054,0.00015740126,0.00029195147,0.000013619325,0.00015114267],"genre_scores_gemma":[0.07719772,0.91908807,0.0014967056,0.0005070023,0.00017835786,0.000652499,0.0006009884,0.000014522733,0.0002641094],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99566025,0.001998683,0.0011757605,0.00045530437,0.0005127627,0.00019725974],"domain_scores_gemma":[0.9923138,0.0053050457,0.0014364977,0.00021785697,0.0006086541,0.00011813587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00828976,0.0026178467,0.013363545,0.0048646,0.00054684747,0.002363434,0.0016103941,0.0019516514,0.003539485],"category_scores_gemma":[0.01738182,0.0012581983,0.028197471,0.006029297,0.00042390413,0.0011202472,0.0011443943,0.0015002862,0.00027409356],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018032484,0.00004416202,0.005183247,0.49743897,0.47396338,0.00016267115,0.000066522916,0.00056499545,0.0002628276,0.00017172561,0.0010260235,0.019312223],"study_design_scores_gemma":[0.0004563356,0.0002008095,0.0043416712,0.029129269,0.96304274,0.00012540405,0.000033736986,0.00017353572,0.00011371724,0.0001756684,0.002187967,0.000019246161],"about_ca_topic_score_codex":0.0064075934,"about_ca_topic_score_gemma":0.013446038,"teacher_disagreement_score":0.013363545,"about_ca_system_score_codex":0.001851046,"about_ca_system_score_gemma":0.0037656785,"threshold_uncertainty_score":0.043840945},"labels":[],"label_agreement":null},{"id":"W4286296056","doi":"10.1200/jco.2022.40.16_suppl.12056","title":"Remote symptom monitoring (RSM) during treatment for metastatic prostate cancer (mPC) in older men: Feasibility and efficacy.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Prostate Cancer Canada","keywords":"Medicine; Prostate cancer; Quality of life (healthcare); Cohort; Mood; Anxiety; Prospective cohort study; Cohort study; Physical therapy; Psychological intervention; Internal medicine; Cancer; Psychiatry","score_opus":0.22121105787326412,"score_gpt":0.5433773381928398,"score_spread":0.3221662803195757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286296056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964122,0.001956558,0.00015726642,0.00010318053,0.000019267976,0.00043261694,0.00024471854,0.0000133823005,0.0006609543],"genre_scores_gemma":[0.99824154,0.00064209435,0.00042712662,0.00008684955,0.00003680564,0.00024724624,0.00020004803,0.0000015889857,0.000116763455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863535,0.0008059192,0.00011895355,0.00014671903,0.00020030892,0.000092730384],"domain_scores_gemma":[0.996436,0.0010997971,0.0015920684,0.00014371861,0.00022596637,0.0005024519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031965114,0.0003341142,0.0007190929,0.00033664843,0.0003082343,0.0004585902,0.00037241503,0.0004264704,0.0017076171],"category_scores_gemma":[0.00666238,0.00022201762,0.0010716455,0.0003649966,0.00024427215,0.00059491355,0.00073803245,0.0005536059,0.00020432194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035525206,0.0100291455,0.70650756,0.0015240419,0.001210317,0.00007859509,0.00084805035,0.00047381961,0.0011376383,0.000056574416,0.00083111157,0.24177797],"study_design_scores_gemma":[0.0038558613,0.068256795,0.9241302,0.00022717482,0.0006490454,0.0001636023,0.00034770792,0.0010725982,0.00033226525,0.000052075644,0.0008802188,0.00003255782],"about_ca_topic_score_codex":0.001182642,"about_ca_topic_score_gemma":0.0023677375,"teacher_disagreement_score":0.0031965114,"about_ca_system_score_codex":0.0003074803,"about_ca_system_score_gemma":0.00055200496,"threshold_uncertainty_score":0.01690495},"labels":[],"label_agreement":null},{"id":"W4286298168","doi":"10.1200/jco.2022.40.16_suppl.e21559","title":"Whose mitochondria are more stable, male or female ones? Response of neurosteroid status of mitochondria of cerebral cortex cells to melanoma development in presense of chronic pain.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Estrone; Internal medicine; Endocrinology; Testosterone (patch); Medicine; Hormone; Cerebral cortex; Subcutaneous injection","score_opus":0.0911648732861474,"score_gpt":0.43104749565425093,"score_spread":0.3398826223681035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286298168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960936,0.0022152746,0.00042034796,0.00010370522,0.000026166179,0.0000075585317,0.0003453119,0.000007556038,0.00078048266],"genre_scores_gemma":[0.99728715,0.00085022475,0.00021595022,0.000032897886,0.000010137085,0.0000108926315,0.00027479313,0.00000409821,0.0013139267],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991345,0.000009243986,0.0000051681614,0.000024112114,0.000018917624,0.000029059393],"domain_scores_gemma":[0.99988675,0.000008338664,0.00003912249,0.0000073702367,0.00002141935,0.00003700886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010289665,0.00013797989,0.00016762476,0.00022442151,0.0001898517,0.00026768615,0.00012213289,0.00019812393,0.0017998051],"category_scores_gemma":[0.00010123318,0.00008155976,0.00013652105,0.00012756088,0.00024157295,0.00029420134,0.00016360177,0.00022290912,0.00035257908],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009588701,0.000044851804,0.011768327,0.000055799388,0.000013305262,0.00022491529,0.00015715446,0.000007823401,0.98455966,0.00008205539,0.00006726859,0.0020599863],"study_design_scores_gemma":[0.000044742268,0.0015434816,0.6105905,0.000025317646,0.000072082075,0.0015866362,0.001690232,0.00026229565,0.38024125,0.0002366568,0.0036894777,0.000017437109],"about_ca_topic_score_codex":0.00059738714,"about_ca_topic_score_gemma":0.0008790059,"teacher_disagreement_score":0.0017998051,"about_ca_system_score_codex":0.00016709513,"about_ca_system_score_gemma":0.0001245665,"threshold_uncertainty_score":0.0060209036},"labels":[],"label_agreement":null},{"id":"W4286853546","doi":"10.3791/54552-v","title":"A Simple and Efficient Protocol for the Catalytic Insertion Polymerization of Functional Norbornenes","year":2017,"lang":"en","type":"article","venue":"Journal of Visualized Experiments","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Norbornene; Polymerization; Monomer; Double bond; Polymer chemistry; Chemistry; Polymer; Copolymer; Catalysis; Organic chemistry","score_opus":0.08528256066835141,"score_gpt":0.5132603269641078,"score_spread":0.42797776629575646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286853546","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52688736,0.005593302,0.43977147,0.00077737443,0.00053774053,0.0019374025,0.0018674076,0.0012864115,0.021341592],"genre_scores_gemma":[0.8034615,0.008018405,0.1694031,0.00029824636,0.00010585309,0.0013510028,0.0020918737,0.0002875092,0.014982531],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997342,0.000025537807,0.000035890305,0.00006403999,0.00008830846,0.000052008563],"domain_scores_gemma":[0.99989593,0.000016869604,0.000027354143,0.000023104461,0.000016086546,0.000020749532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026681524,0.00082085107,0.00041415638,0.000367341,0.0003782275,0.00021601492,0.00051887863,0.00046728193,0.0026985058],"category_scores_gemma":[0.00022481901,0.00040864103,0.0003549882,0.0003177777,0.0002393758,0.00071414816,0.00050849275,0.0019172673,0.0012607859],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018700342,0.00006819641,0.00003177382,0.00017567689,0.000007749521,0.00013333706,0.000050798008,0.00023603033,0.99024034,0.0011524002,0.00023577409,0.007649229],"study_design_scores_gemma":[0.000027985801,0.0003044171,0.00038109958,0.000015494157,0.00001335466,0.00040798864,0.0000151771965,0.00073122355,0.9827527,0.0003248765,0.014998713,0.00002695144],"about_ca_topic_score_codex":0.0002435387,"about_ca_topic_score_gemma":0.00095421204,"teacher_disagreement_score":0.0026985058,"about_ca_system_score_codex":0.0002453985,"about_ca_system_score_gemma":0.0005710492,"threshold_uncertainty_score":0.0090274215},"labels":[],"label_agreement":null},{"id":"W4289000605","doi":"","title":"Pilules Orientales pour poitrine idéale","year":2019,"lang":"fr","type":"preprint","venue":"HAL (Le Centre pour la Communication Scientifique Directe)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Society for the History of Medicine","funders":"","keywords":"Art","score_opus":0.018244937452025132,"score_gpt":0.27571412983419546,"score_spread":0.2574691923821703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289000605","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17049731,0.005235963,0.18027084,0.0078046015,0.003372014,0.00025816495,0.00069568295,0.0011062319,0.6307592],"genre_scores_gemma":[0.7050402,0.0033939437,0.045495294,0.0016455569,0.0011883224,0.00029208552,0.00068668096,0.00090392114,0.24135399],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.999298,0.0001680642,0.000019671204,0.00012807471,0.00022807237,0.00015806567],"domain_scores_gemma":[0.99918395,0.0003157149,0.00007193893,0.000084592204,0.000178933,0.00016484976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059256144,0.0012716879,0.0010097822,0.002279888,0.0022192968,0.0034434404,0.0006172354,0.0016345864,0.029792741],"category_scores_gemma":[0.0025107074,0.00037958025,0.0010174409,0.00062513986,0.0028773001,0.002564408,0.0025037646,0.005317908,0.0068184305],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014161976,0.000041344327,0.00012447847,0.00011054948,0.000016865071,0.0002076178,0.00020399706,0.0018726849,0.004405969,0.9752053,0.0050562588,0.012613222],"study_design_scores_gemma":[0.00006786151,0.000072261144,0.00041748278,0.000072669776,0.000021908689,0.00066493347,0.00048514162,0.009121067,0.0039996426,0.92376107,0.061276466,0.000039581944],"about_ca_topic_score_codex":0.0016734448,"about_ca_topic_score_gemma":0.0013279465,"teacher_disagreement_score":0.029792741,"about_ca_system_score_codex":0.0013819501,"about_ca_system_score_gemma":0.0005802706,"threshold_uncertainty_score":0.099666715},"labels":[],"label_agreement":null},{"id":"W4289878771","doi":"10.1093/noajnl/vdac078.084","title":"SYST-05 OPTIMIZING HER2-TARGETED THERAPIES (TT) FOR BREAST CANCER (BC) LEPTOMENINGEAL METASTASES (LM): A SYSTEMATIC REVIEW AND META-ANALYSIS","year":2022,"lang":"en","type":"review","venue":"Neuro-Oncology Advances","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; McGill University; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Trastuzumab; Lapatinib; Trastuzumab emtansine; Hazard ratio; Internal medicine; Oncology; Confidence interval; Metastatic breast cancer; Breast cancer; Meta-analysis; Cancer","score_opus":0.10454557952041067,"score_gpt":0.4351710202606059,"score_spread":0.33062544074019523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289878771","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0072346944,0.98202443,0.002042221,0.00048152608,0.00027033433,0.001209154,0.0057384856,0.0001479864,0.00085112266],"genre_scores_gemma":[0.23863003,0.73817945,0.008000186,0.0017303941,0.0003677012,0.0064028376,0.004859276,0.00012607935,0.001703991],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.993768,0.003150402,0.0015308766,0.00064110395,0.0006905593,0.0002192161],"domain_scores_gemma":[0.9921774,0.0053047286,0.0014067772,0.0002565335,0.00069450843,0.00016005454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008389898,0.0023712057,0.018839043,0.0071522496,0.0005348901,0.0030705126,0.0020355124,0.0019280418,0.010002392],"category_scores_gemma":[0.016856346,0.0011796105,0.0326832,0.008471538,0.0005366205,0.0015820436,0.0015274202,0.0016380231,0.0008289867],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013203218,0.000018492085,0.0018534705,0.5434883,0.44335172,0.00008393437,0.00006325604,0.00055531575,0.00026552536,0.00023390692,0.0011604055,0.007605388],"study_design_scores_gemma":[0.0011287809,0.00018163776,0.002552619,0.027286388,0.96471614,0.00008037352,0.00003460424,0.00032168577,0.00010098148,0.00032096868,0.003246839,0.000028933971],"about_ca_topic_score_codex":0.006139398,"about_ca_topic_score_gemma":0.014480309,"teacher_disagreement_score":0.018839043,"about_ca_system_score_codex":0.0022543084,"about_ca_system_score_gemma":0.0037169927,"threshold_uncertainty_score":0.04437059},"labels":[],"label_agreement":null},{"id":"W4292534152","doi":"10.21203/rs.3.rs-1859594/v1","title":"Physiotherapy intervention on changes in post-chemotherapy sensibility with taxanes","year":2022,"lang":"en","type":"preprint","venue":"Research Square","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Taxane; Sensibility; Medicine; Chemotherapy; Physical therapy; Internal medicine; Breast cancer; Cancer","score_opus":0.07127199899828172,"score_gpt":0.4938026132663427,"score_spread":0.422530614268061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292534152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992619,0.00020834508,0.000072989955,0.000012931537,0.00000405838,0.000036633428,0.000030668627,0.0000037527584,0.0003687119],"genre_scores_gemma":[0.99961275,0.000064985514,0.00006471759,0.000011655495,0.000006016207,0.000019143405,0.00003957035,6.3165555e-7,0.00018068979],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99951625,0.00021168595,0.00003451726,0.000051506056,0.00011018966,0.0000758275],"domain_scores_gemma":[0.9990005,0.00029428324,0.0003763639,0.000043004056,0.000113494716,0.00017246055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005925247,0.00024021372,0.00032083923,0.00027356774,0.00018972339,0.00017879119,0.00012335058,0.00029903644,0.0031685773],"category_scores_gemma":[0.0022243285,0.00010259957,0.00036005347,0.00014709405,0.00017817563,0.00016735934,0.0002227485,0.00031754875,0.00026410562],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013801744,0.010576317,0.82832825,0.0005061433,0.0005282019,0.0009263468,0.00073701906,0.00069249317,0.03730569,0.00004808189,0.00043379026,0.106115855],"study_design_scores_gemma":[0.00017238205,0.026887251,0.9703208,0.000017479708,0.00006895777,0.00031024005,0.0001083295,0.00018443889,0.0016658416,0.000008238315,0.00024858167,0.0000073452197],"about_ca_topic_score_codex":0.00026751775,"about_ca_topic_score_gemma":0.00040939508,"teacher_disagreement_score":0.0031685773,"about_ca_system_score_codex":0.00014445161,"about_ca_system_score_gemma":0.00015656395,"threshold_uncertainty_score":0.010599971},"labels":[],"label_agreement":null},{"id":"W4295818074","doi":"10.1016/j.annonc.2022.07.665","title":"537P A phase I/II study of oral chk1 inhibitor LY2880070 in combination with low-dose gemcitabine in patients with advanced or metastatic ovarian cancer","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ozmosis Research (Canada); Alberta Health Services; Princess Margaret Cancer Centre; McGill University Health Centre; University Health Network; Centre Hospitalier de l’Université de Montréal; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Gemcitabine; Oncology; Internal medicine; Phases of clinical research; Ovarian cancer; Cancer; Chemotherapy","score_opus":0.05685263538688413,"score_gpt":0.4240513685658881,"score_spread":0.367198733179004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295818074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98849815,0.0031579125,0.0005536023,0.0009895553,0.00022891194,0.001584089,0.0016317483,0.00021116009,0.0031448305],"genre_scores_gemma":[0.98407865,0.0041738707,0.0012498758,0.00090770493,0.00017002314,0.0015214983,0.0035423432,0.000070436574,0.0042857486],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997675,0.00008726182,0.00001107644,0.000044247867,0.000019873332,0.00007001073],"domain_scores_gemma":[0.99969935,0.0000449959,0.000039181203,0.00002425308,0.00001697348,0.00017529477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007151892,0.0011867022,0.0023823641,0.0005241915,0.0003718304,0.0010653274,0.00079512235,0.0010384554,0.0060075778],"category_scores_gemma":[0.00052451034,0.0006203842,0.0015454192,0.00052107824,0.0008542626,0.00070348993,0.0003476032,0.0035705802,0.001173972],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7275381,0.045916203,0.0045643807,0.0013709973,0.002276329,0.00037121723,0.00023246957,0.0037672613,0.066982284,0.0005152288,0.008674986,0.1377906],"study_design_scores_gemma":[0.6346281,0.34210718,0.010643213,0.00006774141,0.0011332813,0.0002580094,0.00009250142,0.0015540406,0.005031642,0.00022856862,0.004207299,0.0000484617],"about_ca_topic_score_codex":0.002436553,"about_ca_topic_score_gemma":0.007826753,"teacher_disagreement_score":0.0060075778,"about_ca_system_score_codex":0.00095650397,"about_ca_system_score_gemma":0.0019084221,"threshold_uncertainty_score":0.020097375},"labels":[],"label_agreement":null},{"id":"W4295828440","doi":"10.1016/j.annonc.2022.07.1492","title":"1360MO Quality of life and patient-relevant endpoints with darolutamide in the phase III ARASENS study","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Cliniques Universitaires Saint-Luc; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Medical Research Council; Université Catholique de Louvain; Bayer HealthCare; University College London; Bayer","keywords":"Medicine; Docetaxel; Prostate cancer; Internal medicine; Cumulative incidence; Incidence (geometry); Rash; Androgen deprivation therapy; Adverse effect; Clinical endpoint; Cancer; Randomized controlled trial; Cohort","score_opus":0.13070937859407863,"score_gpt":0.4640188743778277,"score_spread":0.333309495783749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295828440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99078244,0.0041813245,0.00028095796,0.00039327622,0.00010314883,0.00035211115,0.001923819,0.00003624834,0.0019467088],"genre_scores_gemma":[0.99235874,0.0018063801,0.0006503576,0.0003827272,0.00009308141,0.0005379597,0.0023561076,0.00001754648,0.0017970252],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992889,0.00045729225,0.00002743124,0.000056923855,0.00007498622,0.00009452075],"domain_scores_gemma":[0.999451,0.00012869773,0.0001670512,0.00005379219,0.00005063193,0.00014880927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018400458,0.0008137779,0.0015100281,0.00019872916,0.0002207368,0.0006413308,0.00040874214,0.0005162344,0.0022050794],"category_scores_gemma":[0.0010358972,0.00019743279,0.0025026095,0.00032239346,0.00036791,0.0004236244,0.0003725553,0.0018651551,0.00037231456],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8792433,0.007188784,0.02141997,0.0009490167,0.0077132233,0.000104513325,0.00008660551,0.0034078483,0.01004691,0.00046166684,0.003729727,0.06564841],"study_design_scores_gemma":[0.52159554,0.26071593,0.18681759,0.0002135588,0.008262549,0.0003316308,0.00013972416,0.004097897,0.005235011,0.0010448118,0.011459276,0.00008643166],"about_ca_topic_score_codex":0.00081774424,"about_ca_topic_score_gemma":0.0023582547,"teacher_disagreement_score":0.0022050794,"about_ca_system_score_codex":0.0006047506,"about_ca_system_score_gemma":0.0009846251,"threshold_uncertainty_score":0.0097311735},"labels":[],"label_agreement":null},{"id":"W4295865713","doi":"10.1136/spcare-2022-003815","title":"Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"BMJ Supportive & Palliative Care","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto","funders":"","keywords":"Duloxetine; Medicine; Chemotherapy-induced peripheral neuropathy; Placebo; Duloxetine Hydrochloride; Meta-analysis; Randomized controlled trial; Clinical trial; Internal medicine; Peripheral neuropathy; Alternative medicine; Diabetes mellitus","score_opus":0.22426579728075305,"score_gpt":0.4838111190861874,"score_spread":0.2595453218054343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295865713","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016029158,0.9974554,0.00019971271,0.00014440902,0.000081501195,0.00020019153,0.00017121182,0.000012154424,0.00013235424],"genre_scores_gemma":[0.060225625,0.93612856,0.0014586728,0.00062640477,0.00022579043,0.0008058722,0.00033160252,0.000013269364,0.00018425878],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9912826,0.0043194415,0.0022028214,0.0007604823,0.001173549,0.00026110685],"domain_scores_gemma":[0.98147464,0.013889358,0.0028634318,0.00041242898,0.0011667786,0.00019333688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013853568,0.0026671155,0.016969481,0.006662387,0.0006238783,0.0031605482,0.0020024192,0.0021442682,0.0040021385],"category_scores_gemma":[0.03048184,0.0013569412,0.028823389,0.0065800054,0.00077627186,0.00164814,0.0012131608,0.0016601748,0.00025011713],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012589539,0.000027972377,0.0022893029,0.6734048,0.30525002,0.00010690724,0.00007361296,0.00042013545,0.00015271461,0.00014786793,0.0007492692,0.016118372],"study_design_scores_gemma":[0.0007469531,0.0003325175,0.004361762,0.09290603,0.89822906,0.00016389733,0.000058546942,0.00024603598,0.00016000189,0.0002900024,0.0024733485,0.00003182942],"about_ca_topic_score_codex":0.007679013,"about_ca_topic_score_gemma":0.016562121,"teacher_disagreement_score":0.016969481,"about_ca_system_score_codex":0.0029345136,"about_ca_system_score_gemma":0.004853132,"threshold_uncertainty_score":0.07326555},"labels":[],"label_agreement":null},{"id":"W4296465570","doi":"10.1158/1535-7163.1207.3.10","title":"Topoisomerase-IIα expression as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel","year":2004,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Docetaxel; Doxorubicin; Confidence interval; Medicine; Odds ratio; Internal medicine; Breast cancer; Chemotherapy; Cancer; Oncology; Paclitaxel; Population; Topoisomerase; Pharmacology; Chemistry; In vitro","score_opus":0.019418069999127794,"score_gpt":0.3001555046830174,"score_spread":0.28073743468388956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296465570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99949443,0.0002160343,0.00008496919,0.000021517228,0.000011130652,0.000020147416,0.000044614546,0.0000017113254,0.000105505125],"genre_scores_gemma":[0.99964845,0.000052012976,0.00004950666,0.00002950753,0.000024668576,0.000019005654,0.00011035801,7.262975e-7,0.00006561308],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99937695,0.00023376745,0.000045575638,0.00019209555,0.00009495554,0.000056652923],"domain_scores_gemma":[0.99880254,0.0005062068,0.0002850777,0.00008489589,0.000062775376,0.00025860875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010024895,0.00029451342,0.00076107157,0.0003380065,0.00027803998,0.00048508047,0.00019314335,0.0004503864,0.001041192],"category_scores_gemma":[0.00242287,0.00023388526,0.00057641475,0.00019597512,0.00041843296,0.00033696613,0.0002514312,0.0005342537,0.00020435936],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05403247,0.0008958776,0.92655855,0.00004918667,0.0007221345,0.00022312357,0.000079579164,0.00055130845,0.0062018563,0.000046232646,0.00020972796,0.010429947],"study_design_scores_gemma":[0.0036851938,0.02614863,0.9623059,0.00001635443,0.00081731036,0.0011190682,0.00013322415,0.0033084895,0.0015309451,0.000153759,0.00075956876,0.000021641341],"about_ca_topic_score_codex":0.00033515962,"about_ca_topic_score_gemma":0.00030864187,"teacher_disagreement_score":0.001041192,"about_ca_system_score_codex":0.00021094702,"about_ca_system_score_gemma":0.00021775132,"threshold_uncertainty_score":0.005301714},"labels":[],"label_agreement":null},{"id":"W4299332341","doi":"10.5281/zenodo.6974577","title":"PKC isoforms activate LRRK1 kinase by phosphorylating conserved residues (Ser1064, Ser1074 and Thr1075) within the CORB GTPase domain","year":2022,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sciex (Canada)","funders":"Medical Research Council","keywords":"Gene isoform; Phosphorylation; GTPase; Protein kinase C; Chemistry; Kinase; Domain (mathematical analysis); Cell biology; Biochemistry; Biology; Gene","score_opus":0.028267698779940183,"score_gpt":0.2665394141196706,"score_spread":0.2382717153397304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4299332341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930058,0.0024085287,0.0013324412,0.00023521316,0.000081708975,0.000036885045,0.00037586453,0.00006781533,0.0024558087],"genre_scores_gemma":[0.99180603,0.0018280615,0.0012175402,0.000081182,0.00003205867,0.000049527785,0.0008304122,0.00001028063,0.0041449834],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998883,0.000015539244,0.000010425314,0.000020062747,0.000026247131,0.000039487604],"domain_scores_gemma":[0.9999511,0.0000059928143,0.00001815277,0.000007192625,0.0000042418,0.000013260121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010101283,0.00036131594,0.00017791893,0.00017224968,0.0001300833,0.00018602256,0.00014936436,0.00015567358,0.0033138478],"category_scores_gemma":[0.000077396784,0.00008712815,0.00031110484,0.00013581871,0.00013370249,0.0001314711,0.00014472927,0.00043968236,0.0009556723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005974138,0.000082615385,0.00053579354,0.000060968312,0.000012202667,0.000100115554,0.000011172366,0.00007639865,0.9957444,0.00008961283,0.00012072176,0.0025685786],"study_design_scores_gemma":[0.00009258031,0.0003635937,0.0076450547,0.000006159305,0.00001807855,0.00043394856,0.000021508442,0.0005127701,0.9882664,0.000058154325,0.0025784413,0.0000033158174],"about_ca_topic_score_codex":0.00030543163,"about_ca_topic_score_gemma":0.0005084145,"teacher_disagreement_score":0.0033138478,"about_ca_system_score_codex":0.00029342654,"about_ca_system_score_gemma":0.00019129209,"threshold_uncertainty_score":0.011085868},"labels":[],"label_agreement":null},{"id":"W4300424574","doi":"10.17615/nn8a-yn80","title":"Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy","year":2020,"lang":"en","type":"article","venue":"UNC Libraries","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill; National Center for Advancing Translational Sciences; National Institutes of Health; National Cancer Institute; National Institute on Aging; University of Alberta; Breast Cancer Research Foundation","keywords":"Taxane; Medicine; Metastatic breast cancer; Oncology; Internal medicine; Breast cancer; Chemotherapy; Toxicity; Cancer","score_opus":0.012601772211202514,"score_gpt":0.2434031850421806,"score_spread":0.23080141283097808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300424574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99857175,0.00066648715,0.000025646024,0.00005789284,0.0000032548999,0.0000050740623,0.00014365833,0.0000025720424,0.00052372355],"genre_scores_gemma":[0.9994479,0.0001930648,0.00003449999,0.000030686504,0.000007998857,0.000003922964,0.00015465805,6.585496e-7,0.00012668806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998241,0.00006467777,0.000023016595,0.000017227128,0.00004402778,0.000027086884],"domain_scores_gemma":[0.99921966,0.00013869799,0.00042956902,0.000019202054,0.0000614318,0.00013146372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002855931,0.00012346637,0.00021461173,0.0003323304,0.00015653319,0.00031911687,0.0001313146,0.00018683885,0.0010126396],"category_scores_gemma":[0.0017600325,0.0000673344,0.00018760271,0.00058873306,0.00009750039,0.00016069284,0.0002510788,0.0003622223,0.00010674975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003013631,0.00006991266,0.9949604,0.000014569624,0.000041592844,0.000028131239,0.000019939134,0.000075127464,0.00013505931,0.000007737618,0.000102295606,0.004243923],"study_design_scores_gemma":[0.000009931285,0.00030588428,0.9991646,0.0000079886995,0.000025226671,0.00011047524,0.000040532876,0.00017445355,0.00004487993,0.000012823769,0.000101697326,0.0000015229873],"about_ca_topic_score_codex":0.0018503272,"about_ca_topic_score_gemma":0.003870102,"teacher_disagreement_score":0.0018503272,"about_ca_system_score_codex":0.00021479494,"about_ca_system_score_gemma":0.00020418367,"threshold_uncertainty_score":0.0036790967},"labels":[],"label_agreement":null},{"id":"W4301154975","doi":"","title":"Abstracts from the 2001 Annual Conference of the Canadian Pain Society. May 10-12, 2001. Montreal, Quebec, Canada.","year":2001,"lang":"en","type":"other","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gerontology; Psychology; Psychiatry; Library science; Computer science","score_opus":0.02810918024924491,"score_gpt":0.23976308317448847,"score_spread":0.21165390292524355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4301154975","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022032598,0.12304442,0.001182531,0.020255774,0.036229163,0.0009931496,0.08165361,0.0010944157,0.7333437],"genre_scores_gemma":[0.0016296484,0.031079473,0.0002582546,0.0009992411,0.0013258263,0.000103761005,0.0076587223,0.0001198212,0.9568253],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994824,0.000029028284,0.000030429275,0.00003662188,0.00031182403,0.00010976421],"domain_scores_gemma":[0.99773467,0.00016264633,0.00008930168,0.00003904458,0.0014622139,0.0005120357],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007861291,0.0022051162,0.0016429714,0.0026192602,0.0028288767,0.0029442094,0.001499318,0.001523533,0.62455136],"category_scores_gemma":[0.0018298554,0.0006436534,0.00074390386,0.0041682487,0.00067697774,0.001184817,0.0010933096,0.0014416896,0.2686587],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048207625,0.00001175065,0.00008930515,0.00014555221,0.000004145902,0.000021741691,0.000014607527,0.00003514941,0.00007328848,0.00007688533,0.9832266,0.016252747],"study_design_scores_gemma":[0.00005149062,0.000025806976,0.003927788,0.00043111545,0.000017269896,0.00006186038,0.000117897944,0.000048421367,0.000093271985,0.00015393489,0.9950507,0.000020334108],"about_ca_topic_score_codex":0.51980704,"about_ca_topic_score_gemma":0.8571927,"teacher_disagreement_score":0.62455136,"about_ca_system_score_codex":0.0067495406,"about_ca_system_score_gemma":0.011609804,"threshold_uncertainty_score":0.9660418},"labels":[],"label_agreement":null},{"id":"W4302770549","doi":"","title":"Abstracts from the 2002 Annual Conference of the Canadian Pain Society. May 23-25, 2002, Winnipeg, Manitoba, Canada.","year":2002,"lang":"en","type":"other","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gerontology; Medicine; Family medicine; Psychology","score_opus":0.03281260093596796,"score_gpt":0.22661787894862595,"score_spread":0.19380527801265798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4302770549","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026108657,0.10653327,0.0010942275,0.0227706,0.041319724,0.0010317801,0.06562869,0.00094144745,0.7580694],"genre_scores_gemma":[0.0014312703,0.02992096,0.00027405526,0.0010814016,0.0013892545,0.000092740294,0.007524842,0.00011376441,0.95817167],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99952996,0.000024467587,0.000028449129,0.000034330536,0.00029696798,0.000085846856],"domain_scores_gemma":[0.9981877,0.0001148898,0.00006920154,0.000027790926,0.0011409387,0.00045939223],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00070868945,0.0018384211,0.0013138596,0.0025207237,0.0024890597,0.002784907,0.0013266545,0.0011576043,0.5735434],"category_scores_gemma":[0.001544718,0.00050707825,0.00056709134,0.0035013119,0.00057717034,0.0010618566,0.0010997903,0.0013144754,0.2559898],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004282088,0.000011415476,0.00007662684,0.00013982515,0.0000034393681,0.000023312903,0.000017201713,0.000026135494,0.00009142198,0.000076697106,0.98199695,0.017494095],"study_design_scores_gemma":[0.000042319007,0.000020306448,0.0029125174,0.00030606185,0.0000131372135,0.000053375203,0.00013618053,0.000032166892,0.00009143207,0.00014205575,0.9962374,0.000012973094],"about_ca_topic_score_codex":0.32782283,"about_ca_topic_score_gemma":0.76349527,"teacher_disagreement_score":0.6721772,"about_ca_system_score_codex":0.0043096086,"about_ca_system_score_gemma":0.009592173,"threshold_uncertainty_score":0.65182936},"labels":[],"label_agreement":null},{"id":"W4303520542","doi":"10.30683/1927-7229.2022.11.06","title":"Retrospective Evaluation of the Analgesic Effects of Molecular Target Agents Against Cancer Pain and Oxaliplatin-Induced Chronic Peripheral Neuropathy","year":2022,"lang":"en","type":"article","venue":"Journal of Analytical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Oxaliplatin; Analgesic; Peripheral neuropathy; Bevacizumab; Neuropathic pain; Colorectal cancer; Panitumumab; Nociception; Chemotherapy; Cancer; Cetuximab; Internal medicine; Oncology; Pharmacology; Receptor; Endocrinology","score_opus":0.025996025064766823,"score_gpt":0.36276928919290896,"score_spread":0.3367732641281421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303520542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979765,0.0009233404,0.00016045281,0.000012965128,0.000003749418,0.000019712845,0.00027986747,0.0000026838388,0.000620748],"genre_scores_gemma":[0.9991099,0.0002835343,0.0000894972,0.000028277698,0.000008978559,0.000012935082,0.0003539644,0.0000014341684,0.00011145874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939895,0.00015512819,0.00012633487,0.0001239626,0.00012817673,0.00006748882],"domain_scores_gemma":[0.997624,0.0006529976,0.0010748768,0.00016231222,0.00031105432,0.00017474529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079539407,0.00013092339,0.00030450587,0.00076868874,0.000254153,0.00024174625,0.00016308685,0.00018716104,0.0011865931],"category_scores_gemma":[0.0018650823,0.0001322035,0.00032352316,0.00088833587,0.00024382841,0.00024629247,0.00027935763,0.0002032893,0.00018968758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003630358,0.000032369277,0.99541384,0.00003290882,0.000043415086,0.00017251873,0.00004783568,0.000025986783,0.00048816475,0.0000186997,0.000050229515,0.0033110804],"study_design_scores_gemma":[0.000012636999,0.00076139916,0.99646384,0.0000073906504,0.00006632487,0.0015256708,0.00013277662,0.00009353539,0.0003368332,0.000012606653,0.00058305165,0.000004072321],"about_ca_topic_score_codex":0.0012845565,"about_ca_topic_score_gemma":0.001278517,"teacher_disagreement_score":0.0012845565,"about_ca_system_score_codex":0.00023738256,"about_ca_system_score_gemma":0.00024618683,"threshold_uncertainty_score":0.0042064786},"labels":[],"label_agreement":null},{"id":"W4306165741","doi":"10.51731/cjht.2022.467","title":"Selinexor (Xpovio)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Dexamethasone; Multiple myeloma; Drug; Drug class; Family medicine; Intensive care medicine; Pharmacology; Health care; Political science; Internal medicine","score_opus":0.039031156922889484,"score_gpt":0.33490013292492893,"score_spread":0.29586897600203943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306165741","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029341307,0.79492134,0.0033839564,0.009015828,0.0016391601,0.00043031105,0.0034918522,0.000518689,0.15725762],"genre_scores_gemma":[0.24242225,0.5775577,0.006955508,0.014115853,0.0008620446,0.0004031254,0.006764849,0.000077162156,0.1508416],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999803,0.000047601923,0.000021683209,0.000031786138,0.00007485186,0.000021053678],"domain_scores_gemma":[0.99984145,0.000039256644,0.000049098937,0.0000058416103,0.000038760125,0.000025539426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046953993,0.00029857722,0.0002741061,0.000597638,0.0001578546,0.00059819454,0.00036379832,0.0004220552,0.01657585],"category_scores_gemma":[0.0004991143,0.000067443325,0.00046400575,0.0003259062,0.0002476573,0.0004877925,0.00034991046,0.0007241488,0.0030391973],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072479306,0.00010204638,0.00061508105,0.0040832027,0.00013708447,0.00022184114,0.000042509088,0.00029823903,0.0072962064,0.0039413814,0.05637424,0.9261635],"study_design_scores_gemma":[0.0007768025,0.0016838872,0.0038811578,0.0023838102,0.00018841446,0.0014343327,0.00006179253,0.00023901829,0.009075417,0.0010470491,0.97920483,0.000023416791],"about_ca_topic_score_codex":0.0027017929,"about_ca_topic_score_gemma":0.011489174,"teacher_disagreement_score":0.01657585,"about_ca_system_score_codex":0.0006103794,"about_ca_system_score_gemma":0.0008409831,"threshold_uncertainty_score":0.05545169},"labels":[],"label_agreement":null},{"id":"W4306359299","doi":"10.56588/iabcd.v1i2.66","title":"IN SILICO SCREENING OF MAJOR CANCER DRUG TARGETS (GROWTH FACTOR RECEPTORS) FOR NATURE DERIVED PHYTOCHEMICALS","year":2022,"lang":"en","type":"article","venue":"International Association of Biologicals and Computational Digest","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact","funders":"","keywords":"Drug target; In silico; Receptor; Biology; Chemistry; Pharmacology; Biochemistry; Gene","score_opus":0.013647804335840933,"score_gpt":0.32427777211326664,"score_spread":0.3106299677774257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306359299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90071344,0.01118615,0.047235776,0.0010075594,0.00019882202,0.0005306553,0.016900329,0.0052014873,0.017025784],"genre_scores_gemma":[0.9002201,0.005412623,0.06131162,0.0004726609,0.000038794264,0.00061105523,0.02656461,0.00032575443,0.0050427117],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9995091,0.00014900566,0.000036391713,0.00010895313,0.00010532662,0.00009128839],"domain_scores_gemma":[0.99946624,0.00039848764,0.000041653133,0.0000208206,0.00004101026,0.000031722688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079377106,0.0017194991,0.0021313182,0.0013362749,0.0006441051,0.0011725371,0.0010399221,0.0010341258,0.0059424154],"category_scores_gemma":[0.0012860727,0.00060170604,0.0030716017,0.0009950494,0.00024681457,0.00052364316,0.000563918,0.00071712944,0.0011941832],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003575496,0.0018873165,0.06498487,0.0068922155,0.0027331293,0.002913009,0.00022920566,0.72448224,0.109797396,0.0058992985,0.012825922,0.06377995],"study_design_scores_gemma":[0.00035031664,0.0014786216,0.0059858225,0.00014370288,0.0011974676,0.00051225483,0.00019217454,0.9533549,0.021966511,0.002089298,0.012662546,0.00006635601],"about_ca_topic_score_codex":0.0033216418,"about_ca_topic_score_gemma":0.006930327,"teacher_disagreement_score":0.0059424154,"about_ca_system_score_codex":0.000512632,"about_ca_system_score_gemma":0.0014780866,"threshold_uncertainty_score":0.019879341},"labels":[],"label_agreement":null},{"id":"W4308158641","doi":"10.1016/j.ejca.2022.10.017","title":"Measuring variation in the quality of systemic anti-cancer therapy delivery across hospitals: A national population-based evaluation","year":2022,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Cohort; Toxicity; Cancer; Population; Acute toxicity; Colorectal cancer; Internal medicine; Cohort study; Emergency medicine; Environmental health","score_opus":0.1279048075481206,"score_gpt":0.4373227682302942,"score_spread":0.3094179606821736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308158641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98947716,0.001098086,0.0022168898,0.000340093,0.000024807065,0.00027464746,0.0054420433,0.000023240695,0.0011030812],"genre_scores_gemma":[0.9929438,0.00034240534,0.0014558937,0.00015458814,0.000026061334,0.00034195778,0.004629997,0.00000981681,0.00009542763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9635362,0.018303553,0.0070650955,0.0038921204,0.006142501,0.0010605049],"domain_scores_gemma":[0.9170205,0.020052167,0.045137066,0.0052419743,0.009813702,0.0027346236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03414365,0.00042570435,0.0008422542,0.00398441,0.00064629724,0.0017970599,0.0015867528,0.00080511294,0.00091580744],"category_scores_gemma":[0.052602436,0.00046575526,0.0021156801,0.007906322,0.0013803403,0.002320505,0.003195018,0.0008713972,0.00023258214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011057768,0.00005355618,0.9953289,0.00009961568,0.00055705314,0.000012080396,0.00023702659,0.0002604231,0.000028333123,0.000041759467,0.00027041754,0.003000237],"study_design_scores_gemma":[0.000014586252,0.00032599262,0.99803096,0.000053453503,0.00012789402,0.000043106334,0.0004131483,0.0005120977,0.00005349017,0.00003720005,0.00037501738,0.000013028218],"about_ca_topic_score_codex":0.0170938,"about_ca_topic_score_gemma":0.017406188,"teacher_disagreement_score":0.03414365,"about_ca_system_score_codex":0.004027163,"about_ca_system_score_gemma":0.0026428315,"threshold_uncertainty_score":0.18057102},"labels":[],"label_agreement":null},{"id":"W4308834775","doi":"10.1200/jco.22.01637","title":"Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Common Terminology Criteria for Adverse Events; Oxaliplatin; Colorectal cancer; Cancer; Adverse effect; Peripheral neuropathy; Odds ratio; Oncology; Surgery; Diabetes mellitus","score_opus":0.09447792420464099,"score_gpt":0.45060245459565806,"score_spread":0.3561245303910171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308834775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978046,0.0014901912,0.000050101222,0.000080380094,0.0000058363294,0.000032452528,0.00029677554,0.0000017668457,0.00023792678],"genre_scores_gemma":[0.998831,0.00044928593,0.00009199957,0.00012921283,0.000018004132,0.000026652395,0.00034241943,0.0000011696985,0.000110411704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991177,0.00054732006,0.00005752587,0.0001040667,0.00009532518,0.000078066965],"domain_scores_gemma":[0.9968208,0.0008950184,0.0016099473,0.0001921805,0.0001551164,0.0003270307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002515082,0.0003006949,0.00051066297,0.00023999605,0.00025146667,0.0005959229,0.00031810478,0.00034280747,0.0011190738],"category_scores_gemma":[0.0028131132,0.0001833068,0.000738158,0.00049265526,0.00027097372,0.00021455507,0.00043821265,0.0005040954,0.000080356825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018253775,0.00049461494,0.9708773,0.00016499181,0.00077760103,0.00008969568,0.000094887706,0.00012654802,0.0014763532,0.000029016384,0.00017866804,0.0074365013],"study_design_scores_gemma":[0.00046796858,0.0013390747,0.9971903,0.000013716118,0.00040758325,0.00006213095,0.000058646106,0.00011162527,0.00009554218,0.00002098441,0.00022842022,0.0000039679235],"about_ca_topic_score_codex":0.004104049,"about_ca_topic_score_gemma":0.0075566545,"teacher_disagreement_score":0.004104049,"about_ca_system_score_codex":0.00032655406,"about_ca_system_score_gemma":0.0007351419,"threshold_uncertainty_score":0.013301134},"labels":[],"label_agreement":null},{"id":"W4311301274","doi":"10.1111/cbdd.14192","title":"Protective effect of a mitochondria‐targeting peptide against paclitaxel‐induced peripheral neuropathy","year":2022,"lang":"en","type":"letter","venue":"Chemical Biology & Drug Design","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"National Institute on Drug Abuse; Japan Society for the Promotion of Science; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Paclitaxel; Peripheral neuropathy; Medicine; Chemotherapy-induced peripheral neuropathy; Pharmacology; Chemotherapy; Mitochondrion; Concomitant; Tetrapeptide; Peripheral; Apoptosis; Cancer; Internal medicine; Peptide; Endocrinology; Chemistry","score_opus":0.019983420148005655,"score_gpt":0.2885066232253277,"score_spread":0.2685232030773221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311301274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78141797,0.05725238,0.0033719442,0.09511605,0.009111789,0.00038452502,0.0002952449,0.0004257808,0.052624214],"genre_scores_gemma":[0.9200761,0.014519581,0.0024467981,0.039097857,0.005967192,0.00018289467,0.0001593326,0.000019770378,0.017530395],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999418,0.000016238728,0.0000058116607,0.000007832297,0.00001769036,0.0000106726875],"domain_scores_gemma":[0.9998356,0.00007860862,0.000023148279,0.000011811815,0.000027237256,0.000023524046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001555448,0.0002260532,0.00025465825,0.00011543575,0.00022392371,0.00023524795,0.00018179299,0.0022131864,0.0010296705],"category_scores_gemma":[0.00046899304,0.00005839709,0.00015042491,0.00007558579,0.00026973567,0.00020756619,0.00010302438,0.0010435506,0.000520859],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008029292,0.0023834505,0.0062748687,0.001844405,0.00015146918,0.092234656,0.0002976113,0.0009733779,0.46785572,0.007674127,0.11317562,0.2991054],"study_design_scores_gemma":[0.003297044,0.022551725,0.021472048,0.00033303665,0.00027002374,0.12969099,0.00035373218,0.005379134,0.27852088,0.0052881376,0.5327215,0.000121713194],"about_ca_topic_score_codex":0.0001905697,"about_ca_topic_score_gemma":0.00031870458,"teacher_disagreement_score":0.0022131864,"about_ca_system_score_codex":0.00029169553,"about_ca_system_score_gemma":0.00020596183,"threshold_uncertainty_score":0.003444612},"labels":[],"label_agreement":null},{"id":"W4311566589","doi":"10.5281/zenodo.7439018","title":"SDC4: A Target Enabling Package","year":2022,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"Computer science","score_opus":0.042803861407230664,"score_gpt":0.28872400763245576,"score_spread":0.2459201462252251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311566589","genre_codex":"software","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053968076,0.0019408948,0.19773674,0.0016392341,0.0010621335,0.0021196846,0.17567232,0.49395055,0.12048168],"genre_scores_gemma":[0.058920674,0.0051197545,0.14081734,0.0028747593,0.0006993561,0.005926396,0.3833298,0.12768906,0.2746228],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99938846,0.00007058906,0.000031639127,0.00008382771,0.0003093347,0.0001161986],"domain_scores_gemma":[0.9993038,0.00012740787,0.00005250926,0.00013785445,0.00017630843,0.00020207965],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014837211,0.0015753283,0.0012386746,0.0016328185,0.0005653471,0.0017995848,0.0027330013,0.0014435779,0.31221297],"category_scores_gemma":[0.0022856742,0.0010110751,0.001270205,0.0011311705,0.00045008902,0.0015687997,0.0024520282,0.0017663159,0.2237176],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014181902,0.00021186422,0.000871722,0.00183844,0.00009300434,0.00039611806,0.000087152956,0.0016641238,0.06547381,0.008773555,0.76744884,0.15172316],"study_design_scores_gemma":[0.0003052057,0.00020402831,0.0010011758,0.00010472823,0.000044989127,0.00025776596,0.000018274099,0.0030366897,0.035272077,0.0040327418,0.9556445,0.000077951314],"about_ca_topic_score_codex":0.0010212483,"about_ca_topic_score_gemma":0.0009404397,"teacher_disagreement_score":0.31221297,"about_ca_system_score_codex":0.0010886405,"about_ca_system_score_gemma":0.0015075159,"threshold_uncertainty_score":0.9810447},"labels":[],"label_agreement":null},{"id":"W4318938350","doi":"10.1007/s40278-023-32610-7","title":"Canadian product monographs for apomorphine and lurbinectedin updated","year":2023,"lang":"en","type":"article","venue":"Reactions Weekly","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Apomorphine; Computer science; Neuroscience; Psychology; Dopaminergic; Dopamine","score_opus":0.029778618625921984,"score_gpt":0.32089397946147746,"score_spread":0.2911153608355555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318938350","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027914308,0.07058003,0.0009216459,0.018191857,0.020334871,0.0003582269,0.002769964,0.00086976035,0.8831822],"genre_scores_gemma":[0.0058231433,0.026238544,0.00079875154,0.0024479365,0.001998625,0.000038853064,0.0012137011,0.00010085842,0.9613395],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992817,0.000037221318,0.000014851265,0.000032344607,0.00055826205,0.00007560141],"domain_scores_gemma":[0.9985719,0.000077827295,0.00009100305,0.00004263527,0.0009389005,0.00027786422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055757124,0.00086605485,0.0005106722,0.002751729,0.0011200241,0.0011443099,0.0006864229,0.0011812476,0.18625972],"category_scores_gemma":[0.0013342669,0.00031450574,0.00040849927,0.001777745,0.00045024688,0.00036727186,0.00043605414,0.0014324044,0.047786027],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050866278,0.000039440503,0.00018454471,0.00014465656,0.0000044092035,0.00006356484,0.000010607576,0.000048476017,0.0009807927,0.0003544588,0.89728826,0.100829996],"study_design_scores_gemma":[0.000010883703,0.000019150779,0.0011004092,0.000054516746,0.0000060521725,0.000119577824,0.000010099482,0.000036144567,0.00017463119,0.000045048368,0.9984188,0.0000045509214],"about_ca_topic_score_codex":0.273249,"about_ca_topic_score_gemma":0.6332719,"teacher_disagreement_score":0.72675097,"about_ca_system_score_codex":0.004751879,"about_ca_system_score_gemma":0.012012408,"threshold_uncertainty_score":0.6231008},"labels":[],"label_agreement":null},{"id":"W4318967494","doi":"10.1097/cad.0000000000001429","title":"Efficacy of Duloxetine on electrodiagnostic findings of Paclitaxel-induced peripheral neuropathy, does it have a prophylactic effect? A randomized clinical trial","year":2022,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; Island Health","funders":"","keywords":"Duloxetine; Peripheral neuropathy; Medicine; Chemotherapy-induced peripheral neuropathy; Paclitaxel; Randomized controlled trial; Peripheral; Clinical trial; Internal medicine; Chemotherapy; Alternative medicine; Diabetes mellitus; Pathology","score_opus":0.027619715702373142,"score_gpt":0.3820460627967212,"score_spread":0.35442634709434806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318967494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978403,0.011843717,0.00068827125,0.0010062738,0.0009647602,0.004591979,0.0004973867,0.00009062875,0.0019138466],"genre_scores_gemma":[0.9852657,0.0059807007,0.0013932559,0.0011212811,0.00094473653,0.0036803326,0.000406054,0.000011980037,0.0011960682],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99864906,0.00094226253,0.00012556255,0.00011695392,0.000073247735,0.000092889924],"domain_scores_gemma":[0.9984199,0.000845332,0.00028439835,0.00012156092,0.00009104735,0.00023778195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022012042,0.00088012055,0.0028853102,0.00042621416,0.0004035621,0.0005610879,0.0006750125,0.0023785797,0.0046080058],"category_scores_gemma":[0.002955675,0.00047020544,0.0015229689,0.0003447439,0.00093361444,0.00055989367,0.00023475612,0.0013511311,0.0004734331],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97363764,0.005946632,0.0003276623,0.00085350533,0.0007106365,0.000037123464,0.000021036094,0.00009709364,0.0016656583,0.000076025935,0.00020457919,0.016422356],"study_design_scores_gemma":[0.91288424,0.08490429,0.0009360974,0.00004640703,0.0004955487,0.000018597373,0.000008742588,0.00016294573,0.00023395073,0.000050684495,0.00025119676,0.0000072114826],"about_ca_topic_score_codex":0.00060615456,"about_ca_topic_score_gemma":0.0013652659,"teacher_disagreement_score":0.0046080058,"about_ca_system_score_codex":0.00045932934,"about_ca_system_score_gemma":0.0007381084,"threshold_uncertainty_score":0.015415311},"labels":[],"label_agreement":null},{"id":"W4320486525","doi":"10.1097/01.reo.0000000000000332","title":"Improving Evidence-Based Methods of Characterizing Shoulder-Related Quality of Life for Survivors of Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Rehabilitation Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Waterloo","funders":"","keywords":"Breast cancer; Quality of life (healthcare); Range of motion; Medicine; Physical therapy; Rehabilitation; Population; International Classification of Functioning, Disability and Health; Physical medicine and rehabilitation; Internal rotation; Cancer; Internal medicine; Environmental health; Nursing","score_opus":0.14602390516567995,"score_gpt":0.5049144695426756,"score_spread":0.3588905643769956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320486525","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.128016,0.7455531,0.034456756,0.04773259,0.0031803432,0.010009212,0.013647091,0.00027136545,0.017133579],"genre_scores_gemma":[0.628164,0.19660781,0.14771204,0.0076310746,0.0012046274,0.010461139,0.007210532,0.000057129604,0.00095165905],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.95012844,0.027648043,0.010968371,0.0012747394,0.009428283,0.0005520203],"domain_scores_gemma":[0.8210377,0.08614138,0.032618187,0.006876188,0.051136784,0.0021896735],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.08086278,0.0009394139,0.0028003212,0.0095323175,0.00074964034,0.0047243317,0.0033856588,0.0017122894,0.0032337124],"category_scores_gemma":[0.18079835,0.00044717005,0.0027332418,0.007354183,0.00083698827,0.002303359,0.0017910515,0.0019092743,0.00041333857],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005206474,0.001060482,0.35132763,0.05680643,0.009184449,0.000036780177,0.00056643895,0.0008806809,0.00031563867,0.0016606348,0.009125329,0.56851476],"study_design_scores_gemma":[0.0014123933,0.0023167457,0.76410526,0.15042102,0.014717126,0.00025957814,0.0026603055,0.0027534082,0.0011282047,0.0036086284,0.056448016,0.00016924742],"about_ca_topic_score_codex":0.012088739,"about_ca_topic_score_gemma":0.03538708,"teacher_disagreement_score":0.91913724,"about_ca_system_score_codex":0.0032354002,"about_ca_system_score_gemma":0.011742923,"threshold_uncertainty_score":0.42764837},"labels":[],"label_agreement":null},{"id":"W4322628515","doi":"","title":"Identification of taxanes in solvent extracts from leaves of Taxus baccata L. using 13C NMR spectroscopy","year":2009,"lang":"en","type":"preprint","venue":"HAL (Le Centre pour la Communication Scientifique Directe)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministère des Ressources naturelles et des Forêts (Québec)","funders":"","keywords":"Taxus; Chemistry; Identification (biology); Nuclear magnetic resonance spectroscopy; Stereochemistry; Botany; Biology","score_opus":0.028268699338527225,"score_gpt":0.3064491115604126,"score_spread":0.2781804122218854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322628515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98778486,0.0039054211,0.0022870458,0.00023770843,0.000054785676,0.00006016685,0.0018511666,0.000056897887,0.0037619262],"genre_scores_gemma":[0.97553116,0.0052627358,0.0063685332,0.00032279015,0.00005568462,0.00007059384,0.0035936225,0.000046187997,0.008748686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99996436,0.0000043480145,0.0000017809907,0.000011162968,0.000009953681,0.0000082784],"domain_scores_gemma":[0.999905,0.000019493451,0.000012832549,0.000006902238,0.00003280762,0.000022959284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006437213,0.000284662,0.00020833989,0.00073888997,0.00045507876,0.00022724479,0.00013103904,0.00028283327,0.0022572554],"category_scores_gemma":[0.00009429172,0.00015699689,0.00015591693,0.00053131464,0.00022608337,0.00026445233,0.0001511513,0.0006407837,0.0004873243],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010883194,0.000008845404,0.00018609835,0.000035020035,0.000003708515,0.000026389625,0.000019766783,0.000015837724,0.998563,0.000021935512,0.000016555503,0.0009941648],"study_design_scores_gemma":[0.00007611198,0.0008644665,0.054520026,0.000057205652,0.000096553274,0.0005699234,0.00036884306,0.00080724736,0.93400335,0.00033529665,0.008271354,0.000029612987],"about_ca_topic_score_codex":0.0023239804,"about_ca_topic_score_gemma":0.0044216723,"teacher_disagreement_score":0.0023239804,"about_ca_system_score_codex":0.00016241273,"about_ca_system_score_gemma":0.00028083439,"threshold_uncertainty_score":0.007551253},"labels":[],"label_agreement":null},{"id":"W4322769430","doi":"10.1158/1538-7445.sabcs22-p3-07-10","title":"Abstract P3-07-10: CCTG IND.236: A Phase 1b trial of combined CFI-402257 and weekly paclitaxel in patients with HER2-negative (HER2-) advanced breast cancer (aBC)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; BC Cancer Agency; Princess Margaret Cancer Centre; Queen's University; Spinal Cord Injury BC; University Health Network","funders":"","keywords":"Paclitaxel; Taxane; Breast cancer; Medicine; Internal medicine; Cancer; Oncology","score_opus":0.0716905380113208,"score_gpt":0.46528426938408063,"score_spread":0.3935937313727598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322769430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9397475,0.007494424,0.0005788321,0.0041632135,0.00048503556,0.006964053,0.01220885,0.00048821868,0.027869752],"genre_scores_gemma":[0.92848414,0.004751286,0.0022142192,0.0038712688,0.00046225966,0.004635759,0.021709489,0.00013926608,0.033732414],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99974483,0.000081473925,0.000011278782,0.000036911544,0.000049070506,0.00007629878],"domain_scores_gemma":[0.9996536,0.000036944308,0.000042991356,0.000012297723,0.000025968518,0.00022818334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000682313,0.001000116,0.0011516348,0.00041751,0.00043522296,0.00077647757,0.00090293644,0.0012424464,0.01673221],"category_scores_gemma":[0.00040836824,0.00039823868,0.0004892796,0.000442084,0.0004356748,0.0003141578,0.00031041246,0.0029832586,0.0026540097],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46385413,0.03334483,0.011596495,0.002118869,0.00083592004,0.0012263405,0.00025264046,0.00259152,0.13420908,0.0007956837,0.12998368,0.21919082],"study_design_scores_gemma":[0.6839605,0.23158598,0.037920114,0.00021336545,0.0005700086,0.0013669597,0.00006894332,0.0020736384,0.013136631,0.00029441313,0.028736476,0.000072938696],"about_ca_topic_score_codex":0.0043593366,"about_ca_topic_score_gemma":0.015865294,"teacher_disagreement_score":0.01673221,"about_ca_system_score_codex":0.001284313,"about_ca_system_score_gemma":0.0024518427,"threshold_uncertainty_score":0.05597484},"labels":[],"label_agreement":null},{"id":"W4322774088","doi":"10.1158/1538-7445.sabcs22-p1-01-04","title":"Abstract P1-01-04: Comparing the Effects of TC and Anthracycline-based Chemotherapy in Women with Breast Cancer HER2 Negative Treated in the Adjuvant Setting – An individual Patient Meta-Analysis","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto East General Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Anthracycline; Docetaxel; Taxane; Population; Meta-analysis; Regimen; Hazard ratio; Cancer; Confidence interval","score_opus":0.10972099519088875,"score_gpt":0.44410646641234774,"score_spread":0.334385471221459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774088","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.051967096,0.931435,0.006179219,0.0012345316,0.0017432197,0.0019708294,0.003273597,0.00027493684,0.0019215452],"genre_scores_gemma":[0.84015113,0.14243485,0.005877176,0.002505231,0.0008850458,0.003468033,0.0022376834,0.00014634045,0.0022944915],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98373127,0.011318072,0.0022174993,0.0014082048,0.00095331576,0.00037174003],"domain_scores_gemma":[0.97950405,0.01636927,0.002057411,0.0007299997,0.0009780468,0.00036121946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020350536,0.003305668,0.01805935,0.0032969948,0.00055097206,0.003832582,0.0024629717,0.0035454992,0.0072966027],"category_scores_gemma":[0.039211694,0.0013536202,0.06436039,0.0038309002,0.00077709684,0.0020325775,0.0016473408,0.0038541877,0.0006640089],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077334633,0.000028519906,0.0024002034,0.058493417,0.927415,0.00011457682,0.000034848574,0.000784072,0.00021204192,0.00010702,0.00039993238,0.0022769386],"study_design_scores_gemma":[0.0016600266,0.0002983273,0.0015386104,0.0019926259,0.99325824,0.000046581667,0.000018162815,0.0003816392,0.00006688718,0.00018164054,0.0005445084,0.000012772875],"about_ca_topic_score_codex":0.004346458,"about_ca_topic_score_gemma":0.0063347,"teacher_disagreement_score":0.020350536,"about_ca_system_score_codex":0.0017785489,"about_ca_system_score_gemma":0.0017950399,"threshold_uncertainty_score":0.10762519},"labels":[],"label_agreement":null},{"id":"W4322775022","doi":"10.1158/1538-7445.sabcs22-p4-07-60","title":"Abstract P4-07-60: Identification of Optimal Carboplatin Containing Regimen for Triple Negative Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital; University of Windsor; Western University","funders":"","keywords":"Carboplatin; Medicine; Regimen; Triple-negative breast cancer; Breast cancer; Cyclophosphamide; Internal medicine; Oncology; Paclitaxel; Chemotherapy; Chemotherapy regimen; Cancer; Surgery; Cisplatin","score_opus":0.14303665979491595,"score_gpt":0.4943778950274041,"score_spread":0.35134123523248817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322775022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99021566,0.0055432497,0.0006328208,0.00022580431,0.00003599988,0.000244494,0.00038778596,0.00002562003,0.0026884996],"genre_scores_gemma":[0.994576,0.0018723364,0.0017821647,0.00019156713,0.000052859214,0.000106697116,0.0008403803,0.000010537508,0.00056757464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998894,0.000032737218,0.000021978018,0.000023054741,0.000018400206,0.0000144912165],"domain_scores_gemma":[0.99984515,0.000042130487,0.000041871364,0.000011787431,0.000023151722,0.000035904763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026240715,0.00015934739,0.0003833707,0.00033620323,0.00016590631,0.00031921486,0.00020110539,0.00023886033,0.0025256155],"category_scores_gemma":[0.00056793843,0.00006591573,0.00020822867,0.00031508767,0.00012175661,0.000191575,0.00015900421,0.0002647808,0.00043838707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017352434,0.00248673,0.53066283,0.0015304585,0.00024556275,0.005799702,0.00016854618,0.001079682,0.100972824,0.00035030188,0.004632961,0.33471793],"study_design_scores_gemma":[0.0025019862,0.031650808,0.80535066,0.00046391285,0.0011220211,0.032393735,0.00042414328,0.00288012,0.08446975,0.00072020857,0.037977308,0.000045384422],"about_ca_topic_score_codex":0.00026982647,"about_ca_topic_score_gemma":0.00037291792,"teacher_disagreement_score":0.0025256155,"about_ca_system_score_codex":0.0002710618,"about_ca_system_score_gemma":0.0004838085,"threshold_uncertainty_score":0.008449078},"labels":[],"label_agreement":null},{"id":"W4323050383","doi":"10.1158/1538-7445.sabcs22-p3-07-18","title":"Abstract P3-07-18: CCTG IND.239: A phase 2 study of combined CFI-400945 and durvalumab in patients with advanced triple negative breast cancer (aTNBC)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Juravinski Cancer Centre; University Health Network; Hamilton Health Sciences; Princess Margaret Cancer Centre; Ottawa Hospital","funders":"","keywords":"Durvalumab; Medicine; Oncology; Breast cancer; Taxane; Cancer; Internal medicine; Immunotherapy; Pembrolizumab","score_opus":0.08534702685228639,"score_gpt":0.4775520246060658,"score_spread":0.39220499775377937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323050383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675515,0.0055812974,0.0005966208,0.0022438476,0.00034405172,0.0049974136,0.0057888026,0.0002661412,0.01263035],"genre_scores_gemma":[0.96286523,0.0034437028,0.0021849556,0.0020743017,0.00037007246,0.003982234,0.0094617335,0.00009809302,0.015519712],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999757,0.00007557694,0.000011229397,0.000040363015,0.00004745809,0.00006839813],"domain_scores_gemma":[0.9996177,0.000040168936,0.00004281805,0.000018595969,0.000033340817,0.00024736288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007851929,0.00096094137,0.0014881472,0.00037994556,0.0005380205,0.0007516999,0.001067939,0.0012405011,0.0087322695],"category_scores_gemma":[0.00036439826,0.00041549813,0.00067785,0.00038480386,0.00039300404,0.00037755547,0.00029352645,0.002897799,0.0016593459],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41715246,0.051999927,0.011571261,0.0018129685,0.0015263349,0.0016267705,0.00038951743,0.0031040693,0.20225522,0.00073052285,0.06956202,0.23826894],"study_design_scores_gemma":[0.6742592,0.26145685,0.028799476,0.00011235041,0.00068451563,0.0014939752,0.000069415524,0.0018315742,0.012447501,0.00025508847,0.018521678,0.00006844057],"about_ca_topic_score_codex":0.0033320738,"about_ca_topic_score_gemma":0.01107251,"teacher_disagreement_score":0.0087322695,"about_ca_system_score_codex":0.0012649543,"about_ca_system_score_gemma":0.001918378,"threshold_uncertainty_score":0.029212296},"labels":[],"label_agreement":null},{"id":"W4324130405","doi":"10.2174/0929867330666230313141452","title":"Oxocarbon Acids and their Derivatives in Biological and MedicinalChemistry","year":2023,"lang":"en","type":"article","venue":"Current Medicinal Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Chemistry; Squaric acid; Bioconjugation; Biological activity; Combinatorial chemistry; Organic chemistry; Stereochemistry; Biochemistry","score_opus":0.05574743216562191,"score_gpt":0.35486049300474515,"score_spread":0.29911306083912326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324130405","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015900234,0.9507213,0.0047465344,0.00052697666,0.00084006577,0.000029698787,0.00009048688,0.00006674782,0.027077908],"genre_scores_gemma":[0.10212149,0.8728103,0.0061893933,0.000564825,0.00074513006,0.000058034606,0.00017527524,0.000024443143,0.01731115],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988604,0.000026868607,0.000009941803,0.000022758748,0.000034055432,0.000020328273],"domain_scores_gemma":[0.9999143,0.000032400105,0.000019936393,0.0000051013144,0.000014166752,0.0000140585835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019687918,0.00059523765,0.0003956229,0.00069854147,0.00020787022,0.0005792174,0.00030882764,0.0005454547,0.0032648214],"category_scores_gemma":[0.00021502547,0.00018940038,0.00020185306,0.00092306576,0.00040458483,0.000762336,0.0004573979,0.00095963624,0.0013808162],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040034286,0.00019628448,0.00033303068,0.0068480917,0.000057872818,0.0014012638,0.00025089397,0.002893779,0.38201535,0.05909308,0.010513236,0.5359968],"study_design_scores_gemma":[0.000023529272,0.00076116825,0.000842114,0.0005236414,0.000045089277,0.002484177,0.00007580211,0.00035155492,0.083371595,0.007270617,0.9042112,0.000039471175],"about_ca_topic_score_codex":0.0002909237,"about_ca_topic_score_gemma":0.0005960609,"teacher_disagreement_score":0.0032648214,"about_ca_system_score_codex":0.0004218754,"about_ca_system_score_gemma":0.0002970038,"threshold_uncertainty_score":0.0109218955},"labels":[],"label_agreement":null},{"id":"W4327975269","doi":"10.31083/j.fbl2803058","title":"MDSCs: The Key Players in the Formation of Pre-Metastatic Niche","year":2023,"lang":"en","type":"review","venue":"Frontiers in Bioscience-Landmark","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; Jining Medical University; Northeast Normal University","keywords":"Niche; Metastasis; Suppressor; Metastatic tumor; Primary tumor; Cancer research; Tumor microenvironment; Cancer; Tumor progression; Biology; Medicine; Tumor cells; Internal medicine; Ecology","score_opus":0.09182187031085254,"score_gpt":0.39535667811366904,"score_spread":0.3035348078028165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327975269","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042030704,0.9969459,0.00048579957,0.0005039422,0.00020389543,0.000009406429,0.000034069602,0.000013835368,0.0013827927],"genre_scores_gemma":[0.002785688,0.9952604,0.00042080964,0.00022950255,0.0002154156,0.00001518945,0.000050938128,0.0000017735646,0.0010203207],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999033,0.000014896786,0.0000101046835,0.000018677469,0.00003807603,0.000014900864],"domain_scores_gemma":[0.9999105,0.000030412448,0.000015435533,0.000002501217,0.000028469896,0.000012687894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025906487,0.00057481765,0.00068570965,0.0011614093,0.00024118727,0.00086959737,0.00045527183,0.0007277005,0.0019808004],"category_scores_gemma":[0.0002640137,0.0001576768,0.00029138007,0.00081568846,0.00041688775,0.00087066554,0.0005319932,0.0015075576,0.00091346627],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117969714,0.00007263822,0.00037286675,0.01348762,0.000056166777,0.00036027332,0.00016969407,0.00045891217,0.01231521,0.022740813,0.024571473,0.92527634],"study_design_scores_gemma":[0.000017621305,0.00009071826,0.00087973877,0.0017328163,0.000064846216,0.0011904584,0.000085931126,0.00013491494,0.0029466941,0.005201509,0.98763716,0.00001750423],"about_ca_topic_score_codex":0.0005249405,"about_ca_topic_score_gemma":0.0008019647,"teacher_disagreement_score":0.0019808004,"about_ca_system_score_codex":0.00047609178,"about_ca_system_score_gemma":0.00090315455,"threshold_uncertainty_score":0.006626487},"labels":[],"label_agreement":null},{"id":"W4361942958","doi":"10.1158/1078-0432.c.6517089","title":"Data from Preferential Killing of Breast Tumor Initiating Cells by &lt;i&gt;N,N&lt;/i&gt;-Diethyl-2-[4-(Phenylmethyl)Phenoxy]Ethanamine/Tesmilifene","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; University Health Network","funders":"National Cancer Institute","keywords":"CD44; Breast cancer; Internal medicine; CD24; Flow cytometry; Medicine; Chemistry; Cancer research; In vitro; Cancer; Molecular biology; Biology; Immunology; Biochemistry","score_opus":0.08498179919500738,"score_gpt":0.33827458147501643,"score_spread":0.25329278228000907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361942958","genre_codex":"empirical","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9521905,0.006637066,0.00727075,0.00096648483,0.00044326426,0.0003154775,0.011331581,0.00044819535,0.020396551],"genre_scores_gemma":[0.9584515,0.003941452,0.0051509826,0.0007913923,0.000107162865,0.00048088044,0.015543455,0.00018196797,0.0153512],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996475,0.000068524736,0.00005059409,0.00007159052,0.00009245297,0.00006923812],"domain_scores_gemma":[0.9994448,0.00019691823,0.000059271515,0.00009949198,0.00008165558,0.000117987285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043421908,0.0005799748,0.00049830787,0.00030845628,0.00023271878,0.00033637157,0.00038162558,0.00039636242,0.010892522],"category_scores_gemma":[0.000371955,0.00018158875,0.00048619744,0.00023673115,0.00025081827,0.00029458952,0.00017370872,0.0012256725,0.0022696198],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00554691,0.0011263537,0.0010965766,0.00049598026,0.00006152636,0.00015126746,0.000050263785,0.00021451927,0.9739516,0.00030308607,0.0021264362,0.014875444],"study_design_scores_gemma":[0.00038249878,0.0046511893,0.006654108,0.00001848216,0.000092420494,0.00058521505,0.000049913255,0.0005584372,0.97779125,0.00008102641,0.009124685,0.000010708615],"about_ca_topic_score_codex":0.0009168128,"about_ca_topic_score_gemma":0.0009938225,"teacher_disagreement_score":0.010892522,"about_ca_system_score_codex":0.00026158732,"about_ca_system_score_gemma":0.00043452487,"threshold_uncertainty_score":0.03643906},"labels":[],"label_agreement":null},{"id":"W4361946665","doi":"10.1158/1078-0432.c.6529577","title":"Data from Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer Survivors","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Cisplatin; Internal medicine; Neurotoxicity; Cumulative dose; Cancer; Gastroenterology; Endocrinology; Toxicity; Chemotherapy","score_opus":0.20863364170785656,"score_gpt":0.437044148083167,"score_spread":0.22841050637531043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361946665","genre_codex":"empirical","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868471,0.00089670887,0.00044666886,0.00011063993,0.000017360604,0.000027159704,0.01098282,0.00001727079,0.0006542452],"genre_scores_gemma":[0.98915863,0.0004203308,0.00031687593,0.00008583194,0.000020471782,0.0000463086,0.009465068,0.000012269973,0.00047425274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950564,0.00008927456,0.00008947145,0.0001872506,0.00008548514,0.000042858144],"domain_scores_gemma":[0.9979221,0.00035950105,0.00073054276,0.00030934278,0.00044243367,0.00023613343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005034644,0.00027337324,0.00044523008,0.00078736694,0.00040397784,0.00050450786,0.0003190816,0.0003417582,0.002269053],"category_scores_gemma":[0.0023455613,0.00022442066,0.0007091985,0.002131594,0.00015042504,0.00022292272,0.00045201008,0.00037781906,0.0003533771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050376286,0.00002442484,0.993095,0.00006922322,0.00045949806,0.00014734743,0.000051123112,0.00009324725,0.0011953851,0.000029529323,0.0009677141,0.0033637737],"study_design_scores_gemma":[0.00001806488,0.000046862227,0.9983777,0.000006565668,0.00024748,0.0002135514,0.000033518467,0.000088106084,0.00016961155,0.000030667037,0.0007636426,0.000004274126],"about_ca_topic_score_codex":0.006121205,"about_ca_topic_score_gemma":0.008493306,"teacher_disagreement_score":0.006121205,"about_ca_system_score_codex":0.0001882501,"about_ca_system_score_gemma":0.0003177268,"threshold_uncertainty_score":0.012171149},"labels":[],"label_agreement":null},{"id":"W4361948728","doi":"10.1158/1078-0432.c.6517089.v1","title":"Data from Preferential Killing of Breast Tumor Initiating Cells by &lt;i&gt;N,N&lt;/i&gt;-Diethyl-2-[4-(Phenylmethyl)Phenoxy]Ethanamine/Tesmilifene","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; University Health Network","funders":"National Cancer Institute","keywords":"CD44; Breast cancer; Flow cytometry; Chemistry; Internal medicine; Medicine; Cancer research; In vitro; Molecular biology; Cancer; Biology; Immunology; Biochemistry","score_opus":0.08498179919500738,"score_gpt":0.33827458147501643,"score_spread":0.25329278228000907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361948728","genre_codex":"empirical","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9521905,0.006637066,0.00727075,0.00096648483,0.00044326426,0.0003154775,0.011331581,0.00044819535,0.020396551],"genre_scores_gemma":[0.9584515,0.003941452,0.0051509826,0.0007913923,0.000107162865,0.00048088044,0.015543455,0.00018196797,0.0153512],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996475,0.000068524736,0.00005059409,0.00007159052,0.00009245297,0.00006923812],"domain_scores_gemma":[0.9994448,0.00019691823,0.000059271515,0.00009949198,0.00008165558,0.000117987285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043421908,0.0005799748,0.00049830787,0.00030845628,0.00023271878,0.00033637157,0.00038162558,0.00039636242,0.010892522],"category_scores_gemma":[0.000371955,0.00018158875,0.00048619744,0.00023673115,0.00025081827,0.00029458952,0.00017370872,0.0012256725,0.0022696198],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00554691,0.0011263537,0.0010965766,0.00049598026,0.00006152636,0.00015126746,0.000050263785,0.00021451927,0.9739516,0.00030308607,0.0021264362,0.014875444],"study_design_scores_gemma":[0.00038249878,0.0046511893,0.006654108,0.00001848216,0.000092420494,0.00058521505,0.000049913255,0.0005584372,0.97779125,0.00008102641,0.009124685,0.000010708615],"about_ca_topic_score_codex":0.0009168128,"about_ca_topic_score_gemma":0.0009938225,"teacher_disagreement_score":0.010892522,"about_ca_system_score_codex":0.00026158732,"about_ca_system_score_gemma":0.00043452487,"threshold_uncertainty_score":0.03643906},"labels":[],"label_agreement":null},{"id":"W4361953704","doi":"10.1158/1078-0432.c.6529577.v1","title":"Data from Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer Survivors","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Cisplatin; Internal medicine; Neurotoxicity; Cumulative dose; Cancer; Gastroenterology; Endocrinology; Toxicity; Chemotherapy","score_opus":0.20863364170785656,"score_gpt":0.437044148083167,"score_spread":0.22841050637531043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361953704","genre_codex":"empirical","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868471,0.00089670887,0.00044666886,0.00011063993,0.000017360604,0.000027159704,0.01098282,0.00001727079,0.0006542452],"genre_scores_gemma":[0.98915863,0.0004203308,0.00031687593,0.00008583194,0.000020471782,0.0000463086,0.009465068,0.000012269973,0.00047425274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950564,0.00008927456,0.00008947145,0.0001872506,0.00008548514,0.000042858144],"domain_scores_gemma":[0.9979221,0.00035950105,0.00073054276,0.00030934278,0.00044243367,0.00023613343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005034644,0.00027337324,0.00044523008,0.00078736694,0.00040397784,0.00050450786,0.0003190816,0.0003417582,0.002269053],"category_scores_gemma":[0.0023455613,0.00022442066,0.0007091985,0.002131594,0.00015042504,0.00022292272,0.00045201008,0.00037781906,0.0003533771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050376286,0.00002442484,0.993095,0.00006922322,0.00045949806,0.00014734743,0.000051123112,0.00009324725,0.0011953851,0.000029529323,0.0009677141,0.0033637737],"study_design_scores_gemma":[0.00001806488,0.000046862227,0.9983777,0.000006565668,0.00024748,0.0002135514,0.000033518467,0.000088106084,0.00016961155,0.000030667037,0.0007636426,0.000004274126],"about_ca_topic_score_codex":0.006121205,"about_ca_topic_score_gemma":0.008493306,"teacher_disagreement_score":0.006121205,"about_ca_system_score_codex":0.0001882501,"about_ca_system_score_gemma":0.0003177268,"threshold_uncertainty_score":0.012171149},"labels":[],"label_agreement":null},{"id":"W4361954206","doi":"10.1158/1078-0432.c.6532530.v1","title":"Data from Dose Escalation Data from the Phase 1 Study of the Liposomal Formulation of Eribulin (E7389-LF) in Japanese Patients with Advanced Solid Tumors","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"Eisai","keywords":"Medicine; Tolerability; Internal medicine; Limiting; Gastroenterology; Animal science; Adverse effect","score_opus":0.11807570324119707,"score_gpt":0.4081435852882266,"score_spread":0.2900678820470295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361954206","genre_codex":"empirical","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9633836,0.005473642,0.0024416512,0.00062449934,0.000098908145,0.0038084371,0.016754864,0.00017893904,0.0072354674],"genre_scores_gemma":[0.9581311,0.0024786247,0.0031194068,0.0012920564,0.000072421106,0.0031517828,0.028182616,0.00008290919,0.0034891565],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99917513,0.00035596456,0.00011116623,0.00010358364,0.00017655981,0.000077634584],"domain_scores_gemma":[0.99851435,0.00030580824,0.0003923532,0.00024542664,0.00023951671,0.00030262274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027517462,0.00091337966,0.001539509,0.00035792208,0.00047756857,0.00066457555,0.0005577504,0.0006479841,0.0036232325],"category_scores_gemma":[0.0014554871,0.0003833254,0.0010755002,0.00079607574,0.0004723141,0.0006499726,0.0003319441,0.0017055568,0.0010269377],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34362826,0.02952794,0.050636046,0.004605174,0.005185198,0.00081594574,0.0008450939,0.010525449,0.17498606,0.0005981348,0.036951557,0.34169513],"study_design_scores_gemma":[0.19483362,0.3937574,0.2619722,0.0003063338,0.006422961,0.002036986,0.00038648106,0.0038881232,0.059361093,0.0006353855,0.076195486,0.00020396413],"about_ca_topic_score_codex":0.0018771618,"about_ca_topic_score_gemma":0.0039542783,"teacher_disagreement_score":0.0036232325,"about_ca_system_score_codex":0.0008402922,"about_ca_system_score_gemma":0.0016977992,"threshold_uncertainty_score":0.014552832},"labels":[],"label_agreement":null},{"id":"W4361954463","doi":"10.1158/1078-0432.c.6532781.v1","title":"Data from Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Capecitabine; Triple-negative breast cancer; Internal medicine; Breast cancer; Oncology; Medicine; Basal (medicine); Adjuvant; Cancer; Colorectal cancer","score_opus":0.07879141937988557,"score_gpt":0.36353671468517146,"score_spread":0.2847452953052859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361954463","genre_codex":"empirical","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956039,0.00038530497,0.00021510127,0.000057619418,0.0000096516405,0.00004389905,0.0017160632,0.000007892215,0.001960661],"genre_scores_gemma":[0.99781394,0.000071883536,0.00009888766,0.000048403628,0.000009743597,0.000048234462,0.001498964,0.0000031000911,0.0004068134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995579,0.00014045407,0.000056686153,0.00010338001,0.000092950875,0.000048537033],"domain_scores_gemma":[0.9988906,0.00041790266,0.00032593566,0.00017115659,0.000055495442,0.0001389626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009831191,0.00016533196,0.00051397097,0.00022582615,0.00017277079,0.00036020714,0.00020941513,0.00024211738,0.0038784037],"category_scores_gemma":[0.0015547215,0.00010325541,0.00052841415,0.00028369098,0.00016842295,0.0002543627,0.00020017373,0.0002772493,0.00041897397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03587451,0.00029324112,0.92362237,0.00020268951,0.0005050293,0.00019214302,0.000077744895,0.0007614007,0.010151041,0.00014214971,0.0012490799,0.026928626],"study_design_scores_gemma":[0.000662582,0.002371865,0.9911335,0.000023232624,0.0003199402,0.00047372116,0.00005357313,0.0008883064,0.002149592,0.00012175079,0.0017939653,0.000008063348],"about_ca_topic_score_codex":0.0008526073,"about_ca_topic_score_gemma":0.0021201386,"teacher_disagreement_score":0.0038784037,"about_ca_system_score_codex":0.00029856898,"about_ca_system_score_gemma":0.0002457244,"threshold_uncertainty_score":0.01297456},"labels":[],"label_agreement":null},{"id":"W4361961198","doi":"10.1158/1078-0432.c.6518529","title":"Data from Potentiation of Taxol Efficacy by Discodermolide in Ovarian Carcinoma Xenograft-Bearing Mice","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"National Cancer Institute","keywords":"In vivo; Ovarian carcinoma; Matrigel; Paclitaxel; Chemistry; Ovarian cancer; Cancer research; Pharmacology; CD31; Apoptosis; Angiogenesis; Cancer; Internal medicine; Medicine; Biology; Biochemistry","score_opus":0.1202556091447616,"score_gpt":0.3734226369487314,"score_spread":0.2531670278039698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361961198","genre_codex":"empirical","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9258028,0.005793691,0.007912122,0.0010687957,0.00046079836,0.0009603126,0.030045401,0.0014205086,0.026535578],"genre_scores_gemma":[0.93556374,0.0042859744,0.007242573,0.0006324556,0.000105226165,0.0013532307,0.016337104,0.00023601313,0.03424373],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996667,0.000055531254,0.000046640234,0.00005174572,0.00011459266,0.00006486333],"domain_scores_gemma":[0.99952567,0.00009769676,0.00010660979,0.000052482406,0.00006727977,0.00015020547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036020423,0.0008891594,0.00071872567,0.00083157694,0.00021954921,0.00031224647,0.00031424616,0.00069098023,0.0075654783],"category_scores_gemma":[0.0001950516,0.000220327,0.00055130007,0.00043045043,0.00031122318,0.00039727066,0.0001645034,0.0017048386,0.0018152238],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046921447,0.0012356791,0.00080141495,0.000276481,0.000054632073,0.00017896281,0.00005902732,0.00031583826,0.98157203,0.00024557355,0.0017476729,0.008820523],"study_design_scores_gemma":[0.0005039034,0.005475109,0.006875405,0.000025330206,0.00008572695,0.00032968723,0.000055585344,0.0008577172,0.9760587,0.000092250215,0.009619811,0.000020628553],"about_ca_topic_score_codex":0.0010700546,"about_ca_topic_score_gemma":0.0013522247,"teacher_disagreement_score":0.0075654783,"about_ca_system_score_codex":0.0004196253,"about_ca_system_score_gemma":0.0004117478,"threshold_uncertainty_score":0.025309026},"labels":[],"label_agreement":null},{"id":"W4361963257","doi":"10.1158/1078-0432.c.6532530","title":"Data from Dose Escalation Data from the Phase 1 Study of the Liposomal Formulation of Eribulin (E7389-LF) in Japanese Patients with Advanced Solid Tumors","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"Eisai","keywords":"Tolerability; Medicine; Internal medicine; Limiting; Eribulin; Breast cancer; Gastroenterology; Adverse effect; Cancer; Metastatic breast cancer","score_opus":0.11807570324119707,"score_gpt":0.4081435852882266,"score_spread":0.2900678820470295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361963257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9633836,0.005473642,0.0024416512,0.00062449934,0.000098908145,0.0038084371,0.016754864,0.00017893904,0.0072354674],"genre_scores_gemma":[0.9581311,0.0024786247,0.0031194068,0.0012920564,0.000072421106,0.0031517828,0.028182616,0.00008290919,0.0034891565],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99917513,0.00035596456,0.00011116623,0.00010358364,0.00017655981,0.000077634584],"domain_scores_gemma":[0.99851435,0.00030580824,0.0003923532,0.00024542664,0.00023951671,0.00030262274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027517462,0.00091337966,0.001539509,0.00035792208,0.00047756857,0.00066457555,0.0005577504,0.0006479841,0.0036232325],"category_scores_gemma":[0.0014554871,0.0003833254,0.0010755002,0.00079607574,0.0004723141,0.0006499726,0.0003319441,0.0017055568,0.0010269377],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34362826,0.02952794,0.050636046,0.004605174,0.005185198,0.00081594574,0.0008450939,0.010525449,0.17498606,0.0005981348,0.036951557,0.34169513],"study_design_scores_gemma":[0.19483362,0.3937574,0.2619722,0.0003063338,0.006422961,0.002036986,0.00038648106,0.0038881232,0.059361093,0.0006353855,0.076195486,0.00020396413],"about_ca_topic_score_codex":0.0018771618,"about_ca_topic_score_gemma":0.0039542783,"teacher_disagreement_score":0.0036232325,"about_ca_system_score_codex":0.0008402922,"about_ca_system_score_gemma":0.0016977992,"threshold_uncertainty_score":0.014552832},"labels":[],"label_agreement":null},{"id":"W4361971407","doi":"10.1158/1078-0432.22441467","title":"Supplementary Figure S2 from Potentiation of Taxol Efficacy by Discodermolide in Ovarian Carcinoma Xenograft-Bearing Mice","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"National Cancer Institute","keywords":"Long-term potentiation; Ovarian carcinoma; Cancer research; Bearing (navigation); Pharmacology; Internal medicine; Medicine; Oncology; Chemistry; Ovarian cancer; Receptor; Cancer; Computer science","score_opus":0.03555906193426502,"score_gpt":0.3214741373801006,"score_spread":0.2859150754458356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361971407","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005614595,0.00079192524,0.006965959,0.0025640682,0.007816509,0.0002870318,0.9426166,0.008079768,0.025263594],"genre_scores_gemma":[0.031241901,0.0018442478,0.03177492,0.0015070662,0.0019140525,0.0011171025,0.8534709,0.0052889325,0.071840785],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99877673,0.000068302536,0.000080557606,0.0001602987,0.00071598083,0.00019815176],"domain_scores_gemma":[0.9971738,0.0012165816,0.00017755666,0.00024868443,0.00069982803,0.00048351884],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00065964664,0.0026182414,0.0018411515,0.0026781734,0.0010369661,0.001426821,0.0019945388,0.0013595885,0.63599044],"category_scores_gemma":[0.003325785,0.0009429096,0.0021765034,0.0020897842,0.0005100532,0.0011120987,0.00073976896,0.0025723714,0.13701583],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009478258,0.00014831318,0.0003469804,0.0010205094,0.00011067349,0.0004123649,0.000036935257,0.00071278703,0.015842168,0.0020432845,0.9650925,0.013285703],"study_design_scores_gemma":[0.0024085355,0.0005942718,0.014571141,0.00039799206,0.00016877247,0.0016162188,0.00012246509,0.0072738584,0.063526034,0.007759974,0.90138793,0.0001727794],"about_ca_topic_score_codex":0.008630492,"about_ca_topic_score_gemma":0.014158854,"teacher_disagreement_score":0.63599044,"about_ca_system_score_codex":0.0017326955,"about_ca_system_score_gemma":0.0024643452,"threshold_uncertainty_score":0.51921546},"labels":[],"label_agreement":null},{"id":"W4367362646","doi":"10.1111/j.1742-1241.2003.tb10544.x","title":"XELODA® AND TAXOTERE®: A REVIEW OF THE DEVELOPMENT OF THE COMBINATION FOR USE IN METASTATIC BREAST CANCER","year":2003,"lang":"en","type":"review","venue":"International Journal of Clinical Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Docetaxel; Capecitabine; Metastatic breast cancer; Oncology; Internal medicine; Breast cancer; Anthracycline; Adverse effect; Hazard ratio; Chemotherapy; Cancer; Confidence interval; Colorectal cancer","score_opus":0.32721851629816345,"score_gpt":0.5989358573477391,"score_spread":0.2717173410495757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367362646","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019929008,0.99884015,0.00011471409,0.000101931175,0.000083915904,0.000008063616,0.000015132061,0.000006214392,0.0006306556],"genre_scores_gemma":[0.00070435693,0.99856645,0.00024240192,0.00008400547,0.00006735265,0.0000073554384,0.000023589695,0.0000012566295,0.00030332248],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974376,0.000046308134,0.000049907412,0.000044488337,0.00010074212,0.000014851502],"domain_scores_gemma":[0.99963844,0.00017331982,0.000061216604,0.0000108169725,0.000083758365,0.00003233734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007612765,0.00089249696,0.0019307799,0.0037034259,0.0003030384,0.0008117816,0.0010584506,0.00086765894,0.0034987307],"category_scores_gemma":[0.00068460737,0.00042443225,0.000598259,0.0037488847,0.00044203788,0.0012771575,0.0004338676,0.0012816467,0.0018014464],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001340027,0.00014712517,0.00019923603,0.024471408,0.00015119757,0.0004546783,0.00007225099,0.00046795895,0.001714416,0.0014645086,0.018385978,0.9523372],"study_design_scores_gemma":[0.00008892347,0.00035829327,0.0017842974,0.0059959786,0.00024884823,0.004111017,0.00008039452,0.00021056025,0.0007983982,0.0013495875,0.984945,0.000028583381],"about_ca_topic_score_codex":0.0012496165,"about_ca_topic_score_gemma":0.0027072076,"teacher_disagreement_score":0.0037034259,"about_ca_system_score_codex":0.00043129528,"about_ca_system_score_gemma":0.0007632861,"threshold_uncertainty_score":0.011704445},"labels":[],"label_agreement":null},{"id":"W4375845874","doi":"10.1134/s1021443722602403","title":"Polyesters of 14-Hydroxylated Taxoids Found for the First Time in Taxus canadensis Intact Plants","year":2023,"lang":"en","type":"article","venue":"Russian Journal of Plant Physiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry; Polyester; Mass spectrometry; Secondary metabolism; Taxus; Nuclear magnetic resonance spectroscopy; Stereochemistry; Botany; Organic chemistry; Chromatography; Biology; Biosynthesis; Enzyme","score_opus":0.020871426017641675,"score_gpt":0.2859280231812252,"score_spread":0.2650565971635835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4375845874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99046457,0.0018924251,0.003767167,0.000027801223,0.000023187957,0.000059442285,0.0014642281,0.00006507814,0.0022360673],"genre_scores_gemma":[0.98434305,0.0012179373,0.003929526,0.00005488797,0.000015507989,0.00007757567,0.0031312124,0.00005170074,0.00717857],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988484,0.0000102253225,0.000008784936,0.00004607448,0.000029053268,0.000020994528],"domain_scores_gemma":[0.99959654,0.00008739304,0.000109046036,0.000049796432,0.000073098,0.00008424729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011811692,0.0006228247,0.00023446779,0.0009853824,0.00021420674,0.0003141015,0.00016200254,0.00026643596,0.0014462852],"category_scores_gemma":[0.00017620012,0.00022996232,0.0003867552,0.0006633448,0.00022805874,0.0004772541,0.00036232002,0.0005782827,0.00040039554],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048876467,0.0000055647556,0.00023624355,0.000023376006,0.0000044699827,0.00004274036,0.00001953073,0.00001630511,0.99868935,0.0000150043925,0.0000031854838,0.0008953281],"study_design_scores_gemma":[0.000009353359,0.0003045634,0.03646803,0.00001489524,0.000060105038,0.00028178337,0.00015733177,0.00045802712,0.9589988,0.00009754598,0.0031321542,0.000017377439],"about_ca_topic_score_codex":0.0009586493,"about_ca_topic_score_gemma":0.0010443227,"teacher_disagreement_score":0.0014462852,"about_ca_system_score_codex":0.00017186363,"about_ca_system_score_gemma":0.00017011813,"threshold_uncertainty_score":0.004838288},"labels":[],"label_agreement":null},{"id":"W4376613623","doi":"10.1016/j.esmoop.2023.101409","title":"220P Oral selective estrogen receptor degraders for metastatic hormone receptor-positive, HER2 negative breast cancer according to ESR1 mutation: A systematic review and meta-analysis of randomized control trials","year":2023,"lang":"en","type":"review","venue":"ESMO Open","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Meta-analysis; Oncology; Randomized controlled trial; Estrogen receptor; Breast cancer; Selective estrogen receptor modulator; Metastatic breast cancer; Fulvestrant; Cancer; Cochrane Library","score_opus":0.22772770467136944,"score_gpt":0.4902644295594634,"score_spread":0.262536724888094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376613623","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040978245,0.9938111,0.00043107898,0.00019811827,0.00013378801,0.00044047888,0.00058054423,0.000027213411,0.00027994922],"genre_scores_gemma":[0.13236448,0.8608745,0.0021842753,0.0011126728,0.00021423145,0.0018328862,0.00093938765,0.00003231023,0.00044532513],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99259394,0.0036088966,0.002181448,0.00064667,0.0007308148,0.00023823237],"domain_scores_gemma":[0.9889297,0.007986302,0.0019550165,0.00029682307,0.0006817252,0.00015051817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009498674,0.0024565004,0.018463483,0.0049545234,0.0005328257,0.0030437922,0.0014891374,0.0018670523,0.0039863097],"category_scores_gemma":[0.024274398,0.00115284,0.03167697,0.005485023,0.00066857773,0.0016557975,0.0013194731,0.0017572072,0.0003475818],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025337343,0.000026514945,0.0013827357,0.5939812,0.3881149,0.00008238954,0.00006966936,0.00042180164,0.0002676523,0.00015441678,0.000646975,0.012318084],"study_design_scores_gemma":[0.0013185506,0.00023292194,0.0021653292,0.04557832,0.948046,0.00007066798,0.000044323384,0.00015944788,0.00012791717,0.00022845693,0.0020045647,0.000023367074],"about_ca_topic_score_codex":0.0063531497,"about_ca_topic_score_gemma":0.014590473,"teacher_disagreement_score":0.018463483,"about_ca_system_score_codex":0.002608409,"about_ca_system_score_gemma":0.003283156,"threshold_uncertainty_score":0.050234377},"labels":[],"label_agreement":null},{"id":"W4377091662","doi":"10.1016/j.jcjd.2023.05.007","title":"The Reponic Classification of Insulin","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Insulin; Internal medicine","score_opus":0.03561556174936899,"score_gpt":0.30364494623674976,"score_spread":0.2680293844873808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377091662","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.082267195,0.041514523,0.11134341,0.024381489,0.016112875,0.0005071773,0.0024048456,0.0008883058,0.72058016],"genre_scores_gemma":[0.7236842,0.018951649,0.11603084,0.012428823,0.008631293,0.0006568417,0.006706842,0.0005275848,0.11238184],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976693,0.0007159827,0.00030284483,0.0003031575,0.000554913,0.00045379484],"domain_scores_gemma":[0.99691665,0.00046128657,0.00039971175,0.0004181382,0.0013392997,0.000464904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020616464,0.0010511932,0.00048271814,0.0038258228,0.0015701461,0.0044837785,0.0020119222,0.0010807336,0.008791167],"category_scores_gemma":[0.0058048735,0.00018018394,0.0012517244,0.0025131067,0.004471597,0.0027125801,0.002064458,0.0036390228,0.0058444752],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005773869,0.00014074765,0.014395736,0.00036635937,0.00007385767,0.0011627075,0.001777068,0.00065984915,0.0033820411,0.5736753,0.06386114,0.33992782],"study_design_scores_gemma":[0.000095297306,0.00044197243,0.016873013,0.0008593944,0.00012450347,0.008343767,0.002302336,0.0031034462,0.001812703,0.24059635,0.72534066,0.00010660545],"about_ca_topic_score_codex":0.005359533,"about_ca_topic_score_gemma":0.0034024378,"teacher_disagreement_score":0.008791167,"about_ca_system_score_codex":0.0022821387,"about_ca_system_score_gemma":0.0027993412,"threshold_uncertainty_score":0.029409409},"labels":[],"label_agreement":null},{"id":"W4377103226","doi":"10.1097/01.gox.0000937824.10049.d5","title":"58. The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Enhances In Vitro and In Vivo Peripheral Nerve Regeneration in a Mouse Median Nerve Injury Model","year":2023,"lang":"en","type":"article","venue":"Plastic & Reconstructive Surgery Global Open","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Regeneration (biology); In vivo; Gefitinib; Nerve growth factor; Pharmacology; Epidermal growth factor receptor; Nerve injury; Medicine; Neurite; EGFR inhibitors; Biology; Cancer research; Receptor; In vitro; Internal medicine; Cell biology; Anesthesia","score_opus":0.031017146634097686,"score_gpt":0.3058278036731925,"score_spread":0.2748106570390948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377103226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903384,0.0028049361,0.0015748693,0.00018363923,0.00014362771,0.00006340183,0.0007110416,0.00023496576,0.0039449646],"genre_scores_gemma":[0.9872913,0.001874922,0.0017786118,0.00007722924,0.00003042702,0.00009789822,0.0009842667,0.000022981063,0.007842355],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999826,0.00001681465,0.00001982887,0.000032241962,0.000045650024,0.000059567312],"domain_scores_gemma":[0.99990964,0.000008219286,0.00003082963,0.000008141025,0.0000112366515,0.0000319036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016174663,0.00038699177,0.00038729463,0.0003676078,0.000110591456,0.00022615561,0.00018449548,0.00038830648,0.002598957],"category_scores_gemma":[0.000066549095,0.00010499155,0.00047049823,0.00015045748,0.00019573627,0.0002813637,0.00009449406,0.00060644,0.00060632447],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069654064,0.00029520402,0.00019655078,0.00012310912,0.000012658066,0.000052393276,0.000016550674,0.000116031115,0.99390477,0.000064392974,0.00022171014,0.004300044],"study_design_scores_gemma":[0.00006290658,0.0043062996,0.0049894126,0.000015274292,0.000038663293,0.0002125352,0.000028329974,0.0005817872,0.9874442,0.000022363945,0.0022921022,0.0000062883705],"about_ca_topic_score_codex":0.00066360564,"about_ca_topic_score_gemma":0.0014440357,"teacher_disagreement_score":0.002598957,"about_ca_system_score_codex":0.0001871423,"about_ca_system_score_gemma":0.00024038284,"threshold_uncertainty_score":0.00869441},"labels":[],"label_agreement":null},{"id":"W4377131253","doi":"10.1016/j.bmcl.2023.129345","title":"[18F]ONO-8430506: A novel radioligand for PET imaging of autotaxin (ATX)","year":2023,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Radioligand; Chemistry; Autotaxin; Potency; Radioligand Assay; Pet imaging; Pharmacology; Stereochemistry; Biochemistry; Receptor; Positron emission tomography; In vitro; Nuclear medicine; Lysophosphatidic acid; Medicine","score_opus":0.021097422483209578,"score_gpt":0.3009944322556821,"score_spread":0.27989700977247256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377131253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.931749,0.014108382,0.019238621,0.0009879054,0.00043763453,0.00028248734,0.0011782548,0.00057569466,0.031442028],"genre_scores_gemma":[0.9451632,0.0080608465,0.027287818,0.000556478,0.00012581091,0.00022117935,0.0032385883,0.00015181613,0.015194209],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980706,0.000054026757,0.0000071275435,0.000038005863,0.000023160555,0.00007063817],"domain_scores_gemma":[0.99994504,0.000010197054,0.0000090364665,0.0000064558058,0.000007684568,0.000021610087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033926443,0.00060729403,0.00060669874,0.00034797768,0.00039905065,0.00060133764,0.0010484573,0.0010820801,0.0020327189],"category_scores_gemma":[0.00018049775,0.00029935822,0.00024011137,0.0004608896,0.00028084512,0.00053070753,0.0003750823,0.0008342671,0.0008646902],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022106115,0.00023520202,0.0006337374,0.0003559978,0.000049697315,0.0005880396,0.000070786264,0.0010426292,0.95712554,0.0013600718,0.003764589,0.032563068],"study_design_scores_gemma":[0.00041270824,0.0027095343,0.0038745308,0.00005582619,0.0001764565,0.0045678867,0.00005500405,0.0045521334,0.9322215,0.00028318772,0.051018648,0.00007256145],"about_ca_topic_score_codex":0.003606832,"about_ca_topic_score_gemma":0.0035875516,"teacher_disagreement_score":0.003606832,"about_ca_system_score_codex":0.000745313,"about_ca_system_score_gemma":0.0008403939,"threshold_uncertainty_score":0.0071716905},"labels":[],"label_agreement":null},{"id":"W4378627997","doi":"10.1080/2162402x.2023.2218782","title":"Eribulin mesylate exerts antitumor effects via CD103","year":2023,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Tsukuba; Eisai Canada; Eisai","keywords":"Cancer research; Cytotoxic T cell; Granzyme B; Tumor microenvironment; TIGIT; CD8; Chemistry; T cell; Downregulation and upregulation; Immune system; Biology; Immunology; In vitro","score_opus":0.011743955864055916,"score_gpt":0.31917743913521274,"score_spread":0.3074334832711568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378627997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921698,0.0015142948,0.0009128931,0.000114516035,0.000031902444,0.000032465803,0.00024066019,0.00012441889,0.004859047],"genre_scores_gemma":[0.99474925,0.00061290147,0.00047249877,0.00006352674,0.000010763225,0.000028367653,0.00023609014,0.000010363377,0.003816228],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999232,0.000013428993,0.000004779715,0.000012469612,0.000016457518,0.000029615003],"domain_scores_gemma":[0.9999778,0.0000032149253,0.0000051110574,0.0000029198345,0.0000024929457,0.000008435183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004400039,0.0003349236,0.00019403841,0.00017459161,0.00008379931,0.00014720336,0.00011173521,0.00017239756,0.0018694485],"category_scores_gemma":[0.000042814172,0.00008294489,0.00012311075,0.00008798696,0.00008248725,0.00012752123,0.00010654585,0.00046620567,0.00042561023],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001495755,0.000064301625,0.00014335602,0.000032255983,0.000003953452,0.000044155986,0.0000056109666,0.000071147115,0.9953858,0.00007762998,0.00008412595,0.0039380807],"study_design_scores_gemma":[0.00008506366,0.0010764672,0.0050481623,0.000007857013,0.000021455404,0.00033158492,0.00002099684,0.0007688177,0.98643214,0.000056531935,0.0061467187,0.000004310279],"about_ca_topic_score_codex":0.0002354407,"about_ca_topic_score_gemma":0.0005212668,"teacher_disagreement_score":0.0018694485,"about_ca_system_score_codex":0.00015522256,"about_ca_system_score_gemma":0.00009954779,"threshold_uncertainty_score":0.006253898},"labels":[],"label_agreement":null},{"id":"W4378674654","doi":"10.1152/physiol.2023.38.s1.5732754","title":"Electrical stimulation-induced muscle contraction does not reduce intramuscular accumulation of Doxorubicin 24 hours following administration","year":2023,"lang":"en","type":"article","venue":"Physiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; McMaster University; Laurentian University","funders":"","keywords":"Doxorubicin; Medicine; Stimulation; Pharmacology; Skeletal muscle; Contraction (grammar); Metabolite; Context (archaeology); Drug; Anesthesia; Internal medicine; Chemotherapy; Biology","score_opus":0.08696506435945868,"score_gpt":0.4138742210970389,"score_spread":0.32690915673758025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378674654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976743,0.00060989533,0.0008291329,0.000048336748,0.00003300684,0.000036250884,0.00014022121,0.000026210451,0.00060260453],"genre_scores_gemma":[0.9949066,0.0007322001,0.0012366028,0.000057810426,0.00002218789,0.00013071875,0.00038637457,0.000009905226,0.002517543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999324,0.000008737694,0.0000061141504,0.000014652489,0.000016293614,0.000021779864],"domain_scores_gemma":[0.9998698,0.000019510991,0.000047030077,0.000012775428,0.000019434536,0.000031350934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114993556,0.00021492975,0.00023062149,0.00013189475,0.00006990436,0.0000916358,0.00013381077,0.00017305717,0.0019263688],"category_scores_gemma":[0.00014996919,0.000057473742,0.00017386994,0.00008147798,0.00019499563,0.00015397777,0.0001030181,0.0003200019,0.00021677543],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037404697,0.00042615007,0.0008626499,0.000097054544,0.000015686412,0.000025436513,0.000025297531,0.00007443027,0.98647565,0.000024418585,0.00012090389,0.008111806],"study_design_scores_gemma":[0.00017094697,0.028332984,0.039666906,0.00003033082,0.00006149127,0.000118277305,0.00011614979,0.000897712,0.9287006,0.000037340687,0.0018559223,0.000011475626],"about_ca_topic_score_codex":0.00024350086,"about_ca_topic_score_gemma":0.0010095922,"teacher_disagreement_score":0.0019263688,"about_ca_system_score_codex":0.000113911905,"about_ca_system_score_gemma":0.00016256502,"threshold_uncertainty_score":0.006444335},"labels":[],"label_agreement":null},{"id":"W4379281682","doi":"10.1200/jco.2023.41.16_suppl.e17075","title":"Darolutamide and time to pain progression by disease volume in ARASENS.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Docetaxel; Internal medicine; Hazard ratio; Prostate cancer; Placebo; Oncology; Confidence interval; Cancer; Pathology","score_opus":0.0763143164530647,"score_gpt":0.5133563349878346,"score_spread":0.4370420185347699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379281682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948672,0.0030291134,0.00008277025,0.00014665551,0.000023351255,0.000083325285,0.0008626389,0.000019945825,0.0008850113],"genre_scores_gemma":[0.9975465,0.00060653005,0.0001247624,0.000096320866,0.000015539988,0.000056113426,0.00092754274,0.0000034750676,0.00062314485],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99970514,0.00015090947,0.000020335994,0.000037979058,0.000041093044,0.000044462355],"domain_scores_gemma":[0.9994646,0.00017561433,0.00020600394,0.000026888163,0.00003290325,0.000094096256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000865901,0.0002806679,0.0004963791,0.00023432833,0.000093191244,0.00032957472,0.00023626104,0.0003056294,0.0030105766],"category_scores_gemma":[0.0010980138,0.0001532368,0.00095773314,0.0003256894,0.00020630265,0.00019476596,0.00024984565,0.0005847508,0.00028027565],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45654896,0.006136387,0.34430468,0.0013152031,0.0027517304,0.00036328557,0.0002099532,0.004310173,0.013316433,0.0004125903,0.0052827275,0.16504787],"study_design_scores_gemma":[0.07597653,0.14953884,0.7495344,0.000265583,0.0024555442,0.0011408724,0.00022736695,0.0066360524,0.0035058497,0.0006625997,0.009999497,0.000056777426],"about_ca_topic_score_codex":0.0015393104,"about_ca_topic_score_gemma":0.003426947,"teacher_disagreement_score":0.0030105766,"about_ca_system_score_codex":0.00043196202,"about_ca_system_score_gemma":0.00065797026,"threshold_uncertainty_score":0.010071337},"labels":[],"label_agreement":null},{"id":"W4379283716","doi":"10.1200/jco.2023.41.16_suppl.e13033","title":"Incidence of interstitial lung disease and cardiotoxicity with trastuzumab-deruxtecan in patients with breast cancer: A systematic review and single-arm meta-analysis.","year":2023,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Oncology; Trastuzumab; Metastatic breast cancer; Cohort; Population; Incidence (geometry); Lung cancer; Interstitial lung disease; Cancer; Lung","score_opus":0.2038903981286359,"score_gpt":0.5079035114256127,"score_spread":0.30401311329697683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379283716","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008539202,0.98899186,0.0005075233,0.0002010325,0.00010560391,0.00034233637,0.0010084728,0.000023134893,0.0002808809],"genre_scores_gemma":[0.28984606,0.7032303,0.0022800842,0.0010342277,0.00020860955,0.0014140201,0.0015750992,0.000038631635,0.00037298494],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9920265,0.0033136124,0.0027989622,0.0008150452,0.0008210438,0.00022485918],"domain_scores_gemma":[0.98698735,0.008731868,0.0027212026,0.00041256376,0.0009618566,0.00018516743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010193701,0.0018929502,0.014009941,0.0062823333,0.0004904991,0.0024115648,0.0016600223,0.0016837406,0.0025521915],"category_scores_gemma":[0.02051002,0.0011452138,0.030597843,0.0072277496,0.00060319377,0.0013644678,0.001364579,0.0012165727,0.00027130175],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015220676,0.000027137447,0.0064314394,0.40742514,0.575036,0.00012781133,0.00008879259,0.00036970462,0.0002598337,0.00011130396,0.0005450583,0.008055693],"study_design_scores_gemma":[0.0004960867,0.00017659341,0.0055791223,0.02609857,0.9655018,0.0001287131,0.000050952505,0.00017447547,0.000119437485,0.00014569258,0.0015055946,0.000022974878],"about_ca_topic_score_codex":0.0052280803,"about_ca_topic_score_gemma":0.013156025,"teacher_disagreement_score":0.014009941,"about_ca_system_score_codex":0.0019706413,"about_ca_system_score_gemma":0.0026735184,"threshold_uncertainty_score":0.053910136},"labels":[],"label_agreement":null},{"id":"W4379334895","doi":"10.1200/jco.2023.41.16_suppl.e15003","title":"Phase 1/2 study of tusamitamab ravtansine in patients with advanced solid tumors: Pooled safety analysis of corneal adverse events.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Adverse effect; Perforation; Carcinoembryonic antigen; Internal medicine; Oncology; Surgery; Gastroenterology; Ophthalmology; Cancer","score_opus":0.0696800325846888,"score_gpt":0.49284928820567564,"score_spread":0.42316925562098684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379334895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865986,0.005886166,0.0015473022,0.00017213097,0.00007792751,0.0023567847,0.0020269493,0.000110338355,0.0012237937],"genre_scores_gemma":[0.99190944,0.0016436437,0.001338314,0.00035824176,0.000153191,0.0014001756,0.0023312117,0.000023497665,0.0008423075],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9986307,0.0008817259,0.0000855223,0.00017860672,0.0001377587,0.00008569627],"domain_scores_gemma":[0.99849033,0.00039023522,0.0005799115,0.00014847665,0.00013994031,0.00025102278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041100443,0.0013851679,0.0021757248,0.0006074512,0.00027750264,0.0008568403,0.00054532674,0.0009169063,0.002919837],"category_scores_gemma":[0.002541481,0.00046667963,0.0025966761,0.00065369124,0.0005162794,0.0006608835,0.00039646745,0.0014805942,0.00045785878],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8154036,0.015107247,0.027005041,0.0016995189,0.01493331,0.00028110298,0.000204747,0.0037782376,0.03451462,0.00014839131,0.0031231341,0.08380107],"study_design_scores_gemma":[0.4036085,0.46728012,0.09882305,0.000089937545,0.010812229,0.0010137643,0.00011922938,0.0040225782,0.0088650035,0.00032800433,0.004953951,0.00008363337],"about_ca_topic_score_codex":0.00043620507,"about_ca_topic_score_gemma":0.0008457949,"teacher_disagreement_score":0.0041100443,"about_ca_system_score_codex":0.0008358183,"about_ca_system_score_gemma":0.0010124655,"threshold_uncertainty_score":0.021736205},"labels":[],"label_agreement":null},{"id":"W4379341012","doi":"10.1200/jco.2023.41.16_suppl.12100","title":"Patient- versus clinician-reported symptoms in the POLARIX study.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); University of Alberta","funders":"","keywords":"Medicine; Constipation; Nausea; Adverse effect; Vomiting; Placebo; Common Terminology Criteria for Adverse Events; Incidence (geometry); MedDRA; Quality of life (healthcare); Internal medicine; Diarrhea; Clinical trial; Physical therapy; Pharmacovigilance; Alternative medicine","score_opus":0.2938817515610744,"score_gpt":0.5797884005485378,"score_spread":0.2859066489874634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379341012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9522987,0.017145291,0.0015260181,0.0008673042,0.00037501665,0.0037887334,0.011762401,0.000052639338,0.012183941],"genre_scores_gemma":[0.97534186,0.0034006573,0.0014254773,0.0011164089,0.00039034768,0.003827444,0.012027753,0.000025982668,0.002444149],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9948258,0.003686068,0.00023028963,0.00049623323,0.0005963531,0.00016513052],"domain_scores_gemma":[0.99369353,0.0029139626,0.0020774966,0.00028933588,0.00040562043,0.00062004995],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.011010455,0.0008138321,0.0013121457,0.00046452577,0.0003137214,0.001302568,0.0005501633,0.00084077445,0.008811626],"category_scores_gemma":[0.0076833344,0.00032150457,0.0014143944,0.0010741737,0.00069431507,0.0012563027,0.0010963624,0.001592352,0.0009381138],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84548336,0.0022538146,0.09814959,0.0025776844,0.0031720365,0.00010161175,0.00029353332,0.00059506716,0.0018352212,0.000502556,0.0044394126,0.040596057],"study_design_scores_gemma":[0.39304888,0.15010317,0.41814858,0.0010378596,0.0069766594,0.000704535,0.0007667683,0.0036085541,0.0015504922,0.001212926,0.022652956,0.00018863623],"about_ca_topic_score_codex":0.00047180086,"about_ca_topic_score_gemma":0.0007070046,"teacher_disagreement_score":0.98898953,"about_ca_system_score_codex":0.00059382245,"about_ca_system_score_gemma":0.00089237065,"threshold_uncertainty_score":0.058229566},"labels":[],"label_agreement":null},{"id":"W4379345342","doi":"10.1200/jco.2023.41.16_suppl.12092","title":"The impact of population pharmacogenomics and risk allele frequencies on cisplatin-induced peripheral sensory neuropathy (PSN).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University Health Network","funders":"National Institutes of Health","keywords":"Single-nucleotide polymorphism; Allele; Population; Allele frequency; Expression quantitative trait loci; Ancestry-informative marker; Genome-wide association study; Oncology; Genetics; Medicine; Biology; Pharmacogenomics; Internal medicine; Genotype; Gene; Environmental health","score_opus":0.1847579850841918,"score_gpt":0.5206790500866666,"score_spread":0.33592106500247476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379345342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99337375,0.00073073216,0.0029517212,0.00020835281,0.000022762228,0.000020927613,0.0012304916,0.000042672218,0.0014186472],"genre_scores_gemma":[0.99862194,0.00008872199,0.0006401778,0.00003639508,0.000009106651,0.000013872233,0.0003227928,0.000018841583,0.00024824127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966606,0.0017847959,0.0001787697,0.0009216314,0.00026968712,0.00018451782],"domain_scores_gemma":[0.9963284,0.0019743936,0.00075693754,0.00057206105,0.00018662369,0.00018165514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032376938,0.00038642224,0.00035060986,0.0009170211,0.00041847903,0.0007832783,0.00039244525,0.0006351973,0.0032462643],"category_scores_gemma":[0.008250608,0.00020231704,0.00078355824,0.0012074147,0.0004121167,0.00041812175,0.0005937701,0.00055975176,0.00027629142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009853842,0.00005521648,0.98111457,0.000034928275,0.0011709548,0.00030671625,0.0001851558,0.0006604701,0.0021133965,0.00035210597,0.00041217645,0.01260896],"study_design_scores_gemma":[0.000018028019,0.00021695573,0.9940275,0.0000101905125,0.00048256337,0.00040840477,0.00009025879,0.0031800228,0.00034400253,0.0004911987,0.0007213109,0.000009442272],"about_ca_topic_score_codex":0.0029636233,"about_ca_topic_score_gemma":0.0025506795,"teacher_disagreement_score":0.0032462643,"about_ca_system_score_codex":0.00020089265,"about_ca_system_score_gemma":0.00020254713,"threshold_uncertainty_score":0.017122746},"labels":[],"label_agreement":null},{"id":"W4379376363","doi":"10.1002/pmrj.13007","title":"Brachial plexopathy after breast cancer: A persistent late effect of radiotherapy","year":2023,"lang":"en","type":"review","venue":"PM&R","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Brachial Plexopathy; Breast cancer; Radiation therapy; Hypoesthesia; Weakness; Rehabilitation; Lymphedema; Surgery; Dysesthesia; Cancer; Physical therapy; Brachial plexus; Internal medicine","score_opus":0.03475781185850126,"score_gpt":0.39094667303833547,"score_spread":0.3561888611798342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379376363","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95872766,0.023747953,0.0012611137,0.0039109886,0.00026579635,0.00009882339,0.00019363538,0.00009808221,0.011695961],"genre_scores_gemma":[0.99268544,0.0045367144,0.00019743333,0.0010268277,0.00020759321,0.000019548324,0.00008217541,0.0000058878604,0.0012384384],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99965787,0.000058853828,0.000026151247,0.000055284683,0.00009634714,0.0001055565],"domain_scores_gemma":[0.99871266,0.00030755997,0.0004999204,0.000078935445,0.00018431147,0.0002166881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047908188,0.00025428995,0.000471441,0.00050433644,0.00074896985,0.0006872202,0.00032687176,0.00077529385,0.0011055539],"category_scores_gemma":[0.0030311933,0.000120804936,0.0002513214,0.00090488594,0.0003756187,0.00064620544,0.0003718756,0.00091914856,0.00037931005],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006416985,0.0005281723,0.48471156,0.0005049937,0.00011854493,0.40452158,0.002213428,0.00043056588,0.005027986,0.0005995388,0.004343699,0.09635841],"study_design_scores_gemma":[0.00004407943,0.00078841636,0.50854385,0.00046369698,0.00014364661,0.48072556,0.0015159864,0.00040282254,0.00067876163,0.00079995894,0.005857307,0.000035883142],"about_ca_topic_score_codex":0.0042491886,"about_ca_topic_score_gemma":0.0061000735,"teacher_disagreement_score":0.0042491886,"about_ca_system_score_codex":0.0008726128,"about_ca_system_score_gemma":0.0006853339,"threshold_uncertainty_score":0.008448899},"labels":[],"label_agreement":null},{"id":"W4384789985","doi":"10.1007/978-3-031-29277-4_11","title":"Principles of Clinical Oncology and Systemic Treatments","year":2023,"lang":"en","type":"book-chapter","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Multidisciplinary approach; Specialty; Intensive care medicine; Systemic therapy; Immunotherapy; Oncology; Cancer; Internal medicine; Breast cancer; Pathology","score_opus":0.27799483519115437,"score_gpt":0.4768419341880442,"score_spread":0.19884709899688985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384789985","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002519241,0.049383827,0.011679983,0.010553933,0.0042444617,0.00013287194,0.00013337063,0.00014050413,0.9234792],"genre_scores_gemma":[0.004404753,0.038170855,0.0065995227,0.009571748,0.0022205338,0.00027852092,0.00011431948,0.0001233601,0.9385165],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.999476,0.00016338954,0.000015223908,0.000041770854,0.00026634036,0.00003725757],"domain_scores_gemma":[0.99959356,0.0002316839,0.000018583072,0.00003863137,0.00008256517,0.000034999925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008489677,0.00092152273,0.00065350684,0.0010948536,0.00094845454,0.0030894496,0.0008134177,0.0016737483,0.04099583],"category_scores_gemma":[0.0011954393,0.0003536931,0.00034363594,0.0009889016,0.002470017,0.0018694912,0.0014635121,0.0048124897,0.021506054],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012485711,0.00005749214,0.00004494031,0.00032519468,0.000004702884,0.0000857523,0.0003458058,0.0006193878,0.0002798748,0.32830316,0.50640064,0.16352066],"study_design_scores_gemma":[0.0000034732434,0.000007683471,0.00003863055,0.00016191334,0.0000017334638,0.00015453194,0.000036109595,0.00008461194,0.00005401892,0.048822608,0.95063126,0.0000032752619],"about_ca_topic_score_codex":0.0014847945,"about_ca_topic_score_gemma":0.004687016,"teacher_disagreement_score":0.04099583,"about_ca_system_score_codex":0.001861705,"about_ca_system_score_gemma":0.0029420168,"threshold_uncertainty_score":0.13714474},"labels":[],"label_agreement":null},{"id":"W4384963325","doi":"","title":"Pharmacogénétique-pharmacogénomique. La dualité hôte-tumeur","year":2012,"lang":"fr","type":"preprint","venue":"HAL (Le Centre pour la Communication Scientifique Directe)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"","keywords":"Physics; Computer science","score_opus":0.02703725457329485,"score_gpt":0.30575072114727975,"score_spread":0.2787134665739849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384963325","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26586542,0.3916139,0.058246337,0.14018402,0.0038472887,0.00031343853,0.014988654,0.0009788848,0.123962164],"genre_scores_gemma":[0.8739892,0.06318577,0.009590817,0.00499266,0.003347441,0.00017367015,0.0022385037,0.00013366007,0.042348225],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9991689,0.0003662693,0.000030439376,0.00016651677,0.00017103275,0.00009681024],"domain_scores_gemma":[0.9983302,0.0010593239,0.00024720264,0.00010297071,0.00013138553,0.00012894854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016861486,0.00063176255,0.0013029551,0.001234434,0.00050217105,0.0026848135,0.00051929103,0.0018865931,0.020624604],"category_scores_gemma":[0.003957811,0.00036602977,0.001057893,0.0014003302,0.0011131321,0.0013819023,0.00076426147,0.0028952318,0.003044047],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046821586,0.0009214859,0.109920636,0.0036533084,0.0018297096,0.005288748,0.00069135276,0.005146976,0.056007147,0.2342906,0.036632214,0.54093575],"study_design_scores_gemma":[0.0010226518,0.0017059468,0.28776324,0.0011743824,0.001969908,0.03624143,0.0011576621,0.01482856,0.03657,0.2215937,0.39575058,0.00022198596],"about_ca_topic_score_codex":0.0074297823,"about_ca_topic_score_gemma":0.0043225493,"teacher_disagreement_score":0.020624604,"about_ca_system_score_codex":0.0024234601,"about_ca_system_score_gemma":0.0016167706,"threshold_uncertainty_score":0.06899619},"labels":[],"label_agreement":null},{"id":"W4386033484","doi":"10.22201/fesi.23958979e.2023.12.24.85532","title":"Prevalencia e intensidad de síntomas en pacientes que reciben quimioterapia ambulatoria","year":2023,"lang":"es","type":"article","venue":"Revista CuidArte","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Humanities; Medicine; Philosophy","score_opus":0.019909686006555873,"score_gpt":0.34819240296453907,"score_spread":0.3282827169579832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386033484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98665684,0.007461357,0.00032454438,0.00031143456,0.000024470703,0.000087122644,0.0010624861,0.000028488159,0.004043157],"genre_scores_gemma":[0.9946873,0.002849192,0.00044684662,0.0001413703,0.000032691183,0.000065128304,0.00065012666,0.0000040157174,0.0011232753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99947435,0.00013467776,0.000074214215,0.000100581565,0.00013599823,0.00008019115],"domain_scores_gemma":[0.9977894,0.00048182454,0.0012921535,0.00006656046,0.00022198143,0.00014822054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007204486,0.0002507783,0.00037920286,0.0011420524,0.00026891785,0.0005293728,0.00017617173,0.0004053471,0.00391474],"category_scores_gemma":[0.0023699,0.00027245682,0.00039801668,0.0011434386,0.0002905606,0.0003865652,0.00035123562,0.00035186976,0.00039895097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029293526,0.000074892334,0.979422,0.00021269202,0.000053292813,0.0002367857,0.00029171476,0.00004094789,0.0011607911,0.0000404867,0.0003748086,0.017798865],"study_design_scores_gemma":[0.000010925855,0.00039260843,0.99625236,0.00008131917,0.00004270439,0.0013676317,0.00029377392,0.00004506767,0.00041241082,0.00003184213,0.0010637984,0.000005587826],"about_ca_topic_score_codex":0.0025318505,"about_ca_topic_score_gemma":0.002889992,"teacher_disagreement_score":0.00391474,"about_ca_system_score_codex":0.00037594038,"about_ca_system_score_gemma":0.00047026397,"threshold_uncertainty_score":0.013096094},"labels":[],"label_agreement":null},{"id":"W4386122856","doi":"10.11159/icepr23.132","title":"Encapsulation of Sertraline in Biodegradable Polymeric Nanoparticles","year":2023,"lang":"en","type":"article","venue":"Proceedings of the World Congress on New Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Encapsulation (networking); Nanoparticle; Sertraline; Materials science; Nanotechnology; Computer science; Computer security; Medicine","score_opus":0.027799375505903896,"score_gpt":0.30472048180490385,"score_spread":0.27692110629899996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386122856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906748,0.001910253,0.004430516,0.00011899052,0.000059121478,0.000031694588,0.00007983726,0.00009963292,0.0025951022],"genre_scores_gemma":[0.99291986,0.00067632797,0.0028784303,0.00006886457,0.0000139075155,0.00002080229,0.00006674639,0.000021304904,0.003333883],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991405,0.0000145668955,0.000005603007,0.000023643594,0.000015926327,0.000026161566],"domain_scores_gemma":[0.9999325,0.000017750832,0.000023775108,0.0000066740427,0.000010654395,0.000008750445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013440233,0.0002289662,0.00017306162,0.000099269,0.00008687602,0.00025715644,0.00014654387,0.00032504948,0.00064902304],"category_scores_gemma":[0.00015354322,0.0001257486,0.00021327846,0.00006516772,0.000109449604,0.00026258032,0.00014384929,0.00022672753,0.00026998165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098272685,0.000014595747,0.000057876412,0.000054762073,0.000008740033,0.000047186477,0.000016142083,0.00030901306,0.99578863,0.00010300794,0.000058607642,0.003443086],"study_design_scores_gemma":[0.000014925616,0.00035867427,0.0004843587,0.0000058248665,0.000018865281,0.000062341016,0.000008810146,0.0015723701,0.99586296,0.000015925645,0.0015897884,0.0000050616204],"about_ca_topic_score_codex":0.0003783516,"about_ca_topic_score_gemma":0.0005544424,"teacher_disagreement_score":0.00064902304,"about_ca_system_score_codex":0.0002166027,"about_ca_system_score_gemma":0.00013623235,"threshold_uncertainty_score":0.0021712184},"labels":[],"label_agreement":null},{"id":"W4386277530","doi":"10.1016/s2152-2650(23)00614-6","title":"POSTER: MDS-634 Efficacy and Safety of Oral Decitabine/Cedazuridine (ASTX727) in the CMML Subpopulation from Phase 2 and ASCERTAIN Phase 3 Studies","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Hôpital Maisonneuve-Rosemont; University of Alberta Hospital; Queen Elizabeth II Health Sciences Centre; Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Decitabine; Phase (matter); Medicine; Internal medicine; Pharmacology; Chemistry; Biology; Genetics; Organic chemistry","score_opus":0.10738174308216894,"score_gpt":0.4665188563372431,"score_spread":0.35913711325507414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386277530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.950244,0.01299566,0.0014068546,0.005693259,0.0008095851,0.0017892172,0.007923277,0.00051055435,0.018627543],"genre_scores_gemma":[0.95238674,0.004991236,0.0019622142,0.0017350948,0.00047927359,0.00079019985,0.0072792564,0.00010598358,0.030270008],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998078,0.000073621915,0.000015025351,0.000024186395,0.00003062991,0.00004873226],"domain_scores_gemma":[0.99974793,0.00005032405,0.00004316431,0.000017709142,0.00003634231,0.0001045409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078400335,0.00066243444,0.0007721153,0.00024969396,0.0004534573,0.0005400502,0.00042642734,0.000648597,0.014313143],"category_scores_gemma":[0.00051584654,0.00023038105,0.0007976746,0.00018465864,0.00028040446,0.00027643924,0.0002811291,0.0017519172,0.002089482],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36479047,0.0125903925,0.0064199343,0.0013845592,0.0012105114,0.00041435257,0.00035651188,0.0022277765,0.1636975,0.0007760224,0.06579019,0.38034177],"study_design_scores_gemma":[0.2459744,0.43597668,0.08879276,0.00035620262,0.0021996563,0.0014604989,0.00024219502,0.0021415872,0.10603326,0.0013882304,0.11531505,0.000119563876],"about_ca_topic_score_codex":0.0012235531,"about_ca_topic_score_gemma":0.0034559844,"teacher_disagreement_score":0.014313143,"about_ca_system_score_codex":0.0006735727,"about_ca_system_score_gemma":0.0009579869,"threshold_uncertainty_score":0.0478822},"labels":[],"label_agreement":null},{"id":"W4386277882","doi":"10.1016/s2152-2650(23)01205-3","title":"MDS-634 Efficacy and Safety of Oral Decitabine/Cedazuridine (ASTX727) in the CMML Subpopulation from Phase 2 and ASCERTAIN Phase 3 Studies","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Hôpital Maisonneuve-Rosemont; University of Alberta Hospital; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Ottawa Hospital; University of Ottawa","funders":"University of Colorado School of Medicine, Anschutz Medical Campus; School of Medicine, Vanderbilt University; Yale Cancer Center; Yale University; Vanderbilt-Ingram Cancer Center; Vanderbilt University; London Health Sciences Centre; University of Texas MD Anderson Cancer Center; Roswell Park Cancer Institute","keywords":"Decitabine; Phase (matter); Medicine; Internal medicine; Oncology; Chemistry; Biology; Genetics; Organic chemistry","score_opus":0.11731023287305228,"score_gpt":0.4757566492205611,"score_spread":0.35844641634750884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386277882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924591,0.0026156527,0.00041370993,0.00034490397,0.000034246623,0.00036579688,0.0011400328,0.000106487176,0.002520024],"genre_scores_gemma":[0.9912635,0.00136791,0.0007717206,0.00023091475,0.00002946472,0.00031677738,0.0032259917,0.000028446142,0.0027652367],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997745,0.00008016774,0.000017291157,0.000027085696,0.000041110085,0.000059783742],"domain_scores_gemma":[0.9998149,0.00002811157,0.000035134704,0.000021150932,0.000031434654,0.0000691659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080233585,0.00054200203,0.0010947937,0.00035992,0.00047883074,0.0006053991,0.00040327947,0.00042847855,0.0034494724],"category_scores_gemma":[0.00046404448,0.00022788637,0.0007389917,0.00031921305,0.00032571767,0.0003301559,0.00035293808,0.0013607532,0.0007096664],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28935114,0.013362772,0.016294234,0.0009485275,0.001380757,0.0003895427,0.00048031504,0.004538368,0.27168462,0.00056976953,0.008569297,0.39243063],"study_design_scores_gemma":[0.16457212,0.50629425,0.14291237,0.00021335059,0.0026154912,0.0018836511,0.00041217243,0.0039699976,0.12943447,0.0012865915,0.046275925,0.00012965073],"about_ca_topic_score_codex":0.0014019734,"about_ca_topic_score_gemma":0.00473507,"teacher_disagreement_score":0.0034494724,"about_ca_system_score_codex":0.0006820868,"about_ca_system_score_gemma":0.0009378671,"threshold_uncertainty_score":0.011539638},"labels":[],"label_agreement":null},{"id":"W4387310638","doi":"10.22541/au.169633092.29115365/v1","title":"Physical therapy for deficits associated with chemotherapy-induced peripheral neuropathy in children with cancer: a systematic review","year":2023,"lang":"en","type":"review","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"University of Alberta","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Physical therapy; Clinical trial; Randomized controlled trial; Physical medicine and rehabilitation; Adverse effect; Psychological intervention; Peripheral neuropathy; Cancer; Systematic review; Inclusion and exclusion criteria; Quality of life (healthcare); Incidence (geometry); Range of motion; MEDLINE; Alternative medicine; Internal medicine","score_opus":0.05965829511089113,"score_gpt":0.3861156272695795,"score_spread":0.32645733215868833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387310638","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006422628,0.9986078,0.00005182813,0.000104888786,0.00005888291,0.00016989543,0.0001412564,0.0000051141214,0.00021810866],"genre_scores_gemma":[0.006791605,0.9923224,0.00024921104,0.00021577561,0.000034275232,0.00020470434,0.00009391982,0.0000018673002,0.00008633745],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99804616,0.00059160555,0.00067954615,0.0001608906,0.00043303514,0.00008861951],"domain_scores_gemma":[0.9930617,0.0048658233,0.0013766973,0.000076404925,0.000522838,0.00009650993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026537045,0.0010378995,0.004970834,0.0049403827,0.00047048499,0.0016388951,0.0010515568,0.001347898,0.0042651733],"category_scores_gemma":[0.012853198,0.0006149037,0.0047092084,0.00566426,0.0004764321,0.0010911407,0.0009180768,0.0008817258,0.00025187267],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015156655,0.000017768634,0.0004916747,0.94380814,0.0055593117,0.00007579574,0.000097231255,0.00006338434,0.000109047956,0.00013735153,0.001556132,0.047932692],"study_design_scores_gemma":[0.00029684772,0.00022707335,0.004615339,0.9219449,0.05088071,0.00045969334,0.00019349919,0.00007664088,0.00014275165,0.00018189322,0.020953864,0.000026809352],"about_ca_topic_score_codex":0.00839911,"about_ca_topic_score_gemma":0.024399258,"teacher_disagreement_score":0.00839911,"about_ca_system_score_codex":0.0024178696,"about_ca_system_score_gemma":0.0068929307,"threshold_uncertainty_score":0.017542899},"labels":[],"label_agreement":null},{"id":"W4387644499","doi":"10.1002/cm.21706","title":"Front Cover Image","year":2023,"lang":"en","type":"paratext","venue":"Cytoskeleton","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Actin; Biology; Front cover; Protein filament; Cover (algebra); Anatomy; Biophysics; Cell biology; Biochemistry; Engineering; Mechanical engineering","score_opus":0.02480909933930069,"score_gpt":0.3483045585586491,"score_spread":0.3234954592193484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387644499","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003852738,0.00055760663,0.0005179531,0.0013482356,0.0054232273,0.00011983179,0.0041530877,0.0017446517,0.9857501],"genre_scores_gemma":[0.0011715069,0.00034871834,0.00026321475,0.00042725884,0.0005735136,0.000031945583,0.001956392,0.0004067527,0.99482083],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998292,0.000009148965,0.000004824537,0.000029127943,0.0000833492,0.000044457018],"domain_scores_gemma":[0.99945706,0.000055135803,0.000019164898,0.000049543418,0.00017909579,0.00023998828],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00015179663,0.0010355755,0.0005992965,0.0011719123,0.0010150655,0.0028571466,0.0007916435,0.0016274529,0.93614614],"category_scores_gemma":[0.00073803845,0.00043802432,0.00059071294,0.00087720284,0.00029980464,0.0014269963,0.0012714311,0.0016835539,0.8306796],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020222382,0.000017368944,0.000026497892,0.000055110286,7.344601e-7,0.000028509483,0.0000040710192,0.000030219757,0.0005397933,0.0004734625,0.98227584,0.01652813],"study_design_scores_gemma":[0.000013695361,0.000012401173,0.00039938244,0.000034764398,0.0000012400624,0.00006986949,0.000014620963,0.000059121234,0.00028321685,0.0003103462,0.9987978,0.0000035385365],"about_ca_topic_score_codex":0.0016974307,"about_ca_topic_score_gemma":0.004331218,"teacher_disagreement_score":0.06385386,"about_ca_system_score_codex":0.0009351069,"about_ca_system_score_gemma":0.00057076296,"threshold_uncertainty_score":0.09107971},"labels":[],"label_agreement":null},{"id":"W4387774241","doi":"10.3390/curroncol30100665","title":"Toxicities and Quality of Life during Cancer Treatment in Advanced Solid Tumors","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Sociedad Española de Oncología Médica; AstraZeneca","keywords":"Medicine; Cancer; Quality of life (healthcare); Solid tumor; Cancer research; Oncology; Internal medicine; Nursing","score_opus":0.21365993891603335,"score_gpt":0.5182036367719955,"score_spread":0.3045436978559622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387774241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99774617,0.0013606224,0.00013695884,0.000060940984,0.000005705578,0.000024510537,0.0002328542,0.0000026601303,0.00042955554],"genre_scores_gemma":[0.99924517,0.00026247956,0.00010564089,0.000034245426,0.00000792349,0.000014583135,0.00024588307,0.0000011537525,0.000082887105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870884,0.00065152557,0.00015363509,0.00008853774,0.000278358,0.000119160555],"domain_scores_gemma":[0.9944031,0.0009975269,0.0037012498,0.000103573264,0.0003118397,0.0004826785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017448706,0.00025117386,0.00050420495,0.00059019745,0.00028090243,0.00061324594,0.00019722377,0.0002754209,0.0006912895],"category_scores_gemma":[0.006671873,0.00011150307,0.0007230193,0.0008833185,0.00021954587,0.00040785162,0.00050618825,0.00050703035,0.00009166158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063021976,0.0002016107,0.9900615,0.000075651034,0.00017967027,0.00006262905,0.0001318233,0.00026609693,0.00028559088,0.000020253136,0.000089957,0.007995023],"study_design_scores_gemma":[0.000018470086,0.00062914187,0.99855787,0.000012127796,0.000035352397,0.00017907158,0.000076291304,0.0001939761,0.000069670146,0.000028854995,0.0001950961,0.000004156873],"about_ca_topic_score_codex":0.0012448231,"about_ca_topic_score_gemma":0.0016671242,"teacher_disagreement_score":0.0017448706,"about_ca_system_score_codex":0.0006468407,"about_ca_system_score_gemma":0.00028334014,"threshold_uncertainty_score":0.009227872},"labels":[],"label_agreement":null},{"id":"W4387782509","doi":"10.21203/rs.3.rs-3432816/v1","title":"Patient Perceptions of Altering Chemotherapy Treatment Due to Peripheral Neuropathy","year":2023,"lang":"en","type":"preprint","venue":"Research Square","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"King's College London; Bowel Cancer UK","keywords":"Chemotherapy-induced peripheral neuropathy; Medicine; Chemotherapy; Peripheral neuropathy; Physical therapy; Internal medicine","score_opus":0.11219272509237521,"score_gpt":0.4667034907685857,"score_spread":0.3545107656762105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387782509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98592013,0.0012643428,0.0005375771,0.006787217,0.00008889104,0.00003917917,0.000088417415,0.000012594069,0.0052617337],"genre_scores_gemma":[0.9976737,0.0005793303,0.0002657901,0.0012186684,0.000021879181,0.000013938564,0.00002109473,0.0000021489614,0.00020351568],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.994027,0.003970363,0.00037776004,0.00019228592,0.0010409962,0.00039151506],"domain_scores_gemma":[0.98530143,0.0074512386,0.004082198,0.00022853732,0.0014666778,0.0014699536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049193865,0.00016211954,0.000270772,0.00038076413,0.0011426999,0.00166825,0.0003125172,0.0008408609,0.0034812368],"category_scores_gemma":[0.021261916,0.0002073417,0.0005303199,0.0003261642,0.0011037282,0.001223391,0.0013247695,0.0015021203,0.00021865321],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062897,0.00051023613,0.66695064,0.001420888,0.00036858543,0.002696149,0.2061629,0.000678168,0.0034761284,0.0016303726,0.0097915875,0.10568538],"study_design_scores_gemma":[0.00013112328,0.002646527,0.40266266,0.0016807003,0.000281639,0.0070817918,0.54112923,0.0015617935,0.0013453343,0.0020175243,0.03924181,0.00021986708],"about_ca_topic_score_codex":0.0027834692,"about_ca_topic_score_gemma":0.003920564,"teacher_disagreement_score":0.0049193865,"about_ca_system_score_codex":0.0012233945,"about_ca_system_score_gemma":0.0014716155,"threshold_uncertainty_score":0.026016474},"labels":[],"label_agreement":null},{"id":"W4387809675","doi":"10.1016/j.annonc.2023.10.015","title":"LBA11 Datopotamab deruxtecan (Dato-DXd) vs chemotherapy in previously-treated inoperable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2–) breast cancer (BC): Primary results from the randomised phase III TROPION-Breast01 trial","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Foundation Medicine; Loxo Oncology; Jounce Therapeutics; Genentech; Gilead Sciences; Radius Health; MedImmune; Clovis Oncology; Eisai; Daiichi Sankyo Europe; Sanofi; Daiichi-Sankyo; Pfizer","keywords":"Medicine; Oncology; Metastatic breast cancer; HER2 negative; Internal medicine; Chemotherapy; Hormone receptor; Breast cancer; Cancer; Gynecology","score_opus":0.06623516967856484,"score_gpt":0.40216623548961317,"score_spread":0.3359310658110483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387809675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860405,0.007383742,0.0002778199,0.0008509133,0.00031969894,0.0004651978,0.0012800233,0.00007682644,0.0033053863],"genre_scores_gemma":[0.98576725,0.0047526094,0.0005325643,0.00091058505,0.00016195457,0.00050402276,0.0019220507,0.000028834364,0.005420171],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996674,0.00019867925,0.000010767593,0.000044561624,0.00001917899,0.000059501315],"domain_scores_gemma":[0.9995542,0.00014439979,0.00009692806,0.000027006894,0.000014360731,0.00016301304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008983587,0.0010738678,0.001509374,0.00025738333,0.00017338553,0.0008705897,0.00056171103,0.00077489536,0.005955098],"category_scores_gemma":[0.000930539,0.00031004156,0.001188249,0.00034774176,0.0006352436,0.0006006469,0.00031880426,0.002376077,0.0007645546],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9359836,0.003272335,0.0014228127,0.00085918966,0.0012397206,0.000055718807,0.00007410369,0.001832134,0.0046495176,0.00033546754,0.0027584918,0.047516856],"study_design_scores_gemma":[0.848263,0.13203312,0.010149943,0.0002012177,0.0016268018,0.00019891592,0.000111521826,0.0016748467,0.0013022559,0.0007538719,0.0036498057,0.00003463045],"about_ca_topic_score_codex":0.0015330351,"about_ca_topic_score_gemma":0.0049400474,"teacher_disagreement_score":0.005955098,"about_ca_system_score_codex":0.00093339157,"about_ca_system_score_gemma":0.00067536795,"threshold_uncertainty_score":0.01992178},"labels":[],"label_agreement":null},{"id":"W4387812407","doi":"10.5603/pmp.97647","title":"Can selected physiotherapeutic techniques really help in treating back pain and improving the quality of life of advanced cancer patients: a randomised controlled study","year":2023,"lang":"en","type":"article","venue":"Palliative Medicine in Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Physical therapy; Quality of life (healthcare); Cancer; Rating scale; Proprioception; Physical medicine and rehabilitation; Internal medicine; Nursing; Psychology","score_opus":0.03757804652903827,"score_gpt":0.4208004199338231,"score_spread":0.3832223734047848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387812407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90016145,0.047154117,0.0019306759,0.0018507731,0.003750425,0.040687565,0.0012163714,0.00013119083,0.003117521],"genre_scores_gemma":[0.8909822,0.02937815,0.0071414234,0.0022738413,0.004705702,0.061758015,0.0007293173,0.000022107934,0.0030093826],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9943268,0.003671564,0.00086964277,0.00043597224,0.00040834,0.00028769873],"domain_scores_gemma":[0.99492115,0.0028705404,0.00096175406,0.00029577516,0.00025576903,0.0006951022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007007119,0.0011638646,0.004994015,0.0011306313,0.0008282607,0.00118706,0.00130556,0.005052217,0.011290698],"category_scores_gemma":[0.008581675,0.00079692283,0.003212426,0.0012790937,0.0017207561,0.0012916968,0.000787041,0.0017727831,0.0008553593],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9496093,0.019517899,0.00041642535,0.0050697713,0.0011409468,0.000036706933,0.000098783275,0.00010609012,0.0007373573,0.00010167532,0.00024544343,0.022919603],"study_design_scores_gemma":[0.89525783,0.10160261,0.0011172555,0.00031297278,0.0008155729,0.000014803744,0.000036535075,0.00006865023,0.00013225146,0.00006843145,0.0005607436,0.000012425042],"about_ca_topic_score_codex":0.0011850664,"about_ca_topic_score_gemma":0.0022135845,"teacher_disagreement_score":0.011290698,"about_ca_system_score_codex":0.00079944,"about_ca_system_score_gemma":0.0020786587,"threshold_uncertainty_score":0.037771165},"labels":[],"label_agreement":null},{"id":"W4388205306","doi":"10.1200/op.2023.19.11_suppl.275","title":"Feasibility and acceptability of an mHealth app integrating pain-cognitive behavioral therapy and pharmacologic support for patients with advanced cancer.","year":2023,"lang":"en","type":"article","venue":"JCO Oncology Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institutes of Health; National Palliative Care Research Center","keywords":"Medicine; Cancer pain; McGill Pain Questionnaire; Physical therapy; Psychological intervention; Cancer; mHealth; Internal medicine; Psychiatry; Visual analogue scale","score_opus":0.11148505310438467,"score_gpt":0.5054033039505176,"score_spread":0.3939182508461329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388205306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932681,0.00012480609,0.000558355,0.00037993948,0.00005223896,0.00340114,0.0004448717,0.00006505082,0.0017054968],"genre_scores_gemma":[0.98866886,0.00016345846,0.0051957592,0.0004776863,0.00006131808,0.0043957573,0.00029604655,0.0000107355145,0.0007303416],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980154,0.0010378899,0.00024321869,0.00015465435,0.0003268673,0.00022200884],"domain_scores_gemma":[0.9957644,0.0027272208,0.00045275048,0.00016751992,0.0003991422,0.000489079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004775084,0.00039482076,0.000355701,0.00025255993,0.0005417118,0.000762884,0.00034835408,0.0006710802,0.0035069128],"category_scores_gemma":[0.011597887,0.00023085049,0.0008817073,0.00012823458,0.0002885022,0.00066229084,0.00091828237,0.000666078,0.00067842455],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035190616,0.050597683,0.35184684,0.0018272023,0.00044095734,0.0010382746,0.007809625,0.00092679914,0.00805613,0.00022167081,0.008968452,0.5330758],"study_design_scores_gemma":[0.015255002,0.23309895,0.7015989,0.0006227394,0.0010705324,0.0017785068,0.008186985,0.009317629,0.007998664,0.0003700776,0.020378001,0.00032399918],"about_ca_topic_score_codex":0.00077202235,"about_ca_topic_score_gemma":0.0014291424,"teacher_disagreement_score":0.004775084,"about_ca_system_score_codex":0.00035927448,"about_ca_system_score_gemma":0.0009579623,"threshold_uncertainty_score":0.025253296},"labels":[],"label_agreement":null},{"id":"W4388734631","doi":"10.11606/d.22.2023.tde-14112023-115104","title":"Neuropatia periférica induzida por quimioterápicos: sintomas e o risco de queda em mulheres idosas com câncer","year":2023,"lang":"pt","type":"dissertation","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.03387971318718226,"score_gpt":0.3652915117221109,"score_spread":0.33141179853492864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388734631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7900792,0.1855964,0.0007512797,0.005750445,0.00024182988,0.000074647534,0.001329958,0.00005403988,0.01612217],"genre_scores_gemma":[0.9618784,0.034913044,0.00051436876,0.0007230142,0.00014836129,0.000038417544,0.00030025133,0.000006133339,0.0014780812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975044,0.00006519877,0.00002217695,0.00003903156,0.000065625085,0.000057507597],"domain_scores_gemma":[0.99920267,0.00016154778,0.00037479404,0.000017979888,0.00014082201,0.000102215774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039189958,0.0002347624,0.0004278343,0.0010120586,0.00054775097,0.00097580685,0.00023701572,0.0004800494,0.002836198],"category_scores_gemma":[0.0018577777,0.00013513959,0.00039271935,0.0012926611,0.0005551933,0.00043052368,0.0006601841,0.0007569138,0.0003179377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008071011,0.00022183917,0.8590479,0.00161197,0.00027775712,0.0025525875,0.0016427753,0.00019091515,0.001641574,0.0012830688,0.0046383115,0.12608415],"study_design_scores_gemma":[0.000032131833,0.00039795434,0.9682603,0.0011969331,0.00031195485,0.011727446,0.002303028,0.00034233613,0.0005023974,0.001339902,0.013555955,0.000029781748],"about_ca_topic_score_codex":0.012440283,"about_ca_topic_score_gemma":0.011806253,"teacher_disagreement_score":0.012440283,"about_ca_system_score_codex":0.0010560262,"about_ca_system_score_gemma":0.0009085464,"threshold_uncertainty_score":0.024735749},"labels":[],"label_agreement":null},{"id":"W4389704510","doi":"10.1017/s0266462323001848","title":"PP33 The Cost-effectiveness Of Regorafenib In The Treatment Of Advanced Hepatocellular Carcinoma From A Canadian Perspective","year":2023,"lang":"en","type":"article","venue":"International Journal of Technology Assessment in Health Care","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Regorafenib; Medicine; Hepatocellular carcinoma; Sorafenib; Cost effectiveness; Adverse effect; Quality-adjusted life year; Quality of life (healthcare); Cost-effectiveness analysis; Oncology; Internal medicine; Cancer; Colorectal cancer; Risk analysis (engineering)","score_opus":0.031428478712202806,"score_gpt":0.4230383136949414,"score_spread":0.3916098349827386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389704510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5631329,0.09079483,0.028107572,0.04414974,0.00059759605,0.0016290414,0.0880423,0.00046225812,0.18308379],"genre_scores_gemma":[0.9712747,0.011764618,0.006652168,0.0007531818,0.00008134859,0.00016673288,0.0049968944,0.000043011925,0.004267389],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9981481,0.00066246284,0.00006826364,0.00013164827,0.0006243573,0.0003652341],"domain_scores_gemma":[0.9978582,0.00081843825,0.00017869846,0.000046414574,0.0008618855,0.00023625031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002464336,0.0007033733,0.00086453033,0.0016935873,0.0006994192,0.0021613478,0.0010388329,0.0007151687,0.008967239],"category_scores_gemma":[0.008178726,0.00033873168,0.0025645115,0.0022458504,0.00051217125,0.00054982706,0.0006669105,0.0009279087,0.00029416042],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024846387,0.00017439995,0.039593473,0.0026688408,0.0029268146,0.0006159456,0.00022082706,0.7317303,0.0013021537,0.058233645,0.031057972,0.12899102],"study_design_scores_gemma":[0.0023729412,0.0011859101,0.10071434,0.0028225635,0.0066016195,0.0011329305,0.0008932876,0.7449036,0.0019223666,0.026774975,0.11017652,0.00049890415],"about_ca_topic_score_codex":0.9589626,"about_ca_topic_score_gemma":0.9469493,"teacher_disagreement_score":0.06231008,"about_ca_system_score_codex":0.06231008,"about_ca_system_score_gemma":0.0737744,"threshold_uncertainty_score":0.45209342},"labels":[],"label_agreement":null},{"id":"W4390082929","doi":"10.1007/s00520-023-08209-0","title":"Patient perceptions of altering chemotherapy treatment due to peripheral neuropathy","year":2023,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Institute for Health and Care Research","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Nursing research; Chemotherapy; Physical therapy; Intensive care medicine; Internal medicine; Nursing","score_opus":0.024814203176223164,"score_gpt":0.37247749659345863,"score_spread":0.34766329341723545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390082929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97176874,0.00120319,0.0005051034,0.0074110236,0.0001717556,0.000037158537,0.000060591276,0.00001845816,0.018823953],"genre_scores_gemma":[0.99747366,0.00037686012,0.0002761055,0.0014259813,0.000029402958,0.000007043994,0.000014515166,0.0000030082044,0.000393423],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9959331,0.0025919448,0.00025114682,0.00011112839,0.00082483224,0.0002879764],"domain_scores_gemma":[0.98752904,0.0061964225,0.0030479664,0.00022462905,0.0014345684,0.0015673136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031565137,0.0001530633,0.00019207323,0.00030469956,0.0010512187,0.0014938285,0.000233433,0.00071031286,0.004498845],"category_scores_gemma":[0.02172055,0.00013493962,0.0004119284,0.00019019684,0.0008412384,0.00064641575,0.0009330498,0.0017225073,0.00022388849],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024160568,0.0014326974,0.70408,0.0010870752,0.00074890215,0.005601983,0.088077575,0.0012453613,0.006926487,0.004157155,0.013262227,0.17096455],"study_design_scores_gemma":[0.00041043904,0.007376821,0.63277936,0.0012714583,0.0008112986,0.022781953,0.2678049,0.0029346368,0.0034947623,0.0041089826,0.05589907,0.00032628258],"about_ca_topic_score_codex":0.0020825604,"about_ca_topic_score_gemma":0.0036576719,"teacher_disagreement_score":0.004498845,"about_ca_system_score_codex":0.0011804618,"about_ca_system_score_gemma":0.0011292418,"threshold_uncertainty_score":0.016693413},"labels":[],"label_agreement":null},{"id":"W4390261395","doi":"10.1016/j.jns.2023.122221","title":"Modelling the pathogenesis of widespread pain syndromes","year":2023,"lang":"en","type":"article","venue":"Journal of the Neurological Sciences","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Pathogenesis; Pain syndrome; Medicine; Neuroscience; Physical medicine and rehabilitation; Psychology; Physical therapy; Pathology","score_opus":0.10685306971262418,"score_gpt":0.3416423176652513,"score_spread":0.23478924795262715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390261395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53189176,0.0036265082,0.37643915,0.0048604715,0.0007774619,0.00023221108,0.0008700345,0.00035137773,0.08095102],"genre_scores_gemma":[0.9723828,0.00094317266,0.016066656,0.0001491155,0.00009701854,0.00007111797,0.00012094436,0.000036520654,0.010132686],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99981004,0.000081601014,0.000008209898,0.000022510347,0.000039521736,0.000038129194],"domain_scores_gemma":[0.99957734,0.00020099123,0.00007791622,0.000027408401,0.00006602096,0.000050298913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032819292,0.00066236756,0.00056724704,0.00046398188,0.00027688028,0.00093978766,0.0011766943,0.0016522007,0.004328028],"category_scores_gemma":[0.0012058865,0.0003212325,0.0006596624,0.00025545002,0.00072210486,0.0008821468,0.00067206746,0.0009686135,0.0004353817],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012462746,0.0001064044,0.002350626,0.00014497255,0.000050058716,0.00063575944,0.00013907945,0.87874407,0.010592733,0.099593066,0.0009420437,0.006576553],"study_design_scores_gemma":[0.000033145498,0.000066982,0.0006267582,0.000017333734,0.000017821105,0.0001637786,0.00004839329,0.97256684,0.0003722287,0.025112856,0.0009619269,0.0000119853785],"about_ca_topic_score_codex":0.0044712187,"about_ca_topic_score_gemma":0.003764115,"teacher_disagreement_score":0.0044712187,"about_ca_system_score_codex":0.00043553842,"about_ca_system_score_gemma":0.0008312478,"threshold_uncertainty_score":0.014478743},"labels":[],"label_agreement":null},{"id":"W4390766126","doi":"10.55729/2000-9666.1289","title":"Comparative Study of the Effects of Duloxetine and Venlafaxine on Acute Symptomatic Taxane-induced Neuropathy in Breast Cancer Patients: a randomized clinical trial","year":2024,"lang":"en","type":"article","venue":"Journal of Community Hospital Internal Medicine Perspectives","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Duloxetine; Venlafaxine; Medicine; Neuropathic pain; Breast cancer; Taxane; Internal medicine; Adverse effect; Anesthesia; Anxiety; Oncology; Antidepressant; Cancer; Psychiatry","score_opus":0.028891393484244694,"score_gpt":0.41975775293647277,"score_spread":0.3908663594522281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390766126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817539,0.0061722137,0.0003597447,0.00046206653,0.0006885739,0.008829625,0.00048357123,0.000038811915,0.0012113806],"genre_scores_gemma":[0.98187596,0.0032615075,0.0012561216,0.0007363064,0.00069062214,0.00990699,0.00052258844,0.000008370973,0.0017415263],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99797994,0.0011478228,0.00021964821,0.00027057677,0.0001798177,0.00020231507],"domain_scores_gemma":[0.99745435,0.0008397612,0.0006220156,0.00015869681,0.0002371147,0.00068810943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028667864,0.0011765513,0.004648771,0.00061673607,0.00056783506,0.0009742053,0.0011916034,0.0024684856,0.007905754],"category_scores_gemma":[0.0031289584,0.00066076353,0.0024764142,0.0006509241,0.0012077149,0.001094655,0.00049605203,0.0019503079,0.00078152696],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9836099,0.008625504,0.0005608484,0.000533366,0.0010046663,0.000024254137,0.00003316115,0.000050111164,0.00056416634,0.000042048912,0.000118357006,0.004833677],"study_design_scores_gemma":[0.8724239,0.124075726,0.0021025361,0.00003917865,0.0007367045,0.000015223154,0.000033945573,0.00013359282,0.00012694427,0.000056400906,0.00024391264,0.000011855138],"about_ca_topic_score_codex":0.00088243105,"about_ca_topic_score_gemma":0.0018925979,"teacher_disagreement_score":0.007905754,"about_ca_system_score_codex":0.00092522305,"about_ca_system_score_gemma":0.0013815594,"threshold_uncertainty_score":0.026447356},"labels":[],"label_agreement":null},{"id":"W4392372006","doi":"10.1007/s00520-024-08416-3","title":"Equity, diversity, and inclusion in the Multinational Association for Supportive Care in Cancer: a global membership survey","year":2024,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Diversity (politics); Multinational corporation; Inclusion (mineral); Medicine; Health care; Equity (law); Multidisciplinary approach; Public relations; Political science; Psychology","score_opus":0.07244674065194123,"score_gpt":0.44486324833724505,"score_spread":0.3724165076853038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392372006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99714214,0.00015622555,0.00003513689,0.00094801455,0.000009554928,0.000014618026,0.00024743742,0.0000011570778,0.0014458399],"genre_scores_gemma":[0.9992624,0.00010225357,0.000032158885,0.00014834509,0.00000903969,0.000015275024,0.00018215462,0.0000012251262,0.0002472264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819356,0.0006962279,0.00014475729,0.00011505275,0.00031701472,0.0005333773],"domain_scores_gemma":[0.99475706,0.00073879195,0.0019619877,0.00018406355,0.0006562522,0.00170183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003440382,0.00013865768,0.00022180392,0.0010337416,0.0009814791,0.001145391,0.0005266211,0.0008310343,0.0019905667],"category_scores_gemma":[0.007138658,0.00017900833,0.0003390845,0.0017379343,0.00080380094,0.0015167334,0.0031191423,0.0010617544,0.00017385437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003343508,0.00009102589,0.99167645,0.000016621134,0.000024620284,0.000029997065,0.004042932,0.000029882367,0.00006516833,0.00014266933,0.0005438856,0.0033033062],"study_design_scores_gemma":[0.0000031371026,0.000051496685,0.98717576,0.000026922788,0.000007852827,0.000039481693,0.011482068,0.00007050371,0.000025007526,0.000059290633,0.0010529943,0.000005466338],"about_ca_topic_score_codex":0.023659188,"about_ca_topic_score_gemma":0.031735543,"teacher_disagreement_score":0.023659188,"about_ca_system_score_codex":0.0009102663,"about_ca_system_score_gemma":0.001419735,"threshold_uncertainty_score":0.047042966},"labels":[],"label_agreement":null},{"id":"W4392377811","doi":"10.1158/1538-7445.ovarian23-a066","title":"Abstract A066: The cytotoxic effects of oxaliplatin and 5-fluorouracil against low-grade serous ovarian cancer cells","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Oxaliplatin; Fluorouracil; Serous fluid; Ovarian cancer; Cytotoxic T cell; Medicine; Oncology; Internal medicine; Cancer research; Colorectal cancer; Cancer; Biology; In vitro; Genetics","score_opus":0.05591241180573824,"score_gpt":0.42301676986968617,"score_spread":0.3671043580639479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392377811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98602027,0.005710297,0.0006790072,0.00015966482,0.000119335746,0.00008280048,0.002077868,0.0000660643,0.0050848336],"genre_scores_gemma":[0.99040365,0.0019378217,0.0011179047,0.000063316584,0.000012339524,0.000055394914,0.0026644303,0.000005291537,0.0037398902],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999058,0.00001498358,0.00001646224,0.000014395132,0.000028894665,0.000019550735],"domain_scores_gemma":[0.9999546,0.000010570385,0.000006079313,0.0000064409605,0.000012452747,0.000009963042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012139548,0.00024334884,0.000321768,0.00023895646,0.00018962554,0.00020159436,0.0001702296,0.00025600375,0.0020118265],"category_scores_gemma":[0.00008680894,0.00008391054,0.00028552747,0.00039218384,0.00007904339,0.00011013567,0.00014493852,0.0002956655,0.00037177862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011066687,0.00039232417,0.0018808362,0.00051457685,0.00003331252,0.00039795967,0.00010473652,0.00043213813,0.97446877,0.00022725714,0.0013692029,0.019072166],"study_design_scores_gemma":[0.00025789815,0.0054567,0.027621519,0.00005898004,0.00009750956,0.0012286995,0.00014587888,0.0020667843,0.9446015,0.0000751927,0.018369189,0.000020178617],"about_ca_topic_score_codex":0.0022279148,"about_ca_topic_score_gemma":0.0020578788,"teacher_disagreement_score":0.0022279148,"about_ca_system_score_codex":0.00014124492,"about_ca_system_score_gemma":0.00022543246,"threshold_uncertainty_score":0.0067302585},"labels":[],"label_agreement":null},{"id":"W4392399684","doi":"10.1016/b978-0-32-390644-9.00155-4","title":"Introduction—Chiral Auxiliaries","year":2024,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Materials science","score_opus":0.016295373888407735,"score_gpt":0.287305418496087,"score_spread":0.27101004460767925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392399684","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036824492,0.0046171807,0.0043856227,0.000593805,0.0022754166,0.000019978585,0.00009650105,0.00019063689,0.98745257],"genre_scores_gemma":[0.0057939766,0.00723,0.0028388565,0.0007029423,0.0013185814,0.000044660068,0.00014771814,0.00027951036,0.98164374],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997836,0.000039829058,0.000009010853,0.000035957033,0.000103305276,0.000028307048],"domain_scores_gemma":[0.99988616,0.000043149576,0.000007694323,0.00001894408,0.000029888437,0.000014066207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027319294,0.0012676603,0.00065526064,0.0013143439,0.0015184835,0.0027362069,0.0009768133,0.0011001686,0.1559582],"category_scores_gemma":[0.0005171177,0.0003533889,0.00044261114,0.0012483811,0.0015284882,0.0031231423,0.0016840792,0.0032316134,0.0820988],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036574897,0.000058456437,0.000019467101,0.00028062396,0.0000031064208,0.00011582371,0.000133802,0.00038162,0.0014147228,0.66052234,0.17809355,0.1589399],"study_design_scores_gemma":[0.000002699987,0.00001197755,0.000017863234,0.00008193292,0.0000014049584,0.00011310507,0.000032628788,0.00012624438,0.00052633893,0.032824468,0.9662552,0.00000618974],"about_ca_topic_score_codex":0.00090809335,"about_ca_topic_score_gemma":0.0015410555,"teacher_disagreement_score":0.1559582,"about_ca_system_score_codex":0.0010554092,"about_ca_system_score_gemma":0.0006210622,"threshold_uncertainty_score":0.5217322},"labels":[],"label_agreement":null},{"id":"W4393884706","doi":"10.5281/zenodo.1481254","title":"Cancermine","year":2018,"lang":"en","type":"dataset","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Computer science","score_opus":0.0489869270264531,"score_gpt":0.3233024353023956,"score_spread":0.27431550827594253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393884706","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020533712,0.0033865557,0.026649049,0.0019346888,0.00074603193,0.00031819314,0.582747,0.3356247,0.04654039],"genre_scores_gemma":[0.009663203,0.0022551492,0.037376586,0.0035444044,0.0001537037,0.0014797542,0.81008613,0.0992281,0.036213025],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99824536,0.0002619962,0.00014950092,0.00055844727,0.00058480754,0.00020001618],"domain_scores_gemma":[0.9980883,0.0008706509,0.00013137473,0.00038785464,0.0003948524,0.00012689103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023958338,0.0022443326,0.0019629202,0.0028154256,0.0014946109,0.0045903656,0.005697446,0.0030868747,0.25876737],"category_scores_gemma":[0.008047453,0.002048093,0.0028792473,0.00258038,0.00043489886,0.0029601355,0.0032863286,0.0023723815,0.22693041],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033944132,0.000035949604,0.0011751803,0.0019535269,0.00011839166,0.0001281767,0.00018002595,0.0007698821,0.0020138787,0.0035652963,0.9596754,0.030044872],"study_design_scores_gemma":[0.00010333322,0.00003891624,0.0006892414,0.00019963413,0.00006205018,0.00028929682,0.00004661397,0.001124059,0.0027021526,0.0032678233,0.99143267,0.00004430714],"about_ca_topic_score_codex":0.004764018,"about_ca_topic_score_gemma":0.006934684,"teacher_disagreement_score":0.25876737,"about_ca_system_score_codex":0.0019635062,"about_ca_system_score_gemma":0.0023917048,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4393988434","doi":"10.1158/1538-7445.am2024-ct131","title":"Abstract CT131: Effect of rivoceranib administered as 200 mg once daily on the pharmacokinetics of CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 substrates","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Altasciences (Canada)","funders":"","keywords":"CYP2C19; CYP2D6; Pharmacokinetics; CYP1A2; CYP3A4; Pharmacology; CYP2C9; Medicine; Chemistry; Cytochrome P450; Internal medicine; Metabolism","score_opus":0.10281463531614428,"score_gpt":0.4939783001597105,"score_spread":0.39116366484356624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99478596,0.00095326046,0.00053409155,0.0001836593,0.00014449208,0.0005528095,0.0011781241,0.00016704104,0.0015007815],"genre_scores_gemma":[0.9913952,0.0006060822,0.0010975861,0.0002468628,0.00013889332,0.00034336746,0.002109193,0.000044874,0.0040179593],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99947375,0.00020356425,0.00003459135,0.00011520031,0.00010274327,0.00007023937],"domain_scores_gemma":[0.99942696,0.000112924405,0.00013051911,0.00006215935,0.00005432188,0.0002130661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047025835,0.0010234958,0.0015038456,0.00034401834,0.00026303635,0.00072853727,0.00055231835,0.00102548,0.006481667],"category_scores_gemma":[0.0011226267,0.00037280805,0.0010670532,0.0003641616,0.00065569475,0.0007736978,0.00018700976,0.0028495248,0.0010831954],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58470917,0.0379596,0.0026519375,0.00053432793,0.0011428603,0.0003136264,0.00010850676,0.0019151698,0.2941239,0.0002643578,0.004791526,0.071485],"study_design_scores_gemma":[0.15094244,0.72520244,0.020639893,0.00004677179,0.0009850676,0.0008440706,0.000062031024,0.0034573998,0.09098762,0.00014966045,0.006577506,0.00010510163],"about_ca_topic_score_codex":0.0018309619,"about_ca_topic_score_gemma":0.0021816876,"teacher_disagreement_score":0.006481667,"about_ca_system_score_codex":0.0007784423,"about_ca_system_score_gemma":0.0014047065,"threshold_uncertainty_score":0.021683395},"labels":[],"label_agreement":null},{"id":"W4393989233","doi":"10.1158/1538-7445.am2024-lb054","title":"Abstract LB054: A novel chemical proteomics approach toward the identification of kinase targets to sensitize tumour cells to the standard of care drug paclitaxel","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Paclitaxel; Proteomics; Identification (biology); Standard of care; Medicine; Pharmacology; Drug; Computational biology; Cancer research; Chemistry; Cancer; Biology; Biochemistry; Internal medicine","score_opus":0.06782009018706889,"score_gpt":0.41930999430651594,"score_spread":0.351489904119447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393989233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.798172,0.010591782,0.17058125,0.002027376,0.00039100295,0.00069095055,0.0030530219,0.0025623804,0.011930327],"genre_scores_gemma":[0.87432206,0.004890711,0.10027688,0.0009613621,0.00008156651,0.00030688982,0.0025690508,0.00010860781,0.016482715],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983406,0.000021914497,0.0000092331475,0.00004143293,0.00006687915,0.000026488868],"domain_scores_gemma":[0.99994206,0.000005938451,0.000017420452,0.0000043310943,0.000015122975,0.0000150763335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021285345,0.00058256485,0.0002487352,0.00045741905,0.00021030076,0.0003959783,0.0005133264,0.00054025487,0.0017478756],"category_scores_gemma":[0.0001142634,0.0002192996,0.0002802783,0.00026255078,0.00025907252,0.00033975916,0.00025800322,0.00057100947,0.0010302961],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005319433,0.000025928359,0.00005687999,0.000042672913,0.000004473173,0.000023413242,0.0000036274776,0.000065392225,0.9964385,0.00012132674,0.00020614041,0.0029584032],"study_design_scores_gemma":[0.000016285978,0.00019768972,0.00050951424,0.0000041478597,0.000009764866,0.00013751998,0.0000059846066,0.0011115816,0.99408346,0.00004478984,0.0038721627,0.000007254812],"about_ca_topic_score_codex":0.000652231,"about_ca_topic_score_gemma":0.00080429396,"teacher_disagreement_score":0.0017478756,"about_ca_system_score_codex":0.00062916585,"about_ca_system_score_gemma":0.00033702818,"threshold_uncertainty_score":0.0058472157},"labels":[],"label_agreement":null},{"id":"W4394104687","doi":"10.6084/m9.figshare.23258805","title":"Additional file 2 of Analysis of the utilization value of different tissues of Taxus×Media based on metabolomics and antioxidant activity","year":2023,"lang":"en","type":"dataset","venue":"Open MIND","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Metabolomics; Antioxidant; Taxus; Value (mathematics); Chemistry; Computational biology; Computer science; Biology; Botany; Biochemistry; Chromatography; Machine learning","score_opus":0.06158169867422322,"score_gpt":0.3631834117211762,"score_spread":0.30160171304695294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394104687","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009861663,0.000026300666,0.00004168259,0.000023701421,0.000008385811,0.000010293244,0.99955696,0.00010655407,0.0001274444],"genre_scores_gemma":[0.0011254448,0.00005408522,0.0006019274,0.00012239392,0.000010958401,0.00019364414,0.99697924,0.00010031593,0.0008119885],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99916625,0.000121349134,0.00010035072,0.00031405946,0.00015576903,0.00014211146],"domain_scores_gemma":[0.99558145,0.0027665442,0.0003612406,0.0004626191,0.00055747066,0.00027070602],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013244414,0.0022828216,0.001874784,0.0028588276,0.0006750016,0.002375896,0.0021527768,0.0027190165,0.3241504],"category_scores_gemma":[0.009254179,0.00069704896,0.0021621902,0.0031511725,0.00046705597,0.0010539783,0.001345415,0.0015750859,0.10060585],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052615977,0.00017411062,0.0046861665,0.004378744,0.0002711726,0.00007488919,0.000046512792,0.0012762599,0.0005288003,0.00054592395,0.982275,0.0052162106],"study_design_scores_gemma":[0.004763834,0.00026267415,0.02504775,0.0018210538,0.0006213605,0.00034707724,0.00021693144,0.0030660233,0.0017904929,0.006407607,0.9555018,0.00015351805],"about_ca_topic_score_codex":0.01253418,"about_ca_topic_score_gemma":0.026048156,"teacher_disagreement_score":0.3241504,"about_ca_system_score_codex":0.001260538,"about_ca_system_score_gemma":0.0024633375,"threshold_uncertainty_score":0.9640174},"labels":[],"label_agreement":null},{"id":"W4394109314","doi":"10.6084/m9.figshare.19962745","title":"Radiotherapy-induced bone deterioration is exacerbated in diabetic rats treated with streptozotocin","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Streptozotocin; Radiation therapy; Diabetes mellitus; Medicine; Internal medicine; Endocrinology","score_opus":0.03970293078839421,"score_gpt":0.318702161557957,"score_spread":0.2789992307695628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394109314","genre_codex":"empirical","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958027,0.001405963,0.0014099112,0.00009342163,0.00005423541,0.00003368623,0.000355741,0.000091594346,0.000752758],"genre_scores_gemma":[0.992384,0.0016773762,0.0016845502,0.00014114469,0.000024210394,0.00010106394,0.0007416521,0.000025410416,0.003220467],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997731,0.000025580677,0.000025750103,0.000051982417,0.00005268232,0.00007096709],"domain_scores_gemma":[0.9997627,0.000012621217,0.00008110288,0.000025682883,0.000021663196,0.00009610065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019798381,0.000617949,0.0006636398,0.00085966784,0.00024091607,0.000253738,0.00019119235,0.00042028987,0.0018767784],"category_scores_gemma":[0.00012244108,0.00029194955,0.0005241575,0.0004715318,0.00027709786,0.00020384947,0.0002473866,0.0011976177,0.0002835455],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024711967,0.00044653655,0.0018674816,0.00007166644,0.000031632942,0.0001888631,0.00003531017,0.0000748992,0.99178046,0.00007114562,0.000069154135,0.0028915654],"study_design_scores_gemma":[0.0003810485,0.010450792,0.0716047,0.000040430765,0.00021079712,0.0012507058,0.0002482954,0.0018522101,0.9098824,0.00018724204,0.0038493967,0.00004196447],"about_ca_topic_score_codex":0.0012436593,"about_ca_topic_score_gemma":0.0018066415,"teacher_disagreement_score":0.0018767784,"about_ca_system_score_codex":0.00022157267,"about_ca_system_score_gemma":0.00031776348,"threshold_uncertainty_score":0.0062784553},"labels":[],"label_agreement":null},{"id":"W4394887595","doi":"10.1515/9782763756592","title":"Robertine","year":2022,"lang":"en","type":"book","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.021981222096098766,"score_gpt":0.31726187599746475,"score_spread":0.295280653901366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394887595","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017149614,0.010753613,0.0018420111,0.023187999,0.010616437,0.00007833375,0.0009977338,0.00085905433,0.94994986],"genre_scores_gemma":[0.009371849,0.0029045304,0.00069959107,0.0033905415,0.0007085481,0.000037226375,0.00031260596,0.00029174087,0.9822833],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981535,0.0002543522,0.00007724055,0.0005376046,0.00068374746,0.00029362744],"domain_scores_gemma":[0.99868983,0.00018018395,0.0001003132,0.00019746258,0.00050894835,0.00032320843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009849487,0.001098415,0.00057101133,0.0012229064,0.0050162305,0.0073182667,0.0013221861,0.0031250133,0.37700963],"category_scores_gemma":[0.004197691,0.00039259906,0.0004244644,0.0011307773,0.0018703091,0.0035947333,0.0030145624,0.0035925065,0.19860965],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005666179,0.000026260317,0.0004684407,0.00021149318,0.0000066008315,0.00028620719,0.0010837,0.00008788621,0.0005439202,0.09188978,0.81224364,0.09309535],"study_design_scores_gemma":[0.0000011317424,0.0000022069987,0.000096212,0.00003079704,6.83581e-7,0.0000706688,0.000089306566,0.00001109926,0.000062608844,0.0006303332,0.9990023,0.0000027053302],"about_ca_topic_score_codex":0.028099012,"about_ca_topic_score_gemma":0.05030173,"teacher_disagreement_score":0.37700963,"about_ca_system_score_codex":0.0048226453,"about_ca_system_score_gemma":0.0055190455,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4395019655","doi":"10.31857/s0015330322600401","title":"Polyesters of 14-Hydroxylated Taxoids Found for the First Time in &lt;i&gt;Taxus canadensis&lt;/i&gt; Intact Plants","year":2023,"lang":"en","type":"article","venue":"Физиология растений","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry; Polyester; Stereochemistry; Botany; Biology; Organic chemistry","score_opus":0.022831436125968246,"score_gpt":0.29155822286879274,"score_spread":0.26872678674282446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395019655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98354256,0.0024911498,0.007475235,0.000058918995,0.000038850856,0.0000686671,0.0020846936,0.000099425,0.0041406252],"genre_scores_gemma":[0.9759479,0.0017788573,0.007689718,0.00009440249,0.000021461474,0.000079225196,0.00460388,0.00007768477,0.009706899],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998981,0.000009331327,0.000008403606,0.000045169396,0.000021856935,0.000017158305],"domain_scores_gemma":[0.9997285,0.000056396322,0.000085858745,0.00004008766,0.00004289506,0.000046330395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010765659,0.00058182876,0.00021544268,0.00071980216,0.0001662674,0.0002725615,0.00013976995,0.00020974125,0.0016108848],"category_scores_gemma":[0.00014984026,0.00017628448,0.00033314855,0.00059552933,0.00023208305,0.0004859799,0.00028531766,0.000491325,0.00047854485],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042409192,0.000004277882,0.00017560713,0.000023442366,0.0000039232323,0.000044481465,0.000016421725,0.000015899715,0.99827576,0.000023647981,0.000005086024,0.0013691625],"study_design_scores_gemma":[0.0000055687897,0.00016110901,0.018032806,0.000011197289,0.00004473443,0.00030300327,0.000084417785,0.00026413347,0.9769363,0.000083392515,0.00406172,0.00001160195],"about_ca_topic_score_codex":0.0007705017,"about_ca_topic_score_gemma":0.00094840664,"teacher_disagreement_score":0.0016108848,"about_ca_system_score_codex":0.00016728818,"about_ca_system_score_gemma":0.00017526913,"threshold_uncertainty_score":0.0053889155},"labels":[],"label_agreement":null},{"id":"W4395034817","doi":"10.1161/circ.144.suppl_1.9398","title":"Abstract 9398: Dantrolene Prevents Doxorubicin-Induced Cardiac Ryanodine Receptor Dyssynchrony","year":2021,"lang":"en","type":"article","venue":"Circulation","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Dantrolene; Ryanodine receptor; Ryanodine receptor 2; Malignant hyperthermia; Cardiology; Internal medicine; Pharmacology; Receptor; Anesthesia; Calcium","score_opus":0.027568795474461467,"score_gpt":0.31415617423006703,"score_spread":0.2865873787556056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395034817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98947,0.0024887559,0.0019378393,0.00044225858,0.000223498,0.0001894292,0.0019502193,0.00043402726,0.0028639326],"genre_scores_gemma":[0.98221725,0.0022582484,0.003263139,0.0002580254,0.000054039636,0.00045773204,0.0020969226,0.00007038794,0.009324195],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987817,0.000014689862,0.000016983753,0.00002949737,0.000029186987,0.00003151523],"domain_scores_gemma":[0.9998759,0.000009913687,0.000045761582,0.000015497792,0.000012855977,0.000039970564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013066086,0.0005668406,0.00073279697,0.00040908207,0.00019676508,0.00027714728,0.00042232446,0.00046987121,0.004837784],"category_scores_gemma":[0.00013636232,0.00017458978,0.00032157998,0.00014811376,0.00033624074,0.00034674516,0.00019680934,0.0013255134,0.00085887156],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071501057,0.0018314545,0.00045156022,0.00027144447,0.000037257272,0.00012680748,0.000033390672,0.00017564223,0.97139764,0.0001982664,0.000851956,0.01747437],"study_design_scores_gemma":[0.0029770574,0.025792938,0.012363129,0.00010882723,0.00016911379,0.0005592986,0.00010129159,0.0019183601,0.94664985,0.00021951881,0.009107871,0.000032678417],"about_ca_topic_score_codex":0.00041125354,"about_ca_topic_score_gemma":0.00072680815,"teacher_disagreement_score":0.004837784,"about_ca_system_score_codex":0.00022011409,"about_ca_system_score_gemma":0.00037798457,"threshold_uncertainty_score":0.016183972},"labels":[],"label_agreement":null},{"id":"W4395237039","doi":"10.15468/dl.4j4fq5","title":"Occurrence Download","year":2023,"lang":"en","type":"dataset","venue":"Global Biodiversity Information Facility","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Download; Computer science; World Wide Web","score_opus":0.026970555402614272,"score_gpt":0.28410025626638435,"score_spread":0.25712970086377007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395237039","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000059375703,0.0000526658,0.000047489553,0.000050561768,0.000015154519,0.0000073951815,0.9985869,0.00049554225,0.00068490073],"genre_scores_gemma":[0.00017689598,0.000048941558,0.00018925176,0.000062167135,0.0000040321142,0.000042369164,0.9989336,0.00012036378,0.00042230898],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990274,0.00014053383,0.00012601312,0.0003535005,0.00019543183,0.00015717368],"domain_scores_gemma":[0.9980336,0.0005654708,0.00017089024,0.0005115438,0.00048645807,0.00023204551],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00090142956,0.002081966,0.0016987959,0.004494563,0.0010325792,0.0026345493,0.0029212602,0.0023069168,0.13078704],"category_scores_gemma":[0.00553856,0.0008847088,0.0015273519,0.008492131,0.00044765472,0.0022027683,0.0023864803,0.0020850939,0.19974609],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041257113,0.000015634423,0.000502246,0.0007090895,0.000020989299,0.000020097412,0.000022053666,0.00016180996,0.00013384935,0.0003639308,0.9962334,0.0017756034],"study_design_scores_gemma":[0.00011022149,0.000012482128,0.001974019,0.00023443451,0.00002103941,0.00005599546,0.00006757112,0.00024951473,0.00023076561,0.00089169084,0.9961331,0.000019131989],"about_ca_topic_score_codex":0.019476736,"about_ca_topic_score_gemma":0.030717762,"teacher_disagreement_score":0.869213,"about_ca_system_score_codex":0.0016600024,"about_ca_system_score_gemma":0.0024651743,"threshold_uncertainty_score":0.43752623},"labels":[],"label_agreement":null},{"id":"W4395932807","doi":"10.15468/dl.a275x3","title":"Occurrence Download","year":2022,"lang":"en","type":"dataset","venue":"Global Biodiversity Information Facility","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Download; Computer science; World Wide Web","score_opus":0.021311865194612072,"score_gpt":0.2715757229429666,"score_spread":0.2502638577483545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395932807","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004257357,0.000036462192,0.000042013657,0.000043876433,0.0000111883455,0.000005826305,0.99894184,0.00033247346,0.0005437075],"genre_scores_gemma":[0.00015774384,0.00004291303,0.0001741721,0.000053469525,0.000003274184,0.00003821484,0.99905485,0.00010744122,0.00036801444],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99902153,0.00014913622,0.00013114203,0.00032768896,0.00022046518,0.0001500992],"domain_scores_gemma":[0.9977197,0.000718751,0.00022556333,0.0005306325,0.0005226864,0.00028269945],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001119679,0.0019433803,0.0016182723,0.004277504,0.0008879072,0.0024852739,0.002774569,0.002123628,0.12863061],"category_scores_gemma":[0.0058303424,0.00085427274,0.001234043,0.008116693,0.00045187498,0.0018177141,0.0021505377,0.0020695757,0.17455317],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041796,0.00001462018,0.00044400946,0.00061672536,0.000020118629,0.000017992974,0.000020731644,0.00016313125,0.0001294978,0.00040108323,0.99667764,0.0014526777],"study_design_scores_gemma":[0.000113967755,0.000011042453,0.0019972639,0.00021153079,0.000019658153,0.00004721524,0.000058525817,0.00019572057,0.00022079599,0.00078879914,0.99631774,0.000017774453],"about_ca_topic_score_codex":0.021453181,"about_ca_topic_score_gemma":0.033728987,"teacher_disagreement_score":0.87136936,"about_ca_system_score_codex":0.0017100932,"about_ca_system_score_gemma":0.0026003923,"threshold_uncertainty_score":0.43031228},"labels":[],"label_agreement":null},{"id":"W4395988032","doi":"10.15468/dl.efu6fb","title":"Occurrence Download","year":2022,"lang":"en","type":"dataset","venue":"Global Biodiversity Information Facility","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Download; Computer science; World Wide Web","score_opus":0.021311865194612072,"score_gpt":0.2715757229429666,"score_spread":0.2502638577483545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395988032","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004038015,0.000034760702,0.00004263953,0.00004428464,0.000011992214,0.000005707533,0.99885356,0.00035751678,0.00060922164],"genre_scores_gemma":[0.00015371552,0.000041138734,0.00018118868,0.0000544448,0.0000034883653,0.000039358765,0.99898106,0.0001297379,0.0004158968],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989172,0.0001629236,0.00014028963,0.00037060544,0.0002404328,0.00016857055],"domain_scores_gemma":[0.99759775,0.0007249683,0.0002265632,0.00058477826,0.0005750471,0.0002909301],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001154119,0.0019995568,0.0016931107,0.0045990143,0.0010258636,0.0026953968,0.0029917846,0.0021827177,0.14305037],"category_scores_gemma":[0.0063259,0.00090319675,0.001293118,0.008923411,0.0004845896,0.002117985,0.002394199,0.002205522,0.19740193],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037317914,0.000012956306,0.00039719505,0.00056016527,0.000017798058,0.000016219277,0.000021173806,0.00014153648,0.00011148872,0.0003980507,0.9969446,0.0013415423],"study_design_scores_gemma":[0.00009628682,0.000008963025,0.001650763,0.00019988992,0.000016956406,0.000040970863,0.0000606893,0.00016953342,0.00018972815,0.00083734223,0.99671185,0.00001705662],"about_ca_topic_score_codex":0.021581754,"about_ca_topic_score_gemma":0.035533644,"teacher_disagreement_score":0.8569496,"about_ca_system_score_codex":0.0017400028,"about_ca_system_score_gemma":0.0026490088,"threshold_uncertainty_score":0.47855115},"labels":[],"label_agreement":null},{"id":"W4396006386","doi":"10.15468/dl.cw5uj9","title":"Occurrence Download","year":2022,"lang":"en","type":"dataset","venue":"Global Biodiversity Information Facility","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Download; Computer science; World Wide Web","score_opus":0.021311865194612072,"score_gpt":0.2715757229429666,"score_spread":0.2502638577483545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396006386","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000041501426,0.000033745247,0.000041221443,0.000043297125,0.000011556777,0.0000059055524,0.9988906,0.0003435874,0.00058863166],"genre_scores_gemma":[0.00015388272,0.000039833205,0.00017750975,0.000053630374,0.0000034357906,0.000039812883,0.9989926,0.00011903458,0.0004201367],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99902225,0.00014905314,0.0001246763,0.00033726788,0.0002164516,0.00015020314],"domain_scores_gemma":[0.9976713,0.00071058446,0.00022078496,0.0005619272,0.00055288966,0.00028256688],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001132268,0.001987951,0.0016021531,0.004302224,0.00093708246,0.0025475358,0.002892304,0.0021273375,0.14093311],"category_scores_gemma":[0.0059900437,0.00084869436,0.001290155,0.008114954,0.00047079052,0.0019153138,0.0022638708,0.0021247296,0.19546407],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037738322,0.000013720532,0.00039953002,0.000561367,0.00001795971,0.000016031094,0.000020135609,0.00013928155,0.00011575126,0.00037471272,0.996971,0.0013327464],"study_design_scores_gemma":[0.00010576358,0.00001032618,0.001839214,0.00019999342,0.000018053664,0.000042414442,0.000060297567,0.00017730928,0.00020781255,0.00080160494,0.9965197,0.000017527758],"about_ca_topic_score_codex":0.022041041,"about_ca_topic_score_gemma":0.03596313,"teacher_disagreement_score":0.8590669,"about_ca_system_score_codex":0.0016908081,"about_ca_system_score_gemma":0.002571999,"threshold_uncertainty_score":0.4714682},"labels":[],"label_agreement":null},{"id":"W4396094664","doi":"10.15468/dl.cvfbrb","title":"Occurrence Download","year":2022,"lang":"en","type":"dataset","venue":"Global Biodiversity Information Facility","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Download; Computer science; World Wide Web","score_opus":0.021311865194612072,"score_gpt":0.2715757229429666,"score_spread":0.2502638577483545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396094664","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005456143,0.000039873405,0.000045439727,0.000052701005,0.000014812385,0.000006824326,0.9988304,0.00037103152,0.0005843177],"genre_scores_gemma":[0.00016847925,0.00004037556,0.00017885723,0.000058150847,0.0000039006222,0.000041521136,0.99899906,0.00009889103,0.0004107638],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990107,0.00015906544,0.00012242257,0.00033910538,0.00021190196,0.0001568361],"domain_scores_gemma":[0.99776554,0.0006775486,0.0002115628,0.0005618822,0.00050215714,0.000281253],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010797452,0.0019727985,0.0015753021,0.0041045286,0.0009607697,0.0024087972,0.0028890097,0.0022171247,0.12322536],"category_scores_gemma":[0.005498453,0.00080036424,0.0013220733,0.0074442704,0.00046492225,0.0019335322,0.0022837278,0.002203349,0.1710852],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003868346,0.000015984513,0.00043688124,0.00053429,0.000017695469,0.000015852316,0.000019087256,0.00015949606,0.000114826915,0.00035154598,0.9968881,0.0014075068],"study_design_scores_gemma":[0.00011690082,0.000013292478,0.0021221994,0.00020523426,0.000018780594,0.000048407877,0.000065616456,0.00023639559,0.00021933606,0.0008550311,0.99607986,0.000018896673],"about_ca_topic_score_codex":0.020275572,"about_ca_topic_score_gemma":0.035036936,"teacher_disagreement_score":0.87677467,"about_ca_system_score_codex":0.001665307,"about_ca_system_score_gemma":0.0024497886,"threshold_uncertainty_score":0.4122299},"labels":[],"label_agreement":null},{"id":"W4396166580","doi":"10.15468/dl.d2xkpb","title":"Occurrence Download","year":2023,"lang":"en","type":"dataset","venue":"Global Biodiversity Information Facility","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Download; Computer science; World Wide Web","score_opus":0.026970555402614272,"score_gpt":0.28410025626638435,"score_spread":0.25712970086377007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396166580","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005493691,0.000052194195,0.00004882757,0.000050838775,0.00001589368,0.0000072316197,0.99855167,0.0005018842,0.0007164769],"genre_scores_gemma":[0.000175626,0.000050589406,0.00019473521,0.000067499226,0.000004153733,0.0000442561,0.9988631,0.00013845584,0.00046163698],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990213,0.00013942005,0.000123397,0.00036205686,0.00019531998,0.00015858548],"domain_scores_gemma":[0.9980008,0.0005834962,0.00017269808,0.0005221331,0.0004845694,0.00023620861],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00087965943,0.0020873712,0.0017385579,0.0045060692,0.001089862,0.0027720279,0.0030410646,0.0023671282,0.14391679],"category_scores_gemma":[0.005563732,0.00092732045,0.0015326871,0.008754417,0.00045331637,0.002288218,0.0024726384,0.0021590877,0.2133414],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036761772,0.0000135626615,0.00042877626,0.0006900601,0.00001928864,0.000018355113,0.000021485881,0.0001487705,0.00012582561,0.00035325583,0.99653184,0.0016120598],"study_design_scores_gemma":[0.000100571604,0.00001140236,0.0018156818,0.0002333034,0.000020485002,0.00005290046,0.00006558114,0.00022704573,0.0002202339,0.00086757826,0.9963664,0.000018786051],"about_ca_topic_score_codex":0.019500572,"about_ca_topic_score_gemma":0.030593356,"teacher_disagreement_score":0.8560832,"about_ca_system_score_codex":0.0016775108,"about_ca_system_score_gemma":0.0024460335,"threshold_uncertainty_score":0.4814496},"labels":[],"label_agreement":null},{"id":"W4396570208","doi":"10.48252/jcr25","title":"SPECIAL ISSUE: JCR’S WEBINAR ON THE ROLE OF EXERCISE IN CANCER REHABILITATION - French Transcription","year":2021,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"","keywords":"Rehabilitation; Transcription (linguistics); Physical medicine and rehabilitation; Medicine; Physical therapy; Philosophy; Linguistics","score_opus":0.15508723887291045,"score_gpt":0.5391637038495084,"score_spread":0.384076464976598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396570208","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00069966895,0.008940456,0.0008235872,0.20959124,0.6966373,0.00039337654,0.009557132,0.0011490304,0.07220823],"genre_scores_gemma":[0.005905764,0.009463584,0.0011505819,0.13463731,0.38600856,0.00063007494,0.009715763,0.0020074388,0.45048094],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967325,0.0007143464,0.0003550423,0.00022784836,0.0014614628,0.0005088289],"domain_scores_gemma":[0.966738,0.010712278,0.0014362261,0.0011050621,0.015607039,0.0044014663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00466084,0.0012927897,0.0016953844,0.0041481066,0.0022134979,0.0050017503,0.0014715196,0.0064488873,0.26352543],"category_scores_gemma":[0.022484979,0.00039907632,0.0012789414,0.002396399,0.00090850313,0.0019599483,0.0022334855,0.004349162,0.09847011],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013667601,0.000008193225,0.000027680864,0.000060170147,9.993266e-7,0.000018340763,0.000009915201,0.000007633982,0.00003279625,0.00008689433,0.99731904,0.0024147562],"study_design_scores_gemma":[0.000019263704,0.000020204021,0.00094242755,0.0003175368,0.000003783645,0.0000673197,0.000105458435,0.000051359293,0.00008358863,0.00025647122,0.9981217,0.000010935921],"about_ca_topic_score_codex":0.018405855,"about_ca_topic_score_gemma":0.032303248,"teacher_disagreement_score":0.26352543,"about_ca_system_score_codex":0.0038468994,"about_ca_system_score_gemma":0.0063356096,"threshold_uncertainty_score":0.88158035},"labels":[],"label_agreement":null},{"id":"W4396587059","doi":"10.1158/1538-7445.sabcs23-po5-05-14","title":"Abstract PO5-05-14: Survival in Young Women with De Novo or Recurrent Metastatic Breast Cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Metastatic breast cancer; Breast cancer; Oncology; Internal medicine; Cancer; Recurrent breast cancer; Gynecology","score_opus":0.12425201806634079,"score_gpt":0.4887938110640621,"score_spread":0.3645417929977213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965312,0.0004144735,0.00006804655,0.000053320422,0.00001067601,0.000013122277,0.00230914,0.0000051068555,0.0005948913],"genre_scores_gemma":[0.99749196,0.0001917956,0.00006361472,0.000028101973,0.0000150414135,0.000018369466,0.0018543624,0.0000016129088,0.00033521053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998392,0.00002996032,0.000020317822,0.000044483586,0.000030157196,0.000035933597],"domain_scores_gemma":[0.9992168,0.00010095517,0.00037152777,0.000031054282,0.00010865588,0.0001710103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004012224,0.00012783437,0.00021484513,0.0005589624,0.00024796303,0.00036806572,0.00023490637,0.00024175638,0.0023216333],"category_scores_gemma":[0.0012490358,0.00009320929,0.00024010865,0.00076541555,0.00013141695,0.00029425323,0.00035566723,0.00019543545,0.0003616395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018804122,0.000013525417,0.99735945,0.000014156467,0.000015435318,0.000055056462,0.00002302621,0.000026007003,0.00011421941,0.0000070223023,0.00025822228,0.0019257633],"study_design_scores_gemma":[0.000013089154,0.00014480823,0.9988507,0.000010624381,0.000022042674,0.00026978608,0.00009738789,0.00010034027,0.00009457783,0.00001701996,0.00037761996,0.0000020507416],"about_ca_topic_score_codex":0.0038904329,"about_ca_topic_score_gemma":0.0047245757,"teacher_disagreement_score":0.0038904329,"about_ca_system_score_codex":0.00033719995,"about_ca_system_score_gemma":0.00043588207,"threshold_uncertainty_score":0.0077666044},"labels":[],"label_agreement":null},{"id":"W4396587819","doi":"10.1158/1538-7445.sabcs23-po3-16-12","title":"Abstract PO3-16-12: European real-world experience of patients with HER2+ advanced/metastatic breast cancer accessing trastuzumab deruxtecan through a named patient program: first interim analysis of EUROPA T-DXd","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Trastuzumab; Medicine; Metastatic breast cancer; Interim; Oncology; Breast cancer; Cancer; Interim analysis; Internal medicine; Clinical trial; Political science","score_opus":0.09008420133693715,"score_gpt":0.4725778209887704,"score_spread":0.38249361965183326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941624,0.00042673913,0.0005669527,0.00014226315,0.000014517842,0.00023370556,0.0035295659,0.000022110671,0.0009017377],"genre_scores_gemma":[0.984658,0.00020525984,0.00081220566,0.0003139929,0.000037562633,0.00049783644,0.012372439,0.000036825146,0.0010658205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947607,0.0032933904,0.0003308559,0.00061881676,0.00048393843,0.0005122969],"domain_scores_gemma":[0.9893411,0.0035280192,0.003485713,0.001465642,0.0006835276,0.001496035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011246856,0.0005920697,0.0009928402,0.000385729,0.00036641295,0.0020173667,0.00076427957,0.0009310498,0.0029140702],"category_scores_gemma":[0.010180232,0.00034158264,0.00220959,0.0008960548,0.0006202142,0.0010740029,0.0015829786,0.0011821678,0.00070271397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21427828,0.00843188,0.71453214,0.00046497968,0.0035236485,0.00060092984,0.0007715007,0.005139523,0.0015068316,0.00044006473,0.0056290296,0.04468126],"study_design_scores_gemma":[0.027371468,0.053497043,0.8949284,0.00022837694,0.0028083157,0.0010183202,0.00088211306,0.0058045024,0.0023990108,0.00041813342,0.010516255,0.00012814855],"about_ca_topic_score_codex":0.002787073,"about_ca_topic_score_gemma":0.001562557,"teacher_disagreement_score":0.011246856,"about_ca_system_score_codex":0.0013499787,"about_ca_system_score_gemma":0.0017682735,"threshold_uncertainty_score":0.059479773},"labels":[],"label_agreement":null},{"id":"W4396587962","doi":"10.1158/1538-7445.sabcs23-po3-16-11","title":"Abstract PO3-16-11: Attrition rates from first- to third-line therapy in HER2+ metastatic breast cancer in Europe","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Metastatic breast cancer; Medicine; Cancer; Breast cancer; Attrition; Oncology; Internal medicine","score_opus":0.1729663906008388,"score_gpt":0.5016200254026022,"score_spread":0.3286536348017634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940071,0.00080975506,0.0003250789,0.00021396697,0.000013388976,0.000043063676,0.0036507293,0.000014678923,0.000922162],"genre_scores_gemma":[0.9947855,0.00028987986,0.0002011458,0.00018506208,0.000020204141,0.00007185918,0.00414472,0.000011835554,0.0002898829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99386436,0.002440987,0.00096667785,0.00093664415,0.0012770757,0.00051428936],"domain_scores_gemma":[0.9769239,0.004676401,0.013984721,0.0012397197,0.0020600797,0.0011153122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009858096,0.00020904707,0.00058136834,0.0011781916,0.00034933203,0.0014613513,0.0008996886,0.00059300236,0.0017269342],"category_scores_gemma":[0.01938124,0.00014799164,0.0011556305,0.0026229585,0.00035693,0.000921654,0.0013997363,0.0006580223,0.00040985862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076467637,0.00005847395,0.9923609,0.0000480039,0.00014162989,0.000031427495,0.00012856364,0.00013758786,0.000043110438,0.000042323318,0.0005852787,0.005658053],"study_design_scores_gemma":[0.00006899959,0.00036548966,0.99595636,0.00008436238,0.00009524302,0.00027489712,0.00034215124,0.0007379656,0.00018617952,0.000053805383,0.0018256621,0.000008924761],"about_ca_topic_score_codex":0.0063352045,"about_ca_topic_score_gemma":0.0028857025,"teacher_disagreement_score":0.009858096,"about_ca_system_score_codex":0.0012994342,"about_ca_system_score_gemma":0.0012624261,"threshold_uncertainty_score":0.05213523},"labels":[],"label_agreement":null},{"id":"W4396588160","doi":"10.1158/1538-7445.sabcs23-po1-11-02","title":"Abstract PO1-11-02: Reporting of Post-protocol Therapies in Metastatic Breast Cancer Registration Clinical Trials: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Clinical trial; Metastatic breast cancer; Protocol (science); Breast cancer; Oncology; Cancer; Medical physics; Internal medicine; Alternative medicine; Pathology","score_opus":0.6962956463772917,"score_gpt":0.7109323885794232,"score_spread":0.014636742202131514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396588160","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039862376,0.9884139,0.0011155141,0.0008211514,0.00028666563,0.002697174,0.0019308454,0.000040402647,0.0007081624],"genre_scores_gemma":[0.12337117,0.85157007,0.006664394,0.002599347,0.00048416737,0.012016668,0.002791997,0.00008708021,0.00041520118],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.7751903,0.11172168,0.08470814,0.0066822,0.020396141,0.0013015207],"domain_scores_gemma":[0.4115016,0.44769883,0.105020344,0.009948186,0.024149004,0.001682074],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.100192726,0.0019251773,0.01191364,0.014326805,0.0009356117,0.006235196,0.0033449824,0.0031384649,0.005519959],"category_scores_gemma":[0.38306406,0.0016902061,0.010890456,0.01634988,0.0032460652,0.0073308554,0.0031911298,0.0024625617,0.0006232736],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054919603,0.000015032535,0.001735363,0.96681243,0.014546273,0.00004608158,0.00016031235,0.00007374089,0.00011066716,0.00017472765,0.0009577705,0.014818411],"study_design_scores_gemma":[0.0013619983,0.00036810388,0.008258948,0.89695543,0.08203516,0.00032541613,0.00031759683,0.0001905988,0.00031298006,0.00058417144,0.009230919,0.00005873912],"about_ca_topic_score_codex":0.0038258715,"about_ca_topic_score_gemma":0.007849569,"teacher_disagreement_score":0.8998073,"about_ca_system_score_codex":0.005772231,"about_ca_system_score_gemma":0.013328013,"threshold_uncertainty_score":0.5298761},"labels":[],"label_agreement":null},{"id":"W4396591179","doi":"10.1158/1538-7445.sabcs23-gs02-02","title":"Abstract GS02-02: Are nodal ITCs after neoadjuvant chemotherapy an indication for axillary dissection? The OPBC05/EUBREAST-14R/ICARO study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Axillary Dissection; NODAL; Dissection (medical); Chemotherapy; Oncology; Breast cancer; Internal medicine; Radiology; Cancer; Mastectomy","score_opus":0.09843576198026013,"score_gpt":0.5145686091155839,"score_spread":0.4161328471353237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938455,0.00062210485,0.0000841884,0.000142158,0.000015492053,0.00006163244,0.003222257,0.000005425976,0.002001182],"genre_scores_gemma":[0.9932288,0.000171689,0.0000832021,0.00021690031,0.00003188564,0.000055702854,0.0056090048,0.000007736167,0.0005951071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926513,0.00030483023,0.00006774739,0.00013511637,0.00011045464,0.000116735915],"domain_scores_gemma":[0.9984907,0.00021154621,0.00064691727,0.00017612719,0.0001132565,0.00036138194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001419645,0.0003500641,0.00037234652,0.00062092126,0.0002730812,0.0008570383,0.00088942895,0.00057788624,0.0023421573],"category_scores_gemma":[0.001459893,0.00024293202,0.000503915,0.0013508596,0.00034297028,0.0004928567,0.0006008149,0.00050841307,0.00052834186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036627268,0.00016934912,0.9921118,0.000045237546,0.00013713185,0.00009567413,0.000054337674,0.00009795372,0.00057651254,0.000040375824,0.00092886365,0.002079958],"study_design_scores_gemma":[0.00040087829,0.0006815197,0.99651474,0.000037831396,0.00015828792,0.00022133703,0.00026173986,0.00018329686,0.0001303543,0.0000457526,0.0013572101,0.000007196086],"about_ca_topic_score_codex":0.0064165187,"about_ca_topic_score_gemma":0.013004807,"teacher_disagreement_score":0.0064165187,"about_ca_system_score_codex":0.0005775958,"about_ca_system_score_gemma":0.0005345683,"threshold_uncertainty_score":0.012758374},"labels":[],"label_agreement":null},{"id":"W4396591270","doi":"10.1158/1538-7445.sabcs23-po1-06-03","title":"Abstract PO1-06-03: Efficacy of First-line Treatments for Hormone Receptor-positive, Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast Cancer: A Systematic Literature Review and Network Meta-analysis Feasibility Assessment","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Meta-analysis; Human Epidermal Growth Factor Receptor 2; Metastatic breast cancer; Oncology; Medicine; Hormone receptor; Breast cancer; Internal medicine; Cancer","score_opus":0.16044256383264885,"score_gpt":0.4900248596452728,"score_spread":0.329582295812624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591270","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019131185,0.9355523,0.013173881,0.0021691427,0.0011454489,0.020270368,0.0055419165,0.00028840732,0.002727347],"genre_scores_gemma":[0.5051562,0.381835,0.03550106,0.0033586868,0.00088669796,0.06663343,0.004806985,0.00016221314,0.0016596898],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.93589944,0.043734904,0.012079933,0.003181293,0.0044947313,0.00060972676],"domain_scores_gemma":[0.91916716,0.05872551,0.012779163,0.0025940912,0.006033776,0.000700254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07119826,0.0030354445,0.016155738,0.0082189655,0.0007725861,0.004533794,0.003028742,0.0026105412,0.007306101],"category_scores_gemma":[0.1373001,0.001789303,0.042303,0.008114739,0.0013139184,0.0034813858,0.0027886357,0.0020141255,0.00064386934],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003097218,0.000037610043,0.002578514,0.48799276,0.4905912,0.0000983522,0.00011689374,0.0007860117,0.00020674462,0.00034615005,0.0010219616,0.013126586],"study_design_scores_gemma":[0.0031435762,0.00053013867,0.0036266253,0.049128387,0.9389338,0.00008771978,0.000079286394,0.0007628553,0.00020809172,0.00078608183,0.0026710448,0.000042460284],"about_ca_topic_score_codex":0.0038903595,"about_ca_topic_score_gemma":0.007499208,"teacher_disagreement_score":0.07119826,"about_ca_system_score_codex":0.0037559026,"about_ca_system_score_gemma":0.0075228363,"threshold_uncertainty_score":0.3765369},"labels":[],"label_agreement":null},{"id":"W4396739232","doi":"10.1016/j.cca.2024.119020","title":"Macrotroponin interference in patients receiving cardiotoxic breast cancer therapy: A pilot study","year":2024,"lang":"en","type":"article","venue":"Clinica Chimica Acta","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Oncology; Cancer therapy; Internal medicine; Cancer","score_opus":0.05585533204993259,"score_gpt":0.38399887067794264,"score_spread":0.32814353862801005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396739232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99912685,0.0001948576,0.000096953256,0.000021855787,0.0000068085897,0.00013484422,0.000041933246,0.0000035941555,0.0003723371],"genre_scores_gemma":[0.99871707,0.0002892083,0.00025346928,0.000112276015,0.00006919651,0.00017290628,0.00015309853,0.0000024039837,0.00023034774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994821,0.00022219606,0.00003368894,0.00008989638,0.00006707466,0.00010502698],"domain_scores_gemma":[0.9988977,0.00038047927,0.00018145853,0.00009469898,0.000071335584,0.0003742782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073386583,0.00067418383,0.0009783668,0.0003147277,0.0007440758,0.0005076192,0.00024487494,0.0005773393,0.0017857697],"category_scores_gemma":[0.0015776752,0.00025440563,0.0006433005,0.00042590793,0.00068564975,0.0005266957,0.00043696564,0.0008907477,0.00034806313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22268015,0.06373318,0.5695559,0.00044600657,0.0008423945,0.0049733664,0.0026412543,0.000809003,0.06019947,0.0002931133,0.000754201,0.07307201],"study_design_scores_gemma":[0.018234085,0.44489095,0.5251749,0.000028254964,0.00091991515,0.002691812,0.0010273176,0.0009485834,0.003816158,0.0001566579,0.002061956,0.000049385315],"about_ca_topic_score_codex":0.00073887163,"about_ca_topic_score_gemma":0.0007750752,"teacher_disagreement_score":0.0017857697,"about_ca_system_score_codex":0.00033732018,"about_ca_system_score_gemma":0.0006746449,"threshold_uncertainty_score":0.005973935},"labels":[],"label_agreement":null},{"id":"W4397046205","doi":"10.1681/asn.20223311s15b","title":"0.075% Capsaicin Lotion for the Treatment of Peripheral Neuropathy in ESRD Patients: A Multicenter Randomized Double-Blind Placebo-Controlled, Cross-Over Trial","year":2022,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lotion; Double blind; Capsaicin; Placebo; Peripheral neuropathy; Internal medicine; Pharmacology; Endocrinology; Pathology; Diabetes mellitus","score_opus":0.027881706333506142,"score_gpt":0.34954070250963665,"score_spread":0.32165899617613053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397046205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847899,0.0052691237,0.000601359,0.00042805515,0.00058972876,0.006911195,0.00045579966,0.000076812765,0.0008779788],"genre_scores_gemma":[0.9815824,0.0035941976,0.0019104538,0.0009995882,0.00061663764,0.008815031,0.00045207157,0.000014814898,0.0020148838],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99922204,0.00037149782,0.00007581725,0.00016641038,0.00007061171,0.00009361556],"domain_scores_gemma":[0.9990846,0.00020521671,0.00026450225,0.000060542654,0.00011376826,0.00027138926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021886514,0.0013954585,0.003131696,0.0005005291,0.00058361905,0.0009023375,0.00084524584,0.0021271778,0.004597659],"category_scores_gemma":[0.0015277897,0.0008366231,0.0017147649,0.00044175185,0.0011155976,0.00084889575,0.00037228598,0.0016808369,0.00057061313],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9705264,0.01588102,0.00043462773,0.0009261846,0.00074178015,0.000030278949,0.000050102975,0.00010880662,0.0041323234,0.000046344085,0.00025993394,0.006862367],"study_design_scores_gemma":[0.9169432,0.08103467,0.0010186342,0.000032326403,0.0003090894,0.000013661113,0.000014148325,0.00013367781,0.00028306906,0.000027424652,0.00018327049,0.0000067983524],"about_ca_topic_score_codex":0.00070883764,"about_ca_topic_score_gemma":0.0012892251,"teacher_disagreement_score":0.004597659,"about_ca_system_score_codex":0.00048164555,"about_ca_system_score_gemma":0.0010870985,"threshold_uncertainty_score":0.01538074},"labels":[],"label_agreement":null},{"id":"W4399058478","doi":"","title":"Presentation and management of docetaxel-related adverse effects in patients with breast cancer","year":2014,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Docetaxel; Presentation (obstetrics); Breast cancer; Adverse effect; Medicine; Oncology; Internal medicine; Cancer; General surgery; Surgery","score_opus":0.0699298032326448,"score_gpt":0.5124680099515403,"score_spread":0.4425382067188955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399058478","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41589975,0.5361726,0.0026236766,0.0060957232,0.00040374833,0.00018122472,0.0005198366,0.00008094049,0.03802254],"genre_scores_gemma":[0.87382126,0.11845348,0.0014550469,0.0021495137,0.00043181464,0.000050603277,0.00036167345,0.000013872532,0.0032628279],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99974495,0.000068900496,0.00004585571,0.000017682727,0.000086685555,0.00003595225],"domain_scores_gemma":[0.9996549,0.00007684504,0.00017742426,0.000005248541,0.00005344727,0.000032030966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027533475,0.00015428274,0.00036564874,0.00037387546,0.00021898473,0.00039531602,0.00015211539,0.00024396261,0.00092447235],"category_scores_gemma":[0.0012746371,0.00007393672,0.0002315729,0.0006858687,0.00011849428,0.00025125218,0.00019935622,0.0006048417,0.00018324195],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006373941,0.0003123611,0.45783633,0.0021658207,0.00027507852,0.030930404,0.0011270461,0.0006882402,0.0050285906,0.0015895035,0.019352425,0.48005676],"study_design_scores_gemma":[0.000110551024,0.0007910911,0.65291274,0.001703758,0.0003437725,0.26403105,0.0013095154,0.00080078084,0.0016190587,0.0016501292,0.074653,0.00007446163],"about_ca_topic_score_codex":0.0007982684,"about_ca_topic_score_gemma":0.002036898,"teacher_disagreement_score":0.00092447235,"about_ca_system_score_codex":0.00034868452,"about_ca_system_score_gemma":0.00033316505,"threshold_uncertainty_score":0.0030926466},"labels":[],"label_agreement":null},{"id":"W4400060891","doi":"","title":"Living with peripheral neuropathy following completion of cancer treatment.","year":2021,"lang":"en","type":"article","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Peripheral neuropathy; Medicine; Peripheral; Cancer; Internal medicine; Diabetes mellitus","score_opus":0.03282162499685082,"score_gpt":0.2934406140165395,"score_spread":0.26061898901968866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400060891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6378504,0.04226418,0.002971999,0.1013325,0.0055119856,0.00091087166,0.0023795082,0.0004654483,0.20631312],"genre_scores_gemma":[0.9108345,0.011408102,0.0010919212,0.03770366,0.0018677178,0.000128392,0.00080227945,0.000027541759,0.03613597],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99981195,0.00001965032,0.00001137883,0.000026781303,0.000047588142,0.00008281548],"domain_scores_gemma":[0.99929726,0.00006498619,0.00016833967,0.000021415013,0.0000739859,0.0003739801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026294007,0.0003359948,0.00038301016,0.00042738143,0.0016168023,0.00052951963,0.00042935723,0.0014697298,0.005566561],"category_scores_gemma":[0.001322193,0.00011811794,0.00039999821,0.0005919156,0.0003441151,0.00052488147,0.00056430965,0.0019882584,0.0010075878],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061305345,0.0009034492,0.108205,0.00043745732,0.00011164382,0.7253873,0.0012762529,0.00025201135,0.0011672212,0.0010656537,0.057703346,0.102877684],"study_design_scores_gemma":[0.00015195421,0.0026898,0.22020856,0.0007981544,0.00011258609,0.73669297,0.0014633829,0.000461972,0.0002585744,0.0023726583,0.034726627,0.00006279],"about_ca_topic_score_codex":0.005093711,"about_ca_topic_score_gemma":0.0162512,"teacher_disagreement_score":0.005566561,"about_ca_system_score_codex":0.0006321917,"about_ca_system_score_gemma":0.00089935306,"threshold_uncertainty_score":0.01862204},"labels":[],"label_agreement":null},{"id":"W4400130556","doi":"10.3390/ph17070834","title":"Impact of Cannabidiol and Exercise on Clinical Outcomes and Gut Microbiota for Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors: A Case Report","year":2024,"lang":"en","type":"article","venue":"Pharmaceuticals","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; Jewish General Hospital; McGill University; Royal Victoria Regional Health Centre; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Fondation du cancer des Cèdres","keywords":"Duloxetine; Medicine; Cannabidiol; Quality of life (healthcare); Internal medicine; Breast cancer; Peripheral neuropathy; Cancer; Chemotherapy-induced peripheral neuropathy; Gut flora; Oncology; Immunology; Cannabis; Psychiatry; Pathology","score_opus":0.1282861343355018,"score_gpt":0.524191456849437,"score_spread":0.39590532251393523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400130556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856451,0.008253605,0.0009985301,0.001423248,0.000065728775,0.00012206952,0.00014379258,0.0000420276,0.0033059837],"genre_scores_gemma":[0.99459153,0.0031858275,0.0006248902,0.0005998708,0.00017609163,0.000019717085,0.00008124712,0.0000073482147,0.0007134068],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99978215,0.000026900914,0.000025777583,0.00005785676,0.000039791794,0.000067561465],"domain_scores_gemma":[0.99966323,0.0000868244,0.00009567914,0.000023622024,0.000033260614,0.0000974397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014027546,0.0006582738,0.0006128869,0.000807042,0.0014660857,0.0007285244,0.00041980314,0.0018492822,0.001213503],"category_scores_gemma":[0.0009049083,0.0003936238,0.0005092941,0.000662927,0.00063190464,0.00070351776,0.00056125806,0.0012486767,0.00026080388],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018975603,0.00017584662,0.048715495,0.00010402286,0.000042741165,0.9412322,0.00039892926,0.00006317433,0.00146364,0.00013217414,0.00049559324,0.006986506],"study_design_scores_gemma":[0.000019752088,0.00021207849,0.018156257,0.00004388955,0.00006179746,0.979422,0.00026261553,0.00024179966,0.0005560594,0.00012822877,0.00088010496,0.000015456291],"about_ca_topic_score_codex":0.0036763146,"about_ca_topic_score_gemma":0.0038781217,"teacher_disagreement_score":0.0036763146,"about_ca_system_score_codex":0.00074112124,"about_ca_system_score_gemma":0.00047924515,"threshold_uncertainty_score":0.007309854},"labels":[],"label_agreement":null},{"id":"W4400143961","doi":"10.1016/j.annonc.2024.05.021","title":"10P A placebo-controlled study comparing doses and efficacy of lentinula edodes mycelia for chemotherapy-induced peripheral neuropathy in colorectal cancer: The LEMON trial","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sanofi Genzyme; Genentech; Foundation Medicine; Sierra Oncology; INCLIVA Instituto de Investigación Sanitaria; European Society for Medical Oncology; PharmaMar; Daiichi Sankyo Europe; Gilead Sciences; Servier; FibroGen; Astellas Pharma; Eisai; Natera; F-star Therapeutics; Ribon Therapeutics; Ipsen; Sociedad Española de Oncología Médica; BeiGene; Clovis Oncology; Merck KGaA; Sanofi; Amgen; Pfizer; Les Laboratories Pierre Fabre; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Lentinula; Placebo; Chemotherapy; Colorectal cancer; Peripheral neuropathy; Cancer; Internal medicine; Oncology; Chemotherapy-induced peripheral neuropathy; Food science; Pathology; Endocrinology","score_opus":0.10373159142677914,"score_gpt":0.4469295965515289,"score_spread":0.3431980051247498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400143961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782445,0.009509787,0.00075385417,0.0014999988,0.0011410138,0.0027415112,0.0016690776,0.00022945211,0.0042108647],"genre_scores_gemma":[0.98315597,0.003255063,0.00081771467,0.0019089605,0.0005497662,0.0018081443,0.0011012382,0.000028356553,0.0073747765],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99945337,0.00028267907,0.00002835778,0.00011288195,0.000031601892,0.00009111422],"domain_scores_gemma":[0.99928457,0.0002450245,0.00013645564,0.00006747543,0.000043715034,0.00022288831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012266178,0.0016265931,0.0029851256,0.00042254914,0.00042363937,0.0010349591,0.00091864425,0.002486984,0.011622954],"category_scores_gemma":[0.0014590999,0.0005618283,0.0022657176,0.00033890302,0.0010928347,0.0009285384,0.00041908203,0.00372318,0.0016292367],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98520654,0.00382211,0.00016906612,0.0004607105,0.0006346676,0.000023722128,0.000013197901,0.00008038566,0.0018601095,0.00005269679,0.00042196407,0.007254757],"study_design_scores_gemma":[0.91403365,0.083178274,0.0010721392,0.00005449985,0.0005410999,0.000019072424,0.000018150242,0.00015158973,0.00036148573,0.00009646718,0.0004600311,0.000013475387],"about_ca_topic_score_codex":0.00096394675,"about_ca_topic_score_gemma":0.0018674034,"teacher_disagreement_score":0.011622954,"about_ca_system_score_codex":0.000746056,"about_ca_system_score_gemma":0.0007268771,"threshold_uncertainty_score":0.038882673},"labels":[],"label_agreement":null},{"id":"W4400274087","doi":"10.1200/jco.2024.42.16_suppl.3081","title":"Long-term efficacy, safety and PK data of TH1902 (sudocetaxel zendusortide) in solid tumors: A novel SORT1-targeting peptide-drug-conjugate (PDC).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Theratechnologies (Canada)","funders":"","keywords":"Medicine; Conjugate; Drug; Peptide; Solid tumor; Cancer research; Pharmacology; Term (time); Safety profile; Oncology; Internal medicine; Cancer; Adverse effect; Biochemistry; Biology","score_opus":0.1771831390670611,"score_gpt":0.5125324242608817,"score_spread":0.3353492851938207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400274087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977576,0.0008649158,0.0003104878,0.000058886275,0.000013061992,0.00009828846,0.00042039418,0.000020741285,0.0004555954],"genre_scores_gemma":[0.99642205,0.0007059233,0.00035705024,0.000076008575,0.000021486994,0.0000982408,0.0014163632,0.000010416596,0.0008924328],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998375,0.000060786504,0.000011860364,0.000024902069,0.000028017594,0.000036882066],"domain_scores_gemma":[0.99975306,0.000054049553,0.000065800225,0.000029480407,0.00002133883,0.0000763435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048096615,0.00039566853,0.00054915505,0.00023113679,0.00016792121,0.00037005273,0.00034729615,0.00041839987,0.0012878592],"category_scores_gemma":[0.000322506,0.00016544867,0.00040784557,0.00025217302,0.0003324762,0.00039676632,0.0001709233,0.0011970304,0.00039960738],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12326557,0.027366994,0.014377658,0.00079509435,0.00067048933,0.0012004921,0.0005875978,0.007507116,0.70467746,0.0003769063,0.0040734345,0.115101114],"study_design_scores_gemma":[0.01828161,0.64057326,0.06331571,0.00004715877,0.00087394175,0.0030410644,0.00020884859,0.0058511705,0.25610805,0.00019837642,0.011434126,0.00006664389],"about_ca_topic_score_codex":0.00070103374,"about_ca_topic_score_gemma":0.00083019055,"teacher_disagreement_score":0.0012878592,"about_ca_system_score_codex":0.00059151463,"about_ca_system_score_gemma":0.00030477133,"threshold_uncertainty_score":0.0043082833},"labels":[],"label_agreement":null},{"id":"W4400875353","doi":"10.1186/s12885-024-12558-2","title":"Association of oxaliplatin-containing adjuvant duration with post-treatment fall-related injury and fracture in patients with stage III colon cancer: a population-based retrospective cohort study","year":2024,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Mount Sinai Hospital; Health Sciences Centre; Sinai Health System; Sunnybrook Health Science Centre; University of Toronto","funders":"Canadian Institutes of Health Research; Physicians' Services Incorporated Foundation","keywords":"Medicine; Oxaliplatin; FOLFOX; Internal medicine; Hazard ratio; Capecitabine; Retrospective cohort study; Colorectal cancer; Proportional hazards model; Oncology; Cohort; Population; Cancer; Surgery; Confidence interval","score_opus":0.006283467043504114,"score_gpt":0.29340427456957224,"score_spread":0.2871208075260681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400875353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99803513,0.00049467344,0.0002599752,0.000041287924,0.0000132867035,0.000036158355,0.0009010069,0.000004442931,0.00021399687],"genre_scores_gemma":[0.9986779,0.00017946959,0.00019323736,0.000048359587,0.000012812366,0.00003418084,0.0007309242,0.0000031217412,0.00011984316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990435,0.0001830222,0.00013675072,0.00035171895,0.00015966615,0.00012533632],"domain_scores_gemma":[0.99808216,0.00017892635,0.0010076878,0.00031749698,0.0001774153,0.00023635787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001162756,0.00040743363,0.00056289847,0.00070666586,0.000639104,0.00067083334,0.0006379009,0.00065435696,0.0012181748],"category_scores_gemma":[0.0025679548,0.00066781294,0.0013184595,0.0014488169,0.0003203517,0.00046468835,0.0004726629,0.00092825136,0.00021984562],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030225018,0.00005259473,0.99845076,0.000015232228,0.0003302344,0.000051592906,0.000028877557,0.000053658823,0.000119093296,0.000019269704,0.00012403044,0.00045237088],"study_design_scores_gemma":[0.00007207891,0.0003328061,0.9978492,0.000015678312,0.00031005763,0.0003981054,0.000106485495,0.00048510658,0.000051794097,0.000045043755,0.00032247722,0.0000111489835],"about_ca_topic_score_codex":0.010551674,"about_ca_topic_score_gemma":0.014462804,"teacher_disagreement_score":0.010551674,"about_ca_system_score_codex":0.00053640443,"about_ca_system_score_gemma":0.00067684904,"threshold_uncertainty_score":0.020980477},"labels":[],"label_agreement":null},{"id":"W4400977834","doi":"10.1089/jicm.2024.0452","title":"The Society for Integrative Oncology-American Society of Clinical Oncology Joint Guidelines on Integrative Therapies for Symptom Management-Overview and Key Recommendations","year":2024,"lang":"en","type":"article","venue":"Journal of Integrative and Complementary Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Calgary","funders":"","keywords":"Clinical Oncology; Medicine; Key (lock); Oncology; Internal medicine; Cancer","score_opus":0.3065192811758582,"score_gpt":0.5582366200334965,"score_spread":0.2517173388576383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400977834","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00074153446,0.558513,0.005833471,0.36910415,0.030904101,0.0014891909,0.0019792581,0.00032964896,0.031105645],"genre_scores_gemma":[0.007598184,0.7931604,0.049135406,0.11216012,0.015996747,0.0035090998,0.0055934153,0.00022101866,0.0126255695],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9857875,0.0041600163,0.0037065835,0.00055732956,0.0047647976,0.0010238797],"domain_scores_gemma":[0.9533758,0.0105797155,0.0044432683,0.00072705455,0.026971605,0.003902491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021190206,0.001819065,0.0047742208,0.007755882,0.0026531566,0.0061433823,0.004785013,0.00893681,0.009241194],"category_scores_gemma":[0.044405352,0.0010763592,0.0044465153,0.0074596405,0.002369447,0.004444544,0.0050432268,0.01593001,0.0069646034],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013240802,0.0003391409,0.0020134149,0.009485735,0.00028845127,0.00022491123,0.00032738314,0.00036605968,0.00025680513,0.0074987006,0.652681,0.32638597],"study_design_scores_gemma":[0.00024488874,0.00014560937,0.005522431,0.053920556,0.0006202416,0.0006803954,0.0006081885,0.0003620937,0.00022228477,0.009036692,0.9285185,0.00011814251],"about_ca_topic_score_codex":0.017977832,"about_ca_topic_score_gemma":0.05124333,"teacher_disagreement_score":0.021190206,"about_ca_system_score_codex":0.0063112057,"about_ca_system_score_gemma":0.037486743,"threshold_uncertainty_score":0.11206591},"labels":[],"label_agreement":null},{"id":"W4400989855","doi":"10.69645/oukm7723","title":"Cytotoxic chemotherapy","year":2009,"lang":"en","type":"article","venue":"˜The œbiomedical & life sciences collection.","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cytotoxic T cell; Biology; Genetics","score_opus":0.02450387734023167,"score_gpt":0.33666335329922636,"score_spread":0.3121594759589947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400989855","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.124097,0.06423981,0.012844923,0.0033965665,0.0050493474,0.0031339286,0.017849574,0.0033619325,0.76602703],"genre_scores_gemma":[0.41180366,0.04143478,0.007911075,0.004096803,0.0005753522,0.0019259932,0.030890748,0.00035629317,0.50100535],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99969745,0.000034087545,0.000017338383,0.00007565949,0.00010584515,0.00006968278],"domain_scores_gemma":[0.99986696,0.00001527009,0.000010485465,0.000036409187,0.000036423186,0.00003437075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016836819,0.0006022838,0.0006635199,0.0013894499,0.0006720191,0.00065103365,0.00066268037,0.0005794722,0.06269104],"category_scores_gemma":[0.000319238,0.00023668127,0.0005844594,0.0010254434,0.0003655501,0.00037732287,0.000598349,0.001807449,0.026335001],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034519022,0.0025448059,0.002350499,0.001984365,0.00020682329,0.0012414956,0.00021593057,0.0012456203,0.20494327,0.016755326,0.20582081,0.5592392],"study_design_scores_gemma":[0.0008682737,0.00271728,0.0052838707,0.00028359637,0.00010849396,0.003440908,0.000076725206,0.00050893734,0.093161814,0.0024430295,0.891049,0.000058170404],"about_ca_topic_score_codex":0.00093380036,"about_ca_topic_score_gemma":0.0029325332,"teacher_disagreement_score":0.06269104,"about_ca_system_score_codex":0.00056769757,"about_ca_system_score_gemma":0.00091258326,"threshold_uncertainty_score":0.2097224},"labels":[],"label_agreement":null},{"id":"W4400996848","doi":"10.69645/aavj5507","title":"Role of the lymphatic system in drug absorption","year":2023,"lang":"en","type":"article","venue":"˜The œbiomedical & life sciences collection.","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Lymphatic system; Drug; Absorption (acoustics); Pharmacology; Medicine; Optics; Physics; Immunology","score_opus":0.017050475659600488,"score_gpt":0.2968312853489863,"score_spread":0.2797808096893858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400996848","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45795858,0.3776485,0.02855945,0.026141202,0.00238673,0.00043018325,0.0023277474,0.0005462893,0.104001224],"genre_scores_gemma":[0.86000216,0.105128735,0.0049003474,0.0013286725,0.00095110515,0.00013136808,0.000509551,0.000071173905,0.026976988],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993142,0.0002901655,0.000042846335,0.00006914795,0.00014414267,0.00013942477],"domain_scores_gemma":[0.99901223,0.00032828646,0.00015490824,0.00008528395,0.0002445866,0.00017459056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011807336,0.00035227754,0.00053354434,0.0013160977,0.00070931675,0.0026862093,0.0005287807,0.00053973706,0.008339094],"category_scores_gemma":[0.0012284407,0.00024323656,0.0005181422,0.00058907067,0.0012082256,0.0018283745,0.0015607361,0.0013856131,0.0015733091],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036687525,0.00093141897,0.038694635,0.00454753,0.00033341796,0.0041952105,0.0010635688,0.0026020848,0.31199512,0.0667849,0.01745395,0.5477293],"study_design_scores_gemma":[0.0009147463,0.008874148,0.22315751,0.002348958,0.00060120656,0.012589589,0.0036558337,0.009295136,0.25526544,0.04401577,0.4390157,0.00026595284],"about_ca_topic_score_codex":0.0021878215,"about_ca_topic_score_gemma":0.0021256052,"teacher_disagreement_score":0.008339094,"about_ca_system_score_codex":0.0010524177,"about_ca_system_score_gemma":0.0019742711,"threshold_uncertainty_score":0.02789712},"labels":[],"label_agreement":null},{"id":"W4401029234","doi":"10.51731/cjht.2024.939","title":"Drospirenone (Slynd)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drospirenone; Medicine; Internal medicine","score_opus":0.03349572096903707,"score_gpt":0.35530262858401573,"score_spread":0.32180690761497865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401029234","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026913833,0.8932527,0.0016208694,0.0026423486,0.0005687551,0.00033098905,0.0040987213,0.00014653329,0.07042535],"genre_scores_gemma":[0.24945338,0.6917593,0.0046818354,0.0027749261,0.0003343695,0.00019787965,0.0026860647,0.000024034436,0.048088156],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99968445,0.000048016907,0.00003301353,0.00003434357,0.00017475436,0.000025448431],"domain_scores_gemma":[0.9997547,0.000073139425,0.00006562048,0.0000078043495,0.000067004454,0.000031665157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038776564,0.00022685294,0.00021921055,0.0007093303,0.00023138375,0.000478875,0.0001875741,0.00027223895,0.0074365125],"category_scores_gemma":[0.00070410565,0.000084925145,0.00040197698,0.00043238513,0.0001850074,0.00017548384,0.00016761215,0.00044586035,0.00078803685],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005473283,0.000072082075,0.0017416701,0.0073803486,0.00017745273,0.00040003817,0.000058753954,0.000213555,0.009122319,0.002349579,0.021073567,0.9568633],"study_design_scores_gemma":[0.00040103498,0.0012554169,0.015467322,0.0046024513,0.0004715126,0.0034119454,0.0001643871,0.0002074883,0.013054381,0.0006609062,0.9602672,0.00003589734],"about_ca_topic_score_codex":0.018452296,"about_ca_topic_score_gemma":0.093574636,"teacher_disagreement_score":0.018452296,"about_ca_system_score_codex":0.00087367557,"about_ca_system_score_gemma":0.0014266777,"threshold_uncertainty_score":0.03668976},"labels":[],"label_agreement":null},{"id":"W4401108535","doi":"10.1080/15360288.2024.2383423","title":"Methadone for Pain Management in Chemotherapy-Induced Peripheral Neuropathy: A Retrospective Review","year":2024,"lang":"en","type":"review","venue":"Journal of Pain & Palliative Care Pharmacotherapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Duloxetine; Methadone; Chemotherapy-induced peripheral neuropathy; Neuropathic pain; Peripheral neuropathy; Cancer pain; Analgesic; Chemotherapy; Anesthesia; Intensive care medicine; Internal medicine; Cancer; Alternative medicine; Diabetes mellitus","score_opus":0.0894108614538968,"score_gpt":0.46636517855346593,"score_spread":0.3769543170995691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401108535","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00051106006,0.9992078,0.000021189639,0.000031313328,0.00002324345,0.000014755892,0.000047076457,0.0000015384073,0.00014204787],"genre_scores_gemma":[0.0031719632,0.9965342,0.00007615855,0.000059948798,0.0000318985,0.000016706264,0.000059206315,9.53783e-7,0.00004884598],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99911493,0.0001430946,0.00039208893,0.000107722655,0.00020990481,0.000032256597],"domain_scores_gemma":[0.99790215,0.0012818992,0.00051149033,0.000039558057,0.00022520646,0.00003971288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010679216,0.00072707655,0.0018239861,0.0046488834,0.00030812237,0.00082030444,0.0009720599,0.0006978941,0.0030569157],"category_scores_gemma":[0.003253439,0.00038374294,0.0018512222,0.006926604,0.00031724857,0.000988434,0.0004423633,0.00056023774,0.00035974846],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046986228,0.00010392918,0.0038947936,0.47406986,0.0027110835,0.0011044303,0.0002535597,0.00027838032,0.0007827174,0.00058379245,0.011156997,0.50459063],"study_design_scores_gemma":[0.00050677254,0.0013361328,0.053623747,0.533065,0.04371647,0.031296775,0.0010455603,0.00042051898,0.0014125246,0.0009824767,0.33244094,0.0001530462],"about_ca_topic_score_codex":0.0031602823,"about_ca_topic_score_gemma":0.0062181656,"teacher_disagreement_score":0.0046488834,"about_ca_system_score_codex":0.0007193091,"about_ca_system_score_gemma":0.0020384795,"threshold_uncertainty_score":0.010226369},"labels":[],"label_agreement":null},{"id":"W4401328578","doi":"10.1002/cmdc.202400437","title":"The French Medicinal Chemistry Society–SCT, an Historical Member of EFMC**","year":2024,"lang":"en","type":"editorial","venue":"ChemMedChem","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Society of Transplantation","keywords":"Nice; Chemistry; Library science; Political science; Engineering ethics; Engineering; Computer science","score_opus":0.02161798569034573,"score_gpt":0.3374337246193246,"score_spread":0.31581573892897885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401328578","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007232759,0.03869161,0.00019975638,0.053784914,0.9033599,0.00001753559,0.0000408684,0.00004961861,0.0037835487],"genre_scores_gemma":[0.0011017504,0.027629634,0.00024094216,0.030847859,0.9197841,0.000026315834,0.000050619463,0.00005054132,0.02026815],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99641126,0.00075933954,0.00033956266,0.00042856028,0.0017911085,0.00027016073],"domain_scores_gemma":[0.9892039,0.003076131,0.0007938475,0.00026911765,0.004297522,0.0023595232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053602266,0.003152921,0.0017478633,0.0033672012,0.0023561777,0.0063321134,0.0018234227,0.009462019,0.008026256],"category_scores_gemma":[0.011454561,0.0006071991,0.0013996216,0.0016486257,0.0019842584,0.004185244,0.0012671436,0.010948857,0.009185293],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028812063,0.000012231821,0.00003371383,0.00022954763,0.000008984685,0.00012258417,0.000017101785,0.00002962288,0.00007754118,0.00086325436,0.98528016,0.013296378],"study_design_scores_gemma":[0.000009893669,0.000014409776,0.00009423186,0.00011932023,0.00000615699,0.000197098,0.000012388263,0.00003555261,0.000045616813,0.00038562968,0.9990748,0.000004820451],"about_ca_topic_score_codex":0.0021084654,"about_ca_topic_score_gemma":0.0047128345,"teacher_disagreement_score":0.009462019,"about_ca_system_score_codex":0.003940682,"about_ca_system_score_gemma":0.0044894563,"threshold_uncertainty_score":0.028591812},"labels":[],"label_agreement":null},{"id":"W4401363999","doi":"10.5737/23688076343404","title":"Effectiveness of an Intervention (Effleurage and Petrissage) on severity of Chemotherapy Induced Peripheral Neuropathy (CIPN) among patients : a pilot randomized controlled trial","year":2024,"lang":"en","type":"article","venue":"Canadian Oncology Nursing Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chemotherapy-induced peripheral neuropathy; Medicine; Peripheral neuropathy; Randomized controlled trial; Intervention (counseling); Physical therapy; Chemotherapy; Internal medicine; Peripheral; Oncology; Physical medicine and rehabilitation; Psychiatry","score_opus":0.015399905078331803,"score_gpt":0.3404048594157788,"score_spread":0.325004954337447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401363999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98500186,0.0014897705,0.00036407597,0.0003575408,0.0003724735,0.011074714,0.00044378644,0.000058870897,0.000836861],"genre_scores_gemma":[0.96953875,0.0018293571,0.003076256,0.0006705874,0.00062172045,0.022126585,0.00048821274,0.000010332349,0.0016383589],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980768,0.0010475032,0.00019481474,0.00028882094,0.00016336025,0.00022869416],"domain_scores_gemma":[0.9961553,0.0014942363,0.0008050352,0.0002031114,0.00026359674,0.0010787037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002891189,0.0014799605,0.0035510983,0.0007797353,0.0009469832,0.0010055806,0.0013628872,0.0026709791,0.009501375],"category_scores_gemma":[0.003834623,0.00089717953,0.0022087346,0.00077588286,0.0015495679,0.0011061308,0.00078758225,0.0025392745,0.00074041355],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9597505,0.03178041,0.0005321799,0.00060242316,0.00043941746,0.000024664134,0.00006463547,0.00008593191,0.00056285673,0.000030968695,0.00013605956,0.0059898105],"study_design_scores_gemma":[0.85512674,0.1424963,0.001661393,0.00003100092,0.00029127268,0.0000076234696,0.000023999077,0.00010539744,0.000103051396,0.000025987452,0.00012026014,0.0000069572066],"about_ca_topic_score_codex":0.0021049439,"about_ca_topic_score_gemma":0.0032206269,"teacher_disagreement_score":0.009501375,"about_ca_system_score_codex":0.0010006718,"about_ca_system_score_gemma":0.0024974798,"threshold_uncertainty_score":0.03178525},"labels":[],"label_agreement":null},{"id":"W4401364396","doi":"10.5737/23688076343412","title":"Mesure de l’efficacité d’une intervention de massothérapie (par effleurage et pétrissage) sur l’intensité de la neuropathie périphérique induite par la chimiothérapie : essai clinique pilote randomisé","year":2024,"lang":"fr","type":"article","venue":"Canadian Oncology Nursing Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.015141523650745996,"score_gpt":0.3529744220570991,"score_spread":0.3378328984063531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401364396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9355533,0.010766071,0.00783632,0.00034651055,0.0009668682,0.03928844,0.0017816987,0.00021257329,0.0032482394],"genre_scores_gemma":[0.9464638,0.0024102887,0.0071265493,0.00038369338,0.00031379462,0.03838627,0.00082797825,0.00004502595,0.004042643],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9960907,0.002257509,0.00045988444,0.00055665284,0.00042483854,0.00021031644],"domain_scores_gemma":[0.99405956,0.0029632829,0.0010396319,0.00074589264,0.0007421508,0.00044953814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009128238,0.0012687921,0.003462438,0.00050855457,0.0004092096,0.00085680967,0.0005890294,0.0016289009,0.0067786924],"category_scores_gemma":[0.009091977,0.00070397614,0.0029172602,0.00047929585,0.0009878771,0.0009746389,0.0005679969,0.00168471,0.0009003493],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9262291,0.0085486425,0.0036127463,0.0020126014,0.0043929317,0.00004466887,0.00019039887,0.001082257,0.012277171,0.0002312226,0.00066257914,0.04071561],"study_design_scores_gemma":[0.35217896,0.60356855,0.02480609,0.00028396127,0.0062996405,0.00009291332,0.00008175038,0.0013492141,0.0061051482,0.0007852698,0.0043847957,0.00006366022],"about_ca_topic_score_codex":0.0007129496,"about_ca_topic_score_gemma":0.0009285418,"teacher_disagreement_score":0.009128238,"about_ca_system_score_codex":0.0008237153,"about_ca_system_score_gemma":0.0012748464,"threshold_uncertainty_score":0.04827535},"labels":[],"label_agreement":null},{"id":"W4401668772","doi":"10.5121/ijbb.2024.14306","title":"Bioequivalence and Pharmacokinetic Evaluation of Ethambutol 400 Mg Film-Coated Tablet: A Single-Dose, Open-Label, Randomized, Two-Way Crossover Design Study","year":2024,"lang":"en","type":"article","venue":"International Journal on Bioinformatics & Biosciences","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bioequivalence; Pharmacokinetics; Crossover study; Ethambutol; Open label; Pharmacology; Medicine; Chromatography; Chemistry; Isoniazid; Adverse effect","score_opus":0.15841834261451096,"score_gpt":0.46024416857855505,"score_spread":0.30182582596404406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401668772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98845774,0.0010063193,0.0023824542,0.0001627737,0.0003460099,0.0065960204,0.00047370887,0.00007560034,0.0004993693],"genre_scores_gemma":[0.9715793,0.0016087517,0.010063821,0.00059229817,0.0006486751,0.011258049,0.00067709724,0.00005324972,0.0035187309],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99706525,0.0014191093,0.00026913336,0.0005413879,0.0004807811,0.00022434113],"domain_scores_gemma":[0.9983394,0.0003468665,0.0004390942,0.00030517147,0.00021015735,0.00035914275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039869784,0.0018405039,0.006154275,0.00076048326,0.00071065413,0.0009648459,0.0014046751,0.001971951,0.0044319932],"category_scores_gemma":[0.0029544777,0.0011105927,0.0015081923,0.0007355763,0.0017552886,0.001468742,0.00050226104,0.002669119,0.0007984362],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.780237,0.12212166,0.0012791589,0.0011690363,0.0009337901,0.00010988181,0.00033522354,0.00053561566,0.07331479,0.0002965112,0.00058834435,0.01907898],"study_design_scores_gemma":[0.22873041,0.7529509,0.0064781606,0.000036375022,0.0007062472,0.00012378712,0.000067534056,0.0011628879,0.0079262145,0.00016733723,0.0015904573,0.000059657614],"about_ca_topic_score_codex":0.00041733787,"about_ca_topic_score_gemma":0.0006254635,"teacher_disagreement_score":0.006154275,"about_ca_system_score_codex":0.00057674473,"about_ca_system_score_gemma":0.001376176,"threshold_uncertainty_score":0.021085441},"labels":[],"label_agreement":null},{"id":"W4401715201","doi":"10.1188/24.onf.445-450","title":"Exploring Analgesic Use Patterns Among Cancer Survivors With Chronic Chemotherapy-Induced Peripheral Neuropathy","year":2024,"lang":"en","type":"article","venue":"Oncology nursing forum","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Chemotherapy; Analgesic; Peripheral; Cancer chemotherapy; Oncology; Cancer; Internal medicine; Anesthesia; Diabetes mellitus","score_opus":0.08659785023606503,"score_gpt":0.3585534567688497,"score_spread":0.27195560653278467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401715201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992268,0.00021520769,0.000025400856,0.000046439687,0.0000016747417,0.000014034884,0.00011911121,8.2663513e-7,0.00035056472],"genre_scores_gemma":[0.999137,0.00039237816,0.00010568195,0.000047349928,0.000004022556,0.000021793692,0.00014995859,5.2003617e-7,0.0001413531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999788,0.000056601413,0.000035305595,0.000025611229,0.000057921083,0.00003659746],"domain_scores_gemma":[0.99911493,0.00016985272,0.00047140298,0.00001749658,0.00013459312,0.00009165962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039146887,0.00008271063,0.00017175174,0.0005188428,0.00033115927,0.00028867414,0.00016188118,0.00023537605,0.0016618756],"category_scores_gemma":[0.0018883717,0.00008924163,0.00018733101,0.0006536103,0.000114529896,0.0003498431,0.0002736554,0.00026180115,0.00011053801],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005705858,0.00008873433,0.99220747,0.000059601713,0.000026260353,0.00004589423,0.0005486535,0.000018472148,0.00020363393,0.000009185185,0.00009589785,0.006639104],"study_design_scores_gemma":[0.0000045852385,0.0003478837,0.99704415,0.000041409265,0.000020233607,0.00024856723,0.0018711162,0.000059769176,0.000059292168,0.000011890289,0.0002882303,0.0000028021302],"about_ca_topic_score_codex":0.004726027,"about_ca_topic_score_gemma":0.011694884,"teacher_disagreement_score":0.004726027,"about_ca_system_score_codex":0.0001787692,"about_ca_system_score_gemma":0.0003807516,"threshold_uncertainty_score":0.00939703},"labels":[],"label_agreement":null},{"id":"W4402137407","doi":"10.1016/j.toxlet.2024.07.508","title":"P12-15 Eltrombopag: mechanism of clinical hepatotoxicity; mitigation strategies","year":2024,"lang":"en","type":"article","venue":"Toxicology Letters","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Eltrombopag; Mechanism (biology); Medicine; Pharmacology; Intensive care medicine; Internal medicine; Philosophy","score_opus":0.04376039383244327,"score_gpt":0.4019078637320621,"score_spread":0.3581474698996188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402137407","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5455547,0.31565014,0.04453094,0.030850556,0.0007261533,0.0010470807,0.0009979911,0.0011115014,0.059530944],"genre_scores_gemma":[0.9038076,0.07003292,0.006848368,0.0025093365,0.00033755088,0.00020276217,0.00033978815,0.000033500757,0.01588818],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986064,0.000056143923,0.000006813694,0.00001957907,0.000021343347,0.000035488567],"domain_scores_gemma":[0.9999038,0.000019796702,0.000035608995,0.000009910495,0.00001566704,0.000015197648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050030655,0.0006711828,0.00041808488,0.00038673545,0.000253028,0.0010184583,0.0005853335,0.0007261896,0.005545408],"category_scores_gemma":[0.00028263676,0.0001987887,0.00039020972,0.00025454877,0.0004938448,0.000653929,0.00048396277,0.0008884011,0.0009574357],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007870494,0.0012480214,0.0070402445,0.0031972986,0.00036023936,0.0024117692,0.0003064367,0.0026257792,0.29888943,0.022195563,0.009719884,0.64413476],"study_design_scores_gemma":[0.0021321669,0.028465247,0.028316185,0.0012573908,0.0009911716,0.012847904,0.0009635594,0.0066435332,0.5449132,0.026219325,0.3470932,0.00015725654],"about_ca_topic_score_codex":0.00079844304,"about_ca_topic_score_gemma":0.0012250189,"teacher_disagreement_score":0.005545408,"about_ca_system_score_codex":0.0005937534,"about_ca_system_score_gemma":0.0006268313,"threshold_uncertainty_score":0.01855123},"labels":[],"label_agreement":null},{"id":"W4402325391","doi":"10.1136/spcare-2024-anzspm.97","title":"P-49 Cancer induced bone pain – the use of edmonton classification system for cancer pain and management of refractory pain","year":2024,"lang":"en","type":"article","venue":"Poster presentations","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Refractory (planetary science); Cancer; Medicine; Pain management; Cancer pain; Bone cancer; Bone pain; Physical therapy; Surgery; Internal medicine; Materials science","score_opus":0.1412995387380517,"score_gpt":0.4006066395295091,"score_spread":0.25930710079145736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402325391","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54414713,0.09351933,0.012064431,0.020698301,0.0029639676,0.0074525187,0.029712481,0.0003757498,0.28906602],"genre_scores_gemma":[0.9341109,0.016960546,0.011045284,0.004781778,0.0008982471,0.0024581007,0.010900975,0.0000653203,0.018778862],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99841917,0.00059211854,0.00015597396,0.00010877663,0.0005173734,0.00020659428],"domain_scores_gemma":[0.99815875,0.00035405112,0.00076127436,0.00008568421,0.00041012408,0.00023005786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015967055,0.00024771492,0.00027176982,0.00087665097,0.00046968824,0.0005102713,0.00046909408,0.00043683732,0.012414889],"category_scores_gemma":[0.0043606013,0.00008498412,0.0007709971,0.0011119811,0.00043261703,0.00039097824,0.0007378458,0.0006585364,0.0012614646],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018078076,0.00058388675,0.31321827,0.002715055,0.00030229162,0.00075552985,0.00045180172,0.0006308379,0.002736314,0.005800165,0.13502309,0.5359751],"study_design_scores_gemma":[0.00042341978,0.0014487241,0.8776853,0.002249862,0.00014722618,0.0026798141,0.00032585926,0.0009056966,0.00057506695,0.002193395,0.111309774,0.000055913693],"about_ca_topic_score_codex":0.01154567,"about_ca_topic_score_gemma":0.019622628,"teacher_disagreement_score":0.98845434,"about_ca_system_score_codex":0.0010608273,"about_ca_system_score_gemma":0.0019764313,"threshold_uncertainty_score":0.04153198},"labels":[],"label_agreement":null},{"id":"W4402325634","doi":"10.1136/spcare-2024-anzspm.11","title":"OP-11 A double-blind randomised controlled trial of dose-escalated CBD/THC oil for symptom management in advanced cancer","year":2024,"lang":"en","type":"article","venue":"Oral Presentations","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Double blind; Medicine; Cancer; Alternative medicine; Internal medicine","score_opus":0.06454688435615415,"score_gpt":0.44059640639391845,"score_spread":0.3760495220377643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402325634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9526094,0.004805788,0.0011049402,0.001263863,0.0021180038,0.029280404,0.0031774922,0.0004580935,0.0051819226],"genre_scores_gemma":[0.9449129,0.004824847,0.0038904343,0.0023422216,0.0008613475,0.031322118,0.0017437189,0.000059479124,0.010042848],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991142,0.00044143896,0.00007566895,0.00014457291,0.00007400572,0.00015013691],"domain_scores_gemma":[0.9986021,0.0004588503,0.00024778317,0.00010778098,0.00011623557,0.00046735088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018584605,0.0017945741,0.0041286377,0.0008224361,0.0007935566,0.0014980885,0.0012454464,0.0026174893,0.01853036],"category_scores_gemma":[0.0022875029,0.0009600812,0.0021597268,0.00066384696,0.0020432032,0.00134267,0.0007774971,0.0044959034,0.0018645143],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9807598,0.008989878,0.00008592856,0.0012718604,0.00037741885,0.00002501847,0.000035487268,0.0001255878,0.0013203436,0.00010378465,0.00045726149,0.0064476673],"study_design_scores_gemma":[0.96645087,0.032705504,0.00025554124,0.000030900785,0.000099625555,0.0000061918436,0.000011831871,0.00007907214,0.00008841685,0.000052745687,0.00021312476,0.0000061024966],"about_ca_topic_score_codex":0.0020303803,"about_ca_topic_score_gemma":0.004457154,"teacher_disagreement_score":0.01853036,"about_ca_system_score_codex":0.0008852632,"about_ca_system_score_gemma":0.0026005113,"threshold_uncertainty_score":0.06199026},"labels":[],"label_agreement":null},{"id":"W4402501795","doi":"10.11159/icbb24.130","title":"Comparison of Reported Adverse Events for Two Plant-Derived Anti Cancer Therapeutics: Paclitaxel and Docetaxel","year":2024,"lang":"en","type":"article","venue":"Proceedings of the World Congress on New Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Docetaxel; Paclitaxel; Adverse effect; Medicine; Cancer; Oncology; Pharmacology; Internal medicine","score_opus":0.06794039534938733,"score_gpt":0.3975944316342401,"score_spread":0.32965403628485274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402501795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9517483,0.030986892,0.0027614818,0.0005511393,0.00017588746,0.00028802946,0.0063603274,0.00007942906,0.00704847],"genre_scores_gemma":[0.9864499,0.0068143164,0.0015370855,0.00032653566,0.00013224978,0.00016347466,0.0034433156,0.000019838575,0.0011131605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99491876,0.0013205964,0.0013044744,0.000497427,0.0017677821,0.00019093974],"domain_scores_gemma":[0.97816205,0.0071956743,0.010155146,0.00054372003,0.0036178397,0.00032563816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036578667,0.00020349292,0.00049135287,0.0013297772,0.00016224077,0.0006365145,0.00021364153,0.00022425315,0.0013844998],"category_scores_gemma":[0.012498654,0.00007617806,0.001256979,0.0014774977,0.00019053373,0.000599503,0.0002533505,0.0006041621,0.00018988861],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009702045,0.00036999816,0.8011959,0.0026265914,0.0023878852,0.00036382666,0.00038680554,0.0010629299,0.0053032096,0.00034640534,0.0028178487,0.17343658],"study_design_scores_gemma":[0.00016653269,0.0037627958,0.97701716,0.0002444986,0.0011739555,0.0016901765,0.0004567648,0.00078398344,0.0056959935,0.00021375228,0.008755364,0.00003891189],"about_ca_topic_score_codex":0.0009528447,"about_ca_topic_score_gemma":0.002228257,"teacher_disagreement_score":0.0036578667,"about_ca_system_score_codex":0.00061914907,"about_ca_system_score_gemma":0.00047743178,"threshold_uncertainty_score":0.019344866},"labels":[],"label_agreement":null},{"id":"W4402514041","doi":"10.1097/io9.0000000000000064","title":"Pegulicianine: a game changer for image-guided breast cancer surgery","year":2024,"lang":"en","type":"article","venue":"International Journal of Surgery Open","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact","funders":"","keywords":"Medicine; Breast cancer; Cancer; General surgery; Oncology; Internal medicine","score_opus":0.12327069539616463,"score_gpt":0.44639782301600894,"score_spread":0.3231271276198443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402514041","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004393474,0.09965438,0.004751398,0.4357859,0.43515253,0.00014470251,0.00036854122,0.00062126515,0.019127851],"genre_scores_gemma":[0.029929716,0.10703256,0.0041702306,0.2919223,0.49427646,0.00028115156,0.0002626518,0.00023836439,0.07188655],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.999577,0.000103304905,0.000049243303,0.000050185143,0.00018010184,0.000040266175],"domain_scores_gemma":[0.9987012,0.0006072721,0.00015681847,0.00002744451,0.00028639348,0.0002207782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080845866,0.0005262172,0.00048596977,0.00029332977,0.00034197804,0.0012192758,0.0009612019,0.0035768696,0.008427768],"category_scores_gemma":[0.0047733644,0.0001592933,0.00043864816,0.00012244354,0.0005984637,0.0012272075,0.00044284386,0.0047809817,0.0047902907],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018100285,0.00003616134,0.00022500276,0.00054596394,0.000025329618,0.00053235784,0.000049812967,0.00007642794,0.00070493337,0.001246147,0.8818693,0.11450759],"study_design_scores_gemma":[0.00006715026,0.00018568421,0.00040015063,0.00040178827,0.000033661967,0.001955686,0.00006610812,0.00044068214,0.00066054653,0.0009826212,0.9947876,0.000018413599],"about_ca_topic_score_codex":0.00035347653,"about_ca_topic_score_gemma":0.0010432389,"teacher_disagreement_score":0.008427768,"about_ca_system_score_codex":0.0004121949,"about_ca_system_score_gemma":0.00042547917,"threshold_uncertainty_score":0.028193712},"labels":[],"label_agreement":null},{"id":"W4402551704","doi":"10.1158/1538-7445.pancreatic24-c008","title":"Abstract C008: Patient-derived organoids and precision medicine: Insights from the PASS-01 clinical trial in PDAC","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Organoid; Precision medicine; Medicine; Clinical trial; Internal medicine; Computational biology; Oncology; Bioinformatics; Biology; Pathology; Neuroscience","score_opus":0.22716179798124075,"score_gpt":0.5427648478731496,"score_spread":0.31560304989190885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402551704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96356547,0.0068978784,0.0026362892,0.003323289,0.00028357137,0.0016662632,0.007587283,0.0001760795,0.013863906],"genre_scores_gemma":[0.96841407,0.0038061263,0.005070573,0.0023109938,0.00015459309,0.0022558996,0.0112761585,0.000073926974,0.0066376664],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985858,0.0008336285,0.00007293416,0.00009914479,0.00028438374,0.0001240458],"domain_scores_gemma":[0.99739057,0.0006574502,0.00044189784,0.00035994351,0.0005106796,0.000639464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057106763,0.00035501074,0.0005796647,0.00021375444,0.0003313857,0.0013551345,0.00046501248,0.00097575755,0.0040965057],"category_scores_gemma":[0.0029311758,0.00013963928,0.00064370123,0.00037803757,0.0005419057,0.00039911337,0.00072330463,0.0017698329,0.00072969386],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19558145,0.018062098,0.06547516,0.0047992524,0.0025852274,0.0020266427,0.0014592307,0.013379625,0.18270124,0.0058401134,0.08719914,0.4208908],"study_design_scores_gemma":[0.04290452,0.43296096,0.12948813,0.0011866614,0.0025809966,0.0036035303,0.0015552292,0.008900955,0.1521023,0.003091452,0.2214502,0.00017512556],"about_ca_topic_score_codex":0.0014856685,"about_ca_topic_score_gemma":0.003020875,"teacher_disagreement_score":0.0057106763,"about_ca_system_score_codex":0.00094208977,"about_ca_system_score_gemma":0.0023858456,"threshold_uncertainty_score":0.030201316},"labels":[],"label_agreement":null},{"id":"W4402554993","doi":"10.1080/14656566.2024.2402022","title":"Current approaches to the pharmacological management of metastatic breast cancer in older women","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Metastatic breast cancer; Context (archaeology); Breast cancer; Intensive care medicine; Oncology; Cancer; Personalized medicine; Internal medicine; Bioinformatics","score_opus":0.2769222624376801,"score_gpt":0.49914402222175996,"score_spread":0.22222175978407988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402554993","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000070666036,0.9979919,0.000105536485,0.000828021,0.00021047906,0.000009079433,0.00002369247,0.0000061671553,0.00075446797],"genre_scores_gemma":[0.000761313,0.9979948,0.0001557332,0.0006093063,0.0001830485,0.000010734447,0.000028638378,0.0000011420043,0.00025537016],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995449,0.00012495203,0.00007402054,0.0000630096,0.0001652998,0.000027821015],"domain_scores_gemma":[0.99920803,0.00045213258,0.00014949417,0.000017982748,0.00014923081,0.000023182909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089183013,0.0006343645,0.0013699412,0.0012795975,0.00017155126,0.00092672335,0.00094026094,0.0011474431,0.0041928384],"category_scores_gemma":[0.0018518066,0.00019892349,0.0010302926,0.0010494526,0.00038159607,0.00077777094,0.0004505822,0.0016287179,0.0015674453],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009635447,0.00004088708,0.00010455659,0.05198811,0.00029027078,0.00007682554,0.000049412636,0.00029570804,0.00051891524,0.002323101,0.035457805,0.908758],"study_design_scores_gemma":[0.000116720636,0.00016436579,0.001300303,0.047749296,0.0007539027,0.0010109021,0.000090300404,0.00021349486,0.00032551313,0.0036885722,0.94455874,0.000027848844],"about_ca_topic_score_codex":0.0013729185,"about_ca_topic_score_gemma":0.0029786867,"teacher_disagreement_score":0.0041928384,"about_ca_system_score_codex":0.0005857492,"about_ca_system_score_gemma":0.0011218047,"threshold_uncertainty_score":0.014026403},"labels":[],"label_agreement":null},{"id":"W4402558712","doi":"10.1016/j.annonc.2024.08.2123","title":"1905P Impact of proactive callback in patients with solid tumors receiving systemic therapy: A meta-analysis","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Systemic therapy; Callback; Meta-analysis; Oncology; Internal medicine; Intensive care medicine; Cancer","score_opus":0.1488304167108582,"score_gpt":0.4629236299410243,"score_spread":0.31409321323016615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402558712","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3317835,0.6426423,0.0072517605,0.0024340919,0.0036260511,0.0003639547,0.007025333,0.00044304418,0.004430027],"genre_scores_gemma":[0.97461003,0.018769795,0.0012612304,0.0017929863,0.00079368363,0.0001641039,0.0012249998,0.00013695305,0.0012462995],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98980284,0.005269506,0.0011771232,0.0024498482,0.00068454864,0.0006160474],"domain_scores_gemma":[0.9819671,0.012571658,0.0024386325,0.0017537393,0.0007556058,0.0005133293],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.009681608,0.0030374075,0.007088859,0.0011400606,0.00076719513,0.0035612362,0.0023516617,0.0035303428,0.006352858],"category_scores_gemma":[0.025555914,0.002040038,0.054161128,0.0021875342,0.0010164954,0.0021851906,0.0016434673,0.005274712,0.0007355556],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024461802,0.000059646696,0.041310236,0.0078082057,0.9190714,0.00018685042,0.00006304689,0.00092065515,0.0004263089,0.00013623583,0.0007710723,0.004784541],"study_design_scores_gemma":[0.0023515222,0.00060265133,0.020504285,0.0004906277,0.974004,0.000096783326,0.00004862364,0.0005079409,0.00012695386,0.0003429319,0.0008867065,0.00003693483],"about_ca_topic_score_codex":0.0098346,"about_ca_topic_score_gemma":0.011484085,"teacher_disagreement_score":0.99291116,"about_ca_system_score_codex":0.0012827201,"about_ca_system_score_gemma":0.0012725845,"threshold_uncertainty_score":0.05120188},"labels":[],"label_agreement":null},{"id":"W4402561515","doi":"10.1016/j.annonc.2024.08.227","title":"286P Impact of adjuvant endocrine therapy on survival outcomes in female breast cancer patients over 50","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Ontario Institute for Cancer Research; Alberta Health; University of Alberta","funders":"","keywords":"Medicine; Oncology; Breast cancer; Adjuvant; Internal medicine; Endocrine system; Adjuvant therapy; Cancer; Overall survival; Gynecology; Hormone","score_opus":0.09601065234537197,"score_gpt":0.491891860198112,"score_spread":0.39588120785274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402561515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99224746,0.0017440541,0.00003583397,0.0006087231,0.000049613045,0.0000047947015,0.0010834275,0.000005148994,0.0042209676],"genre_scores_gemma":[0.99765503,0.0005900127,0.000013377185,0.0001937425,0.00005417734,0.000003260666,0.00053383893,0.0000019734887,0.0009544752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986506,0.000025870058,0.000009376335,0.000017166152,0.000024117688,0.00005842247],"domain_scores_gemma":[0.9996214,0.00008840204,0.0001296313,0.000013542936,0.000030483934,0.000116510775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018850372,0.000099616926,0.00020269628,0.00027480922,0.00024197776,0.00051381934,0.00010650369,0.00025376462,0.0039992696],"category_scores_gemma":[0.001257764,0.00007284864,0.00048992014,0.00056417385,0.00013568708,0.00032090253,0.0003538452,0.00036598125,0.0004234841],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020481038,0.00011296215,0.9718623,0.000040471263,0.00020073926,0.00027848207,0.00007378414,0.00020912594,0.00041841206,0.00006958613,0.0011475479,0.023538543],"study_design_scores_gemma":[0.000031171967,0.0002513008,0.9982358,0.000012532129,0.00011026134,0.0001628704,0.00011553746,0.000084489446,0.000049368908,0.000050221875,0.00089262176,0.000003815783],"about_ca_topic_score_codex":0.0042399783,"about_ca_topic_score_gemma":0.007866607,"teacher_disagreement_score":0.0042399783,"about_ca_system_score_codex":0.00025060456,"about_ca_system_score_gemma":0.00030107785,"threshold_uncertainty_score":0.013378859},"labels":[],"label_agreement":null},{"id":"W4402561660","doi":"10.1016/j.annonc.2024.08.378","title":"431P Exposure-adjusted incidence rates (EAIRs) of adverse events (AEs) from the TROPION-Breast01 study of datopotamab deruxtecan (Dato-DXd) vs investigator’s choice of chemotherapy (ICC) in patients (pts) with pretreated, inoperable/metastatic HR+/HER2– breast cancer (BC)","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Incidence (geometry); Adverse effect; Internal medicine; Chemotherapy; Oncology; Family medicine","score_opus":0.055316604342201675,"score_gpt":0.3768241193797079,"score_spread":0.3215075150375062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402561660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98678,0.0038526668,0.0005494465,0.00018290263,0.00007557897,0.00011769506,0.0063589616,0.000042190022,0.0020405946],"genre_scores_gemma":[0.9928664,0.0008156785,0.0002269386,0.00021559083,0.000044278677,0.00008473164,0.0045007723,0.000017240236,0.0012283698],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9986694,0.0006345274,0.00010380576,0.00030031233,0.00015937592,0.00013260356],"domain_scores_gemma":[0.9984572,0.00067954673,0.0004659609,0.00016064035,0.00008344704,0.00015322622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002627368,0.0005954045,0.0010422028,0.00036565936,0.00015430701,0.0007218035,0.00043544127,0.00066186645,0.0035935617],"category_scores_gemma":[0.002129134,0.00039473042,0.00416377,0.0005936929,0.00020708071,0.00058461924,0.00050453,0.0021398673,0.00026027006],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47695535,0.0012995906,0.41119346,0.0019529007,0.037347544,0.00037755768,0.00023877757,0.004813397,0.007866841,0.00038915296,0.005817893,0.051747486],"study_design_scores_gemma":[0.022552568,0.03587114,0.90812266,0.0001256331,0.01923117,0.0006654305,0.00020821336,0.0031815474,0.0022682645,0.0005865223,0.007102364,0.000084501546],"about_ca_topic_score_codex":0.0015206287,"about_ca_topic_score_gemma":0.0028819977,"teacher_disagreement_score":0.0035935617,"about_ca_system_score_codex":0.00035643947,"about_ca_system_score_gemma":0.0003945961,"threshold_uncertainty_score":0.013895035},"labels":[],"label_agreement":null},{"id":"W4402561714","doi":"10.1016/j.annonc.2024.08.376","title":"429P Brain imaging screening (BIS) in metastatic breast cancer (MBC): Patients’ and physicians’ perspectives","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Metastatic breast cancer; Oncology; Cancer; Breast cancer; Internal medicine; Radiology","score_opus":0.05707386712719624,"score_gpt":0.4350356522901061,"score_spread":0.37796178516290985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402561714","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026103787,0.041260283,0.00026534573,0.9011515,0.0023557625,0.0000072673497,0.00013126538,0.000010136937,0.028714763],"genre_scores_gemma":[0.59263396,0.089584805,0.001444663,0.289305,0.022178309,0.00003379548,0.00020322096,0.000026045083,0.004590219],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9974247,0.0013974758,0.00013540672,0.00017524822,0.00046871422,0.0003984751],"domain_scores_gemma":[0.9912913,0.0040102657,0.00089835795,0.00008958541,0.0016495101,0.0020610571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035898362,0.00016522291,0.0003603703,0.00056897925,0.0017354351,0.0030403736,0.00048028008,0.0039153052,0.0080702165],"category_scores_gemma":[0.014030382,0.00018368717,0.00046305492,0.0006028891,0.0015502594,0.002309316,0.0014142125,0.004753002,0.0007204373],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014146671,0.0008017705,0.08707256,0.0012438664,0.00026853336,0.0059552756,0.0055248584,0.0008438571,0.0015613607,0.045977306,0.39018884,0.45914719],"study_design_scores_gemma":[0.00047974134,0.0009584122,0.08898333,0.0045442358,0.00031263827,0.01225292,0.025684003,0.0007793616,0.00093495613,0.045785863,0.81904876,0.00023573071],"about_ca_topic_score_codex":0.003959742,"about_ca_topic_score_gemma":0.01118603,"teacher_disagreement_score":0.0080702165,"about_ca_system_score_codex":0.0017560893,"about_ca_system_score_gemma":0.0032532287,"threshold_uncertainty_score":0.026997626},"labels":[],"label_agreement":null},{"id":"W4402642904","doi":"10.1007/s00520-024-08878-5","title":"Exploring the reliability and validity of clinically-relevant outcome measures for chemotherapy-induced peripheral neuropathy","year":2024,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Medicine; Pain medicine; Peripheral neuropathy; Chemotherapy-induced peripheral neuropathy; Nursing research; Reliability (semiconductor); Chemotherapy; Peripheral; Oncology; Patient-reported outcome; Physical therapy; Internal medicine; Intensive care medicine; Physical medicine and rehabilitation; Anesthesia; Quality of life (healthcare); Anesthesiology; Pathology; Nursing","score_opus":0.21328150948830082,"score_gpt":0.4396497949564378,"score_spread":0.22636828546813698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402642904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99176496,0.0009838248,0.0031356292,0.00020394064,0.0001385594,0.00028837446,0.00037618313,0.000020999154,0.0030875576],"genre_scores_gemma":[0.9975623,0.0001679423,0.0015038954,0.000058134974,0.000034771267,0.00018765609,0.00028344468,0.000007882343,0.00019402477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9819177,0.009472096,0.0025974119,0.0012994797,0.004166107,0.00054726994],"domain_scores_gemma":[0.8605495,0.091931574,0.022559788,0.0064103743,0.017129878,0.0014189663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025391648,0.0005338905,0.0006996195,0.0022327218,0.0007467406,0.0014580999,0.0009481081,0.0011004264,0.00080705783],"category_scores_gemma":[0.103085384,0.0002775423,0.0014951981,0.0014683722,0.0012785991,0.0015180664,0.0013672312,0.0012465233,0.00024782665],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009913165,0.0005091106,0.9682161,0.0001737634,0.0007437185,0.000045350986,0.00092411163,0.00077031413,0.00055226183,0.00052589626,0.00036605293,0.026182158],"study_design_scores_gemma":[0.0001016342,0.0019470219,0.990493,0.00012566724,0.00023429864,0.0001430811,0.000773141,0.0037150143,0.0006168757,0.0008437789,0.0009732632,0.000033178017],"about_ca_topic_score_codex":0.0018822504,"about_ca_topic_score_gemma":0.0037870833,"teacher_disagreement_score":0.025391648,"about_ca_system_score_codex":0.0010789139,"about_ca_system_score_gemma":0.0012447229,"threshold_uncertainty_score":0.13428551},"labels":[],"label_agreement":null},{"id":"W4402670104","doi":"10.1200/op.24.00089","title":"Protocol-Stipulated Dose Modification to Manage Chemotherapy-Induced Peripheral Neuropathy in Children, Adolescents, and Young Adults With High-Risk Hodgkin Lymphoma","year":2024,"lang":"en","type":"article","venue":"JCO Oncology Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Vincristine; Etoposide; Cyclophosphamide; Oncology; Internal medicine; Chemotherapy-induced peripheral neuropathy; Prednisone; Peripheral neuropathy; Chemotherapy; Vinca; Pharmacology","score_opus":0.01621319297402094,"score_gpt":0.3474002585708698,"score_spread":0.33118706559684885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402670104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752661,0.008306121,0.0016616622,0.0006174719,0.00011495167,0.006170549,0.0009027351,0.00008797535,0.0068723904],"genre_scores_gemma":[0.9879288,0.0014903051,0.003971112,0.00073266483,0.000054537373,0.0042728,0.0008653996,0.000010582458,0.00067387713],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998329,0.001030568,0.000226856,0.0001090647,0.00019857338,0.00010596268],"domain_scores_gemma":[0.99801683,0.0005607594,0.00087655854,0.00015841093,0.00012687214,0.00026059375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027196347,0.00021589878,0.00032394196,0.00030292748,0.00020814392,0.0003146758,0.0005915533,0.0004887301,0.0015240475],"category_scores_gemma":[0.0048710033,0.00015405915,0.00048284652,0.00039527606,0.00022840843,0.0002994347,0.00038843532,0.0007577066,0.00017963808],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07829941,0.011263445,0.18773812,0.0022780325,0.0012024704,0.00026739136,0.000616261,0.007942941,0.01056356,0.0009966262,0.009072728,0.6897589],"study_design_scores_gemma":[0.07525413,0.22127847,0.61802554,0.0019570794,0.0011488553,0.0017775825,0.0004327578,0.005050502,0.013470747,0.0012449533,0.06028928,0.0000700545],"about_ca_topic_score_codex":0.0009042899,"about_ca_topic_score_gemma":0.0031672043,"teacher_disagreement_score":0.0027196347,"about_ca_system_score_codex":0.0010530525,"about_ca_system_score_gemma":0.0015486557,"threshold_uncertainty_score":0.014383018},"labels":[],"label_agreement":null},{"id":"W4402708995","doi":"10.1158/1538-7755.disp24-c051","title":"Abstract C051: Impact of population pharmacogenomics on cisplatin-induced neurotoxicities","year":2024,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Pharmacogenomics; Medicine; Cisplatin; Population; Environmental health; Internal medicine; Pharmacology; Chemotherapy","score_opus":0.12669799011986316,"score_gpt":0.4877148667696302,"score_spread":0.36101687664976706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402708995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957093,0.00028676545,0.0010763407,0.00016303401,0.000013593171,0.000017175973,0.0018616804,0.000020750607,0.0008512784],"genre_scores_gemma":[0.9988393,0.000033418302,0.00025133815,0.000040198607,0.000008368914,0.000010317921,0.00052465807,0.000009855207,0.0002825442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816835,0.00080282247,0.00010056419,0.0006091792,0.00017467982,0.00014434474],"domain_scores_gemma":[0.9977584,0.0009622632,0.00045854395,0.0003932344,0.00019978195,0.00022768842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001691035,0.0003404214,0.00035771244,0.0005501665,0.00050349225,0.0007296448,0.0003911667,0.0004172072,0.0055593303],"category_scores_gemma":[0.00426588,0.00011431037,0.00087590155,0.0012260742,0.0003478082,0.00028476492,0.0005937616,0.0005661106,0.00027643106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009189311,0.000041239324,0.98827493,0.000026406862,0.0010160583,0.00015674245,0.00007526791,0.000606284,0.0021553917,0.00015600918,0.00050389726,0.006068778],"study_design_scores_gemma":[0.000019835976,0.00020582303,0.9964826,0.000005254111,0.00031025047,0.0001896657,0.000066928485,0.0015399015,0.00045887922,0.00013546021,0.0005807596,0.0000046797168],"about_ca_topic_score_codex":0.0067202896,"about_ca_topic_score_gemma":0.0039031692,"teacher_disagreement_score":0.0067202896,"about_ca_system_score_codex":0.0003224734,"about_ca_system_score_gemma":0.00043983958,"threshold_uncertainty_score":0.018597782},"labels":[],"label_agreement":null},{"id":"W4402740022","doi":"10.1016/j.neurot.2024.e00418","title":"Neuropathology Evaluation of Olney Lesions in Regulatory Drug Development Toxicology Studies","year":2024,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Greenfield Research (Canada)","funders":"","keywords":"Neuropathology; Neurology; Medicine; Drug; Drug development; Neurochemistry; Toxicology; Pharmacology; Internal medicine; Biology; Psychiatry","score_opus":0.17460154155608504,"score_gpt":0.4482295772712218,"score_spread":0.2736280357151368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402740022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93800604,0.0075149075,0.01206705,0.00038259925,0.00013597458,0.0014861138,0.001124281,0.00036013464,0.03892288],"genre_scores_gemma":[0.971084,0.0060834046,0.008024965,0.0004133406,0.000038034137,0.00029030052,0.0009469558,0.000039401595,0.013079518],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9995906,0.000093419505,0.00003777222,0.000055970857,0.00017133224,0.00005091594],"domain_scores_gemma":[0.99909127,0.00007309924,0.00027304946,0.000053908432,0.00039822797,0.000110337205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014198857,0.000529314,0.00030461533,0.0020636085,0.00052903575,0.00036217878,0.00027792205,0.0005633993,0.0035157541],"category_scores_gemma":[0.00087836717,0.00017161932,0.00023174785,0.0006532183,0.00052438886,0.00048198868,0.0004179968,0.00042271052,0.00049200526],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042076246,0.0010314162,0.142463,0.0014478753,0.00019811909,0.017797163,0.00096837676,0.0006022872,0.7279928,0.0026406234,0.0038001414,0.09685068],"study_design_scores_gemma":[0.0001717452,0.015316136,0.4326129,0.0006689497,0.00044665427,0.034295805,0.0014160761,0.0020156521,0.44533902,0.0015756093,0.0660532,0.00008823523],"about_ca_topic_score_codex":0.0014813133,"about_ca_topic_score_gemma":0.0046309684,"teacher_disagreement_score":0.0035157541,"about_ca_system_score_codex":0.00038996674,"about_ca_system_score_gemma":0.00044046875,"threshold_uncertainty_score":0.011761367},"labels":[],"label_agreement":null},{"id":"W4402767152","doi":"10.1136/rapm-2024-esra.562","title":"C26 Anterior QLB for which surgery should we use it","year":2024,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.17875451984818697,"score_gpt":0.4210764028740764,"score_spread":0.24232188302588942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402767152","genre_codex":"editorial","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048318892,0.041338544,0.0014410231,0.17042753,0.7139225,0.0001292877,0.0007771609,0.00033591076,0.07114481],"genre_scores_gemma":[0.0057249195,0.07542875,0.0014546614,0.20644529,0.5422991,0.00020154608,0.0007920833,0.00028676988,0.16736694],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993268,0.0000959499,0.000093763876,0.00010923412,0.00028665434,0.00008759748],"domain_scores_gemma":[0.9967609,0.0007880486,0.00024232572,0.00007772217,0.0016142459,0.0005168489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087863416,0.00059213117,0.0006654232,0.0009399869,0.0010502803,0.0024748447,0.0008987011,0.0039846236,0.08010851],"category_scores_gemma":[0.007331685,0.00023780006,0.0007636914,0.00065503205,0.0012764424,0.002228063,0.00086176,0.0054916567,0.03298242],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002482371,0.0000049485375,0.000073482915,0.0003872625,0.0000041431485,0.00009604071,0.000016785387,0.00002423845,0.000113631344,0.0013557113,0.96811074,0.029788163],"study_design_scores_gemma":[0.000010012561,0.000011834675,0.00027531496,0.00064699835,0.0000042676365,0.0002519272,0.000040416402,0.000030239757,0.000051990646,0.0006371091,0.9980307,0.00000914812],"about_ca_topic_score_codex":0.0056906673,"about_ca_topic_score_gemma":0.011210793,"teacher_disagreement_score":0.08010851,"about_ca_system_score_codex":0.0018679163,"about_ca_system_score_gemma":0.0024080914,"threshold_uncertainty_score":0.26798964},"labels":[],"label_agreement":null},{"id":"W4402985353","doi":"10.1200/op.2024.20.10_suppl.397","title":"Health-related quality of life of Canadian patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer.","year":2024,"lang":"en","type":"article","venue":"JCO Oncology Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); McGill University Health Centre; McGill University","funders":"","keywords":"Human Epidermal Growth Factor Receptor 2; Metastatic breast cancer; Breast cancer; Medicine; Oncology; Cancer; Quality of life (healthcare); Internal medicine; Cancer research; Nursing","score_opus":0.05588669378253575,"score_gpt":0.414979273414401,"score_spread":0.35909257963186525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402985353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95884085,0.0025232977,0.00012084167,0.000863738,0.000033236243,0.00014171854,0.02949214,0.000016531918,0.007967549],"genre_scores_gemma":[0.99102825,0.00066234986,0.00025067094,0.00014907443,0.000007788231,0.000046322475,0.0068521644,0.0000028716547,0.0010004686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999342,0.00004822106,0.000039981238,0.0000710331,0.00034354784,0.00015514124],"domain_scores_gemma":[0.99908984,0.000041481133,0.00021515993,0.000018201334,0.00046546402,0.00016976862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061516836,0.00027558714,0.00034013737,0.0008605964,0.0015074902,0.00063702336,0.00068227336,0.00025450485,0.0033904682],"category_scores_gemma":[0.002189142,0.00014042547,0.00059993594,0.0026046862,0.00032936587,0.000269924,0.00060108124,0.00058320566,0.00028230847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017020044,0.00007678415,0.9742829,0.0001914935,0.00011385197,0.000086178974,0.0007511823,0.00024243131,0.00013631626,0.00013315938,0.006978331,0.016837148],"study_design_scores_gemma":[0.000013461765,0.000038495826,0.9971042,0.000036191665,0.00002684355,0.00007478755,0.00035167683,0.0001802391,0.000028917406,0.000018467184,0.002114985,0.000011737461],"about_ca_topic_score_codex":0.96441036,"about_ca_topic_score_gemma":0.9800949,"teacher_disagreement_score":0.035589635,"about_ca_system_score_codex":0.016875789,"about_ca_system_score_gemma":0.01273187,"threshold_uncertainty_score":0.12244296},"labels":[],"label_agreement":null},{"id":"W4402987295","doi":"10.1200/op.2024.20.10_suppl.391","title":"Treatment patterns of goserelin 3.6 mg once monthly and 10.8 mg every three months in women with breast cancer: A real-world analysis.","year":2024,"lang":"en","type":"article","venue":"JCO Oncology Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Goserelin; Medicine; Breast cancer; Cancer; Internal medicine; Oncology; Gynecology","score_opus":0.021120972590215396,"score_gpt":0.3761987553108591,"score_spread":0.3550777827206437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402987295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942826,0.0011337749,0.0000799513,0.00012800549,0.0000067309848,0.000031305048,0.003950123,0.0000044209105,0.00038312646],"genre_scores_gemma":[0.99648726,0.00043552666,0.00016609773,0.000082092076,0.000008102151,0.000037975486,0.0026859145,0.0000031582183,0.00009381847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838305,0.00045549875,0.00036325105,0.00031690832,0.0002979353,0.00018338393],"domain_scores_gemma":[0.99543625,0.00083080825,0.0031647882,0.00014920451,0.0001930189,0.00022590032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012880745,0.00015603025,0.00041485837,0.001175761,0.00028452338,0.0006903575,0.0004146652,0.00036805836,0.0011363887],"category_scores_gemma":[0.004299927,0.00023384401,0.00094154786,0.0027360753,0.00020049808,0.00064817246,0.0005162511,0.0005734166,0.00019646868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006077732,0.00007141029,0.9956864,0.00008103785,0.00023810992,0.000059368227,0.00009209004,0.00008727696,0.000077501165,0.000026750808,0.0003698573,0.0026024608],"study_design_scores_gemma":[0.00005419931,0.00021339298,0.9971938,0.000057797188,0.00011638744,0.00033235317,0.0003942441,0.0007488373,0.000075692515,0.000035458306,0.00076723984,0.00001056465],"about_ca_topic_score_codex":0.010197093,"about_ca_topic_score_gemma":0.016198676,"teacher_disagreement_score":0.010197093,"about_ca_system_score_codex":0.000869599,"about_ca_system_score_gemma":0.0006749259,"threshold_uncertainty_score":0.020275474},"labels":[],"label_agreement":null},{"id":"W4403045738","doi":"10.1503/cmaj.240221-f","title":"Deux cas de zona atypique chez des personnes prenant des inhibiteurs de Janus kinases par voie orale","year":2024,"lang":"fr","type":"article","venue":"Canadian Medical Association Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine","score_opus":0.016298562639727603,"score_gpt":0.29636701199564586,"score_spread":0.28006844935591824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403045738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94637114,0.016130662,0.005310544,0.009244502,0.0009124003,0.0002709828,0.001001617,0.00027222605,0.020485925],"genre_scores_gemma":[0.9900405,0.0022060722,0.0012374625,0.0013834295,0.00023095318,0.00002435134,0.00016266812,0.000019887177,0.0046946923],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99963975,0.00004726892,0.000041639552,0.00007842804,0.000090815585,0.00010218435],"domain_scores_gemma":[0.9991922,0.00030414274,0.0002537355,0.0000618608,0.00008405298,0.00010401016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025443183,0.0004190413,0.00031693839,0.0009803011,0.001229085,0.0005103321,0.0002903698,0.0021492532,0.004662307],"category_scores_gemma":[0.0023474367,0.000312558,0.0006058262,0.00059095566,0.0007640553,0.0006397256,0.00039877056,0.001480093,0.00053314655],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013818321,0.00019972632,0.14119859,0.00026958258,0.00014661704,0.7964517,0.0023627805,0.0002793456,0.012732705,0.0013770986,0.0066786218,0.036921494],"study_design_scores_gemma":[0.000069379435,0.00034850772,0.07650993,0.000090361245,0.00009472297,0.9062137,0.0009535666,0.00048014094,0.0028290546,0.0005150649,0.011848646,0.000047017507],"about_ca_topic_score_codex":0.012227375,"about_ca_topic_score_gemma":0.013218747,"teacher_disagreement_score":0.012227375,"about_ca_system_score_codex":0.0005597691,"about_ca_system_score_gemma":0.00046022364,"threshold_uncertainty_score":0.024312437},"labels":[],"label_agreement":null},{"id":"W4403075294","doi":"10.1016/j.athplu.2024.08.019","title":"Bempedoic acid: real-world efficacy and tolerability in lipid clinics across three UK Centres","year":2024,"lang":"en","type":"article","venue":"Atherosclerosis Plus","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Tolerability; Medicine; Internal medicine; Adverse effect","score_opus":0.05047745627176591,"score_gpt":0.38038505729493916,"score_spread":0.32990760102317324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403075294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99807966,0.0006562106,0.0001203389,0.00019127475,0.000006990837,0.000108248794,0.00020809619,0.000013148886,0.0006160227],"genre_scores_gemma":[0.9988882,0.00027365866,0.00027882383,0.00013886848,0.000008990797,0.00004057213,0.00012536535,0.000007794055,0.00023772837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966732,0.0016574933,0.0002998999,0.00041937898,0.0005311862,0.0004187729],"domain_scores_gemma":[0.9903593,0.002997127,0.0028994903,0.00038865866,0.001392678,0.0019628222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002966351,0.00023225928,0.00065126695,0.000508517,0.00081510184,0.0016973458,0.00033473907,0.0006734892,0.0023535967],"category_scores_gemma":[0.008670837,0.00033657235,0.0003480711,0.0013112868,0.0010397983,0.0007128596,0.0011835367,0.0007606673,0.00031492638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03647615,0.0041288002,0.8384053,0.0013367449,0.0005737092,0.0012502534,0.014764279,0.0010768806,0.008105796,0.00026656047,0.0019404511,0.09167505],"study_design_scores_gemma":[0.0018232521,0.019052064,0.9669166,0.000200964,0.0002619028,0.0006402784,0.006705518,0.0005894337,0.0012483293,0.000058567748,0.0023938806,0.00010920754],"about_ca_topic_score_codex":0.03699571,"about_ca_topic_score_gemma":0.053945817,"teacher_disagreement_score":0.03699571,"about_ca_system_score_codex":0.0037918391,"about_ca_system_score_gemma":0.0025911976,"threshold_uncertainty_score":0.073560715},"labels":[],"label_agreement":null},{"id":"W4403089800","doi":"10.26434/chemrxiv-2024-25k81","title":"Total Synthesis of LL-A03411-Beta1","year":2024,"lang":"en","type":"preprint","venue":"ChemRxiv","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Environmental science; Political science","score_opus":0.028569721522363277,"score_gpt":0.3329215473271281,"score_spread":0.30435182580476483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403089800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88050646,0.010775624,0.061326418,0.00049066177,0.00046858983,0.0009405821,0.012689616,0.0020246585,0.030777432],"genre_scores_gemma":[0.9151254,0.006056381,0.043915823,0.00033417306,0.00009609904,0.00055152073,0.00974668,0.0005175665,0.023656301],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997788,0.000029562361,0.000021693026,0.000040516275,0.00006377571,0.00006562889],"domain_scores_gemma":[0.9998412,0.000020302465,0.00002500046,0.000024938381,0.000029534196,0.000058944115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001789614,0.00058672123,0.00060401845,0.0003980656,0.00029915734,0.00041508384,0.00039546055,0.00033788293,0.0036351006],"category_scores_gemma":[0.00017512415,0.0002022692,0.00031084748,0.0004840096,0.00019877125,0.00021980997,0.00041141253,0.0008648645,0.003609242],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014306343,0.000026550328,0.00004656236,0.00009844644,0.000010151196,0.0000834262,0.000023601293,0.00023144858,0.9912363,0.00033078567,0.00025480526,0.0075148167],"study_design_scores_gemma":[0.0000480181,0.0004516326,0.00051019544,0.000016526652,0.000026488338,0.00021934205,0.000012236473,0.00036271225,0.9773597,0.00012122857,0.020856855,0.000015057406],"about_ca_topic_score_codex":0.00047009275,"about_ca_topic_score_gemma":0.0003973337,"teacher_disagreement_score":0.0036351006,"about_ca_system_score_codex":0.00038263865,"about_ca_system_score_gemma":0.00048459356,"threshold_uncertainty_score":0.012160659},"labels":[],"label_agreement":null},{"id":"W4403227546","doi":"10.1016/j.cjca.2024.08.059","title":"THERAPEUTIC RECHALLENGE WITH ANTI-ANGINAL AGENTS IN PATIENTS EXPERIENCING FLUOROPYRIMIDINE-INDUCED CARDIOTOXICITY (TRAFIC): A RETROSPECTIVE CHART REVIEW","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cardiotoxicity; Retrospective cohort study; Pharmacology; Oncology; Internal medicine; Intensive care medicine; Anesthesia; Chemotherapy","score_opus":0.04974458200963158,"score_gpt":0.32640631288086197,"score_spread":0.27666173087123036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403227546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829829,0.01129757,0.00049929006,0.00016830304,0.000028016393,0.00014871244,0.001815645,0.000017861881,0.0030417584],"genre_scores_gemma":[0.9939797,0.0040273126,0.00034194565,0.00018730716,0.000027967688,0.000036693127,0.0011250059,0.0000070471165,0.0002670313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993405,0.00008840366,0.00019352052,0.00014018372,0.00015028968,0.00008706116],"domain_scores_gemma":[0.99722016,0.000670288,0.0014485166,0.0001223788,0.00033435624,0.00020427973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035917052,0.00014613949,0.0003163102,0.001492381,0.0005025925,0.00065287406,0.00027253813,0.00042695814,0.001659669],"category_scores_gemma":[0.0018217632,0.00020066026,0.00046404358,0.0016708823,0.0003009774,0.00051188574,0.00029406394,0.00042934026,0.0002633814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012960192,0.000052461226,0.98380685,0.00017863297,0.000043583732,0.007970948,0.00027041053,0.000031483327,0.00061918516,0.000071474955,0.0003875578,0.006437804],"study_design_scores_gemma":[0.000015694166,0.0003732159,0.943636,0.00023292484,0.00016998376,0.048532873,0.0017731694,0.00014941946,0.00068770524,0.00005606095,0.0043466487,0.00002630673],"about_ca_topic_score_codex":0.0038192878,"about_ca_topic_score_gemma":0.0042653475,"teacher_disagreement_score":0.0038192878,"about_ca_system_score_codex":0.00048070072,"about_ca_system_score_gemma":0.0008790194,"threshold_uncertainty_score":0.0075941086},"labels":[],"label_agreement":null},{"id":"W4403302620","doi":"10.21203/rs.3.rs-4888430/v1","title":"Patient-reported Strategies for Prevention and Treatment of Chemotherapy- induced Peripheral Neuropathy","year":2024,"lang":"en","type":"preprint","venue":"Research Square","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Peripheral neuropathy; Chemotherapy-induced peripheral neuropathy; Medicine; Chemotherapy; Peripheral; Intensive care medicine; Oncology; Physical medicine and rehabilitation; Internal medicine; Endocrinology; Diabetes mellitus","score_opus":0.12186299430374842,"score_gpt":0.46838301937153787,"score_spread":0.34652002506778945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403302620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7120633,0.09712946,0.014523719,0.052341476,0.0012752985,0.0012326385,0.0029408454,0.00042967114,0.11806353],"genre_scores_gemma":[0.96394265,0.01968467,0.010062585,0.002292929,0.00037625665,0.00024443152,0.00045461263,0.000013074351,0.0029287129],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9991296,0.00062047533,0.00005969597,0.000039660612,0.00011725069,0.00003338338],"domain_scores_gemma":[0.9976222,0.0012737233,0.0006098996,0.00007792031,0.00023979455,0.00017653574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018292249,0.00020696326,0.0003289538,0.000508871,0.000283031,0.0007241592,0.0003332597,0.00045387808,0.008610686],"category_scores_gemma":[0.007948849,0.00007262903,0.00034406752,0.00046696624,0.00011586696,0.00044238774,0.00030000566,0.00060583226,0.00049108925],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021924716,0.0034469566,0.06936804,0.0018308552,0.000542666,0.00022610708,0.00063064584,0.000831498,0.00095361174,0.0031187679,0.015347138,0.9015113],"study_design_scores_gemma":[0.004540116,0.02588303,0.7513416,0.0072107627,0.004380021,0.0035190291,0.00500677,0.008988693,0.006767418,0.02755858,0.15458246,0.00022156246],"about_ca_topic_score_codex":0.0005231223,"about_ca_topic_score_gemma":0.0014434542,"teacher_disagreement_score":0.008610686,"about_ca_system_score_codex":0.0003478397,"about_ca_system_score_gemma":0.00082534447,"threshold_uncertainty_score":0.028805673},"labels":[],"label_agreement":null},{"id":"W4403420038","doi":"10.1016/j.jtho.2024.09.094","title":"MA01.07 Long-Term Analysis of NRG-LU001, Randomized Phase II Trial of Concurrent Chemoradiotherapy (ccrt) -/+ Metformin in Locally Advanced NSCLC.","year":2024,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Metformin; Oncology; Chemoradiotherapy; Internal medicine; Term (time); Phases of clinical research; Clinical trial; Overall survival; Astronomy","score_opus":0.03301604970201223,"score_gpt":0.49432315396629145,"score_spread":0.46130710426427923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403420038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979542,0.006703795,0.0007735992,0.0021639422,0.000788293,0.0016565403,0.0041745226,0.00025641773,0.003940772],"genre_scores_gemma":[0.98206216,0.0018168348,0.0013385568,0.0019189435,0.0005773253,0.0015789436,0.0059086657,0.000049930302,0.004748647],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99910176,0.00054082467,0.0000398221,0.00012565336,0.000058200654,0.0001337633],"domain_scores_gemma":[0.9986603,0.00029152844,0.0003335588,0.00015016734,0.0000864087,0.00047796773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023470002,0.0011707558,0.0020826645,0.00033183402,0.0003367447,0.0015417741,0.0012003885,0.0012429778,0.006454894],"category_scores_gemma":[0.0021470482,0.0005611681,0.0022131526,0.000408516,0.00081470277,0.001223701,0.00048545699,0.0032388868,0.0017712968],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9618285,0.003075786,0.003076637,0.00036938395,0.002747146,0.000046956615,0.000029415849,0.00064231775,0.0053596487,0.00023957432,0.003004808,0.019579984],"study_design_scores_gemma":[0.8706259,0.109482095,0.011764601,0.000066397326,0.0029461249,0.000083439736,0.000047256886,0.0011953689,0.00080855185,0.00033032228,0.0026183615,0.00003154659],"about_ca_topic_score_codex":0.0013454349,"about_ca_topic_score_gemma":0.004452324,"teacher_disagreement_score":0.006454894,"about_ca_system_score_codex":0.0009770478,"about_ca_system_score_gemma":0.0013800944,"threshold_uncertainty_score":0.02159375},"labels":[],"label_agreement":null},{"id":"W4403461604","doi":"10.6004/jnccn.2024.7028","title":"Sympathetic Blockade for Pain Associated With Nonaxial Bone Lesions in Patients With Cancer: An Uncontrolled Cohort","year":2024,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cohort; Retrospective cohort study; Blockade; Cancer; Visual analogue scale; Cancer pain; Multimodal therapy; Anesthesia; Internal medicine; Surgery","score_opus":0.023184458604149603,"score_gpt":0.3193258889044194,"score_spread":0.2961414303002698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403461604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999316,0.00022484585,0.00011389428,0.000013330133,0.000004423081,0.000038998114,0.00010859446,0.000001777573,0.00017809463],"genre_scores_gemma":[0.9990396,0.000260055,0.00014954469,0.000044844583,0.0000233954,0.000044978384,0.00031738626,0.0000023416635,0.00011794158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956864,0.00007845179,0.000042723765,0.00012288571,0.000118011245,0.00006931895],"domain_scores_gemma":[0.99933916,0.000119250995,0.00026352785,0.00008537273,0.00006889519,0.00012377823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005385238,0.0002799421,0.00047214684,0.0004931984,0.0007607935,0.00059325,0.00032596555,0.00033563303,0.0011944944],"category_scores_gemma":[0.0010385627,0.00026069276,0.0005403555,0.00050701736,0.00051551644,0.000398211,0.00039838642,0.0005679019,0.00023549593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048066906,0.00034978773,0.9954668,0.000014841542,0.000059518436,0.000579726,0.00011242719,0.000020078345,0.0007415477,0.000020120266,0.00008827617,0.0020662025],"study_design_scores_gemma":[0.00017001305,0.0030351826,0.99036014,0.000016563761,0.00011967996,0.0046879053,0.00052203116,0.00024490381,0.0002535215,0.000040243012,0.0005339584,0.000015803547],"about_ca_topic_score_codex":0.0026052487,"about_ca_topic_score_gemma":0.0035657657,"teacher_disagreement_score":0.0026052487,"about_ca_system_score_codex":0.0003240402,"about_ca_system_score_gemma":0.00061866886,"threshold_uncertainty_score":0.00518018},"labels":[],"label_agreement":null},{"id":"W4403566765","doi":"10.1007/s12325-024-02985-9","title":"Differences Between Intravenous and Subcutaneous Modes of Administration in Oncology from the Patient, Healthcare Provider, and Healthcare System Perspectives: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Advances in Therapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Health care; Rheumatology; Administration (probate law); Internal medicine; Intensive care medicine","score_opus":0.06060773984211042,"score_gpt":0.4284270474126201,"score_spread":0.3678193075705097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403566765","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00060413784,0.9990332,0.00005086863,0.000057380363,0.00003136,0.00003601389,0.00010884229,0.000001458546,0.000076798715],"genre_scores_gemma":[0.008719006,0.9904952,0.00029353725,0.00027824327,0.000038952523,0.000056246492,0.000069615766,0.000002279213,0.000046928075],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99661463,0.001052852,0.0012438279,0.0003881783,0.0005717137,0.00012890915],"domain_scores_gemma":[0.9862083,0.010982239,0.0020443976,0.00012851837,0.00051987683,0.00011675647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003992161,0.0009698716,0.0059860214,0.0034893483,0.0003519071,0.0020030178,0.0011732761,0.001528238,0.0037248943],"category_scores_gemma":[0.018941233,0.00062443636,0.008143806,0.0055926135,0.00063192094,0.0015339406,0.0009966518,0.0014709921,0.00023233921],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007145783,0.000045183675,0.0013894304,0.8908645,0.025650367,0.00009121567,0.00014294374,0.0001503317,0.00022075487,0.00025757344,0.0015365336,0.0789366],"study_design_scores_gemma":[0.0011354585,0.00054681726,0.012450936,0.6666734,0.28968418,0.0005108679,0.00047263512,0.00013307658,0.00029897093,0.00061436417,0.027388979,0.00009034483],"about_ca_topic_score_codex":0.00659142,"about_ca_topic_score_gemma":0.025810204,"teacher_disagreement_score":0.00659142,"about_ca_system_score_codex":0.0017853335,"about_ca_system_score_gemma":0.004311917,"threshold_uncertainty_score":0.0211128},"labels":[],"label_agreement":null},{"id":"W4403915835","doi":"10.1093/9780198925330.003.0006","title":"Diophantine Problems","year":2024,"lang":"en","type":"book-chapter","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Mathematics; Computer science","score_opus":0.03175583290706256,"score_gpt":0.30715707152249255,"score_spread":0.27540123861543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403915835","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036364025,0.008750076,0.024828894,0.008976914,0.0014309604,0.00004909654,0.00015637602,0.00011651008,0.9520547],"genre_scores_gemma":[0.20238204,0.013521683,0.028124232,0.005708806,0.001874062,0.00014295852,0.00044335122,0.0002384039,0.74756455],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992206,0.00021536734,0.000047811984,0.00014513331,0.00030897022,0.00006215707],"domain_scores_gemma":[0.99918646,0.00044819684,0.000035734847,0.00009919817,0.00018656257,0.000043897515],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000867654,0.00054140826,0.00037890347,0.00069301046,0.0020136577,0.0023854782,0.0007578864,0.0011678754,0.030748876],"category_scores_gemma":[0.001999727,0.00026264242,0.00037454988,0.0007399353,0.0044727474,0.0039923843,0.0014599458,0.0042855986,0.00648641],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004204033,0.000008492476,0.00002299181,0.00005286621,0.0000015734572,0.000029847593,0.00043028544,0.00023126646,0.00011082475,0.96732247,0.021911204,0.009873883],"study_design_scores_gemma":[0.000004502558,0.000010568955,0.000061682134,0.00008345633,0.0000024945102,0.0001433115,0.00015987066,0.0004797204,0.00026065545,0.55169797,0.44709057,0.000005178386],"about_ca_topic_score_codex":0.0019513004,"about_ca_topic_score_gemma":0.0023223548,"teacher_disagreement_score":0.9692511,"about_ca_system_score_codex":0.0031374565,"about_ca_system_score_gemma":0.0017582573,"threshold_uncertainty_score":0.10286522},"labels":[],"label_agreement":null},{"id":"W4403966203","doi":"10.51731/cjht.2024.1015","title":"Epcoritamab (Epkinly)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.03514424862429699,"score_gpt":0.3569083070650617,"score_spread":0.3217640584407647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403966203","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0282546,0.889278,0.0018437145,0.0025388554,0.0005591979,0.00028143387,0.002020188,0.00018671065,0.07503739],"genre_scores_gemma":[0.31659213,0.61904085,0.004984432,0.0049291765,0.00045433154,0.0003943764,0.0035334975,0.000050468814,0.05002072],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997781,0.00004712925,0.000018587922,0.000027551087,0.000105329855,0.000023340239],"domain_scores_gemma":[0.99982506,0.00004664669,0.00004879523,0.000006592994,0.00004976314,0.000023123675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038992192,0.0002644604,0.00026631253,0.0006627,0.00013862833,0.0005308666,0.00022958725,0.0002752408,0.004865766],"category_scores_gemma":[0.00059002393,0.00006887707,0.00034700622,0.00057171116,0.00015038892,0.00034665424,0.00020933211,0.00059914653,0.001174679],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005940317,0.000059205504,0.00057901227,0.0027681398,0.0001392554,0.00022338808,0.000020277344,0.00023365147,0.0059445165,0.0012602917,0.022105554,0.9660727],"study_design_scores_gemma":[0.0010482344,0.001223371,0.008506406,0.0027041724,0.00044448025,0.0033714601,0.000042848325,0.00022901081,0.009419726,0.0008182864,0.972169,0.000022878714],"about_ca_topic_score_codex":0.0043546367,"about_ca_topic_score_gemma":0.013624957,"teacher_disagreement_score":0.004865766,"about_ca_system_score_codex":0.0010558004,"about_ca_system_score_gemma":0.0009700935,"threshold_uncertainty_score":0.016277611},"labels":[],"label_agreement":null},{"id":"W4404073942","doi":"10.1038/s41525-024-00443-7","title":"Genomic variations associated with risk and protection against vincristine-induced peripheral neuropathy in pediatric cancer patients","year":2024,"lang":"en","type":"article","venue":"npj Genomic Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Children's Hospital of Eastern Ontario; Centre Hospitalier Universitaire Sainte-Justine; London Health Sciences Centre; Alberta Children's Hospital; Hospital for Sick Children; University of British Columbia; Stollery Children's Hospital; BC Children's Hospital; Health Sciences Centre","funders":"Canadian Institutes of Health Research; Health Canada; University of British Columbia; Centers for Disease Control and Prevention; Genome British Columbia; BC Children’s Hospital Foundation; Michael Smith Health Research BC; BC Children's Hospital; Provincial Health Services Authority; Genome Canada; International Association for the Study of Pain; Government of Canada; Children's Hospital Foundation; U.S. Department of Health and Human Services","keywords":"Peripheral neuropathy; Medicine; Vincristine; Cancer; Internal medicine; Oncology; Genetics; Bioinformatics; Chemotherapy; Biology; Endocrinology; Diabetes mellitus; Cyclophosphamide","score_opus":0.018750058743133857,"score_gpt":0.28043040614022746,"score_spread":0.2616803473970936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404073942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987729,0.00023091907,0.00012205388,0.00005280437,0.0000024282829,0.000005742247,0.00038700132,0.0000074787176,0.00041865496],"genre_scores_gemma":[0.9992411,0.00014323392,0.00018313907,0.000016996873,0.000004750152,0.000005255994,0.00030071073,0.0000039291685,0.00010083774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979764,0.00005094393,0.000020292291,0.0000616103,0.000038064885,0.000031495114],"domain_scores_gemma":[0.9994997,0.00018424679,0.00022182056,0.000022281545,0.000025761285,0.000046133046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016667297,0.0001816071,0.0002095084,0.0005604065,0.0002057944,0.0002369938,0.00016399629,0.0002935911,0.0021829884],"category_scores_gemma":[0.0011975898,0.0001300818,0.00022659311,0.0009835397,0.00019781642,0.00011415003,0.00014605979,0.00024687554,0.000118843935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000802245,0.000041096646,0.97542804,0.000052648193,0.0001624048,0.0016663296,0.00026076083,0.00048323363,0.0076393327,0.00018696708,0.00048129627,0.01279561],"study_design_scores_gemma":[0.00003103324,0.00012373172,0.99549234,0.000011835044,0.00008870351,0.0024214892,0.0000869152,0.00026979164,0.0007846362,0.00007788822,0.0006072246,0.000004335402],"about_ca_topic_score_codex":0.003900436,"about_ca_topic_score_gemma":0.003163957,"teacher_disagreement_score":0.003900436,"about_ca_system_score_codex":0.00021745836,"about_ca_system_score_gemma":0.00018344929,"threshold_uncertainty_score":0.0077554584},"labels":[],"label_agreement":null},{"id":"W4404183409","doi":"10.1136/jnnp-2024-abn.245","title":"Immune checkpoint inhibitor neurotoxicity clinic: a service evaluation","year":2024,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"","keywords":"Neurotoxicity; Service (business); Computer science; Medicine; Business; Toxicity; Internal medicine","score_opus":0.07210992567287473,"score_gpt":0.4148161720280177,"score_spread":0.34270624635514296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404183409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93621427,0.0021944884,0.0014262163,0.01142225,0.00039369127,0.0028569803,0.0031360113,0.00034938904,0.042006753],"genre_scores_gemma":[0.97072744,0.0021841084,0.0050054155,0.007011986,0.00055855745,0.000695433,0.0023977535,0.000115040915,0.01130427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908745,0.00012948363,0.000094653224,0.00010006587,0.0002992699,0.00028907205],"domain_scores_gemma":[0.9959608,0.00013370262,0.00031249205,0.000049399307,0.0008928299,0.002650795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056585815,0.00031618963,0.00030193993,0.0007086918,0.0023318145,0.0012401538,0.0008220334,0.0006701445,0.008028892],"category_scores_gemma":[0.0013096724,0.00025550215,0.0002874575,0.00086684996,0.0003858018,0.000580752,0.0015416419,0.0010742964,0.00197027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002230153,0.007906148,0.6291591,0.0006441598,0.00012032246,0.06036332,0.002865947,0.00089610484,0.009528204,0.0011825494,0.08150857,0.20359541],"study_design_scores_gemma":[0.0010611437,0.015922599,0.8202997,0.00049394864,0.00013069913,0.06514344,0.005341236,0.0032578828,0.0035868408,0.0007007857,0.083927765,0.00013391834],"about_ca_topic_score_codex":0.028288031,"about_ca_topic_score_gemma":0.06680288,"teacher_disagreement_score":0.028288031,"about_ca_system_score_codex":0.004480806,"about_ca_system_score_gemma":0.008118609,"threshold_uncertainty_score":0.056246758},"labels":[],"label_agreement":null},{"id":"W4404230732","doi":"10.1093/neuonc/noae165.0956","title":"EXTH-25. OPTIMIZATION OF NEW CHEMOTHERAPEUTIC AGENTS BY INTRA-ARTERIAL INFUSION IN GLIOBLASTOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Pharmacology; Chemotherapeutic drugs; Cancer research; Internal medicine; Chemotherapy","score_opus":0.025620880079863576,"score_gpt":0.3435177750892911,"score_spread":0.3178968950094275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98827654,0.005526322,0.0031922844,0.00021096822,0.00007642622,0.0002069582,0.00026642522,0.00013292143,0.0021111115],"genre_scores_gemma":[0.9908579,0.002933384,0.004051165,0.000085316235,0.0000216089,0.000116412244,0.00040520902,0.00002520217,0.0015037499],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991274,0.00001831045,0.000006683783,0.000015241109,0.000022570206,0.000024516625],"domain_scores_gemma":[0.9999573,0.0000042310794,0.000009808645,0.0000030459864,0.000006382388,0.000019164125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022545095,0.00033251615,0.00029390672,0.00035077802,0.000112548325,0.00037553345,0.00025951207,0.0001963258,0.00062802335],"category_scores_gemma":[0.00011175887,0.00013155436,0.00025336863,0.00019425168,0.00016091701,0.00015608857,0.000156987,0.00045324836,0.00020710024],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037807792,0.0017457423,0.0018483087,0.00028528087,0.00007575934,0.00038838174,0.00009815297,0.0046213125,0.8814023,0.0006210639,0.0014341219,0.10369881],"study_design_scores_gemma":[0.0008957039,0.03416529,0.013485064,0.000049292383,0.00022999392,0.0006813841,0.00008113799,0.010440235,0.92022717,0.00020593528,0.019485386,0.00005326444],"about_ca_topic_score_codex":0.002234324,"about_ca_topic_score_gemma":0.0044953804,"teacher_disagreement_score":0.002234324,"about_ca_system_score_codex":0.0004007029,"about_ca_system_score_gemma":0.00051162817,"threshold_uncertainty_score":0.004442692},"labels":[],"label_agreement":null},{"id":"W4404363416","doi":"10.1161/circ.150.suppl_1.4141117","title":"Abstract 4141117: Semaglutide and cardiovascular outcomes by blood pressure in the SELECT trial","year":2024,"lang":"en","type":"article","venue":"Circulation","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Semaglutide; Blood pressure; Cardiology; Internal medicine; Diabetes mellitus; Type 2 diabetes; Endocrinology; Liraglutide","score_opus":0.021216265972904984,"score_gpt":0.30678456023898193,"score_spread":0.28556829426607694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404363416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97383773,0.0161996,0.0005493083,0.0018476269,0.00055584963,0.00089429534,0.002535293,0.00012053212,0.0034597493],"genre_scores_gemma":[0.9841653,0.005261596,0.0008856105,0.0016915686,0.0008085125,0.0016196648,0.0022017045,0.000016216309,0.003349854],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99964345,0.00021293937,0.000031213393,0.00004142377,0.00003617358,0.00003469893],"domain_scores_gemma":[0.9995554,0.00014431227,0.00012744663,0.000021472006,0.000028237986,0.00012303864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010882408,0.000844006,0.0016246019,0.00025830668,0.00019175136,0.0007723855,0.00023486672,0.00076981215,0.004875404],"category_scores_gemma":[0.0010036692,0.00020252279,0.0011831045,0.00030643906,0.00040403655,0.0005220128,0.00024221091,0.0012326984,0.00040317414],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95737207,0.0011048615,0.0067886445,0.001902054,0.0020192764,0.00012445074,0.00005368086,0.0009003164,0.002647444,0.00039123028,0.004519431,0.022176582],"study_design_scores_gemma":[0.914517,0.05310382,0.02117658,0.00034541954,0.003650019,0.00017425991,0.00006564116,0.0016375756,0.0009536657,0.00075546355,0.0035911493,0.000029278144],"about_ca_topic_score_codex":0.0003500716,"about_ca_topic_score_gemma":0.0009037059,"teacher_disagreement_score":0.004875404,"about_ca_system_score_codex":0.00023490637,"about_ca_system_score_gemma":0.00042846712,"threshold_uncertainty_score":0.016309798},"labels":[],"label_agreement":null},{"id":"W4405047039","doi":"10.1182/blood-2024-210101","title":"Performance Status, Cancer-Associated Thrombosis, and Bleeding: A Post-Hoc Analysis of the Avert Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Performance status; Deep vein; Pulmonary embolism; Cancer; Confidence interval; Thrombosis; Surgery","score_opus":0.029107800812314795,"score_gpt":0.3362708158909196,"score_spread":0.30716301507860483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97260207,0.013600143,0.0025663264,0.0011563788,0.00081255985,0.0015808718,0.004723551,0.00011063841,0.0028474736],"genre_scores_gemma":[0.9882059,0.0017292097,0.0013585082,0.00055170857,0.00056994683,0.0023433876,0.003184148,0.000074562384,0.0019827841],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99300134,0.0051041353,0.00036424023,0.0006603371,0.00036858296,0.00050137634],"domain_scores_gemma":[0.9860926,0.010124049,0.0015551192,0.0010891424,0.0005482078,0.0005907959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013293219,0.001612087,0.0049687405,0.00043105357,0.00037381114,0.0016772938,0.0008633812,0.000965094,0.006427706],"category_scores_gemma":[0.016954795,0.00037792674,0.0067176386,0.00056052825,0.0006768862,0.0016855459,0.0009858969,0.0026372494,0.0006122905],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92984617,0.000946752,0.013228771,0.0023929651,0.03570915,0.00029423393,0.00011933676,0.0019073243,0.00071797,0.00049155415,0.0037203045,0.010625485],"study_design_scores_gemma":[0.596195,0.11614079,0.114971116,0.00082557416,0.13312556,0.0009645912,0.0004516828,0.018300265,0.0021652135,0.004873673,0.011700762,0.0002858135],"about_ca_topic_score_codex":0.0004688013,"about_ca_topic_score_gemma":0.00069446996,"teacher_disagreement_score":0.013293219,"about_ca_system_score_codex":0.00044047146,"about_ca_system_score_gemma":0.000943013,"threshold_uncertainty_score":0.07030213},"labels":[],"label_agreement":null},{"id":"W4405107591","doi":"10.3390/curroncol31120577","title":"Peripheral Neuropathy Instruments for Individuals with Cancer: A COSMIN-Based Systematic Review of Measurement Properties","year":2024,"lang":"en","type":"review","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Systematic review; Radiation therapy; Quality of life (healthcare); Cancer; Physical therapy; MEDLINE; Medical physics; Intensive care medicine; Oncology; Physical medicine and rehabilitation; Internal medicine","score_opus":0.36920949434097494,"score_gpt":0.4725893028435873,"score_spread":0.10337980850261236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405107591","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00073748274,0.99666166,0.0004114333,0.00031236888,0.0000881646,0.00064071204,0.00079546985,0.000012582814,0.00034008428],"genre_scores_gemma":[0.010502174,0.98471284,0.0020365082,0.00050623814,0.000047841495,0.0014893609,0.0005950812,0.000008404042,0.00010153692],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9842404,0.006191181,0.005671121,0.00086095673,0.002763639,0.00027267096],"domain_scores_gemma":[0.9329283,0.053711224,0.0074096187,0.0010008471,0.004661525,0.00028842408],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.023724422,0.0017193919,0.0071298624,0.012943188,0.00075422594,0.0028054602,0.0018353986,0.0015948246,0.004758202],"category_scores_gemma":[0.090081714,0.0008787969,0.010150461,0.013072095,0.0009583069,0.002513231,0.0025683665,0.0014345243,0.00038071093],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014219267,0.00001548059,0.0006341762,0.92420727,0.0062451367,0.000029977009,0.0001577894,0.00010772634,0.0000814921,0.00038358718,0.0014503472,0.06654486],"study_design_scores_gemma":[0.0002376456,0.00017894553,0.0045711733,0.92468953,0.047652196,0.00017508505,0.00022526542,0.000104587845,0.00012973635,0.0005466049,0.021448826,0.000040417803],"about_ca_topic_score_codex":0.0071610864,"about_ca_topic_score_gemma":0.023210503,"teacher_disagreement_score":0.99287015,"about_ca_system_score_codex":0.0042836783,"about_ca_system_score_gemma":0.014682027,"threshold_uncertainty_score":0.12546825},"labels":[],"label_agreement":null},{"id":"W4405133624","doi":"","title":"Rational treatment of chemotherapy-induced peripheral neuropathy with capsaicin 8% patch: from pain relief towards disease modification","year":2019,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Capsaicin; Peripheral neuropathy; Medicine; Pain relief; Peripheral; Disease; Chemotherapy-induced peripheral neuropathy; Chemotherapy; Anesthesia; Internal medicine; Endocrinology","score_opus":0.20080068029625364,"score_gpt":0.5229844981380706,"score_spread":0.32218381784181693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405133624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93584836,0.057163186,0.0021510914,0.0008980814,0.000092230446,0.0001765485,0.000054689357,0.00003986187,0.003575849],"genre_scores_gemma":[0.97754276,0.018658808,0.0021539037,0.00026595962,0.00009731977,0.00008930181,0.000095311996,0.0000045268794,0.0010921939],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99994624,0.000017063296,0.000004398017,0.0000060128214,0.000014519971,0.000011775217],"domain_scores_gemma":[0.99996746,0.0000078054745,0.00000954996,0.0000032166158,0.00000609949,0.0000058605497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001416821,0.00017451921,0.00030700283,0.00013309027,0.000084033774,0.00019917135,0.00015596539,0.00013659461,0.0007996815],"category_scores_gemma":[0.00017731315,0.00006837812,0.0001476542,0.00009319275,0.00013289943,0.00019572263,0.00012701239,0.00043364574,0.00017889265],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008480967,0.003156895,0.018353626,0.0011834903,0.0001361857,0.001456831,0.00026374718,0.0017962486,0.32456183,0.0008508336,0.0029270903,0.63683224],"study_design_scores_gemma":[0.012249481,0.19769312,0.38593906,0.0015610821,0.0011320029,0.029659102,0.0015051794,0.01938142,0.22121081,0.004150539,0.12531953,0.0001986672],"about_ca_topic_score_codex":0.00020896556,"about_ca_topic_score_gemma":0.00056555023,"teacher_disagreement_score":0.0007996815,"about_ca_system_score_codex":0.00009277371,"about_ca_system_score_gemma":0.0001448871,"threshold_uncertainty_score":0.0026752353},"labels":[],"label_agreement":null},{"id":"W4405182261","doi":"10.1158/1538-8514.cancerchem24-a019","title":"Abstract A019: Discovery of a potent and brain-penetrable tubulin inhibitor SB-216 that shows efficacy in primary tumor growth and brain metastasis","year":2024,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Taxane; Medicine; Brain metastasis; Prostate cancer; Cancer; Breast cancer; Cancer research; Metastasis; Ovarian cancer; Pharmacology; Metastatic breast cancer; Internal medicine","score_opus":0.024585093130380844,"score_gpt":0.3082285957801095,"score_spread":0.2836435026497287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405182261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95249325,0.018701289,0.0077087367,0.0007843678,0.00038755845,0.00037564727,0.0031360923,0.0007340097,0.015679099],"genre_scores_gemma":[0.9620807,0.011262041,0.008852546,0.00037232475,0.00009431861,0.000140699,0.00464664,0.00008519481,0.012465597],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995685,0.0000053274866,0.0000040633568,0.0000077088225,0.000014801568,0.00001126423],"domain_scores_gemma":[0.9999517,0.000003836845,0.0000073364995,0.0000026948296,0.000010843667,0.000023543858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009835689,0.00050837256,0.00032911598,0.00030949345,0.00017268464,0.00036002725,0.0002997209,0.00030785956,0.0020776156],"category_scores_gemma":[0.00008816157,0.00011548024,0.000294136,0.00021162552,0.000116507115,0.00010579233,0.00014192252,0.0005667965,0.0010099881],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004982449,0.00032771006,0.0004344153,0.00022361314,0.000036707086,0.0003510867,0.000018026854,0.0004041792,0.9775144,0.00029344883,0.0016668619,0.018231243],"study_design_scores_gemma":[0.00047299074,0.0051995805,0.0031723678,0.00003742134,0.00012379777,0.0014328515,0.000019871291,0.0021582153,0.9651088,0.00012768844,0.02212812,0.000018326014],"about_ca_topic_score_codex":0.0013117522,"about_ca_topic_score_gemma":0.001946392,"teacher_disagreement_score":0.0020776156,"about_ca_system_score_codex":0.00024490882,"about_ca_system_score_gemma":0.000366501,"threshold_uncertainty_score":0.006950319},"labels":[],"label_agreement":null},{"id":"W4405321781","doi":"10.30683/1927-7229.2024.13.09","title":"The Relief of Nociceptive Pain Induced by Panitumumab Could be Sustainable during Chemotherapy","year":2024,"lang":"en","type":"article","venue":"Journal of Analytical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Panitumumab; Colorectal cancer; Analgesic; Chemotherapy; Nociception; Epidermal growth factor receptor; Cancer; Cancer pain; Internal medicine; Oncology; Cetuximab; Pharmacology; Receptor","score_opus":0.021294008650601496,"score_gpt":0.3750127701912288,"score_spread":0.3537187615406273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405321781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945011,0.0023502912,0.0007259681,0.00006822086,0.000017508257,0.000039523213,0.000107841646,0.000022436947,0.0021670419],"genre_scores_gemma":[0.99884903,0.0005016637,0.00020065503,0.000037046266,0.000010088198,0.0000101189735,0.000074062256,0.0000024518342,0.00031477914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983084,0.00005045606,0.000023577659,0.000020904412,0.000041449555,0.00003272878],"domain_scores_gemma":[0.9991277,0.00024583162,0.00039855178,0.000067832436,0.000101350255,0.000058756235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002646594,0.00015609097,0.00026197243,0.00031996347,0.00016699605,0.00026348012,0.00011957406,0.00016240761,0.0011764645],"category_scores_gemma":[0.0019127459,0.00007042216,0.00019043965,0.00031584193,0.00018241095,0.00020135021,0.00016148036,0.00037893237,0.00012218997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006394458,0.00062625366,0.60401267,0.0008748681,0.00018173637,0.008331531,0.0005516419,0.0005705692,0.15645324,0.00041499242,0.00074678723,0.22084135],"study_design_scores_gemma":[0.00006263826,0.0045082825,0.95040756,0.000054486707,0.00012503297,0.01075509,0.00019073854,0.00054801104,0.029693805,0.00012308783,0.0035150475,0.00001617059],"about_ca_topic_score_codex":0.00042061732,"about_ca_topic_score_gemma":0.000772564,"teacher_disagreement_score":0.0011764645,"about_ca_system_score_codex":0.0002075284,"about_ca_system_score_gemma":0.00017537129,"threshold_uncertainty_score":0.0039356947},"labels":[],"label_agreement":null},{"id":"W4405736154","doi":"10.3390/jpm15010002","title":"Personalized Risk Assessment for Taxane-Induced Hypersensitivity Reactions: A Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Journal of Personalized Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Taxane; Risk assessment; Bioinformatics; Oncology; Intensive care medicine; Internal medicine; Computer science; Cancer; Biology; Computer security; Breast cancer","score_opus":0.20605221238580662,"score_gpt":0.4988666928121446,"score_spread":0.29281448042633795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405736154","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041284394,0.9922828,0.0016191851,0.0002990288,0.00016093931,0.00052256614,0.0006446271,0.000041435716,0.00030097144],"genre_scores_gemma":[0.21935523,0.76837444,0.006117744,0.0012722325,0.00042869188,0.002380794,0.0015602687,0.000061944964,0.0004486277],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9840899,0.009027032,0.0035560497,0.0013774323,0.0015563376,0.00039313015],"domain_scores_gemma":[0.9748915,0.01933375,0.003147258,0.00083601184,0.0015549499,0.00023651945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022511084,0.0035733194,0.017761188,0.0077239554,0.0006156801,0.0036395367,0.0023561285,0.0023542575,0.004594396],"category_scores_gemma":[0.0434362,0.0017241989,0.055678125,0.0068345373,0.00067519525,0.0021346714,0.0018240242,0.0024012087,0.00032788957],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001430259,0.00003009332,0.003304372,0.27603585,0.70535743,0.000095839416,0.00006994518,0.0010453799,0.00014440276,0.00016646115,0.00052613806,0.011793799],"study_design_scores_gemma":[0.0004310025,0.00014878756,0.0020174393,0.017623492,0.9779398,0.000073227595,0.00002745865,0.00032119456,0.00007513799,0.00026003015,0.0010609513,0.000021492688],"about_ca_topic_score_codex":0.0052001537,"about_ca_topic_score_gemma":0.00994672,"teacher_disagreement_score":0.022511084,"about_ca_system_score_codex":0.0028958665,"about_ca_system_score_gemma":0.004128846,"threshold_uncertainty_score":0.1190514},"labels":[],"label_agreement":null},{"id":"W4406416874","doi":"10.1016/s0246-1064(19)30188-4","title":"10.1016/s0246-1064(19)30188-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.011410983651304779,"score_gpt":0.24813887476696986,"score_spread":0.23672789111566508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406416874","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037140443,0.0005065919,0.0004947457,0.0003963644,0.0003637928,0.000100368314,0.0006945263,0.0006998747,0.99637234],"genre_scores_gemma":[0.00042766865,0.00018710937,0.0002459028,0.000162625,0.000066207125,0.000040940315,0.0002953108,0.00009673809,0.9984775],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993988,0.000034464883,0.00004776664,0.00021451624,0.00017899572,0.0001254542],"domain_scores_gemma":[0.99803466,0.0004438694,0.00013493815,0.00021485442,0.00042326047,0.0007483367],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0009980857,0.0025461973,0.0017315644,0.0025526236,0.0022744462,0.0037861136,0.0030921383,0.0055895858,0.9895858],"category_scores_gemma":[0.0015010216,0.00093141536,0.0016266311,0.0022939348,0.0018397219,0.0040712026,0.0029401137,0.0026665982,0.99221194],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004157177,0.00024674257,0.0006898109,0.0007007265,0.000040150357,0.00022593515,0.000088862784,0.0003683355,0.0023104053,0.005935564,0.34153754,0.6474402],"study_design_scores_gemma":[0.00004749262,0.00009921391,0.00056435313,0.00023865639,0.000010804736,0.00027052723,0.00006821552,0.00012993973,0.000328341,0.00043164697,0.9977937,0.000017045604],"about_ca_topic_score_codex":0.0035324693,"about_ca_topic_score_gemma":0.0030564114,"teacher_disagreement_score":0.010414183,"about_ca_system_score_codex":0.0011832775,"about_ca_system_score_gemma":0.0012565646,"threshold_uncertainty_score":0.01485455},"labels":[],"label_agreement":null},{"id":"W4406418012","doi":"10.1016/s0029-7437(05)71319-7","title":"10.1016/s0029-7437(05)71319-7","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Tamoxifen; Internal medicine; Medicine; Breast cancer; Cancer","score_opus":0.010925323716180007,"score_gpt":0.24643326244259203,"score_spread":0.235507938726412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406418012","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039467355,0.0005372909,0.0006095229,0.00040661354,0.0003547272,0.00009000955,0.0006255711,0.0007083976,0.9962733],"genre_scores_gemma":[0.0005079401,0.00020387875,0.00030303022,0.000159528,0.00008014935,0.00004727477,0.00036246635,0.00013362104,0.99820197],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99932873,0.000046297915,0.000053818807,0.00022145272,0.00019691997,0.0001527558],"domain_scores_gemma":[0.99738485,0.0006736158,0.00018288585,0.00026602225,0.0005562323,0.00093647116],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012295143,0.0028629508,0.0022095332,0.0031719499,0.0027400558,0.0045435424,0.0036447726,0.0063756364,0.9881578],"category_scores_gemma":[0.0019043123,0.0010425146,0.0017303037,0.0027613214,0.0023302475,0.00488408,0.003279563,0.003181726,0.9923092],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037902867,0.00025452924,0.00075975596,0.0007177848,0.000044939334,0.0002591163,0.00010797301,0.00044567356,0.0025464736,0.007238468,0.3276784,0.65956783],"study_design_scores_gemma":[0.000052955962,0.00012871252,0.0007685357,0.00033050324,0.000013311331,0.0003088595,0.000099795194,0.00019649575,0.0004022836,0.0006854351,0.9969914,0.000021782344],"about_ca_topic_score_codex":0.0038987338,"about_ca_topic_score_gemma":0.0031106507,"teacher_disagreement_score":0.011842191,"about_ca_system_score_codex":0.0013124283,"about_ca_system_score_gemma":0.0016685979,"threshold_uncertainty_score":0.01689142},"labels":[],"label_agreement":null},{"id":"W4406423789","doi":"10.1016/s1541-9800(06)71089-4","title":"10.1016/s1541-9800(06)71089-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Course (navigation); Engineering","score_opus":0.008990203248631074,"score_gpt":0.2357868402439816,"score_spread":0.22679663699535055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406423789","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004107775,0.00052439445,0.00053726754,0.00050125574,0.00035978106,0.00009543728,0.0006854431,0.00079022336,0.9960955],"genre_scores_gemma":[0.00046247977,0.00019872787,0.00029849773,0.00021041774,0.000075190575,0.000042397438,0.00035406876,0.000114535214,0.9982437],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994186,0.00003806091,0.000047916597,0.00018782339,0.00017629757,0.00013133763],"domain_scores_gemma":[0.9979126,0.0004702909,0.00014302766,0.0002050929,0.0004644179,0.0008045725],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00096996035,0.002491842,0.0016300768,0.0023335868,0.0021982766,0.0034785,0.002752754,0.0053971927,0.98798686],"category_scores_gemma":[0.0015709866,0.00081641006,0.0014588722,0.0018779301,0.001437724,0.0041524107,0.002899392,0.0026880878,0.9920889],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036004325,0.00023112161,0.00072041247,0.0005197004,0.00003210396,0.00021323418,0.00007384209,0.00032506112,0.0020329596,0.004222812,0.33952373,0.6517451],"study_design_scores_gemma":[0.000054387292,0.00011163687,0.00073084305,0.0002504974,0.00001165536,0.00031706964,0.00007650201,0.00013642732,0.00037781903,0.0004766645,0.9974377,0.00001871215],"about_ca_topic_score_codex":0.0033248477,"about_ca_topic_score_gemma":0.0030457347,"teacher_disagreement_score":0.012013137,"about_ca_system_score_codex":0.0010416231,"about_ca_system_score_gemma":0.0012493214,"threshold_uncertainty_score":0.017135262},"labels":[],"label_agreement":null},{"id":"W4406498593","doi":"10.1016/s0000-0000(06)47810-4","title":"10.1016/s0000-0000(06)47810-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Lamotrigine; Medicine; Epilepsy; Psychiatry","score_opus":0.008663809262238148,"score_gpt":0.23338828864041833,"score_spread":0.2247244793781802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406498593","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00063550967,0.0004884393,0.00047995456,0.00095245714,0.00042535688,0.00013581105,0.00084747106,0.0008591126,0.99517596],"genre_scores_gemma":[0.00087637844,0.00013915992,0.00034582624,0.00029685185,0.00008841183,0.00005815234,0.00041091113,0.00014483873,0.99763954],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999373,0.000054898006,0.000049161048,0.00017241616,0.0001630502,0.00018740956],"domain_scores_gemma":[0.99713576,0.0005194831,0.00020177895,0.00024046269,0.0005246626,0.001377726],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001083531,0.0018106118,0.001381774,0.0022034906,0.0017907575,0.0025313026,0.0022663353,0.00491692,0.9871454],"category_scores_gemma":[0.0020956926,0.00067068887,0.001150569,0.0015741707,0.001529216,0.002784528,0.0032207202,0.0020347724,0.99109674],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003684083,0.00023709067,0.00141947,0.00036123133,0.000025958869,0.00022552791,0.000080789534,0.0003057141,0.0012275745,0.003671285,0.33020586,0.66187114],"study_design_scores_gemma":[0.000066842535,0.00013543938,0.0013735966,0.00032586348,0.00000946346,0.00040536677,0.000085517706,0.00020051684,0.00025528533,0.0006281489,0.99649554,0.000018412331],"about_ca_topic_score_codex":0.002552659,"about_ca_topic_score_gemma":0.0026061523,"teacher_disagreement_score":0.012854576,"about_ca_system_score_codex":0.0011531118,"about_ca_system_score_gemma":0.0011991479,"threshold_uncertainty_score":0.018335402},"labels":[],"label_agreement":null},{"id":"W4406521498","doi":"10.1016/s0029-7437(06)71491-4","title":"10.1016/s0029-7437(06)71491-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Disease; Breast cancer; Medicine; Oncology; Metastatic breast cancer; Internal medicine; Cancer","score_opus":0.01081559120924108,"score_gpt":0.2459003852081964,"score_spread":0.23508479399895532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406521498","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003784894,0.00054046774,0.0006144761,0.00040025314,0.0003353582,0.00008956058,0.0006652659,0.00070980104,0.9962663],"genre_scores_gemma":[0.00049968367,0.0002119658,0.00031159748,0.00015597812,0.000077107405,0.000047828107,0.0003773323,0.00013936088,0.9981792],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99935025,0.000045814966,0.000050495382,0.00021603673,0.00019064518,0.00014674568],"domain_scores_gemma":[0.9975151,0.0006370939,0.00017515883,0.00025808802,0.00052525906,0.00088935514],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012089014,0.002924954,0.0022438318,0.0030480393,0.002647972,0.004571926,0.0036314998,0.006063275,0.98865056],"category_scores_gemma":[0.0018348125,0.0010576255,0.0017447976,0.0027789513,0.0023342206,0.0049125776,0.0031883765,0.003244606,0.9927791],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035748107,0.00023849079,0.000730368,0.0007245702,0.00004518624,0.00023835388,0.000105070874,0.00046061582,0.002359706,0.0068829474,0.32467443,0.6631828],"study_design_scores_gemma":[0.000051058643,0.00012176285,0.00072302454,0.0003289134,0.000013414118,0.00030400028,0.000097747994,0.0001925414,0.0003942097,0.000641879,0.99711007,0.000021434065],"about_ca_topic_score_codex":0.00400423,"about_ca_topic_score_gemma":0.003150921,"teacher_disagreement_score":0.01134944,"about_ca_system_score_codex":0.0013122526,"about_ca_system_score_gemma":0.0016103949,"threshold_uncertainty_score":0.016188502},"labels":[],"label_agreement":null},{"id":"W4406525024","doi":"10.1016/s0024-7804(97)85041-5","title":"10.1016/s0024-7804(97)85041-5","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.010604451534358317,"score_gpt":0.23589752661216534,"score_spread":0.22529307507780702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406525024","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00043750834,0.0005950555,0.00065079035,0.00037391178,0.00040449982,0.00012397546,0.0007277123,0.0008356616,0.9958509],"genre_scores_gemma":[0.00045383672,0.00025525884,0.00030689305,0.00017316653,0.0000979543,0.000071310315,0.00037405503,0.00015499572,0.99811256],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991906,0.00005258288,0.00006450089,0.0002962938,0.00020880082,0.00018716123],"domain_scores_gemma":[0.9971028,0.00078755204,0.0001963815,0.00028754547,0.00058821676,0.0010374808],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013999376,0.003992868,0.0030207224,0.0036565964,0.0029803724,0.0051299483,0.0048608948,0.007262764,0.9891915],"category_scores_gemma":[0.0019553942,0.0012847161,0.002206153,0.003427719,0.0027898387,0.005686624,0.0037455915,0.0035124577,0.99333787],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054407545,0.0002676852,0.00072424626,0.0009918711,0.00006387301,0.00033179938,0.00012623372,0.0005375337,0.002719311,0.006184975,0.35000983,0.63749856],"study_design_scores_gemma":[0.0000841743,0.00018700086,0.0007738779,0.000442052,0.00002104488,0.00037466214,0.00012171801,0.00024570062,0.0004427397,0.0006527052,0.99662304,0.000031210235],"about_ca_topic_score_codex":0.004152975,"about_ca_topic_score_gemma":0.0031949636,"teacher_disagreement_score":0.0108085275,"about_ca_system_score_codex":0.001536092,"about_ca_system_score_gemma":0.0015022347,"threshold_uncertainty_score":0.015417039},"labels":[],"label_agreement":null},{"id":"W4406543571","doi":"10.1016/s0024-7804(98)80004-3","title":"10.1016/s0024-7804(98)80004-3","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacology; Medicine","score_opus":0.008528636096497767,"score_gpt":0.23167398840472175,"score_spread":0.223145352308224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406543571","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042420303,0.000560871,0.00062733394,0.00038267561,0.00041790525,0.00012773121,0.00065035117,0.0008371678,0.99597174],"genre_scores_gemma":[0.00041745263,0.00023509147,0.00030366256,0.00017431706,0.000101746424,0.000070129645,0.00030755336,0.00015021925,0.9982399],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991843,0.000054334334,0.00006724763,0.00030285123,0.00021288176,0.00017837115],"domain_scores_gemma":[0.9968773,0.000870469,0.00021080999,0.00029830443,0.00064371293,0.0010993822],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001447131,0.004003437,0.003007631,0.003802476,0.0031909917,0.005055852,0.0047318195,0.0078035546,0.98951054],"category_scores_gemma":[0.0021618856,0.0013480958,0.0022762269,0.0033225936,0.0028951797,0.0057899333,0.003732323,0.0037079505,0.9934598],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056826416,0.00029189631,0.00075419387,0.001016756,0.000063399464,0.00035820837,0.00013250431,0.0005255447,0.0027688674,0.0061167027,0.36946762,0.6179361],"study_design_scores_gemma":[0.000083101215,0.0001823415,0.00069345225,0.00041601362,0.00001924598,0.00036509553,0.00011526651,0.00023189186,0.00039334546,0.000587011,0.9968839,0.000029340066],"about_ca_topic_score_codex":0.0040824474,"about_ca_topic_score_gemma":0.0031157606,"teacher_disagreement_score":0.010489464,"about_ca_system_score_codex":0.0014937068,"about_ca_system_score_gemma":0.0014297413,"threshold_uncertainty_score":0.014961839},"labels":[],"label_agreement":null},{"id":"W4406544302","doi":"10.1016/s1553-3212(12)70130-9","title":"10.1016/s1553-3212(12)70130-9","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Drug; Dermatology; Psychiatry","score_opus":0.009539171293836832,"score_gpt":0.23262179708815348,"score_spread":0.22308262579431665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406544302","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035662443,0.0004950284,0.00050311035,0.00039757797,0.00030217608,0.00009365898,0.0007332337,0.00078901957,0.9963296],"genre_scores_gemma":[0.0004583874,0.00023506705,0.00029281338,0.00022720534,0.000083566796,0.000053705644,0.00038431672,0.00012399975,0.99814093],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993549,0.00003822253,0.00005659341,0.00022011662,0.0001915617,0.0001386074],"domain_scores_gemma":[0.9978707,0.00051835505,0.00015123712,0.00022876276,0.00037940525,0.0008516943],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011381333,0.0031876748,0.0020614453,0.0029492793,0.0026441303,0.004088008,0.0033783268,0.006787167,0.98903185],"category_scores_gemma":[0.0016895449,0.001073631,0.0017617767,0.0022445044,0.0020087613,0.005174649,0.0038575453,0.00315874,0.99324083],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046712087,0.00028416156,0.0006998192,0.00068798126,0.000037591406,0.0002507313,0.00008919826,0.00048319696,0.002071276,0.00514478,0.38307127,0.6067129],"study_design_scores_gemma":[0.00007495231,0.000136623,0.00075428624,0.00032409624,0.000013858729,0.00034279673,0.00009090012,0.00017858553,0.00037197955,0.00060434814,0.9970829,0.000024652592],"about_ca_topic_score_codex":0.0040547345,"about_ca_topic_score_gemma":0.0036325888,"teacher_disagreement_score":0.010968149,"about_ca_system_score_codex":0.0012719186,"about_ca_system_score_gemma":0.001385819,"threshold_uncertainty_score":0.01564473},"labels":[],"label_agreement":null},{"id":"W4406550127","doi":"10.1016/s1541-9800(05)70334-3","title":"10.1016/s1541-9800(05)70334-3","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Sciatica; Medicine; Radiology","score_opus":0.009126257941548064,"score_gpt":0.23611929952766114,"score_spread":0.22699304158611308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406550127","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00043607925,0.00052872504,0.0005509035,0.00048146062,0.00035328788,0.00009680771,0.0006475815,0.00074904144,0.99615616],"genre_scores_gemma":[0.00046085648,0.00020839307,0.00028721325,0.00019807914,0.0000746279,0.000041747593,0.00032676733,0.00010769788,0.99829465],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994172,0.000035513513,0.00004582127,0.00019575268,0.00017299992,0.00013271019],"domain_scores_gemma":[0.99788445,0.00050096685,0.00014122193,0.00019980546,0.00047197824,0.0008015148],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00094196055,0.002645388,0.0016523406,0.0024869177,0.002270432,0.0034996017,0.0028016716,0.005729361,0.9879275],"category_scores_gemma":[0.0015075943,0.00082298607,0.0015107536,0.002037527,0.0014681875,0.0042443774,0.0028386686,0.0026746793,0.99148995],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039285756,0.00025804617,0.00071920216,0.0005436048,0.000033465756,0.0002319506,0.000080023725,0.00035752595,0.0022470301,0.004306099,0.32368007,0.66715014],"study_design_scores_gemma":[0.000059545706,0.00012990074,0.00079421164,0.0002719778,0.000013710186,0.000336656,0.000085318716,0.00016017929,0.00043284762,0.0005034333,0.9971917,0.000020491416],"about_ca_topic_score_codex":0.0035781716,"about_ca_topic_score_gemma":0.0032652232,"teacher_disagreement_score":0.012072504,"about_ca_system_score_codex":0.0010816576,"about_ca_system_score_gemma":0.001254199,"threshold_uncertainty_score":0.01721996},"labels":[],"label_agreement":null},{"id":"W4406550251","doi":"10.1016/s1541-9800(05)70073-9","title":"10.1016/s1541-9800(05)70073-9","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Computer science; Psychology; Medicine; Physical medicine and rehabilitation","score_opus":0.009141083813437286,"score_gpt":0.23713004757284734,"score_spread":0.22798896375941005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406550251","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004911393,0.00056759105,0.00057263876,0.00048662873,0.00038938932,0.00011326505,0.00066443096,0.0007869436,0.9959279],"genre_scores_gemma":[0.0004631311,0.0002103882,0.00030367984,0.0002086182,0.000077813056,0.00004996605,0.00033933905,0.00011014122,0.9982368],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99935776,0.000038826183,0.00005216738,0.00022361557,0.00017473423,0.00015284185],"domain_scores_gemma":[0.99789196,0.00048348773,0.0001385758,0.00019217741,0.00044253338,0.0008513256],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010376594,0.0029925045,0.0018538816,0.002624612,0.0025753423,0.0035924707,0.0030359265,0.006465891,0.98847616],"category_scores_gemma":[0.0015695258,0.0009285193,0.001597853,0.0020630744,0.0016775995,0.0045300983,0.0030402883,0.002818608,0.9917698],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047919163,0.00031094908,0.0008081683,0.00063432346,0.0000380191,0.00028954746,0.000096698655,0.0003760911,0.0025392317,0.0044875722,0.32483786,0.6651024],"study_design_scores_gemma":[0.00007091358,0.00015802021,0.0008558556,0.00031305195,0.000015408279,0.00041086727,0.00010526405,0.00017427937,0.0004618419,0.00054692494,0.9968645,0.00002304907],"about_ca_topic_score_codex":0.0036092522,"about_ca_topic_score_gemma":0.0033214665,"teacher_disagreement_score":0.011523843,"about_ca_system_score_codex":0.0011289374,"about_ca_system_score_gemma":0.0012925139,"threshold_uncertainty_score":0.016437292},"labels":[],"label_agreement":null},{"id":"W4406552357","doi":"10.1016/s1553-3212(07)70199-1","title":"10.1016/s1553-3212(07)70199-1","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Drug; Medicine; Physical medicine and rehabilitation; Pharmacology","score_opus":0.008980656897264317,"score_gpt":0.23650032082382352,"score_spread":0.2275196639265592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406552357","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034623517,0.00037060687,0.0004098445,0.0004338982,0.0002718922,0.000096267686,0.0006447519,0.0006494566,0.9967771],"genre_scores_gemma":[0.00040929372,0.00018265129,0.00024479046,0.00023592198,0.0000665776,0.000052767315,0.00034177265,0.00011246501,0.99835384],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993461,0.000042006814,0.000054399028,0.00022484425,0.00018950332,0.00014312402],"domain_scores_gemma":[0.9978551,0.0004970013,0.00013973303,0.00021068055,0.00043313313,0.0008642413],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011191203,0.0027903416,0.0018991468,0.0028405357,0.0027484216,0.004177165,0.0031452465,0.0067486614,0.98991114],"category_scores_gemma":[0.0018364192,0.0009663251,0.001516805,0.0022661574,0.0018509096,0.005199777,0.0034003349,0.0027397706,0.9931999],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040291518,0.00026060845,0.0008104298,0.0005461691,0.000033037293,0.00023231686,0.000091444475,0.0004438653,0.0016708447,0.004939755,0.4189268,0.5716418],"study_design_scores_gemma":[0.000061515646,0.00011811979,0.0007150897,0.00030146178,0.0000120684335,0.0002854515,0.00009924038,0.00017721161,0.00027869918,0.00055925694,0.99737096,0.000020901778],"about_ca_topic_score_codex":0.004790966,"about_ca_topic_score_gemma":0.0042404593,"teacher_disagreement_score":0.010088861,"about_ca_system_score_codex":0.0013859688,"about_ca_system_score_gemma":0.0015534806,"threshold_uncertainty_score":0.014390528},"labels":[],"label_agreement":null},{"id":"W4406554405","doi":"10.1016/s1558-0164(12)70179-7","title":"10.1016/s1558-0164(12)70179-7","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Intensive care medicine","score_opus":0.009783646173913746,"score_gpt":0.23374823914299583,"score_spread":0.22396459296908208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406554405","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033821492,0.00045986762,0.0005165968,0.0004131174,0.000345375,0.000085978594,0.0006131048,0.0007503414,0.99647754],"genre_scores_gemma":[0.0004206061,0.00018689147,0.00024757397,0.00017806595,0.00008215869,0.00003696686,0.00032103446,0.000107165855,0.99841964],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993369,0.00004035591,0.00005340969,0.0002253561,0.00019902198,0.00014496372],"domain_scores_gemma":[0.99780136,0.0004967054,0.00016006612,0.00023049962,0.00042218767,0.00088917615],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011111605,0.0027922755,0.0018085912,0.0027408912,0.0024739278,0.0040673264,0.0030602582,0.0061106756,0.98890346],"category_scores_gemma":[0.00168908,0.00095244264,0.0015885003,0.002094833,0.0017688207,0.0048417225,0.003527422,0.0026872912,0.99266386],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041736462,0.0002517435,0.00071032374,0.0005715878,0.000036275254,0.00023948909,0.00008717663,0.00040155672,0.0020741972,0.0052891723,0.36306304,0.62685806],"study_design_scores_gemma":[0.00005833813,0.000117226955,0.0006153164,0.00025426332,0.00001239148,0.0003069872,0.00008145887,0.00014767086,0.00035985134,0.00056549074,0.9974613,0.000019647845],"about_ca_topic_score_codex":0.003212379,"about_ca_topic_score_gemma":0.003084371,"teacher_disagreement_score":0.011096537,"about_ca_system_score_codex":0.0011426051,"about_ca_system_score_gemma":0.0013597666,"threshold_uncertainty_score":0.015827835},"labels":[],"label_agreement":null},{"id":"W4406617687","doi":"10.2147/jpr.s500717","title":"Efficacy of Transcutaneous Electrical Acupoint Stimulation on Modulating Upper Extremity Sympathetic Skin Response in Alleviating Cancer Survivors With Chemotherapy-Induced Peripheral Neuropathy: A Propensity Score-Matched Cohort Study","year":2025,"lang":"en","type":"article","venue":"Journal of Pain Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Medicine; Peripheral; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Propensity score matching; Chemotherapy; Cohort; Stimulation; Internal medicine; Oncology; Anesthesia; Diabetes mellitus; Endocrinology","score_opus":0.06804553324391915,"score_gpt":0.40178361071503055,"score_spread":0.3337380774711114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406617687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993789,0.00022464759,0.00015972873,0.000014452525,0.000007227665,0.000018986619,0.00008747523,0.0000014376661,0.0001071257],"genre_scores_gemma":[0.9996512,0.0000727358,0.00005798174,0.000014859449,0.0000093346125,0.000012651211,0.00011066457,7.314125e-7,0.000069995236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955183,0.00011878009,0.00006100506,0.00012762545,0.000078744,0.000061975916],"domain_scores_gemma":[0.9993131,0.00009017877,0.00034009558,0.00010898434,0.00006500607,0.000082629595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007997634,0.00022364441,0.00032203097,0.0003258947,0.00035775235,0.00032366352,0.0001900781,0.00029364706,0.0010521249],"category_scores_gemma":[0.0016483795,0.00015353282,0.0007674178,0.0006357345,0.0001654804,0.00024108424,0.00023996219,0.00030427313,0.00013284595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021281962,0.00019286288,0.99178433,0.000029899531,0.00049254805,0.00008640666,0.000049143622,0.00011892661,0.0005562747,0.000034084387,0.00011025936,0.0044169007],"study_design_scores_gemma":[0.00016229785,0.0018855252,0.99545825,0.000009214119,0.00047466828,0.00026373303,0.00007833839,0.0010040035,0.00020197213,0.000056232333,0.00039804995,0.000007757438],"about_ca_topic_score_codex":0.00075786,"about_ca_topic_score_gemma":0.0009750563,"teacher_disagreement_score":0.0010521249,"about_ca_system_score_codex":0.00018009478,"about_ca_system_score_gemma":0.00027651672,"threshold_uncertainty_score":0.004229605},"labels":[],"label_agreement":null},{"id":"W4406643018","doi":"10.1016/b978-2-294-76306-9.50419-1","title":"10.1016/b978-2-294-76306-9.50419-1","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.014027716722857589,"score_gpt":0.23121214584389738,"score_spread":0.2171844291210398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406643018","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013845022,0.00043433937,0.0005872788,0.00024706358,0.0001409053,0.000035663496,0.00046543826,0.0006768668,0.997274],"genre_scores_gemma":[0.0003785518,0.00026324386,0.00030202736,0.00010099443,0.000027616712,0.00002532266,0.00029319708,0.00016616394,0.99844295],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996468,0.000021235855,0.0000197637,0.00012192208,0.00012773425,0.0000625573],"domain_scores_gemma":[0.9988493,0.0003628033,0.00007697997,0.00014078173,0.00021924076,0.0003509781],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006870018,0.0018735594,0.0011942487,0.0015977877,0.0013198026,0.0040951967,0.002238625,0.0035408696,0.9788463],"category_scores_gemma":[0.0014516445,0.0006997365,0.000710879,0.0017076251,0.0009983549,0.004001914,0.0030019372,0.0020350164,0.9885289],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011335085,0.00010184182,0.00028484067,0.00037668739,0.000011875471,0.000107084925,0.00007705913,0.00027838087,0.0017753587,0.0065678973,0.40000147,0.59030414],"study_design_scores_gemma":[0.000011340717,0.000031396146,0.00035644064,0.0002353335,0.0000049901223,0.00014693267,0.00005745998,0.00008417459,0.00020664308,0.0009955144,0.99786097,0.000008952152],"about_ca_topic_score_codex":0.002753216,"about_ca_topic_score_gemma":0.0029164252,"teacher_disagreement_score":0.021153688,"about_ca_system_score_codex":0.00085784635,"about_ca_system_score_gemma":0.00075118284,"threshold_uncertainty_score":0.030173063},"labels":[],"label_agreement":null},{"id":"W4406643172","doi":"10.1016/b978-2-294-76306-9.50324-0","title":"10.1016/b978-2-294-76306-9.50324-0","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medical prescription; Medicine; Pharmacology","score_opus":0.014062326421774917,"score_gpt":0.23135419043262012,"score_spread":0.21729186401084521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406643172","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013577566,0.00038607686,0.00061345904,0.00023851379,0.0001376245,0.00003606264,0.000413531,0.00067123637,0.9973677],"genre_scores_gemma":[0.0003639007,0.0002515134,0.00030480212,0.00010236089,0.000027873431,0.000024918689,0.00027093373,0.00016192503,0.99849176],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996513,0.00002067809,0.000019975716,0.00011797115,0.00012966794,0.00006040013],"domain_scores_gemma":[0.99873537,0.00039435792,0.00007772774,0.00016231058,0.00024257382,0.00038764632],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007086414,0.0018513703,0.0011558639,0.0016345294,0.0012659493,0.0042271316,0.0021836867,0.0035570748,0.9793992],"category_scores_gemma":[0.0015088214,0.0007034276,0.000747486,0.0017475204,0.001011738,0.0039516105,0.003036979,0.0019848165,0.9885633],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011101804,0.000103844686,0.00029331076,0.00036259394,0.00001218657,0.000105210864,0.00007523844,0.00028692954,0.0017475287,0.006332759,0.39983007,0.5907393],"study_design_scores_gemma":[0.000011599329,0.00003173529,0.00036382786,0.00022656228,0.000005019524,0.0001427393,0.000057637033,0.00008738336,0.00019675588,0.00093328196,0.99793434,0.000009215244],"about_ca_topic_score_codex":0.002889081,"about_ca_topic_score_gemma":0.0029189747,"teacher_disagreement_score":0.020600796,"about_ca_system_score_codex":0.00083257636,"about_ca_system_score_gemma":0.00075451104,"threshold_uncertainty_score":0.029384434},"labels":[],"label_agreement":null},{"id":"W4406643442","doi":"10.1016/b978-2-294-76306-9.50119-8","title":"10.1016/b978-2-294-76306-9.50119-8","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Geology","score_opus":0.014342846896414128,"score_gpt":0.23102920739712393,"score_spread":0.2166863605007098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406643442","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014572102,0.0004448622,0.00059544644,0.0002187936,0.00014072175,0.000037711903,0.000498871,0.0007177949,0.9972],"genre_scores_gemma":[0.00037245153,0.00023787344,0.00026988366,0.00009306503,0.000026138257,0.000024738332,0.00030353994,0.0001567077,0.99851555],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996394,0.000020856904,0.00002012637,0.00012567877,0.00012849375,0.00006548083],"domain_scores_gemma":[0.99885523,0.00035679305,0.00007492388,0.00015204975,0.00020818463,0.00035290743],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00067948626,0.0020123904,0.0012102304,0.0016047995,0.0013547608,0.0041817776,0.0023738672,0.0037271173,0.9799778],"category_scores_gemma":[0.0013435436,0.0007940514,0.00077133544,0.0017093299,0.0010987567,0.0039854413,0.0031421024,0.002079008,0.9894225],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013108824,0.000113306414,0.0002960713,0.00042921104,0.000013845881,0.00011846235,0.00008098563,0.0002933616,0.0020628977,0.006399106,0.38988274,0.60017896],"study_design_scores_gemma":[0.000014049383,0.00003756688,0.00037810896,0.00024566773,0.00000558393,0.00016055467,0.0000620384,0.00008675312,0.00025681435,0.0010350625,0.9977077,0.000010061902],"about_ca_topic_score_codex":0.0026637982,"about_ca_topic_score_gemma":0.0029277338,"teacher_disagreement_score":0.020022213,"about_ca_system_score_codex":0.00084545807,"about_ca_system_score_gemma":0.0007298764,"threshold_uncertainty_score":0.028559268},"labels":[],"label_agreement":null},{"id":"W4406648659","doi":"10.1016/b978-2-294-76306-9.50759-6","title":"10.1016/b978-2-294-76306-9.50759-6","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.014016383764465961,"score_gpt":0.23127365897618693,"score_spread":0.21725727521172097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406648659","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015607374,0.00052904314,0.0006618519,0.00025886836,0.00015707254,0.00003855823,0.0005443583,0.00076336466,0.99689084],"genre_scores_gemma":[0.00041970293,0.00028497181,0.0003141792,0.000103469836,0.000029591136,0.000026437865,0.00032632102,0.00017506279,0.99832016],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99962723,0.00002184339,0.00002206225,0.00012876562,0.00013257463,0.000067470064],"domain_scores_gemma":[0.9987802,0.000390655,0.00008738074,0.00015139156,0.00022488157,0.0003654056],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007257713,0.0020269337,0.0012458024,0.0016452473,0.001309067,0.004192872,0.0023504267,0.0036481267,0.9789979],"category_scores_gemma":[0.0014043393,0.0007442949,0.00077398284,0.0017425765,0.0010606823,0.004098434,0.003186007,0.002114552,0.98899233],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012804217,0.00011197279,0.00030367717,0.00042488507,0.000014504285,0.00011592626,0.000077150005,0.00030466632,0.002081838,0.0063465834,0.37393156,0.6161592],"study_design_scores_gemma":[0.00001356205,0.000036699937,0.00038860837,0.00025819897,0.0000059297163,0.00016735235,0.00006116128,0.00009239907,0.00026539853,0.001049603,0.9976508,0.000010381501],"about_ca_topic_score_codex":0.0026302526,"about_ca_topic_score_gemma":0.0027854312,"teacher_disagreement_score":0.021002114,"about_ca_system_score_codex":0.0008419689,"about_ca_system_score_gemma":0.0007512158,"threshold_uncertainty_score":0.029956996},"labels":[],"label_agreement":null},{"id":"W4406649148","doi":"10.1016/b978-2-294-73068-9.00531-4","title":"10.1016/b978-2-294-73068-9.00531-4","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"History","score_opus":0.013911229146785475,"score_gpt":0.2312093027820703,"score_spread":0.21729807363528483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406649148","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016144384,0.00059378135,0.0007306885,0.00030199008,0.00016403453,0.000035257715,0.0006039338,0.00077483134,0.99663407],"genre_scores_gemma":[0.0004362266,0.00031345492,0.00035673095,0.00010793238,0.000032787364,0.000025502753,0.0003586212,0.0001837554,0.99818486],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996723,0.000019075218,0.000020075426,0.000110957844,0.00012147209,0.000056241155],"domain_scores_gemma":[0.9988445,0.00038012446,0.000083079285,0.00015004429,0.0002132913,0.00032896685],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006991882,0.0018711559,0.0011611101,0.0015768807,0.0012101613,0.0040882947,0.0022962138,0.0035709639,0.9758163],"category_scores_gemma":[0.0013504929,0.0007001544,0.00074430945,0.0017352096,0.0010272753,0.0040400783,0.0029512614,0.0021337636,0.9873498],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012420764,0.00010141807,0.00030202832,0.00039699968,0.000013916004,0.00011103745,0.000073568495,0.00029477224,0.0020356206,0.007068859,0.38297385,0.60650367],"study_design_scores_gemma":[0.0000134487145,0.000032148335,0.00039270194,0.00023436495,0.000005571916,0.00017035281,0.00005528057,0.00008680738,0.0002788309,0.0011655188,0.9975551,0.00000988089],"about_ca_topic_score_codex":0.0025389679,"about_ca_topic_score_gemma":0.0026887269,"teacher_disagreement_score":0.02418369,"about_ca_system_score_codex":0.00082270696,"about_ca_system_score_gemma":0.0007206447,"threshold_uncertainty_score":0.034495115},"labels":[],"label_agreement":null},{"id":"W4406650615","doi":"10.1016/b978-2-294-73068-9.00496-5","title":"10.1016/b978-2-294-73068-9.00496-5","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.013893331216032888,"score_gpt":0.23111898853512058,"score_spread":0.2172256573190877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406650615","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016414569,0.0005835827,0.00078313274,0.00030226048,0.00017307342,0.000037279984,0.0006152427,0.0007970124,0.9965442],"genre_scores_gemma":[0.00044973422,0.00031996457,0.00037986354,0.00011263918,0.0000356664,0.000026257154,0.00037376283,0.0001940972,0.9981079],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996567,0.00002012549,0.000020741205,0.00011611422,0.00012743182,0.000058912326],"domain_scores_gemma":[0.99875295,0.00040845427,0.000087392684,0.00016398245,0.00022867805,0.00035850785],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00073296594,0.0018818355,0.0011873817,0.0015760837,0.001183778,0.0041925213,0.0022945374,0.003553444,0.97611827],"category_scores_gemma":[0.001376433,0.00069598586,0.0007698063,0.0017236393,0.0010388374,0.0040878328,0.0030671137,0.0021817787,0.9874742],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012976096,0.00010773999,0.0003081257,0.0003943766,0.000014516836,0.00011394173,0.000071962,0.00029933982,0.0021393711,0.00687726,0.38104534,0.60849833],"study_design_scores_gemma":[0.000014018073,0.000034153254,0.0003964977,0.00023608509,0.000005684311,0.00017040902,0.00005401864,0.00009024043,0.00028509254,0.0011706001,0.9975332,0.000010015178],"about_ca_topic_score_codex":0.0023198007,"about_ca_topic_score_gemma":0.0024465187,"teacher_disagreement_score":0.023881733,"about_ca_system_score_codex":0.0007749733,"about_ca_system_score_gemma":0.00071244093,"threshold_uncertainty_score":0.034064412},"labels":[],"label_agreement":null},{"id":"W4406652952","doi":"10.1016/b978-0-7506-3430-4.50024-9","title":"10.1016/b978-0-7506-3430-4.50024-9","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Superheterodyne receiver; Computer science; Telecommunications; Microwave","score_opus":0.014096913105306363,"score_gpt":0.23096065712219396,"score_spread":0.2168637440168876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406652952","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015146576,0.0005615305,0.0007486071,0.0002495808,0.00015161924,0.00003855331,0.0004763269,0.00073973555,0.99688244],"genre_scores_gemma":[0.00037843134,0.00033091696,0.00034312316,0.0001018693,0.000032997017,0.000027722164,0.00031525135,0.00017132548,0.99829847],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963,0.000020766658,0.000021126903,0.00012824965,0.00013733629,0.000062622436],"domain_scores_gemma":[0.99865216,0.0004314512,0.00008922895,0.00017612644,0.00024696797,0.00040402074],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007623505,0.0020364444,0.0012677895,0.0016690658,0.0012846703,0.004047664,0.0024658085,0.0037942824,0.97601116],"category_scores_gemma":[0.0014635705,0.00075022824,0.0007878368,0.0018166458,0.0010604595,0.004113223,0.003071809,0.0021179395,0.9877867],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012815367,0.00011002694,0.0002844708,0.00039948447,0.000013192099,0.0001096286,0.00008033713,0.0002832612,0.0022547487,0.0064379205,0.34631768,0.64358103],"study_design_scores_gemma":[0.00001434094,0.000040273473,0.000433764,0.00024781155,0.0000061676255,0.00016603361,0.00006414512,0.0000897312,0.00026887664,0.0011122413,0.99754566,0.000010939309],"about_ca_topic_score_codex":0.0029021078,"about_ca_topic_score_gemma":0.002864292,"teacher_disagreement_score":0.023988843,"about_ca_system_score_codex":0.00077994075,"about_ca_system_score_gemma":0.0008046286,"threshold_uncertainty_score":0.03421712},"labels":[],"label_agreement":null},{"id":"W4406655258","doi":"10.1016/b978-0-444-90336-5.50016-0","title":"10.1016/b978-0-444-90336-5.50016-0","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Biology; Medicine","score_opus":0.01398723163953765,"score_gpt":0.23100879619618728,"score_spread":0.21702156455664962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406655258","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013082384,0.00045023375,0.0006492356,0.00022155586,0.00013657683,0.000034670753,0.00042236212,0.00066947227,0.997285],"genre_scores_gemma":[0.00034949667,0.00028543235,0.000307889,0.00009376607,0.000028398938,0.000022876733,0.0002740216,0.00017764814,0.9984604],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966025,0.000018736522,0.000018178998,0.0001132841,0.00013365784,0.0000557727],"domain_scores_gemma":[0.9986737,0.00040795215,0.00008386639,0.00017262872,0.0002498507,0.00041203003],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00071128766,0.0019211464,0.0011521857,0.0016917943,0.0012613942,0.004198622,0.0023738535,0.0035796342,0.9765802],"category_scores_gemma":[0.0014204639,0.0006892144,0.00077289646,0.0018511614,0.0010281791,0.0038429054,0.0028862196,0.0019642352,0.98722047],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011097337,0.00010362407,0.00025617945,0.00036182,0.000012053646,0.00010291694,0.00007254168,0.00027265013,0.0021070465,0.006220965,0.37853274,0.6118465],"study_design_scores_gemma":[0.000011912357,0.000033655455,0.00036346092,0.00021718854,0.0000049596565,0.00014180114,0.000056946777,0.00008496527,0.00024673267,0.0009902314,0.9978387,0.000009368958],"about_ca_topic_score_codex":0.0032611114,"about_ca_topic_score_gemma":0.0031978318,"teacher_disagreement_score":0.023419797,"about_ca_system_score_codex":0.0008480424,"about_ca_system_score_gemma":0.0007984883,"threshold_uncertainty_score":0.033405483},"labels":[],"label_agreement":null},{"id":"W4406660252","doi":"10.1016/b978-0-323-76033-1.00008-3","title":"10.1016/b978-0-323-76033-1.00008-3","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.013761846637671325,"score_gpt":0.229745232072932,"score_spread":0.21598338543526066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406660252","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013032679,0.00044625797,0.0006060952,0.0002373682,0.00014029747,0.00003549648,0.00044373967,0.00061226933,0.9973482],"genre_scores_gemma":[0.00036492763,0.00024236942,0.0002898473,0.000086210646,0.000028998871,0.000022722263,0.00027676765,0.0001536248,0.99853444],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99964654,0.000019929306,0.000018766952,0.00011593667,0.0001389625,0.000059981037],"domain_scores_gemma":[0.9988172,0.00035393683,0.00008008617,0.00015604075,0.00024304804,0.00034972845],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000660259,0.0017219508,0.0011104315,0.0015722555,0.0011473343,0.003849217,0.0022041774,0.0032734212,0.9766292],"category_scores_gemma":[0.001335622,0.00062648905,0.0007317687,0.0016482084,0.00095672265,0.0032527356,0.002708906,0.001851506,0.9878243],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001198803,0.000098681216,0.00027508452,0.00034895627,0.00001253108,0.0001031261,0.000070950766,0.00026007023,0.001993425,0.0065924963,0.37018117,0.6199436],"study_design_scores_gemma":[0.00001213271,0.000032067415,0.00037698518,0.00019767441,0.0000047700787,0.00014420797,0.000046859637,0.00007324557,0.00021137425,0.00090445817,0.9979874,0.000008791374],"about_ca_topic_score_codex":0.00286184,"about_ca_topic_score_gemma":0.0029477375,"teacher_disagreement_score":0.023370802,"about_ca_system_score_codex":0.00080890756,"about_ca_system_score_gemma":0.0007259502,"threshold_uncertainty_score":0.033335626},"labels":[],"label_agreement":null},{"id":"W4407080953","doi":"10.1007/s00520-025-09190-6","title":"Patient-reported strategies for prevention and treatment of chemotherapy-induced peripheral neuropathy","year":2025,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Guideline; Gabapentin; Pain medicine; Medical prescription; Peripheral neuropathy; Duloxetine; Intensive care medicine; Alternative medicine; Anesthesiology; Nursing; Psychiatry","score_opus":0.031056202105445168,"score_gpt":0.3857902453382773,"score_spread":0.35473404323283214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407080953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7614725,0.10425736,0.008903228,0.03653689,0.0008249561,0.0011849994,0.0016526781,0.00028323822,0.08488415],"genre_scores_gemma":[0.9674575,0.019427193,0.008129871,0.0024319321,0.00020647513,0.0002018688,0.00030016183,0.0000067908218,0.0018382564],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.99932194,0.00041770271,0.00007966741,0.000033330758,0.00011339144,0.000033993692],"domain_scores_gemma":[0.9983468,0.00065388746,0.0005734819,0.00003597226,0.00023116489,0.00015873721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010741139,0.00017487051,0.00030270894,0.00040485337,0.00039181873,0.00053652487,0.00029399528,0.00038129318,0.0033166446],"category_scores_gemma":[0.00562916,0.000060141516,0.00028901285,0.00034494905,0.00009206981,0.00036157385,0.00029878397,0.0006513725,0.00020907696],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001131022,0.003194158,0.1452428,0.0022611402,0.00063018734,0.00037971593,0.00094783516,0.0007862976,0.0011591914,0.001397731,0.012142199,0.83072764],"study_design_scores_gemma":[0.0017892765,0.014974443,0.8198655,0.0076460573,0.0029708769,0.0050960807,0.0056277527,0.005269966,0.0046895323,0.0063714227,0.12551366,0.00018549927],"about_ca_topic_score_codex":0.000701537,"about_ca_topic_score_gemma":0.0028306083,"teacher_disagreement_score":0.0033166446,"about_ca_system_score_codex":0.0003755825,"about_ca_system_score_gemma":0.00079527654,"threshold_uncertainty_score":0.011095285},"labels":[],"label_agreement":null},{"id":"W4407341078","doi":"10.3390/curroncol32020100","title":"Trends in Kampo Medicine Usage as Supportive Care During Anticancer Drug Treatment in Japanese Patients: A Nationwide Cohort Analysis from Fiscal Years 2015 to 2021","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Kampo; Medicine; Medical prescription; Adverse effect; Alternative medicine; Drug; Traditional medicine; Cancer; Internal medicine; Pharmacology","score_opus":0.028409353968328707,"score_gpt":0.435025681013385,"score_spread":0.4066163270450563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407341078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949098,0.00093692867,0.00006528897,0.00007930145,0.000011559113,0.00001402236,0.0034404497,0.0000057086636,0.0005369306],"genre_scores_gemma":[0.9955806,0.0006152569,0.000091487935,0.000087507695,0.0000146386965,0.00002497206,0.0033524663,0.000004603236,0.00022851785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994381,0.00006809402,0.00012236682,0.00013943367,0.00010368711,0.00012838889],"domain_scores_gemma":[0.9983966,0.00009307196,0.00092000753,0.000089904235,0.00029450448,0.00020602494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059697905,0.00021773345,0.0003696007,0.0013006198,0.0005181696,0.00065484946,0.00040403407,0.0003166204,0.0011947413],"category_scores_gemma":[0.0015944883,0.0003313516,0.0008652948,0.0029316088,0.00019709386,0.00058972853,0.000603184,0.0005080013,0.00021064372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054751803,0.000009280193,0.99884015,0.000022270304,0.00007335375,0.000038411403,0.000054761567,0.000022509023,0.00006213483,0.00001026587,0.00019728224,0.00061479874],"study_design_scores_gemma":[0.0000031058244,0.000020018575,0.99915123,0.00001111723,0.000053920307,0.00009331301,0.00018023711,0.00012882624,0.000020876043,0.000005699974,0.0003280492,0.0000036471972],"about_ca_topic_score_codex":0.071380675,"about_ca_topic_score_gemma":0.10265537,"teacher_disagreement_score":0.071380675,"about_ca_system_score_codex":0.000888363,"about_ca_system_score_gemma":0.0010305749,"threshold_uncertainty_score":0.1419304},"labels":[],"label_agreement":null},{"id":"W4407590206","doi":"10.1093/nop/npaf017","title":"Corrigendum to: The feasibility of a multi-site, clinic-supported, and tailored neuro-oncology exercise program","year":2025,"lang":"en","type":"erratum","venue":"Neuro-Oncology Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Cancer Foundation","keywords":"Medicine; Medical physics; Oncology","score_opus":0.09498768312600601,"score_gpt":0.4426270637157845,"score_spread":0.34763938058977845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407590206","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000072204166,0.00091902725,0.00026925476,0.09165686,0.90105414,0.000032588356,0.00044302648,0.00015400881,0.0053988015],"genre_scores_gemma":[0.006596902,0.007570761,0.0023718278,0.23739514,0.42874742,0.00025439134,0.0017181365,0.0008621148,0.31448328],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99684143,0.00058094715,0.00050711597,0.00041190645,0.0013583396,0.0003003212],"domain_scores_gemma":[0.98035353,0.0059764455,0.000687761,0.0007135264,0.011105099,0.0011636262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030556545,0.0015942156,0.0018376706,0.0019032648,0.003139657,0.0032565256,0.0027531337,0.008071084,0.09943985],"category_scores_gemma":[0.05358634,0.0008924905,0.0015173886,0.0010177104,0.0016938411,0.0017951055,0.0016518192,0.011221528,0.050321173],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009434765,0.0000046937753,0.000030140583,0.00002642807,0.0000028266284,0.00011119579,0.000007889102,0.000012280574,0.000006659205,0.00019134373,0.99671763,0.0028794843],"study_design_scores_gemma":[0.000051666702,0.000031122527,0.00077802525,0.00046497994,0.000033168257,0.0008060725,0.000101716665,0.00020634718,0.0001789958,0.0010906659,0.9962135,0.0000436768],"about_ca_topic_score_codex":0.026186075,"about_ca_topic_score_gemma":0.042555336,"teacher_disagreement_score":0.09943985,"about_ca_system_score_codex":0.004533344,"about_ca_system_score_gemma":0.005087543,"threshold_uncertainty_score":0.33265948},"labels":[],"label_agreement":null},{"id":"W4407699857","doi":"10.1200/jco.2025.43.5_suppl.tps891","title":"ABLE-22: Safety and efficacy evaluation of nadofaragene firadenovec alone or in combination with chemotherapy or immunotherapy—A randomized, open-label, phase 2 study.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; McGill University Health Centre","funders":"","keywords":"Medicine; Chemotherapy; Immunotherapy; Oncology; Open label; Internal medicine; Randomized controlled trial; Pharmacology; Cancer","score_opus":0.17611272513261214,"score_gpt":0.5627920855961613,"score_spread":0.3866793604635492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407699857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866173,0.00421062,0.00086947426,0.00036423167,0.0003089597,0.003842342,0.001694506,0.00014973735,0.0019428497],"genre_scores_gemma":[0.98676014,0.0025109977,0.0015919917,0.00090327015,0.00037536374,0.0033166655,0.0017365683,0.00004257468,0.0027623174],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994361,0.00028990078,0.000027198577,0.000114452974,0.00005317149,0.00007921917],"domain_scores_gemma":[0.9991159,0.00018723667,0.00023123488,0.00008001055,0.000052528427,0.00033311194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002113535,0.0016335858,0.002097543,0.00043136845,0.00028821625,0.0011645888,0.00097364065,0.0016980926,0.007395918],"category_scores_gemma":[0.0011739458,0.00069568946,0.0016699281,0.00040042627,0.0010863205,0.0012169175,0.00034811025,0.0027094008,0.0011920228],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92132837,0.040884074,0.0009374345,0.00063540274,0.0011952188,0.000061142346,0.000055224336,0.00040011475,0.009638941,0.00009788696,0.0011143283,0.02365191],"study_design_scores_gemma":[0.7143486,0.279782,0.0022505473,0.000029438084,0.00051963143,0.00007357322,0.00002203812,0.0004063754,0.0011664389,0.00009937117,0.0012800554,0.000021865659],"about_ca_topic_score_codex":0.00057527784,"about_ca_topic_score_gemma":0.0013022511,"teacher_disagreement_score":0.007395918,"about_ca_system_score_codex":0.00067736494,"about_ca_system_score_gemma":0.0010243845,"threshold_uncertainty_score":0.024741828},"labels":[],"label_agreement":null},{"id":"W4407827083","doi":"10.1007/s11764-025-01763-y","title":"Impact of chemotherapy-induced peripheral neuropathy on physical function in pediatric cancer survivors: a systematic review","year":2025,"lang":"en","type":"review","venue":"Journal of Cancer Survivorship","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Innovation and Economic Development Trois Rivières","funders":"","keywords":"Medicine; Peripheral neuropathy; Quality of Life Research; Chemotherapy-induced peripheral neuropathy; Public health; Chemotherapy; Cancer; Pain medicine; Health informatics; Peripheral; Physical therapy; Internal medicine; Pathology; Diabetes mellitus","score_opus":0.04792525501676669,"score_gpt":0.42288818760567476,"score_spread":0.37496293258890806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407827083","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001090914,0.99850625,0.000038067526,0.000052947784,0.000041861782,0.000035893154,0.00014975862,0.0000025770123,0.000081735576],"genre_scores_gemma":[0.014743711,0.9845846,0.00017827535,0.00023944132,0.000037587783,0.00004913703,0.0001064813,0.0000017279581,0.000058971862],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99879825,0.0003044009,0.0004305869,0.00017599318,0.00022320857,0.000067543464],"domain_scores_gemma":[0.9946859,0.003882478,0.000991824,0.000060986382,0.00030080506,0.00007804214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019019798,0.0010202297,0.005331523,0.0025440836,0.00035124668,0.0014709115,0.0011172928,0.0015678282,0.0037118066],"category_scores_gemma":[0.010294664,0.00074064505,0.0079886485,0.003690331,0.00044070857,0.0010308586,0.001018062,0.0011584614,0.00020864564],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048768197,0.00004088088,0.0033279343,0.9024748,0.0390256,0.00014102108,0.00012384991,0.00019245577,0.00017917255,0.00013464734,0.0017362589,0.052135814],"study_design_scores_gemma":[0.00073636463,0.0004680502,0.022928046,0.5375584,0.41812634,0.000715672,0.00035391861,0.00015764317,0.00022209506,0.00036795923,0.018274864,0.00009065852],"about_ca_topic_score_codex":0.01084521,"about_ca_topic_score_gemma":0.037312817,"teacher_disagreement_score":0.01084521,"about_ca_system_score_codex":0.001265346,"about_ca_system_score_gemma":0.003433534,"threshold_uncertainty_score":0.021564186},"labels":[],"label_agreement":null},{"id":"W4407850244","doi":"10.51731/cjht.2025.1085","title":"Clindamycin Plus Benzoyl Peroxide and Adapalene (Cabtreo)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adapalene; Benzoyl peroxide; Clindamycin; Dermatology; Chemistry; Medicine; Organic chemistry; Antibiotics","score_opus":0.026654558932749726,"score_gpt":0.3470699517471535,"score_spread":0.3204153928144038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407850244","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014049303,0.96787685,0.0004377196,0.0010668044,0.00022427319,0.00014281485,0.00056017394,0.000028499924,0.015613485],"genre_scores_gemma":[0.13216929,0.855605,0.0028676246,0.00087059377,0.000156814,0.000098245095,0.0005128765,0.000011956357,0.00770763],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993092,0.00014809534,0.00006293745,0.00005238509,0.00038124833,0.000046214784],"domain_scores_gemma":[0.999413,0.00018588199,0.00014146457,0.000011259221,0.00021472662,0.00003380478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069975783,0.00020940098,0.0005043117,0.00088306103,0.00024548345,0.00050463434,0.00020901179,0.00023986494,0.0026244475],"category_scores_gemma":[0.0011466776,0.0000813443,0.0005746268,0.00092501246,0.00014517808,0.00024013796,0.0001631805,0.0003435025,0.00031251597],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007764963,0.000110845154,0.0017371101,0.020309431,0.00048354638,0.00016107324,0.00006038162,0.0002235031,0.010645805,0.0012399912,0.015350307,0.9489015],"study_design_scores_gemma":[0.00046745062,0.0023993792,0.035340074,0.012978427,0.0020440735,0.00219108,0.00027606048,0.00025600274,0.010502204,0.0004273568,0.9330777,0.000040279014],"about_ca_topic_score_codex":0.020330857,"about_ca_topic_score_gemma":0.1267087,"teacher_disagreement_score":0.020330857,"about_ca_system_score_codex":0.0015319131,"about_ca_system_score_gemma":0.0020793849,"threshold_uncertainty_score":0.040425003},"labels":[],"label_agreement":null},{"id":"W4407947753","doi":"10.5737/2368807635189","title":"Programme pilote de rééducation sensitive des neuropathies périphériques induites par la chimiothérapie (NPIC) auprès d’une clientèle oncologique","year":2025,"lang":"fr","type":"article","venue":"Canadian Oncology Nursing Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Centre Intégré de Santé et Services Sociaux de Chaudière-Appalache; Université du Québec à Rimouski","funders":"","keywords":"Medicine; Humanities; Gynecology; Art","score_opus":0.03158974179252376,"score_gpt":0.3669483739962365,"score_spread":0.3353586322037127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407947753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8555795,0.0018417245,0.01842972,0.00289267,0.0008332374,0.090166554,0.0017327623,0.00061979145,0.027903918],"genre_scores_gemma":[0.743496,0.0033533482,0.08852671,0.0023705892,0.00028367693,0.12186542,0.0016731123,0.00014421745,0.03828693],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9961777,0.0018172963,0.00020254706,0.00036976425,0.00077772205,0.000654972],"domain_scores_gemma":[0.99208987,0.002343254,0.00049102516,0.0007079163,0.0025589282,0.0018089606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008726027,0.0008542845,0.0008779968,0.0008076548,0.0022231266,0.0007485168,0.0016798963,0.0011995175,0.014801822],"category_scores_gemma":[0.011121336,0.00049872027,0.00095287926,0.0004368134,0.0011661813,0.0006162631,0.0016448684,0.0021345315,0.0016094935],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023950724,0.07000105,0.014989593,0.00703537,0.00044225183,0.0014631087,0.017161151,0.0030023146,0.021612618,0.0025596204,0.020238923,0.81754327],"study_design_scores_gemma":[0.03921252,0.41328135,0.22915302,0.005781838,0.0014858261,0.0015133509,0.015981065,0.0053434903,0.035536777,0.0046120337,0.24762075,0.00047806188],"about_ca_topic_score_codex":0.03592056,"about_ca_topic_score_gemma":0.07139427,"teacher_disagreement_score":0.03592056,"about_ca_system_score_codex":0.003193629,"about_ca_system_score_gemma":0.017717525,"threshold_uncertainty_score":0.071422935},"labels":[],"label_agreement":null},{"id":"W4407955481","doi":"10.21037/pm-24-42","title":"Physical therapy for deficits associated with chemotherapy induced peripheral neuropathy in children with cancer: a systematic review","year":2025,"lang":"en","type":"review","venue":"Pediatric Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"","keywords":"Peripheral neuropathy; Medicine; Chemotherapy-induced peripheral neuropathy; Chemotherapy; Systematic review; Cancer therapy; Oncology; Cancer; Internal medicine; MEDLINE; Endocrinology; Diabetes mellitus","score_opus":0.033167198414578616,"score_gpt":0.3701007508465554,"score_spread":0.3369335524319768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407955481","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013724802,0.99735546,0.000084445455,0.00013962432,0.00006640353,0.00044433642,0.0002483538,0.000007119729,0.00028181198],"genre_scores_gemma":[0.018075878,0.9796703,0.0006161396,0.00041758418,0.000058020727,0.0008888604,0.00016980941,0.0000034053876,0.0000999855],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99559397,0.0014530037,0.0015835575,0.0003374831,0.0008655195,0.00016643127],"domain_scores_gemma":[0.98539954,0.010591596,0.002663992,0.00016131623,0.0010167497,0.00016687241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004658098,0.0011484475,0.006553701,0.005961815,0.0006357233,0.0021627026,0.0014806857,0.0018136892,0.0040333434],"category_scores_gemma":[0.024575664,0.0007464756,0.006243646,0.006849789,0.000710475,0.0015871268,0.0011616129,0.001132699,0.00020062696],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001672318,0.000020111527,0.0005812921,0.9664893,0.005036835,0.00006881596,0.00014259666,0.000054029515,0.00006291998,0.000105713865,0.0008203058,0.026450979],"study_design_scores_gemma":[0.00037000782,0.00025850744,0.0045726504,0.9375378,0.04577521,0.00038705472,0.00027673136,0.00006818487,0.0001049743,0.00013518296,0.010485334,0.000028357621],"about_ca_topic_score_codex":0.009314477,"about_ca_topic_score_gemma":0.024135897,"teacher_disagreement_score":0.009314477,"about_ca_system_score_codex":0.0038951777,"about_ca_system_score_gemma":0.010607252,"threshold_uncertainty_score":0.028261602},"labels":[],"label_agreement":null},{"id":"W4407964923","doi":"10.5737/23688076351103","title":"Sensory re-education pilot program following chemotherapy-induced peripheral neuropathy in cancer patients","year":2025,"lang":"en","type":"article","venue":"Canadian Oncology Nursing Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Sensory neuropathy; Medicine; Cancer; Sensory system; Chemotherapy; Oncology; Peripheral; Internal medicine; Physical therapy; Physical medicine and rehabilitation; Psychology; Neuroscience; Endocrinology","score_opus":0.03476836165448303,"score_gpt":0.4104621421885149,"score_spread":0.37569378053403185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407964923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906156,0.0002787852,0.00046149045,0.0003446033,0.00004928093,0.004398232,0.0001347846,0.00011532388,0.0036020041],"genre_scores_gemma":[0.98706776,0.00086957216,0.0037071947,0.00046958984,0.000056457553,0.0036271831,0.00036492344,0.000007903942,0.0038293411],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99975044,0.0000649418,0.0000123326,0.000020937445,0.0000385516,0.00011290871],"domain_scores_gemma":[0.99921966,0.000093990435,0.000055987555,0.000032161683,0.000102884405,0.0004953125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064297655,0.00036665823,0.00046662916,0.0004106416,0.0012591879,0.00027201997,0.0006523361,0.00038622573,0.0055921096],"category_scores_gemma":[0.0009185444,0.00013527446,0.00051257125,0.00035221624,0.00025129842,0.0002100769,0.0006492077,0.0007101274,0.00045417456],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024206465,0.19542903,0.03850498,0.0014703322,0.0002088535,0.0019428477,0.0024638614,0.0018939001,0.010558955,0.00024948907,0.009833022,0.71323824],"study_design_scores_gemma":[0.018796248,0.39936686,0.552206,0.00044132824,0.00028658911,0.0008755675,0.0021060356,0.002649945,0.0052030543,0.00020846054,0.01777263,0.00008726603],"about_ca_topic_score_codex":0.046046644,"about_ca_topic_score_gemma":0.11366976,"teacher_disagreement_score":0.046046644,"about_ca_system_score_codex":0.0013593802,"about_ca_system_score_gemma":0.0048580305,"threshold_uncertainty_score":0.091557264},"labels":[],"label_agreement":null},{"id":"W4408237108","doi":"10.1080/14796694.2025.2468578","title":"A plain language summary of the ASCERTAIN trial: oral decitabine and cedazuridine versus intravenous decitabine for MDS or CMML","year":2025,"lang":"en","type":"article","venue":"Future Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Hôpital Maisonneuve-Rosemont; University of Alberta; Queen Elizabeth II Health Sciences Centre; Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Decitabine; Medicine","score_opus":0.025476626718189566,"score_gpt":0.38500189559359743,"score_spread":0.35952526887540787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408237108","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018416481,0.25610408,0.010854464,0.2758379,0.09375203,0.047671966,0.20662113,0.0022162674,0.088525735],"genre_scores_gemma":[0.0736869,0.16047639,0.019116214,0.42583463,0.049200986,0.07342276,0.06689822,0.0009858997,0.1303781],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942081,0.0038243814,0.00085483515,0.00027047595,0.00059419736,0.00024787177],"domain_scores_gemma":[0.9842799,0.008668,0.0040683476,0.00041544065,0.0018183015,0.00074998115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009251399,0.002015205,0.0038679207,0.001073385,0.0006716048,0.004504724,0.0017337837,0.0045000073,0.054784443],"category_scores_gemma":[0.028738698,0.00094650284,0.0061804475,0.0012076033,0.0005419248,0.00185783,0.00080033904,0.0049404018,0.010829221],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057025503,0.0004574934,0.00066410913,0.044212345,0.002828044,0.00030310923,0.000112695285,0.0011380779,0.0012214324,0.0026276424,0.77728736,0.1121222],"study_design_scores_gemma":[0.19590622,0.018578269,0.0061159786,0.04247985,0.008441633,0.0005244583,0.00023690354,0.0014158216,0.0014413599,0.008119624,0.71638256,0.00035726363],"about_ca_topic_score_codex":0.0023710513,"about_ca_topic_score_gemma":0.0037832265,"teacher_disagreement_score":0.054784443,"about_ca_system_score_codex":0.0019219192,"about_ca_system_score_gemma":0.0026388995,"threshold_uncertainty_score":0.18327224},"labels":[],"label_agreement":null},{"id":"W4408275105","doi":"10.37275/bsm.v9i6.1292","title":"Serum Nerve Growth Factor as a Biomarker for Chemotherapy-Induced Peripheral Neuropathy: A Cross-Sectional Study","year":2025,"lang":"en","type":"article","venue":"Bioscientia Medicina Journal of Biomedicine and Translational Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Peripheral neuropathy; Biomarker; Peripheral; Chemotherapy-induced peripheral neuropathy; Chemotherapy; Cross-sectional study; Oncology; Internal medicine; Nerve growth factor; Pathology; Endocrinology; Biology","score_opus":0.11304871936280521,"score_gpt":0.4823205871577496,"score_spread":0.3692718677949444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408275105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99898213,0.00047757154,0.0001365716,0.000014014663,0.000006192479,0.000020656958,0.00012878516,0.0000016768788,0.00023244132],"genre_scores_gemma":[0.99942565,0.00012590489,0.00015696815,0.000025371335,0.000006811704,0.000019448276,0.00015250714,7.0404985e-7,0.00008666456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995289,0.00013959418,0.000069834394,0.00011808737,0.00009273073,0.000050882656],"domain_scores_gemma":[0.9986559,0.0003339689,0.00048633825,0.00008330119,0.00023520764,0.00020519283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010710169,0.00024176722,0.00033574234,0.0005417025,0.00036145395,0.00047431188,0.00014831542,0.00033637462,0.0012779842],"category_scores_gemma":[0.0014990411,0.00026041252,0.00034949358,0.000655403,0.00020721521,0.00040945367,0.00025089047,0.0004355139,0.00020361053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011447611,0.000056116223,0.99901104,0.000012447394,0.000045679724,0.00003114112,0.000029144021,0.000011474263,0.0001584366,0.0000040880454,0.000017076236,0.0005089123],"study_design_scores_gemma":[0.000012678503,0.0008625736,0.997999,0.000007936017,0.00008645497,0.00046774684,0.00012740519,0.00013853938,0.00011055988,0.000011502808,0.00017188706,0.0000036176039],"about_ca_topic_score_codex":0.00083975116,"about_ca_topic_score_gemma":0.0011468049,"teacher_disagreement_score":0.0012779842,"about_ca_system_score_codex":0.0001964492,"about_ca_system_score_gemma":0.00025430982,"threshold_uncertainty_score":0.00566417},"labels":[],"label_agreement":null},{"id":"W4408519004","doi":"10.1188/25.cjon.113-118","title":"Optimizing Assessment of and Education About Chemotherapy-Induced Peripheral Neuropathy Among Breast Cancer Survivors","year":2025,"lang":"en","type":"article","venue":"Clinical journal of oncology nursing","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"","keywords":"Medicine; Peripheral neuropathy; Breast cancer; Chemotherapy-induced peripheral neuropathy; Oncology; Chemotherapy; Internal medicine; Cancer; Peripheral; Diabetes mellitus","score_opus":0.04311397590925742,"score_gpt":0.4976242138566784,"score_spread":0.45451023794742096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408519004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93752205,0.008303395,0.0031367703,0.019948052,0.00050304714,0.0014871826,0.0005811493,0.00016215276,0.028356226],"genre_scores_gemma":[0.9591196,0.017104857,0.012925936,0.004184668,0.00022035788,0.0011759421,0.0006156266,0.000021986907,0.0046309405],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989484,0.0005058237,0.00009785436,0.00004879882,0.00023719984,0.0001618885],"domain_scores_gemma":[0.9980578,0.00043157843,0.0003584154,0.000039375493,0.0005185042,0.00059439143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020743308,0.00017903428,0.00046376942,0.00054750044,0.0008332029,0.0008582899,0.00043271523,0.00046474612,0.0029064547],"category_scores_gemma":[0.009904973,0.00017599325,0.00039501465,0.00030373345,0.00017733022,0.0009563531,0.001451905,0.0013439686,0.0005649296],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043299876,0.0052841534,0.30765283,0.0016526246,0.00015474054,0.00060854264,0.014577936,0.00066298014,0.0012169848,0.00054023566,0.039065856,0.6281501],"study_design_scores_gemma":[0.00027531327,0.00593172,0.85943735,0.0070316927,0.00034281006,0.0016754122,0.039076168,0.0029817605,0.0017673642,0.0026496283,0.0786718,0.00015904776],"about_ca_topic_score_codex":0.0079429895,"about_ca_topic_score_gemma":0.02098308,"teacher_disagreement_score":0.0079429895,"about_ca_system_score_codex":0.0010841701,"about_ca_system_score_gemma":0.003496761,"threshold_uncertainty_score":0.015793502},"labels":[],"label_agreement":null},{"id":"W4408686924","doi":"10.26434/chemrxiv-2024-nmm8w-v2","title":"Machine learning reveals structural characteristics of stereochemistry-specific interdigitation of synthetic monomycoloyl glycerol analogs","year":2025,"lang":"en","type":"preprint","venue":"ChemRxiv","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Glycerol; Chemistry; Stereochemistry; Biochemistry","score_opus":0.022581448016313278,"score_gpt":0.3084476592570899,"score_spread":0.2858662112407766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408686924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945774,0.000065103224,0.004237025,0.000044830987,0.00000419458,0.0000069512544,0.00005108008,0.000050183193,0.00096327654],"genre_scores_gemma":[0.9981725,0.000039139122,0.0015597648,0.000011054467,9.2054205e-7,0.000009743613,0.00006291049,0.000008883277,0.0001350343],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99996126,0.0000067512724,0.0000021180706,0.000009704482,0.000008494514,0.000011674813],"domain_scores_gemma":[0.9998727,0.000051123992,0.000033053082,0.000010732912,0.000017117862,0.000015240935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013567414,0.00018688873,0.0001506803,0.00017035236,0.00015618624,0.00018224599,0.0002402394,0.00026299022,0.0007899522],"category_scores_gemma":[0.00038496236,0.00012092284,0.00016544583,0.00012351206,0.00021217606,0.0003397114,0.00012906852,0.000304862,0.000078053694],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048715016,0.00029233537,0.0107479235,0.000129283,0.00007177479,0.0001856036,0.00009011242,0.7658122,0.2000633,0.0052604363,0.00049451686,0.016365457],"study_design_scores_gemma":[0.000008087197,0.00004819702,0.0015436459,0.0000018828407,0.000004260881,0.000007634419,0.000008648356,0.9872973,0.010609024,0.0003246993,0.00014184033,0.000004794458],"about_ca_topic_score_codex":0.0014899125,"about_ca_topic_score_gemma":0.0014261535,"teacher_disagreement_score":0.0014899125,"about_ca_system_score_codex":0.00043562517,"about_ca_system_score_gemma":0.0002782683,"threshold_uncertainty_score":0.0031606555},"labels":[],"label_agreement":null},{"id":"W4408731079","doi":"10.32000/2072-1757-2025-1-83-88","title":"Taxane-induced acute pain syndrome in patients with breast cancer","year":2025,"lang":"en","type":"article","venue":"Practical medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Taxane; Medicine; Breast cancer; Oncology; Internal medicine; Cancer","score_opus":0.018436983059207226,"score_gpt":0.3792075519894902,"score_spread":0.360770568930283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408731079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99692553,0.0021272881,0.00006894839,0.00012448916,0.000013959188,0.00001657957,0.00011327648,0.000004080173,0.00060593145],"genre_scores_gemma":[0.998899,0.00067804795,0.00007663835,0.000072636576,0.00002578379,0.000010397225,0.00012045411,4.2164055e-7,0.000116561896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978966,0.000067529756,0.000026768705,0.000031194653,0.000053666867,0.000031151336],"domain_scores_gemma":[0.9993374,0.00013811846,0.00034307776,0.000017233822,0.000057471392,0.00010674026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026405577,0.00015720374,0.00031332386,0.00029288683,0.00029039304,0.00026076782,0.00010532737,0.00028856628,0.0011240857],"category_scores_gemma":[0.0015945414,0.000103335195,0.00019621651,0.00042931834,0.00014516189,0.00024905198,0.00018062258,0.00036410918,0.00014701314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026910522,0.000058328893,0.9920718,0.00004408753,0.00002690892,0.00039754965,0.000057772017,0.00004378083,0.00060726417,0.0000088837205,0.00013780828,0.0062767626],"study_design_scores_gemma":[0.000017670873,0.00028304855,0.9975637,0.000010967042,0.000015939948,0.0016971482,0.000067965404,0.00007583717,0.000047362464,0.000013923822,0.00020368546,0.0000026443224],"about_ca_topic_score_codex":0.0011007132,"about_ca_topic_score_gemma":0.0018489582,"teacher_disagreement_score":0.0011240857,"about_ca_system_score_codex":0.00018318328,"about_ca_system_score_gemma":0.00022356851,"threshold_uncertainty_score":0.003760457},"labels":[],"label_agreement":null},{"id":"W4408933349","doi":"10.1016/j.jpet.2024.101314","title":"In-Vitro Evaluation of Efficacy and Specificity of Novel Protein Inhibitors of the Oncogenic Myc/Max/E-box Network (Abstract ID: 157603)","year":2025,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"In vitro; Computational biology; Chemistry; Biology; Cancer research; Biochemistry","score_opus":0.051527384515127436,"score_gpt":0.4037711886759621,"score_spread":0.3522438041608347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408933349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816636,0.008155006,0.0030978033,0.00016001139,0.00017404954,0.00013664823,0.0018296659,0.0001274687,0.004655765],"genre_scores_gemma":[0.98777163,0.00366752,0.0026669297,0.00006822162,0.000056483263,0.000119098564,0.0025941327,0.000034394,0.0030216782],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99973804,0.00007307802,0.000024897714,0.000042280488,0.00005699557,0.00006473706],"domain_scores_gemma":[0.9997658,0.000120017874,0.000024276007,0.000021991445,0.00003268386,0.000035235655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005507898,0.0004425158,0.00045513254,0.00022932516,0.00021358959,0.00028315056,0.00044345198,0.00027716815,0.0034483024],"category_scores_gemma":[0.00028004032,0.00018724582,0.00037269792,0.0002729404,0.00021822582,0.00025673336,0.00014322954,0.00078784314,0.00074192823],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028934106,0.0011647469,0.00033658853,0.0002313723,0.00005445734,0.000057660163,0.00004029753,0.0010817619,0.98750407,0.00023044081,0.00047960135,0.0059255348],"study_design_scores_gemma":[0.00019970267,0.0040899436,0.0016370926,0.000008192221,0.000059848444,0.00010744514,0.000017852652,0.0014208854,0.9903978,0.000033182452,0.0020216687,0.00000638348],"about_ca_topic_score_codex":0.0013253399,"about_ca_topic_score_gemma":0.0019630054,"teacher_disagreement_score":0.0034483024,"about_ca_system_score_codex":0.00032704693,"about_ca_system_score_gemma":0.00037011693,"threshold_uncertainty_score":0.011535764},"labels":[],"label_agreement":null},{"id":"W4408936584","doi":"10.1016/j.jpet.2024.100587","title":"Prophylactic Inhibition of Matrix Metalloproteinase-2 Attenuates Anthracycline-Induced Cardiotoxicity by Preventing Junctophilin-2 Proteolysis (Abstract ID: 161175)","year":2025,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Proteolysis; Cardiotoxicity; Matrix metalloproteinase; Anthracycline; Pharmacology; Matrix metalloproteinase inhibitor; Matrix metalloproteinase 9; Chemistry; Cancer research; Medicine; Internal medicine; Cancer; Biochemistry; Toxicity; Enzyme","score_opus":0.02369589794576152,"score_gpt":0.38325157296342605,"score_spread":0.3595556750176645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408936584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934609,0.0025895836,0.0015072725,0.00027006064,0.00019095786,0.000084528394,0.00025840412,0.00018446735,0.0014538277],"genre_scores_gemma":[0.9950433,0.0012080283,0.0015093754,0.00008292532,0.000049780323,0.000056920133,0.00028377163,0.000017182172,0.0017487083],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999039,0.00001253368,0.0000073704477,0.000017059287,0.0000144999985,0.000044527387],"domain_scores_gemma":[0.99991786,0.000011008512,0.00002707465,0.000006868195,0.0000045977044,0.000032514996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013711542,0.0003961501,0.0005559683,0.00019694846,0.00017856204,0.00027486868,0.00023111147,0.00030416175,0.0029225477],"category_scores_gemma":[0.0001529046,0.00014003315,0.00024288177,0.00010117237,0.000300445,0.00027926764,0.00015274809,0.0010668956,0.00046572753],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051036417,0.00070747186,0.00022652003,0.00013329565,0.000040616753,0.000107764135,0.000021221656,0.00014328356,0.98677516,0.00023444051,0.00034606026,0.0061606015],"study_design_scores_gemma":[0.0011254696,0.011527001,0.006642922,0.000028728924,0.00012314576,0.00052621396,0.00007869297,0.0016417463,0.9740631,0.000191382,0.0040355558,0.000015884589],"about_ca_topic_score_codex":0.0003123757,"about_ca_topic_score_gemma":0.0006782027,"teacher_disagreement_score":0.0029225477,"about_ca_system_score_codex":0.00017258916,"about_ca_system_score_gemma":0.00034322523,"threshold_uncertainty_score":0.009776831},"labels":[],"label_agreement":null},{"id":"W4408940911","doi":"10.51731/cjht.2025.1104","title":"Venetoclax (Venclexta)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Philosophy; Medicine; Psychology; Internal medicine; Leukemia","score_opus":0.025457065611933158,"score_gpt":0.36479889377678365,"score_spread":0.3393418281648505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408940911","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017980546,0.8435696,0.0015155944,0.003850053,0.0012535312,0.0003859817,0.0041747293,0.0004310958,0.12683885],"genre_scores_gemma":[0.24480934,0.62895256,0.0058783195,0.006850792,0.0010586173,0.00038877985,0.008695036,0.00010012078,0.10326655],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971,0.000061083476,0.000013546411,0.000038752405,0.00013488639,0.000041570227],"domain_scores_gemma":[0.9997856,0.00005676854,0.00004859608,0.000009634517,0.00004922292,0.000050158913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000422374,0.00020495101,0.0003270354,0.0007986877,0.00033467717,0.0009009475,0.0003739435,0.00043740383,0.01649772],"category_scores_gemma":[0.0007431577,0.00007408712,0.00031490476,0.0008501942,0.00025188708,0.00028929987,0.00026737063,0.0011790224,0.002165489],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072669965,0.0001529935,0.0008242144,0.00403822,0.0001149169,0.00033429667,0.000054140364,0.00024053927,0.0046940115,0.0054221437,0.13800853,0.8453893],"study_design_scores_gemma":[0.0006212487,0.000557279,0.003968762,0.0017515229,0.00011700803,0.0015112952,0.000033955097,0.00011068223,0.0019851585,0.00052864355,0.98880076,0.000013747597],"about_ca_topic_score_codex":0.020069623,"about_ca_topic_score_gemma":0.069845326,"teacher_disagreement_score":0.020069623,"about_ca_system_score_codex":0.0011375579,"about_ca_system_score_gemma":0.0017206464,"threshold_uncertainty_score":0.055190384},"labels":[],"label_agreement":null},{"id":"W4408996213","doi":"10.1016/s1556-0864(25)00631-8","title":"439P: Standardization of endpoints in early NSCLC randomized clinical trials (RCTs): The DATECAN initiative","year":2025,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Standardization; Randomized controlled trial; Oncology; Internal medicine; Clinical endpoint; Medical physics; Intensive care medicine","score_opus":0.1275065917859283,"score_gpt":0.5891366432201496,"score_spread":0.4616300514342213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408996213","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032364517,0.08943408,0.58031785,0.065223426,0.021156235,0.11395513,0.046146613,0.014544891,0.036857255],"genre_scores_gemma":[0.100367926,0.012257856,0.71138597,0.018904677,0.004834852,0.12582941,0.017596712,0.00443751,0.004385087],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.22175887,0.6820582,0.049422286,0.013538416,0.031248987,0.0019732346],"domain_scores_gemma":[0.17388016,0.58985335,0.08334763,0.09733963,0.04644159,0.009137529],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.6265874,0.0036388552,0.012703627,0.0069825538,0.0017136845,0.012527619,0.006540151,0.008058259,0.011177156],"category_scores_gemma":[0.67396706,0.003920337,0.0152207995,0.008611471,0.0045255907,0.008068824,0.016089855,0.015425175,0.0029899646],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10778026,0.0013737651,0.016303062,0.05615133,0.091350846,0.00019031168,0.001411574,0.007114433,0.002775124,0.05386012,0.15269718,0.50899196],"study_design_scores_gemma":[0.25540796,0.011015902,0.058320902,0.03799647,0.06022291,0.000691234,0.00049945206,0.019667827,0.005487807,0.109123774,0.4406725,0.00089337584],"about_ca_topic_score_codex":0.0009968774,"about_ca_topic_score_gemma":0.0017659705,"teacher_disagreement_score":0.3734126,"about_ca_system_score_codex":0.0051637883,"about_ca_system_score_gemma":0.022867694,"threshold_uncertainty_score":0.46048427},"labels":[],"label_agreement":null},{"id":"W4409182905","doi":"10.1007/s00520-025-09387-9","title":"Practice patterns in the diagnosis and management of chemotherapy-induced peripheral neuropathy in adolescents and young adults with cancer: a survey of oncologists","year":2025,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Peripheral neuropathy; Vincristine; Cancer; Young adult; Medical record; Pediatric oncology; Chemotherapy; Nursing research; Internal medicine; Intensive care medicine; Cyclophosphamide; Nursing","score_opus":0.028437643587462307,"score_gpt":0.3798294281204562,"score_spread":0.3513917845329939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409182905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779886,0.000524229,0.000053341428,0.00049234316,0.000009364869,0.000025737958,0.00020774284,0.0000034357192,0.0008848529],"genre_scores_gemma":[0.99841285,0.0006778204,0.00020825939,0.00033104137,0.000012796962,0.000033551118,0.00014964583,0.0000017267664,0.00017224195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986242,0.00041944842,0.00028091043,0.00014575693,0.00036947132,0.00016012725],"domain_scores_gemma":[0.9932545,0.0013620859,0.0037769424,0.00008478991,0.0007395814,0.0007821846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014600354,0.00008171258,0.00018735549,0.0007604362,0.00040658528,0.00050227065,0.00026115272,0.00051605725,0.0012216275],"category_scores_gemma":[0.00537591,0.000217054,0.00022803046,0.00083636807,0.0002981622,0.00065994693,0.0005840871,0.00043039705,0.00019667992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015603107,0.000030348689,0.99477094,0.00004092104,0.000012050779,0.00009628481,0.0014826551,0.000023175071,0.00011114501,0.000015919397,0.0004087605,0.0029922004],"study_design_scores_gemma":[0.0000056625277,0.00012837339,0.9899194,0.000086659886,0.000008636143,0.0006722184,0.0077154823,0.0001342038,0.00005103249,0.000013290623,0.0012598705,0.0000050846893],"about_ca_topic_score_codex":0.009828074,"about_ca_topic_score_gemma":0.017527433,"teacher_disagreement_score":0.009828074,"about_ca_system_score_codex":0.00065052346,"about_ca_system_score_gemma":0.0008274564,"threshold_uncertainty_score":0.01954168},"labels":[],"label_agreement":null},{"id":"W4409209474","doi":"10.24875/recic.m25000505","title":"Seguimiento extendido del bal�n liberador de paclitaxel Essential Pro para restenosis intrastent","year":2025,"lang":"es","type":"letter","venue":"REC, Interventional cardiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Paclitaxel; Oncology; Cancer research; Internal medicine; Chemotherapy","score_opus":0.03670316582772031,"score_gpt":0.3641109099535619,"score_spread":0.32740774412584156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409209474","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006630392,0.092859164,0.0019110466,0.3234683,0.5662985,0.00013621415,0.00064096984,0.00023229327,0.007823194],"genre_scores_gemma":[0.04796185,0.07844169,0.002268237,0.1326212,0.70250267,0.00013165179,0.0002933706,0.00015773781,0.035621636],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99936074,0.0001224497,0.00012662339,0.00011426788,0.00022276632,0.00005317144],"domain_scores_gemma":[0.9957123,0.0019531357,0.0004963452,0.00007584339,0.0014424186,0.00031999146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019567441,0.0005971794,0.001245202,0.00086106843,0.0002862195,0.0012759459,0.00122553,0.002653164,0.0058090165],"category_scores_gemma":[0.00946025,0.00024262068,0.0005728651,0.00041823395,0.00061970897,0.00090497517,0.00019699578,0.0042804414,0.0028581333],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015282934,0.00007395427,0.0012524459,0.001658522,0.00012114656,0.0022055286,0.000078329394,0.00020451778,0.0007319846,0.0011807045,0.8776796,0.113284916],"study_design_scores_gemma":[0.00039397727,0.0008081306,0.005576285,0.0020956215,0.00049803435,0.006793836,0.00021932989,0.0021097427,0.0035602606,0.0017066376,0.9761672,0.00007099938],"about_ca_topic_score_codex":0.0007557257,"about_ca_topic_score_gemma":0.001245167,"teacher_disagreement_score":0.0058090165,"about_ca_system_score_codex":0.0005233627,"about_ca_system_score_gemma":0.0009108107,"threshold_uncertainty_score":0.019433081},"labels":[],"label_agreement":null},{"id":"W4409569512","doi":"10.3390/cancers17081359","title":"The Effect of Staging Intervals on Progression-Free Survival in Registration Studies of Oncologic Drugs: A Meta-Analysis","year":2025,"lang":"en","type":"article","venue":"Cancers","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Confidence interval; Hazard ratio; Meta-analysis; Internal medicine; Subgroup analysis; Random effects model; Proportional hazards model; Gastroenterology; Oncology; Urology","score_opus":0.08701339651513051,"score_gpt":0.46273568055379016,"score_spread":0.37572228403865965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409569512","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024059886,0.97087336,0.0022230442,0.0003934469,0.00033779937,0.00030517686,0.0011781674,0.000074124684,0.00055496837],"genre_scores_gemma":[0.7115005,0.27798414,0.0042238426,0.0013801288,0.0006509206,0.0013164133,0.0021576476,0.00012379343,0.00066256704],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97995293,0.012684301,0.0034978532,0.0020801378,0.0012317024,0.0005530382],"domain_scores_gemma":[0.9532901,0.037553594,0.0053485967,0.002079793,0.001345299,0.0003825591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02694286,0.0032422077,0.0144699495,0.0050079813,0.000573764,0.0039862455,0.002116801,0.0026566477,0.003496977],"category_scores_gemma":[0.05017372,0.001551042,0.07626476,0.005471986,0.00079391524,0.002099847,0.0017732844,0.0029875038,0.00035729836],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005635533,0.00002193193,0.006567048,0.043950018,0.937663,0.00008239912,0.00003552405,0.0008964242,0.00017426835,0.00009122709,0.00027453413,0.0046080155],"study_design_scores_gemma":[0.0006797109,0.00018128552,0.0033517443,0.0024889458,0.9923403,0.0000441545,0.000013673707,0.0002475272,0.0000678869,0.00014041361,0.00043288054,0.000011409228],"about_ca_topic_score_codex":0.0045268955,"about_ca_topic_score_gemma":0.0059643104,"teacher_disagreement_score":0.02694286,"about_ca_system_score_codex":0.0018181326,"about_ca_system_score_gemma":0.0016647199,"threshold_uncertainty_score":0.1424892},"labels":[],"label_agreement":null},{"id":"W4409625280","doi":"10.1158/1538-7445.am2025-3012","title":"Abstract 3012: A highly potent selective CDK9 inhibitor OBP-004 reduces metastatic tumor burden in bone, brain, lung and lymph nodes and decreases growth of triple-negative breast cancer cells in bone","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Lymph; Medicine; Cancer; Cancer research; Lung; Breast cancer; Lung cancer; Internal medicine; Pathology","score_opus":0.028284781724783745,"score_gpt":0.3899130281984032,"score_spread":0.3616282464736194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409625280","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834426,0.0052124695,0.0025807964,0.0002934449,0.00010739559,0.00016208056,0.0021702172,0.0003344522,0.005696613],"genre_scores_gemma":[0.9763367,0.003974183,0.0028909154,0.00016780914,0.000027482218,0.00020875284,0.0039755832,0.00004373686,0.012374828],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99994195,0.000009181281,0.0000040412915,0.000010119811,0.000017981305,0.000016647475],"domain_scores_gemma":[0.9999714,0.000003422503,0.0000053654485,0.0000024899832,0.000003834393,0.000013571965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008305705,0.0004200075,0.00034528907,0.0002840981,0.00011345789,0.00018264992,0.00026050713,0.0002638791,0.002975938],"category_scores_gemma":[0.000056988778,0.0001293672,0.00018489895,0.00022687868,0.00013155662,0.00013805766,0.00010932318,0.00055470795,0.00065546826],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00128212,0.0005621269,0.00027077846,0.0001710639,0.000019234725,0.00009658615,0.00001146927,0.00025666095,0.9858024,0.00010415344,0.0010337032,0.01038969],"study_design_scores_gemma":[0.0005666062,0.0051196045,0.0044365595,0.0000116466435,0.000054244814,0.0006223942,0.0000185856,0.0012991178,0.9789373,0.00006319981,0.008859324,0.00001143053],"about_ca_topic_score_codex":0.00087800896,"about_ca_topic_score_gemma":0.0014122442,"teacher_disagreement_score":0.002975938,"about_ca_system_score_codex":0.00021463505,"about_ca_system_score_gemma":0.000340827,"threshold_uncertainty_score":0.009955525},"labels":[],"label_agreement":null},{"id":"W4409627228","doi":"10.1158/1538-7445.am2025-4357","title":"Abstract 4357: Disparities in neurotoxicities in cisplatin-treated cancer patients: a population pharmacogenomics approach","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Spinal Cord Injury BC; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Pharmacogenomics; Medicine; Cisplatin; Population; Cancer; Oncology; Internal medicine; Chemotherapy; Pharmacology; Environmental health","score_opus":0.08408665197021355,"score_gpt":0.45947699120615626,"score_spread":0.3753903392359427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409627228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994441,0.00040781594,0.0022386871,0.00033747262,0.00001270255,0.000029331233,0.0018564599,0.000014630072,0.0006618197],"genre_scores_gemma":[0.9977441,0.000113943424,0.0010390911,0.0000666901,0.000014134939,0.0000285008,0.0007080359,0.00000676761,0.00027883027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99941206,0.00028590558,0.00003465152,0.0001687147,0.00005053078,0.000048112353],"domain_scores_gemma":[0.99944097,0.00021418185,0.00013308015,0.00007529103,0.00006416845,0.000072284754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094821234,0.00021542462,0.00035898603,0.00097323774,0.00042398743,0.00066680426,0.00037501025,0.00040702446,0.0035146633],"category_scores_gemma":[0.0020949605,0.00009936512,0.0007625209,0.0020783106,0.0002109625,0.00024904724,0.0006043366,0.000506471,0.00024024215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021450897,0.00006403984,0.989019,0.000040215116,0.0005992427,0.0001148233,0.00016556363,0.00035723584,0.0014955451,0.0002662719,0.00046907386,0.007194486],"study_design_scores_gemma":[0.000016421734,0.00013775489,0.995752,0.00001558903,0.0002894661,0.00015604985,0.0002621096,0.0018102039,0.00025024984,0.0004990738,0.00080541783,0.000005699292],"about_ca_topic_score_codex":0.0057893433,"about_ca_topic_score_gemma":0.0045118635,"teacher_disagreement_score":0.0057893433,"about_ca_system_score_codex":0.0002453522,"about_ca_system_score_gemma":0.00038264596,"threshold_uncertainty_score":0.011757791},"labels":[],"label_agreement":null},{"id":"W4409628026","doi":"10.1158/1538-7445.am2025-1605","title":"Abstract 1605: Pretreatment of bone anabolic agent delays or prevents multiple myeloma progression","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coquitlam College","funders":"","keywords":"Anabolism; Multiple myeloma; Medicine; Cancer research; Internal medicine","score_opus":0.11802903711022525,"score_gpt":0.5170269246188987,"score_spread":0.3989978875086734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409628026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908757,0.0034987158,0.00080777437,0.00032565434,0.0002569991,0.00011260346,0.000658282,0.000201149,0.0032630502],"genre_scores_gemma":[0.9878207,0.0019488493,0.0017489402,0.00025653947,0.000099337725,0.00014943621,0.0015067843,0.00002441518,0.0064448183],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999866,0.00001636151,0.000014997149,0.000025823178,0.00003438088,0.00004245646],"domain_scores_gemma":[0.99985147,0.00001811893,0.000025202784,0.000013934608,0.000018128438,0.000073229974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010688797,0.00035439833,0.00051645783,0.00037371222,0.00015053927,0.00020454571,0.00034559373,0.00046441975,0.0037640831],"category_scores_gemma":[0.00015428627,0.00012969549,0.00032734266,0.00018062274,0.00026841988,0.00022470241,0.00016721165,0.0010020698,0.00062149524],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005481255,0.0019048033,0.0007171643,0.0002827832,0.00004065445,0.00013386259,0.000044818473,0.0001802552,0.9771852,0.0002772076,0.00095567026,0.012796298],"study_design_scores_gemma":[0.0010427379,0.030019797,0.008346128,0.000052928644,0.00013171772,0.00043833148,0.000070790964,0.0010431178,0.94777054,0.0001597359,0.010904474,0.000019740546],"about_ca_topic_score_codex":0.00091260107,"about_ca_topic_score_gemma":0.0014026574,"teacher_disagreement_score":0.0037640831,"about_ca_system_score_codex":0.00016791784,"about_ca_system_score_gemma":0.00059583085,"threshold_uncertainty_score":0.012592137},"labels":[],"label_agreement":null},{"id":"W4409637253","doi":"10.1158/1538-7445.am2025-6919","title":"Abstract 6919: Targeting CLIC3 as a novel strategy to inhibit metastasis in breast cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Breast cancer; Metastasis; Medicine; Cancer; Breast cancer metastasis; Cancer research; Oncology; Internal medicine; Cancer metastasis","score_opus":0.11760117573500518,"score_gpt":0.5142735370755451,"score_spread":0.39667236134053996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409637253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91080093,0.04667717,0.010191612,0.0018711219,0.00045527442,0.0009556035,0.005890102,0.0010785224,0.022079729],"genre_scores_gemma":[0.96698415,0.013331786,0.0055093938,0.0009544071,0.0000719753,0.00022997307,0.003774919,0.00007089099,0.0090724295],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99992657,0.000009081224,0.0000046811533,0.000014179699,0.000020655201,0.000024937559],"domain_scores_gemma":[0.9999572,0.000004494199,0.000010900629,0.00000295815,0.000009015161,0.000015401654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012332035,0.0005828,0.00048439775,0.0004819744,0.00018414996,0.00045090835,0.0004228881,0.00043302492,0.0038183283],"category_scores_gemma":[0.0000964088,0.00015391392,0.00040772313,0.00030695339,0.00018314815,0.00019139954,0.00028852114,0.00075416267,0.0011750383],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088939205,0.00039658992,0.00086969533,0.0004903597,0.00006122979,0.0004821873,0.000024151981,0.0019019332,0.95860624,0.0004781003,0.0026542873,0.033145785],"study_design_scores_gemma":[0.0016102717,0.007965462,0.0069245077,0.00015280886,0.0002762107,0.0023775215,0.000075528726,0.006643772,0.90968317,0.00046198393,0.063762285,0.00006651817],"about_ca_topic_score_codex":0.0016713812,"about_ca_topic_score_gemma":0.004320278,"teacher_disagreement_score":0.0038183283,"about_ca_system_score_codex":0.00058028055,"about_ca_system_score_gemma":0.00046736523,"threshold_uncertainty_score":0.012773573},"labels":[],"label_agreement":null},{"id":"W4409786349","doi":"10.70962/cis2025abstract.169","title":"Clinical and Genetic Characteristics of Global Cohort of 132 Individuals with Janus Kinase-3 Deficiency","year":2025,"lang":"en","type":"article","venue":"Journal of Human Immunity","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children’s Health Research Institute","funders":"","keywords":"Janus; Cohort; Medicine; Janus kinase; Genetics; Internal medicine; Kinase; Biology; Demography; Oncology; Environmental health; Materials science; Nanotechnology","score_opus":0.02760460059912138,"score_gpt":0.37842068128187706,"score_spread":0.35081608068275566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409786349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998355,0.00036453074,0.000063170606,0.000019360617,0.0000031062953,0.000015520905,0.00076619623,0.0000037644934,0.0004093313],"genre_scores_gemma":[0.99738055,0.00035974875,0.00014082497,0.00003617343,0.000014711066,0.000028677092,0.0018500496,0.0000040971677,0.00018499886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997788,0.000024715548,0.000038756883,0.00009052598,0.000030115745,0.00003710208],"domain_scores_gemma":[0.9995962,0.00008194536,0.00013769201,0.000040600884,0.000050783212,0.00009280244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029702307,0.0003592534,0.00049438665,0.0016423677,0.00062287756,0.00048612218,0.0002220481,0.00032450052,0.0017391035],"category_scores_gemma":[0.0012085421,0.00021476422,0.00036731298,0.0016162081,0.00033613545,0.00034649103,0.00047346717,0.00020989469,0.00038139263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012424395,0.000023399643,0.9929427,0.000032776043,0.00003596038,0.0034375181,0.00024537274,0.000038763406,0.0007915752,0.000022796072,0.00018963775,0.0021152685],"study_design_scores_gemma":[0.000019559091,0.00016376296,0.97624856,0.000023934697,0.00008049415,0.02140339,0.0005733666,0.000074232936,0.00020553646,0.00007518967,0.0011210776,0.000010822002],"about_ca_topic_score_codex":0.001520654,"about_ca_topic_score_gemma":0.001923504,"teacher_disagreement_score":0.0017391035,"about_ca_system_score_codex":0.00019423223,"about_ca_system_score_gemma":0.00032462925,"threshold_uncertainty_score":0.00581789},"labels":[],"label_agreement":null},{"id":"W4409821253","doi":"10.1158/1538-7445.am2025-lb432","title":"Abstract LB432: Clinical-stage anticancer agent BOLD-100 demonstrates protective effects against oxaliplatin-induced peripheral neuropathy in an in-vivo rat model","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"iCo Therapeutics (Canada)","funders":"","keywords":"Oxaliplatin; In vivo; Peripheral neuropathy; Medicine; Pharmacology; Peripheral; Stage (stratigraphy); Cancer; Oncology; Internal medicine; Biology; Endocrinology; Colorectal cancer","score_opus":0.15867087670373162,"score_gpt":0.5111299242472217,"score_spread":0.3524590475434901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409821253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850301,0.003617449,0.00341271,0.0004968844,0.00024260556,0.00020862174,0.0022065016,0.00037975944,0.0044052782],"genre_scores_gemma":[0.9807153,0.0038278967,0.0033408897,0.00032789574,0.00004400576,0.00031062492,0.0031393464,0.000044526267,0.0082495855],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985504,0.000024129155,0.000011456239,0.000028109778,0.000030604497,0.00005063385],"domain_scores_gemma":[0.999853,0.000012570269,0.000034265966,0.000014856044,0.00002224527,0.00006299855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003015642,0.0008317632,0.0005534869,0.00043366084,0.00023094715,0.0002565809,0.00042702875,0.0005906932,0.00416224],"category_scores_gemma":[0.00013310094,0.00022508283,0.00047893325,0.00037648476,0.00026797826,0.0004596872,0.00016183674,0.0022538686,0.00080920785],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056469366,0.0034222368,0.00032911767,0.0003887057,0.000053907595,0.00017880957,0.000041215168,0.00043766422,0.9806137,0.00018566407,0.0013223508,0.007379733],"study_design_scores_gemma":[0.0013043215,0.040348433,0.0076648667,0.00008164076,0.00021712876,0.00055727846,0.00013248785,0.0030745505,0.9398499,0.00021920935,0.0065141236,0.00003600581],"about_ca_topic_score_codex":0.0020446612,"about_ca_topic_score_gemma":0.0032031531,"teacher_disagreement_score":0.00416224,"about_ca_system_score_codex":0.00034152254,"about_ca_system_score_gemma":0.0006180144,"threshold_uncertainty_score":0.013924122},"labels":[],"label_agreement":null},{"id":"W4409917815","doi":"10.1371/journal.pone.0322371","title":"A remotely delivered exercise-based rehabilitation program for patients with persistent chemotherapy-induced peripheral neuropathy (EX-CIPN): Protocol for a phase I feasibility trial","year":2025,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary; Canadian Breast Cancer Network; Princess Margaret Cancer Centre; University of Waterloo; Canadian Cancer Society; University of Toronto","funders":"Cancer Research Society","keywords":"Chemotherapy-induced peripheral neuropathy; Medicine; Physical therapy; Rehabilitation; Randomized controlled trial; Adverse effect; Intervention (counseling); Peripheral neuropathy; Internal medicine; Psychiatry","score_opus":0.07331928424602854,"score_gpt":0.37915361167379424,"score_spread":0.30583432742776573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409917815","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0059710904,0.00011669089,0.0005990082,0.00011688068,0.00008198837,0.991859,0.00064497057,0.000039345727,0.00057101296],"genre_scores_gemma":[0.0034612075,0.00012773353,0.0011166545,0.00012344847,0.000020496758,0.99466276,0.00012924339,0.0000024667931,0.00035601621],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99362046,0.0033217582,0.00054610067,0.0006270902,0.0007965733,0.0010881249],"domain_scores_gemma":[0.9943539,0.0011138283,0.0011372305,0.00064560707,0.0012884521,0.0014609008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014620525,0.0042543407,0.005328577,0.0017899547,0.003149181,0.002365388,0.003897284,0.005197234,0.04685804],"category_scores_gemma":[0.010650089,0.002155212,0.003085104,0.0016606364,0.0026919753,0.0023074523,0.0023868403,0.0072646863,0.007405576],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69932073,0.1999897,0.0018432105,0.01431468,0.0011338289,0.00046835054,0.00090466195,0.004411742,0.0051022014,0.002250896,0.015535991,0.054723952],"study_design_scores_gemma":[0.7986533,0.17068529,0.004171246,0.0016177595,0.00046340807,0.0000840552,0.00031236777,0.0011023094,0.001038952,0.0012283761,0.020538162,0.000104682746],"about_ca_topic_score_codex":0.002729274,"about_ca_topic_score_gemma":0.0054573724,"teacher_disagreement_score":0.04685804,"about_ca_system_score_codex":0.003468012,"about_ca_system_score_gemma":0.015816743,"threshold_uncertainty_score":0.15675575},"labels":[],"label_agreement":null},{"id":"W4410642937","doi":"10.2196/65924","title":"Effect of Immersive Virtual Reality on Chemotherapy-Related Side Effects in Patients Receiving Paclitaxel-Carboplatin With or Without Bevacizumab: 2-Arm Randomized Controlled Trial","year":2025,"lang":"en","type":"article","venue":"Journal of Medical Internet Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Paclitaxel; Carboplatin; Bevacizumab; Randomized controlled trial; Medicine; Oncology; Internal medicine; Cancer; Chemotherapy; Cisplatin","score_opus":0.020467767564954525,"score_gpt":0.42765156547027355,"score_spread":0.407183797905319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410642937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97602886,0.0070598475,0.0011802488,0.0008182357,0.0012180038,0.010598522,0.00102154,0.00016106854,0.0019136177],"genre_scores_gemma":[0.97196275,0.0034523488,0.002856562,0.0011133731,0.000841828,0.016859462,0.0006920615,0.000018346776,0.0022033672],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998771,0.0006415899,0.00010902167,0.00023055161,0.00009428904,0.00015346395],"domain_scores_gemma":[0.99859506,0.00050268945,0.00034218398,0.000110433015,0.0001021962,0.0003475444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019811615,0.001781713,0.0049888478,0.00052596827,0.00051068317,0.0011613707,0.001094104,0.0020580844,0.008744437],"category_scores_gemma":[0.0024671354,0.0007903844,0.0030377384,0.0005657314,0.0010783533,0.0010886743,0.0006427492,0.0024373773,0.0006881465],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9819448,0.008571325,0.00025140154,0.00082511373,0.0011829544,0.000018637224,0.00002758496,0.00015584262,0.00059447525,0.00004263191,0.00019551873,0.0061895843],"study_design_scores_gemma":[0.9493652,0.04842547,0.00081677455,0.000033488584,0.0006815415,0.000009047943,0.000013428965,0.00029348806,0.00009486255,0.000049565802,0.00020706514,0.000010120573],"about_ca_topic_score_codex":0.0010035029,"about_ca_topic_score_gemma":0.0015641736,"teacher_disagreement_score":0.008744437,"about_ca_system_score_codex":0.00067306095,"about_ca_system_score_gemma":0.0011718012,"threshold_uncertainty_score":0.029253066},"labels":[],"label_agreement":null},{"id":"W4410818215","doi":"10.1200/jco.2025.43.16_suppl.tps4630","title":"ABLE-22: Safety and efficacy evaluation of nadofaragene firadenovec alone or in combination with chemotherapy or immunotherapy—A randomized, open-label, phase 2 study.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; McGill University Health Centre","funders":"","keywords":"Medicine; Oncology; Immunotherapy; Open label; Chemotherapy; Internal medicine; Randomized controlled trial; Cancer","score_opus":0.17611272513261214,"score_gpt":0.5627920855961613,"score_spread":0.3866793604635492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410818215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985776,0.0045484216,0.00090790587,0.00038128585,0.00031936637,0.0040763295,0.0017975491,0.00016475577,0.002028437],"genre_scores_gemma":[0.9863788,0.0026127114,0.0016442849,0.00092263607,0.00036659278,0.0034253246,0.0017781003,0.000042778694,0.0028286995],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994135,0.00030454886,0.000028003682,0.00011788754,0.00005484434,0.00008128754],"domain_scores_gemma":[0.9990916,0.00019111659,0.00023800116,0.00008114071,0.000053970904,0.000344151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022254009,0.0016565709,0.0021409243,0.00042989518,0.00028775938,0.0011832583,0.0009735706,0.0017535231,0.007509955],"category_scores_gemma":[0.0012274332,0.0007096295,0.0016951688,0.00041046354,0.0011069556,0.0012475566,0.00035482954,0.0027677761,0.0012377634],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9207322,0.039912593,0.00092474435,0.0006918869,0.0011830238,0.000062339546,0.000058992628,0.00043796917,0.009961722,0.00010370042,0.0011662593,0.024764614],"study_design_scores_gemma":[0.71400577,0.28014967,0.0022107854,0.00003094773,0.000494623,0.000076600896,0.000021995429,0.00042621727,0.0011714037,0.000106121544,0.00128319,0.000022692251],"about_ca_topic_score_codex":0.0005783152,"about_ca_topic_score_gemma":0.0013272801,"teacher_disagreement_score":0.007509955,"about_ca_system_score_codex":0.0006901494,"about_ca_system_score_gemma":0.0010708179,"threshold_uncertainty_score":0.025123298},"labels":[],"label_agreement":null},{"id":"W4410851732","doi":"10.31027/odprn.2025.03","title":"Hydromorphone dispensing across Public Health Units in Ontario, Canada","year":2025,"lang":"en","type":"report","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hydromorphone; Business; Geography; Medicine","score_opus":0.1421986454523517,"score_gpt":0.390048475903994,"score_spread":0.2478498304516423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410851732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93357235,0.0076564853,0.000681447,0.008247322,0.00015455192,0.00060521037,0.021941857,0.00017024628,0.026970496],"genre_scores_gemma":[0.97847533,0.004510174,0.0009181677,0.0014013116,0.000048151003,0.000099522884,0.002517403,0.000036039884,0.01199384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99692094,0.00017841182,0.00023415142,0.00033506562,0.001662752,0.0006687659],"domain_scores_gemma":[0.99290574,0.000422288,0.0016145731,0.000111820984,0.002878263,0.0020672635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007083569,0.00029956747,0.0004249602,0.001630479,0.0034435946,0.001637277,0.0015019194,0.00050861127,0.0051508364],"category_scores_gemma":[0.003090234,0.0006056386,0.00044972036,0.0050842757,0.0011056382,0.00056868186,0.0013524862,0.00075740763,0.00047853694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022124498,0.00014940405,0.92151546,0.00070434867,0.00013741541,0.0012996198,0.0067203073,0.0004318633,0.0012201227,0.0007579821,0.021223098,0.045619123],"study_design_scores_gemma":[0.00001670385,0.000056154695,0.9890456,0.00014339125,0.000026312026,0.0001945067,0.0043968414,0.00026759523,0.000115830015,0.00003529053,0.0056799953,0.000021806154],"about_ca_topic_score_codex":0.9978834,"about_ca_topic_score_gemma":0.9990854,"teacher_disagreement_score":0.08380833,"about_ca_system_score_codex":0.08380833,"about_ca_system_score_gemma":0.13517754,"threshold_uncertainty_score":0.6080749},"labels":[],"label_agreement":null},{"id":"W4411015928","doi":"10.1007/s00520-025-09553-z","title":"Cannabidiol and multi-modal exercise for chemotherapy-induced peripheral neuropathy in cancer survivors","year":2025,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Jewish General Hospital; McGill University; Concordia University; McGill University Health Centre","funders":"Fondation du cancer des Cèdres; Canadian Institutes of Health Research; Réseau de cancérologie Rossy","keywords":"Medicine; Pain medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Nursing research; Cannabidiol; Chemotherapy; Cancer; Peripheral; Physical therapy; Internal medicine; Oncology; Physical medicine and rehabilitation; Intensive care medicine; Diabetes mellitus; Anesthesia; Pathology; Psychiatry","score_opus":0.02979570122995216,"score_gpt":0.39500522739729105,"score_spread":0.36520952616733887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411015928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996967,0.0025070664,0.000038523176,0.000081834034,0.000008769648,0.000052181334,0.00002861426,0.000003827604,0.00031204353],"genre_scores_gemma":[0.9979372,0.0015651234,0.00020147004,0.00006709595,0.000012123298,0.000033791577,0.000027856702,6.909864e-7,0.00015464975],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9999105,0.000039510105,0.000008506186,0.000009499232,0.000018994146,0.000013049044],"domain_scores_gemma":[0.99973744,0.000102402715,0.00008680146,0.000007980043,0.000019879371,0.0000454734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032471344,0.00012850607,0.00032748346,0.00017046416,0.00014232473,0.00014452352,0.00015440327,0.00017673183,0.0011185581],"category_scores_gemma":[0.0008064939,0.00005907065,0.00021652837,0.0001734644,0.000104954415,0.00011030246,0.00015310914,0.00024308889,0.00006831835],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08005674,0.020528425,0.2196174,0.002644615,0.001826278,0.00024333205,0.00039932365,0.0010062756,0.023560949,0.00011834452,0.00068159256,0.6493168],"study_design_scores_gemma":[0.009013729,0.11725952,0.8593677,0.00044632284,0.0021885207,0.0004341671,0.00054361275,0.0017201281,0.0056867506,0.00017678404,0.0031319438,0.000030883668],"about_ca_topic_score_codex":0.0014417404,"about_ca_topic_score_gemma":0.004016801,"teacher_disagreement_score":0.0014417404,"about_ca_system_score_codex":0.00019885428,"about_ca_system_score_gemma":0.00040465716,"threshold_uncertainty_score":0.0037419796},"labels":[],"label_agreement":null},{"id":"W4411048955","doi":"10.1016/j.acci.2025.05.004","title":"Azul de metileno como terapia complementaria en el manejo del shock séptico refractario en los pacientes con cáncer: experiencia clínica","year":2025,"lang":"es","type":"article","venue":"Acta Colombiana de Cuidado Intensivo","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Information and Communications Technology Council","keywords":"Medicine; Humanities; Art","score_opus":0.013509889801242653,"score_gpt":0.35029425572198314,"score_spread":0.33678436592074046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411048955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97382927,0.021555023,0.0004819144,0.00086590654,0.00018609026,0.000094243376,0.000082969134,0.000022749027,0.0028817921],"genre_scores_gemma":[0.98511314,0.011225335,0.0012950324,0.00026535825,0.00010676854,0.000044718436,0.000035839596,0.000004626941,0.0019090977],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99991155,0.000038185102,0.0000037256198,0.000015360409,0.000012804602,0.00001847087],"domain_scores_gemma":[0.99990034,0.000041679654,0.000012981847,0.0000050300896,0.00001495854,0.00002509862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023193461,0.00021456486,0.0004682022,0.00018301305,0.00038473876,0.00038658822,0.00016354967,0.00032310456,0.0014941486],"category_scores_gemma":[0.0005146705,0.00006403032,0.00022687716,0.00014782521,0.00022082208,0.00016772549,0.0002282974,0.0006397418,0.000112935464],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08252372,0.022591243,0.017702421,0.0049600503,0.0004862384,0.0037373537,0.004703071,0.00082079426,0.13077368,0.0015434767,0.0053834217,0.72477454],"study_design_scores_gemma":[0.020335715,0.50877756,0.17731282,0.0021607643,0.0037440753,0.011808714,0.014502129,0.004621586,0.12143681,0.0023220007,0.13271499,0.00026288148],"about_ca_topic_score_codex":0.0022940943,"about_ca_topic_score_gemma":0.0036345066,"teacher_disagreement_score":0.0022940943,"about_ca_system_score_codex":0.00020672008,"about_ca_system_score_gemma":0.0004293863,"threshold_uncertainty_score":0.004998386},"labels":[],"label_agreement":null},{"id":"W4411257548","doi":"10.1016/j.jbc.2025.108742","title":"Abstract 2631 Neutral sphingomyelinase 2 and Extracellular Vesicles in Doxorubicin-induced Cardiotoxicity","year":2025,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Cardiotoxicity; Doxorubicin; Extracellular vesicles; Vesicle; Extracellular; Sphingomyelin; Chemistry; Cancer research; Pharmacology; Cell biology; Medicine; Biochemistry; Internal medicine; Biology; Chemotherapy; Membrane","score_opus":0.032158003070425836,"score_gpt":0.320819838211508,"score_spread":0.2886618351410822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411257548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8967366,0.08008065,0.0056395046,0.0021815314,0.0008983581,0.00017610137,0.00079417205,0.00009057404,0.013402555],"genre_scores_gemma":[0.98066163,0.008364549,0.00091316947,0.00023821223,0.0001255252,0.000035697045,0.00034647217,0.0000068926493,0.00930779],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999238,0.000020994066,0.000007059169,0.000011415887,0.00001981304,0.000016948235],"domain_scores_gemma":[0.9999106,0.000017320133,0.000026608528,0.0000061121045,0.000014213455,0.00002525993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028816186,0.00032824455,0.0002515132,0.00023253536,0.00011273705,0.0003309273,0.0001143494,0.00047016534,0.003104442],"category_scores_gemma":[0.00014770222,0.00010663458,0.00024984396,0.000104940904,0.00025131184,0.0002983493,0.0002826885,0.0005409505,0.0006359972],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037820227,0.00020194636,0.0018477436,0.0005768142,0.00006273302,0.001798078,0.00006505887,0.00040506324,0.9649537,0.002792901,0.0012053865,0.022308666],"study_design_scores_gemma":[0.0005408652,0.0035197104,0.053723887,0.00016009594,0.00017556257,0.005924808,0.0001843549,0.0046205684,0.8893254,0.0033280721,0.03846387,0.000032804644],"about_ca_topic_score_codex":0.00027549887,"about_ca_topic_score_gemma":0.00019078897,"teacher_disagreement_score":0.003104442,"about_ca_system_score_codex":0.00023279645,"about_ca_system_score_gemma":0.00014082291,"threshold_uncertainty_score":0.010385394},"labels":[],"label_agreement":null},{"id":"W4411302561","doi":"10.69854/jcq.2025.0014","title":"The Effectiveness of Cryotherapy or Compression Therapy in Preventing Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review and Network Meta-Analysis","year":2025,"lang":"en","type":"review","venue":"Journal of Clinical Question","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Meta-analysis; Peripheral neuropathy; Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral; Systematic review; Chemotherapy; Oncology; Internal medicine; MEDLINE; Biology; Endocrinology","score_opus":0.20216772835175253,"score_gpt":0.5373493894484948,"score_spread":0.3351816610967422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411302561","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041913614,0.99369746,0.0006738132,0.00016650726,0.00010619405,0.0003656171,0.0005613774,0.00002807737,0.00020962971],"genre_scores_gemma":[0.17157577,0.8209306,0.003166705,0.0007487324,0.00024476126,0.001934024,0.0010339337,0.000036005193,0.00032936482],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99035865,0.0048500365,0.0024477865,0.000975614,0.0010688779,0.00029906206],"domain_scores_gemma":[0.97460777,0.020333417,0.0029679693,0.0005202911,0.0013055946,0.0002649796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014507622,0.0028786806,0.02052598,0.008575718,0.00071744906,0.0029688226,0.0027003326,0.0022529627,0.0042743245],"category_scores_gemma":[0.034682997,0.0013238543,0.04189422,0.008444976,0.0007074566,0.0018409771,0.0015957085,0.0019132458,0.00028469512],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015511035,0.000028849721,0.0034836698,0.4216144,0.5618674,0.000101859274,0.000060341503,0.0006118572,0.00012175552,0.0001120405,0.00043520072,0.01001146],"study_design_scores_gemma":[0.00035216834,0.0001447035,0.0023752828,0.021196127,0.97457904,0.000061401115,0.000026283695,0.00023268205,0.00005960357,0.00013444097,0.00082297914,0.000015355623],"about_ca_topic_score_codex":0.0076230923,"about_ca_topic_score_gemma":0.014183935,"teacher_disagreement_score":0.02052598,"about_ca_system_score_codex":0.0028756806,"about_ca_system_score_gemma":0.0040332917,"threshold_uncertainty_score":0.07672453},"labels":[],"label_agreement":null},{"id":"W4411649910","doi":"10.1177/10732748251353327","title":"Enhancing Duloxetine With Mirogabalin for Treating Taxane-Induced Peripheral Neuropathy in Advanced Lung Cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Control","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre","funders":"","keywords":"Medicine; Duloxetine; Chemotherapy-induced peripheral neuropathy; Interquartile range; Internal medicine; Lung cancer; Taxane; Oncology; Cancer; Peripheral neuropathy; Breast cancer","score_opus":0.008538142592791792,"score_gpt":0.3406774960586971,"score_spread":0.33213935346590534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411649910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923637,0.006329093,0.00014826049,0.00015528765,0.000020941394,0.000054731856,0.0001558177,0.000010478423,0.0007617391],"genre_scores_gemma":[0.99673766,0.0023594394,0.0003567844,0.00013126893,0.000028269726,0.000033999717,0.00016941159,0.0000014505777,0.00018179422],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998349,0.00003813767,0.000025968622,0.000026015967,0.000042595788,0.000032384247],"domain_scores_gemma":[0.99979466,0.00004456687,0.00010142719,0.0000058385185,0.000018779743,0.000034675755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017492354,0.00015032568,0.00032602338,0.000204245,0.00021040747,0.00025637378,0.00016816652,0.00014542192,0.0009716127],"category_scores_gemma":[0.00051032746,0.000048419646,0.00037473883,0.00027634384,0.000103928905,0.00013540595,0.00018573934,0.00021726543,0.000098724595],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004441705,0.0009968445,0.7955334,0.0010154062,0.00052561006,0.0021667029,0.00022560894,0.0002980129,0.01655465,0.00010413647,0.0010476817,0.1770903],"study_design_scores_gemma":[0.00024673343,0.0040791873,0.9877121,0.00016502269,0.00035806978,0.0026749067,0.00024951855,0.00057267287,0.001702838,0.000064410495,0.002163109,0.000011529316],"about_ca_topic_score_codex":0.0020660197,"about_ca_topic_score_gemma":0.008149412,"teacher_disagreement_score":0.0020660197,"about_ca_system_score_codex":0.00035597544,"about_ca_system_score_gemma":0.00044363507,"threshold_uncertainty_score":0.004107952},"labels":[],"label_agreement":null},{"id":"W4411995564","doi":"10.1136/bcr-2025-265205","title":"Multiday intravenous ketamine infusion therapy for the management of central sensitisation syndrome secondary to chronic chemotherapy–induced peripheral neuropathic pain","year":2025,"lang":"en","type":"article","venue":"BMJ Case Reports","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Ketamine; Chronic pain; Anesthesia; Refractory (planetary science); Analgesic; Neuropathic pain; Cancer pain; Cancer; Internal medicine; Physical therapy","score_opus":0.01782999677625906,"score_gpt":0.31770209473204847,"score_spread":0.2998720979557894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411995564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78966165,0.14748521,0.021149192,0.009615089,0.00085947895,0.00031753903,0.00011301781,0.00032909622,0.030469827],"genre_scores_gemma":[0.9796697,0.014709303,0.0027169737,0.0014988772,0.0004126839,0.00004016114,0.000051953444,0.000015131619,0.0008852277],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998945,0.000027218372,0.000014374939,0.000012058939,0.000020912245,0.000030954965],"domain_scores_gemma":[0.9998085,0.00003956863,0.000068362,0.000010443259,0.000009543235,0.000063618565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000118425036,0.0002625155,0.00036856066,0.00041235803,0.00040746396,0.00023951917,0.00026838918,0.0006686756,0.0008769601],"category_scores_gemma":[0.0006274428,0.00010052699,0.00037868915,0.00028636822,0.00037029447,0.00045247024,0.0003321461,0.0010683464,0.00025458058],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008178582,0.00044053103,0.030620193,0.0011335491,0.00016768953,0.7068642,0.0005705959,0.0008906464,0.02666315,0.001874642,0.007827018,0.22212996],"study_design_scores_gemma":[0.00013771038,0.00091102335,0.021147888,0.0003697669,0.00006481373,0.9550801,0.00019042748,0.0015544529,0.002618919,0.0009835741,0.016911648,0.000029591962],"about_ca_topic_score_codex":0.0003834992,"about_ca_topic_score_gemma":0.0012453129,"teacher_disagreement_score":0.0008769601,"about_ca_system_score_codex":0.00032000343,"about_ca_system_score_gemma":0.00040392138,"threshold_uncertainty_score":0.0029337406},"labels":[],"label_agreement":null},{"id":"W4412048074","doi":"10.51731/cjht.2025.1159","title":"Semaglutide (Wegovy)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Semaglutide; Medicine; Endocrinology","score_opus":0.02301648044997576,"score_gpt":0.35637882620294414,"score_spread":0.33336234575296836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412048074","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23430073,0.23122308,0.010811312,0.023170639,0.0041394224,0.0016399728,0.017211584,0.008475956,0.46902722],"genre_scores_gemma":[0.6982787,0.053763155,0.008488359,0.017395953,0.0008251837,0.0005816145,0.017683912,0.00036228893,0.20262086],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983764,0.000027094744,0.000012286012,0.00003035903,0.000060431328,0.000032182917],"domain_scores_gemma":[0.9998946,0.000014556807,0.000015547865,0.0000072971525,0.000024229219,0.000043836393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023420238,0.00031921547,0.0005772474,0.0005670978,0.0002908957,0.00067347416,0.0003908398,0.0008576526,0.02033779],"category_scores_gemma":[0.00041570497,0.00009966291,0.0004849905,0.0004607956,0.00021619994,0.00051761226,0.0003529095,0.0017477126,0.010024074],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055019027,0.0009894093,0.0020682458,0.0013947872,0.00021732003,0.0010850846,0.0000756631,0.00051976414,0.021579307,0.0034330778,0.17670704,0.7864284],"study_design_scores_gemma":[0.0103883175,0.0062448904,0.015247959,0.00082420325,0.00031321225,0.008564725,0.00010990204,0.0018272012,0.019649876,0.002580938,0.9341617,0.000087104825],"about_ca_topic_score_codex":0.003894619,"about_ca_topic_score_gemma":0.010231606,"teacher_disagreement_score":0.02033779,"about_ca_system_score_codex":0.00068326894,"about_ca_system_score_gemma":0.0008651171,"threshold_uncertainty_score":0.068036675},"labels":[],"label_agreement":null},{"id":"W4412166556","doi":"10.1017/cjn.2025.10214","title":"P.033 Long-term efficacy of Efgartigimod PH20 SC in patients with chronic inflammatory demyelinating polyneuropathy: interim results from the ADHERE+ study","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chronic inflammatory demyelinating polyneuropathy; Medicine; Interim; Term (time); Internal medicine; Immunology; Antibody; Political science; Physics","score_opus":0.027385750175935825,"score_gpt":0.3082753978035754,"score_spread":0.28088964762763957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412166556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.946547,0.015913013,0.0010816907,0.0018827921,0.00059314753,0.0029173899,0.015496829,0.00024714472,0.015321064],"genre_scores_gemma":[0.9708853,0.003760309,0.0021690417,0.0019361156,0.00078914297,0.0026579583,0.011898637,0.000037610185,0.005865998],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99947315,0.0002306884,0.00006136733,0.00006430916,0.00008572262,0.000084899184],"domain_scores_gemma":[0.99887866,0.00030619887,0.00031233224,0.00013108365,0.00016312036,0.00020860229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026998431,0.00072354655,0.0014510867,0.0001822279,0.00035623022,0.0010876356,0.0006237505,0.0010556686,0.009304362],"category_scores_gemma":[0.0014211898,0.00023678105,0.0023184018,0.00030700458,0.0003491349,0.00062443933,0.0004142156,0.0015455202,0.0014020363],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81633097,0.0069264914,0.01385034,0.001824542,0.006248943,0.00025806602,0.00012209851,0.0009651904,0.009825133,0.00025153297,0.014174654,0.12922202],"study_design_scores_gemma":[0.60011226,0.27473965,0.101475276,0.0004380934,0.007349528,0.00037975778,0.00010462908,0.0011424917,0.0028613154,0.0005151824,0.010824568,0.000057241752],"about_ca_topic_score_codex":0.00080368493,"about_ca_topic_score_gemma":0.001669704,"teacher_disagreement_score":0.009304362,"about_ca_system_score_codex":0.00037246596,"about_ca_system_score_gemma":0.000798205,"threshold_uncertainty_score":0.03112626},"labels":[],"label_agreement":null},{"id":"W4412443876","doi":"10.1016/j.jval.2025.04.227","title":"CO142 Association Between Event-Free/Distant Relapse-Free Survival and Overall Survival in Patients With Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Luminex (Canada)","funders":"","keywords":"Estrogen receptor; Oncology; Human Epidermal Growth Factor Receptor 2; Breast cancer; Stage (stratigraphy); Internal medicine; Medicine; Overall survival; Estrogen; Association (psychology); Cancer; Biology; Psychology; Psychotherapist","score_opus":0.021796428215652187,"score_gpt":0.3126796995815,"score_spread":0.2908832713658478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99826306,0.00040735627,0.00006425023,0.00009244351,0.000019792833,0.0000028358943,0.0002984082,0.0000034367313,0.0008484732],"genre_scores_gemma":[0.9989986,0.00007210641,0.000024953817,0.000030293253,0.000026261443,0.0000023493942,0.00028821972,0.0000017578187,0.00055541605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984634,0.000042408075,0.000013294145,0.000030167366,0.00001872345,0.000049034043],"domain_scores_gemma":[0.9993563,0.0001990619,0.00016219186,0.000035469417,0.00005661778,0.00019036347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027955108,0.00021414751,0.0003283851,0.0003516796,0.00026251024,0.0005227014,0.00023176442,0.00042888086,0.0031638579],"category_scores_gemma":[0.0010611063,0.00015540545,0.0005034366,0.0005495221,0.0002026758,0.00033072828,0.00030347006,0.0006862921,0.00035513632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013106641,0.000051404426,0.9961694,0.000009509253,0.00010611429,0.00009621175,0.00002033991,0.000054303262,0.00046978108,0.000022480674,0.00013028478,0.0015596608],"study_design_scores_gemma":[0.000033626962,0.00017538162,0.998782,0.0000024067551,0.00008542626,0.00017412669,0.00008531017,0.0003057587,0.00008679305,0.00005627183,0.00020844788,0.000004320446],"about_ca_topic_score_codex":0.0019114274,"about_ca_topic_score_gemma":0.0032610947,"teacher_disagreement_score":0.0031638579,"about_ca_system_score_codex":0.00022713863,"about_ca_system_score_gemma":0.00025251176,"threshold_uncertainty_score":0.010584116},"labels":[],"label_agreement":null},{"id":"W4412474024","doi":"10.3390/tomography11070081","title":"TACE Versus TARE in the Treatment of Liver-Metastatic Breast Cancer: A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Tomography","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Breast cancer; Metastatic breast cancer; Internal medicine; Oncology; Cancer; Overall survival; Liver cancer","score_opus":0.0575185709616946,"score_gpt":0.4119265318816077,"score_spread":0.3544079609199131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412474024","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011635523,0.99788266,0.00009360829,0.00016726964,0.00008136064,0.00023076695,0.00018704482,0.0000060224506,0.00018763707],"genre_scores_gemma":[0.018980699,0.9792317,0.00045124858,0.0005157573,0.0000969424,0.00045483655,0.00015872442,0.0000050526623,0.00010501954],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9958609,0.001734573,0.0013590445,0.00027799286,0.00061202864,0.00015551496],"domain_scores_gemma":[0.98651147,0.009567255,0.0024646935,0.0001342596,0.0011464065,0.00017595994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047235717,0.0012118772,0.007766593,0.00555107,0.00051781855,0.0018961618,0.0013939462,0.0016846242,0.0032958698],"category_scores_gemma":[0.02049377,0.00064449746,0.00821374,0.006786447,0.0006513809,0.0014874954,0.000892801,0.0009964539,0.00024707406],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002963871,0.000015382306,0.00042131485,0.9657336,0.0119020045,0.000062014406,0.00008260756,0.00008994639,0.00014262056,0.00009793244,0.0007931461,0.020363089],"study_design_scores_gemma":[0.00068384956,0.00047710512,0.003727491,0.81965446,0.16214274,0.00037591273,0.00022332951,0.00016706427,0.00022499613,0.00023468432,0.012053063,0.00003523091],"about_ca_topic_score_codex":0.0066190446,"about_ca_topic_score_gemma":0.021257043,"teacher_disagreement_score":0.007766593,"about_ca_system_score_codex":0.0029016165,"about_ca_system_score_gemma":0.0073534204,"threshold_uncertainty_score":0.024980962},"labels":[],"label_agreement":null},{"id":"W4412479885","doi":"10.1016/j.annonc.2025.05.048","title":"36P BREAKWATER: Post-hoc subgroup efficacy analyses by chemotherapy ± bevacizumab regimens vs encorafenib plus cetuximab + mFOLFOX6","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Sunnybrook Health Science Centre","funders":"Cilag; MSD K.K.; Chugai Pharmaceutical; EMD Serono; Nordic Pharma Group; Novocure; Menarini Group; American Association for Cancer Research; Incyte; Servier; Pfizer Japan; Sociedad Española de Oncología Médica; PharmaMar; Novartis Farmacéutica; Daiichi Sankyo Europe; European Society for Medical Oncology; Astellas Pharma; Eisai; Miyarisan Pharmaceutical; Daiichi-Sankyo; AstraZeneca; Genentech; University of Oxford; Sirtex Medical; Cancer Research UK; Springworks Therapeutics; Seagen; Sysmex Corporation; BeiGene; Mirati Therapeutics; Takeda Pharmaceutical Company; Ono Pharmaceutical; Eli Lilly and Company; Les Laboratories Pierre Fabre; Pfizer; Taiho Pharmaceutical; Boehringer Ingelheim Japan; Merck KGaA; Natera; Regeneron Pharmaceuticals; Ipsen; Array BioPharma; Amgen; Bristol-Myers Squibb; American Society of Clinical Oncology; Revolution Medicines; Exelixis; Sanofi; Celgene","keywords":"Medicine; Bevacizumab; Cetuximab; Oncology; Post-hoc analysis; Internal medicine; Chemotherapy; Post hoc; Cancer; Colorectal cancer","score_opus":0.08269816231793721,"score_gpt":0.46742718925177834,"score_spread":0.38472902693384115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412479885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84426206,0.014347581,0.015166426,0.009777502,0.024887927,0.016195575,0.048023965,0.0019749657,0.025364019],"genre_scores_gemma":[0.887232,0.002213924,0.0127978455,0.009788083,0.0023830847,0.01924584,0.010192342,0.0010154595,0.055131435],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9816535,0.008770893,0.0012414919,0.002987157,0.0012319768,0.004114987],"domain_scores_gemma":[0.98714346,0.007838713,0.0012213895,0.0017529584,0.0008543865,0.0011891985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013116333,0.0055175466,0.013946258,0.0013865331,0.0010599485,0.0028292655,0.0036081518,0.0048808013,0.040110152],"category_scores_gemma":[0.022964556,0.001985187,0.024476374,0.0013311692,0.0016730314,0.0065139304,0.0022456024,0.014964338,0.003582127],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9307256,0.0028192035,0.0018122642,0.0014608576,0.028475437,0.00023570168,0.00015758046,0.0015355265,0.0028202843,0.00055167143,0.015045047,0.014360923],"study_design_scores_gemma":[0.5549055,0.2130443,0.0693918,0.0009613555,0.080712244,0.00030616552,0.0010755295,0.019711858,0.013152914,0.0082624145,0.037900925,0.00057503296],"about_ca_topic_score_codex":0.0054887566,"about_ca_topic_score_gemma":0.011005903,"teacher_disagreement_score":0.040110152,"about_ca_system_score_codex":0.0036433102,"about_ca_system_score_gemma":0.0052925986,"threshold_uncertainty_score":0.1341818},"labels":[],"label_agreement":null},{"id":"W4412612589","doi":"10.51731/cjht.2025.1174","title":"Leuprolide Mesylate (Camcevi)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mesylate; Medicine; Medical physics; Chemistry","score_opus":0.024821458400973634,"score_gpt":0.36169274152501346,"score_spread":0.3368712831240398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412612589","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24083832,0.3838225,0.009130719,0.0121986605,0.002659487,0.0013750205,0.013550417,0.004042252,0.33238265],"genre_scores_gemma":[0.7710422,0.08049145,0.010455725,0.0071436306,0.0005954485,0.00043933428,0.011069512,0.00019615707,0.11856654],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998179,0.000025079851,0.000011588154,0.000037302143,0.000075772514,0.000032344993],"domain_scores_gemma":[0.99989676,0.000013345043,0.000020121704,0.000006598581,0.000014503823,0.00004853807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010186628,0.0003448524,0.00039520487,0.00073487114,0.0003100398,0.0003342569,0.00037955405,0.0005408512,0.018765183],"category_scores_gemma":[0.00031280544,0.000116264506,0.00029911372,0.0004416045,0.00022237713,0.00024014297,0.00034776266,0.0014193848,0.0067771967],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048860954,0.0011242109,0.001869567,0.0022265492,0.00015368742,0.0031555428,0.00009100878,0.00050766184,0.12998278,0.0035192168,0.0734671,0.7790165],"study_design_scores_gemma":[0.004338309,0.0059756152,0.016379261,0.00063939096,0.00016889423,0.021027377,0.000121745696,0.0007763724,0.13107602,0.0011990789,0.81819427,0.00010367147],"about_ca_topic_score_codex":0.0041072234,"about_ca_topic_score_gemma":0.008484108,"teacher_disagreement_score":0.018765183,"about_ca_system_score_codex":0.00055052503,"about_ca_system_score_gemma":0.00059863884,"threshold_uncertainty_score":0.06277579},"labels":[],"label_agreement":null},{"id":"W4412943763","doi":"10.3390/reports8030133","title":"Percutaneous Peripheral Nerve Stimulation in Chemotherapy-Induced Neuropathy: A Case Report","year":2025,"lang":"en","type":"article","venue":"Reports — Medical Cases Images and Videos","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Oxaliplatin; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Adverse effect; Percutaneous; Clinical trial; Chemotherapy; Surgery; Anesthesia; Oncology; Internal medicine; Colorectal cancer; Cancer","score_opus":0.01885543846147116,"score_gpt":0.3567036263699896,"score_spread":0.33784818790851845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412943763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9055522,0.035793077,0.016252106,0.008209954,0.0011216268,0.0005440579,0.00041602965,0.00051989063,0.031591106],"genre_scores_gemma":[0.9847799,0.006082944,0.0029917222,0.0016486406,0.0015114751,0.000066743996,0.00010221424,0.000024748706,0.002791613],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9992785,0.00009656617,0.00008030973,0.00019101895,0.00012082922,0.0002328085],"domain_scores_gemma":[0.9988201,0.0003642873,0.00030022993,0.00012711565,0.00007206831,0.00031618317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003686557,0.0022461389,0.001481216,0.002302141,0.0028627124,0.0020264506,0.0014752798,0.007193672,0.0036283284],"category_scores_gemma":[0.0020954083,0.0011574615,0.0012520202,0.0020093885,0.0022119884,0.0027792435,0.001653092,0.0038188957,0.0012294252],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014527462,0.00004023697,0.00138617,0.000039430877,0.0000066305925,0.996651,0.000057866797,0.000051981842,0.000270761,0.00009274687,0.0001749068,0.001213852],"study_design_scores_gemma":[0.000006882096,0.00003272573,0.000698318,0.00001562372,0.0000070173974,0.99858654,0.000045022178,0.000113006914,0.00013425227,0.00007350625,0.00028206353,0.000005159197],"about_ca_topic_score_codex":0.0019053784,"about_ca_topic_score_gemma":0.0025412405,"teacher_disagreement_score":0.007193672,"about_ca_system_score_codex":0.0017630266,"about_ca_system_score_gemma":0.0010748381,"threshold_uncertainty_score":0.012791753},"labels":[],"label_agreement":null},{"id":"W4413927988","doi":"10.51731/cjht.2025.1211","title":"Relugolix–Estradiol–Norethindrone Acetate (Myfembree)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry; Environmental chemistry; Chromatography","score_opus":0.029234205271672614,"score_gpt":0.34878129655109763,"score_spread":0.31954709127942504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413927988","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24665178,0.43661922,0.0072964546,0.019370342,0.0025863377,0.001648053,0.013612976,0.0032703697,0.2689446],"genre_scores_gemma":[0.6757724,0.10972998,0.014750122,0.013875101,0.0010447395,0.0005799941,0.010386334,0.00019198818,0.17366934],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985194,0.000024756471,0.000009046395,0.000022222519,0.00006782836,0.000024122775],"domain_scores_gemma":[0.99985874,0.000025112418,0.00003623016,0.0000101685855,0.000018003093,0.000051785628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028494062,0.00019572303,0.0003536661,0.0006155728,0.00028312276,0.00028424925,0.00031165316,0.0004892815,0.014785047],"category_scores_gemma":[0.00057236187,0.00010484589,0.00030401564,0.00027855474,0.00021043894,0.00018438452,0.00032161037,0.0008650863,0.0034104185],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004736495,0.0010708205,0.003625067,0.0014732168,0.00017402254,0.00090961595,0.000076282646,0.0002537256,0.026617877,0.0027601158,0.08112333,0.87717944],"study_design_scores_gemma":[0.0045262976,0.0056676036,0.030979175,0.000741655,0.0001326559,0.007423949,0.00008651567,0.0002913659,0.01044079,0.00071815006,0.93894786,0.00004390078],"about_ca_topic_score_codex":0.006732976,"about_ca_topic_score_gemma":0.01867568,"teacher_disagreement_score":0.014785047,"about_ca_system_score_codex":0.00042542035,"about_ca_system_score_gemma":0.00085503457,"threshold_uncertainty_score":0.049460948},"labels":[],"label_agreement":null},{"id":"W4413971696","doi":"10.5737/23688076354533","title":"Evaluating the effectiveness of an educational program on chemotherapy-induced peripheral neuropathy in enhancing competence among nurses in cancer care","year":2025,"lang":"en","type":"article","venue":"Canadian Oncology Nursing Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Competence (human resources); Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Medicine; Chemotherapy; Oncology; Medical education; Psychology; Nursing; Internal medicine","score_opus":0.0312821815795119,"score_gpt":0.4631359078486351,"score_spread":0.4318537262691232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413971696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978946,0.00015182559,0.00009950994,0.00008747627,0.000017834414,0.0010686911,0.000023611014,0.0000044084704,0.00065217813],"genre_scores_gemma":[0.9947336,0.0005143071,0.0021659643,0.00008529512,0.000024679395,0.0019539606,0.000081519756,0.0000011536446,0.00043963402],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984493,0.00086180324,0.00012470728,0.00008057637,0.00027524377,0.0002083089],"domain_scores_gemma":[0.995959,0.0019032458,0.0006155383,0.000101317324,0.0003891197,0.0010318431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034581893,0.00031705323,0.00039085269,0.00035476935,0.0005134898,0.00034668812,0.00063267694,0.00047859456,0.0019042587],"category_scores_gemma":[0.007677491,0.00018945258,0.0004786033,0.00024920804,0.00020800244,0.00040075814,0.0006203064,0.0005823375,0.00015283754],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017923115,0.24125628,0.17327753,0.004173239,0.00042097524,0.000363427,0.0072229374,0.0019019236,0.005847882,0.00024570705,0.0010832794,0.5462837],"study_design_scores_gemma":[0.005125856,0.31988263,0.6620626,0.0010354685,0.0004790205,0.00011739383,0.0028547102,0.0016042554,0.00394193,0.00008768142,0.0027642953,0.000044160355],"about_ca_topic_score_codex":0.0024814515,"about_ca_topic_score_gemma":0.0050235996,"teacher_disagreement_score":0.0034581893,"about_ca_system_score_codex":0.0010221627,"about_ca_system_score_gemma":0.0034742714,"threshold_uncertainty_score":0.01828885},"labels":[],"label_agreement":null},{"id":"W4414040538","doi":"10.1002/cam4.71218","title":"Impact of Population Pharmacogenomics on Cisplatin‐Induced Neurotoxicities in Testicular Cancer Survivors","year":2025,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"National Institute of General Medical Sciences; National Institutes of Health; National Cancer Institute; Regeneron Pharmaceuticals","keywords":"Pharmacogenomics; Population; Testicular cancer; Peripheral neuropathy; Allele; Allele frequency; Incidence (geometry); Cancer","score_opus":0.0466725608984853,"score_gpt":0.44975108906430644,"score_spread":0.4030785281658211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414040538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982216,0.00028234578,0.0006128426,0.00005933593,0.0000054920138,0.0000063971365,0.00047913392,0.0000070233878,0.00032595755],"genre_scores_gemma":[0.9995534,0.000058126872,0.0001193116,0.000017113587,0.000004254399,0.0000039238953,0.00014462501,0.0000031558982,0.00009603794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994405,0.00020240953,0.00004093024,0.00019213965,0.00006592492,0.000058071386],"domain_scores_gemma":[0.9991666,0.0002657678,0.00028685477,0.00012675958,0.00007829529,0.00007576613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005213771,0.00018825546,0.00027760293,0.00046831937,0.00035200428,0.0005025568,0.00019668254,0.00022956295,0.0022942896],"category_scores_gemma":[0.0015880564,0.00009334288,0.00052923855,0.00096265314,0.00026001481,0.00016558124,0.0003669684,0.00030741817,0.000099627556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030603958,0.00003423072,0.98780113,0.000023030392,0.00063452683,0.0001627292,0.00015439102,0.00042931325,0.0042138374,0.00018760012,0.00014084634,0.00591232],"study_design_scores_gemma":[0.000007763466,0.00012563016,0.997265,0.000006021766,0.00025913471,0.00023964515,0.000112858535,0.00083499437,0.00054224924,0.00021815444,0.00038333933,0.000005251566],"about_ca_topic_score_codex":0.00453549,"about_ca_topic_score_gemma":0.004474253,"teacher_disagreement_score":0.00453549,"about_ca_system_score_codex":0.00017510026,"about_ca_system_score_gemma":0.00024314706,"threshold_uncertainty_score":0.009018183},"labels":[],"label_agreement":null},{"id":"W4414649848","doi":"10.1016/j.ygyno.2025.04.079","title":"Updated duration of response for patients receiving dostarlimab plus carboplatin-paclitaxel treatment compared with patients receiving placebo plus carboplatin-paclitaxel in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Placebo; Duration (music); Interim analysis; Interim; Clinical trial; Overall survival","score_opus":0.03125459928371742,"score_gpt":0.3467446620976846,"score_spread":0.3154900628139672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414649848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96443605,0.018974088,0.00083463336,0.0012775427,0.0006780327,0.00047095664,0.0070688147,0.00010368855,0.0061561815],"genre_scores_gemma":[0.9876002,0.0022935534,0.0004746406,0.0009559841,0.00033902505,0.00040430165,0.004879405,0.000028316243,0.0030244691],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9987846,0.0006269635,0.000092166025,0.0002331648,0.00011712763,0.00014600977],"domain_scores_gemma":[0.9981185,0.0006629359,0.0005849379,0.00019672578,0.00009338589,0.0003435557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030670248,0.00077236886,0.0027682972,0.00033704052,0.000274052,0.0011052807,0.00055573334,0.0010522818,0.005367836],"category_scores_gemma":[0.0025821738,0.00035693456,0.0034566678,0.00037967582,0.00044324403,0.0013963066,0.00042268954,0.0031646758,0.000595677],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94620365,0.00076790084,0.007994202,0.000798304,0.0068225055,0.00006071135,0.000060315408,0.0013673591,0.0026015497,0.00026445728,0.0020634716,0.030995695],"study_design_scores_gemma":[0.72594774,0.11490263,0.12415442,0.00033454088,0.019027447,0.00034343585,0.00014839174,0.0026400925,0.0014883856,0.0016890855,0.009200986,0.0001227589],"about_ca_topic_score_codex":0.00075247785,"about_ca_topic_score_gemma":0.0019099478,"teacher_disagreement_score":0.005367836,"about_ca_system_score_codex":0.00078752224,"about_ca_system_score_gemma":0.0005623796,"threshold_uncertainty_score":0.01795721},"labels":[],"label_agreement":null},{"id":"W4414696025","doi":"10.51731/cjht.2025.1245","title":"Venetoclax (Venclexta)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ibrutinib; Venetoclax; Mantle cell lymphoma; Drug; Lymphoma; Public health","score_opus":0.025457065611933158,"score_gpt":0.36479889377678365,"score_spread":0.3393418281648505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414696025","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03938493,0.21899396,0.009629728,0.019947097,0.006526858,0.0017928117,0.019169858,0.009074755,0.67547995],"genre_scores_gemma":[0.3223414,0.10593909,0.019282935,0.01981222,0.0033347951,0.0010154268,0.029212933,0.0011969855,0.49786422],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99948406,0.00008559611,0.000016920712,0.000081746824,0.00024171705,0.00008994519],"domain_scores_gemma":[0.9993767,0.0001035826,0.00006905691,0.000054778968,0.0001279632,0.00026791877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006774502,0.00034514608,0.0004614514,0.0009290042,0.0007101829,0.0014983781,0.0006347038,0.0009413985,0.0949412],"category_scores_gemma":[0.001467845,0.00018080298,0.0004724289,0.0006427167,0.000415809,0.0005764658,0.00070151826,0.0026864072,0.01869743],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001582477,0.0005200299,0.0015610268,0.0009443933,0.000065833934,0.0006958016,0.000090421825,0.0002780165,0.008312667,0.0076338043,0.4269719,0.5513436],"study_design_scores_gemma":[0.00093357573,0.00054343086,0.002520991,0.00032361352,0.00004702722,0.0016322536,0.000026382271,0.00026760506,0.002667057,0.0008562734,0.99016833,0.000013304734],"about_ca_topic_score_codex":0.0125794625,"about_ca_topic_score_gemma":0.023549149,"teacher_disagreement_score":0.0949412,"about_ca_system_score_codex":0.0011937943,"about_ca_system_score_gemma":0.0022121652,"threshold_uncertainty_score":0.31760997},"labels":[],"label_agreement":null},{"id":"W4414786598","doi":"10.1093/neuonc/noaf193.335","title":"P10.24.A TARGETING NON-GENETIC KINASE-DEPENDENT SIGNALING TO PREVENT GROUP 3 MEDULLOBLASTOMA RECURRENCE","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Manitoba","funders":"","keywords":"Medulloblastoma; Hedgehog signaling pathway; Downregulation and upregulation; Signal transduction; Kinase; Sonic hedgehog; In vivo; Hedgehog","score_opus":0.017074041001101076,"score_gpt":0.3307893227200309,"score_spread":0.3137152817189298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414786598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846526,0.004278899,0.0026676564,0.00044400047,0.00033171795,0.00044345987,0.0016338687,0.00068596436,0.0048618685],"genre_scores_gemma":[0.9861069,0.0027519185,0.0023611598,0.00020504146,0.0000524158,0.0003135434,0.001942162,0.00006767046,0.0061992817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991107,0.000009302465,0.000005910819,0.000018269464,0.000016865451,0.000038561982],"domain_scores_gemma":[0.999928,0.0000061307637,0.000018320998,0.0000067352667,0.000005671241,0.00003503051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012619222,0.00062746427,0.0005022309,0.00034228447,0.00015681075,0.00030580835,0.00053160364,0.00035118024,0.0036693246],"category_scores_gemma":[0.000102919716,0.00016017242,0.00039204347,0.00016658765,0.00034331458,0.00016998276,0.00013104467,0.0010776822,0.001013364],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008901252,0.004670056,0.0007592744,0.0004678428,0.0001411585,0.00050371885,0.000039112678,0.0009640781,0.93400604,0.00074472936,0.0038007011,0.045001987],"study_design_scores_gemma":[0.0046423883,0.04891881,0.015279225,0.00008140919,0.0003230943,0.0021035029,0.00010727786,0.0036686843,0.8986427,0.0006097229,0.025571775,0.00005132401],"about_ca_topic_score_codex":0.0010547724,"about_ca_topic_score_gemma":0.0018711184,"teacher_disagreement_score":0.0036693246,"about_ca_system_score_codex":0.00030804423,"about_ca_system_score_gemma":0.0006159713,"threshold_uncertainty_score":0.0122751},"labels":[],"label_agreement":null},{"id":"W4414825731","doi":"10.1016/j.ijpharm.2025.126235","title":"Self-assembled leuprolide-oleic acid nanoparticles encapsulating docetaxel for synergistic drug delivery","year":2025,"lang":"en","type":"article","venue":"International Journal of Pharmaceutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Research Foundation of Korea; Ministry of Science and ICT, South Korea; Korea Health Industry Development Institute; Ministry of Health and Welfare","keywords":"Cytotoxicity; Drug delivery; Nanoparticle; Liposome; Drug carrier; Docetaxel; Dispersity; Amphiphile; Bioavailability; Particle size","score_opus":0.029062348444428687,"score_gpt":0.39374474259336323,"score_spread":0.36468239414893455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414825731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898393,0.0018028211,0.0053038695,0.000072033414,0.000046383448,0.00003946059,0.00008019869,0.00009236739,0.0027236391],"genre_scores_gemma":[0.9943327,0.0004652161,0.0026045763,0.00003555709,0.000006999843,0.000018549763,0.0000423661,0.000011533704,0.0024824517],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999125,0.000009429527,0.0000059248127,0.000020618736,0.000025946796,0.000025529942],"domain_scores_gemma":[0.9999627,0.000005211914,0.000011732691,0.0000021564033,0.000007242709,0.000010963326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081164304,0.0002435134,0.0001641737,0.00012467655,0.00012306133,0.00020086297,0.000113857386,0.0002201038,0.0004932156],"category_scores_gemma":[0.000081433005,0.00012897243,0.00016829837,0.0001001144,0.000105792526,0.00022857946,0.00018932238,0.0002257465,0.00020153652],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072245246,0.000014351462,0.00005652593,0.00003243288,0.0000044765848,0.000045224966,0.000013231856,0.00023824602,0.9971624,0.00007954886,0.000050242514,0.002231023],"study_design_scores_gemma":[0.000014395031,0.00019961453,0.000481169,0.0000036547676,0.000016763917,0.000074441625,0.000011670088,0.0017049945,0.9958438,0.000013772246,0.0016294915,0.0000062139993],"about_ca_topic_score_codex":0.0005519131,"about_ca_topic_score_gemma":0.001511297,"teacher_disagreement_score":0.0005519131,"about_ca_system_score_codex":0.00023241919,"about_ca_system_score_gemma":0.00019584341,"threshold_uncertainty_score":0.001686275},"labels":[],"label_agreement":null},{"id":"W4414883356","doi":"10.1136/spcare-2024-005348","title":"Memantine efficacy in chemotherapy-induced peripheral neuropathy: double-blind placebo-controlled randomised clinical trial","year":2025,"lang":"en","type":"article","venue":"BMJ Supportive & Palliative Care","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Memantine; Clinical trial; Peripheral; Randomized controlled trial; Clinical Practice","score_opus":0.11171978564011496,"score_gpt":0.4790628836052997,"score_spread":0.3673430979651847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414883356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9127533,0.026511226,0.0023281742,0.0020659592,0.0048540304,0.04343,0.0030413747,0.00040623985,0.004609543],"genre_scores_gemma":[0.90701747,0.012507024,0.005067862,0.0027061508,0.0031096304,0.059367042,0.0014267786,0.000056737557,0.008741283],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980234,0.0011195375,0.00019152388,0.00032489022,0.00015266617,0.00018796031],"domain_scores_gemma":[0.9977755,0.00077885145,0.00054174353,0.00018422987,0.00019923948,0.000520402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037748935,0.0024234278,0.007322685,0.00091717584,0.00085324765,0.0014415502,0.0016347801,0.004063631,0.014623541],"category_scores_gemma":[0.004622821,0.0012097608,0.0022099223,0.0008751575,0.0021388177,0.0015904686,0.00063383393,0.0023820025,0.00174558],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98952544,0.0032589221,0.000081778235,0.0013056037,0.00035295467,0.000023628307,0.000023228265,0.00006304049,0.00096200616,0.000048925664,0.00027887602,0.004075677],"study_design_scores_gemma":[0.97930795,0.019973477,0.00016768982,0.000039003127,0.000120498844,0.000007673106,0.0000054975667,0.0000659943,0.000073971605,0.00003794768,0.00019490371,0.0000053653525],"about_ca_topic_score_codex":0.00070357334,"about_ca_topic_score_gemma":0.001432628,"teacher_disagreement_score":0.014623541,"about_ca_system_score_codex":0.00084383076,"about_ca_system_score_gemma":0.0017018474,"threshold_uncertainty_score":0.04892063},"labels":[],"label_agreement":null},{"id":"W4415314362","doi":"10.51731/cjht.2025.1255","title":"Semaglutide (Wegovy)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Weight loss; Comorbidity; Body mass index; Type 2 diabetes; Clinical Practice; Body weight","score_opus":0.025126934297497214,"score_gpt":0.35846029367518983,"score_spread":0.3333333593776926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415314362","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019053211,0.8873493,0.0017877561,0.0038522384,0.0007938872,0.00035832525,0.0045194635,0.00039102798,0.08189479],"genre_scores_gemma":[0.19905369,0.72288764,0.005772119,0.0074376073,0.00043284864,0.00028595745,0.0067152153,0.000065069216,0.057349928],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970216,0.00005690076,0.000031888256,0.000033567096,0.00014243524,0.000032976386],"domain_scores_gemma":[0.999739,0.00005281403,0.00005689233,0.000008027931,0.00010329957,0.00004003452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048392193,0.00025290163,0.00040490297,0.00092228164,0.0002174648,0.0006733243,0.0002989196,0.0004142407,0.00776267],"category_scores_gemma":[0.0006939982,0.000070795926,0.00047419977,0.00090902654,0.00021586112,0.00038277637,0.0002139718,0.00062013237,0.0016097632],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007644407,0.000073362506,0.00086509174,0.005110773,0.00018021988,0.00016684282,0.000030711344,0.0001726269,0.0031210186,0.0018141541,0.056017518,0.9316833],"study_design_scores_gemma":[0.0008876557,0.0008977784,0.008904487,0.0042916983,0.0005305001,0.001410998,0.000069465335,0.0002639788,0.0038688472,0.00062359957,0.9782218,0.000029206682],"about_ca_topic_score_codex":0.031258825,"about_ca_topic_score_gemma":0.12833285,"teacher_disagreement_score":0.031258825,"about_ca_system_score_codex":0.0014248074,"about_ca_system_score_gemma":0.0026748423,"threshold_uncertainty_score":0.062153757},"labels":[],"label_agreement":null},{"id":"W4415444744","doi":"10.1158/1535-7163.targ-25-a085","title":"Abstract A085: OBP-004, a novel small-molecule dual inhibitor of CDK9/13, reduces bone, brain, lung and lymph node metastases in vivo, with highest potency on bone metastases","year":2025,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Bioluminescence imaging; Lymph node; Prostate cancer; Bone marrow; Cancer; Breast cancer; Spleen; Metastatic breast cancer; Bone metastasis","score_opus":0.022776783337146733,"score_gpt":0.31268964073595384,"score_spread":0.2899128573988071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415444744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885843,0.00300708,0.0019534067,0.00021685692,0.00010382447,0.00018407707,0.0018697417,0.00027637908,0.0038043899],"genre_scores_gemma":[0.9817576,0.0020061245,0.0026096974,0.00011983653,0.000032848766,0.00020955603,0.0029621213,0.00003303412,0.010269213],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993014,0.000009603057,0.0000050428616,0.000012163855,0.000017393617,0.000025711595],"domain_scores_gemma":[0.99996054,0.0000047269546,0.000008847974,0.000003092636,0.000004627417,0.000018166502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012657749,0.0005100107,0.00037451473,0.00031618963,0.00009930535,0.0001945961,0.00030879964,0.0002983823,0.003723081],"category_scores_gemma":[0.000064276435,0.00012618005,0.00026297892,0.00019110649,0.00017325049,0.00016411941,0.00010934581,0.0006502771,0.0005632473],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025702722,0.0007375437,0.00030434286,0.00019952477,0.000029107598,0.00007513527,0.000010415421,0.00022802684,0.9820024,0.00013486044,0.0009860408,0.012722362],"study_design_scores_gemma":[0.00096510956,0.010348858,0.005278962,0.000011755058,0.00007978085,0.00045183938,0.000014762704,0.0011378003,0.9752759,0.000051118113,0.006374458,0.000009782924],"about_ca_topic_score_codex":0.0011110033,"about_ca_topic_score_gemma":0.0014044631,"teacher_disagreement_score":0.003723081,"about_ca_system_score_codex":0.00029617868,"about_ca_system_score_gemma":0.00044582065,"threshold_uncertainty_score":0.012454987},"labels":[],"label_agreement":null},{"id":"W4415551402","doi":"10.1080/17512433.2025.2580349","title":"A review of current and emerging therapies in breast cancer: implications for older adults","year":2025,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Clinical trial; Breast cancer; Geriatric oncology; Alternative medicine; MEDLINE; Disease","score_opus":0.1191470631710012,"score_gpt":0.599206417123631,"score_spread":0.4800593539526298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415551402","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048762988,0.99892044,0.000050741422,0.0003835078,0.00017510692,0.000004759414,0.000017628543,0.0000036839822,0.00039538008],"genre_scores_gemma":[0.00032171933,0.99890673,0.000093661016,0.00031092516,0.00014177787,0.0000056823096,0.000017527067,6.9365e-7,0.00020118286],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99965334,0.00008301939,0.000070688024,0.0000523134,0.0001138541,0.000026909867],"domain_scores_gemma":[0.9991198,0.00052182045,0.000119261436,0.000014243502,0.0001842444,0.000040686788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083296,0.00070135517,0.0012317161,0.0022711386,0.00028765213,0.0009357945,0.0007262051,0.0010565071,0.0050380924],"category_scores_gemma":[0.0016599497,0.0002332497,0.0012053485,0.0018854521,0.000298633,0.0011122301,0.0005213117,0.0018399679,0.0013460892],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009302575,0.0000606066,0.00016070527,0.060401794,0.00018880548,0.00013227263,0.00007885316,0.00029789357,0.00070893165,0.002546658,0.050123964,0.8852065],"study_design_scores_gemma":[0.000036651305,0.00014482178,0.0010687103,0.033609677,0.00047946564,0.0010768798,0.00007506831,0.00012315341,0.00019091899,0.001894514,0.96127826,0.000021880904],"about_ca_topic_score_codex":0.0012529811,"about_ca_topic_score_gemma":0.0031032516,"teacher_disagreement_score":0.0050380924,"about_ca_system_score_codex":0.0006608649,"about_ca_system_score_gemma":0.001563365,"threshold_uncertainty_score":0.016854048},"labels":[],"label_agreement":null},{"id":"W4416454378","doi":"10.1007/978-3-031-93616-6_27","title":"Miscellaneous Agents","year":2025,"lang":"en","type":"book-chapter","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Waterloo; Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"","score_opus":0.03062335143220128,"score_gpt":0.3182470025553903,"score_spread":0.287623651123189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416454378","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002872677,0.04023396,0.0014635352,0.0037690825,0.00741505,0.000055214543,0.00028072073,0.0002602544,0.9462349],"genre_scores_gemma":[0.0010740317,0.012495399,0.0006295481,0.0030975523,0.0014432919,0.000028444301,0.0001535479,0.00005985069,0.9810184],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996842,0.000053878375,0.00001215975,0.000039421982,0.00017932024,0.000030981882],"domain_scores_gemma":[0.99975735,0.00006805974,0.000023751885,0.00004223447,0.000070811366,0.000037832175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032810282,0.0009408246,0.00067544525,0.001184042,0.0008857192,0.0024208217,0.0012485922,0.00175223,0.22278705],"category_scores_gemma":[0.00092214684,0.00027095922,0.00044685922,0.0009715428,0.00063889363,0.0019481612,0.0016055339,0.0026766045,0.15031466],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032929194,0.00007068057,0.00004355355,0.00045233386,0.0000042852053,0.00016224232,0.000088275934,0.00012407773,0.0010166547,0.02490089,0.7460255,0.22707847],"study_design_scores_gemma":[0.000001636014,0.0000069855564,0.000017466833,0.00006592153,0.0000015402824,0.00009031008,0.000010155505,0.000011241398,0.00008786599,0.001204414,0.9985012,0.0000012714572],"about_ca_topic_score_codex":0.0013824386,"about_ca_topic_score_gemma":0.0049121836,"teacher_disagreement_score":0.22278705,"about_ca_system_score_codex":0.0006240889,"about_ca_system_score_gemma":0.0010204717,"threshold_uncertainty_score":0.74529696},"labels":[],"label_agreement":null},{"id":"W4416538819","doi":"10.1097/pr9.0000000000001366","title":"Comparative study evaluating the efficacy of duloxetine, gabapentin, and lacosamide on oxaliplatin-induced peripheral neuropathy","year":2025,"lang":"en","type":"article","venue":"PAIN Reports","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lacosamide; Peripheral neuropathy; Duloxetine; Neuroprotection; Peripheral","score_opus":0.06668038684894914,"score_gpt":0.4238710606191592,"score_spread":0.3571906737702101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416538819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99681973,0.0022122688,0.00010775086,0.000043599928,0.00004721962,0.0003581777,0.00009926739,0.000008877043,0.0003031739],"genre_scores_gemma":[0.9972566,0.0013172858,0.0003535763,0.00012106777,0.0001242003,0.00033883133,0.00021368133,0.0000029810788,0.0002717082],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9989009,0.0006309557,0.00012274999,0.0001266116,0.00011917222,0.000099569545],"domain_scores_gemma":[0.99826604,0.00069028727,0.00042198627,0.00012409693,0.00013129241,0.0003663561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014181263,0.0005658436,0.0020836557,0.00043823145,0.00030672931,0.00039506136,0.0006535455,0.0008148146,0.0026504262],"category_scores_gemma":[0.0017383669,0.00034932452,0.0012797444,0.00047012593,0.0007368736,0.0005777037,0.00023607051,0.0008846595,0.00025718022],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91857964,0.026964804,0.0041815974,0.00063380075,0.0017770154,0.000087032,0.00008861653,0.00031784835,0.010064396,0.000060897288,0.00017516798,0.037069097],"study_design_scores_gemma":[0.27641794,0.70676225,0.013323547,0.000029017521,0.001061514,0.0000960958,0.0000428404,0.0003119883,0.001526259,0.00003841877,0.00037233127,0.000017855691],"about_ca_topic_score_codex":0.00069558766,"about_ca_topic_score_gemma":0.001498849,"teacher_disagreement_score":0.0026504262,"about_ca_system_score_codex":0.00060772686,"about_ca_system_score_gemma":0.00066946563,"threshold_uncertainty_score":0.008866608},"labels":[],"label_agreement":null},{"id":"W4417362519","doi":"10.1177/10781552251405216","title":"Comparative incidence of peripheral neuropathy associated with taxane chemotherapy in patients with breast cancer: A network meta-analysis","year":2025,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research","funders":"","keywords":"Taxane; Peripheral neuropathy; Paclitaxel; Docetaxel; Incidence (geometry); Breast cancer; Chemotherapy-induced peripheral neuropathy","score_opus":0.05753993388737121,"score_gpt":0.4269587812516558,"score_spread":0.3694188473642846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417362519","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06360084,0.92261463,0.006124035,0.00072655565,0.0003929195,0.00052705803,0.004737067,0.0001254326,0.0011514708],"genre_scores_gemma":[0.8499198,0.13937719,0.004911001,0.0007982851,0.00025289794,0.0011105327,0.002956692,0.00008705845,0.00058663415],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98367137,0.01073172,0.0021765241,0.0019441961,0.0010894708,0.00038669872],"domain_scores_gemma":[0.9727706,0.021597922,0.0029641774,0.0012295346,0.0011033666,0.0003344496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017525405,0.0023780796,0.009368029,0.005763943,0.0005038626,0.0028358435,0.0019246322,0.0016719986,0.0036883224],"category_scores_gemma":[0.030041298,0.0012107303,0.04846195,0.0064351168,0.0005136379,0.0013463655,0.0017249254,0.0018933627,0.00024837497],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032774014,0.000022069893,0.017443458,0.032799345,0.9388249,0.00010841759,0.000036175556,0.0021853384,0.00018309476,0.00013022624,0.00037487294,0.004614755],"study_design_scores_gemma":[0.0005745104,0.00019512416,0.008521255,0.0022555708,0.9857239,0.00009874615,0.000024081259,0.0012525858,0.00008686596,0.0003437041,0.0009029922,0.00002078028],"about_ca_topic_score_codex":0.0059233764,"about_ca_topic_score_gemma":0.0075886054,"teacher_disagreement_score":0.017525405,"about_ca_system_score_codex":0.001559503,"about_ca_system_score_gemma":0.0014359847,"threshold_uncertainty_score":0.09268433},"labels":[],"label_agreement":null},{"id":"W4417481745","doi":"10.1016/j.jval.2025.09.314","title":"CO213 Review of Index Line Selection Methods in Hemato-Oncology Externally Controlled Trials: A Secondary Analysis of the Hermans et al Systematic Review","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Statistics Canada","funders":"","keywords":"Selection (genetic algorithm); Index (typography); Line (geometry); Time line","score_opus":0.10674046071374535,"score_gpt":0.5357651114473563,"score_spread":0.42902465073361096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481745","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011957006,0.9631454,0.0065359473,0.0017350615,0.0017135495,0.0071551637,0.0047549778,0.0001733324,0.0028296385],"genre_scores_gemma":[0.45570773,0.48344108,0.02528505,0.010290349,0.0015824421,0.01625602,0.0043383962,0.00047469002,0.0026242568],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.8359142,0.104968905,0.041230205,0.006906039,0.009684805,0.0012959151],"domain_scores_gemma":[0.7794969,0.16283019,0.034955326,0.009799802,0.011850695,0.0010671339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.079668224,0.0027670024,0.015157876,0.0062850905,0.0010290424,0.006072348,0.0023813986,0.0035236194,0.012250982],"category_scores_gemma":[0.25937575,0.001809433,0.027564622,0.0085088285,0.0016877933,0.003320114,0.0025720214,0.0029773645,0.0015290049],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008296988,0.000067826615,0.004601025,0.57873505,0.3710869,0.0001354307,0.00031949015,0.00025766666,0.0003650556,0.00057716214,0.003923013,0.031634424],"study_design_scores_gemma":[0.01634213,0.0010888615,0.009697658,0.15729438,0.797971,0.0002308206,0.0002226471,0.0005427449,0.000495508,0.0014318705,0.014529747,0.00015271638],"about_ca_topic_score_codex":0.006321355,"about_ca_topic_score_gemma":0.019634502,"teacher_disagreement_score":0.079668224,"about_ca_system_score_codex":0.0040358347,"about_ca_system_score_gemma":0.008692636,"threshold_uncertainty_score":0.42133087},"labels":[],"label_agreement":null},{"id":"W4417501047","doi":"10.1186/s40478-025-02171-0","title":"Vincristine-induced brain toxicity is reduced with prevention of peripheral axon degeneration in Sarm1 knockout mice","year":2025,"lang":"en","type":"article","venue":"Acta Neuropathologica Communications","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; Hospital for Sick Children","keywords":"Sciatic nerve; Axon; Knockout mouse; Neurotoxicity; Peripheral neuropathy; Myelin; Vincristine; White matter; Brain damage","score_opus":0.055004066787984626,"score_gpt":0.3718341388987574,"score_spread":0.31683007211077274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417501047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872097,0.0013418905,0.004521961,0.00034987635,0.000061755316,0.00010611007,0.0040139756,0.00048375299,0.0019109524],"genre_scores_gemma":[0.9687487,0.0021450822,0.008890609,0.00022933392,0.000034728448,0.0004249023,0.0037450609,0.00030839597,0.015473186],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99966884,0.000030816504,0.00005721277,0.00011358559,0.000060754403,0.00006882432],"domain_scores_gemma":[0.9995598,0.000038248014,0.00019433821,0.000028570046,0.000032599775,0.00014634427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003073824,0.00084401603,0.00055945065,0.0012790273,0.00034140324,0.00048582564,0.0006050965,0.000966705,0.0038600052],"category_scores_gemma":[0.00017324835,0.00047545758,0.0006435319,0.00031035504,0.00057669886,0.00036088578,0.00032510032,0.0015862219,0.0009959039],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039875472,0.00013704489,0.00042046298,0.00009778981,0.000020300477,0.00019287835,0.00006708297,0.00016345223,0.9958437,0.00023649285,0.00020795876,0.0022139968],"study_design_scores_gemma":[0.00022478831,0.0014523518,0.020166408,0.00012282602,0.00012834476,0.0018045926,0.00017385492,0.002923192,0.96436334,0.00025803558,0.008345821,0.00003644753],"about_ca_topic_score_codex":0.0010769321,"about_ca_topic_score_gemma":0.002174305,"teacher_disagreement_score":0.0038600052,"about_ca_system_score_codex":0.00056331255,"about_ca_system_score_gemma":0.00031456357,"threshold_uncertainty_score":0.012912989},"labels":[],"label_agreement":null},{"id":"W574944135","doi":"10.71781/11996","title":"Études vers la synthèse totale de l'indolizidine 223A","year":2007,"lang":"fr","type":"dissertation","venue":"Open MIND","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Indolizidine; Chemistry; Stereochemistry","score_opus":0.046775355274704306,"score_gpt":0.4360629892014676,"score_spread":0.38928763392676324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W574944135","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04345567,0.9015028,0.009563218,0.0031948565,0.0022661893,0.00022460139,0.0037137365,0.00020832801,0.035870552],"genre_scores_gemma":[0.21069352,0.63827497,0.027310742,0.0018792405,0.0010816093,0.0004981859,0.0041535716,0.00041598684,0.11569223],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990934,0.00035528414,0.00009213914,0.00010458512,0.00031182403,0.00004275953],"domain_scores_gemma":[0.9988298,0.0005080853,0.00017590528,0.00008624313,0.00034352273,0.00005652409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020760272,0.00062108436,0.001122831,0.0029105062,0.0005649363,0.0016962296,0.00073501054,0.0005122977,0.016705949],"category_scores_gemma":[0.003758405,0.00037680846,0.0010565409,0.0021466592,0.0005425722,0.0007694202,0.00048917235,0.0009881421,0.0020976907],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017032719,0.00027044807,0.00096141483,0.013584803,0.0013453856,0.00035191112,0.0012377005,0.0011189847,0.06381329,0.013896418,0.021028088,0.88068837],"study_design_scores_gemma":[0.00019365961,0.00076606206,0.0041164183,0.0022743063,0.0009986989,0.0005672918,0.00016245403,0.000153744,0.030906068,0.0014485787,0.9583575,0.00005525534],"about_ca_topic_score_codex":0.012706259,"about_ca_topic_score_gemma":0.03015119,"teacher_disagreement_score":0.016705949,"about_ca_system_score_codex":0.0020460647,"about_ca_system_score_gemma":0.0037780402,"threshold_uncertainty_score":0.055886984},"labels":[],"label_agreement":null},{"id":"W596742190","doi":"10.1200/jco.2009.27.15_suppl.e20680","title":"Comorbidities, concominant medications, and clinical guidelines/algorithms in treating elderley patients with hormone receptor positive early breast cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sudbury Regional Hospital","funders":"","keywords":"Medicine; Guideline; Hormonal therapy; Comorbidity; Breast cancer; Internal medicine; Cancer; Hormone therapy; Adjuvant; Pathology","score_opus":0.08677737473387369,"score_gpt":0.4920250777672494,"score_spread":0.4052477030333757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W596742190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97611564,0.008398595,0.0006626124,0.005318524,0.00010281144,0.00039763743,0.0018288713,0.000028124487,0.0071472046],"genre_scores_gemma":[0.9903904,0.0027491837,0.0039428473,0.0011281213,0.000043729975,0.0001519558,0.0013559803,0.0000053260705,0.00023247875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99527115,0.0019793476,0.0014724962,0.00024747956,0.0007904754,0.00023909396],"domain_scores_gemma":[0.96950644,0.012461191,0.012294978,0.0004706519,0.0036652014,0.0016014904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061411383,0.00009645661,0.00023365548,0.0017997485,0.0004037372,0.0010433979,0.00034697662,0.00050883944,0.0013427774],"category_scores_gemma":[0.043901164,0.0001685579,0.00037565234,0.0023354047,0.00021187324,0.0006896983,0.0009402085,0.0005099572,0.00013888793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051215822,0.00006139999,0.97137195,0.00017621876,0.000034789526,0.00006440908,0.0003188111,0.00011275892,0.000024941037,0.0000823426,0.0017078609,0.025993355],"study_design_scores_gemma":[0.00004976182,0.0001740966,0.989233,0.0010122949,0.00009921314,0.00045029496,0.002149813,0.0014986361,0.00009356753,0.00023012683,0.0049953107,0.000013854052],"about_ca_topic_score_codex":0.014631122,"about_ca_topic_score_gemma":0.031111883,"teacher_disagreement_score":0.014631122,"about_ca_system_score_codex":0.0012837889,"about_ca_system_score_gemma":0.003811337,"threshold_uncertainty_score":0.032477856},"labels":[],"label_agreement":null},{"id":"W6419410","doi":"10.1177/070674370304800615","title":"Methylphenidate and the Cytochrome P450 System","year":2003,"lang":"en","type":"letter","venue":"The Canadian Journal of Psychiatry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Methylphenidate; Psychology; Psychiatry; Medicine; Clinical psychology; Attention deficit hyperactivity disorder","score_opus":0.014644390905662124,"score_gpt":0.2641553958577898,"score_spread":0.24951100495212766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6419410","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062422957,0.008710909,0.00028575538,0.9616165,0.011354576,0.000016355421,0.000056007837,0.000033646727,0.0116837835],"genre_scores_gemma":[0.09098218,0.013948906,0.00092821475,0.73741144,0.13308302,0.000052089457,0.00008516124,0.000032787873,0.023476271],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99916184,0.00029674507,0.00010130241,0.00008459388,0.00025386552,0.00010174313],"domain_scores_gemma":[0.9978802,0.0013104014,0.00017213266,0.00007803611,0.00028753266,0.00027171898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009532033,0.00045662024,0.000985158,0.00039919672,0.0014497028,0.0011335317,0.00068401714,0.017597282,0.0038550943],"category_scores_gemma":[0.0070294267,0.00030645716,0.00080290565,0.00052502454,0.0013643237,0.0014815821,0.00046973463,0.0123390285,0.0015935389],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042632327,0.00015031623,0.009122485,0.00017886331,0.0001168294,0.056991454,0.0002281831,0.00032377924,0.00074575224,0.005706697,0.8714726,0.054536708],"study_design_scores_gemma":[0.0007685641,0.0003004061,0.012581615,0.00041380184,0.00016514595,0.078897014,0.00066066725,0.0015786065,0.0007254118,0.019656895,0.8841794,0.00007246985],"about_ca_topic_score_codex":0.01349815,"about_ca_topic_score_gemma":0.029933209,"teacher_disagreement_score":0.017597282,"about_ca_system_score_codex":0.0030966525,"about_ca_system_score_gemma":0.0019131463,"threshold_uncertainty_score":0.026839197},"labels":[],"label_agreement":null},{"id":"W6912356257","doi":"10.5281/zenodo.16575162","title":"Perspectives and Insights on Antineoplastic Agents from Plant Alkaloids and Other Natural Products (L01C): From Development to New Drug Submission (NDS) Application for Health Canada","year":2025,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vinca; Drug; Human health; Health claims on food labels; Pharmaceutical industry; Natural (archaeology); Food and drug administration; Good manufacturing practice","score_opus":0.02096300875185287,"score_gpt":0.2828287138600296,"score_spread":0.26186570510817675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6912356257","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018070895,0.1295882,0.015999127,0.4987713,0.00637169,0.0011262967,0.005463468,0.0011208544,0.32348824],"genre_scores_gemma":[0.18339673,0.2834077,0.06180154,0.25699192,0.0049971114,0.00070147775,0.00672246,0.000982649,0.20099838],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98474854,0.0019361945,0.00083032495,0.0011832158,0.009153867,0.002147919],"domain_scores_gemma":[0.9721271,0.0031179981,0.0020514976,0.00058985647,0.018049302,0.0040642484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01558075,0.00080058083,0.00067507074,0.0023556566,0.004140266,0.012482503,0.0032782834,0.0063928473,0.02326124],"category_scores_gemma":[0.014839432,0.00068438397,0.0013303173,0.0021456748,0.0051494953,0.0039400323,0.0027406772,0.0061222357,0.0052163214],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005482617,0.0004738176,0.005254894,0.0032369106,0.00006968727,0.0025342552,0.0011716619,0.001927662,0.019779665,0.11018372,0.48735288,0.36746666],"study_design_scores_gemma":[0.00006980722,0.0002713773,0.0032036393,0.0011974437,0.00003586455,0.0009839213,0.00059131073,0.00058063463,0.004918209,0.0061242636,0.9819371,0.000086434426],"about_ca_topic_score_codex":0.5341283,"about_ca_topic_score_gemma":0.7261261,"teacher_disagreement_score":0.4658717,"about_ca_system_score_codex":0.03083882,"about_ca_system_score_gemma":0.17043851,"threshold_uncertainty_score":0.9372306},"labels":[],"label_agreement":null},{"id":"W6920683022","doi":"10.6084/m9.figshare.14889342","title":"Additional file 1 of Network meta-analysis of eribulin versus other chemotherapies used as second- or later-line treatment in locally advanced or metastatic breast cancer","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Eribulin; Metastatic breast cancer; Breast cancer; Cochrane Library; MEDLINE; Overall survival","score_opus":0.14348126166137817,"score_gpt":0.3813208909546553,"score_spread":0.23783962929327715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920683022","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00057243183,0.00065902935,0.0005310269,0.00023201038,0.00006927432,0.001063667,0.99526227,0.00019550578,0.001414734],"genre_scores_gemma":[0.05749143,0.0053014755,0.027133524,0.0032034048,0.0007484218,0.10573085,0.7549367,0.0014080507,0.04404609],"study_design_codex":"not_applicable","study_design_gemma":"meta_analysis","domain_scores_codex":[0.998083,0.00058939535,0.00047796758,0.00033849303,0.0003280828,0.00018317137],"domain_scores_gemma":[0.9571973,0.036380064,0.0029776478,0.0009546751,0.0021213081,0.00036897327],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0037701016,0.0017812001,0.0034408725,0.0047545405,0.0006929084,0.0016773936,0.0019620657,0.0014885432,0.78308487],"category_scores_gemma":[0.053559627,0.0010228081,0.0058080773,0.0070105474,0.00029466845,0.0024592467,0.001342814,0.0011249417,0.030303773],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046336763,0.00019462586,0.0047694915,0.3524938,0.006284859,0.00027887535,0.0002244961,0.002759275,0.00052856933,0.0039294097,0.5998843,0.024018668],"study_design_scores_gemma":[0.119760804,0.00254806,0.06495934,0.0967261,0.040221065,0.0013195948,0.0007238734,0.009279065,0.001807713,0.025302624,0.6367169,0.00063488894],"about_ca_topic_score_codex":0.009052817,"about_ca_topic_score_gemma":0.020101978,"teacher_disagreement_score":0.78308487,"about_ca_system_score_codex":0.001923517,"about_ca_system_score_gemma":0.0030814502,"threshold_uncertainty_score":0.30940306},"labels":[],"label_agreement":null},{"id":"W6922195932","doi":"10.1021/np020361n.s001","title":"New Taxanes from the Needles of &lt;i&gt;Taxus canadensis&lt;/i&gt;","year":2016,"lang":"en","type":"article","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Taxane; Double bond; Ring (chemistry); Methanol; Docetaxel","score_opus":0.03539712637794722,"score_gpt":0.2786272392488673,"score_spread":0.24323011287092006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6922195932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.933535,0.017275298,0.004889488,0.00039760434,0.00020119517,0.00039137583,0.009542859,0.00018674799,0.03358044],"genre_scores_gemma":[0.9143181,0.016564015,0.010700291,0.00061602704,0.00011876445,0.00016608852,0.017175825,0.000059605696,0.040281232],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999646,0.0000014229461,0.0000021260084,0.00001004251,0.000013595643,0.000008261752],"domain_scores_gemma":[0.99995375,0.0000036647273,0.0000059120803,0.000002727134,0.000013077953,0.000020832087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003220569,0.00053667935,0.00023176773,0.0008847838,0.00046846428,0.00025670105,0.00017185693,0.00021641712,0.0024639936],"category_scores_gemma":[0.000068272246,0.00014944686,0.00020669091,0.00064225995,0.0002577355,0.00026583156,0.00019871401,0.0006503124,0.0006341608],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002568817,0.000056913665,0.0015139948,0.00028125194,0.000027502367,0.0005588351,0.00018606149,0.00021309606,0.9668315,0.00026327962,0.0003874337,0.029423187],"study_design_scores_gemma":[0.00026378612,0.0013025897,0.1773082,0.00019506448,0.00033620448,0.0027037326,0.0012537226,0.00091718754,0.5808104,0.0010409146,0.23374999,0.00011827644],"about_ca_topic_score_codex":0.015796574,"about_ca_topic_score_gemma":0.042370465,"teacher_disagreement_score":0.015796574,"about_ca_system_score_codex":0.0005440029,"about_ca_system_score_gemma":0.0007513633,"threshold_uncertainty_score":0.031409264},"labels":[],"label_agreement":null},{"id":"W6930144206","doi":"10.5281/zenodo.12482719","title":"mcdonalds coupons pdf 2023 ontario","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Download; Launched; Order (exchange); Ice cream; China; Mobile apps; The Internet","score_opus":0.040866210933963,"score_gpt":0.295677249557855,"score_spread":0.25481103862389204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930144206","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00053431693,0.00033185826,0.00017318332,0.0012133577,0.0010732282,0.000100856174,0.0024952267,0.00074037595,0.99333775],"genre_scores_gemma":[0.00094180135,0.0001010759,0.00006751303,0.00019239754,0.000055038035,0.000014051338,0.0004368801,0.00019324987,0.99799794],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991684,0.00002884022,0.000020551059,0.0000830533,0.0005260536,0.00017305155],"domain_scores_gemma":[0.99793905,0.000099366625,0.000037502094,0.00014484974,0.0012955187,0.00048370034],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005339495,0.0008794675,0.00074830424,0.0013565233,0.0051982794,0.0046030153,0.0011689996,0.0024304665,0.88805026],"category_scores_gemma":[0.0024450468,0.00090026093,0.00072109746,0.0013146814,0.00087802776,0.0021615063,0.0017475188,0.0021871128,0.7110115],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026397805,0.000010228276,0.00008442184,0.000042589374,0.0000013773175,0.00004157511,0.000044114884,0.000023534492,0.00018693846,0.0012001372,0.98899275,0.009346001],"study_design_scores_gemma":[0.000004855424,0.000005500373,0.00044266664,0.000021979244,0.0000012120884,0.000020861153,0.00007014394,0.000016559963,0.00008490664,0.00009023538,0.99923587,0.000005138846],"about_ca_topic_score_codex":0.26361927,"about_ca_topic_score_gemma":0.61621284,"teacher_disagreement_score":0.26361927,"about_ca_system_score_codex":0.007889617,"about_ca_system_score_gemma":0.005710998,"threshold_uncertainty_score":0.5241697},"labels":[],"label_agreement":null},{"id":"W6930270977","doi":"10.5281/zenodo.11755733","title":"Simone thomalla playboy pdf","year":2024,"lang":"de","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Happening; Kingdom; Nice; Character (mathematics)","score_opus":0.03552001724424897,"score_gpt":0.29336595627818085,"score_spread":0.2578459390339319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930270977","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038975378,0.001522301,0.0019843304,0.0020575507,0.0040463507,0.0001293012,0.0023923407,0.006056935,0.9814212],"genre_scores_gemma":[0.0011697275,0.00084424595,0.00063450134,0.0005218549,0.0003912253,0.000036243677,0.00083318487,0.0013175767,0.9942515],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993747,0.000037493417,0.000020528088,0.00008602281,0.00040693575,0.00007439226],"domain_scores_gemma":[0.9986059,0.0001604256,0.000039228777,0.00014736959,0.0006359058,0.00041115584],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000537376,0.0012849058,0.0008142099,0.0019986539,0.0017266998,0.006184104,0.0014516991,0.0017442114,0.8596127],"category_scores_gemma":[0.0029526341,0.00058789167,0.00070295983,0.0011722249,0.0007173882,0.004889877,0.0030256896,0.0021854255,0.81247455],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003138697,0.00001756028,0.000032033167,0.00011621995,0.000001517389,0.00007297022,0.00004242641,0.000034930246,0.00048444263,0.0017102119,0.9537901,0.04366616],"study_design_scores_gemma":[0.0000035991472,0.0000071959366,0.0000909071,0.00003856076,0.0000011438956,0.000078904064,0.000033049455,0.000027592818,0.00021939755,0.00033083843,0.99916434,0.000004565944],"about_ca_topic_score_codex":0.0025449053,"about_ca_topic_score_gemma":0.0056740064,"teacher_disagreement_score":0.1403873,"about_ca_system_score_codex":0.0012247534,"about_ca_system_score_gemma":0.0013257944,"threshold_uncertainty_score":0.20024538},"labels":[],"label_agreement":null},{"id":"W6930353111","doi":"10.5281/zenodo.11088244","title":"Interactive figures for Lawlor-Forsyth et al. (2024)","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Truncation (statistics); RADIUS; Function (biology); Contrast (vision)","score_opus":0.041705744124566096,"score_gpt":0.34507318309689317,"score_spread":0.3033674389723271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930353111","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00057233346,0.0009027836,0.009511222,0.006256155,0.016331524,0.00039511974,0.6119826,0.026840804,0.32720748],"genre_scores_gemma":[0.011846836,0.0022018894,0.023887483,0.0061677466,0.006492211,0.0010826793,0.37853125,0.04225762,0.5275323],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99910873,0.000089389956,0.000037481077,0.00014243841,0.00047947993,0.00014234199],"domain_scores_gemma":[0.9950358,0.0010573182,0.00019793288,0.0007659191,0.002152317,0.00079060585],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013586663,0.001444416,0.0013015883,0.0030104606,0.0016721642,0.005173775,0.002759254,0.0023608205,0.90168035],"category_scores_gemma":[0.012962826,0.0007866102,0.001533896,0.004052954,0.0004979757,0.0042839507,0.0029711302,0.0022355893,0.696809],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013905241,0.0000067164956,0.00006870775,0.00009205273,0.0000044978774,0.000012530211,0.00000897129,0.000080885584,0.00005158551,0.0006526685,0.9945314,0.0044760182],"study_design_scores_gemma":[0.000026372272,0.000003206302,0.00047189987,0.00007459395,0.000005816941,0.000031968964,0.000029861107,0.00012571395,0.00012301301,0.0018474588,0.997247,0.000013046843],"about_ca_topic_score_codex":0.012054887,"about_ca_topic_score_gemma":0.017679939,"teacher_disagreement_score":0.09831965,"about_ca_system_score_codex":0.0018490102,"about_ca_system_score_gemma":0.002722571,"threshold_uncertainty_score":0.14024097},"labels":[],"label_agreement":null},{"id":"W6930680253","doi":"10.5281/zenodo.14812110","title":"Entre héritage réglementaire et imaginaire du risque: gestion des zones inondables et pratiques d'adaptation au Québec et à Lachute","year":2025,"lang":"fr","type":"report","venue":"Archipelago (University of Quebec in Montreal)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Western europe; Black sea; Turkish republic","score_opus":0.024844888969109198,"score_gpt":0.2824100367619338,"score_spread":0.25756514779282463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930680253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8002493,0.0048212023,0.002829742,0.013638243,0.000109090746,0.000068607544,0.00060083513,0.000048566362,0.17763448],"genre_scores_gemma":[0.96674377,0.0013736109,0.0006712393,0.0003512405,0.000012481079,0.000025156965,0.00009538601,0.000013760502,0.030713271],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99937385,0.00014450723,0.00000976582,0.00009613064,0.00016329963,0.0002124773],"domain_scores_gemma":[0.9989293,0.00023161474,0.00011430998,0.00005130188,0.00036959094,0.00030376567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007679822,0.00028710853,0.0002408924,0.0010441651,0.008674899,0.005305565,0.0010009,0.000656758,0.009495145],"category_scores_gemma":[0.0014105372,0.00014966991,0.0001781442,0.0021155153,0.009736702,0.0015596449,0.0028412393,0.0013892574,0.0002453332],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001315847,0.00011746034,0.16173613,0.00040078847,0.000067983936,0.0015174156,0.47136396,0.0021496867,0.0024987888,0.17741133,0.021161243,0.1614436],"study_design_scores_gemma":[0.000008049038,0.000063125015,0.37407193,0.0005707389,0.000040067767,0.00021977353,0.35793293,0.0011342874,0.00069254765,0.007095489,0.25807366,0.00009735256],"about_ca_topic_score_codex":0.98574674,"about_ca_topic_score_gemma":0.9950799,"teacher_disagreement_score":0.055039592,"about_ca_system_score_codex":0.055039592,"about_ca_system_score_gemma":0.044184368,"threshold_uncertainty_score":0.39934206},"labels":[],"label_agreement":null},{"id":"W6931567091","doi":"10.5281/zenodo.5051418","title":"FIGURE 1 in A taxonomic revision of Piezura Rondani (Diptera: Fanniidae)","year":2005,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bishop's University","funders":"","keywords":"Male genitalia; Type (biology); Taxonomy (biology)","score_opus":0.030910984920870032,"score_gpt":0.28786707629374797,"score_spread":0.25695609137287795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931567091","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03496779,0.02913546,0.034694236,0.0036245899,0.012451813,0.0012386454,0.025535978,0.0039948816,0.8543565],"genre_scores_gemma":[0.2120017,0.018370645,0.08291799,0.0021804273,0.0031640774,0.0009415332,0.03589148,0.00077772076,0.64375454],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998807,0.000022646951,0.000009948123,0.000029921186,0.000042052056,0.000014774985],"domain_scores_gemma":[0.9998971,0.00001751068,0.00002128875,0.000012806054,0.000039699407,0.000011544397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020859788,0.00066621293,0.0001980512,0.0014490817,0.0008049814,0.00042268453,0.0005354814,0.0004456356,0.092567824],"category_scores_gemma":[0.000410921,0.00012693889,0.0001975501,0.00095722044,0.00054402865,0.0010216531,0.00044416607,0.00068396894,0.023632664],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001545591,0.0000418331,0.0038367389,0.0006402311,0.00001442851,0.00040911516,0.00059890334,0.00019759797,0.0062278886,0.009334846,0.40720972,0.57133406],"study_design_scores_gemma":[0.0000058862415,0.000027305397,0.0074384413,0.000102166945,0.000008613479,0.00064586557,0.000097194286,0.000106177664,0.00032821068,0.00047680855,0.99075764,0.0000057461043],"about_ca_topic_score_codex":0.0040053823,"about_ca_topic_score_gemma":0.012044351,"teacher_disagreement_score":0.092567824,"about_ca_system_score_codex":0.0004106113,"about_ca_system_score_gemma":0.0004541302,"threshold_uncertainty_score":0.30967027},"labels":[],"label_agreement":null},{"id":"W6931662947","doi":"10.5683/sp3/jxutck","title":"Environics Focus Ontario 2002-3","year":2009,"lang":"en","type":"dataset","venue":"Borealis","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Innovative Research Group (Canada)","funders":"","keywords":"Focus (optics); Public opinion; Field (mathematics); Focus group; Government (linguistics)","score_opus":0.020736693375873257,"score_gpt":0.3002779631562972,"score_spread":0.27954126978042393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931662947","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031471354,0.000078380835,0.0000155758,0.00005941613,0.00000871257,0.000008103555,0.9988418,0.000038660786,0.00063467474],"genre_scores_gemma":[0.0012658705,0.00009816457,0.00008131821,0.000040498293,0.0000074765503,0.000046727684,0.99623305,0.000018167853,0.002208761],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989004,0.00007729687,0.00011192872,0.0002511139,0.0004066614,0.00025257323],"domain_scores_gemma":[0.9962489,0.0002015101,0.00047726676,0.00030591423,0.0023809078,0.00038548495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073526904,0.0016063758,0.0013354054,0.0041817236,0.0016054009,0.002220859,0.0025343567,0.0010410546,0.03050405],"category_scores_gemma":[0.004771797,0.00081184116,0.0011908187,0.014205782,0.0004345282,0.00065744936,0.001180458,0.0011012964,0.021871815],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011233316,0.00001411057,0.005976351,0.00037814194,0.00005118956,0.000034707547,0.000040584164,0.00017214671,0.00005473506,0.00027793788,0.9912764,0.0016114432],"study_design_scores_gemma":[0.00039678128,0.000023975812,0.09236792,0.00034839901,0.00010103122,0.00007600628,0.00020345107,0.00047884817,0.00028663277,0.00027350872,0.9054033,0.000040032064],"about_ca_topic_score_codex":0.94571954,"about_ca_topic_score_gemma":0.97219163,"teacher_disagreement_score":0.05428046,"about_ca_system_score_codex":0.014782184,"about_ca_system_score_gemma":0.023415854,"threshold_uncertainty_score":0.10920018},"labels":[],"label_agreement":null},{"id":"W6931706087","doi":"10.5683/sp3/nvqfmr","title":"A question of ethics. Canadians speak out. Public attitude towards political ethics 1996 data [Canada]","year":2014,"lang":"en","type":"dataset","venue":"Borealis","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"York University; Université de Montréal; University of Saskatchewan; University of Guelph","funders":"","keywords":"Respondent; Politics; Public opinion; Interview; Telephone survey; Survey methodology","score_opus":0.15716032733664317,"score_gpt":0.4278815861904258,"score_spread":0.2707212588537826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931706087","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07875647,0.0041757855,0.0019000791,0.037301265,0.002100047,0.0030820335,0.4736797,0.00052196346,0.39848277],"genre_scores_gemma":[0.43988094,0.005564143,0.008517207,0.014429929,0.00034101168,0.0072273463,0.16312192,0.00044470667,0.36047283],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995021,0.0006984158,0.0003484911,0.00038575902,0.0024520007,0.0010942745],"domain_scores_gemma":[0.98412204,0.0024537942,0.00075849856,0.00048325027,0.009999767,0.0021826401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004156161,0.00043332117,0.00039024616,0.0041096737,0.0056012436,0.0029509554,0.0010102552,0.0009329684,0.045816313],"category_scores_gemma":[0.019429646,0.00035841495,0.0002843452,0.011097214,0.001430722,0.00090497255,0.0014375527,0.0014041268,0.009889581],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014266912,0.000062401865,0.043464936,0.0006328933,0.00000974721,0.0002703697,0.030988596,0.0001271451,0.00046003846,0.007936137,0.8111936,0.10471155],"study_design_scores_gemma":[0.000020890195,0.000020623555,0.10862071,0.00029746388,0.000005151146,0.0000647457,0.018182972,0.00006938566,0.00014155133,0.0002786701,0.8722656,0.00003224878],"about_ca_topic_score_codex":0.9836527,"about_ca_topic_score_gemma":0.9820104,"teacher_disagreement_score":0.045816313,"about_ca_system_score_codex":0.039656054,"about_ca_system_score_gemma":0.06847438,"threshold_uncertainty_score":0.28772616},"labels":[],"label_agreement":null},{"id":"W6931716704","doi":"10.5281/zenodo.5791255","title":"Survival in women with de novo metastatic breast cancer: a comparison of real-world evidence from a publicly-funded Canadian province and the United States by insurance status","year":2021,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health insurance; Population; Breast cancer; MEDLINE; Disease; Socioeconomic status","score_opus":0.04286436815109104,"score_gpt":0.30959993904754857,"score_spread":0.2667355708964575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931716704","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.061380126,0.005985679,0.00016718623,0.0008939563,0.00008583068,0.0001964605,0.92714524,0.000038149257,0.0041073873],"genre_scores_gemma":[0.65150344,0.007294321,0.0013984126,0.0013092934,0.00015146128,0.00084756414,0.33240205,0.00006306576,0.005030375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972024,0.0003201829,0.0005765697,0.0005092543,0.0007696083,0.00062200974],"domain_scores_gemma":[0.980261,0.007416491,0.005440433,0.00094786467,0.0047647157,0.0011694524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028897088,0.0005501725,0.0014558211,0.0038597742,0.0008826711,0.0015739145,0.0025787961,0.0010074831,0.053198222],"category_scores_gemma":[0.037571132,0.00040386096,0.0041111005,0.0097284475,0.00049777,0.0010274177,0.0012198142,0.0008943839,0.0009085092],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011811361,0.00012904199,0.68140656,0.023984244,0.015964491,0.0003612469,0.0007233966,0.0016301981,0.00021532478,0.0023627938,0.21558937,0.045821913],"study_design_scores_gemma":[0.002672749,0.0002503507,0.9529987,0.007948053,0.009593581,0.00033274654,0.0012346755,0.0006246273,0.00011086481,0.0004164345,0.023699002,0.000118238364],"about_ca_topic_score_codex":0.88875365,"about_ca_topic_score_gemma":0.9318431,"teacher_disagreement_score":0.11124635,"about_ca_system_score_codex":0.008813737,"about_ca_system_score_gemma":0.020518284,"threshold_uncertainty_score":0.22380292},"labels":[],"label_agreement":null},{"id":"W6939530163","doi":"10.6084/m9.figshare.28756932","title":"Additional file 2 of Results of the preclinical multicenter randomized controlled paclitaxel-induced neuropathy prevention replication study (PINPRICS)","year":2025,"lang":"en","type":"article","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"","keywords":"Randomized controlled trial; Replication (statistics); Peripheral neuropathy; Clinical trial; MEDLINE","score_opus":0.05133684051177635,"score_gpt":0.3821693012866753,"score_spread":0.330832460774899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939530163","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":"reproducibility","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":"reproducibility","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003647567,0.00009189291,0.000590379,0.00014726588,0.00006051317,0.00095366925,0.9949098,0.00030479938,0.0025768734],"genre_scores_gemma":[0.028869009,0.00073747494,0.013454859,0.002751987,0.000541545,0.023286346,0.8806943,0.0019009392,0.04776351],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99778605,0.000694003,0.00042875108,0.00038057705,0.00042709298,0.00028347445],"domain_scores_gemma":[0.9526951,0.035992347,0.0035396083,0.0026990036,0.0039813244,0.001092552],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0041904915,0.0019477394,0.0030098397,0.0022854742,0.0011996427,0.0023814258,0.0025330333,0.0018738938,0.9118507],"category_scores_gemma":[0.05077869,0.0012950104,0.0025925376,0.0032870767,0.0005284058,0.0020544885,0.0011629941,0.0014544007,0.17962348],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008427272,0.00059778016,0.0020630006,0.010834508,0.0005152696,0.00008405266,0.00006300401,0.001083556,0.00014867132,0.0017340775,0.954778,0.01967071],"study_design_scores_gemma":[0.22325188,0.004869451,0.04022987,0.011464876,0.002810814,0.0011708307,0.00039243378,0.0060977945,0.001882961,0.03435274,0.6730708,0.00040556298],"about_ca_topic_score_codex":0.0046352367,"about_ca_topic_score_gemma":0.008997729,"teacher_disagreement_score":0.9958095,"about_ca_system_score_codex":0.0015494057,"about_ca_system_score_gemma":0.0029592093,"threshold_uncertainty_score":0.12573421},"labels":[],"label_agreement":null},{"id":"W6944998808","doi":"10.20381/ruor-29549","title":"Les familles en trans-formation : Les réalités vécues des parents trans et de leur famille en Ontario et au Québec","year":2023,"lang":"fr","type":"other","venue":"uO Research (University of Ottawa)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Context (archaeology); Perspective (graphical); Futures contract; Michel foucault","score_opus":0.11771835200405015,"score_gpt":0.3810843729934636,"score_spread":0.2633660209894134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6944998808","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786901,0.0009048882,0.0002890615,0.0035384889,0.000034300443,0.000020930618,0.000250671,0.000008150411,0.016263416],"genre_scores_gemma":[0.9900845,0.0007308369,0.00012901945,0.00023458383,0.000005304841,0.000020680944,0.00008259213,0.000006999793,0.008705417],"study_design_codex":"qualitative","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869895,0.00037839456,0.000027358159,0.00014164661,0.00025797868,0.0004956657],"domain_scores_gemma":[0.9976615,0.00037298247,0.00025022597,0.00009153518,0.00085288327,0.0007708898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011952029,0.0002611557,0.0003358158,0.0007167964,0.013610685,0.0034780405,0.0008060752,0.00059456745,0.0060418067],"category_scores_gemma":[0.0024315882,0.00029133147,0.00021893275,0.0020273891,0.00530056,0.0017646999,0.0029625979,0.0012754318,0.00027222623],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056382734,0.00001855681,0.07765853,0.00006298424,0.00001445316,0.0009056416,0.89935577,0.000090637994,0.0003946977,0.005699214,0.0032333233,0.012509755],"study_design_scores_gemma":[0.0000036132667,0.000020586782,0.09789513,0.00008385868,0.000011506244,0.0001457171,0.87515914,0.00007994246,0.000095587406,0.000315512,0.026169572,0.000019753965],"about_ca_topic_score_codex":0.98782617,"about_ca_topic_score_gemma":0.99564266,"teacher_disagreement_score":0.047682967,"about_ca_system_score_codex":0.047682967,"about_ca_system_score_gemma":0.04396214,"threshold_uncertainty_score":0.3459658},"labels":[],"label_agreement":null},{"id":"W6945111700","doi":"10.25384/sage.21754014.v1","title":"Visual abstract – Supplemental material for A Systematic Review and Meta-Analysis of Robot-Assisted Mitral Valve Repair","year":2022,"lang":"en","type":"other","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Mitral valve repair; Cardiothoracic surgery; Mitral valve; Mitral valve annuloplasty; Systematic review","score_opus":0.09381252800281335,"score_gpt":0.40026350052405274,"score_spread":0.3064509725212394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6945111700","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00043695912,0.0029473356,0.001106867,0.0014480113,0.00062651135,0.0015201166,0.98424315,0.0009932854,0.0066776876],"genre_scores_gemma":[0.02298014,0.014078311,0.024983257,0.009945909,0.0034900557,0.03518106,0.77406174,0.0030144907,0.11226499],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982109,0.000435555,0.00044770053,0.00025792714,0.0004837454,0.00016421262],"domain_scores_gemma":[0.97142583,0.021369154,0.0029203657,0.0007207847,0.003074669,0.0004891597],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034306552,0.0016316024,0.0027689924,0.0050883684,0.00044125857,0.0024099858,0.0016371727,0.0015729938,0.8408182],"category_scores_gemma":[0.04934928,0.0008286621,0.0036234926,0.007065164,0.0002459269,0.0021955997,0.0017066468,0.001149888,0.11148777],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078675593,0.00007573572,0.0010535908,0.19310589,0.0014651729,0.00007905247,0.0000663259,0.00035584084,0.00032069362,0.0017024239,0.77217853,0.028809913],"study_design_scores_gemma":[0.012973639,0.0005586236,0.021065615,0.07442489,0.007726737,0.00065031095,0.00020069258,0.0018746154,0.0007231829,0.01787564,0.8617091,0.00021690194],"about_ca_topic_score_codex":0.0043484387,"about_ca_topic_score_gemma":0.0139588015,"teacher_disagreement_score":0.8408182,"about_ca_system_score_codex":0.0015280916,"about_ca_system_score_gemma":0.0042632236,"threshold_uncertainty_score":0.22705346},"labels":[],"label_agreement":null},{"id":"W6945201704","doi":"10.25316/ir-14565","title":"Nanaimo Free Press [Saturday, June 19, 1886]","year":2020,"lang":"en","type":"other","venue":"VIUSpace (Vancouver Island University Library)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"","score_opus":0.010649458422789231,"score_gpt":0.2183261277355767,"score_spread":0.20767666931278747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6945201704","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006366751,0.00661565,0.00007859636,0.0019905844,0.0033483764,0.00003484072,0.0023449012,0.00016561229,0.98478484],"genre_scores_gemma":[0.00061858946,0.0006830892,0.000025535439,0.00013304556,0.000079219215,0.0000073565207,0.00018292193,0.000040611092,0.9982297],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975854,0.000015739051,0.000009653846,0.000038812945,0.0001102456,0.00006697002],"domain_scores_gemma":[0.9997874,0.000024746703,0.000010531048,0.000012351936,0.00010391324,0.00006111145],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026975316,0.0009768212,0.000531905,0.0015906352,0.004680587,0.004904123,0.0006976175,0.0017306347,0.40914467],"category_scores_gemma":[0.0010399964,0.0005101689,0.00036566757,0.0021645257,0.00049754395,0.0015893542,0.0012334401,0.0027186908,0.19092144],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030055851,0.000009146145,0.00016755275,0.0000726615,0.0000029712362,0.00007814131,0.00008248733,0.000044198878,0.00009310633,0.0049154097,0.9660335,0.028470848],"study_design_scores_gemma":[0.0000023096677,0.0000029423627,0.00042132474,0.000042419244,8.562673e-7,0.000017682722,0.00003451204,0.000010410849,0.00002770564,0.0001693338,0.9992679,0.0000025614497],"about_ca_topic_score_codex":0.15228729,"about_ca_topic_score_gemma":0.5705983,"teacher_disagreement_score":0.40914467,"about_ca_system_score_codex":0.0031329931,"about_ca_system_score_gemma":0.002508122,"threshold_uncertainty_score":0.8427834},"labels":[],"label_agreement":null},{"id":"W6945264092","doi":"10.25316/ir-10072","title":"Nanaimo Free Press [Friday, August 6, 1897]","year":2019,"lang":"en","type":"other","venue":"VIUSpace (Vancouver Island University Library)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"","score_opus":0.009710918655201186,"score_gpt":0.21578980006829002,"score_spread":0.20607888141308883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6945264092","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007045425,0.013618237,0.000089353176,0.002943185,0.0049190954,0.00003286991,0.002525847,0.00011766612,0.9750494],"genre_scores_gemma":[0.001093814,0.0015733591,0.000033141678,0.00020141463,0.00014436769,0.0000091740885,0.00021658729,0.000042098305,0.99668604],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99969923,0.000021101101,0.000012876709,0.000044059114,0.00014684917,0.00007595466],"domain_scores_gemma":[0.99978966,0.000028561468,0.000013404644,0.000013868575,0.00010268738,0.000051831405],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027467273,0.0009926982,0.000575653,0.0019778681,0.0050708437,0.005355559,0.0007622794,0.0018728328,0.32277566],"category_scores_gemma":[0.0011155955,0.0005313005,0.00032401484,0.003073417,0.00069719605,0.0016822354,0.0014174357,0.0030143347,0.1212595],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026267417,0.000008232926,0.00017349992,0.00008470037,0.0000034214354,0.000099973084,0.00012482236,0.00004506432,0.000075428674,0.00906681,0.9619675,0.02832423],"study_design_scores_gemma":[0.0000019534189,0.0000021296573,0.00039727145,0.00005166374,8.7051086e-7,0.000018658924,0.000043478107,0.000008861479,0.000026642803,0.00026004968,0.99918586,0.0000025810325],"about_ca_topic_score_codex":0.20992598,"about_ca_topic_score_gemma":0.6413713,"teacher_disagreement_score":0.790074,"about_ca_system_score_codex":0.0048271734,"about_ca_system_score_gemma":0.0032908893,"threshold_uncertainty_score":0.9659783},"labels":[],"label_agreement":null},{"id":"W6945416801","doi":"10.24433/co.9571035.v1","title":"A Broad Review on Class Imbalance Learning Techniques","year":2023,"lang":"en","type":"other","venue":"Code Ocean","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"","keywords":"Class (philosophy); Taxonomy (biology); Support vector machine; Statistical classification; One-class classification; Ensemble learning","score_opus":0.028189142237622068,"score_gpt":0.3642957447447873,"score_spread":0.33610660250716523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6945416801","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014000755,0.9123974,0.05633046,0.0043450333,0.0028928446,0.00015806014,0.00058179384,0.00055753806,0.021336898],"genre_scores_gemma":[0.010967854,0.9412751,0.03163766,0.0024278485,0.004848435,0.00019089678,0.0015484517,0.00017353972,0.006930301],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978974,0.00036818103,0.00024610397,0.00038321936,0.0009912516,0.000113742906],"domain_scores_gemma":[0.99641633,0.0020752018,0.000262578,0.00016128054,0.0009946421,0.00008985024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028945548,0.0014121938,0.0016761882,0.0048660156,0.0006994575,0.00276535,0.0018368469,0.0015202044,0.0071789757],"category_scores_gemma":[0.007003092,0.0005255145,0.0013304049,0.0068409066,0.0008370182,0.0036265133,0.0010148135,0.0018672016,0.00557369],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006936541,0.00006554245,0.0008753466,0.0051103528,0.00008723086,0.000095812116,0.00009552783,0.001872375,0.0007320542,0.011759798,0.068202466,0.9110342],"study_design_scores_gemma":[0.000020059697,0.000105183906,0.0023502607,0.0052387696,0.00016886136,0.00083258084,0.0001624672,0.0043491665,0.0014153239,0.024681004,0.9606094,0.000066939414],"about_ca_topic_score_codex":0.0016601336,"about_ca_topic_score_gemma":0.0013304752,"teacher_disagreement_score":0.0071789757,"about_ca_system_score_codex":0.0010957051,"about_ca_system_score_gemma":0.0018422402,"threshold_uncertainty_score":0.024016023},"labels":[],"label_agreement":null},{"id":"W6945603724","doi":"10.25384/sage.23667810","title":"sj-docx-1-psp-10.1177_01461672231180450 – Supplemental material for In it Together: Relationship Transitions and Couple Concordance in Health and Well-Being","year":2023,"lang":"en","type":"article","venue":"Sage Journals Data","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Concordance; Personality; Association (psychology); Personality Assessment Inventory; Big Five personality traits; Social relation","score_opus":0.07495274882805165,"score_gpt":0.40538519943044815,"score_spread":0.3304324506023965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6945603724","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003858041,0.000115294395,0.0005465688,0.000942078,0.00054652005,0.00029691897,0.9609628,0.002598022,0.033606123],"genre_scores_gemma":[0.0079680765,0.0007533472,0.0040365364,0.0019817366,0.0008114318,0.002686693,0.82632643,0.008068544,0.14736712],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.999009,0.00014063354,0.00012485406,0.00014804972,0.0004246089,0.0001529251],"domain_scores_gemma":[0.97939426,0.010993287,0.00078656647,0.0012035517,0.0060071107,0.0016152352],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001508491,0.0013519428,0.0014681218,0.0032027557,0.0018750133,0.0047593336,0.0024670428,0.0019620713,0.9566283],"category_scores_gemma":[0.02797799,0.0015250513,0.0011375644,0.0056357356,0.0005207803,0.0042947344,0.0028191844,0.0020516815,0.7794592],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038038474,0.00004399921,0.00027405104,0.00033490863,0.0000041512762,0.000009572146,0.000050067527,0.00001881937,0.000026280397,0.00017687432,0.9945456,0.0044775377],"study_design_scores_gemma":[0.001028453,0.000117491385,0.017730953,0.001669914,0.000045220095,0.00015686528,0.0011795613,0.0003045937,0.00049852824,0.004516747,0.9726308,0.000120896424],"about_ca_topic_score_codex":0.016989736,"about_ca_topic_score_gemma":0.025959305,"teacher_disagreement_score":0.9566283,"about_ca_system_score_codex":0.0015798806,"about_ca_system_score_gemma":0.0023080034,"threshold_uncertainty_score":0.061864376},"labels":[],"label_agreement":null},{"id":"W6945881801","doi":"10.3389/fphar.2024.1519522.s002","title":"Data Sheet 1_Association between penicillin allergy labels and serious adverse events in hospitalized patients: a systematic review and meta-analysis.docx","year":2025,"lang":"en","type":"dataset","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Funnel plot; Adverse effect; Penicillin; Allergy; Meta-analysis; Relative risk; Data extraction; Confidence interval","score_opus":0.07160547246490633,"score_gpt":0.3671827157821908,"score_spread":0.29557724331728447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6945881801","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010995275,0.009560311,0.002506019,0.0015364978,0.00055684184,0.03402523,0.94697475,0.0008754605,0.0028653117],"genre_scores_gemma":[0.015713895,0.026728533,0.036856506,0.006478533,0.0008086845,0.6521278,0.2346269,0.00092434057,0.025734853],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9941928,0.0017208351,0.0021833787,0.00057871547,0.00101391,0.00031042058],"domain_scores_gemma":[0.9593199,0.027860945,0.007772766,0.0012015266,0.0034480782,0.0003967406],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.011053995,0.0033878332,0.008645889,0.012944175,0.00088394614,0.0038640776,0.0035623095,0.0021112715,0.46106213],"category_scores_gemma":[0.08106997,0.0019297418,0.00992668,0.017667215,0.0008895967,0.004909322,0.0020463723,0.0017169457,0.017318904],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007516701,0.000030539468,0.00055401586,0.9021208,0.0027825353,0.000068011264,0.000091149326,0.00039852198,0.00013621732,0.0015008425,0.08342964,0.008135976],"study_design_scores_gemma":[0.018332385,0.0007076232,0.014204419,0.5236603,0.03066264,0.00063719356,0.00064795726,0.0024540324,0.0013379052,0.013397891,0.39353827,0.0004192835],"about_ca_topic_score_codex":0.0054325596,"about_ca_topic_score_gemma":0.012391362,"teacher_disagreement_score":0.46106213,"about_ca_system_score_codex":0.0034787797,"about_ca_system_score_gemma":0.011056992,"threshold_uncertainty_score":0.76872945},"labels":[],"label_agreement":null},{"id":"W6946174010","doi":"10.3389/fnut.2024.1467751.s001","title":"Data_Sheet_1_Joint association of serum sodium and frailty with mild cognitive impairment among hospitalized older adults with chronic diseases: a cross-sectional study.docx","year":2024,"lang":"en","type":"dataset","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Logistic regression; Cognitive impairment; Sodium; Risk factor; Older people; Confidence interval; Cognition; High sodium","score_opus":0.016606342629779815,"score_gpt":0.32013459202497646,"score_spread":0.3035282493951966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6946174010","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038396209,0.00008132277,0.0002553884,0.00023350003,0.00007357621,0.0014944914,0.9919996,0.0001155077,0.0019068689],"genre_scores_gemma":[0.04745535,0.00061585126,0.005352402,0.0018391806,0.00031932577,0.03878991,0.8913839,0.00017878301,0.014065284],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9991498,0.00014959484,0.000290247,0.0001287046,0.0001901518,0.00009150167],"domain_scores_gemma":[0.9938205,0.0023981822,0.00113962,0.0004357419,0.0019434274,0.00026257793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015632899,0.0008694382,0.0013630508,0.002631872,0.00077848835,0.0008152809,0.0013077765,0.00095568225,0.21662721],"category_scores_gemma":[0.011824955,0.00073042646,0.0010260058,0.0035279216,0.00022474356,0.0012956496,0.00055376714,0.0010523044,0.015922641],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016468167,0.00039025326,0.06614947,0.007384607,0.00029664463,0.00015153928,0.00015641528,0.0005946975,0.00028326036,0.0009690641,0.9028767,0.019100698],"study_design_scores_gemma":[0.011847399,0.0012272844,0.6654053,0.006963023,0.00048514444,0.00087901065,0.001182784,0.0026182542,0.0008792102,0.0033969951,0.3048639,0.00025174374],"about_ca_topic_score_codex":0.011908382,"about_ca_topic_score_gemma":0.012400077,"teacher_disagreement_score":0.21662721,"about_ca_system_score_codex":0.00079927925,"about_ca_system_score_gemma":0.0017225565,"threshold_uncertainty_score":0.7246902},"labels":[],"label_agreement":null},{"id":"W6946201193","doi":"10.3389/fcimb.2022.947486.s001","title":"DataSheet_1_Genomic characterization of two metagenome-assembled genomes of Tropheryma whipplei from China.pdf","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tropheryma whipplei; Genome; Phylogenetic tree; Phylogenetics; Metagenomics; Whole genome sequencing; Genotype; Bacterial genome size","score_opus":0.03462018715582865,"score_gpt":0.31468957245483603,"score_spread":0.2800693852990074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6946201193","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05052317,0.00081243116,0.0062963325,0.0002568738,0.0001673837,0.00026664961,0.93428314,0.003314278,0.0040796404],"genre_scores_gemma":[0.025525713,0.00055109,0.015137889,0.00011465543,0.000027541351,0.00037387625,0.956082,0.0008428919,0.0013443606],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995914,0.000026627422,0.000054882363,0.00013830754,0.0001127553,0.000076033],"domain_scores_gemma":[0.9991929,0.0002956997,0.00015174647,0.00008097854,0.0001442078,0.00013439171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066976907,0.0018965815,0.0015385161,0.005446035,0.001409259,0.001064165,0.0014557755,0.001311388,0.028674308],"category_scores_gemma":[0.0018981048,0.0011685948,0.0019301542,0.009243662,0.0003777616,0.0010262517,0.00096155045,0.0016965955,0.010426242],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053693815,0.0008430848,0.04072575,0.018708527,0.00091814966,0.004072169,0.004084802,0.0072459527,0.60296744,0.0048913984,0.20522492,0.104948424],"study_design_scores_gemma":[0.001340178,0.0011816944,0.39016417,0.0013093032,0.0012132829,0.0035182282,0.0017367613,0.013691257,0.08143368,0.0032803894,0.5004328,0.00069821905],"about_ca_topic_score_codex":0.009426703,"about_ca_topic_score_gemma":0.009274929,"teacher_disagreement_score":0.028674308,"about_ca_system_score_codex":0.00083476247,"about_ca_system_score_gemma":0.0018243628,"threshold_uncertainty_score":0.09592509},"labels":[],"label_agreement":null},{"id":"W6946280202","doi":"10.3389/fpsyt.2024.1414291.s001","title":"DataSheet_1_Targeting maternal gut microbiome to improve mental health outcomes—a pilot feasibility trial.pdf","year":2024,"lang":"en","type":"dataset","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mood; Anxiety; Psychological intervention; Depression (economics); Randomized controlled trial; Microbiome; Mental health; Gut flora","score_opus":0.07816319721669086,"score_gpt":0.40960999324039427,"score_spread":0.3314467960237034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6946280202","genre_codex":"empirical","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6060021,0.017429251,0.00590721,0.017416868,0.005338542,0.26851347,0.044816397,0.0014862505,0.03308996],"genre_scores_gemma":[0.56577945,0.011042339,0.023283808,0.01087506,0.0021877822,0.35392916,0.008635772,0.00015749522,0.024109073],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99925107,0.0004346214,0.000059260932,0.00007612804,0.00006415052,0.00011469225],"domain_scores_gemma":[0.998423,0.0005860867,0.00028187293,0.00013896049,0.00015248702,0.0004176664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030904806,0.0010028229,0.0017453457,0.00045121965,0.000626444,0.0009418955,0.0010854066,0.0021101206,0.0491325],"category_scores_gemma":[0.0037997083,0.00056560553,0.0017995619,0.00043205015,0.0006097598,0.0011994188,0.0008176496,0.003010276,0.004383379],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86899143,0.03453279,0.000902457,0.005450498,0.0012423946,0.00010652506,0.00013474045,0.0003237525,0.0022358594,0.000701713,0.01600734,0.069370575],"study_design_scores_gemma":[0.8997083,0.08990092,0.0022819648,0.0004451978,0.0006113602,0.00003158447,0.000051541672,0.00022206447,0.0003498387,0.00043973356,0.005936559,0.000020887492],"about_ca_topic_score_codex":0.0007725827,"about_ca_topic_score_gemma":0.0012257245,"teacher_disagreement_score":0.0491325,"about_ca_system_score_codex":0.00036279098,"about_ca_system_score_gemma":0.0020470503,"threshold_uncertainty_score":0.16436458},"labels":[],"label_agreement":null},{"id":"W6946446326","doi":"10.34943/edda2d79-31ed-4841-858e-4976bdb54483","title":"Strait of Georgia East Hydrophone Deployed 2009-09-27","year":2009,"lang":"en","type":"dataset","venue":"Ocean Networks Canada Society","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hydrophone; Underwater; Sound (geography); Waveform; Data logger; Software deployment","score_opus":0.008496672297777478,"score_gpt":0.2410771219399118,"score_spread":0.2325804496421343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6946446326","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014074552,0.00004190679,0.000085368534,0.00006180677,0.000018019746,0.000014719803,0.99700457,0.00018584442,0.0011803203],"genre_scores_gemma":[0.0023802237,0.000031095376,0.00024767822,0.000027219427,0.000004607559,0.00003161522,0.99617827,0.00002407647,0.0010751999],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99941576,0.00005895433,0.000059045142,0.0001499069,0.00022291992,0.00009338054],"domain_scores_gemma":[0.9987128,0.00011716222,0.00014057616,0.00024002121,0.00067815953,0.00011125688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005661009,0.0011017523,0.000731699,0.001928081,0.00050409033,0.0007549177,0.0013811548,0.0007201634,0.00818309],"category_scores_gemma":[0.002150282,0.0002807616,0.0004667041,0.003482188,0.0002391566,0.00036980107,0.0007592834,0.00081993046,0.014774103],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017660508,0.00003607875,0.008196581,0.0001997251,0.000039415543,0.00006417873,0.000031346986,0.0010105228,0.000317114,0.0003950181,0.9843955,0.0051379576],"study_design_scores_gemma":[0.00019536821,0.000041803287,0.07936925,0.0001791849,0.00004088011,0.00013323146,0.00018356892,0.0023111014,0.0014257075,0.0005243754,0.9155477,0.00004790029],"about_ca_topic_score_codex":0.27455762,"about_ca_topic_score_gemma":0.40228993,"teacher_disagreement_score":0.27455762,"about_ca_system_score_codex":0.0024745692,"about_ca_system_score_gemma":0.0031145345,"threshold_uncertainty_score":0.54591906},"labels":[],"label_agreement":null},{"id":"W6946476987","doi":"10.3389/fmars.2022.926442.s001","title":"DataSheet_1_Using larval connectivity to inform conservation management of the endemic and threatened Atlantic mud-piddock (Barnea truncata) in the Minas Basin Canada.docx","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metapopulation; Threatened species; Population; Structural basin; Marine conservation; Marine protected area; Marine reserve; Endemism; Propagule","score_opus":0.050226766250569634,"score_gpt":0.30861901493072447,"score_spread":0.2583922486801548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6946476987","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009196369,0.000039826256,0.00018213171,0.00015720662,0.000028938955,0.000105883184,0.98976105,0.0006479417,0.008157317],"genre_scores_gemma":[0.02204926,0.0004396016,0.005781392,0.00050256774,0.000050831364,0.0009270875,0.94243467,0.0016994878,0.026115151],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997869,0.000010425182,0.000019600006,0.000031460015,0.00009407518,0.000057580055],"domain_scores_gemma":[0.99792176,0.0003133155,0.00016689456,0.000095874035,0.0012393784,0.00026279275],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0004245028,0.0006687007,0.00047544582,0.0019526539,0.0009949091,0.001297908,0.001650956,0.0006090884,0.34516457],"category_scores_gemma":[0.0034764858,0.00056883827,0.00070343324,0.0031217635,0.0002737013,0.0010053369,0.0011909412,0.0006122301,0.05161243],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006177667,0.000025285604,0.011279778,0.00077772955,0.00003089996,0.00008167745,0.00017945892,0.00097236515,0.00017202296,0.0005505885,0.9750447,0.010823791],"study_design_scores_gemma":[0.00048011518,0.000042700027,0.08956487,0.0011312158,0.00006825248,0.0001599753,0.000650635,0.0031708705,0.0010202117,0.0013920013,0.90223813,0.000081040846],"about_ca_topic_score_codex":0.73852324,"about_ca_topic_score_gemma":0.8483029,"teacher_disagreement_score":0.65483546,"about_ca_system_score_codex":0.003941627,"about_ca_system_score_gemma":0.0066346894,"threshold_uncertainty_score":0.9340433},"labels":[],"label_agreement":null},{"id":"W6946579554","doi":"10.34989/sdp-2022-3","title":"Payment Coordination and Liquidity Efficiency in the New Canadian Wholesale Payments System","year":2022,"lang":"en","type":"article","venue":"Econstor (Econstor)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bank of Canada","funders":"","keywords":"Payment; Market liquidity; Settlement (finance); Payment system; Payment service provider","score_opus":0.015316754972193486,"score_gpt":0.26377668062816056,"score_spread":0.24845992565596708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6946579554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834894,0.00026876805,0.00065637456,0.0014107287,0.000012818257,0.00008904272,0.00044645875,0.00002286287,0.01360353],"genre_scores_gemma":[0.99630046,0.000096769116,0.0005931443,0.000095585,0.0000072802964,0.000015845406,0.00017174712,0.000006942026,0.0027122726],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958895,0.0008950623,0.0001604182,0.0004152199,0.0012691825,0.001370621],"domain_scores_gemma":[0.98784685,0.003867779,0.0025754622,0.0005527534,0.0033127873,0.0018442693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004771195,0.00032979128,0.00046651263,0.00087097846,0.0030629595,0.004737657,0.0012286402,0.0006800671,0.006221841],"category_scores_gemma":[0.019534526,0.00026373548,0.00032506685,0.0020251328,0.0015982646,0.0012527627,0.0012720695,0.0010964746,0.0003636339],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064111473,0.0014300245,0.67076695,0.00035077226,0.0004598869,0.00073757797,0.01239093,0.079228655,0.0077136713,0.06385714,0.02293193,0.13372129],"study_design_scores_gemma":[0.00091362034,0.0008244047,0.8529368,0.00015125173,0.0003705357,0.0001760293,0.018763592,0.08613166,0.0024621051,0.007686558,0.029284187,0.00029927946],"about_ca_topic_score_codex":0.96368,"about_ca_topic_score_gemma":0.9764382,"teacher_disagreement_score":0.9510971,"about_ca_system_score_codex":0.048902947,"about_ca_system_score_gemma":0.046178896,"threshold_uncertainty_score":0.35481733},"labels":[],"label_agreement":null},{"id":"W6947437112","doi":"10.3897/bdj.12.e120340.figure1a","title":"Figure 1a from: Douglas H, Renkema J, Smith T, Konstantinov A, Moisan-De Serres J (2024) Palearctic flea beetle and pest of hops and Cannabis, Psylliodes attenuata (Coleoptera, Chrysomelidae, Galerucinae), new to North America. Biodiversity Data Journal 12: e120340. https://doi.org/10.3897/BDJ.12.e120340","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Voltinism; PEST analysis; Coccinellidae; Range (aeronautics); Humulus lupulus; Flea beetle","score_opus":0.0538825984972584,"score_gpt":0.2903534393078463,"score_spread":0.2364708408105879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6947437112","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008331973,0.0015934608,0.0012313206,0.002003066,0.0061252797,0.00036112536,0.2809475,0.0027614576,0.70414364],"genre_scores_gemma":[0.0048836307,0.002229496,0.002366664,0.0015808108,0.0009814335,0.00018843774,0.14132191,0.0016876629,0.84475994],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995378,0.000029160388,0.000023016324,0.000105675965,0.00023109373,0.00007336041],"domain_scores_gemma":[0.99838376,0.00023892101,0.000090671645,0.00010609145,0.00091076235,0.00026977443],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003631716,0.0012304772,0.00089780934,0.002552585,0.0015526415,0.0026583322,0.0013117372,0.0013934823,0.889976],"category_scores_gemma":[0.002735304,0.00044991972,0.0006202798,0.0037374403,0.0005749229,0.002060647,0.0015906678,0.0016983859,0.7571044],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018768802,0.000013390337,0.00019836618,0.00018394645,0.000002102089,0.00003220739,0.00003511644,0.000019968065,0.00013414999,0.00027992608,0.98812217,0.010959911],"study_design_scores_gemma":[0.0000070856477,0.0000062448794,0.0011356341,0.00009309091,0.0000020135976,0.000041307776,0.0000362704,0.000017167713,0.00004489736,0.0001228226,0.99849033,0.000003000538],"about_ca_topic_score_codex":0.022587212,"about_ca_topic_score_gemma":0.05619519,"teacher_disagreement_score":0.889976,"about_ca_system_score_codex":0.0009817778,"about_ca_system_score_gemma":0.002371279,"threshold_uncertainty_score":0.15693575},"labels":[],"label_agreement":null},{"id":"W6947656915","doi":"10.3932/ethz-a-000596014","title":"Kanada, Pont de Quebec","year":2001,"lang":"es","type":"other","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"","score_opus":0.015375188878213188,"score_gpt":0.31692760275888077,"score_spread":0.30155241388066756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6947656915","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025023906,0.013996752,0.001034067,0.008990899,0.0014352096,0.0002211964,0.014369071,0.00060447486,0.93432444],"genre_scores_gemma":[0.015452772,0.0022979898,0.00052156416,0.00059221394,0.00003903194,0.000029775743,0.00095575105,0.00014217668,0.9799687],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99952793,0.00004939685,0.000021621643,0.00011897315,0.00014565987,0.0001365282],"domain_scores_gemma":[0.9988607,0.00024306976,0.00006877918,0.00006904515,0.00047494244,0.0002834303],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035393678,0.0011460994,0.000506919,0.0010530631,0.0041486877,0.0027524028,0.0011643354,0.0016382493,0.47571483],"category_scores_gemma":[0.0012864929,0.00049925275,0.0005510266,0.0019623355,0.000768628,0.0010990645,0.00077572686,0.0023959307,0.07280373],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008844717,0.0003874877,0.013104353,0.0005742877,0.00009055797,0.0023117878,0.0007549475,0.001784447,0.0023453117,0.014850753,0.5400291,0.4228825],"study_design_scores_gemma":[0.00015625334,0.00007022266,0.029264655,0.00023007853,0.000032555796,0.0004982362,0.00058515434,0.0008515452,0.00086593477,0.00079366006,0.96662337,0.000028444563],"about_ca_topic_score_codex":0.9080235,"about_ca_topic_score_gemma":0.9703593,"teacher_disagreement_score":0.47571483,"about_ca_system_score_codex":0.013545554,"about_ca_system_score_gemma":0.015658606,"threshold_uncertainty_score":0.74782914},"labels":[],"label_agreement":null},{"id":"W6947768459","doi":"10.3897/zookeys.894.37862.figure41","title":"Figure 41 from: Pentinsaari M, Anderson R, Borowiec L, Bouchard P, Brunke A, Douglas H, Smith A, Hebert P (2019) DNA barcodes reveal 63 overlooked species of Canadian beetles (Insecta, Coleoptera). ZooKeys 894: 53-150. https://doi.org/10.3897/zookeys.894.37862","year":2019,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Scale (ratio); Biodiversity; DNA barcoding","score_opus":0.03479664510707907,"score_gpt":0.2533969660608693,"score_spread":0.21860032095379023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6947768459","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00051527546,0.00091078127,0.0015657219,0.0011422274,0.002440516,0.00014189846,0.022030149,0.0031335843,0.9681197],"genre_scores_gemma":[0.0027372378,0.0008916795,0.0014760102,0.00038319328,0.00026383018,0.000069153444,0.011660173,0.0014291746,0.98108953],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997999,0.000014863444,0.000010920597,0.000033992957,0.000108702596,0.000031646297],"domain_scores_gemma":[0.9994709,0.00010530391,0.000027625327,0.00006099035,0.00018476091,0.00015043103],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002406805,0.0011641158,0.00065875676,0.001642746,0.0010844014,0.0017656913,0.0008585553,0.001262265,0.9133466],"category_scores_gemma":[0.001541305,0.00040163513,0.000632205,0.0013808938,0.0006004926,0.0017192216,0.0016347863,0.0013648545,0.81642485],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017130262,0.00000823529,0.00009972806,0.00011554764,0.0000016247269,0.00009320835,0.000035112396,0.000014729318,0.00021161676,0.00057034346,0.97362715,0.02520557],"study_design_scores_gemma":[0.00000419463,0.00000433073,0.0004381341,0.00006878078,0.0000016854947,0.00020385951,0.000024871602,0.000015517226,0.00010590465,0.00018715714,0.9989429,0.0000025916431],"about_ca_topic_score_codex":0.006857478,"about_ca_topic_score_gemma":0.018754676,"teacher_disagreement_score":0.99314255,"about_ca_system_score_codex":0.0008650993,"about_ca_system_score_gemma":0.001205089,"threshold_uncertainty_score":0.1236006},"labels":[],"label_agreement":null},{"id":"W6947892687","doi":"10.4224/21274575","title":"Hygrothermal modelling benchmark: comparison of hygIRC simulation results with full scale experiment results: report to Research Consortium for Wood and Wood-Hybrid Mid-Rise Buildings","year":2014,"lang":"en","type":"report","venue":"NPARC","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"National Research Council Canada","funders":"Natural Resources Canada; FPInnovations","keywords":"Benchmarking; Full scale; Task (project management); Measure (data warehouse); Parametric statistics; Scale (ratio); Simulation modeling","score_opus":0.11988483381714417,"score_gpt":0.43920326451251096,"score_spread":0.3193184306953668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6947892687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87599486,0.0005119951,0.060621977,0.0005041549,0.00016587904,0.000875464,0.016046027,0.0044284705,0.04085122],"genre_scores_gemma":[0.94249386,0.00033854187,0.038137764,0.0000695225,0.000015452075,0.00037291282,0.013244095,0.00043634573,0.004891393],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99793124,0.00046510252,0.00012137866,0.00017256125,0.0011807263,0.00012910394],"domain_scores_gemma":[0.99727017,0.0008271038,0.00014113796,0.0006417718,0.001040707,0.00007910813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037061207,0.0008505649,0.0008861173,0.0007720451,0.00046151172,0.0011705935,0.0015536383,0.0009766007,0.0042189118],"category_scores_gemma":[0.003487197,0.0004317284,0.00072559813,0.00088813616,0.00035771792,0.00095483,0.0006922557,0.0007403356,0.0012167328],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018819482,0.0019814414,0.018957464,0.000689848,0.000121594814,0.00025026654,0.00027214567,0.85057706,0.065805204,0.0022866828,0.011053811,0.046122503],"study_design_scores_gemma":[0.00031847323,0.00239949,0.024930615,0.00006092682,0.00007870274,0.00014663459,0.0002400686,0.8710421,0.08770859,0.0005612213,0.012375215,0.00013803279],"about_ca_topic_score_codex":0.010136185,"about_ca_topic_score_gemma":0.011636722,"teacher_disagreement_score":0.010136185,"about_ca_system_score_codex":0.0011336684,"about_ca_system_score_gemma":0.0012378232,"threshold_uncertainty_score":0.020154357},"labels":[],"label_agreement":null},{"id":"W6947938144","doi":"10.4224/40002649","title":"An impact analysis for the National guide for wildland-urban-interface fires","year":2021,"lang":"en","type":"report","venue":"NPARC","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"Institute for Catastrophic Loss Reduction","keywords":"Research council; Reduction (mathematics); Government (linguistics); Work (physics)","score_opus":0.10122277738270094,"score_gpt":0.4765250050053514,"score_spread":0.3753022276226504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6947938144","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009703277,0.0038982374,0.16357328,0.0034966075,0.00234922,0.0059172786,0.30273232,0.0072923596,0.5010375],"genre_scores_gemma":[0.050245047,0.008178155,0.35685676,0.0008664379,0.00028480368,0.0041505927,0.13688137,0.0035227458,0.43901408],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99889225,0.00015294617,0.000064978005,0.00006486793,0.0007141207,0.00011082824],"domain_scores_gemma":[0.99813133,0.00025700402,0.000068193585,0.00011932698,0.0013625119,0.00006167279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016568147,0.0019907572,0.0009921952,0.00479684,0.0012841112,0.0022368757,0.0024636583,0.0011552101,0.090456285],"category_scores_gemma":[0.0035416316,0.0009507653,0.0018386584,0.0044036903,0.00029234926,0.0023871944,0.0011760012,0.0017706462,0.024099529],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058840717,0.00020636673,0.003858377,0.00044071613,0.000047121754,0.00016862835,0.00019162934,0.027417514,0.0006398558,0.016737867,0.7894587,0.1607744],"study_design_scores_gemma":[0.00007679674,0.00009526733,0.018398289,0.0008939898,0.00005612925,0.00017242953,0.0010351995,0.028303793,0.0012158869,0.013640983,0.9360022,0.00010892775],"about_ca_topic_score_codex":0.28319266,"about_ca_topic_score_gemma":0.42202395,"teacher_disagreement_score":0.71680737,"about_ca_system_score_codex":0.0040989364,"about_ca_system_score_gemma":0.013541109,"threshold_uncertainty_score":0.5630886},"labels":[],"label_agreement":null},{"id":"W6947978506","doi":"10.4224/crm.2003.moos-1","title":"MOOS-1: Seawater certified reference material for nutrients","year":2003,"lang":"en","type":"other","venue":"NRC Digital Repository","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada","funders":"","keywords":"Seawater; Nutrient; Certified reference materials; Nitrate","score_opus":0.026769559002263424,"score_gpt":0.2959820051996737,"score_spread":0.2692124461974103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6947978506","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15418147,0.005271451,0.09280174,0.0011304691,0.00094069936,0.002040988,0.3514093,0.010096886,0.382127],"genre_scores_gemma":[0.21230306,0.006605508,0.15608957,0.0009407765,0.00020019211,0.002582421,0.41887906,0.0025677427,0.19983162],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972373,0.00019850308,0.00017301533,0.00038221772,0.0018850986,0.00012382632],"domain_scores_gemma":[0.99861526,0.000046426714,0.00014398718,0.00013620478,0.0010057334,0.000052355106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013828625,0.0014297522,0.0007623207,0.005368475,0.0010287978,0.0010592595,0.00288255,0.0009157451,0.017326891],"category_scores_gemma":[0.0027148074,0.00032000314,0.0004317982,0.004615376,0.00041697695,0.0007485746,0.0011254422,0.00064509874,0.014592902],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012799462,0.00048726835,0.041040294,0.0022840009,0.00018841913,0.00061921135,0.0004498496,0.0038654737,0.26623544,0.015096909,0.32001966,0.34843355],"study_design_scores_gemma":[0.00014016143,0.00025884676,0.035406604,0.00032606005,0.00011143354,0.00054179586,0.00018594385,0.0022969793,0.12512691,0.0031193057,0.83239865,0.00008726232],"about_ca_topic_score_codex":0.025426978,"about_ca_topic_score_gemma":0.04923807,"teacher_disagreement_score":0.025426978,"about_ca_system_score_codex":0.0014535106,"about_ca_system_score_gemma":0.002944485,"threshold_uncertainty_score":0.057964206},"labels":[],"label_agreement":null},{"id":"W6948105744","doi":"10.48448/ywej-t259","title":"Progressive Gradient Pruning for Classification, Detection and Domain Adaptation","year":2020,"lang":"en","type":"other","venue":"Underline Science Inc.","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec","funders":"","keywords":"Pruning; Benchmark (surveying); Filter (signal processing); Convolutional neural network; Pattern recognition (psychology); Computational complexity theory; Artificial neural network; Kernel adaptive filter; Domain (mathematical analysis)","score_opus":0.053086511062157095,"score_gpt":0.35086075353029494,"score_spread":0.29777424246813783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6948105744","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025474586,0.00053478486,0.9672319,0.00015167156,0.00008211326,0.00009332298,0.00016842957,0.0032528362,0.0030103314],"genre_scores_gemma":[0.30419755,0.00051261164,0.6856743,0.0003140136,0.00008937046,0.00024638476,0.000998572,0.0007379384,0.0072292653],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9994485,0.000077419856,0.000036551377,0.00012331233,0.0002450189,0.000069158035],"domain_scores_gemma":[0.99908733,0.00033766576,0.00008873312,0.00020021808,0.00024923842,0.000036788377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086204574,0.00094648206,0.0006108671,0.0008542248,0.00033631994,0.0006615007,0.0012107453,0.00074239826,0.0031345706],"category_scores_gemma":[0.0040371264,0.0003100741,0.0006177124,0.0007183265,0.00044408604,0.0009239339,0.00095114956,0.0010253305,0.0015322099],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022830187,0.00014425332,0.0020945552,0.0001743414,0.00006841189,0.00026191917,0.00011461405,0.10391577,0.042208564,0.009472263,0.011135754,0.83018124],"study_design_scores_gemma":[0.000026365373,0.00006948485,0.0012560543,0.000038391623,0.000030062345,0.00028880071,0.000021934844,0.9456043,0.035899777,0.008853144,0.007892331,0.00001928347],"about_ca_topic_score_codex":0.0032809132,"about_ca_topic_score_gemma":0.0055463575,"teacher_disagreement_score":0.0032809132,"about_ca_system_score_codex":0.00046156254,"about_ca_system_score_gemma":0.0010661483,"threshold_uncertainty_score":0.010486186},"labels":[],"label_agreement":null},{"id":"W6948228693","doi":"10.48660/17050087","title":"Donaldson-Thomas transformations for moduli spaces of local systems on surfaces","year":2017,"lang":"en","type":"other","venue":"PIRSA","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Perimeter Institute","funders":"","keywords":"Surface (topology); Space (punctuation); Moduli; Deformation (meteorology); Product (mathematics)","score_opus":0.03554836986628001,"score_gpt":0.3360074698001141,"score_spread":0.3004590999338341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6948228693","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41885385,0.0028484936,0.08474331,0.005561953,0.00092194957,0.00010575376,0.0004535165,0.00042391478,0.48608732],"genre_scores_gemma":[0.84933126,0.0013705613,0.015051504,0.0005141463,0.0010039399,0.00006733117,0.00043936181,0.00035599104,0.13186578],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995511,0.00010303776,0.000022996752,0.00008070791,0.00015072043,0.00009138621],"domain_scores_gemma":[0.99957067,0.000076371376,0.000077559394,0.000075876116,0.0000747813,0.00012472011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068239914,0.000841139,0.0006548342,0.0026383284,0.0014822383,0.002974075,0.0008061216,0.0009986194,0.015338124],"category_scores_gemma":[0.0014264563,0.00026314348,0.00093444384,0.0010069703,0.002298895,0.0032187079,0.0028397567,0.0019250473,0.0017879001],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018417935,0.000012085367,0.0000728918,0.000014114115,0.0000045101483,0.00003365782,0.000095491276,0.00034603357,0.00039370905,0.9936458,0.0008521294,0.0045111747],"study_design_scores_gemma":[0.000015007361,0.000014551181,0.00021148952,0.000013745391,0.0000047928634,0.00013452645,0.00008185521,0.002882918,0.00040353148,0.98913807,0.0070900167,0.000009559257],"about_ca_topic_score_codex":0.0008680769,"about_ca_topic_score_gemma":0.00074928044,"teacher_disagreement_score":0.015338124,"about_ca_system_score_codex":0.0016219892,"about_ca_system_score_gemma":0.0007592844,"threshold_uncertainty_score":0.051311135},"labels":[],"label_agreement":null},{"id":"W6948524537","doi":"10.5061/dryad.63xsj3v1v","title":"Observational evidence of herbivore-specific associational effects between neighboring conspecifics in natural, dimorphic populations of Datura wrightii","year":2021,"lang":"en","type":"dataset","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Population; Exclosure; Intraspecific competition; Cannibalism","score_opus":0.17429175883816506,"score_gpt":0.3565134667975447,"score_spread":0.18222170795937964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6948524537","genre_codex":"empirical","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996718,0.000021848324,0.000049186347,0.00000287198,4.5778646e-7,0.00000183541,0.00004026324,0.000002135726,0.00020946472],"genre_scores_gemma":[0.99973947,0.000009647054,0.000095093856,0.000005167144,7.749448e-7,0.0000024457024,0.000066736546,8.7223583e-7,0.000079741745],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984825,0.000029279843,0.000010532754,0.00006599497,0.00002706683,0.00001885963],"domain_scores_gemma":[0.9992126,0.00015795075,0.00030754847,0.00009466418,0.00007396792,0.00015321292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022346579,0.0001407005,0.00022096529,0.00056872197,0.0005721775,0.00032373294,0.0002637893,0.00019165137,0.00082337164],"category_scores_gemma":[0.00056426204,0.00022472364,0.00010550229,0.00024362764,0.0005526583,0.0001733976,0.0004367093,0.0003016666,0.00008422961],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008388205,0.000061021652,0.95514816,0.000025122294,0.00006643393,0.000085636624,0.00070357206,0.00005907696,0.041284896,0.000034788292,0.0000784077,0.0023689622],"study_design_scores_gemma":[0.0000011447054,0.000020162863,0.9995666,8.923327e-7,0.0000047049207,0.000052390493,0.00010233925,0.000039516708,0.00015918477,0.000005289769,0.000046548477,0.0000011145111],"about_ca_topic_score_codex":0.006768546,"about_ca_topic_score_gemma":0.036812555,"teacher_disagreement_score":0.006768546,"about_ca_system_score_codex":0.000277739,"about_ca_system_score_gemma":0.0001039876,"threshold_uncertainty_score":0.013458312},"labels":[],"label_agreement":null},{"id":"W6948718542","doi":"10.5281/zenodo.12090299","title":"Die prophezeiung des ra uru hu pdf","year":2024,"lang":"de","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reading (process); Subject (documents); Holy See; Kingdom","score_opus":0.04414482844277448,"score_gpt":0.29861463189202475,"score_spread":0.2544698034492503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6948718542","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0077360393,0.008664634,0.01558385,0.0013879837,0.0063438597,0.00044243224,0.009209283,0.011668082,0.93896395],"genre_scores_gemma":[0.022285067,0.007845958,0.009730379,0.0008896661,0.0010152934,0.0002409986,0.0063344077,0.0037608822,0.9478973],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993118,0.000043818865,0.000031244155,0.000080620746,0.00039722605,0.00013537276],"domain_scores_gemma":[0.99945825,0.00006929675,0.000026990861,0.00009563372,0.00022018682,0.00012958553],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00061577023,0.0016776051,0.0009820341,0.002098842,0.0012947774,0.0034904743,0.00078943855,0.0012343499,0.5051539],"category_scores_gemma":[0.0014453868,0.00058881583,0.0011658381,0.0012080646,0.0005850931,0.002565634,0.0028176138,0.0024990481,0.5248561],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043831425,0.00015896559,0.00036716159,0.0012272967,0.000029843577,0.00115269,0.00025008534,0.000531625,0.039762706,0.007501856,0.51663685,0.43194255],"study_design_scores_gemma":[0.000023568327,0.00009570923,0.000716487,0.00016058651,0.000011740969,0.0006601103,0.00008520824,0.00018421223,0.022830896,0.001014739,0.9741915,0.000025247678],"about_ca_topic_score_codex":0.0010736571,"about_ca_topic_score_gemma":0.0013993843,"teacher_disagreement_score":0.4948461,"about_ca_system_score_codex":0.00065394706,"about_ca_system_score_gemma":0.00090903946,"threshold_uncertainty_score":0.7058379},"labels":[],"label_agreement":null},{"id":"W6948776317","doi":"10.5281/zenodo.11853314","title":"giles tours 2024 brochure prices pdf download","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Work (physics); Paraphernalia; Government (linguistics); Pretext; Quality (philosophy)","score_opus":0.02835725750319028,"score_gpt":0.2939479869599686,"score_spread":0.2655907294567783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6948776317","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034513997,0.00025607104,0.0004584697,0.0004832535,0.0009358086,0.00012867957,0.0036627348,0.0034099948,0.9903198],"genre_scores_gemma":[0.00046690516,0.00011595241,0.00020373293,0.00013097169,0.000094028735,0.000029436484,0.0012885451,0.0009450922,0.9967253],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99964905,0.000020135183,0.000011048374,0.000051242234,0.00020740365,0.00006109804],"domain_scores_gemma":[0.99896014,0.00009170697,0.000025590438,0.000094776646,0.0005011901,0.00032652583],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00038775403,0.0012541058,0.0009582763,0.0015115984,0.0016288947,0.004510236,0.0014457131,0.0017632254,0.9600794],"category_scores_gemma":[0.0016596541,0.0006841218,0.0010390363,0.0012808504,0.00042168322,0.0028012295,0.0022810823,0.0018542778,0.932822],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003244143,0.00002174708,0.000032150063,0.00005372546,0.0000015775979,0.000025710757,0.000014114381,0.000029759709,0.00018486164,0.000425586,0.9823156,0.01686258],"study_design_scores_gemma":[0.000011949782,0.000019086958,0.00032016673,0.000038443774,0.000001973698,0.000031579017,0.000051172672,0.000042410164,0.00009408388,0.00018210203,0.99920064,0.0000063594284],"about_ca_topic_score_codex":0.0083519155,"about_ca_topic_score_gemma":0.021648616,"teacher_disagreement_score":0.039920628,"about_ca_system_score_codex":0.0011293826,"about_ca_system_score_gemma":0.0008889536,"threshold_uncertainty_score":0.056941926},"labels":[],"label_agreement":null},{"id":"W6948911925","doi":"10.5281/zenodo.11575074","title":"https://www.facebook.com/VidaCalmPills/","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Active listening; Component (thermodynamics); Natural (archaeology); Stress (linguistics); Natural materials","score_opus":0.04492699362946698,"score_gpt":0.3108033095064527,"score_spread":0.2658763158769857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6948911925","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005800036,0.00049531716,0.0009118665,0.001244973,0.0009395449,0.00010137436,0.0064918054,0.014304785,0.9749302],"genre_scores_gemma":[0.0045964574,0.00057813973,0.0008291905,0.0014665466,0.0005440363,0.00013694489,0.0058029043,0.0047633187,0.9812825],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99964595,0.0000571867,0.000014550746,0.000050860086,0.00014663184,0.00008484919],"domain_scores_gemma":[0.99821115,0.00021799521,0.00008214724,0.000282716,0.0004997802,0.0007062553],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00044662927,0.0014527141,0.00074751314,0.0014364237,0.0022176986,0.004951119,0.001322052,0.0018641745,0.8786131],"category_scores_gemma":[0.0027950727,0.00047744933,0.000691135,0.0017585033,0.00054716313,0.0058011734,0.003701718,0.0016709738,0.8854457],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003429425,0.0000329286,0.000100299985,0.000079581165,0.0000015122532,0.000045694956,0.00004843054,0.000026954316,0.00012124719,0.0011038783,0.9650809,0.033324208],"study_design_scores_gemma":[0.000008969008,0.000010719254,0.00021256991,0.00004368897,0.0000020296218,0.000047451435,0.00008094563,0.000087137654,0.00018523869,0.000644405,0.9986669,0.0000099374865],"about_ca_topic_score_codex":0.0036068454,"about_ca_topic_score_gemma":0.008034389,"teacher_disagreement_score":0.121386886,"about_ca_system_score_codex":0.0010966377,"about_ca_system_score_gemma":0.0007943863,"threshold_uncertainty_score":0.17314357},"labels":[],"label_agreement":null},{"id":"W6949313636","doi":"10.5281/zenodo.12468292","title":"evolutionary computation pdf","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Human-based evolutionary computation; Evolutionary computation; Interactive evolutionary computation; Evolutionary algorithm; Evolutionary programming; Computation; Genetic representation; Evolutionary music","score_opus":0.03571109198576974,"score_gpt":0.3052525024612195,"score_spread":0.26954141047544977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6949313636","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015619517,0.0046986425,0.091698974,0.0071484563,0.0045384155,0.00018385737,0.013295101,0.009467295,0.8674073],"genre_scores_gemma":[0.034124188,0.008401577,0.056461398,0.0024454787,0.0013371828,0.0003140819,0.018948415,0.0068992595,0.87106854],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99948454,0.00008872667,0.000028906685,0.000115161565,0.00024507355,0.000037564256],"domain_scores_gemma":[0.9987404,0.00038729055,0.00004226948,0.00026442247,0.00043935893,0.00012632269],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006945222,0.0008879552,0.0007068474,0.0014841364,0.0008943271,0.004039242,0.001604678,0.0017310419,0.5301074],"category_scores_gemma":[0.0054520536,0.00052557356,0.0011225904,0.0017367069,0.0006594889,0.002771096,0.0017770369,0.0018313315,0.31163612],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034228895,0.000031794974,0.0003274876,0.00037215772,0.00004065158,0.00009561685,0.000042743213,0.0045852275,0.00074956287,0.04866733,0.7263632,0.21869],"study_design_scores_gemma":[0.000026678677,0.000021351674,0.00040033765,0.0001531885,0.000019483203,0.00016401408,0.000057653095,0.005506948,0.0006666114,0.044245265,0.9487124,0.000026069863],"about_ca_topic_score_codex":0.0022079097,"about_ca_topic_score_gemma":0.003355395,"teacher_disagreement_score":0.46989262,"about_ca_system_score_codex":0.0011504829,"about_ca_system_score_gemma":0.0011784862,"threshold_uncertainty_score":0.6702448},"labels":[],"label_agreement":null},{"id":"W6950052835","doi":"10.5281/zenodo.7888865","title":"Rosa sherardii Davies","year":2014,"lang":"lt","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université de Sherbrooke","funders":"","keywords":"Face (sociological concept); Perspective (graphical); Context (archaeology); Focus (optics)","score_opus":0.04013349967546066,"score_gpt":0.2904047175538307,"score_spread":0.25027121787837003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6950052835","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014489443,0.131004,0.0052823317,0.41728708,0.17279862,0.00012115039,0.0013022703,0.0015691781,0.26918644],"genre_scores_gemma":[0.011676143,0.057386942,0.0025992568,0.07462771,0.027168987,0.000099915735,0.0005265405,0.0008392424,0.8250754],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9991516,0.00011090988,0.000032516487,0.00022115641,0.0003920766,0.00009170215],"domain_scores_gemma":[0.99722916,0.00038947997,0.0001696575,0.00014759495,0.0011207791,0.0009433303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001400405,0.0008708793,0.00060208864,0.0012619639,0.0010255553,0.0019703722,0.00095287693,0.0020141304,0.112877965],"category_scores_gemma":[0.0038190011,0.0003211915,0.00036590942,0.00046268915,0.00061048294,0.0011859541,0.001501702,0.004465386,0.09754468],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023738063,0.000009342299,0.0000888818,0.000056120545,0.0000032273927,0.000066650835,0.000022408016,0.000020558105,0.00021267272,0.0022661542,0.95679384,0.0404364],"study_design_scores_gemma":[0.000002817736,0.000005767175,0.00010105721,0.00003987028,0.0000019350437,0.00019624652,0.000014303178,0.000011291548,0.00012397076,0.00034576395,0.99915314,0.0000038187322],"about_ca_topic_score_codex":0.003109867,"about_ca_topic_score_gemma":0.005091983,"teacher_disagreement_score":0.112877965,"about_ca_system_score_codex":0.0011322598,"about_ca_system_score_gemma":0.0018049979,"threshold_uncertainty_score":0.37761444},"labels":[],"label_agreement":null},{"id":"W6957928404","doi":"10.6084/m9.figshare.14889345","title":"Additional file 2 of Network meta-analysis of eribulin versus other chemotherapies used as second- or later-line treatment in locally advanced or metastatic breast cancer","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Eribulin; Metastatic breast cancer; Breast cancer; Risk assessment; Overall survival; MEDLINE","score_opus":0.1391850297347036,"score_gpt":0.3806538797079082,"score_spread":0.2414688499732046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6957928404","genre_codex":"dataset","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036408994,0.00039643026,0.0006398902,0.00025508527,0.00007026884,0.00097433623,0.9958733,0.00031940074,0.0011071637],"genre_scores_gemma":[0.052109003,0.0033300577,0.03052575,0.0039033964,0.00073591335,0.092878975,0.7701473,0.00246439,0.04390512],"study_design_codex":"not_applicable","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99730265,0.00083345344,0.0006981086,0.00045856732,0.00047378257,0.00023340464],"domain_scores_gemma":[0.93343836,0.056918982,0.0042402935,0.0017216029,0.0031790878,0.0005016026],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0056049074,0.001852443,0.0037129086,0.0044386634,0.0007457724,0.0022752914,0.002341405,0.0018245964,0.83511347],"category_scores_gemma":[0.080656,0.0011067452,0.006147588,0.0062690107,0.00033642558,0.00262649,0.0014773583,0.0012380689,0.043011393],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034998537,0.00015481618,0.004152263,0.30409867,0.0051383246,0.00022818647,0.00022789733,0.002527094,0.00039576966,0.003984834,0.6558132,0.01977911],"study_design_scores_gemma":[0.10419476,0.0016609982,0.04171457,0.09576574,0.027543988,0.0011503083,0.00061704055,0.00985654,0.0016260312,0.038178645,0.67707133,0.0006200623],"about_ca_topic_score_codex":0.007168858,"about_ca_topic_score_gemma":0.013988399,"teacher_disagreement_score":0.83511347,"about_ca_system_score_codex":0.0017752302,"about_ca_system_score_gemma":0.0033306442,"threshold_uncertainty_score":0.23519063},"labels":[],"label_agreement":null},{"id":"W6958488379","doi":"10.6084/m9.figshare.14889342.v1","title":"Additional file 1 of Network meta-analysis of eribulin versus other chemotherapies used as second- or later-line treatment in locally advanced or metastatic breast cancer","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Eribulin; Metastatic breast cancer; Breast cancer; Cochrane Library; MEDLINE; Overall survival","score_opus":0.14348126166137817,"score_gpt":0.3813208909546553,"score_spread":0.23783962929327715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958488379","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00057243183,0.00065902935,0.0005310269,0.00023201038,0.00006927432,0.001063667,0.99526227,0.00019550578,0.001414734],"genre_scores_gemma":[0.05749143,0.0053014755,0.027133524,0.0032034048,0.0007484218,0.10573085,0.7549367,0.0014080507,0.04404609],"study_design_codex":"not_applicable","study_design_gemma":"meta_analysis","domain_scores_codex":[0.998083,0.00058939535,0.00047796758,0.00033849303,0.0003280828,0.00018317137],"domain_scores_gemma":[0.9571973,0.036380064,0.0029776478,0.0009546751,0.0021213081,0.00036897327],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0037701016,0.0017812001,0.0034408725,0.0047545405,0.0006929084,0.0016773936,0.0019620657,0.0014885432,0.78308487],"category_scores_gemma":[0.053559627,0.0010228081,0.0058080773,0.0070105474,0.00029466845,0.0024592467,0.001342814,0.0011249417,0.030303773],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046336763,0.00019462586,0.0047694915,0.3524938,0.006284859,0.00027887535,0.0002244961,0.002759275,0.00052856933,0.0039294097,0.5998843,0.024018668],"study_design_scores_gemma":[0.119760804,0.00254806,0.06495934,0.0967261,0.040221065,0.0013195948,0.0007238734,0.009279065,0.001807713,0.025302624,0.6367169,0.00063488894],"about_ca_topic_score_codex":0.009052817,"about_ca_topic_score_gemma":0.020101978,"teacher_disagreement_score":0.78308487,"about_ca_system_score_codex":0.001923517,"about_ca_system_score_gemma":0.0030814502,"threshold_uncertainty_score":0.30940306},"labels":[],"label_agreement":null},{"id":"W6958548528","doi":"10.6084/m9.figshare.28756932.v1","title":"Additional file 2 of Results of the preclinical multicenter randomized controlled paclitaxel-induced neuropathy prevention replication study (PINPRICS)","year":2025,"lang":"en","type":"article","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"","keywords":"Randomized controlled trial; Replication (statistics); Peripheral neuropathy; Clinical trial; MEDLINE","score_opus":0.05133684051177635,"score_gpt":0.3821693012866753,"score_spread":0.330832460774899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958548528","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reproducibility","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reproducibility","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003647567,0.00009189291,0.000590379,0.00014726588,0.00006051317,0.00095366925,0.9949098,0.00030479938,0.0025768734],"genre_scores_gemma":[0.028869009,0.00073747494,0.013454859,0.002751987,0.000541545,0.023286346,0.8806943,0.0019009392,0.04776351],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99778605,0.000694003,0.00042875108,0.00038057705,0.00042709298,0.00028347445],"domain_scores_gemma":[0.9526951,0.035992347,0.0035396083,0.0026990036,0.0039813244,0.001092552],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0041904915,0.0019477394,0.0030098397,0.0022854742,0.0011996427,0.0023814258,0.0025330333,0.0018738938,0.9118507],"category_scores_gemma":[0.05077869,0.0012950104,0.0025925376,0.0032870767,0.0005284058,0.0020544885,0.0011629941,0.0014544007,0.17962348],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008427272,0.00059778016,0.0020630006,0.010834508,0.0005152696,0.00008405266,0.00006300401,0.001083556,0.00014867132,0.0017340775,0.954778,0.01967071],"study_design_scores_gemma":[0.22325188,0.004869451,0.04022987,0.011464876,0.002810814,0.0011708307,0.00039243378,0.0060977945,0.001882961,0.03435274,0.6730708,0.00040556298],"about_ca_topic_score_codex":0.0046352367,"about_ca_topic_score_gemma":0.008997729,"teacher_disagreement_score":0.9958095,"about_ca_system_score_codex":0.0015494057,"about_ca_system_score_gemma":0.0029592093,"threshold_uncertainty_score":0.12573421},"labels":[],"label_agreement":null},{"id":"W6981874261","doi":"","title":"Fisheries, tourism, and marine protected areas : conflicting or synergistic interactions","year":2015,"lang":"en","type":"article","venue":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Marine protected area; Fishing; Sampling (signal processing); Context (archaeology); Data collection","score_opus":0.04435512989047324,"score_gpt":0.2988391767246766,"score_spread":0.25448404683420334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6981874261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83015335,0.037219077,0.0074274177,0.030969644,0.0006981223,0.00016770627,0.0022447198,0.0000823012,0.0910377],"genre_scores_gemma":[0.98616725,0.005763917,0.0021224285,0.00070359814,0.00022637466,0.000038573176,0.00019958375,0.000019256346,0.0047589634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777967,0.0012488068,0.000084308966,0.0002544466,0.00032908877,0.00030363112],"domain_scores_gemma":[0.9929924,0.0030530724,0.0013307742,0.0002593822,0.00068216544,0.0016821695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017711576,0.00059140194,0.00082013884,0.0020480596,0.00089579396,0.0032112065,0.00067823415,0.0009857283,0.01403479],"category_scores_gemma":[0.0047871843,0.00034312773,0.000651525,0.0023778284,0.0014796258,0.0017857832,0.0042075748,0.00087620923,0.0007077766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006916583,0.00038846795,0.7963533,0.0016421925,0.0029310938,0.0017368183,0.0042020506,0.002230572,0.004328991,0.027392812,0.011254599,0.14684749],"study_design_scores_gemma":[0.000020751999,0.00026377497,0.94585997,0.00087503553,0.0005957237,0.00066841464,0.013133773,0.0027254338,0.00025612532,0.021189827,0.014302775,0.00010838173],"about_ca_topic_score_codex":0.0075545204,"about_ca_topic_score_gemma":0.020599289,"teacher_disagreement_score":0.01403479,"about_ca_system_score_codex":0.0006342312,"about_ca_system_score_gemma":0.001143063,"threshold_uncertainty_score":0.046950996},"labels":[],"label_agreement":null},{"id":"W6990572815","doi":"","title":"Docetaxel-associated myalgia&amp;amp;ndash;arthralgia syndrome in patients with breast cancer","year":2017,"lang":"en","type":"other","venue":"Dove Medical Press (Taylor and Francis Group)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Docetaxel; Adverse effect; Breast cancer; Regimen; Clinical trial; Cancer; Medical record; Incidence (geometry)","score_opus":0.014629426679049849,"score_gpt":0.2897363246098439,"score_spread":0.275106897930794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6990572815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99753463,0.0014177966,0.00007748192,0.00007092181,0.00001023436,0.000021115417,0.00010203745,0.0000038314633,0.00076189614],"genre_scores_gemma":[0.99919564,0.0004984584,0.00006329685,0.000038479047,0.000023170378,0.000009124117,0.00010156954,7.3053974e-7,0.00006940876],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99970007,0.000059505077,0.00005015113,0.00004836234,0.00007579134,0.00006610613],"domain_scores_gemma":[0.999138,0.00026539245,0.00039656652,0.00002503124,0.000053588632,0.00012129318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003023657,0.0002624767,0.00043068867,0.0007218681,0.0004445238,0.00040087523,0.00024316375,0.00038250754,0.001347216],"category_scores_gemma":[0.0019750746,0.000245948,0.00023612569,0.0009638669,0.00030012152,0.0003290623,0.00028336848,0.0003137274,0.00020744829],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000126335,0.000029487202,0.9922375,0.00002638735,0.000016176971,0.004619638,0.00007895852,0.000028427532,0.00038078008,0.000021410598,0.00012938918,0.0023054394],"study_design_scores_gemma":[0.00003688014,0.0003095706,0.9668633,0.000041260533,0.000038121707,0.03155491,0.00034395323,0.00022303425,0.00014573059,0.000036775196,0.00039932545,0.000007150224],"about_ca_topic_score_codex":0.0013487282,"about_ca_topic_score_gemma":0.0021910248,"teacher_disagreement_score":0.0013487282,"about_ca_system_score_codex":0.00023010442,"about_ca_system_score_gemma":0.00033895005,"threshold_uncertainty_score":0.004506886},"labels":[],"label_agreement":null},{"id":"W7002200986","doi":"","title":"Mgr Józefa de Laval (ur. 1937) Gdańsk – AM","year":2013,"lang":"pl","type":"other","venue":"CYBRA (Lodz University of Technology)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Deformation (meteorology); Work (physics); Context (archaeology); Point (geometry)","score_opus":0.007200186693487449,"score_gpt":0.22502227151875775,"score_spread":0.2178220848252703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7002200986","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028992558,0.10481988,0.006434034,0.012268182,0.009043252,0.00032184966,0.019620154,0.0026283213,0.8158717],"genre_scores_gemma":[0.091611385,0.032534048,0.0058439295,0.0014735959,0.0018542742,0.00020382482,0.0064390423,0.0019622,0.8580778],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99952304,0.000047556656,0.000025273099,0.00022381471,0.00009621204,0.00008412669],"domain_scores_gemma":[0.99973625,0.000065286884,0.000036788126,0.000036626327,0.00004671738,0.00007833634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042926308,0.00137447,0.0012122593,0.0016746679,0.0010716113,0.0025021762,0.0009031068,0.0013706929,0.33449858],"category_scores_gemma":[0.0008178728,0.00032510806,0.0004676467,0.001082375,0.0007215449,0.00093622034,0.0019697496,0.001606258,0.21141677],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001371038,0.00024181977,0.0024129073,0.0017543908,0.00010287896,0.002669988,0.0003757832,0.0012306443,0.014154487,0.02888102,0.28235927,0.6644457],"study_design_scores_gemma":[0.00005146472,0.000087096836,0.0045235218,0.00016424636,0.00001724209,0.001608505,0.000080709346,0.00013558398,0.0014506632,0.0014455665,0.9904206,0.000014712022],"about_ca_topic_score_codex":0.003075516,"about_ca_topic_score_gemma":0.003615326,"teacher_disagreement_score":0.33449858,"about_ca_system_score_codex":0.0010557496,"about_ca_system_score_gemma":0.0009964814,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W7031579885","doi":"","title":"Cincinnati, Ohio","year":2009,"lang":"en","type":"other","venue":"OhioLink ETD Center (Ohio Library and Information Network)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reading (process); Government (linguistics); Legislation; Quarter (Canadian coin)","score_opus":0.009558345908054303,"score_gpt":0.23698795135256653,"score_spread":0.22742960544451224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7031579885","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008666744,0.003286604,0.0009123532,0.0033966415,0.0041686823,0.00018453918,0.0071738297,0.00085042295,0.97916013],"genre_scores_gemma":[0.0017156521,0.0021638682,0.00064001046,0.00073810073,0.00023575305,0.00010767765,0.0021581235,0.00027877197,0.9919619],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99875474,0.00011908275,0.00008847293,0.0003963341,0.0005013882,0.00014003184],"domain_scores_gemma":[0.99738055,0.00033695056,0.00017669745,0.00031014532,0.0011159051,0.0006798135],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001052211,0.0017688838,0.0007505682,0.0015003677,0.002494184,0.0045641395,0.0013716383,0.0014087377,0.8167124],"category_scores_gemma":[0.0030769361,0.0005362508,0.00066559255,0.0021723134,0.00079276686,0.0019712595,0.0017203548,0.0020221455,0.557824],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012539656,0.0001244352,0.000699646,0.00018051165,0.000016396549,0.00024319309,0.00009187798,0.00012732318,0.00039896922,0.0028952144,0.8633065,0.13179056],"study_design_scores_gemma":[0.000022143982,0.000025670448,0.0011385031,0.00010274292,0.000005517222,0.0000727907,0.00009725306,0.000041701118,0.00008745162,0.0002624125,0.9981358,0.000008146666],"about_ca_topic_score_codex":0.01081826,"about_ca_topic_score_gemma":0.043134186,"teacher_disagreement_score":0.18328762,"about_ca_system_score_codex":0.0015470963,"about_ca_system_score_gemma":0.0029283299,"threshold_uncertainty_score":0.26143748},"labels":[],"label_agreement":null},{"id":"W7036834546","doi":"","title":"Collaborative Research Partnerships for Knowledge Mobilization","year":2013,"lang":"en","type":"dissertation","venue":"TSpace (University of Toronto)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Office of International Science and Engineering; University of Toronto; Strong","keywords":"General partnership; Mandate; Work (physics); Service (business); Dissemination; Face (sociological concept); Service provider; Organizational learning; Knowledge sharing; Organizational communication","score_opus":0.1001176590182759,"score_gpt":0.42018984454233976,"score_spread":0.32007218552406386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7036834546","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019221975,0.0125453565,0.17455311,0.10697307,0.002350214,0.0021991755,0.00017270268,0.00048142456,0.68150294],"genre_scores_gemma":[0.7296484,0.011458778,0.15409364,0.011417218,0.001486468,0.0050608786,0.00029422133,0.00032316154,0.08621722],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.87775934,0.097307734,0.0030283094,0.0053929673,0.011688894,0.0048228074],"domain_scores_gemma":[0.87964094,0.06672415,0.008616995,0.018960547,0.011369473,0.014687919],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.07256045,0.00090639864,0.001025544,0.0046510287,0.01261027,0.020575734,0.0033730986,0.0062682806,0.025971083],"category_scores_gemma":[0.09348467,0.001104906,0.0013476523,0.0042951116,0.027515914,0.022080574,0.040921178,0.006550876,0.0061142123],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038594397,0.00011756048,0.0010450947,0.0005974503,0.000051046685,0.00039509338,0.04847038,0.0004238616,0.00034347002,0.84000844,0.015292626,0.09321631],"study_design_scores_gemma":[0.000050826795,0.00011319764,0.0006124375,0.0014244244,0.000025585266,0.00059463474,0.026856316,0.00042682045,0.00031981996,0.42914227,0.5403921,0.00004144546],"about_ca_topic_score_codex":0.0015479281,"about_ca_topic_score_gemma":0.0022662643,"teacher_disagreement_score":0.992653,"about_ca_system_score_codex":0.007346988,"about_ca_system_score_gemma":0.03191647,"threshold_uncertainty_score":0.38374096},"labels":[],"label_agreement":null},{"id":"W7066306365","doi":"","title":"Hvilke erfaringer er hverdagsrehabilitering basert på?","year":2019,"lang":"no","type":"dissertation","venue":"Duo Research Archive (University of Oslo)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Occupational accident; Research data; Elderly people","score_opus":0.04238307803496155,"score_gpt":0.3403818738690905,"score_spread":0.29799879583412897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7066306365","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17136289,0.04713654,0.011405341,0.08382331,0.005709562,0.0009588341,0.0036327646,0.00049913494,0.67547166],"genre_scores_gemma":[0.6505658,0.048108235,0.018082744,0.013916555,0.00063497585,0.0013081324,0.0040423423,0.0005013133,0.26283994],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9927193,0.0022057164,0.00027777263,0.0008354978,0.0028988812,0.0010628208],"domain_scores_gemma":[0.9946865,0.0016027418,0.00038119187,0.00048135658,0.0015808019,0.0012673122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076343915,0.00078531937,0.0007819672,0.0013847537,0.0054755732,0.010011958,0.0018912392,0.0018237386,0.048161767],"category_scores_gemma":[0.012098915,0.00038812993,0.0010813726,0.00215951,0.0036294179,0.0055141123,0.006777646,0.0040729977,0.010185543],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036422934,0.0005562692,0.024594877,0.005325263,0.00015084431,0.00065854297,0.1359759,0.0005962464,0.0017641415,0.048683498,0.25449538,0.5268347],"study_design_scores_gemma":[0.000057821835,0.00016376875,0.040150385,0.0049791634,0.00014872912,0.00050209154,0.10667624,0.0002508489,0.0011189056,0.00939544,0.836438,0.00011861905],"about_ca_topic_score_codex":0.15730137,"about_ca_topic_score_gemma":0.33091968,"teacher_disagreement_score":0.15730137,"about_ca_system_score_codex":0.015944863,"about_ca_system_score_gemma":0.027178789,"threshold_uncertainty_score":0.31277156},"labels":[],"label_agreement":null},{"id":"W7067073702","doi":"","title":"Investigating large gray cast iron pipe failures: a step by step approach","year":2001,"lang":"en","type":"article","venue":"NPARC","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"National Research Council Canada","funders":"","keywords":"Cast iron; Water pipe; Pipeline transport; Gray (unit); Process (computing); Canalisation; Work (physics); Gray iron","score_opus":0.02232881541524079,"score_gpt":0.2956053366356067,"score_spread":0.2732765212203659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7067073702","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17377405,0.0066205193,0.76201135,0.007871423,0.00050214527,0.011480323,0.00081999897,0.002180968,0.034739237],"genre_scores_gemma":[0.08743918,0.0035821006,0.8998723,0.0010073368,0.00008145778,0.0010185307,0.00026193104,0.00016083606,0.0065762573],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979583,0.00072191184,0.00015649453,0.00017447458,0.0008861125,0.00010284512],"domain_scores_gemma":[0.9955485,0.0019436156,0.0004173852,0.00025615742,0.0015554233,0.0002790013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025735558,0.001232891,0.0015471345,0.0042062625,0.0016701355,0.0016176777,0.0023803974,0.0018540958,0.0060611954],"category_scores_gemma":[0.006259056,0.0007947963,0.0011339913,0.0012505768,0.0012556369,0.0013624753,0.0019484273,0.0018050977,0.002292089],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006801756,0.0021622586,0.035277847,0.0037732455,0.00028019422,0.0068502473,0.0033201315,0.008949475,0.1142064,0.0053541223,0.00939107,0.8097548],"study_design_scores_gemma":[0.00062210305,0.015966626,0.16679122,0.0024555756,0.0016585762,0.04852888,0.035031214,0.0762182,0.32010716,0.10241175,0.22886409,0.0013445797],"about_ca_topic_score_codex":0.0031320103,"about_ca_topic_score_gemma":0.013182696,"teacher_disagreement_score":0.0060611954,"about_ca_system_score_codex":0.0008139582,"about_ca_system_score_gemma":0.0034922278,"threshold_uncertainty_score":0.020276725},"labels":[],"label_agreement":null},{"id":"W7067112653","doi":"","title":"Layered nanostructured coatings for aerospace applications: 2nd progress report","year":2001,"lang":"en","type":"report","venue":"NPARC","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Aerospace; Metal coating; Coating; Aerospace materials; Welding","score_opus":0.046210654189172744,"score_gpt":0.3935619237602408,"score_spread":0.34735126957106804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7067112653","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2240727,0.09921564,0.023696233,0.03197893,0.04438895,0.004011233,0.0055220425,0.0021880588,0.56492627],"genre_scores_gemma":[0.19936477,0.04519988,0.014239771,0.0031456717,0.0038437692,0.00063871394,0.005069964,0.00033609362,0.7281614],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99785405,0.00015445633,0.000099656994,0.0001836066,0.0014506128,0.0002575118],"domain_scores_gemma":[0.9969373,0.00026787084,0.00013708395,0.00029523764,0.0019614175,0.00040115113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022726248,0.0004397094,0.000555446,0.0008189779,0.0016807752,0.0018350772,0.0010184422,0.0022966254,0.022760175],"category_scores_gemma":[0.0022365192,0.00031364785,0.0005250083,0.00040344696,0.00039081505,0.0014199135,0.0011223743,0.0011836755,0.009599324],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012752408,0.0013955967,0.004553833,0.0027946867,0.00010782232,0.0017104575,0.0004990268,0.0007327384,0.21144131,0.0060920254,0.32293537,0.44646198],"study_design_scores_gemma":[0.00009867718,0.0010763166,0.006534385,0.00020811909,0.00008504946,0.000894467,0.00023567313,0.0008805587,0.17796613,0.00080082676,0.81117797,0.0000418268],"about_ca_topic_score_codex":0.0019177792,"about_ca_topic_score_gemma":0.004634328,"teacher_disagreement_score":0.022760175,"about_ca_system_score_codex":0.000824589,"about_ca_system_score_gemma":0.003123723,"threshold_uncertainty_score":0.076140404},"labels":[],"label_agreement":null},{"id":"W7067703441","doi":"","title":"Nature's Past Episode 051: Has Environmental History Lost Its Way?","year":2016,"lang":"en","type":"other","venue":"York University Digital Library (York University)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Environmental history; Scholarship; Power (physics); Politics; Environmental movement; Environmentalism; Social history (medicine); Materialism","score_opus":0.011958860210772936,"score_gpt":0.17734312070659947,"score_spread":0.16538426049582652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7067703441","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02110139,0.054048374,0.0004621719,0.7694644,0.036141455,0.000012229699,0.0013038496,0.00007442457,0.117391855],"genre_scores_gemma":[0.40057543,0.10337702,0.00081178924,0.26409575,0.03142892,0.000047197285,0.0027424004,0.00037897547,0.19654253],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99899656,0.0002319867,0.0000361749,0.00012810204,0.00038650166,0.00022069673],"domain_scores_gemma":[0.9981026,0.0008050569,0.00015945343,0.000081673395,0.0005090832,0.00034209498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001676497,0.00023689758,0.00030145067,0.0011631642,0.009581497,0.008621818,0.0007411622,0.0035880152,0.0089139445],"category_scores_gemma":[0.005022794,0.00026665602,0.00022615561,0.0026416478,0.0042641507,0.005706229,0.002069802,0.006228983,0.0010497181],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032516255,0.000012381366,0.00355234,0.00023414227,0.000015221994,0.00075823296,0.02486863,0.000045958768,0.00015744219,0.03659291,0.89754087,0.036189422],"study_design_scores_gemma":[0.0000014022996,0.0000033780552,0.004904972,0.0002713743,0.0000053081712,0.00015391162,0.018765714,0.000022626746,0.00009164628,0.0026420422,0.973126,0.000011563259],"about_ca_topic_score_codex":0.27134234,"about_ca_topic_score_gemma":0.6130151,"teacher_disagreement_score":0.27134234,"about_ca_system_score_codex":0.014913864,"about_ca_system_score_gemma":0.0078538265,"threshold_uncertainty_score":0.53952587},"labels":[],"label_agreement":null},{"id":"W7096959898","doi":"","title":"Yew Poisoning in Horses and Ruminants","year":2007,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ornamental plant; Taxus; Genus; Woody plant","score_opus":0.018929790186412603,"score_gpt":0.36687791814119697,"score_spread":0.34794812795478436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7096959898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8612523,0.06567708,0.00067942514,0.003456365,0.00013689713,0.00008364978,0.00039369956,0.000102906786,0.06821768],"genre_scores_gemma":[0.9685609,0.02113006,0.00039123406,0.00041547397,0.000085212945,0.000014727639,0.0001946296,0.0000051443376,0.009202595],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9999217,0.000027994418,0.000006087049,0.000009018142,0.000011992393,0.000023209162],"domain_scores_gemma":[0.9999654,0.0000048485626,0.000014103713,0.0000022643007,0.000005671021,0.000007678234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009317685,0.00024003974,0.0001468684,0.000538532,0.0006053803,0.00033797894,0.00012135185,0.000748074,0.005124162],"category_scores_gemma":[0.0002630785,0.00010807615,0.00010820236,0.00039453406,0.00034030294,0.00041044244,0.00033272099,0.0002544949,0.0009897623],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013328348,0.00041160677,0.45745152,0.0011912145,0.00013305317,0.12795548,0.0026858095,0.0004504218,0.040507324,0.0073577324,0.04140129,0.31912175],"study_design_scores_gemma":[0.00004601186,0.0014942281,0.5054808,0.00076637266,0.0000707346,0.21076392,0.0033523974,0.0005520297,0.0068200836,0.0022833887,0.26834065,0.000029464078],"about_ca_topic_score_codex":0.0031096868,"about_ca_topic_score_gemma":0.0040115826,"teacher_disagreement_score":0.005124162,"about_ca_system_score_codex":0.00039234987,"about_ca_system_score_gemma":0.00011711975,"threshold_uncertainty_score":0.017141998},"labels":[],"label_agreement":null},{"id":"W7096964449","doi":"","title":"Pan-Canadian Oncology Drug Review","year":2016,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"","score_opus":0.030423650132107644,"score_gpt":0.3776439855204452,"score_spread":0.3472203353883376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7096964449","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007652247,0.88896614,0.00015643063,0.028310306,0.0048142,0.000057001456,0.0014522078,0.000070103764,0.07540831],"genre_scores_gemma":[0.007560163,0.9478076,0.00062170083,0.0071379165,0.0014220631,0.00002294766,0.0008403971,0.000023331675,0.034563895],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990332,0.00011641969,0.00008095278,0.00006757307,0.00053898187,0.00016279747],"domain_scores_gemma":[0.99625057,0.00027597797,0.00026819046,0.000057088797,0.0026989519,0.00044919876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014739844,0.0009447964,0.00097088394,0.005621561,0.0015544832,0.0027291558,0.001143449,0.001209422,0.040284015],"category_scores_gemma":[0.0032145234,0.00026286638,0.00067154685,0.0089873355,0.0009058573,0.0010023129,0.0010860892,0.0014211845,0.0065829675],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012324046,0.000045071123,0.00056412193,0.0041479855,0.00009628717,0.00015290585,0.000051397303,0.00013239095,0.00025488305,0.003520443,0.6684092,0.322502],"study_design_scores_gemma":[0.000016434196,0.0000146452985,0.00093588926,0.001180914,0.000079917205,0.00016538998,0.000033452652,0.000023218738,0.00007935217,0.00017347174,0.99729,0.000007417355],"about_ca_topic_score_codex":0.5630804,"about_ca_topic_score_gemma":0.8273342,"teacher_disagreement_score":0.43691963,"about_ca_system_score_codex":0.019046342,"about_ca_system_score_gemma":0.061860044,"threshold_uncertainty_score":0.87898546},"labels":[],"label_agreement":null},{"id":"W7097389390","doi":"","title":"Taxus baccata L. var. procumbens Loud","year":2012,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pollen; Evergreen; Taxus; Bark (sound); Stamen; Stalk","score_opus":0.03613886832449913,"score_gpt":0.3568093581603192,"score_spread":0.3206704898358201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7097389390","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42685825,0.017795023,0.0081225615,0.0024520834,0.0011926475,0.00395354,0.0877946,0.0045144497,0.44731694],"genre_scores_gemma":[0.6635409,0.0081751915,0.013845685,0.0026848454,0.0002448415,0.0018990005,0.104034275,0.00057274156,0.20500255],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998913,0.00001096819,0.000011422702,0.000037534126,0.000032464002,0.000016348728],"domain_scores_gemma":[0.9999119,0.000007853251,0.000012497901,0.000009165782,0.00003874072,0.00001981341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011876271,0.0011704558,0.0006138699,0.0026488488,0.0015849717,0.0005118084,0.0010325969,0.00030659305,0.030042661],"category_scores_gemma":[0.000092381044,0.00027531743,0.00018300013,0.0022581567,0.00029028868,0.001162745,0.0006545678,0.00069642183,0.017085526],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013431837,0.0018633448,0.037448358,0.0020904667,0.00014361188,0.0045394357,0.0019085354,0.0010598061,0.26806304,0.004795745,0.10087205,0.5758724],"study_design_scores_gemma":[0.00014755406,0.0006941635,0.2350295,0.00024164445,0.00009569732,0.0028196094,0.0016752195,0.0010437722,0.009017073,0.0013724954,0.7477521,0.00011127084],"about_ca_topic_score_codex":0.037649915,"about_ca_topic_score_gemma":0.073904,"teacher_disagreement_score":0.037649915,"about_ca_system_score_codex":0.0007989739,"about_ca_system_score_gemma":0.00037364455,"threshold_uncertainty_score":0.10050267},"labels":[],"label_agreement":null},{"id":"W7099910180","doi":"","title":"Reserve Bank of Philadelphia, Université Laval, and University of Montreal. We also thank","year":2008,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Empirical research; Work (physics); Official cash rate; Central bank; Bank rate","score_opus":0.028214338395888255,"score_gpt":0.2547882993626513,"score_spread":0.22657396096676305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7099910180","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027703745,0.032574955,0.0013699197,0.12022939,0.0066282246,0.00018926738,0.276371,0.0030583297,0.55680853],"genre_scores_gemma":[0.015558946,0.017729446,0.002191672,0.0027634006,0.0014229218,0.00019890716,0.044925477,0.00077736465,0.9144318],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99728954,0.00014232068,0.00013933309,0.0006312925,0.0014135361,0.0003840054],"domain_scores_gemma":[0.9936739,0.0011685888,0.0005316381,0.000498372,0.0032361953,0.00089136284],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001988604,0.0012468843,0.0019148571,0.0030242614,0.0022693186,0.0061817924,0.0018455549,0.0024876583,0.29826018],"category_scores_gemma":[0.008932753,0.0008089819,0.00050599553,0.005286815,0.0007133091,0.0032552548,0.0011843082,0.0033869753,0.09957812],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043620472,0.000008645923,0.000733862,0.00005207038,0.000011244355,0.000036698086,0.000037393707,0.000057472815,0.000029621284,0.012822189,0.9656423,0.020524822],"study_design_scores_gemma":[0.000031829153,0.000004363462,0.004275851,0.0000705359,0.000009899389,0.000028752198,0.00004848361,0.000103420636,0.00007015123,0.0014944952,0.99384344,0.000018782532],"about_ca_topic_score_codex":0.50258195,"about_ca_topic_score_gemma":0.5315625,"teacher_disagreement_score":0.7017398,"about_ca_system_score_codex":0.011174158,"about_ca_system_score_gemma":0.022319729,"threshold_uncertainty_score":0.9993132},"labels":[],"label_agreement":null},{"id":"W7116331886","doi":"10.6084/m9.figshare.30925843.v1","title":"Additional file 1 of Vincristine-induced brain toxicity is reduced with prevention of peripheral axon degeneration in Sarm1 knockout mice","year":2025,"lang":"","type":"article","venue":"Open MIND","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Degeneration (medical); Peripheral; Wallerian degeneration; Axon; Axonal degeneration; Toxicity; Neurotoxicity","score_opus":0.03830301222465152,"score_gpt":0.36229533325953645,"score_spread":0.32399232103488496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116331886","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007294292,0.00004841314,0.0012383692,0.00016628097,0.00010101979,0.000096898104,0.9952158,0.0011208504,0.0012829424],"genre_scores_gemma":[0.016435739,0.0003868616,0.0151518,0.0009532141,0.00017586723,0.002551853,0.94528997,0.002108564,0.016946172],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99948347,0.0000500664,0.00008271259,0.00012078003,0.00017751637,0.000085395724],"domain_scores_gemma":[0.99150664,0.005296256,0.0009292072,0.0007170667,0.00085644587,0.00069437217],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010227053,0.0012216845,0.0014290478,0.0026065635,0.0008585733,0.0011911489,0.0022402871,0.0016114225,0.8565763],"category_scores_gemma":[0.0072728097,0.00085520203,0.0010229027,0.0021090726,0.00036888212,0.0012306067,0.00075322937,0.001435638,0.1481408],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013520413,0.00060412876,0.0025095486,0.0034932094,0.00012738461,0.00035957294,0.00009271416,0.00085047213,0.006128675,0.0017353784,0.96003246,0.022714544],"study_design_scores_gemma":[0.011569556,0.0021153097,0.05671633,0.0040978924,0.00045382098,0.0044312547,0.00044419648,0.007913221,0.03108738,0.022002896,0.8586404,0.0005277281],"about_ca_topic_score_codex":0.0033941483,"about_ca_topic_score_gemma":0.007615954,"teacher_disagreement_score":0.8565763,"about_ca_system_score_codex":0.00088754523,"about_ca_system_score_gemma":0.0012026386,"threshold_uncertainty_score":0.20457637},"labels":[],"label_agreement":null},{"id":"W7116425450","doi":"10.6084/m9.figshare.30925843","title":"Additional file 1 of Vincristine-induced brain toxicity is reduced with prevention of peripheral axon degeneration in Sarm1 knockout mice","year":2025,"lang":"","type":"article","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Degeneration (medical); Peripheral; Wallerian degeneration; Axon; Axonal degeneration; Toxicity; Neurotoxicity","score_opus":0.033756578870344896,"score_gpt":0.3244834700401362,"score_spread":0.29072689116979133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116425450","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005029117,0.00005136986,0.0010375578,0.00016433137,0.00009314601,0.00009747218,0.9953135,0.0013208144,0.0014188362],"genre_scores_gemma":[0.012661554,0.00040136903,0.012362783,0.0009006888,0.00016370881,0.0023463606,0.9520083,0.0027021414,0.016453084],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993918,0.00006156944,0.00008888349,0.00013942854,0.00021227897,0.00010606173],"domain_scores_gemma":[0.99008006,0.006395516,0.00091428723,0.00084304507,0.0010113724,0.00075575366],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011392876,0.0014227241,0.0016654545,0.0031243463,0.0009849314,0.001449473,0.0024925403,0.0017604798,0.8919973],"category_scores_gemma":[0.008238825,0.0010512372,0.001284513,0.0024688495,0.00040165253,0.0014816936,0.0008945572,0.0015918093,0.21729672],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010533966,0.0004456614,0.0018039711,0.0030751633,0.00011569033,0.00025327428,0.00007114829,0.00077012414,0.0042878953,0.0015156562,0.9685725,0.018035505],"study_design_scores_gemma":[0.011722966,0.0018521531,0.045580238,0.0036291804,0.00043437525,0.0031280774,0.0003707225,0.006707264,0.026327813,0.020928504,0.8787984,0.000520264],"about_ca_topic_score_codex":0.0030422402,"about_ca_topic_score_gemma":0.007332157,"teacher_disagreement_score":0.8919973,"about_ca_system_score_codex":0.0009932464,"about_ca_system_score_gemma":0.0012940298,"threshold_uncertainty_score":0.1540528},"labels":[],"label_agreement":null},{"id":"W7116883596","doi":"10.1093/jncics/pkaf119","title":"Assessment tools for chemotherapy-induced peripheral neuropathy: a narrative review of clinician, patient-reported, and objective measures","year":2025,"lang":"en","type":"article","venue":"JNCI Cancer Spectrum","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto Rehabilitation Institute; University of Toronto","funders":"","keywords":"Narrative review; Selection (genetic algorithm); MEDLINE; Narrative; Health professionals","score_opus":0.042048921667640515,"score_gpt":0.412333420777878,"score_spread":0.3702844991102375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116883596","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029634338,0.99863654,0.00016537686,0.00028169403,0.00007777477,0.00011648971,0.0001488134,0.000003982989,0.00027288875],"genre_scores_gemma":[0.006086683,0.99180144,0.0008378325,0.00043488402,0.00011040247,0.00048797036,0.00016792884,0.000004541764,0.000068297464],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.98266786,0.0066169878,0.006403711,0.0009946432,0.0030522703,0.00026450373],"domain_scores_gemma":[0.8706446,0.105426945,0.013833311,0.0010687307,0.008635692,0.0003907309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021560486,0.0016540162,0.0048254835,0.015890352,0.00067402766,0.0037602677,0.002143854,0.0019679049,0.0036474299],"category_scores_gemma":[0.10598373,0.00097243785,0.005208417,0.015314658,0.0011489799,0.004201484,0.0018819082,0.0016057565,0.00046738927],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018050148,0.000036639183,0.0011334714,0.80111116,0.001954238,0.00008544739,0.0005516754,0.00012522649,0.00008795513,0.0009891321,0.0041689076,0.1895757],"study_design_scores_gemma":[0.00008016598,0.0001312066,0.0036788585,0.9511943,0.008496108,0.00038960777,0.00046171065,0.00009329457,0.000105504194,0.0005176322,0.034809716,0.000041935502],"about_ca_topic_score_codex":0.0062812734,"about_ca_topic_score_gemma":0.0124637075,"teacher_disagreement_score":0.021560486,"about_ca_system_score_codex":0.004788636,"about_ca_system_score_gemma":0.012257071,"threshold_uncertainty_score":0.11402416},"labels":[],"label_agreement":null},{"id":"W7120615709","doi":"","title":"Sensory and cognitive changes in occupational performance in adults and elderly submitted to neurotoxic chemotherapy","year":2020,"lang":"pt","type":"dissertation","venue":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Normality; Categorical variable; Cognition; Descriptive statistics; Neurotoxicity; Test (biology); Epidemiology; Peripheral neuropathy; Continuous variable","score_opus":0.023189169966795396,"score_gpt":0.28559422707330206,"score_spread":0.2624050571065067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7120615709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99915814,0.00016562158,0.000016324702,0.00001717495,0.0000028461866,0.000008628106,0.000058291924,9.2052437e-7,0.0005720664],"genre_scores_gemma":[0.9996749,0.000104612256,0.000020335092,0.00001461071,0.0000030966512,0.0000037236368,0.000051099887,2.9468853e-7,0.00012738627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972075,0.000051773495,0.000041492764,0.000037849913,0.00007658898,0.00007154111],"domain_scores_gemma":[0.9993333,0.000075838354,0.000283717,0.000028526523,0.00016112853,0.0001173086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042427122,0.00020482244,0.0003205515,0.0005911238,0.00037334106,0.0003952742,0.00015355698,0.00019736898,0.00081167486],"category_scores_gemma":[0.0017286679,0.00010233205,0.0003059282,0.0005062606,0.00025352978,0.0001994123,0.00041158652,0.00022223301,0.00013683319],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014253189,0.00018815824,0.99169946,0.000035847945,0.000031275125,0.00035169054,0.0016331977,0.000038007143,0.00053737033,0.000015293515,0.0000855403,0.0052415133],"study_design_scores_gemma":[0.0000016896682,0.00029218473,0.9982784,0.000008922258,0.00000892024,0.00019923651,0.0009821202,0.000022787977,0.00005172577,0.000010524846,0.00014080154,0.000002635433],"about_ca_topic_score_codex":0.010160877,"about_ca_topic_score_gemma":0.014474636,"teacher_disagreement_score":0.010160877,"about_ca_system_score_codex":0.00032963944,"about_ca_system_score_gemma":0.0003140958,"threshold_uncertainty_score":0.020203412},"labels":[],"label_agreement":null},{"id":"W7120681099","doi":"","title":"Peripheral neuropathy induced by chemotherapy: symptoms and the risk of falling in elderly women with cancer","year":2023,"lang":"pt","type":"dissertation","venue":"Digital Library of Theses and Dissertations  (Universidade de São Paulo)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Peripheral neuropathy; Falling (accident); Elderly people; Cancer; Risk factor","score_opus":0.007411627230751816,"score_gpt":0.24348563191238937,"score_spread":0.23607400468163756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7120681099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99346995,0.0027939128,0.00005889123,0.00034404555,0.00003312774,0.00002352709,0.00047703262,0.000004682025,0.0027949028],"genre_scores_gemma":[0.9977475,0.0011960877,0.00008552288,0.00014440763,0.00003497142,0.000012097261,0.000226675,9.586304e-7,0.0005518106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988544,0.000024901172,0.000017327546,0.000015340436,0.000032470158,0.000024559176],"domain_scores_gemma":[0.99939597,0.000061537175,0.0003360426,0.000010562304,0.00007082817,0.00012500254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019381357,0.0001490707,0.00021422697,0.0005160157,0.00036685597,0.00048643112,0.0001226664,0.00044796124,0.002753199],"category_scores_gemma":[0.0016960317,0.00010565189,0.0002945252,0.00087389833,0.00012544537,0.00030765624,0.0003174646,0.00039493464,0.0002478217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106777865,0.00004554144,0.99555945,0.000033691427,0.000019594565,0.00014208857,0.000066304376,0.000019849414,0.00006886599,0.000010350564,0.00019091008,0.0037365318],"study_design_scores_gemma":[0.0000049168925,0.00016096683,0.99871135,0.000028819552,0.000018566516,0.0004938116,0.00018637964,0.000059210568,0.000011449749,0.000027764461,0.00029426458,0.0000026035536],"about_ca_topic_score_codex":0.0040899822,"about_ca_topic_score_gemma":0.006098889,"teacher_disagreement_score":0.0040899822,"about_ca_system_score_codex":0.0002531781,"about_ca_system_score_gemma":0.0002546097,"threshold_uncertainty_score":0.009210348},"labels":[],"label_agreement":null},{"id":"W7133002764","doi":"","title":"A remotely delivered exercise-based rehabilitation program for patients with persistent chemotherapy-induced peripheral neuropathy (EX-CIPN): A phase I feasibility trial","year":2025,"lang":"","type":"dissertation","venue":"TSpace","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; European Oncology Nursing Society; European Association of Neuro-Oncology; European Society for Medical Oncology; European Organisation for Research and Treatment of Cancer; Cancer Research Society","keywords":"Chemotherapy-induced peripheral neuropathy; Rehabilitation; Peripheral neuropathy; Adverse effect; Randomized controlled trial; Pilot trial","score_opus":0.03387657429575589,"score_gpt":0.3985864567391276,"score_spread":0.3647098824433717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7133002764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824004,0.00069810817,0.0005596472,0.00021504793,0.00006773667,0.014628511,0.00035782886,0.00005201734,0.0010207983],"genre_scores_gemma":[0.96270657,0.0016514224,0.0040684673,0.000631293,0.00021305497,0.028023422,0.0006852519,0.0000134966,0.0020071375],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99941456,0.00031839052,0.00004011836,0.00008000944,0.00004616186,0.00010073662],"domain_scores_gemma":[0.99911934,0.00024923834,0.00018964724,0.00008748087,0.00006976133,0.00028457586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00195797,0.0010976844,0.0010198127,0.00040480553,0.00044044544,0.000629433,0.0009995293,0.0012543979,0.007211283],"category_scores_gemma":[0.0013047756,0.00037028137,0.0009491004,0.00035136205,0.0007723432,0.00067108433,0.0004953733,0.0018765811,0.0007616448],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6737827,0.2350298,0.0025497193,0.0018693001,0.0007127494,0.000109831664,0.00031557953,0.0009786828,0.0083977925,0.00014073617,0.00074066303,0.07537241],"study_design_scores_gemma":[0.4516907,0.54329187,0.00363106,0.000059219652,0.00013613903,0.000030929095,0.000055579058,0.00027224483,0.0004663149,0.0000396908,0.00031837192,0.000007902251],"about_ca_topic_score_codex":0.0007156061,"about_ca_topic_score_gemma":0.001557413,"teacher_disagreement_score":0.007211283,"about_ca_system_score_codex":0.00047213922,"about_ca_system_score_gemma":0.0017722928,"threshold_uncertainty_score":0.024124205},"labels":[],"label_agreement":null},{"id":"W857806473","doi":"10.1158/1538-7445.sabcs14-p1-10-05","title":"Abstract P1-10-05: A cost utility analysis from a Chinese health care perspective of Nab-paclitaxel or docetaxel, both as alternatives to solvent-based paclitaxel in metastatic breast cancer (MBC)","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Docetaxel; Paclitaxel; Medicine; Oncology; Neutropenia; Febrile neutropenia; Internal medicine; Metastatic breast cancer; Chemotherapy; Breast cancer; Cancer","score_opus":0.1695356685572058,"score_gpt":0.5457196015391899,"score_spread":0.37618393298198405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W857806473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9510504,0.015218509,0.011559663,0.0036517559,0.00019935581,0.0015420361,0.007682228,0.00007212597,0.009024054],"genre_scores_gemma":[0.9944364,0.0010688026,0.0017224326,0.00022666364,0.000035851772,0.0004228803,0.0014604927,0.000011737638,0.00061474816],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9939412,0.0047120973,0.00018479377,0.00040079703,0.00037319917,0.0003878543],"domain_scores_gemma":[0.9926642,0.0057318253,0.00050611724,0.00016924072,0.0005411784,0.00038749198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009272213,0.001553784,0.0026319206,0.0036765188,0.00048001713,0.0028839963,0.0017084203,0.0016384957,0.00782103],"category_scores_gemma":[0.015966581,0.00087892724,0.00865595,0.0032463477,0.0008695016,0.0013728654,0.0013885887,0.0020096926,0.00019744181],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019944342,0.0015091262,0.07961498,0.006191351,0.028008094,0.0018865156,0.00030283825,0.8002472,0.0012156437,0.010967526,0.005953287,0.044159148],"study_design_scores_gemma":[0.00640012,0.0065475316,0.07662678,0.0011622463,0.03161241,0.00061909785,0.0009655192,0.8631866,0.00091873447,0.008268489,0.0034108495,0.00028164824],"about_ca_topic_score_codex":0.03947763,"about_ca_topic_score_gemma":0.013571262,"teacher_disagreement_score":0.03947763,"about_ca_system_score_codex":0.009953448,"about_ca_system_score_gemma":0.0077800243,"threshold_uncertainty_score":0.07849574},"labels":[],"label_agreement":null},{"id":"W882957321","doi":"10.6000/1929-2279.2015.04.02.5","title":"The Clinical Efficacy and Safety of Paclitaxel in Adjuvant Therapy of Breast Cancer: A Systematic Review and Meta-Analysis","year":2015,"lang":"en","type":"review","venue":"Journal of cancer research updates","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Paclitaxel; Medicine; Meta-analysis; Breast cancer; Internal medicine; Inclusion and exclusion criteria; Oncology; Randomized controlled trial; Adverse effect; Adjuvant therapy; Cancer; Cochrane Library; Adjuvant; Alternative medicine; Pathology","score_opus":0.39836466501685047,"score_gpt":0.6138328843908791,"score_spread":0.21546821937402866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W882957321","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0049245064,0.9936069,0.0004012452,0.00016091847,0.00012290801,0.0003325204,0.00029387223,0.000016651202,0.00014054283],"genre_scores_gemma":[0.15305445,0.8404834,0.002762754,0.00091565563,0.0003559738,0.001515313,0.00061836233,0.000023159428,0.00027086923],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98801404,0.005361548,0.0040069567,0.00094727834,0.0014001422,0.000269916],"domain_scores_gemma":[0.9816914,0.012399171,0.0038007428,0.0005040796,0.0013488455,0.0002556645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014106409,0.0028424812,0.021074263,0.007915118,0.0007010912,0.002603948,0.0020174512,0.002351495,0.0027034753],"category_scores_gemma":[0.031105364,0.001661985,0.03053184,0.0075368187,0.00081754045,0.0016039349,0.0012254431,0.0015160317,0.00023079767],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019859532,0.000043368374,0.0035501495,0.47997716,0.50334936,0.00013841862,0.00007863745,0.00036288737,0.0002848481,0.000089541936,0.0003554333,0.0097843055],"study_design_scores_gemma":[0.0006185881,0.0002864099,0.0028294101,0.02492119,0.9697337,0.00012132912,0.00003553745,0.00014511516,0.00013329425,0.00010822926,0.001047039,0.000020170035],"about_ca_topic_score_codex":0.0048329453,"about_ca_topic_score_gemma":0.011996138,"teacher_disagreement_score":0.021074263,"about_ca_system_score_codex":0.0025329767,"about_ca_system_score_gemma":0.004286826,"threshold_uncertainty_score":0.07460272},"labels":[],"label_agreement":null},{"id":"W895155927","doi":"","title":"Hierarchical Linear Modeling of Anatomical Change Over Time: Bevacizumab With or Without PDT","year":2008,"lang":"en","type":"article","venue":"Investigative Ophthalmology & Visual Science","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Concordia University; Université de Montréal","funders":"","keywords":"Bevacizumab; Medicine; Ophthalmology; Internal medicine","score_opus":0.10796250007377865,"score_gpt":0.4023168014464516,"score_spread":0.29435430137267293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W895155927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87072605,0.0019484344,0.119929604,0.0014759185,0.00025052344,0.00013759035,0.0030685598,0.0006445228,0.0018187414],"genre_scores_gemma":[0.9867194,0.00022385213,0.008467506,0.000100027544,0.00005046681,0.00010664461,0.001020459,0.000081866514,0.0032297974],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9988336,0.000542,0.000041675707,0.0003145057,0.00007787094,0.0001903247],"domain_scores_gemma":[0.9938328,0.0049705496,0.0004589188,0.00029932428,0.00027488216,0.0001635178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036477768,0.0007792566,0.0014405011,0.0005802117,0.00033075668,0.0008879365,0.0013185549,0.0015218932,0.0029060398],"category_scores_gemma":[0.009331385,0.000611771,0.0021570914,0.00081846566,0.0005026636,0.00069056253,0.00052150554,0.001516075,0.00055348594],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017103745,0.000917381,0.043832157,0.00038745833,0.001847683,0.00029357814,0.0002772311,0.8178214,0.0057922318,0.0021966726,0.0029140133,0.10661643],"study_design_scores_gemma":[0.00019248412,0.0006652762,0.01620131,0.000016029431,0.00059973524,0.00007268339,0.000039471997,0.97925866,0.0009111025,0.0012996267,0.0006970346,0.000046523754],"about_ca_topic_score_codex":0.044200394,"about_ca_topic_score_gemma":0.035967067,"teacher_disagreement_score":0.044200394,"about_ca_system_score_codex":0.00086448464,"about_ca_system_score_gemma":0.0015883475,"threshold_uncertainty_score":0.087886214},"labels":[],"label_agreement":null},{"id":"W951540943","doi":"10.1158/1538-7445.sabcs14-p1-09-29","title":"Abstract P1-09-29: A new model of care for breast cancer survivorship","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Psychosocial; Survivorship curve; Breast cancer; Cancer; Oncology; Disease; Adjuvant therapy; Family medicine; Health care; Adjuvant; Internal medicine; Gynecology; Psychiatry","score_opus":0.33005454113380644,"score_gpt":0.5245493284618102,"score_spread":0.1944947873280038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W951540943","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.061708864,0.0036953515,0.0718423,0.45663372,0.009280494,0.0022231024,0.0015565882,0.0024561626,0.39060336],"genre_scores_gemma":[0.556307,0.008808024,0.20181519,0.09682013,0.0040892037,0.0041147363,0.0018550673,0.0007456818,0.12544496],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959394,0.002387684,0.000121412,0.00035399385,0.00083674316,0.00036069754],"domain_scores_gemma":[0.9941076,0.0010283164,0.00022907849,0.00052160776,0.0008113688,0.003301958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057365773,0.00042596273,0.00030409795,0.0006423554,0.0031338956,0.005292024,0.00255275,0.002223826,0.025826894],"category_scores_gemma":[0.005343636,0.00028322346,0.00088041497,0.0009056403,0.003042188,0.0048855054,0.009175543,0.004891959,0.0051331953],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021346408,0.0018714495,0.010705543,0.0005139375,0.000045639867,0.00068563496,0.006496915,0.0012881766,0.0012310038,0.12320222,0.42678666,0.4269594],"study_design_scores_gemma":[0.0002726775,0.0017168885,0.011963055,0.0010840794,0.000058633617,0.0013331797,0.009655886,0.004776413,0.0007764089,0.07218014,0.89608765,0.000094987685],"about_ca_topic_score_codex":0.010369121,"about_ca_topic_score_gemma":0.024530558,"teacher_disagreement_score":0.025826894,"about_ca_system_score_codex":0.0052489378,"about_ca_system_score_gemma":0.020474436,"threshold_uncertainty_score":0.086399615},"labels":[],"label_agreement":null}]}